From 995d2f54817423808d4f7341291996be203bcb27 Mon Sep 17 00:00:00 2001 From: Anh Nguyet Vu Date: Wed, 25 Oct 2023 15:16:40 -0600 Subject: [PATCH 1/5] Make workflow step name more specific --- .github/workflows/schematic-schema-convert.yml | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/.github/workflows/schematic-schema-convert.yml b/.github/workflows/schematic-schema-convert.yml index a21a6ac..ca794ef 100644 --- a/.github/workflows/schematic-schema-convert.yml +++ b/.github/workflows/schematic-schema-convert.yml @@ -70,7 +70,7 @@ jobs: id: setup-schematic run: pip3 install schematicpy==${{ matrix.schematic-version }} - - name: Test generate + - name: Test generate googlesheets working-directory: tests/generate continue-on-error: true run: ./basic_templates.sh From 86ede531728847cff0c105a101d141df3b2eb0af Mon Sep 17 00:00:00 2001 From: Anh Nguyet Vu Date: Wed, 25 Oct 2023 15:17:34 -0600 Subject: [PATCH 2/5] For test, point to other staging config, add back Excel output option --- tests/generate/basic_templates.sh | 11 +++++++---- 1 file changed, 7 insertions(+), 4 deletions(-) diff --git a/tests/generate/basic_templates.sh b/tests/generate/basic_templates.sh index e592441..10c1e73 100755 --- a/tests/generate/basic_templates.sh +++ b/tests/generate/basic_templates.sh @@ -1,12 +1,15 @@ #!/bin/bash -# Test generate GoogleSheets templates +# Test generate 1) Googleheets or 2) Excel templates +# Generally for 1) this is run in test directory with other tests -CONFIG=https://raw.githubusercontent.com/gf-dcc/data_curator/staging/www/config.json +OUTPUT=${1:-google_sheet} +CONFIG=https://raw.githubusercontent.com/Sage-Bionetworks/data_curator_config/staging/GF/dca-template-config.json TEST_CONFIG=config.json CREDS=creds.json DATA_MODEL_PATH=../../GF.jsonld DATA_MODEL=GF.jsonld LOG_DIR=logs +TEMPLATE_DIR=../../templates SLEEP_THROTTLE=17 # API rate-limiting, need to better figure out dynamically based on # of templates # Setup for creds @@ -45,8 +48,8 @@ mkdir -p $LOG_DIR for i in ${!TEMPLATES[@]} do echo ">>>>>>> Generating ${TEMPLATES[$i]}" - schematic manifest --config config.yml \ - get -dt ${TEMPLATES[$i]} --title ${TEMPLATES[$i]} -s | tee $LOG_DIR/${TEMPLATES[$i]%.*}_log.txt # get -dt ${TEMPLATES[$i]} --title ${TEMPLATES[$i]} --output_csv ../templates/${TEMPLATES[$i]}.csv --output_xlsx ../templates/${TEMPLATES[$i]}.xlsx | tee $LOG_DIR/${TEMPLATES[$i]%.*}_log.txt + [[ $OUTPUT == "google_sheet" ]] && schematic manifest --config config.yml get -dt ${TEMPLATES[$i]} --title ${TEMPLATES[$i]} -s | tee $LOG_DIR/${TEMPLATES[$i]%.*}_log.txt + [[ $OUTPUT == "excel" ]] && schematic manifest --config config.yml get -dt ${TEMPLATES[$i]} --title ${TEMPLATES[$i]} --output_csv $TEMPLATE_DIR/${TEMPLATES[$i]}.csv --output_xlsx $TEMPLATE_DIR/${TEMPLATES[$i]}.xlsx | tee $LOG_DIR/${TEMPLATES[$i]%.*}_log.txt sleep $SLEEP_THROTTLE done From 4ee17285af825bf0f92dd2f5b4de6469649a8d6c Mon Sep 17 00:00:00 2001 From: Anh Nguyet Vu Date: Wed, 25 Oct 2023 16:26:15 -0600 Subject: [PATCH 3/5] Fix stray inheritance --- modules/classes/patient_and_specimen.yaml | 11 ----------- 1 file changed, 11 deletions(-) diff --git a/modules/classes/patient_and_specimen.yaml b/modules/classes/patient_and_specimen.yaml index 3d7ff49..64fc3c1 100644 --- a/modules/classes/patient_and_specimen.yaml +++ b/modules/classes/patient_and_specimen.yaml @@ -271,17 +271,6 @@ classes: - DaystoRecurrence - ProgressionorRecurrenceAnatomicSite - Dead: - is_a: Demographics - annotations: - requiresComponent: '' - required: false - slots: - - YearofDeath - - CauseofDeath - - CauseofDeathSource - - DaystoDeath - ################## # Biospecimen ################# From 161379fd2e0ebae6f18c9a3d76cf5e4efd206c46 Mon Sep 17 00:00:00 2001 From: Anh Nguyet Vu Date: Wed, 25 Oct 2023 16:39:07 -0600 Subject: [PATCH 4/5] Update Excel templates --- templates/CohortCoreTemplate.xlsx | Bin 840267 -> 649470 bytes templates/ImagingLevel2.xlsx | Bin 839644 -> 839644 bytes templates/ImagingLevel2Channels.xlsx | Bin 0 -> 1311237 bytes templates/ScATAC-seqLevel1.xlsx | Bin 643427 -> 943055 bytes templates/ScRNA-seqLevel1.xlsx | Bin 525656 -> 842981 bytes templates/ScRNA-seqLevel2.xlsx | Bin 474640 -> 1065761 bytes templates/ScRNA-seqLevel3.xlsx | Bin 0 -> 1045349 bytes templates/ScRNA-seqLevel4.xlsx | Bin 0 -> 1045358 bytes 8 files changed, 0 insertions(+), 0 deletions(-) create mode 100644 templates/ImagingLevel2Channels.xlsx create mode 100644 templates/ScRNA-seqLevel3.xlsx create mode 100644 templates/ScRNA-seqLevel4.xlsx diff --git a/templates/CohortCoreTemplate.xlsx b/templates/CohortCoreTemplate.xlsx index 7a4f131d9f517c91e485376507906a4b9610446c..fbca476e8e7ae4d37a7c9f1f06dacc3fdbe3726b 100644 GIT binary patch literal 649470 zcmeEv2Ut|+ws!2@u|jMh7Hkx|#x}791P!sHf`HK&W5JF}nV=Y=Bmo6QVM5Uv`;0&|>wMPaAoZZ%(I6s$tpM9Tu&OK+s-rxIvZN2MV>kHd@ z_1k^axN+l;!aU~8{z&70TEV~Gu*~vH*X7F>tysHefW?O8%g)VCS&=ccRrzLR+^3dP zK1%pIfBe+?s|-HhKlqyiy;FxzNf~C-(RM=5X+8TSq=gs!+AhT}Z{jV3O-(XaZun~W zny1Y-DqW@-G-&{T^mLOioRRFU#~3m_>ai3AmRh z`XaL9;X5Bq>VNs?hG*Pj)?D`9@$%OL4{Ul^*Y%h;bZJYA-N7$kHrd_l#NEvHIg(E; zM~;pAq{-5C-L_@~%@4gX>5Hv{>xjcI9Q)k0S?e`pKM$N-$7J@r)t>|g_M9FT)@a?U zoi}>8Dnr^$yEdU+P}5%4owkRaZ{Mr`>{s2)o+tm>@_YIB2@m#IY+bZ0y|v@9pjX>> z|Gw|#m7jXoEtoJh;Ka?jCnpa0t<%v7t41A`e{ZxR?%Mc|r)?0m^}M{#Jnq@SSgW7S z4Q{=B?eS=s;N{<={u)?PG-=oMbCZ`&eYI{?>hmW%h7n2eH(U8AejPbvyU(_;L9xrO zd=xPKx4?bTud`cc{`pxy$Ll@=59KtSTxUsW{C45d)RZBUT}B@MXX^4D-!5pja7l;5 zX(PN_6^0CH_xsU_S4Rx`?Rux!Nyp|L{dz>*37fU-4xopJWXN$6IHr}_30rYQDJl*Sac&)bcy6e(_uJMP5MvnZX10Z2iHd=k#$yQn%Z=+>X89uHU8gEC2Kye=(+)yb%#RM98+&)foOTyYCYo+B^Ze%3 z$GxqRF5DWhwW*O?$0@T#`yAH%V3dADaB_FM^t5J@c_W&JKkapERe`cxc6ek%(+uV2 zt*uHH_ek3?KBV(sA>*?{7c^TJ?A7Dy?TeS)?ES~L^Z2CxGx#n^^Ez)72CuJ-?ol-C zyFb=PMm*c-dht}<6(+ME6~;Wb@3F0<-9LMVUJeQPrQEy8HlG!zU%DC0dm$A6&>^#I z?7pPq=gs~~`=vwn@`TI6yqo)-e63Sm$A7C-ekb1K{{E37 zz}sj0+@X^n&3qhgd|`H{facr3|88ZUuN(Zm_9J7rg7ck~{CWSIb4g>qmF_{fi0D6V8sBIOqK5^J42?Y}cXR$`=zi9$k6&^rhe} zqkca&_k31z@sZ(Wk;69*7ympz?ckuqPSdPUBo7}}8ZXpoEYIY z*kwusug~{-mCxuszU$Gj+6;~udyBsMcwsk%5=~IKmDPII6H_Dt+|9Sn>;!o4+H`wd`?Voet->qKmy+3?qk7mX@ z`|n)aZR7GlpRtopdRqTxeS2HxRnu*ocU~?r+17nhubsn&PU;+#dDVBJ(WFb0y#M-a zZ=;DDGqwzT)5R+2{9|vI7J^q(M-A_5WVQQzhPQW5fB&p2w~B|KK08FvJZIxC{?D#V zeFgt+ilF(iO~3f(T)Fic{@o%$^QG>;_~&0cl)q}>61h>kd!?Tmrw3Z4XC&SpI;QvW zBJVNRd--2a*b$cJ@r8YMJ$|_-f2gX3Gn<#BDOp%<$a)%(L^HhiQ#`Uyn&lkhiP&6D?JL zqR(${|3qiipO`+OAmeJA6fOVN!j#K)BhGo0T9S)Kv3=8m+^{&8Fp+rN3E!nV0BXQnNg`*GXx?dJdUdHoT!~c5ALyx>}*$iFcUdL$p z4PjZq%@u3U%O)&n>(Twi={5~EwLe?r*u7zQ4>hi|^`yd~i?hk*DM^0OU=oJhKS zq+6c*{3EAZd;SnN*Jjq}5swEpe|G0=i_ETvcaAvP-rAe z-S=Wnp9j|C%11RBuI%_aHE~+>^}9}qsqGT#bg_#wix|Ht(f5?;{OG_%pSk6GU--IS z7w;R17l+F-Qcv~0HuPNYe#=hHPdo9~nQj-H$f0bsV9AySbw2v25ez5w`b#mC1IcqE zKa`lEbaP$3bj{a`7Oh=lsro-ER_;$t*_nH9qxrL5&)mLvmbUYSLsr1qFBjCa?%dY8 z^Pp7;Q>LfFyqhfx4$wb5=0*5cU_fv zey$RE@ji+2`2{zLJkC}0GTuo@JavjzMo#7ROZT?vI;Dk?35|LFB%X?gxW ziD%J$V`ZSk<7M9c5KkhGD9a<1a3>&WfM&86(k(>v@^zBabKio;FQuX);}B8Nonfywy=>uGUM9*O`R2_TS0YJDl-LP9u1U%Z z9Tnl0k~hV2Lh)SwChLYGCB#c!>Poyx5{iBly~#?EoqCxhRFo5C(rD$2=`vxy5#cT! zCj9GyRFdjZN~|h15z6}oA|EMH<}V?_ zO7A$CIe8ToNFB>xyLx$CC35z;DwF&Pt1?UBZukdFJWK9ddc6$Eka}IrOcHgACZ4+9 zG=zZ=!C1`}y;**d$a5VdSI8}iJU`_bV`73L+%=j|?h6+wl01+HOQF_5ik!36@yHI|=EUObylyXU#V<&Z2-l?ZZUtCxw zmB@dc;Zfu-%8UfoI7Q2DEEW+jPak)h4Tq<$*lEwSFD$9cl?-a~G=%twF zsk}K`TK-BXQhpP%T~dDYzLWB`F(E%g$exP`xlkDxT)N=$YGO^6GWdFqzw}Sh%#E^$ z;zHZ3e1RlV9zN1v=w>8(K1z|Vlqml`=yh_G<4mutf?~y*tTGAVwy`Xtc=gPUp5>PP z!iBTvi;j*W@&&}AjJ)itDR&)>lsS@Xsm5bciv^M(BT?QSH_51POAQNO^^>Ng9x+_$ zCVHLpvY+r-q@C;I{PY)*@^hk4JO9V|MQ^ecb93&Dyyz}!>?V-B36#BRm!Bq$O-(KE z3VZc@z@sRKV6VJRidRPY^9iBC`=b1nX@1&C;*?j`xirzH_N8vKMe{``Ufl>O$`NKt zipx_)mkP_{UMD@7t^E3tXhczY#@*?}E>XxM^8bH#YlzotCx;LV55nWM-Rq@cc81ZS z2<5!;he=QFY%OpKcYVE7=turPBj0R!-S5IC+1kgxLWf;mSq;W`y!nz?S#GHmdALi6 z1kobJE2oLi7fVGY*+MV*O$kh2;~PSccw?fQ;)^%=M=VR?M0Y$&wYxHFxI%* z@+}wTb$kc!d{FK){;Q|y^rDWrDKk)yciKj}DUCob%lzxM}oobm!84@_v=ZEfK^ST^&8yeNU-4*CjP> zqab+nGWW)HCbjy>a9WSZo%ziGr`H| zT847RsC?sVV|L`XePC4VnI*Ps=ia+?*EfRKMn8`}>pndH*Oc)R-#bR%jsC%XPf7m* zmj`i|d|w(_xF?si8t!PVdNFs!;~k^Qi>(iq_-8I5tV_174M{8sDCpq&m}GHwC_4W_GpI^ah}P_O95RwTZUSf z6kqASu{>+XWf-j-<&NC8&&TY@Gm*}2DW7o4ceT^ek}nE=eK0=KH^b=C=vVH;^IVeS zF8VGJyfoT9`ndb>g7nkA%LU$dw$@MIU^4OaeSy)n6iffi<%D%wiT}b73@i3q^k|&W ztk2FU&qC{bWnuIcr3*3HYxgm?ai%>3O+GnMZ*Sc`OJ-XCIM~{+^NyC!ceEYYwfjJm zL8rU+Tm6|u;&=7^JGQxY=DQi!Pd+bc?bxEsZPafgjc$zz+<7fv|2^-?-a%*khJMyD zbmC9ezONFSbO>m@H=x6ufcBqsH(WS=vsH_2nRCYXU37n~{QESkN0H?|!H)(!+&Ssm zLhH|SK0W-Y&D{3Wy0^I9%_?;Krc9saiQi97{J|`7`~DrxPMcgg^xcHw<0iXKNBSG2 zMwU)0{b@?+Pg8>@+nA1DJ-5-o2Gef;5zui-fWar-y4>#GYvHG#EgbjN!m+b5e{cwB z(Zpy-kDZHK91TkKJS$6!vWs?G7VY*!^ulQaJM6qOBA`#e&RJXkwcc_zvGwx+qfbog z4eZu-VE1OHyDiS#yv(}rcat5XmRg79<{z3U%lB*({bk$eFWZ@N`(ig^^Q&$Jfkj>R z6?Hi@U~kam?=sJ}T-Y=;bf(FW+g;69PZ$wu^?BmAKP3A6mALtMVuy&Xo!X50#=1vR z$7y{c}`H+NteWS){~Bn`zCbk+|2LSTKn%0sMBFblf63{%-Jz$_1K|3HvAi4eQ-$VwDqO8 z7I+fT_R=%t6UYr>xxYbx4=k#BSBfR zD)YX7cZsNTS%b_(*REDx4ayG1zfpRgie5}U963;GY<{n_!0+{F@)^RB1H{*-qD4-} z3+9jyM-G%*`MoZeFYrtvpD7$UAe?)=Kx&xdZUE0xjvOHL$N}MH%X|pJfgj(#`mfqFW2f3#09YV)EfQ9erUs`oeVdCLfN|akR%-`Qvh!X(f1b}!4`EZ5U3m~5F z+3IXa{XDC&@;U!_eS9{gVP3*m`Nn^|x}FVboM$yozV{!m-e*Ia<|T}iNBrZ}|7=L} zJgf2Y2mg2tKO53AFJZjA>>saB&xW+>Quh6`#KjY=#`G9b+~?K~|7}W`6&?V^9P;4^ zMMkZJBFgffof-LXT=<^D!uK2&z6IpNapALrh0hKazP9AUb>Vvh5N~oi9%4^E93j2~ z5Z{5>_9yvpoNWik%sn1*Qt8wQX3QzBGv)})m?JP_wvi9l8RH2vrbfc#1u)GaAC54+ z1ejg|On;FNSD0W?41q;)u>m|>7exguiV9d1&yWwtMKK#7&IXA0k`Gsi;TS5ESl&xA zBOi`4kvwIV!A$&$d^pa;B$$awFcSxn57(JUF1GrD*eT60$It*Ct`HXk#KqC}5;6I3 zgg6)=4hD#~k`G6Squ^*Gfm5cX8ToL8I13=o0*GD6ha<$60I?-N+>CsLJ{%#=0f=(|;_KwY6=GPZonWD!Z2%9~S^NfO@f(=M zr^$!oEWQu3SZ@&L0mNUD4@Zby0b*BxxD)wsg;)*{yE`41+LI4Qh*JRK6oB|D`EZ0d z4Q89K6-*(k83J)28nYnm1}s-_Y9&dfuJZ{oL)TFGA;!n6zcEP2gZ#zq2-r zpLbh6?fd;Bd$jiJJSw#HjTOsE6Z20Rb=X(Z>(a)B#~&UZ*yqBA{xhw^;%)v2`|O*r zL;p^STD!C1k|5J1yA77?`uq08hoP-LakK7b@W}@2?z>Zy^LL~=jUG6(z;5l!MEj^I zi>9q8a{eR0#&6dQ+aLe6u{s*K>3NS9w|h^yZDxME?}0GCvy)6#=LbwMTU{9NnOWqi z)b8#VH!WQDB;?uC9jCVMyB_-J$(0!tkzoTiiC?niw&@&8fsI<2#o4322xIO2R z^}cr9vRh92vs)v+Cj8xH=l2s^8r}YW(XjLG3&Uso|8P^;Hg(j%S?&nn z(@5ZzD&XI620pKQWaL~$fdlzW3gi6q{2h+wN;eDg3B{21qyaI~5FXLAqlkfu2thW&JssG=h8rZ4fh6 zZ*b?9z#?O=EVUpXEL+?S33ohOqWp*`JX_M@i8MT03Z94x@N97_lDOg75-F2L;@RS; zC~!nC4*G$6y*$wf)|N(w@SxY0Eq=rnJX@~B6Iak|As#=02fMb2Ru;j7U0Z|~W$<9v z7GnnmJlL&7V4;KuyEy0v?nuvt{;(4rA|LclbSs{?g=fpNC&V*6ThMNr2$>Ln zZV7Qvz=K^|>@1Y)nHmi0xV^?0^K%7plH zONgTa9xPjuER^tI*|OM>Sd3@O89(9-o-GgJi3j+_K|gR`@XyWqrbx7ke6Z&h$we7F z*mH}Mg908bTP!V<@L<_uXh<01+2ZF%_~F?SA5X;N+4AHG@dUp(=m+i;tCCIUWRgqd zgJz4P!U?~&gj*=#!LntxAu$`zmScXzF+5xD#uIn(Y8RERQAA!I5Q;)yFFq4KbXOgKCquiu5Wouoti?(lbRP)q=7$@A3cw2i+%#5FHmY?( z0LZHlo5kur5ZV>M&v_w$YdQcNdW~zH5CE9~5Szv7J`mbXfS>b10N2bFIC%J@gaEnd zfq0F>wROFl{4(!F$N5ox1Di~JIjUc&B;d17#^zbST6LaaA3W<%Ur&$IDNl%$c;W(F zh5nimwAyd$(P@8}-Gjs&GP9*JHN-UUw#k9pJ)^<`hP!R(X|}2`pr_fG+>F3f143${ zlt8>-(c#~M=9x|2HEq!;GBE}+ODc16hAs(i`8>$tx%t*VBjWnGY}?{%=2GNh9Flup zMyxL)^57;ksD0R@1ulOC_4OkYQy`_MGAHKjq{y|_N7hbq?bGA$F7un%b{@5`iJw3& zTX=zdX~GpQfP0Vj&N65=J#5CD<77q$0*xGv} zzYO$*7q>Ko2l4BKUXkWXCkyfk9XNgJb#sHmHb+m}li5U&j#HV)wC}8~?^>JSSG&hO zd6d3O{O6VNyTvlGzuo$I3W)>xAcss8A%iFI`s9gyF4*ts8+LsGnMnkxIF(6E%WqqB zx!uR{_PnOs*7(kjZPQ3FC-zC)m@yBQ7ZIz;r`N8%+o!EK)qkeVu6Qz!2r{rLQB>K6XZ*nFdQChX}H- zD$|#i1g?J`@cHwdY16FtkG$Mw_wWsgZ48V{imt8jBZA2X%TT=lo!v{mW}bq$C?m+Q zFK)aO;t7BBR|_qaA~eb1rHKqQ)c$^iF?wdfOT(yP`JM5ENIR&o}&@K{I42r@K|!#XLR2ti{FFHPXL+ciZ5nQx0b28WQN zhCRr_OB49xWcCxNc#A#M=>_W1V;+PPWkftdq`?hDc*%3%bk6sOgkJJha)`zgw=x1x z$@XzSONU&rgLt;_=rJ82p3U*{0)Kp+PJdjg+aHG!Ga!g(Mc3>VQ@CG2LQ;Bx5a4eV z@&gC~oUfanQW!Bp^h!obFx>B(1$h7$VdW2l@5=oeqD;mA@g%#F47lyCEF#j;)7;mO z5TK{I&_N->pQ_WJ5OL^fE-)mF(JMNjT{MURUoe9TjS+>$OG1bM&-6;z!uwr?p<7 zRxFgjNe#j(PI#>0q=pYfK`aR$4uY4K;O8|2(C{%Z2xH+xj_}et1pXj)hY!E$1?thl z2L-h-IIRk+NMK&$gBuW^z=s%I4atx`GNJ=7twUTzFFFJq&DQZD`PvYY*Pr%sFeEn# z#FyF@oL1?BLSBd9s&-*@2+*9O&B=H?egTJ#2Oi`>m=DQw70+R_bwwZk^#U|(m!%NN zsBOV%l?u)45S&vqusQ@pG9b%>sAa+Fx9K>%4#7FC1*=2I7D|Y0!jK@`MINV#XC>Dr zWAd01bc!o`rQzesAYt6s?T_mgQO_v>8GtyH073m>+*7zjD?kPygqu7_Lk8zWsuE9~ zWDtpNGKd@gk3(R?9|9Y-EjX9;2}UWed(Qp4&HpgBRJV{Hpg>oG~bR_YLNG`r7d$#XJOsCeSU z+aXwcSKPf$3&FhN&nL-q^`G#52oBpVXioC;WQx2FLNcEv&)!s~S_kzKl2;uP^a3<& zmr{si@JaF<=H*)-9`A?XU=@W(Mgc@J_#}C*MpMY_=lu|@ZNV9Vp5;k|rIILB$`%s0 z@&fl_%ufDXGTh58JFWkzUqs8Eb=KNCzMenDw84NONnd_LG+T1E=+-o&O@EH{S+^v< zCm5%}Jq#A&gDMMg$;&EX_h8!O9dk$0PrHzGPG`P#PCHeJd`Fql`IlXv?*#ucxTe86 zZ3otAa34f#8UUUzqO%civJEC}#B)dw^2WCw>|WwrbIAQLTaeWWPLpo=;!3xCg}(D>Mi5t` zL2&}TKn*w35Wu=35{$&UA|oA#b%pr=hjm5JABlB^`2dG?h4}!7b;w)u0diVb=sUP+ ztrw`_W|{*x(~3G4IHFY4vB05KQO5!|WEFKRa1^bmV}av|<=cWKxOwUHHbRG+9H8#N zgWP!Z0yNxAOJVP*2w>o7QepGQ(WJuWkE2P2%^yb-&`8LfLL5z`Z<9xnGvclAZ8*i9aD%}+K)fHkIj%2W$z@iX}gBo61<=?{1tP0%}$8UIP z{9;5FKqCEHxJj)SsA0P#m$C{|4-RWs6JTazv92)n;IOVR_296EmnPHEaVv_txEKy= zScCD)sM^1Uo7Q@P8q5P41*>paR|qsXtc7olB1o(&3RdB;uF&FeOSq__U=?%IIM{Z^8pU)ii~s|*21?%kdRnc1pRSXSC|iQSc~2k zK|(I!75WZtTI&UBBRHB73gQVND)6@}F-{$`_b6iE$}j2^S5DF)t_+e#m8v$JB|Wnz8p?!t7>0x`fbTyUWcHu;QeoP2+*A1q!v=k zg41u)Gk6_>CZk2Wyol5x;G`A~DMWlop1N|nR&5eOVE8DQUPAJ3EfabHTCq?Hw*fvR zPhBlu>zuB6A^Eq51ib(a+a>7sPPHsJ{dT+LbqLPeB~pig?UG!|YFltxRk{h5BUN!R zTwsIOA!z!2R8Q0c%}JwR6)uQX1B26=1*?!jEMAA8N$jqEl7&cyJ2XkDWx?sUhZJ6i z;2g=o>JXqg!O^U?1*hL0&3GMx^U(~cL%4gK77{NBKZ1x7j(H$jD_?jRA>fo`=oD8L zx@wlx;T+Vi(pi9W(sO}MN#dZAS5jtrwQr*5h6932Hq?W)Z$#d4Nz)r^d zA-J8?HiG8FC&|-T@ZR@Ik=_^H4?)wJv%13z+S$G9_K1+u-?jC`<$OT+4jyElBp;He zDSxZgodx-{WFLnQ3p8|pl^T$hgz)K|Qa($bx`FHahSS=oy+B|CnhNkq^4zS&uwB9$ z`v1EhLK$p6a?<*lDVryxgbgoCi{I*!o_+0;(CIc; zBBmSIuPh8|H0x1r#tugVvc0TGWu$8Q+~w5ZnUl`NS8rIo$tLpE&NS$@J+0~A2TsRq z-g0D=_{mqs{<){gPQt3Dyu)T%3;e>4+WcWYw0h&`=?}x8<1}>Jp0+YSsDVM}QCZ&Y zheZlcOM=Nhma3MJ5l6>uvNxMDbK3G#)%!0WyloK`dI8#P2W?(+#7zA7aUa3)iw_dI zN19c3|D4kPcHDv`f9(9muX?-dS3&EaLxXT=x7}|4$VJ`_8rf}hj=wp^=)oegkEN>n z=ZZf9j0|k2@0u}hS@ovVN6y+>J~xN9)nShx^=W1{e8cs6{Z^C|C0dX#t?K@{divH^ zV*8)}2z|JqdUNv8VUC+7xkB^kJ`J)zpW}Sx%5)?9RcHLI*3WqtTkIR^8-II7&$|Yl zsx>En-Y4%iGzf=Y-F=3;U9a1$<-y{Z?fX1OoxV|7*yPa+lhJ0o5BEKKKDl~xa=RtL z^KZ|Cj@j>HEm7w*l4fD;Pq%EVU`*6PGp6xNlAuNbUF z>cm$R*6M&03hT+gVXG zQTvurG*RcyplAYV31lC7+kzeL0)@3YjUI({WjP-1h-}K@E3-b#vZ@*-%(l)}p{*4X0DMOdyYl zm9;2PSi_MVf2xL;ej8>(VXaR0MNMnC4Zx@&Z*G+l)ej1_GSSP)fGnVazYbK^qCjB{ z=jyj&1!i8uOGD;tAm(rh^IBbt0);gk>0#8cSgX^0QCL@|`(mcGUZ93Btq_i8{%`BT zBg3@nS`?^xt*%9Z!n!iu7jrbLtVMysy0YvD25X@{Lh^6Jw0eOWj%EcgulbNXXZfY( zh2-_9zQEDU4dfR-B+pf8BWhkq{;krc7pRqq(I64lvhcJ@4d!(Su7WJwJWw~L@*SRV z{D-qF{tONWO8h~X*CDv34AeXwBBi@rDI{Er2#G{!1m=N_q5ofv`{UU<{c(|Qf4o4aKkgK4b@d5hoC=zNgnM$1Tn7~e?g9yL z7vMwkobLiPFC_o=E}$2v;V!Td!nA7h0P2p4*1VAX+c2$OpoXJa5**F=kUZz388S;=k0JTDM>D-Z4M#I~ zK1-fAL7$hCC~L}#v3BI8J)txwZo^$b2LdoHV{6G zsg~&w>qQI6<3FD!&(XYCSxXd^nNrLA5G9FTiV&zJWJ(Z3QoHaz0Gxx<1xyr_6eOqO2k1-m1q50~W&g=eJUUzA|oVq#nI@Rq|Z(rSg z_2$)`S1+Zmd&BdMN}A?&Np79o!G62Zxa-}1I5_Tlce8w1S!2FGS#MxWA z&aPk5_|l?)V|9;hS<%+Mlf9w6adNBVkCWRacTR4T+%ef8d60Otc(!vv%ug|Y$4q+A-z8l{?whl(x4 zW5g!n0pdR5PsBaNL&WCd#m?@|;W266UAzx?hdnb1HH&@LCv;Tolb=HT3kzPiF24Ch zv|i-najx;|iO&AN%xf6YS3Kg`Q15fz>%3okxA6Yady4l>Z*%Vx-pjp5*GsAA-k_vq zZsXkMW)lS_i&}qXXOh+0z)j)dL!9&vaP3H(k$2BL_E|u`y6*K;2PV$+zB~3pljALp zH#;s^)_7U-Wlfj0T-Ib+i)GDnJ0u$=_Y=E0TRAUw?z5?JAHV*an)dM*U(CqvuDAqW zxbf{58tM3ja=_5EScTzsoiH2~Ykc3*RJi%=|7I5J#;pzI3yQnTRR259LZI8o>-n|h zMDl6Z&MCW=H~Dt@nyCyI*4R_e?;Il|}b4Neto?iXzTP$@pKfdL)xX#d6)8yv!ocrb0 zOK~2V`|SboFWr15{NC4R#>WLRv-EWX%Dm$<8yN)7wwP!UJ5cd7vAwvBr2X;lhKLRB zUD=fUQ74zS%f2%gw=eNtF7C2E=5zZmT94~Cqy4zPKe&19F1)ly5urI`=aBy|GE_Kbo4fzdCY^?FPrm zUe2l)*k!xJPuyJc$?68j|8#9|%%#Qgt?R@_Lt{QmuD{Qv*|M#k&YhO|b`iHVnBf!9 zc;?oCrWsvAdS13L6^d0aa6K$>qWyQ$&JlHIJ-M*?uDId7*b(-EPR`wzZN4dPa6Wd7 zxW)OnmdQ<;^&MyJ^T#;rtwld2wV7`iXlzfuz{ad;ncd9dTz_(?)30dWm2d3pEp_Q~ z+_#0e_0TI{CD)zjVw~JC#idcMPlNU*J;u#6360&5VAVu&((js~L7=4$BOkkE8Cr69-TwdL0b?e>f!>mqzyGwS$dB}0^bK;iw;upnZiMlnm= z@m|ba`$jn~^_KZe5qCHrGb_2#dF_mcQG?gVat=lfULS+{;wItx1Kqf%BHF@K3aFpL zqu$By+A#cN_xN%^*;PF1u4d%xqf!4cJ`-LajryrQ@cL-fVbtLD(TgmM8oWMss_PB( zpu%j}A-2V5_QI1!@#li#ws_pU7N}kTJ9NTRd&n2SE>t0~LoC3v#?H(XUI4vD!>Gdx zpeGEBI=ldyvwDNwMwSBy3)o(CSmeE6gVJGhmB7J5hyBe7XrsdxV`*jzFMy^E982H@ z(6oV3hZjK821XrT0DG{|8|<*Xdct`Wb~qgtY6+}1I&6?qpp6cDlq=9iht&qQICudx zZD4PP7eLbnMjc)NO&b_>9S#S2gWbQ4GQz@C1gp&z{3a!|pRB}PV^jxPV>9vv(5sEW zAP`;vO`Ar3*Wd-vwAm7$2`_-A4U9Ux0QO7?qh1CtfIXY&4R)(01l)clKpP#-Hcmhr z9abAl1M&sXv@!I%1}}i7jbD5wya1Xu@e7LK1<zzblHw0eX65JWfq zt_jUd2_04&V}n4E4zv-dUI0xS-}p>;0W@vm78Jt^plJg~T6h60ZD7!`InVv+{u5;NbaFpnXVroy-yAukvpFp zhrhW;Yn2f?B2aM7ryxF47#R#eUS7jJWJ;Xu>0xO~JcuIyF$cIttKoLBs^&(!RmVgD z#4>bPxItqu)?wl1MGnNm?cc`B(U6oVoOBrZS{ZCtsY@_wyu!j&)w7X77zHE>KG=?t zQ+b62A!GMWPXZadrbfF}GB_`CV6|Yq!5&n2AGEO=8tqo?ZxUYQK&&>Zq#3=zZX=U} zHdaHU-KwM;DKBzhbFK6RJKSE^IFcGejf{5lB1g>>IY1kW0&T2@M!Qu>cD%@ejaKUo zcF@KkW+JMg(QZ{jFfVc-Vr8nciQZt3@^Ru-3SOlsgfh-Uot^#3AI1m!^1?g7<-N&!PbL59FvKvs`(Vg12H|!_9ar2Cq`^ zRt#*o8SlX1RSMpUfpvs4IdF(Gi=@NP_nX(|(8Zb> zTBS6zRNKbix2y*h7Jz6=pZzVbw4J~IdzIy#KKt9V(sr)h@(wxoblKlyDsAW5E$y=eP?*l?2gBA^V$&HVlDLCfYD$e>2gBKIxy4HuUjuM%vIP{WGo> z`huNRy#S_>r>_^l^z97UY)qtsi1-NI1laQ0beM+Uw|Gs#-J=MZ=fI) zLvbD&)K%wGL)wZ={~hS8{5?#hVUSRma5JV?&X|UdK{;chEWN*nku~)G9!B8ki~BWe(8pC7 zX+vMxh>m}&y2?gOtA*ZRKjb3;`OTF+uF6CkxRptDpbdSA8%EmD zm$+f14Sn`EBW>v8s*JRO)dpUGD!qe=HZbaRm5rEI3%$WUHC716aRF_K8^+a!zQhe9 zZRktfFw%y;#0?W|7?S>(Xd{BvhNiL+6K#YLt)@u^W1@{QePtu2)k1Hu_fD6>MXIJo zyGcVMFLI#ICVGQCs89-Vj~W{7Rv8)zSZ!!Z+%T;+BKo9%rqzZQIjB-k={6ZQnRrYi zUn_&{s`Bf+!a|W!MRTg!V3{6HL_!&|kq3J!k|0)}O;P`ymUcP^`B&)})U#P3j6UA5(ivDmc)luhRQPYZM%VCrD&Um$;&w!@IujU5Z*%aqt zI@?182x3T7mHg;=Q*#v-8(9Wp%MK>e=q=jKrez21k`3`A0eulOCf4vG2SN}9ZEPdd zzN?|pZk4QP$BP^k>70zKg}z`1ZS0Z-sWH^ZXt%0*055VNRvR{zjc86~s!hfTt!;re z=441}3^g*^t*RctiySphU^{t4tf6)W{VFU$g$a;|Qae-n|8tS!J7V#T=vC&k&-eW3^XC^v z97!?TJkfmUxjn?EV-BvWv%UZ9uED|cW8d`;*KQ*Zfe06+X~5I@T?=pRHgei{`j~f3 z>nUvHw59>$cTMXlY~-}20l~7$ruFaJ$a|-U!{viEdz|+7%(cTCy=!_;QGI|edmQdv z4Alo{`{I^(ziWE0z4`!cJY62cL>t<`Dl=^?=}ZI6w4sfsGt)+Ium=^E!g@%XJ~Ut=(8kl5Y2!*~8epakWS7AUP~>wm(}p&l&b(Ua4R#w@HslJ> zWsft{hBkYgnKrc9~Ut=(3%FAX+s-NXI?Gz1v`uD2J^_% zUN;!Ooz^|gOgh-3V3$L$7IX<+%=3-*y1~qN*dXEcDY~OFbB@k3&pg>-)Tr;6|0U?m zu{~zgVT;jakAOuUwh8U&(=1S@>$b*>I_z)o`e@YYVtdS}!>Cc0Dq%()Mh#w{B8`uE zs>7*<($w}}g3dxZW8NWXH5BIAN?Q$!ap=en)bIjW%F_CSm{~(x1dSOu30)C1<_Y6O z*ZG{8v$Troe+fGa>5Q2+v>FOCZRo0DF|TycfttDnHZyH#{XxvM5z+aBm}w)V>wL~k z8`>gh%(S6ZO#egJp(a!gVc~a;_-Szy;ta&HwKw`>_yA)j8G!*ka4EY(Ffa#7QW-EN{{v#I?yY13J89qpUtIFDw& z3eXl*XTHPnDn(f0MEmcgog?bbdU9d&U2(&Eu_NpS%u^k-9VzZS$*UA_dj*+9y99G(%5fw>;&XrbY~6m+$Tn8Pp-O#qpMqHhPYxCK!h zWH5rcHW9B3ZaqozdQ#T|aKOZ?0dNAoPm{k7l>K=g`n;biu|-?U2#9ttItcaJ*8; zVKQ!ONqsM9H0#PY_Vt#!bUE(JWZc%0`d(V^nDdb1-si+E@5M10x3vV7<=!*J9q+}= zwQrQ;!sPeYlKNgA)7QSmQfKqyTV6Bz{k5dNdpWm1{@oC>y z0EOFu^#@Q0A*}gFC4{i1zf^nGC)Tr%peX#scJj+8dXTgHfZpl;+6@mZf3I42wNwCN zO#tnN2ew}im7BCk39QlAZg^nLe(i<_*3fHjbHJMVU|7)NbK$b*Xz{sx7}$dfbF}v6 z;4<=BGUK>>yB7aG2hwTr?{k42Qpe%-tDIuF4E+0dPA-ghdOtIc3+J>HZQwB3wFDYI z4Cs{F85h!M5mC6{rp4jIVdxZE96lThcldAtF64cO50?pJ_kLdwE}Ye3 z?D{aUQ`RBlLK`g(A1<`f;_%@@oAol;_&$}uv2PhTxg@E4jC8PykCcm6K&pi_;8_(^nLA&3vFEA*Uq@mMvHdF zg*I@Zg%>~{4zxIYJ`C)Xb;vl-M(I4D3{)J=L|!hm(W0Gkp^fl;hYuIpXsJWSg*IC1 zka3}nmO5lyRvRta85i1Uark@?*r5)YyVfq&oM;294V1~z^yqM*jRa^@t;Q-B+Gwd# z!-Y0ls?>0yjh5m>Txg@EI1v}xXemy_g*NY}{eKwPp=Vj7g()AZM{iR2P(2y6C3}a1 zR#2s;6&KpPUz~^wZS)4aRTBw>jQCi+hQEr-G7X0+I2WQ%^R-f-Dd?$CN^UGDCXABW zC>MiRutr0(X1z-ZwYO$qJ?Rt_y(L)hG}$`JBosZw*?)j;L3*?F5M5P<`PzGkvt2c1 z1=`z-us&%N==1^5tpwe%OM{pz`cgX zyH#npyvTvsuJi~xTr5aUl8?1(rekuskMa_WW_wbW+aqkRj)r8Yn~$|y#12$EO>8f2 zBVm2Gg!?Ejv1k@iV|l7N1TJP(sJpsPh2`&6l|E}}tetFG2A#{vUNhKOIgGlZT1|B> zw`sUaS8tupaW0u!VzH5VLO<2_TitLu9`GUuFLJP7CpYvHSBiV=PSDB|T9Z(jMYAc&NIiRxaB>UfkPH}FJA}PP8hq>vyB7m%q z)ufw3r{C-P_oH?E`w=?+9$HW6^!<^#{oc!o1YWtgv`w@@+stleajri()ah5ma^d1d z3f>2TJ!#;zDPE-51D=A7*nv0Xofw=qDqf`czvTl_h>}mcI^5W`yveuI-=une-t0`{ zdx!7+{L(lvVUWeAt)Di{EWT~4*v-L-t>IW0BfA-J!=-_jEjuT+>h7TtPB&J3m6#>2 zE9uG3fNvvP2X_x~<&u!QMcO=~^Q^}geAs*7HI@X=!hI&eaZNdWyM{SS;58_7wY|5r z4SV}Ph%oB1~j<^j*UOk3b!Q>1qo+26YV!JO=f5%~dg|Yoyg- zP}fMS!=U~y%z&Bd8es;^RM!{i?((!jR^?NsTI7~C{mDwv_uaH$|DOA1%;0;+r_ z1Zy;vGsJAwP|h$DMngHna2Dp9S}^^vu)n9AVQ8b_Qo+zh!=-|ujfP7FK^skT5`s1w z${B_>!guB*3~e;bNf_E_2&Nwv_V<)C3~e+d6bx-NTq+paXt-1`w0UPv!q7(Y&YXmy zjfOc1LmLfq5{5P!g6W5a{XOLjLmLg33WhcsE)@iAG+Zhe+K7NQ6=4+&Z8VfK3~e;( zh+$|0-XM4Zl}?YLjfP%h(N_tiUa za~{8{1*tGISVM^5Ja|pR4qt_S-3TXhz|?_M3ANpG+p@)4c%yH-=9-KzbK7dgmmF3f77H`w3nz|C=c zR=M@{7VTCg-S8p@>0!leGI|p^-s`}PxyI-#+C7H6y=pc~L2OdI$noJt4(Pz0O*k3^ z5?wS(LUEop)k{Kg1z)kzJl%aj8ELh!G%axO;mrK-ss)KS?>5y-LUH~8@LELeQIK8( z!$3ESSk3{*(yBGBI3pmcR+NkL2e|8qfJ7$*-g8@UMi5-+dW&|e_Ir)?3!Lc-DTlns zfjuVTVFzstXk%AHqur|81ut@7X`?sTr^b?n$ZBe|TgQ}sUgXe|$k99fKI}4lu$_Cb zy?X6Egc__jJA+;omP0;LSm^j*J2LzQ(Qa2A^4|1iXHX>!=?io)Ge%pG8TIO7ST!oz zUA+bxChQ0!uM2B)g2uwynbOaT9FxIHqOz=Gf);p@1GF)?y*inhicY<4 zip4o-1iQ1|qTMRm@JT3`q<6eTebQ1k5=+xxENyMux^_6JF)S$FJ?AA+CQyGb=%OeJS>vEtufb6TibR|=aISJ z9uWW1&1b^zeSKzpTp&|TD-97yUH?|AaeIuo%leql?Z0R}uG@_E{(#xu7DG|lJ| z(i5s>YluMh-$^@1)SdO@!sff;hWBDe*b6#2cVD*orntfR*rCad&d0S(ZqlspIBTCj z##wJI`l+;ySGjc2fHG;3S-NPwdHTrUZiX%$yw+qkwcjRX`vJ0ys&)a+=!I0Z3vm2~ zq&8j@9i&-*07Y{O*8Hg^rKrm$&AalAeZ8eFU5@*<5VszB<*Ven^ISUR)=P0|lxh6vM+B5mcS=*s;W&kY3KOb^^Ev)rH3hYFcwkF_ zYMuqe6x8r6aHeln&jM%iR8?_yrw_9_`Ry(lmz7sb6KyUluZD_)S$Q>7oDU1TjqD{@ zT{JukT&EpL8x79_hBog!3mDpjyz?wzXrmF%$IwQ@v%q=Dhg4h*s|toT8Y&KkHu{1c z+BIIXAQRWsMQ$)7uTkU%@$DK#ZZM>?e3y5Rfn6i-9x>lEqQV%)gMtLFU!{IE>rK9@ z6o8oQdILSEP=0BT$Gajo7}Oy^Cau;xj>{gQk#~oF_G0X$aP6xY97Q6_%RnoorZN zM&LXNYb3ltm9Ftz&XXEC{fC9UcRK0u(Fo^bXrmF%$IwQjFcV^>(=5z{q0KuL2SXcJ ztJGE%%sLBugt{;jW~qZ^T9++GZ?FdyCc)W2!?S>)jYeT61Z^}6Ga+ar0uL;_fM#zB zmI0)sHgJ0tzEg29w9yFXV`!sMm7vtQLBM-9}alw^t3%0){pkg_$t4fz<|H z081OmyTVKu+GvFHF|^T8aWJ&eu&Q8aqoLwpRttT>4!2jgs-6V|Z3tLxpfVJeHllZh znJ}~wnvwBx^x1}2DKz_LeK3`R;8hA4uTts}y7!FlKkyy;r65b>V8YG3N`bz;DtVOx zdp6-!icD;*j8`epXOr6MrBJ?++*nX7$(R#MUFo?G8R1R~wagQg5(VZ+46c z2h`4BJL#C?eIN+Jzt`*-kpNXYgY7DpcJ20o5FzFx6HYnI+5OSQFzJ^w{U-JQBxz6t zvDIT#dfm)lx49Jld$&s)4Rq1!2Xr-#TF6tm4`egF4n>7MLUm{tCJ!*?e3 zUS7Kkqg5Hi@B*rq#I(7nD*t`6cP93>LfZ{aWI+%zhno4iPWtbY8@w~IZ-edI(p1DY zg_-o<=WedFU(5bXYLmu3g<0jlUw@^tc7ex}#Z3yTRNJS$v8nv`k_LSEKpVEXtQ53io6AZ;8@9ng3fizuVb)F?3Ck2_3fizu zVWyxB+Z1LB+OQ1{QmhtwgB?zNPNaPn&M&GGLbRtoijik~>ZAB}jhc|O`@eS5f$qu5 z{YwEm+q@d>^NsbXPdno+S-O8IILFrgt9`QT4Rkp5!9vH@2&x@*wx>P{)Y%$ADNtu? z1l5i@+q@bI)Y+c;C{SnV{-v1eU@L>yXAWjlOm%&Me#nQ&S9Nh_ zDp3p_TOB|Qc!< zQf*~_Lt9Mx5WJS}S6&QOX$VObogHXH@Y=x7R;d?4cT$SDyoO$H*ER$aRZ|S&!5KCp zh?dn_;c2Prt#PoTw+3xcOdI(_RIRr~C1&uC*_chArlO4k1av|tJ9say=-|!uJ|$bH z;|G-LhybAz0$?*+I6trP$cA%gQTOELcHf&2WQP761$3@F}uTR*ajZdl}+2DXx!48Vm#*$^h4vN(V zZo}{bsy5QJdOZbg*k(Xe(1vZD77E(HT^wEjdrX8;FM}7rZZZK^wMpS}0ZR|uF|4;g@wtm{yyQS#umUr#|PV)EIJe$6tA!_IqKd&PeL0X zxV?&MXtZ0EJ;93{*xRe#V4o8k&Z`tXd6j}!DU5lQg3)G05dh*<3Uv0A9j{U_HcFz1 z8}cdzI)KEh6zFg>uTr4JEncO-UJs+uDjnc7;&tE6+VfP0W_(0z)2N@`QRYSc8v zSBY8Tx{{v9wKh^G(>1{Vp57gLz;{#ifUjOP>dCP27QXFe<}O;h$g8ex-~u=P^^aC< zR3A{iYE(N(ht;1Pk8y2s%z4Oh?{ngo_u?8RH{RzwXqop3aSPSn02X)|*#^Eb*#=%w zt!h-5>}J3Xmj+(8_F5aslUozi4~Vt;y|2%Nj|*f~t43{h@ZtD-RUH_$ZD6cLEa&lq zURLUWd{;x4K3;<|SKE6_+sx9|LR~dep?*MN>pz;Bw7v>nCCvuj0e)hxgLm1&RP7e& z34SN8EtWc)AK&s?TxV#kX>#*<&i$5cQJo~Ae!v*$ z{@z2?{XP7hTcimT7v;*F`|sQ$^&=YF7VR?$j%%veEp9q1uA_ak9Ou!?zWq_$WN4g0 za?=!N)rJ3;Za)5B%xt`^e_D~MD2LiD^1)%RS~Utu8?|i!NgH)Q9!Z;us!>SVgg}Ul zbc-Nqqt;=Nv{Ac7khD>|MUb>nyG1@Y>{Y5pAx9px2uRKgcR+r-`re2mol`~q03__{ z`T@9sSJw|fGG3k1h~%6)r4cvT)%62DIOx68!=Wgn+9!h~joK%J!>zKPF>dH8eKI)8 zs(ms@)&S#G_9!H9KstDV%d3$SMlC!dIjc9=tMq+Gj=XC{-*@D~^aL}j5O5r>T0}r1+KLSY_wd9IiC)LI< z+|Vi1#xNXZD;s#@SOa!E@&&NK!KkZ@VaN#svqj|xL~>SdutW7b*k0Az8V2A2=Q1e)=y&-9% zu6~E4joKK7q)mn7ilmLCqWT?@HtOnkNZP2Y-yvzEHijWr3%$W^BP)PdnYuO-k~Zqv zNI2RMu-cFfypgmKRk%fvv{47-k+e~l#6r?W?G{1OMyCRU=h#q>bV@nqllXa=)PfkO`I>VQe^^`>G$>K<4SthQL zT9KoUA5g7@H|HRGfsP+Q=!!t8jtGc!(rKVV&qY2|ufvs=S7;DtT&U0k3Qq_hs<%My zTD(Goh&&$hae_z+AFIb4G(b^>m@Pzo(Xqc;DbT?7ddY%}l&eZwAy4;Ce5f9~P6Fv* zzV{2pUFvG8LSxlL0`rxR)g$K{FVNU>j$%N4Sx-kYQvSAv8|UAv8iw(qdi3sEI~5w( zUL!0j8`U7EyO0mnW4G7Zsn9^~JKSC+e5f8v8(yJ7-Cl{4@48p;p?a>_%t~INL1d52 zg1S(02_YI#M*IZp-s0dk-7uFaS;pMh`wNPNk->%M_8=}}q)wsJ@7I~9FC9=u>KtGu&j{ys{_-$&~5dtRi_o1cK}YFkTfB)mwW zH$Q>OeN;PbB)mxRwhJXMQgAX$zUw{CJqp5$6ngU$sJ2&Lq(Fx~c|!p*>8@6~NN^$r zA(&V49~d6Q7PbxT?~90-^ij2QTAf6^-NA>pN2F(^@p=Ln?q`7EUS*h9ClODyh^6h3IYwOJ*B{pn z3J&yD6&!$@jyf{g&CrFmL8NhVMZJRm5$wQB$P)mepH&xYijh}mw&1>9?LrM>YEP=2 zbdVYXug_fNjRJPH3l%r;Y8NV!@#@SLBQa^^t0<TFw=YoF?P(5J?VV24oq1(2js`vs7=sr>@D zp{uls;3!)uLf}}VwuvBTtEj>zf?OumHWB2(Kwq$LuuS(SBF&%!x7ule`Tpuo3$Dk5 z>P`#VuAtgBNvCRg{@+PEN7SA5yT`RHL^dy1 zEG}i!16|wsPF~e%!5M+-P77`bR24ChGuRkXK}lOFhQW{$C}7z_n_|~t+d^9#eZftv z7BP?ux7uleT)5S>uy6}Ej5@o{>Dq5}LdXDy7htaYt!3hB)WYHpdsPvG`|lSw0ovHH zY)(Nz8+B162vr z7j=x0XP@&ah|eT_8c};Lui>5mB7sU)mZrpmDDoe3fP40fqFOyC&N(0<)#^EMO@JZh zS1m}zS?2+#i2Hyt(&=GoT7XDmDb*1HLMH?u5oHzlxNB&%TNSMq@FE9eD`oBZOL~JH zv@x<_NDYm4tM+?d>;RtT5Uni}m^*<^T;V>L1sp*Pr}12^RT)XtQCUgXf1$N?R=`CvOuMzs>T2eIdQ3WbA#!x|LR4>?!C7Xh z*7t)W0yeS?jk-j*v^Tv)yHzG_V+cFe5+?_dwA(Xd?#X4gAML+gkiTZ`o{8e$&n35e zX`Gla$l}x1Pn%{I-?oL;=~b=R?ED(?n4wy&*et>Ibnc|pfzQ&fG3H(0c(ntcla!(5 z_bPIP06EAe)(k0D#>ow}I{59_`85RZTBlcW@UxUM8lAtQ)xposuK`)W+8zAt{2C?R z%e6cB+4(gnX~WL1K}j2S3fBJ~c1}_T6>Tip`8B9$!_u!oMH_Zf1|@CS`86nM!_Kck zNgH;44Jz8O^lMPjhNYD8zlXhQtup!~WU7&8nG{L&?Z8?1e8#kYD$=nlJ3$3I%d!(x z1J5oKmXh)8;xts8gHdBsYlLdDv#T}ozX#pFjhB-l*@IfD1M2Lq?3AdpD?34jIv7>p z^_gHZVMjl=O%^G05F0+-LHH&h>uoJ7PIIB0L%9oflx}?s5@ie&L%AV8dS6qu~V@A z_pnF#IB_yuX#D^Vh70ZJaWGtHr7j1>$rGV~OItKZ9m4ba)DDCGw_GO{8 z{GL}SRLwWgS%17r!Pq;4YQqoVy%ZL>)NBRsr9fM7@ZoAzH8BXfI_Z$a#Cs{Q*8>=J zHr2qiTn|*iay;z3O2MlXv^{I7QV{S48eXN~Rf>qlbZzjca&GVj8eXN~RSI6EplZr4 z7oE@Tl(2r$ytWFu;GY!?)f3YM+=D7Tj#vRtoDgi{$Y!;s)nq zwL9k7^sF~dt~<{~yJH?w_Q~$)wC66tGVc@bJLXx3WgDH3nML7vXW<#htvAoPABE$c zg=e6|+g#k9!tu@`8ZVDANN)PRtmq*wrPaq7NirLx2fhpVr+-$zCu^u&8%IHF-8TlA{LE2K0u>B9oMoH_!u& zMZF8{sH?;$y@4K7m;f)&LcpOR4cR*!x~KP}yE)O|#>QqsGjwd+MKqK(hL9>#r8Al> zOTg?dqMNNO+(mQ~hDFbMI?n11b{pACa3`@4aOh~mq8Jt(ZCDh;qM=O)3*C-}Hg?Q4 z(CBEx!d*m18x}Rt=xD>D1{&RJp)c5BdtC?3qgWKfqM?lh+6lu_j}0WiI?pKJ(9j0< zS9k&1QYUn@VWHd6(T0U?M@JhL?jkzcu&9AXw_4~6cE|>ewjc}CkhNN{w2=aBbchAG zGDmgkXak`HcmedOjzxtWI@++PkV8is7KM@MXu~4+oNl$y7wnJ?>R=csWKki9X06tfx7f=neKmJ|buyRa2wg zs<pF z;yOcPO_Q6`trmKN-9`reK}n4P!tH2DRbSC=RkoxPFLEFc2YQ1Yv@uWEq-toiTXmi0 zMGo|8p)c4$8;gK??lm;pt%{!UA_r}O9jZ(GWj(?U!8=G*lRy-QsSN;C1b`Pgz*B%- zZEC5L*sT9^{By+Q|u8W-(W4IS^~z;3U4gWbJ} zgjXpb)lf$(g3dvHUZvnwion^(Km?nz4Kx`@kf#bkAaumHhWbEwl>&|$;03`RHH;x{ z__J~Jpfw0oDM9qMmc7d0nI)OFkB$I%O2ZZ0ak`|@BCwF%yf(efaV z`AVw^o^9?s)$dhmf&}2D&wclF9z<=TXATRG5qF?A(KF}18z(oXHqkTZz6+LpM{S~K z&V6q*G)}9DUZp)U=Dz3tKla`QKC0?!8|NaIpb&`yDqt!aL@uFd#afhUsY(qf#v%lW zBtelXp{Y=%>>)&rz1Tw-ID4^&aKYG$J%pIG zABTL2!VcRjY8Dbv4;>g_F@kqZ0vauA#Ci$9zxjIiao@zu@!p=VPh}$ zxI|&cI^+qzysb%%@ZIhE=7pfMuj&fJZfjB_{P2)x;qgUcN+IHHOZh^~**g;n7ds?* zczn?X`w|5`B~S_7DYh~fA!zIwAYt6>y}X2<&TC8j2_b8*ZW5x#UgjbUoV}NqaKYHB zn}nEkEbOqoPJVQty|s}LHueQ^A#B{XUH?MZ*o!@cu(9Vsgs`y}dkA4;>u4p0jqUtz zakhZlD?9-85=9StWkPk8ci*Vfq3eqis>gu0(u7;aw_aLyNB^}mmIT&h-oAR~22ZQ~ zMNLbZugK&F&xP_d;v+XW1w|zA(sr7Y46AfuQ%Ekm>%T| z6h!+1D8Y#!0ytMGegwQxy#S1*1u1u;ZEchvL1dSy^qe}JE!;V)mGy=T`FI#jeJAg6p6Xy90 zRjcO?1r{dC`bp5N%JahZ3RN873dj{GRjMcFNn2kg;r8l}QHCbf=Ys83mFlUmal`fs zT!Em!MF<;L{bXp6Qv`(DE37zGtIxVNcfyetY4iLoh7?_wcKPwlyR&D!=!p|=ueMVJ zgg1d0C1|ilWWw94D%F$oBy6wZX)D4!>5Wl_Ce`PL?NycPsj#7!>UG(yJ33D`T=nZ2Q19@T;aWQe3RAh=QMdctL5rB6Ft}W-f>^aW&BMx_;io5 zvAxb092yW9K5zly_rOy`^?MLZMD=?ZUa?_$u=v}gX+1jcxi@XDze8c8Azy8p^{J=n ze&5g1;@fB5m_3W1cdEBX`TN4?exIA6efa7zl?mJ1UUfvCrU{LV^7mj0MgRL1Nnz_Q zB(63ql0sk{$~&ehl0uOb1lZ`xQaU%KND8O)1W0!w;f=PZ?Fa>4w$WkZ7&oOz3Oh-m zkV{r768YvOMN-%fj}X@0l#GPZpsYxW%wFd~&_J!CD3XFA*Ha{gLxKX$9JhX|NEAuI zm624rOWw`tP`YGX+>Bp;KmGe(t#97;>}&haB<|ULTk_9aA8m2u^uPAC-M{nMk_PRw zt`f<%d3uS&TKY^R+ve#d;%h6aBH1?Q{YskE79<6-ZJtc#MB}kp9alfs($l*4PPW=# zZz1H#WX_q|*4b)(v2T?9?}gR)svX1AnjOz-oSpZ8NbS$lOH4QW_wv>LJQAj_2L&6R zUIGalo?Ze88;)KA3mcAJ0tp))33JKA4!%*%go_(*gg5fj@kBC6$htTp86;{FIoc>> z;Nm&jDCC0SjqpZdmZy!nv8xl5fw187xq@5-bHk@%TSlDm~ zS0rq_990++HW>h$tX@;TwmNqsVFM>&cz{Te3lcUw!WEe<91Hv6ib^=j^Zcxku;K7e zSlDppdSGG05y>E716v$(W<3%%aI|1*qmZzH-5nkvl7B+NhG%1j%odJ?Jtc4q?0GnT zR!G?J{H&0$adSj6NZ7bIA{iuXcs6E8*zmMbNZ9af%#g6**_a`-g;QY%d!DIa&jX5g zsFz33mRQ(uGy_Q3csZH@By4!DPDt4Bq#{VzD3&5ZQfD7_#ZoAif&iN+$*HMv?x25k zuk-#>-OJpQdX)89W|6&PHraq^I0R;|m>*@0JnAC9$dn560wPl?Ov-kHT4LnD>h)7K zZ>v7-!jzGy2pkj4;KpQaZ?rtmmZ*51#T76llxNXwpF8zM02i~2D2~W6T5Q+t*g3x3 z$fF8;HKs2&@~{x23`?pn5sG)QTJ2t10rw(~$Oe-z1S7nWs8J*bg%B0?|7OTqae=n35Va^s1H$`$#kM;#IN^*!*Wk}dKR_)feS4DC}h!K(5 z!ZDJgOIbN&n^>)OYh61$kqz=}033rhHH4aN;Ao*p4(Tq%#TCWCjm2oS`-kRgMRG(K zZDQ&^PKI4Lx&nCzR3rzPQmvmPhj?@aa+3-{wqcF%Mi%7IV z6iY!_u8O5lI*@S7Oym&{>PJK!h>)c?50mEG9~cjl=D%E=oBzq{rQK)UTlnVf$6O2M zk4c}=>BBaAzW&=XvoEGVhR!LlC8ptI=$ryuym@*WTZXPTDX=hTS%g#w?pisDrSl1g7)Mi_l*lwiwu?tcOnY zyR&7eSkSSLALy{NWvJK>&yk^G5f5Jt9^YDyMq`fM8G~KyZ0&I!1ied{9|&7^EgcOS zwyhC1Zk#dD*iXlyP_U47vvnd^)OeXX5p>|#IuZ1OVe3TDm~|}di!1!V+_7zq(6C|K z8lhpswl%`ShC`uXVdG{}C}`NQDHJqp*lt#6*sygX=xpIs*uNMMs0t+cu9)+#GKp z6n6Oov{A?bN2x?;(8`QpaL|c6p6Lx#2VoakrJ!NM?jlCRhHaICh7Ef*1sXQ&0orKT zz%daXz}nY`g-rpoix>@?K}@R@G;G*bDRmHbkyQ#BHf*aDG;G*i#Aw*Ctx~YC@v^N_ zu&~Jh*hKQhXxQ{*TBV?21EoKB0P>BP-8^0gVHa7Ypkd=wwOeloRU`+wfaMs;Au#$x zFWCB7Y}dpdiea(zKV$M_m$Cvl%*SfATT@#ol7qaxIu>@3(I@s`Q$LICdKaEzSmeuY zsXi|hJz}-mt&17ivm3D25Jhs3^CX?*=u+l|?KMWL-F@}#RgoN|BEN%S-@2^gxMC^t z6icC43dK@T%gu_Vpm#timcru9jjmoPmLkH?9bIl#EQQ7EM6nbTJ=gc%abL-0|1b9B zE0!XEFVwIUOA+{JVYker+-_+tF$HUZ3>C|$0wd{+BtWqgKqpfGuUHDUxevBh?ov{W zisPPw9oC#nVa6KTg3=p*R+-x z)qO^|UPJO7iW97Q4e1xC3ZD#7_2nJEOn$CSphuQIg4=$4eAF+nJzVY}{Q?%fhI9nn zmI>gpAPi0pp8!6+V#N*1idqDhdRh!AvbR2nn1(F*d;QL8Qanh1zi`C^VFjBN53(OG zT=5`{{&2;^iP`=u3Ofw>a#P+Tp6if~8S%A>2WjMl3tgmF4zRc;3aM_xZXKvX`SNhz zhH8i2_&|AglWhb6bSB#fO4v=EtdtLLvW*}h-c%!^V9w+fLRjpkPS&~&dW6J>0veOV zhY~jvc}Dnj=4r?T$mW_PJ_OXbY9&6Dz!lU=d?*WMP_4v=f?1Qqr*6X@VO2)>^8Q-a zD$2W?Y$FJuGucK^!fq-TP(HlLHiCe7lWhbAb0)74%3?Qlves$PSLJy@K?}PhsH^lj z&=k;^#7&gAnZ!+$PiNA!5g;2hvBd<`fTZj^Jb-TLNC=!s(?(e^usIu=HVS4P3wx^1 z59d)>GLWsvXEKw68wEBdaT5hLCQTa!Hm3346xh^G#-P9kzPd3Pg8~~!(;%uNXA8%| z9zmW_U}G}0qQJ&92busIv&4r08+R>vMuCm1mOP`t#^hs0*v9PBE z%Ar;kqt$Nf9B2w`OtwxG*qCgcD6laJT_~_I**a0Og;QZKPYRxKFWYs*y?cFL=pZ=z zXgXZ!_qPntmJYsmZPK)!okIt=<(2O`vNGQzoAIopDWqSZGThTh8h%l~!1Sn!{N2k6 z!bg}(M<6sZd;+-amK7+Eisy-#GeB9vj#ayLg`;U2vh2sROhcAMzalx}Yg+Rp*L|0= z18~k$#dc66Q`VbeSYR5mhmUlUJW}?Lb3fWnGf<1kYWFZ7tQSRcQ1hf?VFzvuMr_7vwOjACQY42az?IB4 zW8$0)d#cX`+*qtuyY<_vA~`exF6A)pSlA6^ zd6Y$dceF1Mt(e0Vts2GR3MHL;EVC;l_xp(16_UT#iwVuzYEu-*EmVr+pk7Mhs~fW` zD7OpX7+g^_T++jy>RSiJ2vuw+p3h@c&Y)MIoC-P=??C!g5Tn&@{nIIugPJED3;U`( zt;JXs+ll3`7?m?P%CO8&sD|O%|L?T)hq4d$U;FhxHeR;pmJ5S#KJ$~=nGcQKa6bs> z=XCvY`zxNKw+8+*rTDhs(LHTE30|gxy053>q#X~YJ=D5ir@?Ldb$wy-G;4kD+T008 zTBObMGv&jHC9V2o-rW6-<~Ou{tHlj%KIrp>i2V)0{-~y z=Q?_>YCAY@LGwrEENF4KqkiKyH8GnlNg@UO%{CUbDv7(iYrkLRz18nmb56aa-?&}1 zP0Zbka$ZVr*zME^mVp061jO4H|zN;6aMKwbrpZ}l_5L|xz!7wMP5UT*ZDugY@+k78=y zrYsm!`!*$Rrpl(|g0U8~36SLsV~(_0;N(eDL7T8zISxSBJn60N+NWUFv9PE5+;HwQ zwQo~kV`|@~z{b?RO@WQ6eVdSMs!bj>1lX7g+LS!&2G~SS*^BhY;cTy_u6;_ja4hT* z%5B1z_tz@7DerE&>JUI@Qf^bi4owp9_|~~1=yQ#!nT&vVlX9Dqs!UfM%3?Pux9c?M z+w%OO$-@R#`^}b6(vi1VLP-P9Wicd@{RF{@;aUah2v}$gX#j-M!+984`~{+Y0e?6T zBmV*x9!B~FENT(S2t-&yN&a3xXPGRaq!Ao$2_^gX7PW*de8bfel+2k}OC(5#9*);0 zB0+lX!a2!ABv8&tCjO{y!@juU7>F%Q4mlLqu!mq{kLPBG913h|9danJDX1-{Q(!Zw z)**)i8{5sCVDVbU{1;36U98@(HhXNZv zz~-?ZB>a?Y1GfXiFoXgdIH1D=kYQu;iJ`#8)Iv>xjmam5k}aGHJ8&6=$(>cLom_P_ z`NU9QV``x$z{czoL)c^-3w!@K&5aDQG;B2FFK?3I65bs)D8@__MRLq|(G%CZsBKA$ z(oA-_Iz~wj*j}f?>~vLYw+weh*X|U>LO4~y_PQmxa|rynpx96Ny|sCqaw?0}TDx8` zQWT42vLuFLf$bGaMsS>l137tnb*kQNZS5hPsuang88T5WLFAz4XqHf+$`BYb`A>Bz z3!Qkl-w|j@lg?LeDANxgSUsjPVSC%FD8C0wqNsikRraWUpAp^fHJT!tzhCo|>d`s0 zerjAse%$!h(${cp@I*Af4@LR+`$6o{c9CZ4wQkpCh0P_ajuDPflE2rRuN*6OTOFYY z7ee#c3&N$y1qT(dq@o^F66+_&(WR^yv=*^i?AA23isK+x9UTk%;tI`&EJlmnKg>dg zYy(9cYPNw2j^a4NW_;f6v5v;#G83$d(CL4F%)nhCofnfC?IaH^-@Iwj!=hnN2sZH z4G0uKrT=3}pIr5O;lrV&394h^b0efrN7lI!vW4DYbV`7Txe?MNPt-3kHA*pw_o5af zRJ3&E;k32g2Q>KnU*&IIzw4&ue>(QZ&qMwC{`q$ePyg@xKYr#nYtK*ZHRYI?$ipX;eP7vb0dP5pmj)u=T+hr54!sQ(OL<8L137#Dr^Y0kVnD zS8csvTjMy0$M!>VFo*4jWG{Bdg1)$-YWs3@#|As<*i$4Y>ey2xC+hELk5A5X*ft$b z)Uh2K?5M-p8&tLSLJ!VT$DSfNOC6ft;qmS74*%_-!_;@!A+X{m4rs8%A17{DaTEK~ znWw%>9xU{O0kpxw1CS2}SWO!{a0PHMs2LO~JUVjHet+5`P@nV8u-w*kCnnY}mjShvIuVuz{lmO4G*4Hn6+H1CU{Z)wFT4 zg=1k)2^@oK3|8F4h7FqUWy8h|*#;hfdb)5S{o^>WN$jqP>d4s!>mSF-Hdwxw0~;*g z%gGi_g%+(De@41|{)fZ&GfgofZc+Scwk@Hds3?4s5XW7Y8<2i4O-hSQj-8 zY_O~+8#a!GeSKa=X!3}G)tXbQYs<2Vl>-*$dt}e#!KZtcP3?8Q_|MuP?Q$E%2rGIA z^x504sTv`&b%MChgM~dm$UNFD3Y{3{s~mOuV;jo?#>%PQx(xp2;Fx0VUo+XJsf~r7 zXkWlv{=*FN^))ldr6VvQ$_V(UYV?BpTz3ehVkzeOI}|n=^3|qUpL!zwFB$kzEQMkz z2w4N_)v#@#TG!d2gIYvJ6t_afQrLApur?bg`O>K=#ZutJ#H>>S)Snbf0VDf_V#LU^ zwPGn0OJUoQ7zrD_eSuC+DV9R96t?aGoGec#rxZ(}SPE@GD5Y*lC#Mukp;!uHYbBkW zQY?jHDX5J%=vgljWe3GlD3*fCY0}B5_1f$T#ZoAiLa`KZt3){~MPzQJrO?G3N=qS{ zrO4to6-$9IzvNUhl$L^8c~n{oA~&V96!uoNoYktd6jYI=(o)bxno3JCo|x*CmVz$n zc0@}NDqcGMaLL;2`x~r$_`s*5JMVmT|9=+zDfIK}{LeJlb!%n6?4Db%R8!xNV7vA& z!PIv@IM8C-w>)z4ATYBUDQXn~WZu|^9KfPbcE z*}Bk{?wvz@{+tvnh5-l1D3dLsHa&VeO4Fm_i>62RQUTT{bVoaYx@x#4^C-}Lk-o5L zhh!x!7tDsx)FLA>YLRAo3vjKa(M!b%)!U*p?(#=z+@%e-pud3fqaAe`I?U|3^LSk) zS8Jx#QFoh%hI^E&5$BMGZ5?MHbI^JL25d(^)sS+j^yGf8Zez#Q0M zyT3WG!IslGu)$gru@481g}r~A8(fh6$nI~}v3yVP_jPnS)%drjs09%Dixsiq&ejHl0zC9Awxy7IyFp*o=2IW*-mW zSO+Hr^1EX@@z}XaF)X%vMD~dkZDsx64*EzRh%JVJB~&!SEpnqR@*j?}$X^gujU0;n zo1-l9S4LUncLPBLesD0sx_sA>l{ThajB7>kzc<{1#`Ab#1UUT#v=IWy=n(>(t3~}R zwrhJmc7y=uY!97v;4Ng|NXxm4W82;tu-)ol&=*(ihDH>abb@lTVyA6Qor4;+!rm^? zqgL3T&V`i+u{VuGs2^cQt#D8i502`Jiw;Yf>` zzra4yIu>@|#$c1Gr!D=8|M$#p>TpV=Vj-4KXQa1=iRZgclH+NSg~E--4(-PCjgEN`nEiGb@{u?gXPa?gDaLI z23Ig(7mT*ZzdOnzzbmR5c>!GFqZD(LM=9nArT;LUS~q60n@-I*9|kI;*ur;vH2htPch{YV z#_eyKKYZ-?>c;1v`JhP`U;51SkigkvC~IcOVOlJ}J5jmTP zR{M*ZmNZ|Hd0Y0(HJ+A+JS@=skvR*RAO1ljX&pzpCJjn+-@V@;Xx#1??GrRS|sAFMI z^<}{2!zip0VPh0liLfyWt3=os-Qz^q81-}-Y@nR2iw20Wfn2B$wk5*GsHYRNg=1mw zQdSNXGNXH(2pgk&oCq7Edz=UxqkEhPo0@t$5jJq~(g)iTVUtrc*p>(zqn=L87LJ8| zam8_H%&R%S5WhUEIQ{%We0SsgLIa&~ej$b(mODKDx^&`tGde_Qh=;ERkH2+15pzac z5N)wL7W7n~mgtOP0Ws?DXx*gbqXn#1SnuSh8x;mHgKNQMwb&|KbOYz*p*2phuh0lb3+amA@hD%w%7e(3 z-K;!_bObCsh;#(3JcwKbpfT^gWUYByA1*;m{E0Q);}ir#wK~40dz_f~4T~J&3N|cq zh>6<}4G|k0E!_{s@a>ORdu`16CrWH`U@?-lgmSH0G&dJMmDc7#8`%_^LcD(WzoP@fM^Q z7WvyJ++GWlJG*OyBJ#fvbHgIWO_3bkmeFpnu}X3PHwL%YSgm&Jw^v1SP^;CBg?&|C z2yU-2TJ8R!vr~~A)Z43LVIS%9hI>L$HreX;qAc#^2!LtD(_mVWseANLX-dbc-Fk1fA~~qXM90Dow+k?( zs;4deisW#JSs&8A~_sVasW35OngrLZ0T1dhi1)0?yshk9I3u_(Achu z?efKTU8fnNat8fq;Z)H3$7zX9727HIc&K{94&jeMIfH%$b1LX?dz}C#{BU~(O#$`x zsz?ru_~=6D;JfoXlx`Rux8T>`Px*cCc02D~^L6KAt_A(t{4OIk?Y1kfzq|a-6EjwN zK(l@ih|UKaqI08d|K4QZt-+&v+ISMY9KC$AA2jRzI)UiCt06i!+V(rO6Pv*HInlUJ z=FOm4zd;k7w=qWE8*TdwZQQ;)o}1axbCq>4B^XZWZTo)%(fM3|hr&ifzS_jr%UA7a zRT5_!X$m*oEy-H@wBElh|9hQ3bJz55KMbPvqMVn~8+JQ2f~~iop4sd~9%$Zg>i5VE zuNtCtqqKPocomf0(SPlXC4n_;y?x&r&3giP6+CQs6&U^7SKG{kEzL?SY1k(VtPbXZ zSHYWxSAo&C|Gdq}vXh>87Ho`)HW4;P+ddICM%z9OHjafodU8M(;)Lok zP)wgdiM&;U* z$QcWqJ;!M3qh&rQEb0n+3jU$J%eZn9GhdBu0`a8L6KVUz+3SrfCo%JRG}nhIUlWfx zP6gdUozXyJP-n!rCD!PJh@UPVIbC975%Yv-=!1y+rJ)ZZZdryth_+zRLq!<54u-*8 zq|WL(?BUcI5jF(?8_f-i2%AAQCTPS=XPBT7VPlw}5n+QJp*^XDc^}0N72&`J?xXMk z_I~f|`>4T~)_K^&sWT#MV3YA;rb}?L4di*)V(n+{arP*~1dRwA*y7*;hT6I^a$sYa zpwV_n^iUBtY~ZWoCa1HnMex;i6SO)HdpLDQ%rDf0tiYjlqjVN*YA?RxFbTVs(!giS_w z+;j=f*~D;0B4!K6!oIk|4`N1DYp33X6vbli^&Pp%qy(me!+VWwB5}dOu?|iM_TyAJ zr9MS+5K~obk{r);15cB_(heMmHE{ScH`4WU*U6*(WNFgIaZTD(pawO#zN1MvL8H z6F-P`1jTXGJ;wpm*k%}o9HYfQUB*N>NPhbzUn` z_v~Cw5MRxYQc2*BR!LwPJRz+luv$7vi%Be&PSRo$tEH2yn8a%7B+W8eMt?}YK-e5c zV&+pM#{gRQR7Sm2k)-+(;bNim1k~!63yPjl?5Ca(6YD3%(xt2zE*5p8C%E9sK6uC4 zum7>}vK_ZvXnXAUn}%JMKRo||UZI)O?mFD)>a4XtPwu%b@8aP0a1lJNd%S8#?~+yw z5j?Vce0t`^!R-sQ$?Gj@Ca)tat9@$+xBp6;ygsL9@;W3mO!s(V?cnw>5j$)o@BmxK z+wd^)wS(KkMC{0ddb5o?C$U8AIMKj~#-*8kSR!_uXyDw;$gnT2sD#EmT=zKZ_hH6M zV%C=n8(jA|7dE)=aUN{o-h?Tr^I!uvFWq>F2pgnmfCn2~L7fX5$HJZxmGv9>uf^AL|bGV?Hp>kHy7cE^I=rA$k7 zxM~3}>X0iio)f&N<2)z0QOA{tcu|K$1&?oABH~3IS0ds@9oK`)Tk4P{;ql2!-Kn5U zac4ZxAcZ2lxZ(6c+$@RX&Ulc$I6|9tFhJ^qc&pWo(+BYuj0>j^;$arao&ER2F2$Yk zV1pBiaAAYf2XSG8;2b&ON8*PL(@lfW*ac4Z(xN1gd6R#mi3pO5XaFpqPKkQqVRU8XF z+ICT>BhnL!xoljP!3KgVI5YS`&`KbQ5cVfnhbKaq@posSEtQzy*Tg1Ky+Ea9w1j|% zU`D_lZ3IBA5!DNLqly4@=B2k=l!&WsG9w6nw(&TN9On1Km$Z2+7-x~ghA&*Ja27e- z#EokoXJQwx8epznZ8`+5q|Mv!9Si%aJQu)b5Y8fp2ODJjI1e_sk~SAMIEx%EY;YDi zT-e}L16)|@v?k1YPVjkRwPHvksMvh%7H+O)oS+u zZIek=v1+tSjSKdi;c?( z<2(s26>xiX#b~u#*Oe)fgL(~dEbPFI!R<9xtKItkrbrGuT^S?W=$d!O!k+4L!|gRj ztKHM|+p8iusJBn3Pl@%$|xh?wu}%L=uH?A0N0B5Vz=6@yH+6k_LYIoQOZLwFbB00k5(&;*K$HESV?%-MhwYU1%(yvGkhr*uf^TX|; zp0@NWk^?pVfp<2clN?>j4nPNnDz?iP+ry?<(^`}rlQTHVu&m0{5}hixQ||Fl^^8$D zgMI~bD(G-~ElloQPh0vG$+29Ml2C82bdm$OF}S^Y>t{><|KCZD!=d$~{XgB)#DZJorTG?oVxabMN{1BZseT_m}1qnv9?FO;UE=1Dq;zXz9RFs?3rsgP6ataDW)ju`bHq`4!LwepBm@B;2+)Vyx+z(O85kU!?s0m@drSN zC4|65xJHRzz@CN>zW~BDN(i88d)Fv2ei5!w!sUZ-jS{Zjpgj>JdV$3iyKNN*qTlP~ zF|p!62mpJGaf!zcbQxm5FT1dd9V_fUyp3ap9pc4Jw6>TNH__THcAFB&0r2Y$l6SywnI&USYl%rxItoNmED37E30fVD^^xr z!mux{(8|eTLn&L>h$S|*umL4DJOIz5&JH%f`H7}b+rb7BrN~Fj4mOahM5Ln~Y+#Ro z2jJPX*uqBaBW4R5$HJZx025?w2sB*G$k|3Lv9X1X*hkC`HhzH3W4)&ES|aUWlOy&K zvx5!X#o+6B3&X*<}mI!j5Sau>11$v)HcdWE8`~anlk2zA~Y@+PiPm zY471-zR-!`zR8@CEMnO0ws$lVZjuPGgy0>(&1&n?ifzk-V=5E2w_7wh*~gfyAbx=Z zQNDn8oi^4ZbZ}c<`K}`?nFGj$Nh=5gxNR(%#2dZe-jYdp$_YJctCtZb?Ep+5kKzTo zl+BOfYPa6ZnW_6aQL8X6v8|F2{fguOmSrd*abX-Q?7ln{uri`3CB$g49nnuI%y;%< z^wYzRajX#LoqAhr*N=#bVd1z#3jmKAmLmAQezbS2+O3mQO36X(tsdl*k^?g= z#ddpjtlF*DpF~QI6QP6e=5#1sGA?e$ufOj_HU&Gr{HwGmVM`F-~%8XwPUY$IZaws&{{=GgahGtYV&+6eds zCF!ai&z3ac3;6X^F6g_To_Tln3>yi(pzpq~=lb3P75n0fVmNvU8nA7CZ&#a4Op9-C z<31p2z>Z&S3ma&A=Xru)U?V6=V_+lbyT`yr(07l4jiB!y0~^P}o)V}8CPUDGje(7z zB#nU$zX2Nq8!x}_9s?Ue-#rF4f|4`_HiEu;3~U5__n2(qRM>&Z*qp4jG=Y$poaY72 zIf!=`$e%Hw6Le%@!Y;TkAl92e{)|C4>PqR|97w@=_OA17Vgrh)|gFq}FbhVYtil`&1f=67 z4LgjsIAA+~+x7+Q25{R&&yI$$g{}<^VH-fZ0o-=z4cO2SwlTD!A#4GhYa^DheE}P> zglz1_K*GO&J3lLE}6EHeS9v5C%3Ge0LxWY6wnk)L8w6~mO@uRQ`W1drc^8iOJHPk7*{OCBB-}B4W%&W8pTpDI{t00 zA&R9?ECoyUZ37!SX_R=m0!vY;Sc*8sQYe-}(DRR3f`XoZ@e&N^EzE-H4K_y=y#SN$^2PAQf`u@s7>@ZLGT$?ErWn!KIWa`l{v z9t63iv=rnbkkV3+m0Mn=r63e-^_!5=Qc&fB(0~z52Zhp7Ftpb;H&Fd5K^M>{mO`-< z_omJDcPMN$px$0t5}Fd2G@p2Kgd+V|azfNUTKC`sK1?E932Q0ie zoT0qgkeyGZH6EMQ(MCQU+{|_zN=(B%!?dLpobebJc63c^IX1J$>e)8RdCm;%%EoVJ z-oAR~22U#+-9K+U2Kog!<1x@Lz!{H$j{s*phRf4pNYQm^mmjxN|8vG;RLy+EbKU+O z!_%7CSRe4lW5lnn$*^JpKW`i|`tJwBJ%%(C{rVtzh?It+zdqYP2pxR3Sw9+kpbUld z3Xg9-!=j-NiU-CSHaD})>bbXj+V03>9nbvpmQgx$bg2yKuN?c$Y7u( zK3#6)L=_pxx*{j4$e<<>I@c{`V={q@kCaErEEopyD1%uB@mM!u=iNSJzC7a~D)a6P zCAS3VKniVDa?6CBq2!kN@R2=IGKh!cyH&|8gE@whTVk;@~m<((flxy9DojXxQ1~v>~m<((p zg<(>#iKJX*U;|s6b!@y0Y~W~NwXc(b4eajl0AYGU8Q3uF>ttZV&;!;@*tru`Bw)j^ zuakidgL0LDjVn?ZCIcIWFiZwE4Es76*f8wtWMIRfTxDRxn5a@GVdqX%k%A3m8zBFv zl>=`ittZVu&rD|Xrlvk*lIF_FkiX~Yi)7-aI1cK`z92?94z8?B1~!fryY<#>#c`O`h%(v2 zF^+>PE0Z~uIach}ns$I|q!z}bb9>%%mcgWxC*~Y12 zcR>>L*eQ-9Ojah7Ega)GxaM~{cA&;4KdMm-)&UMO zo0Mb4ZrwdzaU5aReKN3dD(saBxflGSd!2XB9}^c^KQ_)!r6~OQdo_w+YOg8BI(09~ zc`3bNw^L|-%$+_UFmhn^`l)g7uj$h+>)PB2M_Q!K^JBkYfMaTe-ffEE&7*n&&g=;E z3vfnQqpx%>_6%ZgnZwpW-q>x~>VBeUEyl%Alrj1hXSN7V-# z(hn|e@YBEf|MPoo(tP2Y8~zmfdEY-j-SGJz5B<@yWh2`LdSu~6u$CU=svRwYOR?H( zH~?7cbJH`McHgJ}v zd)WnJX}XuitYcwM36w*gwRB(0!p2gWl!T47AT0?ScX-piENmyqzoRjo^c&T`3=4ZG!%DY@P(Rt2(%w^SBn zF=uI?lw9mi1sx2bjxlFjNWqRZfm`MSuqJRzeSgLTZmICIW?RUhk2Qf?3jEQ&Kxkwn z4J7pf<->iIqfQqb(*8AH6gJ;ivEoLl7buUUfg~cpoWL#dd)5SQDFjDO;Ffy($gX=S z_(qn5CDXRG>s}`Gj0xN_YnL&BTXNG#gi?j6BwTl4XEq_r!p7pbAqyKz6S6F9EEO_Y z*jQ#;$il`_7?p($+>6W;xFumz5Z;6=3!6dVMk{p}c4iZ@ENm=I$g;4p7_G>{#?pi= z3mdo>!2?|ECY6MZwJ<6Pn~dE8%q;%-G!amge(giOB1pzY%E4A zvaqoP&$awYPY_KURLrV;~2w|>hnULt*0&hisaC|jmSL&bdsY>nHRR#`q|R2NRIryASEGhuXK`w zIeAfXd##tn_JDqQj!ij(vkc2fpFcEt*ud(^cMS*>fUVKThE;ZZ+H}KJdeOYq$0VWqF^NSeurcu{6xf)=A{5w| z#3B^fn8YG=8us}KxsQeoy{CM6Q>BFP?k3|03g}F|sFbjqdQk}<9_mYm@dE|%rb-C` zbEZlOWwD#eV|5$!l)!P|t4%T)0%&qgG8sbLK&7HRfJQu0J{^P|9$<>bAWAp=^?EYHMh`J4W!~kvrXtdc706X0Pnh-bha0fsM%vi~<|e0B#CwoCap;<-zi2mR7j7EUj2MU}3&T z_634Zhu6`iqh}c{Aq`zC5g`2n6Qg_qn4fK?Vx+ffuZ0MZet`*5zJNcR$&ijf$THkR zatWmb4u`k>Oa5MK`Jk7p6-$x7H@=3umtMQ!mR6L^t5^zh^=*)1DVB9=mqp1Iilv~I zd=*PUEVcKnZQ`YzkLlEuVks0$LCuq7a!RojyN*Or?N%&>Hr7M(JgHa;#ZnMpW7YFX zo+lMcQR`kOUHSl>ief1UQUB*a+wJn4tI5uzJeEoyE;h|HM!B%$Oi+lTe2zaB6Ks7L2+m;8%R3>b1w`elqcCkBltKEv^h*6RwC2$6~u^8>i*AssMTuMjL zTZ|RSLGG9&lN@lnfYG!WN)kY0my`~KP=#4saR9d0812c|w^vX?C@DsI9;JuCv9McB zj-^k@(bW9j=4m|f=7OC3nWh#ty6CZR8(s4TUsL{rrH843`qtplJ#9P*Ugp62zMhVgc08E& zQ0so32DjF75K;nRjQ;c+nHryQpnR zi_*-*l2&~(Z|?p^^BY>f)#8RWAN1*~0n>Ew>Ry!dQhLK~r$+32Dy{L@td6UnYw2m- zd*>4+jYed(Khd}}tJ#UXCT(uGsox_vyy|;qw?0|Y)Y?M%@FoH772Z3?H(C9DPLsE@ zTCScm(Q|$89ru-7wj%5D>^b8+@!8LH^jy_;aNdIEkIY%n;&4a(^k6z|FD<*H|JoT# z0&6mFUp;e!r`7(VrX|f+WZsrNbB(9vxtS+DjVJkLJ%44wU*Ed&;jFEPb;oCu09P{V zdLjp&zeYuxHrL;wu+D;>>MIA+D3hX(67}#I1+q~$ZQqorn-qP7sQYUbeUzx1WSo?! zTV@nUM%}c1Q~_mF*!O>GOx+eNjmi5>=7mNnzRyx%xjj&$S&LnuP~W2BD4)?zpr(4qQIu0 zmPVj#*n?`d5){~&9GxhzF*!O>U}JK0qQJ()9#LRpq7f*taVqREPzBC;833CagBuEL z;5rLs-HUUer8Y~*HgKba2e@d)D|;I@8Qf4{W2&lBU}N$%qQJ(~I!=I%shCd57LJ7- z2CBd&1y>`ea*<&JS5kizurc|4P+()KEmB}(vU#Dv##CFRzy`7nJb>1uM1c)_b;IU` zk}Vtyd#cYB-bqW@q)dJv6xf*jJ}9s;`F#*zW43uAz{Xu`^Fo1*tJda)0vnUf3*~HL zYM`#$ursG2OI_#SNK7wR>wWtszYhv*Onx5}*wl8?Qefk)wRxey#$@wCfsLtwngSce zQcx>kilxxnLkN3>$tIMt+~6#qK|56`mO>i@O+L;lmZD}rpG2)ou@s7>Fy=Z+z((h> z>EzV5JkDqf#Zt(0VJMbDu@s$MQPd3;OQDM!30E@s>e>KtLIFsz6pE!Fz{aX^k-W(( zmO`-<)N>x4oKh@>VkwOI-Ljk}ot#oEg~^PbaJEq_#l-=m5-fvaDHKbQ{`?Q~9VK9+ zk4L4GQ%Xy*2#zO|^{Rh(rKPyKu(>2Hr&tQbQnbq=u;3=MN$K0G(o!4&F~?9Mqp7qM z6jE_pUZ^@^Y=!K3+B&vEy5-3-wnB2{jDhad0fCVNtJhDB^XKpFBfoG1RpEwElDow) zXc^OtkU}R$`YK1A{#d?Wu6kRzpOQ4AZ*jDeegTW4m2?EGV=E+6XT;bF$=_SYR>&ea zs-AqkY?-K}7}Uh=loSILJX2uWNsRX7kBJKv^r+giA^qUe26z6g;Hy7;$~4$`Yb<<-uz~h6U2H;xjZx1h!p0Dr5Mg78O^C2D zXq-9^drF`R9P*5MJ`pyC>VOEF8r1<2HvSsb0TDJiHDVJYY>aw75jKX{ga{i$Y(j*M zQ(+Hx$RmDv!?T0-?nXB(5ptOL zT^Vt~7`iedW({3gorgV~u_eOBpzesUF?3}_*ciGpB5Z0HTOw?{HM%k)Yz$o)5jKXd zj0hV;S61g?UtHk_IijIDAi~D*Mk2z-@J6D+CIq)vcz}NpVdDnaXjTbC*chqJQQqI=tVCSEhO-iJ0ngN}orWe8^R`jWr{(R7&Puer?W)l%P!>MeC@0piIK;di zUt_3M=V4Fv6##5vwb-o}s|{x*B5Vv6hX@-uCBg$xxBG(n$#HZkTL+G_v0CibIb*|F zi3S_Raga+$bdDo@G%azHa;n({u;6>&keWNSS@zzatFn6P^*rPg+0~hh1+Ya7Q4f| z^Jur%YQ=F-nyk(4%b^g({y} zTH%5z$}1^N6js57bZ@Fva3R~6YZY9`wwGE37t+1C>&9wQ5BH>=Wm9`iIo3(Kvsfc3 zdUg&S+?H3q>&Qy^zUbhD9`HAx*GQtCoy!T`!Tu;;z$&%# zPfYPKDu&R9bJK&K5;z7rMI}d|3a1>CBRIg&R3~mc(f+{r(IXmtxj46A$m<_zGv+50 zyML5e{9c25mv>vRZ$QsS!smy(YcvCYvzvUS4NgDN*fh62JQ>>gPU(}=r)OG+)*I`h zlZ}yyKC(VOVsJZhgttC9{oG9J;C4e9X6N#zPfqXa`Aes~dqD9%*igJ1Z1uu?kI;jo zr6j*LxJO zBfKM`t{Z?DJ7Ap$Jta^M$67Iry9TK1RkiJYLud3U3wkp?=$GlCd)qfA0vZ-!?C z4e=Q@o)N^|-l&by7Q0~-LOkfugB~vMAs$r>H!EV?4El)n=`?)}Jb?YANA|S_ZPUiS zSs1J#F>nPn0w3an8B}9pM#QY4>#FmxhYNg&urcT(B5Vx$h?eQVL+m^}fc*$0Hf#*m zkO&*dRqy~)Y=@F?E;f)Z-~sGyT{+t;q-l77k%dIq7`m=H4|}-4hX@-(;6sFsVPZzx zqYV0p2pfM5Ye>vCIW?>yG21`|2p)h88^gqm2pcGV!2{TvK(lURCht1=u!q-_<$tfq z2`^gQ&|u?+!#otV?I&lkkCd(&iyIb*RG20lcUH`;vVNeNm9d_u5 znhLNn+P{ggA(yN5>YKO5;)V#DjP9MGUQXVmjIMtoY>f7AB5Vw2BO+`JXCoqPoC>>Q zDQf)dXzLAjN5xWzhhs$E;S@{Jy>lpv!@OcC2zNMODbBl>?Kd>| z^7)oled!uG7z&xS2GT|TDN)tPyO&wT60$Gg&X5?d5xMjS1dd6J*I*Sqy;1T!xzWBr zc~mcu>Pv*KyjZPv>rK3h+6VzvY$x6<6vHB42mtfDb@_W^wc4#W zrzw(yTCH|0?5RGj={;7f-C-ITS|LG^9OP;>o#g0JRt~Kvv0Clc&F>V+LFL9A3;W`V zVmQ>rXti56zf&ZK{Um2r6~f7|gR?epYcX2wRwRe+twg3&oeDc}W80H8RhcTb%NESmL#Zihm+!jwMX`UzA7w|{*0^yS@ zIO3H4jLi3hHM|zdXqi zDqcGM@bITzw{S&+gljf8P3NizBE1weKpclp7k?gTOu7 z^|JQ$wA6W1lZIZuuV>&o=Mzhs>iq&%6?;!y=X`wjY`xTC6_O*lgk~Fe>TSqY0Y9#& ze4=q_rhbkxY3OB&%BjUiIott& zx7d+-#{YiMQ+*nHhI2aMMjcn-;zb=-;o?ReSK;DC9r6UGtjUWyqzZU^yOJ(9>Nuwp zUeqB=Mw8~83VQ#zP29%?T7ZP5+}NNp5v z!60cv9%da2J4{r8mMEl1h6fv@NQMU+oJfWX8=Odn3mY7N#7pu>Z4?(aIBgUUHeQ@I zikB@M3wx^14J}c~aykz-IAL&6R#m|fDJVOwY0d`fQ7i#R=78pqf8{a;A0R)e_9;1@USLHgqM_63hTfs3n-_ z4NOGKJ=iZ$iKhXW5Yh&4BlRlm2uzLg1-y8{4I=_j-h*>qB2)r0?dfmE@5jW!h8>Tq zhcmw)UhBcjyf|kgcJ!f72uFi(GcQi-!Ne}~9Uu*@n8?|h+}VXQwBl{pj)h&S^_>SB zq|plxHaLGDE^KhE?_Aj6{C&8vF$Q?kHf*H74-Ym4I5L2jEe7HIeg6Almuh|I!G>P0 z*2~RMx`P55wHBd~1n>ZMwoqKy;QW1f*+#Jxl&YsxHoOC zze8c8Azy8p^{J=ne&5g1;@fB5m_6$wPm_&4-sTS6P6mydQY?jHDTF5cykiNn`I>Q_ zR4j#JDeRi~7_iZc7Ibn-u@s7>uxr}q-CpVBlwv6qOJS#V;1w;%6B&}kA%0ZBrv!7Vo{mV&ThE0#jB6a?7l(k?nVrC18ZQc%x%baG0u6pE!# zEX9N)Ez;)sTMQ|>F75K;nRjQ;c+nHryQpnR3+Aa_^NsK<2UUQrZv?LfrL+{pofJA1&;bnUvctt>xIv9;;`c^)&45>s)fhh|F%>_6Mb< zpu#2wv=l+th;uJKw&mR(4S$#79hCTF+nulM|9o+nP<}v3qY+tb=`%)i5T8AB4M#EW zMraP2ZQL=0qnJl%4o)-%WOEer2+hH{nLRvhIEr~hHNR>H99kn4^Li-}AvKwvd3p96 zj^Z65HR-E0n6MS^p!7Ho4o>?-Y0WVST4~APgdBaC255dd>jv?}x5`=+Ckf!E;|9tSm;|9!2`~6yB!jrPaj}Q9KH@p!t?Rj{7YLbSp29Gbarx7i7glEMi2|C`Y zOaPie_Ua^2+z`B<=+hxYX(GrXL}>!lV1~{M0*4toFIX@bQJNr679d1vmn7_~^1N&F z_x7~+P!quhjushFtT+VkCxQ(^lqP}=LX;+g4TA0!zy>2q6Tk+(y6w<;0c;!#d#cY5 zM|s%cqDj;U4>b{N5b7imY+!?e2M}r*MX*6w=ZRp0pnC0dKP>@l5RwHEY!H50qO*x( zVP9NP4n7SCGC%|ygk(Vk8^rW+5o{2~N&?t;5ynaa*dWLN5o{2W1rclzep;ez;aJ$w zGq^>tajM#_+XA~4$&oCWN+QY@PLUiigS!engPXf-4&XeExQia^D#goqLF8-(ZUl}+ z`2t>~DHHbvrsGVRxDhBonlkaSc4#C{aKg(y0ptvBPU1$-8Q}f>^|siqH-9UJMPw;f%;Q3q~K&phymC!8y?>l4Dh#Rz^|9cKP+HuQ$c8i29e=H@f)= z)tYl3+z3HkMO`ojPF1_H;wDj^R3t~;haI-pN84!}Lrhk?_3c%W98}mi7Ixsqz#cYM ztKE9njv_gPJ;;K?xMN{Y^||0s7pv9or4=weT#+0i;kD=v=UCXgl=*=hi`8nkHUt|p zJ%U#;gCnh5ksKlgEw@$}6}N?+!Og9;Lbh?L+Fg(Yuu)15p(%_AHclxyUBO)1$1BM_c4Cjxv$w`M>C<5;y@|8z>pK@}f5rsU`! zr{?|Kj-6LeW=OjL$BVS-ZbOx@;kHV@@3@q-QUf0?<0zKqOiZ8}RhZ+xYGS zF55QXzMgCO?gRF1z=^uA2FHECzCso+f{lF}un;!3-QQx^*cL`FQP?3LPQ_Hn#IUig zkO^VqwQU0y!p6Q0SO^>YHeexa>f|^J%3@8zXuW_n!i66Sd`%dtH)F(Y;Swjkxt!Zyf zt$Xj}<3AMT@4f4^z=zgPjmyZ78{c|q*&Y4Y&R7yylX?5iG^Ji@eVZ_XpkeD>x%!sKIL(&aB)R3)E}JE-W!+nV!SqOhm> z3V=DY_bL&>#=ebL2pii9ml!s-qbbC&u`O(hVPo69Erd;hZTGeiHiK*}YJ{+HEbLv% z)s2CzjThVl-~j|}yh7My*miFVVFNcxcmVS08gBCN z03uT;VYYBA?29WZp~K3tYPD8v2CES50jSkxunGx^-MoabfdjUUSBVfdaIt|0Aj1ak z7VrRM*eH^M3>&wtSBVfdE=5xC-2=p%j3OyS6H$cOMv)ZMLcM+Ww(x9X-@VPt7K)@8 zbsA2k)ZHBpRf?p@x;B?Jdx?7(S0sfZDVA~P_;6vPw|>}qGV$`HA}MsM1nLH*NDBG$ zsyY>0omCr1#aBW#yv2wt|e9sl$JI6O!{eDi9x3gNVo-@&NeeWIjm0ZSyZ9!7- zX_TE2zwUxlI`9v6IHd!B*&>w=`~n0{>A*YTV3iJnTLErx2>%7#D5(bj1#p8yxDiMR z9EP4dTOWPy@AWDO^xOegKs_hb(^5UsS%|-Oq4*V}3=QnJs2*f~;zJp&@D~j*JO%Z$ zRIghf)K7*6BtDyywMw}v)u-o;W>4)CW*f!O2pltbXC(0F$!Mol%2la8*>`L3=$uaWW>+XZ0rg62?8+nK66EAX;eu7QdScPFeyT`T<%M8-ReA#Q_DU|*Bb|kWSATbm z%1Drt7lpMtRjZe;)lbu$`|78PWNMtd+CRG2dH4J=aiR5Ki&S`ZVe@?zD{dURBPBS* zbKU+O!_%4_&uW~V_kf3A<4%mS#$63cifzk-ni8PhqRG~4C?oX8Ooy5Bh$V7T-Se#_U-f?fHPfL;;nOn0EQ`%)7H^ zyy%JJD(5Q&qb;Uq_ETQu6@gh}wgQ?Ca_u2+~B5RJB|GR2uEU>A+H zC~3CeJ_4fA7JX~W1sn}~sxJ{PA3PHr``-)e@tE%?sK>|Gl6fNQ1P%>@`FL70Du;%_ zfJdvRLtzviAfku)oJs5=us%qH3Rh;Y$o4P{as-MA%*t^x>|M%=q4k}om_WjYSC2=+ zhNGCk!iJ-mz`};3m_Wj&fJ4I|VZ&2QAYsE(Odzv`V_{!haU4!0aENA!4v=3SR0DA9 zjqKk>zB|W!00}zYwGkP1p7{WBy>ZM3kcfw`#_a1uVvc7%fLrX21zmXgz()NY?HEno zBY0|NWYjroW@Oa;90@xz>O2WMGU}YM@5rSNN)LE^@>1tW*e`j|#iK2dsRGg*P`;5W z7i8Rc;wWU6w!7$|a{)&7iJFg&6iiCM_9%!wwKJnZ7p z7D(9e#8F7t@WfF_*zh!QNZ4=~S1fEenm8JzDpi<@n{PqY&fGWu(06} zP)OK>pjHMCK!uH)LqH*6!{Z&1u;KZbAz{PwF+;+J=VNxM!w#b@&WZ-BGa=5yKmhHwnd3kUKDV(^in1lwv6&r}QB= z83$R43yP&EQ(B5>c_O8y&}kBK@0-$6L@2$G{4kxIQd$b7rAU9iuE{B-rO@V3l21xX zOJP;S+UH57rC^T(MBXTsmf~T{I5c}6T4^bimcm*$JQK=3c*okW|FQA19k*N7Haq;FseFE(=?0*@N`lxd=O&)a|(YY=fXEz!2^)$8DyaR#7mO=vig^=9ChX;WY zWBab!aUH_40D8gL+jpXQ!XnRb05s$9)fiGpOw{%9hE4??23vq9Bb#qVN1d&TLr0w{ zg+xc4-DH4{I$H{fjXJPbjA_2;sI#|k^ipR_A+bx{v7n~}D#6T>O(S4I!C|vx@xmpn%_(SOf0wV`j!~AJ~ z{@y*}M;n33TuUy@3v?-)57s>Fax~`mx>Y`V!U7J#+`$^C z@bMj;Q1InDI$;xcBGb_chh4as#4~4LB+QtLBj^BDDVJQnF$&;P{@D>uyQD9*sx2J=xo8ZdAamqhug(;?hI@+ zY}lQ&SlIZPejjMq39u@s7>u*{i6Z!%nQc?`UH3V3SYQ<70mO^PMwBgjy)lWTW zT?&@sf@{RN7snR9+oR#{QoOtFJT$KD&d>fmd_vgd`C&VsLW-$PL`X?9@3rIaT)iVF z?(NLmks@{z5prU-|BAv6L%!UU_lV~@q>enkR<3bwXU^R8R^2K__`0UGv={K}EsdtR z>s4Rg@yq1r+5~!JwOKtEDWNyXHKtdrxM5jQi{MgEiy=k!D)tD|D9PXJDj!qde&4`H z3-)C-$sLf^LP3T#Y72n9AKxdsI`Cbrfh_ogo1=Vzs^QwFD>$T?OMO9zfGgSvY>V;*{82?SwWC+uaqzq79ysyiRv1(-NI3wo~r$a4t~{%Pr$uOV$ro<+2 zOuLt@3!gn9z1z4m!e>v&=1lAC3F#NG%$|@uCas5KQj`&x8f65$QAGg8HKw;)6sy&4 zeJUQkrC*U84v`$djltlKLG`nxUy&T0UGLCa^6A`Gs!tmL3bnV4DB3j@$w6(Qg0Eg5 zl^k8l%HeiVKU?}0$&tS|n*M4!x3#ze=JcpyJE7RF9|~hs&fqA+lIqhEohr6d?(uLg ziBUO&eg$(X=>6kDaC>!KZ0Y|hbjO%x+s2J}^6H<5QeNBBcTKa7_un_-%hu)dUcD*h zm0zV^J^6$8$IX82=@0I2{hfdQp;15UH1XEb``fk}Kh68)uJ`_V)VK7#j}~^zO#1Cm z&+XZb-_9IS(rV*#pL!Z=%J>^s&t92%_lYaoXa3^e=6`(Xk>;t(Klo{nvad(oTBQ9M zza)Q8Qc1$5JI6O!{r<@o8|RM8Y?FO?>CSVW>n6$u+MhZA~BeM4I+z?fBM(myP(UcmK6Bmb~}q&i$U2t7nbN>Qi$4kfK(azWXIl zt4XuYdTz^}(WK1{kN11zhI_KEJN);&W%+xr(EmJ=+-X_nfX|QaY2!)Q)UD*YjWZwd z^vG^jTJ%&&Lr~_IwBEn-LC^J*=C<_wrBmL(H@fC^8TiMvnQa)dsIku$fkewSn9kb)#&T6LF67)}N)@SFlCD-=e zG3)s&Z~g0ASHAM&7oQ&P+qdiSx!Rv2UE3`j;7R)Jgd;7|=9RX|ZdtmcYf0OUvrlH- zexd<51Dt4nJoDzX_&!BV(;jNwuk+wG{jPqk*MkF|DO~=cNBfihb*J%h8{Z%IQhLK~ zPj8vECaZl~lTzO#&)uu%cFY8EeaEbhCoVglHKwG&p1u~C;cfSx$}hX+8_Godui9>FGchD-dXSzWL-U?xo*-`dmSIx$A>1^C!EeRet}?*vXaWKKi6Q=lUbE!L^qm&`&#ptIo8k-J-88v8cgjL}0nUshIhA^*9_l|6H(z0z)7V&WIx+`xC=esdyYexgOy6tCNMzI5MLUw?G+lV$E{mH%0nGrjVu;OC(;XZEcq zJ-xoTXF);6_TagF({nc$K2R_{_u1Us?_YL*fBvI!)d!CqD=se1$USp*Sygq}(Mf?5 zRnHx(jL$ed-@CnVjjJm7{rU4}_vLu2{h=8{4-@(UN{7r!?se!e$&Dz37~+wh?Q&6<18ly?2>^|%I;PiHlFXh7r3 zu5Qr0dGiLZO&d0}f$9I<2>Xr9@S#jM{!)E>{XI95)ua|k;Beu@?@`W$Hy5_DYf7-g}wJF2B zpZuZl!{52?Y1`zhVZSVxFzu1&9~jhX*xX-jziHgBT1~j+*ROZ_pZF8M>hbndfBRQP z)1Tb-TFJ1MPmURTW!0}=4S9Z9+G_5`ogF%!pZ3_CTX#O%DS6<)j-y*XJaWZ`?sq-3 z>Gq}b|Luu$?VCQPt!vxZXAT@azp(eB_M0m6a?cEZ(Es35=Pn$*Lik5(6_=JC_Pfp> zS{1)#MZs_V*_$T!uevJT-?wk>1XvSgd-t9^xZ>oe-<+I%sPyF7YVX!B4yCXB;$&#b znZtWemaaJY&G}=q*Cr1dzy8_>*FM;D?R@v0MMW#t-MRbQv&Zw-pWL)%{p6vg$G2oW zIDY-MySA13gQa)0%gJ%yUHa+nPrq54{PAxmZQ62Ra{R}WhGu;HcW;w1Het&3`JZ=Zq>udkLh$^gjt`!xK6Pr#isR2^e0=Jo zvL~kf>}Xl_ao05W#Pi21cJDZF=-W?6eSGtoZ6iXxJ`0r(eCN)2X@6?*`tc2c?^jHG zcG6Ej`SifbqZJ*`zr1Hr|AIm1FMPD9|CY&C%#b9mLDYeQ2vReke`YviB&ef}`UTNP~S zcYm~g@}|jK-ab~EvHhM7i7Rt53bt?AT6Or_(;4lKP0l%2u&>!KJN69~eOr|E-rd)f zzW#~3@8M0aPkw#S^@mRM?Qm$?&x#lIA5+lxna!@l)$ja0XN-Ht$?Emx1=-iH-0Jtg zy1wUC?zBPgUzq1wd-Lh)_ctA%x7l^-^|P0KJ80UbKmVrk=0C5wd2ZEJ#RslBd|_U@ zJtNc zy_@z~;`@6>jSCHUp?llPa`^8zhpybvV@PFz{vQ)=%>VR44*ahUg<8XZoSt-F+qbI* z-_?A=J6i|sD*AD|<5h$2zOvor!NGT3J>ebSpk1@y`97iGM8Pjx4Z7+4@vHV0jGzAD zs9zM!Texdh-*z|VH<^CJeM<|UU%2bp?Fl!o+MYl0z5ES*pLl0$F+9P#UpTyOQ|Mrz^y$_8hkx?=%2uzh+`qf~yVGvD@54`g(|&p~SbF^L*FX8% zCnX&|ZolGeYW@`&&;N1fU61T8yVt+(%5{qe4qkZSjk6PuE;#zefBLT}nA`NsPpwkK`wJG&@@6MmxceZy* z@b`~@_Qn_YttnkTu>Gf{Z%k~z=*d;jw%_pE$8H@rIA_)VaRXm_@jv7Kz4^txe^1@^ z;_ywq3Wxq#|NsAJ{7afX+dgemuNA%jw{%9Ju;lMEzi7ID+=s8V{I0j>w~tNgIc}=) z-|pD_;=%C$w)eQdY??W-{rV>xZ)>@_bom4A*KGRd{&DYr@cuua?eM_DKfJl>?9V>i z{8GvCyM`C9T65+PFMhM?Y~Rl|&o5d2^WpKYu4z2)#amuI+wZf@3rd#XGknmiYp$C2 z;*+nQz3;Ql3rpThT=MKq<2v4-JuvB)>mI*yN#2`}|KE};Qg(eF-)Gy)zZjhG+RJ|( zdg~uje1mWOE~RPe{mWD4j@$T4&&3@yiuphtj@{gCiuiwGwrcO;-^~OyPBt5q7@vE1-`sU*&mb~!F z%Rhh6%$G=_j;VTKtQ;wSd@uxpKuKi#8zX!iM+&2+~0Wq!XkU>Ag#DQl&i5bMNtZzjN;W?tgE*w_s%K zWUl$!bN%L8d#^F)nsr*mzCNC!8~x~a*ooLBBq1X=PG5Aq96|NivFh4Hbc)Pdf;CiK zUCN>2W5I?=l^aGmeNWTqvU9%=x=6N14yz9<%q!zCXI4-QB9~f!%j5d&vyjcoFU-(BB-oLQY&7x9Uzt@ zs9260jI?O1v;%gaqDGvqfz3;xP9jNNc-wY>*ChC*a`IrLbtA|g*oV3^>ZAsqFNMAl zN&14PVGnpm5>zIq3r5;Dde{SpQNS@LbFg_iv_~Xq6tBo0P(gxUA?E@{Iy8>h11C{E zV@}@S`3fioENL2#+yT%?67)eX6pVCk6mtO1qoT&0;=tyWP(fJIBHp2PKpF)9qg)yo ziD-Q309--cnQ+Pj&wqp(!;;qUdK~~`BtcbjAHm4SjYkf^EfjDP(EwJchK9kCxACBk zfQ4Jx)p8x+29JI*N8mS9)Fh%09PV3N&Cij%hiBplSihBBBR39i@ap$)1RkP*Q;1ox z!Y614Ecpm8)e*3FEBlk&8o0ryztRzSf{L0#?0^+&p=+?@Q@j~R!0D~*TDcQ&gKz(l zBeAzLk`qnf1jGyyoJQb50_vbtqRCkJSDgU(>PvNUK!`lDU)c$W8&o)rpn(L`L$8S@ zgAXr@&WxJPC$Yn!5IWQB%lGRC7Mi#Zq+Uic1a?_uXh4~)HxdEu0a}5 z{Uc65(x9FhggB(B5$Y|POoor?41lV0G|4GI8iM;l&OnNwJF^HCNK+FuNi>-fU(Ol8 zrOweTrv+&U?bmTu^VW&uMB6w6X@jBnibBD-B_AfgFnS!?F5KkaDtxz1XWM*{7(3cRGBw)$xQ*dhJMF;*u9t^^(bQ!J>QCMwKRO)k-23#uw&TAs z^Y6un`8a8izZd^24qSdxRGIXXBK|+L+y7wjLL5F7RLr0K_wq}I|3Uq4#H1(e>>3e& zczxjyuZ#Wky8a)NBL3eMcSTQOa##~g7d}SZ)~;vkTcYKDP79Fa2%N~n`;3_y>#l0)N}=Uw*o6Tj5dYC@X00+fN);%SB&9vK{;+A#r7Ptbpb`h#_}_K^ zaW7QK5{o>)T&vSh6F~o$D{l~~T{8D4C;yW{4iC*=(*O5kXO>4XU(k+6E_6w&aBvj# zva?(O@g;A>Eam`tREZT33cqxMKLB)je~>~e@X|&9FR4yX1mi**H%vRg6h!iQ4-6h)NVTkGlBk;))^`G6%pNx}xMz#3rqsAfeW%i-jl# z#{&rkKw(y`%y5+8{30>PycLKV|NqMWg|IU*iT?qCmghi5kPGD{gD|0a_Dg~t%v*0= z@;}}hm3YZ;Wi%9a=>Qj2xWlD?=5L_JxiWVAyvj1!X8qQ2hVyR(wg z=Ni+EM%7PtYA>T==F9AkJro!i*S-EJD)x`T!ymD+AHl=$ZdJktK_K2VrF)Q|S8O>E zxy@)eU_wQzE=rAQm>n7tIXP)ZMZ~Y)bCVL{HeRYX??o0~vWG3R6Q>jLLfLQ9nIiC^NP6p*x_s8yn66`x8NH7HB$sEO zEtGeR;M`ueOh_mF%HfTry3yudnez3I8oj-_V`}VY?$A=S68DRn-=q`?l4>8nE}Ra* z)p%}tugLR91T_$IkGk|C@W+k$Pb5(O3=JZzE$l4>etiB2n|5lCIgB#{PmyQXvo-ZY zHC$C1#fkTrbnmT{uLu`yXVwp6iP)TdqVux%R!y^HwJ^e(6AlsK=?arL9GYg=R@)2=aBNs3wqd=3qu49$$; zk0}KL1(UeKg93nD(~E37FJk)OaVWnX_?zcsg)=n$ zfE7cv^xD`BUQ1V`vuDAxp5F9+{<4Z!^~YRk&L-a#;k~6Nt#mAq8rqX^_n%^TSXnuu zYw)C^*$caR)j+_z!v8?GT83iP&T53AdTQ3H(cKDGwVvlc^d=x{?TKHx{nV6$Edo2l z<#@ru{h54ASI)`Hq){c%S?q2N*4NqG_0N9Z+&2TT1FIIfvaU!Ol1n;}H6<|Y1((Ft z^mFrF6~Z1cv6^^WyULoA9&uNNY$qh9KwgzX>{erq&`QXohcWtW4<85&)i*;{uTEE< zB)82+P0RC{tx}t6Xri&GD(?glsJpCYKuR1v+__hm$GPx%^{N(NkDklx=veLUM~Qs% zq#@GuD^NBPXn2sv)4)J}^|290LwQ%GsaTq+iA**Y=$-~X?sT#3pv&OwsbkGY9uA{+XOUlKbt&8j;DE)r!p|r`oM9MXf46hoKP9nD>HssFGp7` zL7cW_BVFUiA7)<+qT3-Wv@aFN3FZSblXD%ZKYty9A={OoXr+-U9|AVMMxWPlYn+Yq zQ_^M0i;NI!I@oQ9JgZsFl@4VUkUaHERYa~vm>Mop>qmmcZa{QxWVo-rXsB}cjd=gP zSaY*4$(nihv)pd+c-Z5&q@V#v=Wx2`4rNMn363Ei|g13(eKq#Kpo~6X9axVC8xl zf6vsncN`a?IKw?)!tqs+S*u)6ZJvNCN4xcjK7LeO2-E(?s;#=Y!yA&TFf#Ie55~49 zA0o^)go}k^C@l<$X`HE!@;q&?C~i%0?e1)&aL^(HhU#^daF}JkjNDu4Y`%Sdc*L^Gy{&{UI5v86yga+UdcWEyf70-C zG3pb~-tpZUAD!KfGCGC9JX5?aO7h7yQwsu6LK2a98x>wCWU z3d;?q3~IhVwL9w7v#&Js;IBPSA1OT9e%$qH|5IF~_olMm{0=8kz?Q4_hC3_MBrMI- z4pw~>zN-{jeb+d z_u3<1&46Flu_TFB@r6GYw!!D>=iBb76cx-%J7^W|sH&)L@7G)e`{<63*%`+9-k-&r zOBie|e5i1V^QI?Q=Q6jNR&&uR(q0C>sP~(7Y}ea{8VoRXA1;2Y@7fWZNH`(Tv^5{V zdU#aqHY7=yDHLc|KIM^^FGRp0yYG6xO@(1Bj6pKuQFIBbmt~sKlbi@ytrC4nKi)LH z>8PzTFKFA6z`+NcZg~bp+_|T&3qb?Sp)zImoo+#`H_923+l~Rni)QiL8*18U44KM) z(I6{44!xl*yBeX;(9Ts_DG94>g)H{qAmQtqukP+ak5tUpdN{3;SlR_dcK*t-kJ7R!YaaTe?gEp<{RFzTn% zxDU&}2`&~LD8f82J|(ha94ULjt8QxS`N?xsRFOyPak)8b?-2!QM(&s!F2rz&K=;ux z{`njB>F0U(tzy{1&+TSj<3Q2{m2+@H{WEj=zU0mmuEkuPbDo(44D+ZRRByUaCzfJ* z^`Lc#iP27^(cv)?TYx$a_Lf0vZrcdE3VhY4>d*1))^&vFrrCO~*u1Jk578(S5j5uH zza&eoyV6EV!fOc#P}>tvR1Sb|H7@RSlY?U20|*@V(*|Em5C!ykv_4hbU-3NV@p|mK zn~X;6b;+0vZhY*xjcljsDpsT{YOx(eE`rqUvaGKf1Ifp^NF#;>LDfJLhp#zh8#S{Z zhDmvQ)LntNurblWeh4iV+g9ss<1mWv;3B}==zCA7>>$1(;@AW|nwZhru>sA49vJz| z$QNSnTGLu#q^~IK$DDNq_=@z4Wnn zz1b+R?8eoYnq#d6#R_~f9lZ&TLD|w=-KkJA=+%c^c5}JF$ZuJ#MXu9?5G%-ub1_0X7yb-7D%Tq!e@ z-j5-^FSO$H){w}v6&&KKTy5x;*Ys6w;coRQeP3zL(hs*O=%T`(KQz8Zy-B|cG*O*F z=5;T@=|9csYL>`|~{?GAc2Ryj^_68;vs>&Q$kqU3GL6Ib)YRrb1dc^7!elLojU+Ffq zkC5@k_rgRld@doC)I1Jf`eNC7bC4~-jq>3L&r=;2hBx^Iz*_GvSd<&R-!@Knuv+_O z$27jf2~-<&{|#|3u3QMVZPFE97nMa@)LwQ=20->)S8ovB=X@1U;HxHWkWeikPCk&1 zC_c}@99lO$nzwIQnp6)0QTC?Cki={=-mJSOKfgvrbced1n$N89{leMSTg^Uyn6Lxz zYiOfbE{Bg~7gH1ITC9(4;3~RCb8p0CVTG7Kj!+f+yT{c zaoo|jH*^yAXD!HU2~D*sD#ph(ESHQ7(w>%lhA(mj&VJNt>lE7}w-lj7ut@Hmq8j97e@KHrr>^-Cy5*~twQ!H^zD9C*EhZ9>XYIovk!)V}{E_tg!wXn4!T~!j6mat@O_>>ct{`I~h9k&r7vhyz zRG}$NRIGDoP_tn6qbSh5c(OtxsJl&REo7@(Y4`z>V1K0%`}nIrrPIuY98YeX);tBB z0-Mvz@m)Zu3y$;`W7*qRuD{py%hu>ZGu;7FMb4oTKAX!IGZZw{@2*SI(Lw#7H|G4i zri-zexH%WYM)dCCOs!Faa(v<$nrDK+&t&T3uE~<#7WY)6u#pt7mM*wqLK)=2e%mvy zJ58K;%xmP3hevT{K0JG#z*0{JX>O?|EAR72X6v86~<*Y zmv65v^aEuY0693Hl_ZXt`S?4puWI^It&+>;4VLYVacUx@9m5aMda<*-L&51z-6hxlz+7lA4nsx`$;MnBg>Km97u{upm?Mu6)eBZ zOkIA)UqmX(S{x|MK-!uH;0MVK*1Z%!WKBcb61;JF%EBM2lPf05VRJTv1&LKUxD%T& zZ>B24Wy#;b{cUa|Bs>pV4QP4ODsgs! zeXI;8ao1=(Fj*REuYG$7fA*FR&(0#1C?j}ib5=DPR?Mg>s@yM9Kj+{^kzCoqoXauD zvMiPak9l)C@Mb_^&u6P3qh44IRzFt zRXFGGys)b7vKjH6!1|@>EM^?DzNk8d!O|FQ>2|R+0U(oac~#-g{X-$}Ax#KQ4ieT^ z8BL?~bXmv2kT8)-{%AU|D1_2jKfa8r)XqKD8$K*&irw;%myK3`cI+&;y=L_u{F&xc zroMhmY0{66%_*YNc&i>JMP1t{`O@cs?7Z0x6$>&hZ&~UY-jj4yAYGU)O1b^=#?_Sw$OrvGPD-S zmYjMP2J&d|eL^tUcZmB|)fbdB%8FNf2MuJdN&0>>T9}5Mjon*Zr(Bqr)jGxvsB}sv za~Shu;|GqG+Snha&e%UoIM!n@`mjN{FgNMa!`q~t?p)t*hWvcrnOoCXV=mQCxX;X7 zP-|!HLwIg)LP(JGVaR5J?{|9?bOF$5G$oCv`|)h54L`Hd{9Ne3-a1fefOm;f0oxJw zdb0vilJB*kvaine>YHxecZ6toF4!aLLqu2<%{RxJ!;0p1yK}k%K*%do1zz^0{Qdw0n!K9s6~(l6kUp7&W%p znfLs@$6FuX_fyZ*VOMO_odH5!MfnTUcYXO7QUX-3%aX~PX_Fh~v<5Cv(Z)00+JW_pMCpUslxycxPUn<2mS&H>e zL{c>EHR|Wl_?)qp!EA-=?jm0c9&VDzFlW9F!HYBgaFb#gDk{-ff2UB&<=ms`0on|4 z#wz-;Vx<3D!g%!KHL!tx1x&{n_{C$|6idmEsIh4&{B1otV8pO`>``&E70|>W%z^0o zB)Q)N&YNE9g-Lta*uc<{0dgu4pKY`We*n!G=CYEqGtSJHF5@B!cc7Ys=QWEE^{zvY zcpZCZ9V+qoFn}#=H}Z3aZ<-~`_$M{Bq%a!cI%nRTGLGHy_5=50>$v9}3=h&L%~-Wp zi9JShz~u_?bBrzA+ruIT8px5?<&>TUBXZY68-06Xj}%BV(X1&u0~>2Ik_J^@Wn@GG zfDf9#JBar*W*w4>9euY_^$g!ezvU!PbK-pe8b44n620wYyg@XMm5wvrlZa0@9G}fA zx17Bt_2vjKco=^?k6b=)ZCD*e{J1~p2D0-hU4LUj;+0b!?Y%N|UHnU4sq0t-AJdE9 z%QC7=^$SfL46Vw_Eh~KyzGJ`7R!MgNFXjY16?J_S9!7d=lPi*nAsn~DV7JaC#Ra-F zDM^{L$LCDr+3ONHFL8%}U4LblA&5=uiHosGlUA{UEB`?kV|ZAzA}ZATz^%UQ?0rc0 zSJAPg^^?&BS?Rb*aI)BDs3+$HY7>Lx%Wh;h@oSA&hD}gP6M~tq;t9_>&i&o_%PPb) zTH~uZ8feoyKN)0B7vkzn$0De7rrAjqk+Ky<0%z_xr@ZvO?AsC1qt{1F1dLx>mY$GfTqRuAIt*?_&mMc#b5&BQ0!j4BpS8ykxbo9Z zc{XyysTYol@cAVAF=IQ>DySGI8fh&R5xZB$2Kv(5&t-mQlpicCk88ICx2`<588q65 zE^cTgKCaJDdE(|hWXuA=e#Nm7xKD&C`c8{UF76ToAC4a+BTo^y>sQd;T^M#xbQF4E z9nsH2b1(|sx z|7vkWZVX}mgHTwBNn~F={hXOk^>ap_sN2rRg*3*e|4rPAYe9dp5Vi>#C-< zjn+0kF;wP~kSAASTmo4e+=Rumn=vEi1AFglJKV8WM%>#*GO!p#^T54rgthvwM9GeeSU1RlpgN2|+-eFTE3ejvMc#fSIDJl!isA)l2doh z=hyPS7oX7zH`ku{0-pAob_ULIAE&5M*6}8uGKWl_%4DrEUCvwF-i215ivz8X2>xl_ zlKq^wmuG)X9UX0doMnwsb?_IYQq=B|V(zAd$7vA|n%}+GmXZ7A5oW|G;QonRIsEg+ zcV@qxmv17%iZ-{SeJZMMynBnclzAPbym&RF&WR^O%yNF|yH7cLG+75AEAMHTeqF4= zS@CJv2BL7E%4G5|EDoy0m6;O%=H=@#LgM#SgEllyD-mC`FJ{RV*`84T*~8}#*-0uX z?!p31p2@qomz?C)2kP`{ZNH^aU zek`sntZ?7jIZ6ekx^&%iB`hgf*{j9wi?uLU%IiU0lEg%FvCi+yLNJ7@)fC&i^XQla z_RrW4Kc{S(ex#XWRleOACeWwN#Z2f8d@DtP6BRpP9z8XnR=4cc8Y@>BuEYbJ%vxFIir&&~L|0KvyI&9~g0DGkd^#6A?7P;oeoWQT9Ju7u})5p4W(wn%(y)i+2lZr}*6w6@!){-u+!1wh% zsbGas(1ceI;SIIIocDvbhizwHnpZ{P1bxV;qX@+3(zJK(;o8Myn7SrS`szW;eLMpu z#Ixd#T?tS&=uWalXtD+pqANvkOF zyamcd8Kq#>?dXmaU8y`CNZY%wbgi4pqh2#KM+)Dygsr10GRT~KnRedXCw1p)Rl=Ar zip$q{e&nD)`bQo{W{0z6=Yp3T|HvHCMUS7f{gHH%BSi`VaeFS3PL}(3olL?~3$L=< zkubg~heKtvZQeDkuip(PijO_oeUgpfj)H^_*w5HxCWBjeQ|sQv_)0#g zxtJ9AfDFe}=HiQiaQ?R`Cq1~M1H!@qVWj2ZWZ`OXxpV7(K{I@|@`S05`}jd|P3CYAkGvCEQY_~k?99Q`ked!QC}8}P zPKIETyy)BLISKwe0_z6OFAzIvJyTLW>KL?$p{5mal4hnK&}Tb2nl^(qaVb;QrujZP z4v{_3*C_qb^0Owj&Zwtp!Zr^M%eIc8n}uOeky&Pr(!g438Uo?P1=Pr;HZ)uH;o24` zi`@mp5H`KJ_p#zhe}`TtY-Lf zeqLYYzqtM#2;bDkANRsU{0p$lf`vcZ0^qMee<1!#bN(Jhknmrk{7CfvZp*LLCx5lY z>tdn)wc_N@T9aQ&1?VFtcKFx0spM<_#Nff z#PDCu8b<$)@{3u2X2gF7{51h~nNR++O|%;x><@aafnfamoH?P9q zaejSrUcL(cY!|&{{%wO!XF#Zo@ CS$M(# literal 840267 zcmeFadt8j`-Up1(L5x%?VMIcq5@m^Il~Y-iQ?f`kLJlcJ4jo21IYg0!B-U!lu_mXa zG%6K}$f6+`Nrgs9YN}~w-rqg<$lCka&wih0_1m9!-lu#2vGqZk8dlZd+hK{ z6$IzT3U2(?Yx$^yR)eO}hp6t|=B09>@b_$CT%!l0@BN);`<#ua{yqCh`P-_7?cwPc zHoSPFmQ`98I&IM6Hx|bE?y*kJeJm#Q-EjHQ!7HH!m&O&Wv5NgE;Y4QNghQ;!lUp`> z{;EuSnSA7+uKx8EY-jghHIi30-eRlV6@*t74`p935igv=*?IQ* zlyQf8o9wA-ed_jg@Q%~7Y z`4$o4V-TC;W4*n^N&kFM{BEw(>vc)DemR^v+}n2G?x@C*t@|Gop1fc>VfU`vmsYvt z@q9+!C<^_}W`}kDLW6@FCKve5+n#gy!PLRs?<9OVKltgsO%V<|Y*V&cud%n-bc*({ z-@357>T?cn_-r#iWKc=^pElEmJbfPV#$|4SchaJhF7d^0?woi%*TZSzopTSWs`$;% zU!G4H@_5Q;lQBPi7`07L>+0IjPe$(?llE@Nl9;R22>0GEEkE~E-_ziZrtdzbpEu1( z+%os|rlHm@uXQ)BKe1@tys}{n`%f%kjy(0}#^yX*rp0d;l3rwYTd%z8qxSOLy1_BK z8P`W!Kh+u;SF-=y{_dmV?QRTT)3e9w1G7iZw{~_>Hri6WBydKzHNR|W>F%Ienewer zZ_@LUnG-AS#Qa+8ME7vs7dp}R_?fNyx83ua|NHt4XUk2x^)|8zR*A`7`u5}b!}HY! zzhpnx9<|-Br}?*jr3Y5{Up@GH{SduJ)x|2lKdpLqKh^*Ij+2>=Su=kd$vbnE7G1ul zPq0FrVg9;t%~n4rPCDA>-1(p^Tl?El^LvdPcB*+mQt6r*7A8yF`(}l#(%+(cbJ;o7 z-ZM&4u6#_NXnyO`+nr<8e!V!Ues<}IlX-Rhi$t^5F4!_b^-spSA?6wHlU@WgzZ|on zbc(0Vuj~BccD{;t=zl%g;jDVw`IY^7XEwZBd+e9VQ+jgS&agu)(ihyh(YllVQdDU5 zvvG#?!SL*@%RTmvU8-vI$G|CTjE07eTl{6rlDV~ddxaOjoLdxn$ylX0bf#*~uWPL? zJacUMZGxe1QmDoW)t9fG;x7dp-+7bvBu&^&bVFC;K*-b!i~700S?YBB=)`rI)_MnS zIG&hrZ2p4vmHO*bHeDa*b*aau4P!HXvu&6*CtnU&{n7n$!OuIl_?i06S=4u5?Vx!{ zl8??FYo`t0N-sJ#G52ks^j~&Om^RJN-0zhoi}!h=`x!H@-eb?Re;Uycz}1cj7GHaG z%4Y0>^3`kiow%O$>B@^HtHFWSXio$%o{jV~X&H;@MS44rYoC0PB3!xGuW+;0rkGPc z5enWD4%Zlj?6yv;m=`{S>pem*_Iw;ax9HvaM%uBb!8ZO+M8PY58R&aW?`GpsQ^w$L zhfeVX%-f9S?rk;w8jr-jH5@wLy8EXCjF)}1PHm0OE;!@slLh}}b{_sK`dq=8y1UWy z_smQmQoT@kRz*41^t|Urm8~kP>_4dLg~w=|?de{0@6Vc&qCUxLv#NFnm;0!OOiVkM zKO_DFZ9@6d_g3f1CNs5|{zuP_I;)*{PQjqkyktY-gn_Dyxuc(0t{YYEUuSTra^p&i zUM)MGFSoU@-WkEWUDL4W*?QVQl{{W*AE$vkJuh6ovfyIiy}l0;{rFjJ*L6Jj^)?Y9 zclV7ys6OwDL5uq6z+r}QH?;e&%o}KOT*F93&9C*QR^l>R@39&!%Q9P@YDeF3{^D`% zXUXml=eh|eyG2||p?}dWzM;@ZdHSg8S-+msdve9g;DyDCk(E<@XQWh0qOO+dEt*lS z>-Fx|<3BGh*YLg1hhHR38SrT6oEc|+*>ElVm#2CG-75Q;EVC`lb=-H@-$K8+^+Wxe zW99pt^BSuAESfi5sFI{+Za;!~dY;AJ1Q*kg+MFV;IBi6<*Ujf=T^Da~6fQawCcF^- zN))-UHfihj%s`(4NssxzC@M|$j*0BsyIZ$8THU(M|8HLKVYYRn> z!e#`Id3EvpHY1-c#}r!G!qt`z*CKuI-##_?;K!>?yGBP|9TO(F9erim_9p?0w1rn$ zOSj({ylR7rJMY|u(y@o0ZCiByn6s9S&z4VR{M$M6et+mfYjg9OQ@+Z55hL;$LpO=0 z==iWUEmkK__ngKb3o2Lp6hAv>QFLU{7+2pHFIQwS?UNE#@zy;bbhYf0=j4I$mk(UC zI)&jhC^>eV?z(XU%kJ2<{1>lk zA6O+^b!hVc%z1U>DP8F8`z5yUE$_w&?@vcX=VrI2O(<}B~}R`axK+VpdJiHmG|+nhVEcfsL)S^ttT`igqq3#LyC+B z61(YHoYzZtxSs((tm_>Vt?e;I5&@|?O zja||a-K9s)9?OIuro#{0+4{4`r8kTjV`FEbv6nd~=;YVOqgHP2pF)8v~W-07Qd zgtu*qRC-;>9k7d*+cfl(g4OWd@Gp(FQg!k_Pix)#vlaYHttQTmXRSVr=+OrM(x==_ z&%@i;kxKl^mQg*U0<^~q=hFph*#Yo-1rccluDneXY);U>1)t=D)!@>ATaiM2 za)1>uz<}4Il*wN_TUuwXnaT$%_^GArwa2tcO?9pWWVP-U>a6eCt=q42{vBj#{}W`%uuHlMj(@Vk zE5}4t@rydYpW~Z#%e2*}Yq&hIH|h6wq?hjD$cO!Ye;xRAj`=#j?n5^gGFs~&d2PMf zGGnE>|A@JspZ#2tuBrt@ z&=ey+brB5@z{;YJ;@7}EhgLj{@6;3KtHj3w! zhTNQ_BCw7h+%{P+WZ=rSUV=4mFJDkhUNCKbd-r_S9<%*D!p)Bv-l`q*($+>aRe7>_ zP*eH+g;@`uyWTI?DCj=KA$M&0^j-JEQw?0QqF2w_UKfhk7F(Y4`e(y3Hjxh}X@_io)375>IlP9QcE)KvbRsod_pWrNS!)vLGq7)$?0 z+LfouUmh7*x@}GEsLA!+a_=b3;ICb+Ul>@rEbEvcz)vyAPR*d(J_UW<=g$&mM5m_- zkLRt5j~no9^W*zJs|v=RoOj>~Pm;p&7ku_$`88HL@G?bWS^`g0S6IyOYZR4wOTIl4 zNSeZnlT1ZvvBeDG$8sm0DKE{D~S=in--dbHhD^erQek=ZI1vA))%F#-k8GX#>_NJ&$k1EamA`VvEQ z^;>zG>uXkP)iW(#K+_{Zf}~ATEGl4CZO9ZgCU9EY4*Ch3Tsbhb3|G$mNbfAsr*fgU zB#GnSnCn2#dbM40H&$2|2cJmztc<}CmX~^SgrAM>Ncv@o-#ubv1vVC1eB06zmL+U+ zZ9SAF{8S(j*U}`-;$OsH#2GEc@WASFN&DA;fc6P2VQvje)F5O@K5u9*EAXzYiD$7S zH4-5&OW2(Ig;6(De4}2MQB-Q|LgR_xM~Nihj|^kZtqjY63*jj(*IG(BS5mUXEiqZb z(yXF_;hbs1S?wZY*Q=t2NDfO_x}6u;D2i(?C=P6^-CoaXkwj;Mp&6g5*dnNwDy7IF6Kyfi^=b|@v zk{FVfW)`PaT*HtgS@5!2+iJoa(_&mXGq&txv`NG*)x{ifC9NiU_|3x4UmqpB5mntOm(+dy`c#<4l1y%I z$*3tvkepB91qz=TOX|H{Kj*%yNeB=;5^%)DDdL7gNxLvb@}P0sQ+oLgQf$?LOOP;ugx-yKnD+r4MIBo!BKaWZzgGH!fp z7{Up7z-SPavqt-~(nY`ezk7a564fHEs9qqs#~US}tMGUlf$i^Io#CGtNYztll&8L(sYc$!2jvaKq2(dP7>hINcq?q{Z)*(TRJ z!cUPLNyBFzL)cJLC2(!1VLcHVH$F3V<%?K{TRz?qe~xq&iw|%_nQdh=zSiCoJ-S!E z`5mKWQeC9_A=k<+r@oxpG1)$`ebLZJ^&r>EkCWAYYVbdGza=Si@Te{JnL|gZ*uRbs zJpYI3mbME^^6!5vSf)E7DPe;`{$>v#CWkM{Y`eA_-g zhQCV6(1yRNTMvJAJC69PI^qwFDo18AL_1=%&5{yQE^9S>Q#fX}#-734`PkW>u~H|c zvg(`J5)=57RWseIzb!h}u+YVxu|_AQs;b?`+@+|nwZ=2^L~LX6%N>)9YZ9(Cc)27q zYK-4VrnNU1R|+FpIy}i$pLEeLU)s|eQby1??JQ+ZdzH{=YGBXpr@wgE78_MeRV$8) zclv6k;W4^+e*9Uh={{l2s^vOuW~v_A#U}AgtK2PNO{!%&&1SYyJ@@R`(w}C{=w%x+ z?Cg{Idq*$UnDFUlWkq(DzdzeJDgOPIz=&e?x~Ub#QKy}9b`C$SXPNTeWAx+sr_WBA z9uQWo`dR0;**6dE$0nzlQ*!;os#I%rZkq8uVEG#~?DXJ!)1NqWAE0MDdZNZ~70u9y z+n;yrh@e|p<nUkP5EhVIJ#?)OD{J_o%?R|5 zpaXOg} z=abn)kF~{5;?FX2H-$B*KGUf-8|$&Om>th#1V`B`_iT7SZ0Mdql_(`^o3m&8FE~GX z)t?&+a^2h88%zVO82QC8DN`#RtBX}X?i_h))H|K4jdKFS-lQtsoG2#+5cX2@D8Q6F+UIQsT>++Gvn-UQ47+B&>|aZ3kq7A+O;{S>6MKk zmJTgui8V2sPVe=&|JbNiXTRA|kMob`C!GChx?fnGsz@iyEW+dXW0M5tPr19oKC23K zLblEsws(|bL;r7!cF#~6pwc&Vugy%o-@Pn{4z0{EPT79PxS00UdrPCfdp$57lk=hkCsdLl#F3D*1Vtt>Q;L zg;gPQqjawRyySlGmwGD~kJMiiGh*j}Lc^%x`!?s@Ug?sWqP;Xcr=Ui(%P`Y2fqBI8 zRBzKtlS;iYH+!rZuAjT4-Ewq={E;0C9RQCxs2KQBe9cHvDnBU*@;(!6y9v+^$ zZ?&fF;d{4Mt}spEI;mcsUQyW?cxTI-ilUw2mZR2S)U)56+-cwXDK03QT(rY>|CQY* zlpe5SrmNU0Ul=wiG3a_!zmn;_?<<`cX0|Hma#Y`|)9;<1V_Rf6`>Xyj$6+%ERPNuF zm$}l_l-(~hvRK&UwJSXL1Gxc<8;|*h@d}*U#6i-M=$0Yo*%|6*_BC%`VqF1p!S%1&$~~ z%i0ww{4}lZQs;-3Ac%9#yBE-OnzQQx@6LN;*RN^Dt+lc3qF=;43|I=$oIMYC+3$^+ zU(-xlHym%DHdj2{fTbSI+5do-_ukn3Yno|m?eX@2xndgw)`({@=oPdMoMaAKg* zvz8lkD+TaF(ZoQrXD!d+Z_Ez5KAsq8`K+Z0{>Dt=Ab2jUB_`#$-)kq7Z=iHi1h-O9 zzJbzV)o*sq!}tc)UxH!1sm$7s@eO?A1jB-U(nR?N62pRiGDP_X;)cW9dPK#doX1-+o=RsnzsW`(Wq5{^J?SvGmZw;+(4R zim%T$wQj!EKGivJ*m#CoEPY=gEV#qpeOB3x~J!ldOwJMc!U3}M zIY6gXV09V{D4?JveCk8M6kaL$PQ@gh1O|%gr8vZgY@=Fb#&4g|;DpVFl!&bsB64 z_M>%L9#K)Gvve5NC#WbAq{(HY0cDnzIdmyYT=Ps_667^>r~Oa%I~P98yL-X*;jQD* zDhur{+D^KlcO&u8pV7TbY){&nt<$@bc<_4ks`pD)9#?aIY~p?VsdF}a?eW7aW^LE0 zSba41uuDO6l2&D1b>7`E%?d+YR0q5NRAo0tOCf3an97y*hPERw41b;&_UDl)3mpd8 zj#xMRQDW%zBjzRcM-DIF$DFn4r`$~DET3MvzcFX|>XfeziCy3_YuAvn1eXY5oR)$` z8Exwh(@i(3j*j}nS@qQZ#E1hwT^JUVxPNirCxiJy>UQ4+L47BuyPtwesy^{ngGzcD*j>J0_m|Giuqw z*`Mqb*6GhnJaIj0Ny)5Nb`!Q3nHDLH_c(4*v^Lpo>BOS@2x0@Y#We z9gQpBI=2V)Gw$6l|J2vSqX&W(9X`6*bd+Y|k;RACFPy&KZpejEeG?B)JiMmFW|^Jt zx=|1AU%6*8;?^nV8f5uf#S(qpvO^o%tt(p@vr$z<%HHLGHuu9&q$r)qU#X{zXB-mP?EfB^-C z7Uu@zG|*-rVt`O@@3~lDSxpR(sQ2+L7##^;Z~1S?ENuaFq@PPx{Z7=56hKEd;&$ZD z)~p)bj%@rIP>kD=HC4jXxE)zsD42%Zk*B5g#)L>1Ak-TZBIUdxTUI&)>T0=U8RLHJ zKE}jDF-sE~TMrM#1hkw&K`3sES5ygeaKDCMz6MmFLWL{54!@wn8FUUj6mt`CVBlNShJ*o%?xKEaV1U9P)Gsy+kf=8%_yon) zL%lHpQqCLF-*l+=cwQuQ)Be2?3aU%!g(<96ixD&b+=j=Wze7=hc7hhyt! z<8~wr5bBM&nt}mBy)oZ4a^8>)c{^^W`!gE8itgcd*W#NBDb07bZ`0Wd%z?ui8qkf=B2#s|7@+7OE=E>W31e_E@?oLC=zr3Yl7eILmCKS9e$|LyxH^k}dS}mtiEUZ&lAl#p z`ybsZXxJO7v>|xO;Kb;yhrN!>_0r6ryQ!D^)8p%sSB=#*d%5~{VMy#4<7k)qW;(rc zbE_D@J`O%eFJLVnj`}#f zT>r#t!-x}aRq}r`edhdNsrj0#gl2Q9URBs%i9!a~X4YocKE7W0RMp!E|VBy|)W7 z#{9*=PRBUUJ@qhg|ABwW^!F>VyKQS>XOO1iZg6W)>e`}-P7{tDJi(t(zB;GyXslhz zc428jODjXdY87(?U>S}aN)JZ**pUSVcdLYqT>+}jSwCsojnq<4nsDLW%6~-!CI)Xk zGQMQqkq1|Djw>g-jU8n6C?;aHyFtd>?I*rWs9If8TP_Bxw7)+*O7eRtJU0%dGNqO7 zZ@-G@cdUAk=b@A)a2oL_$+hOdZc- z>>!?Lajr+w@C)x(zFTbI=zRHKi9@zV*_X_`Z8ss^QQItAGh(Lux%4Bco<*x-KaN*- zIhQ$i*PSw!e?&o*P|=upCJO9CMmF5?m%!mMJQEKW>6yec5rI26wjQ2|_hx~H5d~wu z`sBF@MG%|;T?jAJ2bf(r3c3*K}M_WEb$JWC$5xWr9rqP&P z=m1a%3vxUtd{8KWXCgwO959x zAhsUHh}Sc&nf@?F#HI!s-~i^g4$2E-#DfKSZb7j&2lhSiaV4l<66hJ!DI}U2wZ_oV zxJ?MKfch;Vng;c23|)p}@^xWh3QUC=P_OhhP@<0j-V z@_BIVV+>u0iiJRAz%%i>kON&vus3L37#mv;&qVA(*l@>UcA+bDA?k*^uuuTc#Cst_ z!-xwpp-`TiP^>M1%?S&-kT5@?bz!9RnTTBoo0CY)E@VI#qVABvNCnTt>p}^7qYqJ0WSH4uo-`_^FdzF9+opRJdCXacgfy7S5g=*3!8-WS9s z96I(8Yp{pNLLXv1_7HiIkwJw5*0(n8TmC+s*X+Qd7l?Mc6t!CEPVxH~!mO^u@57;2 zBOH2lC2Cc=904w#;`cizuyp7`{5~9dm4alGqR%^{)r7Z`D@C7oQZ+2cEeM*GCeZJ7 zC2Ccw45#@0PK!vp62H%*R|?==(v_%H(&0hz`<=CTz!_DS;rBsM&j3L^y$eyRq@W(S zc#7ZelvS%s@%tiEF$n6r6tya~yKyLfzf&eMIQ8jD{61_>1h6^jO4O=!a{^pE#qW2{ z;ntP-eb}4`0U0RzoTAUAam@eZ!sfGHUiEP<+&1jMZ;LJ#`M;dnsFY~i6ksU{(swk$yr0at>9IPUR4E_VA7l8&;$o0$8Qhz!5TK z0q<0H455~hV+%N?Q|N3E6dWPD!V$7DWtaW?QBY(TQk-sQ2}Pz^U{!$;axiTS z1TBtg0;jSZIvZg}#fkjwuq#l2)r0MkvVeCsM^T?!qtg_H%nvxko?cp+0c1f6;z z%W)IJ=7f+G%W3O2#-j~>TP zh1z2z##5p8RH(h}h;_psC5B!HusG9*gsllfN4V^WJ$#Dx(q4r4kcTtLl|I3O7 zAW*1KdyLyP<(W(-jh*q*dCTc>v=@!<97ekFFdZ7u8!(p20HZtY23TQt#W!m)!V_!G)k=M)}|wM*G9 zl^&pq`pkxKEu9<`)o)+;;3kNPVT z@etWMIm*io7rJ=LivL! zfAHTq=j%#0vs3?nhyXC0|9Xdf?pX5Xzo} zK*azW(*K$FJttXRXuoAuY0$U>_8)n-R!@xldH>=Sv5j=w;p#gWBY8xI|qPj0EpH2pWTicriN-TUWqD&JCCv z0dH{7002#lBaaGi08<2}uD}GiG&-WLU?^eD!PFJx%6Svkhc`5VY7+6TUun}|-t|j# zHJnGl7;%<;(ytw2G_DjEFwabgp20jbkv28vnF;Z&!#pz~U_qW+P-GHlHJ*qJ5I?{X z%dn(h5=^a(6j?E22#6Xd0J6SEQYlEA5K}87MOHYDj>dewJ0NCZNO9&tp#YwVv;UR8 z-sQLn1-UKoE&*MO5YQ0kbe8Bszfwagiy0L8LEa%q$E73V8s9Sob|jp-_&Skj02#z=j)BrXcOYTxePFR42g_vE4DN~SQA!ZB# zfrT9C!Ya%zjFmnUNA@7?LPV{MvPZti;q(L!g<_{WnQAY6Q*|YF8qgIv zdO^yezycA;^-dCbh!P3drtG5F-^HD|g^dy*bXE#X>>GiOK{IVgaSKs^5D2P3ikN(-Wg+mCQJ4*Js_xjfwGFqwGs&-nN^N z?x<~+tr;=X{apHyRL`PSu^-2)yPV6MyX#IF`F`(8>@-6P)?G;=0TM{!$ctj97jI5A zn3QJqt6F?45vC|9l@=pF4wQS++Pj(9H^yej>_@AfR6m&Uu zx{}y%cPWWPpf(FOClou~IUgCkkh>B)O>R!Ql0*VFC&;Px6g!Pzj-(_K_b$xs#HBUZ zO$eJ4}G6`%ihHK`Z2_(YChKb_Rq29Sgz09-@#;mb8 zk?whULdK2M{G}T%o4wH0jX0QZ;C?MNkGtN}?53_|M11~u_cYUVnsw-O!I;sLBl?w> zo_TL#xs@LBT1!u0cRxUV3q8~-Yk#rUx60N%oAf2Few<;a9z1fMxa4H{s_Lt$5BV?h z2f1HKeZ17$)5LsGT*RaNf$o=5A920-Ccc9*BFgjMTlLiJSDtj{t;v+FuE9rg`A-7+ zZ*dKIJxWh7?|y(rTZ^HU>yy&PUKJ#tCMl?L4cCs;M)$?+03mUvU-mUe|c6o?0uF}x`Rz! zT$FJ1w+2W5tTPG4S|Qhjl2^iB6<@rne@iXl8<@o&bX=2W{z7}h!EO1w+=EjaBAH>Z-1CUt>t>EQ zS8-ry)Peb968j&sc^)-qX&=oQi)S32@#hSUnf)9GyFQ5&^_e0{kR*tNd+b>sOr3I) zxmQe_a=o}4-Ny0z`Q1Iu*5dcAb(`k7`ygA{Ja-^hrOb`KRKsSx%^y)VOH~}F8#2c& z?!Q27!GHzo3p9ROyxHHHAu#^%ZG?o?Tn~?aSm3Oju`(^kxo-wDE$9Z@lHc7g$AxWi zIk<`4-8{#DtGe9H$TK*=ZGlp{QjCoXbIjtt7ea2#x1KR`hTV*LGZws`pV!b!^on!l z8C@cI$$>`~(|tzr_m`{qOyY-?_kNL6$5!Mk`(?jj_j{4so2wM(X66}mh26I~Xr|u# z;fqzqg#0moQsRIYHoep|)kdmKQk!{rx@LjaH$TZ9`=suYYb@6%A18N1d87wC(xNB% z$o)8v+zyW{=uJNIHNqpqwZ7fp*tO)$%hB>0VDHnbdJb1JL$i84w{J$@%c12=8dtq} z&mHEF%i(?5YUbH%xILCLb@>VhZ0^rIudz_+m$U0_M_vw98E!ay&hYia_YV&@JY>9< z75ybNF2wk?{;6t}q8PT3uTjx+wyv-4(molvL)oMFz5H_jcU>tqsOV#%?0U;?@*~aT zMocIElH-?{7JPH|K;Q6bZVuc&&0*WvL(T8b;`WSV_VEne$fk`|(bGD+&{l73=taF4 z_CUkE=l71@cYfdK{ev$~&N?HKe%`E2(VI>hnP4=zQ2KfOD-0?oI=Ll>tVmtXOb#n& zm)%{)9n!pe8q=7o`yzW6x0^0g-7{<)Tk~eN6?=4ubI2UMP`1X!u*Esc&JX)-_;32Z z8T>YS%lUULdzz)6mnh7-;PVoNdFC9HKEOB6D>QwOZ?2cZ2Ih9ILUYI+ zH}9p2wM+%ika=vKn|GIRdkgRW)_;qdVW>vV!t;X`DsMQuXYc;KNA{lF``i7q`z!mr z;^`Bg7YdV<-UH+Na$VjV(d9`RG>*k-1}b#Z zp)Ns~b!oplFNcO&7e%iDfp0M(0%nkyNJQv{8H9;Mgl?EYVj}Stcf<_BL?S|jT(@Fw zpSE;ZFYb#ANkFZO1JvanYF*wLRE$Eci#k9ADs;mP5)+9B-NX#SL?S{r%wQl)B;Mu< zX7CG4BqBt}bt_iDnF&w79k!FksC9u;gFw_(HwT~_cS{L7URP9zfEgqv5)ry#262yH zU2lCyDU-ksndk+YNRksBybn8N0P@$U#bvcL%-TCu!yip+nW{{Xj zJm`iQ`~nk+2;DG)Fp-F>JD9`3Kn@(ep$qXSei!H_C0Af-bG00j`IdW?P8MA?+tfq?SoUX-rlj5f?CckibA^=$o#d%{0s=5~EU7$rkMAwpE zz)GwD-d7ao-B}SZ2pYQ>=PlJ-b}{({$YOk8<3e%X2!dip*W$bzdJz!Owd5Bdiy`#< z6zAPp*9vR^UAq?NE%h9LYM?90FF+Ra1`aJL&Kto{)5SP%e`|mUUe}UeeAy%B1G_44Nh!0BkEf6ixxqz03j;_XlWrhbS0iZ z)Z+M&KWxC~e7*5G-vAym=L>3y0(?0FVdwu}%Mm1=uYO8?pLuoG(=m6}JH)gquRJnl zHP3L8BxtJh@7+Wt6Vm%vY}{p<`&<7Kd*Ww`& zS(n9ye0C1{%wBF<>gLDq$5!**J%l-mtK%EAf@#s=xHboqwGQMR*q_%Z>2m;F|0;1m zf&^AM=CvsXjAK1%HmFDt2^2Sa54h>m>t?Q3o^$Z$R7>!ZclQm6ck|%(@(nF_`)-lu z_7vV-19=Biz*}xS79tc3J^vCU;HX(k|K`yed=nG~d=6u+Uo<=3h&{yDsCtlRWI5y; z^ka|U_q5C%&o<)s?(o7Ja23t}{U_&OfAUX?0n6V=ZOmXH^{n1iq{;1+WT$X5Q59kImmGV94#sf`&-xJll4)f4?KRobP zFRl~?ACuac2@`Hy`cRD8T+jSYNOFssj$>4&s>2VyCbH!bPl$%!G?r7m|=fgb31v ziwO~Mstpr~2oWS9i3kxgZX6LJa7NFqW6$&DjIgnYMR;FA#JZ54dc?Z8!b%K0^@tEbdg>7&g47ovLIejO0wxj>B47q#A`u}%u3HgU zUWV8kdYe!H?f^xLmVq?784!6auL z!~f*h@IN^Z`;!B4NfF8zJxOUB5Y#qu-->P4yjW>2Hbp3RT602a8!+Tgu>O%>ZG-3x z9f(UhEOaSCxigYMLY78p8xUk^^4*GoPm1BV%z+}5J1-ZM1&kx^g(+=AXSLL@x|5l$ zQI2KcxU3Xb-9Sq~z&PS@8AT{#D2gd<1H$SKvlW53^aG_gMJQv`h0-=4m=5H+6`#}E z2-g8~I`Ft1xo$*Qi50_2j3Sf~R>+jL0mEh} z*R2REvF)%DqX=b$m6+_l0K^wGrENesXT#Js0Lz;oNrN+Fp1UYm{1RC28XP-v8aA0K z0v9O0UECetE}np|a1brSS2zgp6%MWlpZtsD<@H$S*(cWY{e97tjJoIkYLip@nrH1! ztzks{&RHfdTF#LlhobZD8l-bMUn0@%YmNUJ%ijbi&3o;Z` zEWy34*8G>igNysy2$hO#JzVa5AibaOU9W6sn&nCXZcOHc3& z8^_l2486moLnOl>h-5J0g9Uyjx6hAcf{TWqq^S|)#?04eT=f)g_l#aX)A)PKA(B8B zOzYrQH~4OVS6%LA%vJHrwE|E5MDWxv;VL^$-_O?i5k;}s@lUCigj96%tCtmFR2o7k zWE-c4;eqZ5T2+L54v026(wYcw? z9G4&22@4$;NC-KSOwk>;!L&5HA9vjGTIOv2X$Z7{ga?RrFwd4*^w)5E_+>BQ>NW>~ z>tD?<^m>jxgfWEN`4N?oc=0zeq4JR_x-CjqcD@rugak>h8xf8OZbIA$8DP)FD+?rU z_~)X2`^dZq#NH+Y?AdsoBfCoh5g=d&VImQ~e!Ad)0HOh}xp{C%027IbVRGGy5Glh0 z;3o4T5bGk#i$JUksi{D$i!3h!4zc5=4lQ$$Ri1f(9}Yh%Ui{2w8NAoVFrF z%A`rJy(ex0K&*=_F9NSFGI6OWK*YMpZTSLY8%a z2N4W_2$)Djh#<2L5FtXYTk#_30l;-D(*xkug#&c~HXE@nq`@4qF2-I1#P2YnTc!s< zgb0})01qN$SqF#^L1rBwLWEqmBH{a&c>93we>R~9Xjc4OgF~^E!lPt{da(hMfx(IK zZZg)w<%EQxzS%-qh(Ug~W#QAvk=Qh{C^*oIMchz91n0w~He;}~-!@2RQ5u}jie@KZ zu%Ns$I&s4+ab*B-^CAqoTl7*&#!Isvc>4Sr1UmUcJ$7rhSrhwz*k}Tgj!0<{yExRH zDoum#{~q4iyw+m#!wbf+6DxKz-&d3ka>69g@L#zr3mHDN&BRN zDjub6K#=xfwjvOhAatV$WemwBrENff2>EVBxC;X|E(x&Dpa|v8N}efg1A^vRzFQIQ z!T{ouB9sv<2LvS#6N$J1q_hnP8$bwuAu?c4HX1-&3gEniB9t-eLTMWiHs*5Oia=a? z0C7nX$_T4&O51?30hH@j1ix4Y_{Atf8DZ5;X&W#+uX5dr;AwW1q@{!J|97#q#1pt* z9B=N2{{W5bjZY&7@bGEm0&E&t46X}&g~JVeg+o2Q!a?kbuW;Cot#A;XA@={UKLR41 z9VcX&e;(|##pT!EKOB8?A*;w(Z~x-xfP_Z+{oF|^PmIS!_fdOuPHRZD%H;yDJm=uP z+#yVL&#=!-MXs7J*#E&4E;H&k?;$PqzTkkj|8H-VCmryf)l-TzmqrqylDce5aMG)m z<@RHb;Dh}i;t6C%eSR;}QqPC1gLt-*A)0L4aU=FnA}7e)ZF|T( zw$9D)e|b|q5uWf;ImTuRQ|)5dVy5~JkN)M0OC@I@YgaZgCu&Wc+@|>&RS)vKTc;G~ zX68w=ynBcZ_J1OsK$qXo@9t@~7HO%!3isY`{crERmnkaDN}0)bckziNmEGlP=Gkkw zLw$D-VM5RYkxn2p>Kl`m`cCs1o2pNx!2N5!l zJ|aYr9(_cJkn2{2Xh3&}29)vGcy*xzUn;$V0}Hxk9(}~R$UORZ5Fz8S5h3FH6&z^L zO(Q+}cn~4;=p#aeT(=^esHMYtQO0BALAL|c1svvxbs;_ah;@;9^zk4<#$)3_cgGbR zXxqPzD>$$=R}9jlj|dTR-HM+SMX+C!@z{va4VyLc3J$EgaA4Ifja^4ub;~^Zcn|>_ zePSXJA%f(w5g|h6(Z_=bS6D^BL?S{2DXEatR)hp5V@O~kd2GbGbliJ@b?C%{x`4wR zu`Z-XAF(bLq(>ibbtm)aBSN>#qmKs>-eg<^B1Fh_E4Ep);Ji}CVXYiI>RZ93*kUrfQ3b@3+d5E ztc%Q}j|bf{k3J$q$ari#=$3i(5g~%~=p(KoIvfZ-Br+e^6s0@Ki^f*d6xFSB=&cn z1r@pc(_ICfr@P?-BqHZt{E|gXD$^2!PG-eQbL5He2ylp%b)K$;MoGdHXy9-Fk2CbOAva?jM0ck zjufGcu)3qP4H(uE%vNl(=EPbkQ-m@`T_|k>21Jne4WJ5jTiNE&rPmR9xQmRu;xbkhTgSq(>!+{ zB)sMWxhhhRzGpBQOfVjT32c_CI8HZYj$7P+f!cxr3)B~A{Iqy;J8{ngi1*>%gNlhx zZpk4lQkOH6!zOVz61Myo*}J&ibcxV|acs@z-P4%H+}>m`finaXgt9dtM<8d}510Oy z^Y2=Sn>}3N3>viT>yqy}D`%`s%W>|zfn7$}@-GKBvAdfSp$E&|jQHLCa$MMbo5P4; zf^?-A8x`i5#eFY?-1y4RRlr4hFLrHZvo1y5<{ z!QCZXh31euZn|VJ!4@^cP>r00kRzbH;V&-zv->M)uXxhW3!CPo^d3GV`TNUNd?sDa z_Uc2}^83BW?ah^j9t2%sEAo~7vdzh0g7?E0tBeWx19Aigy!eYtf4XLY^v(>@rEl-k zt9lMsGefg_{nFs_fkZyUkjvqH+0xL19?O|Du6pyHjj~{ZnddbYD*XaE0wXVnsth+A zK4&p+r>a$oV%SE$Mn%ury)(uU`4Cf<(sbRVp$ENg<_u+z;`b_( z1rr>AV1oX~AV*-%(mp@pBKkQFmPT{H=Y_&dex!Nai0Q;%a{LmrukUhhU*GU;?4jm& zXAz+XeLO>_xjAtA+>`|qXhAT6-q_HKdNJ&QKjI<=U!2^2#v2+(W`Rd63u%Ez{Lmy# zjM&>e(gKgzIiv+1r!LZv9GL|k@#{w_77&}8Ok>z|(#XUqCz*T2#3^?W|0WSF@^>*z zzFRTyi9j?jM`nRXtP5#@N308}SU{|cj3!2e2+{(N2oaBrWiWb%9+pVSz`i3u%EztP4pKBSHkR(T9mdgb0{Hm`Fs3Ak!ES zAws5DK!ganZp8{k(HowAJ86MOtP5#@$E*uU6C>7zq=^wB!ke_fBSHjefk%W0Qn7#t z5j=nhm`Fs3kn2|b5-jF}@$Ica1sJ#y>q1)K5$nQ$x&YsfSQpX)j|dT@1s)M1Sg-+v ziA015Qn7#t5wbJ}Jcy9*R&23m2_Pi{pc@R_h;<X!}#DI zz3Fu42_i8NMD(p$b}hwXk#$X6NFxRl7{HU9X`GkCYObeE;pv~ML15b8q){;*Uf9>b zsorW(F%^T3UsD;B=D~JG=2%DE&U7vQm()K|QUnAgo_x1r`x!c@$mp=m1R@=A zn|XI$4h@w=kZb;z)E`n(1OyeCe79oYlVaGoI8gj==k>p`@C3w@C`yWeu)33lC!idP zf{LsZRAdzYi%}O!ih!^Ild z_+Ny&FeoVkf&opgTM<-b<-j#j{BP%McT&QDk|H1&K;^p?6X@SQOT_gOc*97B!pe+M zCK^_R;oB4g_eq;luHR13@=0+$QM{#T_>UCeKQa>kk;V9r{123;9)FYx_>bgaKQizM zvHiz1JAijP>cIa#&25}Cn1DzR@a8Ih&nNH< zo~f7E-!SxO&KyV)=%f2@QUnJ0X!7@z5Ax{?Spr~U_Pe`G8caZ>2fSg^I`Rp6AF#32 zgA{?#7)TKqX#Q_f1V&aHa(iV=svZPc0uaQ|y!!?jOaSQtkm%5nPtbQ@Xp{}42&foA zioiI}kpDhKU`~-EyN~aNqDhb?;LWz=ci%t;6F_QMZ*X(szj52nRd|sj&9s2v z2_g*Sd$fi5QVkmw2%s2qIpm_=4Yt}p1W^2A(1AR*BAh=9;RV#;E=Q{iC{%$PPfACt z%Xf7FT3tHa5FyvC2)i72IDhVNmt)nXgVM#S zONYB0tu7tv0xXE=2s%K6i0|qGG>8Cw1~HNAlCdD7Bj^APBILRi;ruxrP6xib%hBr6 zp)NqH%XfD2Q~$LHBoeIT}R343a?yXb|yTU4RA=9YF_J5a9|CAq_e}g9y29 z#V^5u^>AgzcXv5jT{_eSSasojr*zTk^4(pI1`!rs(uthtga#1+-7t}e(EVLqfCdrX z--8a&AVRKN5nRlWdfMSGM}zL~lrCCbI^5-0b?I=Iqd`PR&;b@iFutn`&>-S_&;c4m zbOaq>L4z4&a-W-CxjLNHm%pb z8}t!)oxpnOEGCF#27LtD@|y=~(C5ptBQUrf4t8r+CxLm2*HuZg%6hixI8 zDcJj01ph$Ft4WN9tV&IbmFu+hGI)Zhoog&c@3@~!tieP}L2LlX6q9d%j#T1E- zumP0oRs3J1dUkE(Ehyz;-^KaZthl54*9AMc;1gaiN9<}E2ccc*g7W3vs~@g*+< z>c32y5q)f2t5@Mk$eUB=OJCFc zFF67i_czg&y^-D<0jDi->HU0q-7N6Ra}FNDF3UZ{R`-Os1T%h*j2th*vM*&~J@*8- znSo2+5}eVa#)3=V(DN@j0*;!s^y`^YwF1a0%zcJbt9VA1?@#Y->6R8gggJ`aO_%Ax z?d2OesxS0TNlQK$f6Dqo12U} z@T{Ivq{$tcq3P4t_pTSsGRL0X-8| ze?(9$alFiWBJZtuiT*7B>O%U<5$htO#u4j6`pXgPLi)=wA%cuLK!gaA8b^c(S=0d{ zM37Mjh!7#yt@xbQmJ07H(qE2P7aHj=$E%Bs8b_=P=`Tlw2s)hO!$jgigp3+Tga}fl zfd~-{SVh1@B0_{*x8f&7k@FjUS$aKUT}Wyivo55+9I-B>zZ?-F8~`G~sE-H{BsGo* z5oFW>B19wrM8HHMLIfFgAg8U^6dVZqwLsEej#w9x8b_>)E7S#bODT&wK&%VwCt)HH zAwoutBSHksAWS48M1XUGm`Fs3kn2`#v*yHtdWQ6uBi4na#u4k{P5R3b>q7d=5g~$% zIzWU79;wnmgl;nG01+ZAq)`W$5FyvCC_2M{0}}?+1&sQLbs?#7#JZ6Fa>Tl@VATyq zeME>LqYe-uLPm|_L4+*o01+a{r~^cZkndIue8Ph>RhhpWu`VPvj#wAcUyfK84nPDL z^${V0j5aBqxS$YVf$}3U|M3Z8;oO& zwSLiG2vYo}g>o4NdDoWSPRt@<`-e&8KE_};QmTkql-mAbQhhP#wm@TI7ApwbKTPUP z43_bmM=LRl60rTlq_X2NC^rsvYkpD;=yH55$qSOUf5aCAY5PY+U()uE_?CsuI^;1R zzQSDLwT-&_muukw5SJS%LYdMwP}+w7k#Gly%Pb%+DMA@Rb3$nwFf?Cs-HJe5E`>!c zY5PZ9mQaK;f-H^FHekroFk2Cb%kdqyf5f9Licm&St}-ZXL#GtQm#F^+%nKR_dAjl-vr z1Mq2NIyQ|Ag>lALIF#Zm95}J~3Wsa>3I`sx!l5ZR3-WnNQ+?Q=8@9u`H`4F#;DgXZ{r_Tb+3yn2zfJv00~##A^~|xMDQX3P3hdAsBnHj!30tgB?GOf42c>YTO%1@ z60mTAo`bY#q)9opVt}|22q!0nB$HA+rvY+og^g*LqBcPp2v$fi$;{km&sy_>{!Tyr zH4neLTlPNy+3WkAXRY;pUKT>g#p@CM@~5;6Q6s7+v^_WehT%FTg7RxZXl+Kdj}MhAGNGYgWUH%82UTA>Q|g zH9P$rHsF|321LxgC$w zTf;(96E-REs+Z(Uc13s9#;cLqJN56t4UYHU%hw%n%njxUEJ&X(9)ZX65zlRXcKhyo zPuI>>SKfQN?qyfMkko{sW@Hki)IF&VZC^7%iL0#J*?$3C|Ie65rAI$qydxOz@Yb%K z-D!wJ#P_}eJHVtx%PQ9FP@0xj*srR?bAqV}DGnI^Eo+Y}Q(e8Ya*{3fnIqpCkW~D8 z$HTjZd=Qx$jCXi+{>-oJ?Y{552Ccoh;y2m7Q_Y8tW`|wams%UNzFUek#`(4qbDkPj zS-Vi}yK%;&ccn+ZQ@jZQ6miy&c!!-E{v37@0TehcpfL5>o2vR+9l0B;`kh+#(&~_i zgK#Y>A|j>!EP@!;>{X%>K!HSy1yMs0K#}YUiFcS82Pk&>z88jt^;KF9Vo`H^{_s7= zF5ME69}ufWMGUm8J8Vu+du5r2B7kBW5-s9W5J0g|4e{vvI}zUtHvpv*Uo$&e+A_QGZgoq`82rMKKB5*6fLJ}cD*R8lA z;fi)~kxz~Dwp6E}ONn(6{##;QaN^e9Z0Frvq!pY95rQryLPVahf)gP^Siy-9q3c#W z8q>KSlLPtGIB!dpbSbYclA|KlMLspog9sBK0t-om2w?>$LWH18i4b8ER&XLj=(-g@ z4s$mnu~ztRiFFYi6|*ilb;Ey4tc&p95}{lAZ;22g=u#p?2rD@8bXNn2z(NusLf5VM zh24XBr3a_(1nM*}2F}xGnL}S2>aw0%7sQ^LsHbkMptg{_(;ZguG8U2u5m-SiBoQL8 zg56k1B1Gu96+edA{ax>&>RH!n9{I}d(cS(?1!oDq^Bcnc;0}`3^L+MzE}HX?-{R0`*WXTa5{x}{@{x- z=S*Er?a!Tdf{3wZ}Z;Yo_x~ zk5+BZen?^P=YG<2lI-KKRT@hMc%u$d;4VLhaSstMiF~bK$%O5ncrF#TeoB(b<;Xq;I77&*)IF!Q3%mWC6 zP-ZBL3~d8JTEuKc5SOhWE)7DNQ5QqoKoB45x)pH}TLI$IAe0G`OGDexGxe{yP3pQ8 zL0oDV7lTkHNS>Xz@=^uG-G;V-AZ=%A8$ev10dZ*%%7nTY+6IE>K;Nwh;_?z^(gvYS zICUG^2EqkU->rBp%?qQGK`1j$-G;V-Z~@eHD}DjWyu;hnJi6QYuia_hGvGg4IR;BS zCC{Z&{~WfejZb!OxdCK%6`$;`Y3GyO9sCNp&+wHPH8((sk;hhId|^L=UFYWFYw1RB zLpZ?ldF#3nF)llMV~yS(Q;BtRa@Bj5`OnU-nS1r)xs(2fWq;oG`@L&k`PR>GdE$d# zPx`kN$@fiE;t{s%^Op}b!%;rmJT}DruNmQcY3T&xiiW}Uze&6S9}-MpDOWvZSLZl{ zj6^9}fp_mGSd&H4L5c&}2HMN=lU=>49l1)X>sHMO-$x54m>+(B__i5C%!m<456vYw zlfKWLcA=z5$VkjnPv=zBE_N*xK?jy1L>pL(c7(Y9H6whK7EZ9U|MUHmitlqIrboXM znoIEBJ4?Ilrvk8)TTz$2=AgP)1|5WJ(FWnEbwT&P7ReB=g%ivi`RSeMkxv)R+%;rD zXfDC`9y{6|wl|<>YRLskyL2@oS-hwDE! z9x(#f zH(~^mLURd9k}6G4t@7!&P#9OskcPO-jYv231s!bCq761H14Cjcv_ytA2q!?GML)z( zJe-L@i;U1*f|Lx4t+CUm-@?ySJw9c7a*rFayQ~e3Bg5;7WjQv-foJ83ADs%#)hA=l*hUvQ%A)WznOYsb^E>f{T ztcyrvAl4-T^a^4vcn~3jL5L6`#4|*QFo|FgB1DK_5Ds+vAVSxzm;&((_A8-SVAe&X zF%at_(in(!nFoCxVl9XeA;dF8h>+p+yyIsnAOZ_Xga{D~LWBriw_*vzGdM2_#R3t! zwL2X|^~Ab}GzMZ_L>dDTBBXeR2oYF8+Ns+I-MAEVV0mN55s z1L7HCT|^oKu`V`|#z3r#NMj&EgcQ&4AVLO%5FtVYgAgIY1c<;w5+Oq9xOCczU)ntt z0r3p6E+UPASeF{q1!)Y#x`;FeVqJuIh6xcO7=#EBSV1f#5h9l06oG{#LWIz9>9ZBT za3);o@-BpYrT{Z)QDFE=NF0SDUt|uGSvYMHrVgVO%y8Ob6b8 z=dpNB9H^qH2i@#8!LDX3(4EKwH3rd5;tyL zw<5-62X8vQ)({Rb_STzEI8fNw0pijilo^r}L)$&r5KLHna`e<8D3CJnOm@L0mq8 zp`}466HeWRwt;W~)ORa_xZDGFqcF9r8o$ngfQ(j)^+G8KQ`3Ocv>CFj#P!iVZOqll&^5`RFD-87?-WYxXd7w3213(8yE*FUAH2}Wj7yR`VrzZQ}umS z&9M(}c}}v$E)3@Pz+gTjGcx1BB=dyy{_|t!512o2{-FEQpX=7-QE;YczWVzX&~5tJ4f#v zvvb_@yFR|ANx8Hs9jq=-SJY-lR4+Z`$d0Zycl2A46Qd41<#-@7W~i86^=V(bSBVx$ z2USQqh%}E!FhSA5@1#96^PyP}&3S14r{6jHg{Cu;&r$p?drj2<>(Siesv*|;OT$mq zj!?$#DSlBIky7h(>_@@$ZyqX>4q}sv2RRlXm>^=s&)2@X;njb6^^I3|zW?(LpJ?(e znIrIaRj>TJTpOAr^QXAhHK*=bGd*WsX4Hk8>6X<#$9_Ca|Be)ybdZ=HIlkx@2qqYC zYDS;fxY)a5r^L?u=Lh4C`J`s}UYK#_=J#ott;SWywLGInSHG0myP)=GO8lw1m(^Q* z(Ge41`Y&E7lMZI?8nht%pAbxN*Pi0Y#H7U8iO(c%NL-(^*|+s#NQc6_*%H~XO-Z&U zH+-lJwYDjJ+gDFFPuOF>s@&>}j>yWHs75x)q=St}I_Uos1QX28jEZ|G{h`+$`u#(L zX7i61Te<uu>TCw7jI z190l%J88h7kEjFU&re1j5Sv>>9ZWkOw>{as$hC0$Zu3;vS#z|ORkAoU?1H(sFLk7{ z_6a4fvQC6#3`R)C$h(WnM{ZN%lV08R>bM{6`q8)z!^)@mw5Ymn#eR?j;1K}9!4m6Y z68>^xU4*}!SeF>c*zryX4VOCl3D~W$kUWTxQ3phb&~+=Wha3P`MZv)m z>r#rkz+XoOK5Mffy$CnqTfAVP$QIv_&CJU|2%k_ZtZ>VOClx^BgK$N^wY z5F9MAE;uY|{&Henguk3v7x_2??{p{S07Qtu3ery9zSEtEIv_$s4NehQNFqe&x)slb zxe)>=Ianfe3x7GYE*Rv)Urwxxd?$o=>dpg1KvzM82oZHaga{FJKs-e_af-k~5+On; zQ*_#jm+c-`Kn_5xi{N01bupnX@Rt+oBK+mVx`?O)B1A|z01+ZY)B*7nA)^j>5FwQ* zI&H;kX||4l9DrCC;V&oFMf%H$brJq@VqJtBfCv#afCwxk5h6s?0TCiZ)BzJBgd9Mh zt$3{?%@Ul>vZf)YsI zt=L_bfRk7Pu9*h^+f(E=qzDAHlD=E9u<;~RWb+LEx99ppjX}pk5-)3p6oH^K)x;cF zNXlgmDl+ZjV(`C=x)@S~o(X{UFGYZgtNsEw{Y(G?F2LDSq zb(;(+0>J>I>sEw{tQlOB!T%Dx8-^5tU_jG%E0!i)aeF;&UhFX55jdHdn%s9baLhk> zpymI4)-{cso;x*y;wO3+L~`@!ZjI@GyW}>4UCsu(9Q~i%!v7~v^8d*ju$FE7zp|A7 zPdeHEWMShWOv?;DnE;lCw1MHd)O9OjTDAh$f2QeK|8(s?mizv<-uhqe_+<8fPFe9k zc6_k+vBO^_K6+=@TkF4y`SkOtvp=?f|I#nQ+s-^uJ4U@dOG_r0Ir6RkNyV=@X2YT% zHS{l7^atd}xz;uh$&cQ1^irJF-fTvUK>J!P*dWAtjAVk1GaelYi+=GoSoGsl{(?pS zu9hUVPxX|RA(k%X1>Z1i4grp}RnIOLS$1`Bjk4%O|e}bjxzqjbmZpcug ztScI(DDl;c)M)E^#0aQSTChP#dIFLO?v5N;42%Atg|O%^R>QBe=wH{Z+qUn{8SFZ> zeMQa$>$}QOS3fOAV6YZ!5R#sNWP;2=Ga})$9>1rkeB?nT_Bx++cUc?A&4B;?M^%y5 zy4+1weNQdzh^(%=q@_C)XkP8mEP=nKEPnqx?V|(!_oWqUA6K%LRjfIv9(Lp^shYj~ z2`wujG>`#d2lKjn-Fxrp z+QqIX%v06jS^~vHEfXUoctZ=d7*{k1F(V5yBQhR*#yskqF(dkJ#lprdIIhKj-1Pb1 zS#=5c-)VIT_}^J|36Rb#hzR)KX%G?czq24B5XC@)2*3V;1`)b$MI6^!L2d>}XIfpr zT)@5kb``BIe*ZhIE&=@m4I=!cGYujF{&yBclwv~ei(;TbgkS$ag9u%>B1UN1?Iz%V zXVqm1>VhlN@3Lui@%!ItbqVMnSP&8LztbSX?|-L3#6*7-0}Uel`Ue_B=(-g_ZXU+y z+3$a+)g{mGf2Y;O?|-M&B|ti}Ai@cV@cG|q5aIW~(;y-c#Xy4yzy5&+5xQf zZuAG3HaYxb*VvJeExS@UHtk78bk#A?=*<;``>90;g4dVK}10RK!XT9x8fJhgew=l zRyd#whS?fTO>n?-ZX2DIK1;c+U0TW+BlOe4On=57BS08jI)#~D3&QuA=?PQx&VBqZ z*Q5YA1MK&k=?Rnc!izpLeW_cT=?N^%l>%X=cS$pS&sh#nnMve4EceQs2f{qv-R#SG zFm=hChaS^K7?(9+Toy3Yv(PeNsHdT&-%w9O%K+=lLd$@mp0;rZ4E3yyJ7B11ZQKC? z1a0Hibt__ArbT387KQ22+qh)qwm+>b2BAz4bQszOooO3z61y(jp9PBsq0A6e8QKPd{E69$ zIEh`C?aw-vl;RX&5XwCjG#c6lf-H^MieJn2r(FvSLYbgk)m}%yLcZBTyZ#y4hMt}7 zzLxDztBXM>_pC0yH}?t+Z3E!~$ZW;0W&6{{Vg{j1ICUG^2F3-D*@|Dw_NPq)4MLf4 z>Nd0u3`ZNW6|c3$bawi({YM;2xN@@HbpBh5D8sQMH-JVKY4lX-fadsT6X+t1o=TwS z^9gkMPy&@eKT9UiH=E9%i7Fx@%sb146#DiIvs{ZF_4+vdr?9WwLnE1#$574~}U_0NYc81Ns+DL6Nz z&*iZ{eLX7n?A(bTL~KNkKx9eKYW=;8qn%+B@-%^lCRjM0y}qhf)3QTLE9&~G(;ah_ z$*x}2e%t!X>McHVz3*LgK);q$^~>*5c`Wy6 zwtcu#P_!dwx!T9-_k>?nZuMmzsNp3!laV8k3fuqKyOAT1WC=++$cWpWaAnmGw_X>ljG{&zwySjJ#3Z=Joi!#u4dv$GvKSNQA?<_9Y6WI1s(DamM>| zcMbXr%`IdfDfz=&A}w2*H&pda&FKhFtvjJax%{ya7tFmyTt;k4-IIu*u)_8~Hxm&Q z8EQyK#_pt3rl<7YiXX;w?n7OKd7D_57?C5utBcGLAl5~2?L>%30H=$E&E!7-k7 z>K3OvtRNPW2oX>#XbVY%2wk^gXIjlqr$)%|dLncS^ERH-%$u`a^AO{|N^5g^t@a_z*rh#UbT zM93Tg9z@6-0U|^QuAK-G`fkO-MkfX)(!5Qqi!g5!>mqUlh;^v}M1UzKLWIZ>AVP%5 z5nw`u$Ppkygy7nV5TWZKlY2_X&~ zo~52(Ow!-|leUV!Bmpd{l`%^%oT#nhIZX(GMXl^P%W)y$%JQ$Y{_!G70PUpgV9e8N z(B+3`UDJdRSk#L>pQwKxwkiwsPQC9L03uon^EMGJowy6b1y4jv!8;StQsxNoHg1_C zK-{=RjsS7vmJ$fw#;xyGylOuJ)@=z+E7YNfuK8LqITHE;Vk=@4h2aqqaxf`FVTiwH zp)Vl*Sn$1Y{u4n_*Nq6`@`ynw8`=g#+wfOu8$euU;!uld{}?JP8iX=Ib7E*481g4( zD}uPZ2gId8C=+C9hPHtL5xQGSZA1fKe*o$9CK10n@sHtTQz}CBd_Aq$O-%}cW3hz4yXAFhnk=AwH^EU z3I``!;Q-=N^MyiO4Q8Im;u(Z8;Vx`w8yI65W-E54Ey4Z&=HhGVMsGtnz_PaMvk^b_ zo;i@8eeCt`Z`%3T%NcJk{&L{<#Jf_Sd34rmEv6r@UooiGRMn9E>SgQ8KOeJm+=7hx z?y`3w*ORJ>k`-8-M_iTLFXW7M{mcvpI86T15}r~YFCLjsc13s9?(F}3|D@vkG~fTz z#XEvw2XB?{^k^zLxj0i#=Ty{gR#)D8x^AvIy&mxfaL~)V1IxMzN|-C6pl+e|DE!Qk zpWc}s`Lt%L{~$6o7NcPzu%|-axab%e;fzvvOk8 zf$eMeYF2$X*3;lv57*)t;;bQI2jv?&H94V__cUkQt9qp_J#;iXEY;j`J3Q)I_JTC6 z-%(jRLK*AolV#3R!w|<{M;t?}7RQk63URDw#9h^-kMjM9>Z-o^eXPIE-B{Jn>bP`= zmPLT<1sP5-*|KJO&O9}$(s5RaK^#LE;uuD0aSRL9kYs}Lq|bedLLu+5=0~?gx?XLL z&mZn8YM!ha{b8V&&i^OXUIn#3QwCd#51SL9N?iN8RXOv+?+@QLV~7?^ zaKJG)n4N%5^lD;UT{j}=O$+GFKaM#E(v(;hX{qP^`VufBhasHT+fo5R>>Nou^8msG zEh-k0`16yNdR}uwL!vDt55x4`ik)euLsKJ6!ctGHi?r19>M~DQ>WOs`v@;PRq@|t* z5v70#EF=*kgr%Mc5mEs`ga}=?qPuJf4o=!R2ir8UE;vQtG)Alo_Gn}in0a-Pv@;PR zq@|t*5m-UZQcr{kVW}rVgj7KAAVS}*SlHNx^J1Q`)D!C>EcL{?NJ~AhE>59v#CfZ#!d zq@9TnAuaVhh%f;nu#iNE5a|v?h|qN_mM2_!32tL)spr+D26cfUoLCoOsVCM&(#}MP z0CZy^i4Y+z^*o4>mU<#Y2n7TYB6Qt~ni{~Hmk%|-BW}CrOncbHR?dj=(8ZXKWV*h4 zj-!wS4R}Q+n-UHn3}3U;V^Q6ValiYFFPqwz^xz!rY9)-*&$pq=WzvIZjM>z4-lQ|l37$jJ z&P247mU5bhd~sr3aG*j^I}svezBmseWWG2NB1FD85h7&NJr5%E-HL^cr*Z$kx%gT` zIA90|{uTubh)bNrOa`G$kenFW27>rW->v8_E5%8y6elr*Q0}SZ%g{Cu#E1HB#ll8S zacL0B1j(g*E`WGhGqeo^X)V+t=dh5J%NmHw4qRLeLYYw)L)$>mJnOm@L0m2eacL0B zgj2W8&^8b*fVyr)#9>w=y4fI<38!vD+raSr=(-iXp0Xw0Lshe`Ises@=Cy$P<#?0M zH?hf7Pnz?P=_#9dFaQj77sKS$`4OK+KF0rY(+&9Y8=!D#<0~9I7QVvaCAPxBU6zM& znL#Ks(9+O05H@aow_;&q2gYRvp-dQ;X-|G*A&KKML)$9Th&$TPtFLsCh`HP}nKbSSJ{*M)V8-G=wTbEsYRUNLG z)!|aN7VXGc?sxw8ZZGoXx%)l(m9W$&?g=sd&xwPo@QCk)5ILD#oVmVvZB^ujeW{vR zU2~~_?Ya7bx)6`PrMP_L%*^7*#H7U8iO(c%NGwUJG(EK{bfpg}{i^%q$DLaClEyh} zaS5^3wL8qx`R@xR2=VBvkr@weP$J_VN`L6JhkpOipqVKdIJ|U*N;FoOhg+jslJ*?C zq@^ZkaS5Ybx24ug=f5wQAk?EDSH5nLIWFndU9XP&(XJnj+h8eIJ!MxzE%m1z54hqR zGBUR``%)7Sm+*)hVO=Mk|Gr>?P>+6cdh~clQqc5&CVihf?ZS204#h936SnVGMpXM! z6A+iMSsCcMJ>+qL!J%Oh3wI4!P?Qlg{lE9l(k}a{>#`l9E+|=(7MZ78!?e@{#3c+j zk5%uG5fmbrAS5heFR~rNcL&oazW3PC_OQLzWjn;5G9SvRaJ=m5r==z!E+N%1SD7p$ zC`2$pNLWM`vK?X<2Gb|r|K*0`F`fI+I6*TwsVp%;GdSm?L(Jf$-VSp2q|QkIM=Wy* zdR&)_F^i!L7cVntI~wWd7m`cBY3>m2e!?CKhUvN$Tf*Ggs7ufcPO3|Y8Jtv?pc$N0 zmmqgff{1y+TmlkA1ak>U5E0BJAVEY3cTa){UAN+w_CoAeA%rQZEXa*>OOF*hikh>?CWp6;EXRf-GDEz;(z(O$h!?q zWgz?>3*Wt-xhMQ0uPk?8mrcOIuk5Hh#8zv9n9#R zxC_HoPrM5UxqC)suyKdv67;w(f<_Q8GiW+?(#9RkC1Ah>&h{bPJpm>$QP+1XerZ4Q zF6f;gVM?k?&E;t^uD}SPNA3Jwjje$Nvnv>g*sdg$>JxqBEHuU4*Vkv2S8kA8iX=OauQ=` z8+xQU`8&`yfVivxacL0B1j(17Z6IjA^xcXeE^&!A2xW%k($F>#G?)5r#qKgEE-p@k zP$o#84Q&HK^Q`YyENm>r{L>(md#3ajr*1>rK=2&sx)oDQ=i5M$7=$w6)a@~}4TKAz zu3Hf~>^4u{iwO6JSKYlI-0#UL+ZprtJT{ry9=2+Uw+s&j1cKfP^w9Ygd>T1{|K;v% z{+HhXg+tA0zP4jOU*X_nD;z*vYQ8jsP$rSDL4)!!;NE@IC9Jr5`@aJW=f{as;xA zW{)gZ29>W%cPtLN^q=4L@ik3IDODd&SJY-lR4+Z`$c|p2G&ypWRLw>IKxWKP8O%`W zctVL5IRaJT+h#4n`yaody4i(Cu0?>0wU zv(#wodW2Z~O+P=WSl~6cOkIo(K^_u|R|f?JPz;I_bL=FWU>-AT|>gcw$|I1)f+Jr%)^qp<7tsi4Y+y z@JxsRbYmfj5Fr!`M2N@}X$(Y&&~+LM-hM2HX; zcp^lY01;S7B18zq0udra8Uqm`^xcZxWi^=(-iVyX+p1^U|1e-c=YE*($wht&Dlwv4krtz4jA$ zOa4ra>HI5OpZytQveVX;@B(~$x8H3AJ7j2DSjX7uP>ImDBH{e9iCyn^> zW&AHM<$t;RBX8N4a~!tzwwMQ;qu*>L%(c#Uc(hgY?6>(A^;?YDx2;|4pUb80F0Gwf z8MEciYIJ!?k=Nza+G*O!o)20J8xKLJA|2~IaFeVq5!{4hod|ByvCi9PrDL7A&kBJ7 zai4YKD2|0B?z191fw<4=x)uAG&UbmnoD+_9W?h89fLIsdSSQv+I@XC0Asp*Oh!6q; zB1FjW1R_L;@B|`6=(-ibT^y-BK*Tk5pWV~#YxQIe+l|0=~yRj(1sL&pmQ@3r3g5Qt$>Qm z;C~5qF{B6#6`8JE5h}97xVRYnFG2t7G^7YU5&(;_M{DzY%z>5eNc& zeYfIeyXO+PCWHSacmxb70^tIv>sI{YWK8E5HgAU)JB)1$PG+SS3;UByCWqWH4>XVN z)@b>+OKzk1Ryz3qz1><*ixSpte zQtg#x9(s4=$YPkm2Q7pde6bq-O*6QEskd$4oio^VYWs?u3D#82?7v9Ztw&kbPDg?O z%=E{VK9!D?%t13E5p*zqPf_{EgG%gQ2s*fTQQbZ2-g{5iE_PWpvwww1J9t>VtpEuE za734wqb$WMm2pLb5OlC0Ga}=`XUwDiLeRm|inWg`S<5Qc98@oAX8*@U+QB9zqP^&_ z=6p}7k5?m`a^{DRN6^79lmX@Ie(!krx}XCX&0H{={c+4WnBeE;-_??&_NkuIG9+_j zvoC`oP8hhuOLFF^QCh~qWXqbpN;E9>GvM8hOon%Rf~6=jF)49&;xmaG62IZyW_@%5 zrn|lvfge>xTI+H*RrNi!^pIxuw~7FT6vr5KVEbAGMX0xDuk4&ai~yl7z5oi7KSp3c zew=G<^N{@LJx6o3tPNMBFXO>dG)Ech>Z4^@+)-J(Q0=>M#-k$EJqsdA0TI3!0UAX3 zV+3dr5s;D4Ai~ex>#`NQ%a*`s2F0WBZqw=leVtF2NvlgBMu1h90C!KTi$6wy1`$|6 z5hFl@2!D(K4I%>EJqsfA-HL^cZBSf(zLpw-16BS5Q5fV-zb1fbg& zBS3=)e~bVPA_6f2G>GuaNN5nD>sAB@p65MOJ?onDlWTU*8Std7oPN}#08kk0$A18C z`44+O!n@I7=xGZ1>r`5%82B*~} zU@JAi|$ZK!b=tE&&Z9{J8`)hzOAPEQru|D;74M21eXmeC_qY^t4vQ z4(&@bem@T;e2VG6-cu+n~LZU}ziuvT&!ntQ04) zQjE3?Lb<1!6GPiT(0u8;6$=~R1#xK*$_!bWp=}^&E_L0CATB#_aWM#GhFs9lHV~An zx^6`fm&-w18iaDsl-|C{fuU_+h}(7DiZIDkBT~j7lnJM9L)*YG9q76h!F6_co8ZlF z!z-d*3%Fm72?joBGMU<)=IrnVy`S{Rpm%~1rc*@RQ)y()^G~IbyWzUvfB6kiIJEH< z4jva@;qVe$;m}={hjE!fC^OK~&^8b@Zhg06VPglzWd@;47?-_bXd4LQGF`VK#${Th z?9Ij3UjL#!OJ=hKgcjz@PgfYifxhbBYHj};8?oD#a&g${=YILwsq?Spet7?fuV>{X zJr@1W6N&eG*JOA9ChGF2pS~Uydv@y+;Tz%Jjw}gUqraDNv@>i%-hd-QrExraeO0ff zWrvnl)b&%RJLW2r_pFarqNFF>@3w|D{0_MEcOdIvU_4yqKUW?h5r3d6*d{NXK;mMzU2s`{qpbcCnYozU_Q?op((UV7F+LO+T01S`T0=4K*2 zAwvxb64;$|%JkF^w_b*)2`(f{%L5H@>WJ#N{Ag?KrC96Q9cC@>z@Nz=vk4H*a2)9g zE`%NIP{K1FELS3e`3?&+_ShQ#?E7Blzs*t`UfiCnOt&Vt3~{Y)9_6|%wO%u=`!gA& z@gLC)CFc3zXCk)Ec)%Q6zAoK7FqrSKr##bJ_9x%>9(iu7^7@5Ii*gEF3mc}Ww^l!* zMp)NfML5A4naLm{BM{AyQopnRdjpe-UvMPC0`C|T%y;;1#y(HlZ++j3!k8zYHdoZP zt9!SvP%pSx?&2NC~mCqk}= z!caQ#YRqDtH{wFm`O|2e!MOtp&oRqVgWoemL&RSnpa~F9>}|=T@j3@9s4XNBAh3d1 zNaD{=+a$4&yyliqjT13U*R8la;YtC3TX=+tb(;n5h8Tmil2wMA3r;~TX=+tbrBw6W?h6wm{=FVqY)uOdW4A(Aw0rF zh!7rOB1F^xBCwD|h|qN_UbTBLIq=}roj^Tx$Kc&^>Z#j?x~!+xrGAdXM4cR91+kDs zh`^jLQ^6~T z`G023PfSl0XfNKkX{%~!CCnPncc9on%Kh-@V^uFQCS~sLdde=&aoE~xv_Dtb!5BE! z+<*$@eWf*}_Y5K_@aI~4K6SimFT6XDDoZ>K^!8cUh^K)B>^ex5C7uRqeNXEW52hkj zmbmMfgb9$i>tF@3ki=al2D=UxlDF%~R9T(2VrQD^r-4*iVqJvuiddIxb`?W9$U_rYHn?AA5!lqCBJqxy-_+t?^eIh98x)HD1k6>$Yq7$hzdJx_>5dmx{ z5pD`40+^VCU}6jsouFaS_CA9|@2Q$f*R2R91`;xZL}zHo3=+L(az@{2R^P1%CI&Mx zgG6U&I1Lh=AmY?_D|V*YaB;C2BsxJuZII{$5w*Ts(OqVPa@>Yfw?U%!^we#T=!6TP zu3NFYEvD0BgAB-908@yq5)3uR0&`^^ce9bqo@{r@M|pq7!xQ;Y@08$Q8G|PKd&h_C0F2O=Am*DWT{e!Om^o-y8 zw8x?wTrGhSi}GMr%M$hTsXiVtYH z1fLb#gZUG0mGAUunrJDIntFO^MePHw_U%LcF#=l3fiHWZPo*PQNp;;S!wELdcyv^H zXvR#prZ|?clv{B$d(DgL#e1jL%0LS(<-nJ{5M?QD&Us1gEyD>A zXz?&|2_m&zg2DYl;wNrEBSH;O1u4ALQ1Z$m_gvmb7YYp}vA3m$lGiz<*nhB)Jb=(t zs8~qi&rfP7dChGS8cHID>ADr62G9&Hz*)cqu`WO{Ep>xeml~0}L9B~ZY49KdE2u3b z5hAdkVj+nTAyYSa5TWe_SV$s7=(-i*kjaBXMnoMD>ms8Lcy)22F35}^)VQ`lnYzKNi&SY4 zAws5Z@F2njh`>S;Awr~X5FtVehIkO6?^bk|)!@EXgSvp@B-TYl9T4jxQ#Xip5rQEi zL|_H6kSY%%Wa&mJwdpo?^c%A+!+g7ENF)K=FN;rTQL$ufFyGn}Oj9JX88}Q}% z{4Za^|8nGedkoC;Sa0!Vmhc?5Uiq13x@Gz@ldqVmvErq}Z}Zfymzki?A}D~N?8 z-np=Xm$8t+>^M2Ns$ z7z;@}P+tcwhk;X!u->H;MfuP#~+N(>dcWuOf2 z&SesTGDL`wS~%XF3oEECBo88Fpo~siu`_MSO~=<7!U01#F!^r~4uH7)1Bgq5P$o!D z=81eLBFq}v27l4Ft`zzFV=d(FviqK`0X}2l7P`;wawGHV{sC9-_9PyCclq zS#x}j!#e`$`OCrmmU6riPDlo*WGeo=BR(?T)(+Eu%`EjK!(_7MqDDz~??=o#80tcX ziQ~u(`0^_Lm%q#Z^1?j6wqrS8;ZVa?IDoip0&!^&%7k&5p=}^+-1=@s9Zc$@m1XW|M|TotEPI_d@K9GTWrt2Ue*8H#Vb2=Djcw_E4NC&|5)`7&A5KO1OC%H zVOTHP3x9d|?w|wydygG$58E3ObYQQFxBfb}F1r}Eb#rg&_n)iy_~+{#@b9O=upXX; zpo7?jK?nT%zua&!X0bCEbkH|{g6q}hwN;VGPpI!J{r)?0mTL(LUvt3Qk(>})iJ*hT zJs}SGIdM4YAMwR}_?({6EsNFI>OT2#$WK@wE&cwfbte=gC{)*7Qo@2!3}Hx47-cCg zA2~C#I2grHl7ze6Du4cpt7S;TL1mORswD~e2{A)+gx}w~c83`W3SWz2=!fKlhtI*KMiwNKkO~t*#%TjCJ)X zsQCxjINx>+FGwJ)jN;91fJjGO9MJtQnyG{G(0M%ZX9hJKDP|tfi5F2KY;41RmFM?v)9T{)Zqw=#pxRk=aRMTI zF#VpOm{uluoMCiH|Q%vVi;=CB}ZnNrQ^T!C#>f)!`X>|$2 z2(Ta`5F6S=XG)y6m1aonaSSIsJGD zPLxoZop294^6vFyGhtSAWtscBAOXfK=3V}m7gq4Ud-QXZA%XT|!S~)o z!h!CxQk=v}QD=it?y2O&&^Gi;bMkkfZ76Jf7bh{`tjMKj!D7I>O*@I*WQ4L$P-SQv z81g5gwgD%x4h%O8LYYw)L)$>mT$(+>$8=Uh=xq?n zgj2VnZD4o~blr*wO)vFkHIMFY+viU6TEPA0Q*ImQo7iNkJI#6e`XB*<$)t0iM@#h& z1PL%q9H;qTZn^-X*+IkT-BY9Y z{{`WIr*uy0fBY~j>!V4jzi_s332JKPulFeGQvCxcJ9rV$cAl7vNgHkL#1!^ zgn*0wLQc>RAK8?Xr-sEB|9B&E1p5C3IRdjYqk=B|ei_4j_Yn|jP(e&P9=AQ&yvVh1 z`)+fzH7nqvKUMc~z|o_!;E z(jrHNx_8o|`XR2$fE9X={c0eXA=zR-Y);4=G~*uR2+YVtjzE%mLeQmufBJLX+LczQ zKF-~@D5s+6@qJn5igi=em4P^i%&-fAV1|WiUy&n_jU0huWl;ILbjRYL)%y8eA78c? zUP7w5NSmLV-=}4^8dn|H@=T_^IX)0>@Hdo2Sm22tEfovD%U)A8z5AIyi0Y+>9NEz;lqN?Y38detK&HoDCAxjxs+{@ZRfwR7 zG>=b@ey8YQFlpq|?;QO?)9CBF6|be$pe{AS0#B@qu)q`RA{7h7x(J$>2oXZDK!gau zwwA^~gb0zwK!gaPSRg`#zFV=o%!&QViMqhRO{|Nsz!U2tXkunvgaw`m5yApbgor$m z#z2G!p;#b7gh*o`LWI6sv9Pfe`NYx!&#Q~Hz!U2tXkubrOn?Yv2@oMdSm22eAuRAj zh>(f}B1DKZ1|mf0x)uAG&bQ%_abbaH)Fd87W05}^qZ}O z3Bvgh7|im>SW_m?Ct3#Q*YE{+HL>fGhi!%I@XEcCLHU;eby<$6Nvk)5Eu~mSs9+d+h=8X0&$*>S?}>F00s~@QOv15Ftc!506YCNq!V`E9A;S}h5FrExM2JWLL|`F#5TWl@ylg)L zGG+-r8gqJHp`~S=w~ErTPW-h9%Q~?Y4HmseEV_@a)paA{Bvyr!n8E)N^cST-94sUc zAY>XpamP2L2tAV`;3TF+SsMH=LH}e(5g2MEUAH1sWNnb{82m3me`rV%dIsG>MW*Xk zyq0Fe#l_%%8A4M-iqJCwut3&&5Bh(ej^-xwYqXDuf8D`2XZG{y%xpoAx&7?lU!} z^Dk^&P0O@PCV&r z@X3T}nIUZ;Ow07$ikOzUFf9{?bs~vp@X3U$upw<=Ol6p@cr9%S+4QV`y4L4VHgp4o z{q(PQ-(T?7|8mu*|9SlG6@zwsu=Ryc-${Wa@*yxizW|Fd^xq? z))I4+rFiDZw+18?|K5?99{qID-k^{9dy9^G!dB*KmjBC8Rn%v1s_K<$KBNVQFYD-4 z4QsUUL|503P{z9YX!iVwl=^rza^s9g?@Et+r+DVBAs>Wih4|GgHn?LxI;%bOa1NH) z^;JXi`&b>h+ItGWxzxuB3%u~YTh~v|nWsi+9_xXYbrY00Bpu8~bVAfdn89N!L(Jfh z$5kg>$uIDE%V9BpcKhyo7v+p~rEFheUhaA#XOS8$Qx0BId$$)I)>0Ev>Yh}4Wtr!P zzk?uwgGzYDgG0>8!DNCn8T-6xO@U_xcpoj9@nJ2`G{mV9)mnbx9o2)?IICS|5)5x& zJ>5J}^S;kf?x?I?i136Yq%lmm8}SYgtC7KY2Wy7Q*4RGgoMgr)Em~GlJ6BzacWX|l zhqb5aWe~$9CCn93panZv)*e^-R62I{Ul6fv#xv&F@^#u{^>^+}+&OyZn4RO^+r89l zuMC*eIB+;1(rEZ_d$KanI<(=SGTAy&Np|&>X%?xjTMHadXz3UwIg>4G_A29w z(h(T3IJ2mHmp40M2L_keI7(e zW}FBS(xlIW2x-#iL4>|ru`A7X2;v!G(kIqMGUL3uNRvLXF2bZwga~QU=Rt&I#)%Li zO!`EKkS2X1MCiE{ueHT=w%ba;T~CJ#ymY0l@j1>da8;A1?2|bTQx{zSXGaffCENqg zceRHNm#?&cG3MMf#!$jkX*&Odt(Q-Fy6l^$MjT_zVmd$Ke|ana%WH1HmmhYg9TQI~ zyzr}8(@ro(GNl)_{^{Ni*FW0nImS@NlWS{4|CG8rw07D|8JDfZj6zzid1xuAaUNPq z*FO<0rR$%EmQLaNCvM!58s}}?()G{VxTWi#xN+;c6)`S5f^nI&TJ!26sc~XmgzKMJ z7wP)vL48x(UH?Rg5UzhBMCiH|F)mZF0}9tau`bf}&#Q~1#));2u74gx z#0b|v4&~}NFGG!yA?a^N5Hx*!AHXq$1Ak1`C7pX3fDie6~Q8a zf+9kW%+BZio+W$F`?27AH6on{in?w@oW!aOLfOzZ7}|!vO51>w7=$(kq0G>n0BE&^ z zite%+D2fe2xo1jmF*z`_4Fqw!u3NFYBW#to=J*_kcSKjhm6PCpr*RbSM<5xXlBxLf zR{6+yuM2MaA8dX0O@_)np(z2B^tI()A4B~KL+8Hg27Gxw|I3%~zubM6uW&fYS2)-X zk+mHdmsMh1W)R8*v^2C0jE!5@t#}ExfB4c2LYZLEGPDg0i=?hw5#uuG{0%~x;o>y3 z4Gb5jNT482ZkgJKuCyh%|KD7EE#2sC2nSf!cKtNspS_lkW>vh^@ZQ7!HU9A3bK{Rs zyzN}S`7_dMyTktc!qD+w)IZbtFW=28I0-lS%*+t0bxBf+>HLaSzE}c$jjLq{oaLje zQ7uV(>T_dK>rN;>2lplA))dEe*#z*^_k+J2cKVD5Hz*;V`jiZdt+CS=O8^;!dVC5J z1Rin4H)Le4ZysS?yTj~r>NlHvTZ*pFCKy*V3^@Yus+X@DWDYT`Tgp{W+0{7?A^T8D zR=}RWS)H(bx6-eAy6d*o`g=4Re6{wb{PhO&`Qi8DRe3FwAbPwbDI}O6eV;q+f*(fA zQ%}SDK73!+q($c8)&e!cy6$l;?!dY}T8X_rNML9G=ldrWYlitMZ?XsT= z=#O$Mv|xv&hjJ<$54hTufv(%DwJZTwzo9v!u6OCr9Qo;;>5*Dg#FV$fcZcLfJa)7_ zY;PbhqB&a&cKCH}U3T${>P7Qd^$x3M)K`b6)INND8pFmJ@2Bk=q(wzM^JwhCki3Xr zZnzk;7;#)8FQU3iqd{J6URxD;L20U=t4wzJQYca_t2bRAb%4AGJ3RV`iumxyiF-ow zBId+3B^)^7(_5i1)_jeIjIHjIA9u=pX#I|y<*F}*;wAN#q1WdK!1N!6EC%@fztM@6 zrl<7Yh}~sN&^VgB2Qn#MS){sv`0EptF0r?3gk7E3Il`_^1PG}v;Qjohx`5c+A~}JG zVft>x!p1fLcb>4T6YC=E>cqMTN|#s{Cm;fLbs|IvyE+jfrsisoGcX}Ss0)Y?A(9h_ z5TWZ<#7XQV4oShFxss-1QG#jnSS()6ClLIgUccUHZtownmRIYhTP8(9XE4 zURmb0x8s=t=nI~*ZBDJWecT1vY*4=tr#orspgu1?&z zrMiH(am(Zc;>InK6NnqPzFV=otPSHbX;&xKMNqoLx(K^Evo6A}PJ{?yS0_S*R2L8- zLL?^;Awnc45FtX}tytK&1>>?9VOQtXMXC#kbrF;c@&+gzPVv9|ApgtT_+ReX!&f-G#8x`3hKHQF)llXahX9VGsb1Yu1=h&8`=iK zSca)>z_=_Q<1&L#X4J*dHV`bzx^6{`%XDq@{@8owKz{ar{P6pmc0Tsy}gp zZ19$~$CWPoncO3JBw*L>(|0`5q@cISBO7ylSw>+%&t1eJ) zwH9eM_}fa%QPNx=@cwU{@#xs}$j^#rB1fS3UxT*)x8B(q8cZLgtw*QHDBS#=TdRs~$c%378XG&cJKu8G$@8`D! zN;51ZueoKs0};b?-HLA{Tq(eTO?v8ib#bCDaD)@&*jJM$pI1c<;w5+Oo(>WL5` zJ@q_@kP-+YMCiH|Tf*Fr!)`1*^~AbJPd%|NfNnU#iFJ{@GY=x9r=AEA!c$L#24yk!?Tcec(-Pa2{)eLVZ&St_1=@A>7t18lQ= z_Wj}pEd<-#E|LUR<_)N1TrRKVyX}=SNuXe>vV$>2c=rZ;Ig$j}UtYlfaubpS z5U;OgD4?A#GUgNR$I<07N#N{gODp64--P?WG;i~E2&c#qAnp*7Yv=6{GDm>7L&zKf z;tnBm1b91yVgv=2j9#(YSin#x;!u?;Gw|RAu=51nK1lLZii_8%qLIe(xSV$s7 z$Q%J4L`bfk2oWMjfCv$~ZbjVx_u>98&D*@X#E2XLUR`940I@ETYv(~k0`C7|DHnA?!yiKf&;M$3GkvRf9h?pmG1c(qJas-GF zA-Q%QM3e#|u#iNE&~+<*X+MI*vL*OvJiN^-^buTLs2rJ0rYHVd@V%hPh^>h41szI+ z959zCjLQ2x<9ksUh4*8@_o6Un9w_R%5pfdJA~FmTouFaS3QYxwn~X#kA{Je@B2HpY z;3Q^{=mZT}oR-ee@YPsFM3R{Sc>c6w@r z%^=ZxBwZB}NrOaZK!l!K@e60dl?&d5prs2An9i4i`?Ye!-m5gp0Fz9`pV!qH1~T4r z2HJ%7G3Hc;YTg7teSt_405{*nP^EWP@f8lI`Cndh1HSw)|I17H3I|UGS>XWUawUjM zgHR@*rJ-%;ndd}o+`4W>jLVK-TxJl;gmIanZD4r5blr*=mt|sHR_janC$b0zp-eC| z8rlYiwU*h6U)l>R@&*(dgfhYMY-k%85TWZ<{3=a*nf&JBYyW?8j(hh%-TH5vC;xWH z%(t(U-~ZwE(*L#LKYsT4_~W)aV@{7-ZK`U>e)Y2T<@q@itf`qXLvu!bGejV=p#Iy+ zxS}`VFW;ubm#@1ISpxm%$Ic%xf8hK}$%Ys9o%`DkD;A zAO2>DKwSH}RXOv+??=!@z;P`#Kl z-LiVqH$w!HUC~{&JNrLBAgMUrv3S>z55hMFa|yn;=%`1V*htYweRgrx5bJMp?Nz;2 z>}#rfS-oZGH$wy#szck?%pCdY==8{UiVh-|AT~ajOYnZh2DfJQkfM+ERgw8qT>rbd zZ+@RsOApzvDz~OMz7Zm@SDEVSy>Z6-vvv(y5U~Qe1f%W_$t8F^uFK~m5TcKM`Ef1J zsCQIHw?ytanj3b(+}l$0jSzt>vq(9gf1=VMLN~@DBjc_;#pNS6DdBMsr9brAL%)A$&`fKF z%QxxLbt_iG^^Xaxuv!!A;)IX{o^@hfgkXVKm#Mh}3ZYr&A$JX^1}r2IB82Oo2oX}S zK!gb4`X@q!u3NDgu7CL6gw>i@7wP)v)kU(z#JUK<0udrifCwxk5h8@^p9m4c^-qKd zDOeyvgsxlhQkc6L)?i_^Ce}r`{+V?VEHSYz!u3yt2bUS#sF)Lj2K(Az5AX~#HMtSc+K?3;!6{rnHMKKmx)zR}i{@WQWz1N>M? z(Ir<1*oZXVwJ=D)_gFbrCEvu`bd9PlO2JfG0wP zaKIBGLJAg$5Fx@Ch!COcR>Zh$8OCM80Z*(;0uH+HZ}aLR1q;Nw2$q-#5hhI3v5-WF z5Ds`EM8t?N1|CF6!2%H?blr*=msMe0CLHj@y37*}cw$`yOH8bbaKIBGq7)E;g(O0R zaKIBGLI@U^5P?$!7Lo`Nx^BfwVXJOBzE<#p;6lM(5?fK2^ofuoO!~y%Grm_N(s}gL z5={?)Z`04K2(IEfjAGC^`;Xd8N_Ir%%#HsB<77$-4ukT_vC_QGYDmZT+q-q5H!!aZbi-Y-|9`#T>nsrnwr4< zaY!l9Y0Z~$@H1me;llnH2QXd4(he_gjC#$~H8E;9&a!nn+7Xd8ND(Gue_ zUAH2}W&1ELGYDnExXjQtFf5X~ZbgjC{(wt@K`0Z(WrntaF)q_}D|XnA7)I}&8omE9 zgad!_o;k4f%~=P35xxJh&VRkO^Qj~EJp1hB4MSe>^q%$o*{x%4-Cgz5hL=xXx?@j> z!9Lky*K!1^!ne(cG>=b@)~xzz56ygN)7T|+dh{@PbJy!tP%zVYhL_kX_OlbDa3 ze%t@sRlV}>a&2hV%>V0}`<`-KQo>vj1$AeY5SR2`CEAxGkeD7hzUUXo5r9>{Pi$Q5 zU9nSQXa4hpamNx4)cDj2kX6jh@6$3{jjPto|IyXady1RQG3vnfwTI0iZul(oP+yL~ zOymfJ{}XZq;I|Ii{?{kIe+D5s+6@qJmyWN22JY8R`++gDFFPgIAV3duc) ztE|)F9kLPcP^=6pU#BG~+_^Jx=jfedc8+^~*T>iF?NcKpHBS6!Y5PAOw>{as$h8pW z|EaDNCEmJzdd@sGs(syy!SD!6@k%A;?#PjY;V&O~H~i&@p$OXkhm}wBl)2|PASBUD z>rYqIW=B*nJ%reZYV)Br2bEOUtp$!Jl&SxpJ4f37DRtRwdde11X}pmE7dl3r_GT_iQmtBbV#6YC;v|2&8=0lKk}M2HY74I)HH+dmH? zY_K|DA&C&7>sCAm+dnchh1Z%`7fFp1>jLP8X`NUXY5V6vgtYw=AwsA$h!7!d|2&AO z0YqRSi4dXdR)id&!)t{cpzV`ucF%ry%mXJmmxH{ngclI?eA44iYb`1Il5ss)<@A<) zImcmZZ;N@rIr`1k9$(xxo6aBegzbQOXg?kn_-f3#Z!xY2rVi8jSGHa*b$8iMOpRz| z+<-ej;(z&R{+HL>fG^+g)%wTla%$}~?Ih!Z3EJt0J-@AAwja@k9&l8E zhb4lWbm{ZJO}g}X;3i%A#C=vW*}Q$$iSrK@lDN-Gmp*Twl`ehWKCACmyq4zdm>MCO zY+_xcOP^O4>Cz|GMY!~d5Fwdt9z;l&J`o~>OP>f4sd%#%3rU0sA*#@6D|VM9VCtBF zb18UOUR|V1pI8^^(&yF1BwYH$x=1FQ2N5yCrO$&1>Cz`cgmmfiAVS}*SlDc3x^6{qmn%TV2oF55 z(9#3XTSe)C=lxnH3J*N56_?=WN997L2cGwPmf`ut9}B*h#i9$gR@aT#UADyFe@Xfa zLyGVZFGVP9Y{N+`&)|Q1u78s6)Dt&oLyEvqD-op#IEkHvbjRR-33V}~2n-dOu3Hf* zvX^jiG5BAC(9~u~5qcy57FQQtx1z1E@m+6Mjn_NooVQ?DVWZd5VaE$tJ?B2Jf%~*I zem3TukCty9&G{$W=>KFP;tt4vW#J|IKY0Yt2E4HKvZ<>hY)9?@iekCu2KOQ`Y$?@Z%i1t4Gx%hNTgi|%5T<4NZpFgJEtr|mKl69qb`QDf#A8+bt__8c93g&{yU&+eGX+q zH_-F_^#87Iz?+bAapVbMKisx|-0bhXHoDdH++10Ds zk*nOA;uxde9sH0i&$dnuwc4q+Yu*$4cs=8E5B zui2p>;;Z;Y^`d#X+Q(YloYUJkCp76az zM?GQM8yuL%`XatJRrN|WBVsS=g3?rfLWy!kR@aHA-~;CMuG)Ata^s9g?@Et+r+DVB zAs>Wig@h+mY;ebXbawPBV5wknU0*dMzmL^{gp>GF=0odum*S5{_@$#I*8hc@PydPknn`ZH_0^49%kB>)q!YE5fctUlOh|<9Kf+rr<@=QaV8i7Fk#hL4y zM_AWAp0h}ePN{uZy{#mW9ifI*)-HreKMBDE6Yhos{$VvT=z#Y>e2?!%VWu^FxII}J zh=jd^O26vquG_0?E0m#@)ti)vl=?t+M2uz4UW75E!}Y&7v#5OJCM7PIbl@t-d#Ku@ zju0I`w-s-2+`A}etSe>v3iEJlfqI8^&Ew{&>McXf11;+U*%1kUO()`ewZcqVMCe4X z9hok=Zp5!WUQR1ZAmE$z>yy+Wv9|+{m$N#@1jK;{w?3N%5P^Vi+Rsl?hrH&t2^TXF z!=#IuhY-wG{MzH?w7N(aGqEm$IwaP`|9CkKBBYC%w?PL2zG>T^qz-wTOAR2x_joxC zBK(h+>#`N`1^^CD9vCnasK=5R7^9zMZu&OVWjz(T>+xtg_2h&V)E1Hl5m>>?SV$s7 zUBNXAG|JPDBx*@X^i`k?U44#$WTDk!`acpS_#+8^Uikd$p_DVukX+Or02JF9MV)I z&kC}Ecz2a#0}p{s!beF&V1FVo2R3lMmb@1afhE~MyvGGzJ7(SE5^xy6LK5$Bx^Be| zdm$cbDimY`u`Yqvj#+gnMO}Qa9n%ia{zPEf;aQRmM2HYRN+Lw~UpuBj#5^2Wu#iNE z&~+gb~W63n+rtVgOm+D!kMai}k zw|wE!C;nK3OP>gex^Bd-G;M1EhTTMbtsxvRgadzzg5_(Em(wo12BAz)78%+GhO~&; zieG!Y+#r;DAo()14Gf6DObiQ2JS#G_4P9wo%)|^rnIX9}v<*E||N3r|x^Bg52>1We zyApbiHi)0SXTX29at>r$ZUEU`#b=RgD)}sO2b)Fqgsr*(a)cZ3XS&buvOy>_d})TZfnZG2cPk=P7IHy@P$u|74Q&I%7^>@5v?AWWz#s2_v+%WaqqiX( zVEMdtEgW!{Xz1F@9vrZ!t9B=x4wRS-jDyEkDed-(|?)nUGuF! zJlw1Eoew{q@lf9W!Q~@oW`>yH=fqu%S?u)bT%dy}sTz^r+p@lSZB=B`vJN=QA5kMT zC;ULo{x3c2PpZ8N>c0)o`U~)^KQRqq2OE?S6Z{)VA0-^X{Cyb*Oi!)yKuI9L@eO(-TU}QLgB&+MWGBKzhQ<=k8389`8sB#xXoy z{*jRJxk<@F2qPOY`76SnVGrdwl_SZmRa97Hmt)WQBQ!xJp) zCMZ)~y%C-;Ha+sQVmq=9!gmML7~Xnkr#tO}KQO{P`Sh~f)fbhlNsG({t`Rw-T;Zv8 zh-9#=)$ISn+gDFFPgHNu%E?p15S}o1*Psug!jN?kyD*r>@aSVRyX>c?Mo0nDlNHDQ za7&Z!TU7e1IgIMcYEt26jEr=r3b!&m+3FVH;+OtXw!V`8NJYjG@WE~{#2}xu4 z<%agKy~vBe1O&gUa2culKX^{*OS`NiaYVY=ADq<$8_!oaEojLVqIi50k1AnN#8w5Rj^gr z!8pseUGOE1Er(kh%G zhUN|+qNRw~C!%E@&~hCUEnh+A3Ko*MabpFski?DKi31fDlDKhW1+kFCja%2Pc%SKf z7v?1594^-Nt_gF|GL|_G-&oQTEGGd>1pwd^U|84o5ryrbw-L_T0W1d5M9wqw{oHfibI{n`@7Hc?DO;IDbx`?Saz`C&18z4l8$}k{w zv(y_PL@4OYMVT$QDMAz}0wF@utw`5prF31!qDFvqSwMB6s1aaYSkwrxE=(B)gou2C z2wF%WM6lEwAVjd#8ze+9Wf%}5B;AU1T}C{k5Y{pgx}}oqpQ1*9burM?jio}FG7Jb2 zw1UDy0wIE>-T)zjR*)7F2ocEy5m2U4+O2p+Uw+H+wX$$P77pBqaDXPUqcn-hgfc*K zVj`HOg#=Dwl)aP+-SK5@gJ;4Wn#3NZNlYe`0g^9S+W^pfNxK!V=&i-XvdM%pKyoQ- z8$5$NB}um;U6&oC>oS>823(iP+6IJIP|~eP*JVj` zT_zLCfa@|@+km((lXNRy(Pxq`lqh-O85NmO_Q;_uYa0LuKxwyPXI%0vXY{t!{Au^7 z*i%t!f_8tp@8aU^o#TA^?djU_`v&D}L(lB>vHtTH2O~bKyY!(g?u63=KP5(0T=AfJ zN%a&yq-==ByRK@W!({F-{%dlMiXQk^9vS!epb+xF2S>Yk;1g!s^gEm$_|+*DNt<5b z_wQQ6P0)_z2bSc9sl>Dcr}6*x^h)M|4}E9RCqExg9{5O&n+Lvli`9FA(*ys-R~t+F zg&tgX&l%M+^L#E$qlm2#(+-@*|6y&LnFl_avJ>JG$patHXZb}$M$C;^9kC^1d9X#X z^qeD%VP9$AG_U9tM^+S9mhih(vHS?_MltQcY5bpT_F`cS8p=-4a}>r<$oU38u=s&D z9{Bu$pxJ+k>$834 z0Ciwt&SLeD$d~rMbl1y!U%qS0`uJAmlg~TC7>XJOR0s1f)o&>sP`6^k=4Mqo-&agK za2o$lazj}d!-s*9*|!@b76*J_9ODXO_`dLhuJ%Vq7(?R80DAf$uq-$&pyb%a+v+OY zxc*|=fir<3kJ1k8VGNItTI@G0Yc_>3WY2R8V~GC;J;y|iBQn{zvWPBy;75y0HmAx8|DM2+#8`Usev$fv0MBl9Tb_8WO!b_s7 z9%DHkpFFrX=oda)DaXSv&n?Ge-yS=LNxKy@YxAitB9o1)i|En^)uy)=>s8xx%7b$A?a2mBYCF9M0M6}vwB+&eWzGjgBbB_1*s?O zF=K*9zbP;4Dq@z;NVdm#2_Aj2Dik#WX5|aVe-vV}>>mBDG3x1vfkL^{o`)uQ^hqM# zggA6`9qtiU(e6|)pOaXF80yd9zua&WzWfmW%T3hfbYm>YO31DMg6HSfc73^U&SWlq zAXbfE`1zYiY|R1T8d0IZsRsFmp*XgW-fi;#x1(^aT~X^Tan((+-WzL3rse! zF3hD5tc&Q<2iAqT^nnl|GTAtY5MBB}h+r;#AVi2ReIP_IQH4ZX(NYk8A}=eP23_J| zadi=0`oOw~E`3~Glmy-6F$dO#G1)+fP%xK14kARCJ`f^Amp%?6q}_^{wKa5ICNkN; zx-geMur8uYA6J)rf(Y`M10jMj*+7U8UHU+XU@m3_BoHE4U<42%B;AUC32!}o%ki~# zUXaQngy-X0k$!$JQZNV(a)jQdZp8hb#qfOGkA=SXJQft`d#Nx$#368?!eD;R^c<5+ zC}SiivbMoP&58824K#_>&?F`k$^glitZhJOz9ij>G>L5>p_@!710thHE0^yrq7&UfB8&ECm>bAX@tDE z^(IIMTJT?P9gqL=4b-XH>)fYGUq^3+>FXxu6EZ%gOZ&pp$YA z?{R|*b3Qjd=rX{s+xvBgzRj6)@Ko_%lf24QNB)-7f6c+V$`|-Pq3R);oC#cTNu@KF zK(y#DBG3O^^_^tV&wj<_V*d7#W0$>~ojC`eCB0ngr>#tRrF6jQ6-V?}xxUfHG5qbz zR8bneGnYWL=)XHCGW!kVT(aoW`FPYWnImg3!{ zrp%Oi+^~|0CHw$qE`jK?et6_!zj4{y$!8rB?UuwaD>yg2HC^}mC1%}z`pu|&5-RWJ z_uq4-!o#wd=t`SB@VJi_nfA9D=2pjZ{@OLwQ@D__u%g@mE-KXFIlRBM67nIeE| zZZSn*e%hT4k-S&gl!oDnTk8j&t{TAm+uoM9xL?{U&Xd!_R!BPZ(5W$#sAVi2M z0zin6bSs|sw$ziOlUcWcbz#%vk5fOQdBXCOqd z6agSauoM9xM2IN@K!{)h2p~jAx)tfVY$e@MFzYt3F5xujk_R4F7coTuSQo}R10h08 z5dcC2OA!DWu|TT@W(>mEBO9#^sn&igCdTYa{&1{(qml;G{%7ik&A!3rX4FH|Lq+5}$%MQ|YnM^1H ztU%$iw!tHd7Q6D7bSu(z*;jN(kO^hLb(ySfKwOtex)m?!Gszd4DHFoQr}05||j zyA?a)l4YZ}r$%pCIPfp5?G{~h^XRAMuYIb@{6=Pc{<{sK1NsII3Z7D}`}tFUc%pI4 z<}bcF@l|@w#ruk`_3Y0c`E3N5>a*S>Q~lu6*O=@H9UN8{Cwq^oi!+%31`*C=0u)3j2_o#t1Tctj z2uWZNA?a46%jOMq+3d7~qv~Ryy4daDu(~+x;IO(l*?Sm7IFboq5aCEBfI);anE(b6 z4j~B)A|&04I$f>FR#!i|$FS`iMOO`(tnW{Nv`;yso0Z)n(GJ-ATQeBle3r5bgeU>T z?jO$R<{GOQB>)&jEnnH`W?h>YB>B zhe3qG5hQ?u2x+%sN1U=f##iZZZ^P>1aBsuv;w0N)b#VjKx`UNBvrave+Hws8)13%u$dd zd@mK|{ZiQPnZB0_101=LEV`Yom2@L^#2IK3llfnS{z8@_{I8cH^b{y*5>pb+%KWdV z5)oO708lGQyA?BQO{5}|`Co*JOqL=5RAiEFMQdlA!Pa84+VZk&Ezfks*$&k!j7gBu zTX6orPk&aR<=4Ny5ut4CD#!oHgZMvLivN>`@qd!?{Xd&$w3$ue>;Ezba(c56&yW6- zXYqfMZ2!=ICGnPZ#9LO`6aL?7fZc4#d@?}&ElV3bROQ?66OgS)5t%LY0-?+&d*+s~ z*F}~#ARt20tw_8jNr7ZO8F5=COB(>UWzufNo`QV3Ez6hrWPqVcmNo!x%cR|knY9P# zwoK-e5w~Tsv;lBiCh1lr&*d62k=4;!Y3a6J5WeWQ(I_}j~>#880{-n+!OXV4<;ZE_yHF?f3qgta;op zZLa7HpTH?J*|SH!J2*1?b7REffTyzdyK)2`PdH}vUQ0I?PuqX_RY|Xu_KQ^?sZ8>Z zU3rA^7yQkBWtHr0dGkOq0brRbocG&0^Wi%e`+bl-d++d1eU`bI^ozGx6kndR3vo!O zky|=E%}Z-c(U*p3|CU1e3q$!}tv-MYjIMlw4-@V6B^5KcU+O_(w;71U?|T;z9nlJoN@g zMnS*siY1hE5J{H$3F9f=;X&Td74M*pr-0oyr$Vawi(OIN5N&AnVQ#WEHc?SlQOt#E zHrihTxabG~@M_z%pSvq-F-0dVP0T7B`3e{8^5~lj>1Ez#yAX#8^YpHL_avysnxl8E zQLi#O-{Wd-NN78|KE0^El%oFCEo z9(Z7Hi_|@?bHo$@96*RE0>Gc2m?D5{ZjrjjVVL*^fJ9rdU2jcsz5xKNi)h`()x|*f z736^j)`d~`z`BSj0zimhDFQ%<5K{zj5Ft|cK!{)|0@7?n;SGRhTeR>70BzRFI%~l< zm|3T*#1eO0d;{R)Ia5y|W{LJ@#WdOp583EnInVeEVrb0N=xQ&sHvqy?2fvCK%39O9 z^{>)`nn?rk-0M%jg&2C0>%!N6Jf~xo&AzDLAf{W(Ir}OqyD6IB+~_+R0n_7!HTW-A z-h?l&2YicIxDv=qJIIJ6XF32Q4hhT)4y=pl1qarJdBK5o5xILDL@XePpoIiN1dAmALWCGgfP)B;y9Yvq zq+79FpGiE27`zUw3y~ZK=pB7BK{t`Gz`8K*9taU)ECCK8Xaz4}*&;EP00$8wcMpUJ z7E2(}R_u;59C7-XfzU1HSmWxFO3?i`D0I`*9RnpAMISQ`x=jQTw2(lEpcSNr1VRL@ zppZ=ugb11O$ah`7`caY@;J#LNS?KbcSlD2sHmwgDh5 zLbhUeoQ@_jolGbL>LP0!5D+2dR_tg|bXj$IWX+#Wx&HZUb+yl6M3NbTWMG~VN+Wl- zc@r6LJxdAq#LZ7di2Rf#0vUg)#%gD%k0aEaU8Q)1!-1Qia7e`~91i2ZJRkq%))erU z6LGngh)bDJ2B4)$);0h(Zb`Qy5trpeT*`zpK%p*c8xURzNw*>qmpl=d74wV==#`^P zCe%l7~72YW1WO^#p!_2e_^;@swg%O)kLz0D)kWBFmsVs1C+ zvp9ja%@ep7bN{U~KbgNb=u_WxGSvqzaoPSK{`Kr`{b^?~!4t(*Ns79aM^weef&6si zd~Pz!IystLLo^`;IB3PWjQI)?rpu1wvpbv*c zX0JCsws-iVtaw-c#HWk@VJ*1o2qxhE&@|~xRU1EH*FLVlb{jXue7imCfF(t+T#NL| z5I(eR)9jItk6rBdeb!M*cet(*JL7cJI3n*1EDQ7013y~y)Z=%u(s$ht7z83+-~QxAj) z(NhnE2|!5C&5oo@kHEi#9kfVWY10#{Pc9pYeo!ZmLz*NksySioF`2qVCcDUrb}2wyAYyn zj5^lyp~4bpIAafa5`+-6sC9_xv1=**%WLpou0wzMNkvx)&AH4|4@67RQ;$PS(NhmZ zOU63`(Ngr(<2G*5QxDv@nWrAOahsR~0=RKYx)mF|Gm`0?$vpMIx-d^YvMw}Gks};f z7sfjSAwu-j10jNW>VXi!JoP|`5G4>mh>&zEUeRY35x+@x0Afvnbzz=*U|quL%telH zTwO#71P~$^?+kVXiEPY^*134{pdsRu#?lRzLLLej0+Q;>%u(s zz`8I`J+Lk&f(Rn;fe^tw^+1SVo_Zui5OmW*0wID)Ab=1d=~ld#p3J!A_*z*wfVk|x z^@IaG1xlL4lmxRfq3o&TMAkNVraAc^pl!&kHPIv{6UqR|SC6c10BF7>-HJW!-j*K2 z7xd)&h-O9CDq_8NBeZFjI1@<*$O;Xmk;|-S{AEHJ;SiCv4W2=_-K!++R_rOrr|YtO znNS8ev}A1q;JQrOt(aMRfUe7ALK$&gCTkl2*JYA!MItWS$rmaU%7Cd`h`FbQ1Rl&~ zZ3AGsGXS*>Z-%!XmW|$?8olkLn{Cx+r=Gd9ar=}l^S_TzFRY$8a?2ZUWbCW%RD64W zxYvc9JN};Slls|KLQgX4+odiQFPN89PvJM#2S!)6asAELdG*sPpKv#r&nCxu_B@wk z{lmf)7X6NEf(bTV<@fJe!}Tp2rPbGq^>7I13l^pASd9LV$$K#K6c~7_| zn4n+N!DaWHQT5k8#NSp|HITc`t8ezoQ@bS{giv%saI`Br;giBGR~1Xoxd#(?onCol zMRDZ-^Q)Y1Np6_xdau5Jbd_7u!FY;Jh}5`6C&UNS%`m;9OZzyf3I$;DD>|NXEJ+{0 zhpC5X6tNYrUgy;xs>yLnI!Mea92w7N`9(xV%#Bzbu_a<(B(WgRy9W~lCvL0XQaT`% zi#3knM`$;OT^AZLk-yzN>A)v`Rw3sb{J`P|-gw~i2ZClVi7(2m&Hrwm(alqjDT|w@ z9`w;JPkn-Fx;Cm|xTfNwPo65B@2kBohvKMevU_+!#NvPtjALAB43EYiw8ovdMgoE9 z95+wB=XKH5{%C)gfff?@^V5+Sl@?M^nt__zC4q?IMwA7o1w^YhWX*c*K-?gQvFws^Z^;TS>ywE~*ar4w;U{QQl09co;_HY70 z0SKy#8}AH)2$!cG1Q9MzJqRKUbnQb6DTq-)5aE(QfFMHBtw?rvgEf^VK*RAaZ_AC9GS|J3WFS`!+TqA@)bY=_H z+Fb|%fXVV5_%A<%|8f)h%dhIog*n&7I|DjXm?B-gGomkPpmOun1G-We#a$8zL{HMj z?IwW$bR?Z;OfFA7XrOX=>OmW~Tf74RCMDmBU2&$JR2SNGL{B}aE-p_!s4i}vdQe?l zyfX+QT%LLmM7VkCK@j2c)Po?xO#%Ue2uZi1r68Q3JDdhx(NmA9i<_q&R2Mf-J*F;h zyfX+QT%LLmL?~RIdJIIkdFnwB;gUdrAVS)$m|0sxcN7a;o_bJST%LMRU0j}eP+i=3 zXAnfVJoO-maP!oIAcCME+(pr=&1+Q z#pS67)rFXQBJhDsha2wseyG8>dwxP6kKNWU579KJi*VJ>YcEy0Y_{7XuLIgM7Tg z!Lk&uaA?OX9FlLsmp_XC@)q=$6LBdM%Aj+rtZe{n+|t%ISPEK*xReQHghE}`HURYG z(r(4f+HFK!Dr7?0bBBnmZ9wS!CEbd2UDim~Wip`*aA;-9+6K=oTK4NQNw*?hm#v}e zGMP{YOx?1!0dZX>=~g7-@+kR2WkMM+b<5fY!~sy!t@wj?hHUiq*y#N~SU4br75pyj zyEmu&cK-KED6C*-pG_Cy0)F41d@a zSdIRuin;!0?hRVx7e%iB2^u#~eQxBd$|rRWPyJgBbF1Syf9;y;DO{9xS)zB7y1$0( z%)?45mhb`E-07+X{DAaI=K9ZmWZb(!OUU)Vl=pFY>IcT(p{uoyInOj2Q%`Q+wNEwF ze0tX!Rf4&M8+f{E08h5{$(l|3xlr@K^oqB+fVR!d_3!u2qKC&7k?a337w9rZ-%&W# zT41qf2#`kO={KY9NvOP=-+#}Uiei4PI;Tm+s5hYP_q|v{Rho_ z@3lpVzVWkGt4FyE@b@i#rXx<*7UQd9Zt(X@2d4#_H`fnO3ovh~4>?`=0^cW;0t#{_ zaKT!Ay;{K!DXDyng)uxlaa<*EHO+4ZUoeE+trwcJqV`d{R;edb*Co#gt@e#Mm+ z@$DnWE_*lAHKd&^<(|h%57q&m#~r^P;Y{bIkdC zOS|{()WN3^+jZ+2o1RwDW;O_m`t;j~DaAy!rhu+hl>0!7dIhm%XEfu#d=>u74d^dF z@10TSd;|cvLof$CaEB0CV&D$J9Pq#$LUh36b_g+y0k}gj!2)oH5W^U7!-^QjAkkL5 zq%UuAJ^}!&3v<8&>mstmz`8I8Jg_dz0gr?T=70x61QRR(Awmpe073){V~}VocEl;^ z(50mFKl!(Tbzu&8U|mF(7*`k30S~MTbHD>3BAm{dw2(N65CscBh+tt1K!}ibE7BtX zbpFq$x{!YxSQqAi2iAqL#K^iZ2RslWm;)XN5erxt0}vvZU;zjbEQ|pN5z=l&dIW&( zt0yuCJg_dz0S~MTV~K%vNhXLO2RslWm;)XN5zGM(ga`u*V*o+~3u6F6grr+>AUy&= zd=YcNBkMxYP5y0QT^LIYtV=3$zyl$IIpBd1!5r{Fh%gaE&_V(sf`u^vAwtrvm`jfU z5Yxy))q#a3&>@%ruA-y~U^~%B-%BQaAmj+!9~B1odnUsB5_CTmzLyFE1Vu?VBBlG& zBqo#SGKnthIsUT}h$gWXn#5!h9ig+4NpygSOwz4LEU(U*xQjj#~vX-g;JNXQ=P@T$R@or)Igzyu0MD1CTam8I&d_z4Oeh1U zZh9X)dXFsigHQh(OMURJD0PB)$*z6s0BtJsRxeHTwr3HzM*xJ5_ZvBsas)<> z&n_IfoeQ}pN1&%b5N6Vx!GZ)PB^ZnO{gV=^hMUhZ6a8UsAPXaKGjc~K2F<*if&^wJ z`o+(RR8P1jNZ{IbP!(q_Ke$X?oHK<#${gxz)L|@)z|F9~mb)t}iQM4XToAnhZ(RCQ zH@H(rQjz3Ket%<9z#1-{B@vu9PGgR8H#dBpYN1alx&HmsQf2WRQQ|Vwb z(`T0sKdowK0TD%%CSXqva7#TXsoXPYU0`H(kZ}=N>V4Pz)Kc%nrG9C5(#3*b+LWTo zi!2}_k*xZ5TmJuBogF$7uZFplND$nxI#FLQ21HOKgFSx1J&a<&)|sEorbG*$Us0mP zokiJx5s?vdBUVRjiMT$|!moNeWm!a3f58nX69XbB@4%jl;T}d25R(1cR!X!Ow1W~Y z<|g|8>qHAgCtjOqA;m_#q_nVvY?S)#@pG3|4NF|Ml|ZhF8D zQ{G}{?3LZ3n;wARtt*+Q{H*Av_k6FmlIO_ormwMzZhF90X!+7EgV42!G6=v{L*jM2 z4C0VO1_78UbW9A8Z|N2y3K|i6cGpe#@)q=$6T3;aOcRM-$qx<$H;1Dh25wGAJqp~M ztTSw%bvo)%`>fMZkJ@LQj(QAG(p9We0D;1uevGI$38}T^x>jSY4csdRSc? zj(XVq<6xa(5aD#x!yv-psE0v>Gu#0M5z=l&dIEq>{|aI^D+G@QsxD4PJ*+NHM?I=8 zPSzO(5l%-v3?iJ4dK5$`9pMfzh;RrXU=ShcRwQ<_k+xK)qaIclhoc@=7l)%BRu?Dh z41)-VqaFqkPDecoBJ$}L#UAbeg9wKJ0tOM1Zbf1@*ATnuWSvoU5w3#m4nSC4=%RI^ zVDyC5#VLS5L4=cahCzhGQ4fO%TEQM#NZ=IV5J12nLei~B?B-E&F*_Xfu)3r=9Q82h zb~x%`b#b!JD2Ol-MA#kmFoR}KOlQKAy7V_Q%7(_S(5HN_4bSs|sww!g#v4+(} z;mEN@)kQ~BHwA(N@9y;WK=7$2VG!YTgQFnA8L19~2xp`^3L=yQ5wwt>CBYz~(r&8< zP7%mfBvTpPBMYMwbdQ!JpKPKUty&X4g0$la{O55fOrIQ~xxL_he$lktDjg#VLD z{GU8Pa*_JcJ%VWB{k+>C(l^2L5B-ywwMU4EkvVjP4ztR>kia?o7UR(ELQF}wA`vm& zM8wD(Izk66bLfC0oTOWkX0nw;#K;^vz=t4n=m;Z%q+5}W|D|-6kvVk0@jsuA|1yW} z>G5CEtw=pYO8$^6ivScV;HeOa4XE+Lp8Zw$6Nb)MCGhq5{?W!Ud}wsl49<%T<`3=-`qXbL zMIHFXx_RpVw53_G)S2~BRvMD#rL9OgmgF6~qW!kms=K);^8oU`n+K*>yv+^OWX~B%f)Mjp2 zS{=;yEelQyGrv?n#C&^MMKKpDq%hc@ynl=fjIKP#4QtypfszjHrRanuiCKjs<9T0~ zr#?DfqpR(*zePbZ4gTceT~S(#iCDqSzqqGaS$>x4##uSc1 z7%p<&X5aM62l?C5tDfM!ODgsZ`jny*mZ}3Oi$Ois74C3$@j**mll@T?3Oi88oLNy^ zF_7QCt4Z~c`EAuI-bl0q2Dszz{Q&0eAEA?AQQbvXb3 zX(OH_H2^gZqhNt$5#8Xpj~3nFz}{xT1i;P_)c`nv5Q7PTKR*^s0BmkCm;i`jl5R!v zd>^qbBXYEbz`~}n=-V(@d!eq&n_|)J+4|NoY9#{8OlOo&(#3d=St;U+J!}JL+q}t=~U|&Uz^z= zEGn0e*u9iZ!YX#GqIV@|Q7wqwA>$@|`3Cft_Y|bkJ}cVGacC*p%YkUgsBs`#npn~S z5G`5K0dV6Msd3!KEhZfRH*S`60Nl8x-HMsD?KJ0#_Htld7&Q*83$vF4>mu6Afe^ux z4uBBBsBt7ju%rVZM6jd-AVf&I6{D3Gj?+1l*~@`-5vg%tU6{QbSQiCLI>14Mm~;Sy z2u6(qAtIb8SXxLNM2JZTK!}iZE9Ql_rqMkQvzG(wlFz7dU|pEK99S1-FGoTIOF95T z1f#}*5V3$Df))}85iIEd2oaKQMY=9KOxI=1UJk5_NR0#Q!tCY1x-fe=5F+RvSXf9P zL@<>G5F%L80T3b#bO5A<1VV(QTd~30@)+IiFnc+$F3etztP7*YfpuZ_av(&cvZMnb zL@<>G5F(gL0|*f&f(TkjAVf&I6|d;6MRW=L&oSr891W}svzG(wqNKWz#sF9sW-kXq z1hba|AwtKJ4uBBBR2o2t5R(pY5FzbW?2Jpk<@j1zI3NoLZbUdhlh|^a#8}cj5N2gU z86fD8wG9Yq5wI1%rd0cG+kOg5YA2PEu7p@`j7Y0>Et*Uv&p)0wv| z;t%Gw6NbcbxkEBed>PTN0_xReQHz;q|t{(;1$tZndY zis+2fkuOvxlo3<6tZe{5gtS|cZ2z}_(c4z@r`_Mq{qON>f_8s;qU-T1vj$ClVD{$~ zJ>EaA4;^wj_l=gKG3-E#?^r5J&9N+;M@AE?dR&3yXvxKJ@W!5q+C z@dV#*nc5K}Fr+Z2m7My676vXHyl}|EpbrZ7>T28Ea|xO#Mxc#E27Sv$nSElJPd`r; zpxHf_;7sK}zM0Yq`fDHJ z1GOwLBDylgk)04@?w_aj*JL|l1m^D@{;B^~SNz1gg?p@Vb=Tw)=)<_WmBkeU%&&5z z%q%cMv$@`posi0VM^}aLevUkg-4s7DG{hA@@o@a?t9ok+3C&2mO{A$XuYtAsTo;SJgysU$qS8VN^BU;q=d#p;n%gbi!JDE`jwfvj z;KS4p@nY7$22?>f&ap2i3)8 zsRz}?jdlh>gv(M7f(VzT9t06?mU<9GxD*h8O-nd(NxBukP;?z6=yqA^L3MGn)MM)6 zW~m3&#YH=VAR?U3T%x5O0}*bPdJsgoS?Vzm;iiB9L4>4R@dt0qSLf_ba597o^d_h- zZkBpbU0jxWP+eTKGYBGR1s#@p5Jb2v^&p6FS?WO$;iiB9L4+&aL4vJ#Ri8;yw;SyY zs*B4~52{NtLAPkB2i3)8sRz}?jdsRBgu!L02SJ3(QV)WNi3Aa}kb*B01Q9L;gali$ zE6#8v#@CH@2GzwyJA>+y>ax^>>f*B0gX-c^K!6~^L=Yib>Om0Uvebhh!Y$na1QD)u z2MM;Kr9ep+CQ7P{XsHL)#bv1n)kQ%!;QwUF*qFMw(axZ{xGeP`h;XyiV<5uKQV)U% zmjVI=5z=nO%-S=z9A9ha1%=@bIz_lWXn=tnSvVju;XqfMjwUggP)0~jWNm|IniJ`3 z8!nr|Td&xnDdj!=bLEBnwYu6&%!w^SkPNul=>Z%6g>F2JtfV(z+#d`8Yzkeac!k4( zo1kz=#VZ_E;S~-y;mfTl;4dfQaxJk%GNBAWOIh21*tjL#ibPzN6LBdM$^eC|tZhJO zwI$t(L|pPjTvp68Dxk!rOeh0Hyt1|d;Y2{TA`zFQ^UstCWq?CO);1s@Lei~B#3d<; zWkMM-b<5fYzyVO&t!ODQ5pgLK%8033);0hRfYNTo%-Vc1gUEz3z@gkDYa0MeqoiAr z{9RPX0-79m*E*SmcRw=j-60`l5)O`b8P-23+;Ua1 z)R{|=S2{4w>-0)W)vXj9@YBtG+>!)tcefr>&_V1wiyj_3o`Mb{HEyos_+ZM+{@9UA z5Sy{)i%soDVf)2DZ-+OI-A_X19^KQur`ywfj`FTe!fu>Y`L@~5+{oRrTCSMbua95T&YwpP1oKO6$LeAHfoUkOmNLTx#Gnb(HSxO`r zK`H40LKH)@+S@Hj;E8ME6BhcM_1!*mnmVvBXR&&SD>l;nn~Tn_U*wRw2wA4RQT$QxxD!+f%8XcKUOpHH`q! zy>RA7VHK@sb;6>mV-cNc*lEw0sj+qoi&}@+y}Azd2&-sMdN?|VKZV#GZo-%A&|gmU zW(n=HqNN^(mZGH|hnAwH9*CAA?TkZ9(Nd4wxJ64naN`!!9dH}BsDJ=&+>&m^AG|Y? zY0hPqdSG2dOFghI%u)}mi%2`;AVRd%10jN0>VXg;TIz8SAu1q%5FzPSBzki^(VO&M zCXuGVx`>u~TwTKH%teN9TwO#31P~%b+8GBCO7dmWLINQ|wAAAuf;1$;LgFAo+O60X zr`#Fit7MjXU|mE@J+3Ybn572+>lHgNTXDQV)a(W~m24gs6bPL4>qhF|)RX zt}#=Yr5;!pW~m3(MYPo8>S7{@ApRZ*-ON%Cgb2}64}=J2sRu%YsDQvhgrr+>iSj}X z(L1809#rhouKgrr+>UwG@` zTaK@_^MW+okx!q)wIWSUc#!*ESH#n`txA1(9ysRYlh-V!d}`1P&&W43L5iN+Xx!Y2^f z3{Zl}+6IIY6WNMa_2m=k83&nA1}J1@Z36-#B;ATcT#|@aCX^8hby?d0(34BM6)gq% zL|o?6wTw(Cd+HF8wG9BBzqDI1v-SX8m(lH;z|7-rF~#QsfOmwq7@=%G0Lt11z;uUf zMItWSiMW&rWkg+MZ3Ex{DCt%t;&K)FLS;f3Fm=n?2E+kS(yd5-G1=(tvC&%=4!CtrgEk$5f@NxT#(@YF7Kh3LQE+1SL+^{-PUmseO z{VX>ky5d3pwmh}JCc9p(;D@wrKB^Aq2at1n_THdHKEI-zgFB0|{URbG=0>cJ*bsv;Hon67MpuRKeq~i7xUpuh^r{(L00k#( zrQn1?J1FO1Zlb>{MPOk39V7;z=yB0q{#0>Al5g3HBgUkFHC(#>FgNgY)d1cnPc>Py zX+IZh?wf9WjEgb%uTw4bDfQVt(@#B)tlL?KUGDO4A31i}{(dzPrexCxel&BJKmBIZ zqy%FzzkgCf)o}AU)r2DbRjzNeaSVU^GF6m$V0y*d+)#5scSSU1G2BgA3^Nn`;%7yw zC%D|@_bq;=C$8HWbnscyrqaRMV=39C!%wT)2dq(t73BtSfzg#u@covlH}L)2vW}`! zdGC_SJ%iQ-MrH>Y7g36U?;5xKiFdYqV}Deg%;2<;n7Y_ww^`7^`Fj&o#aYV_E>joh zOyQ4KE=}}qQuo(n&EtlZR4n1c+BQyCPvk?}Hm&9E%1WZRh-@y1(jAOTT|o!y_I}-= zZ*vA6ykFWc?N0NSdcU+OMU@u=PJ7VYEa+hB$>3d4>ICzWUHjAl+Egy&bma?tpHTG> zP0j=^SerXtwSf0;%gIoMQs%}`%G?+^KD%(_b}qyfKygRmRC@}(q+5~10M;JUML`Vk z4T%A|!`Hu!=|@wW^1_Qu3~(yOw-M2iUFEj8M&>DBUp{AQjptaQtKDW%OfxYtz?FH% z=Mi0*c~Mu}Ip(|&cd$Ek@F_%Jwyv@1X%&UI16tIl-$rz%iE3Rwr$dN4phdlcfJw_) zTLG=25O+X}`c@-gcerp9zTANR^7GyqbtZ=x0Em{1fd!(aiNw-m(+8p@bC(0rQVcr4 zZQP<50Jw3ppabB>Ee0LnHf~XuBGFd7q%UuAiUELiVeWEZT|{>|urAD94y+3k10W%S z1swn(f(0D_Awmo~073*414y(LJK~fy=!y(1urAD94y=oU7$tI-AVe%6 zh@gc8LIevs073){Isih1v|EwH0CZg@iUELiVeWEZU6>dESeImiZn}5`LImB5(n10u zf{6iu5MiJLAT1;iB3RG?5F#YqiUUauV0DNAkac11a$sGUyBt`TR2Fmqga{@E073){ zIsih1i6DX&5(p72=l}>2Obj5=R?HN<4v{kEW3?dt1K56X@+!Yw^7RQYGAv&>HD( zg0|x(e0dA{%RAys#Kf3n5*;A%3cxM7Il}2}gbB2ntX;&A{3m6tEq`9@-=9rdR&rO}do88; zUk`rxp5HzEo9b@UYrnkh>EznKFZ` z?Bp$i7T^#O_%-ff2RFWwsf-b?v0iT}zww_;hRM!|>)L)|DZk;Cyl|ZH!iRKrnSmQ4 ze&Z!qw%gMV@-5whPv0%=;KqO3U5D*y2R5@w@aem!9o+bDr-g|%R?*W3*QOoZI7nK} z_El7NU!Qhx;~>btT7l{fcjl9HL)RNGe&c;f zdtz_q@*D3;L7&PVJ-C)!x$&N)OZ?t)4sN_7|Aj>3#{2Ojx(Vtn=itV>k$Aq|at>}B zCMDmBB%Ns|=}a%?a?k408!zrrU3xQ@dsdg;%;g?IL~l6<9zjHJytro&(Ob@eM-b6l z&VgqTA?a4^DF`R%4kwBD_2zPq>e8#Z+@rem#*2GY7bTq?$)$gd&BZf_=q=~KBZ%mY z7xxGvdd)fT2qJpRIq(P~q}_^{wKcS*F6hNv?pa-We8FJ+@reC zy^Qea!8N8U&mf|=oCA*_qBmaLBZv_0Ft5Lj^$a3<%Q^4}A|&04B%Mj8gL!Y}a*yg_ zqPkpfF88c1z4786)g>lna3&pJt}#7&1`)mF9C!v1z4786K}2dV5)IEFqPLs_k03(Q ztw_?DLv&%%o4MShy7b12dsLTR&E+1|r8jfAM-ZVTh`2uIz%z*GjTiR_B6`a?@CYJw zz2qEt1`(2OMUu|clXRxHq-~Gt(wi~bv$_y;Q)D^tVBTBOwnq@rThg{?5Yb!cyGIbw zTj;w-5MdyQpoIh;043du|5`fZQK4m8o(bSRf}Gw$JUse6-&(Z1{h0}5BkD41&)6&` z8y#M3)9KK!E9s8g<(}?;@N`>%iflAZNU8SM6eg$I9c9N4I&BZbc$u4igb0bLfDnTjtPNh?QptKuNbE z5i#e8h>hz>(?|s&O?tIisW7eMC@#2yD zZJX}siR<6>Zt%KyBGY%p2hE&DZ@^C+Kl6*%A~iF;0)qqZ44e`;`*-odP2nGXY=7v1 zJ|;SCdV`-Pw|-0MfV!3KeL__a@xI!eS2$norsYCPf#_Y2u9`vb-mjne-fNE~W)+T% z=d=7GA|vKTtd7_cu`lwp^2z7z@d~76)-=3O9n23b3r-6tIexKkbj7RO5cBQyO1-&X znUGQ-de=4dPW?ik@3ZEPJj(gR&no16gCAJ@z#9*I{y@;|CGkbN+8^yNj?f{8ufDn~ ziVM?5H4N8mtM9Mb7^WV}4~sUA;k~p%N`WIp;r8x|J%c{=-9GaLbzou6V)YQ$v-d@X ziME389L3}Q&~#6ND%QNDdI~?H%$x5MYn;zb)@04&{LOwsN`V-nFsyCU?2+#diOg;_ zMl25az&K{{poM`82QM75FzC_vgVwkcj&KL{fjF+|}c zrx@=ya`z+S-W?k9&gzGQqu<&5(w3Kg|I(W;?fIl|%T>kFbB?EA@=8afd6iV9981zS zA57mEz>PBB7F+coe_L5av5-J7)cye)^mQ+#;}Q|r_d z;U67k56Rc%Wi=z#G9%eq(99l^|MJ{uO(Wn(bK&@p-fP7i{I)UbSVU7QcPgJufBjO8 zwOd~j<6DO)de`BeI9f$rn@Lzy{uJWZ-9oiKH@fE#x&CQUwTNGjb-b>&ZOr+6OS`bB zC7yR@Q+Vr!PGJ>oW`nS(+-?L69YBBiReibeJ7=zcAe=MTKM*WM*FO-7nCl<7<1p7h z5YJ8QVFn0VvTd6w7J!?g==uk4Ig)P0t~k?9r|TbB7v}m0)j3x%wMaf+Mz`8Kk zKM*1m&(GlIx$&nG2ZfA6OUW`Ulp9(Zs;IknCl-15t44jCFJ_2dmg%m$~->?SQi69H#t9mbzw9yur72{ zCb<5A5W!skK!{+je;`EAWu74Y073+F{R1IF(yh3UT>o^>%Bogb3#P2SP+DbNvG$g1P>I5FzPS{DNHn#B(sKHLxzC>mOGaQLzB5 z3sWorAwo$IK?@0l2mLXaOtAoj2m?U`EhG>kB;ATcyWDbott=dng#$Mt93Ymr#dd`7 z!L-t%x1J@|yAdN2If5orE&B3_cp7;no<`2cD;z9K@d}4_yuv}Z1Fvu>!z&!lpue1m zOWJT`LKz`dleG;1t(vr3(NfSt#HCCqd#2E16Q8VY0BA*}-HMsD+laVS$b_=z3Rzj( zfY547x)q7IY$W1RCX@jR^-NjY0Pspkx)q7ITtmdAOeh1UZdu!aH~>nz6^Xb!O2nm1 zCTZ3Dm}DeYFgs<+-vrbC%f229X~)Sg=zGt5Afh(fR(&@A_hG-;F=fmA?|-xV{m#Gt zGHCF_1%A71zkIv?!8b2^?;CdFtMu3xik%+#MT-~O^HE8IOCR&}u6>gds!s81C!H}) zGq(xee0uF(Fu#xCZx`L=-4!9cUmfKL+()+mNcDup0Z(P^cX{C7-Mh#A<@-qq>f)T; z2kTVD+0XLLYVzhsS3D?~-{*0|#F&G&O%u4_lFB`U)(wu#UTj>tclf71%UmA#hZoN7 z)VDcZ`s!k1Qb6p=Bb7=1Ob#`@WaXi8kQ#J){hWE zBKm8xgcOF`@*FV-;e5Yk>QKrN7)$vRcNS$Aj(mj+c7-tn#rL#(TRIH&^Nh9;-zmCQ zQ9k-xm|6=@06fRc@2|%A9!IQYSGg_jI5WSm|9H;SQ(thCwV~CAxq)TVg+Pk|ypNC= z;T!FUWSGHul^CNb^I$$@Wz0?VkDoPM9pws+7*}|gu67$e{4Sc`znN!z2GNw67j?Cl znfW~|b?~c*qPMQG>1h=O^E)l-({JrluQEsPTB8orrVGg%0bHOEZ81cXBW6crsQfkA zYbhn}_+-qFoO1QB9x=mDTI@zwG;0IdNZxFv8%UN3it)jBKMOf538a?jL zHt7H~9+BE*O9aS#zsXGdB{97KqU1t3JQG=}pyh>&(G_7vpPJ2?4N7cy`I>%uJX zz`8J+7+Du)fd@i_`0zarA{MYT1|UQ*#R3o_#L#{mL`b_8Gi!w?O}bMPEbzd(Fbh1e zE{rAyPTj(_A6ejm5Wy_)K!{)#cpyZGiUlA&zE1}QJJ)4`ls;E{D<7IK129taW40uO`;@!@+MbejkwXd!_R!O|Fj5FzPS+!EfpiY`pV(0*K9lvEco za0BbY6brz*Fbg~oB6M^Bq=f`R1hc>cAwpCv;2=UwV*o;gq+9WrqN|MP9cFS;X!4wNfh+t_9K!}iZD-!K;%kj00fuNzA#$;eC z(&37ZLqN!(lZz}IkdSbIGUzj{ri)|F>$d$!@&3empTbafsc16wNAC<1o<=^7r;(NP zK0R9Da2T&}Xu&HStY*BzVFO;_Z~*<~L|h6Rj!Y5mA|B0 zk%-GfL|n>*GGOXf%Gw5iMN-nO__epC-sFh)2eNoFp$wSrL<>A{x|6jHo=p)%yU0dw zPmSLHvxEbeY??3cEB^N54Kvya3w$hD;Kz<9Pkp4u&GjE2 zeC4m3GO)!}3-*OIM#eqvVP$ap@> z<@(J+0?~G;F z<<@(?mKVCOPj8=Y&or&L=#!^P=lg22cB@tiE_fmNpnqG|Q3`wr=&sl^=))nA+3SrF zivvC|j&ZsEAB{g~jZYh9Myo^bj2FilX?WaLZLiSLt=R^?;)PVb7(mfJGbYUX8!GU#QZg5~-l#ILwLWJWf1sILM zf(d{Sp<}@WK!{-EJ#dPUbSu&WW-UbTF!CN*7lLl0o`H2?Zg5~-#9#s(bUX9wVN*9F z?|~3uAc&xa1VRK0CIC(ml5Rz!T@KSdGRr^*?gdijYuQaV4c+9a2eu*|uGmWosA(~o zdYcM^`#n2fQh;$`bo`?O8xRzw+=xQDztuqaU>ngC-daPfcP!>)P>v>3>7SQ@r;)?) zG_oZLuWkwYyV4@c?#OD{9=NYvKHn|+F?I7Z^ zgf<+RP!`@a^F(zcYa2jXHA%PP58fHcq&blZWsekkvbF&yf0A@75^*`6h|7PDIZw6)gqAiJX8& z4S)lnv|BN=wuOjGnNarB3`3@a9$DJ}H~>nz6^Xd4A>vXdls$FL$=U{xMN-nONW|p^ z@{7rYGGOY~$=U|M0Z`JdNVJRKUA(3ETDZ|$77pBG;XoS&75u9Bk6%$x!QJ&QHr|~X z@-xjjRjAn-^X(5oi@wfXm^3T!aOvuQ7^fvFLRDm}KgoG9&%a-tih0VnlBayo4$38< zC+c0U|AFy$=xQmkkGcM*o($dbQ`tTL`?&y?B~a?KeWss!9NFo!4!d0c-#&8eGQECoE4U)Q`)(TjR^wbg zxGcC~H6Kv6A+bNbQeTuyFVshqJG~#vPoSsiS&+c&y+Mn7enocrJBzYi2@1K9^v~58R^-c9QM8VXbxR#IX2 z{4Z07vLJzVfsxrk#zkbO_g&-W`hRE3H{|-a#Wm(->Do-;>&xd%t=Y~+X`|@*_fTyM zH{kS*6{Prd`r8qsHf8IG;gW*OPgZOsgEt%beJ1>x@rJV zX$q4yo9u}hCB|qLB=Bv-V!v@&?@`jj;L~oI8MA_q)5BgiJ*}e6Y!DXp>9;-Z&Z*V{ z1HC0tKBr@q%_1!76-aARmqWiimt6m@H{jolnuO>~%6%4H|DPpoLiFXACWq_)tp>kp zL|3{Z`|nLqA$qcnqTxw7OrG`kOZy=@@*_&1W6U@NEvX+V)Kzr-KZOCxW~b|aewtSU z04AT5dMj3u>!0c(=A`s`h)^)sKMo>9kp>VV7&8uph;U;1 zXd!VBA?;SYq|dzQbo~SCBEA8SgYJB)3whRobz!c5AVe_NKN2DsGY*6Z=K2RtcMAw2 zXd!_R!Ce0mZN-i_15Moqn!4#$0azEtj05X3k-7eXbz!c5U|pE&9|+wdGY*6Z=K2Rh z1atiZAwt@%*i&GlgSm;In>_2lx-e!OSQqB{N7jX)n>_14h+wXNAVi4FI1nP3>mLXa zVq`yVija0IlIx!?Ohl_St}deMA6OUh4R~B#lmrpvSqDM{bNvG$f-&Pjh|n?DKM*3s z$bQ@bP|~e9kX-+Cr^>9>$ht6Q99S3T`UgU{==ujj1WnzvkU)rF%s6nmGY~}3LINRz zx&DC=A?a2m+T}3aBQvu#u+Yr)4_rkcU(0T~nd=|eigdUVR28^8+GOf&Dh%%TEV}-2 zKNe9%0t7`VH=^MBw;1XL*FW*JHN<+~kD=_!(PS$9^D^)>ayXtwwtR(GIGn*N91QJv zg~K7d!oh@BIFzHc9YkD~$b>RLbt7vV0BRe_Ya7mcXP8KHA`{9UDfDD*15W-V=~g7- z((H8o1CKK@q3o$tk_a+c+u*5sSCFM4Td^Zf+3s}x15a@>q3o%qnx?yaI{wSr22Zrq z!gPmh#h!v>s*7+fL)TllTa+G|PzFqQvbMof(*=p!p{+=+e;3NgUH$jkKJ-oZ$%<5H_&NFCX@jObJ6t=JOIkt2EYLjscj(IMer^% z*FUh(Qs!&nMsHa-05j1_xe=}1`f_XPhSx6{j$ih+93oP+=HH|QoUp~LNsayeTW9`| zlbSusCvA0neCmBA8zL@>vFFZmGimD=6+?y6fRbiHGAZ{gCeuvFwWgO{8OK0ZpQecEuH=^>?#)? z%^us`<3;I4JJN!S{+6OI4LPme;I*vk1%5zDcC#v-?-N_`DmTP@ds#&>7iu0Ds$S?b zj$G{Taf1tU?lmrPx!8ZPZ-sU9i1#NxNdY>4pP`GRP{Z$%y!IWeQx#`F%P+4y&5bD8 zv{oIcU-yg7?4o7g9z( ztVyo@ag6%Dgv!f}E#n84PhKU!BwF=)n<7}hw&*k3Qr<$S-ttOX!Srk9~bX7DrLE~LVhWozS ztlg?ryq7k+UbTVu**f##k>s||-cD}&z!EpN{iDHGhPJNj+Dv)0`Q|G_Kl*r1;;DFU zcv(Qh(!|{QU`;@iI+PD7(KoC6oBPBX|L;pQB|})p1#O+e5{z$*Onjw&K-z?&s*8Rl zIaj#=jelKb8`oF6F-$#{AEw>3Tph!QMH}}FT0}_@bJce)4tOeSzbgsi@g>K4ypFz& zFZ;Rw5^8h)^$e@91Sd-UmaIHdndINZm2KXyp04R%XVh|(1`(!ui1*dzELSD)0ovSG zxVy4~C<U7G zye#jpMvrfpTaBpso99N~Pf^o-V|=%k4ujPZlq1-o}+V~qfCUMf1Z>FL`7Xi2^XfJ5KwPEP`i1zdMF>P)z_;>jrSXwO$neu zODF;KLEg`m0Qy9Hb#krz7v**Q-`qWq)i%)#x#p|UACqzfINZyB5pX#!R|a;Y3GK(D z1u>uHWyR2mm@*TNCA|!}5|{s?ypA_cs7Swi(uwqm@lB<8j1cI>l>8R~)Go0|@;XXy z9lxfVfJ=Feww}fzT_xbLQ;dYaShN_`P3j=eAGU!R?r|vpT)=#IL){ z!fl=PW%>V|n%ULx{6$NP!E*8amUA|1UQ1JZxbszcnrRCPv zvu{77+t5+f-csK6{Q~93-MPs}yW7KOeB6Ecc;m6;jH}HCTXA<=c;?lf_RjNF8(Nev zwttrYw(0T}Q|tTf%JqiWjE<_ZZMG{%bhffan@#zm?PRL1e)@}770H$wU3XP?zBQrq zVqU84$5lGphJ0(6$yT3iogZ#{ApfH6@;ha@2g>rV{x00WKV&_gd%$*iRmQjPPi*^L z{uOK2ufMjPR9L<~k#WJ=IjddSG|SMlF8l>c&pT&?|J=1A{4dXU{H60i=C`@uKa^?t zE^~KGjp0;Y{?(?Q2KwJLnwo#Sl3AACeQd`1%a@+LeCX@vI!^BF&OSH8HZxUs?uc<> z`_W6C-a8H`Eww+IET1P|tUG_@$PU|&8+O!mcWgE(@^$a%&K~Q?}lE!Z1%~ z{lI3(RQ9xWKJ?j%7?ZBO$5f+hK7L=%@l`$6vT$A37YU{pZI*6jh)H*)Ti1C)vD?;T z-B#bC>!@0g*SO7gQhBs{LD7sCpR=jADCz$nQ1-O;RGm>8bhdBG4p61)6AbBpI#6!8 zWX(-A*)Dhb+ur!*o8+{fZ3oVuKXQDVa;DO{E%}Hcv!|<5alm@zMEY~q4`RmcbasOjk@OV zYiuKa*w&)#IgxLh@Oi3D@yM^deJtK5zr90$d!H>IX7+jHSN(4b>f__%)5rYCn1nuV z|2K;M^K+Vs8&cP;Nqh1)zgeF)F?ro@G-(s<|K*;$pIfWBTlnw$fA_1^{qMOwXF+Z3 z&ze`(ygO*_%VYB%`J`mD_n?x7xZ{fPtG@hd#=r?rdC$BM@vHA2%AfJ>)rJ$Vtl0C{ zS(k>dest5%Q#Xgb`2KlLx9sDM|NQN_uYY#`Q&R)0{`CA(!)Gs*RzIzLAjIqIM`z`y zy%@h`-hzRT<~&?JdhNpl)5iV!{fIXe=7%TjTm9ar$ph}4{3rg=fTvci8PxsjcWvCP zx`8<*m3M@7zPK{`7nRE+?*6a;3j0mKqQ~+MkH7zsBU5&4`<(Mtp2%1gqCC3hxibx& zzl(l7^hkSF=9Q)MP4ic`SsHE^mMQ0HTfft^2($b3`8Uh-v!5)JeSv-k(NghGi{EF@&W}HN*TX4KCxmz{E7{p(Irwa@*T}$;n;+>@us0)JG0u1Qg)8s9 zdnwH8yViT7qH-%X4E|z4rmgCWyoXH5Uw!r1V}^{b=Q+x_>e8-}KCvo$s~rWm#yKmdXzr2w4skZEy zbdk<~z(-L$;09e|Vfd?CZPg(dGLodlFKtMMnRq zg?j*8ttk!-3HK=r_bj~rLVqjX^`V#m9amqi%d?QDEc`*dt4+OY1-QCo*v0kX_Js^r z$t^j>EaRS!ze!E`PuRGjjz>hQv_vn&xS_E}LaMa72fG++yenpk+0sLO!v-6TD?4y= zNwivf;U{FDnbS{vsz0qPLhUkSul)BA6W{EQzHxFYB&XluLvDfdRj7A*riE|mh-HKn^I(`Uw ze|OV)t*`rl@uPGHImSBa9Q31cjzg6O3ufr<4I6jh;Qjc?tk|qM{oG~lCC$Q#^St-X zhk+}DzBTW@Pmd+lv%Ab9)$cbzif?#f`??d8DQ3M>eNCDNgrlq1y{wQQGV1F`NbPKH zPVtkE+T*q!;@)`;b@$_|vvHMsLdHch6tq1`F|W`QueCz;T|$Q+y4*p+y0F(zdEI<) zxi{dwdvLhaU%+B6HnDDF_b;)Y+C86M+J5n6)J)e4M6W#OZXuZT(9HH{NAA{S=a631^IF(*BrBmTB{XL9s}yxV`Hn&1OA>;8EkA#eMNG4)?!E;KL!*38EG%u zl-0CivuVS_$p()4&>PQk{E95~f%4l|^zW{{TU;MIPH(o)7W; zgiX}7qL)agypoCRfLG=L`?zR;a1d}QB5JRmpLjto(o@?%u}evfP~7;HxyU8GlvpAw z$5bGkNkwIz>c6B&_I$q}L@slPkct5yi>SSec$%ajp6|9(M|}5f=%!9qa~*!)u>I=> z?z$7$WI5uiUcD8Ag4}8?vsdP06xjs-k}l%;f_wk&@_>e~-aYaLJ2j>SX+UWM-AWqr)P>w6Vm@##QnlM3G|Rkh#Ek?Man?LHJm;nRSES%G*EBj~G{o!ULp zN?ki1Q}$$1AA63{1C~1@r=MVMI?%aS&rqqLkS+L<6G&REiHKDU3auEwiQR`-P-rI? z!4VX{yqr{eG70J}DP9P6@&FWXQoi5u1}TPN7DoV$Uv2yDHb{?%Lkb>LF~A!kc+5!8labE>ET6Z>^?;ZLsfSzhYA zkbE*o%IQ%S_w32rsMHn>S+G6FSKFntR*5*V{joWX)BqLUT(F1RZ?O5Sp7hv)hdF^Y zW)8q!QIoR7u)CdHt0EY8t`c*!C)F37s(%=*eOSHKM87l(a1qsepsP+zru&u%_Ed z{RCd0x@MTfPjFpS;AR?3Vva^E)l(Lzzd{zo5TS`#39J0pE3@?Le$oRwl=u7oBRxM1_7ek8?Yssv1SQC*PQ(Lb z7#x2KZ6>8`5M5eOy^mV@p{f5e+@yg#QTSxo5H?QVT;<=c<^Og~P80dO=$C6CV6}hU zA1MZ7fii4?^UK{Wob|H zm6)hsHAreo@lXQSRa|->4oV$w7F4*p_6=@7Nt@+Zo261|e}4tITvh3RcfVzTR~MiuirfsM#ak^Z*03uXnb zLnHNyCr*9LI3?~In!kpJ)+E^UnI?Lmzma+fHc-YaI&h2~n5{LrqC}f8s|q~VDkK_w zy(JbqcvC_nE?QOGIjRJT_3nz2Qt7TeAI`65nT8V&MYzdjAg$mtq;Pf8;m}`I*;S0z zBk}9G211X|`BgI@3`1pbzJ3;i@H9d7*He-D}lU-B+CkIJ-l{BZRaP>?}c2gi6a zNZ&?}wmq<0%|)U_*0@*{w|L%oC=Y2edu@Vr&2sF$rIOz6q1qAkMjl*Q?qQ*3yoO3Z zlQRBpog2_va~spCr#T ztFb+ErJ3zckSS{pb0dKCZYl>Wks9NzJ-;+P9%>WzLRB;MLKs|LsL+q$SQUwYdT|$y z3fXy}Xe1E5!7;acBs*(_X^Gf9kaj4oVBKmQTo1o`v$2lrujd*ajc_WbRogItF5y)%8Z0?i@7kM;O zwnc;Wg@SorRrI8w3}fw_!D?cZqGo=v*1njg_VY&FCfe~WIOC00P+YqEQ8&95PNhEL za}&T^waoLfA=t9493+YK2R5{C*B^lbHEI*^(YirF#jF}NxXkOwISNIWSV6ftFTq35 zHYHPW8N@`Icu=r;BZ=+Gnq_1kzQNHXd)7c@mZ>j6)-(XqMEG;Y^XI*AHC?u|`Ga`G zD5!VsAhJYUDR9p6{H8=R27}Y+wp+a^747%7T90&R&2RyYRgU~y*&#~P8SEsOkr`wx zZ(W9GK4xIE$swo2qV~v$o0&j%R#dU`)0kZ2vP=?1r3Ne1L3OJezjJ=w`eqF1o@ydCUL*p<$S#m1R_SZ$JDw>bwmn3G)rhWxbjfJakc_o$ zt6l)L!9E)v$cKF_7Dd9Sp5Q@MD7Y8K@A;+SUO-~UtRUF*!cZC1vVyzRVzSf_M9l^d zGC~Doern8k-Wlpk*J+Q#ZPJgyB1A9*a+4fp5H@(NY4n`MeTEk#fP93c^5GdH7CVK; zcrdr!LdZckIO-Il6PfXVP$LI*@Y{u~^_=N}M_@w#y8QgdFeVDw*M<-vZ^GK4tUWh~6?48(5%6j;Cu z>;6NSW!*3frAYb)8YEbO?TCRUIJHON4Wxtz-!P{@;q|3N?}-s7aKI3Ew#^l4@XvHJ z&vKz8hQ~Oy-{*y)gr`_vnQ=rALlf!ktlGi|B=L<2G5$`8zzYG=%M{0OfDj{#5)7eO zhX@oP@jw&pg+y@Uxg_zAf&K>oz$+DTpX5&kYrg+$2L6v3{yzy2fKmNB8H&GSn;9io zK(P)JC_w7*TC^7t!Hw@S-9H8!;}o#Z3rk5uvA#3oh$Qw}q<6e(3nwt$H>SY&I~@Wq zBqazy6~h5a?EeG&ihjG z{Z>NFpm$uzMKjC!w}46&EQrv|Qu!t5h`}Z}tySE{4Nm_G3Vbge3a=lf;@ym%VK3qn z#IFwDPygBBr?37j@81juA(Si40}llP8V6%U!pWZi!bsA{|KUVG3ed!xQT!Ij-8dUkRj-C zy1TjmurY5(w&3Z0v%9mFHm*6a7XNAW;bN$PT>bmw(>g~IP4asWd8fO}EDJ!aV0ca^HZNXH%jyyq|tFK}bpWasoQ!(OXmve1=q>k93M)`!yNJ%Y2 zU<81t^d~a!{#y1tK5qDy(3r@JnWUKEk}8~W9`UD*NFAH@rx({!TVLn8MuqDSnv_RJ zi{}-nA6+SHd!*@;WX=U85!2gTvMQIuV3iY%)T`Vf!K)ZSkQcbMpfw75$o~`s>|d)G z0CQ6tQ|71Nrxl(d&3W4&6c`WwkI<_v?b9uE&C1nj>f}1=yY;*5RVR7vGf-R>kF5kA zHlFf1X3tIaq1M<#*xA3v43xAH!lDO$;CN?cuCIlGfwykhzsh-k;rP=H(k~_@C}lIE zbOjsp*z#-#tHMN#4Jv^jo8e1vSV9*PB_=I99=@As$}Qf8K&Q$pw+OK)a$Fm!SYvJW zgq4K$xvaKs;piL=ie>>Gv%tRaK@68Q#*NV2|} zcf@;KEUAJkBtmPns}P*N;CBsJBDHL6oYi^j-O%L${blbhvu8uVmChGotUc>@v!q{^ zR^N5HzT<8_C=Hm-4$R;8_N}*BTC%kQK!-WpZkW1$5bGW;y8oCyCr$Vmf7SxEy;^+G z=j%x?69^sDyh)e;LQoG=z!v>m3h6~?O+w2!JrgS%^rYdtg~GPI=S82QROHZ4!{RE$ zB23PF7Bu$N0x zW9Q~dzqj*)4xUlBd4tL_RI)rt?Finf82gvO`7T%Alb$LD1nK%9+;O= zY=_&oJiIvnZ;z)`wglTK0;C!k;q>Joo}7 z{r94b^fqzdL=*E$k?2?m({m(sG`splmETpX9*w1&Q=Ikb?mwh{0rrz>ZbUCS4Fp|y zCcAowv*a>$=QXa4<-7NQ=9}FPHDO0J;zQatek_%Mu5x%Rw;ki3tEJle(97tSm%Q|p#x~xF|dD&X508?6h`@qPa ze}8m#MnCM@UQDju_rlXnt;qoHv1t6Pcq09UdUqq;>6yOw?auU>KcX96S8>wjRn3z3 zLq$zt(yHzd{sFV_gY)Hz*9)O9+~j!0v_Kn+#jG^+qwfdNLm{~1Qr~h+#(wB!djAOZ zPnMH$?5P(JesGUH9nYG&2QBiQZ5-?{>v5v6H@+F zvVWe6ddD5w5WBedfiTB%n%7QUTd%hI5IG*caJ;_viH5F?Hc1Kdqqzp7_w5Jvw`Ir| z->@qh+)CLJpGRCdRc+`9>RD1|72{6(I6SUb$v>|b^CNhMV5O13D+9M3Pw&eSKPgD5ElLBMIY0_>K`IMm6GWD{D$YrjI#gZO) zy)c;bQ0e!5mx;=bK(Fgf?736UHh6Mps3Bn?vOIaNFq}yq zZPor(nCygz9}%vz#xSAZdm6=>NC|kHe=HPX4V%FdV-Ta)KgX#5p!Kyo(kOFF8HJzV z8fh~uKjb2IqxGJNpwu^t%r%PXqRTi{6u!(s_#rT=4NC~924_a8$)719<;UkDwqM3b z>*JGNw=$ZfUOXs)HlA>H8+Ib*8c?=kB|e z&uIgTtBD!vAZV3gRdI$3UVU}yp(-};HC3hd$I5$Kxc$n5!cT5xS%Ivvq8zLGU&75| zq1Z_uh;ZdnOT)ExDfRkH;08WA5cr!kk_tJst)21qRMSOs{NdbH}L8>E6t2i|S8O%UMYX6vxe@J;PcASnDSc zMlc;V^DGKZb1FJ%t$e1HkI|^V;O-4lP(L(8zs;`4^B9RnAj#D^GZ%84C)IVEU+?8g zvS4y(TlwyMpf^cuo$Tu-Z-v+1B<+~r;B?vq>A!?OP2_AS5mkw=?q0HsgF;i-HICk_ za6QLAk)?g+=ojVm7HK}-bipzj`I9L3&0^w9o*bUwq3*kw+A^yQf0&Kf3#&3lZNsaB z+VX~WDG9OqO64VGm-8IB>F5o$tq+3VLn@UisXn{AC4}}!mmd(Z0E~5J`mzU_`J+#R z_L#7LUZ*B}716L8W`i4*hJd&{@9l>O4z7ghp{;XZ>A`T-G)b)q)XaoxgvgSq(;)3O z-W7Axov>w3qV=JI*27rV!qug0-`A;|q_=EtDV7l&i|Ql+gi57%7+W_lF7E>8aWPbs z@t-3sSI~`Ue}6rUNN}=xv|x-g(w!})*2+9;5p1(vkr-{@11VXuTiky79^kjbiQe~q z-pPtmFuPRBla9OqE1!%w4QdHvR)u3~n^qlGXMpaMxLn`0I1@8cj@w|jY&?8oCb7ub zn$19Yp4?M3-Rkn$y#XnFtlY49wvGcUCW5XnpCV!Ygg{_bSe0#t$*A-(pr<{vJ#PL* zZo6fukkosWiU@YInJL{$qmsB$Anp&}6M#21n=ta;9sM^vl7Q^=xX44U5yQbt;UeR; zvIGA_f!qG}w<)1PmORrn z%^RSTZJA08u~8T8nJoSqQ9&<8MRNO69#fh=+h({*^C492oZ23D)KG>0^eAQ)wrR30N$Ns3}mSdj1E4%aI z2VEAsBsdw-JeNLXT&n^F52caU%XN~UVaV;>5I?{#VvP;RzeLV&NniIRykKGeiK(kj z{5@iD-ej;hU5}m^pTfcW+v~GY_bO?M`POi&<4CV8!rIIl+~;rGOC$(n`j;3EXLV~!zeS=_N;I&=wxV9FiKauW}{7jlF|PB5Lh z;x~|^(5t=&DR2ZEvH|<)7DVbtrIUoU6BjHFw->PR;P%xwjt0@}x{KwyI`Utm#nxb| zt2?S3c$(-i- z5N}0mancW2-!$~oY3bW;Gfs2P-wr!`4tg&$IE`f7k-rYN`gVp5F8ZjVacsxRP@K&h zb%=Gxjl)nx08x%}RX*BF`>58K0PoJMb5crhhpll1ltK+yYvajw|K>PyRzA;wohKZL(ME;ZF zan^gDQsz1ZQGc;7?E*baw6G>Mq}QE6IB&M;v)B-ob6$2VE1Dx9#DpRK}WV!E^lDDU(O9DLhaA6+W<*f0fAp0bG z$=?|Bv8ql1se|(X{(v0Ao%~OP?aW(0-Q=#qS}F@rN}#n&4Dt*;AWBMGK1JWGuG||P z5@spBIgBk;K|mxNqXBj$QKqsY)cS9arV5QDE~i6U0O{3_w-@N|K+`#uY^#{m4~in^ z`(4X#<=ge9_?4EZwzm7u3R+%YF$0UT9CBQH?!Rb<`nWEWv|y*S8M|D0`mF~Yrih|Z zN9iJyyjnbAif^U)aT1+1x^N=*G2%^Wm^8q}=tH6i2{89Zm%aG=EWgk3DljRvKR$&* zT0}yvy3@F(6YBQ#JU~}|f|DLrI1*u+)WRLa3~i%6oPoa7pPX=gCf(t3;i6})Ugk9} z3>67*>@)f%N!(r)6cno|@)-u5&s2TC2P*#9^Pml8%SD==4qn4D@q;w+*8FK|Zc$%* z&&L|UO(B@kH?uHMiC6X)fT3PdOuuMQ{GMR?04O)zlOVOb=5i zc?~PWkw{r%t|FR}X&dgK*|l+_*dX#ec;7s^ACT{Gw||@OCXal@M$*YxOd>ZcQ|i32B~-j7Y{1x)>)!U)9sZ z(o&P3*b0(uSK_vWd$w)o@>PnF&^Y)I7G>~Br zNvg_w?A7!?C;1w7;z(&K&!vo9ap>k-r%1yPw$Vh@KPh4z%ma9Lc#G@S1!@ z)|)ip#jqT-iZdr0*v%lfzmC?SOQ z?_QD4--yY=FFXgZq*h*?;ac$P5AL0R$`<@J>FkbXo^N&@k6!*)4Ua+ws+VHQEQc8_ zt)ccVvb-)j*fxzgMcl2N*kcmh0$bU(FN+B}Y>Cme2AW50$)yoL;MEOw>q0mpGf`}o zTdc>k4ruT$6S#|Crw z%c&fsmd=dDgEtKGP8n`V(umUSW_|Fm&t=e9_p#XsS@tHhqc+-K*1q9pkZj0%lNsUA zUcM7l|NLaW+3jWh}!B zZnfp;p=7*K(s)I+@6zKi<@LSP=j{OisEt0|fOTF!G7LdvapL`&c07ZiCHlf)?fB@T z&(3~ah$n-mOyjcWN2RnsX>L1Sf)@snI2QRWe_^KO*>tn;I@_KiEV|$lkC4L%er5)MGD}M z#_QG_{AQ8@)wx*@_bPx9qcn=CEa6((ey`-7C^7|No0cPKwEF!+{rly8Nl;4Y||3nn^b4y9pr6~;O0u2 zz0U+!aUadn!{aw=8F@E4mym$k<(VUi*=b!;&D$VaX`_tz)U__w$i)b zBXFdpw$>NeEqey~hSCEFO>IMX{mz`Q*#uTIyICWPdH1puvyL~->qm`PB@7J=(;Fr; zW>lnIc*HCjm_DiG*2@u7pW>Es*M+fDGQ612vKfy~?NNNZup?Q?(rMC6Dy)Rrsy@2; zOiVRp&rN=uQ?9ybF<$Ie?50jx>}~OB6bLQdg&~g?7sQjm@piTLALecjTX%)A*I!-csuQm;>hA)(HS9><3@ z#2m!rlDmuG#~*5}T~c+gsoW{-#TLoL#?|sPiaJblX^KQ1o6e$Rg*4vR8)NlAyL4wf z-~^}>eafK?q!){3MG5WA?em4x6?zu>&7zEsCv2rOq&HT4u5VD4p)yssVL>B z!4#%~N&9J5+V9+NyX#9A;(5*`CK@qK$qy+d-Qy2o8EMppnA7l%73q)Pbb8@;t%Z#| zveWSjNvi1@TNBWpz3on$CQ93KJ2;CBLAK=><3ZHfn)WW?`7Da)AYV~%%s&$$gk%%z zp=ZWt{`x3ndRzu7cQG+vkdZ_do6$?a(qdOPa9N1juo5b_xl)G zB0-ND>usiIIbn3}$lFr)i{GtF{f}y#dfhQ8Om|XHO4f*ZoL%#D`d|6Pnb(ydq)+?S z)WV)AQAQ`;v1o0&JcIa&HYmA<8$w5e8KhfBU)2KXcXP)uNEJNn35BxG2j@y5H9qMr$h*Q_QMiBe724A7{FPZ3vT#Uk zptzS9ClV~bLHMV7F%qR`&h0V*UIbr~u&L8myT}S{V&jnosWw(f%|9%{qK{~arjL|6 zEA9l>ZTdA$-aVHrFIZo*!x?2Xt`QhrAU7pQMtAX0uDyvaD&yq)wbrcKF@)qc#dJi9vz26=~Z2%Q) z;;Q_aw!J5CR>00%fI9Ag< z^s_siP9E5m39{HoTnd=5zE{!tjH7)!TOr8 z0o>4`53xFRE)}ZRWQxR*)kb#ERudi*mR!*>ni2aUs3$}%Yyj7;y2OnQ&)U3YS?uQlvJmOxi9>htC zVui9thokL`0A9J}USB{-znQ#^?edh99hqCGWIA}D#%oghB6Uh?j*bRUWj03F66;Zf zu4d_4>BSmqEQR*~m@ta>k5Dc(4K^k&@t)kC8>AWgsOA|TMJ?71rBA!fk}d>W`SKmE zxx_ScPoYP%P+*U;`0vOqJbb_p-O8_b9>lr-@Lb}0HFtKp1c%pJ6z>|E0Y^6*E5xWB z$*hMg>yltj8}R6=s%)EepL#qvia=x5O~Z3ee3#U(JcF6r(K@>ftX*ligBE-k=T{3` z*rdJAEvcmmDTGw%XINASKj!KIlIpQ6Xa)pfpYj0bV=>6J?vUNHZhVre*7nGi2q-C} zfN(UP66@n5b*77|4s@uU<}=m2bS>#DTf6J%qRZGs^u^3`UvpALFlmd0F=7SHh1zz~ z3m_|*B{y0*=OV~o)l;n#P6fX_Yas6(XSkXbYLy>cXa(4H#5}t(U2cZMULgQ_jLrJRIeP_lym2l#_=pqb+$)&5Zy#-at+uP?e2R|lo?s^mU!h7Z zx-@9~QGpxKkCNB#Y|9^hte`t+TC zQe)nBo(1K>{~-W)CDjPfRh@ZRO-XiHjcN}1R#CMfQTQ@57x22xI{{~FaY_~m#SudH zSyAUF?2iCXO=L1b6`Pbe#9gN*+8j1b*!UWlhjbH7Zd$gaUVr-+7XC>S+0Ex~t@q=` z?|AdLpkOSpI2!7kx@OiL=|gu4!{v?>S)_$Z2S!{)47*~^Ttj5B>x^$2EU6RBI2G3Z8{ku~E4XO6rvEfi? z%g>4@a6dN>R-lud48Q(FA^6Dx(Zi!J?-=P%87V3*UpHugRn{GE3foAPo(8eDrWdwp z&DEgKpM~O4nj82+KJ_NwhRV^p zXd-M|IEz6Gi|0RA+uOvE>oLraA|meA+Fh698<#nzUJp-Mc>;)Z)$8=2s-m*% zJ02*ktvMkG9r|xt0&djH>$V})-bzt!TE$WnD!;BXL+EkfOhAqeGZQNgXO_0l%*}?R zPGQ3}i|TW3it%JP8gg^ntA63fK^@8Nuz@0X=#t#e%;h+=-YH=^c*~n$KHzYr2X~=# zE*)wc0?y9e9pu0<*7airFyuIIYI^SJol8n-vO&B zSQA=iw%uV`F!UYlT2kNge37lM_Qb|(N4ht14a}alJ&x1Y53x}V?@10^_v(WMLk7aq z=iRSDKl395aqHLb=z|OW9c;OKIp_!*8S;NBbo5_^4nFN?WM^mfbb2jL-Zp>*M^bY{ zkm5VGc!C-tl8K6Xe{S)FGi1~Qg2ugQy?Ec@9fj}d$Ly$xs-u%wuZCu+l0vwxJWfK{ zP1dll_6)haX6svbUiH+m=z|FPrG61_zQ(_OtbV9F1XNz)7%pB%Bv7i+V$>*Kn7|obk1ZXK@4T%c$4|Mz&Y&Ztko;!VTqt$&41QCekcBrlfwczv0{#og~a+Ege|qyMqhCP>DIh1&xlwlg4p^V{@4^c%9{rF;@ z`<3R}rwV;|001b4_5B(A?#wf~>m=!#ULKTn(_jbLUzcCP+ByN$P#ITsqz9N%%= z+Ev4g1mPWPs0N#(LrgGt@YhYefTyg@Df2$TbUp^_vsV>DPum%UPibpTL2;4#kC6kF zI>fKA{ocDFissLP0XqWPyJ2>zVs97$tYoFOMkULx7pD{{uqf#`I8cd1PL97h^Ug0# zb~8dhH>6<5?sYIQ$K7csf}FnmA_#%3tiwc8O>58v;Z#S*%+r@*D<=H;E0$4!uaK0> zxJ3=-G^YQ%W!UHK%cAw)d6X0%Me!u$BMy%wOQaTFd`3c$JVE33jt;tr&^_f%F zXg4{oei)U!9Sf2c^&^$=VrVxb@M}q&kAPMSs3_nOa_xW=)gVV`|F=6gbj9s#0j9P9 zeKj|GQ^&X9!P})aU<=x=a_|2rzHTLnLQ-7(%%1k3s!Z(`QrAQL*?ru!$n_l`q8d~l zmOAzY);#~>$Jxk(*_<)@Szy6fYQ(ECR{0SG2Kk!dnVwxYz;`Sp11ef87Grp-`jn+X z4fv3RZzke|3}W`^>G8Bm(0Nn9Fd5sHV2ot%A<|IP(pbfwHU5{Sh~^!%6C~C`x<+Wa zxN$vPdaCbG(pB?(F}zMPV)1jIr)}klSafOhBmfE~$2x_Y%=%PuwddT8Qcf6Po}Fmx zIhpE(R2kP-#azj120Q#}NH(wAm|rrJ03e zIKtQ3T5qNK>lC#rP|;6jJ73npnYTeN)|x4BCTtdzTv{A#=6+90_IQK^XNE{fO;;O~ zl^a;_@P&lJf%xkPwSZk>G%6efgdAvYfdR_iKQGXMYGXSa8&IwspElV1seKcAM`#HH z0ii7i0YUr^Re2C5NZZ80&;`6_fZ5r`TH;rm^(CnNClI`mMF1>_B0OlEfR8Bubv+{e z6X-YMe@o|oMv+DNZ&9B1OZ~~^@8`|`$t3|azxwAH^S@4)|B3SVXy*Yq980l)usXYh&4;fPddd0^XMO*R@vs z1o-DBtv><&KC=aHH~H&QD1QR@FPl&PMELuZ0Xzf#>$>auh4AnB@Sm!Gf3tz-6n|ao zz5fo!zh)SJD*yfA4u1Llb-DIGDgO_z!as5T{^SI|3jVsP2T=b0V)#?>?*sdvvCkMp ef%tD8vr6)?pm7QMD+2WI5j51ehe6{4;(q}l#z4&g diff --git a/templates/ImagingLevel2.xlsx b/templates/ImagingLevel2.xlsx index ddacb4d4e9414e27f675808fed06da4899155a8d..3a8ca0a860167f963c59b30063844fc7b0408768 100644 GIT binary patch delta 359 zcmcaJ-}ugaW8MI7W)=|!4h{|mnVQIryr)>1f%N8EtfyJPj1^oSj3CD36!*3FK|<3-&+xc`8F6QLoM8;<>HE*{Xn=XIV8RAxdHld4 zjc1_>kHbVH&hglRr6SMq*n=6f&+%A*8Q0G7Sb-VB=XqSgjOg<`W?;sY^E@5^JU4Q@ delta 359 zcmcaJ-}ugaW8MI7W)=|!4h{~6=OJnvc~7x21L@7TSWmNn87sIv7(tB5E4WlPi}R>} zIn8#w?RLD3K+FWh%s|Wn#H>Kf2E^<@%mKulK+FZi+}rJVc@&p1zX(yA9MbcH{Kxr+KVFE}t%XhQ|%eh&#jM3}Z-7-+zWj1I&8`5(YWW z;4F_Hn9+C^DsmhqB5{t#4lEUUj>jI%n0=1N0?fE}j>ihj5I)c23T8x~=P?5_rkv;T F002l&fA9bR diff --git a/templates/ImagingLevel2Channels.xlsx b/templates/ImagingLevel2Channels.xlsx new file mode 100644 index 0000000000000000000000000000000000000000..00e5bbee5af4daa803f1dc249dde9caf1a17defc GIT binary patch literal 1311237 zcmeEv30%xu_;=Pso3f;&Qe>})v`*6IYO!5eu147k73zjE4Wh-;rc0Yvifc)XEUCE^ z5vdGfk|atcN&8GQzxVuRT1Il+_y5+M`M(|W`J_T~Jiq6B&vTyV`F@`ziw6xJB{Xc< zFd_AQt8IjMeo2DQ_iR_&;Ns-8$=S_SW7Zz0?Jw4>T`s3JiamrSv8632Y@DYP;~%$S zlQ$?*D3T#UQ@>8GjlTXn<(cU-`b}zvS=u)BFK6h#zYlLXyt?+IZpp1rf2fGRHP}3` z{G6E0uII0h`^X!PyKv}n>vSv_2x+c@( zdHCwcT8W{PqwOA8oY@uHFynWf4JW;-Dhez0Py!XoK8|AN)PFxE+W_VSsO50sLInYXcXv3Z*>2uGeutzjF$i-&c=F^_-iCwln zXxD-K`wp@PNECg)+&jWk=QJ&rm^`C;0DV5)@p0)!xg+WI(^n1~pnYvl(%Rq=_oXcM zOS(>;dgWb9mFw9Z7tfrPjC<&_=fN4{g0b_>28>&CQvI=F+=y8gYXg$J?w``u@zC3_ zTs3A~=1HgfZB?UP>nq1!+$H|fZ_tgciiJ6UuM#<^{&&7cNXX=u``$ae8n<#qH1R_G zy-_-owm%H>ihUz=Sn0$r5gWJ6Cb4BvDsN;)*YBz`TK4H%ys**hyN6!y8G7~MrX%@x*@;H$6}vqQA*!-OJ~8!y3|+8OA%W9=d-_+9z$> zs*@*N#vV$V{50J-)Id>E<+m_nr%P=`^Ws~cjPSU-;gW@g!Jz7cXCpOM2T5#?TiUF+ zT;#|zMcu#VJbO0njgUe4C()@+YnM?y7p=2m-+T2Iw4w^xpg^7@N@<wN;{J=1jkc^_ zId|m>J1N_ZPLuY1{cZlzGtR4Tznnh)!{Xf8(HEzQr(SkYSU73U&Ds;!-uv!&9dmEf z+8pl{r!~!_XJI*NF&2xJZd6S?7qWEZ;lS+tk5kP}VizqtxqgTGjz9dj%C9eEzpPj^ zbkc9ZhBu~p8qIh-*YMbT!`E8ucPB**bf(AHdil)yDB*l}lK!_tJ1zazX8&oIbTL8t zx$elQMMszaRx-=?*!mkYFXVY04Ru#s=^8NN=Go^9mN<(zC#IyvW1?f%O}efyeQ)u+ z6%~tO(vl;u+P^({cim#|x2#t~)0_XU&zO-Eu>QB#;eHyjX;T+WqO3_Y7ya`zp-Olo zu~2sHjWBmAspc3fbH-}Fm(v?t$6P-%Iq^x%Khgu;PRm>$IRCH>armZ^7391(Bbb?u zYe%{zkG2T%7;)kJTGvZ|uMDqWjy1i%bA4U5*n^L&Pp^M-=$qcS9pPWKt%omD8Edg} zQrtyZi^AWAt1Q2vF!BN0k(s&OF~>CjEA@OhwT3XH)@ts-infs^D~4=Z^l)#4PVoz0 zn}*^`o(xjjgPq<=q-$c2iJz`MWt*+pzX7wl>$CjJ!Khs~h9qgeGHi*_xli4aQX0xs zOnT#TcdFRDf$Su!x?0omQ%!CyT{f$5h`3d_`YYRGWOC^(mAB2+|lezF90SZ}MBw1&x6uCDlVk+PmN6+${?xj~Tw8IA`_yV6ySB1y1?t!m$k9 z3d!e}qMYSh<#HrfkTIEq^mh)^gs$IhT_UvAdrow6+~v!ElXtFS&GyBFmMj(?_S{`K zY{*a{p*kfY@b%A*5IODK)Zb#=Wu4?X1+l{%OYs>Xe#SMte= zfQPJ!Ggl2iGV0d#A@ouDLp4oSTbN%qyu9g_b;(&3-SAOU^}@6R?Cy`cl{T^Uh8ki1 zx08wh}c7QnTJutYkj5IQ380)^D>DJno17EnZXVwkwYo zkR0}6e0BN9Crx!Th#FgJ6(V=m7Ac*nUQ3N~f00r7w<;zXvhWY}i_bRGq64o-X3$k5 zr)5olxO~T+l#F%zA5|A+wmR;iYb{D!eKsawbz94*6^YNzGPFnSia9zn zDu%p|xUS%nC|-a5;xi5BvyWJ-oailLJ9NyjO@BovmqwoOx^>Vc&nsunrV5vTXw&8C z=hL^P&C{E?yJj;jYgJKd_12QsoquJ#eh@hM?Ya8ujMk>1Pmbm-JhAm=j7?7YTB$AP zlWAj4Nxy2z{&4mEI-3{7_m;OKt9(;lKT$pXgfOWz+eSA_A*8-Qa$9lhhBpSYN_N*@ z$D|fdrk0Qbya~}mvGUA)%L5-1S#hmtVrk8mg_d=xZCmnowr)8l?7Qzq#m%<8=XQJj zQDL*lxlGw>vyHz#fo9_$uDb5QlLUo>n54@i#=;ktxs|W#qxUpOU^kzZpRRwfZ%Bsc zC*S(ZkDDCpKik9v%*l{*AzD|?Y@WG#*>AE_{TCh(P1L+N)n&@m`@4gtDt-NM=iZ6ser6-;6xSM+ zJqi!@jn`WfD*Re%w)N9$J?$YL6hn!tlR~4TPI>G)(&&&fVdG*yeeL9?52LBr452L@CAD$?_Sf!n z{+fer^U_hxDev)jC21xzryOCf+NrQ{@h5|bLei-Fq>DGf|G`Zmx7y&ydxMp4gbSA~ zY%buwPv;LP;Qav(ygxv*>j$(E)4c6;!`?Z*z=g%Gfr8H|_cXGQ2-Pl=lbt@cw{>oFA}Vq&QohdO_ko zX*l;yPZpBEzxnT9{IPgMarU>{fpIsjmA-gyZ!MOaUw=FBEcYw$!@(c@_b;Y`p8)=i z1~q2RebR5-1qBq6X8hudKNbrYXV-DwsQo8^FA{EA<6pEEmwb8ur-Iqem}OksmHpcn z%{tAi$1|N-YWNYrFdH}H_7EWY~D5r9X@R{?>7g zjP$}$w)s}-;_oIo%LNDKh$p=9D)?=lqvwDLPLBz#wYko2sV&C#()*OFu1XE@7)_~L zrz~FUa_z4v^A8rT_s%x`Bj~;}lQM4ZrMx>y6Kgzeldg^=9m`zv+e&?%ce6!5(I{dc z6ca;q&Wk)<UBaqY!)lndSerGK z-ME{|ypf#2{+320)mJ358#1Z&OqUE6<8dvyH>SB{uq$<0U!~i=6cSk#wHb_RiH6opiH62nc5uw6 zYBeg0KyIzaT1wZlTYY2RlUb#K_j4efBsk*(IZuKwuxePi42nky~qGz|*p! zwj^i9kb~MPjrU=>G2s8sW)|3x+sX*o>|}E5Q8jWiOM%V0P;-h9?T0nyHkXj=8v`*m z(K@G@aHfRJ%*9w$)&zEI38^tV*{iv1KAG{bB*P@VwRAC70-hMFg#9fqv$noof?XEa zSVttcyiOv^zmv#&x0~Gh#aAMi$|x%Nb^&+~5&Y#-&L>( zz&q?pqcq=JmiA+|MytFd=R*ic*l zX^jlrVNiE1ow0Y2n)05;^5ul$3lekoG+y-vOU?>xwi8aa_4!(*71MUYz@qd;Q6M?P z`dH};-??`@ngavByzte&~cQLSdpL-#Yea>31UQ1zeU3p_R`MIiBMhr%KpGz*YW~lpXxnOeS zXTFQ>>}@XD^U1~F*!x^2xh=P?Jafw13`Vv@c9BG2ZA~?~ZO0wf*Os?l`{E6Dx|guq z6mGa+bz9g?nPr~LFJQ~~tJZNo|JGuFeaLIBFJpc#BUCLXyz^by*i?@%f%GXe+=E#c z&d6FwZZ5S*XXX;vZEs2Qm(|*m8p>F#!qzlk7O;v(8BBHm-D)RVJ`lX_;Gen>JdTs9 zTq-NbLp|p&jbS_o%VmC=%Pg1nZ7#+?|6C?PstN@Eo88!H@+i+{JL%etmX_sYOn4s# zJ}1}LNwoOic+8YY*n?G3cbvWv(jt<~hlapYFkDePO33$-+Gvr5|t@Mp!_z@H^~Zo~hqHusch zv~$G57LTucXyY>ry(=QWD2h+m5s?7CbBH$nftI&fRQddjae8H%!ryY=DJ5x#xD2({ z&W+nQXU`MIfRB--uFm4+_(vIUfT!AD?nQihtsKpYt(*^YJO? zqj)9f`<#yfm1*GLKCMi<>w397Dnm}MV(U-8sA6w${Tg*aJE?YP-mM5%hBNmIUre(g ziq@Q2@uu5HwY=6sLff_cJj}3xQ9)MpU=;#*Xql5)!M>r^T0{_HH!AG+vC|VhVHYNz zxm~6_^NNhmNA-(7cKV{$nP2rpBkf*^XFAI?W$uviDN~Q~Db*7_Wp`6N(@Ew_X3&x= zBlav%`#OXwBr|xBow}&s0uA+{*+Sz~25q_`8n$50j-h!%vc`iP)n{6apxvW%`|VPo zrGl-ciVNo_&J%668|HR**1I9;|BP)LxL#89&|P)Kq4)oh89!)akZ9=L z+3Sbq{xeQ*kb|VynY$FdfUq%%haK(K@cu^H&iFdfgIRy{Q_a^ond-7Wb?O#Ab~>Wh z?7}26?PX48UXk@_RM!*BtXJReW2Y;cX7@@W(@rKJbBC-?z4{+Mr8=TF>~2adj2+=V zK<(3zjCW&&yw@v=`V7#RGW5Ya8Ab1nv7#pj%yAg{^xZf^ZwE!O#E(0(x*KDrMfC=n z@7RL07@~2lPs})<0`+6QcC$rkc41iByE!H;CgV6Rw{n-E1IV3+F zT=&lij{|BgL;g{e8Rl(gD0<|8#{8iV6~|5S-t>=X#DO_`hUP2EntMC$9k21DgD_q- zl$tcW&QpuegKrK4tktBU6~1?jB~bk`WZ-X>#>i7?FRA0aj?9ifHdQ(&bauj%sUvbi zuEt-SY8|>I$LH$V&r>{e4(vJ;HDycA;az9nOxgXL@$tWd=iWAbHAT)b!71zb?O-j2 z>ANZ8{S$T?2jm26>zI9-B7Z*N&#VCYi}7~X7uPIHdp?Wzw+R#l;wA+a{o!=mO_}_D zU$wCr#GRv0@c(VIh&#ji|F$+yh&$y&`ToB>^_;jfj{k34_=dQ1(qDZ4-;VuA+K2f{RA-r4wV(X;3)=U#o}!<1KfjLmH+=^}Mvg64nI?5^lH|652#MsNH7 z?*@YMZ13c}z4NAtoSC~O$8UC`#gyea$7UzZn6fzM$kjx>rO{L6a!y`N_&ilOCwNzU z)YP##f9*krXGc^2qnv_g6Z4TV!P9QfLGH7r5B-S32od4R$i}dg#ba7U4@0L&t5h zTD|0C=;%$Bd*k(%&kLQo$?WxV@lfTD#@fqgg--uydTaT_tt*aSESP)G^tHL1ld|*k z<97;F+ae<)mqHup zzre-UX`aoyiZFStZBvzV!e+-=Or4Vxbv1Uz)af}9-;DPrZlAI?C*W$*_$g*N{<{+Y zm|~N2d{>h3^K-JR6Sf^Xel>U=-So{lxxEQ4g9Gjb&zCj(aBh5fg6pAxXTdsa%s!u6 zmpgK0x6BlXr>Yk)>wa%SZ;OnKTncTV{{k1Kzc;ZzredDXFPE8yYHTtJU$!|^d((o| z%T|WY{pkPA;`Nf$Q29;P+DigLr9WEST5>s5?xU6exutWjnidX|+obG7Iev4g);H6V zVdD=g@6-%UgLA_p14Wv28&PzC7Dfr03{WN9fNbV9tS5>o&)FT+w$h(*<({SD1x$~Hua~)p>VGuUUS<_K=cCcBWzM0xlj2QZJd|Ch zygl?drC{EB)8dD6B;_5W0U-HCqF&{7{2BzfOW4n0&QA zZQMIK24s*X(uU*9u5f(00+KJ^g5%4sa1J3j6;<+6IEPRaoI|L;Y+Mjf9R;{d+yTXx zsqf$fRCnR{@NgwrP7WaWe7ubXlJ#3+9XHBGPEI`U zxH%$nOyXI`O=}{fE%FkNJ8q+gHzj&kI_QKyO*~q;^>+A|M9nvjcWC>QMp`e7exN7j zA={|=+3^kSpQK>xg)t8d#Jpr#nr)74G*QLefzK=ybB8`VrkFeY*%QTF@xOJOz=zih z=IWl?Ed1hgY=r!ZYu;PkmvnqHTVB-GC)vPb+%DZh&DqB-rD@MK=j2+Bpgp6^zGP{g zxP|tBGPlOUlXlll^R&el+I_dV#TL7l%YM;(>-Z1NFG(H#+>+?o(-f@c!v@FfJxfZUV^HJ&f=?A)Edt~c0KR7<2#U?Ga z&WwJbFSbv%RkOkIGwoecfpuog146FQvl)uHgP(0z%pLaZqGGP-v(K@&H1rF}{&wJwXTtsglr@si^fdZc(_LghxC$XSUODmUMbe6}O0&T3G!sh-$g*?P@Sj?ZaVl6G1T ziZL}1Bgrx~TO1o`Uz6&r=j_)UVLs=8rkwelgPPOL=Xh)Cp8N7j>nHn*v$_ep)%T3^ zY61(2d?r8(VuJ;xy%eAY)qw>S(FJ5dUt4DHYb3Ea2CuxASaW5!UlQ``uG?1 zfRW%Fv1Zf*-*QR}l?3OEO(-$k`_UyfNN^5W1V{gV%znjEoKzQyZCV|6=*Eh1mZlH# z0|%dTSzu1bjB>WF7}h+lDO`iWDh_^Hy`d#La6~9!-+_sESfE8qtIWg$-XGwq!I3e$ z*rFsct|L9-oU*lir-{{}!&+-@Y8|XLK zZ>Zlezu|tOe&UG+%unm%z5T@}>x6atr2M)!F|ZUZgKHLK4PGZf)+EBIz>eYUz4urt|>GA(A4JVv-{zM@x>Al(!%?72GuzmX^10Q}6c4 zlWoG(37KdaT(cl+@Hz>y2C_ysxab5B!SRjcz)~V%))Mx&Ax9iQ8t<(|ZK4Ezf&MXX zmQ?xJZ4N2&OQLV3X_9UgdDhfV-eM23YH?M9`uM_BY^ zduMwW`yKW>?RVL`+Pm5RY42{o+kTJzUV9IFPy2oLBzrG=@Hw3H3}NX;-Di5HY2D~lWK@E(94IwTmHq;Tg%7g}+Hy1r%B zo2<84@3P)!eaI@$`jl0b^*QTH*4M0WSq)iDSuI(NthOw+v5@fqQ2}G(G6O2>~)+iWPm1@B_>I=tCi3c4j9&^$o4J<&@ z!;dW?F^Oul+yMMjKs`ES)*Hh1^EVVzC&=V0g6myJS|xv7-xN+V4U?af^pUp1mluG7K}>*CKyLO z)+!M7Sgc+!E(r)YKyIMXZD0hlo)6JTN$WQ zD+mU1pk)BALTBp$vIeq7xBe338@yy5!LbG?*;n9%Ou=aOLCfGRQX^|1Yy7Nak9fYhW(B!C(HEi+-%dqUb4o|cU-fAUu zYcOQkEYKE8yq=Wd6kbF)Jc(j*RYS4!A;3<=?lmj$Qs=^E}hgC zI+xPgd;lIop40sXrKZLsU2fp-w}?`GI+Cw$QsBRKg*#a-w-I@ z06ElJoc6@Yp>msWIAYS>we^y?+SY1763VIXwDr(3cr!!D8ps+y%b_CQ5GdaOIaDf6 zd*V=>xs+axetCB_69Y?*oH{9d0-(V6otg=U;>_*dZ3O747AmLR1Nv1(K#+s0jlk`<<;>IQE<>7 zG5kZ8%Pod}$a1;G&<|Mz9Nf706cBsH>M^w??2-~Hn?_NGiyj28cBT(p^uSu%DK?O| zZEKmv^StX|a2MQdTiwC*fxB&+JD5IjW8+S49^CVu+CeyiyJInSJ1GwCL5npDz*Yez z`#KPmN(e^D9xa2n5Q(gTtnsswJ@O5K@(ob3$0hc-6hXMB8|Zh%I21v+@hF}$=1>IT z9K~LR1Z=<0+M+`%iv9&BWoaQ z{H(}?d_$mo0~DE>0WVZQnyvY?jIUgkilQ060hNls8D?{mB^@RR9cL2F&DI`&*x;u+ zu=+#un%mOdLV+H~el~0dYRo;&V#O!-Wmt~owq^JEELOA(-pRDc8ps+TS{1Yni%%cL z6`|XU$3Q>5r;&;cj*Qu)$XQ$>MPH6oM9bh!3?XYEYy2#QihM(meB=9JPmy5$Lyse2 zX$_kg^VV5#7^HnU5|%sO2rYvv?AC<8O#EI#%^GN@6}f3}rApQNNJ6c)V=mfT3z%Dl(8awvnYf$g>$qu6LJU+~-kfz}_p3_+T`+ksyyy7VN#!E|di| zAO-nz=r<>Bs)N{0aE7*5xGLNoMN`;^Y`Z2V>_e7;PgG0~@9)5Y2c&qre!Jcc>~n=6 z7<+}>E|dj%uXG4y!QLyJaVhZkO1n@N?0~dgC=2!>+b)y^`;bMz!EMw60cqFtQ5P`f z8(!L{a|kM0MsoI7WDTxpe76ac$TyI0bapNZj&FQ7eH3om8l)Epf^k_v%ixtIN7g{r z_?dt|@(r$Ud^dd*`pu0yeH1N&Iw7-jBrLK9vIfxY;C7#Pn@o#*LqL2ZIk2<@ud6f( zMtKJ?Mf*qL**3|_%7WDR7E zpGoT>-w-6f=m3 zqgdwXMX@ZkGYMwLA4ZL|9-N?sxtx(6DLGnloTR)3si~9j-tCjlB*ZV8Dsjp=&23Jx zr3B7l=%Z$RyaD;&TeSLq8ES#0M63cM#n&l@~(`e;(+=G&1IIMk!Q8E8mu z>zp0)lL#88URl#}-L&*Aa6U!fOhU!le#JP#X)Q5{k(JIKVK@V-k0zm3{F3Se_#~tV z=ft#1J6tKDkLYM6zvS2eZI=ee+u>ip$W1_x>mxcE@s}K%zTYn(X-6e@P9*zDn-*WT z3ML?1rEAR6&l)QMOVPkmi&osAj>`a9OKWJQXlcw(nXjRpqOGBmqNAakqN|~oqNkys zqOW0)VxU1tA&eASDikbKAT)Bo(gDE(3hqANqR@>z+OB9)aF@#>Z5Dv7^56QS09%rw zS!}VJmWi|S`-m3z>y99_jBWJrrbO>b2c7VzIE58G6l9Ga8yb;s@OP*DxBe);gdD%_ zk3!3MNtsh)DNHMHn|&JB`0M*P5Iq!b`J?>0H!-jjSp!)El#DwoVx86i{ZWKplZ*Ls zpXM18_Y*D$f9}&DvHS~iF<TOg(?BR4%uI*67cJgMZocY)3DF4Q}!1P`)C=L9JkOT#S;@MH|lUCxcN~J zMGpnEDRma9ku{Jter#a)Zw>o=i+ujQVIM7HE$t~qOWwka_Q;JR!QJOQ6u;&TpofAU z%Fh&i`;Bk>w}ySbrAPn04H+#XHSx5gi%wWT;)%-b$QsBRKbtj%e1pHffj8_kK|$je zs&@R!wfsWWj$cXIU#QygElK7_=X(+u4>1(B<(L$?f8|X zMZf`u^8s-x(Dj6?J(C5ayn~j(D?o&-fvoXkgAKR&3i*aW`Npa2ueDe`rnZD#QbJ|Z z{zdU~4+l==X9BTkxXgwfg z#{B!l4ZegNXc^s<;(Pg_v=LKlRL;lE7;)n3$!Q6X9?CFA#%2gFa==DRy|7g2&6ZbN z9(-!vZKm@-;y8meyDxV(8fWrC#LC3$jvMF^?uqG@>vbZm60hL{VevVWTwQ{`qFSS6 zaH;5>%a-5MZjZ3R)Qb$ir`&rjC;agZ}7YR$0V>Js#oat2xkH$>??i_t^j zjard4kTrf5!$bEC5Vcl=aFN&^wcR-v-vD*}W>D9sw%7G*6D4TRD6=nF%F%uh&S1>u%0l&(fErpxr#J$) zc8eYgZ|xRY16ku|T@KKF1E`r$ab`<9(b_|c6m~N4FGnYO*pL0Lr?@hueWeb{L$q#i zW~k4!oKB-tG@LATX>Z-s>qh7L235 zLtFT*r9$Fa$4zS@=Oz9?>227=6>aTHiQ{&KhV)1Si^a4Y$~-5FAK6!rxmwFND*HxO z7y-w3Y9_59gWs-$1RFWfGI&$x$QsBR-DHkCi%iHj1j;u+k*OABM>~iI0dfqmAu6MbM`655GAurCSiL?75keFxD8@+E;R7?%VD99(S|pk~6k*9*uk0WE`f z{3x;pvIfYB^2!T$j;2MvAxOSqJ0X+I&cmpNtz*bFoJ!Mcb(P{WS0uBk9E z!;XqBz7fne3Ld@@%=-!t-w5V?1?%F(LES2?owLTEUKDBtW2^8`^Pp`NP_mEV(cy-D zn{Ahdg6X6@0{&2)v`fGr>ahay=L&++T}%*++iZt`Kg?qVbhmT}_`^I_5OB0l=1Z0b z+EC;+uw^sHPKiHUnF|{^&@y<(7b9yRYkYUJ|Fqs#x1~`ApT3TKLy&v}A3)LuLXITC z;Qpay@D?JGHIOxaRnO7@L_kf|mZH#f8lUhW^V2C~M_n2^XfdfhkJYDMk= zQR^d37VTNQ?sv?g++=70{+1}aS#eRqVPWxT zZv4o?ucY-PXL1VH{&7xpp%pi%>sw~M$$FdhF6({Phph6fPgzx2pR>MXea-ro)sWSc z)sn@?YRh693mFeE9%wwsc(CyhBs~Snj4}HfWA?mG+eOmOd(dLON19 zLHdI9HR&|zOzFqcH0dJgGU;mRdTFNg0LdYeB9dZ~BPB;mj+2zPAT@OxecG;b!!sY3 zx7`CR16hN2S}?K(vPL%m>71(#-8Xt5J;n5-(U4&QCdIkUAw_;k^zB1w1Rg2}S_T_g z<0r%x0<0qsi1Ir$CW=P@qyr<2KdBv6zG@9`f%g>ggRx_+DthQSn zv$|;Y#Okw^sPznM3+wIH$E+_}Ke7I7J=k!Rp^BlVp|Rl#!;OY+>W#0>x>6gRIS$Sz z$?|O;qTNVO49y;tp@85{*kz#4UgV~wZ(%L1p_QVgF+XL#hIWd!hE9r(hHi?khTi{6 z*{xcm?RyFZw9F*AYpf8=djih{E}X~##ZkTVeRw8t;Y1E-KFauxZA6ObK}3x)8=uIU z+u(FNazbK~e^}(JNSUZrQDIT9qGV35IvsZU)oGdNRncM5ucBpQR>g$HyowpNf69LI z{SN#6_MhATaQ~>pv zIJkWjARwjU=L(Oe9L#ftM^g^wUg6P{gSl6DH05CK6&_7Fn1?KnrX0*emRC~_<{`@? zMhUYli+}@^%zI?v!$b}qZZTR0FVh-X16c#-vGl~kN4^2wH+o>`cAuz-clABRX-^DIQn)kDA7#wzJ0d<>1~0@QYanZM)2`?w;v?S>DBl28{aT>Z z&7F~ZGEuAhL|9xT`m`mWJvBHoW*1xF{86XABjTfF@RF^OHIOyBX;*YgRv_OHDBn1h z{j~(E$3UYz70i2DOuI+XOb=g~c-?UWJ;FUPy>h)ygjFIKpi;RV=NnnmPE~Hk*&Hr? zMSW^%rZ-s=s+Je=s0RN2SV z*E^|CkbSg+`UKfWJE>348aA&9f0=mPaT`6nDbc&qL5Cx#aSc~;Gq5BAmLQPC%&_bu zmY{%al}_pt#49z3NwYyrO4xT`BJ3@Tmcb1`I^z!XPL%o~zLUBM_pI-vZo&q)07GJ3RN&lO#+hn z!8p`S_EIIDEA4sZY?6gG=Z@ z%K%b;ol{|vHIOwr2XAzvJ|W)_5a0NY`UE}l;ZhjTG72}ebWVju)+u^$B_@p+qn)kZ2jaZO+IV$QnN*1R&qw`UdEF%ELSH1tar>mciTEf~A9gLgn6vIepSh<12}^>ht^L%tzMzM&Ras(@8sZB*${3?oq4 z^R|yn74;mk_VA_5d3Hrt*1a~FElV%Nml$8L??73&duF!o4nNNhxGeC*$`S7UF--iytNeHKfPeIHvD`z@9cJ1}l| z_`Yd>2c0)c93DPxWA{&phugfYu$I=SD%BFZqgOV)TKj6+cKKA1BA=RjO?JLlHoThp zS^u;0=ke|$X+9($(&6HJU+e;})LyB;HWfWh8LtyEWrXwjM-wlY*Xj6V9UH$ts)-t8 za4C*pacp|g-evRG91K!X8UD!VUXZ4W_@jjbgN;?B9vK@2uTUBD$mC$~MitpdruTx~ zR3z276lwannuG2p zo+h3PJr8`1_c@U83kVXUIkKzRFsyQkCE~@qqNg}f|Q@i#9;HuQb*2AOfjD& zbxcLMz@-HA3mJHY=|z%7CP6wl?lk!90hxl(7_f`h=SO z?#8-trwe8|*idXJT9n-s35pzDzDBxcM2%dHaLw463(TdY4sTSlGnbX}{h)Nfe4>>9 z#))y})1;1mn0VKGw$$;B%BAKyQh^_o2P`u3S+1m{+{5ddGA1t=?SFR;`}cTF%CqB5(k0<)j`B4Bxs7t2$6-) zg66A8h!{%+o2y8Rm@Erkr7~8;G$hzTMNY)*S@0ee1rc+p*-^tq#`W+DKOFQiip`pz zWKAq7Sn05hB1RumGsMX^)l4^5zQD?13uOd-bj|1*u^RcBK{Y<^W=vzI5z~~pfN8Q= zGUSl4(rR;=5T7iiz2=G`e#R5S&8LJM$(ne}Ts`ENvGQy4`5^&W%B|*xAwi`p%pdmj znsI1GMFTa^mC>+wg45wt)1p|X0^59d2T#f%`pB9??xtz6>k4cO-sZn8Fvxdy*iEsf zs8L)f3KSw`u+k#)Q6Yy9DLI;t5Ahv5(cfGp#Q)I5^X4-`jt*9SWUd)<{E%{`xn4-% zU=@*ZR)-HA>*4jp=;1CatQi=fq!yk5VzRYKjDG@Cjn*bO<)=ERIp|XK=>ux~+>LY- z*5zMzNOo{>sC7_q(4y$lRq12tT677zS}$%v4BvtxLXbT0eiXZI&*(pH7#f>(Yhk zVl@Fx{!NFQjyHKX9X+Y2BI0j!HAr1W%zxpxAVZar{>HO|m#B>PH`x`uUS*uW>DAyJ zD)Rnj--7q6C}o}x3JUJwwR+gK-S`Gt z4+{bI0+Io@AmfOKGqk?$Wk{l?it&Qd{E}}D(ih+&G$udfEeGY3(!GH z@8IJDod8@PU_!6a;sGhS5v)KB-U6q7Y9Zj(2_f)5jt4;9hwZdR6-v(A@wU{CqyoQT%aGL03an}0EgsYeT0xD~I>f>{ z#NvQ{7p~i-pWlnJiLB9$(2oL%j4sW%ntar0ql?rdPD?0AVDqw8;Ow%z(avH%#~4rwKk4!!~%f6en%~npTl~uA*bM0pHU^RB~Qrz0LDZ8WP{z zhzL|bLz>=2L*je382SRJuq{A_y?~MuS4LYG6O7OOjG$d!2%CzU056Aj{bz;;5!?|>Z-A&O5wMgfo_%mXPxGVFK=dQ&g-p4xxy zY-g(#xd)uiKWMz#?YGAI-QndTItO$N2M(@RFu(L|MWEAzl;+#E<2kd_@k!+zW_*)( z?{njO!iuiOcQcAKeH>?2J%<_3itSBqJU4^V({a(&cg`8!j?aqc^3n-?z)bG}E4tdg z-HmnQP8Ve4XS9nWNc6ru0=0+ZqO0p#9=SlxA$QZhasiDbtPNbBd%_C7I$;l3!B;2j z>A2vl6ZUjm@D+!U3-k~%AQ$K_DDb3`!$IkR0>WP$f_)hFM1bHc4)w%8;HwiN7w92_ zf?VK8lTTAX(}5;`K7_<%cqjm_&m}k?5%wP$0c!g_b$)k=g#|dMQs&Ud(zWOuQZjQv@6(c@9|b-29d}9QDbq!2jx`-_I?g2} zd-VY=8Twh&Q}271W}lzCk!}Jhj+DS9B`fp+ExA9#KzRchuc-9Ih2!fp=z$Bz*O(OR zfeXi1D8^vl%zEO&@fC^*utTz*xNv-h;-0v0e7zR*V;E?~DjM>z`s(RbnEYdHQpXI8 z4y_da?S!)CC@U!kuQ=2b5s0ri)B_icuQ)`7T{7v34v1WUpG_pl1t6lpzl?k0D-NONe%O^$#P5I| z4xF^2GL(p@C&{K5KGh~S31N$gKE&%UV1X6^xI4v3WVF}jf5e2YQPP%5hJ{iWV>^W<9;`8MD=FbBz35|NmRM@zk5+N~m&c+)_A7!1qQ%#EE zY6>#iXUIzcetcg{jjsm`i1wIi1ikCZJeJO%6>z!v+yk@eU{|QxbU4+tDAuXK9ZZmS zp$wt}em+noXlLj5{?vGG%#ZCcA>ytBmtEy&AkjMc&`+Tkw7rrOfj|LBTz| zRu5bKv=TqAxCf@1Ls#mK=&+3e8T!Dt(muEmOfLwqZHup;u z0P+lMP*&w0m=JM@8#6(~A?|?*4~N>rW_V7BTmZQMM`g8Nq5#f7N&b$3GM3WSYOF?? zOCRcVG<9K70;zp=uL2;)_QkZ`E(QuDDClCKKw3a21Epq2O;>~42&dzz3yR`v!06x- z2Vn}%%@wXW))(V~yBH{tc0v~e#dASdpDWX7ZGuyNs)H^V9jrwkPy@KR%mupb%-r4` z7mTqxC@`=V&^ZYQ(gM0TIFLe;E((loei!E=Bmbp?9Aze5+$j*S(hYHu0xuv_(ED@K zzhj_4SphEt1rii@(hnd3Q5ORR(k|#?pdc53a~2^N=;EQlK!NWWDDZXx^fXyJ0|mx2 zc&yC=NDMts$7P^EJPM%ain$CFcxO>N0|in<*2O^SmoV@>0|j25tet@Z>2BJ|K!J2M z>|&t6+Xd|m6yyT%s&-rw5^@0;DDXW41;z@vrDJaIIYb=dGEm?-VLSZ*9uBoLP>>5i z>mEQZ01*YgW1v99A#U$EL>z)$H*BXLz{4Rf0|mJNyrT%Y07MjcQc1@1w9p$UxLUpt z^E0rUc-kesA?9ab9|csdP!PN{E%Y`fuB11_G;M!|fiN0|&r0TM`9gdKTrFRS0SQ;j z7a|mMCB5MV#qE;b@Sqrj-B?bB4aEf5ZO#1|2EH462N8%+b3g1|0KIIBTmZR%&GY4J zftEc4me+S<@1U%J%QJ(0GlPCHf_^W7ogHYWMZ-(dAs6V!F2KgLSxl^rafCt6-enb2 zG#t|P7;EX6uK_74#abaRfDD`6KGA zRU|}=rGm{>q(w}Y1+P*WD`FZF?4TkiV)iU}kBWkbxzy~a;UeRDc!jGf<+(DbP#0kB z%E-n=uR$i~88j0Bl?aJ_Cg~I{%5KUKx|9=-JOfvp0Uy{3NDu*e z0-O>G6^ZfLglC~8hyXdB3>yb2o{)P(0 zpu!Coiu*GRfXgukF2{h31s8|_69*~|P+@OF7udT1xd3v3evAUSpmGn2mawme&~Ii6 zuyF|by#%=caskNE2t*VB{WBdCp`aEEpx+9h-_2oPjq%oJi#t#(X+O)en9CKo_wH&9_)pcX2-0njV*YPCtMBOXrB zs^`tkQ5jw)>8a4j4Yg1g0OG+%U(C{Q{%9L z4ZKWP{+vt_xAXdKLFZsVE;%13=1TxtzA7DO$K%v|@1~=@GrFC_3JxSLC3E}jxXk$7 z-MR7jbksqB74Od>rvqj@E0z^MY1ks8_@EgoqKg*357JYSTx2{k*g|F0A`|=IKU8EE znZ^fiR~f&^?0xV)6~#plcT7{+*wc$c&M&ih9>Yzia{7(|Il6N`D7W(%?>aV2izmh7 z%xt{xnBYL|O>TV4=tfm;Hj~r#3p5Hk$8&NTfAOYYgZ#@tqX1`S<88kZbhR}HgH%+8 zKQg)(q^TnQXyL$MV-=}K#zw&_RK`3qIT*ZAMfQ>Dy54bwYwcVAJ zw@^j^E#c8Xs|A-b20F^j1x%C0k|BqTl~$X}g!p7B?KM{n@iU$nZayXCNY=z#=ISBG zjFn%T&kqU6Qf@Uj3<)Y-Vg9hE7e~rDJNX&d%D9U10e2Io zF-NHe=qP*Tdlg6>Qc+rJK1RytjM7f?2~vJ46NAksOC32gF~xkA)G-z10`qxN0cVu! z%nhW1R5s2ZEj7ER7e~suZh95;v#6bi#ZfT^l1-*Xu}%f<4xSW_jxk5WICfouK>@B* zgR2-TP>8*#)YIQ#z|jh81|eZP0|VYOXlG!+i%Gc*42V$7Wne%Iin$C7h)@i>VAjsS zfCt57*w=#o36WB3d0@7AY&h8*U zKx*P?F6$sbz&Vjw6+5kn)Ogz>Ij(ph-@Ay|%=t;l#HD}<2I)k`pf8{qss%t?xCh*j zxg$OxJp=rL${q0m35vn}kiaEpLjodjJ(J+}-NL~E{C0#~0J#8%o!&oD00_D2fo?*s zW)wsdKrh^JMXTT;G4$dw88!|;uU;#_K8v7tQ1oXQ0DaYvJG(h01H|t@{0`Vfn;6)M zI^+TnT>!B0@V;u;>1rZuCq(=XSoYaT>@_fK&%K9uMxik@jGDS z5PvB?*yGgG8&vlzE*(?6Y|HOfn=&L%7!F*tU#5u~WKdJEBX>`ee#z0`ppI83HJuGTafCY3ls^gDf;vQoGvrr8b5a< z-2_(rIzW;K^!Q$*#)IZ-RyVNX^9s1kY+g^r)fskEX41uhCW5q6pt~X7X2x8g8-F_g zDUc-?3zQmwMnf;_Gw^~H3@7A0ub?;~?|Fq>0J#8vaR@pJfaYtwqQYCyfPq8b)e~Si zA%Q1uhJr)9*>os4gj@i*01q|3zo9^GB^9SY@Mbb$;1CtI6Y|nzjJJc5H6MVdaYW^Bztcat3wH!vKFc7Q+tV~=pvdP=sSU2u;ffrzB+E4&1vzHl}yfh#vXAv(AXd6Wg z%#R=Am8A_kHs@-**C54|@UK`v3WFfqhZ!qiDF4K)z!ES^sHewaxQRA{5`TfU594 z5sL3o5uqCoiSHpn$@e@Y{wIm3P!|B=!fa4qR)8H93B$ge9Dtl8A;04hN#Of7L@ofb z<;Vs4F$#dvaRs1)K`$8a_Wwh<9zw5J@b>@nJtV~WkkCseyfh%bhlF^R2=-a@9Sw-@ zAz?pLn zt^i0F13N6{Wg_uCPuZQ1$oC`}&I5wI3y=%&jvPZS0Hd!OA_{=ZaUwkal3N0pzp;k1sPOG|gDIYKD;8Hn5YDVKyIi3r-GC8#z zejKq~EJv;;pvjQApm!)yGY-wDXdu8|02THEl1p3}`$jjuffklhVK1P$R-2S@#KUI^UT`(*FrzkcZ=E{a;6nt@z0FwfHhn#Bk(B2Ab zA&qVnz8oJ-hqHoRR%9Yz0bDqj1PzKyY?hMWO{+Q&4GEinf39%zh{slFy8yWWa)JJh z0%0@)jzj*iap*l{9EyRBL#nWkBIE+d1^O`xl!JR2NY{HqHUS2^UVy=l2%#4&2(WPg zdc{Nn_E`kIWYeEv;7KJJ4+)`HERMp4V%Yg|40cdVhF!Cv!iHk#MI$xXP~4wkAdE)! z0!VlmG7ynVAzzM(u(#n@*t-C^0CItTi~{8iWc+gM3)uu%Cgdg-3^o#Du)F!luyKF@ zyN5#o_E{tWyOpdz!@!fu5*!I1Kn5Zz?3}@Cqdlw)VKrYaKQDBTKBM-3)5W4^o zOc24OUvrEQ!K9t&2D@4Uy;uRgRscO!k6ZwDNDR*fK41|v0+xrhV&HmA&3-=zT3F&5+pP!0J3kRd++G9Y^;$q7-Qkvr-E zxx-l~zYq95m_(6#z-gg_#;e^HpI-j^*;b<`=87Wzj@XDw+61w}V_Qn<)6I3H0zW7Z zSY+h0TuDi}hgZGIhrL!9DT;PVL5QM78A6xp+AE%5e!2vhjW&`)OP8xT)Z`6j*PHhC zbTpuQT?VATCAz6T;|z5^t)N01pU*akxKyo1%;`X?aTg(PLJiK!-|udW6XTht|A)Qz zkB_Q6)5aBoF{T(93=v}pNe;!2fU!sgHa{l6bF%ggrPWf4GOaIdhuQ&^ZV+QK1QK8Z zBs0?%wHrw?u^V{%)vR=!*3BEHRVwfn$PA&SofJ|=(x4J z!(6+2p3nTF|2-dapX<4w`@Vi;wFX)OwpVUYJld~ToP4;laAnH^_gJ+!N|`D@i&Dv$ zH^KqRCeu=O{daFnI+^zWC0;sl#x+C#@c8HAbu(jz+sUF}nLX3KjuHYBJeiadctbJ* zc?s|mP%#RuDVJU#9GZ^Cp@V1~IuFL7W#}U0CBRES#VGKT9_K8|19}^bLr!!*l!?Zn zcytl+65u7EVif2f9->$(SZUZ2q!^%3Fq z5t+=#G^!)Q>k}$x7`8=qM0kBbq@%dEHL4>*UIM%X(A@|S1!zQgkpiLMU%~bE`^-Ht z$HSc3ZuV|xUS(vUT;R|57iYC8?ul8EF%s@CJFLVJ0sjUY%fp2glY63}(ML{g6?s`U z<{DYm_6qsbRlAP|-4h!kV`jZkb0NE(ML?i&;Q9;-X5H7@#ym4q$hfaruhaMG=aNsI z&iZWAnJbu9r`x9K7kmv}N4#n4p6-T=(m#&Lx zjXo5k#}jIX0eT$wQ51@V-c}etsegXWI(@u-&N$yOs@I_w4aKR~B@#s)iWAU7vTYrE zU-WHt)JoSS)kYnP)eHll5(*Xdo)F%W!8;;!LjvyycnR88i7rB}?}%gx{HwIzFz|=Cd&M73`Nhdghwi)h`6sQl2WRK~vs5>{ zrg7^77d_AHdGT4xH-(v|lKqyag%nfi1;wnKnz-q~|cw8KaviWHYCJu|3jsGZXE#92AQ?zSmMxNpJVYdy`pW zF3ZcUb}3x1OwUwrgxOxm5;!)fBfgoDEw+$Fs6!WF61oWM&_&2gfR})JQGm9~BgC`m zL*vk5bP?`Cl0@)I4(M8Bh;LqTzh?f8m z1s1hSxz)u1#!PzXB%2TG>Ku!;pij zY~MQFu#E|l9i>_1qskmq75~&E@79Xahwre~7NtEV-eui-Fm0na+q%6d{bli9YyH9W zx5NjmJBu>@C@!%!9L%^Z=2^|}Jt7_s_sfpkxTl9UN^m4LvZdM#{km}rSLPq3=D_#n8;OutjC<^gY;jE3pKk|XT0~>tfbWr13&4Ja;PO_LM-Ut zfC;gnJt-4nL7^DEtdNCRNGLXJLz#;%Gq8AHZ&8X=78*sgAv;U^lXqdwlSt6(^s9 z-N^U@zL42g!K#q;=D=y`xNQ}z3fU7KJ+U`3$|3ABq9;0hWsu5fuc*t2 zCH=tHR%(WUMeRn0gf-v?su7I?sp#ifESg8eOMsVvic#R$U^C-Yb8))Qsac13rLfHbY^3XqRBTEEwp@DNHi7y zd&K#yY5J@FhD@3t>#e^L;(WPj`m6SWB+d8dciL`*IA89Y|C+lWljc{uUZ?Q-$cyt? z)AUzOrmx7D=Ow`ID_#PB&E@pQpun-gJ~l^WO%oD_`q+($#3A{{L>3`y znxHtuO8|{SyaaG4Ky$=ynj>m)Cm^0F z4&V%GU|*>YHJ*a1Q!98^aT65;&S5D+Fz z*6LSKaCBs)$srLAtR)F)VE$?x6Z0oX@FY@jbR-=LCP+|Ve}j+&1@6x#=DU~^qE4jZXgb5KT{6K zjhYWoNA#JZ@ov=HkX?qKDH@NL055?X^g3tl2oMGSmT0^ii9??$6zc{S;b+Q4yOB8b znWFJ-Bo2M1bVObPH)u}Et|DFnKosa7HnJHRv+o1VDU}%+no}#=_aPrnqgoNKsb+QD9>39r9Vi$^GaeOhDt%f8`QjlKdm(|C(o;|93xq_McvH{Nvob z*=czNS8MyV=5PG&t2q@9mREN4?)VSI(Zr|yc4;6WXH@R-+-BJ2+w92iwRPFLTD`6_ z!NmGl&s%@yMjX6dZoG+-Q_N4B8z9E8DtS3@(ShgOYi&>>KQI zV!f}%XQI^l0wuMcWbu^FGT9p&nJ|{0-?6``r;i4C#5LRZn(O!aOntI_foC46v~TyO zD2eq|Emf3Se;}AzPqKL5E?=HMKQfU>^K0k#5BISX5XAy@f`Q?Y6($Cj&4 z$hlZE!=&id40P-rfZazD`~aiie*vwrd+_3llj~QuzUE%#dPu+0 zzQVqklG(D9Ts9Wfmqk&1Y`?vN$sfGQ-WuPQ-Lr)_Q^9`o1Hx2O;RSP^Fzw&tSoGMf zj~yS>IR}O>&pY=Ps3jN}HlhzO)VKc1)x=AG`kMYJdy;*sXNEVCc+lH?4N5*F%L*)~ ztU$KmPh|QFe@P`Ng67;>R$w#F7d}^3_`W$?xTCBn-SQ>j&a&bsEsqO#m6g~m-xuyF zD}CScf-t-6@YDARtHb?f6znFGf}y2VqxH|Pg|#FjBTc!+;+$V3dhYg4F>G-ZR~A&(At8a?lq32!-XVova3)99#7cv}X8VyD7( z`YH?uhC22#&f`hgSHMevmw>ua;0x{2Wg1bC6bTE2G|a+2Pf3b|MPiz!Vc*BUUU3q7 z6(FZX@{EQl5}|jI7Cj_VGYmXgF8Qe+fDh_OiiCw?_@s~&iC8Fxk19!#h=pSGtduDd zp-`-57@)`TWkNzyVPJuXDEL?$AQcAmGt{EL0$u{V1XPRyUuZW5Xh;{2#-X>tIOIe> zj55(h$V-5ifQnJz=%7?hJR*`JVH+}%B4KA_Bt?RDgc7Mhpgbm~NQ6GjjOZB|DH5^I zB2pw`N9AgUftPxmj8RDxd?*mHpcN<%^r1gPqTpk{0$u{V1XPRy{lm>*X1Bbv)1r$I zzPN_(je+ETUIMDucc4pP$I`$E*LP4$3}2d}cb4##A$)PqO90)C082p9(zc{oM_Rj~ zuOA;=4i8+w9Xf~ip0b-`O#A=*zq6-S>J^1?lj* z+7umL0x9w4k|1g^h4N&2QX(VJzbJgLvHVj_kF#1*NQE{ORH04wZuOabbtKQ<;@eSC z8X19pcHBnUX_Lu-PW*+@CLO-|HyiPzMKVkAkE|%DELFTCQ}v6< zvnSKOj_fOS_N>TQhV_>nzS#8XNwHDv2*aA4R^(-odF2`Raeb0~o+s8bmE6-#bML=qWCzL(2rvy8j95n1N1od6B5EN19(e@?ug(G z2`>R&0_c_yhyqggpjH~7%UDXGk*Np9C~Z8nv?@^lya6^X9yr@{pt`urfnxClK6<8H z=d`WrMJJ1% z3Vnb|^Z{~@4}P@bP*}T6um1a z_X96OnODtAfJ=Nn8wyA-8vO4*tIxM({Bq9m7nXi!#v}3DcYoQhyEP%_|D_%M`>f-a z&Lxe<*GDR#^Fx{STN5-`R0zjOa!ze9xSm4mDW^8XH64quj|}aYl8VW|f$@$_xDza8 zv|nS$)hgM(z;nBI3d@Q0rWhKP84k;d4UtV14)WAU@s8!7USi!g(_T*wuBX^~M`2|? zi)jr7*Uz=HnAQ;Gdn~>_GPGYgrk0jkbAv{&j{IJm*R{&U@~Y3ceR_p=%krv2jO(2h z`JJ}Yu1K+N>&!|K@)F=Bpkfp_I;dkf6f&Mi;gAkpgh^-|szVncF9BWxLECv1qQH#x zS4OBG>OnI@SuIC20742MF-_b411 z%PU9WkQQBpyaYno2fPGO(-|NNe4$-pBf^mDIShx;BSI${hluoyy^44V@Dcz|XP6jN zPJ{zoMHCOpc!r^LP8bl93QSJtRG7Z;o_SA!$&s>A{`npIn|g>~ zG?vZ@_!}H&7AZ^xCZ}`CG*jPZU%hXuuOUP?O`YIi{at&!C(*k#Qa;Y}Yv;>rWg{8~ zNChURa~ifdihEnTTDojqWTEYKD=xmV6D+i6dN)@TceX~#NIE|4x3ZOYD4i4bEFv+e z9MY@Uc4q23^y|pOyV9<>Mb%93@Gj|WdBVLmVrJ$Aho6KW+R zJ237T7gYks(sn8P_~6AAC*>$2NK0T$9T>hm@7!Cjxqh#Qv;@*D=mCxn8d+Zme4@(> z17@9v?F-RkA|tvlgpVpy(S0F&RvL@$3)Kt*FZIZyLNd$2_U7jt(|+ zeFxWfaET9>_^4XtMZD@$w7S%xFGH^H;Q9`9OUxxcDna2q^D9c7OB#Gd67wsmzhQ*pVlvgJOO&!6z^@ONssl`R}^-( z<+wDpLfUe1hGy%lY0rqWG~0!Ai}-m>{j2G3i1%xD3K?$kAx*=p8Rx}ZjagW|BvG?4 z+>a4`0)fO!;roS0Cr!FPs7g<;$E1~scUtRe)7FUhShvNbn?%8Cs!iV~&bRJ} z$v7e|vhJ$Q7!9FJ^3|KGF(`iF;D5r##I zC>CK~*y}2aMHv3Fh++|jSAs>c2zd#Fy)1YMMDHpBqQH)&fdRSK- zpaSI-X~D8~ufOuAvCM&x7|a(`0EI+hObC{sNWm&wBIw+AXy{WEDA9TyccTw5gg!tY z`T!S4K1G8Q(qe{md8EbjZBf*Cvm%t4&fFVEFI9eu1}91#fi#-)DH@!R7Bi^Js~|02 zAgIQRjhKfiNnoz-`4kOKlv)y_vHMdrI3X?OEU%my%p|#5{R%sYa=kUXXA5zrg8k+P zgsG;&3+6mwnyF}^<;y~%srXsTH-(v|lKqyag%nfi1+pcQj5rsDlisIiO zykSt31{4g6!~2Fs5sJeyucNrM3GW*gMJP6+w?v$z&={E)U?$al}`-V8tYkVg0(uo;z^hIcs^{{;`3xM&Cwfa)~bkA4{NThhjbJM!l zU-92}PWO0mmwk#HKoeRd@e<%ApcWJ$+P700IQ8gB$^YD*o>Pvz%EHRhko04vZ7dOi zIfeN1vuv-pm{&+dokFtXHty-sR(B76^ytZ_U|3{CAE4PeFnsC0b8jwiopGIUhgK=O z^<&vI%qykZ)u5kiXKpDG^-5V*uxEhiR^S74^sT@0eBvb!>^c}BAx>BQ^M-i)V*3Vr zXp=Csj z>-Nv~z6gWjz7@-jf4=YBPhmhb^61IbU)Ddr2KE{965u7EZWQ=Qk93uurwM2vj77hX zw}6pY`Zf50E}^diE=;W=N z^I!@WCNTN%mYZO5Ln#3M1AIi{hCkiZ0^_w0k-p{G$(vxrekO7H?bMraU*HIdJJ#Oh zg6Vr$(hu$nJVqHO)DZm&{4UX=p9Kl%$N6OR+nAStQUcODB*|aAX|_A@e_Nmb$Cn?{ zO*>fdWUQ%fM7zCU)|6Kt>puR;Dne^_Pz1^3V1^xz!ik~r@!sT+6tX%(!SS*fl1!yi zKOqg$I_eiT*n<*4ri<;hd0i7j;|u&HAt7LDgo5K`DIl4-#2z3SS~9_PiXkX~W2#Vx zKFdBKH2#3=fIBFI^Tsa77d4u?)oI@n@78SlAgxAB*O*qPw~F^^c6^ZjYjL4w*XoS- z#J|%tevolKgWN2ifP}8yZMc-DsuS!EoV5W&&;JKZtfkRs0O#8Z! z9@wA%@Ez9LqO`}vyR2Ierfn2wTelabzbxKstv{IlmiT~mXHmu<#U<8;gBh2_JgfP= zN5sS7exwNg$(YkC>I8e3`#*Df{b^S#t_YjaMMzGs*dipSS6%{89O5MaM1gUqS11nY z&^Sa+uUH%+n@=nbk<%+L0cbzOO8|!g#IXrEy+SWTa(cz$5ZQcUafqB=p*YlsD?+kp zp?4WC0bT+)6d;aG(CHP6L*(%Y#UU0^3dJEU8i&Z~m6rf70ccAML;>beLy6_^uYh7| zGrd!3t=ixSdbcts)0OrV5Bax-+*@_}KK%-NvM0q`8DTNHLXOuxt|2-q~k1Tf+Pl4_Asv1^x}>At_6%ez>xb z7Tawh^H^r3I>WGy8OVn0W0O3KJ&E3}6{VHrDLd!ZvI3iVzVNxS!uQSD!X0Hr>6R}E zca{}DX?a|@tE|Lk`Mz*ZS?T+h7lhemho8PrSRL-Cn8lGrWX4*$V4|J6jO_ZVzM2_HpP@yjfG<1 zs9X*sVrkV-D0ZTs1!{%?S%5O{oDuyupqN@L6jMws_H9TpwOA;ov}!CAQ(83^iqQ)r zmR1dgVl~5nEI^re4t^QHTQYP<1aC-q3Gfm?w3H&S~$^E$@I$i}42_4G{KU zz>hw_D8(#w>^+6!Raaw~-3qT7y}V6DPYBdZ?&l>S^N4r}08yZSxSQ)cXlcaB{pgKF zGx{pxC7|LGAYS!HBzDxHi;(L((Bpbu0$ksrVicg&@u+&q{nEF4SM8tvfcf6|wflbi z?au%E-v7vbe_oz=>l!J3u;;f2swp6t|;m&m*aIGat-UfTBT^B*y zwyLZ3S7hon5{VOtdTppt#E55H4~vRvd>z)OIafQnIoRw}F^V&rcq4l({e6o;556^TQ#1O#~% z@e<%Apk5TXEDa1dN*75EDK!i%tunx#$IXWn2?*=}ht4Vz5EK>#hR_GN_>7`KK@A8- zFD;Q37_bXjs&0}65U>G(REa)7_VK}wR-Aka){+=g2Zk@rJNG7NT7GQMI4fvd1uFvD zUCXvru)hJD5;6Ka=x@+HNJ}gD`&f&fm%|_EvU?rsE?_h!_>hRX*Qpf-DCLA9;jh5& zQ!O*&&>mBZ@e5+4=q6r4^HI)qLB%;2$3S&WGPTaK{hxCY5cv z%jY!bdfiVSd(M~Bw_{>3kQ@la9*^wCW zQ@r&Rg`I7YRffwqHnSO>_OS*$~q`JspHUYjJ75SaE)2@#r zW)3h>j)yrx_xdX#xF(-b#h}38I^$*r1qmd($no4v!h>XzU2JDY1p(U=WK^)&o)uwx zf>2DTVo;E5-@ptCypz4t4UH9f{sMoAKR?UHj0&9kBr+

TQUyJwYfV5>|5m} zur)Nv<0TMH9D<_&wT%}EheGLiFdPbn)1h!^EE^7mLs~Qr@e&BxjPepNISN*`0lE<& z3Q#y6<2i+r*$6u2s_zj8?0_(}a0E_dIY3AQ0z1Ij zpauj5hNG7i4G7C231wCf$u@Hx2LBQu>cDvePfaG}WZvcNCg;E+J*CB&q^b36~DHH|8@DYJb z{zgJEd`1xp%7nD#YKMUday(>DD9iDXEtxFGLw<%#jt6Z>m>iFn051X5>zvvVBnnVC z9ykXE|N{Pk)v`o!vOKB$K-fOQmrh^9weY^y4j{@RVXVbd~zPjh+ekKb>;t($ZG!DTTL~1U9 zV}r7HA(}k`CvU*H6E~W{B)w>;JXC&DzHR<5f4cAWWgA{zJnhz+PvV6)q`IRs8*3i8 z=y_((i|_0+nlyvU#^pQTC0&bpPT`9`Dz^by*8rUx|ld$mgQIEQ!pIK@|jUUwL5a+eC6>b*U2PW z?~@pBBCW>b={iH}sz`OI!Ys`KyU^X2n$>wFzjno6bLi)>tyzOmgjEoWR{ib zFY0Y&3WU;NR%RX39xypZz;-&4Iho^eJRmgg8_NR%9l(h`Ku8NVg8jkkMXGsDPw7*B3fa0h~fuPvmgP@qPP8Ium5D+Am)wBvkD0fkP6-{vPx=W+s+O0s`(cY({?tyaad&$d142M1e)^ z#vIx&E8gco98&D>aX6$y89}rd^!Q25yD4wN^U*wD&i%;O8|#M3X2Jd0yH8V zp_QQ%{ZAmfH6gb(a3+}&)eGF#z^QCXR4;H_gPsw}rftY=jhbO#qCW%jZ(u}2vFy)) zgkssB0r@y*{tPfSDWfnke+KB{ocS}XYym=y5zmk7M{{0B_0Q9TB=A z;U&OJ0NsuNQ9#nR8>MEtjHM0P-GfiTE<`O_-4F_R0BxMHo}tMd9+X}@9U z4{@`_A5HniqDzD4?!Wl?NojW&YXqOuy!7lB?)c8Ctm7BIvc%eOFypeAXEnd~hNVK_$)#987@)`T2(^S~Z~^+UYsSv=uE-3bp0ubPWM&?FKb^#hzx^bdD)eFrU#xV{6uvEcd+HS0SDhOrVK z;#Ge{C*b-HuJ1tiLtNhh?1y9=QZowB>bRQvA+GO0_d{IY5lMZ=`=rSqkTvFFCw1=~%D&GYOV z>|gZUV%Xs*^yg7xb6bk5K|k02pl6D=zM_xE2J$KXK1#*n)Zx1OS4@_ zw}_wD)W4ekhIqebr;yO>=_syS#h#iS**>WxZvBo zDTZB+{9c>amFvoN`}DE)3{RYQXGMOe?KB10e=NrZC)i`s%EUXZb+u`0#CxpUV$w~b zU^UgI?-S=+cf@2I5f@o^)n*Ke+1ADwA#P@QUG2^=zoS1i4=fD?Lcwqb6PXSdRFvjEN3b4cyEK88lD%i%$1KsX!Sf$uskBnI8waXvRb(NNXgrl9|*IKluokNey+Wspd`$%zl{7DMn~(fC^;lRBvv#q zjv|T)ZS87%&Ha#mr9H(H>zV7B<=s?Kl-2r*`+ofjd$K3Vlj2SG#(HaZ&lciL1^dkp z2vbdk7tDFWG*i(+%a?^jQ}MHwZwfO_CHpN;3n`}33zkhn+B^HqW=ojgM$LuncIQ|Q z3GgaVG%yR?XIx*?59yz>PxZ_&Z1dIlOpem5mK1ln{=4>gPoj6LudbrhU*gZNY?*Uw zS%J+wU-(>E;rr%n;f}JRbjz27JIjinv^*}{RaRoNd|$Yytn_`$3&QNO!%yEQtPc0v zQ%i>LLuCAp9?t}GNFKH?wkLYBJa-$mIEs5)t6HjTUia<#Qu}nzOz-B3;?CBp*3<3- z?rPU8eO!Une6J86S9rp_L`aA$(pW@cdR*~WEMFIr;!3O*y^tJNdcyLYkQygy7B<}$ zH#5xd<+*7@HdZ+dFbN9%69fg3I3QB=h(H`rRKd8aDg6YjeYB{TuHn{8W<21G@}pDhd#i-(9)_v{qu%+J7{nD(MZ#Q>f$cP z6c6ZA3{;luoVHcHlRz&6>2gkchi-X?p$60uNPhGIM)&lb>ezeAkq3F2kOYOTj%(0M zBgHZa1jRHeO+`-#V$t(@UIM%XREz@s!&){af=`PT8&TZz6uz-AD!f}zQ%oZg_{t;| z{W^oM?G!g*P)n$G7&ta)WPC>WpiZ%=fON$&ol!!Mi6q4;1=keAN0m-=O9r2nDtafy$LQGj^Wmq~OD9~A$`*ELt1-|ziG#iUy_-*zw9)%&p{<$$K( z);nhB-TDWqp#Mwn{%Yz+zZtpu|NRHV@u8g5#r7#gdewL*69e3&Fu)JEDrElmVub|Vm64D8g7o89?`Gc)MnOL9j-WpRF9DU8K>u(v6`{P@ zL>8gESVZCw+v`Dbh;7%AIK)eUmjL58s1yb0{X9aKp}bW?;t<mjUbjy1uk&rG$oCgB z54(>esY^W-OoBmu34tN>0s7Df@CUPSl0B2iyU^sTaTNHA6bnHenFuli!DPikFwpXZ ztJ=+M1hXP3&<{q@z*>?}5)7Fq=8<`#t*YfUa&A;S43j*!GY3O|iQ-|XB^N`T>|@vv zF@gS~c4Kz6B0>S3AiKSh_S;N^0)yhSK@kcJh$x^?7NMZNf?Qq#yad#Z0z|!LflzF# zfdoPcJtmVyC`crR&*@|l3i2v|&x+;UBJwVRPb$?614O-MdqWmRgPfCT(Q`66j|lZN zWUFHqNd!gkt9E4eiRep`n<$dLy3&s)hl|dt#4c^kpE2WFjBO zT;IV<0FA_4;)Cl3=y5ziZ&Ucr4!$x&FRtNxV_pKh1aLSsu#~L~fha(_WOf4hga|#L zfsaYyQ%YU}=$823Ujn0>6to`Zbnv8e9 z81MZ<&*OJlw;oK}D9*NSFG_z|yw_TPF#Rp@0qf49j6aG?tPKY#&}c(|CfGVxApU2WPL@gD28m~@jUSWUI* z`^5Ry9Wfb4#6{L!wHbqAwzV-vh?`knSGzOJ@8}QBQf0Xm&^lkYjrJY7*mS_b9t0O$wx|lmoG1c?TP2If_=ch63uw!s*V)@pK6!&q=0$ zx*A`dZTd)DYjQwX?xA3knd&cy+XVnBI5l#IWTXkx51a^FYr@F zTm)SboW}0Kj~+ew6dPtOaDOcnQ0Ev6r`sUM(@pkHXZ8%0Emf^mZGlKe)M=dq!WZLq0|L0i5W60VDbVEE4E>3PoZY-iOJiBbX65o)4J95(52s{vu}4F^l3d`}Ep~ zsj+CYa%kvhd$mso72451K{w?T-ghqH@t`si0>uaFuS{N{jP)T%=sty4n zUIM%X)QtiZ7J8X*Xc-!ZrlWD_AR33B0bfPD1b7Lk7zId~9H7fE9*sk9gK@}-ZizF| zMaWBlmw<{<;MiavdzZb7#vyb+v<{6!$><{FCBRESy(mBDlhBu;qUw#tLrn;Uh-0XPn9`I(}}gY3;2 zg9LpSNq+`YSkw#yOqonAA)H2JM8A!JJSGK-b?Bxz6Ai^l=&pPR8j61deio=12ADFL zU5D?W{|4`YuR{s_FfgLKVl5hqQ_)bIfQI62Xed@Q4D=88shnD_v}Ev(2;PvWSY5zN zfD25XDwjsJ(tzZwzaq_A*6hYGyNOqQXlQBGTQ}#yor-=N^Ag}CpkfptYk#&iG@)?_{V;1rAHvnUPV2e~4C|Op7lQMcoWJKAI-TK(^K{6a}{-pl-?_J{yu*#)415EKIdZ)5P z#>!GANL2*cooxYIWbzqj6zpDqg)+J399TX@Dfll3jC&NG(eZ(Vl)ozLgUa`Fb?&hi;$N9F98*!z!%yjmX%D| zfY7F#C3HgHWm+^2Q9dR1UB*j*mw<{<;OJOZG8PEQZ}_X%_yzhlR}^KnzCwP19r|_p z733F~CENDNo{8igm=qb?!k^!&>`8qQ!(t@VAn;+ z!nEMbVB_q>mEEH2Z zBKBFJW*DHyaV6RRQ!E-4gQ>;3a^56#*qaUuZXKsUPC{4m1vNeFxWfpmFHG z1`0^~4Sk2F%@KbT(_!!FS^bTjG4<2`IsM*0Nwc5&*|&^uy_D9OvmjF@Ag54TdQGI_ z%1If2bWrCc(&gJk@~9*g`ZWV>h5USGOq72A4LQN_!J&@5PR6lVMJn`b*vAU@cwCeo z<$WIxeYfiBw*>tj+h&JD15ed(4R7nyrpP{T=rupu}pHR(*i-sw0(E&9wQWqZCX? zL?bU55nQ`ek(sxZW4;8PEsTG=!M@HO>q&^9Jp(TRUIOYy0U9HYFdSmETO1`KvL%+qc*v`WmjEvTbT3-WQ3bNX|#^kt9$o6$vp2eQY-q;B0vio$Df&;z^B(~4!BK_?(Tr}7DNQV{{6K1FFXM-~CWUIxVPol!!MiDa`J*nEQc1MpF$4!ydB&q|qB4D5BTb{IH1*v$S34uXM5izc%zLw|qjwS4cW`|Nx*y^aAM~q8%_u;;>Z{Zb z!S_Yztu1_M3g21&CoTagv)5;R#Z^=E*bn~xL;Hh<#mhF`R5h*Og#oSk8^3Ft)j6}h z>y&qjXBMgPH~F?y6#0vloG_LVmJ&hsIi-Thl2j&(PqI(-%rIk0AM*Lb+tHB3Zn5ieZbRxVM$XK!rlEyrhM{owV?!6ayuvWGMpq$Z@Z$ zC4t*AxSB+a`<&Y5eW^b%_yKe{6$p+Q25wwglPKdyOK*7Wa49Eer69OPI^~v@H zp4+{N-Z8TFw<1B-}1DOVk*60*(9XBv(Id{g!z$k+wnnNqap)>fuR$903-SULx&V06q6;# zdu}o8a1>S+kNdUtk`_6Iw8#y5r+%*eK~GSiJm=Q30-Jfh@VTHC%!gxO_>pT1969quPv*L9DF5kcPPfsyerBHw05ey`0- zE`H;lfj+V%h$Tyc3{NI=EC~4&Z0_X_cGg(u8QgoL;vjYSlu#}$9Y@^v98uEc85 z3(0Y%CoInisd1uaVbg7KGsFB|t~1kC&F$V?$M3lcE zQ@>$f0WX0GQ9!%|qK`vx6riojMjDmMG9WUFfdL_WOvcoJu%?)hSXKifN42sVkQv3G zZ~#6lmeqjBy9hq4Rx=EcTg?lEgpBtKo!2woFA@i2>No6ZNP9z>`i&fw@)AIgN_hzY zQQ)N>CtDpeYkwpTIhnOT5{EKz!&=IzrmKiq`$MlHUIM%XREz?oN@fo;^wvri1w$WZ z=ypIB1tTA3@a?@U3P#Rn;Pe6J4FH|bs2K*14oa*gWQNMnzX3B;M)st#p)wMRC3I74 zWIioODAuA|GTB!h3B}A;9r`R#GYrtcO91#V>mP1r zylQkm0$-WI7uQ_hf$j)-38)wab}S8y(9#kR)jCM~r`Ty!d}>Zx{ZL?W^}?d4KRP8z%)md3e)JUyy1}{;xgf z-uTC7Je8+cwY=t5RNAw=n@E^n3glzG%=l>vci(MY0kQ7ih_eWIS9b zj0SdqfnXR-q8!YmyxU==NyV^BNA1MvShfSkH=mYqJ zX*jnr!&^mzW!R;tQGBF7$?(keBq{n6e@UmDl&Php%t*OJ5asX_3dmDbD3B98Th1~V z6cq|HzE&hiE87%dU=B$ExBE=KIzifOP=x}* z0bT;U1k{ZJ6okTX$RzKVfjGqM_mMc%tZY|tI5d}~G-5784yz77mBjp^H#qdjWAs;d}zG zB3=SA^O=``Dp7zeyGGc<4E+^2(GRmA)d<%PC}K3=!%QK%0C7MOqXFkL3fT&G7X>w` z!1;`dVSp%y1B8U|2@!li10R$A8N4szCBRDn-HrfJfcP^bG%7cu{|U6{x3Qv01$JbL zCKcF`DVkJZN2W;AfgRa<;JZjtL?F1gshVMc9>;z{Lip1V{xU;9jNs!5UIM%X(Cr8g z1wN3Pdz?~t$G8dwG@@uks~ZN;>V|Ig0X{;D3j$Da!L#KOR^31cxSZ48ty|u0r~|zW zBtQB9qkDP=I`&fB669$@yy|MM@8J3lF7e?KA62Wo`iHxj&W!6jxV{5CCTm6ytN(LI ze6BdZ-@CM8(rubK?gjr4c;o-{X4%wJNB?&4*%m2X_OgOK1H(Z<=$du4zX91k;lteGeZra(HMNr|L8 z;5tB}=#L{N3jU#aU}-=Rgsvjq{UmRS!Ne?AtAbgbvLu(uajR@fHfJUU*{6~yH$sx! zi^2zM%B8Dx0;&_#2{y{AWRilt=-cYZt1Mk#5_GjS(Sh6AL-!r~BmKIBB>5HA5<0xCv78n*@ijP#SU_H`Yl4?G^Rdo#-!J=ECwUf=e``vlysS5BE@ZbepB^|86YKZk%EFZ` zU2O~8EHye|qLnnWkzQtxXExHlI^QnemWt9ySxN7y&F&s#j%8>ZV9fIqXIwM%L;8p9 ziJrT?lP5YkPxs6u$EwZD#ks1rsx8oR+8rq;=ecR!>#vab0Dcz{^}Wl!*gnOR<HG9ra_owbUsr$G;fqabhk-@ylAl^alEPvC1|)^UzKux= zhlOI2!eN_YlEPu37`-rKQaC6S8_~}KHNyZ&P>iFB1ch3Ir(jKqvATQkqZKD{2S}xe zkxTQ=y$R#cbdw0@O5!CCtSdT28kj)+^9C4`%s>z8PJFT;IV< z0DTpyS>@F~+`)L&=yA0UjYC}D!Ak&*LtNs6LjmGd`$=@&hdY5Hx>lvWErTB~;w&muB;*-RQ=b+!Hq1;Jz*Y80N+8R9t& zkusb`wfE^)+EYBUyqhYD7~_fYol@<|o=i_lWYVfh8o#kTmAFn61oQC97KLWCm}o{> zWKY0y!WVmH7`7?d^-6AiBFWOX`gT;5K75C@wkYi}@h6k-C30JM{$X@;b6vPG0$p#?-B8ExSuRcKcr*>-_kT*hWz;@cLsTIPoTb?=q+7(#YwBN3e?z=qvs1`$iw|iU zUd=c!=4#Bs>LrQn5B`@wUIPCKO5i6w##vN^Y?zKLLV1>rEJAsdjKm?f(1GF*F9Gyb z#7lr}v_L4(Kio%`p-g)PonT;?`XL><2pRVqibITg4ZVsO^O=_bvL)svfI|U#JrA8# zg7KhVfs;Mo6u4?zk`nUqC`CcJD zuJD9;iI5Oiq_K#?^tj@$SiUYK#g$ksdLcQk^n~R(AvI3aENr?hZf2O@%d!CBlf+AK zB$j1BlN7_Yu2uuN*X6o$-OM7+q0h39S+_CcHm!cKU1!gVOklVyK*+5w4#2MhCIfQh zDSmD1$ggb!>2Q|WnMd6M&+UfBio7fvb8btr&m$GmRBw{EVfSny&Q!49{D3gkRCvLh zCrmRHEwp@DNHi5cYx$-y(^RtG^0bg*D!pLYB&5Bw&uq4Y`N=w@M%{7=4MegGXn{*{ zEll>@;!W{RmZRd64Lcl#y=^J320imHoZ_t~6;h$UxU+4}tz`u^^L*iRWrgpXvxPg# ziqb7#67DQ3e$w)|a93H0&GLQWp0d*SEiVYO%ML$%pRhXIPu3x+90r!Hzv85pP-4?` z0r)bPMF3W&mpQ1BWkpaPOWNo7&1A^Vi zeTNho5bSXTKY$bZFF<|aA!?0N(Or?u`$a)9dml31FARw2c_vf8VK~4`fR})}QJ|-3 zbbwYCS~L*Ccek<{5Q)U_%^_0*BCi4oy}gz_B$0O!oI#;x7@(!eMMA=5=sDGN^qA-% zcuJ#1FK>AX@Dfll3Xm%Kc_P)uqjBhMFb+9^OeUE}l!-1vUIM%XREz?Y_Qc8kT;IX< z9bDq0Zi!F-a5Ljoqc21Fj1WGeLr=(f3Gfn7F$&O#aD?kSs2@UeYPrM*&g${{Mh^6|G1;z1!2_s2dUu7@XoDw^`{)#`12oKLxK;{-{pu- zw$oatpGVyLFOo3*7KL}t6#5gm=fpfO@#jaBeSU0E%Lw?)+z)hu?m=RBj4id2J-2yN z47+?aj(kOb!aM>dXi!d*ETj4cs8B+yWs0sZpy+yXM=-b)`3Lg|xY@hCq9Ch{NkA5p zDkAj;h(JP{-LBTxNP+Tuaz{v3)ECSnV4?zJsyCSo3L>w;;3dG!Y=~XJO8|gFXcQo_ zA(P`dLmV3v4u!;Mup$g;!C*MV%>9s85ibE=0xCuUN!u=6Z6+C#w1MTIF#W+9*Vo9d zX+k&~(+6j@q_{(VNn2SsTZA2xw6n(b2ax;7h(18`1Odci%7)9Dm=4DT%D3xF?Lo&V z%7>$LxCnbjbxffDL+-)aL?ct%NrLG{I>{&6K3WiqvPwM~r4obHXEXdIU;$7Dv*I*xcY&k@gNa&W^A zIDukb_p2b!1_H&jSJH+i$`Bx;d2T{*k^}h)n13NJ0bT+sMgfXU&L$mFXtf3dLim_0 zwBAJ_F?>`zwqHhF1@KvMh~ogei{Qg*HN(K7b|VwzvIGRC#6r!_^2*(I_sE3&o_c!QXe`SJ|EbL(h-`+KmV~^vrU@}`D8VBTX zKIG$g7x*jSCBRES#VA0J<8B(#Y0)?YUzx!d*IeI$9@6m=P%#RSiL0MRRPYHAd_aSq zkHDvtyaad&psykz3P|09PHBKvhEfVm?L92s0kW`YM5`N`(FYhniwi!w(c*#&#y>j# z@q?I-`5wm;|KjL5{)1=M#!M2<&#Ntxk}ssM`tV%!&i7xQ*8b3wzpME4pu#%yhfSk_ z%JSw8+n(Oryi*Lj9Ql>SiaLFroMS&hpI&7ng}UowS&EThk4Y;N@3hv{rmYe0v2Ke= zH;IDPRGYp}oNwI`lW{~`WZhMpF(_tR8)JmHndNo0JHz~r794)IT)Ldo-o0XZH)%jN zJ4$+6x@-n_g}#zL9TwI%K?RcQUQ3Gk4YEo-HZnnl-$`4&v|S3I58y{1V02HEH$~J>*RWKhinUqCNIbrHJZBBY2Om>)@=JAtwv1Om{zB^ ziuY-De31TYaiM0{>Wufqztc2+ka2Ta!Pc*)rDcTq{rryoFZF1vbrc5jv%T%06EyYo zt)MWF`_Aoq&9%z)don0k5ws}S>TB@TOf)H&OEHo0-UeA0nD_7<*4m=9$Hcp=TMwpf z6lYtv7p1=}-fOKtnEsadfOTh4#vjEc)`o)_m&H7*`MpQP!{L7OYv&IPk34!Z^_TU} ze{Y^WiF`6{@g^!h8C|3cs%n|wl;JaxS4Kf+8&k#QxHPpw+H!G*X6vhI&xo@$+l6$C z_<2qJtLblu_iJ_v8E)|*O~b1h=fzx&Sy;U!QL`}IFFx(JO9NGjmttSH?ID*63=SB1 z3Gfn7HwyF*cQYJ%AB;oIXdIf0#vv2>D&i%;OF+FSuw!Z9BkG5AXdFsH7hxS5hu#Ah zAuj=50xCvndpi4+-=z6t9KOlwtC4s=ZrgdqEm~%h`d@_ zPrI3o;VgYzfz^Dk5Fb}~!n{OCh%3@qL}7Yd@mDNg7n0&itQNhH99Me6@|=(wC;pWQ z)q(me31}paU9o%_Y(nMiu#Ij3Uj@>yA3gb1aw%zf&Ha$RL%-6V;+f^0>P_)Zp6FAu z%$`i9k}0y0W6kc_LY%2!zxe@Ss;TgTIZv2oDq3jyvXE#he%A6$VWz2MzvXEm#Z-F1 zvPnpLXP@~R4^d0-{~o*bvEze7Kieyz$1}#K6EB_onm&{KqNaN0d1e^4IZ7)FD@*-( z6CI3*eu@{ z?kOvM-|~VmyX^4O_X(@R{bm&GUVla9Fz_21RMS7fIy4X^qjBI}@Mq|J2K*K965u7E zVifoSnHW+-1n)=C?Ew5XhWEt01keo`F99G5933>Wm0=RPA=`m|nEeLa5lZM~g%RD7 zI??kP9l9aPM9*i`3pU zj}j8XF9UQ-2JeXA4GAv+bW_Yr0EYsXjs3$z(naIw(4!|M>FY0)tVAvDQk?_CgSXrS zTb&w-+TNag6NQX`me-d^Ua|Hj%9#P}4V(McU-`l0O)z4;)7U-OGxa7It(?hAmMy-C z@+U#O`k|qvRsV8x9_$O0s=XufhUSLI3!mA|l;?fHA zwxSt5q2eXLO8~tp01B*L>Txo)@r~fsOO1xgL*+N++vflBr~6)Cw&CT))3$fS+!}LY zG-=^?vu}C(=u?L_uKN6E;XThyQ+%J5BoMM1HPHi(!rMd9?KczccDfSXUe(IN+xtkF zo#jdJWJX39-(Pn4V$*mM2$?S1l<@XobbCdfKhIy3WqZYSoHY4K_IV@;pGvA|%1Vt4 z>vyB(LUudznN%EA&bW5d3vL5bMk~7L6j!b**WI9>Yk!ak$5XuZzFifCopMrWWJtGr zYAGakJPBm6eGWZgQ^8J;-rPU8FKciO7jPLn%=R_}}u^_`ahF9AFX zkh#|-GWSxFK!7-;#6SRXNJ#?0;gIf=`sdfglPd}ehj&IN6!aY(Ftp}5OF#gpvO5Y4E8d59_wqLazIa;|5Zx3;2$ z91~lfAZLoTh!u>rIM`dFMspgN@~>PTQ#Bx(vLFlyJPR)&=gbk#Q|^XpsFG zvRbNIs%$Cla{YJ7xHR6ANX`^n$(LurPdV~H7oxNgd;nwa@xhN)oP26! z3+P66&KelLH1FJ-3tXVbQD5WwD_0UPQ63MdF&~e^0nJGI#`1VT2XLYfFfPh^tRX*ZViTsKfe^m9 zi$x;yn&x2$*VLl+?@_wy2n-0JwM&f!fy za&wI7^*{gkmk(w=d2B^qp=0yEZvCZ{f7fu{>|@VYygPE=-xQV|qP=D+Lo5w(jq1iZ zr!2F68Bq<_g_7$T)sS&d8S^wItxUYrT34I4M!d(mEhgP03RY8X`aW^Kbw^Cb5pj`q zS8c|im~Cy05#nZ+*VXO}^E(=1oyN;EBu5c#He1IjpDd7TIuU-8L$O?p@XM&5MEr~} z>GN%QgtLH>;J!A_xMX=){vv;Yza*R2C}0%TU>8KrTc1D&i%;OF-EusS*WPSQ(%DJCQkGLI>rPLAS@Ue z6F^{QG=YI<%5_fLs@_SUmSEJsq`gD8oTO-=mOvVT9^hK)HKqudSBgTt1{DEww1$s~ z6zVmwFGPVyH}RnH<`HIUh@@T$>^ zJ5KKBC4e50saf9vM}hv~A>vhYeFxWfp!tkk;=?6AxT}bG)dTb{g71sqTU+$f6uz_M zCBRDnheJxx4iE*1Kf~xN@aY74M))5d(Oq$VzjtZHq+2!Lb}#scM{ob}nge;WZ;2BQ z3O=Vf*Xw@z*mJ&|zW5q3U1M6E-YVXw+3`X8uf>I$U8^(R6aP-r_(8_aWd&QmnwFLk z<~J5dqQ306tg1dM?{jdGwU8cQ)Ja7NsoK>1d$HydV&T(i8JWCDDV zKc6L2Ddq&35w|DcC7{4Hq6Ds$;~`FghHDq1LV4T_{1$~dM0 zxh{nxY6nRDlo*g`9Uyf~0|ElW?lBF>btxRoEyzb&Fy4){YFkn8jLm}gcFNkW-z)pp;Oih`^*MHH%ws4R4J2z`KyAq@zqFP5r4C60)> zh8Y?w@?_&KTcG6?*YTh#H7SC+)J5&m#xV^Ds0hY2AfUeiqZ);^-;d7UK=xdg(2t|= z_WRMg3&u4dpu2!Z>Ol<%=q@0t5qv@rK7}JncL5j%Xq@ODr+Z=U<4=z+kK*3|{z4BM z6B$h?Mvn->r`1LiiqQ{Lry>BrK{0$tqOd+89oaQgz#6BPP;(1>t| zHfBcjKYYM?iwA)ca$=Xh@Ori9{Vq9rb9Mynh8&<8k#mRDRvs~aw%)eY59bwhT$REa*o zSk}I^`|iZ+<|S zYAU>7&J(7YiWXYFEF_wWpS65bm}x56Z+TisF_m7hY!cGm*=IIe!u%e)^|9lFERW}E z;-x>Wa;ik_5rT%<>ab(it=hx2fA8sUbFD-%QNze%f zhH0Le@IrCUn@RQ+6SL!4V*Fy+7a)Z#I7ksC`vX+9ohHA6>IkLB$EW>vDIN7&pabL-q}4kklpbGa{!o_0 z(u!ZTFz|(Tqn416c&AVxG7|L|iUW*#4E+p=eUAMKcnR!**n( zh=d|BqxwKQGA9}bh--xH$jBxIdlwPY1>2F4Tas#F;H4fT3&%r04OtQh6bFcUjQtGZ z?-E`Dyad4Q2oeSQhmCAT_73=;fJvdC9hrniVkU)xKF+mh93Vv`wj(1&B(@_XMI^Q( zQ!@-4B`PB!A^K?uf0@A_M(}qDF99?X^Af;y1EbQ?fM3dfp*Z0DpG(`jVWeW|xu%|h zj=cl0-LWzE_~6AAC)dMR%}xq>xjgUOTd>_ROPYZmpbsl97#Iet8wQ4%7HhQr`L(d^ zxf6YWp|ef7#^Rh`VAK`Ft3J#19bDhRB|co@qiU5G@v2`SUNzTupjWqC-@)}A=uxej zQQ)N>CtDqJeFwS-|7+aT|zgzOo3%`6R ztutocnPQ& z1&$8((Q;WN#6&>61b7Kts|Af}OAJJT z8SAfflOk1%#vxgci7Y~wI0h421XWPh38<|-nBV8nuOF_t^VKMo0q(s`fQRdtt?;=@_ zd7XJ_x&FJdWhr@Tdbj$vhCCX4yL?+JN+W1sD%*#u83u@9(?>0#EWkki4UA|gmIW9{ zD3%2nNGN6k3@8*c0R|L`nE(R{#pp@7nqhz*$3ujK@XG++lEFJ7^wN@-051V_I|4)j z$yhF3)>1bh4SoIi;Ck4Fs152LU~iL<00VY_=AZxr)|ht$Jj+=mYqdw0G;4cY~fL#Jqkk81Dc&!Fa+442nYuA21*aiGWZz5DIzW zCBRGIx{RNwPODkY4+sS&I9fx$0{G&Nc~*h`26EOCe0eN8CLwV^i+-KS#%;*E2+p8j z&T(pm0peBX60e$*`_Z4Fn#uigx&qgC@Dcz{%a0D~7_S<=wbG$+i0eCe32=!Im|71+ z0a_i8(CWAkjYC}D!Sx+z9O4om6{7(0sxMOD*JqecjAr&$H2mqyn~Tc+-{1E<@w+#- zTmEpX=FeMS8POj8gT5&t>A}^%X#X%M)ILqJ>;#g>M=mnmXuMt)on+4;J$$l&~K#KZ;AN4F@wWi+NV_dyj~R!~N#h z&L0>aS#k2(3$rr6x2=m(@t8t?oN+zZ{-BZ!*V&fis&;8=g|y}349(V8)1DD$X|@aL z7V-0%`d8E65bxLQ6f)f6Lz;$HGtP^-8ndu^Nup+9xLpFH8UqUDGoGaOm2$8Gu9Aw#@(>;w5lR&%{eW zT`15$+)Vw@wQEfP4r$Rvcx~GZz@ckb>(MVlUIM%XSX}oQ;Z|KJKw7*JdY3uTIFxzK z3<-ck*UAq7ICRZU4N!!<1b7Lk7zHG4yHRS^{iOmW-ZP5?;ZwbvDvHK!BSUKWWYWgh z__pkxEyS4$_M0CNrkV;bnDc~brlN(GFAIsL;%6=26lR)A_FJA7QcR^6ESrS1clMdh zmN37^Zhh?dps~7J&LA0Q`$hWzM(_brok|7?>_+bHTYu$h;-x>0(G7i@9i^4Um4#U? zDeiIS&X8Zg){4@~mO#s#TgwV;=J~?s$_n2%XA5_f6{TCgB-~k6{G{b^;jXe0o8|k$ zJ!PfuTVDA8*?ar2sLpe5G>IkzsUaDIL>BQ~{hcC&3W zX+lh5iy;IiDyX0$O!rBeY!n#M7t_26C+UQKSeSg6s!fy`ao3%(N)xSYOefTUV`LoG zx$m`R!9YD{pR@Ps{N8u3=UUgr-|J%T^?UB;zJDLac_jxPzstd6Jv`UO*UgvZ1It%r;Mqw7Q>?E8L@LN^Sn^o_-9%vR8G<0 zM7brALQAJ8P%>?mWX+M~n&!J9!aq061b>WNN@9HR-`Ut`G|o6^ey8zn<8=q~uWBkV z8V(kio4#qBeXww2(;DO4gGKK&{m7Vdu=pxR%@;b%=Az3yKS*2ir4H#LP0J^9PNV%B zjMb0A?lp@!XmgH`Fdhv=( zKBLfgppPOU@zF5~5U+ZGc-1C!5yA;HaQ=#p$^DAt`G4UOuz%RK?k_d7jlXw(vx^kC7Q;DZ%=gnem24`}i)G=8 zCcTm!YQfZ|$m1o7y0E#9(#s6%ew!9!%#H{0L52ti7 z?>JFIZvZk|o=S6KX8^^PpsP5$wW=-I+v8=*YpNWQMWj~^BeBkm^z$1`874>b4dhU+ zsT>>jCQytKI3_O&ML3n>67?dS$}ov~5sDI+vQH2t5Jen9qktq4^W2`&;~eXMy}55- zBAAR*8MDH~_oZYQ6GxUYvQ}vkZIg4W}AjeDC^WDn!v{Bb_7FHlV~^}w=!Q* zfgNv8_Vkc%QNNA-isDtrqL5QV9Z>JoB%1ElsJ0}bzX^ijeB6^BMFSNe+oViahA+!U zhDnr>nzz@rouq>RWYLou7(PPxKH_cJ7u$Flu&6${|2Thyw|87hf{g4QSXYU@?N7pv7btRk2(}jrN2jYR7{J*sr2`#L-ADl zdvxcNI)?$G+6>dbV5%4_>OeGA3>I}9n5qYi_Gf59HzcA2LDp4qm0UE}7nED%>c z3c?NrDYoSrSp;lrJhmiMK^lnHoYiltGSE!d)jq?7|1i50ggpvWhk_X2ENv_ThSN{~ zxYWLylu)niu~HP8ECKY#m5CD2Qwe;(RJue(I3Hbvb?74e7>q+LXdDtHAWA^TDDVQA zz0zS=i^idkz&K<@<4_{H2t^5q63{UUkl8EW%T9rDs2^Q~S!f*Efi6N(0-^-;ivrIt z3HA2ALP@pYe}Vn+g!8YcmW5Sq3q8--#uL2RuSj((y4qh~p1-$!sb{xFUOkCvo$E%2 zZ#!#3BXR0?3qwCtjXSNjIM*${8D%@V@{T+G9`-8=yA`QkMe(lr+PJ2jDLn8=^Vn}m zoR7wVn3XHsX^Vex(*;R4FXJ6?sby8q8_$-p%{?^e> z)w(oL+m*Y@Ilks(+cMR(EYY>VH`Ct`$gR}KvTJqCZx0XZ90oGijWQC#fe4NR@Xrwa z6^IfLC4g>6fGF^O^VkJi8QPx!cVupKM`lHLWSQuWED_z2Z9{it@1Z*~^twjRFhG~% ze(s9V+X@MN8rjiMY(hhEDjJI8(NMev4aM)Gp;*T-K$qhoz8s@_LU>CC?}*S1i6{Y4 z0y;(k>8=jxQj0Wfr*W~g|NV!?qfMgCX_Y=-(&2vW3J;9bJ3P=l_M0nnVXWrPmUW|_ zTyq7C)9bb$9_&oI0#^XT>q_k>u4siV&3b#6gnm5jS=he9j{X5IfPa7?=nwG0U@Gs- z-U4^!CiLAn9(^^PhQ1k!5)dVzUlgFL@c>b#*x(G!Hh!OxVO@Syt zd*ky&q{~F(P#n4l-vQ&08{HC%5)dUoC}4l|_>%Igt~Gq$yYR>Nm453?-1VD&YRonN zUsCPJ!^>wL+x}4haQ9OWGto6krMh;vt7O+$&T92bAtuh?aVf{QdDXdrN?LcrfH-~H=cgDR2ro> zNW{HCMXB9RQoznV&oj}qyG^B5pO3sW#RKIk6SH z`}!#!@}mW3f5vq0wJPB|(9o5yP`>B8;$6!rqLxVCfm#ZU&JX78CF-{})(FeZy9Y)t ztUPL^7#e61iV_edpkowxvCqvov;&Ppr@%PWkH(=abPW4Tc7upY* z&_zfgv8bk8X^APS8QKzy5)dVzV-)Bh$7{NmxzRX8LCIJgqMTwZ4pB@n^e7S~AWA^T zC_p2^U~s`%_*X!#7S{3cAoT>+Z5N%n!tuYU3t;o)(5;jo*wUGHj{0=D@G${ zf|3Kn&0}Nrqi`f9=le{y46V#pePh?Vl6|ssY<62!Yn5}Cm%U>%U29!QzIb1&^a9OLyR1?f#+HQrcK_+Zm_jW?APIh!6e-ds}ranm!#c_jxPzs;de@EW90vL*F`imN&Z>s~26psmWI{tRMb=}RVv4NCLNO&!V7qdPtj9tzdR?Pu z7?A9x(&r|3k8`a5Tuw(PtSPZy+TC}obI&o@>R3X*fXUuF_{qwnkHESjt9xMN{DQM@ z!j|Vl{p&_Y6VCf!T~Y7QlB!Vs(`7IU$%PBeJ=KNXU9ig$`~`-f{{iX?&rxd}kM4@5 zp_`Joz&(Kp-I*rl^d0Ect%HakHW+iC3Ah`VEp1QRT(SR&lega@Q}ATU-KmvF`x&j)P6SaA-;JWE zSQ5^0RLpfurBJF^|MtK(HIypW>}b5z7#Ev=q;at^KDNNnWHHW)E&O`Zw~dLhMUEz$ zF)6nANYhis)L4sQQS*%0IhT1}kQr~EC!CkjDrq7I>ZG@e)cGt4XN5jf4P*RU%gx#C zA!j%fN<-f1vT8+>O4b15F-+@S3w_tIF9GZ0ndukI%XaSa9JaY-jXXs%X-NCr8SYuS zC&JK(bGfZ6pM42fAJ2T-Y6?c1PYU@=*2r@(nue@PotFUZmWQbbWwb&TA)^(t2xT=I zvIyk^3yDLb1o*%bC7@FjpxrVbhAcsV;t(%1kVWW5_d}U{fkzghC;?FdI!1v*gHj4< zu~+~A1ws}8kP?m5Sc(=a+c+wP$kHuzbq1I$?DJin7vLd)rQUHS`QSx8STDjRUd{ zD2qjziX^kUz06xK>+o2X$!2Zwz8m~C36_~w-5fUv76 zPl@2$dzJ&jZiYN8MmI#V91uAy)-wzc=kOCk!c5jBBY`LmjRWt1KSMW*Vv%2gC;?Fd zIz|EZawRsQ75y)Ob4b`q721)(Ni1xo3hl_y(*fB^6?qo9(HAp4!vI~5LxS8d$o)d! zp=eTJTT`9uJBFLV5+CAK=g_hMJ|RL6XyEe^_>@wV0J+T$LxXNwTFMCz$ionR zD}dk4;a6ky%~X_tD1j&)MK4J2ckTM8`OnTVY zW#+N%5A_dsH#Rm+dMXT`Mac2Ga%qm_eARQ(`v+UnRBd{;Gt|o3^hDPJN^VcoTALmY zdNCZLl z1d2I9wf9pk19@nIA;a}mG|Q~(GFKL_YA^FlwI|q08U(T@P|OLeu569%3HVzTB_K*b zpD1uiBD$ee@p=8IegANC4`nbUu^NiBU`5AUr>dcDAgd5kLn&G)x29^S(5bKl0|f=+ z8W7kETvQ|&WgCd}NOG+1_E)|4OqFAm7m!&B$+0*mFNyq0w3K5>Pb(4(7#P}3iUea- zD_vknl{sX4#5HrODl?hfT3D6IIeDAOGe=8Rrai2HSm*&A$f^be_5!K~1oi^%ooX7+ zT3MHx&C1lSDZ12R@=Rh~s;o*4IW^R!o*CImY%7!EeGYkpfe~W*gmXABP|TD=C5iB*I*^*hGvu!val(!nlyNOKxMm5FbPtDh)@mfNo~0B2$zAa84#l z0Ehy_I6P1D`b63P9*9G=;C8^S1b5?b$jZAlBo2uZ5G9~v6u7&?ZlZgUlEVS)hm;To z91iuPaY)JG03Jo61Vjm-yAdD?92zw7c!W8R$ms-pMkv!>ks~_zgiMqGx*rlHfIEt4 zMA*+B9n8B$0->x3MQ&@{xZj|6-KZ)IM{aB2Y(^G_!x%)oxQEjzSr`su5a}HT&WzZ( zC43kC8=wa?5}H9|M?H<_P!te0&esR428pvFjo`eRi6_24x#V(Z!YmUCB0EL@Ncp6EdN~i%cD!ab>9n_ zH%*`W(>z1aYH11Be)WT#;O?Qqs~k07=rEg$F7uozIiMIzaTbl59KTjp=V#05bcw#} zI6Yp;jaRh!oMW%KK3~qFStzUXzf8(lQs)O6I3qGp+m+Ah@k(yIqRpoqd+qi4sY>TY z>in`D#K9+Zes_CSYn8LA&F=}=Vq6&$+I-Hj*Iu75XVF~6>ikvh-EFMSACeOit+s5} zQs0&St>xp|{Iw*@(^8*LjKhmG)K@rl^MZ_OS3d0r=Q7%H|2FVr?m?CUJ z7ojKtQ3CRYU7sjGjKihGI8>O=KpaxGDmWanqH#!JJ_CzTlz=D!bW03GfkT7+v|hF= zoJSlE^`nbWVLk(KNMSw$k0Mb5=zd6)01gF+ame-zCfpk+d^?5t48$RY_KL%yF!>#K z6p0cLC7@#zh|CC$V-Hi%lr(G;L(Yj^MV0yNoOsf^%(Kkf<0-dQx~BPVnD9;PCqq|l zy%Q&FVt`1j*u=1L;j7-09yTsq?}~RVcV)VgeJTED%L^uK3$w^kR$J>rH6s+cDhS)e zuyNrdRwlZZ!W1a z$+oYuIG7tO2%3+#`MuZKiYH9_s@g-Xni}`Xwt4Ww5C{XbS-wDyp9OYHd zmW`A#9hn<_H-#UDKp3FQ@es9ycJyyxLZ3#86buN(iWCgk6f06NAQUT#P+V6o0k@XD zgEXrTD?)MC0zJckWG|I2n&>N(hMwBpcMLWrvgfE04A7TgN*x$Ezu@efFiNX+T!I1m z5{AYF2%u?k@3;T~b2lMl_vW7J!fuNC0lmNlHR=a+B9FmeU zjYC4>gF^x0RbQZ4Z9nb}6kfIV`i>F%hh6LcGW~kv?>DY`@$75MpRbrzll$!F_ihbk zt~vbF+-vXZOdhECKjt1RdZ+0}#*~A_|B*ORX`aC;k4pZIj=Z{NN|)DBdiD|(~pabt2_ z@n=oX8q?l=xv{b7GEar!vz!h$nMmxDZ6+5I-%t$;j^ViAuHs<9WWHT(U`KgzFt4)p zmTODQ&c@q~Unt4{xG~3geMv!j(^ri*mJ~kN^j+gkB}LArM~yd^6o1_GjB#GcfyZw% zuDRT^yC$c1aEKBj)%9u?QQqXF+Q0_Rs`Y!9O`*HBRkfcWd47s5*6e7!)fg9>f247- zF+R4y&}1>riY@$l)3=R@u|H>--`Ut`G|o6^ey8zn<8=q~uWBkV8V(kio4#qB zeXww2(;A~F0Z{_~A5nnji07#YGtosDhsL3Iz&PYq+-C13+A#))L2zeD2?x*uALE<#ZPq6Bn|0+a~F_cA3g8+R`o7b2nhp;R;uscJmf)m)T-C;@Oc z0z?6tBf9&?b5L+VIL>-qOWuL&$vyBI|Fp7gY+YI9oNQic4i@btP3BUMp~jfD!ZO>i z`K7ccEGdSq#`Gr37Y+34v&B z>1~$V4BJkpzinA$*s&(#BgGT1!?zNZgOnimsVk!=h#}1{(|LJ zNBzF^Ut8{UY%j?8(6ZRkurK4HCD+mT(KjszF8AcbR_yN6I}Dr|>F0le%5OjcksFNz zstySD8LDbL*jFG*AiP=@C7?qTUaTtnN z4j-3~n^;0_=Q@W0x*T7mf5CDz5D9$;n#?9jKuCOai~_`~4iT?f=sVCux=eHtiV_ed zfF9KYB|emU$GmEx??B^_(08C);tsp3bJf}Z`Sa!v5+5{J=EYwB?pWfH zj-_*7o73AfP?`3hkjAT4F5PXa&F3{leI?p2hp}*KeGhS6tHas#nLataes8;m(s;5^ zu<|H%tu36%)Rk9R%&c3EMB>zXrkbWI+4YozlegD-!t<$S(s&|YkDEAP-higb)X8Id6^k?8A*e-k{6pu9Fq5n$fHP<0Qqs1uSKG)U6eWOeiA4$EP~eh8S7WK-^ZHTy{^91Ht}ItL1LAmVcYB$)+?GnJSdJ@Z z!@hVWv^ZF}xAg(T8VE+L%f&%se7Z-PQT32+E_+Wz) zjCGG~NVboRAz?BlMhD2WF|bL=jjs0IVO!}+@+E61O_rW+mW5ETj=*kG!hncoMM5A> zjh;y+lH^|**bu1eqQvMba*YgybEB=UIA4N)b9u3b(qwyzA_Ic8B<`Jx4CtgMoKaY| zDbTlp@Ub=*(=fK0!Kb;S(D%(6g2F?>=et8kD|44+f63I__s@L4IVaG+3(o77Rh z1Q-U+jM!;^FTIQY4LFbp3B?i~! zw$Q)8jy?=p&^RE6bRs`PPH04a1)>B*3FsIF=yH6Fno=tohvbk>Bo1*xBNT_wJ+UYO zQ35(f0peAMu*~k^W})w(qo^NUghJvYBtC5FjqFB%Dlg(y=g@crzOxhLesmFv5D&FnePm~T+(t>xBk{Ev-(OlQd>hM{~tfg2kIh2bdxw_k#0nXM0iZOv=mXN5aL4iF-q2H_I z`>5A}1b=~L=>Nb{@C%qyCxTEGP&{Ii?;0f@k;4&(WI5D)*IkN3iei{SawsjGQmkPG zL|Fe2{o`P0|3nbVjItdx*3MJn5o5@nCELeZoLK*M#iB*Ajj5)X#8|VV@m6D8Z2pnP z#m4y90z;FrLM_CdL*ynrz0T*y1BiPZ?8VErvzSGh*jl=6PX$TJO5i-c#c_ zB#`qcq$;t(J}upCW#M?lEB#vo4Xnjsj~2zDMe(h%YUtF$K`1m!j0s1Bb(vSSNBIqu zS>guTX~3YE*Xw+TSM7?T{u$CNF_nAguw7B~zXDMLq6GAf0yImkpsRsA#=tJkLQq}E=S`zB#@4bjsjT$0qe-lEjVjJpGC3|D(npanGon11~>?X`T_Wq zMjqxNp%^|U;%OojiqUf_d7_Q%%Hgw8d8CfK7U&rU=yE(n$Dtj49Gb$O!;k?556oo+ z1QLpAT$`!-v_K~Itbl+*@w+61f{lu4Wgs!>6A8t#5DM89>lp^fqG6bjP|X8^0g)OB z1-l)qc|fSksY&&}M=ftf35XIvwo)DWq8KrkFq!(dQ25P&kx{E<#ZP zq6E;l5+Dk^*ym;@lNt#H!y$A(v=)s+Y9tiwC=w+gN&q~Za05}`%t#9}D$$1_d}Rh- zT(ff?azZ9bK$L)vQGiB-7idHX-xtBRw&zLb=)iavfC2a;8`F7+<+vNlwkV6IH_>Vc7gZyjycQxTq zEgFYD0^^VsjYEm(qezs1C;=U#z?qRD?uSl+ai||%gjr}D+JP=YQ39d_^os(|F9{9M zz08Ehp?Gu=ZUWmo5tA(3pX~cG0r_$ z^iI={j420;uX5CUp~Gx0y3BK?@W3a{W4|S{9yAiitX$!aG+*zsWxJO8$hfWCTv@D` zwx!y#T-m;9{<=UNyLmo0&lp>0exvbD2YInUGZm4&l=O-eYvr*=`v5n4WE6b!_?^KO*;a(sbWLOc35FriPQR5TRFqnqL_XefRc z+?7jc?t+BA9P1edq`Nw#u@-6APIDq@|N9S7(oEP=H!^Z33Uos0^Ccbb$FA_e$aKR4 z&11j0G8e`s>}**#`pGp{!0422`{BXPq$_X*a1mSpy}e69Kc4n1Y*6Vo4U8O{c?E1# zEQP>7KtJ>c_+T)Vhvjd9k7E=1G>k|0q|?wXp(p`S0{TUP%ypv!v@0xpQj;VCK`w0&_(zT7>C^GmROX4C;=U#z@iSjL`1qIG!Fd^ zjYH^uXf3)3|92{ZG5e#(vmDc|H9YY4f+xz4zIJiOcYgWU6&Fm`Zc4fKrTcpif4;iy z0WXW=wGm|hq;X&gr{F|7en*7HD{=8_!+FhWX8lSQ$7`g?H=eF2WwYf-yXT0|cqJ}A zDIAxqX4WULI9?k~eokz~?mjX(jWm5P+Y~8?CpmmzvyxUko>^bW;&^Q|`OD4Zq($a} zk*4pHmKfzldt1B7n1Ey3nPeJj4LP+f0kSs?(i=qDJxBQslp>6@dxjKYq}?;52+t*) zKN5EIf)t@B0Z{@G_J(>x0ZKsOpyWueUkDCG+C3w1DAMj3f?;x%!qrZb%lif3MPexUlXar zWEJL2k|a-4oD%&p{zQL0YcjRbqVBHA=^Z?^@@S;-KBOaz3=5wu$0jj$WqxIGFjui^ z4CVz3_c~dct&J9Sep>Ik(a%YLgvNo)2#3=$PlOzs#n>lFlDy2Lctuuws=cqVG+QG{ zddY#|=4Iq_363rF;%lfuFgP%NQuW|3jx5GXdGp*R%{#qkm8oRDjQj$z=UG%&JL8m6yM zYM{ME*=0RqqS2J>pPWAt_4{e47ySamlLIiK-W83VpB#V@^-oc%o*aM?^%GgjIXw8u z%A=2{;e=5?k?pAiBj*>K9giZ4`iTsG0VxIgA2>9aO0BUyGJqoLzX4rPQzJ4+AWcbR z21(R`h_7dnF*H%f0Z{@pA`m5@V-#4vZj{54CG@`lzPmM{kr=)?j7MJ&;oIv?=t&)L zcPi5fbqxb&MtTVeO~AE{%&1(B9uv(%Pigi=#KuScW+qC2sAQr9bc_PTtNsMb>=xvH z-IM!835XIvOMHk|T}_9f(08B@L!s{w`VRE1NY5xhylN)Vpr;e?86kW`2cM9M5JcT$#73UD+(JRFaq`Wa;IUQLkh& zWx1IAsuA_~2We}TF!9xXYQfo;U-hi^{J|z~mi-B3JIiykofES3U6fI;L?X?UDd-w8 zZ|}eM{=-Z^@28#84;Q!+U0?RearaQxnQ+7V2g2Okn3r-FGdak6D1%@;O~V3?=_DN6Tg7=ir6BgwH_3Q zc&i4*A>M66aY&SaC;=U#z?V8Crn-?32#Z4>gK@}>#vu};VUHqF0-^-;ivp}c=?!a8 z=!*Eu1YewQuA!F~JkNaKNs6mRzd#WE z0#7&h4Rr1qfDI_5O7IKVO@{}ER~}urs;#^ARj(ofTHs6ZKU-cfp-j&v>%LvyJ8W#8 z81Ku}%0TfK*T2zBOND`viwn;F8aASF?_4)}DdGGd@3Upv9&yQ3vp{`UadvC6cS4z7 zO8L+ax#E1}-Wb>v*rt_(9FNV!dK+QJS-4V)D9L0C~61#8M@I8NhbO%5+xu? z0EYr}Ile%bV-xx-AQw$6ha?{N8$2n8o^3%h7|2W)dK9pkE|kzIp@GPbrt#<*2Iz7e zA|w>#exdI`pG89Ag9bu9qX6-$bBI?BAJz+UKN^Qb37~NZzBANw34Aap=RKhZ#qc>T zd|LuvR)`WnA4UI9C1C%sYu)M12ID_$T>0X6e)Gz`+xNYbke&DJucW-+6`gwKS3gbL zyL93Dum+%pdH+>y4|scs`@f#F@iE$jV#&&Qw-S*_6BLE@o#w7KnzLQBCzd@T!Dp?snq*y4>N=YVN`>*yVsH%suEeid*RHj@f66re0zq!0Pm{-}V zO)}hU^O!^%73tDw{iuEalcg=kXDH(M?$+*cV*tNLk;%uhJ3`RB*ICuh$!sQDylZ+| ziRDH|ZB5$4mYW@0rl;3gjE=gR^p`ESJGM>FIB2=sv7;tq(30cWIo%jLr?j?a`(>UF zWC_OSOT!uvMFFzfvwEC$ULK7)u#fEyDblL_>x}k1OdYk1o!?x4uZ(9}_cC5+x$nq7#&eIuJmY6qx zBP}iCGLOvvcUSj@1qh%*?02gI1jQjD&bMIP8sR#{D`J<2{UI_bmo1Bv*+>D9d++s* znu4_ZEjKwf?@Oz&%yVolNPod{tD}Bj`mZf_I<^;Nd}vwhXxNu=(UR+E{OFsO1DAV< z|35HdLcf3;{Q@ohsssap1>}<9M!&$&(2}aL`llaTptyttHU{cdhm@{-#V=&O>=6>@ zuO~qmWn_k0mwF5}#E!aH(9=DsDCN_b;})w?ZynR}b5z7#Ev=q;at^KDNNnWHHW)E&O`Zw~dLhMUEz$F)6nA zNYhis)L4sQQS*%0IhT1}U`OwI8&hMHmi*Vufe}gkn9zz?qR2MnZ-8 zjOz*EEg8Hcf;S|h1kjgbQ3AMbfG)@V+!dp@6=6jvt|PPKegoxl99D$lIxb8bV+J zt<8qeFA%H@haEw#Cd8}$TMDNs%cnlP@J!}x+r6%E_n;7M ztfYo6CQ-gjw<+g*Le0_%mz#IXnOqcv(mgK9zuIRgt5wE&iZDEp#KxhM-Kb6k|ap{qbO3y=*00<|PWEePf*HUS(Br&%!Eu<>+-Y%)nfDEF%T zrd6#Ayt~DDEup6;`PI8Z9}$HTZ=8u zb&KlVrC29sl5b=NxdqAwihG?WJk{P$HIkyuPwQPbs)VFsZ>GfjUOny>cvV@Qy60D{ z6XVFZa%*6dVxagMnI~FZ+1hw`o+&vn+`Noz&*3;gyyNG`t?F`DIaT*E**Y<34i;rQ zL#>K|;sP>HO!PNsVThFwm~pgoa`g!C;}7L@-z= zCJ_u4iuDWwhsJ|Ypg;s~$>1Fkydgnf3q%Qs62Nr>lGHplY)@eg%DJ45P8gF*daAka zSm&N&urZN++2O%YRvvu>MkRBn42+y#aQ02un5ci}y3x^u^FA1tt!4j`s!;vYWw2>6 z`~~{a{{c7p1%^&F_f!{lcV)TOyW(BTUD2hq($eJAxdmtA(U+rX=)1{V;0b{VeL)u` zAWA^TC_udGX9T%lko$$cL+CqnE%6~xHQ*RG7LXXkkne(QMp>3{i>^?UQ{l8slMl;+K-xUumEOS4Z^ zQYhK;U6Eu{Ww#NT*3D$oS$<~VHUx5mdD`T4lP;W^Ms{$ZEE?1s?CuLEQvGZa+f-R@ zL}o=Z+q8fwxO>}|da5-_iFIB2=sv7;tq(30cWIo%jLr?j?a`(>UF z*qngFqA8JTwQmyTTA3>^^dfA*nlz=D!ouj~n`9Bng zOlTaEB_K!~Vg&~1FqDrXSpb1NibM&B62PGV?UgUkVJK6*ko}O%_Cw+jQ@x-##B4t# z4v7*FC4j>rJrH8R(RFuX|WZJ zLy71j6eS=^0NsrMQGmpFLf;|u9TXOQ3cR@NN8^x?_~^IEUXka#{Wm{*?f1Vw z_{^2&t$7bVw{I-*NXOE-ug&T08L0e{VG%!SYQ5~@K}$XV%(B`*LswBS_jqfWmow{G ziam*f-%qS#?NjU7!hv^cmHDeEmFZRQGS5A>RW8n~XFq^R4EQXHC(}N)o?Se6rFGJC zA7!IGLSCmceX}{Up4Ir13Ftclo3u}@myKL_qm<=JAm0C6|Fp7AU4_Tn{9ab$UuP?J z&GOChZV@z9NnQhqoQrZ)i6vI|ydXwdghWeM%U$@+0*lx`5TJAA4 zyp(ayvdqwET(dYq`N^mL{a>I2xN9VrS9PTXD?)X#3oAl(uZk+d@wFzZ2t^5q5(x84 z^oRn~HCBuATI;xCHGqQI|Bx3@11MlGus@vtfVv!p`q3{i z{6wkM?Oc7F6p4Y&UFOQ-Rg@ZB=IOF=UNp3_X~1A`Y00m4)m=^&nQ5=>Iymx;j4Qzfkx;% zLj&QoI3%hE{GC9x5T0Za4qqeM3Q4E=b6Hg`&31# z_3zK^AIm&mzH`^J8*1+V(Y^ol%M*`n>8$xYab9fNKT2^g+%;!f*8fcGAO8NAr)smq z0{xx)l?;ltwm71m-{PB5wnG)cq=qFhtddXiZx3uLXX?50gy&N&qrnEk8jLJ5{?7Ip z%4)lcRDXbY#T|fU0D&Fl#C+dN+Vls!k5NdUhSBl8=ok1TECNaLT}3LSx-Rpoc2xor zqXjqP1^hiNQLy8Ez6ayWkg{}5rGizdIK3W6s&4{)vG!rOjG<3lvuc3B!aqw z3>sFtl6=Vv^DG8K?V7ajS>_tHoKD+dNjKE3NpG{A6dR)*m*kR z$`bSDZ=|JVT;>@zp01#nNc0O-C@K`%ZRe5($N8$~591n?4T=JVof3MyhsmHKku*39 zd^7zG8fGL)mFO2(rpRDux!&5{zR-Ig*;J?|6}j1RMxv6B`4DN4;>aT-!N0k@_}=Rs zH3ez+TW)e}-j`NkndjJAkp6<@R!9B5^j}-vSwxj>I1zQBkQK((YQ z*-exHrW>L4a_^~?N9Cmg@+*)AS|8N{XCKj~Z_-DgL@%| z3fL(J+L5tS4ibrFryOKQCZQ=zc63K(LUR{nryS(POwTYtmt$TU!moztn;HCK1izPv z5$L8p)O~kQ)qR=MYOnJ82tiIgT)1Q6I5KVn~dGT zFJMnmLOx(O0}1^C?w#vKM-$HbKqHDXBRiQ_jlLWSeTUF@ps%Mw;-g~}AYSz_*>(wi zhtPMRap=FX#HU?)zpL9g|DV6VqRapF&GvVe*00-i#fHYuuf6iDJ%9Iyue|ix4{z+f zJNwP=z0&pP|2K8?FRp*1xvypA3j3dKJG+u)*{j3R^$RGx{@K9h@`B3ZU~YEXF7F*A z%3e;g>_lI(e?y=kSfq_K_x76G2Sx_Ibu{%?^`rmFn&3o56&$GVD$Z{0ZcFx_^e*$1 z+8!cJaDso9e=`O46<4+{_4a6#ARm|Z{*q8d!ugojoYilVBG-SlqRH)c`n}iL)>3r+ zdRM#}Umq;k+g3%I+!Wh#;-hP05nw*>V5xM8-e5lN4W2BuuPzMLy|Ty3?g*86ia$c9 zt&;o^l6*J#ll{~DHRVNnTOaT)BXHC;?FdI!1w? z_PMJGhicI{^br_`tY{ocL>Hkb0Z{@vMu9UUL)?^~0^?9Wx(Kt-IJ5&@grWpQ3FsFE zwk-(_^}a%Rz2JX={fUJ0udruZrsCS>Pbk}2o?Drp?d)!^YTe~IOrC8EeDle(EzaK% z$gOl%X{1k|ZGLXu=ZY{g%W?XdFmfxx&rnm4S_ledTIzfb1)?Tp4648RLuf zZ!gc=>#QR4${w<>jCalVWohG}_=B`HOFB%Q&arLavq*aHTSq(DJF>e~agSW-T1xJb zGyPiw4S@~i=Ir(dJg?bW$U8FAmF=76uM6zZ#=!9YYwtfisB;*Yy>7IZ{ss2O!9bLX z#(^00XZSYwD-b0hNGgkG3Q=!VFSp3mqR2Bf<>q_Gxh*iJ(dY5&J}!KO6Q#U&l? z$FA_ecuc1Tn#X=~WiE`!)!VXe^pk6@fRTvY)rSW=ldj-o1ptrh$x>+yTmVD8OF}=M z_AG2lXEF_p9GiIs?h71i?z3iHA$!O|Ce=gGFYwHWi6_OI&&B%nln8c$$!)fT-xhMfq0{TS(+8Ynh-q?gDuq;Ox z;Vd)`?L!x#C;?FdVD<XdH?|7vVc#9CD*uVo?I31ayo7U+S<+#HUR{ zP_ z@9yiju8bvrpfZd={uQ?KJDdmS(dki(kv=x@whRrXfJz+^P zY&E7gS-xnfe<}TS%N>U8#tg6J9z(-R8Rsm^42{M$ixUisF83@q?;aSr5KaY)bKN3O z^fxo}nHle#*6#N(|2actKA(_T&ub~XTN_#YPZ|f7ghC1DQwEE0!IY#c&LO$lXOQWZ`Rv)oUU|#B zJ)Uyex$Oqkv+Xh2uPw_LuZ<%4Ov!=a=CQH*Q8|YM*${CKN!f<30w%nkl${INtdG;; zli9zpyg+p>Op;v-cLX+Rqe!kWe3sLpcNjP{=;nU`M^qw#NKS}E;((QXPLZD>$D~5P z0#O2@1oVpnlGHqQ&R$(r7;>MgD779(9f;EBOFKHPD>`9NAYDYiKnVN-_Oac4$2#{M zgWU|=)xCqCtUUS%>_F~!D>)>vn?Xyz5(5J32;Arw7#dnq6{>%_40AOh|Nm38H%vtj zNn+4*vJKz~f&EY5m5nF?Q35(f0a_go)07ClFpy)jk=IlB#)6~UVNEfQNZ>0I4i1O4 zggh)ppGEe+CY(P4YYBA@1AWb77pNtK59-|L(+EB(l=E^?^9d%?!AF&x*$lg#6QNT= z&q^gu42Ip#bq)g@jz|B37BmpeM_-QXz@MQV{S}B35G9~v6rjuTs37+XeTUF@2#Jrb zB|b0qx%pls^d0EKQ0O~^z5{(L(lZL28EN712zpQqU)R95CGcg1C;>DM{dXyWQTLStg!;S;k1s-+0y^Mvy%Tn09GnOXm_s$Iz@TdtY|1kJ&sY*N2)Hd&U->dMwo1F@`n zLJ`^B_Ns^F7k>yR1kO^;0eZ-l;V_9$I3aMRKhfWyp#(vcfG7cdqrmcYqeFy4ZuR#|DMG#_cR1GRx2UNwv^8{28+fAB>UOSXF&d;L84E5R z7o%0?uWDo0xL3XR*jAA;d%mj8u4=1l-$j;nci2|Cl6;xIWX-JGXutf_rTWonVdgL3 z4Jt}giTV3hn0O0;;{Ba_Oe*gcf`sQ5oQ)4FVRQ!B!=@uD&jhx!QgzX&@eG{5p=TJN)p0+ygyVup$hLx^7=1T} zZ%$QRGz^O2+j~_P4TEC%?pW1D!=M<=UqHeDnOZZI>|OBHY}`{C1;rBjVqixz7)xBL-oX>1Vjm-yAdD?ka=N{L`Lul5qv;{o{zZEMJP%@ zlt5US4Z9TqQ9$Y)v`PaXEjTMB_pTfDv6(Jpcf1qL?H@pM`#(W*`~R!rf)V?NUF-fb z{d(i?ovY3^-}cG}iRKTkHKu*(FZQ%5U;9Tdp8HE>PvXaoImYWt3euatYP_+e@WH0< z8gD8oayC6`yt$r3Un(BbyFQCeB*4pC8p5PYW3{{;Uu*HyD0ju*VFH+IxlL|~$=xeIahrfWT z1H$|V=nlP~?$D{+xM1FZfSP(&ISM7oca=Z6tgg$fIwUOhUFo0Z-&$_w$V|l}A>>qC z614V6;2aD(GIJ}7S2SV$_kTSaoP<)FBUYLe-g!e>Sk8ydaxA6jj%@YOmtkrk!h>;+Y0N3Ro3PLcG@Q_J!X2RQF8w z&a7%p_Lh=?pX#4!RU9-m_0MEQDjJAnRWNLCu5%b5gN6(AFOW5{NFZWKDijA;5sLf_ zWkDwLD-b0hN`U2`O4EDlsdtFTskIR}6)9K(Mu0Z&(L}x}K4brxG#( zdw~mKArk6D9)rKY5cEGlec?Hw?;yJ#^uRn7-I)uCk0=2&r4=agAzn3Gw+Vd*8i$0w zL+CruIHYG3I5cQw`@;W>zC(JxEPH?H6?x9vfAh1$zkm7n&s=$J+XEGf%1!?zNZgOnimsVk!=h#}1{(|LJNBzF^Ut8{UY%j?8(6ZRkurK4HCD+mT z(KjszF8AcbR_yL0mV-&Py-pxCkQ~s-`R&1i<85k4=Nwg(&k^d?6dtc(NGFX`)kr9c zXWXn1eK@~;8AUXP0~*VVREkfgYc0j4S~U!4WU7xE2}S9MVV=!;lI1U_ghXQ7FxO_6 z%CM1D`Z4}Q&GHcyri~g2b)RjmLUZvalO%jr*%mb@_92zv!V2+VUa(NZpjc4?q6Dxg zFeMTSg+pp26by&dJRlejsgY199CE9+-=YLiN0BIju<<$o1&DDNq<&~E?hOW(a6gn3 zc3y|!(C@ZD8_w&UT1 zsE$z9AH=bVG10Ggbmbj)cDGlxRyqA1HZx``}b5z7#Ev=q;at^ zKDNNnWHHW)E&O`Zw~dLhMUEz$F)6nANYhis)L4sQQS*%0IhT1}n4hMY=)#WzS%!2K zJNOdmw7tyJMXuJVBu375v6Cv&)0cQ!T}jWZ6K-)X$tc-_JLtC|Xo zhJyv>rf(W&A1vJ1w8l91V9`5GKQg8qEWXN7^Mwwxx#%*_nUVv;&CITV1CeTe|ElL? z*hDy+RQdCL*Rho_8wnp)?SomQAJ`Pw_S`&UY@PXy#ygEO>+(Nq%r)LnSFot*YsQ4S z!Y7;l(Kx5B=#8ewjmdSzpEW&eOndj`#>S@0JQaq|ays-51BV8s6lw`sf6$f7HqM~m zfb|EfT3MKn*;$Tfl%k+m)*m1*=d%6)3B@LKOQvR&!l0N05Se8g*q;N$9MCZgT$Bbz zhNNMdk4O!)ws3Hv8!4sKvOTPWTIk_q2f*bB{sK~pq67o|2M!IUQfn+LFhFlGk+1=SVpW8Lyq+=r z9)<&=1Vjnw8wJS8wS_3HvUeL22;sY16KhbANDSW`$`+2uqX53WRuhw9QzGE*R2Dbr z8V1gc^a^snAopX*{R1OH;zRR#A@RWti-}kL2^FExcL;Jnt_T%sy^#2z`HXr-0pe9x z3w=lD9ygH5B=XpJYJK_0MGp;M7UP4~6-p5WTWo*;-MZevr0i2@`$TKjGz9J*y+5$|v|m z3&^iPAs!|AvV8Hrnf?Z?m`3+sd;bT6{rm!&H+4;Q!+Bg4|id4_@d zz-EPjs1U9G9z{sWc-SJOWISvUiV_edpkEZ2J&}wD#UUEzV{wRP=};WvQ8x4_;)RkZ z0c1ZUN&tug?=_Ec3<}Zzu{cERdn^u-vmO+O+-MvUB_K*b$0+cn4ylr+h(x}}0%5#$ z#d0ECZ;T8Fy}@6jxCO5Ep7ba-f{JP3W4860`39N~JXy-JY$D%dk(e|%-yrEhYeYEc zgk9lEV&N)2hKg%qk}p{+^Y>HoEf`6uBq!_ks z++1F)m2=|lHMh%yTs!(KA`Q;cHxqnuigV`_&(6xi%6!GlQ}K=5+jhdMm3wDg+WWFu zl%8QgGIiLc7J>n3J(a_+L6geE#Qa`2dMV-jA7NjD3H<_Y^b7P-3d&gh(~rSMwZ~31 zFS8de{Ur(uLcu3WTinjw$59K5vEjuXz19`Iu$DloYVI58+%o{15J;8K7x+?#J%{A! zqckOl{P zJp>Ny6%Gq&aIjM%J;T6H`=qdA5%xEL?@Y+J3=75Ri9H*aL7^DFHL{|i7{0b5<1*dC z09}s5$#~eyF&YP2&^IGW#=~BYDHctX0F*~0N&tugAB-pCK{tn1G!6-JKYDpAN91h4$x%)rBp@99vu63t38;t+3apjAjp7rgsJUV^-gE61l8(;S> zPQBv?2Oe8~uWOoboC?m=?-*?|IAmeEn|AxkYF*`B$5BxHRI>4u;P?&NL|~9G{qW#W z=brFp`w`bn-|Vt2#DOoK%Jt1|P4<@B#)IQ4TeS(Ik-Z6m3(kfY%X7;%brl{b3cBAr zm2rQat=KioH^;xRypVavDH`R#us6Zjm>dpC%LJACpJ}UfO(ndG68LXh0<6WOA`Gw8 za7CzWw17pZ?3IByq^xyuI3!9ylz_5W*CPs?mRkDUQg7#k0_6|3B-cXUbz~Z}^KaZ? zret&F-g~{HrXcNp%T12W`_d{b^Bh|X(qFLL>ZsqB{%gyfj_m~*A6gbW8un#ewB$M( zKl-NSz~vrU3T1K+j9grBmLxEs7jUCrU}wLo!2yAx8~p+UL#hNuPDbp?ugp8%KGmjb zN=o8VkDl)#RzyyH$k`ASFicFs3LAPUgsI7F9Y#jghlgog2vh!PMb zpkovuEgo+RC>9QiLvHk}oHD`KB?YuKq@##p;jm;jQ39d_^os(l#UoNJ$HI|E3GP}# zv2a)%N50yq@7C=HCXNW-5jI4dPn-V4QBfcP7|XmP<1`UOs*)eS@F7r2O)SB!$? z6?O?KuW0VGSN9GMuROZ$Z?~4x8)f~L>u$09^Yl*Fp&$H@_biPM&MVCQWGv?XRWpMh zJ-GQV0oNbf{9YD?FLx<{WD(+UEkmh77t|mch2+xRs%nt@#P?zK&3vB{7$583UY@tt zdBXFl&8?X_ovzU5$j&B`Y!>A=P>d`hnMRr8BBX4Rd&~ph8%ckPeWWO%RR}ksf zwc4W^8JCl%Fnb8k^2hm;{4xHT@}j-14|v&5+Nz;xTj~_QE(j7w`gJ9aJ1HlVuQmBt z2MdDcU{NqHyKR^E4% zpg59l2Z7>9zb*(AN0PlDP>f!fMRHCdQ0zuu3-k;FbU7ZPzO= zJrF34H0pssaimcX1d7oMqe!D32o&oX2DU8;T_7Zc9|rK24BZjI8xm0hq6EjF;VKyNf95>KM;HOPfFN`{+Q_4sYwYNQ6Eu+f>3V%pJ{Qo zcv8Yf)caxy{sKYtf8YZ81*)1Sg`7nBYC^o~9Eu4Q`VRDjKuCPhOPf?t0-bw0y3Dx! zJyPZM!C(vP%+TZN7IYB`eTOIk9GOi>eB{t_APNw#`WWe5t!Nw)`VRECKB5GI_7A(( z{qdS#-2Oq=H-3J=w&>kI7SAlHTUz+~3sP>%Uz@)k`p%gXZ=IjLY^YUTE@ook_avELoYITdAcqdib`p%fDL~`k{Jnl08NI)BLl_wyElDMU@@ruMg~CW%g3f zZq4-hbcg>fdB3k*;r6Kmq#4Y?4dw<5I21&&2#~D-g66%>s&=*qhFJE<#ZPq6Bn|0v`;T zxG8@dj6-&GKa`5bp%`=#iV_edpkEZAQDT3~$`#Uk;D3Si@oi^Us_YWQY%-NB`&PNa ziZn%uW+g4!T3L;@AyA;98f)NNNA2i#!2PTG(SKFhB}yhu3>jC>RuyTA5-rh}K+?p` z<;9h)OTC5~W7-PKY{TZ4(w?xS7`7VIn=D^6)W4Mey5$bTc4LOua*v_mrHpfyWrjxM zn#Bo*MVEWx(%xSZsvs#68V538b5_5pvaaQDuE2&sU00#1NR#bD1GVLa!J@rwC%h@P zeWo?+mFK{q2Ix+jFUWblp%-jIkA zKqIjz0o=uGtc3)5(xn!uGU2>rn%&}sUC&MpG>`q}%3Rn5*<>0RIX3eO7=gk**4$^! zy21uykepvvYCmyBD~vyJp?68>$J3sL5lGMlAcdB6xF5U11N#E|!9Rc-`UTS7_!8}n zr=h#@x4?H}6Z&czkM2iA35XKVF$#PzXs@P8F??&e2|cAmuT7;tfv1%4)x8NlrG#?_ z;?Yw|J;T6H`%Jtus{;d(9lbbiL4Stx(O-cm0Z{@vMu9UUowPc)qqnA3bP*<^ai|tu zgrWpQ34m`UKolVN!XOdp`q4O)g)YJ!XdF5PE<#ZPq6Bn|0%YxP>hj;5edYAJH~#&( zuPk`w$vdrEOXh7b=6)e)wX_6mzxqK=aQD!ARyMOC2Z5h;w=MKMXH!)1$*hT&rRkJf zu4GU&$eHDtYHGPQndQ4{a(V~DCK3;?wZ*w^@yV+A%3{{UvoxJ`@tH)oPIYDYNF5*8 zR-U)l$=di>v!n4=V_a-37CD-1#-!NdBTY{kQ)4ZL zMa?r}=UnD_VSZY#oXkch603blzN^aW6jl65SrgCh1RPwi1hH&ob$rMf4zAZmn180^ zz;N?2@>QdR$mau_yK+}K6;=FtwndQL2`IQeoP*+Ig9Nu4T(6BVzryfYPKPJ~3c(O1 zpkowRzHama;ZQ%B*+6lK5+boUL?NMA9HN9s=usp}K$L)vQJ`-;BovE76cP%>Ax?&a z;*belgp?2|Nnuh`T}}GSmfIcMre_?q-0j#=lQC$?aqOIKjGa?jTeJN#&j&wg99R-M z^+c)F?Oc5vHKiLHK)=An#T}j26`lT>WgEH*6nlyx*_?tc8YnV3P#f40*i>G?HWk%s zWU@Be{9)ti3d)K_zW`-$VE+S8H}@Uu+;a>zskNI94}P-p=p&W+t6CR&6@!j!w&##d zDkwC%s;#O$MA6Y~)M0hSkx>WPbZBEzk`r68yU(67Fmisu**9U^0ym{0jV7G;o%GDM z-Rn{eIvUuXgH0;@-s@~u@~$=6id}5fk?7x8UdT2b+L)9qH}5_(vXgSdO@B=|e+2Xf z10$5q7ynFQw+jWuoSHq&x*`(>M4Vm!*2<&z!oC7g0-^-;jRGA@LcO#wv7>30u%Z63S!3&dKV)LlTbUf{sc>35XKV zF$&P?n1kct3j>NR$KH+M8w(1}#$L|hD-#NChfW71^jTy-2cA&r83yQb+)pi`guWcx z(Wj9K4aKSGrZ^rA#aqB#x%4g?iqW)YJ;MN9j@6J*D6d+O`_W&46@3jvm@ z93qjC(02%Z2d)SesiDw!ppPOwqX6-$bBI?B-`NR$2O5X;RsyG`H_9?UjJ?V7&sYEQ zXxA&h5B&9u*Pfe|8k@FnEb&OkLwE1Hb7=A5fBCcJfbz(6J0cp%yH)18Wf9vg+c&pt zlM+U?%yV6sKiGtzA%`#w=Lwkmw9_UcM$Dw zCD{Zd`7(XU8j@a_YsUM1=3Ach+-DoIJ>r_F1fm6Vv%^fw<>XNiNBrjme~f=Kc@${J zxO}nC&Tqi;Y|tC*?&BilaWb+9<)sd?2zjRhEkaQOJWLiPfWaX&3XDlhLc>zdGle1d zsftqTadK)Q627^zcvX9ur^}X2J}oii)FOMdR5>Y~(9`36jdtWnsN?Nbt;rt6D{4MT!mg&A*m}|= z<&z|=T|>_(Q&tYv{sS1&qy3%;wuz~m~V!}p%(N}BuYS(0J<9iqQKo9_N8ibM$jQQ**^J%tt~yj(;Ap{xmojmT(YBWpsDNDSXwn$S1^U!2O) zaO7D8-`wgM243uw9Sq@%OBRDcp%}e6mBnCCC`NDZ-DoI=(+6ZtC=!bG3 zp@HakU>tCxJEFDduRxT5C;=U#0P(7MObBFlD~w9Eh(NXj@EH|+L?lW8eH4ij0HVN| zk$$1?pq3auA3;wkg~Ugc0JjU5X*26v5-(|3vAM{D)QCIQ1Uq1EWg=aF0%zyigXScHmB{C665#u!|ay%9z zR<-Z)RFeSc@ZTxBeTtWbBE;$rOR-oB*l(Lp(s--uE)rzbm*;CL#ZpBmYi&%soH3z; z8VW0+SO=EnizR7%qJMjN-d^Vkk9JC^2pv*HFqk3;%~m9#0g_>nJAyfw7c9(ff57t^ zi9)rMgsM6uQ35(Gfk+VwvIwWTuSXq+rkEZ_9fw+Yw}~u5S%e}=ppD5+3nnzdQ9O!7 z2>?+bLWBZ645t`fMjeN&XdIFi2uK`a5sD}Qv36W7RLQw*u z1ayo7G$I@z@;&@3km-IAx$%mV?|PTw<;zCGN&cF^CbFGT#mg#ZzNSqu!M>=aXFR z$Llf$EDx@D~^gYd~QCfqwK0s3H{1lqgb!f_VcaFjwe1&=+)B zha^e>br=eXPdH}=)Q}OcnngxHW_L~p^BK|8;ubUx34Mns0W_ac&nR$c(8@T39+g_r zI3&pZq6E-5^mmi^gsffuS@0JQaq|CR&zA>-8Ald?l$gXg=PqCY6#XKCt8OkWxy0v)r;o zo5k4F`p?D88!w?+_AtjNU*7E6f`x;(QsbB5W+GTC1E&W^*Q`Hit8t zS(e}bcgSnzzIkdQQmU;*iA?s#mF-j`lM^W{IqUBbm#m&w$RZRaAWDE+7M-F1%@IRn zW+RKykT}F*v`AmEsN)ce(U3UQk1j${0-^-CZ`LUaP!38C^+Qubv7(Jbe-lj??WWv> z#vxe+gDgT(0-^-K-3Sr|C?u5QkftWnMI8vIdOpXymb+&9hP%eZLC zbu@nTP0NAHJvp%ziWG~-`N)oNs_8Vz@Me{5Vlhxvo8Nn#t(b&Z|95*|0uJRG_HSQG zn6VU*ZDgw~NtE4SP_mV15fQQ#lCli4jbuM1OO{BxNE9Jut7NSdm9mC}?8cb?J2N^> zzVn^a^}otU2KBiB}4{Cf)qyd3kix#)tR&7*m zQg9&fGFL;)%m6Rs_6!mi(+%ojxfWvO@o&^X!QmmcLe?l=cv!bkAW9gHu@%lhNy5)| z3s<1z;OA^bKB2b3qq{|@^)y3Gg@i=@;XQ`vK4rMvVE_^dCFsTz>i@}=>6ZK%ELNsl zawvYXNRevEp_q`-013s5mFbooiqW86ScFzMNqI+8h&-1;Bkm&@LHp zj|jL!LNNi*NK7#Sa40Z`_n4i+pPG)CMc0g_l#weSEa~0^*Y!UY5SDa7obLlYfEmS{ zTr1;TV2(NdbV^HW?$w{faF*0DN2}HM51PMpBA1L_QpX&*VgCs;U8py;Qfr$jPo)KJ-M48w*jbZ{66IjM50M%7bKy}p=eh28( ztrch^q?iE31VGnS1Elys{TbAt)G>wM0UC!W{0<7g12hgTXB2qRuLkj5fk!8R#|VLk z=ze#EY>u3hUvho$@CQybB8Cq2h@6wZo(H3oAA1bJkNHJ%{x3CgAZXSTq~rg9ZavX& z{?7)BkY+tWI{r`S))W2a|LSW-(5&}w^l$nTy7j-*#G&3{HB@zLRkNQw)gEs)V4L{JS-yzmsr) zxg_5yDE}!21hpz5il_fx&FJ27Vpipsbi4o5Gx%O~3hWttFFFPE42UEg;QM1@?K!B` zkiY^0zCkC{o&$qoLbDj)L89dh17v->fGvlF1otm#B>qV#2IrfTDxZH%r}NJ&heRj_ z9wH$2?E(qKz&EJBBv$*U-16^zyOt{qB(@f zFNbp5EN)>x&T7t34)(u>Gg^rC_MWWjOchPc<&v+jxg)7nJET zNy>E61#W+<(?QyF@0->+Fl)xeh$B`qYc2GErVhZh!syYAIHceSf6Uq#3B*! zr%26MGX(cj?Vwm&1n*Ow$FZJ>bx(C^;(}RnG&Obp;oYlOJC;H*0g4GMZxkR2q0CHh zP2i&-sYI8BSmF@B%el$GLXGy!AxNlj(t)u+1QIIT+QvKtH3})o#HGJ){OZ8=8$}v% zT~jG#{@SI53rUTohk`!P1DFCmfML)BnDH^RD$hLFz7WUp(cO31FWsfF&|y0y8LQGp zJrq6}GI`ERlR!$m4H03s7Hn^${f#=A_*oUA7R~p((vo`wX#6Fj7R~n!+=r&u4gwBq z3pTc~LXxr3Uh3O3{WAP6r#2D@`ce=N1?p8Zss0<~a?$<`L@k={<#tQ%l9ZQ|v}nFl zFisY1X=7|-a5-D31xdzU=5LIGBx5@q#0m%<0wN~QcxjbfR%wI>BZQ1m-0;vWq2s7^ z@Nk51ENVSGB1o-Z4a^dc zpl^K2{G|X{EN$tb7{@iiNVb7l@@a@hYvTgRva3rz3n(T)F@fcc0t6uxXlw9Ovlb9Q zNK|6^Ug-m3d#VN+iOJb;OYamznRU*>Fqlku7r= zfC_CoAb;Q|HXM*=K+c8(0>$K|#~`4%95fUI4^@)0;ebFf@NhYK%OD_73_4zq2M7bb z<7mQiNM85~@LUJ}32q5~25C{SX$O(Z!rXe{Y5XdZ`m;f0klwtzQ3I@!69Bg> z!s8*~JG8%_Hmo;2|#a(MS|V5h5*w$LA%xE%}%xY~GK&P)bQVhAL_Lhbep5<{H>qQOBL z3|>SzqTkIFx>3&2Go=cP00z*9*Vxd9WY$RQ_-_1@ZbzX-! zV1b3meHpi!6d*oe8j%9GuYjM_q+ojnE}fu2KokZ0?F|Y@o!6lfr}T|Yd!Pmds~|d_ z7?BIi?Gi?6QeX&CF$p>#L`kgQ*r4F2DjOgpAht+YsImcPgu6f+A*sp+pb?U)Y$zrG z4u>cvK-xlsK!KmDY(R{F)T%`qG!BtUECAvVsmcZ%4lPvKP)q=vKSVJBa47I|l?}MX zkW^&@5Qj)5765Sw++s*tiWaJDC?)`6Uq;*&l~YWBSZfCa1)wUM8K_0aLV_RMELi9b zu)U4O1yiWG@3KpyD%38F(6o@yvx(TT$x9QfLF(7^ySp_J+Qg8GOn^KC<(wbA0U+Xo z`o7Ftjjy3zO>9uFDni#psAm(YV^eCQ|3bf}-`%Z=z)L5UIDlIU7FvXqUf$Sv-a!iL z*2FMGJH#;rwQVHyY$A1R5-SiO^=tag-I|EKk`^kh!1=@rEkcGJRu+i1t#CP4sDV|- zBC$~GP(t@SQtv$GAx2W?yx-n8Z<)h@qahv(6<#m&1_1XAtiXB2q&B7ty#c^MF{#J` zAQY2&0|10#QlSq(C?@p=00_mPeZu7o1JLGp3_?QSJ|S?I475iC+##Wu0L27AyCVQm z0NNa5A+J~s^etFu5dzL5Bee(t=#i0HgaGu&NS%TJdSs+dLEtHfGBi z2B6I`4njiUTSMSGGte6&;QJDa2~bRc)Y2WCI|2>`X7GLE9r&?9sR2Acls|-u&jCe? zYyK`i2ecrL{VnkUC}}kDx5Nh+L&VR2=b!-ci+|97Kn>t;8W5-f%zbC!0NNSgaexPa zMt@gX0kSoD(Jw$qT>`A^Ce>Ag-kVU0`za;>I!Lsf`5mB90II9*gSr<|_#Kque$a_a z3dM&)@d39KL8;>jD0NKXcTkG^!5JZ`jEO?=0lh0)&L|+CgT_PM3;z%DJ0{S{Me+R4 zS;zD*=VrncFI3sESv>ksG>rAqNw~^zMUP8VYovX=lI1&0fXFyGGn(8lBvsi2XZ`J%D+M^!9&H7rp@np6ub zW=SU$$8H?H0l7wa6)db)i%u90iw)m_6c^@#ovqcT6N!U0g*zh^h52F8wYqc&xQSuN z-~TGvAo!Vh>iY+GzZAP4aoS0wK(>v}B|7=a(f z2$r=GRHXP%LXHs+=$U8_9F9MMhT~Asa7;0RG>Q={Ya@`!Nh^o8C{dtiq7rC0?gI|T zU7+EZVgwW;Sl&ob*S{Ky7+C?27zKicV|vhVyc#qdQ;cAOVg$?D2%xZG4-_`M0DL9_ z4;x}Y!?7r6IHnkZAH@ikwGrTDbIRv0u%YK40Vhi`~RW2bMl?^2x~s;MdW z8-Lp{HL5Fs-ZJ~NMgTWGeL1>p`dc4%uD`|#H^s*EP-C`B%6EEtreT_^THv7dTuZLZ zJXR_aT_3Sd06j7NbhY=~^jvh>SXUbKZ;i)Cqi07)cd7L;KbxaXpV>v5gy(OZ>zm_$ z<3IOmQq1ZQwrk7{T_3H6o4(Nx4Pm^dCe43*a2L9)A&pHsCe8oM9F9xXca8_WG9N#( z0-NR^g6pud#y92Sd-|}fCDG+=xbC%I{Cxx8>*C$C&x~{pd#U;2iq!n3!mQ>-UZwd@ zL3iGIv?Llmmp#(%Ha{|fpJ^B!@xV`qjJkE;N8Hf(6Qf0VdLsiyCJy#9btle`dXM%k-bEqV{d2alWy)#9u9VPo*vRx?sm=|(!>+lP2Mifn+WH( zVhxVc%Cdy+YTUkN=x{?8yFNxN*{HSM*bPMA5&G~c(z3*Yb$H)(zYm^-oVNb4{vMg^2e^7T!4arU4X`z+o z;k!Fx=Pp)@P*fSh1;y$iVVWbH#P$WX@y5~YW-A8y%~#%7ta7w>V#k_h;qPd*vxXK{ z@bS<19uASKI3T=f#}0nGRVD|M?`=>vD%x^B`sE#Fwda2J+-jvx-mSeeu?q2Pi>8A8 z$1Dvy43AFYdRYj!DfAeg<~4K^v}vgREl^*4Fq}&iUfzRTfyEJlAsmxn{KF4Y$FP z%r^xCG&d$Ju&#F>s113(ZYi-*vPesqs=7Yk;9{{+EP1wJz{%dviYxwYVUv4P)BD@Q z8^p$TV|7DX1`>IDhK77CS)TVl$=~bZ&v`AP%GUHG+HY&Q75-+Sui>+eeJ$7bUnokB zcYNS`%WUdUo5ZD@szR;fxmwTrWmPNF4}%5?C6PE z%dVX*=PoGZOyG72TsWK7X>S)jc+%!bZcFLVpSfdEXI^#x=q-Ws_hvfAY>ZV??>QZ_lHUKK{DaHEO`Z%m!xmTU zr?H3LmczcTrHAISHdsfd?YMQK9E9zH{bc#U$&G|N{8sT%0nZ$dYuUR&f3?RkIbfR!Jg zCpNXF*r3H+`;z3#vd#n78?h1A*JZE~R;D5E%_B`h+Rf+AOU{*bD(?>VtHPSWrnt&; zB0iLLvVB~$d19BK_3e3jMBVF^g4SgRX_z;Au^{T+mInq~_&`5xXH$P%hhsw2z26m} z(EHV1(E95^T4s+a0qEcZ6?9+)9UKu1PI{XhxaMfDTWC-%OT9Yh77s;QYx%lPmdYlX z=*{e?Cp+rZ5vx3uXfx#NdRZ!)kELnIteWCMv_J>)(19)CKyl*~PgaY2nuaoT&`mf{ zhYk=gp#vmzU`sea5k5mW*uf8d=A~?!M~rEWZ@q>g|Ckb^(uul0z8^nq%741(H)HSV zYOnRFo=G|Vb@Rf(w+E)fAxW!Z=N|~2&S_DoYk|ec7)S>ME1hOW)HU8PgD0j51O!W; z2*bL2?2YUBXy_Zqv(A|DLCuyvU5Dy)H3qiZjts3?F4GDesJ&k|1q2JZGb31Hr39@z zMxR(eo%mGtj_-f)|T`$D0$@fvF8t~nain)D0TvTBYzAAGXg zmDM1h?;U3NX{hc?jgDle`sl_;4Yd3^?hcl-yV~!3TKD}Mtzn{D!$d7u<$YhTf&K(P ziQ7tQnwuGt0#w+}^$EE=Q52xo3$nUy{J#4EHHP!+A?IytG(;3MqGHxx6pul@IX#h7 zGNmrki)C_*dqs;0t}uSzJ9&L&(&%VlCL#uv9ZbJNVt{%Zcc;@DPUhq01-ZNX{q;s$ zGGUy|T~{3TWjFU&j&9C^&TfQd?mm$16xAtaAR->2>0+5=w(Yp2{|9+Z;f?1+U*t-r z3MO#VTy=;r5-hUhJ+R_7O<>Douf4{doT!NN>te+vct4hUT))>5Ir925%2ZH&SUHwj z{2sggPNSoblDQKbE0Y<-hf-pOwu&Ukr&ls1IAkJe^&{0W>-GQXbWLU@72&r+`YhXC zaf{0$G1Lib0^xVZkWAvTG@_y6vH@@rBb#tIt$5zTsnnuV6-y3L1|u7K{SC%8)S`RR zE8(KtxI02dHW>Iy!k5mA=LNu_FP*%E`u=O9&a4`%%t{*l6m^WK{)Y5Q=7haJpDJcn zQWJhFqR%($VsP3-ic5D?=k17Ef7m=PQUo%bKt-?rV&xScaY9BZqgGj8A;wN|Yu6~y1Ft499-*u@;M8t-6X1t5~JvocZ zqSHEkkJ_r5)Cz}+jhmXTx9?a#?=4hNqbqqHHLjw~oKk)=?aoIGz42c*yYo&{6K+BX z^#oS|OShw4J3Dt)&tr#`(#+1uSHYa>asAx+ouU3oBlou>fRy-2?G$NQIB0FwVTmd_~Op3(0 zuwZtHkG+U*=i{2S5<&yMX{GF98E@}$MM&-U1P zpVh3czczOEi z%F({Ewts)Md{E@tm-?(b z=A-7u!-HHl#-=qioDYn`m<`3F;Eq*yHAk7bwE`S(t`iHq$$?YbYETjK&N|ji26rt&%|P^1z?F+_ zgGYG8o$kG@e>Z!-^Ze_Y=X?XJFCt;g-ND(Z*WI|Des0|w^jy#1ER#)dn(6E3So|YN zgxPe;cV&Pb=3$FX=PkMhIY_kl+D3juKm$#m2~(l9n~b|&p$5l zMn~Po=9>;Tr#J|XJ>B;Om-H~>8NYc?^oJAALneGLc>8F{WNoa@e$dr?<#Y{?0A02F zUCcwJ_*cG%w|*YBw0$TwadT={`_udxBHGwp4zw1hrJ}mU`fn4BlQhvh9IV~#Y)w7g z9bN4`2%dU~xt@EM0;h_`*GJ95+l!n}-s?i-7u&9qy@Axr>(<-OPN#QYmM6eg56dU9 z8nubL*2~02wbtSrjvDPtwcTo~3Bu_Jf9pWziEsV)|B}%@QL+0(Q?W&4RQ*287?KO= zP_@Z&U$3QAiJE81n4Zk;ubI1j-25Gj_-|cAe2rJwL9ci17DCmx?fOupUDmNJhYvRuIH zalUPU-=PUJJC3y+yrNTm?N!v#@$D}JcqV*T1!2zbhsDO~kH(pHin!M7c%YYy`QV7% zm?ifSTW@mg9eam3Ysil5$UfP2OW{*Z!51pHLh?88-Az#%(MUO5HSFh*z?!2|edzR! zJ#zL6!uO-C^MYyS*`H(<3u(VzX)q?oo~LB3Xh*xwro-I%=t`Cod)y8V;Z;2Ga|*=K|3>B6s>v$P^&BV)YTY%k!bKZ;CwiLaM1J7**hG8RKjD@ zd)khgI-Pa=@|LewQ!C!}qNKdySH>jH;s|@WcSc{WYClKawD{QktTkQafro(8Twjk| zOz&oC*6m7H@7R0B7OOuGT}6NPc+Hfg#b=3_+>d{iAr#()f2m$`r0+v$m#WFy!9J~{ zw43(Gp8qUS3J-Vnz95nJ~SmICQk(v4LTM z*_C@s_#Omxi`|#OdA_6*4OZ&OWLEiD1?${P;w~tCcw31YZ=L){hOpdI9L2M-sIkF2%y^t` zcLIIZ8p9di6{%v!^iR`YdCs_|;o}frss^l?CFNFTe=lcJ%Bo!5{yE7b0(!v}EA0F2 zcsEzyw}|cD6K_+^r0i>(wa({E1YH!y(su3s_|g#J*8_ctRY+`>eI!%SN!$4|E_N8| z`jn|nVXf)=hweKD&5IY8DCJ&KQjTz^J&?t+XPdfkg?|e#YmR2_h-QxKsz%l$d5^OB zvT%-}l^WER8VF|&y)4A1(zUdKR{A%0OQ5*wglZ#%&CaJ$kI9VZO}^5ep}&79@$uf* zeAkV_$`v0y#y*Rv&1H*DNM4=1e%v9QHJVjgD?{Rrs=OimYCy2|c@~=(-fCT&z0DaX zqszSBu5pcW_AWr_-jTaP6}^6s{u#BkNAPcClDeKBDV(^s2Xp!STK1#^%rGl~#(Uj7 zW{h+-?fE0gRD#?eJ_T*32|3Amdic(cC=KmiY#3(;g5GDRZhKaDEjsG*U9k!kNz2-o zw?3H_h31WC4TRVWWqo4a|8dGtX1bc0?4rwY%N5U4{i0ggcWyrSrg9Yu}qq#X{>Q z^Ht>OCnek6H<+!~GTD}6rKTUjkz-+=<3v-*smH%=-C2G27QMiA7xVVt;A~iL8ks10 zqUzPQs;L`uop6!CtJkkKMr3gV$k z;V;`z1BV=6R~CjgJ)7NW5;NmDdlB`FD~hT0{TGpqyN)5G&lMJX#hVyp4klgr!r33O zA7(j;`o`HS?TOgJmOM#wXy1T$1^vnPM=R|0ZvA!l>dUn~CJ)~zRNHA&V zXT8*1Yx`O|V$7FU^~0^Jwz8wIk4Zk18hN86YTo88hPgUgB*-}Td@3w@Z+#9me(R&) zFnYyJm3i_XYvGNJvX|ZWrl*#+6&e{-Jiy2Z4gcj_(RvPh-mljDydw z;ZG-aW>fJT`g$XTaoobev||5wYW?wH;nG;qpjWIR##E(ytG2?`e4L)oxaaK;woz3w zh;%zPekmqZ)UfDsk@{`1&nf3GPgRZ|s;u^6s5O!k`l?))dpfs@CB2xpDrIWq+}iC*ocX zTO!`|N>iv>V8`8!6%{P1jw4&DX#@N4FT8_44p;YOciO(R-d57;aayE=R&~wY%R=ow zY<9R?shtAz=pBd5obMmoU-hPGj_SxOejPC#HhkM#0fKSHOKQ>EKryjd#(y(THj;4? z!iP3)ZcfB-Se$|D85vG(^F|fH1`e$RGv*bxCcB?yU4Q9C9ff1sGpA9g_4F%NFyPz8 z^r*ZJlgd&$(%pykD_kGTR>ySZW?yMar=3@MsVGB_+dm>pHCP@7L~ zGvAEd<8VAiKh&Uai_Jh}N~)euwew4d%@UW=UR$n8PPSEgf$f*u>gi$Mfw+N>jZ0kr zl=kS;OT#wB++8AiyPiZ!H=82_1}FO+%7&)P1lqkAHXPYlsw^%TYt5TuHDnp|-leAW z(b4$YY`EIHgBzIrP!~*?WKMpn+Ub3qF(}x~eXO7Pky`Nj_ zTc^#TEyiKU1Nz@Xy1b-kLW<*(KN;c{t2A!s(I+zOAy6bY{B3J~YGDFgDH&c{xRXur zW}cmmfo9VD^kk}n{0YItO*_mxRb-(hzTkr|OR4vh#BIZzoEEG!2Zna`S<*{mhbC0Q zk!?KheZp4g?6`C7_Um15oH{Ssmc-D7-OqXi4`GxrbvfQBF-FbbA+O4sw6}T>!vO)$ zv-x#n+j(+$j8g3)QjOV9UZKhppq&?O-@4Ph>vFCYqo-$vCcHtIao~-x#PoUHyS0ie z-FBhwdZEa}4Q}2+iUSX3Uu910(UouDJXK*DaZQEM<1V7EBs$C%*1x*j)-U6mY)N7} zI#dFEsQc|yt}1bZruI$z?lz!AvOE1(CQqOU`@px#+&@iSxoS8iT7Wy3aZEhv><>wd_AtG|Mmx^?oQ3e`$u z%Z+0B;)klJPTZ4_R(zW1s;PGW5!~iXfU3^PZsn`%?0Mwe9a^r4s69{Aal0RXG=X7e zQ^VA|^0h{Oi8q^Qd@rv&G&C?GkX-C)@y^|UfOb+yN%h5CL6w+V*=j3{lmq#=Z4;9HcP(E$Z1ZB z+}SK^(8wfZaJT+V&A=(o2Kb6Y2yrKw!;FZ+#E!Z>jA03twpu(=n#b5u;>C?=*oB@Q1Iu8M~{dYx|~~%npymU-CJt?z3Ut#}!wjaM0AACB-y5fZcC2HFkBD zNOE7cx?|Ozngq|BSItjUi;p}t<+5lyZId`EMJGIJaqxuQ!LYo;+1GSmeaXo5^z@Nn zH@?nw@bI9Y#HjSW_%Wuq6_x3`i;MhQ>h`_ZI`WC$6VdZmXNTbEk;JSTef--RPelQ< z0Nt5&zRGJ~_VhSwrK#Hb2$sl4v!|{voe#76%=&ifn9-Z}BMdx-7JCoqZoju{Z|*9# z(YH@F-D7Ylr~OcHWXG0--kckgjzhg!4apaL=7|{@URASw7SL0fp(jjVY8p-|Qcgw& z%E`R+Voaom!YHFcR8;KH)BE`aWoQn&xwt^j%7Yj(Sp4l-U7iia&{efhQc8o1M zHKA|Yx?7(l?1H4dT%3`lW7$p6@!|_H+Blw}hla=q%@ab-w16T=5@=^S@su z7V>7uhqG`MVgzXMSjZDtKab@dwEO!xY4syrMSc}RvWq;wBl6?VfsU-YITl^zA5&k8 zFGwEn`gvHPJ&P~+BT2OQD&!HPpNCcbW${(WhV>&BsB&5b=VG!%mAY zaFfg%C2XL7yyQoT7x*9B>BUzdcNqv?>yH=pB>0@O1`oYe2O2hOVfYfj_)4E z;xChfJ7Mwr@sgV*e))e{3Kw68961R~!H<_SmVY87d?x zLzF2)1IiFGuk~H`y4kyT=Y5awd%yd7zkmC`p5u6G^*rs{wSVjU&F6LAdv)mlSV^~J z$r8HV=ML@@M@0baewzCs11cZ*z3$r$ZRF5-NY)%LKB z|K*dcd=0_qnzS(IV-9s*CaVr=1!tX7l2N-Qqa=5re7{Dmq9O@*KrAJ|SjpLJ7{@0g26B$meTP6m_| zzqb&{yPTCCzp>kPUv$I%&iLdq*BhIj-xv26-+q9t_S0zPk(mgET@7iXlH9khhnU4w zSw`%9>+WFBBIuX6h}rAY(G6=D_HO+46gAJ-Y<%VTVx_jZvGAR+6my=`=hac(H#-^A( zF(R^ zp1UmM7x$NnzrM_D-KzU;51mqS%y86l_7CRDS(lEjJQ7spyPSKrhqdGnfo*qhnVgi3 z)eN@GwEMtcaPf}9E2Tg7za5gjBp`jwaihO-(d4H)XAKqyi_86S(2Rxq{*I7Ho7UU+ zcKwjOCa250TqRiQITK%Y(1CdK!r~*dajB(BOim@`#;%)A)v1qgudokwT2pKq=ezsU znr8&ffTxezzxL*z^-pK3wtXiPd$a%TIi{!!D;TC1U1F@%*#GikP3yHBf^|Cc2_4Z@ zlXh1HH*U7$40@JgQ+lzJ&t8c#85_m5{{bF^{j^GEY%!OYx zD3^DST6pc3rMJlP;Ssg(xg%x3dtd3t) z6Fuh~UCAzH2bIrkblFxxX7O$ZLO*s6P0q+k*JNgXwxZl>E_v0wQ&;nPfu!{LRh1omEn0+p9O?T^`(3thxu{{A~`Da3@Ix^rxHN`$SNVlX-Y=(;dxO z-*a``dmdgg-Z5|+c|LRV7x!KGtoM<;%0$fB)y|cu)DAP*Td#En_nE~WcT2# z*p+hc%)#px&$b@4^3A{4w7T#;hwB=)>*awP#P=(FKK`kgzvxfm3X44&JLA~uu3X9# z+5S<;F7kW3Me_cc@P{F)XS>KU_Fg@sZzI~jx!lkGU>G>t_GYT@YQZae%B3)iKB>Hm zL-$VVCf8)!keqh#zow&_F=bylG7~D?UCQen zPsiV$J(jbDJ?%@TNReO1n{qx?7m406#kh{KF-Z>Bt)}JA@x;XA_*{=W(Vg|TKd2-* z=W;kZ1iNUTv2h;u(vhDCi|cECnwCC$pWnxN>G}E-!bp*4slg#zIrWYd}o&IV%y1oBt*5X66 zmaUt$r@iyhlTxRSJMBh4ZrcB$AD^_vnY$0M7Oq$DIH}asaA@mpkKP%sKUZD1aLH=2`u=0;#F^e3jGXcw z%Lxgbl;Osz-Oml|zM1OR;8kv}JP?)Z=v^c&$~a|&un8muHSKl z6W8%H@JIXZju|f90pb|zsX*E8`$@Zs#XmG2Xd5ABFxzYf_O^ zSH1j`_oLNZPugcUtcaDwpRe##k~2Elk{fvT#kk%fKAdAy?s2<=%G|?`6DZPT^@R5E zwtl{B@#3X{FUZaZL=QM$P81^PA52u-+fwo6N!Rg%CgWt`wmpsI$NKE*-+VvV<#R5t zh$6H#!K3(XX2R^qR!W0p6Zx*x>RH$68V<7CnwiHQ)p`jd9bZdl+8)h{)ISU-Nl=t! zJ|}u_+tP#A_%vf<`R&^yuDhDaJ>r{f(B~V$ z6AuXQD~{h^V}3(?zg0`XJv_e>9z1$weV9`zk$6tr{WMjUgowadIE`X=?xAx7A*< z?V^d-?j^$;h1c5Z9NTtr)oIlTjhyf64yt}yp8HBr^`^$=QSgV}<+%-lsu>zNW8e>8 zm*>70RDGl&I}ZLZ7@FHIs9K^SI|2SM9GcrDs9LEZI|=?U5}Nx-Q1!Kj>=gLJSZHpa zplY**?DRT{AKm@nWINpQE|s`8rgtj}gOfdQs~7&m2J-ZcW#ezYs#He3_TG>=UHOkc zXub0ek+?Oz(QG_aU?BYdH26v52Dt-*yIMu;#&(T9=-+ovkp{>|D%QWl{I=UkL|0=Yt`bTJ+i*eM#JmK{r=Q8P~OhcSs+4r^E zo2}y9wbJ7C9%=RuLe6}l!7td8T7BMVE7+f1wDx#4esZwJ+5O?f?!%nt1pDr<`_I<~axU)|mB?@=-mD0!2caMoXz z6vOzD4;e(Jdj{M0&MbOPxF~yNaezXU*rR^YcbclR+nBeIdB@r+4U1niT2{8LtXRaa zUoKv->r7=pj<7{>xShJ^z=ix{^!yj9D<5r{=x)mqt5V3@xXCHUqCNBFgZ24TQ!*X4 z_hnc_N5@3}-!P>N(&Nxf`QI_6r;D58$zyhQ?kAy^Ezj;z-XA?U}l+OKl_K8o^9p2wR<9sHnT~uaAr=`d< z9P78MjRIp+pb16UY^bJl?a7cY+hWe@yi@B@!lU zL@3vX;s?nIt2@ZO`j$S!#WO#yl6+>#@i_9s-sJLN!ptCL=A&gXY0vZ&?%MQJ zwN&x+k7*amXn7WC;zz%w@a%-hL|6SdWuj}gmT)sa3IDpuaz>eOI}1-4AW^2GDHEis?Aq}kIw zLv4eE>2H>ViN0!=c8-qOzG?8U(;Yy;6TB#m`2@ zPfD>{7E`9jJqfdS6N{fyCcouVX6s35l!^M=9h4tZiG&gIe#(Q{>R>&x+j^ggA5v}8 z_}RTrD1CQ3yjKJ#&h(8)`AmFw84Rc;C@ly7I0ydR^q4+{Tr2W10N1PE;XO@xLiu!O zmPDX5PD}YrxsmVpBnpy;Mr}qZps+qt<41{8c>K<=4JGo!RGwF{w}b^@@(=v%XF~1dBncmxNEw<04$uaW-sp*!AiH+y6PDwH zCdr?z@#LnYK|%v*mi(Z@XDUB2iX1lKdpW@Mw)F6pJrNY$ZS6ugo?ni={Mq&JfTUFS z?vK}+Tn~3%Q|#XT?OJ~KZkw*QEpOtyV$P)aTUg$h^V?=C9+0VRzEy=OIY`W+~l<+ZJBV6tzm+b za+48Bdt}0cx5jOdoxR?I{PGz2Wg7V<{K2Fg__cg;+wAoK>i^I^d2aeTes(x<5=Snj zOmyOAg7I0W3oT_QTPZ`el_Ry3;gJ#impgmOoE9o2PAnt6VGePox}0NjZ**@Zs4DvV zuvGU--W6S1FVt^;Sl0jB%2P(o`T=WGFL%qi#+99BiSE6&#BbnsOwi@9mrHMv(w6aF z!m0wKh+C0%H_le_u1c$RaN$P zW|>_XRe#9DXjQ7t+xn+RSXxBCre-IyZ`b9luTP#8WSyi9441de5zR zRlNU4_vprzmwLm-Ll{JwaOtwJvB2Q>%x1Cw&-`tBrG@Pap!sFt{Y){WXY_W z|7)uTP2XJ2fYBw}8P%SjZ{5Fj>N^PpRni{PjM2u_y~W7yG5XQQ^-mASrQNxFgyq}H zLeWtp(>tbLVpX%2!5@bdUbg$k3*?nV(ZAcC{+O zKtOJleBC;UI)Uw~!8=1YuN&VNR6OINa&EFickbuJ`b^%DPLw33UVbKLpwC&e^1Z0L z(U&{f*9Y#$l}R7Ee?wTosCkdIqW`S>7wfn!dpPfiUcYl9_SKSf*21fYm4vlrWc|pu zRgXzKB=0m!-gU-rt?zo99RqjQcu#g9|2_%e`FnM5ol}Nrx9Ope1jV`U$9d{wV%fRE zY=ma)sCp73NtT9>RD<^jP+}?q;8rx3nO*LHiQOb?5H&y27KD8q|Q-$lP-`suM zEH0UB2fZV{PNDqwkAA=KGV~?$RzaRmekqqS)l1Vh>eXzB57fTjl9rv|! z&`#dSZ7Lh{t9t@^BU^AGi$!sdRMbCZq*sbpHrVnet0^UGM19RuWi-jGate{Szw3vt zO32o*tpZ1T%C2WOWH)YH#g#&gwS8cqb&4;qK{K;KtH`$8`q^g9q_7I6kEd#8O18^_ zXSho9Wrz&q$G0AAii1b`DkKv5seaOp@bX!h7 z+(|*K$~h^Dml&x;jCR_Rv4zpz`1{1o)_cjgN8#!$$>%%6hWQu-qic$~YqRNLY=!(7WRehJty9B4c4}0bCX9 z0=3uTB3j1A=*OEhFGO&dTMM2v*=Ngb>mY-AxXuqV0s6adZ51lH-wB)*##OGVx*j6y zX1&MMq1j>OwJUWEy7%9uZFn4L=8$aCmuzvrGrMb5vO!h1uiN83pAYx=L_@w`=y%2p z1E4^rt#`#_ zSY_m6sn8A;I-41CVV|Q6pY7GJA=|?_Y=dm~RIV?sl4ns@vv&}F=VTn#rY<3G zxXHs%>fH%b*QIr7J;OT-4&~!dbOZrED2Y_Y2(Dzk_HReXq4B4|Sv8zLVRzQHmv}c> z#AhpOwqbNum5rYGkxxg~0tCFlotmz8CcOXV@_5!YpEU5}a~rw11?M%*>O$!H=JI4V zG@tbS$I*83s}|guX&o0r-#3?{*_?dRk3BvE2{Y}=lck>DuMYNzbX2(%hvU3ONK<=! zek9BcC{K2Jey<+vxdZ+WQaFwvLL%?+A^zGi`2^VYB-OKCV(VE)QP09SVu3>f&yvN`vw&UEhz0T{MiC1a@tDHY zk9rm`E|#7ZOZ6p;i zgJJOrY|#o13Gx6BwrC}RLxQTg4BL2x9CER!CB~HiI3$Qy00&rBSjZtk9soGNEMEOK zV0GVX;i5Q_g`ySXejt*H*8Lcx747j}V2f7dkN~Y1XIF4YfYwbIqZQ4rAF)L%I3x(I z2oA6et>BQLbp|-VvU&YI!1`wA>64&+FQ-C)4`UxdQx+Sx!0JHrz$I+IEf+Mn0y|(f zlL39EA{wwT4%x`pv{)3e1C}Kw_?m!gA$GuW)&RaHPzoS+z|vuV54e80`2ON4)^!RB#aW0*s3R@HHV`fN_QeUlZ^G#12?`0r;9g-bU{lnjdI9*FfEOTkz|srA*91yJUN*g&6+rW*7ss1X1P!{5ox;FdJPm&qB z61t74=$bTY;87SO&po~4$(gy~KZ5WvN^weBM|-<6H2Z>*2RE+au?veAigI7O@32C(=e;u7 zs_$6ehJ=)>57rZv!-|tmm`7+iN14{0Hoh#BsgYnBZW?bIZJKCW=e^-$MM(1_a@DOf zh04ZHI6@H1eAzp!Ug94~^e4VIrtW&{>iGB9eJIN#2IfYds%sx+GSV;-=@mb8olC1N zbd=w}`?jvzgQsDylC;I`xA#4bd;0!q;nS(7VFQAq_)AZpkLj~FjQV!BWWvi%z~A2gmV;fBy&`9lBYFa1PkQ2&W7(AJL8$=m9&n_ z@N~+XTU`kkSvMK68s!nGOn{UW<$KAc{*Fd`_M5&X7j<)_2Bq$)J5ab~Q&^#3uQE%8 zT5Qje%R&hnk*0NL8ZOIU&b#b!dF--Kn}(s!(#wJUiEGjoJ%L4*&Y`AV?h(e{>sfI4 z>G{LY`eJ-|PjGn874wJJ#`N&Rx6V8|YcTxbDoa|(i%o4fv10>eFB-~>kEc@?@b8tf|q`g%bw3`cSAPDs01fPKK!hie=WxG`bQHlXx|QYTcwtrL3S z#srXHVb%$gP-DUkxODPOrB!ti`h@ zmjwtKaoP(@Bu92Drk+Y=uhS~rqLbWfSfy95LH(lOg|hwa)YVo9l~oC&iw(j}asqyKi@KNQv#Zu+rs>1ecW9Q1+3& za^rGioj%RW5n9_RTS8cHLArX$vAH28K^-ygW0f>Tdb`A93+<*%K5S77zk4nA)jmGi z%)6W4^7da7vUwNNYms`6%Vuzj6xHWyFdV?cb#uoR#iFPyJX~I;vSZfi*6BhX$-7@9 z-yp2f^ykn>6|U1Y)7(_yqWevkKRMjpHA=Tl#(UF=>$j`+J=gu59vJ(!ag}4B$Mdip zr?{u@UX}~zu6r@eXQXVz)Vtx(bs?jC-42#DcaFJ5 zZmutIuu1ihe{N=zkYg*(C)-vXk#+d%Axe|sc1bbv(Cx)5HHTB142N$o=5S0^(UsTD zOAd(mzgEZpDvKdCgo6(%7>4kvNmDU%W1z5sWK478AuKayR)t~b?Tcsx2OqGE z;6C^$79Or-YQh8`Fb#yYHpCMKJJIBD!k`q(LZJN9^v@uReLXf^mK z?E_}jAV`Cy*cS%rsKR^cF~%Xyfh?97TIH`dc2IpV`B@B*041*BUB^-EzbcqLxjQJ_@N#YL5FqWeeuxx<2$e=y@ z*X0h)CjSPTkfQsLEeUBZsTCOCq)cGEse?KGrak-D%_z+#{|1|M=!}toV^Zci9vB&u z0I`ytKR1khF$H3WN$G~y8Ivm@ma@SROK=>-)&UQ(<$(imP|GF)&z!G+U=Ryv1eAXP z0fok|`k&=jfzgjQ82!ulp!lA zhH2kD4v~}tk=-%~@z`hKSsNk+ihzT}WdrHb3#7|A;tY&*iG$c*azIR%Gy=-c*Bj7u zN#j@jk}l!E8+4bopu5zc!#9lXl14!JrMvw72q>gO;B(j{_zXO1`n zBVAfTOqWs+(z#F8?L69z8Af`(i0p*u;N&4*wC}_HzhY5^y zN#j@j90ozU9050J=Wgk4k7gOgVL3WMZoAH1xQ0RAqCI0{|9a#4_p`}aA{p6| z%-!w0p~Em0jO9f`a8;ZF@uC3j*}q=R|J`jusZK5Gc^$ZECvUsq+g9mzVls`0LIn$=nNU|5z-fdiR3ry>d#17j$$PcJ ztyJBPeXiFX!X1H*1lP6Lw_K>wL&hqqX2Khw+ksZ<2yfzwG2sik(Yfh+ z842);g!OHxkVN{HJ$Y5~KmdaUh?!hLrA$n&Az}|r$L573d;oXZIJA!g71vl5;}CmA zmnyBHifEb0eeZnQfJkfDcTWHr2_SSI>Wm6W>|1l^eGe}XN?`yZ6>6wN#U`qjiKE=S zkOWdXrfZG`pyC=!b@O!9QmN7!0*ICg@8pTY4u}LxuItRJhSCPDLQO?fCq*pC=(t-T z5Wu(yL@I8h5*1ujEfaa(d7YFF&_VA@p4x?$1dOR>sq2lX(i$O%mPz2bEt}PneYbA>!cv1qnP3BEmT~C-blhI zl!!=c7;7S0Ch98JV-RT#q2p^vvL4bNVUl$#!* z!T}K{NTm)d4kC0WSU3R{7%ZG1dOEPeAaWA|Rv5%X41);k4OSS018O(83@bc;^|D$h8zw+61A) zQb!Gmg==-xKr@PA$_%DTyr8a$sNP^$$&yb~*(4|o5!D;4s(VnieWsFN(CmQ77hzZ= zlTc+O6orU<5q3q}6sk;v*53$I3d8!FvYjfZgVraA>J5f{+BB6r2IbgzDtC;Cma%}~ zg<%;x>kSEiAYFEYbcqP1KuVX0o(`;ZiHBHL;UK0<4v6Uzp)J{&NyWv&sLMO)LOK{OXm& zx#WNngD@-xK`utbs9=p|5H29BAPdB(paoetJqcCn7~ulKii7hofia=hhgd@(TtHYg z1RQt|rc5DH-iXQ&f^RC17Q_AzOnONWYfVdtwWbtAoFH64SU5q%s9=S`d6>Z1Faj)roq$6*0?5HpVi1Ot0>A|%LG&Hkv#X!~b2Cb_$-luSfJjS0$U8v) z0#<{G=yt%0R)3wF`mPZS2W<$`5Yg>`RV4p@{1cQ{fQMK`5Fkcy3dE`n62Oa$Ng!p; z6K7x$3upusr(cL+zaIgG+P%)hgvPIe&94HRlFwi|Gf$j>z{8^vP=2kfem?@r-|s7f z)xFaAReV3uOaTuMq)Wow6c0waq!CblO_#qP0R?@p9mHWT%*Ocl<5yYgj15vIDWJt1 zoOUE?B2z*eq9%}m#*l(COno^Q$~!~epoJlq2qu@~93(CW$UIH(xI}X==R%Vj#-tqd z_a2B{5tlbkz0P@-daMeHGesp@iMYU zwv|ldHShAI4NuwxsQ8DgZS*8MWn@qsi57ne!Q47b^fI^*aG4lKyhMy@2t88=WF9Im zM@*hL;((}jb0=@e@VZl0ymC zHDfuBrXs2xn#vV8UGJZDQa)@^3%?8WT_S(&Ql7kw;8S5(Xdy-!U$QmK49mxsZ9H}Zl>AP$?as77HJ|L5#4P;Ur zuH^xtl%kwcs&0p!jomCLzzWd5LSf@{OyZySrneN>$ z&TWy+1EMtQ@3)ez`pSQjcUfE^8fR_?WKwK_Ov-ap#|+uGe0)?{n*9nUZz*}ke?u_M zRLsKogZ1I`Bk9)ZLLSLCLm4krvkfj3B( z9UxY9pcsUbE)ljKES#Wka)yHwR7e+2xs`-CA@W>U))1g|g*lp`J^R<~4$UV22Ag~YFCqfYGuO};QC~!aVRMPB>R>kX zv}gai8l~Cf-(V9r@FF7MJm`yv;0$EJokUp6BQovTzwioZHu;rn@%z~XjDGNzJX~`` zj@M_2JHQ=H3`eHFCE0?;C8BYOZ2O{m5B|U75=HBb^@9#`j>rL}kp1n*7U;B>#wGfd zQc2?y{aPbKfj3B(B#k*O*`V9yBN@Y##)uB6G4c*0;ON~=V4 zX)wHnfVa>A><~lhnz0PL;|jw`@)Sgx2m#`;$KkPC5+Tx*0PG~iG^u-TL|_QZTSw#Y z@CWUS1k+e#l>zZK$vl?`#*HT0vlo~=LTPu<8)P(l|4-Q)nZ^RL+#HbuN_+YHkuA{n zlEx+asjiy4*-7IP{c^Jt4!l8oISy_v&y8kAEyP|EFs&i}<`O}<6%FT(4eFP)XaCv* z(rofSWfMTeL*_nnmxG`X@nAOeSUh{mQsLX0fK%qobwg28Z|^F{GWV@~rgi(1HHFna zS0LAmJmkkw8nIkc$~SwXICFK`73nucm%nGSIL_ULCjoNtR>SeV50E?jyK0SVjjhDO zR)~hP*nhxj7=A3jOpMJ1m-wF#D;qJP(gSw4ojJYZySMc39uU-ZceaQ*)^?HhY?@8} zJ2-KP?)yBa2@=$>9nGv?V*6rQbkz*k+ZhV5&2(#~pWCuoJ{%DR+2V7w&kEIg&}}$= z+vVh%qY0JXewSa>uySS|T*mD$WPQMNxp1MPLGeE8$@8B*7a zhRP5_7|E_1_NiQtiPJ(vLDrCDJ?5lLg!>fUO zI6dOOw5+K(AmWCzzI}3}YtSywFi0%46-B!@`qkvc>aq+(E)e@@Eea-rVn@u2Pu&Vpd+HwCAyZ+ozo-Ok=1 z&bp~=_qgzje6fs7bSR9_J=~H9ZXKa&_1qxdAeI_=X}U7X&(2yc=1cqTNfZCPpJZtO1RJQDAg^T`Ww~OmB=3Hatjar45o$bn z;;@4-qIu&w^Qxf~l`@G>5>33UBZDkNSA{kT}nYrm*7SVG@O82C(v*LR3TxdO9I4nNrD&# z5!GT?VQ>zDP|_t(Eru2b;lTR{kvx+~As7r(ib+vd5FBQutOuGS7;t)9AP;$rBIb=Hc*EJ2vY^iVZk7kse%@=h@cLZ*0w~LQgEz2MwJ*s z9TNyTVLA30q)H5-aS#!7!f?t)eu790!TBOl5*GIO1L?8?q)S9I0akYjWILdxOCZ|; zD_tV89k9|R!uEjGUE(07OAd(Xat?w}(j{P$Kuec!;0?OV)2Q+Q;ydVNFl?6%WSA`p z?b*L9cWCzhb>a2<*@W=em~s|4W-uC2Q2GIeg(kw$oqINv)e#QjYz7Z8I}jjdH44OR zOo6z|pmf8le#jLNt2Q_Q|7JKl4TON^T4N}l38yti-v>f__ODzEnoa%TL!o#BxP=4Xz{eA=#^!-^he$}sG5DvUS zx+H;gIY(}RkuEzRrb`+Dv&7#;;>1fI1msX9Pa)N6H!>Jo;V?pYtI z4iL&m25(uz@|ssIyf2afi(Lh}OF&znC%3>zmpF*&l14!JHC@6XprG9)jbHUkx`YF7 z&|M}1;dDIeJE#m0mb6FExx#EoXwUxjb}`K+{|1}n>x_|rW6pC##tko!yZ`su-z^lo z`aNOCpT$b*>i3c?S1R7_6<)5&^(XI-8K$r(`%|YD_aFb>99Dl~{D!i`(Y0>;t43QF zuX1l&Z@ReJiXr3T&Ox>~7q+kO$W4ZApvirGl||rA58+FW@fiaF4&T%>dTM$?DH+BQ z>2)^=Ya-)RuFJ`9lF+_em-^9Dk3UW+QZgm@t<16founH3ts^1*B{x5Fm)z{n+6XW)LI>tl!OQK3-Oc&j?dVSXS z(?R;P4=H)Z`B$&tM{lcEicaFrh(}r&SC-!-S{NA^X^C#)N=cXdg40MzVoxG!ZVWs8`+_ZE8x6SD}D6us)fI3+m` zu|wLpOuN_4zCQ8wZl462F6^w8IKQ(=;-XOYQj-#~Rio`UC*PLb_(qUu{063eMQO|2 zw8;T$by9e^zDplVZ!&H$HhiJ2MigV4sxTn-mTMV3sJopjcHGRTso@sUsMm1nn1t^s zzR{NJQL-Eb>`Tu$FIrmYyj=W(UG`#=(wpOqHTjG`oPaiiGk8<#7d8J7qwn}pQ?a77 zkbs>=MX9$_!wgNtwD;M+#s_KZ;r7JEMRKR?v#mI%Dje~T) z_YVG{W3@Wt{66U~MLS0_FKllCldcxEXE*@Go`@Na?NQoNVm;QcjkAbp#N>#`D~9`c zM}w0L>jT15kEE#C?|Yv+bC0;o=uTbA=o>S}Zwg=XxBfqbJRXd5!RZs{PTv--{RQuh zIp)WpVx9;U^ZIZx-v<@*Mo=+7j~YmrZ-5%+@4yZ7upnQXGSv@~RP@~G$5U2J>Ep1D z^HOjz58^MxIIja0^OkVqJSaIJmNxUKfm7O$;FdO^!##{!RHe{Z?gZWG-7-|wBz%87TpcYOz zs7ZtZcP2EC8aOi{JlwkJ4b-{`8srO%DeYj0+cJkBp`ymL6O2a;Mfv#MdSEyyDC1wwZ3w z^^473W}+I$l9ZFJKEZo!d@;FD>Sn9u`K{8Fyw8hYurWSi3+Wf&5r{^&DD*R)e>e`E zy4bq(;rUD}z8RZ<)>4=V%6#gA_stt`)~(XJxOJobjWB)zJzoaZIHs$9m!&zm%d|C( ztmU}hF0u3-wkW|5vTjsdXT|=K@U7sy8`EMJ`kphDYL)1grkReyU&{L=VV$C{gw>{I zMoP1Q=Z=9t9+#->tv$BvnsDiw2s!<#ppewk#R4_HYGu1)m|3lbl8Ms1td4$JrCw4W zEXNrl&Muc``b7F+zN29Eh5SWs+k4jcp!+eW^OPVfw)QtFi$XRoL;UKQvsU)E&xglA}Qdhv_n%m{GK zO5SXZE@`1FSnIaj4PDbHln^ws8C^swYphtCSss?+PgU}VD3?lRb2P~E{*k05%_LM~ zbYC#pK6{7eh*hZc@*`!crp)$Y*PfU0b~;M8vrbGGpLYvb{HbK7=?3e@{Eb-S@}%XC zf&+_AT9F-V86qBYdGW1l+9jzfiLS61CkB_i{qXINg4Iro4wfoRRInG&yNNV2{J3yN z-PcNv`P0qh)7q!}E*_8iG( zaAIirfK%>auS~GwX=dtM&35t4h8W+lPonRZ*U6c#OFo^g8M8#zS|Gzuj!WIfI&esS z)gZ$Y%d(k^I;%FL$b94%iZL>Mm`7M8t)HT9+qps=W4E0adMWkDZ#jw`Kb=*lvBeI} z`2SVR{GE-T#W2$`yW$h!1hXI#*VeLb{DH$XG8CO3*NLH&3SC2^@;dXfN^GOD7s+oD zXI}Ovn$OFGuF;PFb2&n@{(qIye{1kquufC}-{qJK{J{(>r#Z0CE4aDPaD#P8wDfmu zOYwFoYw~%xS(gcJXu!{xJdkRVMbXlS(PA8Y4Hy^WKVheq0ZP$8D1jUI>EV`C@Sxwc zn0y-KEzY^~+bnuU_Qk&96oHI=P{&fseMs16hKqfDxCJu-lp-)|o_Xw?Tm+?^NQ4~r zLA-(4Y{7$m-g!bBNL%yGqUnwt$_MOwQ3kl!huka@AlLhlTWL$k*q_Ia`3@+91|GO! z|F0HKs!X5Pg`)NRD^Q4ai0%v&C>xH`0BNGMB;&q{dw%b+8y}A4f|4%!#*_V*D}nE5%R&_bsP|q9FYA%@p%VI zDYlE(iT>jAXPA>vI!s!$^c1$cA@U&H$GckYDDpEv850dUtGuygOi-Rk-Lxo6LzmKh zLf4A1C7BW0c=k$JH=uNqu@&ka*s{P#gRI~Sr2?k_`HnGOJOP>(Fi9Lr)3PZ0f-x>@ zy%zzK)F4D8#7d*sPG@JvA>tD3g$jRSB0(B1L!LiEp3Xv^UBe!4(v1I~F%u|Rspcj6+>Va0M$y{GiZeBv#bodlZ%G-syv@)2s=4|--?8jP z3T47G%H`axMFO4y+pYAQSqV=O$>-{pVG?m@lr^+n0 zEYY}Swme-;yi8~FJ$kQJzsU=FF=b+=MJ=c4a+r-;^(yl!?Ru0Z5gsiTXIWyx4%e|$^GT&Y@vRAyKJpRzWV!~Seeds%k1g; zCo8*^&R6Kg;F|qJGcGnhPGDLVFa3;maGJ&cRZx*Rj}MNQ#sj}GWw`69%w}ax>2y}T zrzR=bRC=bFj?bEtoM6p5&>r%*d~G)H4}5#2cgX))TzM+2Yt5C>{%zZN;7S9+J!U;J zZu}VmY}v~dIy+WB{4l^)p!{{w*)ofX?!Z>20Viv!$HM&)!<^ z7q^V-#x=7l^)!XuE7Cba{S&fz*vkykO#B>{UmY^M)=#$<UIY;7N;^2s;{PhBEd4MDQjp7B z3fe<&+DyQ%Z1$i7d6_hympRrcSYLU}T)DzZ^HAE#G|vj2H4M*+{or3 zdkK#3boTeQ=4)r=5@_&C8?tTCR#43o2;1xZr}$UDq7%!4RP)vwUp4iMK5Wi3^aw1K z;ne%IgVQYjzu6i>g$mGq-cxIY?&a|`;__dK8!H}4rU~Wne}0ToN=fFG@hjS@)N>X zhzv8_{&jE|b@O~lf$aWv%$9|A@C8O8G>b1ZHG>3|)g_65myifCd-}j^wL~E1AlktfVuH{t zz7Y2Y62_N)$O7XbDVV&3`MeBcddmuNPD!F2d;um1&Eo%&vX1f+AVGz3XdHB&iV%4T z9rJk^M*kKFv8$yWe4+M@X7L4h36P)ycnQenbAD9@gO>nxn+0<@NjvyL9Tv^v3pC@9 zpaQ10XTf!^`DKBK9y@vJNN<}7MW)81+Ha4f=V?V`6Td8n7I=V zv$CB(I27gpjUTf>5eJJOL%rU>0ddIpJCeXaX*&oS&v}{&jO!{ie#}BQ$Z7nTg>LSW zV21MFkOa1c<3laQv)ONwRPI5igYaVjZQ~oJS5_#>>{bQLMrO!GZw};BJBCsTctCP; zE{i}fVNnu@|eD!-fB?X$w zs1h6;Gt+*7kCX)z%ek9bsL~;PZpvTjmFEOFE{G%<-(Qi=X29AQpjl=@y+%xx4l(fB z^xT_{V!WaV~9>=UN-fPGCf7bT5w=bWlc82LsUQDQY-s( z3H#g)(856T%J8*`w-kO{1WV>ZK+RZlzsqY6#~tD%~kLDQ#DoAPK-12xq7NPUy{h?qF&rq z=sDHQbm{}DsIpjJooFj$%y*j`T-^4{q-q~fFK#CdnOvKuv!Dv92tPn=-t1R3fZ548 zK6r3`Vp6b{*<|(6z5|g}_)0rC&EgAz{I`V)+XsA;UJU3y!VfIkq(9AD@{%0zSl*4z z4P3B(i^!gw{m>!e^t6q+VD-Zi6RIRpOGt|~uK5Bgro^&sbxK$y5K}S(l0+*WQWcM= zl0?_a4sITx_iCed!LeM~-*X2M>4Q@kM#QXmX>i#Bp6i3r9U8Nc<9 z+{E^wK~9CPf&XTncmgD*z-5bW$LX7A@SC% zPX1J(Cbk0p9~b!Nq+m+I4a5#GH(pBf@7uM(dK2|RJ5{J@;}foKmGeJ;od`MK*3+?v zw`YZ$LYKU5NQYhXNd>`BF*9p#Vklr0p59tsv88) zI{_aBns)*Q5Ipas9ee@rq*;6+?}P*u;GLGhJ8dB5PM{kE&pTn}PTIj2@=lt?5na50 z)ccU2a-5D*1lk}#V4$`^O>{?o;9IdR_`zHqUcnFM>d;&tERW!IwP5Q7udAK^I-zv6 zFx?Xn0pNADKtTXnR|^T`&Vc;~nteb7prSl$(aW!dN7zm&p!VZ1$1AjhFEr+(S$u&> z93-d!?;Ho-IiG`IcqgQ|f{uh?rU}}?7xGS;#TW2SNKgUZ*#S0(`1wK$!pf6e4zZ*l zz^t1&VAjpn5bNf@zD^k1AfVO&Z5u>^Ipza`3h?S?I3OS1ex5|`u;cth!41&I90Y66 z$LvSX%3OtLuy(C4DE(8SP+U2mfJ%TwC@w7&~8xR z(nD-NaWJzScnuS@cuqU`LIp0(;tLeGke~v*vlbM%fAM2r6u2}d$O0P*8r_LTcS7Gd z^k4FM`AQN23oLOy!LeB#!L+(X=xcz=2W_OSKi@dR=(K1D|0nkwP~&J8|0k6nBF6bj zEP;1g!t~BEh~5drl;G_TX$N1xJ82eQ$U7lHg|DOocxMMp?|cr?J6&LUC+*-1cqh%` z3wb9bsPL5#kXs+~{1_N~cp4LAq4CQ6su{{9p82nHJ9sTJ*7x^lbf<+Vw~#>ILPstD z&Efp)#*t2T8i(ilrTVA@8JFd;#x-1Qp<&p5V6hJU<2or;o-2`9=5w3_l6;y*{Gg{nx$V z9|WiOTUUI2bbrHZiLp%Oq7~(u+~FhF*Zd%bJj_bod|9w7hJNq1++$YAz3K_i^M46@ zv%aJwFca-ves9DPuJr zsD?EAX$?eG7KPjmxogdqfhc59*#Fkv-~%r=&lmJ8+0*Qg-oKaGwz?q9AKbq;1o!WS zGW-L9w#VEBj^M-Fn1+g(M*v<|R9j6}6eHvGsh$9%~ZmF z!NK+8s`pgyU6Rj6!~D;a(j4#r%sPW<-W?sY{s`hP9>PY^!GJ(Ho}w8mQZCY zk*{T_PRr^W*UYO_fliC4G4A$?w`J-;lw?koKx6X_dan+@Nzl+-w#%Neq3U|{IA3mM zEnq3&eOrPko(vDt{Uu29urpZEP1%jMmNZ`42=3n-mzgy$0Xi_K zPRqo`=i_u_G9h0thN8TUNjh(76ydANdE#uqV<9)G9b^?SAgK=5Q`I)?$XqqU%uf5M!|Owy{_MKeII#hp`_`s}lG^?EU* zm>vEk9i@Q7s*pL{48>xvuk z*e|fZoYxeQRUq?Q{iR@|Ff**~tTAvtA)6IdCb0FAaT8(%$^jg#!w7@MC&0^dd4$lM`T?oC4@`(7sR7_#$0J zYeO_}Nw@iF4Pq7*8HXyoslq;JSY(vWp`5@F<{+NqKoo}-xd7AUsf;N(hdPRJqaB=@ zL1`9WD9QbXP+1GOMZh}&w`c=3QLtGZ26|ywrRS4$gQ#dw4w9OwDl@GZCZV4Xj#QIj z80P&aE>zJVXs%BHG;wG(CIq4twz@&DK%QoR!vR2YYvKn~)WkG2p>TT7S$(H~-IOFQ^N6(Y^z3yk9+ zK?Rhy(_kJ41XZXh$dW#$8E7hCIx+)f6trxHQGEhV2edkicJP1B`H*^_X7L5a!jPa6 z4CK4PTo}k$P+P35MY><{825%yyCAShht|~64!+RtgJ$u64&g!V2?;6{fV%(!;{3X) ziB9+j4&yx;q>T`@-iNy2qaFNzvG@LQQI=W%_|PQCZxuli5fud$3DgZt)G1S1e`mRd zLNcS|Zi=Ym3K-!GGKiWcXc|4FJpEiV#K}^e5N8}ThSkmQR?3v%fK2hUBA{+U3(b7a zb>DLjzixVV^FI45eXqave)Y$A_HeH2I_G`f=Y4o8Eb4K-VjL+{R*S4D@OFY21X@eQ z3fdlM@0$X%sI_|qqyG-VA!vv&bvZBPp)b1Jtw!6KX7Z?Vm!O;kQmcT%6j~&rUglxk zt%Y$uxrBxCV@~Z{0{j@ZHvzmtw7VP#|9B7xQjn*KtnJ$CL6@!mN5pxAe3KlY`^r)# zB+KLsBC*F>9m7S2#rt5 zkKyBJOE4?vzQ~X9sG%gVo`VRE&Gq1xV6M_aIGzQVfw&8?wxx#i@e-)Vd3Xs(p#rJx zEqFX(4HH^w8-|(Mf)WfGFM%4)m)cT~^Q5*&p#rIGI`mfdBJvU0VVs_(6Byg zI1ev@dc4PQAmpA%p#r=F4KzQv5d;ig0%jG2TGUd*`FIJKV>Z;|T|ExG1Tv(~wVT$7 zyxKekoC_v%gRUWn)zmHu*c);j(W#_kx)PJ%gWEiI~V5N zOxj!Juh|pFNI_)JXlBJG8lBV5-%$H1CK}RnVr71b<*bs0_mMsCniqnSMd;Fi(QIB* zY7>KaZ)l~%basWRenQMYzS%1J$oW}Vp;{97dM>NhpmwrJD$J0D8T}&a_Vv?v%0m(} zZ?j4kZ|e`_zIN96>W-tJWRbwsdFmmoFv;1$b<>pPj4;WwG5zMpN0E7g-LS4D#XMQg z%97mI*;Fio8~UY{t!e*gWXlstS?ksQtX{*?)XDqzM}l6%DbQ<}$Q-r%Her(2SH(Fs zpJ9YaTt1Y3zpmZ^M7cK=M>oD27hS~2l9Y|GDXO%nN~If&dn7*QnTF$P_tSN(M25@a z=x6Q*fkcMSG0$9v=cZq26DE0P&n?jiR+vQQJu&_EbWl_o4;pmUxt9#AEQwKUQ&c&k z9@5~Rf2VwVm6OK%^!a2~u4PGW#c$``0J)a0K(6H^lV2NMSz(fuyJ4?S9V1LKzHs|{ zCk~T(=_2e6ijwKbDir4+^rLrlOn4Gqe#rg>2tE^nhgz3I>EAm0EWd+E! zuy}f!O_*fg4v_=;syOBwK@X^6xRbg{HU2nrCz7uw0WVwyn46@3jTrtp z^CjH94OW$EFqV^=Bb-mZnXjOAGV9V3RHQx+_>F_d3XW!P^gdEleu+ zqR15rRl%NTkD5)4-Vs{1wN2`Ul2=f}d&_UB$BFD-rxX-3R4$1uo8fcTy0i8!1#?5Lt&qFN-U&hUxS$6e?`H39|}9%JNTD)W zX^n!n6Zi{gbtmu_@Yr5q76oMub%lm0YpC}DCnPEeJFiB`H~&8JO`r8RWexRG zdIFOli3-BZO;Yj=Uxr9M-W7PFtfAhgnvtj=%=|7T-|%I&)Z<+nwv;v0`*b}L6@(E> zpyZpb6&B@bb;HTq6%n_`Ixl+n`-d71S@th2c=s*8r_UZp2~u0LKH1{=hy7E_rX~lj zlBa(+$tB=os#{GHY}($yDra6gXVc6rnpMP!WURD_WJH$v7+tP6m-~UbM^uCIFstq{ zy6ix1$nySIcZ>rozUm?e!R_II=Y*)EgtZYAW()`;O)#(JWj^%r%&)B1?^JJFzaC2-ud z+|1o~hU?&61{xY!Gj-`4rtx2Fp)>QkL@`D%D z?I&St6SL0ucZRE+NSmuoq-~AyA&|qfqy~bzT(-a3i&d9PNS!Pn>k8^}?}579iY{_w zkU4wQNbF0dUNDLClJxHincS9hOT)py=mv zHT!7R-p(NGl0EgX5}RA<2PK?s@18)39B6Y^!Q>gMYpreIlyikF5TPMWwgtlh1yM}1 zfNmj@zntM1FDPo7Xp?Y8DVweA#(HwIKy3l*(*--99XpS35+clU#ioIdgMuIhImphR zfjp62F^6+JZJQ2J0#U-s^5VFh8s4cLz(IY~<9xsqQmCvJDc}v-#>&pe-{-b%3zbt4 z{D$3+g@fM|U; zmEoPpD6y&f`DFxEc0GrP-`kq!9voR0{rBGn{obw6_qLq!T$kQ2q{#C>f&KIFrIsY+@-6mwZhWXL3M|HmoZoa zAYOykAE$fOk8`Qo4i$F{ABZ(Gn?Lz{qNY9_Wxtu+%=BN|MJGe*~4Pm;tj8uWH}cmZMyl; z#-x{gS>D3b{#SQD9Xi^1!^Jb6HCw&DQy5hhh0253&y(Tgud5kqtH$Tr`In3$zdKD2 z&p#6tSPa4ej%hdd4UxlmvfBUtMOHeX-;q7fRAhs&$2<`B2xRI4k6EWiFMZ{=`q)X0 z;?x@q_h)j5^jlda5%x$fCVC`K6lHBukBHDkw?~~H)cCo946~g-(pr~Q1)3y@+3B`% zwv6C+mfj_k&x4M6{*}ErGoL=*|LW-d&CB*&7g^Ha*Wr)zhPV2z`jTi3jD#*D1EGdf zYL9DWj>ese;23?iuZB!)8@&`~bJ7A^GH$EG*qQBd%?Yo~n+b{vOQFR$j7bkR4mjrh z){5DKZtUI^pu5Lxg28hOXZS4~_8*ur1^p98m#NkcoSPc*S-R*7ONadUp=BeI{XwWD zAti*!w3t`KINg$o6EA4JCe}9YsUl;t4Z9>O4W+qlx@6-Jc2IV3>g0K217MPU0!*^= z2Me$Y6PD@zTvkNp@EVfHaAIbh>n-VwMCIPrl@yOY)Ku}65S}iE{kUcGM3a-j63);$k!ZI{q4!$Ftu3i$fY5( zPVF3X)*GPodiKs=?hxWx;xRHpcCv&4>gAz@nLnr-S@ryo-jUq5XOhubw|ThYv&yG$yF7vs&Z;R>wFJbg&0xZCOQJdBDgx& z^edd+Fb(GLD*8r{Cy86zz%8J)hITwRUk%B2u(#zYMx;^#_re zSg0qWJf%s1@CsK5wQm}sd)X_fn5p2%msY^?P;ta5+@z{F&XoJ)t4YA3IlkWEa->Yo zmizE^SIBFt;GXEa{BRAa_HU7|9|Z&|TD6!z-n3P8Z(&{)TiC)^yO6<>ju5cIpzpdr#WMuUc^ z;XKd~^|&_=G=vl?01Xk~7O3rLZ50V-X3H6l()Gl|C}Bw`UPi&;@F-nR5UxT)L_eBNm_3 zaK7S`dYq^DL<$usJ|Ba}lgrC7cnO&Gp@PfGG4fApI3F*8dYp%sfD|f_+7hlXu*n(x z(^q#Hv`&Pj@^fi322P>Hgq^72JncQ|alTG4Qm9N*O01?Ay}q-0v^ZQQ#cZVqLi@R2@Nl&hV$_fsK>UCN#w5jFnPMKW`7pwhCBnhA)$#K%Qo{=`&LbNYW~#u9?%Pj zO5B%?J@-Akx2C8Ta-t;H@04d$fzm{SnA4eXTO3`KKy*U}AM;$|>enIt6;#V?BTHgP zG`m0%`ja-IzM+X7-DwTB*y1nq;zUW3+c%ADnbqjtrn9MUj4nHn8?qd9CdPH&8#0&K zoq7V)H-JO~N;i_*GkdO0Rw|w{+C?n<6~hgsIca4xIZcwEcll6VLFK}{0#@qgPt}g$ z9|3+eyNC#?WU!Ja?NRz5PJZKdYu)3GAgFRbgOgL~bvyWhX0jc8rF{iyL2>}-hK%VV zuAHdT1}56oR9=;Mm_a#27QpF-B&1H3k97rwjQ2nxV}-Gk%9S&ta<#?lJIFkUuGot$ zL>!)%vUk~q((I3w)6LQ*EQ+ZHkpv!ft!CK_rLU6xGvH8=Io=hUT6*Xp5he~K#0P~_o?B%mT%PK9U|ZMY8)xX_c^qu!4m|$ z2<8b|FY*Gdu=(Z*L{u_{(S3a2(h$huXr&<`M8OUVoSK#z-l6nsM-iyU`QQ(vPyyag zoAnU@ol;Ugq-zQ4G)?&d$c1%YMD~DKT=^E!mkaa0V)IY<`g<2K`v=3~+Uut&zYki# z7(SDHy(AzoWJ&Ya{n0Dv6m$B?SE+ynxitmx#}zA`!mCwtLo>hqQ#JF|Bw#ueU+J(Q zQuYjs#lhDXLIz6r4LccMJ4|4?Qe zWexQ{n1KrPVdA#baK34kKIn1E8tQ!#1__E|@n%e9l^V{|m+XslCtwXVS)Y%PS(=)M z>lkLw7SXf9()#w@61|@v{sB8=2VdU{NQrN~g2^&z!K5TLVgC4859z1Q2Uai>ndIw+ zfFlmtB5_`l{#|w=lY9xu0d2wz7F3E^DVobCDJ4bu;S#Ptfx$}v{TejlI>^A_G4841 zJp6C!alYIcDO85)6mUAN99zRrcLCHk2Wc3+&1?E;F`f@T^hIeVe1A{MrQ*v$F)PHr z$fa5>vX%nzj$>c%IU2Y1CPzQtdE_< z?mg%#ft*jqaC6ql{0p<))dQ`I)V?VJh8eOjqu>4W0r6%Z^D?93^*bw%_J1pAc1G|! zOHU3u=ANti+mpXxMrCbVE0?E+e8%oQ=(+~VOa7?bUCz$yHk3S>xPSGJZoU3EZ|d}*FX{N zjVFq-wx~x$=%U-B&abITAK9WRmBMtd;^o}foLHG(VtLwIqgDSkpx==_&s5BVDc?cI zJpalLh-5x}y#LkFYif@VZE+x*eK>s{R$h4_8Gkge!XCz*ieTfO5>N9H^^gYlwwirm za#wjsV&?7Cu%)V}z24RxSTbR`^VJ={1-yP3b8BuKaLoIy6&EI+^{$(#tY`VHofNK| zHN!NH8fLaqC*#eE!_Fg;^+? _6?R+)+56qOjZMXTy&CB+Hs8||E{&7n(E{WE_TxbxP zJ2S6{ak?cFCtlEcC4N@zBwuWFy}u*9xqOJGpT_(2`Q)=hCd@kOyriaL+`&Sa+8*=P zKL+e&uFa|aukL<2bd}GI-J1e*u&D_cbe-4us^a#>WyUc>ZOXl^Dck>YrtR@Y=d|;n zTw`hdm!q6BoZZwUaFhei(`nD4uu%?I8(x%m6<8KH%3(YnEy@A?>a?~}uqbDjon7oA z-r6UEoOh3}u$C{z48*QmWvSuJg-AW#Atl=JGWWqy;oaja>@zV0@j~pjRhAmgq@UE| z9a5qsLuB60z8ETy+RlWG|FbT7xxyypeqHo(h0Q*-n0Xd8ykl95y{e@i=PNvsLIw14 z--MYn4oF~EDG6H}V%GWq*x?nm)NuRGgAR0sdc0#jMhD7=6ek6z*pE%!BWVeaFBm2T&8Ps*f83FT8#hXsy zCRGJlqV_!V)g&NxV}-qJXg}U_F_wUJt+w9ba->WiBK=lYNxtru2v|?l_gHi$+=bh| zWrXf!ub|?GmW@dECtq42gQWoR?=M!>gqNvbmRiJ>+C$vDN-1^Ch8u(dB+R#pf*buhXJ!VbLMVkKqdzBs`(d z@?%)$08szX?s8OI3n|C}yqy7;IY%>Lmz@cl-J${toZ%=eFb*{H7#SfuDP(~N84Kmd z@PVL|1lIK`=iTEg?C}i7EIu)Lchqpc;*)xur}#t)6(~M??(r26M}%hrq<7G&ETS2N zR(n#z`FIJ`ElJZ7C5z4Vn1LOfEatQRQ?U`yv}8~%yGOW11zg)y>E6DBW#8qUK@ zpdRN-$&o?@cnN?DDYy#}gO`9=>jz+R?Wy5Byaej;uB9P61&0(WemX6T!D+cC$T9q5 z>qdcRcrXhURB(kF&QoDgkMk7cMC=Ho_wG@1!kY4p>PKx^x@a?@umH2-wxmkH=|Bna zkT&SegpmYFHt>}qAn0Vp{Bcy4iRqr`yZmsCxB9O77Ww+ITDVSD>%Hm9AA=So^(&m- zFpYd|6Y#>dO!JhUb3PF35aL8>HXOMj(sV9{@S@~94o$yyZFKGGRu&=H&cd=*|gxzGom;1S9+X@8Xb9l zjqxEy$09`TmzeF(>R5~}JCGZ)y#Li5k2v+J%l;?2V6|`sM*4(d-SGRR@&U;7g5u=v+Ch| znJc4XaohkB8Ob%Qj)mLe=%R#COa0y++-+yIW9>Ub|JVIkLoDfKj#d7-`O+zg8H|jD zx5oW+nFlLlky~3~I5-hxEMDub#y#@o!F7)*J8!S+xy9zbUc14lED4l*CGH4iWh_P) zpHDVsuwpHfr~7L5XMtGDGobDfn#f3SFkt3T)xK5J8Rd4*-j~3wY;AG(+n6#tY5QN) z{TQ*9W#$N@M^rN_*0Liw@VS!%j=3*!xte`6i&fw_x=gipU}p1@J*-?QRC~Qi(79UA z$;6GX8WyU3PwN=5mfcm3*JVzuSc{=K!933g#9Df&AP<Z%87oFmG7Sh1E|(1B^tv0^R0NA|>3%mT5N@gQO26T#@rFcLOy`llux z5vRgF?4MER3TtoM;rgs2M{k1E}5m(J$1z%+;ZUkGMl`4R#-i7AO>K%oEpxk z?=ZqX_M=Zd&UZSILIpHA;SG`iizbGMtoGF8eDG%iq$bcVL=gADd*7(x9h#i>Cy08y zL&LEn6+#M?p}Kg;h2ps&zhGUdi&}%?D`aidU_<>6-EqB@W+_U}Qg$ht-d)sjOASD)yBS0eq z?Is6)I9{HG6y%eXT1aiRn8y>;j?hxu4VW&chV!Jh)Z=`qEmEiq)k)y-lyJ8#LTXFY zj?gYdR0xq89!q#MYv&y8lp#`&cgW;-pv_33;#On26?B<<^^?STM#Y)f(a#YbY#pOi z{lMu8YW9hlXHmoXS}N4z9qWhftv#er0g3t+Ye}NM-BkOSlG#TF%cej`{*d8!L}6de zh~Ph1A!G#|qH5LLP^Q;JzM2I5aRtzodSATtfKAVz-_rJAC0y&hpWSu#V3?NW)1O_u z^q^AGr>W9mL8R=NOVS@-Y$0D?l#G>olO+{}WRJuHwrhWWG2Vl9C)(5eb$|2< zI^}k#AUS}1l?wL8!Mc_d=&1sGfq_Aa9Tot4q092R2m6CU?o8MVX!)&zOUyA~5Y8(t z4uG4>i)R-R)sqZnG020Rp_QO?**n;4Sqy4|t0eDsD9=;0X$|JwX`Y zt(HrhF|tpPnm}ukQ^WbdTk3J1lpHHm9GgjN#ZEIpcsnUShFx{LG-TGPopvzZikVSx zow7!v;%iRY6_*8jSHF?3@ipkHNUf`yvT!sLlkbtqC)=1+^nI+%^(3 zwWWsh@DixU`BGb?P;sj%fX9;qv@lXzRA3cp#E#*AQp5RDTk3J1)D|mL9Gjb9=9qi+ zF?yc%v>Br`)YE`wr{qGo^A6?nQxw8 zUTYo}<9bUv;{mxhR!m}#1e0Y_zD4xq!aT++>E!G00+w*?ThUl1n?(v#qSgsSqE-`- z*7Cy{`dSXjUi1ftb<)tn%pY1)lzY!ajfw=Z2AAv2<$fA}jW}8V2#-L<1R1Mh!A!}I z1Az?ajW)u}HjBYZ?mw#B^%FV9D+&Ei?RZT;EoPs>$+)w`OAg{2$JOqNv$@xEqolzN zdLAu^LD%#IEn&1E_OMzICT5cwP!}v8HQ5+Cjah(bxIeJvk11Og<^`~|bwJyQ#{r_I zhJ*SB^>~jU@3Wx-r?bhfsDN`icQM2woYPr=c{-`#j2@BwCTD`2dYtbCLJAca3Wc{* zi}`kDA)d~7%+pB?=Q*9!<9w$RDOBKe!rN&Z*~WQ0K`I|Dvo&F!PHH&M>7*X#JDo_O zGD)d`x6=k5GO^lP-N-$3+HJs;kQjhbUPNYzQ(+O{v>-~N9775ot+qlg;uT=Ctj#_)`0HtGUE=( z4a04NzuGIgmPhN^d7Uf}x>8Rc?|*f4G^_OtBKb&{76X9TGm05XxCCH~y)@^;oDXH} z_^{POJuoHM4C30cGCxadU~yoIZjmvIN9%cPAtT7lYCUH$TF>X4@7ZSA%Fl5f;~``= zxsaJQtur}9+-y`;fw*=^Vp+fjbF$gP=v>05^{hIj9tcw>jMnozjMnpwPJhl85s(Wt zv7=jN!6@qvb^^aWN*7&qI0wYF6SLO0*6po&waOt%HiSp(`JkE=WWKul>Cjb!8Lj8G zpv$O_r;Qe|+GOJ^R=H|iG{dej+8%eBM1Gr6W+j2Rw)g4UeUb7gxl@Dcc^*OYrTP^{ z!uDr~mP;5xb9jPmvuuinG!c*s`$mxOb7*gYV6jmb%Fhv2Zf(*oLEXagPjTF0M8xy`M?UtOXQJ* zf99p)*@Dq2v`rjC2aZ4aXKn~sQxssjyam(cn;A79(DflVE=%VUES0mCBK|$C)tpWf z&|_?hL;@8RLv;b2$v4Av7cAKz)Ffn)$WEK%q(rv)ewRNzOkMjW`NTC9X z3UE3LxVInUbh0}ta8Bo9%p8;&&T~4c$N5etQmDWl7C4>pn5R>ZSW<*xo=$2w&*`Kd z=R2K9p#me@a5_zxr;`=I$9X$9V4hBDIM3;%9_KrqNTC9Y9^iCJFi$7fRmFhfZL{V$ zbtg5P=X6q!^PNtlP#LPz!s*mvo=(h08EW5?8qRY%smJ+FCsL>k)e*+6olvn(2j{aO05p zF&;HQ07ZS8`yvUGeBj9i2Iw zhYh{i>pR<7D7JCL`^lM2O+DGr4SOXKJ=xHA$1e4Id%!WzB|SOf?N#<=N9%1DXGR>6 zLFEw*NvqrE-c#=6W#_9q#;N}HWDintrO48*wYFJ-Z>=p`Et2_8)ZT{w0e-Gf{{qP9 zyzC)8=`4m7R$zTzqP|AJ-?siZT$kYGc*t)pzgC^Een>NjpKg8svjD%Ibn71n z9dlpO|7!Npo+NZjJK}Hu1M#;lh`){L@1GFuZhK5w5#%;8^IJHc5RI870v=COy(lO@ zT}GzxaFI5wBp+ZUc(XPEOFiyto{OTBm|AxiI*@8~%RaZa`N$-%RJ7{#Lk zQ(#v*+F%n5ay8HEWw6Chk=S#v#XSFL#OzT^1K#ebbkwSGz9(jBzo%_VN7Qg7_4uzR zR7QwfufXZFbzh3p-KDDpeK#fcAt>!_+qh3oNG|{M)`s?vM)jQD3VZ9D0a;I{^T8RN z4QFTC1iTO-U$G5Ap&Wf1W`~o-**YYUP7KHouMjYu*amB{*h#-_*KN(TkglOe%7f`E^qx~0MAU@75ln9oSWP>=_hphxmko5MB7>)l=qDq-W@t7 z#RT)|2Lo;!Lcd>57Samoc(WR-_3h&!UERZ_*Qdl6t&5 zp96AFq)-7tg?n%zawXOYhXoCwcOqzQh*|})bSs>qmKxr@XGH2w>hbQHK9GANg$fWC zeu4{;?dfj2PSl73ghPa#n&DlxaSKpNLkrtQ$Ej(l;XD-<^*CQKjua}ZMOJb;Z9J6I z7;mQ*GqdFk$7re8ws_(k{djf~2M1T>E?X2_l~qx~ff10RoW)gH;w(;{g%sqF+M3{L zwyD=_Xd|=QWdeinHk}p}=*G&jb8via_X@k*Mc7`g1oM1Sm-8W7ebMDu?492?6+`cgAlQDup0&;rpJ!VrQB1e=_uMv>ww2fO{1&;+QFe4mf z7GJ=r5fP?SwQ6pYU@Q}-=9YSHUl`nq3nFD-2uY8@bh#DN;v#AfJ;LWcnRC2%$jYSOwoy5vyD>SQp5RbE$VTevK%W^9GeR|vo$a>TuL+H z`Fq;*!EsV^33u6Ibh9|1AEoBUyvdOe)_M^lmkPwf2uYJG`Z10tE2M-Ih>J1HIBGag z8-aS9uj7OiDsD9=;PH&-Zd;7hmX(vnNo|Kpfj84?EG5zLeGr}IbOWft5a)0@ZMCD$!b8?wBCFZkgC;4Kd zYebn(`$wZ&qLVVyrBUoE!lTUzW5%w7DcrpQp=KO=h!XZr1Co;+&e#GBM@y zq4aw-1MY4rexhhj(UV2l?&^UN=aX7nJT9GSd%V#(?fe?!cF8jH4a0i1XJUEUTccI~ zHNgAGo_7;MK{aIHG0(p`r`3)eo^^oPEP1l|nLW2eM__yy?g*LpM1Mx^WPD?U;gn&E z;Rm%tgg(gVZoMJ%O$ji}kcAoDVw=l%SNUn&?`Pa*R}sFgKal%cVbYgCOd-2Pq}Gbnqp+EL@9@z9Kj&_x>`E~zy|O{{Aa zYl0j4!Hz~tOm13W@%fo*e|F#I($vZO_n!hSm1xjX32w;B+&FjM^%EuT=Y_h_BySd9?pq zL9?@h1II6Sy}IKMAk^|l{mQBRpQ;_xH4sr`*kR_mp^=kEn+v?g(vNJ*RPRm1CPO`RtGhvyM71sjc|!ylXJvKMV%^ z537fG=$A}&COd;hyM|pn<56?sp6F11_&!wBSYdrGT%kLc07h zM3-CNbW&HT#vf;%A@bEE;2UR!@I(7?1!l0A(1PU=acdnUEgC(C3g> zcqZxxvu9}M!n~VFnQ^bgWyg8?NdptNS2s8LAKKKCQRQ`iJFN0n6dFo%uS)}rud*Af zCrtO9Td@KZi2^~9$m_oTiK#BZZ><=3Y)(S$dqXQ7ro*aj*f52b5K+Ua$Cs*}_WCDs zXQWVh-JyLeB+t8SDd;+pYn!K#kI+^|BLl5m0jUW#FDK2N!PIbg_NmADE8D&pDwjl- zY48NWq9*1EdQ_S9Q?|fh0%&All+9a2R~V@YJQRc)-W8~z9`6+}Lkg7_M2Z4XJ6eqh z4S_}m8Z>0WMB}L8JkSvJI3I9}6e^RIiqG@I6>4Yp338VbiE3d>L(s@TD-D4NjaSoB z!+E+B)Z=``I8vzi>d5H?SysHZ3d}&DWwv(1G3rj#Km>*kT1H{NY{^KA&|Obpp`pPD zWY7ogCYNC5Sx7++UC$JNg#v6oKjAPD^uh#ed_arbDno>B6qr8eyn@nyhYdDp=aage zm-5gTUG7$+?MySl$ZnBZwv-?9tK!EnuoK8Y;lc1g(8H^Qkb)eFPryHcpodp{ViL7b zT}}<>DL$#k`HD}RP`NWhskNA1^!m=~QRy&|FhM>S$9$s@jx)GLq`+jE6x2IRjFin| zDWLH6XCYfcm0LxZ7Uq4y@)6LtLjG??C_sCJ0if055@1<3OrC4qHQ9GI-MMgc4Y zt2@v}Jz=2<9&{sl@Z9#E_3KX#jG3DIe(Zn8zBFNO{M;ua4R3Fl{Nf;^b=Hxeyxew9 z*|R!wbWr8*AAy0>LD%$M^wy4uQ>*QZraoyC!Co~D&kEIZxox^2n*zrWjr-{`4|X6t zx39PyyQ z;Str$>R9Xu4t(zJSkNUIaLjXw^SbWJVrO9=AvEeQOpe+1O}Yp~`uJ8?nhfbuFWZ>> zD^-ryWlpT1ilI5dJnx)p?URFncQHX0+Fkdrl2L0p5aW1haY?UI+vw|uKsgvbn<3T*Y1;hgms(rf3mJQWOz%7sk&z+e0?VqY0 z!#{#7SXj$h5pkSAgq&>9CFzeiE~kd`9DV9>zSD^mDsDBVTS1q(+cv4UP1_IfOaO5S z??SW*7NWdw)NsBhhaAazu@r#0`QeP=ZN05hYuQ`n6k*esI|ur5{>e40lA7D%=pyrckW(4O zo87kFn`T?3MlzP~gBH9bU{YcElv||+d0cO+w|;4os6D~0QiJR^FG>Hdkg2n^2=T|Y zn89*o3%7R<^739*t$o;FAZ~2 z!~t;$ty~G<@^YsE`Qa5jt4^um0vCwX<9t8`QjAYhTH$osc5g{;M<{oJ=t)2MSh=_S z(ZY;VYL9DmCWnZdjlcATgPI(*Tmh^Uqb47&gQVYHl4Bfw+tM(U#2m2FppTfV907O= zzyzLblJ+>jlNzzkLJD#awkCKSyR8Z5cmgkK7s;G45KswbX-f^~DYU4^`D${cP=VC; zd4~JP-nJO2E%2hyQrmdU)Rr2~)BB(v=SyvoLS>Rt3r#pJ_XPE}i}070%;a4LUKCpP z2~0G+1|K!NYY&de_o>JEdcjDcGE`@Ux6=Z05X}3wUgQN@xWcx`6`1cE=#t>IJvpyn z^xr|31g|)xF6W~>^hKA$I>M$-G!u-*C*{ZR1q)KEY`Rl(ALYj|Z?hKjF2`)yVgCR0(TE_M0WEh5uU5?sB{XN|tI5Z3(C|CMRkhvl3z;H zGGTIW6qrA5!VH#rOcq!v8VhWaQc{#3F5yy84Dc3qjiG_Jo|xb*HJk^$r5@)4Z;?V} zs7?W=(@rzNXnbOpD|W*%2D7-59Az+z@?-c$KPU;TYiSF-1ejNY9c*~K1lVDS#!D!` z#QLb=JcSnZIA2YU6e_?=fX7pdncBh*L$uU33^TQ*hV!Jh)Z=`qEmEiq)tLZYHE~Z6 z!ZbGQFvM%XMZ>SdUf~Hp{oYX+HT$ zmHFlg=C$TwF|N0yGZJ;$z(jquucqH=eT4B(qR~&fcR7e*vcbzn}F!KksgY{LlbIR|{ zK1LT%I*raw=y2T0}i=bcyPIXZ6KUSuJ8lLb(}27Tgu~ndk;%3VI<*xYV7U+N6dvI%m}5 ziCKrczny(CR3<4EkPF#KqHJSS*mMOJL3Kipgv~xVAtjVNiyD4fzo>h@PdzRRX;5`f z$#FtuQ-DrkHN8NVon3KQKzJ^|csT`fe!`W9mNPv#7s5TCk{-%C0#;ckdeB^idz)K( za-xL06WdKaly?OD@s=J09RY*o9AdC2dMGIg7%V+GQ9=a^47Sw4B!t*jAYK;*fnb=h zk6bq{ig3X~z=W=p4r(|9YEh5#J#u|8RQ5TvZv{m!uJy`}g$j7D0Mr-UwM8P_ZQGf1 z!7_`e;S9J+J+Agn?hf+X={bEUQ~G^XPA3QTVZ5E)$gRR=ww&QM)dS(mTGA%N48(5YZ-QnNc4wvKNJ}Lm( zjlnHw3$7c3Ti84cDaawUH9`8R;QA9RwMf`t=_VW^=n?9sVj-;0?Ows?+H})up)O~# za_aKHu00{p!tG4H!N_j8iE!I~8et<52h*mkA<7z}tf2>|uk}SL2*bOhhO2mLI7)Zw zTJBTUQ17f*%)%D6grkOc%@7&JZC~^_WexSt&c;leDfx!4FG)S#g{K9qA(OS~r1L#R zcD?9*veXrr72hb%#0m$QDdM^-?+6Ga7W5Fu5s(sJiOId`DUKstMQ&-rB=+>&*Ck-E z#3Kfa1T$Eg(1HcP+fAJ|jbZdwoG^I_9Gf4b*-Q=RYwuH!$I61ckJ%xG3h$aE0UsgY z3wB!}BiwBZY<>y1qXL7MKn?E-R4|wp^*A4}{5pH1BH^wz5yf$wcsBf$V z^^N1<&M*!>T*c^2xNf+3#438R48OAc=8;KXRUWuPoJINOtUGMKmZ!RCA>8Bw=9IVj9lA4Nf z2Ma-H;wuoESRoq(Y~`u_8Ql<{8@mCYx)*eLaiTt9neNYJMdF?3s1?NR5~RHct>QI$$TFGTTjZfp)CIl=0N^gFWWnTmO!8xjh-A>KixD#&CMGS<`{ zAKKzDeFL-LbWOj)=?&AAMpXqhoO=9M6)MFJ?OSfBeuM}7vP;ZX;|roGpfVo1EcT5>eoE9IQoNxv7le$bIkLvE(d_Etbc-$Bl@^` z*`7Ah5q81p#}6$Vk?araq!Xy&>`hKR{woQU>mticc!FThA@c-HR=)95cFCi1cX_DX z`P%uHj3U1~O%La9YRRbby1yM%rP}YzNqQoQsBf|AQiD?`&l?*8>QbjbU20jL3S=fc zSh29I;#E~n&G0S*S%i6)Z;3#YwOa%AP`*QG>TNvV3;8bGy2^>9}sW$ zF*7<-tXNn^@HP%bl<8I0~Y5pXkRls7f~uVC2~* zp7pMqsjOd^2V@b9e4iRlJ^oLYhNz(up;W*Vq=0k7JV9>KHP%{zOG6-wpp}L|&%vu{ zso^{*0`)i_{DBlI{yK@Z=@Y^$Y7>1&u$#}tdDnqgBwYTfc+)A|q^da1AX?>?N6O@E%?w|6h0L54m_J^>RdjD*UKK$SwvexO0WaM4EhBU< zdj%CU)js*s3K=W~h`}Pkba@k+%K;kN1Sx0+A~Xb?3p{9u%gZsKA!;}u!a_aH(^f$W z6@Z2|!|8-h9a>ujwLs(y$H1M)2tFDr3?uk>i8*GyPg;y(Qb00Gl5oTAq6>f zJ)5AX%GDH)i1WS{G`oe;)(U_vT9k8!qqJ0Eqcj?-WiR+KFlU&N$BS~LN{i``Yca9D zA&4ymtRQ!CQK zFH#f$H4b)pqVW>;B35uF%vyyS&cg(u9`8z7XL$)op#r=Fs66dp90o4|6E6$EtZJ#@ zJiG+zaXwxGQmFXpv_Ors!)1=)AH#|yK`HAN%t8efprnTLR9MvGJjFOxjC<6WtSR59 ze$>95`QaKeV|R;u{U{(6xmAn#jG|3iMvee2hsygugiruSXdvHy6! z;Q7?L{yQjR%7tC7Qu*dXUX7m{Le-$Vaip~_tLoJ%zhvD^ z+bp5}K<;aWS!m2A^!s&;fWW5WCmMHvyob{*nK)5ZeWytrQQNqu>LC#IXxJrLX}E1Dl{qzJvce=2 zru)vVSOM}LfkfVe!PcH)gh>|Y3y1zl1OzOwmPkJ#<{#gX7v@j(+B(&oTGE_9yetq`jkG!l)A*2oH&l zP)dNJ2U>2=#`K#XU*aZ}!Sq>Xl{-kPFw>j;OX^HciTY|^O~2DHE$5{;n{z!kt<1yd z#7=H6O`W`d|0$4Ei6)XN3}*i-JGre|KItweOd|81n0}iGlZSB<|WvO$^N%ua4+1qY5_?s|2{A5>&El&H1Tj$ft_wR6hv%|1quW?S5TXI9cvjqXv>0GrfVZN+crT?3J}VML^j z!PTd_Fj8lO)?73&axG9ApdEb+FwoI53dpeWGDOI*vwo-k`zbO^^!}OaBU7F%np2ed zgW4fN-`LvXkiRh{Iw=E$rS4w{2s0;}Z>Yuh&$9w>-bePln-B^TQv->_6w}{%hY^4a zk}ccwG7+%>20GqN9-pYk%d?PzJVL1jw`ehsCkP&)1>y!wms7)eiV5m*BEHkTd_xKq zKb-^~PYHM1BBZt;c!YN$0#1tezEQ(@pd0FOp41jA#@%a7pjXSi`j3cXj0%C%71Zn# zGtZ)i6M56_`9AeH5vuN%k|Tx68Mm4%);6tG;q{$0DnZ$y;@C{ODq6(1lTu?SHRhjSeN+Ay zA5GX#XM)t$gm^qb>j*Ekjl@iCso^}71nP0V)D|gJ+-nNp@#Mfb3}8rsnc8B)pVV-^ z)RuajC$+^26~|^GBOhjaf?ju+2m_&l4XH8dial+{Xigwekg4Il4ogyx^K^odVm!{N zx!ig%VfH3=9j zCd^>DvQ>0xVcr)k0SvzG3OE(qo;E@!_j>;mW?+(hofT|`hq8uxAFM~Bf>82Judg%p zc-PmNvW9xsV32Tt8Af8>vxsZ7%D!B=zh?HK^%;x4KfHhG{{KpPJh$CCCfu4az2xw3 z_Q(7s=5*lOAD7m9%O5SwI0Z|{>r4(2Hyc$|ZbW9HEC9qY%pOMP5}U}xj^M!OP7XNc zzQpBf_EFU-^}y5mMT|VgJIzb>)QfI__6BgSR{2h}8e3p&Ge{FVx@A_;tfC!{s(r4V zf2lo67hQEYCtpTnLt0lq)ws9HAxbuc6%8>oCz$8?z@Y3r7?eGz_KDDgatJdhJ9y^q zJHvHtL6^aMb0=ng8_+fas7qr~=9^afy{9SQY4vL~)$7Knz72hos0*YwdwmncRwWRL!-Nk_z~CT8p2t{2qpt4-pa3-ioL zyQ*9@E}CK2bSq+m9&G1snqTR;SIS{gX(!!N@aA}f!vVg{jcsA2TQ`2 z>Q@;1$I5~k>5V0=<38IgYJz!FSYG#$+aX0m8rk_?6`Gqi>bX(Rl?{t=1#u6HzcjFM zk>M|Dq8ifvQD94Sqw=uYmDLPMNS!Pn>k3jT@4@{uFUHkR2ErkXl!{Bh#Z-@)bg%CK z<{5M7{M~)&o-mudzhtaD%sj!oHb%To=3iK@6(?S(cGmcw2ECIV5*U*;_^Z8=Ygyde zZE7Y|_MM^oU{xr%1#Y(slVdC&op4wHWvZ~2J4MI_ zU6TG-evX`mit0g{A#%Y25je$oE~kd`9DV9>zSD^mD&-=}SrGlZV7qNAML|%b9x{~X ze3VYZ2<~2s5qhvAWrUj|XJn6+2! zoy=$v4b9rOYPwVNIp=#``Qd06q6DtN7{^PJ`!hi3Xf8FJdc4=SvoD6qYLTKE##&^y zCup6>tIbp3bS2C7E;l*A9Uw2B-Ix`Z73aQA8d{k7Lu-n1@0qAkk!3`Zq`4e)-!$T6 z{UfX(Np5Y0;owBo+9zKF<+lm4&_orek}%3|<6a(I_n5MU5mCa+v#8IaXz#eDO4sY6#zHeU;RgwyI^8lC`6b|SGcqpBl|?nv#8-b zEfwnVu3Zn*7@wiEwrj5kUAFok5$CM{_%k^`_Z0}92-oNf6sHC(odZakU#_+9>V4&0bxW%qc|@~|1R5@B>&6} z0egq0HW9@32W-2R{4;`qt0Tm%TIe)eVPzQ8pTKxQVU!&Y1_AW|wEnx@D;QlH2`0uu zUCvh`_C=RN{i$KMouSbZ0x%;HDe-6eHZZV&hxUPp4IZRTSwlRy7G(|b@|}-y+Z)==;4Y$PfOr91V?ho>Iz+RUP? zq232GC~Jr>ZAR^_P}We_5d_K_>OHkZqJl7^O_Y4YhpbYMcTa68YpA!uLrg@Nl5hTv zz|13%p5 z?f3Zae;>xI2>;N;3~rBaJZ-4Xxs`KE=6py7LK9lA#LuexX}nLLPc~*q8VxgYqGXGW zHYJOtsgu`^^#dh~Bf+se zb^K>rL=sk*MCM(%?Ki3PL?x)Esr;< zX2`BaQoE_j4;XIlvs0; zVT<7h^~0Ccpr&GSj;L$gUgdIK8r7f+NHLEv99F~f2X+pB!gSwL`}e{e{xX=uhyOY^ zFDsLg;8;`p-q1>i_9{l01cd(ov7Qkoxta7zmAl46GvbicH$oTP9(8_A)$=(p;GdZ7 z-&*%-m006-UsY<8Ysm_JXW7Yt$K3x4axMR(Dh+r3c;f(O(s$z7!FAJ=1&lBWh%7JD z-X_8%&sMF^Eg4lgsBMBr)^0TCAwbO&gh_KccqDwH$3u_-bAR z$hE8hxt7D~Awe=94@N*BFYEPHAfmUK5hj6UP=70Cgh_Ungvuk$)66f$Y=6Nh^1IXY zaQ>#0Cz7((tNoK}_C?7(&5MknOv=i&cpurbq9PjPT0#JxhW|R|vi=E1XXfMPXZG9@ zZA;R(L)8S!pnf{dOwDa7p3}G^E<4V1zS_-C8fZBzoznP-0d!zamwB{rda5y_$~jHH zl9g+DTYq3l$k!m(@&_0>|D%3oo@)8j{*2Cy&&u7Ke02&EERZ}g!BQ#mxewx;g1QB= zK0LPoEQsM2f8CXZc`#N0JF<|@J}ZZcboRMFC&t+a>>Kawv#WxU&OWm{2HG(rPT+Mg86w8%48uH~dc@O74d*+Z)Z;v-6Dd^S zbhZEl62NSQfHH_I3#}En*q4!wN=OO61oP+v_Jvl}!cZGtRcrrqvU&UZR-Lgi)8nk&|pkDTvWJu4k19w%Mw;kqv@*#h=!E%zQ{S9>wV3bT|RPPpEFQ@w3F9_iPTe?~AO z$mY77%wPDaG*6mfE0~~Ca`Odkb2~pS--tpA&YzZ2tS4;f?z^ssF^uZkh|4r z37Lv}px239+X4jU#-XM}lpn*#jpP2D7~D8}F@$mUDG97=`uu`O@iI^bIVuPSsSgBO z&=4FDCBlQAsNr2>g&_-5kMm(>NTC9!lMs42DhS5u48}a2n9l??obPl}kMm$=NTC9! zGaXJRM+Lz+okK8BCsI3@8E~M6^PNuWah}tO6e=%>tZl&Q;|LY;;uxcKqkwoBOnp#( z4Bx~T<;U=4h!U;=k5Se3K@!*_;?_36ZS7PL1X3U9@8HqbK*k1*s6`Fu8-b-B=Rx9- zLIqAI>8jWPXN1!UitKo&6SMI_4d*+Z)Z;v-6Dd^Sbhg0hwD&zQPABHui8;E9I*CmU z=L>QgDnziO*80(l^}kiu{dxc6#a|USE?w*vxO~CqtAnzC3VZi<$ctk(%^tp4v^(2p z?VO`NlUxEWp7E?{vZj2k`cYf9S@bOI->NJU=Y69%)BA3((mUl&8h4FYo=AE!DcfJ|)s(e+z}i^}sgvbnT|t!OJ$@;ENhP;9tddn4 z`k6&jk(Snx#iNSLJdC?oZI8**eKq^DK-;4iWzPC7+~TlPjMC80>}qS+E179nZvY*R z`~1aP=PbmCDeZV4mj#!XdrL z38T8a3De~*)41Jx-!Mu;KeHb1{$~LJ<_L4L(IM*2%A@_?3YxtmIPkfX1CF^b0j-v! zs#9IXZR{gIQz<0kA1c@+@KEMKG-x<97I~V4edskchm#^}b ztQZ+{*`|Z+)`66}rJR$1{QI01xcF_WH8yw1y zV4p9F%cFxR1>~Mc zp#n=Git@wlC6?dMOIrV;+R(Q38PGD}s~{Mz!YgX2;oWyDK;20_E(=V|I?SkdN7ueH z6!wQe?uisCLv>oX5VhPBMn2)vq>8qQPGQjd45X<;6e zz?1CqWNk9W+iBbX2%SR&T$M8%qosm+f?$vp4Og{awivi7kS_3WRm=+!23hg)ETkZZ zRlX(gGy`j%@p-Ysf(D7eAiNb5x&fLsp3gb2VDxIOAX$laKB>!l5H$eN>WeO~a%#R} zElJe3n`$3Zen8qyK*PB$=n)OTB=!{C61|@v&KTZ8_(NX^h-$UoLnDF!%j8oJLg!iG zcnRnfgg;a&V8d2>0+FbN>T*3)57^NO1$W${8b> zqlWWTy0^0#c|9)k&c9DdCNW`k2bYJmAoJ@8cz@Q*+(Y<6Q- zTvnX>I%#NO<`1nY%DrczMn#tS7+rqJG^U;NfKiQOHp!{sd=(b;I8QN-6)KL+S&nFu*I*D(DfwD(dcV&dGJ8izY$Ku6aO&}2Q>e5!w6|EF zkC0iKnuqJYnjEw3n=PVeLGVPtt7V^^{_}}V*GH(U<%qcT3a4PRjT4y>?)0~B<>(@C z;j;9fkF|PW_$I89sj}~T}QhQvhGesuqsy*d_ ziQE68?x%P;H#YaWG^#<@N%r7%&}o`=bmr`_g`M(X)xK3Ar-JHoJGY2jxZejYc&YgD zqS-~WigrAz_PKWcrS`TR?q}MbNK!3S`<|}Z7bXvp`z2=kchYJ4aS(_G_3tJcl-ayw z574>nqCprxUdnOB7IPv{IU%_p=6on~FU;Da9$`Hv6E|+l@soKa?g(wId!=f3l_O|P zbP|C&r&{~uV7{k+l2QVrXA+h|ySRh}k%S9#(t3qmFwlC%dE`74AqgrP@7mwfo-@&xEC(9LuCe@PiDA9xJQT(qFHPWr=$qLJo+q)hP?aG{Hh8S z>b7O8J?^q)`H%v>o=^(eFkX0?8TmKi9=HxEC7hew*2fUKLOdcy402#EbjZx$98Xs5 z2qzE=aEfx)<oPQp0 z!d^gmJ1v-vf39ZEGz^?+SQt=I~U?Hr`Vn?JP@1jVAb3AQoEhzmD2`dMI1NTwG zdD;ln<9r<_q)_RiNQ9HxvT7|jsck%FYD*30No}de`BEXIQ0bybgfp(fsz!r>)gPLv?!`<)euaHs>+a2{%$O#_O0e9lpyNrXk&Wm6K) z+ev9Ae1Z5M$fdGK@{{+^EE5Zf_}|XCs+{xC?{|6)(V4%S z_~gQ!4=s-VAc3e@_#E^6t4owDY`E$jX78Sl?3q1(6xpWyK7MG~5k@#9A!VI;n0bYH zT8yWkG%!)G1!0V8c6Qw;R!q-L8`ZKST^i5Mu`j8q7-u{CyYQ6$S%|Q#TbmM?mXPp|o^pzOZ+(}V7HDF?t?S&-Oc@+*RdwKO_APtL>2y{La#oWE$M{YW5$p z4y%WF=$9N_rdm7jmGJS=)5roPJ-Q}Tj|H5o{^}vW)6AYL)vP0Sp z8ImK0(wwxind&fhV0&D1!fW%EfhfsZ5G6UT_PVcsVyes4-A{+E8W?o(w|4GdMWON_ zd1F5YU9sq*CyM42W&WUch|mYMN0s?hJCj;tJAdHyA% z2qxn#hh?sfMU1kHZbWO{t}0heWP`ZvCaW^@PeeIz|InfwxPN$24wo`slmi%u5#U`{%H-^|1z&fCd-$iyREzGN8Qx^DY7cd`c-{P-(*(<1+ zN#w|vR>1eu3e=)=&Ie+de29FR1WdLFwP=Ih%w~z?OUM)y)Q<4}p1@oBExlO=#8UV$3=V1b3+6-RphoaX#P)DO7xQ@qj!*LmI94 zB%7Mhiq9d4#V0kK4_&1m=P5q1LdC6yoK7u=3uC;Uz`8)oZ0&{Dd+_-XwZC z+PF^Z^)&)E-`in7+SfsD46U4a=e&Tlo7Q@)-yS1wt%KB7Y|Hqsi`EEB=mXBWCnmHC zo1@S$VQM%ZLP5$rT{c()riP^#?o1@T}ywq^M)RuajC$&Wi z6-aH#>E!4R7_g8DvxChU&a5#KSjxc8qWa&+NLJaGpXb(m_C``h()V-!c4F)sz6p;` z9kQe-OG}f8=Dg=^Ghu6Br=f=+8bj)WWtA$WB>X*H;Ck-g(3`8glve3-jV8d^w1EUYtSfsN-_O^if+z!bUb|6}j`IQh2o%vqR{XEYw;O(Bycb{v&FM8eo`PX!HaXt5a z{rFt(J1Zt*;~h81#DhKu{7bYyO!}6v=Txx-GBJBy%;`MYd3bl6FCqtLhY__^P*!jj z@HY+?a1e|7y6B8kS9l~w!Hl-W$(he)7Oc>Pxj`lrz~0yakcs((#o0h06Qg}sesN4* z|60&ZVR%_n;kkK6X+vgGMN&m_Mg9>T2eGiXYm1Jx^GFPxkNTW>l=+a(|LBbl$b@YY zpf>^!$Y=BKom3N)O7gWs16n;MtTfpLR)b|N_wM+W8RlP`FPO*bLM{TtLZdF%_037+ zkr?sUwhz?z)CV6uneB#Bd85~bO)tRIbs1rP>G~6t%JAdCHxf0sToZbERR9ri`{;f3 zfZw=i;!rKkO+oS38+jxK5JW~tR1T>$#arHTL#fCCy)gw)Dm;d_g`iXh6jUyvNewfzgV=&rM3{;T#MIbHNGa6=DHdpaPHovmwGux~itiG4i6WkbQi9miE28^>K1e#~@BaE|tSGNMD z<$lyT)I5tBew4$rF^>b?@PA0jkwPWRsBkuY=5t?N2aw|Aws)Lry_lC{bU~QmIu4%dYE&?fKeAzl6e`df;yPvmN(H4g1W(LxYeXom zAth#Oh#5|44Ka_?T0=;ovO=cb16L3anZRic3Hkz*)=(Nh+reoKF~cbx7Uppi2Q}|9 zB|{38cnxXX3j4h%cc;KLM#*d)qTv{QC)8G-u$YXJQE)GWf}#Uw>Z#zBVmMPz%$Bp7 z=WXGP;E;kGQrjk&sVW7ZKjB$=Nz%>`HzKd$_fAk+w@yr-i(WyQzsnIbe&+H}755HH z7s*3+ba|+e8?CrxCK!WHrjMZo3)9C?+D;Cn5d|5;889m$q#%dlvmA;~UT=w0dnk37GXEY9+)Br|1%x$7!h$QmBL)4WJcv z-TLHxK?x`1Fqd>-slzg$xJZrPNt8c{XLmJhSp+1YJifdrxG*I zLJD%&#?FCt6@{=;@-}(oLBe7m+QLpz&r4Y;v8&_nJicZ1yWfZW*Y1UD^IqQg&a;QZ zXI>w^#pdXL?|M$ZVXLRVdrbCj*~05}9>AK=T6?Fa$21fuubT6UVK217=!OoN`V$}- z4~~fFklZ0I*2FA(f-%{;r?^bzmr+pNd?r*c&kD^b40A(=yyWu}AQ=W1Iz;YTX>Hh| z_J)<#psXh|@(=0yJJv<@3;>`?v~8)SN2)5;emA*sqt)xO%G+&2dG1dk!F(+81FW7dpi1sP z5#+FTwido)Ui$ms$d`m@9c7c!a)EG%5{QE4AIIg)aLP@{Jl=~kmqH2^Xzz9qiR|Br zOQBL;69TOTyCk7Prc&`gXJ0PJ*F&<_t z??fc}c#n5nrE}G|aLEet4k8iUaDo;^vNnaumCMVrAT zbV2xW7aoVpSa`{mWCyN&ttedLs(qfNBwet$h(rj%(m^DG9*CfFldOcpb9pBs5l(AJ zptaz%hWHI-oYoLCoYop*9;dX1kU|AoLu;UMD~xxRivt+RZa9EqqLwS7;V6xG%s>xtNUo4V1yb8OcwIxy3op_{T(zVl@q|*Erxt3zoF~EHoaJhs&5Dzj zBLz7WpW|WejF zGQ%ml1mvACJU!ESEi*~7&aLAqkzfM_ zx$y3lWGi1z*CS~NDwB>!(x9a!waP^8dQ=PH$Lla9NiI+mmk#mIyGa);iHO01Dlx-z zISf8;z~ECLs-O%$<(Pv{9;JknJ2S&+nH=*tCFw^B6&QTpg0EA~uWi>pAw2dV*$oG4 z+X8DBr=KkvjD?6Ezm?l*ZlW z>f(=zKT`Q0ELf`>>`s~pby!MrBXW#0Ed@LxW6Xqs`W*#;$oS>{#L1Bd3yPq6PdYMm z&YJ@YwlA9C-Ry3-cb~GjvsVK3{j-9z#vaT+q6@fq!wsjBQKLx6T4@Wg_*4mqj7`xI z^A7hp;6K~_GSY-7`Q1#~#8Rq6Cwy7b2$e0QXT)T83@!Z$IKPjKM_3q=w_Na3P@WsfD ze^s;(ekQ{-EN7Z+q50S53p%fhrtvA;-Ek`Z>IQRlNkV#bgNf(B4BWeI!Pz9>!2Dv4 z;=RC&reqjl3XkJGKYFj{x;pIxcs*pxD?0n)I?v5BN^O~2tbTf5{h*7+`6=GF-Ek^M zuWb+0kIV9I(7w!bV20N0EQxuk*M&{P3x1e1$28x<@dM_>B!MuZZTRUmvL^m*pHF)4 zRyX9z;16pZRgxP%FMM9jpcKE`=@Z>?D)IJDB3hFhHG6b^JO^gUx-nUie!zkG0A9qM zn&L+uJ>rqsiZ9j$)aM1=1YyLm-6!vD&yx>{SM8{Z%!;**kRZy>dmIM^00<*ajY)BQ z(&Pd1#jNfT>usG07EFD~oDTNL(92rxC3R;u^KjT;d)DW;Kr5Tw#V&DlF!4S}~3kD!DSX!*Dt3 zoHJ~%XX$)st!68X-#Tg}?0!0q$;w1z-ggw`4Y)dgO!9CR*dts!POtu@3vPH7Dxg$lHW zZo$_H0v)um3TnCHG901r!~ty3K7A$TunDOa;-{WKX+rD9!O{%gNe;>)v=JOukb5<& zK{&vHL(s}k08Q}UKE@{mY!5V_yS#!ie^+CEpUma7{%Uu0IW%u`-DD;hgHP0k0@KIP zGEk&$1rve&t3_Z?eBOuj7I=PW#pf){lm+BjXc;Iooc8H6k5h_Iq)>t4b1ht+@QN9l zE&*P6LQ8JBH?`0zA!ayDm%uzukqRS)3Z%9tK$mbDQI`NOJfZ0lxHq-XbP3FGiY|e9 zoTf`a3Kh^LSV5N{HsdgK37Gvd)b=McoT5u$9;fLNkV0j&Mhy!>u6?hunk|1Xlz4{+ zShZ-SA?orGGn`UkF^|)Vaimb0s4+O|R&YF`^B&VV@lBOHeHrkGq}vWuV+wmvg&(r@{_M)=SCMZyEuzE;7>vySlFp75Xfo0P#) zhbYuiV!FHu&E?PL>4Bkw5eM3ng=Q{64ez3+Jq)9rqRHPcNU; zqfpi!|%V|YuRzjA-;?aJ+gB)U;2Be8_I%(nxc_N3q zPF`*0nF`NTOr|3;s_&lJWPQu(oozhfMw)mK2>gv+RQ|?7X!Gzgn)To1@uZ33m=ZcT zWTpL+@XCnR{4iat8-L>jP)YjHs3fB`%8If$CBMNntI9up5oE#n3%1aaC%HGa`|HE> z@&--b-G%#m?Tebskwfl90#Kz71*ighzL_RFFXmL87DFz*t^8qqJN+w0Izqr02?deyy!M zTS3q}ezvKPfXsxdGt76)dFkE_Z@K}AVu4^&KquI&b)i~N4n$`7LjpSHaSFQ%?oO;w z>0SRZoGY=s`sbTWo_I23-cULM>T28KNtw?#dM2c&x#7az@BzM*mdcmQ&^+Y)u2Enm2SvEBw;SP~r<_PGny@>x4i^kRm~n8#^kxo#RNUd?sz zbs7-wPVSXM7{K6Uwl2dlDiuNVi}L9^F*6EbNP?5^^O|4DORT3gki!Xsz*$uoC%HhZ zM9H(Tf_#9n4%||Q_<0Hl8=TZuAiE%#jCjqYJKt6ujFBVQgwt$x`LX0V&+-Q z@P{;RFqvQ;?<$9c+!HBO8a>vB>p- z!j{mEBn+0O+agK{(jh`Sl5XnRc5A$VQsSB*1dS!#biz>`AaJ)JN#p@jQr&T*HO>Vv zQ|0L%$~*ByoGals1PPIVB|#|=U4~_YNdD4-saEwL0r88q_} zbfm@;<_G~P$U$7x1fP%+akAp9LG0Z+F?}w21tk*Y{5l>=;mlm#<-H+Z9@8CNKESAe z1X>~96d1Y$%)?yJM55fy>zUzQRj6=%GLO@mw@9JVyZ$^hZv|olO7m99Z&u?pZv|8f z${oZEr!{Yx$0^NQtWfc4u7v|pAU3>;(Y#F)?`4b%jz_iN)GEwyTJx59oYK5S3KgJ* zaif(q%*vDLV<>-5rjL2(VN`eZ8pcW99YtWh>zlwWD-l0W17>O~kYG?!TV^;dwPhZs zq_$Y0;?;Z}E>E#3jFH+ZF;iR2Has(&mfA9pQ&J(MP=VC86^1I}t$&$3GAQ8?8}4N> zZAKYQV2bUT;SaHQU~!juyep;&FUDIv?Dw5dl*Ku7)&-=)(^Sek<24@wF-$^HLOG@o z#DMwZH!xKu$I(e8DQK;oyh$hq;U{nJu!6h>ZHJ*ZZ2Bi~I ztplMZ)5p**A_>#PI{*sF+&$oncZTPm_)G1D3m1Ok^Tc$M!*=|8G!IlRZ}%4aK{tC&<#=&$P=e{!ik zw=mM0H>A=y*AmoXQmnMa!!mA|xQrXTcia54Ww4B!49mFD4Fwxl^_!V=WaykXUoagU z@IbZ~q-dt7>8jv^i4EfclJSeic=HkSTJw)Ok9bp*Wt+N5r>&CPLM*pP`1I6`5(4`~_v(ue2+^n>G#$(F~;?ly((Ue%g!?UAaQW${xVFS%UYZp;=59COx@a{6^vemg&9{xWy>5|(s)9038*)-iSG=?QG72WDV(oX6 zGbc5AURDXa)w8di-M{NN>{kCf>{kEQwD753&tDrhCno90=3(cymiX6i2e$w_q~F|= zKh!+onPO2(Y`IeB^Q)AeAIYl%hQzD3R{3X*$_mSxn4u}s`NZF-OBi{r(No{^sA;dR zzhhlQWq51;9TC^Ezj?{GQ?CN9<=+6;GF}z?xc2?7fd~&NqPd(I&OH8N-=rCv|L3n0 zD^y^+1-{NY@zC

71)1K5c<$k9OL+497Tap`D5L>8lsxoVN1%*Me?B%bpyz6&$GP zdgjIjZ!RcYAP-HC$k^~zTWi3yW9`pm<{#3*<*2-BUICn$1d%f{V#2^9JH`QLrU*DQ zGcA7J*M`5VUH07mkP_`nqwjf4fCmbSW|W#nq~uxF0vqdB))mFeOKun6R(WPUOQcr7T`J_*EVM3*zeyCho7lVHC+%qq)fn1o>oOc8Z-&7X-f0WFL})36Qao%iQVM7}prsVhE5SR- z6__anQjo`M3||wh7oSsLe4dz{gjh_MGs7vp8|HCZ!jBXxp++@yod96PA6f&ACTQ?V z+b)CgE8b}<8ZL3WjAU^zBE>7$rsTchtY9 z`n+dKrs;Rw_`QPsOS<8{ydL%Mc?<3Dc}eD2>n5o9QWnypU`h~NB?u{PQF|<~y@^)Z z8pJj~Mz@^FojNDaOFY|dfC@|$-(Y;6a?BnJJi~<6O<;!8QaR>vO4g4QDu+Gn?eKMq zf{M32Mm9*A-7+P}BgCbsJr*W+qMa*94IEUtlUMUCP=Sf!8;sAh9J8an1u=_bhIdZ1 zcwIU3IHjSD6e^I~o`HpE8S7<d{H znm2WbpC>%RhNp5CJ6af9$INirz6$d=WkDS)RQ&79;qt_+JW*>b%xZ!ePD^c>$0?~0 zQm7n*7w(;ZZ*szltzlBUhM*V*JtHkF!8u-@{)vyLpzMiPNxACnc*JPlE;JU9g}$pWqf73it)( z%0<@x(D?TFblQLvj~GMt%f^O4uTO)sX4#h62BrAjPM?@ztcn<^%1+AMG)mXMp=ey9 z`H*>qE-brVy>F=Y_kDV$;vN|#lnSx_uH6uJHPfTec5F6O?hzSHurx}dZ;*e=)8zpP zrtuP@hc-9%npV1}xJ>2O&@=Z& zkvuCVD>S1ptSxPSuYFOI^V5<)v`qq1OC*q5cusLHPinb#Xh3Vv327#~F>?CSo(JvU zt@T*#v-7LD=7}XAl`Kymb#NmDY)8kXa zTPIf}SL7ej1zfE0I-Xz(TpDd#YUz=C^6I)98?9TdUYAwgj{YN(_WR7Pe|z?b2Yn9s z&-S@cxSs%)O$&Lt)Vi3{c^>E84F6nnOnX+!gZx3@O$Fwszj0dWIsUZ09vD?7*=c)1 zb8A|uT0CrDeg^&*q`dOqfVU-|P>qR6|7&f9-{xth8Ap>Ew=5`H;JI8CcCgTYU5+;L z+)VRVx}Gf?s_&lm)(7kTkJbd(W9MjJ40_KP`~IAJ;lMiyJRqO#7pjVB&{p%jljgbG z+I#Gcg-0yzfyH;QZVgH<0f$k5f`|tWX(MZ{R8w zXxN~&h2BKWY+Z(9lvuHdpT6S@#Eilq9<~@IR)5Ssf>>c;oaAYkc@|QT9|fSo+i|W& z0!C_!S?i;=ZkXYe)RuXimf9kPN~)2&JYA+#m~t~(@Zugzkkq}+wR{n@@gb|U{tw;b5Fy0KhDv-RwK@!J^LF8WjzMWzvuba zJiyUbei{sa*#{D;OzgP}jo|1?UhD*a*+dBk@Xj2xABVx`yD<2~)FtF2wucm$jSyxy zW$?*7P8)n8h00Nl6TVKDS_31)Wik`m-;-&nXk8YjrRrSWUhd)GWU(N(BeGbG&ocWDy5Q1uWiCd|b@h^~a%cg^~IkMf7oaMGbw)wU|!cvI8Ugr~kqj7`Pmm^~2EBBhK zi*sudb+K0k4#bk*O`QvDjAg*aI27jt6o|*QTuW`VAFwgRhdeo&0=&Dkc}8hNX3+xf zb?^<`nz=FAo^W!h_2uGJ6~G@RHlGR7_s?2s@oxDdmxqz;g+=qJfPokV7>M8~u3NW} zEDtZ`Fc2OS022cbdBRHdYnHXLPkeS>IaIQ|czMY*vSx1Ctd6#9tMbc=$pCDHw`1MV z)}%)NcH@b4!e;W$*&|-^0f0rp50gGK4QtR=uj<2XZk-wl01JX92eKWvs35Q6V7Z5@ zU^_l*RF)6N3z3E1ZF;P1beF)C)+7MiP73QPYco-wfwh#@gRQ8@yHmbs-` zSPBau8}g+EKxpx9hKB>-Ay00lT17Bx*_Fu^&sIG5#7Pc~ksjgLlm2Am6XruYSfn1@ zc4LdxPd~1~v;BHCzkWX}`NJiVuu>gzK>lanov`_6dX{X+f6A>?%l3{_IRM`XQ-BE# z<24rT*~W|JvF0P@NCNf9IAsXRIDMt3KKLjgF+9~1N^-+nH|3?L9T(Q`&ko;p5a1Z! z0`XwJDiFHHPxaz9W)_7297AE`xs%*Vb>Yk0+u)b30MSDqqJQi*kYzMQZ8;mhI#xBL z(gd`C-1_a&S+TaOI(fsJtvp9%0xnF4b16pn`;4DfZTp}a$|utv?V|9|9g-J)Sq{f zm(FVPWNWxT=`9aX7Fi{XMdjC?r7MZd1wJC~Us8Ud=kLpImJwwUcpd)rK*B$1+wBRO z2T`1|h>Jz|*Ln#9-H|9yKS7j5@P%^!s*}*=YD|~cVY>YMYqI+@IAsxcD8j$&5}vsB zI?Nw$MGKb8GRISJS-|@^E{p9CRQ@3zP5?;_?c3+ygC5gf}wq5+Y_eB{63nr{&H_p%M?kld?F2cm?$aq{1}` zQwpw#Ga;5M@Q4Lo^~nsU6o|~@v_=I|sJLMB{1xOC_o;K0gf$j-FE1AEWsKespwH2| zAk1)DH;#Fn(lEmc6&GxtTtQEGmR?dHleVb^Aa1-KC7{pIYFcJEt-@j+rxfE@q2krt z1dkAkjrg}c&cO@561EVz7kn{GL(I_!Gn`goF^^M4 zCuYXaTuzfbbVrw0de~dtWF{EdEz`%)f(0ob>c09ICIX{~z!rEn*E$ncnCx}e5($q; z2bz!;g_K$?1?Z5*5grkU%-~=5q*OfI!W4q69c+9fh~w9QAd&l*LBgJyy4*XiPJ8wc zQLu6UYLZYMr^Ix56Q;{=p=od0WsWAyAJ0V#7SJWU3-b@LO2p75T`6j`F?0#15E}}!FpFDeI7OGhJWkUkAcab(F%9M)Y2p=xp-WI9 zc5nM5_9@ph!zo)r%;Pj&0#c~>*Ehi?&r0D6!q6oc#CsWIcPbRIcgqZ?=@OX7DY^u# zQ1NO$54r?#REE*HRf_jA#tt9maFQ8LtFV~IDaANasDLhko2!V6s$a@rWn0RwE!@j# zn57}+YA`dLR$(!ZQ;KnJ+A!aS5pqm8uaby;IVqs>W1V~w*NjCZ66&`N#G4{ zxd9vGfU(#G6U<}_VNDQ>#Q+z^LfQHMuwVg)_weHh9QJl?(Xn-E?vV^|5BQGPz}lwxzxav_o>R(+u`T1kBq@X)QePLHaq0?> z3n`e-839<5A|1~TAy^V$5lbST5dwfCse(gr6!4S`N1iF!n#Y4N zEL!DKTL{5UxS=NQg#&;i5C9wi5$3)J0^oSx1>g{8M*PkUGn{-4%;P_kPyw96L|EGt z6B{0<5S&E-IU@|1$;8<<#4{2zm%UB!_YiK0=d*)yU z%e!6GTyxDAINX_z5Xp>&S(eRJJcP`ztoh6~E6=fWW7j1D>}(Fe&IYM?A{l|5^&_w| z!$WE=$*u~o<}=XZ^%ka#LW@_rFo)5rqH~K^x=7@3DqSQU%y13!IOWjlrlCS#J(KQ4 z8IbNwIo1ItBB)o%Q9MGk;ChbYy zrM1>Ag51CUJh(-aa|!ANNiA1mR)|5J)eFpUjzG*jPV26A$58QVu7%WAlyhOEwrQBD zZ9!*6zNGgXGrVhA%Vmhn;{*`y)}?S)&hiQ!sV;p;ZQEf!D$2Qd^@6nNil{0SaPQJ) zpQk%1@|ocZj>yhD-g$V)zYNd~LxsMxE$J16I{S$2teTg$#1f}XJX1m1Pv3xM zoFX(CW6<11qa*D}-i4*qErQ&uSq)dSQxxU%3!ze7&Aik_f%yp)BIdR(uV6%?8uR;P zE~m+3x}(cMm+&;SD8*(RhAsiKUxwQLWQNnm`<+=z(l(r#$2)s`h0Mvd%EgQY!aPoEmm!79c#XkX_iE5hXF#jRIgXCA$2+bPSn|>pagL`Dg*{G8AxJr% z5Ckw#4`F?zE41u+nA)3(n14?Yt#x_aO}Y~C;m6%1RDnJGxSLcJA~bJrK=W37g$bj1 zE60)Z^Bp@LsJN!N9H_yt1=Ykf#4 znBkPA<}UB)F^`k|ccf5(sb?;HoubSH0s%40DB zRXl$(GHaG?gl$=h=W{fdxA_=*b5FJ(-%~7pjVB z&=Pb=FA*K0hRUi^lmW-nrN62FKSohU(=R+8Mgou3Nr7vy%4_ z=*cetdJ=fi1W=U(vgO+wwtU^hxsfTWE&Me*&9>M4Yx4!2*G1EKi=VSa=aExq&P$KT z*pPR(%RcK1>&Ey-a?q2h06p2I3yC+)wfKE9LCqK$t4MFKtPcR)VdXSoVil=l!^ix=QpIuw^a zb05#<6+p~zmpGSs{AUmBzNe%@Od?ZQv7bG z$J#H~cvxlMYAJF0 zh#k;uta61Ym#~@%9KH&zV}=yuZjTXSeV*JyZCHUg3)AJya7rVdd7L&uKnj(P#|XKp z4N7Xu?Sx|;h#X4^EwyEaQ<{{_nCl}i$N`JaR%1h|{)Fb{K1Rg85vGs8P8%=qh* zd7L5`L<$wq^l=Xoa%+TGnm*Ki8MnBJl_N64X+03;aZ0-kDO5ny$4TeK%o#(|hg!j5 z)+)?!N)Lq4tFWp==JC!Rzb$h()PDjke}WZQMBsJdAv3A;_Km<(;a}AvH=N|c9!w#K z8cztKFs5N@Zv;LL-@my(qtu=$;osB1Kf#9c4HJ8KJsYKNDk(aNq3PjOx ziTCW7KIYLod`SA3MDBq^HRee!$DEWQ)#RbZa&SvI;^(;@vqI!pN@%(SW;jKcz&zf$ zLL?GRtQhyN{}?V$4yl5b+8QtqM2@9|mD)1HX{jyqI3=~k3Kg&BI`}#bh<7K`$52P) zT`y*5`Hb8ti$doe?K%E~-?Y!Ul)1Ecq$9F9cA3NTwbco}TT^Bnw8+LMlRt4N^Wo0Mq2k2m#O?R3Rbi&e!lUU#-0hPmB;&!NZRi+yZ-F(T?c{g@h#9j=BuI` z3O26l$I(3|2NI0MZP$~yiuS?J!10{3+&0KI-!?u)9-1D}kgqP+X{&;=p3KNUr1Mud zn8VD~>Cp{Etx3=I8XN9AVc-WlcEO(SeAx2^ut)W(K5vmd-xmPD0foU8?E?Y%xwy`A z^NiAl%%TMw7reQ^`?kt6Lp!m#DQNeqoTSW6qjbSXuWb+0d+PhckKA3jzt_H~$@$Um z&p8};z<;*ig~ER?*rV$oV46*sCsW9t@5ioppVv3!%0M=D>mhO};-epU)Hv6&Ntta6uq}iiIi0(2 zsP^}LdhXr!%d=DW$4?#wSd!pu)552EJx{PC!wB5tc&7O7^Mg;CcydT`#j_R9Rc!oG z=Mirj+}7$d?N~zixS9})@8#w*Z&~xLe%Yq0>tg3}%0M-KPqJ{7%1pl~~-BK%C+M;N@XdY`mVqU8o91r*xPiLaaCnwsr)Y2nW z73#2*BoybKoM{PdD%jd*SyI1sW2Q#N0IlT+&{_a@l6!5);{_b8rG($x{@mw2*H({7 z|Ld6(yg+Y|-b){%54c$4W$Be$Ul%>{TBFw5J2gEfqehXC<((A^KXRk`#lA^1Husp7 z{Na+wIic@`9FYInH$fHqxb}U*JlR1QHtvSE%HX@GN{y(MFv_{Z?Vx5CPLvDOC7dYd z&WIj!aiTm8Gs^kL6(o=HL`|)raP^2$woKH(AGUi0Iban|z{k(OrHJ!+3U8631fqcl zUE#Q#8BV$2n8#^X5K^eXi%JXN^5oX4xzl#J?8$by#K{oX5A;pJIS{$_F53OZ4DXz1 zkt>LKoR;t-g-X0e4H>`i;I6V|tmd7+7fPIzi)k}P_KBKjF~ccUE%P|7@Wcs~yAw5P zN8KwO@0}^C0@5>`*CZ_W)e8u#1>RDF3XT^SNmm}0*LncXCyTFZiC#p)qPcdh41_sW z{@y3lAnAGu_BzZTzcpS1?5E702kn+t89@?BSMED}3og6)YyWi40OE0O9Njp4ra@r!SX_FFj1}Az2W&X}F75M5< z`gtvLIaTt|9bFE>d3Tw~AmcfpRZG`O;FJUWlek=;Li$KV?ejBz46RLxG(_N)1DIzy zC!EJ>fnWuBsF5432#aA46$7xzuYIN4WvB5<&`cC_dAm_*{%weDZIR z;^-3UFkQ|Jrxc&eZ3e4J*8BWn9FptwxA*4_VH5x!G z?7HyU>>KXoAEL zWd(V$i{IlR&qqn9csPHX6UFHHnJRfcO1jmlw%eH6n`jH(>JzO(KN~w1!~# zL68ktx`Zu=x`cAf)(|tC(i&nOr?rNVLM2{ffYuN}HgNe0Mr+7~IDqF^Eocky%y3F; zhjpEu8+sAO9Zv zheN6Vk^j`9$E*78TTpA~fenFQraySKl|xNrRX$TOxgx1z(^y@|#gnhw6O75$yolEP z8M=WjUnu;tVzNRr3d4BR#L$|ZB{2^;07tJ2h5NNfI$%-nH_zU7OC|st77ZM!ypsq^ z_){7~%)89LHeb+rT{MkP*{=4sY_3{qOVs(q*PLiu{A}iPnH%ruJbBW@l67OUBGUlC z;R^tcUAmACN_oG;t#=xal7+5r zEwXyYpImC`uO4YWWL}{Q%dY216TN38SJjr`O1YN%|+fcb8`?fTuDn$Imv^Ho~?n#dEnT?BE%LXU3^3Rezy%X%K_+ni^Jzz;-t!>!ullQ)9 zbWI;eYkv3f!C)~>z*(WE7Ld&z5;go!zd7PG#BZbNtnL`gbIVdB@6%?=80>l%^ z(q`{wxR*hEj#dS6k|>OPpBetBx|4alOKFH1DvM z!VITWSj^+JVjL+{VD#c_ayp#w+*woefM>`()O(1uogq$JlwmUR{j!}i21wa;asut> zk~W|3P)3!-9h0y_>C6c;E(!ADn~3m#P%mK<(GE(Kvr)bIwk`Z0oRsiLY`c&6+aR|> zv%4Mfw*k?FW;fd361qY+Ao~PS1X@=}j@cCgH56J`h#5}n3NepUx(-!>PfDx$&!W9Et4OArlb(wGZFySFrk z^gm&vjp@I96UYNhoc;@n&-;+x0x1x!_?(5AvVe*YEdynS(~3{#aZ2%t6e>`Bu7%4J zNP%dQg#L&JB8Lb?tAv>0G)V&Uc&G}VUgTcs8|_jFBZUg2w!#BuXp#hY+zCyRz&)ph zCP`q1cf42YlEO2O($|47L5q45vsEn8#_71f)7!ul5Ku%%07WF- zx}@V+K>FuCJLi)XIPPCpCEQZu^g>s(Q#iw~kbgBvxMbr5U!eWC8lXFwrauU3B>0z< z3kX1H`eRw#hrEmm{`I|-awL!peIGS_8NdDt|9V}@U^#&pENT$0p}D*c&E-rr^ypn_ zBq<2L70kppl-rqkyz}kMR73v&lfYC%l->|i4N)-((ydK3J5}F&T~dGgoy`2q?|+Q` zF!G&&OUB;Xw{_&q_B8XGb*kc1qgP+=u`2WROP$A~Oq=@%A_+V5JD>S1J$NL%1}RkF zmVFJzqawlrV`Ez+sbI)wIZ`3oc$67V8;>%NQ^uo6p#tO4&tYR*L|9;KY>Oln3~`=8 zy3|7#oSk%J=$tnPaD*lzLt}?Z!C6xI0l>_DHL;sBku>KxG8N zpGY8t)Rw`B9szwsBFqqmCu9217EhSRI~NlSMnr{=ViINuOBQR1kQx4Sq9`#K(W6Pv zm}xWW9v(BCB3bN?9#7Ob+tqKw%67s85EXG?@G#@IlG4K3&aahyGo$odo<#)z`kREx zLVF$NkFO3h{x&Fzctyeet6DvR zQ(VflR5WcIqxp3%CLpzK2b!NqRKb94uEfj`Pb0QhnBkohEq+~vd7P4yBZUg2wrgNr zMQjRVNN!Pw6PR3cW_agBi+@m@d7P4yBZUfR`Zz(nNL0aCSHWaSt1)SQ%y7zNf_a>l zk|Tvmo=j~wd>M7l8MfE6lu&~L(w9k!470=IQFua-Cd?nlWGN}}R3-uSAEV)MK-klS zDb&hC6l$U3s|mV#uH|msKBiE#Zo9w2HA_0 zFGjkn*W^RuRXhIIa>QEaZvYpPa%R_x{F&d^ee>(ECpXTS-7r}fJ=U3TU-#CAp}V&P zhiX3kX4<~*`s{i!Z!`agX(-^x(DEZZ{MpcKE` z=@T0Y)ZQtkD}D7o@iifqt;%>?wk^QolY683#lA^1Husp7{Gn~q{`kp}urn7ziqu^4 zYQwN=hX%BI9Ov~v?*!}aEw1z2JfpNBv%ngpAEfuXXd0g)&%IXXv3pg{3SZ$ zzTICRruWP?U0oMDNBd&Xd&Zr!M?C0rz<;*Sg~I*h7B?;2KUce~@04{hr&q|-0M1OwA_eBI*b4A5z-BC>)qHjUB+t24}Z%wf8qmeaZW zhH8J`r{~^nzdT#`;)=~v_a{!~p)M_C{rLq`>gYz#bx;Dsxci)M%7aguJYXi6U76Il zWkJyb&*iGHgN4=2O|ogn5{8aDxzy4l_3oKX*0-!4396OH`;SQ4?=!pp?C@Q0^t!NV zzxIbo-;(B+Dt1mx(vi)>jtAdJ)WF{zrp9LvYIZ5w2R{SOXNEJ6|ExkKUZecDEKUjM z8#Q}$NiuPw~F3inS*g0~_Bm&(IA#YMg8TB)l>r$2ijx z+ElQ$&$6U`>&8rtR3se<9|4@EBc$DE@w>3~#Zg0jR(^3zUJr^z7Dn@no94nWw9CX3CsgiE)EFFfuLRw6 z2DEydI|Q@Cs(|!NNn1nCoG{}XK~a_5Ks8r(e@3ZY!oHIlo;$14p5+X0AI$w{3=+<4 z%40km#VfoRjFFxtx2EY^BM@>ju(K z`0T8cu*(nnAH2UONUo6no|PT|-U_;@7BeD*$%>;8F~N0Wj%{3C!H_&CFtcaoa#~}n zJGvZn2^FAA5W5u^1t`3{hgNFIF^dXjI3>en9;aovNTCvHEQj_`IpXcfJ!XVf^1}-? zc)A2;_)*i$u1XN*aa9b+a=K`5kV3^D79pa}#fn!DhAu(8mofUQ@Inn*C(*zRPgO;C zm6bD(({u?)q2krt3Y8~3fq|w=s1xsHjQXtzv8rW;)5b45 zv-Fbsn1t<5xR+6-1DHc{W;m_FVjiay<4B>XDr>B@=|bVwloNaYs2Cu$x}FY~EhontlkEv7ms(#gPF00Ac;sH+-al)lEm0SnamEepF%_UBu%7(qUZgR- zk&H-|5-5p1m&ngR#swUy zB|}rxmb2ljV^u>cP4O1bmQ#vY+f{R3dYa`ex82QMKs*@+td_pyT=pi)#dAFIJ(QgFwO)$)?hg-tI2Q(+J} z-d6SDmEFpP z!1OF3DSb+S4SU@TA5T`oqc{MRjo=zQGfo+TGEQIVsSiGSaO80 ziTeb$#%;9XeELG4M|YcWU?e=s&zHpseIB?c2&E~A17u{8HF=Nt>vcZyHySrseJ`iW zEkWwz#kmo!`FW}YH^|Ifz*y{nwe4gwX?R@AQMX3>5sbxat}Vry3LcCl-32#crOD3s zd2mj0p_wVK3Lv}9DMrB;~b=^ zQ&J9B5K^c>YP-h;4Z=xn3y8n~=Ri#3ThloA8#BB?TivyoU>@hhkX_3+q)>s>mdgCYRe3#q_)iCwA2}OX*+S4*(YkA#S90iWT%lQw6dAUxji5EaVpnVMGBQr zqZ8Uf0`cHA%PZuK2Wgw|YRvmh*pSDmYI!IDP8lR{AaII9=5lUlvuj7IJG#6A9`beW ziB~zC*Ag|Hj7E1~cC$s%DB<)_fvGYn2XlG-4^*~9q9dIuq3!+zLH{$Mfhd92OE|D~ zjF$_NE9g`Z_Kt*F4d-5w8U$S}!cvm(@5xj{Of|$*LrkZ|1ZG4T$5ca)P?s{*5K|5P zRIxCgG>)l;9-+_1lY->QnD~aKh-V&uNNvwlLyuPSBS}FLHK62A!|a(c!zs<7?&xu* z8hUhUYry=1m}-bNqF|~ac$&&>>w~F=9-Z1ENkK?z%fvVTLh((v^*B=vJvy~Tl7f)b zR*88rGs7vVZFlrIQw`BK>k*|O3L_KWP*?`c;}4@Lm}=-Bta<-5)zIG+W!Z;MjrjVv zet+B5_~AEsW6#NaCof(c`c1WSqqQyivHuwR?bcDR9$vFMsNqfJQd_2yJYz%N-80*)WW&1aR`oJql1y>m zs`eGPs=EmEI66j>fDIYk*6I_wx)p#PE%`Hav5wM`R1P8X5H@7g9K}!{H*82U!G>_3 zTIVA25I{qwiF^!CXQC>i@kDWMO`^`H$vmkNhP3E zo(LDv0djl0w&+-UQlo#nG0M_kea<|J!w7Um2fP<@KwjdG4tU>%4(P1@y9msXNC6$t zkgqP+_035$SF043$J(!NAE+l7fv)I)Z-E-J!yPfx4-hk9MuW5Ivkr1m&DWl#mjRm# z)PuK0Sc|tK&y;M<3vb<&m;S$xMfJN~l`fJQuP~~?T>gD5Sc4*PAqfNh{6oqm4!xrl zKrj=Vn}Xu6Hv$Br!Luwq%|1G!l0ad)f?(zYd?(Ni1hb8RVA^hXRW3;wFOI~n$|VWE zB2<^xVY=La`QuFw!IY#r6@i?)+6`jE3v?w6bD(5+^F(_=Ln~na=b3;BwH;T_g!_Pnhg>A^S+1gUS(4au;`t-|_DjK@N{X+;>xTV0@mlFauF!DPg#r z8Qw9&>?l8($2&IixC)Up1(8ApQrop~2Z?eNjMTP2;(@rHf5}(e;F31AWrlam(p_y3 z=5gNyRjdFxbhYDIO=O>!3c9XbZwhpNG2XFPw-FqN~cL+ z`WU8tj4Is;lg&K-hBNA~dVok=Hoay*47 zVR2$glFA=~DM{FQszp7C#Ty#eh$PvN~3jKQZI zbMR>tNZS~LPi8o6@X0(*scw-%1qPqD;Oi9C8gF}?YfxIH&HI_mB$)E|MC~OqEfwut z!R%>c1-V!AEvP@E1?>RF=UI+fQ*7z<4wJO!3NyR|oz83dIT7fk#Y}BYh^Z|zoOT5s>HV+QOBH;?c(DaSN)buS5iu#niT25Z0m3BhG z45w-On8zuaKBQ0qP2bb7-*B?iJ7y9#DB)hltb(xeeIkuxhEt?*%;U6GZ=_HGO&>Q7 z7FYKN8qYauu1G5#z}&7kVAizEa7u;6JWeadkwOJvn+b4t$`R{Mr_N{ROCB-e)2MD2 zbF=f(XFG?TUj2%nF7>}l{(OAfzR(Z?^n5q`t(RpxZ$DY+-ROZEUDkRF;gQINk_s*08r(Kt}lT>T-f^Js6~NMU%cSme8Pned8N*C^NiAl%mQnW z9*+HsrtvBA(B`IIWvg;uThl+ED&Woru&QI~at@3n)se&56HjmN; zA3eFS?M9K+TOXEfoO!(eh@|~Kv+K_e-}OeX3!C<9f0*>GDVeZf=ENi&**vARUqqO( zJ?flr0KJ_j9}=%RTos%(%eKrmD8=t~`os*QAtJ+c1!yEkP4N~#_3@JSA(b@&mMyJG z&-EG`?mJ=N2Rr2ZzU#9KfGYDXy$B0t*>n3tM*Hks^asy%b=n7lG~#fR2Q1}fS0*)X zSx~gVbGa();6D}QOJq*YE&MIJuw|^~oxc}KY`Jg(p#&nT%bDSnPoH_5_I2Wf%IQ{_ z}dI|%&8ZJOK?+g z{~3dX*O0PF#2vx?NnQ<;@N)jRU3{nw4%~C&RQDu26WiJog@@X>Yv}%rQoDqAoCDM4 z&ML&er}L`F#)1o!JTWKX?Q8&T-Z)iOO!{9TtsrbH$#NF2<};AW3Dlrh(s+5Uq}i5& zFC}sEihRB|jdD9P!)bQ~^Ef4~Knj&%o^9vh>lFAnU!L%a`_#Eg!W)jO5P7f7tX#`Gp#pM-@ zTVD{2pj6CG=5pG#-yK~((5QA7-(biRkOUP>HN;dyOf~e+>z!~E6})`SfZ26ohEsYV z%;U6n8BVC2u9Z33)y`HYh(OhaOJu5^2ah+zYjlzhKGjz5xXar7VBI}VAQP{Wa;VD5 zhK~Ap3Sx~Frg|y$F~<>q`*XzKK7sh#nEq}`)Le?{eNeNDQ}rD6*(jxuswq$Q>5Ks> z9x0{5cQf8^Gr`a!GeiaE#msa!l#7{pyz|A(1VjH|r9|vzqpXzh+deog zEu=Ogzf!^kLlj8@mMV@3h90@9hNS`_OIb{JLkV)`@h%cACK!5TYMX|c+A`e@CADQ9 ze<-zOf}uyO?jor`_)To4yZP7YZn~|T#GiSl^wmrTftEazvO!jWs!lCnq&I_Mc!^0XJVd)W# zGtFP=0M>A|ZSkbc=NmP9bbdU*V#&HOS&?Y~uyOLY8-f_GKQuF|=l9 zNz8*lKyUN{^oEw_V-WPl`^~er-Qoxq>wysWN$=fio?u}eRUA|DQSnDAo*Lo|(DluU zwk@>)HDsmzlkm!j9OFz&0S}oNGhv{9M=U@l3IH-OHHF8W5XgkD;)``enFpY?z%SDu zoFPDxv&?Yj@t;+w^sX<5Z8O-Z9Jc%9z3qAa>5H7#GV>Q~Sx~URpJ)2COCvD!Zr=aQsF?B3cN`0PlPPB&Gh`}y#&w%VvbW|QXHQUKvNbooO%4`6e=gYo6k6_ zR+#K{*PhmV$lXG%9@FnArOZFKx6A%m7Ds*?7%iEmKS=n2w%t$Ed>=J^*}#!bODp%E z`Ch{0)&aVo&wX~z=kI;^&%7?-*Y5?Vu`Et0rl4arTY%-)Gb=JHIBV=dLVmna=MjIs zQETlDLrXs$jjwoUe4hYcQC`5$7vmw$2rnwcMO#Q#&SqO%f%EFqcsHIBwA|--haYt z4Kc$*Ie9_nW*qZ4!2@?`eqg77u!4MmYg?NH%W_#zyIjKNjex&LyWpHiIfeMf13zuTh;q!Hvl_sOXrnAwm!D%y zNIYnEe1UkBqmB>&Nq`aLi)GFnU=b4EAhm1(KhbIm7cS7WFY{=aOmSy^K-8Vb&_laM}o)d7M0q z=#s3Hfhtm{)OohucV3BCIhvXuH-5{h<3P62qL5M-dnQlz&5Tm=+f5$R$Ep4zp>V+d znu1f@9O32m@SpjcgrZyZ6-;3druGIN(*j5Tl3x_y#7RvO>YUY>Ki-NNENc*hg?k(g zNd-2*r~qApLhP|%=n^oe2=MS4TEBcfGn}GJU>>LG5|Bd0#XCW34RH_)v_3yzL(p17 z%y3$3hf)H9mY2v+%G5Y{)2-=XG8BS{rF^^MPLr9?lts&v0@YXc1$1Bg$h7gEK1CiygQ1(de_Od?YU^|;!AIB{<>wa(!2R{@@NoupM2Bkxp_vZ zEt7)>6fGbt#D&$(O`-Aijhn5HwHr_92C7Gz51Ci!!m{f-mWY>x!+upi*stR88`WgL z%8TEx$~4*Gtro6c`m9|BnlybX2PKK9CEO5Iti64c|FMLj<4z{(Vlz%F{IX)QLNf}( z+{hs>^#V3Q!4I7oSI-hQ!N>4WH9U_45?AG&L?S@n&5;Sr{9?7m&v`=S+4z=uhECq# zS9bTz2J2R<*JYKr+iGsKu=tS%av#DxQFFh}i|ER;LkaVQ5Kr`kdmzuf zRyQugc%`r2rzJm6^`s-EIJM+*dP0NIjeL**-ml@EZD!N*iX z0omc`MSv=6gKi3ab(~<~Pq+2o<;ma-wT|LAFeN<3Lf7AsSL0<3D=AA?So+7`*xpkg ztoJ`!6W|827zwNLzk^lzWn@UA>rcjYL&&Opt?O8xRmBgz$PQr^51DB(8CF^}RS{W1 z4W8|$rS?yTR1U2?nQh5;!^{)_$l{kkC*aeA79M1wB_IpGX;Xc5}@dZ8(DSu51$%4p6!pB)S zP9>afl1KUD#@kWn4E!Dbrz^ZztXl;6VwpP4g$=^_Jc~#ji4%x*m@a3Acd)-)pFZ<= z$McLGR}fODjMk_tT-cylRs7zWv^fR8*@AN*DtK)K&i%#=KWdukmS~YHh5eVO znlM2YRh~^WFVzw@Dx5i(KVBUmkeZ;d<^FY5!m8QuF=DWkV+KnrTCkjvIgUYFi^m2j z@5B=%k+jVOPsEm)lHc^j>4GrBJFxJsCMEN@_K+^9Yr_mFRG>8k9kcb~^^DQE-GbN} zD#vUMF~cdXA?9&fYX~V+Mr#bv8ZwAi5JqdrgfkH$jS7LKgwq;ghErNY%;U7y5K^cB z^8~(5K>&m^RuM!UI8#qvuM7no!qgMBN6Bwj;tZPvZS5W5fJb(k|`(!RJqV-q1qsu}4 z=PonB$ZnZFh88UR{xi-v*noLzF%cLoy+sOgC_X{dXW+%TIJyLQ7865`NKzJorG!&_ zGQ%mwC-XS%>qH8b0Y)WUp02zcLzjSAAEH)5%y5b>fq9&k3L%9`@A^8>3X9V3Odd%j zsgz$>n!)K)VCGrOaN2l}d7Lr{MhX?HcXK&Y4bfL^m}-c+JLP1mA8&eHEV$qIi zSZJ3Vl7?lC4EhwzwszTG9!;>+XYS+KVW7EMlGACGXp7q0vbicKE7lSk zUlU@#`)uQzR$qW*@Boe%){XIvRL}q%{jP3ZtuWpvXo9mNPj0QL;IJeOov5Oo zSLY-(_ROtWYT2MnH0PD1szNi)@ca#*S;_lslPLU+ZKl-Gjh^eS68^?JktwS!YdO-y zl}<96Xh&FjMB_|zb^1z6@6_fq-ul?An2e2g1T4w5v%`P)1`SIxdtJ=wJlT039P;U7 zF#%Np@a*&9s!q!xrwpDMr>^+u`#1QPsr(#mLt3B9EC8Yk&)*m}VPL@y`92DN!*}Hu zupRaq;cqP2o&JTYmLpAMcOp&fZOhRV9ZLvr-B7K1GUKE|VLM?yr1L*|gNLR61*=*11Y@#w zPjT+atGa$l6Z(rj}rUYGCk&v=`5&K~}N#>j95BB%IAb2&4-W7NPr{tv%Sq)@pm zbBteUvP14cPTPUTbB>xTopvj)*LlQWZ`4}-S~h*9>#2UDxP54)DcDP`L>D$H#r{!|ShT2O_8Ve`!N-;maIk<`OfUdAuvq%XN2l$52@zQqiH#S=P>w}M;%oe~{%}e@C zO{9Ubh93{Uk*K*fqqGiw5-rbShIe#fn8*KNN{$pN@f!8lJdcQ6L0)m6I#)@SHn)0A zfO{EM70{|6s39@(eP(!9@T05lWFGI({c)usYN&)74R8g4%9>n3Pk5GIg2&F>l|}z_ zY3RT#4S|k>R?{-Wdv)mkT>TH`aY`|c6)FMs=bbs<2zdC#;NW}*>qCg@_?Vr;+sx4%i>LC%}AjVuQ7mD*dQK=7`g;twV-96K*zz;B{0J~ zmMmPl1mlzgh%yt5 zsV8c=A{vfC1rSSel&L4v$Ix0VOa#`sw1uf>6KqT?g$^i2`RS}dY~4El8R6Y^=cliF zPuX^TdgU{ffBWI~fr{(T> z>a+CP@OQP#p4%TXTl=R)?|L^M^SKX4(1_*fcg~#Pw!$x5(OP@z2kSj{tNw3$-vLkM z-~Ml8@0F~OmB?tIj8l|I(vT71NW(4_$~ZC`BqJ$FgQhqdB#DlMmL^B`DBoMpmUXhkWHA?YQ?!Gsbi;4O@%npMUB87Z~G9%%|Q)CknDp$AN z6}iQi5ZPt&gS0v|>gqn>TVj{DuMxUFyX-ZgJwbr=WNV{k<&M+c2~sW+IwWPX7`4fTEnrW_T(Zna*qyQV;|F4+m0l<24 ztB9+R$IsA@RlUrVJg2CwSt`4wFSdcDsBAt_j9`#Zf4UwIh+$}~C(8ntY**3;yb9(w zjMivMN80Ogt6bhLbZf0>>&9LNjJ5UpUU921<5>th{OL72wrq(ZPvg|DRqcqix~!;75&ZV4mm8-&di z+z?Qz-0V~C(5M`)T3@xK5nLcb`q_$uP1244&X+E^n77QBUrM8fad|6ltNNr1Cx+j2MKr=)D zc7dmIOmI4>Ev9jLsVyW^ku1f581%c503o%dxIjD*p|)-?!Rd5YFpbkmZDH9sfER%_ z-|wi;=dueB`Z2T<_d9Kdk$u9L~mVRmg86hP)%;bp-5Kgh$ z)e{~vu*WZ3!JMs&_n-|Yh)t0<`x#gs5@5bOqn)WHP3r+|fMDlK`pCfP#MqEt*s$^j zZ`xP|{4>K0Y{pSm^1BpsZFNA}@P^1g6T+}2zd;yvJ_qtC-a%(JrAI`rJz=1+G{gKn ztM@Z?Tc&=djXr=)b}?`|F%cw<=pvss5CZ?qFNVc9cP4@~3NND7IT?Un zKUTNp-u z3xF5!dPCD%fiiyws19fyGfd@lArJpVm9r0I%!HZ1=nesh9yCk*-PVFJM8NPd^xBk= z@G-PW8O*aBYF`VIkxQ0lfaYz+bdm_cJ;6F7c+)JfqXru84ilUnE&7=%>Ooe@*A6$d`4gF>(-lgti;1C z;#m;{741$l0#0gXpt1DB{5(5h0<{dG0kyzw>{H-2_H+sg<2E)}lLl?fLroYS)U#Q8d{14vIz4E zvzkB=Kj6r?3$UD$h3tiMYn~n=Ku-Yfe(8Y?(LwKApE;kzGO_ZT=WQYbX zS+Arv#gUA*aVlI^VH3GXrpHEpijMP>Nq9K;RR5>O%ozxc7IK9*slBswzp_KE;LI_x?EzHI$ z)D|KpIGxlM(>T4<7Luvxgb_fy`FGT(t!rWI*aK$v2{q5c1otNaD*3;UR4|R>!MJGl zXb+O9$dr~)13pLoBnXT$zq$hkSzw!00fPNw*aVK!Z-DIc@}ZT7$Yw7_zWe}f%@kT? zAv?ZG7&s*(TtGK_AzImiJ^?BvhRqH$Xq&xgL(f;b`0tFIsMgXpd(oP4V6EDO591Ep ziBXuJr;z}%pUna7!=szp7&ycxykSN5v(cvS=%zLXPCc7x%kgNvgs*8@KN&U)_F)|> z0h4Cx^!y!01O?0?@Y*2AJ{VZdq2F48fl9!^?6F`fr&l8W6IBlC&lR9MG@U=gfF;Pn zw8Uw_G1QQU5QZAUP(%Occqd4R3KYJEVOaiy7#2+9V7VK8;3^~=$52Da<~aJOSV&M1 z6#t2XITOMJr!y1!Cu$r+4Iyhf>7%nDK|xTkJqEs^H=)2Z{`X-Ph8jXP^wPhWfuV-z zrOi-hD;R3%?^h5o)X=|9Z6QHH(9{+K-_YxkMT_NC-&&4_gzR|%m6z`-5@!bXx-@OvzyMyMJdWo=4A#c1% zEsVq?g+P2afS3L6$W0YU8%dm_a@ULJ;Cd^io0%Sum}3aa=O)fkSLGD*vp@5Aepf~) zz1L6{59lUj0SSknlvj)lje282SyF-t9Yu*foW@4^r1p&h)(RbxGC3AEx5K7Ghs>`(;B2ipzIhC1Dj(jm?#gyE+xRZ;wqtz>(vQ6J}D4j(Xj{tx!EBc z7CljfW+HO{4zQ3Yc!j?n+qv3jtxrTRk(I{l;TE{WPl*TcdSrp2(RMN|SfN+VIc3WO z`CAT&d<8=zVVdNC*Tautl6NvWp)1;y^LSG-{AE{pkrXk(F^$tR@_($U0Pj4|h;qOj z-$k6bU(cjGf@@fua2tt&E+|opI3=WvysdQGmQ=3m9H5_Ck4gP)eV9k@2nu90QNIh5)4x zG}lKceb6(@2vGW%_oY;BL#U33C>s$E^$DJ}FBDMin3CtD4OWCVoM>RL$8*pankom} zI@Zqx3{C4n=lB7UHrYY(=YmEj2Bk~8QA!_k^@uOm8xcyMsz%{LZiMQn24N!#YHil_ zDs4olb~w{qmQw6aJ0t*JoSsq|LzBeCSjQ@3z|f=$hDLLBP~IJs(ubF{PWvKj;Ea!R z9HI0nbXZ`E0If?=HX_Z5@o2t>M>i;542nQZwYJ$ zKbsn;^ibX^_SUQOs+k{y5Cp2!a8)$|IBX%M)Kxp0xMrrW86BGOn7^BZBCNPcD^G-;n0`{DN zG6(=@Xk`$)RvxvL!3jTrioi?wA*lteY5~Cvys8$=N1#=;zdueGRV`pqf_5MxEK1O- zS}^W{SJgr?a_ule4j@#RPCxlvT&ZOY?oz<4$HDv`UV8--oKBk$(>T3O93)c#-U-TD z!gLIR;hm7q6|^M`HB4ZF)A3GB z@`&H%5m(Z7bQp|0H8F6~T$0P0>O;z;O%IVLMq)KeV1Ay}hnPNCrlN)zf;|0TU>js2 zNT&3li1Gsz!Gb&$GjMu{fQBG_p4wqJP=4a3g9VHP7c6*z7Ug7Np68h0bP`-lWo#jbTVe9?v{+7@)w8PX#z{CK1MF zw_t8#1+)GHC|+n23QTZ%&^S!v=xW5jLo^|o3h>TDz&ioW1e$)r@J>yb-bsS!otWVC zyc5$n9q)u>D!@BKfOp10^iE%x-U+tHK#QH2;Pku`(>NXPgk&nfJ4eB-k7;}i3``$} z1fhG0XL{5OV{9}1agHK;xfy(akAlIS=z#iQ898rD1}F}v%UU1SR5F!uH%ZY;b`+TP zIMntECb$E#a^&wm{L+4u}-LqPKGUtrpI)G@*l;q~weiyIr|O4~OY)xhiEqSh0KGpY=kd6Av% zV(gZx_244=;#us+8%UY+z9Hlr6!6g?D}rfPwj1vx1j*IP)gpJ~rCby!AtdF75P99Q zxn%C3_IPkzzGDU_$x)T7)_1{{iOoEpV)mk=G}3A`$|h;4nyy5638(KQz^CEOh+j2jF4#^Ibuz}UjNLy6@x+u8D;MZprIy z0M~@aY?fkS<#IEQf&N2GU^iO>&5O`2ZE+2(h3thWjRlj`V84h?YadUcM1H9aS&9&R zdVD4W2e*MlR^l1Jz_ESy`hZAt?f0M=1M~CjhxYQS-<(9q$}qr5bZ#=Hh=Do>Eh<*p zt~206AYCYOP#9g6vpNUiJkcpNofwa_d^m3G6TO%yHu78+(4Wj?vS6_?z3HX|m@MYr z`a3tDGJZ?!K_=unJAg&mGpo@URqkSf11rZg{x=%Of3&H%F%b~rE#Nn3c$O-CMJZ!o z5JCuY05k$xUXekLtO8txG-jVVOmJG7h-v%}ZTs&O^q*)dOTtP3GPh(p1o64-2KTlZ zmr@`^O<>-Q#%1KDMO9x-rQvDM)1C+i6dzHDYJ?Z*dvZDr&*K$UJXitfpk}ZfUMWr5 zyvUyGQ}hkMa<~kIinYq2R50eLq6#ty?-m#vy8(ts8pBi%Cir`l8Vl3-AKLbRw5dpx zHiOc(c{&8KYuy6_7>3s5p*x|J&7kt6k+nc;CSZaioOpj46`02VW#0*wsr(*~q9F(j zVCn#yA45w+!gO3l=Jbp%4FS#?+20MNro{wD=74&fCFxo}sa2A+ygfjxi*3La1kDzFD|5<&YssR7Vl4sZ#8^(1t$yAnv;SgxtbR7qy00jVNXsMhP%mfz`oX&V3 z(>SuLk00HEk&4235$p{lQ;{fj2JIo|=@0}1mjDOOPix+S6;IHbx1pHebegxA#_2R~ zVVMeVOFx)=0?r0#xCCTV5;Vv<*xLiGlZXjU50`*xoDMDlmZ`80R0C+7z*Gn-V1CuZ z(A#7nF5{--GK|s?=8zl{oL+^6X`D_m4#`v$S;r9XoQ9de!1Q7G7-U!9?CZN2KE{Sl zQ47h+X?J-3i6F4woF~vyTLR3~7Uqx~6P#XZi)oxrY75I$elG!~-I#>X7DD*npfznv zVCKy*4e@XImxL92}65=n85kmc<1!(gc+9zHxeU@mimD!gob#{i9u5z6Q39v zqDX(#2|*8Il=DOu5GpL1MX0cV%eNfN=|Q$Pg#d~Vp`pdZ{Fcuo$lyxZ7hviG=u`l7 z9oJOpUD-=y^=~WQBxG!P47uFjVFEZ$lxA_BD7N02H;UfHqalEP=JnGERg7~?XD|oo zKNaqKQ;F~fL>3QJNEPxG%J`RVd@R1m_y!kBOA^cpZa+rOy8Wp5SghR$;XIl0W88=# ziWak}{4|sEM8%HOC{YL)Pc9P0DS-+F@&#r56mXcMj6{rcP*7h_G1wqyB1(_LxC3|M@HAWmi4-V3 z4&%ZQVaGJK2pn59;F7$p!VCthbQi9GJsk*t70GF=J+2|TfnVQ6rHMyO{$nJ{>th5+ zrmSa?Osx@aLP(~Xf5W*do}m9sKf_LQ4$yFfsPbl*FaHf(njnwT=&QI3C1=td&9Qi> zuTTKUjzCL6*0)2a!=KEoKj?IW^Rn_9gf#5CJfPkYo<+TrIA9Yy&O|AmW|%?(C`w<& zs2Hd7d*2zDlHf*`ql`q1Gjn9JTZ$&ah*|(Ry2ycXmIy{i0<_T)oP-Dy{P%ox%J(si zUlBq{=Q%EK7rM3fPwouKRHRA?fb(Rk4;$L!$+UD_fWfuURBsJVEkuJX!l{L(I^S?y zpEk*WR14AWD=@qknt8zzgl6Jcipi-}F8u z1icU+Lc7$$xCSMdlTE>B;8a17@_lr`hY9`%`iIWo(7F@T_#dd)?^!S`Q(+$QRVealpsL%J`FQ*rtxhubnsCE z(-Nlz$M7*Td;Bn=1F-NhXl(uskAcw>ror6cv_K#kxex0Yvdnkd%3-)CRG=12m1Ba_ z>w#bzr_(NjWGc<9W8>5vI(SO|KG{;RKI&&4jgg3fD3c19K#v*JHzN@Q6d2VB8VXFRR2CGVveP*z zjOHy&=l}=I<}D`pZ$9}y&09?4^qRMjOogunhd}P9VJ0vzeHcE5&gY5YV`ki!{oMrp zjb4M%kozZszyRd-4`CP_Tmp?u2~JUN1rwKm2~MZb!Zc2=CWmAyQZos|;NTKyyju*P z*`hZDr|7Go%x$JvpfJHtY+C#$wZ$|}Cl!KaDtt2u!=T_2N@%PKaBvAz^i@#6_L$)G za0!^k>EIGznabY?!=T*8#!a`JVBE%rS=3^J(?fn^8mDtf0FtSIsb>kezek1H780Nl zVlpzmeWTuU*EIKPf04iH`VYr^tGd^`#^qEiVRQ2#*~*jk_)VoAuI21+>*_4?>p+$kGT#s<*n3;E7Ec- zAbRn`q6GmlhAvj*XqggzTh$`3}w7l{`e{UEiucwxBYjDYh0;QbO|Msjcky(HgRKA-a`)ZK{}pEV7logdC}w9iH_8 zy)IYYh+fz(%XejPAAByj4^B&KuA;k0=K>@5Vxod|5EK^?nw3kI zk|<>imK>bR&-4@jgfri}+pK8S0=D z`(;Y~M6Mz42HZQ~=`q6se=rlZkl&?{YwLD2k3*iC7?>pDa#`(sNXfM97I|W1>YUrn zl#-^EMN5ak(-#J2EMwylziH>uG|`#Wj!a-&X-n(hOjou@kC)N?8vq!Am)}AvDQNv0;#5U} zP`@&|e*<=W!0X=t)*xv88>po%xYG)we*@LX`C6($TMHmYpt&b*y0nF1h$0YGjtPz| zvzXnw#Wap=3jNbvMZFW2sjv^!g47luMxdp(&M;HkD2S;oCOEy+7SlML)E1JdfYf#z zTnhz=5j5)8GR+;4W$?Jk7iRYP9Ach@2~Mv`iD{fpKO2&%+-06<2C_Wy}0*9oJ}L~AS$i<*pKTvHf> znf#|=CK#6Le-xIgj)_tTmN85><6yWa%zhcT%?b~`h6zrm2ZCvwUb_sEsQ^qL5A(E3G=j>Zw(~SybVKk#}ec@o9 zE08Kg3^nwxuODI<7CQYKSQr+x6OU>9Kd5mGHAKJk1SE&fFi&y}d_yNg#5Df*#uJ7b zx)DXU)(0?TNKg^N9yGq&Sv#re9Q?#+pXLs156F9B~!}2Sr zM;||wVdKhHw((+0PcH_r-+jUey~molbITX94>Y%MVe8+aW6zXuQDal*J<0ZE5^ipK9Dd@LlRzumSuYDm_sV`$RXQ z{2rC0EAzfE&8IP0?Bc2k?lk~4&CS02${h*ar)kt7L@7#f*^)k^(`k5~9&o_K>-x!d z*pS)l2Wk8sq@;HX4-4Jmd&m7L<}VbAMlwhFJ?!m7uS%EB6dW1Bd}^FqsOBf*N23n$ zFDnVKd)~<5x76#XAzpK0(6le2fxF&CpT_TD7Pv%GNfYpUYzO=v>FANK$A$2FEZ{lm zn#>y5fNrumqhvSqUbn%GX4;k;vkK3aLT?KQ*t2UK+p0g4U|N$&WcdMehYC&_T3_Y*j@0 zJ=E1tZ02v-FY*;!uC`8bd0qR4^_XR9m(R%tu|obrlsaTiQERildV3#hp+r95_YkK9 zDvYl7iSj1O(D*$R4J6_c#R0#^9RR%8h`QQ^NQB=bA!@Dm3uXf_O9#`27sA;;KOaWu zS{l6*iWbz$*P_%RF1iyzF}oT<)T;ed56fC-%jKAh*Y_{`TGLE?;!^G zJ!tVH3FY^=OI&EWBCG5M{Zf%Dq8Gk+p)5PMjg@G zc6Ee@j13bA90l5e2zqwV;u|J7a=&VJ2*NauT*aG}3c)fJ_JMwo3r$D;>&)4JQGv1P zO38FwhLL^3%(F1T5x%h5`97v`gfDDXN)E|XE^rJ~Q}w+_6U~>UOFtv^#C|5vaREja zLh4#}7oiL5X5Sp=Qhv818Y2l_* zP(GJkfHRD-&4g0r4bXZ+0x-KEnBaiDZgw{g(>OwOIJ;p6$yDZ*W`NdE#&ik_p>rDw zvqz}{vo(YXPNy}5X`Ehb2$HGrw&a4=kS4^|P|0*$hS4kMf!G?t1gF;;!Zc2&H3Z94 z*awitEe>MrM7Cl=%WQuO4x{e`vquTGV!|6XP50rUOg#Zy8Q#W(m zQmPD%m;}|iJChn?J42u?Oqlk47%l{eEa2%JaECy%M1-yd8Y%%(Il7NwR)6)MsB%%( zF=Vtd4Ksl;_{8ur^o#|=#~@1+X1AS6V4mgT5Gx^AM$X&P57JwJLxqM*D1iyo0$ha9 za0!^;^ombRfj} zJphE847?~%v7f2iG8IK69Y&shF%a=Eaag+ah{&~k^xg;Z^n`(EVFFa_%_)f38!F6~ zmsBuk>*76V7eByL7bA^j6sEBpfM_h#`Ott`^Gam_ECWnDbfH_3~8`z-rZbLD_ z>EIGDjnl&=Kr$8HmTHiKT0v|L;UJaG=p8=5zyYl_gb7ZsHH2xLPHPC3sQ}Is&>8}p zlF$$Yqc!9_9hYIuJppwHw9zCcIK9>org1v0AxNeIT0=rdksOjJiDOut`sQ?`~`Abv|=Gq)Oku~+0Bl*?gd>y3HsJb^}B zLo&*E<&@I*Nqm}e;K}nq2Y1K%jzxBSo-T{Mq7QTu`8~xe7vt5)lKD?196J0fd+~-n zVUxydIhV@|dr90(JO@}s9099{YIfuUqEJ4{D)Lw4Ro7U}mY<5R0#YN-*|Aty={ybt zPuZ^%)K04<+;&->ee?lQ;!S$l%IqC-1(A1LJjv{Pyb|i=3u13OfB9`V?_MWaUJ3?k2k2)dfVXR1AvPEer;Ls=p92#5f zxIFO+UQq~##yhTc<@20Nhs;w|Ue7uY`a zuw(VaFTJ22bI7h}l@FK0(;6b*8}fnz6CZ(YJV%fCBI6re2`(?q&b$IN8XbT}V?ACe zJ1UMShLXjoNQ>t?I1y55F7M+cU*iZr-OHk2)TAWV?;$%Z_@zuTQ!L-^)^{WCMSpVRnoR z(fJ1FW#u*Dixsvl5xK>e0Ep8TMx7zf)gjrSbTR4stYZh+3^F1QhnuG!S0es!E8{t4 zo?7);x{#$%xRBeXOwx`gt+ioAcG+h(KMOK%X!1IZ0X~7B1haqQwQ1w2~gI@MH5+@)OIBUJgVlD?DHq^MI!#g(&95SKku5*iXM> zggD>7H1zU<$n%0+`LWhj8vtXB24IX4wIOXMb2^}mF$YPTwV#U*1Pg!Vg6dBq8%P_} zk7lVzIjsUu{}_V@-ip{Huta#?dL6E}0w0Cwt<#!; zpHWX%KSOJIkgKDAp2q|KO*G7??V0Pa-^VM$a5kuNC3Qk5=CR-_VI4R&8Gk2$B_l#lOsGE2MEsJR<`OYt< zjK_cJ#)Td*=$ve(!E-BH5$q->}`A9bk6wi&09JAZQU z9f8u@SszbLcY93;2^=cucBb|Tl#DMPifNua@_CZ_R)mtq;q26?F8hOAD<0CL7g_|K znw@^+fxmnl{B|cH;9Z4AuFnh2ke=H^6`_9bDvX+{Vs=zr2VeZP>)PSB0poRRW%WxQ zRe|rT*8D{-|71CMDe>{czjpfO_~;1y@^PM|+?8$kHkhOzLO%KZuJ4P+Pp|v%&4VwW zEV8xLy&V%$qB)+^ljHLUeY$HvvFLm4OT98qm^|e?5^`=wqnp4uc#2w4^5`6{XFQ}% z_iJ0%?m=SblODC9v9kA;1_M=^<260GKEF7YPy8bJzU~;4v6?^9aW=%$C)X!mVEiZe zS6{csjENJX1xlL1U(Y}Jz1&bDv_x~F#vt@qMVV1~E_g%ic=K9=p0h%=XG45VgMz=0 z;H^UIbURzSz78P&SlR*qLra6m2b@QWB`P@LV+?;5oDDgUlj~C>5Y+ebiEj7pv|p?H zGki72n+!rTg9lY!3>1Rr2Is~e*^vhEP+y&jw4dcA8qzuwr2g0K0%L>axK@FTiM#!; ze{_94Nr+h9^I})?`TY}{j%!k^B|%9Ts`@inrpv9Y&t#gmev$?oy^3W5b? zsJAypH{OSEWazI71;ZmD0ppb6Ud;+kN&#;0A!R~kK6OGe=ZSM872h&UFwl^7ZkDF{ z4L5%4E?OD7qpY)dU}&9xh)7+@1owg>s_-eo>9~Ne~5Uy{v6ISvil!@yrlQiW@2$YGz0_VY@+S&}Np~v@$;mM&|=K~Rsx~og( zWEg}7P{$hEuRHg*SLfoWyZyh94UJc1;6g`+jY0{NKWn3sD*F3nOQ`2%aZdAbp-z8j|Mxjndp_JiJu8M%tl2EqbBdm(?86{&!GD^S?bp2&gr)D4cr*$_ITBRFWueaM~ee|fm0JG38$zfzBs<2Nxz`cvsPDw zo2i|{vNwDx>)#i=1daFOLcV~5`;QHe#X`3qZ6*&a+zpkzj zP~Y>p!H9pcJBRUK3oO2^%P`6u{`xY`^~y7o0Z9-0qjJ9CGQrndi3EqoVJ)#uZSxG= z^@Pf<9o}B@;aK6TeYiDq+1l()G7bc9J7HkG~c^q4Ka?UD7~ znSI&PYh-&q_dTA1<6ASSM3Z{{==`VBGCzZNMlE@|V}Zto4Klm zhovY#i`JjfKNqZj{ve@I|AXtmh5?%2NyrR#@+TU?%lEN)!d?(n%fuSuG}xUxLCI_LrvN?*Z%6`Li;x-@A-w6Xy^=A zuf65E{B~NeukYD_dgt4BGQz*qygaJEY*EOAmj)LO_TPRz_)^mMv$p~6K*I#3J!ZH|e8R1*wpX8X zcS$XdJeg!pXA4<8TEB)hhr#~*(X>NRdafW`iB-J6MIfJTgFKuwY z`cwdyZ)oR4sKeRrp|;Lkt;RQ39-eE=?F#tPb)@iyZ(4QF=C04xxa9c77o>Mp4Sg>X ztKL2ArFY{+#m3>sZ}w>sDEN=rtcE!I&f~EH3{Jr>J56OzuXB$eb&`I9AJL6NKlq z9a$^L*^?|MSXaWya(Qx<;IZE3IY(PU6*R^fBoGasJz#j;l zEbn9z7TgzX5>hqc8I;L0j%12AQ{8@S;F##u2*G%>6)TSo9uv)skc&4nUwQ2NG106D zt#~v0m9a}zH^l5$KJ!iMP3AJ0=jT3NE7MDAi`9OUxpF7?Z`F2f4W36r>&JR?pHtsN zSFhS|AbgcsH5ZFey5Jm^BdZ0EbtqesSlVqxUy(vbYz@ab|u=loO0r3twe(ZO+k5 zN0B*x-=pN@CT+uA1Xl2!;|=1h+7fNp5vxVM-7LZ$G@PoXU9iw+@rklM177O{4H|^z zSOv^^+AgztAXt3CeB;oyg2%>y_69t|U9QTTz1_<{5(Iw&(mQ$=jbsjE*9nzejzVg=c+}iiCal7*X32U zHt$n+JKb7kS>JK3L%!1D%{;SLD|X5)6?wkunZ`WU!a`SG#XT?P^$f;7eH+hpKOoEC zm`9E2as`3at2<(!o^at!nX_}?^^182&uEilp7Xv4Tox?FXEi_Eu_N}V;|9)%(Q2OO zEj$6QBqY}Mc;dD{G2FX%%a)6A}ZN&yZgeF`^=9MJ4Ltnxo6qh>5TI}m*WM`qwMOL zfrH;KZZ)gQI>TL%sUh-83Hf?eCyVv`zCA0V?mMpEv3-kQV0^V|=9ev9?-LWt>O(fl zFFw2FY)Z0p)6WCk?uE&Z?q_!F6F$Aw>}A%+EG4Cw_M;b!*K4GI%u-N_QHYp&-bt`5 zb=(5}ouo$x!I!6iFR#j~mx@V9EaNiSD6e#OW7m7|TnL_#x1UPBV7qbU#`SL!Jic%D z&pI!yDw@lC{DSBSh2<>|f-U&;t`yk5$;nioH&wJt>UmRDRtGcr-O-J;2 zc|q!pkG2}ogH4a)?B3g|A1_Z#{ja~*njUvG-=O|YE#=wN?~1PG#>k(+?QA*}B;j4Cu$d^4^n39Qp*$Jg{c8Nk3_X};5Q`~y$`KSI2z8w7d znegqn1?7pccCKO;OY#&IQudnM-Jo7|Ovxrsv0f@w*dlxS%j^=5D@o+7Ny|N)_e{hh zTW3<#!eE?q()GBwg#q~Mr|4f_p#AZgYDysTRrgnwSO0x|7`+;#%DBv ziL18YCTR(>w}=GBXayzZ^9Z?rj^k`xZ&-SIgDhED{&;*-lb0xuhU1%wSGp6sCNHS? ztH_#qDs~vKnwr`ho_8W;8G4VF8n3y!|8BIRy6B}GoiFEcJBGt4d?0ou!}4-{JCmA8mg3?pFN< zWlEs@{fc#qQp|oBuI0K=5|BY`InK8EjO(_%Bg}{rqL_!p?t|oG5%a%Of(R`=IkvD?UCu1+OJkNUEj|76c8LU=K;+3~dp!3#+X)KJ?ZCfiTRt&-fO?qu=;_p`)UUDG zts+7L9z)-RbKQ)Wuq5k?s6CE8o?Ol?FSKy!T=B!JQ-96swh9TXvhC-qzS=WFdSv7pL*cD%yA>Wg4OZHc5UD=DZ`$>@5URNIkY$*_o3 zYqcHg56q=B-OgjbA<19pn`>A*tREQBEaOpFShsygXhC@p>*MYnn!yDTquU?jguA`= z)X6+etp>$c+&X!o0}8oE__}mK}i}a zX8Eh_R&P~U@FKHF)~KSds@IeZorDa01fHeJ3?I9fT>N3tV(lfYpYVGcZ#auUUtzZ!? z+!VvL(XTsG`kwFMz(w8P8dN#d9g4o_`kyhjx8E}~a$4udk-0ou!*b1?HA!~aY9tvU z?Eq&LQvRDP*A-V>@wn?O65BR&u(jOv9COOzJjS$DIOWi-39C-g#=xO~5* z-+3=1^xVJugjPO2+~mD(Mq$m%FM&7HH%kna2Yr;}>t}!QXz9R>Hy66q&NGR7&b!&Y zf$yI2AlF=zF!${FDo3+LCULqJPoo;}3D#PZH&5U!lv=~Co%`IqTVkQ-gSs~jzaF-w z)Kt8b?h-$@Mu@8;GAsR-uUOSzwYuRi%|orP2$+v?_WhMWEnT#k(x4$S@0zhr9q(2j zuRfiV#of1zPAF&^Oom-v8{U1&)#zxAwokuvc!V z%AsfS{Nu|nWNg30HywHzH5`04FvvtJbMf=6!uI#qj#Nm<&Ux;4@A%^tNuPpu>i*Tg z-R-g3aQ3KGebwEc=xMX->QVecRwkx9{Qu6;L}`w8U@zWpm)q8Ze(pYd4j?r^oZSxF zdOg8OwsF~m--*8Vm!kT_i7JY#LUdMb6#m@zM0JF0qh^t#7!&DS(jFP5W6K|6k@;?~ zQD1|^&mXzlvdR-L*w$PaJ{7v6hil2r*U74Hj*Jf7ruZ7RMl3t`vF5G4ujP}`+Mia} zn>e1Xi^FxFk^e}LmL9vGx&D{4mt}N-U-u%3v0OF&;9j%cPZYV&7zG{(9P7K3_~OSJ z4=Is1M|?wrK8VC^c9xPfy7PGQK|pBNr=RY6vY&5#Ewa=z|)a$PK3OkX-Cf(n2o_QyEZ22a)t?reM z2HVaGkJd~Ffjfgwm%FzZG;CVvT_dljV3}(X_vN!r3+2PtXPYMrxC;{AhG-7rPoAue z+_1Yb=T)-E#ncU1OP=Z0wF*{!b9@v|I@Yzxc>WT54nOUC8Tl9AGuMkR$yD0ytIpS` z^C`TvbVXJczJ55_qw&|O+BZ7GIb^fLzFU=wK4>5GeAzPEk&?`3?wR{)?gl0$_JnIT zii0-&n^zR9?z&T_W3{0%GOlSy-dP!qrp4UaeBP}e8qC|bUhf)tb9}4V^PM)gHItbH zH7xxvD>@b*+I3)0yXJX=_&E=Y@8vr^2v{PmbL>>j#`dJx{a5^=w&(loFsq1MyK@O! z_*eaexdEr;`QJJ5HFGw6DO3sT*|jZZxI+A9L7aZknT zF}VjXE-D6(F28fxG4+0Uc2>ks7xL(jL$4mbT~{<-V$_!-ogsa)``klGg7ATIL*wPE z2;y;+1#N%nuXGG)3B6aOKIAANR?`rDVg1WRB%z(2+(IvRv6vR@7nC_HvH$k!oQDsD zOfHw5=8aRxBk$e)kX89wS!>^ChdfmcMIrms`0-z#U&JoazTy6U(dZBIEuz8q<_R-T|5vR}%+`{Y#ZIXs_T7 z?Jjh?${?rkz-{YT>(xfP%W-p(m-?lwSYG-o-6pDc&w*vOUV4^tH`AYeIGE;ma8HhQ z?pKZeSB-grl%MRZ7gyE?Sg#?y{VK?B?eXIBa96^bzWn=(c4}WR`$Bfwz3(sXuoHc5 zdE=`;ymrxx;69#hneDXBZ@>6@zw~bpJ?5=+FcsBI=RRo7&iVCwGo|6eD&?@NpMNIi znY5ixvcGx%YQ~`&p^q26Wx6&AU%m4!VeH(Va9p|Q`@(dwHOWL>a^<0`fiJ$h+AT`8 zy5{IHcOpHxOJpO@p)z^NOgDqq<_?`Mr(SFDe&nneoPc>|XcWBatauqr$s$PJQ>>??Z;gUfh4VI}4lb z+k8^~L6AE8*!|?X&yS1xu3TyzACFNfiQrQm_0RN0@EGA4Ip zEKibc+wBIk&Ym&>)eMm}ez(&KaMJ6N#W&WxZOQo5bl+qDMc>a0Bkr~d*?+U&>JWG5 z__~A^4eP;6F4^H%wGS@t>U$JuB+k5k{i^5){7k>|MhVjW+zP zpW57E=Gj6Ax~1>MraCs4%9k_*k?O*f&KfOH3q7!xJu|s=-C6%-9Rc?bF?Ro?{9LBKbLJ%l_`|b&|M*|e$l^jdp~7bFYo#OIwCvl$JT*xwSOM-@Oa!6xORc4u}bre~lR^{@MRd{Y7H;9;*_ zXk_|iQ}0(#%K^)RVl~}G_9*UZIQ8k9#kk;}Yq@sDIwBg9r8h6+_OqmD=6zVW(P`0Z zGh)#NL+PhiI`R`(443RIv{9Y^-G; zpjT|7n)l;`H6O<=B*{>QE6UcXcb0`wCA3<1F`weeJM&d|ok>bq^eKrmCLG?M?;YYR z6wOZK6lrrhJ~ue;U^Cy209n@uEm@s;WBIwY_xpVXmJ+H~k7zZgc_%u5Y2R9xe=4bt z#ABWAxs{~hbx5YIX3b~Q6i%BJqB`?~Wo*8mc~)Ihc~DQra-IA+fj7eKUwRCb*X%j| z;ZUc%U^myw>$^I&wGEcFJ=5Vkec8ph;c#m6C!3SZtCowM(8j$GHHrIv>w%?RO4_yU zRgU>G+iP77j}B)lp457m+)We!gYofcvdI2RZZ~mB}e>!>wL;cRcA8g#|I~4|Rudmq7pZ6!*U~Z2_8TBduyzUtdqO^_pnm z6QL!#*7mKTT(yWvvNadC+m>xFGH-qKXFfH_X*01p-=wNsXq!gK~HBLEk~*h$y~kEH+u* zS~ct9*-Pg#>bZGyL~GpV?&~`B(Uw1TKxx(66B=z}XFQbo3Wc}mM&VBy`vu;c$bK5B z_Ux!Db8m>M8t(1Ep~w%3`rY0_UmLnEMzUWpF1swUy_w71sN8I6z)IVtYi#!JKfONM zqI0=xSL}s!^PuNmANMX*y_iw6oi8oTZN=;HZ%cF!9@x{Yc$=D#n5taG>QQyE-}TYl zb_H{*vRKXcwu-XdBj5Hu=^c9_Tkp@VzI$=8!9uwNyySJ~-tFOy-WA2A9!Zs1!ng(} zb*>Pzvs*Z|0$R&01NVzKJ;1Nj<6M}@Ja}|PJaxs^#|JVa_S35GJIb|VwxHu^VCE--7Tv{(mL6qVf>B^xjPRzs1QsF2L)vez9->MEV%QP=D;y-Wq+=hLJ?7@?FUk&L?T$k9C zzUxH#X2F1KOnI`b6s3AyOWXFVxy~F14_-DFu3o^=MP8sfma^_%r5&^Pf8w~))o?o>A%$+5BLh2+NSywtNFvV1lit#{>1K)E&K4Xmxk{bJ;8Q?WrVl?Z{(8CZ5gP7pvS|=u*yf z=z*%HURA1(G45fhuxmt^k!e7O!HxNQB$oK?{cueI_cGPg_hFJpGW$=B>d}T0sZAlN z+3#3_ukyI`b`8j;J@VNUxZqI6yXUfE&c_uke6_gklqrh1ren|5FPGjAJNWU^o)v3Awi_)0EomMr0IBE!P<`c3ER;(F_@ykAsz`TG0wv6k<(E#7jf zS=@U=uIM^^uv(bgMRB30)=mz^{M6=GHXJd@&)iHT)QtBDTu55Di8ZU{@^Let;%LFM zp|53*@nt7iRkZ7CWOMB$E&M3$W#r(>?;w^~q2si55ATJoSz&@9gXsz4nF?v0S*zU3 zZ7PxvUjOvI%;?eXs;y%7pO3hv4yw&rFlg^|XqQt=-p;I>>pt~dzH;zjkgDM3TVhT- zyF*k5H6J7maVByHh8w%agxezdhpK`!%yV?Q9T*4f$jwjjSE)!Kd<*4RK#)7Ez`@^S^?}8g~Lg zCSfJP#3Tqly}$ng)4-j+-rnG|I)FBjW`Fk+e6C&M944k>D<&qXzkO>ycqjO7H$Qv; zQWtCbdwZ>+J!@-#=h-jfaCMJh10r$&KSAbee|{wZ=a~7TsW;LU=U>02ftT)E(4OFI zS!NDP|1OIP=m-3LK>BAiI{Pg%XNd}bejM;rY{Eb5Ep*4MvtKx~1^RcfI@Zj7;h%xz z?6=J9A^u&g&<(TSGDECC&C}U0oY^ZuT91EzMOdOQoZX0={eqdfEYec>^Q&hQ`hx$` zV43}fnJEL3^Zxl2XG?p-?+keMx6X`gNKWzR*WT^F)iIr6%>L$?hdUDd{`{J7K)?B4 zgu>bHnR#*|q2SLiogMr$1HCo40^K4aGPX?JVAH*C?Y(=z@0>4Tua$dq`(d9y@jTC0^j@{rs#W#Y zTUB$dTes=nqJ8`JEp8n+X4j(8|9uJn_H;FI=B-<|a{cB_-;VNJ=X%|K?WTgU-Q{f? z{3q4FJmpg0?zCgk>xwX|kWMjq={jlIPTlKYcR4zE;G^>QqD_M)4b%PN7pEM(y?w2u zKF{Jy@*|{2&w9HrTeNBH#IMAGKL^Cz8eRDOgXDd!Fl1oWlwX(pw6^Z2nB^R=Ee(&( z#4NZ!#4~AY0r&PF&qwe6v@&?>t#`BPqAzDVUXHrbwPoa$C$2vZeKcmo3D2?K2?Ap4 zd;9$@@_a9>;j9T?H!wBxm+2KDPtK%YK0j;dn2F}yXWK6>%G7({pUv$T^>Pva?6$19 zxpyX}1UXO~=T&=l6Yf81xaL)6{Hmpc9$0P7S?}J1}pK(*nIKxjgUdxxL$t>pShI{(Xj?6bv|6^iba| zTCyO#P2JtvUsv_XT3{I>wmmh+)O`Bz=n*9jM<0iU=|8iZT5g_mBgSU&uHpl;dj(I; zIH|W_Q`@3F!*6|9&^0`LN~0F4lG~em z4qc)@$anqNRbQ;Mojt4j%8T6J76sYq8s!e}F~odY_OpTZCzk$jH>1nOu2ZcW5?1&6 zvu+^Q;qt5#!}Ho5eeimrQ+Dv=PqVt7+CQ;eQCR+{A=9V9XXA#C>(56nj8B+zzFla_ znRYK{wOViNyX(}T$LSk8{FylX`-RuH*Yx>)qZ>4C_Qo^ ztJ9w0cd}d6W$awKIr@*3aWC{zh;@-yHa+Wc^=I27rNh@P>R#w@?PhgM^`|wy-`%|L zLkPy|I=fnaG3uyj|DTRe*U6`C8glJLVmtYthVE-6qs}cnVtUEJGRJq=eZoo zr*Q$T=k%Dg{EJP?PtR(rYdyQ7d)cS7UH5Dp{+vF!)Ai`JMrAD~&L7&Tv%@z(UnyH2 za<`BF>9HP8+y_UTTisc{!ugwBRyTjv`O@|PFSXMt3#WhO)+LUjJqN z+&OU@-vwCf-3eRw@b%`H{vU_cdc^J9F|^w+KD!p|_;tbpr{s#zYw7ELpVTAj?v!6b z?;rYk&-x#7pL|+c`1Sdk7F*p9o~@tUZ~K?-2WPbN*lk7l#hzF;FWx;%-Xdp7hEqn~ zG~0KMOTyZ2F1xq!#fxiSB^Tv&a=p3N#?9w+jVQF}=Cr|H^QX_!N$%xqnCWwS=&5CM zjEb^1OS1Q`emO@hJ$YK|oy;BDwndA6U0cBa|KF^v0c~YhxH);atY5v!#C@IXH2UA)j)H%eAODe; zGraqDexjoF^2lP>s8eU{PP)8)8Jjm^-JRQk-J-3g?oYhBw=|c_Pn>hdEplRy#DPEN zIZi05yBiX>?XjfbrQ0{@zK*u@zx1)}|J(1uow|ASXefP9p3!dSlrGP|9M$&nn`50n z7F6WD3M;n$V&%fbKWvvC8#L7?%($2N!(Teay9fDLA4w<|AG&g`b&q{R<-Z0SO_-f& zW&P{+kO9tZZQ_TT^tiIvPU;qc*jXn;F?nZolBRw6v7pXa$+HIZM@j?%SqW7oM z&zi1ye&KA|sV%otP2X*0O@tlJyz4{@6aQN5gmFpK9mjcb_`fI@`3hY-a0wKb<-oQO{{}d&ar7 zC115p7+7MT=zc$>(6>WjYR`&r@$ssxW%$i+4DZ%k4K&C)z47d`!h_>FWkhv8 zP`%hKd*Mg<6v27(^M$v>+pX8yssUi4(XZ|29cAmYgng+@Obt`tlivAv^Dv0!uCeTAbOcH|CPy8MS4t49t# zgYGya=}e3?d-@@RSG6(ZxYd|%CIvOT+_$o1^lASz16kYZ1wp0l(>n~h@%@!uJExg{ z9XZg_DCk(*s)<7_%UZj2n=*076XT#0zkNN%Fvzq^Sht5st+saSzM`V#XlwF+xK{Vw zHot+3>Vl>n4D0r2?TJAhXStP6?K<<&oI$4Jt@<2!cU|w%$U~b4Y;`{TWapvWx}YZm ztxSgny&hWq+fd%NxibU>Kd1McJoHlj6!U#X`}aLK7+&r<*YQz-^VX|BZSAw@^>H1) z+Q|=R)~xukX2R8&*?Ju#yn+HtAN^jsafM52zwWOjUmNBfo|#whFkNCc;gWcYd6H3J z68x2Q+cwx2?Amt3rr*)Pfz~Q_(pA_(`CJ?=jK~qn*YM-A9Y=? zbA(S&p!CrnQuwRhhJ9Yi91X>XXNt+cYChqTG|^mW6euLW&1b_Kk+jY;bg~!ucch6< z@p_U<^Q|@Jzl>Zb-j(cSSXSV(?}HC~xX?(q)F&!XI_!7qkA{w<{>-_b=|6KdN~k0A z3>`rKnMX+~!Cd=QH>BkM+b~{y_y=Q=T$eNxcgDOo5w>p8!fC=^nTfCd!%Qgc1?7~T z`g7^}q;I~^`Pi+j^8%sE;;*_*?Y`{KIp1`CGkCqh!NA9z|H$=yK5M*-cgue3QaSbF zr|UQ0sGGLD+qQuvSG%_L>Jd}9bYN#O@7mF!6Lw}g?s_m|NzncEvY1}uE~mwv8&K}O z?A+BZJ_nK)&$2U{_-6DMA6~?CdiV9&LlZA_cxL5p_bj4hde!&sk9*&{89L-`Nn-2c ztqZCZvom+!7}rrc8dxEF6dnO(QIx*%M||3G5cEij}IPxvvgRt zrGmK6Hd@^fKY)C)WnVa!FO{EO*(}wq=VJI-t(~ZgKyMDo2z4EvrftReJE; z)^7S~<;u;QOsM}*r}AW8&Y`kbTZWVvWr=_L)5rSa#Vwm3R(#d&O{=c{)8792aMFz* zuJ=Pau11Lp0ns6ewPV!2g)2tIFXj zr2IO*uZ+j#R|^v4Atr)`3Vji=o#P{u3K~Mh39@RD{8Oe#QNc}UDA~{B*Vcv#8eT|= zM`D5EeS}GZOd;~E=J4g^p@RCV{d`5~pYTn!)jZ$o{7kM-r9Ver#pC3Q6Y3)y4n*<^ z8K%KhR5fg+Zu^5^iq2^X$>5~m^p{)Zxno#cq08A%e7c@cmuJH%jv!tK)(<;qxbU5!uPoCrn_sO5A7~CBq(D|t8tGe?Mtm|Vydy4_inhrGuu*z^f+uJw2ocDfzT@|) z&k3x15F!p#2t?cJWdeC&sFYK5Za=Z%@&iGFNFJ)VyVf!bBym%bA1aWAh|B928ZPs#$}i>1ia*M@KHG?75$qCCnIlk$4Ee8pKEf$1 z0j=Z+d@IF#c_v?$!>_7b_tEoR{ey!=p)<@IO6oa=TkAKzE6f*Hh1$f)HoncX=_dB| zEas1|Qam^)aA8L>alCxK|`tN6&T)QgfWpDZv=IT!l0Btbtdv>#DlwP~I--cuo{b8c|s?hg@7 zo?OBs0;IA0lSHjxNEKYMw{YB^W)hP9Jl|jC3LV8q{Ytq_y(E%TDkFN+n!WQLDlA{PTrbjlsB~_5evH4D-qU`s%{F^a5T6kV3a@g$Epy6E zj`82Bm)h@@*%E0~xruwu)O)@|9*$~n((i?}-CMcMh)Q2USMP_CAn_Sb0e7!iT*aB( zsn`8q^eZtN>;04T&+_~@e_tXvRdFxMf1}=ue(%jjdfQ7kLJPhr)du&pYE)x}{c?3^gB_Lv~sr0t>p-`O?{)!V-#ZopvM{zhRldWTJ) z`0hYWTxrs=mc0&kICik@qJtx@ZcH}lnrQ#)ny=Olx^>o|`p@m0=x@Cr1@#%`d*net zcIpV*0X^I-)`U%295(ftW!jxlCwm2TITqAwQBaRt0}M>#`gb|tcVSQTj6-X0f6LqQ z;YC6}*~~#x-NHP7Z#jM0!LApAy4eowls=%Z+YB$^mi#B%4?NucN(ix#cXCD0G(ZRQScXr=8eO8#o9Ls>Qmisq9>{Yxq({D`c(F3}T z9;kbDz`_*;drSxIjQ%F$n^%@@vrXS$p6K)Yr0Jsv&D>}7Y2LdY!wz=*uK&37uZ`3D zuMR6(s{ibZhd=-D@W9B2`<5IGFc1c{Pf41eY(MbPxV&FuSJm!a(}P^>>GKN@E)1JC z{N3)Cmb+ps{ZAe|?Xh&in6C$p?my=0*CX7fk6-UOb--7;^Ex>P49eW>EZmoAbbKMb zP#=a1T^Txb6}?cmp3D|{!{_%{dZD)+m@U*!x_7ZYy-;@s3$2NLA)F{$J&{YT^lUZ5 zm2L|y-bStT*fV`bE6rc%sFchWdDUhvlgBUQS7wN|)h^`9^A_^!Geo|%nOwPiA;0A- z(e~Pfj`F_t{0^@~J8Lr?c!fe0#&H?`N#AShZq`-Mf9RxgYmT`=;mF-YLDUt`w)l zf%N7C%RTQbD}N~3&*(vd@0efaIFeMc<)P6qXM3F=uKG$y_Jitg%mE2a%u zF{9^-=~o`6bmCdIadx`sbm`!`EqnoHr3srDVBy34AQL5L1 zv3e8!q}8j-T)psPq_Qd;8M1Bkm8z>irjfv~KYdfqte*O6`e_@-<5Y2AL)g zYI8Qqy_N_JGff`W8o0^#EfEaNGO?nC6O5cot|BR6mFY6PUkrGjli#&9{C&()8zBluuW~Mx9=a?TgZTeAvB7CgU zX4x>e`=A`s@<vyN^)wC2LW#TO1gvlSbdobDa=~v+tzjMi+v6UpP9kcw}ut<=YEW zdWTyb51+m`JR)Xm#)c3At6TGPhb1K=`UvBrwu4WFEnX95R}yyZr7UIt zxppo`hPVXxbUAt@{rv)-?e4=HgFO1Q>F4tHj^C$`QFCiDY=;!uZalZ*%+Sl>wim+= z&$kYEIqTHsU@wtp<;$-F(g!_FA8XpiAYp9!+>SsdKBqv6XoiKEC!tA8#0T*zLm2c~|F-eQP^xLAuq&@EL2u=S;MY=f!!h z37X+@XqC%ByW-*NmemfKKB1S+)(2DG92|0b)XNuB=P6dq>%7u-R1XiYB||?f7#==r zqSf`6mX}{zt-c@)(6{N7K6G~aNaOV3OT(W=2*cVN6?`q8(0+3IJrCX5KaX&-k4#m5 z_SIqjOg`IeY@yBg!nsOiyFNa{MA>??>krTVPIW|1xSeNmL>eu5R?o+0`>;#?zqQMo z!H68MT7AN8D0wQ5sG-<4g=^Kh2WiLc$qu@`YrVJd)8apVO_a`tyh&OKF4p>38%x%FqUx z;Mk!3I5udx((IzxAoY?D`7t-U?2?=MtWREg-UFVRNjL`V6wVoWhGYF!;~cPS7^YK% z;}nR&6+pJT9yqsIwarLI8*!U$^h@O6j|i3fTyt~opUgabc;$FF`y7k2&p8;*pBU$T zmE!EPxAHn8?Q=ZNbyjWj5oXUE1aj!x`~t$7KacREl>2Nps(a0FhOQ7t^}wRMHikI& zSr2EQb#V517tTH>Vwi2h5#u_mw|THGbB`Bwn>U{^Hy>MQsJhRAx^3fUG4z)MarSv8 z&OZNvv(L|Q_W38AeU8B}+nm=JW?Q|@k1UvnMTpxBZkP?YVMaJ^7#3Xc2xp&F@Cu5b z&j;@wIfBK)WRvqP~0%W73V(VAQc=OHw+8rNW=G3` zJ^L0TC=Jkj9l|=K$7OK#E_;?xsfb3!9FYvS>ca3ybwgV!d;SPZi|2{-p#4i{`Uv{@-L2u@V?8 znva67nBe$e%_@PxqWM6HU=9nhXnvE)1uU8mG$ZD)(Em4RzJfEpY@nap;90Fc1m8{= zHYUz8&_pa(=%?3wA5+!$>Afi(j!ir8`;p-^h3Y~`JJEzsnKU72NO^kyQ_E@(4Vc`^ zWa|TKVAm)XoPS`eh_ohYDmAx;4Lf4}-F!>HMQL(P{Mfpb=K`9EG~Okob8*eZknZ`9 zJReP3M$&pBEzE+e_)Do&SlVo>GfN(yu>hV5P3tKMPc;2SF^-}@#aP|hY zy|)#7;L=Q_6EW8Qo4qou_kCOu_pYxANg7*trk{1aO$bT%DBd*Bc4&y(`5*{>XttV{ z%g2B}_%xSjUHYiL>BS37h9w=YJme8a(yzFFULy-RXe;LTD2YBoY^Ja>bJM|oZo~Z9 z1^@NAMB8D{#pk(!;SC|mLtVUR=m*XPW?L+PqYU|7riYr|V%S&!1JJfO72`~sV4P`o z!A&+>axhzWFw9mC#uoE%wiw53xnrDZcEL@0n80jtz-$F#m@Phz+1iM)#Sbvfv?0cs zW*6Kvvt{J>Nyb<3hYQ z=jdfszl1oZsA`rwaeqkZ6wtq~hoN6=OwsIqe zj}wk#OyInzINm%5=SHZsg#wPL;wBUWf)z#-V7w8CTkLX1;WM(3zyVMH1<031$4W8O z#l;8})!ITaAek8PtpMjnY{3Z15w{rJc|#3Aj^xg(4kn7Ki!si}IgD2^6l0szX$*G3 ze~AQuJ6{SOm>c@%N{L@v%2<9OsaVFbJ2rX?d|<_f@Usa#AXv!z1yQEoAgUyS3- zi*U{~yWl1Pm|(Vwz-+0!Qxvm>46LMmS{ltOM_ z{4qD38Gu@Vf%=wW$l{>QMHs&;#gMH>MY$s_!s>jZ>rWw{SdLM97zhAaLAq6ATDKtt}J>vpJ#qF?0Ex;3_pvon|qGuws}M{1+f! z$iD*O%cA;CGawX|@?Svpfo8*pbhX;4UVY{_B8*9X9wGr8#~2avrPPJx&9kU})3`G9 z8-cdPlZ{^rfL5TwsZme};$MJ#afsY3st@5gGxi7K7K1xq1n#^FAV+cMZ7{qSmiErX zerOrb-{p)i)N-f+a+F6=h3cauZ*iPk9FH6;j9?esq+%T~TT(DvDu5itZ1FJ6mO6@H zR-Z&aYdFq4P6Wa(xM@KIpb(RTtFU}|6{?S7ws2f(oHziBufi_4X=bZ?iHN8t!W)PL zLC3)qa_iN77BhyR?_>SBwNf;CQxLg6dcCv!f38u|H^R`J2PV(8#Cx zJ$?%l_aBf&Sj-ytz2Ae%UK8CyHXI8WIeP2NA#@EB_^|NalSx0i)I?R2Lyg-=*jV{; zI8`t{EIur@rg9-vjh{I9XwqnP#X0Gu08Frj&ZJS}O`tZPobw?G*niHBuA3?z93LJi zfZ{3Pfggkil|?-?jTo|i7oqS9Xh^Esd}_c5Z^`8Av#2WfStiBCJ`H54`>GXHzx<#s z?uSe~Su&AFl>?}1^Qn<4J_T;(oADfQ^|^=b*SlzAck8E^$!S#n%-i-b&$6h+8H39X&am~%`SLL6U`Q6 z@W?DJve^P43wev-$tF9IAek)^$U;8T@Z2MxX?DR)HCrMuTfp>0Hd`c+g}lW8WFc=c z09nXqnul|y*#$S%Y>}mAQ1OLqws0I<0J4zH771h_pJ@QHkk2%`;HH`_GM^2VM95}~ zk8_J57mmEeP_u<>wjhCzex}(4H`Q!OflCARfFv2#lw#F0jHv}UF*VNFQe6n7m>TDN zsI*08D^xA(sL`3Co1SZqQce1fEK7IzR2KoA`kp>~*Y}vZ*#*v_CaWi@*M-WWsru}Z zLtV2?N1ayUP~jmp!R89G%f^_`U=y61h`7avE#wLg0S#~XBCg*d%7#!4Z0yGp&?vfcm!WA5lU=4!bmdbHO>3GA z6+u)@qv%R(44T$3!N#ak0J6;uL``JV8U{$fCuCX3I!eLeD#EZ_1dijAhVinoKMeDV zn*s*VaL>P>YG_MBR+|9<5&2zgPFOR&PbzJpyo)#ij5_K# z*m=5~NclDaZp7qmf|LS_N`bJTHdn zrcj(M#_>>rQ;WRCs#F9@EWj@K=)|UELBVW6wV4{^MloB;=74nLZH8tGa@xpdi;Hun zRjCLRv&Am>!eOr_nJqDxEfvU(Vzxv$TMRuIkOOPr)FPWLRVo6-Y_SV&vf0`SMY5_` z55;WZIJP*<4-Uqe#&U|;1vk}fiNI{Bpfwb;CBWHY9B&H;#Kb{f*#$S*Y{>xMQUT;t zZ9hYgsX1ZIbltZ~TPPGgoI{P3U&FbHh+AxRM$r&T2#(OL=qcAH(87vPcgtxCtC66% z@k-YRI-)Q+oHV~3O_oD-VnIXKL#cN1Xy|$*#ZgB?*QFFk9SvQln)D!|>oT&@jxuV3 zW;sld06DU3%v{178l!Gfrj1c77a!+URHXz^U`Y0dFEs6WqV4U!plU!Nls%m(6M%BM zniJMc?-LG72Pc40M_tUQ>;GCh0V=Sel+jRWedw|cCRtQS8L{;9msas(o8mw~MazY~eVzILr^65CY37W*6KfI}K(_3^W-Pw1(nsAwp|(OGO;#0|&%Zr6Q=w zP)xY8(2bE@aMSEGm@Vbt9|}lBDXjj#hc(N&H_8UhbogV%+f+8i_|efn)Hy~y5{U5!>& z1$S8D@^;ag-)Glz*FT=p_QIeACWHOnp6xULaBo}d5=%3euLHvNj;#*RwYeM?5OcV5 zy47t<)8hOEt*zdM{U98@W5n#qBj(4zoWa@Oo&Wl1SV?%;+}tC(*4R#6W7YS9QKztj zV-K!M*qDFeXv{(P^eGdq^oxg>#jW|;>g16}4nsDC?_KS;Z#?uu9;VYH?9lvpXbyhD zZSL$fmc|zb)`smEduT}d6Vp+XuOAwpK4+q(QSpGhF#m;}2JJmOdTVN%D`P7!&3%5h z!35U2bN-==A%`qB&g*>9s?&wRTf$C{4VsZY?Rb5P-#NSV8LzE$iU%zXJ5lrT;*LQZ zZHMrV-90+wbdTY$j}V2h)}UFowYIiHK>_0~^uHeV%ge*<(k+i$juGAb_;S{3%Spvw zp9(Y?jQWNh-h6OQ4(~p`Fig2}r+IT236H@Mo;iQ0>tieBVM#iBlF4CtnRb3|){(`ybd;{T4qUCx;QF}vPKwb^ei zb|?-u{ghH~K&a}FGBu@k=YN`~c!cx(us_Y{?fMrLzWBT$JoxG}j&ja8H*tIo^-m-D z8gFoX4Yd_Vx*)s2ubML4D#P093@9KYY|qO>6K!pJTMl#?@N`>2(!9TPEb$Dn9+qR7 zh;y@%Hyb87f zo9%KY0b(zGoR^b}^>UJN3v%Gb{xtKK^WRbU;`3a1IkC=}0PE#c|1^?aAQ1`VC>`&V z?#HqVfJmrfM&{1EiR%49dIYcz8uDhtFj06pd8#i*dO0`YC{6v-NJ@K(V-5vaFQ=*M z5kR^j?{RL32uHirKx`!$sza0Q5t~-${4CHC(;c` z#xQ6iHgFdM8e!Dk^*h!CGC@39c$_gjPC*PIST_XKA^#V1Ax3_mWT6D) zab%N5bf@v&^K--ajF4vY-!Wina~zD@7YpM)fQ)gk_WQICN4Q51G8Lf2Mj$`HB+Rd! zgp)?G!AYZt&@&;6&j$izss>hW&i#$q8H0co3kSo4lh~hToaFqM6yCFB4CIg0hImx> z4~C4AeJrkzl1vX(dBjL=DHd}0@BB0*IlHWTtU2Q-=ZuBN!P#Px4sV=>L5f$kFc)H@ zTMGt_P-E0fhW^Q6#32BsvG6!^7_9l_LVA{rfR|H^9imt?EcB0y^@gxN&6olA?VSUVqw`6HZ(0~sm3oi9f}v*)>fGrsqU15e+_@Bc2gcg}(Gl+MoQqEoZhm3`~c zIc3n8k(q674If%+A&d>Y$+HhP7;)fe%0-^FY>&_F=-2knm&U#7RT|JKWrp+N=(`e?mIyeeN39F*gh*9XORT$~iXrLGE{79extEq}#iTzg^PZ zD)PPOlRQAET*_-x*Mb1%O9|a5iaKX%_tl7i1)^X{r&KTJ>(MFpYcGv?Wnge1AZ3X2 zwXNdi&n~BocfJ#yoaItB+TFnW$*Eo6KKdec+>|RFAKwm=mXD|~cvY9u(K$T2Bqu$= zDTH@v{Hw3l25d?3a^4mFJZpvPc=6IFw=%L;xth9vH7Q_e%6jL(TbsTaa?I)0kcSJV zEYhz^knfZ2F&0E8*}Gi&bR&jmUuzH%FfL`W^QmZImZR&~@x4ww_153Ce%y^-IRSlB z<~WB$=VUoo^f_R)%Kl0Rw*_-w`Ni=B1qt~Bx2yj~T~|kh@7OEb!)v2nOa9ay2wQ7f zVPM|>EA{aZw@+E)91#7=e)T2O@n0DP%uZQVExdoyAz)pKyR(1vi>#Gp<0ZdN(s4f2 zD|qeBB|VO8>0g>Nv%x1nc^h|okCa)?8L@+XcFD&uKOk?#x`yv%tuB3I*E=G?xco$Y zLJQ_8eqE)LRS70{nd(IB@R>@&ea49N9T^{1V@1M8 zC-`;MX+0*^jbeOxd-Az;-@vb{ZtoLmTl;mFzJ1lZ^gwM&JLf;5A7!};@BF$cBKm38 z`m%4_d*3;bm(p)jk>d}elig+qMeMvf>YdMifyuUC;n!7Xp4=$L_vXGx-<N>SnEfN4yY#GL|3{efNzwyO+i11DM>nz||HKoR`cFK8EB}cnP@@tT z5wiD4`mVU%W5Pe-J#zmEPsv2%JfeF_xW}Y4ClVf>MxRnsPGns@-2L&vbveH;{Z!E< z^YGglMPELyjw3qN$L$MR@yGcc9iBM8vRh6hy4klJ;nd^Oo^eqd$+SBqiyBK$mfQlET%iQm1^Svr#VvTOtRCo9gX?r)CGLY_b@ zOX8L3?p+zBSLU7lN9;YtuEMBRc1gqSJFRszzO<{>Q@nlCK-Zm5quSm`8lTm9(uSgL zJ$Hmo9lYE2=Y_grVMSx{Yo_p*SaDW$e{*aig^FCMA16z{YpSDRmh|dO-d?#*s#Dub zyB9?Desy=Ty-sPRuw~JVtTrc{bY1<{MfG)m^UP>uD~|uH_TgVf_7ukFH5OmZBmWXB z&Z_ROkIk}pdAwMcA8j%yIMF;xyfRSORi+o5+|j;6gyXnNJFZ7{epL|P`dL6!hw;fh zvpVKDPAa>5%ErEpZ|9?5&g#F+IL`Y{WAQX$6#OMtoK@XlADhYEvPxpTEQ#=m^R_nL z<>M$yt%who7>@Ms5!KZ$agBZJwN8C6J@D2!Y2eh&b&qjWj~j{ZSvw|$MzwF~Gra#1 zi@3#}Qb~c(;kHQ_eQ?u+=|26h_p!S>%f4-dQ>ROQTcY}j`)*jjdv;W>8+Yxp+T}Ru zRBTHc@Nv`m-E%uuuF22KN%Q6vCj>2SC%c;vV&-iv^?S+4JtT4|8KrkgeF>9;FO%YZ zJpl@nS*+<*)>^hqQf8c|Z_CKs%Wq4AD|9c=KF+n+&0I@kM!J{beSIjN?)hSj#e>be zDc0qXmI~eGX~dCi9xG11HqA?QUb3wsec$C=%aN49>lZ(mp}})+EPguP3H}n3JIjhI zHQ&5cS1U>L;nwNMESA%6#RubP!tuLH+mA+dv`g-7uUqP9CYX)ZScDYU@YSXs$>0!Pv^DdlS4%$HlvJ0yP$acInhHCEBG!-}qXI04x?qy?P`BkHEAUhyJf|Z0|RYUT}F-w+&hhHjTFyn z#F0F6R-8heQ36VBRo%7NP(pmeq(SuHPV7q>^cOm;VaQ0~V1o8>c%Xe+JO%Vq&gp3i zL1zR9V4?29c)1uaXAp^(GZ5h94B+c;;prYL-II|M2sW>^Iw(Z4c^Yvfo5zYH+dOSm zT|{gsaOjNGFw}Dg1PY!;9EpO*iX*cZwN-V190M0hgW4mJQdra;o%Y&X(>1jcF+{W) z4;AT|Wl?*Q&Vz(LDw=7!1`Hn1=m<^D013fka|SdQ3MDFSt_hQfSng+45=b5%TV#Rk zqBT?1u|*b|0u!VREh|pe<}g(qTV#RBq+-R%+8m~Q7`Dhl!vbT>sbC9CR6KR2s)Hhn zA|g-XN60*-!E~8Jp0{;5Lu$YSyqrO(lq$?n5*W#n14hM=3QW{pjQ8~fC=BXCkZU}) zh^fL1s-kZ-Rc*qE{VB!!dJd-Ug*c1%l5GSol$tt=#&%bWBf$xpUuVUca-pRvcf?ao) z%?^%QVQnK0xSLN_GYoL)U#_IoUu$KTbdf?SAF5g+WVIlR4O6`J8>BnqooG5f@a{K~ z)&0q2Q;BKm7O!(?O8qLbFdM1{0kT`9>5dM9#+_p1S*l-JP!1&es`5V6Go9>dp%EwP1FMuJ&a61Ay8m`;4hemsDFru6e>7S0bi3@i z!zw~m+wI>eitOAI=aI-a$ugk(sDPWSPu4$8ph~<48HbTQEi~dJec*|*G@KP@RrlYH z&7gRBf>>7&ZL)&w2CxM>_&ibUQr6q)890)idpyNEiDglybRU(w=20eOYk&nr5^zUdn1- zeL|1}0|+Z7R)n{B1?J+t@fI)grdCY7m1)#2G62x5)I>d;#}CS1b>S|PZT%3m%vWYkbhZP4r z0Syq)R@D`kXF`J4PxaFDi(e@*WSk#Xi<7hy=ILct962+ut*T4U5kpLEp!QI_QlWzn zqoC|Fai+8cDx%l?Ix9}kd1wlwL#tI67Rv!XiN>=|0 zMSLOCxB})qka-3r@03g*Frq@qH{rqNPzFL~NlWV{2u0Gjwmx6g7B&c{FP>@Z|rX&kKg_H6H>iOAayO-Xq?zCUkOC$eItUw`-Hfd1j zH3H4NQ=z{U5LcS`C!ih21G@ZzOf0|xl%*6 z{WM}?Lun2_S&0$oL*e95N+E&%9mbb-)dGRz?O*SnFMP4G62n}Qr!1vty82~u3Xdnt zP{_?!mQpl*@o9LA7o1k-gbZaB%FIC1&z>Cf>qF_{5waKn4v#V=MHU(=3u!8a9f+q< zZI#9SMrBE-c#T_`5au|#_mWlSlKrJII#8*%7 z&gyVyLyzE$xt?qYPxUvnRuSEaTF^~)wlnRTi$$C2fSnm#|6q-$=c{hWh<4Y$Ab`# z^GR=58O4=aGZ8M+JQhUjdJHqltr>WWp|WK zx0)Ww0}i9g=AsRdrJcFmI0786hnknc{UpiIq zDa1>s*?1&_hraQmc)6S(=#$Skbm38idY`gvW%H<}2L~KX)O{P(@rk7K!_iaqo@zRH zT1t0(0zx`@Z^^0(XkgTIAV-V`+Ve3NUyGM8!Tfq+GEU0DTPDTPeR@tHg!C{AnrcIX zX!JDVNLPmy-@O3wsn=H3g+Y##8se>t%#gqoBfPhk74Hy%=pt&X>a2JI2+1`OeT1?L zH=~GNBaQ?Ju;P@Dfr6!ItLlIb&yo6R(1?Y~F5FFLMF0e-5l15Qu;Mfw2BK4_RBaZT z2Ri&#z&nm#h>BAsWyhi5I|v{&Xyja&VeywkIrB z5GqU3JakCUtf~wI5r1Sse|zMpf`cpEpudD< zn`>*fCoGl^22Y?)xF8ukK3;9uIB?WwCM4<)?IbP1WIcPiC> z$vI8vMosu>x`!*P#6#VS@X8dpm^B(4JkY)xZ}E|s2@}k(FTzPVyv`Be=pMin;0GAu z89j|SlCQvuBZDd0syYBuwpHkI)Q=?+Ekz@a1g5a!$S$JRs?JMR3ngXhh#sw^Of8O9 zQpSo?b)cjgU?Nx3SrLslPRlf3BauN!tDztwm6U13kxI%~ajJ%uY}Lr9dik@B(=N>y zm!|;-4--kzh$GR>S#hdt9fhf{t*T4U;X*jBNiQSu0=Vjs1SzKYhnW7v>eM-IALifw zX8)YxSgzBZt!+O1n3)k@ZD=|C+LTt&$45@L+#Tc1-AJ|X+

tW23pc(AHp6qiRjr zn@~Yi`z4)^emSfEGUGUM0y&^PmLqo+M!lsbKXo19)T7ZL8mQqZYSa}$lE~pZb-CGR zc>g07af>~rtNq5)#*Mp!Do|TVQ2MRmjxAyKR47s2eHt&6E1U`RbbL_}!(OWzQX!6N$6z+cs*s428D08ui5R z`IyGFZ!^k&R{QWTBYO(tKNBb0s@-G78`UVYs%w|yq*J#0^JB9tUY;P<6-1j13Qlyh z-^;RUrWQjZPWB6CY;ag{QuEDAb*grH%9my)Z?9a3@k`@~_fWCo$Zx#1s!k#) zqGove#(7&CQ$CJ2?*hYy4 ziud(mOx;(+lPgyGm*h4uaIxU2y(!k^L}5L(8gZoef)z)8YPD8%Ub3wseP4A@hxF8H z#K~#EjAKGp966lUTGiD`$ceT<@l=N6Ue+*Llxa8)eI0PZaX@eLwi^06VBs*(&;tjD0d6l24x`z4Bpe2P;}`PyB50<97tsR66HE7y*1*v{^mV|| zJ@j?J!N8!e1J0!biYLyc6R9CEv`eSnc(hB0zVWq^G%$ET@x(EB(ANP+_l9`7=iup{ zk7w|J;)!+XfZ~aB=^(LzbLli2k7V%BH+~_H5K_&YaUeVv^#3rgNL#4 zwUScE*Qni$Kw(#)hcZp~sKwKu2RZX>5i5?IXwz2Jm6S{2omIO?{o)71NLxk-Tw`&x zETj6@S@Gtg`HY-US;9xnD~}Y$l z;e%C-6!;Ei83UN1y@I=4m2iOXV4SbOP+TOQ;u5fSEfnL&*<^**;{7CtOKU%#O;)HA zHEgDZA@dL;Rl+7K*klDdX_QS?U=ViMWCb!M0V7MrCM(!v1-ijwlNA^SPg^S#*kpw! z*TE($*gTJB(Cc56G_lDFHdTUL%Z9ExHd&#qct2HzsI4D=E!L2@Q?5%$3-TOjmOKlL@~>LbMQWI+mD+OnFeGhw8AF5cJsitu#5NlaFR zsParuWW$6`Qd0f^68k$;EG{%&fLa_avCoPlKX%%xx{RDO;01KUqkU?`k$3^DI5ICl zTU8ekEBLHJ;cxo|G;mzAtvbite0Amdu)M?EV^590x9WSOOUr7*hZ&+Nj*&yG?XQNP zlO}b}t=~QU%?7fk!oipz33PPuRSnvs8bXk*^;Ko{S-Ru%RF(3F6er6cj{d$YR3{=4~P zFOC5&(D${mIEl89t@T;)?E$Rn{^HmamywH5A&p^?XGQpms9J+AV!n z$J=o^s?&{RVU%8(?xYPx-FogwCVRL{OSgDUc92nvlP)0D4UQEzU{&`Q$0j{T3@)H* znr?`hs*#=&Axv5p)j@o!Qq;=9$-vb=-pMda-~G)qqmixrsopi*)`gvD~8pec@0!ajZ;IH9gu`aaMKz>#;cm zy<@26g!It&t231Y_87&YWOKqrEk`(IP|XRM#}umh(^PXp=Dwk7{xsd3kntODqBiwN zwpw##k?tJSDUKci?D^YeWMTG`Mtu<_J7;@}4-h@GI_5Y|g1>z?A*!{9xl@-3RA0zJ z#$jY{LcX%C`WC9w*|A1_5zE@1_$cf}7)SNEk?5XfAlc#Lq*JjC`a(`1`$AeSwp4bd zRBk-Ui)9Q#pl^JBb`FOS-!N$q&3x^!zAY3^gyearLQ;c~hem*m)GxQAeTN8WEg3A< zy~RiYvLc~Fg2_8OD7*musb+UKJuV6K=G7+zIVexQa&~vqA9{{BzEEaCFW!t=2&3JX z-b^fMgVx^TA2utFPX3 zhgC%5mZVL(dW5REI~ste@b~F|t(9HUMMSG-h-bDmi$}6M?Bcf{jVfWj^EIk=7Sz;u z#Gn>4x-i7^5;^K?gLHC$A-Y0oag~#dUnNbn*E4V&*t8c54>ng%EJJivRDHS;FD+0I zlpBu(N1$)K6^{dn4S?p3(eDLPc%czTa&=g7>ZL}B%(PW?FmejIsD!F52GT>T5l1pO ztT=LXp{=TekyE#!|F-(2`6Kp;Vi%*(0IEGT;$+V&#-SA}PDNGCN_Ac`A4u#wLw<|$ z4w1kVjW|+B&Wa=XVKm`5H+PB=%LacoBI4YH>7P04t6Re`>4hip#~2*jIzM zXuJTmI2td26-Ne;v{iNKIRbhn5Kbs7P=_Q)F@?6m?lc7qbLX3BzGbqvtddwSOCo&2 z;tOd6D?T=tVO${-#Z!3(C3;9A=!`NR{0h9B0d%aw$r)7R{K@pt0T6;%HGVD~=r1YOCss%ZnhY-K$E@ zqdl~0akQwG6-SP0wN-WLIgvnDhxslz!~l&rQhJ#c2O1hR;g~UrP+L_O7ApcU1!mLW zu-!G{NDN9=oT4wH1SQ(4I$*m49Yy2WBGFMa;z)E9Rvej*qOGa}6b0xg8tfN|j-nAq zf{s~nWIBqrst)KV-T>aIt0d4uSr)ZNJ~;p1rfZ0_;8S7W2d*veeJWl4cye~`gq@qa z1m(z|mHsW$eGvTB+f-d6|S7p)VuK!D2KXp7LJL65fDJQI}9Z6^> zi$=(LhB%MA{DH1JpGMJTi=WkJCtZsbH7dm@YwOK*7aPYC%8?Fa;RsnX>nYw&%*bkU z!ig?H`_Eci=r2W~+w>QZI6FN+o9sexJ*xAog80@71E+4Tdz1w!|53aK{iUc%jx1eC zLRmJ&=cjui8fNK}{NO-o=Q`f**-^c2(A^FGqm)Gk!!W3F0Fx{kkg~}n1Kpts>g4Rn z_6UEYKdCY+6YnSnW-p1&)AKBvxOfiU;uV;SSCz3Wi;@DZncRk^?>RK!6=uqXhj6NUG8t8JQ z6lZw$>D~maID*;GZq=o$`b({9OC5VE0AY0J>Go7gaVh{|#hYj@o3HA^Vz~gf=#y{@ z_0mxR2tD?RZ1Y6c4ps_V5&=;i#wRNaKmTWQ0gX5nfUx4M>i*`~Sn&kVT!2Sa|LB+b zWK(>2M*bO~H5ze>56_A>(Y0;9ssp$Mr~@2|I6*px6d#_EZwVFd8gYu1&5Dx^wwmCU zH(%8O+yXr<=$M}jiDXgyR@jx=-Q%Y{*KNhI=Opl__9G0Mch0j|4)XZ+uuR0mhyt7?P`}DJx7@Pf<%z z@Ix91ps1zj2am6I5|Cbb&Ejdo4ZHZeO+WYOJKwkz139h`;B7tTLrp9vnW^YTgG%b4 z8x3UCp1yTdDF*s$LAAa@zqDL+K#BBPpl>{sVpKOO#UNh{snAWP$LPh7ZN$qN6yfCz zU?>Du!bF6ZFoB^EI0+M&h_Q|P@UrsaFix1L%2-fS4q{~~24coTRf>U>tb(2v5Y-y0 ztrk*Ls}Vg(u zT%HDe5=;zFBaVawvEs;d6m3;qdX5N45t?WoiH@QXN1~&!;uQZ41$Ea})rG~9Wf&a1 zP?kmQ(E+&Tny&GZiQt*lewO+4StD)1F_;L!8}`Jfr(`N6XFg0 z8)bw1=d8^6{il!wpKdw#jlU0>Z1e04(W&06N1J;?M|bbvCH<1IediG{9uxXYMbm}# zWc84Lr>HLCQybQ+`Z2VGRuOeY-FogwJ=4`<*u4lp4|0w*Fg*9JjOt^zg!18*)71#7 zd2PZ;`MK(z08si{nFiC>L#XNN3w6chJYqqXe%DmT?=Ib>hMV4_s}WSAW#c@OZmHWj zKndsDP?(}UikhMw*;A+-ZaOG9(anA%RgJKht~jLHIk;{Q@D%Ufq$cx2Dc*e!OhaBm zO+#L09H(NfSdQFP81)t^&-Ti7luR+QA4XOSgGynCB6T|rsHxh|huNw(soAP=i#?_8 z6zN4NPTG~OtT@$5gjL;N9GhAdYsJ1@s?&X_JnO0^C6hf=qFRoB8{h4jx($n?VU|8Y z&gA`$oXP8X{bNNrO}(JSNrZHelGDtJv#L{d@A)6crbNYBiT)xuc^?!24VD-x%b%3v zi0^qDom98(A!|bv^}DCPaXY_zZpX?s`FS}s>4g?2IeM0?_+3_Yu77=OvU4JdJLS5B z%u^b?m@;@$p)FH`_aHuYGuP6XdZt(NiW7ns(=TGCYY*vVQdHfT0?b* z{dWuJb~w}hZAQ|a*ifl3-KYO`>fE1>50_c2VdSJJV2E~w?ggcfW1OdN%jlVxK;tN! zuZKDa@{@aw^zQ*xht^WRmyCQQvh@;tveLzJxNQ=~?6t_m`+5ARG@*Eso~lvEtxcH!szdl#}h@0i3=^ zo6DNuEPfQzXx;=bn&;w0^Dqz>HJbM(yGnplN(b{u21k*ky0T~o#}CjGrIUf;9YcTk z<;qt+89s!Oi}TsWBf&W68y_iDB!KRnRk}w4QWQ{!ffLaN;OX7~Pxq$kONXR;K=yGU zG!f>di^jWj>WxRcbm$vjQXUHD9{9012G0;r_Z&Rk12G!M;6XbREQ1F#vv4jQlv3ar zJZNWvWAHQ^k96tKHy#WgG>-zBAx>ODw))1=J@89$bPweSIJ$?f5Xwu3qf%JZB^ZB9$keYF35ABQTIG=>vDz$ z&kzsxhEW$J(2odvd&^3NB+#$qMUdHt%XGK9CZ?-!L3Z0 zu36~$mJ-#d3);6w^YDO;j}scO;>aGJwyG{eHR?hc6C!zdz{bZ3DOqtU!HeP?Ypd!a zVg8D+PjsV$o`pqT+E2S<}ELh_E$a|RUkQ?v18g*RjBC&tEm$;i%8 z>YM@EGm9C~vN;2ib&Cd}q2~-J_N02_(Qq8}jgL?@Q&Cc$kqjQ2Ge9?Zm_aFe&VVv_ z|6a1lOC|+_r_LFm89X*;fK+EdG86v2oB?I<)Ekdx@X$9tLN&|`Cq;|trLf}27@oGO zZlP+JnUYrV!8lqqtG4NtNtmn*Rvft|Oj}h4!~lAj8IF60=_Ih?$hCyps=Cwh@_Io| z!bd@%2ahgOfZ^QN85%raET+A;Y%31zT~QwCP1SW!6(VU=xdtQVDjyTHhw<1r2@?Tk z$^kM=IO!fAJl&_^#ikr26bfX2%W_z*Cm$)D;lcS`3JTbJiCoqm%9pm z+l#&DI)?V2X@50*t$VV2){aTgS)mWrS>aI6bY)+M(IXrOU%E~8b$GJIzBROzfG)_% z%Ek(Wvceqd*I|X--C6cq=qZyKQSBgbgE3@#lm+q%Wu>xS znQo4gP6b&YKY=Wew_I$g#9Lrw+tH{J3Sb@`;naz2DWPB1snn@8S+UxntQR%R(!Y`X zzsz~0Mz)P`%AiV!R@f!?w%09%zKRCQa??5<-4g?fq+R{{-XzOS^T~440WST^$?|-_ zTduXTOS(uA1s`78GmdPFuq?_{*;3=9i0+92rK(w-Cv6~GY9x~_HKwIE8rcTb)ygT8 zoz^-+X@9&U&tA{KaUitR5YRm_pdCk4U-vi9prwXC)lwtOFHH3sKj{b*yHVaX!P)$% z-ml0yWoTs^)o=XW8PHRMPdCMYejHAd%Kqo@c-Ru9IQbf1W5rq3{mrqlQoY88CyHH6Jrs>NH5io@Z@P2W zTvg{K+a%IgIFiGNNzaxVD$3ZiRg06%3+9e7D~=pfXshaKBqVo09T5czM??P}rV)`^ zoGh(p9#FC3$g!xFsxJR|j)0Kz2_oSm;WH>ck&0*U)V5=K_CmdR*$FL_NQA=;le>%@ zJUL8}1{pe-mIRmUG7F{&p?9jJt$j-xNx16MlG(k1zE`f??Q}?0W}Kt%$S5X)A`+Y* zhsIAhKMu3UF;)&K35*|C;H;iS1PnoVUXLUUK))!*$ZS5E8e8Ecym@=SgZ&LdQfeM z6VGbIk-`dAoFrp3E7e)?$hq;Fa2SaapbH8KYUL4p0<`Wi=5I5+y(*js(B4 z;>ff=ZB^Z5Z&?wsUY1124oZR@DDYD%bVJBh)F%Yd;%UMvpZ>9oxOc=IX|P!LmMUK$ z(syH&9hN}frET1YmzA_h@=F-Gm(cTy{A4BXu~25Qo^iTD>X)lZwZK9caUx_}#Ky2< zRiY=s>#Wv<(LSSsd1dVM>0RK({ z`lB&YSkNCm+0|S#9_cv(dh{d?;TY4|`1f#g2~3_O`-kIXS=odMijxY|&zoXhj{3Pk zqJC<`krFPfIC5E#)~e1+wiPCsEytpMYQ&MKpR71?a$9RvS0gEfzyit@>6ZpAL8}%= zOVG07$O&3)Rb6qp6cV)1rH?M6M2lzD;%Et4RvbA&tF5X_&mreYX>bsv1g%CKDM8DM zqW}?9epg#n7Zyv#vKk5*Qq8tT94X7liX$gzwN-U#LWPtc>yuB&Exl7|(BGSPORmE# zX8=U~{}ncub6m5nI>+36b>;c6yvQe$pI&Z%N$oo#qig?sD*tNJgo@&d` zZ~UA1fr=B3V_bJ!j_L&c7_#6rxKuZTt@z2DNEV`uw^s;b&`%GWcks&6QL#J|} z`NW9zvI;6m;nd^O9v{c1Enb1S_@ZnFNQRKLolOHT_(Vs?LXg7I7Z;_}yIT zeirUoEhlX((rw(1LV)@8QXJhEmp|CVt%Iow*J$mP7++JiHEZhUe| zzheqz1*|x$y1zL#Ry;wdEQtq)h2+w1%vs1gCf6Ck#6>yXSlol`E5M33(YtHDsspCp zWT_uX+@KxvNUEV%_vlIo;H-%tP`n0|wE=}3H7iCm%t zWL&&Ur`dS4OQ(J(8E?FoOa$l|Nl?UyX8G!Ki}d*@+pi%qN@rBS!g~^K{tHi;r%gc-Kat2&H)ZLeZmoTZuTf7)= z@qE}WNK+^s9Wr~tVE4n~Y+whCR2`n5)iYBl1FAA4_z>{xL+#flJ|XsznJWVN~az8Wu!qD(Oits04=L}siw za!{+as;iO6Af|>X(8{o|mK<}zG$hxEBSrMAI5HTbt*R?7PlJ$_th2?y@HFB`NDwPd z(Wp>>9BoxydX5MPAsQG8iH@QXM}m%7agqqstW*ccF=VGXc%dwd+EWZNq=VC3(=}c) zDR_4p)EB-OuTsAv4KyU-w(t$GQLGpNq_M-KXpDy}n<>gozlk z(2`=*!KWi0!hH9}R(lGJw}>GNI$(lI4}>`;B^N^$bif3KN)hJL6e=T@OAJ}i0TUE@ zRG5?599GwfAq!f+L}6)!IR;B3hAeCv6bFT+Non(_Id9$e2PU_yd-}Qgp9bGtdHC9h zM;CtDdf(;D4_kfT`-k1%Trhgfr2CyfGqm?Bm5u+@L{!34tY4rqv=x0KB&a$sf-7@aY`%4yp5(`1CsGJDymqQQFnn?*E?4u&r zOt03Rdvy4_U;V7L;V=;jq~-**BFxM8+tYzgLbxvJw%O${1JMt3b&gKYO`kH&+Fj|E zQ7bBuh<$Wm$Ldv-ilZ>I=W@pQ@}_sk%(>_2u8LwyoH-%-*-Jn#!hFj};ku;TX0gQ< z2sgkS$t%n4w=H@s_<7b|g+%3+Pa3`hqyhzZdUMXSQU02S*;m`Mrw)Gefx9;^e0i}c z-~}NUYEI-tmPsTk!d$p6`L+RmscRCy)NHSFXJ!4G+-FZX9e+{?EtDzc4X>>aY+g%w zpN5A|SGnxN9!r1Y*7=hj&pKiaKO4w8m9em?;J)1lI#1*s%C4410o1X*8J{`F9*^OD z>fB_DG~BWJz8}r`R>k`L7rXrJPRDckbF(&`vw!yfla`L!ZA+M*`TUT#rF7DMCCb^%bX@O!iGk}tepIgT=3c!y)n2|fHPOlMY@E1pj+ z*Oi2y2YPtOf~QI^-9wgF6b2uKmf@xem%PKZ3z{N?h0J2c{6Y{vPWpzUl-=7;`#Ib0K{k7OM?sVG;`+uuoNT+ zb4+X9(5^e-aYX|)**(5vhaGa+92B)rGWKZAT~5*{kdXya0iLOF+e&j#lr$|o zMuAeOIVz!ZWJtAi{%pmUhQc9a?IRiqM3)1lPuZW{v7PKz=#{L{>`a?4!av zYR(LZArF->Cqo7)<+|@$!@bc};f84G5$ghZ%)x5;4I}t7c$TMbeah3!S+wVDIRyBA zy_sjuAmEKS`FaLnzF*HdB4Xodn82NP0O0Bxk_>g{QFGM673SzW&#z^Jaf61)IlrUn%~iNiu^<~T5uFqcLl`-721pKN+~&AfoX)x(kHqSyLnjmv zqHm1@Es3R4V`K%TgaGkJGOZegafonTt$kcg{W^DfPL+MwZPK*r_VF!bPTB=@*;5Mc z-hHT(WR4%v*?gdcB||t-m{tvzmljSb+T^#V70)h=(KCjTLkQuYSX4JZ_jxIdeXCU! zFE0QwEHdmG0aA<3v~a^B_bnj*-t{63yUrrRu5*{nEeSshw<4%q?%wc*{rvk65f$%U zh3dQ_kctvgj2=R2F*I25o_%CZV|v@Q%`qyMWClnxC%58sVQ#;DMxAh7f7_-zco}ZR zqoAldXi8!0@~x7JccVIE405rA5ag-_*a=2;n(_)KfR6Wp%fnx-J43is?pQg=?~gSn zx8f6vg!%nN8-(ln+cq8kPob+(0j#rw7d8C0>2^uQTZ3d1saxPux#$B@i%fS$O~VX# zdd}+hvE$1d375))Eptwi0U*tsbV5I*h;CsnT$gy;w5ZHcD~15!6fj3M0dtfFh9~mW zgiFN*1LCvo*+mu4*e9+#eSGrN!CNFQmFkKQ6y_+!oFL79BFwMY2MO2pw{5Cb=BSTG z`NOat{2g=0czVFMzS(t><-yU^^Hk<2B_sMg zYhN^mBu`&P#F)o#mU3KObA z-oKVka!9eUtftLW$S6A{eX;!51S1 z5L6w7%(u(=FfO4bN`=bWVG`IRk}Ez6u&30Jth>q=0~{ph;jaZQ)TBFph=q z@Y|sLXw$y_VY5^h2v-F&?ic32-sGY-6c2^LhT&E5YqCBq!Oe*snTB4MwggKaU1b*S?SyMs*!%VjK#XTv~Yg zE5}ESDJ?)esX0MQG4+SZLnX{nt#w1YPGyeb!Ug=4E3E+LD4zI8m=iz;Dxte^uIpBr zqj+!uoMjYY4u}j~1rk1acyIxn36(GhL~pxH#h#3aj|g~66)<3q z@-X&jqiuXucOPHb9A*KyIvxi?q*0(?CrSOE2|gIS%-65kW0krj5(rHeLT74l19KGD z#{+W|&&LCERBiU3mAW-+v#P~Ibfsw79o42aYxyuLp|xpw4Jt9A{T5W1!%=pZ@Q0$` zf=S0AqYVIf6ByKa3dd%x{)Z~yML9PfDS0ZF2Kk?unzV5rkHT_^k4Hi6p-BtVwm{6l zlhj61wCui;$Owvl3qh+h=SCg=V}KhjR~s%k*s*4gi;;ynI=wKe>sma`zzsT<@1dpU zsHaMp6To*$xvtug4^Ksg*4anFj;T2cb}Y;Z;5(&UH&11b;=u)2_|ghtj>ZKT)pd|m z$jng+{1Al;;4GsEb4($kny9rJ)pbxsk(r|u*eVJazzJXz=4f1iQC+vbJ9su42}FSn z*|oKLX0B8Nb9f6FF~_|i_~6MXP{$;KL)fMvqcCUyHcA2R{n9~f1vrq4I8l3(I%H9k zUB@<~0UZm!$*utHmxl+F3E*I~u<7B2zyAKob+0|#ab)>lK7H}gKRVyL@Khx2zMhHy z^QYfl`aft&&LSvxQWLFf#?+y

zdvi{^M$f3%1U~6t{%5TXhe7Jj2|rktlzo!?4#Imu708cShxW{D_@*0XtgmOYAd<2{ z7sqc;NG%1kjk#35{j4)BGNEv65iko}&&BaLD8~cZ$*eI`Nz_upT%Fw$u1mIU5>ZPr z?Rr9@5>Id>%+)ED0WORbc3mQBDZ&zT_wJ3#;N8|x`c=#3AKHOg;Ck+#_4_Y&5fYVn zZYW_cT=$*a{UBu*D~_=8~L*Fdw4AUIqy5QrC5@o+{{OQ1xx1NWd1E z#+j3nyf7c3W=;bH^{MN+T@Dv?Ghkdz(e9Cy&R~csMqlwrah>hXqK&}OcRgj)(OnhA zq;F2mB>@;=uCitc*Cp9D359=HbJ6RBe^_%0f{%;Qd}odg0UsBm`Of^t)2kkJSC7(; zEb7c1sKBU$ybEn zSolQ3Kg{nW=Y0n-BSroN<$D*W?=?9FQ~~HZ;UDHh7ccz7eCPlR&vWRg;uGr7;TIk* zJSe_JAu5xv9Em8I`Rf5yx=bltV&Xe9-^K$}sUqZo+d10D6NK4a;^SHB82FXn=g3T` z-^~=I_0{iYy7K$#cQf4^ef7KjObvrTA1w~1kGJ*F;$ZvuK4KVb9}mP&pja;Jm^^9e zsNHswwPA6c^g7$G@1rEb;`>DU-OSHzya2Z_XUJ+()O886Zuqa*IWs@ z02e`f2A^l`jS}G~rbeOY8PuaAG}jv=7)m9wscH&#>f{CP`SdrF7DMrjG~Ct_7irKTVhK+{!M~ zZ&@y^dN-hRWP??n&vJev@s(LsxA_wm} zF=U|)n1~4xCM*xvgoqfjp!G`>08*H587K2yvA~eTkOdw%D+Wx^K>r&#WYG|Pvgz?P zryo4I3K%2Yzx%JEnfZh6?JA!B$G4;Z@XwL-jW4%8anGDPs{hS#=gLVE+wdQfP|gw> ziL*}A@%QW_YZ}wtAg{Z_J}Pp}^lII?M~A=r)jNcFk5OIM;U^t6jb{2f-cUkg@dsF0Cq%BpsfIgDhA3}oQ%l6OeE z%%ssd#M=0G#grWpGFD+`0y7Pp2U#{dYx#z1LRq`N(qJkXHm8|E`#hJ$w{tEN{ z--^_A9dISXj5+%Q`dFCl?;G*s@n9B<*nYKD)G^bIvtNZ zK_({?8Pr(_(b8#LJ`4rkgu3TCA1c7NCKSBac~@s@M;3MF%*o`sbcAOzD}_QgOlA>c zbc6}}&HBK`wKAh;aHF$ua_1&nq~VU$_x)(jw<_i?nJWq27pTfR*U5GL%@@AIPcmAl zvGP2#0CQBXOO)?joW9=+I#YEC2#0n0UQ<27`97KIkq#oB_<9CqprsM2kk!YnLDKwCxWh+HDA2L- z!!Ss})A4Ze{rX68fM|xRS{~$=Xj;5_d>`WTJ#W9p%j5f!@UtKrpykx4VhS}!rG>)$ z4g2}`Q_FST!OI{Ua8yMjZS_uPz3^hquhY`ib7qBkLh11@x$8Rop8}Yvg0GUInd52^ z!o07Bvd$WoQC-*KF+-b>mfb(k+80#?ks5Dt>&xajGg9F2;VS)VAp+{568#oXFIyT! z)%@`b4;d{X@zKiexMwy+%kC|Nf!)Pd_U24!fluVa-5b!+AzgS}fP`Q87EctM2dor{ zg++CwgbIx}Pmls+&OA+4Ghf}Bemt(tN${=;hK{(ADIta6HdQ~qL)DeqCuwWq(C#ob zD4XLVJYkNG@QmuZ7FAb@2l>f~3K8aLjJ9>*y5rf&@0tl*DDep1~fzF$ExB;_7&C%^948@S1Nz z1&FVBe9zgh0pctCh{!w`&j~jGQx*^Gn3|(fa$%0HW*F6V+r4E#5L%_x13u1M!Fb^T z_LZ6w`uC5X%1wK^aN_PQBkelwOJP1;>CmQ<>!5^pC}48&RZ^%qsum&4(THgSxGq|i zmGj4U$31!Y+p~85GXI_TuZ?(g@Zo=*)^6Um%eATQpT9Y2>WP;BFR!mGEl>j_op&U2 ztwf+<)0KWiE|nSY1Oto0T(~Z&HfnW6(s@V1TS7QchhDhk9TX+K?8fo#5uSpa&bl3s zK}epUYL%@kxEjk>WZVflVc>!${-p33}MNzaDrEM)jQ!*S&G$z^$~QqStwl7MZoW zIxUPd#HXBb1|<`r;8wk-E(w{4?tL4(@Dy(J#VmZaBMP|zoz2HRwh3nQS$=+k*?g9b zXXD#B^y6_$FFt-z9N0_e%C~r2aA{CZ42pgwtM|1c@YDq0T$W2iLuFHN zF3Y8n0GzAS_sPgmSYC?+&=ZzJOBWvXTHqHRvf2XylUYkkf93cnvPqg%WmtJ?j>>9< zd3-x96+Ex%PVr>5puNPC)e7_YK?;Vu+OV$c4qkxx5(I?gQ35*u!}8K-=D3GSm>0G# zPc7Fa9l~IVP!fy+2y=aFh@is+yz9h}#biE2j4;Qf*6ZsRz>r09 zr3>9v6ftDcS7<|b&){z`WDzmvt=pcK^SfvM=bHJ^%1i(Ih0|l^{O-{2{$k$t;EKk7 ze0a$}-ZJ_d<*gn&RRKS0o!m21oy^~`!)_|BjU89*4V)lqAi<5}?0@~KPvW^6*Eupq z;qypwgH0R$at}Yex_!d<^2T?^%((|RDNcG^&0eB9o&n6cnc*&??6IrBk~{M0f-K;p zun(H?nR9I9mxZPxSpfcFcSVkm4rxOm_}x%NCImy)`VqO;_U@6C319$7_s_pS);!=P zP*Y*P1UMNA(~1UI`P6kC1cEPinam*1DR29H=kj3YZkYc0_U`iiFdYvp@h^uSzG_j4 z1qS65W^}#S7&C2ajWzc7-udCs|s_K)J?cf;iI^I+jIxR2eW(rP`mAfX;Iz3Z!Nu2 zdBSEN5qv2|HO!lH#-$MpbZ%aH;PS}WQQJ84&`UtrEzCawVgVw!CS0fRQCz=mI{eLR z^RJRQTRAv9PjpzAV#_%5u92WHAk23YVu2ZTKNuh^PhHowczo@(7m56McJ81l=3pzK z4!zesAx6|;ePDA`V->KEU3cdA%&CL7JaG5sg)bADyg2hyg#S{Q=Mq8&5XTg*Q^+W; z-!_2Jdqp4S4s@D0V5XvFu^{Hr!I2x7>$){~Zly+fJq?6U7l^8m`?J6_EH@I96aUiexk zsdcM&CMkh4rNp1^BY)B_*MX#8!W3irc&hF#-U#Q%hxtCf>PezV;gPEm5(^j8dli*M z&((uR#4VVrU;!TAS35ExS^#Q1p68aDqaG|_jt=vT>N?P2sR}ndqP;hZEpIVico3vg zb5x8g%+cwAQC$ZOT4)pIYjFyyK}*e9L(FPt++P>wjJ<86dLB}XvM!TLi*Hd4T567J z&+v8no0LRlF7E zq&1#WuIunuL92__%~6%(Of4lrN{N3{kqDxsz3sH{wwqZ3-Ax~{|jDMUCG8lnW1S5R{licOeHgMb(qmr-5U z;t4<a>t+l^EdmR{vSJ9ez@kJs;>?I&v&P- z``)*s<&X7FygB&P`%f&$Eh*VEf7s4j=b2Vo;$-3|Bbqc4Peg#dhflYef-jX8-9h2y+?T~rrOvm?)0f*j}iz{a%-d9JLy9widk_r*wHCz6Si=jGft|MHS|NV~$_ zAuDJ{h?Mb~SSe%Zg397O%@UPFuJMVJfM^|NiBw3s7-n(Usyo&GGxU?NJ|n=sq_t&R?Hck3t^O9q_U8`+a=A=l%7Gg-~?*zB_mpboT1h zr<&^Q>HhjybLN-c?-%CCAj#0K>+rWji1rFpm!%7j>c+E#Xqq`y9~b62-ilbyrnPyG{dHmfNu9#m{pEHY;0GYFpttqs zgcg(%Z|mzaQgc*vE6n3%n;81LMs?jg&fXp(;O*M_ful_dGY*F;J+>I70UgKA3|)@! zoK@(S!x6rg!v!yqYEa@!iL#2R-;zW@TkqmWYWaSBGhf5R#@R68{PpcTzE7$us=HkT zCBOvglEPeH4KGDqmsC}hCBmD`ml_CjbP3O>u1l^es`sgZ0FkqPDa_Fko>5%~2+>0U z6YUv1BvIrQj#L@*^&tR7&j7t~Zd}j6dN_9BpOgr^zqp0(@CP6~qm>X;Aw~2IrWCd= z$ANKfSkK@CN8G}rYFPM%hYRmuK;p2Gdj_}*PxK7X7v7EQ8ITK)kQd#UW>JUV2m7A( z3{V$dzUUdCFT5MpGmtJky6~tA55Mrqb>kUYv_8IOlQ55$UQYqfC)bTq3(f%?|+54nt58s%9 z?UW>qp`b!41Ezy9nw0|&1ct+Wzup{@w5=6L4C(wZ^(iAxKHqcx`oz-hI!nKxHvmPr zQCf_K>e5nkRF_tmqcanux(*^dZ>XY53(-)hV``4VPYQE%glAOOL4*gTV+vaS717XR zdTJmar{<_QLzttd{tfH8lJEt9erj_DIOyl!dd?tv;{AWQ?SDP{-qK(F4!i;c6VMa(i^ydZ|iT!q|AviS9 z`_Pk zz)_YZ0osH0R@YSv8ONxplZpDe2+!XvmFF*<5R0!rt%xR?;?Tcyd#wQ?{jHE3N)s84 zUuQ^Xk0qLe&>x*vC2C6OzwXNtwNw~8y z^VyHWS-3Y1Qm3@ITtu(^(WId&Xz+U(IA8Voy%1=Z}FD3 zB^bldA7X`H;OiMARNBz*dmm5Fpv4>E{CKWzQHQ@Ou4=DN+Asy%w+rE0q-iK-Oa zbD@b+;j&s`9z%(d8lD$J7GgpKSR@U9a>7L+DXB~M~X z3xqi)uoXiVoHZa}9!tfc7ltH;EI7e?!W@I8fgy`4V#q?$$52qS*J`)rG4*T2ki{ff z*8Lqx@C0bD81B42q_no0&bx-Jd%{!mzuqi+`~O|_?48APUU(Q#X|s_@v}%?$j+rflOsbJ7yjF zcAuHa9%*>($ddITq7Dje^xRv*b+vL3oSRMtdNwMgFIz+Dv--@wUA>P?Ag$kjv5P2x zLuX*`SAylG*;W$B?Y)gmGY#3Luucaiu3mNh0Mo^_WQ^p}Q)f@XQ{FKKC#39R*j4Qu<5 zI#fMy_vVE!FE$0dfXOzyGsZL(WV%D|6VT9@rb42Kqe|&q@(yb6Gn{Xhrlj|b_c~#e z0R}nls;r-F4@i8^cYT2ie?^s!S604cL8qB{<)KQ)vvGtu`pg;Cb>~&-c;&|Eu5{b% ztTzS}dw4D!VUE75jq18qRXSdIX+F=|8!cdcX`tA{^H2$M^c!zf*X>e;MU@EUXty7MZN3J)9wUqO`c zZ^9f6M=`4FT0Jg+9@45kszEEN_IS)`inePYsR#gIm-Y-$wL8%>z~hBewPDiijr7_a zrDvkEz0RF7;yL79$k;9;au=k}pa7;x0iOvvx|OeNZVos}pFzQ@O9gxuxOeX%o~nB& z2qM@#9}gnfJUs&&=f`t)JZwDu8UUuqlNdZnt(cO)-+E@g@~4fjj1?{5Do1cE{CWQ| zXqA;~&=M5dotmS@YlJyEy)dflT0PA$7&TTyhM=N6YTh{#{wJpHdfZV(bb|Hj@c-Otncguy3*k+MIpV)^cSDZ9*h* z)@h0mHKK7f_3PY&atbrsu9;q~J3~kn?pQg=PbeLrv2vY6;&@34nGi|*!J5$%0*P8# z3VB__>;soG#+Nq|QiTUw=CpVM5dBXG&sjm35Z=6B)!CB;ZD)WS?$1Kgt_DD8R2H=D z++4c4J$vflEfT9jb;SpS(}9|+tZc$uxURo#Q|&NA?g6M`MVeEkhnLlCiwFZrVChAl zDfp7CX6qgvK7Bkt_vUnojbol^CE)_0<|-qdFc+@tZ`(jyqeqg&*!qE^O%jC#XuZd# z62KIu>2aSqktD{`g%gPy2_dgJQe1BXk%yXw8SeC)g2|nma%{2k^Swtxl>yU1!uhi_ z*hvJrRqmY`b%cH9l6OcHIE&mPJOw$O8+O=7b@f!lC^-i&BvRDSd)=S(K=yT*1PAJ+k(LOdv(G7%t=>b1+e+)f2oAI z;`x+v9Wd9z9EPn>6+c&{MR!*`Z@*nvfJGP<8)~=x1b7KsC7Qn{RC2?j4LZ~D3UoSt zk}xdxWhrNRsGu>RWL2oUnjTry#>wv^LajeM1BOKy#CU=bQa&&7JHDl`T8^4fKzJS3 z2R255biAnI8T-U_bq~9T7DpQHSUro7Th3iFmr!fcg;zykzo>-=kw*v;W@^4iWwcOS z=Q*@KPT%k4^S!3$i}U>-_zvA`e20#+hD8@1b?ER54;Nk^+S;K^8Kpug%X8uN6`RwW z6iFA}P%S4yh1Q&PpiI6)2c3!Ogn{>vL}>dFQ$8wF%JN)z0G9fY;1$kGgtpVaz=iMd z`{2UM=DY9!Q_pkZxj22#cj5IFYh!zCZdlP@I&^@kS8D#KLq``Lb>ZO`e!I8K7pkC7 z-N$(=qAGc|z6uJLvfa{^mo zk8XuIIx#S)>(+M%o1>9XG*l4{z21F`9B6zp0m$DK&U^bHJ)OqPkoW!4K}urfD9Yc! zlvok+Cr?I!+#$9$1&6TxacDX4{BdY_)MVF5-5TJ%@|)PYH8!90gOzNa{0>E`KwmZw zV;CoDZ&Knr@;jK~yIvTh;BcIe&v9!x{&=+`6RO5T`Jy{&j*1b4Il5|WRM*Y3m;oI6 zh?W(gs>akDRlySGv65j-1$U#m4sr@e3i7pV5|vX>b5u?t%+Wc8QC$Z)#q+V-vp(&*MBR5TzT%rrbQ{poAzgS>fP`Oo zxbW7>0(Nq@0e9hvZUg$lqxCCP0qVwe8>9;lzwj+8gAWfH#l?5w!7Kq+r)L>or$=-f z&}j{R;o-uo4VdUthpHM=bJU>~=4d#HVO>`eChx4)8^)oaG;yuC?hs36)^A9PDL-qXf_L4LCGgEkre2Dfs`jbduxipVaAx+`2fYJDv}akq)(C zP@DZ{wtPOo_v@o=(olrjEP*)_wnk5g&-a|a-p1p5cxn#>OlGamhk9zMIqInu=IE!^ zu&yf!zu?O#(}Hu^OH}jvf&(s_Q!Z zdjR!GM+{If_iU~3jH*B8^VMNoT8Mypkr6NK=F{+c0Qh0MtyU3Wcd$2qseBko%f!Qd6KtPe{&Hz%1 zBgJ(#GRt8fA`eKfZXZk8D3SqFJAr>SbOWr|IGR4z4ULLTn+wsVCtO5z36T)1$uAgm_9JB(1^dJ}s!}VvKX%Rxk z@=}&e<5Hee6+2ZAvx<)-xD$oBa9#3klN_`H>=VGX4~!JYtV4Td0*B96@(QLDZSvdG zif6}CQN&?hXcJeM3)dyzHpyEWFq+w!76v^0)&V1wM1^%>E?n17V4Jk1!4lafD69)} zeMv!Tx(-?zvUYbkK}$pL)(L|8^^5r*${mp>rS=4w-q4xVeBf{;WpAi|-S$Q7{}jGvA@JC8&)v9J)mKP?kdnx}?|BkbE%< zpBx{`;CmOR@A)pgR4w{T4AcqOC|C|%A~uRIWZ{#8Rv1oQBItxL*HuhORo5j2tuWly ziJ%k0TvstARb7`9w8HYrCxA`}bA6rp6m?yPKLmvgEhW3%xjdM;`=xK&$Frmbn)y3U z!Y(Sz^&>h`)O9VMDky-_bW+n+VM!;cxkl3_%m+jQNl8J9y6#C!w8!^M{#D;YC-Y>b zgj3cgzf2gVd+Q__gV0;Q>n-JLIRNbvPs<_dO*jUjHz^7~%lGTs`Pw~6Bs%maq-DT( z6{?WsO@J^#he+>}Na^Z=hKmNi? z(QXf1cpxlFi~hI^&!|X$Ll^y}3(v-P;n9W1U3mC~@9-akVoJHHwty?9Xy&+LiZE~Z zZBuHwuEo;~@9bEOv>sJVq2{P!iZG8;&tpjpjOw~-M?Rp?63jcYgm=^&g@F_1aZGoq z;CWEb10H0G!=gOM3@I5kr(?FlT-Qihin8`pbW?s@=y4}jxFfnsZ zm>f!|3a+;T7Yrw)ozngBT-~C17F!(BpYlfOUArW@lX}1Y{~ppmQk9i6uYBT(nyiyM zGbg{6*LL95N8f4hwS3tAZN$!-JPAJYcD(qq~@Hs1P&NxaaDefb}oa^^r?DE4D z3Y6*gj_NcuO|z01c<*gQi)M%_R~MMLdQ~i=MTAgNtoilkM@L+G>dYyki3+{kWtr}b z%B4XP%PhN(Xx@!bsnvjzqAixuqK8mYoO^WmyI=jRwc)TsuFoC?0*R@IC6T_PYjS}e zZk&YSkSQq+#xh!5C6p9R?~a*s&(U2K#TJPFp+5Tx;g47+sgk~O&OUfi!@a5q4p368 zjb*gB*bI~uZ$5DM=7ldWHU+#;8;2)t4B-LjltlW*G!+sh9aY8#7%AH07%i%Rkz(4G z`NMYJx@Y|3Dyi9BWT5-R@~z%6;Zc>1gx^gSQwC~*<8h1@W}p^$Ed7mJ=TCY(>j)7= z1(2g+PH2Aa66V5n5+g-F+eXEQ&Lsog?>F706FqJRKgtn#v9dj=T&^D5}|Zgx@~sW2n9fnJOPd{N5_UnbzQ59 z4^<-D&$ISM3s@st&cIlhqjL(Qx^9=lMF#7G6-q|*ao)0MJ!?ip%}J4uIiV8f=v>sO zu3K!0dP5Zed*DfB0rtR?QxIlLp4jkJzBe8u*LjK_8|%h}wnnei z)+jw2DV?-mDZN&9nSR5x^~=20 z1)+*RDYetQL)q0#<-;&EWlm)*REwV-wcD03rSl=ak2mvue1!Akp{D~5lPkB)(lRh5 zl~LF&u-r=7oA{Bfa;#9P@YGU7)gDu|mmfUN7o&hL(g7+Jo(BiN@U5P$@Z6?p4;Ct` zrRJ!1k1$7PwMKQ_E=Lt)wUha>T568UYK1vEt2L_Y7F%4<;LYYsE~q&wJQwEZ&b(1w zx5r!N3sv~El>8yfE4@P*qC+V{q2^?Ugawu$%r(!altU3VoI0O%pD+M`lgQMJc!oD^->K&uR3 zn=w5D6b?%C4Dfj2RBf2-bC{!nn(Q9mvBM6f=LYf z*q68(CO*E82lgeNj}P#Dye+`da_~BP13Vp%R*yLjYmaKwn)xy_&g=pR(7EslH>_$e zhAhl{SuHh3rDnn$oz)uFbz;au%ji)ld6_WBOo)gf3!}~{NQ0C{{qbVR!l-i!Qfz3{ zA1{V1j5?PJQdIPdvER^ytD* zUmS8d^TSr(_X_rWb3yL=JO3^8*>PYs*dnnSR97UU*WbPAiha-w5S;&6Xxddv#WVJa z>*{0{4Ph=^S5d7_o_$0JET&mCuH@XI7Yfsg2m?r9=|$fNPeD%S2AMwP_d9?MBVA&{ zm}go^xH#ZqP|P(lJz*|f*Uz?T_C|Vbj?y#HMD$Vt`M#ac_lfn-b^3mu z#S8$^QJSJIWpdQ}^>OBu$x)aOym3<3b=$pVFl}3pIZ0JrppxG!t6nM?S}s5ybd zzol@@33K7Pq}!$>TYwn}*TCsaOAeMyN-O1e);N>oi(-5FWj!fSF8U(CYK(*UCK*KhSs507I0 zdH{$j`xf={0VDYq;gFRnSywP+bP$+FId={)YVa(*_;~5YVqN)ahYf@YT-v39$}19S zA2Gy-iL{Rx9%@1Y#ItjN1c>L-fN=tzQ^#5U%;!6_bm37MA;-d(gbAI6_FSMMJZg@6 zZM45G%nL{Eu3$NHMs;0xFa&Xec4OckTFsn5L)oJgVU7;)4C=ZwCp=ZrVoydSaHl^@ zE}M5b&jmA8#(I4{gT$H;I_uUeElD&X^d<+ri8UegUK&X>A#{i5K>ftkawtwH0j|5_ z!PPTZX|cg_LzhI(DkV8@ro^n5t6|a|JPUVTof;+K?mW#LcjpOn^qpr^*LC>YA*X&t zjjpM%sO~c#Yfcd5AF|z-!kj0s(H72No^SE&0lqS-dylH&QFGRWT7psu^EhEqmLi%_ zU03b!0hno~R{KR^p{O|u3nk3sghh2n#&HX0EYCyb7!)39)gINL6;*o)zKB}+RBhLE zt1R3~&j5vk5+qq+|CY@tI-`+TT}mYSnLCBhsHi!iF|-f{Md zAq&2uy%@6CmZyNZNbBb7pVTeUnUaek3p!wey0C>g=E4?37GgpKjhw~1P7GPN_^_kG z9F@$AAq#E51O)*6vJRMZM^C)}FSq4BKkcLc{g3~Z|Lm^6jQ-c5qrbQG@1y0_(FGIB-1@f5py3dYh#8O(s znTK8i9D*?KRHi|M>ym7nYDZPGBs(Q>QmhJ}&)OF)fKdpEz2cJwf@;6$9UTQ`i<&xR z>hb7~>{v>RIPLY(<2(C{XsU&34hwF}oJ**1{ynkCsOd1TPP%kfcU6U=8zj48P$ zf{v}TKGZX_euaCm!Ur<8xV9jMM&u=jY!uvuOk)3*C5$S(>7F*ux z9lEPw}eklbuXhLqbP>2b1HP`Tlqb*B=k?{qYw#{&)*)8Q{57CN+`4UA{V^>qot^ zT8YeqyDbU$o=|br1eB3CnH4Qdg7yX`Uh>`i%R*C;%nnY%lo!5329; zoy+BsGbY~yQM5Ehfb{(YWjq?`dlk}*^u0wpbSU5ZI1k-kHNwFiI<-8BJapQ^;|?8u z;afarxbQMH-=nfwGoSBibcyo428l-cUL`U?UU-}M4jr&;D`ivEg{MNLkcW;gJnGQl z7alIWFkE;l!0;K|g{J}xkr$o{FhpK>*?f;pzINzPzISmRI=%}}BLYDlI&I-`7ao4$ zMYAG}@5T}4n}5uHVTfkMWWL){m`ha%#;is(D>zd+VLoQjsUT~BBAOMP>8LOVa36E| zOf)MvQ)yvNdR(kkh^t-xJ<GdPN-p2FsaOYi#t=i)XDWYnRd2gzn zfT>8;c1?@N2bE)5wMSKsIpZ7`UlGe@)T+JIDofFJ4P1Da;lk6Z_P7gARPE6h9%qnf z*mg~e#|0N2t=gk5JW;im5h;Wbg(=1YY(R>(Yv96L-(@oMLGY+KYj!i&3J5-7j!6uS z?YffiwYH2hl|iOvk0NxzkXFT-qrgb?uM2aggx0{G?+#u77@3Ab!-aR6Ij+4d%q7e! z2LESN*LCwE< zteF}aMQK5P4-u_DM?~vCYi&5}09610HXogyn?7Zlm9TH_9kYncSgZP&fgP(?X=D`P zy4tJlW5<^_y*p;kJx6y{6kCA%6M)UHEVtjb=&>Ln?6-+bWi%?n>%Y}(^31DftkcgC2eg8OzK==?ZuS+stB?hv@!RNbv3#SI53sX$uz zv#LjOZ=SYg{;-|5?iufOf(A7;Ct__!g}HED-4FWRHjg`dj|5ESz1eqF*00HZ_QbCo zM?^`NSDNnL@S1R) z%0+SgwkZie5Bl41!B5?E&i)z5cfZm*bV}j482O${-r?<(RA5x+tG3yNqYvD6@1&p4 zIkIGZh-gr2=7gMSj4+p{yKkBxT&HqTT)%Cu1jE1#4`Xk+w=@<0e)(4K7{E(4+)JjE zh4g;8DC>hVEJ1O00yBPv+{Octye5j968RKgsciyGB+ zyHv$^o>Ufu!<*OcdS97jBObGK7G4jzxjDWW* z+yGc3W#Lgp2#$p>3H#ug&D6fWyV7j~Y&Kg7$Hw>bqkKt8WDDQUp&yT`Ux|;Gif^nN z7o;$HY>v`1(b-<-PPvfcbo`02kP>e9<{iqemd*D$p39&69#e=2;@=&$+m=X)O|!S9 zbkcsNtqk8`8W~(=K1(4zK^$Ye!Mk6 zzF4l@o**B>mKEAU(t1hB!8_72FjbBt2LmR+xAN3d2(X#w!Q%{(p%-k(s=f5!nfYD} z05)?)I@-eHA|3p~pZ6bw=eAsZuy9$eW{!)LggH8^HLB}cJN8f zIV&tdm}{O-Dc9}sMgWdNBU=<4g_^S_)DoISm=hpSO1Tc;D9(V1mH<(36l#tt9Sd^; z1WGN}X^QbY4O&sPM{k@|ZP)B_L;Rl;{~Kg;NY(I8_@aCp>$i#h#2v;Owb9 zx#)k&y1>r}53qId^$ZU1^$afa^$hm#^$c8`J%fXMA0OiTco$F00p@s$c{(2F{Z(;T zdsHn2kF`(fs=WkZOwo3Y7_!LZ>s1MJOiC_>EX;gpE@6(!ti+H79~esvn2^~VW>|q3 zvd{)haOhEC4zoGTt`kERoKd|n$6#s1kOgPmTbN_8G^sUY5v|G!fB5c?+dui%$(_Xw zBmeEd&7W^SoBj{c34iTge5?CcAKqG7wDObMiR(@u2TFx45~V_Q#Rr7YK~+nW2_5!P zE{V-Qw0|wI^rCNsM^^SNEzIex+X0LU=@O&DJkv@-=m4`2ZxMd?r4pgT3d$uh?3V?9 z?>&6lHLj*!V#^OVtaF#=z-0Vw(q#Ph@h!?Mge;scwQ)a+;gXn9zv4)7y=_X-CW)>- zSmC#)6~lz{ENQ~|uB>Xp=K!rpSpZvV$GsK9B~i5TKh_5}Mi;qnvDSO-qdHBV!l7Mc zQgs%YRGqtIE}6^M)Y7CFjtF3@dJ9xq@={|&ZucjZzEh9s|lCJ>mO_j z!hE$RlPA5!PsC6H*oV(J>oi3`@Ld+<&Mw+A@c`k{I77HJ?pQggLmhaOgh658QPCA0 zPn5fFnou~l=nvM69tS9Qn*az^knc{o61cMzMGR#!zu}wipM|DfwSa`QBu`vx?{nY77zdZ{p(TU&eRuFI zkOR~yTFSsJFkRAO$yK;O2D~%xXN+P zo{megp(?h9e5mMEkGiX2{^lb>*^8{hWb@Tw@>SJ(TpflkJb^_s*I_sozB?F#=uXw# zLO!#c7Zywp@zlV4oWAF)foWoE$U_IcxStG~QrL<-bSgnS^3c(RM;$u+!q2lrVg3h3 z)0O%o>cZ1Bw~)S9#nzC%=d2&9{PZ%DFp-U73QmDZnCHR+bR*B9GxHrfy6~tAk7MDx zg8{hkpeM9KuArgv3Q_dOM;X9;#dF~S^A%6go-RD6=sv*K0of8|?b@MD{ptN{I3vf|SEj35ImBJj2X)&tnwtLH< zhDR$wALp%z#!`b0+?$UxC%g>IfFAnSg?Vn8epG~kJr6p{wE>e$t74%lDbyU5j|+3q zQO05D4C}g*@CCq=XhnY5sbbY+8JX3h-_m z(qDoW7`5nc>=BQW@LCwsC{RHq4_V&o9m)h2Co>+JIT`b19}yAeXgH5SU3an5Ull#< zH$}s9txfMqa3-teAmh#pp5+@;Xy%*IaB&vxIj0;r8zw+J#np0H%hz)7@%f&sVFJaJ z1E4p{2TP&msJB*_qeDc)x~?Sr0_e>y<9ceTIqInu=4ecdVO`f9BsDy(5`-Hm)68*m zQNkPz{xquVI{XB5tU*_Cl@!e!Hy0($(IaI>bzO^xD6C{_^+yygAW4U{*POR*d)lt! z6+d}yezf%WS-*H_^ylBZ`T3ETGw0sB?|U1aznEJ1$I5j98RNS?up#;bphze*6~VA^ zpDAO7RRU-q6ng%TKq)U=SF6q;UGff!z6RsIjpN-wE|H8?0%#u;n)SEdu#X6qmli7I z5@(%h5yFu0QkEUaC6cj95ZVWsn`=4L611oouQITcyms>Mnfmwtthz1u}WyQCYb-8q70IZSyVsUo~@EY z94W4|5yYE)NDXjHBqEg{0Ml&ughh|ZgdU)z0`wEA{(HX*U+t)Z?Kv5`{_@I8bw1XW zr{+?5T$t-WG%4!3c@`JoTgj~`-xv~pfc3_p=2FTl%=KTkDe5{vOZh?-q?;$dG*We$ z^`)WaQpzjL^*_=n>N+U!ftalg3Vd>eBB#8J5ehYzQ(j@NJGe_x*R2l*!;*k^Sv3$w zNwIOry9W4sShi01S*ftDM&^XQh$*-QJqob#D6uhNj$#TAZ9ZuVL`h2|7AU4)5Ax%{ z9Hk}(g!hUmwgy27VxxrSWC(>R$|&>l{rczmd@oOd_?5JVv{x81gAW{Lo{xv87G`ZB z3F3KbsX6MY73S!4+NiFBr}lXO06>vaNynv8Tc#UJ0hn^6;{;%eOUEU4Pr@p}QHSA- z?en!Gi#l^IEy}@#DL^N}Q-`4oFOAxMaSPw#AsjvyzKqt#>3hIisZSm0CbPVhz^qCD zraZm}RtcUO7^(1b96G`(!Exvas|3fPqYIC!Mc@}6E<6I50-Pbwg+~CU9KI(2Qx4w~ zRtXN@lL>Qgskqw-m5jtUZlIl8fLRM%0h3pqlOSX7uwrvSFX z2bY>u21k4({yG{@a-&=aS{G(%3?oFeE~K?T9IEu#K&yrU5F=|{;9Cx-_=@(jScO`L zVQx8aRoz>>5vL^gpyb1n@B~Yc5(N2io`wl$yGNMOlt5;z@eAMKuYwDY7X48do+$d`FFelh-l*LkxbU2^exzLV z$6a`$=r2Y*8i7un0a`%S%s7fEM2?IjN)hJhYKT!?N7c;ad|DbkV?qEbl3X0Eea_%m zm}7>zr2g&=a~)MPliSOv@QxFXBh1lboJMsW)w-pWs_w0DFspl7??p?Wbv9;OujV-P_pW6L@ zULE##r_Y~qXN+koxKE*jI0_e%N{29`?gvMT8xCr03Z0uvFE;1r-aKu~{9!w9-824i zmC)?2%KA0H2k|S%(a0tkoKpD^iZ;BqKCpSMMyKE&9zI>=vJZPK{f%4aPkKD-h!xQ2 zW_z|`P5_3l2=iRig@XHq>-yO?DxuljshiFLkH|xoS9*uSQ>OB0xNn+p$veDVqv5cR z4c41&g`*GLcJHL0&pEPWeF*B>K&z#glkt}^!rVUolll_jx_-9J6_wB|_m(E$pV{gi zBhA>V{44fBGd^>UJ+9HW6in{iWQ#Q1vHHFr&G}Zv`u!KX{4yV!Y)+avcfsh6FyC}V zxUQdVb6zDh+xwMD;4Qk{dAFQ&d|i_-KWd%)w#N5V_pp0tw5Q_xr`P;?^P?j!J$2@k zN9IG5%}En*E(yJb`Gvx?BH=oPCall4Y4woqE%X4FeQoL%NHD@7N?m4=vqSz8=PGlYT z0;*J)?-s7>XWJ~cM7A<8S>;55r7=<#D*|u$n(a-oS|~nqwZ>YWKm}> zA9DZY_S+O{!(~ufRA_&Q46rxnOq)gtxvpXM)%NVEgWr7M?#&BdUTg|@fnpBk43R|) zuM_n7=)$9l5F87CCFp{8(yV>`=UIEBq_E2L^-;bWN|e0KQci7@NkkFB}OxidWH zDLKNlE(lfpiJ|=Hg$dzMWtZtU%Ds_wDq|s29Vd9fn|CO?S}tDhb3B(n_dTY>2>K~J z9}j&2u8)Ta5T1_@ILQ}hNhP!=r4M0>?xUxq^^&8sAo(RMrCUw!j3=q3$qDMk0%WQZ zWTIZIOzqA_U0Xm$!S!NsUik%lp$gDZ@Vpp+Oyvnx@C(07RgLFKFMx2GXX6NSlGvfn zoKao3SXGTzVq8>|_XyvGBh1m+g;8C%M^%kiUYd{dmPPBCA}m?Eoadp+=X>XbIi@o& zCABxqb$|93Ul=uZCjd%POJ(f|0?4DD)rwcpRKYe7w}#XDtCeX)#B9&*WcqZ7sIQMgMhy zto@AbvIuYo@s!PBf`g}L(9G8}fI$YXo&kt|^L#wWZ18+MsBiN$Orl<%mV-6ygd0h&23JQwDQJ~I2DfKgr7 z>IpzG1+-;&(C*Y6g+~$QWX>R^T(=9v_e#&u$QD(@qvos$wFH(I=4d#IQC+v#Vhe;D zXzdpTN1^5@{F^XG!%>XtI;b4W#Ee`GTF!orn35P6P!cug1z%6wb^LdQ&&@C1GIrhN zvH$wOZ|_(%`Y+~fyIh;<9{*vb{fPyS1S+1fPh5BU_~faBw@9-X)fJlJ)QH^SyJU>t zK6TI(D05^&37bR+F{;z#Dah%p+wn;5&FK=M#5~hVGQ0)5`>k=H1h6zn?v)klydiMr z$fO8SX|O-jol#T2&Rw2UWgm8%#3!+Re2X#(GJOh6P#o$!F#+`E)WI(xi;{=iqtbx( zYsNRzgu1^MnH$-Q*c-P1~*PFL0 zs*Nn_*tyj}#3IQ-DCdRNbMBF5b;EVF_K`J>>223GfB*DqG9v!^2it;* z9E7rQB{hkczAZCC0NIo@b9vE6Ca^lw!VNRr={c+0$Br*=Br}%}w#+%{*(0fc=M9=t z*t)z~lG0{6^@<$C5SU9RyjCC{&Twqu<7NG9<xFJOGoaIqOSbO=doY zIVMOlwCfUyV5bXn`|Y|y+Z1+PcaZeb2tl|USxcItBcCqF+P&$D9W(}HW(C*RYU&obVX`i9 zHcterII{U{Ewn_%hWT2EfO_LOFIyYv_{v8Xb><=spdX=R739rfN=l&l4$ZWEgBLaY zwnlsMt zu#NA+<5>9aU^~PK+Ns;>oel&(tYL;`PC$C>QHn5^iry*Yx-%y{0ZG0)JlERvo|MvB zEe9D>S|Wu33e@PbHw;qX%ib$3Fi3GOJZBZU^My&m99_dRtm{DmozNgtCM(YXOq8h9=C>rC+1E zuEmp2=-agt8VZh*&sRco@x_LsXON4Ae$s{if}2H9FT z2ofe3ZQ*exF#N)|c*p<{?HQmhJkc}2H%V_;&p^Vu(}hP}c=&~f3(qPuAo1iCqGy1H z(A~J6fpp>Bux3$OY@erk>Cx@rfh;ZfLdcjXD2 zrZ%g02$-4^P7CH4VquQ1!5P(c^DHjlw4lgWR3(L)qw;ZKj-F&Rs_V9UBQR1%i~cBF zz?W}OAQUY+@lg8if3Nxe$J2V({>T6G`>Zib=N_5aYx(fgUElb|4_==%=byH%ct)LZ zKV}`;Gqd5FZcXEp(lQ)bvYv8vhwJ_-%|gs2g8|vQH!5@1TSMtrEt`L6mj+qlSsB*v zzu4smh@`~&5iCEa@Jqo^Mt<%Pb%rW1@uF|oFAF4Eiul=hRX$zPM(s>%%9drTAOozm zk5GY@-kj5}(KG5LT8jAT^3N0*Y(Tdjo$el5nJ-aVECbM4DW#D-Qe0=dvuLA4OA$X> zugVz%x)pSzMoo1|lom%}Fd*D;ubR594{V73zhhp8qEmTCD}G003^@Z z0@?9wdk+jezS27s(1x8RO+WsuGc7WqaBPt(9?ug6&s8blZw~z=$7Q|qU zP+*KgHkUbTg}MIVE=66}>6Zn(OOIF=WJwpEEa1&@W05HgNzp-mXNfukQ*4|cl0?71 zB8S#Qz?&gD4R|A}9)%R#l3xPzAo{QCV6&p=KyG_kew-;Zw*_Q14LPzW${0++ttLN? z{Pn8*IMVk4MNLD_iij)-Q(~dYkE1>wB0PBtgD1j+SpdZx72yeUbZ~4~*Oi1X$ixVH zBf?Y5te-opUp#slqZ|dMrZQ@!fy%aRwbE7W#fQuwT0@CIT8o(m69JIH-cm6!14O8`0Y_};7?I+X8i zd>5W9xh2P!@INtyrvzEdnVZmsM;$u+!h_ryTzD?c_oxdGK#n|*4G<%6U3d~xxab)G z4K_>9K)Ueg!s8Ade&N+QTV>^OH9WqJ1Jj;7`%ajnuge?fx-06OEl&-PGrAS#=>D!z zU3Xrcv*iizI3sgmj>ZKT)pf1v6o!%(NV-!@rBgtb;)6>ms}SaBJc&_Vx6hFuE%szY zLYKO-_Dco4Q`QAAg~3$7+saw?hCc~y3I&dnbt+>a6EGnh=4+UkIU6QUMZg=`a=6U* z>p|y367WX09Dufpv?-L@D|^31m2O9U{FUHYsHD`XMKD~KRx`(SX@xmD!ZWJt&inVk zTS{y+jcpdis*9r0pApeB zkb-Mt^$f^`cjKBx=l$&fDtU#kMN7?5jXq(HuHhNgb*&zfSWrj{s)k3+CGB|D5}+_g z*YJ$$x?K(*B%~CMg9`7cIVvj>=IB{Mqq=Uf#RlLeyk2+%s4g$l4z*U@G95yZFl9K>P%43VDKepX0gwxkPhA z|M)ZKoB+sMb2Usr-kN8^q?xnj!0CI=0hM;1k8kyCg$OTA18<@tJZg@L@Ps)!!ZWJt z0P7w%XMlo!VtWRWs;rzpzB~TYlYf`9Gx~?cKUiye^wCe>-gs@)U2mNDM*ZVItSlP7 z;E})&m&}!N{={;1GwKK-!X@vJ_C;<&2hlmi+Bn;u9l5so`={6Zdh??rUjJa5#DbYv zx~gac;X^pPUs-qCOA0-`8}71zgl-7$0Sd9Y>9Nl%F0Cq%91715|gZhA}ugstPgBl zJEdro-=0Pkely(}(H9%;Sbg7*=6tJS?vlAB;b%b&SzGxy!WF$MPtD`xK!o|ghbC2B z*B!hJNB*cPvKYq@ulvT(%;R{*g}IK)Hbq_6;U^m2ni6z8cc|W%Ml+A+4i)ADKhi1c zx)x6WLJX=%5yu^>H$tK2r~pTp_u&rxvU|STLF6!~5OW-NsNTqyn#Xa63iE-Jf)sV# zJPR3i%ug&kr8gs@=5gGi!hGOlGDTen+@VehxR6LwRBtXy5Gx6E-*x8{NiHKa}Oe<0Y_lZJy*}9J+4YhSOD@Kt z>*HaH+ch^7ZI<4v7uI={UZNUt@hW2 zdEv<270=sm*Oin3W0_$+-yIA?V6Q1T;~KP@IWDab=ID&fsIKeqH$#I~g970iw3<1t zK`YGrh&$>iL`Wbkqq?reQgjK(3v!T;n#Nu1JPbz)Ro<1%baJiOO@|c&U(hmaoFc{6yV4g%)p+~-g1Bg@ZHZ!Zb^AiT@e zN{6VLu}v%ep=x(gzHBzKMO7ZhMVIvBQFt2h@$!L(iNlW=4m?!v*2?_ha-R#A&vJ&h zKs2~w$Zm9$!wDzCSKM##h=QS8EiLNQnX>Yz%mQYgcs7nON1r*Px~|$$1<=pQd=D)( zM?F=-ypL?WE+|mk!Wql+AR7;86rkCAOHK;nWaD)u1##vmI0*gg!hCo6etY^SjbC=p z10=u~s__MjOsc_Dh>iEC?EEYnxo2h!W<0=Fs$oJ!dA#-wYn{8 zW}BL$diuir4g2}`zqGE4j>=oN{egRquY3Br`7?i;{rA7vbJN}5etYAZNZP^w${E(# z`o!=BHQn98!7?Yq0m9{QM&WYk@CTs8rid`85sJ-YT{2zs; zB8kuA^l{(;*`o1)3^)Z5Zmo?@;Y79N{?B}zc_P$`Fi-YYq^|3# z9r;kA%;>ka-2Y`AXP&6SDa@0-bE)e(s4WAn07#GbQ(NvoM1k5eHBVF=7Us!9+thU( z&lS@;wGz6!Cn88 z)dOC4QLVI{ur}RqMm6wQdH?xf+{dFrQ}OXKFcXy0R$K?n>~H1a!h^0xw0}y_jEF=6 zTU0KSy0#HA*wy;UU${zR%awWrP8W$vzh@rO$^oc6 zgn35d{&EVtP7jGnznAsER35@SJ83mw02Y)lt?TrVs0^5u^-tv?%#*=kV(DuV^3Qx} zU8jdcWxx^|X9Z4}qv0qiH60_Xux9p{y0)OL+7$$^2Q+W{m82K0T3R_&!LhqG*M*mjK=vf$kH!W%@?SnGZ|z-_1N6Ejsbgh|cdEe(B?TPL(#K z|Hsz%@0-^C_Fv4~ntb;>*78(IVfoFE1l}vu)HIG1H`xAOZ6LdcA70%)A(j(jZT?jP zFU`&!G{qb|MaVzzbx(*HFkc_o99^N##oNcOJ9B(y>|lSpj4OT|$cD>04-=KRAKPcf z&<$Vm4v+qaN=H#JxwB!1g$|d`vzV*G4Ud44vtY>X9`|C)TfIYf6ym66fasNVnOq<$5ZpM<{@0)8 zJC_GDcW-nS(h;JULl0lIyrgiT49Y3Y=z6g+hR4JjYwmLrx@}>u@GuJ3CEGS7;md6q z5g0z|95SWg+_73|-f@VvF^1$ju;ZfdE9#8xx`t_O*ItU5It#{`OQi~7{&eBQ-9!*U zxK0_(zHZxGJmoP*L+*@7==ETw$F!*K-?!c`@kTLiowFy1g0p;I`kX{SdR*toUAlwY z{ANjiI%D^SH!{Orghh!dJdBh{qZ4v)S}d_BG5z}HeWaz~myew^kiisN+p455Rzh=0 z%9 zENbJ}AS70z98{RnP`mAf^i-7s9pI#WBZ4o*jLms-&bYp&4uEuSUV7m2NJ`G>_s1=K z7pd}naSLDVa6uu($CuI4%mnBApYr)0(D*#Qe@#1dDBn-uJ9IPo4jrlQs!;}_hD8@1 zcj&Z~lzHJx!tJo{2}qIS!XqF>j`}0vl;F7V2s)L+_h#+Tp?q)SyYL8^2+xIA&v)qP z!lMoye&Ipi5iUHJ=6h5LkAM`_)B;gUA^MIyz6VYTo(qov?Ucj@^Vr<5qQ4Yn5Kak> zLq``Lcj)j7UlP97mQhAm9#c$-F~>wH!dxn2rIhQsgCwz_;pvsi6E-_*cuLJt(XB9t z8Wt`wFskc1{2@q4X=shgXQ??VND$^y@e=dK8`X6!o+`i<(CDx=Z$-48sdO4=jzTri zzb?!f0U<_pUBDaZbsej{=-T>$qfO2zPvos)+WGkKLKo`qKs7S_Q04eR71$DsN7>k z6;r4=sv089(bF|Xbsdb^!aGaD(_M~_BAb{HfN|!mqeW7ek^XgIu74`a(5{0qTL1=7 zJPj(mqvj|KoG>TDd@1ER7_sLNw59 zSJ0QJ2#=bhLNsBHnY))FJfpg9p2Y^^*R*GV8lz3YL4h7~-n#8+S-;!=^mFq=e_p&| zt?AK)iwBLq^>XHit-kLS?D^(`n$0`^E%egDm#Zs2Z~$X7skDvAO~!SzboHtVXTgM` zEzZJB_n@3h&H1@EPunto*v?z$nO0grOqrBe$0g-FK76`ug!TV#?@QpJUcdkCYZ!Z! ztjSW=vSgVeQr41e*$G**YcO_^h{_U@vXsacl4WeAB1GAphTk`;=2td!*WS3QQifeWshd~8(4kr zRVDO`{&u-6Km{XX;_+HA)P(xQW?WcwT=hEi(_aE?`aAQF6LuR*0Z?|8lpUc^WHpDQ zYpg!Pk&7MVMOAJc`xgCJa%oX(K??m&KR_Di7l(iX`IQy7baByT zeRJcRJ`-Bo*AT`;eG|bB zqHYt14q~@TwY51$2EY0g8adumEpnJrf$B6KN$G)q}d?H1a(u`{87TDn!6)>X_tJLb-#*D zYH=T+VxY6`)-{yBLbUy@hO$BaS9K6~$+uAM{-vw~Y>!EJ^@e8q4V~Y;QND*H!C18S zx0>w+`CkDk?~-p}6#PqB_jhoVe`^uJfFM17BEGqU}MT| z4G8gDlVoe`^WW-*TVtR9_KY{e&WVAg;GjcRuyJB+4SK(o6Jrs8<@^nN&ToAfJDzv| z4Fmjl&@i^1eAH)*YyF1@>#rcNw{!x*M|v?8mnzTdxOQUh2(q_j4o5;T^`bC7p!GX~ zjp~wts<}*4Tgx7J3RC`Q-KfG0WK+2|v8u~uTW{Eim%l^M-g5RA;n)p68N0zlu^c?) zcj)C?$?o?FC}3JZf1Z{f(8*`pV*Y0U-y2;|!1r$MXuc(;DD6hYvJQfTncgj#k6wBq zfB12B=7?eaX&CLuve_7XC%Pc;?%>x;{r!H~VK?*hi%ozF4;>$ig)e2-YrpeV2UJ5@ z*K~H~b>AAR@3)%H#>DT)3%2u#2g+~*RxQ;}RcA+5?FRXdtlC}j{{#;3TZh0um32TF z?%t)KWb6*w4e}iwRlDRnb_o1aSqE6PFQ>@S@dN9o)gyFZ@}@F>w*K!urnWQV>_J?QX4xhGPf*1FXF1=}4FjBa8(#Yz znX<5-CdrO$ihrrsetpgTORsCBA#ga#9!SLSPAwl^w=2qvd$ws;!28O71A)EujR$lR zyE}sy*xeb-VRvVcgWa7049h!%66^-Qgx%m_OPFF=n9$Aj5?tGeDgnX++&AAD>@4`sh->}}B*2UO2e&_=BNj(jOt#M)!7sj;*!{;6L3-6V_MBnxzc$f>LfQkNme;wHggYukY!l*+$W`f@ROiUsNsDLE%=H z#F|U8|7X332zd2AAeJP_m@unnq68gQqLqsdx9?zb^K;ETAl6^bSpnqc?Y{p1KlATH zAalhb-UF?IKnW_TDl(mt?!4lj-YPyFbQ<^gp3=(WI#m0nd#U??q=%x)XSwu6Rra}3 zlWV@45#~ob(8(5V{`9#{#Utyu5f{;Rxm1lnE@fK{QJH(KJFRW-kz9V;AiLas;}KF| zV`_SeV2qAE_n5jq#oe(--&nhYtlL<;gT>valEYErkAfv|EZOJnjVU9wK6}pVIOp40 zeif3K8eBh?-#TyxCa$Y7mpm(AAs2UwW#%(Mf(iLJnZC)saiY?pMk*Zw%AeI@93n7d zJ_MA(cZd9dX~*1uh>qi-tEN;!PJ4-0UGBgut-jbnR9ZFpVh*3dujWVPik9xDLlx6x zK-m0x0{}>sdoI~_#D`@mNE`6r|1o~xYLZ+KOVQov{f-V^av($K$Ht3J z7TVUv=hnk$2n6E(vG1c}a@SL>{^q_7tb2d#79Jy(Y6BX7_s6!4fsp;*oBC@IZ-9Gf z7zWJy)q#RPl-uSWGj^hv10<+oGkLqO|8eGFfE2d5?*EI-zXl(CA?St1JX$~V04xJ3 z9m4IX41mVYh~2)mjE9}<8ezF~$+6oxHgRtqjdhzEgCLgsCLwm)b_H;Oh>f|1#pJhi z#{!3@@=x|ZDQ?)Nxd9wI6}8y)KNd^jrNL5o(FoL7oI4xb+mW^Gg}%$eLfsX_^4vIx zrSR^2@}qkzj!%*s0cSln$1XjV{YT>oW8o{o(%4zvu(fuiux@a#2~%cpyZSQ!&!xXJ z;lh0HVuw{A7UAhz_^IqW=z9Ed4qe- zn7Sa_bTcgzVW&3qVX514-Z^0~^(B`3)@W1VX%RFCCV`hvn>f?7kk0mH*#k zzVyQ4r~?>jNi~@RI~zuOKQJhF4eaq)ZCOo+)W(F+Y!z)b?q(C5*xugl_KM5}ur;*uA9u9y`DLDls^QFBXEsO1SN;M;&v z1!83c_!gOrn9pIYfY-p1q3~pAWMneZWVMy5&wFvs$Y*VG3Oe^0hFBgbP4-#!m=;e) zAp4LSC?xRDGs$y9Aya+OW#kCV%N8*No*!8Pw?TDe*S?pk!`3GH5CcPfD0Q$Gyt}DR zI~jqnL?Mh&^T-jDCtnk4C}Rq_Fq{KhErqQ#IUpw;kgMwOd8kVbYIG1aJp=rOLT0q< zZot-H70Xj#WJOLNavD*GLM*rYoE-o^Td7$BBi0g{Di8x9OHgD8YX#5))Pnnbaxba` zITQ(9U74LB>_ZN@OU1CtmZ2PLS;1wfSXL-<*|H8?4n?)PCzqp!+>;RloZgFYswwCi z0uF|H!J%tvg@O*1%gZKwW^g}ez}=If3uEQTDZ^gmBx4S$RJ|SbdBg~LEyt+5EZb*h^;5=} zb}|$J{A7C8ZTZz0Rq`|N+PxtrquvOZ2V$mmp{~iuduFU0ikK}zzJj+WPZ~jy?{k(` zffg&^uf||-7leB8fB{FGt*ly)UyCB#AwkC*7x?7pS+Ar$`9|5Mv#{-V2OXdcDgh5y43l^#R5JSbN zF+qjZc0&}rX#nbj8c0SVGN${G4jRhDBzAt1jRKjZI2msYaWs_i3FvT0NJwyAhR0vT z+4OJ%pFL~^-5s24oUJS@T$}}soGfge1uEKqm-}U3-1Y5Zl>&ZH*!=i<}12>Y!3b` zUKsXf>{N)=poN|esL zni(ATsK%9!JiU_EVnlRQG`&NY!rIaX1lLSO<;r(c1{YQBXIb$w3lga^;1EzzVX>e% zZq?Z^?R~{dfj)D3YJF-~77<_fpxG4ch{9_F zn4o}%vjv;>{tq@`7$kybP*PlX^g|_3aI$fqUw=gqpR{j^nnbJFSVI=E8)Ye^&bX6? z;tsCIw_>B`cdv*P;F(R`L5jRxMuBg{RE22L>?4jEj#3HXw&_e~Z_#-6Xx`Hbxh(7H zsLCnm@4`|mLN7n3_2p~G2iAZ`4TiJXprCVNN^>bCN5TyH@@F0SquCtZCMng!Y|Uc` z6jqKwie?SC{TI@BLXX&Y8}O4p{OC2-+%)-}T|9w@E>fiD5XX_;d*&RJVNPpa`zB`f zi@yYR9XuEJ_L68BYGqG#MI~h@5Qj4-UxC9z402-zRhDi2E=d?2!bYp`f#t z9i_Z;avH)WGUQ6Qvns3%in>)RzFgb2^!{e;{NWriM5rs$=+I^TaKDQaI5t;NIwy5p z&raHCN;=(qW94XF(x8Z6A~?uHU*GU%=?pJ&>@;=#Q1jscNO}M1rtU$nDrSnT%*ojS zORk8O(x%svuVHCklF;~U8-=OPx38vW?+?fdnv2jo6dR}KF(eqXGA5g^@#`^m&oVo> zCXK!njHK_eUN}Co7#k6Jk~*9yUYfbHq{#|&9~@pEF)VPmlb3vUcGSe2DobASyvIRV zQ~yt)>T&(9gVeNYNz37(Zb@;*4>b?n7y6J*tEnx+zO?R`;#1AbHUQ;6> z__lJ2?L?Ecs0b&BZG{mJHyU~n^k6yhgm3?i%jTWoStJB6zS3SNzWGX}JN>3BpBc*~ z{F?_sR)_sgn2{2^5aR^(cL6`P+4N(Qu4Dcm#`Q|`Q*W|5_j@FONE|0ZfuCsN`IRcN zRTfJ6;j}Znf0NIoOHJZMK&=!RQ>yv)bJelR*Q9>F!wIIT_G+H{s%OHK?j_Ya1j=r2)bo9?kwjCubi4D;n4;iMMd{4^>~h@1c~KbHg4 z|4^NcQYI0y&;IKmbM6OzJY0cQf|j(Y@z0ZGvyK$f=SgeRxuoO)wzVGGt379H zuHwq=LoU=2Z~P)%R6A*=peu-6N%$UxdBkWqtE7NSr0LPcyrR)?b!|pwCE?@5PdPg* zm$R-O(|`RklWZzIWA1rI=5&jPiso=8-+mAEk^GEI$NMtx{b%`_Wb1Snj#fCQXI?i- zV^O8o){-#0&rRBMPD=uO|EpwucP5!-O{;mpQ(MPG3iTyt1&e?oTOoZ~%4gM8S0&=I z&k$>W@0Va{XsZo)>fyMb>axx3z+*273D$--g4%PqS0BgH+zXW8W2aOjDL6)b^}?zB z`>8M2gzHT8DrXn;?@en`Y>RA@7fs0S94^;cXmOusMQ=(gfhrN|1UNVn3|nnVTkhSM ztqHSt-)vGQs}=$g_0xKU2tjTakyBfD-6Z*ZR;Kcn3Tp>9duU{DuPq(9z@^5u2Jtlu zMB*X0L#&E6TwkQ|6%}=5?ip66$=EGb%AI<2H9wf^Fx`V^V#D#=;orIUJR(2L&aJf9 z)PYUN$SMKd7?cY*#nu6SGEE?1k8Q zDL=f-X<>vnBpM5A_2lm~mGon}Jbo-4=uHkdi_ z*4K+qDG)!X^eb=rK^a48X?v>LIF^O$1$W9@`Hl#S;D0i){QMX;#`)w?#QC#Sv!T&B za>_K4sx{>zqoHnBqAzh>(GhH~dbNK{xW8mA>D`xG{c=al#^_DYY1ZMrv6C=l9mzONzu(j>hL`&yM=}NwcA*j zP?3qhe2aK;Nn8D}$CIRUOmnXwADJnph~B*voqpVyIL3buhtX#5lQ9*F0=XGd26fLYiSBTLI z&Ek=t2@gIFPB!IM3yp4lp*dTbI9Zr$x;R*C0jiJw%X|VKx5*W-jk)3zNCm7nhk*v zGpCQ{oqH2V)uCN=5%ovHYSXUEY9 znQBz~kT&^53-j?-9@BiEOy-<|o~eEtokaW<9gj-d*K$vq=ib?_QJKVR$FsMP%8FLp zX|SPPxcoxl)paSpkFD{->Pkf~tS-59GSQxyzQR|L9j;^*U9&&Ao71{6r|P_tazy(* z>a`_A3CBdUh+R)j6_M=zs!=!YLzNf4v6|ma z;(>fRMGpy@8}QI7?74jJstEcQ>0T)Fjl&D zY9{@Hb3rQRDmUWJ7Oh3uL&bv3qWGgeycla2nXe`S9U!cwYT0WluUMDVd2@)RetdcS z1KDH0h39c#wnizn#C`m?zqwTrgq)u6O4y z+%EiFzNS;G&Axzo(?G=G`esm~D&mZ+@=J){fom!zhNhh-p610$x4p_oJZ#PhT)Glr zXi>d-S!b!L&zP?`@u7u8Cv4vErV-~*cNas-TtUhl=vo_d2ib_@fFbm&OXv7Uoyg9x zTSMLyjnw6OZLjrcWORBP_Prmdw$wF}daNa!SV9}ffi!Hxcxqk9&@$`hK z3<<3ciQP9Ig3*`uDGDl#R6WAwvU}e#J~s7wR3v&WuZ^p$<_PS~(pw0ACY_-1t{}XMAI=gt0E3b|zww=>DpF*!Zb5GYR!TW5MKDk@5c?0_i4Y60sBcuD| zZ1c>cyY4@W$5T(cnM(Qc@=05}y+^WHxd@pS;YQa}FAZFGY~3SZeKnBN)8zT5yJPfv zGzMB_#&t?&BHYidqP_?>kRFe|7oz2jn|sXFtC7%stdh*~OxoRo$Ibl1=cT*$=GV%m zoaQ@`Axol=pV}<9&zxb7Zp0IOsWsgKKvw^@)2bv36C zkJR|0n1lu_a3jd`?tY~?Eg$0>9Km!~p4hIdz?GteE-QhAcF-`C!7IT$H2} zJK)7~arSO)Q`;LC2^Q7U?D15MG(*GV(%h#kLt9-(*g<2Y$1^NOgoUM#4%UiM+)6Q) z>+y{1`*iUJ?uldcVZz{dbn-W6GYeI9ViMBz-d-wV(Q7xA@momcx*_!8&REBs%3|xQ zFA&e1#`^9HETrb7c1dqyMR`hKUYSB20uxR8~!RMv0#*=S5_1vuyq49&sNLD%HqefQ;UW8QyT)~U8 z&}5;TYsr|O;~2RwguLe?d$oFe{~`6b31KrCXeW!QgM$smX%MY!A0R}hpxrFP)Tm%og_y^FY`s2WJp zv;4v@Ro*s0<|7IxU2+%cOnR5Y@33FsO}iiaAU?U9Y|k^gHfsjQ(TI=QlyTDsPc(-K z3@+cj!c9>^b6z~i0&VM7f$2 zTD?9}YuQ&yqVC7FMNeI{x_awuu=2<;)6ww6q%)A$wjZrTdG9B;=}{ykm`lEge-{yV zaklK^dWwpQj^lodf937{Dbtq>L!4*SYr+Lvw7FQv7Qb6nOe|NhcDoTBzI>!ynujgQ zggL`#LeKxRU0r$QmD_L9Xuv&&he^GaV$YKZxevTj^|(rFSZH!wf`lg(cg9aL5+$iw z=A0UE6^T)2vbo!rwE>&K3{YwQv*U|-eNNWBU7KeHV>6XUt6r%Q0tEs7uIruc`AJ20 zXe1M8-V~`)v1R31m@3QNLoP2Si5+!iixW`M9+VND^0s>3>$RucqbBb76dj!|C7!{A z>WChpAbes$=K85Frq7TNGDVf#C(qi{J8TBy%}Z|)guFspd`C_#eD+GPa`sUd4>t zzE~!MLw-*0$f0~5<5xJYg}j0iZ{zIcz%MFkOapvn72Ur`KR#f|B;sV%n$8KXk5hDb zar??0q7{Lrr5@Nm4ez+D4|raW$c-mPr&$wT+G}`lxF&yi%}Q?+%BAceM5e=y|Km5csg1*8=x2Os|)q^fJMFL zkCgvnqp)XxW+sOt&qQAKg;iXAh&;zybo+^A_;Jz;cxg0Rvub139CD}DT%L(v&XFqdHjf5= zT3bq}l6`qFDAwma%XNyZDD}D_DS<3ft7@K)`)y_QO)2&1qwB;BH7)lfYNq*uyl0Z4 z7*jbDM$%4Lzq(j=$0g%aOO5Qy%WpO5b-S*a#?9~(aLni$x>^{9_`T0Bs~o%YHRI``^~BfIri54sk`O&J%(55sb%9w~Aw(}uxhJLj8m)-f#t#kmV z$>#3-Xa(ca`L!>b-TZ&<3+En8E1O*V8&3Vrt)Q<2HhaN2H--aziY+4jI~N4MHn`b? z_2+I?6#v@bhAaKoRyMnU{@g9ivR_--bZ@cY`}(!P&89BebF}g3lw%tF)sOUR1Hqeg zS+qsG@l;h}8u%af@vkjxRvFMb@5aOaYQ2S@8t|{An@={hPO4{trjtukCE!InhVK#`EqS>E?ssSHjH;`_H^DtS80!i)~gznUDzGIu-B- N2`n}B_rU7H`F~?6EMouw diff --git a/templates/ScRNA-seqLevel1.xlsx b/templates/ScRNA-seqLevel1.xlsx index c188c434f497c66afce59518c9831021e524f5ea..70b8b9bf53f6d51f68392480bc67368ac2ab0ca3 100644 GIT binary patch literal 842981 zcmeFad0fnG`!{Y&B?_q!O^Za^kQ9{$E!vbslD0u86%~b+K_v+-maKJ2mXaD|NorJ5 z36UsTMmwsR_Nk_3e&@_IuIv82Ufqc9JqDMxPSa-I{NvL2X@CkPfu5`1HMbu4|#e#w)3=+)}GD~7#5pLkYD!t zM24I0tfJW_bLZC1m36yXe4sIF)wcVV&rNisX%)1sKRvcz`RP5iW4wpuw~F2V3E4Gq z+P5T^`8aKTR8b}4(L3q#+vYbGeMc&`q-zt}gfU6Qx1OBnJ0jAR9Y-g(?RuhGJPEs> z+&}+m#nlrV+NXx=U){KP_@(X6j#OgW`SH#*JNHDcbv>~2(Uo-3gngbtxC2S9N4;>H zFHjZTXfaJH>ojOKi5q?`NICzer_bMY{_QUVP2s~eb=SoXmD>>#1MPxl{QT*iQ(-WD zoXO?oR+sptFRP?;xFg64-P zdB`O#I=}G2nvmkvp;tdhT~6pVk_+mumfEqkPaw>rBlX_2b@#RAVT6BXzdJwmd}QVn zo7pyU%;}YztM1u)*5CW}`puE8wpX4j2iBzQKi_idf$HOEo#!4~uS?r^ot(0~ zpg{h-RGE-2BT}R2ip9M3E}=p;vg1qh&WGL+n&KL`|DdwlrmT)9LcTvuW+%?uC8(n8 zW4&l&vxjkQWK@e_A;GJ&H1fXHMDMNEw>Q)$W~_9(cx6^#+Q*F_Hsoy3`0=anYF`T8 z@rmCYwdE={pVwT{`84ZH+4;{k6N9T$1`>q}15+L@Rv)leIQ7O*L8E8!WTO!pZ zhb_9M)@g3J@l|Kr503@zrPgmgxD8OJni@Qv`9=8N=U2w-JT|Nx2$h$le&0OndWmwp zQ&VGjd%Klm(D1F#721C4wYlZ4n#UxM8Xmqkr^c~2+w-&k;Yb;;etFfD_jB~zKKm>z znO$&h;VP-K%AK|XE;=iIP*OTGHaE~UeK0mZzpgre<=V%dLpr4i+b=n0ObII7P?RdH zI<7Z*f3r{Oh_C1Crx%(CE$}rZICFPaC!X&IcsT&NhiM9FU&pv>cN+T$)_FSdxD-t zMF^|?2#`DT-u?N}B^Ci{awX+Wm-0Jvw;Bp+m^B4mITG>ACo|4RZm0Dt@2T-e>A@?P z$V|OKqq$59l>QZyt}&?c_^j%O$ffvdi%QFJI=3%%UYsHN-CP-pl5c93^<}{60VP_#O3kI+M28b}S2%(>T3tQGxFDf#&c4>*GgN%O`D{ zJ4N!*>gWqQsuR<8^esEBX)$*OE-KA9{3`M6)~gQvX}gBMSca?@tvni@yj{(&OtHIp zrdy21yqpzRju|%3DWi4 zeX{T9NnhFV@axqun}+2Vi;eV*-?h9LKTh(kwaPsy#g#Im7;LG+r|Q~Z(LPM%w6@dp zUxmK9Ts2|h$zxOX{L4~LEdOFL*+6sGGE#kge#5+X@{YS>UcB7n*%I$Me%tAsd1?2y zKe)ntx93gebJvxMzc5Yby!Ss`nq+vx|EwF`XO(@LH9=ZeI}bZmb;@kb)=euP_B9vz z5MMi<-m7Yq>6Z7vtL)IC&+B(bR&DWqFIoBBzT@JFv_6A*>n67BR}hZ8@b2)r%zfe5 zjVXrF=kVv76EhNbwH8|(GTnOX#UrV96^3iH`nXspwJoWwpLXyUwzu{jwqDZw zS!zSGi}82;l&E$(&GRV6Ie>0F^it?)dQOG09I;jZSnS;h)1c#TlvS?`%+yueGm&Pv z`(Pk_fB&ygx3}FV3J)xtcC#;gzEg~b{J`SuQpezKI&;DXb3vhKujRc{CyyIf zD>-i5hW|2?NOLmDP9MC#o7Zk%te>ZcA?N3%>geb8s$8!st=TU-l`3_G+CC>6ZStlVO$Wxl=SNR}XQD>Jy#BoF2uK3`jrlbL_j3U9VB3Vn1h@{2C=SswioAb+48W)_f z{*|_%C&+B($Is7WY79&ngFb{u3yb%pq$QuH7@EG{z5w%t+e_9m#4IN5AJU03C8aA9`4h)c_jaQidNTwuhrcdKc_uL1Ikz%C8xl6ErV8*s@x9MRv8bu_oo@r zmHy-rX+iha9edk*b|zRAC^e-GZ`r0Xu!Htal;JaHC`*fS+p=Ka-~z_Q<_^swivrObHD^IqLBfZ}rx8X`V0)b2t_qx9(YNrj_Yj^F*`S zyjaaW#TTqhCDCuv@TQU(jrXlgWmtcb8>_dc__0;7>cv+#R!_0nwZ^7)An9~Yh=uU6 z@Dma;zYO&BW{N#j)RdV!`*7g-@O4dVo`k+N$k!3;JtiY_L-6ZNGqGvrtI7+H9LkW{ zX?}8*W@_IC45e6}CcAAd6_3vjA3SO$nT!73DKQZh{qpd@hbH<(7e55r*>&I0|8dT! z2d(!jKQBeB7oVW|P^`;JNS00{wiyIfD@9U5JcMh)!wzDa8}zpx!0a^tp|6@sUxJ|( zC(_aKH2g7UPGMot!yl{_gY4{Rczwz_BN|$flArfntlK+5?>Tz*0~nbvL6@TFjUR)e z)o#!`h?M-mYNaU7>f!9w4|7)6p1`LMCRVO|M<6ps&`AU|6f*;Ur-jNr*a;?7(F4)J7F{DU*3w= z*yo$jRG!jKVuhtc6ZUslP8v5Z*ZBV{EY1FZg{6`B#4dENe{l55TQXI!L%dCNbFG{G zY;l8GP9H3nh<;b}l8%XbBYLws_@kMYTflf3&l21K^_|y&C;f)o#RC<7J)9|UL?WZp zQ9+ct@6m-tD~?yVgcKS(L>G9`Gv+M6U;5&Xe0zY?org1mPUqX3*{;(0t}*q;r;KTh zvbSS(l7-)!`q{p}_sghjwa}G-SI-g_*8j?#cx7TkH)DN8=#%ABXlt&|8(bk5D!F}7 zfVS&MepjueGISm=~<&ehnTa_s4ziSv(@6g^wf-%#^FxmfG*A{CDZPPO;nK9Yax%rd3m zcDE3L@#Dq`PW%_9)L``td{h1#Q~K}o+3UN<)%Accmi=FBue?_CHCD0kLVUZ*hgC24 z*G}?z@1d}G+kvR|I)k^q*KXu)7ymNu)P$Ee4))@1JL=|<6(#Aon7ix9_SQwEYl=O# zx-$C+%!aG!xPhuHY7X<)@KX}KhoYT87%a}(M+#&XrsoWol7n>4#1R69d(Ke_{qXSkEuY(-`L518N~Tre#mA&41AtqtldObE{z7<@!8#Ss{7SFt&ReV?4Q zhUosxH)m;t!B1P9a~@GiL#^6qiMlvNayEUCwL$}d*^g@dip7W zf$_IuGPP=g7+-4~pZw|+VW={CabKjIgDZR9k)AXgD3J7H$jrW$3+?_SW;>n4=;+-- z&e=<%H_}PL-3?+)60?KSN<%ihgVV2ezQO#3L&me}_(~PbV=42x!9&c6_qR8TeJ@%%EWz zo!v|Z&6%;!$tz^AXgFPghB1yO_%ch^$pp_oydtnkK_QBCRxfz=;o+Z{-h?xH!#Z6D z`a_1hqx6_Moq_#D>lhAL(%Bb*vj-l8R8$ajx(8d|wt6>r6Lh-zT8pYY8_^2>3C>wV zLs~sO4{nHweW!FR>o3BU*7OQj*I<|t`dwa>wDj+kzNr)${lWXK2G0WYEQ1v} z4-nZ$%A~iHwonG=QqGpvDPW%KhiAp*zb({15G3ZG9*(P7cjUSL$*layXY_aZIA&dq zbHc0Pc2m8eM$Avfpge`jXu{+Vhchjo;q@pV#(RcLrLXukQ4*JVZIPN@;@lz81rs_3HE+3l(FBH>sds z?DpQe($?~AQB0d)l``f{@Wbm573m-Q%ofnUilSfY&Z1v_S`IbT?#9(@Jskbj%HR6Q zPF&6A2=vQ()-R3&k9Oi5tr?0hN`qe{4(&aZFdSI0h;XegT_GVO6AK#E!WP!ZEqR+8pRwQs3RFtaYJ!G zhD(=;6<%&@VT3!&N8y-T21=Q?E{6;Y#Otq)$yda9A5MHLu5T4OZ@cK?aOH3vrr9}z zt5F9ICzj%i@Ne;N;@%(LUM#*>bem{Ej=`kklvj;=U&-67{*bUjXznaA;b6niU-5fB4S!neBV2>y~f4UDvBC`4{u! zsna(p{jjviF;>+Om^2&_^4FTq=y4Iz2ckcT2Mu-@CUhxX2`SFiZ?e)1H`lN4GQ6x5 z7%#N))x3?On?(;YE-Vb!!u;$qOvsPUzm$I-d%gQrtkRcxPv-RnhX19r#(#U)^6fE; zWq(-Bn>6iI_#~6iq>yXzKf1$}2CpFtScvwmBqXkM=$a9y^hU3)+ptKkIojv0&)x2H z&6ODgCUHuG^G?irJ@0nl&udB-^&T`6n}{vClRgVS7eALiBhq608bZD7o(*~nR?9D# z-`Hd5tgrVm4q3p(hlm{ze^(b9^-RyYSvWyyt?1J5^9C0Tt`lw*-*~s~x!%W?C5=m( zmo%BT=sjqRSRSqxzKSe&*Yd;lOMz$Xc1{r*6c=0*QZF}trrb~2J4%CtbrCtuR+@t6 zLW15U>=BI%eAN`8Vb!lU!{_A6qBauaukT2$&OJd%C1R;%dj zs=SS1_fO?2Kd_Kkprvy5l~=*J35#RPV%}p1_OHy&H-BHSx-H!&usG9UNmKOVn9d@! zp$kj|k~{BDF58}Ba65cz^b8Gr_vyFC-%j}|tJ^1JF7ZTp^1W9Yo1-gJSIo?ku$q!& zVzy3))L1p}OC5(98oyn(PgGE)NWez)^2|9=7U=PhZ;GBvc9&JVt+Vq;(YQHs;##Fe zszs^M(;n`KB5uOp+fFo7wGoJTcS_;Gw$7y0r;-jNb(`nZWKi~(AD?|PJKs^nC-=O; zZNt|J;^^~`l}LL1bgoHcvgluOX}Oj2N<;jJ7_2 z-TEos4J^B%HF>t17{O?owmy2(0LCp%#(ho3V@*c3CZj-;@lKQRS(8zt$!OAKv}-bY zH5tR241wj0Y0DWB%Ng^RGZdFI)Rr@rFK4V;&M;ceSiig}J!LUr%ld&5_cvr)8^-f1 zU9`{VNyOVjXV4#|E+*_=KVZK14cVSfsOhKd)6NN~?q_WndKum~>3^|+uc}e^6YLMS&Iis77tV{9%x-W zKwmr{qC6n2JfNaHpsPG!t~{_!d0?;dK!EZrr%0bP{=bCnBZ`{bc-W=%9(Wzw^a1Me=pNl)7p?0>7P1pSdy^3Wjqqb(t;zGA>JLRF=Yy@5!{3B|S4#u>E-q&Xc}O06PlW+I1np@&CnKRXd9J)r zMp9ybSP4KG3B4jJfLLond{}(5{m=WAUaAwF5BG%VBF1#lN8XJ5bh?${z{#Jk^*`~ zloVKNLVTrsv;C{2FgDHB6YGqU!WNFZ0VM?qw!5*`gmAY4_E(D5gh&cboTPx(g!oGN zX8Tu3VQiWWC53jB6gb@Cw=fl#?8cmm36S<^Qo4O;XB{#VgZnBzdqTp6PcsV&N`9emFA7$n(FY7_c{Da#s zINZ2Ymbs$f{Fee1$yt%7Zk=-#V=y|tdoNqSdd8o*4PHfS3O5y>->r+~sCMlwI_if4Bwq?fOGR@CFH~P74YDL6mpRny_E%mc(?4{D}HmE9Jw7j^g zKRiFA&@E=CNuSvr!KiL|!TC0dHu1@5%x9QlvYb>IZ7=F)(VKKkGj?HG!e#qQ_NLNq zE$Y_4Bya6o>Y!v>EOBb_^++2FH^&#-*F3mur?a*1J4Q@QM#>~s?yJgm8NIY<07DXV zkRg@1hO~t+Ro0d zVx!`w&|a-*R+HGHcB1u_a^~8lw|u=%ExsSQMRk#+gt=0Q%+TK}T8hQT*-q8DZFXDF z=GZLLh)pr>!4Kpf&uhE%%XFgKg7pr#WsjFUj@2rA@0eJwW=7ur%rZ4rWtNSO)SXLZ z&kq$G-){Zjz{9p&jQV~57a7N=7CZgy`F_}~fd7zuOaAZm$?gym&cU8~*iC>H%sX>K zAQH|$R{WXUU3Ll}s^#D6MW0|aCzxaJ&*nWV@*fhVMZP8fZOP&n+#wcj-Z~L`U)JE^ z79IUVAHqV;CdV!=-6U(YQGRpM6=x3uH5IQYwNSITpL8a}H*V3v$g-!i z)5PyJPANG5zF_g~40Wdmf7xwPy{;P2@sAZ(9dfc?`s0%FjSCbv8l?;roGAAp z?nqIZmK3AuJ^Z#juiWgLiLQUd#;1#dBI|S>n5Av7_~~$MyIE_!gvcqQg0kX=f`n%o z`WM03FHSE8Y<-HCLI; zd;cI7_hp@v{Tfc&^de(B{~`ZvC&srVh);eU$i>Z9zi&0tLG*uLBP9yblWq!P* zaau9J#)ih&fVXz;>+NWLX`7%!q>PE}pm;A`k%4tGVso@5{RFo*w;P-C$_ z(2}1*(5Zbtx8a|--D2@9a4lTW>c0oqm{DrFh2!T5#x6Q?D>*HNqP}cR%3}3z{xwY5 zkfotBdh^9)jxSayD>-){#_PR?_0x!)ciz_y$LtM_c&{cTet+Ani=nRgTMtX~n1|H# z)bB4?*Cn=DB+6U`Gx@gtZF!rB^QK|tF-I8QvS$KUEM0z1vdrw;is0S9Tz)NZOuG8W zqTDlapYOcgPK|T%iM}FvhOLreiukQ|$!(812-%V{akjAv1K}xQg|{w5TVsAi^5u+Z+p^c4x;BC~N1JJhgx?!f--?hDnD zE@XHQy)Vx#H+^oRz5DXrDnoMfiuW&ymggC^NQOpyQJZ3(_mH^p>+U*cFz}u*UjXk3 z!I|YO#W6z$pYs~Z-h>}ZzL;FJN#1p%+`*)H!aNfNjHSi9q_B)wt+V9II+t`zrG7T6 ziXXiCqiSB^WvNW#OFycQFZuY~2ybd9X{$_E9ZIM`>zMg0U~YKa@hqbY?~>xGtZ~8Q z@+On{$t@VcvZ8Qtn`LftXd2Vte_QmnWtq|Ql_iEX3kS6dy_=2FW-QcsDr=G9Wo{heFO215|I!TwUvkcam# zrQ%kvAnK>s-!g*JWqAIU)6HAOP%X^%Y&6N$J?5cZJZeeet;?~fAJvk)#zYSj`_4~L(ZUUT-*~z|>=Z~4-Xiq?m zGshEOWYqKMiTWbUza7!N4&}+Q=7{&C80pAyu$+B9g4O$h<2{0*eI`L~3$vc{Im1~o z68h^KF=C1&)W^a%BCoj=*b{s6n1Lulbg?7Ehk&{@%ubL9fd;Fb3I{4e6ho(~bI>1) z5_GDvf=*Ql;He7D31Cwd#}QG{1eK})9r3dWvlSIh1sqSLh6xTAf)q{QVOt8?6T$O< zGqfjyCl*2{bkPK!?nfN)a~@Rn4(N!s*dZ#a!n8S_m@OsKgWLEnIATP&{+@3{fc_rRh^W7(Bfzc%x@W;c zw-_YoI*bY4N{$#2uHNPwk=HQ`8aV(OG1aLbhk6X~)PjTdZO90b5QatsOz;r_c=F4K z?lHi#sTg!j1W(V9j_6)TV3abQ?U_{iqYl=*JzFv!qRGcO0gqyxq37)_(DU|Q;CVZN z1Uw!mL666A(0f7#owuW=rG+)OkL3(@)$a%LIM_W>M|kmjvil>u<1c1Ef3o{8Xcc^l z!T54@JOd7(3<#099u?2+^|wqlz^v} zKWnnf1_0rcAD?2tNedoROmW@cxRcMJP zU8zqDsu&j2m~AlI8mCt$cS%D&d%-|BTyMia1`hzYf+wI6JqEY~+<%lF1Nx>C&^KiT zP2?Y$g^tY;6bEkQ&q8@Gh5oGL)<^1Cqf4%21e^j4pCH1k`qJN2rIauz)f+xli6;~e z&0|;+Fe5W+xWmWb+u{s98HA>!jp-RRhql8fOYlP5K>#!9?-@1R?2d%{AWSxh(JdBn;-&LgpIIl;M#jW%LYKS zl5a%bjEMSsR%RJV1aSR5pCAIz-}8+)wv34SdlEv9NzjL0_>vL41u-^pfN#VxX2cXE z=#FC&+=fZi(!6u%M01b*p)!C|V&F>qIOtR6;3xmVnF!!Y`_RJpf7;1^zS2IJLZTS7 zR3`?yA;*EE<$n~#0I@AwP=`Mvqzy-Q`Liaw{NvV8^2K9W(H)UpNKU^mk$_Wx;W7f? zI7oa(06??LHzH3)9%B41VlW4ERd>_J^P@%Hk{S^UlizKg_%j zu8(9X?V~CT2MrwmS(9B(OypAx{x7E(AhOFak`4z~fB_E>WatuyKgC$!RPH`UTGg(82?W@`OjC{2fGe51p2x$zKX&BuPO$NI5pkE@$&>@7ah6v z^VhF5BLDUZINlEb_6pwTF$v(Q3Q(yX&11UJJZ5C>2B*jms43X? zr~{qL!9iOQ{&q_6;U(XQ0CER_Mr6%nkgNrP^ZfzNW165Z^^Sw?vYp}h5}ZnL#E5sn zcs5MF5qSp!AdSf9Tk`pqCi9b9FoI=8;o>&S+~n>jooVpDEqdFs%;@>b62qE>gIa~& z%|>Z67V12ewaDC!s zZ|PQ$|B@%R1fOpiA7`sKm8W}B{|}IK`kcocOkk2S7-ZV+I@7a_m?LU>KXLjzzc&-D zqkezEx-PNJB2nfln8~;8Z_C?6oHq?Ck2%8dmOT@=V(Id8l4WM!Rs`?<&Af3c@1T6!jJLV`hm;cw?M1Y z!`=pu)amJe+!X|{HwGXutQS?DBif&EVAzOe>}If2@XpX+7`!4YxPU6(h`dHbM2-YB zA_Bv>w^y*z3Rdq2Kw3fQ+MhMq<@CDzJ0Ezg9!9QFL5>JeGvfz;7pC##p$Sy2~KDe$0c!RHvy)Vn2+LW5B$nZS1LAVPzVnBul zx52w-KE;41#y{%s6aKz-9In5|K*vNJv?uZcV0V9G8aEFTdf(*Q$ z!yx=ocRtWnhyHd%xC_q`+PmvM8@sS zNSq+~AF39J7s(M5V1DqeTf=;?WXV7Mq2QS2L$2JxgJG`RLBQqNPa_Ur-J#npUm+yE z44sCss7WL)P!&h67SY3^kbg@+2yt7(xvA{cvCw`TjcJX#k&XB+43cqw@qJon|nybNrd?< zgTW#0Aj&GbZX)kL2-#BT)JtAO^5u+Z+p^bvx;BC~N-<-_1X6q-sS-=GJMb0%KfWFA#4nX>1Bl{33pf7Uf-jKe?J~+z+^hJ(70bp1haYewe z28whT;$B50DW;ExG!?9#Q^k0 z&ZrD9MU&a^KV(=OaYeXt5z-YAM;Wy)oDl_N>%t*H0s0~bUI%PlM%Z(JzQ~zT0Qw>h z+!r|-@PH|rGe!XnizBWGSS|v(B5GYosCD5`$pBlI5nXFQU*u@P0Qw>c+!s00Er7m= z1%!0iZ8V3R23anaKqERMt_at-nxvqB3$bN>53^~Od5{q?>0<8ccojgpsd2YbBrCl!>UgU(dl|K4mRfP z=F0nmH0TARpcgEKUN9YcK`Qiu3D66Yp%)~9E{L*A70NDWptH+9=&86GJ?@4vC)J92#o21`yx0n_8!_7{lR?^92mRK z35#&PNCgjzBd!Psj6u30x~YOc)926hHHqVITTR-Odo=d%%AB)_#%I%&r^!#&-4LX7yeA2 zCtqx1pVHvZ^g&t|@Tm)brvFc^qJMc}=+B$!_u-h`ggalD%$CPpdDoUOU8C+x^(EY$ zCSP&NVOA#VxL2MIKKqdWbgfh0OdEIMBZ-?U7uHr9QKo0wR4TSf4qK=lPhP)7$^Ocg zV&fa%CW}n@tZ%pJ(yU!!w_elyJKF~wzb{aEE8OjDOORSoa_XC`&;25!7}mA9@~Prq zBK-yNH}76I^pbocv@OiD{)}UzXpC-{W1iQ?(sKDr-zNDc-a352V^)eM@vjZ-Ax2@Q zcw0O7K!OxGfh?f@l>NZH{>NJHgFSEqdf=D8AGizbfpO@8DKEJXyp0I&#p_v|gX6@r?lCx5RhFzu{bFWf_et*YwU5OlB^HKl#V2gdrQuW7W8iIk5+ z_q`k0DWytLMe~fUbt9@(J!U+aQuRtYt7yKw|CFrIn#6=;qa}}pn+?somA@|9ROPbf z#y7#pDd+N1iRJwa^?z*LXL8sx|C?GT9aMa*8(HTjg<3;<>uc6jE^=3jxf-UHXN$jj zXopm$L8B!;j<~I7*<+#GTDjNuxH&0Ghq+6uF4{zQvBqz_Byn*rnOx9aJG{O+3vYRe z`EW36I?bzma?D;M^-~V$8Zrs|b)wS?T_I_s_60tVh(?vl9^(7jJ>ribLDI!37#Ea`|&p^eA(g2#aH}%9y zJfq|nb!~Ol7H3 z{YT4-)kiB77mQLU9t9_^@b7FuSqX)9c2??je8~_8jK!GI@?wKg@?rwY%A*pC#YW4E zxmyQaP~b+Zpa>tOP|QSG`G2jTU|_fTot>0<-(&m%bCO`P;;3btcQ~?>ifluv}N7Pn(wp9XQIy>TNj1430d`I>9(_3VvX@cskUiXI|@%%AFrNL z<)T|FA|Y2Ex~F630>y1NzD>WrA?W0qOJPPU;yd@M2V-b8qzBZr)MK}zt~Vz>WbS`z zkhaciwR-*(k5EUKEkgkzHQuyi)#81}v+?4LOEKG`x8bEd3IlG)hhCXJE&g=UPL)m4 ziQ*|@ONAa0g$kDimlk-Fho$M1H*@UQHSE-M z_qCdbG-6}#Z}2>6c~}3H?Atu~d8PfUqzZ#*``WTp_PYGs(USQxC+m5YT!n(RY#d%d zD^H!M!pP30Jfp9s2nXcW5`_tGi`0tl6Q@0C$lfqx?fR3Gt&BH5lt`KOQTTKC?9i=t zp$&6LE%nc+j59(0uG3V5+VrF<{kQn*HXdo5+^CWI(zsHdmeN~BRIE;8ciZtBW(F^~->;K3c; z8Qzvs@IDj<{_XHh2^NN6O}Si(fb!1okp9ldm01T8+D0Ly!>2MPe6;+X!r`(6-;`hp z7uJ-`^`)r75`<4Ys8nN@fp9(~2A?Hz!7B|Me0Jn+4qW-mM5P*V`HO)se?#C?IH*%z zi6o%XlE7UPuHP92M~AoNDEQDQd^>zof;Bv#rgZl0q@uio9SP~595(e~KstM70eDC! za1jl-ROSpHEv3Lg622+H@FrMO>Pg`kR3eo@t_x6iXJJl-nRnZ9)jVS_oee9bdULX# zuo1z?BV<)hj&Pj+Tc)5r+ni;p=j|S-hr$H z_$6`38)-FXa1@Lwaa{vVEk3 zghShu;Jxw{xK}2?xA)@kUdi1YxapP^yjMoRhf4TD9n>jN)5Dtba7PoGQWu89vv?f3 zvSXz)yjOBZQE;FWEa=akxnkkHlDj#8GgtToJ__?PP$s}AIOV$n>OY3faCpJ*u@PLX zgazpNOaLf;%Ks5efKi~Qp!w*0G#}+M0pKdOQ3${AX$O|$#P%T)d_?D)5^O#SYs%(& zR^H);^gEe%+W>$z7WEFE+%*cRj0|5`jsjndZ%Q!g9jGZ0RIrkg^?OhVmv}%&Q5+^L zp9ug(g#81V0Bj;Gs8b@SfW^z&-;}5jhMC%fnsTo? zV-?CfTqeMk$Ty69UMEIuyom%~4sjU}fb{uDaA1`Q4=D3Z33l=X)Rgfp^)1Z#eKkzo zz)~aj^m>KVV+fc!cwS3lt$zjQ6b72+w(^dA2g|@OIUjyW4ET}^o%crB)U^AoV^-|N zc|R*M6m*Tn_}Ioi6vbMc%JVs^eqZ<{Ti}TrRA{0`bA2Hy-MGVMxU)QbCIA?hk-Is7 z)2%;`3BW#42o7F#$N36R1<7)7NOq^LsP_ zcNzhHB=dU|1vhhr1^wAGS3VN}KofvHFLQ=(n?aotoxTo26B+J7N;tfLJ2nE0m7oAU zUlU-=Y637Hxwe=Pt6t1q{j?`gsY=eweQ)CH`0{LK*o#5&3yb2T@90k#o-WsPs3x*I zn=VDE3ENB@BnD#lQ`Oz28|@o)8jnL}yEqTt9zx<56LTd10mEx@R&*|X4qsoO=0W0lDijP2rr-ZQE0i?N8x}vS&NlUwE93K4HDpwmq^uDC5u#N zMSh!{DVd2hOtfCk^ax%5LpNWtJgvx+sM|I^AhA#+Q`<+kZ6dv%^g%Xsp`3EyoX4@+ zH*U+#z0oYEgU8MbU0m4ebnWlWX$m+N;BQ?eTOnT|SCK#2?)Vv^aM13`4i zaBtsSWRyuOYqiAoe|t zLPm~boBJ!jEBj@3));ikxa@vk^f~5^ym-42o_PbrD>3k183OK=1QgF$Ap_7W#o)b? zyE!1SlI@i^c&`)$50y+5&VWNDtW);YQ&Do{hTpGFv-&VF$q_#MjzZcQg~&Dv5uI;J zu#yeblqF6>th~bw=~a<=3GZ@ zMu(~DEWd1GZBz;G;LA`zZDd!iqdgmRVm&XfI2M8oS`kJhGScupkqR3Q=lwAeMntFs z5A4qHfqfLf&@k{E$u}h!atUk7hf+9%3Svgw@?rL(HXICOi(pk?$QB0=jtRoom#E5s z8ziu6b?)W>LbemZ!7&0nI3@;<*n&DGf(-P~0EJuq_azb`$~J`HDZzW?D{!w&fX`&& z@LtK?9JuM06}(qQz=z6_Rvd7S0P2+3fKFD)#;r5p(6&*iuefz3;LH`iuEfH7C3kZG zXRh!Gd=!dbP$mF7fx|jwTLEjz!yQd{V5iW3mdK}R8^gGLQD)p8V~B{ziwLSlSVg3U)kO^Kia zDq=okM=&wCeur5Aj)@WAVHaok#$E~>X5*U@jE@g$${jgUBnI^Wx;mlZxzsJziHUBf z^AM!a&Wgj>Hv#@`Y)(FFn)`)!ntvhuk}dE{j>3!6;GeP-en~2F9U7&KbNZwyJ1dp< z11-3gY{XJv`(+@@owo8$dLcj)H4tQQ{U1yKxFOFdAhz&GHSDn{HW*5R2Z8yf1Uth7 zYs$X*LR7kOhs|)r96l2OtXAi44&Zd_&tn3x+gwjfN|2!rD=kztGQ=-$?sAS{T8GvXTe0>GW zxGZDXMQ=lL8M!QW+9v7587X2hVJsz&Ekp5<-8po0DHc*2>3PuV zfJE=AS+GY*(Lo}TpYS5;GJ;;lKclauOha-R917b-5LAoqBfX6Ie&4e<%vihr3JoXo$n_j3{EGaBI z0dq{&dn5;2P{R`PIPD;aL{Zu%XEl(KU`rMfY(Xk6xx0oQ$Ua3XE`F8AXlspxmdh#Y z%`q*uzpG`aun8kCqKlL~()w3PwFJ?S6c$n&`MIMa6J5&qjD;Y@#k9I0QIr}N{~`L( zRo*lt*n(7CDo^7i8*Pz_i>Pjg(_Nt(3k}1R6c%q4`HZw+ei`h24 z3fa`3B`>4lGd~rHqDZ%$C18k3l$_{*|Cv`Joib>zM3-X0c_k8Pt3?_(If%NBt{=KC z(v}rD2AvXJiiJK$bfX6Q#Y-HJz5$F^?f~~nB!va-l}HMU9WnsD5!-q;xr(7<@jHlJGgw5IE_brmusRK!l=xTRpM@Lt?1E(F9Ha@Tq5#YZa zzA3>-5j`5m35C3 zaH)!}d4Z0VA>c&;s8hapUr@@_ZO>x*_s2(~+3{fIVRbWzuV-jQsZl2DTso`MORV;f z%zN9M0KMe9f+*DV2*Ni#@bOIyKE5F= z1GwqI!6#kr<^VQ52+IIYx)}JRi>{RbF4PI2PKj;;zRtM`7`W*f1<1&#j2(Q>T2hV}Wu~;_&1DEQf01=G>G{!e2z(i&gyb|36 z?2GVpZgU1V2i-peTvI2&*VN+h zH8mIXhnu-_HwSR$iY~>1ZuH<0dQc_+C+~ndCAt&~H9Wto^k$?;wV!uLgUut`&}PT5>fMoF^A6tfFiB_-W<4?F$$my7i@wnRbktDHkBIGDJwGjdkJ@fXiQPEuQh9I zuUl&520?4Xv}7)#vCgHlINxYM+{HUnj`ZHwn!>t_fkjkCi#PFJTM`o3#0L)N8!cYK zJ7brz5}s9|2fw5a{F3_cO9sHxNqm8qL`@Hi_stzP!!% z!8+EN0PLm*)+w9o(^1odg@>upMeM*$&nTR_afbJyQGl`drUYwxKuw979v0Zf#j)V# zqoaUh!9peM^JVZ5(Qn)mE=%xD2{s>vHRTl~CQ7ILZqDF_JfO`Pr+9&HN=Km?$HC_^ zzA3>DA%mI{oxbiy2Yk81X1K(Y0PjP5CIGT2$jlW7KiwMZOaQhd0IXBKD_}J|+$tUL z^fg}-07|KXyE%Xd5r8xS7`SbIv4$#Xd&eIz!!6rao0xp`+)>Z(<)4QHyBZD(o!;_E zb4L5Vb`q#)=;J( zX$zv@5xtlIq(c$p;yffZH}t~-!*J})EnN%BHDAe=>%CfFk*BJdl7ys;}iKKc38;u(mHqKPdpW<;s?MGJL`@7k){$WVlqH^M@_@ZniM4?Z_ zGDN1W-7_;WKklQ-;hFApw@-JM**N|tn4T1MHcoFez3X;z&E3N%O)rIRwR6{_6fkOsk&w}A9Xrz2 zY^0^E{dl5}f{(b5@I}0UR=#A9BYt4yQe0^}CS%p;gw#*Qnj#avGTW<1=X1Rs zVkHLNE79d7z+Op!kCo{93uv$8ZVp@mM>nWICvZXVP>F7ifllC{PWc60W6JcSQJAaF z27I(fl|~iSXfMRqLujWZX8S+oR9JhcHJ-c|ZH!u~Q2^EJKD%1|SesSFdjUN3h#c8h zTf=(sd+g`sy=v=!0KcR^Nvb_N>oL0kW|?3w&oyx#%`ih}wS?dY(}zt4E=ofN!JtrUdIqVNHq0GHS_LEVW*C$qHAwjY7#f3Z*)H zi$Z{J&G@DS!(L!b*;armm#PRZWWhJ!&FN1+UcFaJlO?E$T;BF2aWPpK(4AAXE(C8{WWB}`wef4C7r=x2< zp@%$?;Ev9$2Zvus@IHiYhJ}XP_@)G#@_?E$-)X2CjrF*0*_Zf$xq;WAD|?Wj1n)!W zN+aMwLIV7^BMu*bxtjwwbG3pm3dTAU0NyDP(6$#*Ah^TkZ;`JV2E2pHd?o-SKZUzF zaQu`}fGoLC?O0_3i~>ESt$>P3HZFn%hf$9L+_VoqR>H$YFC4BVnvCD)ohU~}&ql4e&tV9D3-I5@dsjy23qUM|Z5#?Pdfq3zbCPiI zOEM|oM2+B4SQ4I25=;euaYh^Pl4w5q4b4Zn>}R<7s55*gJ_=L40-nBxKg==;5Ed4G<_ZtpaW@BW z=K9}2mdw(N*B9h^_P9*QF56f9BuVjj(m9)H*TU(Tq?-ZO>uqyfbNY`~k5l;z0sEor zk#NNKD2dEzne+W#TJ~`CELN8+x{!)gH%yTDgl3*?r7&GLm|D=wmWp^g#ctpM9chDH z|Gco#y>V`%JyLqWi&csn%R(|pm&h+wv!#jHJZZpB_esvD+A ze8RYLiY}f|NX>p$%aV$?zID6`&X0_`qDS9C9nLs}IEb{mtZEw{P*0X>JHu+%&1{kA#sVZh zF&D4W7CJni)K^bKFOE%@kFe`RQUlG&fi0QvKK1AYOco0}+v>SC%{XmM zTG&CNOyAK}om7!NV?+`Xx{CBnaxp4C(muLvN3Z|j$gCW@Xsx^zscys|O_V*M_le?t z{zJ8qt!$#iWeH-}4jR%1(Y?36=yTEXqQ^whFZnV=B}PzgElZdIFOK9)`ga(48F+=y zCyEcVWmXn_&@fX}L8=?ENE77@QNk~eah4q5osF(#$<}=|!8W)p2c5*){a842Zsz1n z$uGG_Dkt{6B4I0~Sw{vvjw3k}LTZs`Q9E&>Um{0lMZn%Td8cBzrr}I?nZy}S@+>RK zodMW18U+EHyKP^-iK=1o)KazNwkTA{R^;i}i3Plj@23d_-29(=C3kZGy|Mw^EBAqV zC9VDlm4OH%y982)Dua+V$onzql;0w8=yOEJQ`n!QS3t~H!d(!r%mw#K1ja#oB?2LV zVb6{d6+ba=b2<(*vcVB|W`OFDxu$#4K(axa$gyq3j5;1n=Vq%NaT5JY+D z44*1cK@S~`P$L5!h2bl8zA3?)9#~Vh7et|c0v(QIyXDjDB6LO@q}zk9V8r0-YScCY ze>*t%3WmEmfXyE28iAWV41BCa^D5x7ngHsQkEL+wG)e;Z#rxzRL6mK%+e3gUv{!nA z*VX7eA9N;r1@4u*|UNVm7q>p;WQM4Fefgo;fd8inp6;&6A9kY zM*+@(hp|QhzT=w`3<-rb<+n%zLRWu7CGAGLm^XOu?Gf}n3Q!3=L^KM}7>=95;j#qZ zlwg=Ys41NTI;qIhvEcm_=+J_7=lmowHG5PkKfsAS^~+2MFOzdI;6UJhuj%HidJ4x8D$oKa|ZxSIpV z%Nd0>@6TgEyg<_(<}j6sPH2-G_F`RF6e3rw3j|!?jE3x#8X|`=_BC6Ycl0h8&4si4 z^ErHlois1r$58!;Ya-ifr;SYQYqG3)Csj~eozSD%v1yEG?K8a3nVImfO?xhdc4UNE zkmY}qcW?-CNq}FQlpYXMlZEGy+8zdI^G<3T%A^?iQBRD}J}5Q363`G-P=WFexBP`0 zjs9jTz?HwFQ1)Ztp#so~n$0QZn-UHx0By<;RDhVzIBquz2NjIe^Yb*4gJJr%Lp zxR@B=IRto23@MXBQ~b&Bkxd((<-<26*qJR*QzA}|FUmXIi9H-AXB2R@QGjwr0m6cZ z?)atzY#b+vjor>o|wSch_6cl4m-(a1xy@1v5aI17UjCvHh6K+=qcmNr+ z{vEqo4P{Jx$@`ceUk<7rwftH2^uheZBws}>ogf_Z*wB#(vsqh;HcPuqFr4l#BQN}j zD6}_{o?VIbHqb2tU&l#r*~?f>MR6!QtB_;8m-Xy8202Z5s`?A_OI_Yu0i4$ELD&NZ}a3+ z)hM*>0c>T1-4i_=?$@C6aarGlGv{Q6I-HQO3sWO1FjnQhznd-VA6DbyUpbMW7ZV^y zI}zmK%#kkHzPe=g1wEnV)0QGtkeJY|cA<|8hMhdvavKznqi60tW{HAq(UsFyh>I>E zPPj)D@Owp4s+{v!sxgfy-6k6FJxa+3+gM8!Ym4MamrUI==Vq)R631AGR6$~wh(r>f zJgbVtp%+K}2K&X|IUPWvAWDt98fW^CrRy}`8 zYMx}}3}(E`?sBK-tUNEGZrd?jd{K6EK)yZ^%h4`b`j_izGa01WatWz|nB=Ld=6$OV z#y(+R0pYLp^7ZF$NE9UN-u39KG3G_CcE>hXPSC9c zEnpf$I7q>h2a9Q0MMDas^K5L@?i%9pev zNyny-3IWp-oA55noU9Qmv?6r!8T>o;Zcww!-5NvUx53$ZMJ6ALO!CY;aR` z)SIq(94{N}WI?B`-u*?A366RGkxS}yx9leNdf2}=+0%e&Rw+v4m&{tZJ5kWzTk3i4 z(HG;7#Q&8F^j}#bl2BX^q1emB_5HeA^f=pNFJiJTWkzs(li=eUy?aK-H%g4)q|03n zFzM1X5u9}C-7`Ar`r%7Ks8gC~k15r_v?`OWfgSnuINS5kMp>7piD<7Rp-8Y-=5~e* zpjXnnXS7#xmxF6i=HR`OM%?I7xdvVeLY-1Z#5bz_2~A-g{T1<3^f((*`_q~ru%qko zX-ACrAwmto-wv~JNibzM^vZN`M?HyA(YhS=daQBFU3s3@zXU;;@gbdHLv$)5L=GG+ zd4RD5Q^F8ItSOtS7_d!(?{{dpj}E|i{Ei2RhzDp)FeME8hMH2VYmrfBPtWmLPd_O- zNGga3Je`L7=;l$6&t)``M&~l(Nq}>iU`p7O2W!d_k)D9IWPIWwQUlnBc<6YzP7gRp zz_%ydz5vf$d1yzWPDwx;H9TEaIu2;#p*!KaGThA7jL&2w4hODPyDkR@ zw5`H}B>2`*j|bYIPDw!9aw^%lVe^-&3mwx1CV&V06du|g?s9Pa6du~VZq5YYfu54) zY-n_?w3%FT+Gx)(0g6qkdc@bWKFyi0mpR=$8k&q}dHzAJPlq4bQEOv}4=Y)k6Ajy2 zJ@53|bS8$SP{%UH7!!C7uC^@4vnuR(Rs|144JZDuyof&1(NIlO9&Xr-!wV$%k&M6u zpfc0*?~x&eK6p$3mK2J0$~sjp;ndu)8Au8hm;flMGIu#ZQs{%n1aLEzp-xHj(OPy{ z4|+bz13tt9E(V2O*vQ5M67k-XeOZS!rK5qNQ**;+T;dU!0I+wi+~we61`lnS7#}O~?I_kM z>r_m`!&T`(piN)`pnx{+a)3bFgU1AL18q>JB%qDN5EPxmm`Ur3!~D?aOBajGrCt{l)mKMenTi9k}cdE05cq`aL15o}aehko3?g@Bi8`@Tt2^ z(q0|AYG$d26qhZyYuHnl6O|HfjnREETsb;)!tZt@o_&v09kNN)VXu1d?kdd7#F7a^+yd+rxq~qB8ngl`j^E zhAO`p8N213oUz{rqz=s|t&#kIs}=Evsm*e+jn$qA-&g+4?r4T$WLdQ_aeHERqVI~7 z@mAm4UzBY1ZHWqtEPut&bIGNp)6-|zHXKy@d>6CXf4{P3?u3j{$)q*%2x*PXuUKsG zstaFluWDztC(cYr=s4cUNL;s#-!nGn@Sej`-@* zGXMLbRs=_51_UlQ-H;tY2Pa{`U`aPfdWP zpJwRQvc-m=t9h&Zg6_y-(>I-0_b$$_-eTNk>=7ju{WH5y=tS?Fyk(Y|rKB+P7%9vY zD2vnsi|4e}t0d?nYgHjmxzo?64Lq0fef2PTjzQ7lv12mvjRaP~@hyY`B{;qj^8y^- zXt)oIZ#vOEmve{_Q~JhpPhZb!PrT&*cvjnIcMPuCTk}HA6?LDh74_-?S#rY${fLaf zv@PS+gQ6!}GA#oP-rBk1iC%fnZtFj4#KLbzU7i>lN>WOr3bS{rvl^U9Mt04>>~WjF z4v{mnhO?eKdaJIL7$@7An0}G8l%l@xeonbU-0>+TG?J%d9sRgyd;3;T6B>KrG_XQD zI*n1$wxqrl>_dzUBd#_OObIKqcrayC)kXTmNi%_U%iX$XtbnqO>PrR5;DUW)zqC*TTomNuViQx=Kz)a`X82}js**BwYzfRE^e zM54WthfKz0a9k_ibvd|JoZxY^SK`yH7#}L3PD%R}N-0Os+7C8I7*uCEDj~Hhy-7mX zSG1=X94pQESV{B{v{!PM0|AKG%7x%@wz~x;aDvCd37nW!=uioDN>Ye-5+cZ*iL2O{ zh1_6A=fRdd_z?cv5lo50si9s;P=SV^0uJ-XK?M?gNGFyWI+YPi4IC}8V+1x!2&P0# zWOy)TQl(fin?LEV0T;d7A z`w%`$&~P99?eLHtxvBsMKk$&sh_jE5mH0^+)G2dmC6+7QX>&!FI>XqpeW~ap#Dqs; zljqcHf5XgM4>AAyyXQkAg~=JFll{d#9cBLKIiX~IJ^n}@{z^0auk0wb$GvHvJ)RwA zGXHaVJRfaai>H$~@vMqQ@R0-=+_-1hyi^>}>gTy*680U!)q*&9RbT=LOaRa5cUY%v zs!FD&Cz*3}T+@S}BXlt!a0Ltxb0Z!`6M`vWO%K$R)by;QriU9gm1_@+l-0#Jy9 z6a~3lti%-s-JJ=*f^Ar*q=#}e<>5ZZ>ZFm55C}hzhlnmP0Z^oT9*B25q+2KxfF-SB zow8PCrjl({XN~|;siC7N_Nj;&A1m?G%r2USzy$E<%>eN%xv4#n$_I5ynvW7Mr)zwT ztJrvObRKMpXOr;o?FgoX%}24Oq>Vk4cO+a$$3X==VE*`72M;qI=oo>XmJtRjm=XpR zKut+dfs?L>o4Mlp9n$GRzeCV-UpTJ872~-+w6O=x^$|>o!sfAFStL^2`|KQ-cmyT@ zed-WUtg9-(#SCctDju6{u%PW=%8NCpS4@C>n~UhQX9Ib-6yCWZEyGUS7I-krO0+sOGLVLmE#zxM_^*B&>KxSs_gF-JWe{pBoj+y`Fmzn1FUajseR#754TgGe; zAEN1bSlv5wLvXX*JM%M>PsT!nZ|2tMJJo?2QN}7mUq_WZFHE`Lzt^E1^Ugk7FgZ5h zW51m2xPN5Huyjzwcw6I3T2eR2axeTl=wsDtwaos_9f=!XF!YQn+tuQHIO>M2w`Q!hkG67H z%Z=?uA5EmSS8IcA?!cH?+j`9TtiUpIeo&bAm8~@uVTBbRR<$RlIZYCEr&Q!xI$P%X z7v5Cb+Sk#!EHi@6?uJg89zhFkNZp{*(Lbjp+Sef$o{V>N5#E;Ba34}g;opv6N>~`e zn({n}#Ai9pou0m5bIU3*LPA>*JfyomgQqh6ad@;`)tSP9Swb)+Ea5^;snyWVGD1u{ zJ^cx0i8dsOyYR(}1fR?N@VRU=JeLWkgq4<9Q$~_Vywl`*sk79$nSau?8d9z%;{&h= zpUbM?xlDo2Wr8VTO%&FYHyawMYYv1b9tqxu!tq(+4E)>4#b-zEa)6Kq7b|g)#vFXC z+zwCSSf@OoN~VTKj0f5{`~e5FVLQExRTMIO;F*jEuzXhjb z>sL8V`pz6NX)TGwpMt=@(5}o4|1O0?SUfcLJK?dCyPP5%{2Pf+;CLX11F&jwGYP0u z5>#-KhB4)Ej5-9L!SPMF0v{`R03W!^!6k4WKo<^d!j+ZSww|4oL7lRAZS%LT$*ne5 zuw(6|x`%=m)?J8Og_!V2iq~GUYvs(mwJGs#tF6QHp^;)`W4>ADbWcZV*xv5>z_p|P zLY&@iTe)H9;UebmZS@>sY&&^Swcc!EY`KE{dp)1Hw#cGH?WNk19+Qt=W&d8g$HVL9 zwfG}f;E$B!k6aEuQnt2v={>{dKd3HrRC?~10uzA325c}PFaf$JJ>`5A0~c_eIB-6S z@5H+p5V!({hbEVY=3X!*EDS+SNllNO@($NX;pU?Xe0R@71Ia_SX0t` zl<0h2%^7Y!3T@8ZG)5kpQhYPc0|+6Q5;h;jn(}6YnTV^&_#ux9j@WiFAaGMXJ${-g z#)H6uDPeSKs3}c}ZARkHbHip_;t`kt^j&%mwK0zyxXZ!Cj5+u@LU(5Z0 zeKQMn%FKxM?dDg^?fS~~5pOa~0D9Nm1b6}0P|ZHEU)3uu@d!I?H+%f3uHhKVQmF4^ zIJKA^5bHhX-tq7H6Hq2EkfFzksri6b8^>sh$5NIf7+ZrD&e zP~$zha7 z+|>5eL}rZ27*x1rl6vsfyj6ZdbECo{%U?0{TykmY^z<3F4F}aeuIxUc6TNe;pR3vX zmiHvzd0vzJ=JgvZ9iMing_XAPyH|w#`6a`h@ke8iZn~oGbG72ByG_zwsWU924gHs- zjD0h$rl}@a9hiAt|HW|S=+Fso4bi+K&iiv{zr35FGo_;nv(E>*)#*r^?O&Q*sXmta zn!PnIsE1xHTb!`9G&=3+rftTD4@iB|;&%ILf;GJ|DOs+yEt!@925;@1DDe9fE$}-b3Cc$?_%J{HYC>Abpkaenm{<1S;5 zD5ahGr7E~-YOlfA7b#w0(Y5P<0)3%+7+Y@^qmiiWE zzkaK(vd`sRHM7)1ipv(5s&mpZ>dwnF&4z z!q?lYNR0bOD&&_3*XVM_<{VC$c3$z9G`F*y^)EAQQEihEDktt4ZcU!VsrA-^grng*f_;SCc?&`6JD6j1P(N-;Q8P%4wM72sI_? zjkZ$W;l$Eey-`SL`?26NB&3`1sq9DE*`DTbceMPGcD7*3gkCG8|MPO_e}^fHL@uM< z)V2EApgPkr9a38UNG%c*HGZU$iOFR@($0qDvL9(@V{(~b%HB3pcQmD=!Awn5^1a(h z3OsD0+)?94g3piu{9~13NG{XkbJ>ryvoX0$FlCu8svDZ}T2kAmW^LD&BwXV8(F!Zf z53jg)13e^5B;&swXie<~+OFTLw-1RKJhWv$T44o=l{~bgP^ToIjcIteDjf&3@z9-c zT^SC4;Grv9g$E0`%fSI{dOXm^L+kjX6;_Z?iFL}Rs$44B{5lcF-MVM25=30 z_Www49}+8hXm_~FVHc}m5;(rili(9L5A7|~DUB+#OQw~%?9DpSM=z_}mO6FMGy%Sz zmNjP8-TH%z`<#h=cY4jv`xZ+q_8juh zy>AP|C!UYX^mNa56MN$qng6}!IX;w(KhlgpQi49RRuw{9<^1q?0kwF?-Hu6N36ga~ z@bRse({^S;LdS7nDF}^k0uz8@Ixy)%opObEeZAcz;c8%O+)J)J&qJHQ1Tf$ll&;IM z!Qk2lkO_dNr_g-#Ho*lPJ_MYP;_;zmeA@(=pzL052-GH+lG!cnsVQk6 zquFli!kln0H4m5*9&78`9**Np@c?59ri3M2tSKE04A{ouSi|Hw1_fq5ipR0K7!bGs z%mYNk12iU>5;h-&nv&+Daw4vB<7?cIN5S<_xH6q%Kpc|87=qmPa2#0Rs)B zT+N29f1M5Y&@^yBTi4~_GWY|?1Ym(Ss8bTqww6jZZrFTWw7q?+r}zUKE4dB|7%QQ* zD*HT9U;^}X+AyyZyE_vA@07Xn=0@7GXmdrEI>Xo*d#UIn#MdLS$#d$pzd4ukef1&c ze}DJRa^KpU>{- z^+k_ye|&k_sJuI$iLbho*}l>tNpC1^{lSL$WL|@T85KE#=z8JF9lqv7?Zfz zXs>dxvJMvl#vQxLG)6D3oR%I-i;}jyVCWfDwyVYYaMTBmO~yf)n@v)`w&qw{wlT=D zG3%0BZA7^*XYZqoLw@SC69YAmkx>;Z*#sRXEisLd+%Gg!bv6Q(c1V60*muds(+B=BS@Y71z8djWh&1%0lK?l4^9)5QC_l zRU3Kc)gg<{P9xoxu**}_4BoxjN6P#WBu4}mFOV{Mt%WWMct|@uL^gax7fcB&*|4T85h*C|(1?Zg^!>V9%tJX3 z%Rn~a@(|LYQG+e}iTH*tENN*;~@=vr@f~+IUDj~;O?1YDYf4t`t9$Nd1{@Ic` z9sOE0JC&eopXYh)(qV$%_HyvgZmQZ%4G+o5vsL<+stcqd3K_rQ zA02O5s0Wa#K+AdvWJ~UJbYR8CF%@w1MIH!pJVZ7g zBD!Eoa!*Vj0W~FYa+tisg>)b%2TwlZA(inEE%8}`hwLbr5~g8z1S$d1sV1RFE3@t1w5_TVuU>U1s5`t!P0 z*Hnl6(h?em6B(cm#VRms;P5DWA&rUL-LjjqJRh;Q$h0Ezof0=&!K`fsFiD78 z06mhR>ZJr3a6@(+R2_nk>)n0W%*J(r0RgMBx;q1clntoq;fCx$UJkxPnS&qeZO8L+ z@EmgPa)7)XfdK)SHJ6C=BvO&wnInKxp8uu8W|#Ebg`AYg%yApiKl*O;v!geSJO1Rw z8y%v*H6QGE;+x;EYY4mk(BPStF$umaQpOifHxHZq$IRIDP3P6Ui}S0u7*Sd}~276hVyZD$r70+(S48oh{ZEUfV4D!f

EE_&{$bdVpOd(J4SnDci+}4 zX!K%ZCCxk0v62vcv{!Nh%DAONgy4s}#Z?83-lLnYsQX;4cCzbnt!o{22P%rhmcNlKXlp8gQ7V;O9-aKt@D8v8nr5g-DxAG z1b6X*+etzc7Ig7KybEwEL2RId34P8<9JnRS+;b0Fo3w2en@9ScNxewAHKhJZx6r;Yj?l1|EL69{*P=@U~Q#@mnf1_$?K3@RkZ; ze>OTt;z3|~1B}j*$@m<}1FqcNO<5$8*qpWy&X$g_{>ONNPz1s z3AAQqAzRYiKz}>keU}Cc*%A#3J#+mE{(<}9+gzwq5@c}N%q*aAM>gE*d19QPz48ov zw{9*MGMHx-n6+vG6M!OIs>f@Dc6gZSL7kGCoh+J< za^V+OvGEXoc}P2?hXO7FX@g1B@&5Z1Rve2)FePk0iZvz8M=9@gg>>9}l!uTGjT&r$ zMbFaF*e?%RLNFx^$AOxXpaOe)eY?1`c)|5Mv~~j>fED;wg7i?(Tp!wCg3e`vDJjNX z9$cf#8JlxBWm4hBBK3eQxnV;s?GBz?IoR;_u%L{njJ{Uoi!JVT#{HAyk6NCiCA=}T zeE9hU?-kN-&#(;-)+;q4iOZg8?=atxi=Ss+iqO!xmc$MA$VV&;TUef&&})S>_y>o& zM-eS|PTMkGJt%szCDSs%;H|ym-t0T1bVuUZ_h?IUHf@LgP#ti!;^uaC?~q zudll5%KyRBfhyO@m&MPnuA4dd>5|JQMx7h_%0m-a^a`W(F}nYzC#S!E>Y>q* zGd>Da?)Uee6TcwC|6||B`(4@kSjDqX`m9j3Y7925;w7_N!c|kkln|#ZQtDSEfeKWU4r_5<8^@SC?)PWt*l@X`pakf6%%35nO=iFJgY*gR8TK^B`W^D_5UwKkpd@5JfRN5NuaIZ)@=wsDtwIee6 zTKX}~^b3Z8nHBowhTgJcHKr7qp_k)Kh?t6>@oGP-${7>qH7PXU(2hdO@cBV6J@T>N zJmtHq2VWiRTzlL^-$SW;ao5_7S!Bvs+lItxj8aR#sEXMw&i>l3Y=bmG)&cUeLoGM5 z>777t$HuJYqyn$J(Xkcp=Inh`nL2$(%y*%0uMW6SQQNRSqPW$TOLxM`=S8UPHruY6 z;5}oRW^I9VhQZr)NGdYw!epCGQa?kW;xwTHC1q39;(DJ!p_i4v~ChbB?x;o0*L*B4k zl(EV(*wEKeCC~f6dZiTZm14YCX2ZQwPnR-|Q6j{7C3iVMudIN3Wir$&FIHum+kINy zi@PrLc9=}v&?zHHBi?CpQS@0vI+6P|x2zH)Bn*Y%9lbBymacNR4=M29j$leya>SbQ zW`mPH@t{t({5)>C>pG+=(BrFuNPJcB8T{KZ;LH5zPtSD`jh&ms2;oxzjCg=AU$} zhIC~TybtkEvvt<0wK%8%TNSWS0e3k#sDOvU(hnai@dY*1DbpGo8eJiYxWXTkse~=xu7vl7tD*+Pkw%R&8uPxhj2UY9M?v((VTTWBE z=N)N_27hD`{>bG~qV`hv;)1o8?Alh(fw5*e{z!W!<2$Ro_bpt(x|8RyWy3}EkvAKv zsp;tjZ+ay7#A$6Xjg5*}UU7!W{I846q)*~rENU@Mps7KWgv zG$ppx6ECuJ*bF4*a2*toiG}Z=%=pG0-|ldi1B@9ww0Yf~3BZz8p-xFqft{cNZhQ@d z3aa4fFUNoYQZ1A5z^Vw|=D7q@q6nc_Q>I6B5FwNsHUpsofeCf^tv+Dfv8ya4!0zdTiHlXqb;ydrtb+moSrc`E%;ii`mJz-gB5lf0`MSI5h-E_p~;=Yj#na{YW4G+^35n!;Mto$E;QN|#nwl? zcP+iv^VYtpqjDaZ75l>Bo9k@tVoUYfr#^ma_aDL|0tTeyJxzPNVve$^Hsx>L4Ne)6 z8g5}!ZKOeOT5E!9NY%#i*-vQl&97K&@Ty}p`ADzp{xv+L)>Y$PNuIE~v{zbelhVkn zBu|^Zo7B2Aftls?KP75OB7Z^BR=22S*N!Ak=7bhoYFGiVzPB&QHtZ}oxQ7t{%U*fw z_z2l>Sw(~)=%>VYNF{SbTJBGa?~t5j=t6c^W=ixA1JnbH0yCIhnQGr?lC!kTHuRR? z_=(NwV@S$dx=(zE0Ft9ut$OulQ#iP{q-6_I}(izC(JWd)x|)>S0-Z4cltHHH-qIVaqVm8_fu}ZqhaXgplW6+7Vje zAR*7665kD3SH4+YJO3XLQQ(|&bdES+I{+NOL_9ogaI8}n*FSmk>;W4{kb z9h&c-IxL@*LE{Zmn}1q-2jG?Wi|+uuk`r~rdFB1`c>u4xe}SOqUfHFLWOK^~0=)A6 z#fbo~ykB|JBd`3)H9XzTDQS->vtohU3vgVty?rYQm3ba3SKTL{2k=U64+OXH1mKnU zSb6^%9)MSJm%}Y>@Z2lS+%}rdg(m>7ynk5*AXMJJhNrtZrK7=2$&nLF=j0Lr7k>Y` zc+VaE-`2%@Zc9Dhhd8}`ZiSU#%AZ|NcXw0LY9EbR+qI>mQ{oy>75Lq^a0=i<_b;6C zJpSIlN(2yp?_W6OdHn6V99*e-|H3IiQE>n27|&y6*UB7RsS0(o$N3B%D>qi z&Hk^bH>0Zi^Sej6xI<%)d(%F9{N}Gi-`cd0y{E?sHk1WL>DL1R`)*od2 z(qUx&cXco$z3vH^)3O$PBsDz@2ElDj$2C2E_@?K6&2SI>lG)RIpJuqH-#FF4_Y2tr zk}h{SxTYrrU$Amp1{#yxLiQdy`YGBydcTmp=Y=}fDIE>R=)yV73E1@DF{ghMy7t_b z$#@^)0mc$c>0ZnY2t!a){x|zfJ*-}6%j5lo~cgN$|k zT@Em2;6az}&IE9SO;D%Qi1aRdroF>_LoR-v8QaqUzgAH&evgM(dh?A^(LZ!iMg8|F ztQzKjM?63BT9){4a#`w-aW2DJ=6{PluPyDZNq=(ME>B44INr$o?~`JWA2&$wtcqOx zk;(WY&G;h~c08Q~%}^;4NvN(4!8bhu69CopbX^Xv>3IN|0POoEs8dqY^Ex#>+{_i% z^ziWdgkwMe3mE)sBNraV5=;qeda$OfRWV>&*Z8_~13h38#lwphC{)6}dQ{*ai|_!A z38sY2N1>*q`RGM@gv^bvaYG&#v^is^TM9gVlZR%Uhvx`_DN!U-tXIw01pbHip_ z;t`kt0u$h8YXb1V1i%Yb&_e{K;o+)u+(U%_X?OCSEA7i)2Uv`@H{# zn1Qk9168fbHM<+Y1MnueaM(-(U$xsz1jl{Y%J;@zCRk1A8AKa%%@{|D-R;nKQ> z^$}NFZMm$<$@eSj*uA|=_CyVj3|lA-EG*xp4(y1oj5sBav-Qzd4pWDBybl3Y=bmG)&cUeLoGM5jX|0r zj*a8r5YJc64Gg<}wr1vln4-|P=Voo2myrFgdgU64=ysNK4y$h1Mq;pxoX_~0;5|V( zht=L!Q)U>vU5BJ1qb^Lg*(CKd1S(GNk&lS1oT~0^&wkrKHD=_LA&bsVE0`QR@MFKn z`yE~#P(0q&_>zv;TI`-feX(1@zqh7W#)ynTlgo!%y`rw0pRjJyF0`bpqpUsT4ZB4d zt4MLBZ}C^UxdUTnZBvGi82f9lD_b6m`7ShGI%sx9aaDU_Vb^M?YsKtd%aY-;r_*DP zR*X*A94rlQlW%!(wexMGZ|2tMlsRq9F}9t?{;g$$Pm9LH6nN*{S+;Cc-@ID?xPqx? z9xJSP)=+#ZSM^m4YO$rS-w4=~6e11^A*Ojfm$bR8T@4CUHQ&ul?onhtIlk41jEjJl^ zXa;Kf9Z2!bR35xzACg&a8k-Sm2zG3UZm#yxL}ol;?e%|gO4^Ba#A)i3wYfH#UF-w# zO1Ewx)GOVa6Omr&)=PwXrCW0d>6P5&0KL+!j|ufkw>~DwE7?%#7KDO^N~lxPPAnaL zj_$P|$#tK{Eq7gq#L89pSn1X_gnH$1yKP+gH^^A&)^vn=C3iWHSjl>&TQv~smF}G^ z&`{}Kn1c+JSf{+%aFHq(x9+@RrF$n9B7-a3n~ITM>0Sx|^-A|r0A#F`;LA$xa&Tp3 z=XNoqSGu>VK@+%pe-$!RVx97!%IqqsmAUNdToo-tP^^p=>1d;z$6rrd(IM4(vuVku zujzvF%`&Iwtwf7FTGU>uEqVAH`Ffn*ZnJw_05>niA9?Z3h##_KtGxHor86cld)%Hh zn7`}XRl!7cGJ)Rnn))LC$Yb~;?f4^e(MO)IN~VsKD=!adZdoNpkFT8RNTKB=+lhB- zr6W@X5A6gGZIob27)}B;B{e;A@^r3b1y*kOl9h*2ore|$-Mpp6vm0yxPQm%W+AJ|04$YD%s3;YLs&e6ARou*#2P_cF1YoIrP^ToQV3A$hHEh0_f6}!Y z5-SBJ0EHvZr@}-q?YbNs!ITHkg#(*#1XFBV&w@=*rz~09+~``+YI6lU)?Q+m07n}0 zOAud={_5IGcCGw5HAB_7+iL6Z6iSzf6vtSW!oC!Si*?IsYWE!fU0(=4vSZOjhWId^ zWy+BWT0L)1+O&A0h6aBm4|Eb8{;xa5o=~k2 zOo_rtu%?Wppzbtvm8`hRjfavIU#fR8$#G<59$GWOlr-1GU@urx-fXBQ?3)`l;}VZV zU;?1pd+u_8?frwt1aQC9gE}S6M~RoiHD|y_aM0$={rV5zl=9GwOYoJYU`p706lzME zkJ|5}fpKl=S-g=)azw0~3$H1VDAT68vj0`irscCzd^z6jn2#ab3anj=ul6 zm8AZ|-c^4PPaQeAtlxVd%1PpJ!IIF0Bd!g$;RMr8GE{YwAEaOLRGes2x= z@EyOrKZlOVyBRuEI@YSpdfTmi{FyH5WX}aj`c8qwY@ciipw(%8;6Bw%&{b?BdwcV zF`NDOD<8Y_^6zF&Rqo$XpxnRpRpk+NpyQY8S;-jMd-r+2gmsHPCFQ{7MYO3n!#87m z;pXquJtpVdA3iWoJG`V~vSC2f7dK*U+l@YsEm?PxU-gf9*S~k^j_1#Ao%?tHy>q|y z->DvySuwTBy{3cI?iTeJD}IgEUhOp9;YWb9X$5@mgQcc3ObLu?3glq>S4dCiJ>q-Da) zQ6Vw2rq7Q#KYe1w0)uz!BYIXFlvMs+>0NkwoXN+iJz3jNGgQ+@Gx%!xn}&yiF3C2X zFL-g!5@}G{*5F%f!kn?T-tx++E#iq@dCzX^nH>L-WqQGD+h!K5+ZJ!=7bVSYU{(G| z-S9%;hP@!C?2?IRfB4y?WsVSxSCUd0*efM?uOx*wuvaoW>cCz}%5-S2B$;@ySCS$h z&@0(cNlJw1PziO)72*z^S)5W_lheI5{C46M;GI5No!faKICeEe>;LHVaX9{ z%F*)X+X`2!%V~2tTWWn0D35EKdRrxzJx{vTS>hA&NOy+JF=^*{Ubg8;9^a&uvT0mp zt>5W+8gDyokIS@gaTkL0*Lt3En{StjzSIS|tF{`OslfB9jdmB%L29X)1J6UctDZTi(p~=2C3#x@l49Z-QcR@U9GrOk@RbHN zPT(vd!B-l6@!65P99&Ztg0Bi_VFS4QRp85CtW!D~m`$eQPDcm!JG8I??C8uMN^mQY zjQ1fC{@W2u3B!hEv894lqi~n{=+#4N#xy!+U zVsr3C0qtN1$4XLON5c1nm%)Kh zEq6IUs1{$U@{n#xc^!<@Vx6+7%1qe2xikE}qpN|y1oSoHXA&;_ECvhrv%u;qd_)&a z37Z%}O-WEeBY8SE=QttyL;F_G;VYxv#KW9Jf-kUm7$M+CCxR(qvr()mi$u&eIUW*E zcOME1Oa+0d;2BeapaKoeMmaPP2Nm!T(V;_OmOsNoCgUKH5KIZ9@j*@bxJeb_(wej``wh7` zgQ4=#47&-$D)>e&OLubs+UgHp^PH$~tToBvv>DxF;qP@($2=d|U&J5D!(Yh|3+yJ1 zoBcpmP4aw*pdgBdS-aLv-XyD@_Izrux5JO*;jd)41$tRyC-1{9-*>Pao12}AEAFFX090#^_T@DUx6BrN} zu+2%m3HK@!2(}4K07~T;+)^-Q_cSFvfMbR{-24Rh0FHt%f3zf|$=-lKB5Z2z6ENJ2OMw%5CH3hva)5 zUhTh2KIKAHrn#MDK|c#9Y^_}%p|+>nUa`!s8DtqlY8&b&teX_a)IqlT9C_IxwaB_t zGPPz_&3Se2;s)K^fibhTDZ@Yb%?Z)RzB$?doc@S((140HyQ?(@o0gG7P1y8$a@|GR zE_U9u!|1Kql$cFw8<|^Pykj4fS!s&O@G}HDHtCwH`)a&3LyF55oED9VDe%s@v+TDs z9Wh0rC+22t3oERc_N1-(Nl{&vlY}ROo>SXav}#CGOmiS7Ds}kj!%ZLW8f&UK5=%$Kd1mEF{D-+VYB_=aS~6 z08t*x?kVxr>buxra4WdU79|w{L^Dij7I#;^mv;xaoW*} zJ_fI-%7_+cKkao}u%@roo5VX>ZfrIxjs2ITjIH+>6na_t%o`J)8YR!G^%$*)zVW`QskD{0x9%L3;4ErSB-upc`I>`!#@4(*Y8%q!hTg6uX{1p%!nq+@O5z=g zxAq*^b3p2oRwd61Q||Zoo)iC<>Sn`mCc8;+3S}kM>FuO9Xo*iA18klH~Z% zUdde!&MQgL5$%<<(-Isi86`__sDwJDt+AonwbEg7MLpV>U&MrsgQ}~DuSc=6G2bLB zafgjdHf^2fk!XDy{>XIrksb9H;YS6xZUF{-Xe<< zHI-`F8_#79ulG3jG_SxPDaRkV9DJnT+U9FiWzm`eHe{L-CptnPRTd*82TtUAe5xRA zI&_Nk!AD`il&IPt>y^@o^;B0&IJdl+f84biQeTp;IXIIm@R{5X|LstL4lXadE(h22 z^u?E#)HQ-*WeC2!ggPZPJsN6y&cK_VIe4$!j`vD@D^41?=%$Ce99+|ri}y+rW=4lf zT5k?+dazD;v%yZ-%c@RC*J@t1N-)?99&_RWYcu10hzA%;FeMBTgqpH4v5f)SI2D)Rsl;h{0XlrZcYYs%lN6eZ;8T=9bIcf|POMFlU~T==>` zkI!X-DPdC{s3{3(TR~$zTE5A4xVXfVjQ1ftgvG421lQDJe51!*4shnmVM93hfrDy+ zGgmymh;_=(tC)s|tI}~8H4ohh*OduO0D%e69q1{)5-F%Tk#y#W%(a&cic=7N3fDp5 zVkNd#W%(%r696_i!OstPXm6oT*`C zR7dksZsv-Esd;#P!UNWZe{ICWgBHP*u=yy~lr$f`mkEHIkMe+HL7@`%eHjmrMI`vz zMKC37J_{@>??T4s)B~@a&)3n3b zbBQ!4ZN~2K46$W^A;?j#$eZRhE9Q}w2{T89#LSvLKj!@Oi4_ZeuQUbgoegi=JKX9> zQ<_Te72O|K{#1fr&=)f0tb&6%B#V)@x#?DOtS#HvLtZ(xMLf|f@7ZlVljA?KOfPtC z+suM>+u{xV-c@UFIFl0XCWU)3;a^NYk|P|I(D$~q*AKhY-bGJj_@rg8R0l^Ns?qI< zN?B#->&osEI?;RHSLYtv`;HJF;^;-g)fF@LwoNtJs6Cp#ZdxcNJEkE|I6W$h46 z@8XKdhF!zvSdwaj)sfcCu9(gK`<0K~dHHuUrz-bvDNyd;`l|BCue`NU>+MzF)wg#p zW~t2*->ZhT>2>w6$$zwa9he(6qNHqrp-Yl)Uud}xj*v*YH@xlqGcMaUz(Z2yEb+F>{!&? z2tJZl{9L2Z(J8O{NnO%1M@Xv2znlpj?p?0Pkg3O~icaNPWQy!m>_tXl!IZFs1~nxu zD4`0bb3w^pOg~b)_9&Bg?t%dNkixzH4w=dQ-0QKB-;R4h39`KGx*S}2+1FRo8tM-&VjCV&vHY+RjDEc!$HR?lHEfo2n!)Xv=*SG7dok zNfxKg*e_unVL9K(Wl5g1KX&7fG+)!z*i9Puq=Ww6)1Jd5x%eZK@kjFT!xiK@X6@Rs zDPI#XMpj+7GCOf+;^su3pU+TnCE@8LXod=HWhAhziwS^Zwk6}sEGSgsCXL}CA|9YI z!IUuU8*9p@s@=q8^oF*Zi~RGwCy;N0baNVH6&mF>zj#LIV!%n0+>>VDg#a^Fv;GWOl{4ag(mD zZNBXqKmsDcrH%PT58s}e`M&CEN2RHUCNN_}M&P*0e%AilugqhuTeLFEFm<@KxBSL# z(v8qCQWU2}V`2)tbM7qr?Mz2ZQD~pMAN)U99q@|uqh@(T$5R*LwD$Dz<)7}p!fXhr z)Aq^;x5QgUCu|vH7?N48Uuf`^*=wRx<`{e&pM{VFM+T$n@rHQ5a&BPQ^|QBrXU$HX z-aqEM(D>^kKd*THhBL7(>wQ(G*|d1m>mi3(?R{Ba%j}w+HM7+H$Eu&OZn|&X%PW?_ z7DkJrIjO)aZ**+MyO)0XrO%Zuzfk^j`i_ccf1mx~XLe0X z%O@0;T~PaU=ql1r$!FMl$Sac6ksZI!S+a)_u&I{kg(>&@d(Vmg%QEr&pqKnV_Itcv zxODKoq57K*$8MCiirxBwORpqObcEPE_M$aLnX7YsLE#}*ZPnw?=TWDrbA17QK0RA) zH*Fh?-kO0L?|stVnOk1GV;_`RX^P75GXy#|>6)u|7&jRiF`#;%L7|tG&%80=sZsL0 zTK~;+v$oB9()*7BZ2h5J>XA#%^IR$Hg8 z8s#2FZB_QPO=;X_eE6KYXH;cGi?g5hx-D4K*Xk`VuWwlzpFS;}k$6_Y3T5IY2hJ2%FM9A;N6 zK>GT~&O`=`mG~yyjE|Lg@S*E+aPT4zpbG~!;mS%Lz$U0uQnS-Y%?{Ut<4`sU-YZGW z{xe$44UCmM00o_!(~(dhcR4t()K##5(2qDm_g(^!SRcb2}8$ z(cLSJkj0P!->2N@wCH`%+BRyVhQ+Rh;r1qfV~Y zyy`R^8I|B9+=ZsOa?cAv{ceV(u;e+ljXd*{R-41~>8R^bmZiY_@P9IYZWT!{GQ7Jf@2RL6M&`bLY?xMrez&9JlwGPeB4sk zbP4?qr-3E)hm1dese{VFr%h*kJEJOUE{_0WjB93Vdh54v=B zCV(4kf;#1jhz{mu8NS)!p<%|;o_PQY1SWvPbl&q(8SyM7_yi7hN@{kT#LMAkuDFWL z1tqPrrK%opOEJC(RAtGQvM+mKPi6&Ec283#T&&7W z;bpuN{pP%}A@>HuQeb{KF^EXQK<7EDVmJQCi})jt;g7WAk3?Tjhh&N4oriyUV!HQl zpA(-Pb8^hq3E}$U&ESfu{j~4Iua@7cKAIT#+MjMGwf))_x6U3hzWig;1^K*s z?YY{anm(Exi9WYeqSH3)ycJdc%H;^sv52zvkmpzXXnZx1)?Td*`Y(nnM~4QK?wEP@ zz}&z47tQ_Ff03bIlvMHAxumuyX`|^^^)DuDdO>^8k*{{mT{7a@@b_|7NP`Qv`l<(J zg&TI%k|;>#Ruc5M`$lLxpi+4F~A*W=beJNMc8+CMc!I7L5d(M&A>VT`2eGJ=51JmN0NGCyCN!loH zp59ZpM_xHqE$;B~jd?X7?E1Na-<|fJ_0VVDN5zBFWkC20gcw%cR~5nlkHsj9QhaUU@s|QM*Y(jx&yRbUJ%p z_j5|Iy!l)D;Up`}{_t8=MaOiASLWiqk~E*uUfIwYGH_l=n$Kvj+o2~LkfpFB|!yK2`b={1P&_T zA)aJR}}&VuY(Sc*qj8iU-`3@sJ(4%K=Wx@Tp9KkCi;6aHvzB z7AZPpr(`a3_3Pr9%(U!A((fE0o{us~omBL-PWuTv%4DXwD?FZ#Hh+sh^4c2lU*)pb z*qNT{oB9{8dXCTA$%0PX-`wL-GC`r|6W3$-BYF5MCDppe?4}Rh^Ki22BG0Fpirvio z|2g**m#lii^O8uh3w-1Wk>s8sJ8;VL;0>Dv1_VP-!4(^R_?8svlmxa-A+U|B)Nx?j z12}AEc{u_D0>;b1gKbc!B(UuofoU^XB|Aucz75i;KwHdsRBk1#F~=8HX8D{ zxcLbVY%}8;~qKlJ9X@tD?lNm#<{KwO z?6YQTZ^$FK>NVoG<&o}(v-6Bvz{A;GnqJ#X?x)vrYwYo!KXUDO%0>rmanHl)uLY1Q zobaEW4FB2dL!9}iWR-6ILzOPba|&=v<0%mx@+G z)ZKk3{J-K^yueiWe=!wY>X*ZxU0wIr!B3am9d&Nsq|YCEwfM@3#tzXpH)f5gsTk65 zruVNjzy9mM$>p!K9Uop2R#Kj6*yxOj^O_VIaA-&2vQhJc@&|wHcZmc%#E%|ri54|x zIsL56``@dtLope?!0>&w<6POpKT1LuZd($24~{? zq?>)5d8hGB_0hGo4tGrnNm(3?JIZK+WNtP!+j}|Am_#Ir;dLP8iH?LlOLFQ`qO4`| zyfEc{fA2Z*3r+-lOnMtvw!TUN9-;vY+YYI|Wp@?Rn~Dy@>k(>ugpJ{-71gksAnEF; zj;yjnr&?odzCqH!w9i6FCnF;$ZENrw;`z$CfnnFr*34WGQ$%_jKln2O9u?Q$CJnuM zR-st^@VOA}1riLeGBGb}2WwbO5Z}ydJ&9t-l1UO{MB1kFEla1R$E9y>QunfFzwMtI zGjht1MQ3LgOpYBtKO~<7Jd&PFY?en{Xtj|DF6oSXzx0}hRsx)2$Y0mOt}&V*+HzZq zvxmIF=A(&BQ_fNkQH-lOQnOMWocWb*?!cH?+mzuW#xC-{LV6qjoc;+3c=&7`yZ&O; zJ(u&8h|ZQV48p}0Rud%B5bT-)1omk1tj6IY}u%> zd9|bhleLWmJml9`SJ^dB+O@Q!nP}l(?|zY4@z{{g=&Ps_8BGvtAMFh@DYa!GqMCsip$vjBfRjO|2l(dhhKaiqMB_#gx;6o($%qB-*{KbDeVtoANE(aHX zxmXD-3ZP!;E(%D499$G&o$`E@naV(OXRv%vLy9^cmw{};rCrisM|Y7(G1!(Q&WtWB zSK+@M!IX&R1n-q3*4s#VhXjDZ{SNJ?Mwdepd^tp$z|fT?30;FLOTm<|h6iiPNh1Bl zRvQnAha~*LKEy+oh{S(8`0U7C4iJ98r!rbQ@1Q^*IPU86J%CZVxSqi3vp`ch(?pH~u;h`lRtXrN-e8drgfq!ZBCb&D{p=RT1 zRUG_)tqRzo1a~=@p#&Q<@P#F9Bud?=WANN072X+wpG`N!h^j zuc!IO6w%kEq-?+pPvSK82)oDgnC5TsM_yYO@z*R;HejX*stogs^`4H)8XI^x(oUDs zN@58#fP0Fu>S@o%Mv_L&V@^hffEkyO3D$W&fivTeR9sv;&&DVlFw;yj!8e|dq7)av zM@|w+Xv!0UN84yF3T}EN`1nTaaM6GP4J5!xm%AKb(?jcU!3C=V4-om`3w5YdQqwc# zo?-J%+BmY>^Ef0h0VqpQI1-ouzUu#2dJ4@)uMzcwn{K@vK{BF{3wPnCTRcqlc$jA5 zr?`SCVPObs$`ujo53;+3(Zn3Q5AndF;o;j6m;fkxU^0HD2X#uCkG9f$l*9aSd{7=R ze>2{eJj{5YV+593E0_{CAH|w-lE_8O=Pq;=*YEIvuJV8?LxD?{Ow9veE0_|-$H$uT zW`mO&9(>{vm;f*aFn2jX_~F500y-Od3gYE(Ggsh41lsM6Mt?a51ddcpyWP=j z5?2niW1sW2`M}fLjs(N>ACZ$|X|h96TxX44j{mi!TK^!3LmL;@c?ha)6}J?yCu4a-Dp+@fmg9 z>7k_c@m6?U=*-j=!zbM>w6%*ZS8@wto0U_(+xW}|uZoeMk2>URAT>4GBJ#3tq3MW` z7HA)?9iSPe>7g08FJ%acf!uvDWo+uP8dCHy^m4@RCaDb4@#yQQQshnZniVs#Wy0c7 z;+R>}e;adtdjE=fzgKF`e4F&B-6UCUKU%o4NV``~XTMMvdTm7H@JQk@RgxG;sZUy5 z(;!Wdb%4C=(5>be+fHMj*0RzT@kFn@XSel9jz4UPD|l_&?1FXMrajs3-Cw=;My)Eh zTJD@<)Q(+|(v)76G@n*tMOogo^s&SzYH@Ms!B6j1l9?Cy*G(Ep6F?%Skz;=%FU9jA5jeK{_6OR+TGev;ThOt9M@h zWM-0b|CU?I{ab&b{NPvKYqvM*o^-ExS=4KVY%HS>|8ep3qchT_JuD@^Tjs<5`bN}vtaPGJMn^!+FS{l)OT6E9l ze4RuRbyqTLzN_)A*-7j=5(D|b-gC)3d7Q0}wsM#{{LRyQeyrKE5%p2IQB& zcWKPJfvH3D15<~+;uk+$upX*!?@9X_}U$mEm4H-bMr1j?DSjim@CRVau zNs9AmuO!8JaHvedhf1hZ{zc!MOF4o>&Dj^XPkfPf03%}MV!T(9;yl_b@v)M2r=Y!( zI~-gBC&hVm0w=|Jbf~-x50zM_Y^rB=&yxTy`{D;ATW_s{)RiOz3#=>ISV=;#Xs;wK zcW|sEbz-zva)*N}E8SH3ffG2X6QdJ2sS|@kCDtix3z)4WwD5yJY0MSx_EFqc_h2vno@)c>@ zI9kJ44exgh_~M1ubD)d10(f2ErcKJ=Tqc?lhFC&PIow4Igb;_tt^A{F_aTCmbIb*` zZ4>xI%FNb+T<5;MES5gQs=LO&jcR=i|H!fUM+)%bPvHN{-{K#cYc9B1H*YSB&+jf* zoabM_FdG}b*XtO+oW=gX>Aa^Wjm{;~ZQ+}D;%8d0m{H1C4NA3i^Lszz==z;ek>Kwt~SSbG6>4t}F zxx>NDT>bIjSZ8Mf;GL2ngYSp}!3~>D1%E@7Z6XsO6F76_4hP6j!B4k3I}<{DhhcpE(`v1!9o@d8;Z|F;C45#wmLf#08dY$X2(VIQ7-)ADz*-m9FB-3K-v)?vf;U1qA6iKcdRLCKFZ`B zE~Ml5paO(+0a6)0T6UyxT$T_`37d~%P1#Uwpj#q__TmND??~WCZ3hDam&;UmxG4n> z{)(ogvK4c832MrJB)8r)9M!j|Hh-6VhPhm}Njc*p;u=rNaeax?Qs%k8MAO`P{AWg? z_($%-KT?1fx8ncHIQ%0Go0UW&NoTH6{v-K}%keS)3oY(nyBL;&=h7p&(^3HGWgM7Q zL6E^xy2`^LwzwgW0En#sNHz3Y6bpvB@gT5hO4uc2tSM^?LaB7~Z?89i#2k?cfP!qf z!vRjW?ms4gXN~}MO1gbLfW#2+cX>oj0GLt*zBT(lU;?;n-pY*_zxdI)4_N;G<`a>5 z^9Ff+{K$=$+`h}dkNj`jSL(->b{TZ|-2o&;5ty-dMDv1)nG-VCg=hkud2a-y$sS%d za?0SS;@W_xOP+|2$jIBFFfCAlo5-gLTj<w)mYVTX_QGOc&XCVGz!>p8aH`&+gqEXp4=GjwwVi^w8Yv$KNooHTQ~5jjZzx3Ol17di{mp zPnjhv3)_;An?K3aGghuT?$jP}=v4EqJD%?n6_>M%WXKQde6;{hHj*?Ls8kH5C6>DF)W0`cO zIw5d(#hWvRJ@0dN?NhSv!}`mk?CM(~hO70r9ZqgEIg?|EEzQ>7HYc&iHAbn$U7otw z9P+>R$^&q(j6`~+HG7GLv}MX;4|bik!u|y9CRx}Co$^%me)=3~uMhh<9@ZM|ab}2D z%Hduqwd>GcNsC0-kb(0`T0Vr1mE7S#Vx`9`tKeRlf)ACnNCX`!p-xHb=l8Sg=RG;% zO87zdtB_bpD>~3#iI0`Engo}@Jzn`K+$*hkuO!iVv{x>GhswqHPziNP+Qg`J=x8&E zr*hd|@EPg!BI-)oe~k9ZO1M|X;k}ZixWQi8aX7fLlBBrN37mA&!J(3Nyr2^})G4Xi zsi8iCdnT@8bK@Od09y*+Ljrs|qA5|`E!Hd3qucb9cdFY%`WVR{ZmolK%m#c&r?nF3 zR7T5Az|oSHouI)7(UdS82WrZ?tM%vI^V-)dWHLb8(&#J%(AM_x>51je(|cKjk@@B1 z4G*>E?kITOx??U2i!r~fyfKaDCHO}!$3Jo@{*eOMG8_M2UVU8hLwW3B57tJ%3_L+) zYj&e^Y4o?b3f9$gnO`gTcK2868L*ARu`;uZE~t+1{x=zv5szchB4Bi2Pr>I%0iZF_ zlz@qh2hV|;k|2Xz@^lV{zzun5_Z_<7699g}!%l8I+$Ne5Hs!&Za$7+tjrIK7@fTp? zp;!SPZ-wHs1g*>ggJUWVxx|5E+~ELct~9&_w|jATa16=>@Z=q+Q>I6+NG1vdmn2S2 ze93)DWCDmxfd2(Q#p9Kooe6-ar|j1@FQt-=8#d$6Hm-vL#!6_d%Ce>m_*f}GyTct0 zj-Mhxo7dTy04!+=>y)&9o~Arp)qgSRg{DvlYYJOevRpoq34j`QsO~=|fG1RP)fI$b zx~(9NnjLOX2yAxnQ@uERvm?MX6W{D`hXYLD_a76$Q&vKqlIEifFNb?3u3{6w(K!YL zkQRyeApux4qA6kXQLHIXRU0Vp7`Tv*^#gyJsbPP1kyDrLxgbNozT?jz zira^OB>ulN;QvbjY^lQkm+qvi;a0^}&s8wy7ypYqZF(^2h32CS*v8>l!1*X1$HGD- z?ENx4MAU&>;&P+_kf3Nv#GTY_1iP%?+i5$;1K04oWAb;?uKHAD#IuASrV@`#!Mh^l}E zA-KZ;LepmAiZ+_W5X2j(P3}Py=KWD%@}VDv~Q^O&6;iU%UL(> z^ULeazS5F`=T)kt4a=fFbuF|3D@!HrTWteMiZfZ)aq`&&}LC01~ z7tH*2;F(d!2Avrj-{&QH?{j@!$^&|mOwj8Nb{Vtp93#9ruR(3@tyL$j4NA--eUaSh znn%;5#(DA>Q%KX3nx!hpDtORKj^cn@X`?u*LN=a-@*sjH&qaY^|QuruK9`r_|}27t(>#UI5n74@!32S_e6BQhY`` zI>{8HZAs$UXdfc+Z1A@uni3Xd%|77x%N-6d{?Z-@bWv~_9xE5)ivp-qT9R8Yu$z56Nup`@L3aYARuv$k(;5h{ zR|=5HxD1XfRk5*>Emdi=54u#vr(0Ef9|0^?p-!n#Hae*{k+z55m!yxk_(OUVW*Y+7 z(N*}gL)#G0K134!;D|1o64o(8O*vmDF}N3JJKL-a3=%zqX*49?XbRnA2g2iomuG91B;u34mka@jGT40ysws0F8;Jgkj%U zQ#Mgh*SB!Z*{S5;A#x9cr$d`Fc8;LJH>CnJ;{t#XqA6ih9;hh^GGGQM9IlK@JU#G0 z7J>cXED?$azq`TPo{q!8O}G5iNrUdbH}Zsrl`Y^dH(B^x(v#-VK;9TYBBVrx~A z34r3K{6{bW1fZuJmbi(K)GTBGK92U3I?%I8rZZ{mV6x1PrwzgWwM3vLAh`rT8)7%#R4DD9Eg<&aNWUnIZ zHYi;D8AQzo@Q>8uA6bTfv z;cv7EfZwIyb0mjb0&}EjO4xi9YD$`q>ThEL;D$Wd=8U~jC_qz+Z^qsD>j-WCEb>xpIdCgbeOKCV&SrfI21JzRvvd+Bxv{wa5fO-M)?! znEYZ9NNZpP{3FTtyMjsKb|!uK)b^o4n(Qq=a~TRgD*xt{c7;I zcb?pTTA!4cv@xk$ zx;(`0rMzq%Fy>D=@tLbhf#Xp9W8*97Xuf+XmN4uZdWSmL@92K)#4}=|# zP*hAa<*i`lEM9oIpLRPnvnj2-B-iN9j>#fQq2IgysJ@C+5D!Z1h5Ji>^&I-yJ zo#j`Ww^SpsZ&WEwD{FgeeMo@A^hVqmTaK-l$w&9ON6zA*5fQULBF&B652p>--FHmY zEYrBgbmv`y(tq8q;_(Ty`zlT1Bzkt>|lx7fk#v5|>w2dksZnjF!iz<*sgZV>M`dN?UpFM3kdf%dvn0AP$K*X% z?mFhwAF=9a_O~Ok`^mT_GhKIov$l`6r?$Vg`?;#eO}qO#R{bPDTsn*}37f z!)8aEub7kALs?nZe0ZH-Nl4N5)JHQ`?QLE#A#<{0Sw}yfJcuqUAP$@eL1;&hqfi01 zr9a+>XhI48c0^Oc!VuP!WfFHCQQzv@J>67rtZf1$;ilk2I$eJTr!tx!19LbVEmim| zA(|3a24YRwR9{0C7C!M1eG*;&3Xml#;opt`*^xUOT=|QQzijzSBqMbBi%;QDr+nQ} zy~}MO3WBRqFZqCJ%v}1X8shl(C(TQ&1vlz;%whWz=GQsiEl=}u{3EZGOa7^kE%UUG z^lLBgj=@n=+_+nZPa=EBL(;`ceNzH=W?9!G`aNaul!pS19_vt_4;2ZjU=0 zAgn?72)H$i!xtNLCln2~L7kGoHfnlk*nkGx2y{n#CD)nZz_#i5YJ={CqP>zk930q2 zcS6x#c?=#Zci}@N)F}yUyGCFe3D$tYHlnGa!L}5}O(7X!#?TDs?fo)h*mPu4J zLkgTV@BM8b%9Ny6dnDOAp2m*{xL{q|uSXfgwR2wMo7&uRF3P0dZ;6Ifh z_(5a>z<6?^DLbbr324ivVGKU;+<(Jn4+B_$?8qGsgaOPpW!U)35`gbN21KZ`u|?%> zal0IDS97f|!&T0?=!+PSHeN25oX`h*7@Xl+#k>4R%{48_gIt*&K6QbuZX^HVQe|<` zzjo9!52t4XNEI#c*WM3*ZG%%;WY)<&{D&>d82%LC)@&=Ch@Xd;PS2jfzjm?0Ut8tC zzV`X#R)*ux4a0F5b!Q(6i%bRV1&sTTsgR;<{EnIvZWz8m+J_ci@w^wrdgU&zgTmdw zfDVN{*MdZ*0_w8beaKX3s7@iMAcb>u98`dxNnkJju^%`V?q@GN3NYpnO$mbvpr$0K zpoQ`dH|M}zfD>TOVdcJXTq+ab5+(lfsAx(YCkJ}}xJ+W8JFWsGp3XiL{*Sm8&t}Jt z!@uuWDU}!qA!zhK|~_K2WkU`^zb1VOtV%^M?3KeeG)37RRMbS?2iYh}o$@=TeoX zF75&HNb|S|#j1Jo7*mL9Y@ssTwOTI^{X{ZMR^s!>r4#RLHT#@h`;_eau#Ys}do{r$ZyIQx<7Ojc0ch_Cs+#_qc zjU+SdYh1F4-lM~YjO}-DOKfp%z|$p9#P{th4>~l!aCN@U*_M~m z4)-~`&R7**T6OO7`J~o5dhrGAFMegd#{Ftc*x`Y17e#4$rfbI8SE@E^0v$VxbQSwF z!S+pY1B~N}NHas@U*{VXc1Hcq^%p*y;!vke7*u>S;Q2)LbEel?cNR31x5PAA)=bqb zFIy3J7$E~L+KP5X;)FQ{z8cx4>kD|^7b(oOLU94kZdUdbH}Bv!IssiJTO_DX+z zsH}vCN~}|!sy0w^G_*VV$J$@n<1oolf_L<4xGh!q$d-ctc0^OcN;aq|S46L9wZ3G% zWjN|e+Q3vVhq523RROA(%?(K#S{z?^YU<17%1`(gL^b$Frd-ti%4K=iQ(JzT>srRY zTs0ide#D`h?5Weq1daSle|N^!`DVptPjN~A?`8h=>WW49M=pjxvJL;@ZI;v3N1Ou| zv9%x_)Nw%5!*qLG1%qpPdf+oTH74MuClp^^c7tc#j>EwDvmd)bMb_W=qmTO`#$afDbXZZ(CiIDf)!vljoz^jHZIAO6a+OqrRplQ(g-(UlWTEQOa@#x7%mI^HDU z`dxTd#eV!Fo%lxz@ZttEon#yB&(3xEw~zIJO^?U~K#}sf!vQuu_a76$)AT@{GCg`l zrpv+&n}JP_$OHgf74h&>L?!_0rU=w2sp(0lriVj9aZQf^ccKJ9fCWIlq1UWDqh|c| zGSQTn`KW3!fo&YRikpuLfUa^32;8kl0q)fa0N9GAgw02>ro2M!Xn6~V*aG_dyzouia7<^+TVu z{<{Ox2JC)#R@EHS*hW@!=nkDS+u~K`U@dL^n02&&qVKiO53loUjt!5ge96>x?iULt zWKMRh+@bOPUbZG+o7$K#GHY;(Z0dxEWv3?mzG_OM@Ak+QtPnS+&&F;?Y8_FijF=rh zyD}}YTe>{tW|O9iYO-yJ>7lu)QLkkf8;l{Ez?|abmjh&P2K1XUX`k(xl2`I&CCl@l zP4r2Ze|PMs?LX>s`raTA_FQ&aM;IuG*L^(pfECJNn=E$~)xYFg)(t!6N>Ft|! zG2f18O4@kc2~C+TUD0N3sJmr2?n-`-*@HmK2Fl#m`R9q_xzfKY6=@#%e)@Hj|08L~ zzZ{Ng}mv<~0fMnf{!(rA6W6H}rwqIc4Iwgn$4{>`A`FbVW^n~I| z1E^E})be@Af#11i7UJkBcw64FRv6<$cj&>2rsRV`baqpgN#dL?$1ct-nGFkovhB8g zC)td`H^hhHmN=&kU-OSpB`*Hnu~Gx`?Hq&0-;Tp!gsw5|{T+K=Fhv2rC7q5h3b-Xa z5T_)e>yJt3np5~@gszYBFR2NG5Fn!8u_zu=6$p^Y?vP){cqMl@xKi~F`E^XGiq8=S zu8+WlN~lxPPAnJoCLHF!S^tzh4szfEVEzVt+F6W`Y|t@+2e8GDPefBnsLJ2yE&UR;1IamNNLNK+<2 zNaqfxMh_cy;8U3uA1m=G9P5;25*6*l>WFMOr~n_)RrvZ>fJ`Pb0Z=(26kkw7osyse zB@vRi@in^xm~R=#V)H6|bHXtob}DIvf@yFi@EMf58V<9GrbIL+c&~ijQN7=-v*_He z=DGrQY){knrcnOXOY0Hm#MhkDMzD}F^UKYfgx0#$T5zLo$DHmbQ{9;64?NZfFP*pu@JMEnXbAer3LgIOn?KD^|#hR1~LL*{sPQ8@G~Cl7=gV{D4G({ zoCsjbhUz%VI|2-O1h`R%pPvXYHxghpA(|34nSh#-E+XXKcI_OOcoyTwTlg$tz&B+A zWJi$+fGU5nPT5pnLr?+tIpUxK0V4YU@0kE?yGF!L-W~GXp$8s+Kjl=zXAc$22JR@2 z`!3YD`RY)0;*h8@U)ldU^1puD^Xyuq?EA1cG(8ty`g{F~=tC_I5@Jz|srY+ZLsF{M zVmW1;Y7DXsV^kcv+4EJ?HIF)y3w2eQnppd)xSd9Qq4MYx8fl$xP}mvuudcr^Xz=9X z+JNUvo`~-~>(cO~Ip&&bT7E%7ET_9C&e^+z)Yo;oep(;x>ZCl<7Rgx|(&+Tb`PAZ@ zHQVHuvu@n=}2njUS-!d)_lUrR;#GU-fp zLg4(0H;aD%>%6oHFBIPln3$M%@YPqA#7R8+a$_TKYq-{=vJ zb|DtU!fwO&o;&T;WU*K_nAJ(+_f?U$NNmNXX4iwUmmOZ(D0_F^(E-hu*PDH{G4^gP z_4){Xmit@gh@UT4Sbk+OSmZa7T4jpN!u`fP4`-=;-nxtrZVU+PX zMqH$askeJ)>O!-Apd!zbsxWm^jV)4!xz^^UrhFn9CM)rIiHvoJ+iBSG~`J5Y=@ubuXAE0bn=QvvjVfcv^_~%#Qs2Ry*1FjK_{{8(*)alDZknr znI*N=Y5eU4F4;uy(P7=k_IvuojFK_&eLwV{p?>Z$-?#g^vJY4k?#goA!7gvjN@rwp z9GR0cW%~xsmXo$fNb2NPjavT{e-#=Tctti*&I-gTs)HXM&w&%Ls zy;`(iFQR|+Q1%xW5nqpi9^}+1Jz?W!u0q8>5~&tn-ECF4JQ4Uti=&PI=hJrK^hATx z!Mu2__G_2r7T-{GE2&ktqhN*Aa*++eWP%p{QJq;;fqo>dsz5)o4F5&j`H^+CUnT*i97|LDoEE6og(w_QCKu3pv>|lG^i1JT6+ zzEmfjYjiP4I@joWLo_9?un*^bPDwyp8I^2R?Js_1_d)lo{6S?J zZ%Of9iHERg`vp2y3IN@4hl87L2>@BrN zkia&s3+M<-Y&~Xneb;5>1KX&|^)xy+C#NMJXKvo4G%YL zepIsK);j)|Pnau(_=r9oKXVnC0H|tc7d})%nE;-9u283pkr;@)nbQ8^r;>ix6pFd% zDl!33UdbH}@b)zxvJ~Lb78Vp^p<1X@5>!z4Xg*%ETm=!kFv$#Gq?bd7@qe0Q&8ad?h7BiIq1m7dA@&|d-J1=XZnX5M;7E- z9jdUny7yL>jy*bdNzpqGL{y|Dc1xFs+-%ZxDT~MoWMn;p#*MM%*m{|Kbk|c}4v@VW z(64+$(uubdz6{7q_%7gmO`mgBSJrzp{_argD)Y)(Y@1>mmgtwBI-+!fb-^ z_YOVj*qF3F$!m|?uQYGz*B6g=KeNd=m67$Bb;DG6u_!h*(q5%19`8L>_CoW>tidU= zsS_TSotp6bsws)S+ap&vt8WvaxtdIJsAulo2T%+);yfGj+D>kc#T|KW^I?B8F z>HLRMChfC5Q}Rl_tYmrqvxz?G^6!p$*67_KM_t=h86Jh3gf6d8_i<&Ewc# z{M~3p9sH4P<#+9sNcXkX8Mhjr)AT=AF(+|d`M8WH8}iK$l1fU(#La%%5N)@ds_0fp zfA!~s;@3(eW`8^Q%&7RVGh^fbt5jX4Szhl-Zq2@H3B)3_T29pCt7aMj;-IPBu*G~VAMqd|WAim|5`tuhB|``o?@p(Lbedn&0G?fv>d z*x?98#WYi%Tec=(o7#B&Mcb5e^|rM`)!Wt$&D*N!J7#)oUBPV&I@rZ`AMpMhmyi}A zZO}X5*~vn_)Crxkp_-AoPT?G#*(sO6Gog77{El4+5J$gr7XrkV2D}g5Axe$;c0^NB zXzzrkB)QS$^obv9|HN6jQAqrqj*q|V+mj?0~?;U+!?U%x*PE%-F@n zN?g;!E$F~CJ$LSa=!8z$RL`sd<|Itn^$I1BgnNgsE~L=7Q+*v`ODo=o?vU!md^@5k zse0>#rle)2*_3y<1*y1x=MJr2Oh|`9C7#NX(=Wm^iy_FR)L~iwqNa5LuzBRx72}FF_Z_>TAi2zd&t;-1VR$;!lmxV0BP@qol7ve< z9ry#Trp7nT9Xlw^%<34(w<7>pz#R@QW(WY1Nbs@pjty3jMi1+h4b@D;!&T|*3SbB- zCO~(>b!F^cH4N^8Zzb;7c7mx@xx)cw@H@7hK)h0b)-l-SI5sk|?EtQz#yTaf0H$F~ z99L)HFlw%Y!o^B#t;!B1?$~yM=|=JGPRHTk61V_uUMFV)c-mX2Q)Ww7xUCI!w+zQ! z$?q{^dm7-EAtpS>bESV*D$%D*kE!9UXK(m&<2 zeBkNy=+`U!Cyy#TQNxXARjd$z`(ed%Kg{4qrb}1cK5WL}1tJrGhOZESJ`O*{?SXGl zIy)19rQboFlIEifT)=hW>`pnzfeX-yW1BtJmI5@n_~u?Tr4$v0u%;}N#1T%t3*YpJ zOaQVeq!sTt99+|LA2I=0dLYy(X+FxV0p>6#984_$<|F{thKF<9co<7GC2T&5H6_hQ z32f`Yv2gv405}#DDsd%KpXbIyL;^r#qA6kXQK%_tKI)`9Ow#t|5jW&LpB>`;~r=?@qj7vNm{s0_rU8>uW*!^T&lgI?%d*wy| zkfgIS0a$Pd>XZbuF%1t_rQ9pw4}c4 zJLX@%zb(LL`lMM|0U!F!P=7OF=B1&3RA(2oXq&Y=nEelPSO4Q|EwjJjmSwfMi}nq( zH(hwPd&gd~K5AdBn{CU~#M-+k>o-eC>Z7lzM^m-3I9&ZdJ#rzt|Kae1C-;;w`x{zx zUfOP1LE7G9NE@SfPL*My$xE@{Xh~I=x-}gOm6D*s2#vqJz$KgLJvyw<&JCrufir`5 zd!JobQZ?f-pR0Xc*^N%m3JjmOW~X1>ZB@7wzF9qN!?GeWNMzR}x=M$p zhkboqvQb|&H#O8Gapt`dkR}^6w%_w7#+QtV@BN|wjJ$VW?Q?pB<7$2TRt@AMUHJd9 z2K~q@^~Y&97Nh0aXZZee9>LM^j+IFhGu0%plB3>n-Ptdv(h`*wV+v_nIj-@zFR7gP z+Pk&X>l1p*rsk_7BcgumeRl0o+4o@|zWVUADs43@KE!BR4zK(+&7)T~!WdGx$GA~L z0xO#|foH0I#N1xsAys-o-=WtKKZy`fGLCgolf720Zsz&&W&W`VLLY zw^Emvd6c30+IktEvrRIQAjo8sk9((FV%CQ%)>!2Jra;vvh02J-6;EiSb-qDiXVgzE z8~M?eH3^II!)J!>?m79=pg+zv*HqtjI3AH=-rpl5X-V2c&$FL6v%Fw#VeG)!MZt1X z{Rxprwkp@od)4)Z*)M0^xYX&bjWWkZbJv!N@@3MQ>V&}XODBv|ddbSd-bl#JANK3K zH($+M!ftHyCrQg^G@sC}7ZP9M|2fWYSHWdJM|Kf#=X1*K1&nH*Tm*5?p z(Y(XjlF|AD`w*jX2>y0NQ<8f+I-ggP_8YU4kXi6_e;k)yB<&SH$8Mg!`9!94a>qCrqHaJU6$A3GFcs4dW#^GZI zqihZ?f0;Gf*jTv>pTeO|No%wj%~3|q6Wi~&@g+4QV+t;Z{P8}-$hTs@9nqAqh6iiP z7zwF~T9^$tOi1@^_JMTvDfo~sfu}NeH9T6X@L57MC9~P56ME$pLKv;L7|nfb;^FWI zAkZd2(_97rb_4(mxWmDTF=3Iu3xp-y=!sr9DS-R3TDafjq&cOgHjeJMKCeJPXoB&yYP zdg5W{S{BSH$h2S>Gj9CF&>oqcP*J_{spk%aP}7sIyoDGcVARo2E4Wz{@OGS z2fwxo|Jt?i*H*?#Eakx-Y>3_;FyGnLkVI~i=%IZyS&s0X3CBp{Xf_(!UJZG+&-3PJ z{3i^BMWzCD2BpHos{Z(*fZ5jzD^+QuTp9HyTvK*s_d)lo5NZmxDPtX7fMyimguC(J zgJ?<^VG3(X;^ffsd9Kj|jz$G&^zaR?0FAu>fQD#F7$*m6O5)^X(`=L*hT{^?E<7j( z9SV1BR0e}$)A5xCcQ{vJBSMj>fcP3uRmTxT%|RN#eg_I^u#WD=LpcIKSOP$IqA4j3 zW2o6sQxYdfL3xLp*yHXXa7=|-EsW-Fz^5`Po|996>_^$_9HJ><2^VY17zuL;Aq5Y# zargtS(!h3lEdC(De>-@vfIA%El^{Gwavw4k2xzOLyHM@Ja3Gxx+LgJoMWzDXMTKQ> zk*NT!5(K5?ZTzIw<^5LV$LMI~-gB7og3%|CkCHSL=_v$Fw-y zN>k0m#WXd#czWVu6sy4Cbc|pxUEgSNv;ijeWq36JnqA*2*Fn_)vhk0E-?P73Z*54T zQ>kO`S52gYa`L~GxgY;XC;pMdEx^9`sp`!Q~X0PgPSf8wzDhq#OjF@5ZR+vHU- z;#AP|q`>h_@1FbEWhh+l{9WO^S7v=WzOu{kfwRMBhs{3PKhgJE>bRS|G`-6LvmVV@ zwO8XeF2~l(HqGRvylnV6-7qj;)wZ^|*uq%3 z#J4`?AloW77Ipy_saqoTc`(*ppj@I-&SNYnFkkp8@NZU)Mu5;zV zui1?u#vK~prcYJHrZW-|nYV$*LQ=>8_Y!16= zIrcv+pC>&&ZU1u>a}s-8`$DmDW66%f?Q-9YyhUFhh)@hvR7IPD-Fe-^M)?$7I%(Yc zy3c688Q!D)XZWPcBQkb1v+`Qg?^5vuc;(&d-T<$>OT84}m3J?n2YBV(%jfxfrfox|A+Xf^mSd$fPP6Q3&u#PP|mxu8Ys# zE3J61ynD3*z$-7`B_+(?E4jnr*0%x@_}!wd0I$R+@ViA@JDXFcOWQuS>fBuTFqm!0ig{a(mQmxajEQXiEBV%DL|GG zO-b+z?Mv@$UP(~FRocVIEmX$!JNInM;U9qG@I~9*ve|&T;BIAR{`HV(%Jw~soz0YG z5_cW#g{p5a(@h1(+9oVo1qi@*Z_5Ehjk~wy@NZA<*_Ok8;@ru^yU z3j9CuyLIdVJ|sYvsJv@w7yoZZfb7Us1vsEhfK+z(as@!F#HVnmQ_^yUnx9^-!1L?* zspSfMANk3>`x^K@@?-oX%khu=iLDYmb8d4>x#XYv*s_P-QrWf4uf4p{)yA4!>ED%# zG|ya^e$CLh8+H~*v?if>7~-L=-TvpMBYFP{fwU6BcZ^2%L!ue=YL06)2Wo>%Qc z%japz(}Abs@B#rwGTbN%2UMrvy;5WXps0MEot{GLvs(zK=7!A+qCaO+!n#Y&c7D!^>3voir$f+^N18>&-iKH3p}ar04p`0Zdo;L?r& zkxhzk$wX7a=A%$k(tMQ3J6uS|%|`_Y>DZ{j($WQpmiR0oni4i2#hQ}lqh^|qa+nyd z-w^=w7hu+bpYcG)2%ZZ!qA9%`mZu?8d#ov&>a7G(r?i(EKsI#&{2o{b1H$ZU*1cKV zRm;CUG2q)Wsl&4VMNR918a>?z`+)c8WQjrH7EReXO-VqTmgv;@#3M2R$fjrd8u_Z;LPCN-e=eSD(}r# z`=0CT(WWD5wmVltWyWW&KBegyTQ#lO^^oo>N02ty-b-1rv-xtKIaup&_nmt^xx~A8 zNPN|sMO%NZPMh#>@y&pDU+r_cs9)H%mU*2`q*+-3ANtKue=}i2 z)zgpprWbew!|zc6iwTdZd?_(6L>}3yTs!Yo*BfTPoOR<;r?)oB92?C&n({_0lg?Bp z1cqNaVVu%SRu=X~LT>(y$9xvb7cF7;mEF6VWRh)&>7hNE2)kNUqw#el7wIY;njZG` zamhw~QA<)aMnIZu(Aa*@pBP^5?k`bwYBTQ)Uc9T^ezTko@LhswSWn{;W=AM?tp zNioq(ii!6u01htNp89BM)h10~+qk3AN0bvC-E~I?Xd>H|g}Ej7md(~xmd*!|Avb?=ge)q;v-d-uaXSo7zujCG=Lot!JSKcdm%-bvP zl|1GhD({gz?qp7Rs@h3byAGh_2 zru;X%yiRY*EA=(hIdb~Z9eYW5$KQK(lzIEmy*kRg*e1`Ed<7 z-}rm)8gkx6!M)<%yo-W+#JxM2Q*JL%5st$-`j2}Uc^|j{j*hpb06rwZwV!`)(UtzvHfkBeg1gE0Kb4?77uqz$_t}vdLnxtTuPi@=mx&Q_hc-7}^#e zbhcULaT5LD#N68)`pIxlUvEM65+RVMF@W-ByK*U8Kh=kJlf^Kk_R6 zkpjH93;$pKTvcKPMz`@%_no% zH5i7ug|P$ql&l09EF#FD9kKm!Ef&9jlK?yc5L-M_eebe(-ffQnAh2jk8opZie>`xn zyh1_!$6+%LGKiy6bvV1(2lnFJ{uCf&D>4DfbvnNB_dkLO;F-BXopO7@E?S{Iy}kN> zRI&q6wlTXCMJ52sE4jmomCz)Ge*w(!Q|><|fQK{%b;``>6;!fubp{Y^!`D|_T?yo; z2v7`(On_X4;_yJlle~-H&Q4FE<@0*V5$(g~(b->IP#u9}@Wpr-OJo9|yz)L|0cFb=SP$U#5?Mnv$s07aTfnPzXfX1eofH zOaN2^bssVT*jp!1r=cfB8qt)n`6$$snbB<)$~)~d zS75(mz>{k^1_ThHF343ZWJkDNTO5we@s5?ec~frug&Wb7G)TbU=ulH;T&;Jx7d2Vj zvG%LG4?lQv&m#Kcew9B?(pGzVqQU7H!47zCv^d)MduFQ%|41|bkpjGU9sa-6v%~ti ztN(GfmYLt*;?H|&K8SzhLU#Vo_+=SG31|V3UYuy6#+Ca0x6NFEkO3aC6#%JD!RJT; zu7ioDgh2*SQxargqTAQ)*Uo{Efye|v)#}{g0AWUd{2XBwya?{>^b~>&vTqwU<8EK? z!bkLWO@JnM#)aSZxoq6$_4$Zfjt}>JIHvb|kN>u2&3m_`w&U3kzxVAs%j?50J+Y9#;?kP%79Z|aGdrg_Hgsa zDT700Qzr~6z7m!ukI2Zggcw})uQ}W3K`(igwwiKD5cYIhU{+Ap=q$g|yrr4}WB%my z-kuN}akyfZsr$t*Ezbvbyo;aC@0v2{1KWg>SMmp)85=($L%mm{yX;C% za$4f(L8U9VhU%OolllB2**@96N&8lnX?mSI+Wkg|JTPsct*@!)#njl>er?=g94D8W zg57!D!$$ec`0C`)t*?8J_A63vTUU~|Q4^G-Ai1(@?AE0}1Zloq;9_(b_e?cDXFO{h zt?7HN@-@@S@`wys!v=HLx$@wQ$(y@r1GSNMFXd&!=L6M4!g{{m@BJm>sf;V!j4b#betzxwk*@vEfo&ipp)%&7Q2X#;lm9aA;SWNB1N_qiM-=d*BD#osnt zTwPs`(lKGP!)8aEub7kAhOsJE?sN_J|(nW{;qp1Rl-&g$>$ZjqeNXFU^tIM9+z8hU4k*oN8CZ2c2`uceO5 zc+%Q?OmWVn%vF0eeuv&YzRJAb9N4s4--UgWx&%V%k$@$yywal z$DR5kb?mmO=etCaL>uXD9;{U-Xt4KDP8CHb!^p;GpCIsG(m?db8b9V7+a*Q zO4h`*`TEIT?z6k%?HR*<2uSN6?landhHtPu%I;{U#XkF8j$Pb~H-#T`CqTTC7W<&R zatYikNzMoDmB;k4V6W^r9Gq8@))Lw)X&)}mEA^7|O4oF=?$M~!e;fyfN~lwk-e@+3 zAySKE9et5>ByA@_gdq}qMu%Tg$wb?dw6noJ?9 z6sLu@BzclV!^D@|#gJN+_MM=;@-o~j7vnP-Ehhn&svU=eYoKT;3)(9`g@;NjK2$=T zl2m$`l8vh~4oUuSYaQPXimg=zsIR!X64%yaGdSDUlL|T7E4jnLwe@j$uN0v8C42y! zz_CtAt4RpQNx@fav`+&Zewo!IU|SmSK18cY(BF<|N*KBbHD#`J#VzYU>TVg1yOM1T z!Z^osQWQ%69j-%1waoUVsJ? z-#7~Z7>K4sOk~)80&B{KYAb4SAr=89Uu_ZTin8$< z@gljN8Ar^)c4aI-P-Ft2NUQfD6M!vMu};}g?W8FWH*7wvH`?RQKv=6H697e}<_-r) zrN)CU9bgkK-9p=X50x6~lw}g8Wb3Fia3~wTzUrteaSaqSgL?@6A`<{W@c)mXrx2A| zNgx|HbH!C`Dri&2QeHR)1dtXfffMiC)o^Z?Xi6NF8tIjvIIEp*omuC0HP;oeOaS5p zAb_^krIv!$x*c=byGG2f^Slee=9Z5oKj>o*d#-KKul>9^-;I~?kNgh*$eN|nZ7}8Xxs1@!NZ~3se0Sf$fWXls1!$b5c)(UPC2T$l zH6_hQTL^69nls#xM+I%p*fLmvrc{7t9Df}_G$rh6Jl2$S`}+24=eWcpG66&;z`v~t zAOI5pFH}L0!6zh!zzv%(7JSw=fj?83u~Ak*in`QtF;Fj`noKC<3!0Z6mWHGFAtf`sGv_W}EyJPUE;#RuUvM)bOnBka&_Al*|MYT_-DM$xmrRltN!fFigcGl1${gyX zNtx=Yny#@&qnlklb(b6=+8%aR66Eq4vqyrX&NnFRjQZ>AFWi{YOIAj*8@c(zf1UTH z=FGA`7ThXtA=ROcOEqoj-zSlxk$I|dN8w51Mvc#`)P*K5cd|UjtdDT5WFJ+vC8defyvwxOHf@7IT_t7`Mi2AMfS(4rOKJ24c zAD&kA?BylVO)ZX4GT^z&oBPjZlTEW@!W6RTh?uG&iK}+VC9TRl%d4(U=59@_BuL}< zOpgSIGw+RnG}-T#jeKozkK$UA-FPCt@20A!6Vt|?u3o_|hx+vKM0eS1(PUG{5Zg54 zi?&Io2ctBP+E=UgYl0nhMal|R5+v>k<0)2x#x;mqy=*`;Q7aTM#?{Ed`!}k>mt>m;A^S3&VQpNn`*Zg#)iFJ z6f6%ctvIdmZPQm}9#Kwqbn!@nG!Kknbz%O6Q(mdRN-s{rHtdV1MfY#<$9UxdxK~Ev zy^>bFfW4AbhtOWh9S+bdNf;IEmD8bK$%abWKZFjIP^WySK;@!E+T1g*>^|Ur6%vL> zTo)aFNn96fOGaE5>_Z0pwp`^v`Zgr)r2q7+JR*E!jvbu~CR3(vBbgZm`7X?_S{H)qZH99S%VPE`g(x|3TOs%>A?v;!2 zUP-H7z?sazWpG>r#T^c?fuc2N;8N9!50%0APziO)-$+!{ImWfW_;cA`m{dpjc2I1s zx(4o*DtxT;$Hz)qfC2VO?r?x@J?&5dCvZ36BH#p0yJLWDJ>Dr_i(cWjW?F9QZt_OIb zhd1!Ya^eJdqznFEx*b<{TNH;qNE?~pBL6adMFakkPWU6+Xp;!^#pTg$wN8>ZXb+j& z3O;Q+%HN9!5yY04ED|a}S&eTem^BdKC@h*1hEror`B}A$a8#V(W z1Ca?JG66ah6M)S-P^Uba)M_RQ1UD!=HF1Ia68}z|uy2tG0OO}{hlAs%+=om6mNW%* zN}7*4iI>C8TyaAlX1y@DIq6_P;N~YOcra9g2Z2RXqQVf?E9KEE8eEo+VKa`HBQgP~ zJA=>zI}QgIGX#JvIj9y#TE&85EL011N`eaX#Mb2yEF4BH0Nf-p0ZkE!O_^aZTTmNGDS@GkYMtxyy>S9w5cV73fQ9d)iIyrRf>)xYD z$Ya~OlDv(Ypd3Xjt2)}QO7hp1{$5n=cQ4n+mekTni%^Uw`@(oHucc!FaCbY6Y6aw~$~QcFVqLI?e~!s}u3T~4 zBl_%-jG3e8r|jF_mhB}vbKPcOl;Tr zd*$bK;(xJMdNw>Fy|P``5$Tm41wE)&USc<%Aia`19H3WvR%#%Vv!ZXmI97Tz7@=P2(O^V+BWXvVCg< z(kr>c!IhP9__DGGtGJI0mF+9bkf9Rmluh+kQa5bhUVyCFJX;%(j_$^n=mxwGNgb9y z1ZloSemkNmVcjj%l#8TotxlEOU3bepAVt|FD)k?)ysck(YhA56DKBYb(oZU_{<5xl zMUpFAr#RX(k%>hgDP#WSe$-#o;x=FVSaLxhJgeewl*WrJx*7j!)4(sQEv@JEMu$by zbr#hc1@^j){9n6G>zJ71Tm4?c*92HqCbKxJiYF*+f%% z{mf>|UzQtx+`t2Z9~!Ey^h|5Jr)MgQE~rZW)w-!)jLkzK4R$8s#zQ$B_#$owB>;3M znv(Lxp3di$1hieHtv(z~^0NyWe_64bb3nEu`Ev^y|Bt+qw)*UM zId9`IG$m+tE{q1}Ckg-yL zc85D09IH!!Ht#-UDl}B@qS+`{_5b`1(_fmw1t`(6Lt&O{h;L0qrozuH>-}Yex9{t2 zaV0XGKo8x+IntckE_@?rUGy#A%V|g+|}?IlnT#16HN)57(q?xR5o5#y{&Y) zb6wfC6f9M8VbL+>8{#l!;iBZ;Dceq;;&kpkF~xCP%T6|Ae5GbY&2 z7y53hKTb)K8?xhY>iclm%t8>Mcrcwi99#vX5*ZLKM=4)ithT^F-F*kFfxCwwG67)K zzi7(NX-WdyT$Fb>s04@@h)e*~_(UXCNIRz~iPfehRvULw1jlNN!xt|cCJ4NDjfdN? zhz@(DSu`b#)rK`?Lv;;7)tnpvF7c>11W&vc&x7kOG9WrJ1ENgAG(0K4keB0*%ee4# zAM>G)ygnb1`^=$1{*QWZ^GnDL(%q8Uj&Gk?c&uOjF|Xffe>v>S~>&CGXQcWRk!>IJsf2JSTk|5v5 z7sJj+#0-q78d+Kqt%+*WS2~WgJn8UJRx+v>?-Xt?nwuJxaa36xuHF{lw{ydLFGS4@ z-W~X%|0CX$<$d3Z*vT%Aq3w<@`VG%*c#LGqW-DTCui3iWCMB*7GI`}x8)8f$icsS? zxs*}G2o22gTrF89ovBU;++F!*(eE?z(kA>)_I+6QOG7`a$~yL45=n}YrsKZSRqyW) zVI<HrJ?XzQE*|fyx*);i7Cikm#Q%5 z4s@yYj8u#2{~1piM`(f$UD7A?mQBs?K7G=&9|e8r_l3{db-z--`y1bry=$@$kWxBH z#DCQNt@4~d`r37SbRk*evbtqO3_se_-c?s`4YqI6`P+7CB#czcW*==ot=FNdF`r0= z$x3{_`0B({Qx3_>!X7Wa8L;NnhhLKawtjgut(qc<_}S+w{(gQ_Hc9X-Jv?FGbO_O2c>wN} zq`!#vO49EKdnM^kqP>#zHqoJS0X$S~Q7O}RO{@v=Lo#o-P)ojqeN^%56rCN82~jJ#`VLsRw)r!L*o zOO&`Q-}5g7;{)P7?84cMq)G@ZG%t4Ws~#GafJy04NbniNKsj zaVxah4zgGFj0>tG5YUOTEx2YS;cRpxMZ($W`jSvPa3d9pF9y588z~abMmJLa_(lrq zlwWcyv^_8W*~AwSWt(S(HrgvmI2-JhyYOBai1$i-Yc?J4mFw}Ll553r_&lx9#yREm z>_!(2WH@y7XwuB4P{=@r*^UZ!bOYX&Sm2VK@!$bl(Uh<;A=Z?yM7LdV5`CxL({V$d zIDAMK0I9}*xr#*|R`K`cx^mt#BignK zf8;Z zN|GEC09UyQ(B0!3NC7DH0ssc0DPgxTu%_%-p$(=~i%b9*=p-@$P>mGUDYtPev{^3s zI&BH9(B@sXF_)r5CIITD-gJCxcKVz}0QxpDLHO=JvU68?5|2n&_LhdswB*)@w))mzD*LK(T)%H4fbY#ZL zjbF!BzH}zqxL4zM=&0lC#wQ)50L&3NB>BYM@rX-11Ifyw4)p7BLv%$w#B1;h*q3~za7z(urP!*Wtl`ppExPWv2OXc zeyBYT6MspJ5bQ&=`-4r6!1zldjOcHt5*~lK!vV%$+Wi483jV+L-UJ@%xBDBH%92E+ zNs<(8WJ*P4nX~!_0Hd zFnznf&+oqf|KD%Uyq=z?alg7NU#>pRbw1}h=Y8JS`yi!A=vavc(m*E#piX%Ni#Q0M z8;8iHbejw8px%}jN(bJBK9yEm$xadJ6QlTB)7T%UXc}-&vGhzw9jy%*I{hWO5h!LL2n}tKK$|l zRR#qvIo(V?0JZ{Cf;GfpP1#vY`=#0Jh#kj}5-yu)aKsz|699~f#oZjh zm;v7@``wuUoP-+GDYLtZQ&>6;Bo@8DF^to;&&J$@ptTJyqZ#|sG!`I|=>vApxtw>V z+~AQ$HcP>ZLkVT~oO#bJ`x)67#8P;~Au_U`*M(Y8Cj$cRCJz-pTJqtNjKGv&_l-bJ zS#2|@i!PXPo6T?skAMk)-b>!=GWP91?&iS73{&{@_jhLkaBxddr?ka)vk9TxW^+wg z0n?Co$~U?jWD6hB;d8d1xhkAj!e#}WJE`2w0lbs?=P>~|2{o)!b{6A)VFCbNg5v|a z%4I;n-R}hjE{E?m^8v6Gm=cxvFjq4{O^Gfd`2TY49FCa7t)KvzSfIJ8Koj6M)&$@K z6X3rgR58S=N%K@GJK!ks*UleNR(hA^#~7cmdr^FdB{9%_ZCu*H4c8tEU5haf?YwcWfxGN12Jt5w4$+aw zNFP!Jk!4iL!U4B7;s6#Yz_kR1_bg4vmcIp!oh& zB6n;Ru{?g3DA946;7-)((vQFwAVm<@0;RHm3sZB}xMw2HL%$!!yuZQ_%bK0`F0#27A73{`p6=)FEm^t}fj~Oew z#Mz1<;)LgA3pmOnEjeZr4K|(>m>flnl=q;YE<$SQLLws_ND<`!msiGxwd68J zRQ^(XtkDFJ2DXgn@8y&(8cg(qkBFaz$9_yqV;yAcn)B?HBl22+UO6&D1=1@=6xwzJ zdgaKBIzX@dxjArNIWndL(kq7*`5;5(h!P=Ws04M&9_ztDa$zom5JJmJx_|s;xMEvk z2E^NATgsgZfHsIb6@a%$L=N}dOe49VIS|O#(a3?`h6!2Ivv>;XtZ8kDjo#H&d2i4T zp~c%tiXM6%Je`jL@JllFUK;1n9sf9Jr*-{H|qknxwhIe^_Q+2N7JkVyf2tTcsB3P7C_0c|T#TW@%j zsglkMV@FmKd(TJPKgr;syPul_*K_3qWXXkU0ei08Isz_Kf;uIF z3K+jMo8d5OD!f+;m;lJ8Ao=u9SQXAIK>@7)JLoAdisR84!3UHLzO3g1Bqm@2K#`_! z@S&0qcqOD$`ox9Vvb-tYEZSE+bSnknE-lvY`joo7%6iLq!l?V(mtlHyNf{j6CG045 z7nNsDQaAmO#utC@1H%v&T0EEcsw^J;xQwpasg^%b;*S>h=be)j4!ziPq`}pWvf>x$tT{2QI$h|= zO=`pTUE60HJgYJ~yL|3qIypkAV)LoyMZV1^4hl)kD{Z$yLg;uN96|F}pLMFtCS_!oAJIzQlGxNKM zq8*{rv8`UMjYO%AFqXkd>8pWBUmf4AZw$N|yf5%-$fv-ZgVMLArQi=CK_9lx)Hrjc zXxdn|kn&0EFzXO&DFr)mt%BL#W9=oJEn2lGihalQUbh6*pQ~5sJMQ0YyHDESytG{I z8LOu;W^bj>n)OJ>5-}4BF0>rMA|W{(5|T5||5ErZhdsUEK!i(VdqlhaX!ZQnl)&7@ zuB$pv*Ncz}rxWKK&5o#x#24xlu}ld`gMBiI1(!Cf`N}#^O`PaFJyEu=VAW+0B#=Kc zT4KJXzhy3lEpI64vA_e}(sn(jN)d~BNLVGd z(O_G@rn9QM!A8R+1}_W`7uYNl+j_1#2gw_9#$t`VCsjTyB)95;@dLvLA(F%~3ih%; zUJ}Qqt9dANOu*;Ged;!FThk@U$jj}=E)h#ucWRvN>iex5llGrlo#cCJ69tL4JnMdf z`DJqkY}g7;T4m{FN6LDMqoVC*xf)RAGyd{2c01W%FGZ2nvnlH=%duCYU|2yS%1gvI zH~Uan$@=P4&VXH!tjSsE!n;6e-Z7fs8yqXm|Cn;67)A z*pm^ec;9o{usZ&*ucOHb$-KWlxVD_Rvz` zJ6;ahT%dQQW$^r#lV8Fw3ICJ?=%-BkTPL0!GC6X+yn7J}9c=B*;r#&%nQYBb;G=@A z6AybtvUTEtqp-k~5NQ_YK!Y{q-#YQYnHyW>5I8w#Y20NAn-sBi;(?PvwoW{7z9BFr zSn399%5s}QPgJ9D)8IOe*fm6r!iO}NTblu<|7-zQ;Ijd`V$R!Kj(aG?(#KQYf82Gy*FeMnC4r|IZ40&V{54&bg%bDAO zgJ~qNC(^*iUow1FfPsH^;GsKP_?Q6?S#riC!6pT;pxDnbNnlQipaOj~wTz2k!C};V zfSXFdvjQr-S1Q1#s@%$$qar>dX;79W@ZoKzLmDY5wOHk7i#qii^MujB(H24B|m z0Se@9j(`d9ThUXV)0-<;v0V);yfr=X5o!{8HHN)G0~vY7sF^Eh#=bO-`y2uhYGar4 zUPBG~H?mm@R-C*bG28nR??jsZwrmVyDX@R=XwLJx@Xo4efnTx*en}cU_k#~~5<2`- zRzNS=*PQYT69ACe24C~=A+6>^Il+fAN?=N`{wSy^QPIO5%E(Pw;rgSnZcmu3P}g7rsXO<5C0KwulU=L*>5;R7KSKKVqm;m*pFy6~Ybfx7FWCCz*w7@!LM{xxzc(~1GSL`^36z`Qdy3#^`Z;%R@ z0AP9lpT`8?+_Qpp$}|iM@p69lT;ZBLw(xxfE&~Ga&RQ{e--rOuq7j%9>>>iJDf^nM z(N#)rvl)(=hafr}Y@fGmG^Cctpd6_lP*6GlZ;YA%8Wh*87CO;q>-3La+r zNz)K80eH{^fM)^>O9Fs8r6ZP!Dn~w`Yyu_#R9Vm692lhvj#q+$P5%dlD*9NiHS1*R zAIqrbsrlczarcep_&vwBp1bDDI{D}bHtlI3wy96Z)h1aO$z@Q^;3l`4Be{$TI$v#) z#1dv36`bEZZ-+!>aG61`vXwnj@+g!ew>4)Ys*S(5y|}r5#|kv04&%MpgQIAXjN~U2 zI?fT4h;zDfBk+Z*DPv-~OHb4zxr{n{(MAb5<#&N=eKhB*x+K&}??}=&QtLoM9*>(H zHJF1m0*gQ$Vok919A!fMvio+{F*Ji-K8wS(zi3M_gAI|BSjOfmhiDzNYNyta6&d_zCn_Bj#%E2o+H zpE9Q)Rf~hgw5)#LxG)E*B>Newv*z|SJdTNUVGD%VAvKQ%JMTfpF}*|dpn8S>hB;Gu ztS2$tEKh7#BE2+DrIj?Cv1YR`M3Ll3hX|>Kiqud@SfqtAQ7eD%VCsxaB$47pIZih) z7F((;6L)6)Q>!E`qse!rUXRm3IvEf8^$-Wwb8`o2WP^%x6?oksy7i!b1$wk#Rme21%ia z#n>%oT1M<=K zUqzSX{OM91Bnh@pUdlp@Yu-2KP@^{siNO-b+|&1pMPl4xyuXSs8C^;!Rz%xXmOk)A za{Gt0XH~N$h4PX74=KN^pFRrT+$E8vjg(=C@&xs=`$!o^(d&JV*+helrvm3(-;y@@ zu4H7;7sE#dNV6tHEuf;#FofoBava@J1NDG-&oWRLVh_v#c63{KTOvVAXdgmCp1|*pz?2Zh3FmNxHRV#2 zpfkF-ZmHpkE@#7J1@JzE#9*Pb0zSMuNDLM@{&F`5FjeKo$|D+JsVaP|L<+^6Isz~$ z0Ch?|t`KV&<+{ZaoPNGUXW$LlrZ70vfQR^TC#U@FDnjM_@{@ z!x7e$>|t`q)6ppX!e!46zlQ@$uB zBNUW8;^~0(4jNwtoV>8dR{@`81o*rF&0K=chXkes!{$LviGVgw)Qo{Yc$DCM2>z5H zz{3xGI32m01J@~ojlY~unJ9d$gg?SToifFb)-w zw=y?(k;-}Rjt0cFB?2$WTv1`1MblU?++atG^N!CC@?l9tEP#GW|F|#@>MpBcLIql! z#&eb1-=>TCkV|^R>4&oyZ{(f-K=ajj=I_n%%N6X!vw3HdAZ`Kdk{_E(e`&JAb$M{` zaUG4rg|2!83x*8UbiXLv09gvsv=QW$rkYhI0nV=0bKD4j(FetDIObG_I!J6_#aSCc@a@`WH%L7Y+;P}w*-fZT)I|2p- z7+LpsXFwocP6eZj3XfC&dCg`tq#2=>@Qq>a<^b|?;Jdg#=_!8>0|N1K{LzMU9bJ<> zG=XJ_G?+BOxa8xV-sRD}f4eON%Xk%Zw;WlI74xT@++02J)@x#y^cXQw_!0{m~`12SL z?bd^X)cw>Uf)v$rGrQHSgE$5dcM+7@vgXnoZVum@y};=D#{2b#c=#pR3IkmvlMxvN zdcz0a$*}xbvI6`m3GwhmjpaZTh$5DKxlPpE;v)-=ZTjr!Xuf^#)={^G>hcCyA8`?w zOhdcut2U{QM{Y#VwwKv!f2aE~hD^u5ZY1q&w;S5qYx9WSmEpD0&B)C_BVRK)Z!hIU zu3E>LS_uyeq`ncN_o^kd9^KFH7|m!VznT#^TX}__d`{Gygj>oY2_KbzE=lMEUXqBx z_0hYKf~j^@{*M=TbM~Q;audqVmTfFkwG5V{jNkdnJ1BNDepS~vBqKl+J*pdtM~WW) zcD93R7V)g;H31`z)xQtzpsxAyc#?u@M_5A zz;%~{ZkDvzba3Ql-I7oC##G{wg5Fl08QL?ol`q-Jo7*jRT}74iTHQG|OASeS6i)xt zZPbNCLi&#TciZlhHaIV>n0v3Ora(kIP&q|YxDe@J}iQy(^z!$5;(&mJKLJUog$ zNON-*ZC%|uyH!TLaGY!Kf={G^mq|G@yn~SL2xYWhTv-m%T+t_DnG%u)`(zReFTGat zm2sZxAniQeL1wo7ry*JMjh)BpPt^xnpK!E1{(?Bx--05a zj%j^>WLzfT|0{Op z`^E-K(RS^7Y{{-$ygNDr&mK*!F#PVIwSPmWEVLO+M;neNHgFuhHmrnc2(sZwF%jC) zktiRuEs+=@un)1&I7Z-iM_@{@Fa&E#N?1I4#Z5=tveITrpAt;`MMBEJJ`_K4I0D9B zG*TJ(-9bXi(D9eMIlVSu@fXechE56&fyYWDy$+oefI6i;HlUN%z~pq0pVZn=D@+f?(kUwe6os0jzUAV zpiU`;?{-2351J1Oj8Ws@BRU^)Hg2v8=asNo0jE>O-5fahfe(o#n%DqcI>IN^piY@g zZ*F6Cb~Ui@)98umsHK-d4Xc9a@C07hYc$(XNPInab zoa=Z8H3sY9m*m4!=1{}>8XK%QokzA+d2eR+JCQM+IVARun{!Oy!gF7^n-+kr#e2JO z`r+*7t>U@G-b{yIvI2U^zUITgWE>{ zZ1P~>4|4ea2_O1Kw(tq7z?5KwBv4bLqQ?^zJ=|t995E*z-iHKC05EzWd@26BGXXgC zKv<{jC{95*HTQLN#!f}k=Rx>^0ww?yX_dP%`9 z2P7080cOD?-+Ta91*Qb+kHVU=uQ?u_J6v=Xus;fquKr{|z@f@G_{5SAfUUrkVEs{0 zQ=6Z!O-Tu(qKgRJ!wm4?fzOAi z@TUZP9{4l=g*zR&n*$g#{yZkY@a;rUr?kg15h0Y@YzD-r1xx@aP>j1dfEN+?kXZia zOn~7#v!G7dYcu$R+>pZ{gtyo{Vlx5Iz3y6wYdqmY?3?CQ!e&t}p@uh^_gpO`C$5`Zyjq6g#*!H5o;_}hZ?JE(@bXcs zkM**zVA{(f;fVg-#%_jgA&NxVA&#EK+I{jtQ8$tJ#6=`NkxrbLQP6dcia(UYmWt4M zI7Ut1i;6D%Jggm;CF-%%Lozw&2ysqF5P?dZ&fWyq6G%9MkX&}4tdls}D{)xQLVUq> zv$RRhQxj#JrzcLMKs)7|1*}ej@ zyJa|=y{46qBvNqZty-;Klua~kX7Qy`nDMi{y(< zh|Rm{NFzh%-u(#t42xOSc~+L9_yU`Lx@7xibY>OIMsg-!OHbDa*H6%~oAZMsXc75J zbDXLPl3AILWLBK*XSoJ7D3a;TM>*}|z2fG69l1y&!zo?PL#oxeb*iOAyPYXTf|YBp z$G)yk8H40Zn3j=s5q0*W9Y({-EizWC6ZXt|x5P;GovzUW*TDNkQVZS28VQ&jqPOoh7laM4zQqWnVoR{}tW7sd7!$5bmV=K+e^djy>y4Wp9KB;Gq9b^RmPrR}S+$&Ls z63{DY#l4L~sBQjSCb^&DkAz!Z{)SGOjv?$qrBTy}qjwtbWhH=YIJTYy?da%+EwC+- zkOy>RLrf^>cSm4KurLH`%D!eA3T^Hqo}QUghBT=_LK{MTfI~V$yP%IUgz`a0OYM;( z9PpG7m=f&31vO>0&EON1VZk3fh;_nA0|9*q{*rg}&aV*12)cqoY!2X9iTXCsf+b`K$fb0fR(99u0Y0*hki>iQr1S{(8{XS(xOp;= zqm#n>l5OxyrnK9%(!1)1y9nrcZFp^$(Tb_nIc2nlEOxhy!CpL@cgWusen~z&B@X^6 z3CJ6%B+ucd9?L>+jA4-~&CSuQ>%3JzUHmus;fq`SYRIVGHj=plyU07R_h(6j$QCIAO2 z0Ch?P6?meQjoT=Mg9>0tAYA&(Wk3L?{YX{^xCg~528Rj+rUbh? z3Tn!1S}~19swc7N{f%Lq9{Ulj2a*!y`5NWm<1XU>+RFu;Yn1G6F2Iu6@Jk+P2pepS z-O0J+%6?uKp6|`}GoD}&mm-sMVVJ#mHP2U~y4&HGz~I27?uP8b;@)ME`{C|Khh|4!$;OY(Aor=0Dwvr+|7Ye zssPdiU^$iBM19IQvf$XJ&o!GIZihx~n!DxQ0ILlbVUc-Vrns{8t|W2vqX?wJP*yPW zT2OlNkc}%x*P+Yx*x7sOY}E~mn24B&@-jKf_jR=f#{~TQ@HrmX z)<&XKN7%4L#`t~m*P}#{`a~4c2H9a5_>h?Km>Sl}5#5NDBpyolLiz?>&axh|9`aej zG4^s9dFT4+V|1?fov4@dI@w?^HP~&`6;!X#ciewOB4gBo-P^v+KFr_SjE+Sy0>Th7CBtnL*F_!I$D+qc?10*~T)*)^V=E z+bP02%~aWrGqn;P78FUZ5WTOZvRN1pcZz7A@vugQ$fGlxpPodbDC>|mh`M^g4$GbO zwBo+TA#~mHr3mG*6$z&G=Pa<4E~kL{X;COu9jr zBqJ|(SRnjT}d3g^2XSL~*Vd#&yqo2AwvLMoiz-x69ck)_=+ znlYl>GTN#nsdW|7L{UN7Ad@FIsV6V!qC4PeOw?p?8trO*zX9d*q}ssxKgB&o%9-IE)L`dL8BNfQ#4FQ-{q1arm0KKEmQT5;E4EZJ@*iG_nk>*>iJC0X zUWt_F;k+^cn?digMUJDDS5jGvq+m$*em|!q<@CFt4d*)gLrg5XW(u+4h-(Aw=zOpx zAAAV@-4U1)EDXV#G802^AD*$m3F&=_h;a>a;39$ubVx@{FyNz%J!1hlT9OZepArI7 zf~A45rbNvklv<)@5XaMB*c?WBZXl^8g580W7t{=bKFe_Mc>!t$LFYpPQ-T#dpr&j< zGw4w*frk44A3TU60_{Warvw%L-GM(He{K$3p$8j(IfWi#9s|cpJ{;koPU($i(4&Hf z`#RQyy+l`ic*Gw#l^!1=Iuba5&e`BkGVTcu2tRN)2M&H9z{3xGIBt>hJa9q{>y(|v zWP~@7N5b#boKHv!5d?2S-F;|BM?-UfZHZda&=3|PN9ZQU$AE^ z4B32VBZ3+D*GS)hcSJC})8;$9t8o~n9?Bu5@V;aP{E{i~OWM}ue4;hv3^yiz;Js~m zhhE5;_}5etei%(hR?X!dpl7+#6UpB6VGI~OuRrg}Mu0o`l1%ugWHxje6KGurIISpT zRR*uHGAer54HRw$1BbSu#yND+gTQ{^(?F1tN|Lm;eGMz<-0E@_z*rfDiN()E`B>oS!{cxQq=8AAY$E2so+_ znmYoW1oDAJBQPace-ze~XzmC)cicxj9k4$NkNNYV*Fl9(EJ51{!z@ODDZ%=qpr%An z!9zqc<@OQa>K#7x5%|zQ;X~gDzBM5*B?R@ElUl->vM!8@x;%V1cmzxUD9Sf?a{zm; zpz)V;5#e`d0t_GFpib$AWuhAx+}9ECA_5;GIu}QWgKGJ3l5tOPI8cncIe^z={y-)G z=XMOJQ=*Fq-Uy=R_FUmEBA`hJ(Bw@rd~t$>2Ud|(1aO-}U`nuy2%x4+Z3x4$GPAr{ zv{Y&sn+Z_sg*^%ZQ}?5lnT-u~oC|C0Ha73bcYhZAlIieEx{xr4OOeUBqR4JzyYNg+ z@1}cU5lg|HbFYqV)oPxpQ;0zi&i$alFUg0eBtvsQ>cW&z(IW+qwh5R3P(=@Sa{!B; zKaUA8T=alCCAxj>_V=}Oz@kUM1c17IEnotG-M$8ON>ucuBb=JsDC{tHVkPiSITUCD zKq^&mHwQ$i;y*J1zOi1^x=78cJ~I0Yxmk8fTivQR^zwDW>K5CpFDB32v1faC%t7@z zB|hqFqMM$QaSQMpDnAB@v@BV;@59O6dI9vtjw;gC`!**OySv0<4)z7s%X=ZU3bn?^ z%9%4V3$!ST^q|wy&IXenYpz#SOQ@AjH}gMbP7%j9MKt$VchDPBh_si<$1X~lvA~cC;X7UPn7K|P%duEqR>dT_SD!Nqtuk5Uyki-sHvHnC6YBcYeH3_2xXL45owld zL5-}369vgtJn(4=u0K&fuFlT89y8w{NqqDBXLBzm2Ra+RGw4;evY*otWO%y5GnML1 zF38n+C~U5;9xKs7diZduhor{>55?pVB!<#)%6knZ@Zp@+mqZEI;9cD%l38Q3hj?XhQqUK}M+KWG5+Re~KQ{LUP=}^6x}J}-93bw|&}0Piyk?sN znHF%?-+S-aWIxLl7>c)(lS}K=R;$((mQo6KqLhiWb3}0`)3R853}rm2`K*G6gom2z z$%aF=Nn#1JjgG5b-U&9qS;y3%x)^^m`*!z(#5iXJKc6zSI6z$ez>lDnsrl;&3yvuHJ$7yZ1 zvIS-LiIQHW{s}V!uS$=7aAwQX^+{Sr3$`gG%6S#oEW6RKi(&ZFT{=jM)$BeLzRAkV z)zR5Gt9nND%mznX?6gv6njnp~@97hVadwfBR}#?Kxlak`>M zhIjTbcxRssABABZa|woq5(MuNH&XSCteJBSB#qI5kL=v11WaRSe2DCP$k_|wojnBJ z*(bm|yCQrPhIP#S8jUo11C1LqKhAt;x(p;|r^83~pHB%_pi=pevzNjPE#!i-r2{&JG&gbv#Y^7y9K;Gl`Y zGC%jQ^h8=x2)#?>3k)oofuttsfH&P%Pgg%Re~NAki8ihBdDnjZ;G6FAQBF;0sBg;A zPq$hVTj$pYdN;@?uO-gf{Hb>CmHSB@>)vhCQnhkk(|M=xJoAVjvpbx{?99Ynpbmb0 z(N^zGX7#!g`a99@AHCyq8B8*vr%;MKG(;Y14rg@_Ws(QV?<=vqdfGm@za;!<$RzhS z;aFcg$%BQNtQILMfl-PJ(C?Qb_xG~;H!|7@10fZ(!6pVZfIfuQt*Cf7Fz{L_mtn|= z8DQZ287;QVb{y+t&k$NmoAsl-uNcexfML-IgP%!COlsm(W;`x{p@e1quwV^_6UqmB zaLnFxC03Yz6YJy26s-OO03uC!CXeBCbp*A;Y93L_uq&wL-B`{^W^byq3duRC=x zG10I8t`Z*KeTb15KGYna>t?DiwRf=L{FQ)R0S&bB3i5)1{!HrCK?~eK_0Y5I+- zv@>%YPNcb&Ab`dYSC=TipH z)&wv=?k9JgCw!nixAkYXl7FO`GLMiKmtvGkv5b0Kx{jxB_o0Er8oyrjSzJzkzawFG z_ZPHA!1Nbnyyn|@S_&i97vJ68=ZK@CFYiIm^0{1p_}`Rhx-_(+pZ(QUSbb&#Au6hm z{m*-`|8g(nyC>lT+dAt)v5Z~M?y*{^m&weJA?|L}!LH1B7ORcb8D8-fhijt+FiMq} zO&IifZ|cy11)1@Y&gx8Qe@I|;Rdmu=UvDc-h$o0q2kSDWl5<&15{=#;LL)P1g#IR5 zWw-(K>A6UKR zeV4Gf0A@HQMG2RSi6>ZpZX0?Qk2`&dge!O&FlO^$zhVDiyn8?iF7Vrjt_q`XN(KX$ z(693NZfekv52oZiN8GU=r4_cUZLfP^pYa{c*~8 zp(2iMq+TZ|LKAwwZztvV^OU5sZa}{)3sO{BLIB7)XH|K;k*q`G-k4?S`%snd>-{h0kPy>()aK8Z8E^x?^}FZ!66 zE=H64${h%oC)lGFI{ z7dI5DH|pR2oUFLNH^aX6boPABX|5sJNx>(-<=SXe6&qL9)Tdni8Xq3!INkBgSV_c;IlhNATg-?N zIwPVJH|F?3oa~r4Lk6xV50hoayvb1!yTLd+Bce-g)r^;YRJ$nn%$gg@yTyEstTcl!thq67_bFeaTFsJc>vor1Ui|sF zrAOD&b|=!QTHCNsq6#*nuY6RFT6yF4nBzvJV~($!Gv>H%g_!W6IP?J7GsFUY*GV7j zQ&_dKM(xC3sin&26H{-jpEnh6Fs1ySQf6g%q05Z!YcnGH=dGI2y$JmhN52-ISlQe* z=6Dg-K;>i}R$SPZFiWi8&sf@8>74k<_R)8?1h*H8+iThk-MAkhV>3FG{k5jz!lB`Y zMXQ=+(KkDxPgI~!*h-HPCaZ|G`Wr{Q&scMr`%52tpf*}dGJdS`zyGJjgpb<>i)lz% z?3twgbdmkRU2{}Ft;u%Xu`@$GTf{j^c8s&fdg-L6muHxr7hgr3JtqIEH2RdWbj3-J z17;f8B1$_Aii}>3-d(cty==+*Cxuh|-tXN|z%r#Wyr|x zn~0_w1?#0nyf5x9u~VILUAOsiQfxwKnPdM2L*-AW76ol_6ka_$&+EDTremw}C&aH> zA9_Z&CFbkvSMM8_I7xSHDxIYHY)tE-w}GZ}MCi%OgAO(%M!Ydz9d~$xkJQq~mtM>Z zJZq%vc*(Ifz_oyMJYUjnlkx|1_tsnX1!Ld6zomUU!hHD-C&?Y@2WMT|I@i1;I{ih& zSW)fL)Z@OH2*Yz|{ z*S#IF#Y9cfZJllN%i%x2a9LO06rhLJH~DO0Vl~0L8!cnC-qz}k$K&*hc{eJz{CE=; zZF15|bM3vG-*2ie2*ES28CWg2iCwUNxvqE_T3jX-BZR`{m^OEP|GN3lWPv^W=5+N$#kw&ooFKC5Ne^mt|%(dvRTeVCRIf_+NU^b zoBFy?Rhv{5Ig>4Yqb@nDn;(6nNG8QH>a^;-)FQR$8xHH%t9PGP{rqyrl)wL8n;&Bt zC1djFWIX5F{YRETzi&`~dP;TpcZ$=s)2df2qb8dC_&2{l@=S7VD>`TS#zOsRQIz_l zqSdwCe_2KaMN`(Ms>qt8y^>Lw7riXCi1Ue}P}Ot(&+l6{7s+6(9A*{E%!z*d&o9t; zROB48XOsG&1XZmq>W6f0Un`Qi&i;-y>WfaRqR%5s_`L{Ijk9!^WRh*!T%)b{sK+d| zNY>=h;$_%qABWJ*>fH{ZbE2md%W(ecwW+OG#+3cdHtO9)GWRT-z0XC5s@Cp^!rpP0I@B=7#L^HDE<$nT!&kDYc`txx5&dYw4yz{+&Z9oJR+SGVQW7Qe=2 zbUxYq`t{wq4YQd(%8yFd%#U9CUC&tj8reIZ_&#*(=8F#7Q;&{f8zE>^uiPV)I?NyS zpNt?ooLn5<=Xk&o%lUs!;`PF!&aHli^w0_B=;oaK>YRC`&1o^)m8`aZ$@sE3wfkm1 zMObS;Gj|I9fS*a?-dT>e!YzwK7B9|=D8EORA1f6Yw#3P0pRJ{|^yF6iXU$6odp%jc zqmD;h4!ZpDOmdU##IMdhpJh_^7-$M#(2-Tk4i3FgJWhGy+{KeIzN;?(nEXMvaLY#D zGY03BzbkrNe3&F>}8UA%qirAF1i#bs@w{FXX=?ixmny_ZnS|^IE{2-lKO`d8ox&Ys% zs(-s#q4}ua)MF=C8ZWZ0^PJ3Vyq7AHG<8Cjdx~Clua3`2s-kmNR*luJfXrh2=E6- z&ft}6wQJ;==X-L5KQ-U&e0t1p{@TFNL8OoKZmH_oOw@IgD!Q!Ld+OnZoVW8AEYciZ zY46mKL~fsT=lZ!V>!rShMx_{-$SmJjn4|e6)XO=_TE*ECTb*A#t$oq^tijl4tr71H z7VK`9bJ)DKRCrRBS%~;1kM*F}RJJDhs@BDB6Aoh-5S zSjswEY=LF6T7lxkMc%e^3Nl{abXcC~V2`^kEWdrT=-BsZF8ww)#ZC!rm5DxbchIy_ z4}bG^RE=bvytw=4*!yo3Czg1%pI(?@f5PyMc6?S<`3Ijnv76<4it+EJO43B0Jz4xU z>E*R{wW~rHmnnDJH%LA-=oX)Bcx-?2^f||qWruLuCiy}2_L18b4&6D8Gf{0icI!%Q z`(F9EF6lKd>wi3Mj;<;#pY{cF#b}~>wI4TsNpu0p zhj8uzBW)|~&9!|qdYt$Ug_Aj*Ex9Iqd@pF3Je=>CNN^rB4~e$hPl*?Tzd z*?QPxznhaMJA*%KvCDhv^6^7s8A^UWl*}bc8=v64&VQE{o98sJV&$8z>sMYsf80yi zT4#97maMgBU3qUrZvNWnn`)oe=Q1D9SKS$vYH%;6YJl``@~n%Wwj~YT>Rm>Q9jtMv zI&{(Fj$Ff|sy#cE+zF(NszrotH8JK**1grA?`#}5Kg<8N+7_Fr{aZcSSXT$%nFsqg zOU$%*_BQO{L#f-Un7hR?yVShjKIuRB+96$r>hdMqFUyDeBqyV}ueQPK@Qwk}MUwuJ z%<9`sEt_7+Moq%b>&wZ^VVY?+m4q5?v(5^jn=NZ`R23&@-gJ?9QASFZk*YHCz!>Pi zn^GC768T6r^5x+JG6%h8Ob(7YvPP|aL+rBn5ald`+mfdjM}5zzI+k)ovWYA=Xam|VJ1eOpCdc%LBO;=+T(5&gBJCNW0nV8lv?}Y@+ak+C)83L)ijj@ zeWFgZe$vCuEy5mc-f{ywHDe%=k>=4}ky0|@!>U%7SaYGBnu_VB>i$YTH$Ds`^oPG_ zx>SD8q;KKwoP3NHChmx_WT1ydxx0E?MbE>^^G;t2D|E{PW!ySL8&2JrJ8PHrtNBg| zY6++FJ`2gZ2qm^ZRUo2W!uGRrNQr^7peMy^?nw*x`6w{p+kJ&$Tt$&($WU z=n_`G?5f<`x#rqhON-V$yKM$dUd8OXt~ao(Uq5ckSMR-M zPa@rA7gSGNQu<)VTd{p9eNU;2D%>TC6H7foOLd5cO!eS_=%WcN?viuJAw zWp;;tUe0KcN+;J$ih88rrM^DA?u=8~;h+C<`Q=4NaHB0=JHfDw2SH)VT z@Ttv|E&C+R4s_=Q#2>!(zV5Xpbzh_6@rOf6xC_{2fp0IRX#_Qs)MZ`NG^!PBHx21e zDjJ%xLGd7Q-1g--P0?FsDFGAe)4&3FH(bE>&8m6`huIv*G|%!IH%K>Bx|Tf zdFi|Tb;=Z0!BK}$6Q|EgMz6Psm&j?a#<8Nhmye3lsk0e8EWapD!6x6eK1NaGA+i7J zioeE}e3O(ZZG3aeT;s9N^ikf*-<(E;iA+1Yy*km^?buM(+60v`(oCccaD^~T&Wt+@wP_dKv<+`cnu z+~v(ir?=i%IErj8G++^SUwNs9r`a=A(J|}yosg+c*<$!G`jh$o*G~+0#xx1t#rqI6 zY4oGSpc{6nr&sN0nniq5v1k5*gPvECcQvh>m8)qHGhR1N>(f-`_`AE#N$#85WHwpk zc;?!==+R%bj@R!Dd@3_TvuD!&qG#A8q=S#_ujF~(l-t)qnlwR9(#ZMJ!F#(5cC3iY z98!=eI5_R`tAxc&*?^vQyDjg(eLh(BSg!R@=+5g(eaj6V7IZN~ahvWR$z*XdwH@p7 zJXm9egyv%Y(*Ytma)2E6b#>&N9F^vE9(BVxS|R=ncE7BXievq`%FiYYX{TE$mIhj~ z8dLM`TuY$|M`Kgp&fR1)|HWD&>6+fO{KVFbNMSwA-C5@Irhor2WzqIeQTL2b)0_s1 zm#(hbynRc8oJsf99ey$X>yvj%cxCQ+uDsGrtJtLNi-Lh`>Yk|DxCd8+O>dsPG2zMH zRjvo7EV!?vGFHBiVSDO^bnO)nn?Mm0~)|~xlUu5f| z=i)1(u7+&)A4Obx#P8);@AkZLPU~)7e38da3)iT(6&_>BFKlugbxtDn z;zyY^hSA4@&&gjj6g^P;@Q7sAq~sVe*=C#2$$qJasgk?Al^oLF-)u|m&q%3$M01x~ zOnADgZy`12K$Pu=maR1z=g!v@NNkIB*;=6CdPK3g%BXgAw3zwwNm|qW6wSX~EUKs~ zJG@MB;~M2FQZHp%K6L2LHgXDmd!$WSx?Oz5ZO67ni*%PX7imdGB-k0$`(CD2num>A zxm51-BHXh{hG)OsP2Xr49dpa-sda{;RkefO@!lIMVGCbhXs7gS=zCk-iuX-Q}EspiX{4h&Y#17`3`C|XQ^wrUltMB_f_uq9oEUNRQ zP_ZF@=jVXR$am5Dc1*mc$$@@Zie8=Y_~-Ahi|3a3e5WpI+$mG&y|{~Lq<^NudhLoqN(*__E_x#YsJH zZh!BY*%r5uc{M=)P(jDEIi{C87a0hL&}Em?lklsHaI5B~G0s0{3bS*gw>3v_e<5`9 z+_?Yb+ET-=%?5%U+}&L`z-E+*+sTEKj4fX2&8Uzyys%At+@3AlpWV3o&TG`UAu;p8 zRT+j)yBIT$eY^74xihJ>?nwVk(&~FjB5gO9%CGylC^YY&+KuIVTiY1^8M7m$o{QZ| zK7PhJ@BA)i+E9AeVPfAT`^Nq=7nHZnyBT-suPgC&P4zdq3@bGy!n4BM|R&?B9RHy$uHQcMiJ%MkdblMM0{8;}bE>Pr} zL1BWd6;*t{e(~DH-YYB?8=3Dr6tO?d;E0s`C<2-@713 zckYZx`>D5WJFQMM94O7nb3R{oQwCRWqb}~h_RGcL$1kC7?M*eEq4In~j@#NaBkzb{s6$&neCH8xl@>n)=B?|anfH$KOw@bU`U zq)9s_2=D6L*k&~r%joRYJ7rWW-+&Jpw|WEd&Vwpbic9mAJ*0>+A&+n5$pnec+j`*8 zt9d=66sb$}CtS5GF&EjTbT};Sd5@0#ZF#d;$J4Q!rM+(nr7DePs@7?5v}n1WVk>(1 zaDstM#Z1vJl$rDTqt`qvTQzGVHVOzbsZv!r5@Z~oTPcl1O( zAF4bjg@^2!_!-l>$3NlQBGTnLLhw9-U26?JMV}L>ao^@X{D$nZ`afDu0)54>*+%e# zRTEAulpgyE;Rk#Bwj8uSlR#WF+f{Pj_D0wpuVJZLVFh(2?|c*kw;IyBXjf=gBynJf^?eyHz)7 zx|6)7$G*3>X5q>&uXcZY-uZ&afJOzqo~&Tze>wTJu-|nFyUs6Pm13T_nfc5-692kH zNzOJ@#l(H#ILp~g6r;&12I3-La9F8?$2CZm!&4Y+icd@a@Vsh5AqSKHVy}qxPu7 zN!@+(&YH@Ogv7&#@$;lN-<7l3-R?iH8=HQ literal 525656 zcmeEvdt8j^`@h55aV+GtiVz!;)+tLg+d8GzM(YqQQw~d%R%{L(2HD6dMcHK;huURD zgXC-^HgbrZBAFa2REpBU)XeXCo~Pxz`;~dF`}LiEvorVi58r)#UQcsB&vjq-eP8$c zdcUu0v}4^*TGXmvzkaP%-`AN?>wo-TQ~2*io>tSmy}V}3T`<2_&qZFIM_lrKjQh0+ zsPoWnnsU=;>2m}Pzp+o9x3NVXk4fPzetEv2%|ySut?os{hu<+BG&slMRxLw7+}rghqM&mDk%DMs~cla$@%F@b1r(;y({s`14N@jTbFgbEVbK;}`re zF46UH(50ujSH^U!d#%KAvcm3Ae5j?!Cj7Xl`OklT^LzKbS2Lg5Tf2K~E3o~|WQJI= zbi)49&G%O-1Yr-SJWZTK2`BHFa{&GVHRJEny1sju+qC13rQg z%j1eCPBgln>DIk=8^=cpqrd94^=v0k@5hH$yy$1#ezk+e%n`>AU-T(FT|405gwb|> z@(mY%a&<4+)gc?+Jt`egLQ{RO#qLTxgZNbm6^ z_xDe}n`2g|Vw}Clg5J({0>iPgb5_UgW7aR6Iib%dOM5h`_aaAT;at1;l3kj!RgA~j zk=D%vy!+;1L_dGg|D>~>LwZ9+=_o6k?4IjAh|cJZ~(A2;S)Y1M1pFVl?b zj~+02{++km-}uN58`%Ceaf08Yh;OdF2^pQ)c0$)*W{-}O4xQ$a^39kHiOnWOW{t14 zr%C79S#26Ua25UFba3c|v<|H&#%1q1vdhjQa(b(^pO}wYz1zEKtna72`ZNfv^G#UO zxwF=tx_9-?^K!wSv8k&D)Lt`S*!@R~=D5za@Yx}JRgyh!X!e37g>!pM?c<%h>S3E5 zezV**bpB;!`wKt6jcX8cZS8B&JEoKhrJXv`zFLpW-Li(vCC>oRc~Fy2JOvI`-*L^TS)UY|!tU zN8K*1vij>>-1l<_pNlR2JvLET@aV^NixZY_Xtt(%dbz2adB@g`Ml@<4&~D4Ut=3<9 z`Tsbo)0ekKE^=Mb@8sN7ljL)JZgd?x^778o;(m(<*0!HJ+qrG;RueDn&2zZ>L(s_A zk2X9UQoLkl+JsU41U=@>Zo4fy;>STldX80X(-0XVWp<}%> zPv6@uU(|nB@Sgos7r7l-6uLCL^Ru8~SN7*u%=xTV?xe4c8?9nhjp! z-dr?#+)A%>qh??1X>fDk*wHP%|08E}<849XU%WYRC04OymBsL8c6F02Iuy1YG40i% zS9WcT2fn(}rp{n#$j(J_m+PHN3ZFag=`vT)Fzd~F&h+bGp~|lMFl2XyUEC6OBt}9T?tx!WY|ZB@5*px1PR`<9)j4qzC&} zmQ2+* z)vLDr*lkt=r?{2gM`Nu&A0^slb-#K0O|#c@e!j1+m%VCu{MctlPUp4VRqVBJV_duZ zy`zUdPwG1;!Q+HO+jE}`YWe5B9Bbu)c7;aOIcfvM-Oz53k-X zZ{O!)BWL^Qv@iOVZm>SnVa@uM0eLaEC!gu?M?`7doGwNU=k`DJ%rGkYx8I(QS!UOI zY?r8hTkpDLY-n|B=<{|RW?7o2kDA)WyMLnpzHcq-#q@lX((87tq~RZJmOCULczMsN zNz>iqw)Fg6)%020{Rj3=Yg`t&XGnvs^(3254%n39ZT9ocA!E%8x*of2^Xzs=?(!zz z#r0{|y>TVEoU~lk|nZHd4zkFatZ0Xx!Z|tt71XLE+`evR{!&S$6ML5szJg|{! zq~oVKlQLpUZ!+=QMldbVeYi@nLqS6GkcNmMNyw=uf82CxaW1F&W`9a z#iA3nE|>RoUHYK&wrSrKkGV7_pmX}1bAAK&55Ds3w$bC27+vpm_pTQo)SVtVe8aaLCbYWvyx|C+=R=wg3;(vWl~;Jzu9qSVN1BWr81{X7 z=Xs;UH`{hTY@ZtPG-6cmMh-stLwbjH&WQSI_Ub-knS*QL4r#EUyzBNJ z-P@0djDKRctV?KU)}>up^QL>uY2V^bQ3ul-8;9L^axv97|*{GlKH^l0gkk;a6TIxUVyOJ;rwNSljhIymEpP2bw-L3wYf% zz+~e6JA#!*Y%h*bJRPI>Qn}*n9osKsO6+VOnuk7wU(FBr(WM|L;FMGQ)6B0bGNlg% zibaw^OPF6RO;{$DKY0@H`Wf>(4+SgV*p|(BX#Sb;naU>2YF^&yeEH9HYt{PI@?)#H z&A(Q2)v{*ezHQeh&pr1=V?m)&p24_>9+TP_4QVmu`nO*gWOkWr92S~vu=_#a4F_uv zzuN7+E(^;GuFhQ$Up92Ak-yoCL(S_gX&LuwvYA1F_u+`HUoOAv7L+vn`wbW7D&jut zw?F07AD#03ru=cJS-{%FNe<%&56tY{_}R_4CQm#39zJkygKHyw$6wp`V%Y1i>TmHo ze@ycE;};2ax72-7q#Sj3MSQ=8rFPp)-hSC}MXRZA>y`eH8M9Y#V9emr6}A5oFYmLu z&PwaZ?#FVw-LwC?a!`XWm2KZ-Ty#E@d|PxeqeW8fc20>sjt^OKapl3!r<~b1WB9_C z%Z|>f+iuzAi^sk!dy;Xm`z7lmT`fEhPI)N3(HveA-EJ z?pcj#>ax7$r`EM*Kl{V`oAre%QDeJ1{ipgovI#SuIWy|BqZj5?J{K#KCWw?T<+iGl zlU8TS-=;_&R4PLy6)%fog^Fy^nXQ;w&1H(03MZLzvy-eMJ2ypDaY-Dg z%rI9KnW|!im5TmyrKCXlrYJ?G$}kjV<`yU`F3AE_l_J$6Lvh*5!{W+{eNHk(WqM4jQPEQQC|z~! zZdtaKxcu?q6jk}w6lKZn9FbU6)VjQ+$VynLTv;Zs%xx{Md|5GDR4EX>+-GI0DA`(Y zru=fLOqI7aHn7}5*tsmvP@+njDN(g})~|l??U|}=Lt%(~Re8Edm1HP-9V?6~6N&uG zFO;gvzdIn3U6ECmZ*kvhq@)_;sS`1Cd+BW3ei?RCvx*`N~OL_U0#H z<(<#&Zj zr942Hl_RMvTUoSub45iLnDw4^*$i6(Z5=3WY-Twu_S9%3Rep7Ptn5_wo63GxGI3d~sHo)foQDrZMTN#UUMd$wmM7(U7blu-P`w@}Q#MQh+a`uycJ;U^0VB5ak}1q&jVlrGx)tiN*Gwebbp4|tb(pL&+}=H=$_T z-t}H5e|!2`L6Kr*uIx^R_o){Z)8@gWxsP&WnPO#n?jN$2s`8r!!pbCJfa0o5^)lU5 zq)2RC@v60|)KHXlQgY^wq4;?~X^=7nxQB%>|%NK-;=e3^FStxoS>iIHpjkx4- z$5Y1^ziKljYRaIWTmRZR<(#A z`)c>~?jaiw^z!VL*UQAvv~OwIocW>i=J)E%{PSR{{j`fyFHY+^wd=G!kKKOqzj6Nh zU)L{OPx|8g7k_lMXyHYwE0N&!#?`)@Ev(X}?VUWtz+5s5y;Y8~Zg*x+%CiSatuw{0HARzQp{4 z_}KEG>?wg>FT2d`8T^#_$F;FXWSGj$HwpjB=y=J>$HVY= z$8O;r2RL`=;v6Q;{@rd;)Q~09zZyRM>mR0fEL!b(alOfe1~#X!OkKF3t>f!8-`lLq z3XZZ5ermsLll`!BTeg1c5oYi_toCPN4So&#`HID%jy68ucgZUbSbcnr%3LMvc&S}_ zBcCD8orm~DedQ3<$^Gi6pg8-L#TS>Zy}07a#jmql-rLY_z)Ran(_cO`|JBC&v(Cq- zMcB=?Up?J^eGB`Lv7KX%du(X+d_()sHZ=Qn!)FsOp6Xh|tr)Z47luM?&Z@qKzsG3&x{Kgqn8Y4bKb zUEf8Z_L~=)=G!bRsGHKRkzx3QgReUD?>ww`=MfE~hIVg$=RsflH4E%R8(&=Y&Be7n zrcViLaxd)3%iUQyF9Y5lpQf-2x4C2bRGpC?1jIGSI34=+!kDk^eUf^vc(9?xr41(C zHZ)o->p$&_NSx+Ca{$%K#T_;PAKU;sg{>YauYd08&cls>c zte$hHmJR02Z5uUgVAP0Drw{#n`tVl0V=o5hU7S~XWBmfv8MBPTW*sjLwrQ?@5`_1| zUdk6n`T2J4e0=7JuhmXMmT@EK}nUlHmXr6_Ip9NvB;^BHPqUv*=Bap4)W!BUw0x;$pTJxoIT zhYOO(_ zacbb$D=DkX-Fpcwvy(1VochJIO_9;G!0A^~)|T(=CG3}-^jF1$UrbGkHcks%kO!82 z6fj~5yka=Kt6EDB@{cnce5$}6UeW$FysKJEuLMi41WPXiOScEtR%hu~g<5H8e|cDY z#@)ksxO*tLdnmZO8MynPLpe_n1tyt2_yJSLLf}SnF9MzW)d#)n1m#lgrv(u zR{1v!3+?!Nz);&&7tNcMckLt@_B3&of7`H7v)7A<+HSaL-n`ttlVs%6AtC?r2ZIr=NgN!z*@%cU8NwEUEyX);>$0 zF0glEEPbAbrT+j+{{ikE0`9(@kGmIxyBEX8au7BaBOV*ec9?|iu(6mklQ5OXB;15a zxCxU0Z{Ha{L;WPYg-JLuDEofS_lg~JBn$F)9|*W}#PDQ^$6ec(_j4vI&d!l6$~TJ* z$Ub6tx@7NN+mib^QxutVB>wrkV*^T#7|KeX-?de~1)qKnJ`JxJ4)3adV+jDC);>#v zyU%1S{R0n67lEaVz|vR1(kXl_tprO4%EPuZ8_TaeHkK6FSW;kP>BDR+e9qBwn1phe z1bF*!_zd-v0O#mnI7i{_?O(%ZsNLOjz}<5$tIYcSw{4UKHgX3WwdP@?Q*Z*Fh7-_= zvC%mmHrfm}+6-I5&#)y-;j<;YhArXs8MD(&tkHC~E@EK|YzASK5jZeZ|n1l#s z5_klBuinBWyoE`C^ZSwopGkmle+ujt6PQVu!DA9~VG?p-5|UvOV);x$B}_s9Oail8 zz-OqPgjkq_SeOKO`|wkI!jLyG32$H}z}ttzXQyLzQ_wDad#&K)D1XWY8KZ}{x!Z(l^)wT&LR zCHg|~zPOPm7ktvzk1d-!{De!_si)ZX12}ZgAM!dv^Xfvm?&tZ&Ev~OYM9$ zb?V!3_oF5cth4%l;IX)?J-c)-0=OUXGe{H5jCZ4)R-+%6DNHm zbJ!Z^IO3}@=_#AzCmxS_8nweKxM#PB-rY7g+`Fm!?mJWZIa~bXY}F*S>!{QomcNUl zN8OJ$+p#BqvtxRm$l1sFy0y_Sn;d@K#e`CX7~JDt=Z!P7T!yJ`5<-2)2KP=*ZIuq zq3Dd`(RPe!=6Z})Z<@`P`PVF)Fw^Sm7^Hq$&v<$)gx>|*#JjfTVVfC_C+9l`G4q;{ zxRd3UJ2pLmCH+j`2&@HvIjv z6zP`>aej#~eSGDQ_fp&A7VY3;IO8PX7Of%9IDS9kj1z?OOU^dD{jwwz=a&MUUm{HJ zo*oK|_6Baz?nW91w`fbA;fyl^X`B-{zhrI0f6;~_{c-`$FA=7XuUv31bvts=B2U^& zxJB!PG>#9>I2&<($=QbgqJ4_@^E^<^fZT^u$Uh1T=u1~ z)dyknbMdCIXjy26|Dx3#cET=N3R_jbXc4CORJ=MAJ(vv`c`sT&&0#0ZqHT{`v=p}b zaBk}yQrN1RlU4+a zmW5{cFIvrEC+wo7uvPVo7GZi%#hXLXr;#VE=CBiH(M~}wS_)fLvuNe8Xjy26|Dx3# zcET=N3R_jbXc4BLrFaxt;Ceq)w*G!(_{N@Ij{SK+KPPd}PbCied4z+07U7_u6Da6M zC_*7_A|P8K5Vu$y;&v2c_Oz0WzZpdbyoT_Z)&FzK&rQ{c;B8MD8W`KvIvuXEcI>gX zWb!Wi3{|J#x(QKJ?ksw?V`;L(z-YI(j;o!+UoM~GHPiL}O4qhy2ajbqO}Cvnx}4js z8?ivI8#amIoDHFmtG7&YyzsDP{!Pm!f3{Cf4_1yma*Lw|w)v@e4p0fh#xu0W4c~VA zMH#+pQ`E^F6VmTRmOPLAbev&JhV4Zk*G|hE%8&JQQ~-0~&y}y^cZ!`Yt2mj%+f_0g z&M1~o8ueYn-(^uzQP% zV-*K^%m^7np7mgeyavxVEq`v+&0*w;MoW%t^YW0xe7+fd1Bj*caqYBB_jKi@_&C#} zefKQs>TUeioY!dJ z-LG8WkWjq2MRezkdZ+JSi;olG7Pk!O0WWs$0_O6b$ST_X?)8BTO+S^D45W6ecT?oN zDSSce;@Pm%1maGFO7^^2&2Z8uRY?Zc4t(1WBnI}Z+`;~j7T<_Rj&Vqxe0^U&98X!e zFyb;3q;zKp^|SYKa)&QoJi80>h)(+%%|OR(&R_h-o(C76^aCM|i2g z^4zxi(7M=(*F+(AVHvx}^PeaP#Slk#CD`!KmHa0PB5X{&$2c!yqK@Jw%9~kG{8tEn z!^1Yb(aS^3E)m|REB83>iBbYf4l_|eW5Z0;6Wl~4;U)^XQ?dsd|A`Xfwle;P9~)oU zKRs0mVB_r}i_@kNk7xq4;PX_neXucYrL!zy`qTQ6FfDe_%iwX2k-3N$stuWCHHTXQF=G z3H9TuWCo35d=iLS>W^djMCJ?Op1@c~?X{xPd=7A^m`xtWP=6Y$5LSdcj#+xDEp8V! z#knMXyt>Px#w-Je>y`L8CtNW62W}suk5_lc(U@hD<7I~|^V!IpKYWOc`|0D=;jkLB z%%S`OxSz4N1pe?L?hX<_AFmFF)s$u6Xf=mRJ?>}~;*M7Ocy&js#w-IzYlN2v2kr2_ zw{nm3zPC~&sOBL!xVJJG9J?FvzPECZ^S`%JB&fResxb%-wqd9E=t>sa;eEPtkMoD@ zC=yg1sI4&wZuGqpIYdn?w3FpEM8)IQ{rBVibLkWbsxE!4IS6i7zC=|ac2vkKXS)JT z;(jC_nuIA1Q2F%;;86_74sertQiTZjte_&$I>Ufmr>QcgLZRR~IvB%rbDtNsf_z*JnY`&O3e2C0O)5oiW4>e|)L-`UoT9FqV+=)<0AFt+U z)tF`AXq^D}Rvf8RPdGvUWil4rTN$*U-3|EPTalZ`f0Pr%GH5l11hKSh&5^MV7g0Q)6da&}BM}wge*6;Z&5@Xw4GNZ0O-E6&AGGVrt=4|$kK0Z(@E%Sb#4q=n+8-T973p%%q@sm}x9N|=xHzlcEGE%?e zLU(3+8Oo9<=;H?3Xqor>^tfFN=cxsgZ0~x+dFHK$v0RHCt_DD2@gECD9xZOc-uIa8 zrTZ902}>W3)=J9&<*7=s9Koh})a}_U?8XSf_-*m@@#+pg%~}Q&lW+xMwp< zM=O1t?auXq7)4{2d5=ROrj>!My09wV<)AZa5k3CJ+WU%rTqiP4Cj5(XQ_ts-+qoJq z3=V}@+%m}IN3fd1hKyWm)1(vU@V#lRCloCu6IZQL$~ zG~3l4NIGL?M_=1>T2$2mj?-s9cX}Q^_j$MXI20m`V3=beEXA(_DAR^PTeRIJfmLnP zIDPi-!f3}6(SLANSQsi8VuA2C{OWj_sz_y-FD~8ZwbxgTFTZw8+WIx_W9 zlbj_P!BhdUNBvY)>CND4fgYtk(iR?KL~k&$AZAm4)GPY1P!ZoBm*IY#!=d>8xES~2 z-mD}LmJ`VE)J@U*as&=64yEpSw!{*{xIipF5pMZ0By_~`V@T+j<;P?y5zCKJ(;$`~ zBYHwCKZZkr*!TDw{(U(DM9d^dP84pRWJu_kiDF3Th>2oSkBEt4Qjdst>;t?x~$$()dilKBMCW^^`AtnkLsIc)Q|44!h}Ufmr> zW0skbE`l@<8yfJ350QZfeVlFm`~e(RQ$j@o_R-#Kb;Mk)Wzlum4ER@kfGK3_yg7 zJ^35H`+a43it1>bDkC;Ny89T0@1*{cQ_1Pgcmpb|-i*29Ku0;Xpj`>4H-l>esPWV% zAF8-ld@(PMd&T?5IqntTALqDNynmeIUh(~L83L_)UycBAZ>303wFtNsZuyCD_g4Of ze_xIOk#eO-(1)ld>`hdToG9K=5LddDHw5=T$`K4@C{OBlNvIXhmLs4@P*v&Kf9905 z1cHM*&Iq{Uum~UTJB}^x<>}+qU0O6|8Q6w@_41J5f?+4z8A2bg?vA4|%K&@`#lqPn z5r6g}G6h8+uMR%cm}O?9%K<)Q6IT4;Lu5LPK3*Mss42_9(aKbC!X2%FxTBRmUft2E zG0VWwT2&|^WpSn zykRM>XgNQg&lE^RGBhdPKh6~`=l$b2K#eO}&iBVvS6N9QFIWmTVW!6wGBx)fCHb(3 zfySVncgG}r?Tw|6wl%E2}E31U#4GRb0 z2=estz7Fr}O8-ykfW|BXXuk!tkYw+oyji8lz(boKudp&M39~rX+^lw?gDj)ZoSj*x z?^as%{-yS$-OZ;>tliUo?1A3S?e>Q3i=X%Bnp-2c-PL|%@lm1aFJ`Eom8UOL4o@~~8J286E^45&(FCt2V_WYH?K`xs*{HB= zd&j7LsjZI6&Dw=sv!C#FtUPdmhlDXp*Iz_GV_|J7@XSd`Pv0tir?ms*j(}%nB|_(AU8p1zvY(=7-*on6kcq|3SLBMFu>{m2jRSzRmh3t%}jyWBnD z5~c4BSr}?LFJ$*Dg5@kH-m{pkoM_MDK9XS1q90k!>2t|jRaPKVS>03?yn5^H;+y^? z$zAL|AZBTVwBh)~ws{Yx9te6Pt!;ho^R&jUZWf-2?QHUvZj)LZS!fVAXnxZr)-JxT zTY^R(N$_#0ZQ=8E03 zY`1$}9tK|z7F>3(7qeoVwCx?YoL2MO#jI>1ZDyVDLs}hIcjK37?t;7(llPvUU#R#s z==%MHL+Pm|D;^s}CN^|wu+ObuOu{wG?13(Z#%^Yw%dbl7#hyohAF>4$$>wqyMi61Uk84Fau@!j9rq{oI`aFIQuvep+@IX$^(V;*p))0A zbpxit%ybqcD9`bl%t4Ctrq7I61AHZE!|&A&J5?;R?Zx;^-Qo~_K0}A85u+t1q<{|? z;e9|t-~%CeAE3i%-e}1QvET!Z@ID|S@PVK4K0t@jywQ>q3cv@9@jf6Y@PT!BAE3i% z-e}1Q67T^5-UoyPJ`jZW0XmH4jh38{1aSuw*qyYzWG9tLO~#*faH+S?y@~JKUUw6g zq}4KZH}VX&l(vk2w7#A1*>BS#?%N1bY+rF3V>|DqBOTkGEEZn-pEWa)N)aK|fxo(3!m#&jGuug21 z)-e6YBm)~a^E`+AZ9%YZ2m)L~2!@&K$_}T-{H`na%mbNcGa|EV!7A0v)Jz#r=3f#b zVdtjHfchn^dB55&{Ht++C(3KMH;W#CxqJ*|{Tbyo<^*1I1Mf8i(VY{4*WjkcLLh<_ zO%M=T5xm+?yw`AVhVmK_!Cvz<-fLRpy+%f`*AT>m$f?Q7RKRAlo1L4d9nwU+w?Tq1 z#hbuuxHm&>gIsWn@)|jT*9^ydO@9KfA=qnhQ{!O}SW)`SNLBjknq6F8{7i#gl|S=3 z*~?yCvCA{s&A?r&0;b0CI;DgX_E`oYJm|ER--!bd8S^Y0h8;>mZt%jcDgxPOnKSpi zZLdkZj&@-R`z(WZrkM}t7eNqMKteDKV5C?>%hAL56h66Ut|W*E3F0m>L3Bfh(Y(=o z3X8x8xF`yBDK+X5zu4`e|C8O$i6Z{V9sF_rn$!Q3uZrKvR~azmLkH|u*SvoU zOUvF1OCc)Zva0{&DL;5HHTIucT+?@2T-Yf;lFqQaWs>3U*wKXSv{t&|Vu_>(xz#Cff zVZ^rj`Gl0hy8wtuDHy)zf`06Csu4zfY;vm6tW^JM)rV$kR`rLH-fC90-~(KVk9ub{ zQS-+ZK{c9{kGa6Rc>Z6SmH*SJu@J~$U*i&9%)Q~g`d^I&KFAtV;{qRIjnQHLzZ=a$ zAc6JyUY7p8W`G*^{9t&l#yvljT~}j)4`tWY>>Lt;c;G|fxtg8hLpLWi4*kKKlbW65 zLpP`Y+o{RQ1iooi4jU9G!uJXkHLvy|h*!<4ahnZpQ~OYMU5(d#D7&u4Yd#pBt2u8z z6rQW`8iH-G>Q0A>B5_j#0FqE~-uoSZ#QPwq!k$sD_91*zjn{B*hVz;a5g*ie&4-8& zYP{xyHzze-^C8`m8n5{f-B!(BgPfX(AUT`^@9&QMt^^Q4BFAAByaa}(!)V@U5kW%m z0q&m5;0L^YfaIP_aM7p3Xx?ZMK{D_GEB01|^MMcPB-I2Et=S3~D6mINhtasvB7&Im zBpeV0$pqE=0uXABDP4ic0JhO@^fG!t*<1N;rwZ>yIUOeXruPxtQ1ZJNR!6n_SV$C$ zg|47zA=EhpDf0i47k_NOAsMC`74yf2sYdtv(P%B_S61;1bx;_d;=6JyA6soo+Ygfs zKW6A^sFT$P-~Uc5^S&1dKU8YrV^-5vh^*R*J8JF)rUV#-R-%^?K_Z9;xLYeK9w523 z5?tHqFq${ozsLpr;{lz4$k;ToKBJfaA{YFRa=afqaNenwP>EKpgveM*iaw*4|0Wmk z1_yKoB4eQ|eMT?;UAmOtm7qHAu$qm7z|bU~Mu)*gs{bxs%G(EoxN)lG4p)C$VYg^H z3;}@%X|&`7Io#Jc@Qx{G&)WxN1U|6l17b`yK0t@jywRYX{W}^R6sQruuaT-I$wmNS zBi)nTI`o*}S3~G!s)@g<;D))f|2si4&x@h$_79gJ{1|zpni7N`+X(y#5HgZsgm@sX zfB^97jkN{GE3nc;Ko65N08&N3=IM% zB^^fdM$5`%umJ-85KhR(-E#>p`g9o08!aod0DOSMp-}sP2p`)hhkc+E#K*`paABpx zXx?a9nM?s=P6Uh+mJmSLBx{<=lkssUZfc;l3B?EtKwU#I!oSxk-tND|JmH{qoh`}P@2-r zD9!AjHEbx&jCWB6UBS>O&5Y8_{?#R&rjy=x{ZK=iBS3|xx!B)uf`L z#;Arxcror70!E_(KTKdX4Msi|6p~O47vsg%LV`MvrC1A4sv)HsQkogWghGOiUGsJ1 zY6iWeG_!>U0LSaINS4yfScwY(k%z1AhDzdSE6t2)iOIoTD0+z%0lkEv%p)B}^G2go zL-r)lYeplb7%^>Zgaj}#0R>Pi%e(!%0T%z9F^q z)%-9NBcvE1#Rw@zSg{!JA+9Jr3Ll~vApvlsl}4i&VTs;Dk$@2@DUXn1gtTN~5XA_A zKSImZ;R`@e9-*#CZ7GjXm&?_aiLLWYCU{!@RVOp@j7091w7g%+;SyQc@P#|>w6vJM ztagLno_)d>7N*GrnoJ<5P)N`PjwTam<7#|RLZEp@(k3a0NI^sjA||}6>$wF}#fpTV zN~;Mo{A_t&87=I5BM#Vc%^ z@hk201pgx@6w-KEJKed$_VLppiNE}`s_tjwZ& z=2hKQP~~ZK1xSC$Tnr@yu_~8+LA8d~%7)^xCjNsJ=Q)}kDj3iivMt+ZjGzy_h`?(I zID-VS0CH*~f(js^O3?L0X9W3d@eh55E`182R2>P$Ojm@sESR9rZ5SpPD50yPkloWz zsuLxF3y>I^4uijWA?F5sz*cddgVb<7p!s$zEajdKL*N5AqxBWYlzzn_DjRHLWD@Oe zQXj!Vr?rs`bX5{^!^fqzg?r1G;C>%#D^U@MukV*a(6M+4ei+@VRu~A^0xrbGZ3P4& zu3n3LYDh~&Fbu6&Swl!1d;QQ#kd#)krm}DMmP;jADcoBZMCD`iyu|jF4i42@HM27*8dY z6A)+!v{G~!%^QtkgcKvB7$L<7DMm;!LUSdT%KR6fTxDqNyWZIP{()gR`Qx@dvtwokDhAcPuB8; zglI@Y&0B}z^8SQ2S&#MBa#_=c)ZzB*(*k|+N`?B=O#D*>n_PODk9EkQwEeNzz23YH3nVKzc8ea`#@^~ zAKBvX7eupOqcc?*Xw_1E zuUZO3LsjWBBbD*P0jnZ2O0L+&iTM<`vk}O)pD^1cXzNE3Sx~JIJ50r5JQN940ngj^n&j)cg~k1NbG#dB-l+Cbgz}lJzBU_ z@6k(IxKw)yer%+wdGwMNE;WI&oh0=%3F=MZ5_xQCZ6U#NgRAt}S0GkWjL?K)gcKtL z_K0?ZcWk7hc_@-%gr`|nxjsXY6eFY+4YXz@mHCEzOhpeXg6ge!UglcDBChN=;UBgF_ch!Ls|yXPF+Imf1Ht)s>HHfigB z-nV%B5!E{XQ$w#evzWfDc7p}C{vj#_B9|eaj6kB*!1dtvFiO3` zuqxSwppwN?4M|kbXmXye$&qcrLpiz(sx*Zu0nn|_L>_JKd65Ih64&4JlAV+%;}|L* z8R7Lu5(2N$mCmE=9l!}k|6;v{lZIv20(0{!mw=uckRQEy2c@GVXasFUWduAsI*i7R z20l;;KETDzC?6n*n`H!wIy#KTjRrnI<;Z%jdIle$a%AuUeO5h#4^TOBz+-|0K1pz+ zmBkb-s2rI|CTO0}#}F7u!Xbhh*PNIv)r4Wf@u;Cj<;YZye1?o_XiA`xEys&-Ye@A> zsfMNiDb!`rp3Z^n ztVu;6_yBQaEyys~v3wUS21k~;KTjx1L(y^)&~m<+u<*Dt%neIdW<(xEfi8iG*R ziRlNDC9O05Tz8iybAFt^=Cr|`#81=eZ*}YAxop3*i8xPM*Z16kTMq}6`Qz&XiU^=c z1)i>`B&duiC$NCFwqTA33WcO8R}U*Z$W7(OtK-T$>Y;}Lvxo31+L&h~Bp}0RzEYRo zqnAE~{2e_On6IFXwJjF8$=&1rW}fd5>EJlz9#I7Cr&0O+=Y#T3+PcBh34Z~mI+L+8u*O@H#M+P0Mn2Q=urrgUKjq+ zUM&&9Rf9G`E zVZb808-6XR&+KeX-wx%+PfVFVNT-2yJ`xHbP(LxarhX!*N6ym9J&HsLZy45;ylNg!^zJGs_5Yqvg{3qdo!HZ zXgn3qdJPAvYFo{60_ZX#NCf8q0lSDqfk?1C=`fl%T11c>e1K!*pcrN(j2r?=5*~$@PrN(0Ud=7qj94}4=5{RdYTjzUbBnKi=Sz*t1^fOrUcZVMR;K`;Db{o zZ7fmxBV^%deTE_dBdnkpAvFA?7$M~mRyBU67$M~m)`lz?FJiDRNuVi@kZEy7F+z$F z>M}-{Cr*>j|Nh_+lZH!OXDdee_HZd0G)HCZQ8Dy-ON;5tYB%`p*;r}YJDJ(7{MyB= zY$9!Do$y0i9anc_WtzJnZ^h)jr$KlET^b3>oa+kRmgTfs5m5Veg$WI%>?8q?35bR| z1EsTQtv)lMlM@&fDgnt%XCO3&{w5|UzOH$NaLu5bKrDfF7ggXMN_Rrw0wji}!w`5U z&S>BR3h)7r%ZBm+eeNjFW}w6b(i^QbTB?aZiy`(uHNUCl$^2h~X7TKI5lB#)4-~>^ zo}q5h85iTpnL>iDFQr&IBW-s;+Z})pfDVxh@=1Y|@>2;UlGD%H^a%kDSC<8Yb*qe7?~5iq7sS(Cn2qKN^qIfJbIax$p}$7njH!p z&=rV`z32-GPAJWbglh)9j5Vo%b{AFP9jYZRfeVlrnhrzYoj9X`4+MY@5VXSN>KksU z3z;@v_0younvCFc=r9^Lnumd{s`QzW%J|`cRgoDbSM1`%JZtq4bO|A7-{FsL-*GJ= zM~9k`TuYD;0ILctYm!zmr&Y{p6?0m}+(KXqcS8<{Lfs7w2}m~tG9S%DWUL@vpV7;# z%pxdSNsu_!=T<;ERmK2{Rt{F2=V)}eqLl=+23qPA-$$6BaY_{{lyAp`h@b)xJ##=5 zs*F8HJwz!rNEE-ChsansUY|>y`V<0*j07Ok6^M+a1xU>h{Avijgx=@?+;HF>Dp!Q; z!A_f#ux>-JZZzM~1$@BvZ}1N11G>`AgCh^=^Vjqhh*W;XA*v&XpJzK0 zXaREGw$~)4(?**4@XPM?Vpfd%xPoPVp#n>9TL`okd{Mw6{4i$-h9USG=xBm2ahQTf zJeigzB_THsrKhrUWMJXeC1&|;>8JgVrscW~_FTG7+Q2%oRa(RJ!XyJ5H}gD)d|Jqy zD^Npl$sr&@AOm(5AQVuAqR45k`qdS zOgx;0FHvM-f|F2A;5FQvUBy%kq39)w=M7|HAdv~#xxs-01gSrq{;`H2G8Ve}Xc0Np zVR!kL%jeiM{px73-#1%b+AJ7U99_Q=h0*S_f3n97j-2u0!|WG62dKD zl#@{IFu`R;D-$EMH#(aiCIEOpy0!f80x&hh9VSSOILF0-pY47Rd_GT=`hJRy^r9AlApSq zL?cXskX2$;wKj0a!ISw4@MJ!JTRaqbmtYtnei$@05!6S(Iyc0h1wsO19>-!r6*A!7 zEY*ZbVJ0?oX|T_&UrfSP%aVaEhQ@AYp3ARF>&2h5t~i)zkk;U&Gs_+hBuIDa3|ENB zNg$_&GEFJdl(xg9gw}{4A*j(gxC=!xtCFqpRXehL3j%%#9Y*s;iwKf|4{+ce&IbtC z6Ixluo81Shsx+ZIT4%l{A}9qI=UjaO6yw|+x`i?Mc_uRCr9OJcYDO8FRzARM*pX91 zTN|0ct;h-otg;$*g0#8jxx*~xjiYtb)<$fYqLl2`> zAajnZug!8{=rEc$S~BP=BxM}jh4KLzfe+B4&5_Rf|JlVq_P)XF%#FT%zLRCs|z>`%6F4)(~ zNcArICh6S9(kTl0MYqqdKU;17w07O*d-k{q@>WdV3(AXfJZ+Ff!A!tTlo7BK33|9x z5OhYC@t+I#zYSf4H8kyZz#bR0+X3x%U=%dtC=L(9)eB=oQ)JG+W-c_e+X0)s)ykZI z4P9txw*!_bqTk&Pa-kzC$4EgHvm>}}(-ITfX*8cg1^56#LBsxdnxU9rvC&~PZ#17m zrZX~k6-Mm?I#ZN^jRy4kYkUez!3VgG4=5ktSn4Rcv33?^V0}QZzlL@{V)(`+{be-H z0j#0YuAK#PRb{Cv;IXPntjXC!>FozBtqjVN)){}UyGxTfKh9rs+Tc#&r)l-Ky7lo~ zwqM#roF}d8d+xxkhfw1#yF+n^G%vodV5idxet!Z*{;+?t1pg<%PQ;G#=8D}jBX>qb z@wKErKM@5qJ-Kdvj_EA2!nPSdjV!2y!Bh+cQ9qzl55A=onKzp2IKS!Jp)Nf7muw4y zdWE<@p{)+siy^_1)*1OSZFRsL1Wp9P6M`CDwABGl6H`O@m`>FrXTt{(j>AM-9WYqD zJ{Ma8a?u-ThsufRo_0v%*#YkzMZK>8JdRf=2-$lQJ`MqXPlv%74Sb*ye1HR?P(DB) zjU!oXbQl8qBhF~x1JD+^s+=my2XI0+PV`T}%cH|++-Tqf3h)5}(tyrXWMCsgef}Eo z0owW~;4wj-fTU;+frLck(B-5pL7}Sl01p~q+aiY&bm!3CCLknSMS`}-HPvke%~hlr zA;k!3J5-7h(srnlGOZK^)eyarVuTbUq!?k4o+F+VBg|*90UWBvqFp+Jcv6gz^8tN^ zA}L15`2fWTIVmox^R<$Ia6_=z^jRcK(8HLZ#35jWDHJ2z7DO?^P>74Ua($=*)&jh; zL`abT(&s{gH6($iJi`A5kFdHYLcm*oc*eck?x z4$D?I445i48GqKnrQSaGCUfT=yqmBjt(LL7k!P@_v}OFG(00COzfFs{&*Dxv9xOzS z{v{z2mYjx)7y@;LY^l9EagxrKY-R*EH5LL9^t&LaYpVI`N;L$evKz8K^I)?wL5CVh zKr?TlQ62L)n97R{B3SY&VR0IMIlw-5`G|e;RCy6=iR6*bZB!;HL5O^of zXy60y6nLoS=(<9%;Q}aq#x-dFGfIP{{m(cbAYgXu3ifPyH6e#V5ygo%f*Xg@p=e); zAwO9yK?f6(X39APt%L{TTM3ht9wg|;0xIFDk~WqnEw9?;8SUn!*(pPp9)#A==te17 znRg+=<2W`b6p`R+SXBz?YHa`@2gEFmkTx8j*!IDLsj)$Cq_wTjeV*3X)y={)(bOhy z={Bjw5%$_nhatGNB8`@n`2_BUTz&{8KcNsWzDJ=}qVG_z(DrXZHtJp=BsfBKr8Ybp zLvXmN4pg~}2x5945gY^rb=OElqWVk&ts(T%rx2v5Bmj{<*M`@rDwh)s0)>k69C(My z6;)L@M1^()FfkoQ^F{+70NDX2!b3Gj7ZSjiy3!w@W~e_kgM z)0J*+k=dEK;!xXHvPav3X5I5jF&U~5@T=BG(Bqe+nQ{@f$L~UeGX(8P2$aQvLOc`+ z^$HIK`^wuO7knBacLj$fD}$aSylxnh*`v-q>)(}IP*X|-+KC(JG| zshKV)K83W7Iq+u)F1or?mEEWCRi0554HQKl(C0=lIwfL<{^*i`$6UJ=)V)AwATm~j zrqAeQasrbq;t~?5BIdZ7Xe_WQA_%+)QY8eNx;~?qKqdwfnVg*)6hKr(JlfltXR90YC`0X~GB8Vi98&H-*5RIZ4&C()T^D;5GF1jHPT4%Hl8;}x`O z3L;}uGWv{OW@V;8EWi~}LlH+vT!6sPbQsMWEi1DCe1LDzpCeQ=~sBlbsj#U9u<9KP`ObHtJYH_DzG+8ev zGY5}&)<}^J}7YHl}SP)EZy8@?KL`=jCpt?XUT+DP;JF|A2Z zL#$r5f+|7%9?kE^v?jp-2$;EK3N9?w6~Z;uqqFr-^jnWEgDV5q7aBz?5EF#Ix}x6I ztvZ;XMZQ~OTI31>^)5+s6$16HgaFZqDXJB>#5=*+!9pW$k_7eFUGF?VZ4(TxeZx(NxGhIAN>8;#Z^VDE-n*}lGp zDyq_&1gwI9OQ!J6!LeSWGlXkelYl94O%SIcS-q^+XeHsA>d{%<2|>g`LV+ZpVrU+{ zq*`REMb6Gt)R-2TM7^6-GwR(GfvEO`bka#4+Gk!1wx-6u7p z-qqsPDTDB35#?AYl4_ATdN4r_m?VtU%3;6UKkB+ZZrg`+zLLi2ih{K^!waQckd2p^|zJ~#G6?d-}vtpdI?VZf* zR(|bbRyL6~vrhOSt&Xd^u`rEUR|y;@?=_*fFYEN z2q?R{Qc+cJY7$fnk!df%uZGaeh#(0RXi{6SP{9;+Ft)zy*=T`-WcuaEsps+(+lwR@ zFR1F+w!hPG&d%lC-A4E=+b?Y*&Xd;lJ$K+1TUmg)O-} zB#K?4c^;(RgS>2Bogg&FO--svMMdc|BUS%X^P5_p%>OlLmWp4$+8XL%5=hYJn1s+r zz#9~z34QYmOYx}a83OPXT{;oS1#o%f`n94e6POa51+>r{s?Z!8&1fETNlwUtvw*ug zq0Rz*R&D7NC50vvXflB&6F48h!SC#~NM}+b-~&tkhEQPgwig2e9IL@!zGmHFmKPh-Sg6<(JTaVs947xhNvRf`mExvA&{57duYBU za8_mx2s}6-3dJtbXBD?jp_d~K&L|ZHs?rdZ_oA#?kr^cyYv-BvSlLqAe0;)em!Pe# zc|S?pTb~`C_Q_WFMxH-=l}%gOPHN;EU2-h}l)^imRxpiE>IZb<_b0&U!~RL^OoOi_ z^)JtLoZs~AP#0dJUnmT?!nPUPfVenB%Bv%b2>&PI?d*4-w7hEf%*cH}%+d&H!|{o2 zA3UhORJPKV{Rn7<7j)hH9IsY*{?LFKz8mu=6+liz{Rt!$-)Znr!GMrJt+7lS`872J z!?8PuRwASkK`D?_18w10XSX z7@~+Hltf5ydhEsn>ja5R<~_)`+$L&%!riw{x~;XBgz*k_ah@kdg=~iI9>ASsDmI zs(_?0iRK&FQW7DX`q8|GU$=&#BtnizN)UJH3?-712w75xK1-k}iIAyEAtVq>;)+DG zF$cjJrFrzy!@ySMR~(`;emGziPzbNs#fkaR?o0_}w&hps@{D#fw8K>aQ{#BC`()eM zXY=Cw3JyB0jZAFl(qNxkznFxpmL&sS42|8)JeOaU){8%9U2!ncAg#ekXTO}xQhXm2 ze*!(T1X~qQ8QMhgSF`Wam(@BEE&t)0q;nVjVk^C$KIyXjz@o3)f6-yt>KEIBY6y7@ zMBA0NM5QfJ{UNc;!CN@8sU8DwtOij+aKdP1wJh2WliGlKiJH^Jx7VKi0_3NC?gXt%S&Qs`elWdYMeyVbXS(fh8dX;6R{ODrxkdCct9exT&!a$ly-Efp@4} zk(fY=OTgx%!)V@U-~$i~aNr%z2XMZ|=2tkaBdX|{?g;-`rJGh7jaICr6)P#(l#)$p zdu*MmJxG9FLTltovew9p@cP{pEH@7jG6I<}NlOy~D3YYna|)gWSrLFYG#ZKo0n$5Z zF^W7uTcQ$_GSEuVGi`^-o(1}hUeb1$v>m2D5QqrC0g`?mnlHyq0Fkk$cFncgAVTNv@b zg%K)Kg10>hzWQ=>t&CJh&!lfHhZYT*qcUDxW^5-}&v$kGa`sA}3Y znLv{XnYnQEbG$)RD@3g<&!=0}0+{241V_b9O{_`9;*yXmoCekThM?9vP8!ACoaitF z@(!HQpcNubDE-|O7=>+dM15SHcLI4m0YevwzEc2+)uZb%fOOiYuoN`1oErO*os?%W zyLZqtU!aN-I@vIV!|S!oXaFJ>k%5Rc1iL-KtAuSO_%etDVq_)sA6A^7#Wb&3IHt)2@UXd#^OxH8axt)Q>k_m4w)E5fN7HiM274}DCv9Mz*eb1IdSQ}* zjhlI%1J{v7^IewyTge0mmwNl$o6Mbi@NUAAv|7gQMxMcz(w6a$LfiSC{WdM)KE()w zW=hH^Mo6JZiV+gXz6s(qiV<@BR8#;(LL9|8G$olCph;#FBjn--tpx9C2v`M-P$}Q- zRN=iSr^6)Q^ge-8m#DQ-Mc3@eN9HG7GSpXUH2bDG8~{ zPowh2xY(23rbPrPP&$mpjRrmd#mcHOjVK==P!*DdQFIsrAHW$6xC79**^s49^|Itt#IIKoucjqLIP}E^AH&;Vb*8#(x(s- zh9toNLBA1B^^EeGsy9Ocs|4|b6#;>spk^a3k;h7wNCGI_)Xhupn@AY3H~3YA(p%mf2l zNHuaaI#h)koq@>Mz(Xquel>(%CMV>;y@0FRiMkiiY5_n7^mW}*7qBHCm)aKYEn|ZF z9XozuiXhj$uIGwT($C`0j!z2~`li*kai1`oy-hk1;7}SzFX3JQ2}2Hu!c{NU6^M*I z*!2g!R0xer)|s7XWmbEEqfFvq)X3?fU%uEZ=-01yTWsGTXl%b@SKI$Z&!ja8XiWlI zlK?L1+(wC078Bevv~oM5dUQ4_qg+#t(TU0_Q?4nViJ+B0I`9n384R(Y@S0s*Ui?gh zU6uSwj+POCdm@64#RSYe5|J=kz58%LnLoZ8Ni0?*48sKChoMbRXq_@_tx4Jtlcjd+ zb>B_e5R>x(f}}sk$3XF=w6nb@ZHUQ9JP3*u5k$o*tsI6n#H=Bij}{L@F+z$FQjCyd zgtTTQtyw84qZpy48J*hO^rXvxvWfzks=!F)y(p_zWJbxw+Igluc-7uZ>Lb|cv|`55 z=mGTuI`R7xfXKd<)MpCxG<`diUx6ObFR!p|7MT&5-Jv){YBK(;`tmd&5@z1$q~%q+ zXGZS4n#Cw>**5}~K+tvbbG%pr{seyl+)Vgx)F?vqpD+auQKL`+VhvGv*q~EO1&Fj8 zCWM0|DmMZxnRX6CyJ51&G_veB%S$B4Gi&ECv>PVt17d>WlQ@l!77s(aVRDm0pp(}b z{S_@pKnoJkf&@^Og+N7A)eI`T7SM=z-B+Oj1VIp~d3qxiqf;?D6{ABBF_LglS4wH7 zn)p|gJ~L7+#1<>`C+M?5LZKs&?vhjyM3?s~FkuivY^RaC*eZfB3_yg~VN$TeP>hgb zgh3P|q!^(bqE&+WMA`{==@xibLtjHNLM;aGSRc?l6iG2ciV;$bkYa=sBcvE1Em$cj z<5{q>MCG1%ZC>IJ3%f3z`}|&r(aBc37H>bIS~sX--43TgT?}0|oZa6uZ|OFv#SymD z1%dE{B+%yh_W!d$3bL|NR%Q-V@#6FlsEUTV0;93vf>x@8IaL%v!W%a=9tO5521hi0 zIA9gf46oS5@obN6N+2vQ$CvYy5p)(I=sxUEP@WO3_yu9H0&f9eTAsJiZJtuk^VK0eg4Ue2KNJ%%XedfdtiUX%_-X z8-~?f8@lQ8Vl_j_K&@;LK|3FnuvB1z1_>ltf2|ybc0S^KfFSmk6I5;2%3&a>2-S@_ ziVdps5eb2sU=`>y`KN|TEz)EHO(xJ}0!=1F1QkFBH13o_Rjbn(h>T4p5EQ2&(4LS4 z5Cmn>kyGPSSoDr+hiZjMJJRTgez~terlc4l1jTqlAH@hMM)-Gw2vngmAp!DFF+z>k z`e!3T3Bg65YY;&(LR7m4ok7)ftJgcl2q{KLF+x^&pp^naiV;%qjuMV3c*pvH=4&5N zjF4i46e9$j!xZ10u8Mn!DoQ{gBM}nZSaI+zV1$%M2%=w#5mFwZQ-xL*6Qn#sy%z?} zhpHJuf&yANiYMg}QXV122q{KLF+z$F1_>b^-j}eMge#IfGCIu!#FVFSM?r>kouh~c_K?`4kPQf+QEBOq8q#0cp zu)w4u0N=#8fWXj;vBN|Jg#xFXBdeh}TM(W{h=fAZa zS~O^m%6M^^v7Ka*Lwjk5Wv&_NRKje)P!8Se#jF@7ZF?s(yOm$Nn3YYW&8!oCNUP)O zZmdjm7v!y&yq7IZpm};CTpn!|=bhM;3QB~gd3=jyb8&Bm^BPJ|1P_BQQ%h}o@!9wz zf?{E#-~@uGjiNPvqmU8sZK-q-FMLN%jZa}N6sY-{9p{prlxJ-cfE@F;Oyk+_1E|mGKH!*N&?CUbf!Nz>jQfIH9m!vc}7)r z)KEf1&1)o?<3l?uyy+C|G{GPcYUdDS6Ex3%Vma3Y%abGlfvfPw-d1#mnwFd(hdTjB zYDE<)lMzth*1$al>aNv=ODM12vw-i>VKi>E$n4A%Rr`R);zS$4jYH{xrj-~*CN^|w zu+ObuOu|*ml7TLU#%^Yw%dbl7#h^E}>8r{DXYckcWD z=Rd!h$N8LdBG26O+|PIJ`+HyC>$<)vYy4}=t4?7Sdh9;Opfd+YUR{PXy}g0sTPvkwtMYQl`6~@Wr)St&T`$INSCD4(}jJquD|6i z2{VBaVrxwtywwQLNEZo=kc+{)K>}6@jF7+x35<}y2nmc(8GsNT@Iu5OUa`0%FhcAg zMPP&kM##sAC%_21DUpWF=@qe5r}u6J$_u+moN=3)VOwYDlV}JXI$Gg}8KhPyJWltNW1)3lj)yrMr2!!ZB7$zNhqCK0Mf#MP8_CVDP`B}lsQ|P6+lp*MZhWFcm zQXtU~mQP-B`Qt5yV_s&_Ez=$Z5*g1xWEekzj~R}e^g3F95d5GT-64bk3YC-?1|d4( zCJn>@;1Bf^{Geh0!O9(l3`7ir;7kEGX&?rGnLP`kW<2mRS?t(O41=%^z)c#6fuObs zCYIez)Dz>BI|8T%yaJK&Ru5YQhNA|F?Mi@$4HSutXJ~X-pF22*H{N16R+l$|GXc(3 zgVGk+z+>xui{N!K#4rOsX(nDxE$K^W9n7W|Mu6bARq8y4_9Pv?u#(qUY5@X5whMlk zL6R`{&4X`+g3y(@2Voc{>_mfn0Qk+QBIE-E!Ec}mei#lV4Zq^{vqCwwRn-6xzF{*? zql3x^2oW&6#Ev`l+12GhXc~mm=%By>LIez-+#u*o|2?S2qDkuK%3JNfA#g9=BRw*daUDhnq#ey1RRlkEiW=_Up z#*i4hp{`+W9S-3tbUB}R+|-bt%N)c)p$F0>8-(H*UVwpWf%X4vp}5Pavo&xHK1dgz zldZszC~3--(zjKwU*3SBZg6WjP#uu}#j%2NCP4v(5gLT^Gy7|hpe>?3Hql{+u(c#? zEu*M3phm{ImQW}np%jPLtdS9Njsb_bYT%j~p-`a-jF7+x35*bwR1s1EoR}96Rgd6GgFgZz#POj4 zCv zu|6rCrY9CSPLr+0{Um3{naSZ<_)FkN0ew$k-xz=hVJ~4*6T23&Z9Azi)w4LV?PPaK z0kg}tP>VAS@!c-Zs=w{$u${b z-5fd(I6BD7^Kd&egjEm7(G9wDv@w$$I5|2(!5dB~k8!8*clKJD?Uuw*m(CwPES$P> zVB0ucDIP9%3X9Ft{(gEIq&<3gJB=-&jVgU3!@qkYWc?Uwn9u9(GH$q0l zos*_PQUy>t4sJntT1pSN-6r?KZoI`!tS&DAJUaw;8WfvzgglZMX5c4{@Hxjm(|m2G zUR~Y-Fclo+hVr%@c%?k|!tdA#j8{0y1V%_;gak$iWT-(1M*;*L5qFvx5EvnwR)CUq zB6NB{;0}`q+~81$q{{OD9>J1qR9=|x?q8!;%()IZ$8d%vTUEI97VPHL9>JEiOVxyeOUdEukR*`$^RA!q30!V5f~wk6T_iuSPUR!L@0U3zz;)UgxDz$0fpg8VKEBBk-!Ks z%oh?>V;?1W2k|5@LM#UO8j2(^LN?8m zfG&d~CgJD1A$%<{0D+%{wRxFLkVD~pH=&Fv(h=lQ`!Q}iRH{Y{Gw_o}c$;EGGXz9| zSLlg=Xcp8KfshdLwSt$Y=!qI6GSHFWI$5ZV043={sNZv?f|sYzOB1iAb^;@erK0c# z35*a>)d`Fcm@0#=JOZGH0Y}Zj!Gg<`v?PEJ5f~wWAov-IBrrmM42FV3)v$zsXAn;U zBgA8XzzEghg@`l+fQXQ@pDI;Gdau+z8=pgushHmTv>P0|Xtcqp$ zPz0hN1mvG9Au_&aI1-(0aHEMh_!ArM>f&y%Apul{Bcul)Fl2-pD?%|F z?$N~Sb@VYWnD%)1)~Z?hl*}T%>f=nAiPDo81tCLF+ENfC%`Na9SNaUG?kw-!oH5*w zqlKUd9*PVg!w&=9*ahqbKcu!$djTN=M)*|!oqO3!lhn_Zx7vS0;9fjSw4~sM?ems| zUXP2fRQ}xYNMeKSd?EGU{=0$Zpopu9c8GdlA*Ufca$X_J5bY4Lq!GcV)CM7H5IC&} zcy&6Qm@0~Bhe)(T1mHnG;~L8C9w9m@{9Lrb78~xIG|#4P5CizJ7Agi1jskAL-I}uifE0?@2zox^2D$^CmqXgp$JC(jnklPWB9sggNdB*ZgX5V zX*whd*7`*Mp_hzSO2a9t6N@t^Aj81{>(UU0L7*oF8Nh>ejR?HKmcj5J1QK&tR1}yL z0fGtM;}ohBnkvHS`0p@U6kWnBd-R77_DR%My5O9wNsM7uwi>S4s`~Z8v2=|)d`|+z zQk8+{XXa(r0(m)(cR`&C23{M572wfiQOU{FReq7%n;<*K?saaelGfBQ8Vz8rRwq`un*vDA*c@N2+_&c<_}n6 z!<~~>UC!=`ipLsM3?M86{ZJ&-xri7BftCb0Y1QQgAO;XPMkroo2z(i0n1P?P>hfAp zE5PMsP-Ig)Y@kd?QJyD)(2cOTgYt(>0$pL-A}Dw}NKcu1RgQ_118=E{9SezJ5D*x+ zNn0ir)Ysj}>ds*)ZPE*Nyldbo&`sh@R0kTHe3G+cQ|%Ve#5lX86aJD`_)7pi5%!JM zoua-}&ti8+4mBJeoh@M@e$94vLgsU=w%;tIm2AhmhCHW>BxlX(xsff!5KmbHY>nDy zk>X549q-2Li3N`1?2`jz!tAMXH}R6`TF6;{4unh63$U92K6+~3BRKKV(;%t-Fw%oM z7)m3YSrL}?fyc+N)rOy;OM*m5kO%{SWu-RuiH2euLo(I47azm0cz%X12@)aJ8=Ie@ zOV1{PLUxoK^2Vons&!qJ{AOtkRTBfBtmv4J+5T; z4U%1k4oQ_|(3QhdDbw2p4VhhVt1bP=W78qlHx?+2I-C(9 zQ28PP5gcW!Acn!2UrsL{gWI^ z36^MxLd~m!HPPECWk|zFiR=b5H%t$3rV$3RVut!+Oz_*CVVDTRAao~5M}Q)s zyBq_$VqlG0Tf{52`C^XY3`;2u+yB;CH;QWW!=wjFUxdP*Kv4S;!wmeSMNuPvv{#0* zF~=L>I7_h$j&>pmq3h|R3(IR1{8bXdCF#TGWNu*yS=lM|G3-e7q1IQh#&Bc=k~}{X z{00fV^la+D*=%XG1z##q(wppTi8v6wL=#%`!RxokqoVs zF}3z_)u}~&x-&Z>&S{uE5fYZ2`)W7-S%>^tI zfNP2`;ZPW25I-9Nv$-fJ;(9m^D7H)>pw*C%MuS8KxB~M9Q8vN-IU{IU9WBYz6{gVY*mq62dSD z;$>)JBG?OBe|Tv_`BEUH0|Xk#m6HZyfbgdQ5Guks7$qU#%3(kZ5dJhE1`tlQ6a-A1 zD~ACwK={*u7=Uwh!SFB&f`pwbhXFAF;5}6g6oxw+B4qhQJ2P(dzR)1iz}XNt1co{r znj(N5gjF&8*>K>!FRIHy^P_$s3hGdRH&ln}h>HuHUMsWL502VR{&;6lRXc>to1f9k zB;^3WHN}A_xF&cAJ0Vv>WEilDkgMakDqN9+D@$WhR2oQza3BhbSHhR|7Zsn3-x*QG zSkxe7_hf`J{D7Cn;`KUum={cYJbY`_EPYC5kzVy>dRho-*vTjCnSJm6qfMl`e=qOo z*#(b~p-}k{EvF zkaB`O4k(tOIxX0hW6P0k4xj-KJh4BDS^&<5I1mMOHdF_<@!kzibAW&-3_L`JF*^Af zz4UAX!~v8;0l^-J*Bo#qdPy|5!l+sZxjK%k!eQQA$-N|+TVWPu2zd=ccF&dEOVH4y zchDM|G$OF*5ahlT1i3Gt`zV@A5e-d zhavoF2!9%)xfRjeDzg?8OK^t?D4{7%J=7tAq9#Xr96q;)#ZZ4!ZscA9GBMHI>R+xL zP?&c=t_md?ge&M{QKO9zHE~erCDGh!knCZ(SDs8XxB9nj)5lAQLD^On8 zP2$XzY>?au5jvP~ZEF#I5{eCEFT6h^8QP!Gv#A+anc;vs6u*RRMZ|S=a=t$VAQ<3* zqa!V_5+@2kS((ugSdfGP9#lGq(c1_9e3qA)1n4Dr(HlyFMzDtwP66CGX?dBAAO>&& z4pa;<5tadj8a^@1z)xCUCR>7p=blh8Kt_lGgo->d%)n1tUM3U704|n?ih*>57$8W> zTsdikXCVgfAkd5u(t&{o1+gp=j?xIAWWuvBuu>PEK8<2ggs`(CFc^a1D2;??A$FKX zDEae>ARBlVwy^cc@ScUf@OtC|1g;@(StD|>XCdKHG#Dx$?nN&Nk0NX@;Aix*x}5D} zj_0>f5;TPTwhuwGL<}?VlU7~MZh3)ct57k3kgakj-xh1G!q<0GU0(1*lMfXGJj1ue zVt}vjrniYQ?VpOWz;I)$!mma*JIb_osslJv8BVu9n>R5hbd za&{b9y0CeKT?;LItWHy3s%LTL!03nFM18UjDb6&MBN;_U_cQi8V!N{}powwDy##?MFj2zv>TaKl|fkO-B3I5fezOdzZrTm6mVF(f-76a)BF~BpFNP+{ z>*c79ci|f0aV4QOipo}_BQQ<5k|luw0SM&O{&t}J*>uyhsTVXmKZSdib;H5Oag9&Rg_4>W_Y(k z1RFuavwC|2?QgTWd~C!nTf##8n(gd=#s*qWQ5ous^W9CnWV&;lIAR&5Aq>+EKTHt9 zFzpCfB_KcoT=QnhYvmln8J1ESwi6RV-qA&M?=tFa4P1i{(#7XwD=;KVnsTM|ZPn|S zH^frY5!?#vK*I-|Ko8|{jc_!iz&Ys0RI8tCSz|Y1PfN0ps?q~w< zR)}CD2(-&=n2RkDX5)T#A_<}E>7xtFYZUxd62c|v!{=mfVF+2-DfKbzNcExCS3m`@ z6TY8^4Z<*k(l*4a2?2`in}?yJY{j!ZZIo8HJYCi-)5U@sV^zO{K4wnFV#bgdyP>XO zZXFKcDs(xYctDi;0TKZ=V^qaAxhscVi*KpWw=QLF+ez0 z5{{LI&3Nk+C>wj6dI+cDKhKR#T?og@a!@Slr_n)e1PF3$g5ZbXl#Z|uz&#qmp^AG6 zeuIQwMp4-0|?kU1+K>e_VFZ!8Td)_Y^nt@fb)Ez zVgSLYj)kBSB8D0GN%L%K2Qh#slazaQwMF!UcTioA;m#iz zd%_061cn%9z$Xoy4S#qx9#tN~Y4`IV&9c3Mfv%NPXn8l31{Mn&X?Ux2LY@qVC`3^U ze$eQk+>7yM+0Ihz;W#S&fT$tl$=oPU_G|*hB9x7QS4`Zwm*B@4_mWkxC$?%|V)ZJ4 z4{J(1ZaQS1uHDehTw0|ba@}I=&|yo<7m|`Q%ouyfJ`6#9J98K8ejzb_qSXPv(_jf8 znE;XrAh{gCCkQYN4*|&phzQ)Z_!_GuKtyaO;AgCIP(ef{0t2uao@huz7zTkhiE=lf z8%e#~1-7#lTb0dGXBh%S%mnH<0z@1H5V0o+0LchORXk(&kI~Hd`ECdx8OsRx+2@h~ zlK+F}>OVJt17``GpsPayD>X+=(*UiThOnv+yw4>8B(q&9_?ZT4E|o_6m)Sp*V<8hE zpb4K#ctYdAH)_qxWcNl#V43j@M8>sk2nNaL5-5*a>gDmAf%#cw(3V zpEM8y-5>^VG85YKj4`$gblZP1;AGXN**iM2^{<|Ya1 zYzX`kgyfqTX5c3c!~nTF2T$_hVgMn@_kd>&_A6ta3j&rqM@tm&WhaJ#dp4jwHkdWM z`480DP!-{9IG;9(-R>UddGd2xqCrA0^D=9}*$@Y!pwuTk1Cg=MhWt!}1?K{wIzUJU z__`GgPc>21ATa^xjRR3ot`rCxZV-a1a^N8{tXv4Uc@C0N9D_#?3Yn0Prn;O>BExBP zP~ZSU*KVSTD!g(N1yqB3G(dgk*A~$~4wU)~ZXAs2PDV%|iD3qO(m)IZf*3#`j_^!> zcx)%&=eu#13hHbBB*#)J)7u+e+V;%oHiga+y)7L!;TiWF4U#H28{#xN zsI#FoJmyO%#SyB&125vQE^h&jg$RXXer^TBQ$Ck~ObiN!2+2Udh8@b40zn{vzcV;@ zRD_mbaCX0(DaC(vmj2N{2&z(oka9pinkZ@`aHYV3C@5D7gq^Toxd0V40}qj5WMY0s zFFl(8i3|lG;*CbuMXZ<`cgGl9|NdJBWs#!T{h{?=C%rE{U@&sZtrxXk)>9R76%vN! z9v5|Bbsrv+vN5IY!dx-gg%1wDmA?D7&P`LtFyZA_gL_{i3K(+ZO@1HhA8at==7{Ki zqpz7ozC{_97Nj~mVb{==bj9TIL-NU)K8)eTsiY!20sgG zMmLVO82VEm%MUlQ<}jr67o@b8KTtPxFg>8Dr&TZ5mh)tdMZY7=lZ{o@!rScrY6cLZ zZ^jTUv0LKQK4xQk&er;fBNH!&8DyLtwLv1kzwUl&+rw?PS_#xvy5O9wNsM7u+jAvK zZ1wBK8p^13XFCpn+xU2!PGaAcouVdYpFh^?;7-Yeu%GPnzgpNSxrVF6mF{ZtES0li z-^Uq+?`k)t>6}i12>cYJ*}_l3NQ5Z}ftv#V?LTIqO#s~06wQ8>!RG7D*LUBcOBH5| zGQ?tRXSrsoXt+`v=;LquOJDb|915P~(KlIR*mo7?h=Vd=&t{j+rYjU??qUci*~z)? z(Yogl=0;cX3H52r++iA!37({!dwplWM~*&ozWxnH57i%o1rfiNgH_bO>1#37*YtoESm3d1 zIocFD5w595xTY2Qn%43Puw&uNHPnJ2jIbcEcQ?p2Q5s=E5QJY4`ey)YK_DS42<+4Y zV$Wu8SgQDz4YeRZKAgJDDzIbaU{B{I^$CZo0Z3bxAWXqtgegE+6UQUOCq4sEdv+v3 zd=5v5PlOE%^5GOxFN35q6ni@7NJj#LIa)$NT5XCj1>y)(UG=Hz4gKz=etz+k2MqFl%R_cY?265&EL1PtEmkf z6Y%^UYD2h-@OZQk9?yP+XhT>+`TKSfNsVAJ&_`Gd!Vw-1!t%ZoA=*?BqK&_AXIE1I z*y8XM3<@~n9qbI-R$KAhI_YOo_9oD+EmJ7Z(J{WAb{PUIb6 zvo5m^oD&h!0-nLnaBP>KflaOY%sQJ*Z8=FcAN*ykJd5v;Zg6;1^u33G&^<)B<^jSr zUI<8F8#LP1US4{K)O>c76+po-6p^E9LJPt*`3Tq4L0?msnGF^M9M*$6C-4q-h827G z8rUqP<^tddhxMRSPoC_EmVhEQSmKmclSFcglO!QZ#jTHXM%0vw`)+7LVtj@VWR5WfOK zv?1jD{CzuMF|cmW>4)f`76U1S$CC|@nlvIT1~?cBw;1sE?X;G6{-DG`5e#?-JL6(f z;2;5;b(#5KN5D61sB`kD?)Z6!O6`q0$vGKaF3%^f<@`nH5_ z#k6_u9kqLU9+^^D%~b`ImeK-dpkLePb|$N-MVc1GDvkVnxqwxbLZkFmv{Txjo3c7O zs~XdSF0_}tzrZ|5>1nRgC9_&o4f|R>4Ex@w8d7>bU)E;5_eksPqXn4@=&^y7{BcY8YDsP1Dvr?EPk>rSNiUSkG!rn8!J8-u#t+MAx+P+DlL=15vl zU(#prv%ad@NM=uaqamx|a$|Zx6}iQx_ffh*-?j9Pmb<-O+7ex=A8l02l2}VRRaqlD z^C<9$==&TO%89**v2KKBonCYaC+E zOY;bt5!5m}sHGvr#-pdVnMql;u(>^{x!tD4l#^_oxUJ`7$%!HxkG^lsft~w1 z^OHLBJygqjcD3w`Y)r9v#teMU>^)7{nHdD}G8-j1}sM;)z29j%n67?!9FSuC*ctEmk+D=>(aeZtg{w!cv| zJ*cd&xr!OsewWpw+fMfHI#Ezb>H6NO+E;z7!-J*1%7i4=xmmP0ub3pTwC{I;RVKni zMhJ+Bi3#l8C}b}1)7N35J!aLDrEY#R?Ti$u*l|?r6?ib$51jkvYed?zV>p zwOIbn{N1Ikw`Lf7n)YmG2^E4#SR^Fy57RX2e@qiLK{MGC6nna4P03Q3Jv3WpW_7o1 zWQ|ka+&jzW4AoS3^m?$vRq(2X!o;WZ%Yq!k|4claE_`QadBEvY-&w7;x+`qR3fD3N z&EEOlHynMH+PwX6;>hZmHcVwna$o>!>M+udSvK0W*F0lYBq^I)K_A!1&&C@9lRR!E zDBd2LPl*blFoyXq-ArT5h3b6)tD|=Kl`3oI zRXWGF4cWiC?cNg~l0>So{QeVX{yb^U)ZLj>Jh8EOZ9u-cUyH-e>+YwzFH~HzR5eU& zzN-JY?Nqi8E4$mib!gDK8pqm0`}7o7?z&7_*Tzb`_;`FgW6hQ^MU~aLr?nqM?K`3M zX5zPtPh1~ZeY<*kW&X-rc}4Hn&;C<)kyVeX$IbPf+jU$Y1@5Xa4)Q8-wHfvN(uJ@0 zOGnaL>f_3~chTQ07o@_x#ed zU1TNGCG8DI6ijnsPOb{9bXzeYu+nE4mg?R zx6~d1FY0L{6dKhnp|+xC1o$^8J<(lTr!?$Rm7|}NKt-HjXt=1%n9=inoo3kkIu(o` z`L~~8zx*a_OQqumr(6NMxLASEFdqpSg<{3|7EZO`w`bUIa5@40!dfsiELv#cJ%+2f zyAnBj%{);tlaE8xG>@zerZ0RUkR_`}8FPOK_}SFO$|e&;_GaDjw$`%l8Mgn^D7A#7 z-vz-h2!p@v@dJPNGB&MSyQ@Pnx^l++4o5K=h1H|S2OW?e`5-&2L$PqtWq}IoAu@6M zCzZZ927c-Nl=;4D0>gz?SGjMSeTY_Ru3~R7X^Q=%tgrigNR8KW19oOiPSdxQwcEMN z{8Hskk==LY?1wQ`rkgQh%QpSlk!w|ccZ~f!@B<@8Y|!slJCdd4()^#T=vWj!s^Zex z?+(U~+N(l!W$iVE|J~&aCD2z*a?9f&-;%xqDA=~kdgIV(Pp^+QR&sk^OlN< zFPrrC&9V>sU7lSCJ$%@4fl5qH?4=HYv0;agPi%FNZ9iS<5H@1Ln&`JjmVI#BC#|$b zY}tl2rj!0ipJEuYbnFDjW!9&1R4#Yej>9f+6tX-Nsj)^(e1ppu6G_WM(lh%1eDIR# zJd+rJ{*53?d`eh+f7^6uFZFTxzcj^i3iK5i(h3~sjNJB z-bmVMipLj0$?s(`iQiSnr_P>kK2&tn%p!p)k4$?e#2dBzo+)merg-kCLfKr!HBSXh zZret@k1-K2Iba(x)?^qxM=W~O&76Pu*5YQ45c`)WnrM#p8yfx7x9n@NZxd`IN@KDF zOu+xaZ_#rk@E_+a8@|DQ_e3*#&e4eq7WN`0${Q+!+20Dad;@o#-IWz%(KhD0xInfdo0ADtgP#5O|5a_Ht|^V7RWXo_!MCJ^nL+5h9+ z;Ku^dL!8$w2fwvU2LIco)CcT~*x&jKTmSg+!j^}x%4|$EuXP%yr75lp@BHRu5v%#` zYm)8*^2*b_B=!c?7w2MSB`P3LHsPN(sDIqYv26<5#}5{mNMucy5iOVV4WI6REP3c~ z=i-B6rOOR64zEyUOd1;zSytvcV(7GuFM6Ko_Bi&QQTI_-UA%3=$9ckw7jG~)y(uf+ zz^y%F!NLoF+}txkbHuspbE;2GI`DbYunR*q$4**0%HEqaHe|HZIkwuU=g(Suv^4ckJ!lB~zo9em7Vo zekOe`4d{Y?Z$a_TZ_4|1=45_%7}3@_R>4lFpND(|-Vh{J|i$19F!7SqxnlOxaT zsHM!CyCwALzEHV+@kgf}y)7d%{mhhu;h{29%4;Tki$40=`1qdSZ^q}Mr0Er@)_ue0 zrIoCa8Z+J6*o384yz#u~{A!uIMd_o>g|qx?CmLR^RI1z+Fglnzf6!7=j{DmLZS!)N}rM6o>B+J&hZhf!vkXgAk+jpyO zN<#v*=v?Tf`k>%sHzw14o40U;XIHhO@BRgkUtH-qb*6ZUV&AcrRH09mR~w!N2TWZW zDjb$lGv(4mgH6Ndxl8AqRB7FN>v-y$sai8;3cs`4TKZ>t-S{gP4y{=({Vn2X(gG7% zy_MOiGrvUmxE$R$!No$mDD#nW-Hh`4J+XNo50@{{a;THHU%fV0XvFBW$weItWDI`s+lxkg{s0AA~Y;9>fJm>o^g`sPMla|?NXIUg@WT_0FvC~F9EBQsd zz213yJMv{A#r3O6BIP%?b!>_k+bghEHhRa^9@BRQ{_&TOzLzXf6!-WXoA_E~_+y{C zebbZeLX2PQ((V`LSNmRxU9H&i$p7tV$wtw<2eX>~d~v2ujYHknuveCbqi-4?~k+wQ!7@uBNpWprU~zVerm zrxp$u{}>t{d(}h!>8B#yko;vq>&{Cr>k#|;=?E)h>gv7^)8s~7S}^DRu(j^4U+3&k zt-ETtZ@l)r-r%@JA$5oBH`T~*j8xKFtZeB_o~jd_mEub|biMoL+Q!#soYY#LTGjWS zei)ahVqP6twj)2RHQ^xYU6lex7}o60f9uRfBK+}z&~hSPIjJ-o7Z}KI=gT6VyD7U=C3?Q>ksP< z>6RW-w)UvbGX0%Ly~RS0E2^zfOT8cYxUO_Z)g9{+li;LuOQ$!-9iDv9eYyOmxA%nn z6E@LNTZVq7-mJO0<6FhOM;C|BS$pZ8i@}SoB{VC|h3+%2Cmu0Rj2f1xT|}|oBcpig z^!9gC9lR-bON@@+tgN8!c>VIkhpv4~y6X1(Y~S=v^Z1&_%kP>-Mrs$!n_qeqnz-_z zOYGSImm9@@s@|!0pQujLwk$efWNq`f?s}qftXrj{{wAAbrHVFV8)s+ViEBLznP<|w zowEYhEzolxr}W(?{dd3WCnLz;H-G%7EP<+<6P@?F1duG^Qlvy7bQPm3TemRan&;HA#O;`OKAKbfsm z^lsy>Enc3LU+ygmG;e*bzF23{__%nXO}kRVB4IcL{Pg~%!e9SiOr>mzKOkCD!d~iI?fBIjRjY1)^-^? z@3TmA_Hvqh%{*dQqr)s!?qKHe=he&WODI})7|L<+U!b!r%k3;&2Ii>;dL zE+Ak*S=qHt)o|52t}G|X(-BUrTdtV)-0bF|id}aug-DC~DwG#_yHvGNe8cjd ziRe&g9;^x;L22z?|0*imNo%*W?uqHKl>5S2^$+w-A2@h<_{}+@?0!n^?dq+CpT~sS z)^%&DOx3vOHS=?T<*Q1sdt0oEOcRn6UXDHJm7RK5yF2z+>)l&BQwt_EojNn}Y>Mo4 zYa88FjXU&QHiq1?KiI%>nHin`q|I!Jytc$N_1h~?{buWx^;Nk(^ew4DR(xMgTV_qC z+m?|J^%}-y4qrV^=l0p>374%W+UZ#eB2pYX&_w7^iPyL5}-!A;n=JkW+CX;ldg-#q;est7r&r_3o zLiZ~U9b+e)@|9-f`y}9?DFV2^KW^sM}zVKS%11G0?KYcgv z5&2T*`-zJSSFc|aCvVccZ$rSbRFecNai6=k&&JMQHRsXL+ArG{xZbcmTI^*#OXTcw zrDZDK&(AQ5r(0T*mrBeWJ*R1-u@mKEK6mAu;TARCdw7R9^E^dHtThT&Dk-A_Ij$KJvM@J zn-t3L$tXEb+pe=&-09QF)q3799~fA_J8Y8qAY%I1uk&x0w}f@uf4a(&xhA4*5ZPJl zmO4q8;(zkJiPX)o&O+C_ow+?OHpvGaJd&G))^9C7P9JJzz2x5PBgsc5hOCzgJ4mt# zj|!O5d~5bh#g&hb{js!$dMn3Q&p%T9)rLy%Qh%|WT_G==-}|o^CVg=3jUB?9C!dtr zIi_aoomci^t5$~DKP#H~Xw`*>E^czs)eo*j&phE4UUDkPyIWcSUeP-a*>5OT^%-h$-dX4N_bzVigC+)x&yYKlgcjcWf zZ}W1#y45>erF8X@oxYl-roSC6eo1;pHr)~@Ng0x|)hc+m;=@^)#s_j)Dpki^K15cH zU2b*F`@8OB6^+#%hT0R=Qx%>$)7u-{F6@}MSoh}j`BpocmdSsxNV(l7W7@3CvKl}A zwATIY8y7K;36V}Zt~JoJSx$Rhu)n9y*u(4Qk&KFlg*~(V(!-b5elpG>8%=)Q`(aBu zmW^MD-E4jy;ALZn{!?&EoH0;e)_drE%@81bB7MxXlyo{Z- zhu)e?oot#o|K+}El^szolO*rUuF(y%+rPlm_f}6rW~fHaZhOIoz$qH!m)_m#1eN?H?#qjbCP(eL(xQ`2^Lvw$Dy! z4IOE!B|f5>TeMQ=O;$T%H~O+ogJnpmTW)HG%dsc%vg8k&G{pm#o>(I`eP_j^mA-$- zZMtLk+g!297X_Pl>qWBk);{#QNd2P^OWYDC6?K?{(~$#6-v0A~Ga7#;IL7<)lfh1h zsYh43WKWj~11Rs__eD2jlaI^l#mGKMUMa1XaKq8wWWnjaj<(o2Iy=-(PFrDKX)vQP z(CKzrz_3)`?32GWju^2)O31olWv!)%c6URo!QO?%ilzSH5{p;RuUs!QWo)ZFwK?VR zknnpKGi1X^Q`Wlu@p4LwpbAsRQ0lbBV>3}}Rqy>bpS9>KURGQc>$op=wam^-0yk8J z`zDs?t~9T@kYq#h_KsU1TQH9Fg)weQNA!|gPv#E$=(xvo*`9?C1s=X3bHCj0dUw9n zY>7_62*1p=`>q&}ylzc+mJ%7hdHCm%A2$caeVdVTvV^i{3dQ#0`}QP5ESkyRCg1u7 z=4J6e&KwAJ0esr}57I_bA=70f zdg54TOVFi+6Mpv6-|f^i&OPz8b&~&_Ia;u&?V*9d(AAb&>Nh9bJ`&h*XNvaRrzhPP zknd&4+EarK7w`Ny@6Rz?6=!-ny}2}=oPTn$$Gu}N$3;7*6|{dyS6UT#GU1g_z=ff< z4PTm6V;;D#@*TH>_Uf^!yiLRe6OZW<7L)oWkjwTy){M)zc9b&DA{7J$N$jFWoZ3xr zBa{E@G1|)5!`<7_-P>lJ-*!hYYxalt(YkzhfF1ON^cjELwrH60)vM#SPj0x8xUNgk z%HMcg&(Wg!9o@f)uM>)wT`$)vTcTff>ixln_vc?veIIxE_2~mEU(YakDW+j^>jfkC zi=TIatc2}^$=jwokR~LbWIi(^g&)t^Y^*{m^ST=RxaI~+HK-*AY(vgBQT+<9+r|0y!7ugY(7s0*CZ ztbONLi`Y?#oOA0R+zop3%<8#rQ-z54gzBhDrdsoslNWQBv)<==&sAL)yrgqXz&xe5 z)zz-XG{epQYAHIAGO?3V`@(HLNxg61zKT)WB&zuP1`F#Y`gcq%k|d>@-)B#|BkGhc zTy}fQirL3&E?;YNZm79f5Oc!6PlWwsMjNiP+5nzPC&(FAnFtDv5csQJvuem5kB{Kz zWy1voWWdw=`xmI*IC!|ZfoJ7~p&h?o9WpMbGYo|GDJ=m3rN3P|4xmcl>dl^ZJJ|;~ zZ67z+h4`OmOap)Z^@T|G&QuZb7D?d6*!7UVzM91U{zCn)_;26Ne|{Bx@Dcm@?exD2 z244O8UVbia{r$b{8HT;ePX(>NN?E_Y%Fnf*@qgV8_)~N(iIcL}uP^vBR`>U}mHO$| z7yPS$^y{nq40iqfZEb4&^;LeV*8PR@{rZAGAL`i{*-@ZOvbTc2zS8?hKW_}bUik9|`|opql|>TxH_PlQ6A|#a1SbdZ OPapWGEff?3-~AtZP)+;* diff --git a/templates/ScRNA-seqLevel2.xlsx b/templates/ScRNA-seqLevel2.xlsx index 09c7f2300e552f3577a0164db8c10704352224d3..c1328dd7bcdafecc76fc95a27cb27eea920e76f0 100644 GIT binary patch literal 1065761 zcmeFa2|Sc*|36;GDQ&1EWvzrl388FL+N>!gRL0&R(IP}lg@o+c!>J@hmPm+6h@y1H z8cDKc$&x)|?*DbqP^a&6wkPMlUjN5$p4aQ?&@j_|eXh^`{=7d2R2hC=F=xSo1#>Je z=pCN(yZ#dk^MPJGMuBeqk5fIYhG$Au(a+<-EM)8X>=Z`b2@({*jS}zJ9g>P%EYkNlp-qq&1 zUMdsNR<4znw2%|NmKTss;Xnpi}FNxQNl_PUcUY>yq_2kv4)t$zQHlc>{Fv?;b-Y0?jrJfOcilMrRL-tQoE|+H*Q{e^M=2E*l+mjJ8K-Q zESB)O#mrgg&@Q;1YuDF5w=dtg6V`wxxmdU=WjHfcOdVGy5+*-X=GG zHWJCJqg1gUmNZ+$zgZ|q>$&Fb%N0!ei#T4$^H1KlCMq9h>K6BT`O8hc&YS^7X+7nF z_`viyrzaYL5uy#J$_0cX-v^#h*?q9naQ793;$N=@A5IJiw%feugb-Pq|{o_%%QN}J|GOQXtUZWy$;dPGHO9CM!J@9gH3 zVC^&PS{Jcn@s3+JHm+_wHk_y4m7BARMfyT>$GMIr(E^z_%7k_gWT;o%xugI15Kq|1 z%A8zFIaSLGy!(1hgyiu%6JD)W_q#jzVdIrIW||*muPB;l9G@HSQJxs#opdh_U)ioI zE7038*Liz&d~Uta?q%Eq_cMo!7hYQ(^vSXyH#lv4k0{eT4ZFsoWBkKBDp}fNKhHmk zn|H=qXTa%NhhB=tEv66vuW_OZB5X2H>3K{ z<>|IsKHIo>lXlv!xvlxCIDy?$IMj*1LviJvRVD8iKI&V^U~+On9{$p@{*&?h@)O^u zh?G6~DQeZSXD`D({ru}LuhllIo9DdB98C1vYZMnIx60@@jr=)kOP@aAvXqn#3K$xz z-aG$YfUtvQOVX}WW=uGfRX-Iza@BlP8E)gE>$%*)^yb<+l4h#^yvs>kEi2D)r^gt@ z8j-H{pLdX#tG|4%yuS7AImzy&{nM(ZjfkV-4>yvBgqnC7w~-69k@Yx?|WHy2STg86i(QJEC-@xZxz+oqLKW$ap!-XC>o-H>u zv!XWbPx)|TQ)&TY!I4!tZ&^-rG2JNiSzjJ1)p4>tpZoFEgyjalj5{NkNM2Wx1?AiM z&B8ywGKf7)mfY}kOI}F|pJZN03g0>RWP7HBP9Hn&gwDp(;14GB51&)uk7OJ0N2WD* zf=2oyrpm|$i=IWF41a!^7Ctw5NkjFOr;ie1KHZm{AT_+*bMVw{ozX9%8tx_1{CPEv zzsy_AlQ_Rw+l2e>oI{y0Sv_mZ5Be)cJJeinZY2G7PfH-7;z&q+_;Th-&iCVv`FEvr zWtYCa5hZ8+9{fdcXpQT$ZJ7?6?3=ERBsc!V<2+yx!jvs*@Q_>j%9@|;-+X+vH%|JY zaur28h3=+ z;;#*}K74Yq75QnfTR}vjnD|5_Kiics_kb$n0$v%e-OBUl%<<=#Gv~mcx*<-Q8!|m( zWN%@8{H&5~D$kFrb4t9>8w##$9<9*FHv-t;>5qu8&{ zgNwsjm$&K%Obi`UNpGRj8c4UM$7?j(Qu}26gXR{h`73lj3o`w2v?1G%CD%YCBu%QeFukwNsb;^4zA-tSz@X z|3pm5IKtVH)ev{4LsV4ag|ynnd#`)^BAue`912D3^Ct6SMC<@tLN<} za;1+A@PAahtK2rJtMRf)>{p#VA;-87^`J-3meyV~Y46{)+O9hz_ZN-3C6%v7hT7hf zS|Z(k!#!#}@%Zvaxy;iA_ZM2cRM~2`8(M9>eC&sN_Sc(^6WcY5xKuTCa}Nd z-lrCp=bctpGkeKv6>v!k4+k@m<*EY2CTAa494{l%UU)%^N%HpM;$KDHvYpDor^c2c= z<7YeZ{IaH|sO($NQP*EA+HdR?5 z=XKa&g}cMGr7Y?ETX~AF$*pJ;yCqi|;(vZc%HW1YL#r4fQS5k47yMKa zPw_o@ucz`lj~L%9cl2u?=GilsSNOfF)xzR^gI<2O{QcNI?|kUie*65(eFtBcEc&wM zh~n^XkGpPf=rM73_9rUNd9!aY-S5^TKekcubG^6EH}2DVTjDhVes1))$Gx{V_L>ws z`)|5A@k@JC-_5`Hu^?~i?}$-<=bwM`UZ3Nm!j)R*t;Nn~PV<_oQomX9Prex^+8ul= z$WHxdn>aL<9C&+oDear{|J^qQnHjI0MN%eKc}=YNpimk@{YLk{{$>zAeDhI-=35|$ z9F14q3Lzg9RB2DNJ!JyCoe1q5TOaqDZ0voog8EMl8qD!?j+_u-K9)Pqh}z1-vO2hy zpXbbR*Z(V9x$6Je$|<8s4c((&AG3bCWeH3c)foM^Lu`4&H%p` z%(vgV{H7vh;WU@$WEpO}@1?cv!?E4QtQYvY(wEP3WXl*h#>d=e^B{P`w#&7Kt|fbq z`WIVIWUQ7-_b?y1Q zV?l&d(W4lF4_yTe5ezMZ6!luShmwm%cSdo2*|yegrSX?}qvr3E5*Y6vls`b8`;2f| z!s{mwsSu$@-5cL1DNf2Q+(zLTZYXROSX@t2Bdm$>k5$W#Q4IWHh#Loi}&R97cv8I7)Fe3!)$8 zj~u1F&6yKte=#$&Ju6E65A{~wXnYeWTpKL#QShU^|9}F2@u|42%4Wiib3HUJnw;8p zQC46uK2V3NYJKo7oO93$*SVuMnZD^ZLg6u#Jn|Mwo^p6~VmywVf_(XMuZdhz(wC2X zZm^+@y(zRIAa86GTn3A?fSZ>_Cj4T2?hfPfkRItKq<>r*85uv^+$% zLYiC#YEy77gN033E{qP`t00UG_#u--!gy#OKF)a(e{JGRnP~pR$b=0-F0>(zjdbG$ zCdUNFKG^dj-QIpUn;iPa)?bgSA9*r5_*ixh3WUo=EO0E!myAlYwWfU35fqx`F8P8II)Wt;dwtF-=hfQ`O-OVo%qB08+ zX)G)>t{Uv1h)@P_H63`eOlLR2syxMqd}a@2$RlPSbJJueOA}?-BPE~Q-qPP_laF-Q z;wb&d1YW^q_!EIL@PJpeSM=1_X95C_u%Hk8R@0 zKdvDPo^`U>!-h!d1P6PE+|M^To@;}|_%)G-Ci`$M!vo$in>$4JQKUZLqg}31nwr3S zHBml`mTf0e3J70J8j<0$80X2sdE|lP{l$19GVr>+rHK;4t1$7B2!6JMFxlntp&=zs z6#3*qKz`#POpJ6M#$A|*Azo=Bk2FTcC=3^8;hm8|AlHmg*OfNJUP_6zyAWEi#5hE zdl5^DeRH7=FNHFE-XWWbWwf@LmDe$wnWeAy)rGEIqNB~tlZ`RGtnztBuX^Ni4)izN zB_f4R7qXZ8r5yh7QjikDgSRefDa4UY9LU2l3;jk9_p$a3540)DDKz45YeYF_FZHV! zwP|6k{W#FJS1$kERgbI~@_61+&yp-8h?o+pIxyBt=$8X;Q`|B!K}^w@T!`;2Zt=*y zf*ba02|Y1jOW33^U_U%`Ml_nIm#{Ksj8sT88^Usfig@~ zkwaJ%hQU9o=`B)+8)g8XRAGZKW_6CY8OsrKk%lk3iz`IgTgE3Rala`H@ZQL(Qi+f=<~uM_OCw=@+u&eyg%@Nj`GE&JST5oZubCQHCaP zm^S8)HJ`8Lg*s77FCRf3Fg811yI{wChU3A^HmPWaQvMrNx zzlDu$(Z~?sS&6IK>?z`s=)7Eyted4Q=^fLJexJJQ^UY!nyBIY+@-HmPrUMV;1ppuG9X_tsm~n@@s*=Q3bzjn*x5UGLN4SQmi2zxNq#y*udV;OL*CF zO&bDnuRbtxnTa1CVD$|Szgz6LEwE!OV{G-lVAGYjR;B3H$`5zB&IRg`!)_~!m&Kfo zG!4OZY<@06c;y_ZN4XJ{HJ(A0kw-KRJ#! zRNa8gw{dZ=US3niS1q2VC(vbfOHVP^&3fVF@`q(9Jt12}{CYw?3zz$+2aaQ)k zSrOK2Ix-aP;_Rs5ErF!F882+B{CsnhQJ$RUCe}!^TLuCV{28hrLtcv-<&s}mFD(3A z>Jq+9r1_Cs%`PX(@J)G9-umTU{MReWJRZ6Ye^$y=vkLKa4F4tM z_2!#L6p3!1J`3maFDc`jF#C||*0OxR>Z;IP6=g*kYDYs(9ea9mJ74_fkDI;P!Ztil zTKdI%(anPRfcX{y%$>^|mv~*9d-KJwWxtmH`f}B>FV{Nvo3ng+nF9U~9`2^D;<)+v z>yT6fo`ew3m*NLSSzj)%=eJe;7@B&_#VpIs=)5UWjVt8T(We#*Th4quA08IsS+@MX z>Z47^f3BX_xF?N^l|P(Kk#KPB)>V?EHJeCl8uqP^H*rVqOB$?Z`>&R2b^RfB@Qf0gI)V8Yr68d`6P5e{4 z@!-bgSK0z5#ZT)#J-zTQ|FyE49cIS*0-IGIZEk*eW0^L)Eqn19wdw;>XjyDtCp z`}$ge{N=TR2<`IlhOnGm*xeRj8D1yCIxPO1$jxJlS#B;18`=)rsjdpyH&Rw)w6KK# zM#z@U9?_wm7U7RXnseM5&g?yK?Deq~Wnu>d_0|rtvnjeBX zkE@xlJG=9Ksn2$!1fzQgw+N|d2|qW#9oQpfnGm3#5ajs$N}-pDzsPp0?Md5vw(or& zXOeSwyz;^^rSrNJ{2gSm=9)GJ;SHq`T5RD=;Sp+7373Z0eDc4frMPssTuq-Fl^MM>st{9=;;xi` z8PneV^aTT_FgPg|k>oWe_8&5pGPM+^o$itR%w6;Me|pa4&v!;~uRzRmHPg+dY}sOh zB9c~;i}voZu;hPZr5)I~cax;1@HtJY$@FA3!L*yJJUAz!lLjjh_~RzgII@Me~t zM{DM3Dx|hwPTGDb;EjL6^Q}tWwn~0h<2B5yw`B^R-QiohaCP_v0f~U@HHTZD-AJuU zt=_PT?M_0l>4SsHcAS}2O378qd8UO%#bQb!To1WwxJI~cn^uZ7R+269Hy6vLvbnBM z8h>KEB)wgGkNK`Rfl8{Xr?(xEHGN+dT|RgFIzdy@&*9~}+b+{+aVcAYLzs{0h8Ov!0kKFrEosN>+9`4Sox}bS#M6 z3tp-v6HYS7=VSfw<2g)2;9P+g@ipwgMvJ6ggSQ4+gkBR&OxgeZ4g8-M0#c0tJD@?c z18LaV0r1wq4isTy2T&=1w+5=fijgWbBFA;;XY@CbkJM{${J>nGw+SP2LBFVf8Gc5$ z4|YqvmY_KZ zcargMm0cM}e~eZ@Hy*=3Y_YtJ^9f7V=$15k>Vy zIYnQJ0(<#3;;s}0e&OrH1ukCtoaw4qS}SwW)(6EVE;&x+RvVSwwew&1h&@PXEqGD& zO#5Ua6+mOr&2CS6UyzsJYI}V@>Eqaggy&Uza#W;`@6ohh@4T=1(T1S6;IRhdm#gag z$)pLSNu_O0Q%H-QPs|`huHEQGFI+BC|I+;MxchjMli&dS9x4)eMl9rG7@m~qLTHF zYo7e}YvRH;@eDSAOVWFN>XJ-oVSGs%8%@j`RD@zbyPNxk`v|k>#7V_jYSA!BM~IJt z=CkywbI0Dc4cuE2qplvenRF;;yKrC*U#IM%l0D(AI-dMd`+{{zj#ZwLo|&HKJcm8` z8~16tEb-(Y-bW&=XI~S@xzxn?IrmiybMF!|1zgD({;4bJ8-neXq?{TJd-E}HQNo3r zZ%oYZmAM8d_$1V8Q?W#(8qwa^0#_$3#?B24O5< zKx7>U`9m^z&Kav4pEN#Z>};$&8gQL=m$C9>z!2~Ac~@KK7lrAbVKk0-Ll(omJ$X_7 z(cJmy!;Si_#@dwRGNm#~KlxQr2>;7SSmT@)Lo-X0M5$^j5-VfaTh^lg{ky82GAe== zw&XWerd{if-HCj#EPfLdgiaf_EP3I%yBx!u!N>?Z6SUM1_+gl=}gV^PAGRNs}uz7<&OAxZj`(?lx4x z?SpD5r{&fo2E|e~Lba4RG!F;KQrbeblpmp5N>~c_l6SBYn93lU#@QlaH#4z!ac7_k zt`(}_o?S24XS*9tmPHa2%?otbl7NVJRG0jF=4);ue_J(wO8NOBONKB*Y@6Kkb%Ub1$rC$HS-jn+H4R)e$euou8;QytCM>eeo79 zt1!#(uCOj;28;FTvEhWrfh&0)i=7jcSJEK87!U=ORXbATP;-(}V?e&v>7$mjva4GB1J6V|kk?bGH8 z)jz{7)+y%`mJz)_iJh}(Z;W&x$xf|9$RR*=#x{aMu}#LCW(Sfu>o5H%qasZ`VRfi zs-lM0$SVt%5X0)j>XmIs9uL-?+xKOE@#zG9`(;6|Dz7SccNRIO?X+4ESp@nz<9bD) zt%C&2yK1#VN9@fdD|hE(?UjpDW1y)MT}*T_(QJ|K`EWv%!NtiBi?NFKG_fHoyE=!~sh;*aXcDN<)iQrVbB6v;yK|G}OaBTA_<+CPC$_5>uNQH`#Sl}62O)-d4=aYCi)kh? z#HRu8Rsz$+jY!)j(wrs}*9g8uv zN*L+{!iWkGM&O`@5%4N|h0wwXXf;HnA66IvuUa{M^{@{k;FYggpoI|-)Cq(UNHho| z%3!rT3DCj_BDCfz9kMr*%zf(WVc#&Ow807^kSP=*_N{3c>IA}wK>$phLejk+7k8y# z*JPl>5NC+BrK3e>0KTT9MSln_8XP)~)+?t=IfG{NCrdDErO{!CGsOKvs7}#gh%E#DtW^MXgWsvfa7z zoo3sKLEfCXo*#Gf%~hPhE9o(r&XYNQ#ku|T>Mz#THeat7Df7LRPqXxry%@$o`N3s+~1iJ{}(JYK8d989I@&x)qyga zVCLDLa(cbG+%}0!e;OMHV8}>d?_86&oyw81f-6+>OfX=s&92o_m1AAH9<>MJD8^?(_Yc)x=%vj$lFq$4k;8JE~d8M|A#*yJ-VtKr4kBpKH zjpbop$(`#*`N3rMN-$Y{HPe_%{eezaOL%@iSuHxn@_^zD)&%qB(D)=G5;(O0BS!)s zAQ`dk;N3?ma+T0pOq=0u3abxy3}7Y!Mq!lYq2TmJ{==Ti9SOy;!&{A$b*Y3LC~1n? z_oOK!-ZYj6UeJLRQfl+qOyiR>c#GAca_T}*T_ zVXsYgdEXdkfI89mBy=UtnIsw|@}G+Z3@yFn7NrP>Q|6XyY0N-?tw&3gwA1k{m9J;x zw#|21g#e3ACScLoo5a?Q@}^K(bdeb1eTiYxPQ{!O}SheLL0+2B&7tJ=F&fDCb2U8^ysHYqh=Si%PuEUDiFfl5hS0uSt0># zdmb|<5#+Gyrvd&7Dib8l8=~ZvSXDlzSTt#&1WGc9mFXkUP=vI?2g(GA6UPuTuA&t^tvb1y>MgC${{6}b1r?ey&WpBj>Kmfvs?SN1Y zMeRc=S5oIipcEtERoqb2KAf@#yb|p6g}@%X0h*RMT_8kp6;Bf}y8Fawo45Af0w4icUi3yBn5K%HY zl%55xQ&QJ`VpXR^`6TFo#~F-gz(CT`rfBG5qKk>T^cvp-YLzzt_w95U2lMd^c-1y| zH85zk6?o-Wx|n7Vt;{Ylf$&d9d=~3o#wyAT z`mvLqx*m?Rj+O1)slT1_yy{t%_mF_|HYy#*R<2N;GlF2)J_-!m@3dMGS!ABJj!MU| z?t40pdtd~fcWNQRm8xFtW9IpD3JZJ_q7yD91Z)j3*IXMlUb5JtxjmHt)$}XYNO`FnKhRx99kyTg{jmKZK*zx%`h?0#zsu4- zkv0NfqFqt-q)I75Ng~1j6}iPdqyK$y0%zxbM}Hk(f_SFb@VY!@UK;TSQ^}p+x5{9w zUr-?V_)^Ydfi%6Ot0?iugR9>Ye+Yr1rU$zrRiJA#We?HlI7||cTN+xfSC0+XRys}@ zP}Fzme^KRQD=4odT!IU)4|5E77t2DUO}WxSQt4d}C`MR=Y9y}u7zfpf=oF!}DSF@2 zrdS07;*UZa(74LKJ}QwqY+olgHz$ZEHn=55?IalM zw;_4ZC`JlTTkzWhf|g28 zMPuC=Q`8!j>`AVm_#Bkr19)`Qznr47WLRw5oZPw}P{GImDj3(g4N{&j|Jp=M9UcV5 zMN=Or>O>dQOzi8d5>vGqrJF!O=G7t2gk$EKz;DPLMFE(Y*;v0qDl;X`L816GtQ-`M zg}REH=H1a%+*o;c1e_RHV@|W>C=d=CTb@!zo;Zb4VA32Rl>!qhM~L^Ju7Ib-D=119 zt9S)bfOU2i%~aqo)xJ`}t5~@~0ff7T|#WaH$Vs?pX*o<=CVeSY@CkMQ3r$hKo1Ut75@=hG!P53kOkHK0+8mVQN;1sXBCg6qH|4*beG&Tc{iVu*%rcdOS+<2E`2$p+zgx zhlgcFnHH^}m?t=G6S|mwsPI1v#dJ?}5D$WX!jx<07M1vj`FN{Z4cY0ZxVsFMfrgPM}ul43cSSSa}8ontLLkuyZIG4ZL`z30m$1 zFEX0CdJwWScrh5dQx!@+2t%Df7=c5vD^p!u?869@d;v}k5gsN2C0~FOM!-W~ps0N) z3E}kB!#<2axlG`M5jbe39ELi9Fv1Ch5u(t-2o!?}=k9%m6-E%Cl|6{i?j8!tg=5O6 zt{#Lif{uXwAp|T4BVqtBb=vNglq~^!gXu8D{|ePReR$YoZQ(^m@ZyzO1w*7kqGy$u zbdI$Xkq!iZak6Q&)=U8P8-->9lO@>U5Vt|Wg8>}kAS@hW3M{ZF5gKUk+@o@bxqE3K zd6caavkG<}tg}P7sB6q=NII116e~AK8HIK4VxXKIh#~wy48c1UzhWOl&|!!(nAf4B zMQ1R;HGRji5A|l1m~`;%F~0*m`i8C^;>B#dfDS{P;q0IWwDQ0d)RvAGMYqWRwKix72u&S;9(;E6sho;XjQMw{6OXU?&eL^Cn(mde!{7-JQRCLVb@H& zbm;wA^N(7sW=o}yD|3vM1Z*96UtZ-pv_4O1aS1V8KfGQ^w(~ue5JBtIQI+S7fDl0& z5F%Kn?M-6qE^?$&F9>|2Uf82%x2C%okURjUcp}hm+8UE^(I=-;jk{iHztrAksmz@q z$V6^Yif}k(-nG*)&>+^mrAaMW?PP3}EsZ>2D~pnz4%o!$ z#7U9%%h32mR&a%Co{F11gh=@;4@vWkKAfj%hR+LbPM_yXCiG zITD8?s{Qpf_jM^VAlm{3cy5F{`bWpITQrYJYYA&{S_pE}_(c}^s&34V1pFc@YWfG z|GC)ct^Iy{79R@26Bs*{9RpVS5+pLkGXv~M1vC*Jx8>p(y1{8i z|EZO<7`j1GXweEf#Q`T;L1!zVL@RVL%_OLtRbm3`yhcHihUTYe@K0mF#L^8;G5Y5m zrBX9u=mwjh<(=pl0@m3e%?+Z%0pIqe)5Y{(l?Uiz`k~k#tn-Qi!9Q+FooMU4uuR&g z8U3@VG_e>)D=1?Bck2={j8;$_J)GLg_nSKDV*0O2m2@%vPzfyeXgeMmL;xFd-$b`~ z5b6pmso+bjbe9lC1;NpLE{f|*!lVLQYet#)zYCtRG7|r>92+a=j>sQF2{dWe2<5fJ zs!mRBfpvBjl~k5fTIz(7k79N2i2rvBH&*r)QGg|+4k$tbSw;$oA*S=rsfB+SDJ@#o zgO{|UzzHZJIhA?=N_l`vy#S?DIej6puNR>x12|nsc$KN?vR)aLJ|8O|2uq#7J}>m6 z(Ec@)ZU)-?hZFt7t3*tfaj@@z!%L>8FGL%4bpuu&7wr~9tFBO~7vPw3XyrB->IA|F zv=lL&w__hhz{{r5QARjn1hn!Bm3je67%_bzun!}qt6EHB*ym2b~Erx9dlzIV97(s*&H;FlVPH`H;9K8t-!04)5SD{0j^mkCcC_HB8vN;s=&(N(NR#Wn(Y_B900-~NP+{=V67n+|wl8imyNHW*}NruiFP!ayN z#Qgg`+}cX476MV@C5tVZ3xu_#Nl`;re4H|%sPEAKqRPisP+m#61Q%W(_7}{Gd#sj6QfVIazR^7Vo~sD$ zuh7_JK?=k*%_i%RE$uP=q$$>C@p3&2+s-Vjb*fG z8xz#x)cW(4iAh)0jUP}6d%V99_6PyOp5*ku*u$ORFF;b08T4Z(J#{@CXB{isxl?~T z<$2Y!zgX}rY#dZ4LZ#7J_l-u!3()A?14J+=AJ-o)covHF+#2+X+~S_m|2{Z@vva?r zzm6|KJX7p1mK6NCeVxcD{~dd1B9()vPOMr&a*Jf(B8zn|VwN!RZTd?B zOf1|WS`nskorAvRG}k#MZtxEYF#lcqIu)(_;ktAzq7}5i0w-Fbi)jWy<*X9ZUlL$q z;Rex)FdR3C7ViIJ58uCQU#FrKw7>En8_KYVR?z;+f9|ZKizy>|r`3wT4Jzqk`k~k# zEd1LJ$^%o&n`|FbyB;Qq$1M#l*JI%Z(TXq}H;5MQ;Y2HcxcLf;XoUi;wn7)v3`$_L zOH9LN6m%u%)V9PQ0S4Wg43aH5qzTs4VFwDO1hROw} zaATpkf4qbni&zhx1chVCr?1}kOSZ76fuWP2aC`>5_!WXWfm$UZ3-SzJT2Nj&K%E4| zq;Wzk>`_X<4EL3)UhEs5^iP^eyO@4@^wUe9t49S8fR-l#APA_Fw4mbl{k|S7>R?1@ z#Rzz*hA6bM2fSz*9pZ*#%b}%D)FJM*nX-py>l-kvxWUV(VW?BJ8D$h9BkYCnR~3dlcm$r6n~j^HzP`vionNSIB)(?p-w?lmOKTmZ?Oo z#ccj$i7O@mjHw18y4MOygAfNTpPoLv?-v>V+ZO^|yNs?MgVV>Qi|L0NgfwvAtP&Fd zUsn_^PK}w0{;{uDqI<2N#IMx7R#2kK>BGam;)bptgVV>Qi)jWJ`B^0

H|;{4h!= zfflfRLst*+Vip&nZV;u&hT{g&g-KANmFdI79(*kdttL+w(+@QWX&CugB_=F|IU&{kf#8i6=d+;?8nj3`Ig@o4|M0bWmsjbk( zG!yXktP&FdUw8EX)HCffuy1DkKLmJ0%qsCAOZNuGUHTkMN$jQMSau5hrYOCXeeL^6 zUQ?@QNvn3>xZ`_%@8;HQ?*!7(PHh{x!}?tXs_Mst8-*H$lh2WF$32X2)NwrISgTji z$4s%0klDQH4C5-wd6`udN5{H3oJOoxSDKp`ak#}xh`2Fi=iJNlP2F!Yys;Y@3?oWC zp&XHZvPd$xp76_PSoeJ0?RC{vX>ng7ID~wH<5bSx(aIY*YLUPwDtRv1_MUA@M$Ld< zM7?E~Ugx3CW5?$aWyhKqU(fZ{8pU^p_jq?ho7CjbBE_~ zRaGV_nUqJ;FTq(_-b*-s=kOi-C^mBMd&1p>7ScNVi_I~2U7J(xdN8FflPWM@MRD#Q zeDI`y!WH3NvF4W@I;&*-Paenljh|rXA)aGMI-r#>>0#%WZGAD=^_V*MiNutInv$#K!a2Ep&n>GbEiB2jU^s@`wsULiy?Um-^G zNIltG_j9Dt*l0mT#ZQHOEEK|li@(m*Gy1sWVbr8tdkRx3Qp1$0sD5XJw_d(IXRZ#j zo#eTsg#5TGDkgX6Lj13VI8j2bt({+opO#`i@7bG3HTF^@cFotl8K*hH@`>jxxU!77 z5i&K}c&%M`(n#7C_iYoUqlGsOzrPcAKiE3BH@HTIa!~7ty1a0nP+oV^dwWJiR-HR^ zWj4bSM2>q2L0;bKqEG5Vslxs~*O-`jSDJXq$ggvDGNeC!eaT98;(R%t(~wXN``RRO z8oEcQe8Ocom4nme>apz7)pAy63Vx=dbtjvY@Xq0WMwM%5M2=3*p`63|-DCUIPf89a z4J8iUe{i{po7}hc+)@2j<}Ktw+b!hbq13rjPX+3h6cSlnTvo1fA@n1zKmE*9x@Z?; z`lp@_F~Z4DD#EOSnrPK8PtHXU-it4BNV;01FeJP(|65TXIzT$%}&falVq(wN(c! zlC~a-5RU5d=}=LXcSuM$ap%Y#r#qRxgsLhXtqPSCl|C8avBm;qzgEeeJ-u@ZaT<(; zcnua#Lq4m^FSn2<-gg|o)I7?F;5O`deKBc^?V5&HETdMIE+;RZI-iU`d^K~%(E zF=POtG$Dj}J;><5;0+_Dq{+Hk?<5s5(P*Q^uMGTipIWENS`~A% zv`V!`r?U6>oIkkimOyMlX@&}qo8>NOm&UmR<)4H=bteAR5DUQw7T1DwoMn5d9qmD|=;;X2P<51dpI)aE5EW^CSY z!|lO=>S^{1D{GCmNa!BeSIBxyElfYgec>o&Qdo%`OB`W<&&o6 z0)lUyu58-ow6k|nZb5GLgH-AEJ$tT3_|NC76gs~&k*U+IYnNm58ZP&s zQ!5kM4sJ?caOhh6>VuNEtWDVxx!;V8O^}hnNpjf;XVRri-Uje!b3Gn#pV`;y*h&jL zdfc2UQs*5PEj?x=UB~_KgD>M5&NCWyi$|V4j$d$)m1JnD&(ETmxi;#6vyv#6+wD`! zUnyp;OWd>arq?n_zQny%K1qt1d<{H=7z9C2PLy%#n=ZFZ@r(&*~5I~bO}Q?Q?_8wJSP(a zZMXP^7F)!V0~v4D`|poeh-GJfdT`sq<2Ut}Rj>0tP<%CF*&)8Jy*fAR15Wx8E2vlD z;n?&8sViXfK!apt?A@0Mh9iVx4&8~g#zD~$95$acK_+HVC{JqeY4dAbtPpbA@Znc> zrQ8AC0kl{!m9HTLd}hW2${vOJ|HOXZD3>o^B*t=p}x5Hm;t(?ftl%^vDf?;>clwGL%B8-(?=u0Nz zQil)I)QDg;8H|-0jn*{rg6E*!I^09b3#@LPQ+FSW)g&8DUwMxZ+OV>8dBdZO4=G+W zAK{lwJcE^w_}%TE94x89Z*N#@zx)0^Yg(SX|Iz4@Bd10#zh$#?Z8Q?@by$Nqg)#yBh-~t}WbLx?L$Jr-%u~b-NSPBaa4-|!sfu*n-uoPAh zmcp`5xg*RKcKUWx#xYjdB3OP8f*Q#o1ZQ9w7Q>1e++kT&`Um|`GJ(c*^rNF69mp&} zIxz_%JDVwwWLH6~Lomz!L1ZTl%OlZ0=*KEFbQ%3{ach@d*xA4S)d4tRmBn z0*7&76)}QTc|r;y6#)+O!gxbG_p%ke=_ zBT#IZ06_z^IwU8ohLsPj$nF^|g$0c_C_oJ&tiEs4v^&CDVW)5RNCn0~4QR!0?A7Qr zVALEV;ExcHCcmZ*d@=yQO}J31DVPD^c$+GS){}>(0C3im)mTANLNI8yLcG*+<7zKQYLWTGVvBLu#3 z#0vG)H#(SdgiwuQ`XkU4FLnEfS}lKSSdvetdwHD3okNmuJjMYOr~MjYfQ4Ir)lP=hyO zOENe~AfN6|amXs@y>`s|7-Kg|*m11CN!aRXu5?dtDr3*W$N@igyTx`kb&Mm$qqmmc zTCUj~l#nU6@X#)fn~qAtJ#OfbkK&9$ggK-^-LM+cVecsX4jDz43A*=g1}JfxHcF z@ow5eQZGry7+B50V1T2Hd+ z6m(UOl<;OzyzDu9Ue#sRolB+ibIe2Xo(ep6D(q!;dJ>(w8gVenG910)Y>2-gx@fJ? zS~i7n{j#6~lCjGYJu;r|uS19bwAl`>40l_^C&Z`1XUX^Az&X=5EzM&{9YA|sIzn(i zl?_l#-ADdKjBd48x9m9y*%dwKhx%0q5GE97MI=JBA z!i4_kRr=9xiEDih$j7qTJw@j;Zzf(%FI}&_>fq{w90xhW-4prBc>GETz)&$_|3m|0 zHUJ_1B$@bBNH?#ZGS*UqAFy_9T%Efzm$?R|H^_ZYJY45yZ&TN3#8Ss9)xs;B>Z35hpnw z1$f7K|XE%6;eg>+1-~0`!9-7OKww+=O8Vp-lcCO*n>{CCVFk~R#S9e7QF1vvdjRzc$xH` z0S9tc7RBW~BrReAx|4Ld`rao$9JmyHQgu;jC(^nNsVpLkDNgR{4x?8ZxkoO_8%a~|5GEF?mA2V2?sI4e;K|C`=@TR2_pEiqydsHeq&KNIrOGJDj+g|Ox*Y{TKHNV+a znqJZ}(Db{zJvmU4O#IL|KUczTlO1;wN~>d6KuAel*!M0qw~!}Q(CQh^pl(xLo)K>y zdy}`~RTU+7jkuc6>$RCI+`88Ot^L8B>P|^rq?7UxM*)}Oe_M%wS$GSM&J&VZ5QJqG ziXfSV7+7Y36_#0m!3Y$y06~d>S*QnQ!5xxWV25QEo5$Efe0&FfS^RcEW86|!3UCAkcMRzo)WJG7CglW`P}+S%6hrz{4^N({~$lvj8hvfS^Q_ zF=P;t0;8CH%?@N$wA9_ug0ClF)yF{|mJlBgAJ(V#agfh7_;HMy1O#Xwlm+RDc!6Nv zeGyKk7Vin?yHhS;)N8BwG$3j-8BA+|q0-97rZa`qj*Nw7QB-LC74+GfuxaWcPEO>q zBZNC>t8J3{Y#8-DkO%UVwqzoS)&c|1_5zdc;Q(;uJgD+m(E6_6+1fB^O`RemS)d_` zn>OIS1S6ywyH*ZT2+5Ztu`-fFGp^NB8F=3QhBqEj)qy%6%zoO4D&Ln0ND2$G*q$4Y5E3y)p zg$`gAzM{{tHVd%A1qh%pnpvPDD}NMl4XgX{^=@NbFquWjN?;ahfmslRRCkB!0-o!W%e|AL@Iz%29uv+%WYk8y1QTAdpL zD2!$nV3nVVu&@izdMmJM3t#Ux)=9)HLROBJAWcYC_V6fyrKAN<1tRhwBuXI_Kvj=a z#O1AD>%H|YM-=IN$|3w&M%_~NWxHRGv$XnEiWMDI*RlF_&{Xt4CgztMK{wbE%&=yGWoKv8jjf*iBHvI$+)jpM01S@$UwkP7@$@&vX- zU#op&1qu%5hhhga7U>W_IiRSxKS7R37p_DXLG!ZoNcGs&0S=IV$k>s-=+M50d@j5Q zK4uyh*<>e&qT)XPF>ox>XffEEJmAM@$7v_q19%_)A-{zl;J0X4M)X7aDyDIfHnP-1 z{1Zs&%hY*bSNB*6LoQP;_lR3w|39P#NdnX$pRP86AhTl{7n#LPJ;Xl&V4Bzc1h$-$ zTP`(TX=Dc5y8kJAf(~F$uq*0oK}H9saghza)I+a zC(!H}-@5Z(d1Aoz{tI%DnVLG>SDu*3hb@0W4l-lI(D9Wg2DLyS$oLa-kQuAdJodeA1iBhBz2z8D$klr?UT3 z;+sQ&_=bC6VvGO=l4u-AUrv_%1;ft&h!O#_FbIxrs^f#bS)i3xur~`+-AwGw0g(;pG?9Bo#Iv@kUvguPjybu+Oy3piM2VXB*nxmlRviNW41e7)OPn*~}o6MM4& zL5YA_7zJiws^f#bS-{@V(V~T^ZYK6-f!58$-YgJdnT4rtCiZ3lR&C+y-NxE1(7Krr z%mVgG1k6GOsB?ccK&QxyCs_W3-QwRU+{3b{Q}fZ-`yyyw99sNC7ts&(LO~N}Hi?KE zA)t-6X;bIXg0K5CQm22Ta|q3LL-TsD;)N;P81@MmT|_?wFG0O4_I{ie3_}o6_ZZR# z@(6@ROho*Ib-*yiu7iD)N@Lf-KB${w*TFuKm?EjdJ_P!D7qEtx5MZT7xapcY)|tc< zNfq|lEB0yx7ArL&eJ#K=5XKZJfGh9INr2${|JZx`sHmc-CSUR5*9<}3++@Hm%#Vkg~RRW}3cG&!9#Q&15OL%bD4btCzZoKB31dy77h_*bkryAVIF z(@{l11e#R9f{@yDu(6=Y z>C|F@N?D+&S+ENdWCeeDZ)5knlBrn;4iR8Mh!*5JJT?}{gatn)IbFMMr}00J4LkVn zi7(F3KaxJ}FXMa7nDX;I4-8)F>hWF6xSw6v_sPK?FP63bTVdpB|2RX;pzPnzN|-Wl zQNQ6*4)o7pp726`b-e|K0%+5*)w(kIkcVS_HJ8=UBt6q=TDobMZ|s|Obhl{$%QTdy zv~GMkCHZdcEj|Q$i*xnbbnJRvj3d->-W256a8N&wCUJtv7k-IR)qy^I`%zaL5eW(v7mW4s>Oo% zOcO?3Ru@|?cI~=lu8K4bO+BGc;z#loDy?0mXIe>_z8iC$48BK8_UCQY0p_0OF^(QL zF5acR*V|z4^;x7CElAHaQ;- zim$L|;7W2X^qX%j)o5Bt6S?nlcW#prEw4;4jCMJ#X_bv?17cAVi60Q_siu8Pnn=um zShN6__cr!q03B8MNN|W&wsUEK1$i!27qAH=b$;Wg>Nu*4THE5|ZH6Ge zf9$;#{K*DbNiG-oYeZHn5H)J}V9=H*OXUDhmk%wGHXU2FC`=4fwdvR@PtjU!I=0H9 zs0BYYtWC$hM=WU5vDIQhn~tp(3;0?IZ94WnVnLgZtr828pFDmdRYz4ZqDny%C@Zz; z*!PG9st2W}tW;Y9Bg-@S)^zN%toG~cH!QjJ&Y0r$HTzcNb4ytrl8RhkCJ%{*h5~l= zO!D{4ZocRIWfxqhzX|u8B&*Nv3|y$dar_ zg(_G#j-dBeK&*1IQYc8s8Y*lFgQgEu+c2Z)1JyR8%6l8Ty~LM9wt$6?0SmH*3L6WW zK2R+dG<~32EXaGi6BbQ5Bd`6W@WBbo9(??o?&P*_hh_iA+xy49 z^5I`U3pMvWQ`L*_v-665K-mRbfN?G#Xv{5ctL|YAG)J^#S6u17WjF-TAH)V6xP=|yKwm45eNH(OpBlP#HA%c9om z*r`NL>Objnl+cgu5CIm}!cQmr7Gq;Ux*EH58TTp{WUK5hoWQ(_g#s!pNLM317P|4x z@+uaj_!1ur^4>aLj+iO8L%Mx7GqoVnMdb#>PT26&AX)6ZUGf zAWD+(qlK7mCU|%?T9EfPHWnmF5`MHmaEJg4LZBu47GqoVnMdb#>Rr33JcxY z340X_q9h3)3+Yr?koPt^7O0{Hf^}5uvBTLU(q; z-o%0=Ny5j1BuT=5M96y^8w-*o2|rpOI7EO2A-B-YY;3PSi=+lF{M>?Um5m)OSg5ej zohP?fu|SnukR(a?SdjNNIu@v+1%g8aSm=P7hw@2zoWVo*&))J<`@h}@x^?QZ*8+Uj+Wj19 zuO*wwaLh*M2%~ZTG{Fy%sZAx}PKMy{euaX0RV_o-1rRqx(m^dW#a*dq=6@ zlq`^i;N*5CuJP3 zFCa=jG1pgM$HdBBzI8B+ z5eu3oRjpJV{}2Hd&H@&asj#5Q=~RmEeMwFyVnNfSs>K5SAp$J40v7C4SkUBjYOz37 zASaO1iCEAyscNx+e~17JrvM8|iVpb^p~>mgw(9wkoKD1orb$(a1%g8aSZD$)Scswp zX?7}pDS}Mdq{-=icw@ha1uChQvbV?IK8)I{1$Z)%8%b`#E>sTXPpWGRYtfxwVTybH z?838^tNHuF4R<9rYU5JB`j>wDPFjoq@{5YU+KQfUyf0+$_E{TVdyK6++!pb`$rlbT z?D550NktnUo7DW;9NsUh?%_c>MUQ;?$acj5AhalNMArC72BUDKrNkdGPc|Py{DJX} zP$eGXPuB1u$3t;+o+SFkpNix|wxKubS(D}!c@JayN~nAYTdAgSFCpKl<+ zI5tszBh4#Png4DrL2yEZAGl z*rjIGlCrql8>@P<3hSeXv#J{VW*yyay2lA{QseTnPD26Y&Q8aAmSpIEzQT}^J0WEz zzm+>|N;IjSU7nlBy*8qzg-pZPi;*hv30g^V+P-&CHwQX z>Hu?3v)a)boG7iquUYG$7p3cI|r|Es(?XHwHe6nSE|TF>X60Zp1SbMAg&MS?9<~YawS=Pnv^*Ofn zHnsE8$o2wN4U7zQnzC}^%PGlgV*CdW9~?6A?fIW=pY^MEgNt%MvOdiR^sXBgA2K`i zZDm&7hcK(|T)nd`9R{x9AEK{y%)-)t*U-cw^QtW$`OhgSo8WrS)4auNIR?hdZiYfU z{8=LR%`NUx-V05*H1|ks_ZQN;zA3icYBFf7p@F?t1EhdD=X)z z%+`&zh?Z9-7)HCC_oBTQ2WApr0sjyI7R~||V&rNLG8QaU(SoKAREq^!`-)vnUh6~p zK%W!Y0v1{U3+Yr?zz3Zu1k&_@YOx?|U(vDPL;64w3qB;W1uUEbEa-@^z)?jDWcr2w zzx07F{Z8Y5<`kX&_0kt-u$PaI{I4bJfso%{P^D9gdE!Nh( z5AN;vOx^Ym4vqIqm^^UL>c^uU*%d1v%$t-D{KD%`6#jDWsJ)NvjXl^WVfvY zL&VtzAaSN`unjPWn){xq>c#glU$D&Ovoq59&rMKUO1zRk)EI3HPtC2kQZX#MFgw0& z(Xx>QqAklo9xx>no_G5rs06f z=5TFF#)$*R4{T^Q-5+aJ6kVeopzjN9uYc9H+19Jp5OcTXge_1`m~gSx$vTgL>+V(a zBUz#dRvWhhCprIPPGi^G2I6hFg56bvbCotD8=0hU{`I z$$~5P=u|7{`4;o=^c>k%-QOHy4lJumy4%urD3rEWA8V>-FvCMic62!l$E(M+8z*KZ zd%V*Cg2l26x|xnSj#$2LR$bQYKC}Hkxbn%D^LJ+#4c<0u!n+|xYtq<0)Atl@I(TwO z{Lf|&m_2ZI_`K|*sD@xmJ_9GP0@(=+`xHsZjxLA$$c3`BjW$CNzn&Xknpj$!66eTi znmTyO&)>BUeRlav{kroE3NFgqKfQgTtMlH*=8u%@=yHPRkL?geuw>z%FN_OC5K}vSuW1$--X0Ku)nFWCuPLq+|y^7P@g__9_?l3sNEv9}D=0C^C;Fvm171X>Mha zNAmRh*Vm-q80#{zD@Zw@YM39K)=@e9IbpUq{8e|$KxFT2@MM_0{Kw|r`%;==-@#uV zBl^7dc;&cAFyPe*zZ(o*hQGc?mVK{@8DZKtWCKn9a|G1EUzz2VjawINSidH2l|!zMGND-aD(1+m!U3_+g3Y|0qzq zy4Z3NiQ16c)KP^c^4`v?)|I<9-#Wq7YuAJD67OcRvsY^?1cwN)&lXBPgr4diC(8!nr+_2{5LJ|_Es<)GmJcn_Sto1lEC=gi(xo@w zU@oz{9RKwSiJuZFM+bjl<>=rE1{t$xG3m&`Ur0$uK@BE(LEvZawIxz3*z=_&%44VC zA)%L#(aQFK8(5iCJ-AM2iakxSr^#OLQKe3Bi1JtoU_p@vVq-y5?5V{9RmN6HK}RCT zKU7&dWp8J;<3^5TDQJR2l;=)6D#^oZ8ygE`iEjKuln)kfY+_nRhdsBcK6!r6 zefE}@+W!?Ty}*G`>*|^0r6K#*);inXDtCQ~q%q-MrurbzI+A=NLE}dAL2HRVNDu13 zml{gIqf?M?e!m&$JvVa;a>v8XbA{avJ=WiE271qJs7;{XJbyj9SQNg(YJG>K7(NAp z)bx%WlCTnf#5EYo*OGcx-&u%=tZdTDu?aT6HGQC32LVkVcuPH^gX2H?-H^qvPpjSg z?CR!2%{zzwI_GagzI=Gd=iI|%c2B@tP*wazXa zzIQ~|j`Q+77i@1F7lD1qAg1f=>Wb|+uMJ~YIWSEUwF5Dj7l0v5z-CjLk}Z5X>+ENEt{1|1)Ew-!|+z@n-pbG)nb-o_r$Cz<%* zV}alh4Pwdg(@7N{d@N|g*wtb|tY+dz3sN-`e@3xb&BXU$R`xbF7Nlw>J{AZL(I93Q zus{_pXv5gmVnJ+k!N-DB&BVuo51Fm{o@4PKrUxuY6(9U)fgoEF$u1XLq(%VznagB( zCQ+Y{j|Cl7Zh>lUu(G$YqXns&i61Qx93pMVr8eX;c2q#Z^fxC&<}>gYms&#bqXp5G z8vhZ&$&oNN7QpZ(1nP_USP*+$D!y`cW3w%|>GqGU*TpzO9p_C!jxBfVryE+7HzI5N zAjXx0&zt;7jcs8q-{(o>jZv{=KONPk0}rQUL&$#oTihawJn`cnZHdzP-Yv)P(iXon zQGIEN>e^U(Rznjf@45(Pb$yTLRt9*;&*ZmqhfRs5ER}C$SFYPG8vl}DRmB$T@aIsO z>VB^%iyIYa#Q1PPgag(>d&vkT8wuIBFxHz+Rr_ZpqB=d%Q%-Fpcp0YZX= z?0X#f?zIZfKAs>5?cBeds~e$bBTO~fZ5qHb4dp4VYR06quVl5N5S@I#i142I&85p~ zMPWek_lpScd7?O1CaV=83=$-t-y6`yfX1)4_A144xBmJ_GwXL6)GQ zN^LQ!q@Z37?65C$ZHd%ACwys%;5osAJBX}4vpHiN`tKR%1@n$tvOjOD4lwtGflfVc zT)fMPM{nm8MST|Od!jJ+YeGkLT(vRw+8BGfLj+j(S{Wg?`Vcl2d`T4M#zFxV7PK+; zYO&x$W9-GdmEaHo7QO;3$m%m}EclWr%#DR)DlBMY?A2mH-rF7B_~YMmzNE8i7`rG+ zaEJg4=K%|{`V1QjlEnpnnO9R*s;nAGJ~8;kS4~-|_9aemhyV-c01I-84jT((2`xE^ zim3i@M+;JPHg>e&OUg>Xf(@`B3xTk)Kqi}!rCQinuuwfBBtK&O;y9I5 zOH)>=jTQ(F5n#bw(cCJ3lChgnb@yCGhPDM+l-k0je)UAZ-=EyO;xE7G7lxsg5 z7QExvJtzIUtH*aO<3_z!^5|!M|NGqeYh4da8_I9ZDB*1>P#h_{pquHK<47_Eww&l* zq&BbcmwQL;eQa;+!9EGo&qTrGh7P5VLJxL7aKLY?!Te;WvoXXR?f~&YXnXyuw#~MH zvdZ&qNe@kmpEP{Us6$=)bp(V=i=Xz!v@fTH?zwbw^|7XU3k(RAZu{!42d3>x8GXKD zVa5jGH(t+;FHJ1Xs*L5syKgC8yvMrf(@m#0eRc8?XerKbd%3+;nNjTGyEcpLpL)VP z*O6udeMsV!{GrBZV+`LbtG@f9(unw<%^om&;Oy{u*+o$e!IpgHI%AjmD0FdMddOz1 z|2(sGvn|jFYPbNG^H|#P#-6n)>1$&A2M-?{GV$&CpKYJ@t9OHoazC;@%?I?Z8x|ij zJM`@w|ES?nGoqG7ZJD)d(S(bwPP<)>WUoJ8U7w%G9XAIWmpJA-#yuAlo)QJ~(w;UA zXi6$IS2mh@r&j8B^Tm8cO1NWN_p;v)XBnovFlFhK6^nw4^7c<}pXj=w^ayc|u3d%v zV(V?u#xXnyUPiW6_cw=_!%{a?I4g!_7iPz|Em}5m=A@d}rWHn>_K!2f49foftb{4^ z7KIMqTDW!Cw!&>ACe^&&yvbh8aScsU$ebV1rMpF3<>JFx#~XVI=?>9ax^?{u)0iV+ zIS=l5&A;Hu;%}ZP9C*4<&E)xpp^lslD<3M_JZ#IKC*=h12!1d4(CbqR#~q9WQ|>14 zXBR`}j#9)!6u~UQPbX^4IY*afkzV{p;%$%mjoes}ZhL$zNVh#c7R1{g9}CiLkB(aiC%07zz^#r>n(hK zOT(lw!#Z~mq!Uvf_(71QvO*7nB>y`6AV}HU*l#0gB0Kuqh~N+b7QO{6%oMv_@UcJ@ z)=2^pd@M+VgwU~2K!pWKWrdFgs<)A{x3RGxs;uzeMtb~11Xwr=ScoCQf`uwtkOU(5 zSdaz@p<^ML3Ja3T3Lgt%%PM}fpzLjIEJ)M1(4z%{Lj+i81uUdfVF4d>Vs2Oxh~Q&E zn#P5W1v?cMq-k9ESP=c|@UfumZEP$^)41@lfPaVp3k6WsD_IdtTOze3YhPNTaV}O1wPeZSB0nOJGq5^aFY{>QNMpqQ+(1*Xv6AyrP8|Rw z*`45@S0 zTyVwijncU9=>vUEWD8hm1T4t6D>fF$?jouh7}*t}=>yfuhULADC>!=Qku8k#vM_ri z*g#HLqZ4c(J4!)Ib@_HvC+`Fd?0L6?A-FRNkG-yJAieZrVIR944BcO-zDpZOZ%H`6 zqLOen5lJ|igX)7s^GAI3E3*-;5!p{iB;kx;y3RsG?4pFG4^-JZrRf9J_D<=k($Kyn zvW;K`0v6<|C^i-}eV|$_P`!<2%4!zuioXx(1I3hyFNtg;STbNi(NJMyLDL7S#e${} zRM}~*>}~9lkuQmCBbZ&l0#&r2=>yeb;U4sXF8xkp-m#*C!)CuYgT?+~^ypW%{B6jW z4-fgAdsx5w_xCM(d;jA{&wb;zPnZTK0RAsVRlWE=J5!dlw?1&YWk<`#m#^IPX$ar5?D6RMpucBV ztb8!f`b6RIy(325V%hPh>UyUgypp8c``MOiUAb#>Mxx_seih$rxyLBQ^Ue(`Z-Ly4yWFV1iXAx07w) z*%4Bd`=T{zY@g|MLvHu%u+=-;(xE&er6ABZolaCGSzyo#{B^i?VTScU)d4}y65Jv$tMH!j?CJBbC)jyd4j;g?nS@SvRSw|jQ1%CD}sfI*JbqKLj18GCdZ|C6|SOIR1iH)9+dZn~YE>yt2f{+`v3i`F1dPf7@W;q_aMZ=`vbLE>8j z{}f3rip!;8Pa};(9pfDCVMYBNTUk;U#y2px@uu6!3sLcbOLHy_-en5wYn?sTFJbB% zQ*SlCX@%r_=e>>1A1MV_*jtlHZ~Td6a+pN2oBL8mJC>spK0h=kWvunSV*SAg4Cjjj|C|OfsTb3 zs%SxKQAEdrvbV9ZAf+Jiu|RN$1~I#U1(~SWj|eFRfsO?`6&9oxMSLtsDF}2dq*Gx* zYEi_;g1on}u^{#N;$wl}5Dj8_zyc?gfYGA`$<-1a3wkOnNY=3ESa6BcG+pRe&{1JQ z>g`0wg0i=S4*67L_w|WY6*!9(bW(Dc1(mLD>^2k z)IC_MGWQ*>3CrQ;xkqqv-E4_G_x(ChRa6!u6j-X9YC46a#R<^sR+R0C4qd2DqC#Y*VV<&t2lRfyTp31UQ6?&3ETcWH=bxH|eTB6)~ z)&%F(BIoMjTsa-NKW?d(rlw<=3(FU_uK&kX(`ife55Gj3;87Y6dDDX1TG*2$bNH8e>r=H*?FsVOn}HJvw^t0GMU$}Z@ljp4>P2N)RKbT!xwRvO#D zN+ZPRHfnHNX$*<~+3W$c2hI+kmt7Q98*IsE-xgbRV%gLVGv?v1!?id+-C@N(0oKTE zr4jD&b3{vaMJI2NncxR84g4Vd_wO_WxJnn68_KJ8o5F6o8hrBv*thhlnLOVh8Z`*^ zEl*C$3EmO>UhtvUrxuPo7~#Cp#(@cmR83e>U7w%G9XAIWmpJA-#yuzasyNoOBt!r6 z6^4x52`QsfEA?|6u?`~-1}ZmQRmS@zOdbe+5YY~|-HF=|;)%jv?j5!FvAwYe`y@;+ zi-Iv8rxa@t%jK>;nW9sz<}r>&Q}5J`BipJs+cw(zW?7RuS%VA(SCy#vprtvYQG?r6 z#V=%9{IoZweK{?3&!v;bV@>s}^WN@q>`qqBQ<<$BZ4oW6d~WK=o-3_2)f#5<0XO|< zt_}e|i0n&)i%p_YjNk|H=pO5)PdA<3^wr5n;v>%GwY}V~zv)3z*0qiGkLnNs7QTa@ zPHHhn$3g)W7NlwdJ{Cm#1bi&a6pM`bSdgj-_*f7dBJr`H>}_l;NYw;%ED#(bz(O-% zLFxrS$AVN%z>gNBY63nM#I_K8EW}V@L8>O8V?nAW;A27A+t^r;>=V$jKyZiv3mt$3 zsl^-}3wEk#L8>O;V?nGY;A26mCg4X4QZ)e|3slj9vbV9ZAXO94u|RN$01MXu3sT1c zIu`U)Sdgj-=va{K6Y#Mh*(cy*LFx%X$AVN%z>gM`y^W0p$vy!c3j~J>=q}Bf3zi1Tg36DCCX!LB2-s`%3c0KF|@DPiH%lhW1_7be(cCm z1txl`WS~wC>9DUoc`smBcU`%OTn@}UMUPBaRk6hiLtN1>az>SbCOAeV(25P30%;D2 z<#LyUtGrm>r3zCSRe(XmVQq<2X^nhqiJ<*f&zkCCHa6Eb(Iw2RUQtkO z`G{Rf!wDLyzm+}t$|EFCzRJd}3$`ri?VfbA;ELT#VwP(pk}x>3%`dfomdLq(xvr;u zdr5D^T;l~-Mq%1F+dc$N1ycC9Vfb;oP|1y2^g5CskMIhO{D zefeYkgogRWog3!owPucYb)M^sJvv5e-oYPoNMHr#c7m5;W?`ruEb3vL$!wO2=2p#5 zPp!=+fuG)37gtv9QiiNzkFKH`=px0;!mvxw>t~ju%s1p<7@!n0<6}X34{8I12M-?{ zGV$&CpG^ZZ8vmNfY6f>h^L5i92qXj8u#-A%L?`>=>B#X*< zd@SG}qCe_goXh?{Ac~wYD4zo%oa-x?@Y|w8VjU};AS?S|f4h}^W&AEvgUKz4e9AQ1 zm9_5k%+}4eKqGjG1-P8Y(vGW|N6NmIRb#@K`L_gRU!vn_eiiSw<9n1Jz$%U|KAd&D zv6tXq*Hir%A+mYjzUNBGU=X{gzQkT5s!{1&8PQ;I3(a8hJeGf1ac8uYArG~aOcRC8 zfa{(fM8$7y1e03#bb=8~?v#m6%zohqK|RDiMf4zu;t=JrQ-Fm6`KQCi0##TinI__g zb=n9fwOAk+!Q{q*vbV7_slGJFERU4{7Luv3AhxXHM+=f^B0d(h5lm{aAZZoRQzpvZ z#>Rp#%`wYkdZ_9t!@jW-k5b(fJb~$+pR583?JT7dD9&~6$T{~!=MDw zN`9z&P{N4LgAy7d^Q(p0lrJsO%64W0or9bmHi`x=Xd}}sa$JJVZn8oFes)+CWJtyn z_>q>jM5^W$3AZcN8<}8`C@S_>qZZPlR53mF8Wzv1jneZjh%;xLDo>2>yvp7Q3#~z1H&AFH!j?q=M@W6sph~` zDslMLcK1}O(9Tn-R^?aMYx=-fZJTZX!1_R+6WIb5&H)x=4HY&PG<~32ERenXwRyXh z=S@L3$Nb&3_MR-)L~w`z3qpQDekEgLf$Z6@=>ykS7<8Qmr{1+}nCg-2L;65510*%3 z;XjKA4w0*kb#OZ&WzxEGyxRqGIcTZA!g@!rYLHWk^LpXkZ#mpN_Xti~4*Ok}Y|aSp z{^ax5qwP3yb#{nK!ucW92brlpD4lAJDyY8EIU)%sOOt&q1qgj67-)_(4t0!ktmf|v zH}rRGWl1Tc&sQwW*dR<*Rz3WEtV<8QQ;LQPyH=^`1JzdiHGQDUAV}HU*r`-s64?S4 z$^i><{D_SOO&_Qh3z|MqEf(axjg19g64{P*S%hdo79wI}LDL7S#R8!|u$7(r=yyZr zl=l2|@3Tei-_5`FlVQQTrbNH?Kl;};51ah+W25H%_P!;_O}qEMvO}Dp7gv#J$T)uB z#DR5(OnuK(rL{Fh#9pukoBd*|Lix?ycvG#Z_NH0ex|#2PdG(R_zz?!74L)QFF0($( z2MA6Yy%Z;n;qejY^4eZ*7p#RK_cb&+Pw<0DhEi%tDoCM5*F@cM5Gf4O(m z-pBUF9`sL`UKX`h$4>$vBF%ypIw{*{dBjz{^QCZQ_KzAKH6vrs*DpRDfifc06-;~EcWg1X+bWVHyI@?BD z-z;lVThc?5;wSm98THY?)4rTGXV0aR z#$!$O38dy!=?@vvjstuR|0`4Inab6CAgieAbvSO}n99Zc z1BuT3-o|iaoCE5K?jqwau6**w{3OuA?Eo!YXsmS(@0aD)!ab~L;c|+iYJ)BL3DT2^EZr=UTcH?;PiOE=9Zf)GWVB3No%MB6xb8T1baj8emQO5qM8%LT# zSY}GOq5P(C)&m7ke(=rI!hz5D)l6Pyh)T@?J0HQP;irmELqg%WgAvXfZCt0l?HLxY8jXK1hh zp*al}8o~XkITxuK zVJWC)FE#{;MFRHsGdiRqfqr7X@V|?NDfZW5tOep=<}&>6&xthxSgK5%8Uedbv=KU9 zYKLu>B9;gW(mJr}Y~NmMga5r!EQP|>t3oP;Hj!*>aBhLJlwfq?zFl+cxq}Srs2*-^ zB?y4T3MEzO2%a}IZ*j8cinc^*l?%SKMDUDg1w{cTN5d=IXM$riT3y@)eg^I|26jv* z_!*GABf!sq1`Leq@v7_vVRRLyFbDh$XdV*aXF&6K1zQlBw;sVUieT=McJd<(JHbHq zsw8`lQ)M!sqmL%5r7e+KeVZ>WQ9~PRg9u+y(&e#FTv%@-kcnynH%%p~sYLHlYfW&7 z01NGa1w~1RjD?w0v7;t%Q`@nisYKO^$Ehkg1cwN)a2>FqDCv-~5JQCpP2i>$3z|w) zEf%OUO$3Jsu;2nLC`vkHETmImK@+&C#e$|1Rf`25Qi%cAl(}1R=Qgdaasds9nem7stuP}u1lq~LOI#-(lvwiGaCT*JWc+SlC&m4s2 z|Bs;gA8a~$*A06oTWJ3OP-*@TF3Q_4H2>>GYsmRM_vxW0|C?gVRg5nMUL6IZHKg!` z;@r-C-=*Dg;7%+b&~oC3%qkKx?Uv1@*~{NeQU~(H)b!$T@VzW5|z4sm(w1Q zdcr){k!Ff>+@E+Qf2c9q81CqqRsRFr=9>jmkXH9}?-~12nyd5f)?YKQWqpOy?LHFU zwrJVNaInybjt}~KcE!pE^Q=#}Ei?jT3yn~)&{!>4Xe@Et4!)OQy8e9i-TG_xf_W~Y zSI6)*qYk~f4ctdUigI7HCXMYgy>5u$KJs>s>^`yu+(#w|?jy^oJ}8UogUEim43ckj z*2zjO?qa6Due%mIJf0Zh)5tXZV72B<9C@FObvz}so77NM!T}seV*C6 z*%oNbosbgXavn=Np0=SPCH;pOOGkpwNfW5%B{xdM3klfWp-f^IE(w?)bNJ3q!fHro z>9n`qLFVR+M90(oD!$otf2{RUegLaDy7+L`@y1@}sz_5$mbtKeVR>beY0MAto0qO~ z*^QDHj9ZeONS6`KAp$IX3_qPT(H9*HP=}$xg5*XCw;nPU00tyj0JjbrEJ$vY=vXKa zhe_dMLEhWwSdiQ((Xl{qhyV+R01MJYUvw-$9fk%Ak{cyD7A#cJ0=RY1U_o-DM8`rh z6&B>ZjgAG$X%!s{1cwN)PytwgVkXHWBAp5g(r`X}EKo%Y;MPHd1t?}(hd?x~(d+7hYG*80*C z1PZdYGgqLO;n1m#eR{MZ}o%IV0(tM3v>wZzIes1<46 z{h;%t$(Vq+&z%`Ye9i%fH_Fbu`db4PPN3}X=P4M``BRar> zCV0FDENFtqAKtGgW*Eq-$(rC%6&5tX+o9WKHm>qDH_9o{D>7;Y0I28aeJg-Rm#?{@){e{Cw}U zo|8_u_r7|0)uM-!pL#Rm|NXGyTYI(8y6mA>jOBNgE-!6J5lt@GEjgw(q1(Tvo~ zJlZ(Y7_mP$&=ee7XBnMZX%2H7Foiq%COY$b8^et=Z*_wh@0T!nAb4p+JKXLGZZD0g zikF6e!t}DJu4D6*j1vcrAJ`!F6t`z=9GTg=-WFoqU^7I!oJZ5D8vSndP8bR%4N>ty zOLKOa!uncg3nmQ*`^Y8@b0Cvv1d|3KljjkehdaLD5Amx^k+Dao@!9MPQ_rR(li3Qs z6RF4bk^BmNg5eg!j;llB1D9rB8eDAZ-(vmESpS5nZ%hr{W8L)Wrqi3gIypQ(;#{8S zLbBFFBfG&iz#MAsd#0)v-)H9)`+%|wwgBT?9@@(#ALgOA+FR_-E*iXT)`WLMjBY!K zJw=-io_r+!XR`;)9ymLEUQSU|t>B{pwR%PL8_7ZK`TPn~-1BD_o~>NX-xqG^?~1Dm zJ)Bk9=r8!4gs{w%azktOtzGQf!F3|IDEA|)=s_a5PRz@eT_^T|>qH#5P6+964_#!S zafxHTW88CY#||sEgkPT#!!Iz5;Umf}>Vh1xj@`G~s=U;%XyapGbux$d%c^^LP>x`A zvPH2v2`S1;6|7D`PvQB%t!&)7V9SEuVq<<=(@ztxH1;${JD|OMPJ8`2+eTaeTm3p_ zPO5orT4CgA|2RX;pzPnzN|-WlQSk7sgx1aL@ap3=6G1}&|jiq!7d9?Bu4`@EO^A`cv$d=&C#%+>}_l;cy#prm=6(P;S^v& ziC>Vh;2E2vVZlQciH8M`W+XH$c*f>vSn!C=(XimzjD&^-Wp86+!9yU6h6RE{1XvJ6 zk;$^O4;u?q(E>OtcJ5Kc!-9u|5Dg0!s%XJOe2Iqz52F(_EGT;$8w+4h+PTpe4-5E* zsJdR#L|Ss2>XQX?#xlL@J&;S|YzNNaHcI?RbVmCuk^9Ds^Xutb-A0L>-6nBPEO)!D zCDI2`eIs_6XpJmXKb`${M^GFH72NI!iV_dQRo?bix$723P=xRi8Y!OdY%!R}8CabS zXM19rn$)j_BsodstkcoT4u5Gx5Sl z5Btm?^C1E({0^|7DDIH4P(T$BdkEq1us{_M&!obFhkYhaNC#PUPcg$xXy<( z;bFnUJ`)WK1cwN)AS51@w3gU*iFS%yRCzjr{elef3z_@;@%?koz^l$DyY z(r1;GfCV9|F00S5vEW0ZFilx`Z&=Wjm1+|i1czvxi-TxEQJ-OB!G}a)A{I1drP@9W zvMilP*ArSHnJfiOaEJg4LfTPIo?&BwDjVqO0*O`wBTLe0%1V{(S<2p)dZf{?;6uvF z@sW&U_Qo@IHen5nyB3BKfoSV8RzU&;RP7*hyk(>^N*;rKtQUrAyT4GqGbX)b2U69V zeMt2|W~vWLr&^;!RNv^lj$J*Iyi^<*^;Ws-QzShvqtf$oH0sv~rW0f)a=LqEd%%q# zq;u58Ol7n}fle;5V5ikJWu@A8vZkz5+ucu~tc+j%qGgZWz|e4d&i?_5S}E_@{;2pWgk>&r_>jn%!r%-v=uf zEgKmQh7i&5L4SAqPFSB13?W7Z$c7N1qP1&-g==n&Ns_wYO7!rTy^P;wYA}gr1E$fg z)(3VvFNc`H;3Dg2XnS>ka|jq-1lF!hdT3Joq~U|!p8wf2u+s3anLN&IHn6gvV5RYA z#Y$r;SZPE$Z(MIm?&#PuS89D~$e+s{FCS?f>KNw`Z5kX~S;f)CYqE|vf~!HKsV8%S z`)*^;tg6^|!g3zm@tXhi_s<**F537J_$P=q4ew+N{s|u{{t3ZFdHbigA93B7%dv|! z(#VkO^)<=P6bV%x0DDrY;0Mt=wUQeT-a_D{VG8_q>fk9qf7kl@ z2ZvI@d7>DcCq#pbp>F4i5sLFfc2QJAu%(2#YV4NG=DE*7+mrFI3;tSDyD-Cgpz46z z8l>`zHhVzoiSoG)aMEzxpLoUXoDLo&KX8dk8rbvfQd4hvjSdKH6t$t|{>BKSXm(;e z!IDx&AE{WF0p1`%{CbwTuzX?b`U*q%7h5K6n(=r})U(Ua^+}jKA6!U8vy-RYE+q35 z7m_{+)6Yb$O=cbYEIRye)a2fDJxZiDinF>B*XHy@$J6{OUNk%52e7PlpSQJawt+Xu zgp>f6+x|PCW#fvmG5&*x4-UzDviOB4a3RULG*~n{8S5vwkStbQNFIrgn3v!7az|?k zv{4Z4g`mUI+>0a*{yO3@VyvlWY<+FC5xhZKUK!bzKhzj)1Xq=^y2Hb=3$x?Ljym+_ zHgF*cDaw7(ZFW*OL~tQ_J4bdQ*#a&k6E3zk+b!2`tRp%_`YV^Di6I@%OC@b(#~ZU3 zSb%4w!JQ9Beo&@UVPP8;7O0{HWp86+ z;RF#D2o4coVF_R%hzJXMDlGIS!h(w`x1giK!UiHNa8%KPvbV9ZP)URZfQVSy@f&rwAS%HGDt!f_%j5F8@Ff(0rBOnxHQT@P!~A?CSt za#(`BMnP0u$R)a6SryT)Q}%)r`CY`Q;suWCGSXAAo8TB_c5odQ8=!&J-?;wPoXSi2 zmrJ;%Xk|*S<*a2*^IW$*<6+k~`z%+HN;zCB(Ff^nG$bFn9$mb?Mi-aFuGS=fhg7pZ z)zKW2+_6JgqKFdiyGteQIAuL{)^+`@63JuG{Uff$D2_KlUW@DaY_24cb^nMKoXRT< zVG_2QD3Nvlh)6;SW=j@!fGEEde#B3aisP)DC|Guhval37Bo$&S}YJ8BEW(WEy%h(>}Wxg)2YRR56S67ENGfk zwOAlHM1KOew-RuBljOYESkUBjYOz3-=q8ZUiC7@3;>dd&TarOm{~|ai1V#6lRA_DtT}*jPZS=8%6TfYb))U4iO|NrnHz7aHD%q| zN#;q#+#&(YEh3ySisGF8`VHBYGPgdN=Q7JXTPrTOVvkO>n#VX6^ADJ-=Cs$Zvu(8X zZ&_dAtZ?`Lw}D;9%r5-d`^oL{`=MR_@}@gGu6pSk-DndGrn(uxWUS;$Ony!0O*;(% zj=qV`{NBcJ<4iuFwEm^^yDve!`ut6(3bRCx*vIoXcx_xm~ag?Z$D{e8Do8&(28aKR5L><`%bA_b>;V z?_!|K5XFBarzom6*pkm+Tv~UIt6}Y}{yVQU2AT(y9c?s)u*{TlL+hOlrryq$Jty{o z=S1AaR;Rtw-mb3CPvnl@GIrUqo+TOjpRX{CsS4#I$}Z}H9I=kwrZC60Cecu3=(EdT z>Q}V!F>r2~!;5ARf^*Au#knPlNv>{e35| zNUv>&J9$NV4MFUy?tKWoc4E1vZf90|Z-aB)56AZ62T^^aJ6Je+?;Ej3sx|6 z+Svy+v;DUXC5Z8G?{0=<{n!rCoxLKx`i;8riu5WL3aBFd?z|$siUoNvKo{oeUXAd( zo5Jl?EOax4+q+l*7>M>!$XMuZ3iprg5Jj+LAgZMsXKAl~BkT8%p!6yhlBuu|(9L*5 zuVO(SI*5&hn6D+X$w&_VI=`axQ~SEG9+F2QCu z*{w$vFSrOU33s|yTO!pZULRVb8OAxmA|a^{uv;*p;--1BAU=1JhJ)np9MiivHtEMV)Qz8fQ-ASXSFamwRaS zjr!!Tu%yte+SLZbiD&FfX|B$zwj6Grd!#lcxp~9Jo3G z7UV)aHWsLq1)9oDZTgI?4zEc?)kX^hhX}ABL<_Q<4jT)a%1v#wKvf;LQ#~T6q#w%O z#*P-qL^A}3Xq=0?40TEwK-hK47%G+R550>z^gE4t$A%wVx%|Z$O$|qmWj|Jz6Ifap@#oqkwvl6Dv zTNElgPmBQPiDt=p!lR|8jNfHyFf|x@q-H;58tuwj_jzXPW?P^!cS1^l%XuvAcw^7n zl=L+*{)2}P4w?A&{LiKp4m|B&GkKgLW>EI;SN1E~JZ#IK6)%mc;H44i6mt+BkBv}s ze`ADkLh38qOn$}_T#RWzQ&Oq9veDE#wNk&EFXk&!!aLgyoa>V?c|JH#40YseSozS? zZs&=4it|LDgz0CbazcRzJ{D$J4^$n<4KxMER({de)HAl;7Hu5EN3^^$vaPzmIm8^6 zx}mdYNBEv)k4MJ`{oQSFVSS=-_}&qt0%YfjP;j1DEjdqk^ra;_p5|Ba?lkqI`~X&Q zbn)S= z*y(HxF^4<)W*rS}uYc9H*%nY%dA=>_p-J(RhOZfQ=*?}je)VohQSOV@q_KUb*A0me znH~Cej_f?K1)L`)NX`=;FZPkfp^kBm)%<FOxM<@?;5_j(AJDsQ*gM&R^TdaW^F(k_-u~(BT|YL^zLAV6 zN&bZKjoe-uo{x>=joAxw7X*c;M5V6Z<+KN+o-ogKq?zIz_a|P-A8L#?s>Onbx)=`& zvZB4-SzTdkl+1?K~NrJLWUt%vfh%)nP`zWC-Vn;jr3Gp(A{e0gLjOA zs6uafFJM3SSka-vIF z?3aY557hL5KBy0LtLgMqvKfLy1X%bAupkQ&v9X}(1JzF=@yp$i|Hq2X7j`NKQs6NO}^+Dg>Zq$jhM$4%roE20O&fDE4 zagv?{;sG!d5_H+XnW>tc*B_V z$KP1|*x;WyxWN&B>9y^@|M_2j+y7sZSN|eD;vCo~bm)^iIyTJZhDN7+Q=4~ISK@kl zNwi~`W1wUHbG^aj!m+t2&*Zmci6fNvH&@24sn4_J*?P2OS6tx)CyifRdFvO44ukQ; za4?>TO3e|h8r;ScPbkI{ehJfCqShv}Q*$|Xp~n7+|8w7!)i+n~v;6g(zj>g!mpSxI zB{&*@qdzM+#Oo8@4K41QP>nkv*raf7(Pw;PlVaCW9u}T1v8oNHTIpg31bB~LOcda=xU;KYH-139Zq;0bY{t+CI} zmBtfk>xxa`sa0bd`OEx-6maNbZsUmuxVNAAYzz1_^ef7J%sPh`>_OZ<4cW3!!%pyN z&|hqAW^0;TgOWOS?SExQdR!8B_P9-8H0H6m|#-}Px<+~N0Zl|Bc4kaNB3E_hnTLe zsBXxg%l+ZQ5aX|mfyR;h1siMQ@r>zw_J^a50jW8*l<*_Jtxl_Myg$pD)Mgo$U6}n) z+h=dgPXf=59pKp!TxJzqF5I3SLuAj6bKu!=BiK^HzTIchQSF5uaCYV#{j@xyL=V5= z7jyU;{#X1VQ{OY-4-#UJF!cZ83w|Ul^oA8}CnC%d=H3q2TWs%xd;2|eA?Dd-FM(%A zJa~3Ys+V3jm;nZl}k;FdhTCS>%3lHWB>b)`VavY*1}KsDiIcj zQeoj35f%!lu+X0h3m1v7Fp~-k^4>lU;SRgn=fQ6R<3pqqs2&2M+l?V&TR9Fb0 z!a^Mp7GkKdAn$E#ELfVIiCf3lIR4JjK(gupsYk zbSzLs3j~K~RRVu5f)rjxdj~+7UaE+jRlS>S|B(? zfCVA9u!SgEh@pxWjuT!_$|Ts|Yjj9532tJE@V|@F9QN0J`gbs-IWNOIIZ626pA%IQ zf0&E5v2PGpz(AI!qe^g+Wwo>=Qmb$Cr6p>(&e|ZupeX4M zuuoiAS1ZUwHG!L^64g|q_o%fdI7EPjcEEz7q(jESOsa4}6S)0wIlNfl)l{Nt#p6_! z9D+jxShx;YP?U7YScsv*f+lcNiv>+3sul}WX;gwk1XyqZ78E5NG8WRQu%HRt)M7zX ziK@kd52-`}3*P}2loTB@7RVA>n!rsh7O0Y_no3k{A2-1v0xSrkCPkWqjD=*XXh9RW zsl@`7GDlO1s>Q+&J4CLSoyPw>_Wr?tpZ($td&@}2|M*>aWVl~QpFQ6N{h#WFVZZ+P zzxI#)^^zqqa~&$o^Yd5}470P#0}ha9)2!7-msiH};dZyjK+eqf&m08Pgpa^9L9l?R z8}^RdG~q+VG$FVsZ~ydmw^@zFhpb6&v^Ax7betfXS*7f4?BN~0&kZAR>rh1D79_&=p2J!uU^Q&1kyPVe1(NuS%?JdDn@iL6Z zW_3vOe04PQeDm2UDo@3;RGx}tAJj_qjZRU0P!rV$Wl{NFen{eb3C_|yI7`d!jo8l8 znyI4N3(1#;E^Cv^^M@LvjWK+$tokg$(DH*TpL{t#7JMe>fX}4h{WvIRyW3|nRQ8!1 z0X~z>o9xvb*U&_8hyV-PFgw1OuSf}ZY-@5mXIh6oyZjt@j?M?qQNagvaDZK`U#%vixtoHN8%&qfh~S}Yq`spmMFQ}U8hv4U@O}L zZUi-z@w-e7CUE&r&3?)>+Lg8L^UT)Gwm@Uf6^H|#P#ve`~@fxR^ILJ{IM9HdP z1fvbLC2FhgZw@i5O#u1Q5{+{)2NaX#QGnQ4M;+BYPF6LlBzmxrRVuY5Qk!b>r6oG+ zWEqg)OqS2{nR*ULo zq&)R9+d=x6i8HoSsDY71!$@HLM99?+pv`0}Q(cMi!%Lf=9LK1+u3riQw^D zP4IX{wZ?>z=@7|2NE1A&O+7MA@c0j|)e;lyM~O0mI;vELCU{i)*ptP)*ioI{heok$ zg2zhzZcXrbvktEb9@TcYX@W;h@F?q`HNm5b?tXWB1ex|s6FmNKxe-JQn&9yV)g$WJ zxsTo&vgq}ViNAk#TyssPMZT=xJIc9 z*W(Qk?)ZW~#IG_%#vYx<_hc2;M-OLJrEMH(ic3ANkK|YI6AUq(eHyL~0nuIdrNPCf z{w>zujP(~pcaJKfyW#N>=ki3+-CB>N)CSuCbEvuRnW|oVAM*vvTs}J^o&Vg_)0kV_ zR^7uKXdde5*|~LRcXrX>ZL=o48)CF3jqNjiPtm4>Cx^uUZ1#ZJ180ZN%PESg4YqXI z^kj;A{_MiDm8<#t!VO{Vt^PZ&GzOXnlpSp}g|N(&azkr&MN0ab82`b;2Zv02d;VwJ zXZ`Bk;G*1*tfKWqe8}w3x3m4DhDXhaS{Ai$)~ZEu7h9e7P7Qt18z9iQ#4+D7?zy1w zlqkn~mSpIEzQQo3DwK~XyQm9t#5#7H!a6s)ywtB~<741(F^3nsk%}Jq^pWj~!$n9@ zUaI79;rRxrY}~qF%Yxo+b>D(3_UKfrd5mK*|A4t_PJ8`2+eTaemh~0RiecG>+3{_Q zmW`YVO;6LH>B&FN5Hl$I_wJ^resa^(erS5S+;!7aEWfLCd1*t+gw$8InF3r{IZtJ_ zZnXV0F(rfF%#AnInzF1(o%NUBJW)9Cbf22Z^9^F}PSNIJTb`Vh6TBn%z2HNyClro5 z7~$;lA>GS7+Bnh}u|GG^6l|>IN=$xD=S@2e0gk?j&ivlSaN|rqpyfpC-Us*gd!}yt z2ZzS{B}^U&Ekeui37(EY-l#!A8Y-mwx*ESI$OALbm}^rA=>3UnpV~5msNSbE$N|2@sozH8FlE* zp?j7+9u*(7G)EN477pJ#Vw7LVwD@UnOuH2e9!*bpSn$w?pkcwY=?M)B9!*bpSnx2u zLBqn(w2lzL(jX#V4}UfNs1H#DO9m`hV;qZlr1&^)}G%Tdc^4LfY{yM(`4GSKsF+42Ddm9@I9;z|CXo27mMKC>Jfuo8R zJUR~0u%M^Hf`{M*4GW$&d1zShY@tBIf`@7h4GYTN#>Rq&Y77qx1cxYsSp+P|M8%F4 zjuYh;EL2zsyVXzy4+~Ve1*Mq=J6iDQH^9S!ytlEj;L%KjhXwpY6q(N~EIp&4iA5d( z^GD(F3Wj+tI;7x{ExFw#59K;y_S=2`P#zMj3xh$N4|<;Jr~CLegF&1f&c4#It7nqk zo6gzxR=Mlb3>>O*P5InQ4J9A>&*2=I?Vlxb-@vEar}_7bCd!+P2pU_^Cp!4X;BL|Y=YnlN8lqOR@a z(aO9YPS`l_S7GdtM|Ty@YY(g~byWAbrmWPIm2}F=uDh$yu;5FgFilx`Pl9VrS*bRW zL2!rw3tvG#P*$HwHjrpo@Fh{08w<%)(SoL|R2wbGdmH=FZ=uRG5ga1G!g;`gtUklW zf-i}}+*q(vVL?+?s>Oo5x6!dcrIjE!M1X~JfCX87hK&VZ5{0?3pr^tDS@BRVSY!8L zkk$0$y^W0pvVt|iAp$Je01I;F9vcf}d2YG3QtzxTwp>IKmaL)r`ijdeM@cWRg4>5t<9rZDBMAe&DAfn$Q~h+` zQfWn({}2f$JN5pq5relp_VvJu_pX&C*jM(R_4pt7hyT`*d{Vb$;VU0+JitG?edv;p zFNDu@%yGmDZUZm5XU47s`-E_4nU9VS`n%g}!1{!{Wj;V|nV06-H?UK#>u;5~X6#F8 zuFgAaS<^h%RBEnlH1$rc93xnptq?3Ou8BqsC+}+9Zt_`H?W(Z{9ljpDe|?QE z?%#xQ6kMX?X?_*&b~SjEA7HOIy0~4LUv)&7UzN52Ogr8YM}JL!|IESQqKzMcmxgHB z@lLkjrSYNSr4d||w|{#35!a2moc_wC5|dlJ+TpxZ(uVPk>}NT4si}98)HGkBhrig0 z(m2Ce!&$-XWM|5fHLVZqblRhhWB7=cS4Os-5R5|u!L;MIqEW*ja3PrnUK;*2lgGI& zJ684+yfpr-cxg-pFO5j&jq6RxP&VCXu?~N(qqM%cdY|Q@<<>zSO-U&*{p)yRFLPC- zsi!@2Vfn)HN-*vCV#}mWGak>0y1Q|^$*g0aMVHw;_c=k0d)Nhkwd3q=3)kG*qr~Me z9wS|eYcngmWt7jpdYutwYy};sPtmxm8cb8M(I$BFyYcJGDE#}wj zYm%MzP;-A{gwbtw;%7XO5n~#_Di&sJuo;5*_37hF6H9AT!1?A|aZvH=9~?>rLz-eR zq!E2@hPn-DMkt0f*+o$e!Il!%d2c6iu*+Sw3p1<-styQdC$W`Zv^DmOt+&i|q?zIz z_a|Q2CK#cH3(hx(-Tp0O!Lwr<7}A6k<-X|ly{Q}GHl)ds4QaN3A%f6&CtaVc{YX7L>h>jfGdKuz-Jv z01IaU3o%4kuuw${VN_VK5@8{k3JU>LSg0eyg0i=T=1A}kObBEUiuU?G_b3;3WDqlFkMEF34of`tkTVN_V4$}K2+ z8ygE-sIY*4hyV)(kmptaw6Y`MMi64+o{Ff9>MkO?#mV9yZHd&>LWLrZFD=oZT&xia zZ8GX|8S?5xU&+`n2_4nz75^Az9(Hjqdn2HMIbZJhS3%6ua@O(@ zyMm-K$tO{2*#$`kk;rX1*YVk0&MhgeZb&|IJ(}UDW>|&A_02xZX;DBW$lZ`0eC%8@ zyILa|GzvfBr%1vk*67yii3W|rkN6Fe4v0CZK8Wla)sn2yst(T4Nw-(k48Bg9oKBO| zfuSmL(4c8j)uuBDG^v0EAM$~Jhi zGQ6fqRU0i}9io%0bm`D1QipE|o%)CWy`0FW?Y?ipGQW^MPh8WT%s)H$*B}4a{;|Ja zvLt55v@fTL?iMBWY&qA^B)L+4-nZIfVpq~OEZDLjcR^5iN>u9lT~0f=TbPwD_I#m> z9h&7^DqBS_i0vO78t<1ddElPaj}LX^Y*_iw(~}Z{UwD09;V<`&+WXkv*n@o%rk{yg z+u3n-Oq@LaWO-?Wslm`AHTx+Om>I15JX5iPa0ylrjXkrfCbo&r32UHTekk~LMBTx! zqh6SJAvvxtRxE!;cIyAM!S}X{&IvQ$KXY|ReBjdTOM`cr!uncg zkM&EK`o`47d#sy2-E?}>S0^8dkC>O=_HsLn@K`I3!Z{BE)4==(+;I*Z@6`X_1pWUu z#R{TYu!0D41m3ui^2wL;cZ1QuwmTRNxCc>4v+Q?9$P?KQbu!UlV4`tYv4UWN z6-4X$3WIKq=$tSSJSVn;(LnGWj0T*-bTQF!b@hjeZ&qk0TM!G_f@CO0Cpy7V1so?F z8=6GtgrUzaf2m*5#>ej9)-llq(~2a=)pVEu_s8bBF#P1~!kZ=!E z2e*zkVaS0v%f8~AY^V1lK16_pEWm=~N{NmI$#E4Q3zFk1J{H7T_V`$kX4&IoL3CUt zz=G(ZhK~h#Z=+*DoMn%X1%g8aSXcsBkX$Lzu^>6F;$uN_Tt&x%G|L_z3zFk1J{CmB zReUT+j;r`skoPt^7R2GI_*ft~MD|)Y8b~MHE z7;i9EAT*Z})a8263wWMSvzx#GfoB#ry_{xf-1JLga)z*U@+hht-$BjMpM4Q4~X z%GZkK>G)T9(ARGFO#G{SoqN72{#C9QN3Gyr<ftX9X2ZvVytlFQfdy1p zAUH&;+TA1Vq|=%!MGO4Jj&Tr?DPUzdYCG)&ZzPj zdKul=(hqHk)M`w8X^CL0of*=BF=_5mE$F36j_Mvyrb-7&{}2HdP5~AaIUO<kHHbk8StV=@=xZX0SUQHNm6WPDf4f_`}SZ`1dsRBb$@q)$5yuFuTQ`E+SGw*+s>cgGYJ5ftX(?NE|iL_uR zhfAdCI;*PQDy|w+veq;9ssH%Pw!7ZYX@CO_&l7-XrIYIWVdAY`Y%S&TpT{+*$RvI6Fu`mW~4d(rTt-*QWyR%NV zK+kDD=FM!Le@iCgL$d0QN&X3wz)E8m7(#^nfFVS)upV0I^74lAh!P|Gbt@kFWmQR& zWao*z-xM#60xON2AF$HsFoJ~l)cj8v8?e#|ldurU@Uuk0Q-{leSiS10= zc=M<(9v4mEap6_nL7ZaCr@Ye42VRydTl8nYe9&fqqXrWw_=k>}a@XXYH!(KxM=J9Kj1?0p|_yK`?9=15C6Ib9h1hm(qnIV*Gg(`#cJ94 zW(4@R%mf#bfFE!nxz2rfy?v9s;0OH{8RgYTwyU@9J{QqqUn@D^tOoym zd@QJE8ygF3YXdqK2rdy|p&78i+`rMWkW7UIX3C9^1$oyTezXuxg$3qpkB$W!RkWa< zZEP&Ctqtf{Ah<+;g$}?1bN@!if|Cjh%#<4+3-xEkp>KRFq*GymIoso7fht;1&o(v| z*wzMgED&5Gz`}Qc1?K*Zjs+tX7MLkFIu^WCwFLte7MQa=Iu@9-J$@3Qo^5O_FlT#o zED&5Gz(PAcAAF2>f-$gw@H?5h^paI1^4HFOW11?O$+o9BzC8~U!W zUHn_5UR%Lw>8KTNJ`4C3f5h)^Wxu?JPIA*_>GI60yaEkg?)xhxp7b3K|1OsQR)uhW4Qv*RAddL?eUPN~Q`_1*#CAAg*hby8UDkvHpl+cx{3V zUwTA~1YrX-tqqFC1UZ=ys0#Q3RlS>|N{@_GMF#aOU*!>4%Sd^60=w3Z2N!^QBEoe zE)ifs{OJ_27B&`iA);0+=t4xTSWwP3HWmt~Qc8kL^q*dv7%eDbEo?04LPV`t(1nOv zv7nr7Y%C;GVS(Th0T#q)K@n?VV?h@pYQ=&sMAV7}_K+i4Pft19*jO-9VS(Th0T#q)L8;thV}Y#BtqTz~nmmy8R&a!f zZN`|ZBVI{Zy6N!WU-w>3dj74urmpk<<)Ej(GdwlpjVCt!>zjurZ9MYVPYZXB-c`6u z_D6PBbFlbbUq0~T{YfM91)EUgxZZ9Ha#q{k515x;X7s+>k&Cs}mnYfky8+gB=5uQs zO2jW@p5pzw*!C@wi@vQzTJjB=J6L=we0whW`?M{Kb}Y(W6cnBkmAZMK+ZmX8(yDfW z^TjUkkAF-r8w4k8Er%uFpt*ysn&Nj`UtWo_c(9;DS|AOYJLCoCB~%~OMD;;rKb@20 z8-c%cHTX-bmWO$`+bHza%bLK@QEW4O;5)0Ar45Jr{&KBrH3=>eVBs=gLA5-@#sa>P zz8pX5tCzKIqaawlEMr06U#@W*g%SS}0T%S#Ri%lgSy~NB?Zr0xnCI|U%_UPs3(B7K z>iYad?gZXGmYehuGjxjV-G2tQ1yIKJ$dYGf$ryQ}ow zRT*0xrXYSZcUu;+RLj1dR9Mh=S7}{Rvn!FyNwBOtQtz%Vwp~K1XtgJD1bg50-Bq`V z1!bqWyA4*fxsi&FP+QPB(WWjwH+g+YlZ7BC{N9q^pj|j~E8?}~YeCZKQ_HyE3 zP$HlzceKlRtS06B;`65SRrm6P_NFZNwBEDV-56pGcMZup9_p!o#j)KH*s^uQwF+si zKpWV4$HD%BnLn_Ws?Ez0G#ENZL zxn$R|47=9tJwenZ;P5*}x@_;7c0Cwm$@(Lz_|YrvGADUCZ>vp!m_eAjK7xaNQ4?z- zIG)3Lm*<02E3KnaZtMXit|67`3P2zD<@GIcc^E#i4yimW3LZab_5*7oU>$s76;fZ1 zYs!c79mHgaA2g#$QZE?bC1E%u>nhgq$VpYLDL`?o>{SrejuZ!uBRU9z zgW>@}9#Lv*ZXLj0uaR7$}#jc(m(p;+U9fOO~AsR0Sk)24I2xp zrV<+q`Wk7iSkTuf%k;;P$Vwqy^sB z{_@4bx3Y^y?wT|8ouMuECng1q+F!Ko@W!*A+~IS>7i1SjH3Zx81<1q+E)ihi z2w=gFsJ5W?La~zws&)~lsKKzK1+reKF5c7_EqJN=?*x|!u-{ChD1}l~Ft9tXVSk zQmfnPyxuM+0oR{bTbavU3tf|+6AcYqn}sCP(Ao;q#HvP%UuvaMT)0z_67Jg7G-KrS zpS@!r_1hQL-e0u!v1!e_=kfkobq|inDSGIWhhCdwn!a@Uis`GC1Q+EUn&o-iE2_-p zYt5-zipHJboZ#1B8jza3=$dnEs@*!#wTzEw**LzfdZ;zT8kV}H!rfcU6%cER9+Ca_ zoP_BMmfSyPXK!N=mIUOhV>|mwUnp%znVPzBmnG1fmGf+7>sH4V|PHoZ;HQux^VcJL1&*_Xd30p*|Pe9qV1!1{AOBC@EgJJ1|NNOM&abck?!_3 zQJp3y0Uf1koHW5a-W+i#cd#YcT*;MK{F`bmdre){q=Q>dwjQ|e!2SPR_u79Po#LPH z(T=!|{VxWM3IsY>{8X2{T@w@yLGrwokU5*>>^chvFj^eK7G&W8J{DLKfR6<^3Bbn!O9Jq*z!F@1EGTCi8w)H6z{di?B?6^%OSzW? zO88iilK^}yup|H<3oHr1$AX*$;A6ok*9P#hz!F?^EU0H28w)H6z{di?B?2r!wBVJS zF!)#isSAv%5@3NUS^!N=2#AsJu^ay(Rx;$;E`AXxh>G8`_!2(|GE!Ai z{iuQE5fRNms){RpyZ6IGp#tinlF*3uu5)|Ry|J)$)p!2z-Y zr3^Hr+GY`83KAh-kpx{fB`(2cH(5mxzYHV`GT5*@egdXHBCVPkUwT9(^@0uZ2tm<) zU3W}CW}xdnNHxx-RfDuF5wGQ6%&r?ZDgd%UJ0&ILz{51ix5$n zqtNw%x;~J(-C_lgzN8QIIgu@3p%$>9XsEEUpz8wzHOhu{ec(Wi+I!_}qigS}O2Y(~ z2(WMgu%KwDu(6=)1GQp-tQ@G6ps}+EvMQZ&wz085R)QwDM1Tdc?5Gsau(3c^4b=64 zmD+}kRP8G^7Lut_api2IV}UAKAh<-C9?olXK-n>??Q!qBqC^?AR2N12M~w0UEYKCz zhtGgrB9sF~aoC47DHzjw!i$`!Y?HoFwX`YPi8I^=cH2ZBltJ}DPO4`F7LYX0sDetu zNv3{P_qn4=I466JFgvAcsIWT{x;}8T#z|{kAE+@1QqMMa5adfDTfl;-PgXQk*jUi@ zfj@)=4;OQFiT{Fk>dyUr{Jx^{j;*oBr!6df;){0MZsVzs?)ulki%Ng{NZhG^Ua%yz zt0Bai{OShVhUV7jBx#nbFNJ5Ma=<~%VqvP5V(>$GJy&j-tNTba!ZfBmsrh&lAbtWBR!Qa9i_)eX3wWXXBL zv$S&oQ&-OppMOLjc#UNx5LK{e)Oa0?8cubad-8X}^58#KEM^O1)76EsUfI9Jdjr#s zz^F(KKdS3`{GhmjyW?m_bM-;nrPQtxwY}FIfvG1i zj5SY`4QWnFhBTt*m>~PNMEC7{bEKQ|P1cko;p#z~f$A0wD3P|3oNqaADDiGT(sk-7 z)t(V;8MeHHcce&$G~w!cLqYa$vGwhI^I13Nn?`qLM|qdCjm@8+W6}ohhS8^0#%|XP=yN|)ip9wojUa_VE00UsKAg*6r&1NMC>NGMvWyx zzEHllxmDmslt@017hA4_42N`{lr?cY=4{RFA4$E_;izQ0oPzTDx3r}Z_Ge!*6L-nL$H zO%!DX@FRYU^hPq)NJp)B^I7O0ia+97B%y@!s&oRtE*K;x;*U55r#UWgG~ehw!6=GM zsEQ0^nI%JGsH>4cK(`qE9>f$q9A2{votGa~q zc<4X8gfq86c)qJ{54p@>pi0VhIbCI~B}mt#c0JqJWfLFLqyiRRgr82;?IB~KfC>w` zoK7ni2;_9qe1wszZ={}WY%KVYCKa&o0$@Sa?IB|!nF> z3x_n8Uv_++r+$-Tt7B-(<_dR(>@%=r<@oUZE1w!0AM{Oj#p?U=>`xbtIWX=~)i`0^ z{wp7wKY~>h%ejUo)s-?&)I~Z%twYTb=BcS0cUk<+Cpj3GZ<2jM29{ki1i4~dZ&|`z zyP9OXj#0mT;liMVCl~Ht_tYp?&X&~=%$}AIy!6#h7ma{~S!Gc#8w6N+Vf;XH(NH(C zBYdN#dYi4ewTI(sqH8w4hHtjq9bFCk4ML zUK$lYcty^Yk^3xRL+o=W`6tYHeMYDM$e8$u3wdoDJYbFE?cunJb{2X%u9n7{&YR9x z-OCT!o3h*ko)hjy$>=08WvthIJgutHKdZ8~ElKhpSq~-}yXO4zosgp3m+VQC2FdrX&(dINFbzn}e%3O<3(hT>t&&^E zcuRCNjbEFS)^;-9hf$zS(B2n&<_(JO86^ZeUq=g~I9-EO+P$#~S zdhC+M0fYEL>fsfM_ChjHMRh%PN#ooi(eRKes_W?$c_&|@zP%#RzEKaaNIWd`umDHH zLXTb2cv$GMOBxLe1yoq*u}c~c3yKdavyeqg_IfU4zmqS~WUozhmhQ3Z673u1bl(h# zh6Ni{v=G*Pc_$tg?A=#gqG2JK3JZbVw~^vuK{?ylSm?QWI`Pa| z8tohPSTBZ$1*&MF$9ge5ESx05f|CjhJ$CfrVL>_D*jPyaQnH3M#71)PSM91h`4Ua` za#ta9Ro>!kcNJR9O-59zcafLsElw8y=#NNiv(1+t(RsI!1*J0;bt443x5|q48t16k zP4?C!ix;ROE&UN`ZdCfxBgzwu?a-%G3bxpJ1evaYs+r7D)iKBf4EiI|s+91hN3_Nx zEx`?AHJ~BY;Lva_4Xt8pqsm@;EDFWT`+KZdMGLhAs-n97h;+fDE_l=hkIzJ{jM4>< zu%1j8Jib2jiS*ifYAza<=Q;)y1|; zcyoaTROK^*O9WUDB@9X<9vcf($^uovi7jU#YxpZ76YNPxvOc^n75(u8(DJx2!6gDL zh%-5goDLfcy2?#!v_RDzx9L(*jV=OYq8Wlq1bxbjFyyEJs9*Y&|65r8*Hf=PHzPD{ z*X(chC9awLqF>?PfA+vs~&%Dua{x}%UZ)U^!Z0PCpylO+a zcY8*-YhmAR13~;|Zc1rlDVQ2qf;xQ~zJ3~p^9S8%IDZBV=SQ;Pd^wV>xWJ;9EsJ*a z={DfHJMminD8+ET)3alWf5MZ)Z|HC_C}Gw)=5WCx*@=o6*YZMXpKb$FQv$v2kJ3&w zO6wFleHuoAXGheHJUc?cvt!*y@+*r)vddWXGT1!6Z_5t9)Jo%9d@&EE2E1RV+sU^N zgTqDkjT|l>ijP>3FFRbkEca(?U6~#@6q)6f@15w=grsHT__pey))1@Ytk~((@D{k8 z?7E@bNp?|G19LlxlV!|%BV?b382)JAmK~9nfkNiu^2M#2D@=wiJ`Jyd!$t6o94>Z% z!^KqQa3QCI>yEIb=3Z-P-}Ws7%Dythx#qdR8N{`v)9hsJ{Y6_JyP;1E?IlXC7S4Om zIa$cOH$t{=LHkB5lEudYi)8V!AZKa#SV)!=Tzo9B7YRNVrz= zO9WVG1uUd1M8(DeRkXlF%=lQ4vow4xut*jk3oMew$AT=J$H#(twz07wr-KAoz`sO* zh0}lqCi6s(7MQdcKU!e!b@*72McMdRFj7SeOe>9!1!j|nj|KH?V`E{9q#>c`5X+#e3*Vkg{yq(-NGHJ8Slb}3cNQa) zuZwNpB7Gx4wd2G7phlu^WNamRM#=5<$+g$Viib|o$Kuo-n^Yk#ye7o+_aRQL8v^gP zJ>}kKKv@h_6~CKv6-sGX$lyGmCW;H@MF@!^<0gzsD$HY-c1jhOF`ovUX9TfHkP@3< z^IKLB;`7@mk6q&DM$BvyKM0Z)g!n;_fhq`MGFnbRxdy+S& zBNwr&7bK5&qCX>VE>XHCR1xJ80#*H9Jqy^aWR409Myi*QLAL(GXE(t$0-eJJ&^agt zC+vWMtb#^Xd!#BjF)I!H*OC5+v>y+TF~`@TCt$(12s+)sAn6yj_OMy+X%@WmZORmbbX*k zEa>_`t+hb)Y-3}Atk6wxi6R6WLnys&`IBgH1T(RR5)j6O- z`vggmA*cp}*dL@C3}S!KmqgEqqY|ass3e?5Dha2PM8XL}64hOWh{z+AMkQsz=J)?& z`oMPK!uxw3Uh?YJ#J7JtxjCufg~q!A|Lk8lXtJ=$^SjAg|Lx#kwhw;kE!WpS+3RlH z>-N)0a(sIE)y|>%I`}Wyj4wZ{`F9!77h_%76|3*do0br~^wkB0zc}#dfyWNS91cjBRVF%IoK|D6Okc1h zbj;4eouhXZ?m7hCAXmW~MELHUlLmj|PU!jGx(QWZhIRtW{Uc;~zTa8(OA%X-p7(NDk!=wgj6ixl#Pij4;=GmT=dQ zM0dWQIourU^3SU4Z4MG*wkJ&*G;4p+w!`R$YyU1d-r&(fCPZ%TlRs2=UC|6EzbC7vFe9s3* z^l;b-DauO~9d-)T74!JFh^c>6k$&Iu=+X7#|DFHxwNU1yopIZcF%BkSiYeScsF`rubM;&Nez0j8U||DbffanZ4mOoavJwuFxbSxteD1*WFJ$AWUUv9Vy26KQ-b z5L_a_f*5EqgHm)XutqRG7MLe4Iu@K%SYU2T_*jtD6!=(3r-~MovyF}gs%U}W62WMd zSX)r)KiIVevVs;{fs2j>BNZ0d@EbZ7n3@6~3kE7IC}$fR3rtOcA1x4EBEW)JTVQ)! z(W3>{2*!^VWHm(xIu>kHSYT=jd@NAa7T8D{eiEUaZFDS9MGFL%2(ZurZ7KDWltv~} z;hqUm@QF%x=*X@s73lOwq_v5|rit<2MFfus2C;2ocULwb=_q3hYErP8u12cZk-2E# z2PVu#1OGiPo6!(-`jxYQ-Q8toH24XNKvfOosDej=Ym^BQ0|)C_yaF?VOmCmUbdea% zabdk=|F|OLka!-LToL1gjE^g}iDGoZ1eh42nSuhvHc`|sd@VapV#He|rxn{oh`pJI zCW<Q`Nes0$HwA>wUH$O$e{o^V>kf>Kb$#)2+H)QSbFW`Qn5)GG2P5F*NxB?Ol!PbdK_ z*r=ifU5Ka^3%U?dj;p3o#>fhtAZ3lX)BrxRSFJi#eqK_MzO7O3<&x)4z- z7LuuYD|e<4QF#8ZvwzRW4-l7GOjBU|z7I5KC=k_+{9Z9=U&UbXJ1 z!yWB19;@jgfC`DJbA+2S_yH~1pSM*9S_fJux(2jgy1Avn!-}QBn_y}1X=Hvim(|e3 z0y4~Rz%J%yFMD7H*W_1&7B$4a5 zJGo<)L`zoHeYiNn}bJ3RbGi=WGX zuRA}?9B5AG{aQ}k+)|~_Tg1kz4qjE(8+PlGW#v4Z*}Byc(Xw%>X@b{nPpfPk+m&n^DeDC}l?7G}ADN;By=DCWCEp2;R z3`il6@O+lC))$@rY;J?b*0(10Nxq7y-BYb91iXRUXT%r*| zfrtgUK#7k9w$lzB3k6hIU@mOG*z^~cG{sw3+ma%#sU*R;bVc|5{(dSWiaui zd{Sdu7+QHj?68pibX13qqq?qSpwl0b)((p=JtAmGRKR^z`iJIfn?<;W*Vbd|OZ=iO zSr?3|f9R#^yy}lgYm3*H9#K%WPylUsjw+9!>KX}Ool7=_9KsK~jZ_H>L3>J;e&~-# ztKP_$9?>MPkOo}>S)_)qU|^~{{Gt|fVnfgSnavlzRDx3~!`NxE{)n`S+utc3rvV^C~x8DymCGXUbAhz`_xzFDP<4Y%J(1H?0bC zvKUpDifUAl`;t`D0Zwn6&@Mnr!dX?ds@R1UsCKzgKg^B#vXF?CD|(&y#W>qsIZ_b_B4*_8L4WH zzNFZbu%Mo8Y%KVa>=lgO01L@fSfG*s>54tA(E^#KNzu_^kHM>F8ygG0Bzw)1B+#m2 zFQYHF=zhw>#X0yJ|8zp`vsq713tjQSFDJkI+vbY%e;Z=iz4ySz!tV?pzhZlS*^?|2Z`EiZ0gMJBz_PeW9pLIH?R(LRGW)iSzbDb1 z?`IA-$MJzJCvVYc;BY{~tg@(=4MK;Sr5Rxj1rYd#dFMYRri}HvkEc~N`e#+v-m1~S zJTMwCf7DcOvo*J}NVYofrgj~BO@XN=jFJ2*eyS;&55HBTfidwB7xLORcv{tT(964T zYHl$hbyIO$^#JQ&>nPX2tomDY>sSD89W}wWe8GFp$(|NsJ9^ktEeBV3ml$qGiEd$Fg8G>9fuD2{HfJ@*H8inwFhAm^ z<`%bgi5l93FX5+?hg_~d-}eUG{`*EOlEwT+G8UNeE;<%iB#Vy)7RlmcK~4wpu@EOu zYT#o*Ios%1kkdhYED&5Gz`{kqf;?}4j|CRV;$uOMWbvZ~7RlmcfrVrESdh~}d@QhZ z5FZQ5*~Z2K8{opn0>LE$EYt!Pb|rE-2^M@TusIEUEHL9;^k~5;7jN*fz=Ub|Sde|* z@Uf6i6)h-d8yyQ&(E`CG0xVnrEHH;(^dy3bckr>mjCawoV5GtV6Q-eKfr)qUvA`5? z_|bxLwz09mMv(BM1%gWiSa1LqRWf4A7rEYAOU`_W6kpy4m>C(5;wE_yUn(Tf$AHbmW?@OdiS{$yMId1!g20+M+Tm3$nLfg9 zc`>TnQ|`T?yXkGUrq+0*R6+?Sf1#?_W|t%Un=PNY z&1?@uZUR-8m*5&DR}0l$)n_AaHeIEQ!rlmeH~8qQy0UV}?FWx+&<;N}(v_7zUReoP zxC~fO)o0jPpeo!Fh{AMb1v7jp}HI8T5@GlWy;WS`DRi7b8 z3%(=@ld+&HD>Y(4S5|86h7w#Nz=GJMR9kJ>SilFJJcmjk3X`!w)zVYj$k@Z&WX({j z+Jbtvv6BcNQdU-jc0s6dTyMAKHq|GKvOO@bd$;3;u8g-?ffg>1D77|th$La~LFH5; zH@+W#x^^M;;{Uq;$Ww2x`tSd*qNMox=R^Ph1AFFd+5MQX>C4O^cYm_<@TI#>&5q95 zvigD9(-MN0zPh0B7Y80a@YsQv!-EoLofCa0I<>2NBcwIY>&q+OJMmuCd%1%x!7-Jm z+L{K&)H}wSC-M<38^^a*54DC^!(4;gzv^w%Fto+~#H4^x`-`?6{&-ycPv;JsJA7{V zg6yKG2GOR$sR}SZS9Ou+7oRtsuez5Xv^QnBr}dt_?#2*nxNAt(@la3wD~|1sz?Q8W zu2qcAF3gT^Te5O|+_ba1XBI}D@z1Jza74~)a}uU6SQ0vBXW`D#y9#%W16PA)a5WGL zs6L478*!>g7WEl{S7fIP$;4PCv>0!WFi%b0xXa>iKFLK}hBYOXS}PkZeyNqlxA znpO93e8}9;H**4_#zZ|6wK8f4n1f91W)8CMi0Ts)Y8_&Yj5$7&|4D4UEsWopQNlY? zGWY>yUm4~g4YDsWW-l6X1AnB@4 z48}F;Vh#fL)llx;4i3KyU6Wnw_`AYQLtQ(Cq?8G@6^k>rI7~tOW^PJpVky|sSb};x z>`XRAkH~&|_5DTLNALJ-T28Rs2c7{AJCWTSb}B9?J~4}SEXrLJ6rK{5x_O`58JK#~ zI^UIMiFMtbcrAaFd8`@iXj&?JJM4^d-Hdcy&$bd;yinR;X)p~)&3@K0!JD<|^UT)m zj=|>KsVRY8_eW_b8VADas@@Je-(**;zAw-Ibm5o-;~otRnHfLx^_gGH3~vyF`f=CFg0 z1%gYI2W6RJn~?|$tc8V-1=gO$#{%0Giykeo78X7h*t9A>7T9_$bS$W68ygF3a2Xv7 z6qhIu%EHAq8xhs8d91=c8BwX;MPzSrviL`TL|S^GViU)g9uZi#h<0xZ>J%$^ ztj-}ByUE^qRPh3A&`dUk9Kuh)^hcz%i|k8}2&`LdkVmlDa{PdS`3&Gksmx~pKd6&^ z2JjOJ<}-jFcdKVX*`R{;k`QFO4*b-JQ?g|2Ou|Uj87H_#nI5jg<^VJZ%n5QCXsIrW zTbEJJLq3)E?6T@I2y95My*}2t%7P(g5nfPS21Pb7^FNF{OsG%ojl>aunX{bkO~LGXibU0JC$Dfg3&s_+BI11=j?Z2(Td9Kq~4pY%KVaC``hFuB_CG1zlOG z6$=EH2(Tb7iB{BS*jVr-QJ91UU0JCW3%asWD;5YY5wt4B+Je&Y$HoF#e_YXIV3*a& z+SaP=B8C3Iz_)?w}& zNg5R?T-i4GqS`M_kC04Gn%^6~!o+{||G$X90hUM0dWQIouq_2ezE- zJ;grOC5@N&@aqUjm{k__a)gi!!bmpK$Em`|eWlQ|NRdn$0===7%Z^!7GIB(#f$iKB zON}MV4kD4>bNLHR^1yuex%{sF>^FB@?U!$45J0$*EEE1lORIkZ#vq#=A!e`|80&Q( zPpfM52djbJbNMTBWY>xAbNTaNF5k@N@^8M&zW>g`%Qtsi9SV*Hf#&%qK{Ri-TZp5zEXiZtl1`8*D*-&Mz{7OHA1%Ly#-RbqgM9o#qxHMR}>r z+(JFuN`Tq86Wk#DB$I|k*PQ-fMl;Yl)&+hY^E~yN99tc?;Loml#2f;Tn5*CsBkCeq zQRN1^T<@$)6d^c8EGTAeie4HE3paOM?LRCysjzVKUH1Kmg_}FB_8%5lQ3W3hH{WI7 zk62L7HZ~SmQ3W3h1eYj68lzyt0Qk{@oDbe;pFXvg$+%S9`( z=R}7u*Jh!gj)SrFhjv!?6M}3%xE#B`K8WfYaa7-kqxwe4s%7GhRWM2YMn(G%2M$@SCmhQ!}M z72z}482YQ6X)kZIn5~}j8U_o4Im#kdZN#2~^p7Z^bN3@oEy;S`OvLZBD`JSrrp+6$c9Ts1DL=l2byst`) zv&tRqG9If*$v6p9ms=$7^`Eyj^+&$aR4-0ekri#J%H14Qqrj=4yYDqM`XlP@!r!G) zsXrnOvVw*-;RxJUwVH}tULY$ElNHvI*L`Su!>jsM3B_!HF$rAuE_D z6(Dsd9#SKjtd5~eMYSr(2`DAh@&tnA$5jj61J%42m`Ii0fg z8mSwcQL7nc9^)T{qCWB95av%fhj99{a>T_F|O!?WM{KInf=zBp*k z&tD7iTWwxtbg?AA4ct8`BYSV&^MA} zhyCg9#uK4nJh6@$PY~D^Z}5mEaVmeVASxpsIjF$jOu`~_%sn36gNnWCa23W<0CA#5 z4k|Fek!+>Gr1SV#P%OEz9miNuF)6ba=?s_ z1%gWiSZD<-q$`1zqLoI97MS(`9}7%-fR6=Pdw{?D#7Tt(0^4F43$m^T9}DW)#>RrI zJs`jWNwjbpu)zAW=+Od4wce1;gy3UA)*j$v!AOM#0^4E<3rtsoj|KH?V`IUGyuTq@ zXaX!G6GaPbQUgC)U}AQBEGU-T*hz$q3JYQ7-hhKC&6u0gWGqnC7SywijRha_{st^` z8LUb-D-I19n^na%I8;BKFKsWEXV}R=r#~XCYh!%q5rHPsDTta#!MNTaoEh_6#Rc$} zLtB5_#k~%BU$ss3pkEmA7TX?{;cDnp88iD z+Z|dKFo9}J@#91OMlVur;66&VfxA`_$cm}Nr-&Q4RqIhPPDR|n-DztHwPA5{_4jF8 zz_mVik?3%mx_O`583>O5^IfoH!gY7zwfs@$v1UzcFNi)ULXhStluTKfqrh5>O_uso z<$D5E7oM!fpg*E8*WmWAdT;0$+G2lVQoyJl8#=O!q8iwS4qtjiVBeAsHjtc>!YZmr z@P;)@+h_dEC%I_Y1(H-Mt{m}8tu(&H7xS=kg!gmqn6~Yir*h){bne@S;|H(EzA{o? z)-uUIVaDq-Ivp+^ijP>3&o=7hO5UURWm}<&Xid66)o>H2%C_oRz?MoFmC6=&_HRh* z2$@%T1;64HL{*?6xJHw`M$xB1dG9H@NUS!m4~fEL36-v_)S8s*%F4|ZCPVL)UN1?T z!|ERHzS3(4tn`}7R(cU!BEW(uN>wVv*jVr(QJAi*^twMvJJF~W3%asWD;5YYQ8!no zT6K*jR_{Ers2R z(3O>1u|RN%CVPd(EvbPbt7`1w1HWs|FW(6%%I&+pe-P^Xv8=w&PK>hLFwr%e zU&BkwmmcAV2^Ghe9m_h=c(1i8l;6%xvD8?4>~mQf1#SAA8@1`j#7A7nV{Ll*#HbtX zLajsl)&mSIyJQG*#kk(Ggt>M#%@{fTXYbfY{q}_mgA$%xxPRSKqg**#RzEO%T0-#B zR~Hoi;=rQ^9y<_oI3QtGSrpq9(!(X`L}PZJ8mrrQMAh{|t8g`~qob*=y=@P)f%C!p za0RTu#raZ(-e!6`9RAiJR>>*yC$aUmFn(u73GYbB;O|Lv=lhw%%{>g%QnQOj7SEab zPTxY5oT8{2QHXL{l|`y%dI-OsQ=DX1WRY<0Wc}sh4EuXk?}@vEV=7OzH4TiZcZ@Yp zu7?Waap9FjX0QBU6=mV5(vUQxzdgkwuDIJd$g# zk9Dp>xkg(ufD%%`{*5?P0I;>Blz9mqpv0uPCgvrZf_G*{U!DXRZx8+ zvY*aM@{K_L#KVlaVsn>UpUiWa4k442er%oK&=&`662X&CQ8{`1p2x46L>sSp6 z7{q;mJuDp2-h52&qPj8Tup7quf@JX%e$1epZMGO`ym^#svP;^tGSszGNJ^PdTd_D} zi^CL{dcqjVui|?wuR0uDwDtXI&AVswfqr$P|CoKl?Rmx?+rIDQO9WW>60o4y++ky( z$D(39Ec94ZjE02*DlGJ{aKyucT$94bLL3zql(UVF1^fuVo3KV%V}@~w01FpYN1E%; zV`G82En$A6_BJtE=&^(w4GYOsSm?2M84nAx_!}P!OcQ_~E%dM_MT-_}RM7&#B?2te z0v42QIM`TVngDz(^w{)-h6N`T7J6)Y!oz~H#f&*mpd}IMRMCQRwy~oHW?3d~)_}MH zF%u`aM1X}0fCag4iXSboc|LqB^w{)-h6N)P7J6)YLc;=cTf&bP3{+T9&Nem{n6L&P z3j~)4uy7O#T54P(n?R!7BCEJURW?!8oLk^YD@_bGko5s7wh;vx#AULsFcVU#iC zq@OCJCVm)}bKe`g0}6gqe9N;_ z%o+_pPbRoTfCaHvsdU`1u|U>B)KzX;u|U;uOQtFUDQ7#c+EDJ@o`EL*VD?e?SRlAW zfQ1Ucf+DBG#zHz(v_RDoReQWXpmLKtmAX_^YqUVs9VfU%fQ2J~1*NZtjRk@hORHPl zK&*6LvCH>l{X+tkn~Vjj&Z{mJ?Ym9jG43_zeN=S#R|{TxM)>e=F@N*_uebNi*|PgF zVN-nkum?u(`OEeJlVU4=)3;BE{6pD(`A^8jgw#Y=v#1&vd#+g8+DsY z!*_O-Gj{wfxCL@(4ttR}cviKmELcl~bi-$@rc4Be&yRcC6FGuQ1Xwr^SYTNVIu@7~ z7at2u|Ba6YIb+Ai0?XL(vA{BR^ewo$;WHFKU0XU`oz~u8wDqwYT0sOCV5I?c zEU=6n^Bc)Y1k2d*v7jsnWs}P|J5P1PXKRR6>-I_YY-4ZDlgnQCSRlAW-~oA=vnFyv zEAxQ-97K!ngYXIGe0O?4?v2Rj);5%^FRy&>M4yg{EgQ$TRS(sA9FkQ@B=QG2sXoX^ z^+7hO59;*k1bSnxFYol}L|$L6YA;1LNcNdAJjSA@PM=OOOx;uN{UjsYwXkpZx*&ct zH>EVOG^?`K64a^M`1)z^=^S(;pUxTJ(;4Z8f$UBX$aP1s?WOg-kXl!|=zAfxM)(AK zA?11?)sA9<7UR7GflM+7B? zE z^+%+kOeep`ed!V9!49WlTY++oWdD}I=J9>6+VV@SG`__b^ICH-HkXFa1y#X`U10Db zm76XV^}0VwJJG1MH0(=K(LA99u#ilJ1$l)5J{HL8j`DCPe!+yG)+A#=mx^k|0#yl` zLMoakl^xaM8FsWlRSi@XoY>I zqlP8uDe|ue#h^?iWu+*1{POyi1dF6`OY5j}+-nW(dyDsgvabwru6Zs^(=vi9pZi@y z5UeE^)qx*0V|9`R*r!bLfL`Q0@K`JX^F&cReB!a1l=F+vo6c9=%MaR{vfR^p&t7+9 zh&9|bBmxaeoJG*;kVdNSAthxtB}dKV*&>W zqH}_-JNxl+RJqPAFYw0KG#QjK6ZSB-F5dhH7H>}Wa#tZ#P%3BG5@@ngV6XbmRl)Sv zq~GtJF+6S8>~G>L&X@doz_|bU)945P?(zG!`kS9Fe(#a7G5@vp@E%dmZi$RJK9e6P zRM;OmmQ~d_WUsm+{i+2FGkVX(&g11*mbfDQwK=BgOQ)}xzG_KGQC_Mz7h6#7h4-P& zKIXZOvU+!QvF#Fs6cfa5&!ODGmSA%wS7PyRs1z*3x%C1;_U*5EY;H9rVUHFRwj~;mJK+NHQgjr>x zyUuB_(U7&@_}7)m=F20LV(Y$AFmFkjn!0h9CD5Cd^K548R!2lkRVcrmn*!FzH74*C z>RtFMw!rs%Vp2fDjMry8vfsY#lWk|VUHo`Ve8h!3D0~^=O(KUc_@HCqixYAU2xK7F z$T$guc3YY)cgNU&-qsWnQ|AabXYl`&m@?MuKAu*UmOIrHy*@f%D%jRhv&!N&r@B?2sT02Y+8 zFm}n2tj;aZw_L}^0#&rYhPUvsK-F8ZQDH$j+vr%Jsx1&)BEUiubO;2cpsolUu zR`TQd+zLU|^{#phG?9B(=C}AGI#*dRgc8E{(os7j zOH7zEBgU&wcv(6DD?$#5$prj}qBA3gB132=`9^CzQjtMTVe>c>8W}`+juM_=zmfye&_q3 z|EYd)(1UyavVFj$*oxoW&d6* z9St50OqlhDsge0Yi@Jat^Bc*Bj@dUJ?YOCPce~Kc25J8ThbUbu<_UR-P@H zQ@k~a9Mc2fp9Q8tIoncgDEDr^k*p@`_*<4?LZ+!arFH9ul;m4=G&ll|1{dnxZRudq zAV)9ww}?eA^J@$ol=N=YBy-)JWnbp0&v9&agtu(k;O=b)*QYJWXJ8AmG{3su*5z!Y z^GCLCOj^ZxKtz9MU!o4T@IAK|7Gq~kiWERMR&lYVZO@HcnYa0rgy*xE5N;h@*qiCo zZi{vGZsE^UMa`x3g}gV_r`_g75-uu2IPo}u$nR^U_a2unNg>}4m?t9WW_r@wWF5DP z>Vv4hk&sICjf6C!58}!caWPQ!rc&J73W7!m26*!sWwByOSu9(0*{9C)Ht&)6LSmMO z=wY2f*6HKFkeDA9dO*x%DEKd=Ah{=pAJsA6Q1qxyJ=@q3J~Q6JkLn06(FmbH#DY9P zh>r!iRgWL17Eobn8JqlIKDEHKX?d@RVVdVDOfRy{rzm~AmS7SywijRj`Bg^vY-OEf}oidayHik(ET zT}9|va8hA`c?RKQL2lLKV}Z5m@v*=be&J(5IosG+V8&bcSRlAWBLrI+v~m;xHQsE1 z;x?;}Vr`g=s8sJFj_NH=7XRpvNNcmrmmX1Fn@|DwRY9G(+GY`8pyx=8xN$8L0_Jk5X^oU@gU4bacpeip==?Vm@X0nkgVIdPR=#NONQo@%W z(Il^s2F*iRuDI@~!yWAscMkUL<8wzywRAPzKfIbwe?Vn6WQM%wUw;u%8 zR52+gI8o<8Ch%@+G2lVQb59t*JnJk-@fgWZD+P!{J6_3Jeg=l zQ30XP!uJwN2uD_2e(KPe9rw@p-~T85#mN%}y!6e_zIZVEZ^qq*({nejeDly#$1i-H zuwzl~qM-1UsMO8-+|Iz%lh*mJG)t`O?!;^Pqs(K?(fqwx^}X#Ncap#OAeX5R@*yxa$Zy-=X;uBJy}V-2wW$BUQNG|k z=M0hu2Mw{2%md(s(gsU|X+UcBvz7_otWBS1wr+O}HbbpC(Chvv?L_0inw0e3rUozB zlO_$CRrhdw$lTC3a{{8qL_HI=GHM5y8cYRuWT#U#%6`6D@gNy*jxbM6-MGu*Z$8OI zTZT0ym0BwsEquwX3%^$ZS5)uWs}ovx^@3ixRGw;U8W>aW7;B!$N3?7l-&Q@;8e$Dg-BQtq zseyl1-Gd`?UYnCJeZi8@F*^%)j^0(cYaEywG;ecOb6i6c8yw7!P^>|Y@@x2J%iS^d zNBChv#qnjwvQ9MKYpsg33=}dKmoIMJyvj1Mx2eixQ}l@Jw^!d^w0-oB&!*)BzY+Xy z@X=RifT>EPyS=SRoxbfTtyhdRLajrrkuk?-@;`~Kw}tULGfH?zN(Mim>?=c@Yo05~ zGPvbrZ)cEEuAD8aADBHYA$aMl3krX6;L!t*9f&zRC}GyQsFw{w*Rwr^nW~&$eBN}v z>Rx`(-jwB@)_eB48$+z&t|3{+Lp}AcIJP?i%PMPod!2lfU9tMUJp0pyV-AdaG%#dl z{LI&9elar?>}b|~)KqV?HMg>2RJFQ3?+(61dBSP<=~%*!j|F*f5FZP1R9IjhzxY^? zM*;A$zy=5LvA~S7(XpVOZEP&CViZ0W2rf~cPy$$B2|GR(EJRabfqDF*V}a$- z_*h^w6!=(RM%n0CP|r3t7FaO~9}5JRC{JhtEI6r>2zhW29}8@R0zZjh9>4flpo$h) z9*vI$IgiFqBGj{ujRjVW!p8!^CCU>D01HMUEHM9Sd@L~07(N!5$1ge-*o+H)w7|vy z@Ug&*veBaj^=xBffvr15#{$76%C8ojLXG2kyR)j*9Sz%^4PYsE##;qGh8VRo?yBOE zC!TL+n27R0O++6gxTrp;k?4brEsDLMv2%AhMmeycU0Ep(^kzPWC?)6;*=-b7iUaJ} zN^y*etI7Wd}ST4DZiYvw8eZ*FZ_kU6SyjyqyiqL98K0>ggkpZge z%+vrsW=K|oAnX?fSwc=#%FrK?<_?Q5J)%6pDc)BlYf*O8^gn^*wjNa)#!Ls5*F0X6!u^VRq zBh;EYHWqZ1n^r6+{UYpnGqRGpE)~@pEf8Fy2*D^eDP_xO&V`KyUFD_`3j``Rn-neR zQc#xVhO*^}LW?|%+fLO_IK(aNs zU$Hg#3~UXS=2zE?`?!2*1Hlw;O(Li7@o3d*)#gikJixyNw$vD8nZx{=2&R`_?t(7* zbD~v@YqOAK8d_Un%IF7UZhi54g~`B&^>)7bK?@_JvPTGe@0TwvewWs9sb|~3tbAgh zhXIF5$(<<7(;Be%TH|0Vcpzojm))KZm@k!3SdbgeC1u!H@TJA? z5*F06jg19gG7|>>7QjL>6&9#g#e`X#L7IpU=)n=SADm zp)vIajXPGPXhA*O*jVr-Ghy&=0W27au)vyf_*h^~Is9mWs?Nk3&iF|LSrJuk%2iy% zjuzCjjg191pSZGJu?a>h&{13>7{vxG*r>2TRa;;KPxx3+HV1bo#>W#xaLe~XiWPJcub zT?5)L^9AjW>RC{BOklkv3{;UxkUYeW|02&#3gRneHw0{H#JMq_xPVaaF#=cQL zsC26L>tfp(8A5x?y`N-+yH1G{<`!wa$v~mP{>ZVcszz8j@|I=TZLG%rQt~jAemTjV z?`!bT#7Hc;Rf-X$7@fd(`xc4cwsOS?az2=XetRzYd!$Z*u|_e1gnW zNzkHe&atU>>qHkU?s56=b?1kf1I_8YU(1Q!3uwl=q|GqW0-C3l1vHNaCd~T7R8amp zuS!QvPLG&BW5!9ag4`nQ)cJW^Q%FpmBisyoZd$TGZ>tWp4up^W@lgZa2XQn%U7ld< zs&d0lC&&skRHZGlqM$(u?66gI2w7IiZoewkC>Ft1ggOt4{IYKj`D@;w4&C14>9u%K+=#>Rp#iNf*)zyh;7 z!N-EWVO}d1l(UW96fK~_0>LE$EUW@7DC#q8EclWrOu~Y$tkfEF>&nXTmQ5S_*g*V) zqk06F2(XY2SWwhw*jVr-QJ91UW_N-gEy#8!_~mY9<%8dRok-P@P|h}XwBV$Q76>j8 zv?|5gf>NTx#sXPE>#K9gCb7N3c|a1BSzd`!>4qeNtj?q>E43yO%Gt)of{_Xf1eXY~ zAl4QXArLke$Ye8$R0|sm$y6Nz-&R(7^Pi1^w0f;eWt+Lij<5TM@k02ott8*v1HkkEE7Kr%en83-2nx^DgOHD!r^BIoqckl zX_PBx%jyS;wvXO1Zdy+88^P}eAAL2UaPr{@cY9kC+%@@0imT@G6S))J+S;jhZaKd> zBbr}in#f0#T`~l@Vq9-o!d$zWW{jNvvv=&He*41O`-`?dHm!O0Jl;R6?!gf`MGt-Q z(2hB#=}V`tn7(RBNKszuEYIU!@M>dn#m=oHj?Mv;z1N(>%D!?0n&!WhY~;-{LT`S6pe@jYe=Fy z-_IOwj^hJcPTpMMFhfx|91cjBRTlNKLFl^qUD;v#V;qORj0jN>)Ys-^j2kPEeNa;$yQERRQ32HlIjKIVukF|vu}Pn1k^LVJ z!*=Xa$ikSMqFPyYiE@u%d0tS@6)64xjpPVlmI~o#dq%~X8#}^hCT#exa#<>b|0*}g zPW$PC< z7MKYeJ{EdyM#2c`An`At!h&+P(Xk-c#PP8}aESm5M*#~=PJxbvXeuo9+KhyR1sheg zz@$R>Sm?DG2?-0yR9H~XHaZr1t{1}!xd|>2VBrNQLaU!NqL*cKzgE>bs-KSR(2-qN zD$wbVNOPakmmU%LIzceZDgDE`-jh}R+Sa4$<#?&OU}XKnbgD>8e?(eayuS2^)_8;q z&g<<;lLfo#Xru}r$@*D(u#! zqFP_$WT~DnNkwn49UBV^y2?$Xf?Su1YQ=&s75(uFa`4D&y1{mAjJ}>Oc+@(%pbH)~ z4}A!_;8EKEkS=(7d&dh zf-ZQxjbV6Q@TfIfNT!MwbirdcEC|d0dg|4Gn=$<7pQU|MQd0Zh$L@Y$@$dg@u` zoR?k-U-@AEUtS5E6t`}{3l|0@Jh>3;k!9bB*^*iR0(F#qP{OQpQzP?)eAsKp0zX?> ztklj-bj{}1@RC>mBm6L-;`p*-StlC710d2eP{>?dzPNRBg~`yx)?g-BTm+nba!tD6AB`e2=gE`39_@Hm3EeH0eMRSlx0~K?SP%sDi&uV!& zHk;ylf$caPZyx2E>{`d)6>b{p+9@QZOsK6`oB_IZgKVin}GnT0i7Z1fpENIP~;)R_6N>ZcPS)FLiUX;5iC_E)9b@M*AGcfg} zb-oLXG+cKlUdtb49%}|8jh4zzTZ7c>qLIaOroJ<@#s0*kfKk#Grg5rgM|M$E1KYyH zrnpM3%Fgy>{60&AMcNPXtYv~XYt!eMt=k=74Kg()(Chvv?L_0itg6Sm*sAOThl`M+ z+?S+fPjwHA4i|6cC=M4pz~RDC?`{))2-y^uvQ|9QI@BCtmR6?un@@7lmSIgvrJ|9B zUuvcCExwosBMsiK(;MV)aM9NH!RU2AanRa&fyu!#cvZ=~z za}uU6SQ4r@T#N&Ui#7Sx^)^`c#FCoxE%FrC9es)Ngwue90-5mmSYQJv=vauO!UCJ( z!p8zjYS6L3k{Wz0uqiHdEU0H28w)I{!N&r@CCU>@01GVe!^Z-fqCm$&G!+(@avmKE zN>YQ41vVCfj|Dcxg^mUFY-3}AB{le1Ah<+e_6AsRQbh}FSOXmkOwW#=L@={Ad@N8! z3rxX-j|C=!L&t)8wz09mWN`RcAh<+e_6Arm5@A76@StOXnZ4m-fsIh0V}WBc-{{c- z8$Q9u0+Yd^V?jOJ*jQk5Na$FgxI{2=30SaEVSykml1h$jumK+n%qAEg3slhpGg!vQ z0-Mx8$AWscv9Z7gDDbg>e~B7lZLm=D<@I*XkXLPcKVTlm7GvX7poJsKzUmG*4$@+5 zqz_70HgI2u8=G8veXMg8N;g8tp!y(n)i?G}r>^?;LQuCy+$oMzRPS8%%|Q$V`_jL* z;xuwPSAC1^h_A(+;y8Ve&Q;&=K9YBed8*nhC89(^WP2_SCEMoX5?S;V!O+aHJR2AFoW1bVE zy6R%vr91l?L&Ul(y9sbrAGu?aK&|( ziu%mqj&>P!QP?eMMRjGRuB=?*qsmIag1GKdQJ-OB!Iwl~5*Bo2rPi0LuB_Br$RM~x zfQ40n1x0;^jRjv4g-KY@m6cktperl2Vu9ci0T#qIfucUc#)2=2!Xzx{%1W(R(3O>1 zu|RN%R(k}owxFobu(9AvqA&>y2C5zbRr647SaTi_Q)QMTw8rzRxvYjJvYwuDwy|3T zWDRSAO9WUDYYR%{9vcf}b#A4%;%x&lxjPLtvf!QnF8llIwddz`{LO#P$c6jwz5CyVU!_f%HS+aOmz=o! zkNcABSIQ&up{*Iz6vKD(-|g*hQC?~013SG2zI_;68nUm9EVjt@3B6q!^4m6eI4%;} z&4xpp&!)#pf7PzCbXy+W+dLs{%T-HQryIoAPlJ!fptDadG|847y?rzy-R*6{_fyz& zbi$H(={cr!+wa_my~VvXrsyty9j}2&LvT^<`*ztqp|?rH)Jv^yp?$3fh-e9zXS_(25+{-=epT#=4K1>V?ynmGe?oFaA~MxYyck zNndYYkQjbQR$Zq@!&~5Pu?yTSLd=rwL?7-J!M1$CRv@33l;#?c7=O^*Yi~nuyN;Ta zSXWM`|H#_=i?%)nrW5mc*$tw%>BKD0<6fbi;sJploO^9U6Z7jRkC3HLIKSLw)gneb zav&KxR)cfoj;S^p@QC_ahTKn&s6h3idAY_dhc8>YuQ%-Ns1lxeN?WnTK647Gsw1}DF zpYY^xunQXNl3Z{4unUR;o5<6u7mY{-DXYPuLf5k`OSy2cZG_OAsQ~~#lJMzHzC?h9 z@8PFoT_toZ6v+BPd@QhL4?Y&;tOg$otYeCg1?EMAj|F*N3?B>X*~Z2KQv;x5f#4DW z7McMItgD2Mg=8u$ux1ZF7G&i&J{DNV6dw!Biv}GFHd)G!j|KH?V`G7-0no8PaESm5 z9e@SaRYJ#tlL`y0*@KS-*+v5&3#?;`j|JvMgO3HOXhA*O*jQj{0CX%6Tq3~2cYp=f zRYJ#tkqQf}*@KP+W}|_R1=cae#{%n^qGN$|O!1=y^=xBffptvLu|RN%01NGa1t`&m z%&UZII&#U;Mui2|F~!FMRc(QFO!2Y6I;Qwopo$jMvyF`f)-grL0>LE$EL?^ zcVhQn;oeI{RI+yw*;||}{?Q+imd>u&#POv^1T)ysXoD8DG*(_#CC^%-bq>kcP4(7e z)9d(Y1i?$9)h$4CSARrWyU4!uh}L+7R>&hbCBDZF7?^ z^o}=>4xT7>{PtY(ijYGhgy2W~BqQ8)ia*M)u}JH@visP5rAbW3JucY_f+46_6NDe} zYb%bhNmK{I30OGrpeSa6AMslx8KRNugUG&-K=X_u1VdNdUR_&Qi$Ryu{o&R`wh(Wr zQc>(Tk`Kx06$=EHC_*p-7F69HHWqX_omMPRDGQ8Ba|*j5LDum9>Rhr(F4szS9cc5e zWNH?IOB5k17^rFsRKfyg?vAgrCF}Pq8WZdZUa~g4c1^0su-E+ikN$M{U*^8_jPt{s ztAG2y?41cb)a(AoE0rzTLM2V5D3q3yHky-)N=0RhGDu0bPRmee%95Q{?K$lwn$g0M zWkS-b(}F26AvrOONtQ74`#-bZI^6DQ{+{P`uh-ny>)tb+>zMQVJu4gGBCScjKT<@35DPW9LXDY+bW?=Eo>Ja0)KDh+Q@)UkZfeA*)44dtUUd@ z(nVP!Zksu{R#t-Bo$yzY;3N&bXN+iW!*;k6-0pCwwd*SVW^RJivnB)&YDh2u{*4 zk4Ic}FlQeuRNc?ccHNJ$uh~D9_L@Yg{rHvX66n!bd z#e}la*h@}6q!z{aG@%R*a*N``GM*5U_drlv6cbQ=5gpYRA?xl;MfF5vU>OR;s^C^J z%r?^Tg;-mwQ1J`43BKaj)i3Wx{*7=2in38|Q9HA{siioM^O!r5ZtVFiEESxS1^Tp7 zVj-1+HNkUY7RbinZ%6{!81y(5kE+kEKzj*4P8BvbgnihF%l9$l@RNP(^hJ77@Tg2Ec-_ zK^AN*Sfc9NAdrp0#{#P3tH8<-J{E+H4Pj#;5fv7Ma~nDq__aUyhdl&~2w=ezGz&2l zE>|rq5863`o5|p7FX6vB0;)-eED4P&eJ>fJMsZL6eQAi|cm)ZPFx}nAzgd+!&!yC* zG=DHn=9II0R}WnUe;hV8}tSWs~gMja5G!BdvBmNe`5}a zhWpYGg;!%t(3p)XjJxM?!r0+{&{8u(2Px>KN`WqtHB&89oRX15@EBPhRW9zC64h~BB6t*o+!Dd#{|^hO5+;Ic zvG6mt$nqEx!K1kOO$50!iQw`7hXsk?QQT+&RbECU=7oKrM3&J)B6y^7e76ICSViEK z2>ke{X(pUY(DDl;FQLI8_t?)f7@SPhWz1#lruEZwQDwyR;AALP4hRq0Rr3u7AuB7X zs3e?JR8K@g^+ep3;z-5_nJATsN?G|FiLw%89yb69gGf%tZ$YD;sY=u$nt1JvrN|N= zkh-@z7URsqs~X{i8BW+Y9VIF^akp}bR8-suzYj@80T#9cEQsWEkg<@63JVgIo48nz zNJYiPLLZWf0xXn*Iwj$cmNv}m?HrX`OD=f7n3UZ?O?#^PyXg*qlNnU(#l;F zX{tumI75ay!>AcEnu4jj_tj)ra=XNjAXYiC(rZ&nO4=%kr_5AenznnLk zE^lL=puGo&u~Vpm=w;Tt(R{Vgx0dr7U2Srwni>@{=P~*Rb1pC9am34rw+{`hwbsV92X(ap zp9a3np@QMx1r*x;>A8(D>!a68*Sko0g|2U+>wD#8&SErDq#3fOSn(P}d7?f;q4Ryf zDw$QX*P0%^b~p>%PGW)Ei5fA_X|{|x&+TNq_3%|AR*hVxc_J)H`-w6&9^;hI75O@= zQ$00rkmm%1t?+N#U#``<*TiK8hn44(>l60yoV1R;ix|mDASK zUZ%Z8`ed9EIPfTlOMh8zSVAe!5-u^_lm10M?r77=ik=3+reRM>|I zeti}`7U-z3AP_mg#{&PF3w$gHL=Nx|5qyyY0xSsUHf$^iT%F)!0l^{y&e8x2fPhDk>}pY=Yrq0ab26a3usj7WgLP2(TcW+pw`9Fd2uB1q6#o3nPI%x8SNq z_M0C1Q1oiz9@(oyHR&)^%M}^uBts-_5vMN=k$)G7LoH9CVpvm9mj!58y{WT%W9;55 zf#Jb#ujtSR=8RxJBJHXt2STc~VXZ>J9mqR!J4%1`fm05}p?ad{Y@wAQ*pT=RgU)^r zZWP=I;hC28TCoi)StI(Qoxr96)RKiKGMfne*6IN^?@F#f(*m_n^8ADlUZIGL!G%ry({Re27UpF+*kvxlFb5zPhI z3M!26tP5XoL_(Eu!lSD4B3MTC?HKJF^;tg4kb#$o!X(N{_>qZ3S@~bAtOQti2e2Si zpTWjLUlN7!1lNhE_9BV0Qe45caBf2vT%)RfAXr2I3vU4ygz7WcSm;ZlFdh~NsIVYW zR*H)S;oOFeg}$V$1X!p5SP-huU}K>#iNbhTprgWqL|G{=7KC#fIu=kx3kVhwzyh}# zA0|aWJ$X*>XIj?xj^$C{h zQM)90oP4_3l`kvpcE)E&OxRoLTM_6Wt#}Z zecTnxQxT@o&QR(pJoAWR`(jS-qB+S*0(64@=W@09aZ4p91ibDK9vJRHR}Ym<05ifh)^hddk$ zs}U_CfCV3b1)!lCbz4=q z-i%L0-i(WZH)A6UV8I(;f$tOpKUxsf>Y<e#!*FA_7?O1y~Ta!+{+wNLoFK8!bp$J&B72;oOFe1v)A$AXr48H8wZ5AZ&*N z8w-+FPvT-h(&|ZEEC}Z|Y%JhWVFAG+0$6xcA-alPO5~R_qswJ8hh~m8x@SfkIIo(j zL5uMt)5@KJ-*(!2oF&7S;q<+&_Zu0Tg$}^soo^(+lIQTgR_O44Q^v-;#AI|l2Au7Y zy*hzFgxnC12lYKBoYXxx&O)_Z`%*i0e&$RvME}LB2y~)gg7r!jqHZ213|dFKbdiA+ z{NlJkPr+@S2PCZi=>?6U>%-S8YC3Cs1)pKj<-Hzc+A(}6pvi<|Q@k!wpJ@1fFN=RH zD?m_7=4Tg>RpC+T7bHW}7W{p8j(?C0^zTBnibi1=H|r>HG=Ls32(IPBU#}z~>0o!x z!}G7@!%sU3uI0lIfrN9RmES@Ij(UMRz4`7IT;T_=Z4aEbr)7>Lfx89#-ALeW0l$Aa zf@P#w$cq?6`<@n-$H~uxHb%&H35h;X~ z&kyjCMJ9bnAIOjC_`+=XphK{T+6u8mEIp&8P0}5kCRSHpN#|wNOtnmL7=)o|@eD+% zOjPPuDk?oMnkNET21$2p*K}8L4}60DlJMh4feRA+LyJUNDQ@+n4=F1F79`!V|36qj z6%bpZ%4JBDmEvNd4=F1F7Cga)J%Qa4xgn0^f>oBQXQ~plh&*#xS>gkdA!P*9DK#?} zbXE4s#h<06h!=G?q)-W{GJ*(1VZ8LPL|GY-`&|e0joP4(cUaxnGZc-Xd8=m2a{G91 z67}&O2l{xo`5SXULQvp>1V0Ncn%l6;)_q7>39t|Vupn@XfsO?_Dl8xnh4Hb#?=K1e z5aEj|T97C!#f=vFkg^hB!5v^hq%wgVE#OgM0f8utUrgq^Ai>814iy$qNwr9PD|z_Q z0(J{{V#Mf0t1rItrQWFcxbCkSFD~#bF}|`!4VnlnF{EbC%kC1?VG85;^;u0u5$z6b zCxs{P3&n~kgP2Z~%se1^@hZTNrg_s$T!83>9&H-2Y)P2q<&w|iL6j6)H#UXB_tM}- zN$R2~NzYpAO*coi&VVFfE0 zRInN%2!&WJr-Uvz;Ns?u;#D)h?YiTYM{=hH`x(;KyUe0#rB&e+8Agn=6b(i!bMe?k z6E5cIuJPQZlC=L9)0P9aG=8xxY24#+(N->tHZJm5X`!f-FPj2fcaf-4O#4ri+n}4vtJlj>KR2crj$_v@_=mELJ|R#SoFkKkG?^i{M+ki4O>+CgB(`mVj$sV4e}wD;xmL^~R=ok(dfl*&}d z)MX3`s18^qvr6__)1%i8XMyoeEHJ)NBj!2HmNDlU-;5I(--IP;mnl=@v2W-0Xc8cB zg*Rp1hEmtk+}*T(nl7rGdHL#D0lAHG+>^8#=I@;D(iRHpSAm9dV+B_f4_nQ=sGJmj zJ8vaTUb=Fkwc0B6wV`s_dfLmhw`gCt+UYj0s*S~Mvm!{|Z0Nza?|*F(0W6e)S7*rI zvY=x@c5x2$DDOu^>p^z{i3hc>^5_qPYzl3xebgd@R6UL;wrV z0Tu)YTqd@KlV^g+jhAbA5H3xebgbS!WL$s6cc5Y27aSP&#{pko2S zA}XxL>M=nI}FrgP>WK>_oMD<09 zsJ@7f>WgYcO}GJrx_A5TwTuboDQv>s0hVm{Zr{C@V8F74O}N=$o8b9$!bxgjZ-h;_ zIe@Cix^?^RrA+G1E)oNz&jf0&)E;c-du@!kSuKGFB=ikQs8oc$At?$|Gq5)#fl?9r zhJ+VX6QDa0QC;|C&^bzmF48o%!?2p+{fM@R&Z;-+R0 zXtnrz5wg6aMDQr)Z35wKRp7*}!ce7TlRvOA6n? zyP97)o_lBhM40f-d^ET-Z&KCPLZ^0g?z1C>*-(IXzCPZLRFM8R8~yBin*sw08iB#Z zXv!drb>F9;5jg%Bo#y*Am|rfrshqU`HZY#xU(G)q$~B(2B{H5+PKrx5@50 zb!3X1Eij&7v+Bt0Y2Ww5;dcJ=6?Og+x#{h1=6iNLeC_Zb&EQ)i=%pmAjw$WLR(r{U@9hCGC+8VC*{*)T4nmO@jQI;pHZ_a*ZYSDnJpXemGwnSDjD4Mo^KY@U zA9Nj0%;JDgfn~0Kc{lQJ@CxX;MeW>9Lg}JTLc*SDUirItJ`G!e35g~!p3t{e{KWG* z$y>@bo|rB#G@eig#uK~mGwZ1&AkimtQDgW8zF1|g8-A3l@d0$L$QA-B58#=0s2`umLo4|3673m^l zMUrus~3jhX4u%L?y3-=LWArTc8 zgmW7@7OD_o0l^{yShxeQAdd(OhN!R*h6oE(RMCP4DlFt7!U6#m7KC#fIug<;xeiFR=@bP6Al@bQ~jdmhr3o+?Tiq zj;sK4C$Yf{xWreOa9<)7j+6zgsd)hw+5i?%Wf>$wL~*eo5h99<1>xL=txvW@75^YuM0Yt< zZnPi_hG9nw5+S0vSda)2#l?bfZo|d`0wE$lJ&a%x0W5H%1)*3AHWnm8L~*eo5h99< z1>xL=jRgckL_QV}ETX#{5{MQ=VlCKMKvm_H2oc+Yvt7iw&v;ErVXZs5;5U4re%V5v31sz}#FKujSLBKNc%L8*6ZQ@V=#AsKM~&uws_>@F+feFSn!B6UPt&FM8Y17pa|%-M zJZmCj?x(CWXTJwG3T}k7Q2HC?^;-8}EP&JnwmrT}4EK|NdTwLP`snr2^)6Cgp}pHy z+=rdZlMu4Nj$T;~r&|%Vtq=qz(me4c_YxFM>GbAL>=a@9d+C>db#XMPM|^DomkPK?+K~o!hXpC4H&kR~$wLua1BU3#gjDOL`TF zdlZ*6{E`KJt?hh6-9TVPtPA{SwXGFB!p=}MhUTr}`p@2!5&F;C0{>a!eP%V43fvOY z1^%;zxO7ewq*FLIT0pRf;y^2f6e=AR79_oj{(E~B@uP)VsGFaSHBD3@x?zV}k|B}| zkru1I9eV=~62hLo;nhGY4M{IU`c_jZ(Vdy<{Zz6W*=B^GG|oG)Ad9qwbGs0-1R7b4 zia@;S-$m;3^{Z!M^8;}h&m@n{GHieqF<=`=T~8bZu7A~piVl4`Bne^$o>P+|aQ$N$ z`m&G0(p0|1VV_F~9(?K9v2@O3NaZOKGoG}oUSOWdeTg-YH2$OpR9}SZi7=qAMe^#f zMnqpkYAvK@2@Fn+xfA^}6!C`^h66Q+QpK&31opo$hy75q`C+<4IfvO0ViqG&-hw_#(UFG)qUFgl19 zsHma^iONmfXaSXg!57sb0+sYbG`IgL7Md}NN9~eiy=axiSHAdepF2Zphw_=wk)h5U zsjsY2gRUk#iW+!&y;H6&Z9jAI*hLdA=IO5S+@+GV{}2{(*@`=6k9gE!5AKR_>xmQ#Go_88Xxv6%@6!%79fet7NY=J$mhM zHZ*B$td+?{HDaFAY#H-&Nf9?6j<+7ZYQ(CMt29r9C22oVrt0|}uHx3QBca|~&^LI&iZrh(i zQJ_bgMl4$rW_h{f^LT3okI=fYDHPS#yalu6Y!)9`taC0e;&H^wh_??7thLtugZpp2 zIv0MF8PMozlRMSasE|32(LW$>Q&)9Zd2qRATAop$q1;%#v1;>AI6OIQHS?l!Quyt> zl{9(j%8Ax$tJF_~%4zFqFVo(leamX6+nlO47FW6YgUkRU7;|z_t;lxq3pa7Lq{Wc3 zD2|kXeDPM%k1_-6o9Oypd6}~qjTC8y>?u~f22q~qOOq>W%AOc{HPpJ@ZOdd!)8YeW zS4Y2;o9ALUD)fSt&7!q#Dta+jVSF!Me%s{VV!SV-t zeXnBS2bV~D7Yo8TwuimGSFs?P+pw|lgY;UjVgbP-0$A__SP-3_AY*}m3JX8V4D>1% zgx614-R;+U6$?Mg4D>1%evldHRV@4{GtjG85Y27aSolGDtyi&tU=aZ<1OP0Et{gzd z0v#0=gqK3%dbk$bt62C!W}sKG@T1H?uVUc`nStKL0;*_1G`C@6;RorpUc~}}MFg<$ zAKV{%^@;GPu<#=RVQ*rA^8*24uVUdx0>WO!!Vd(5y@~~ruto;^5b+}cVXx*EesK5X ze{B&}v#?H#2(D1HH3fB9aJ~3i3#qsNcImSB<~N~}r-S6RkRHvI5`O*ec4zN>5gpYR z;Zc1N71bBT15GTDkO~Ysfs`=tJEO^73-Ga8PCJm0^1E;I6n;71IcN4-t_d8If2hOl zHL7CSKi1*)8icr(mOs+r_R_`&u4BLb#y+8k>)5@wV8QiH1cxJjJp$RW64ilR=JKZ z8X|BVyA_-zgy*9ku4DIFP{+NFjqJdO>ZpvNN-`iz&q#(yT)k0W8X|BVJM&xn1jscB z5~@Tr0ad|Y;|HFgy&7r>oiwVun=JQgYD+Ri;)>ivW+#1MhzNyPAvj1V3YXC+ERU1_ z-A&(K%|uI7ZW5`eL@N5lfGp81k&22NEugA@Ay`C(z)Bu#@L{u=m7VR!xFR>; z0O)~z-{iRWQr%P_r~H9;T`ztS=%$S1i~fTfU++B;3DpzfP$?^)qf%CuqEc3Zp5#Ar zIPE=UHb~1L~9_eISH7X|qfeYg12zDY+aIWAs%2_0 z6guBye1{9ep3OmSiOfNilj4#CjGeHC>r|Y7i=F+T>(n$V2YfpHz58xXz`kd*0}2`k zbGs_S0LRYjm4l=4{sAXz0fR~1P zV0C19RJnZX{-7oj-|ggB&)y(wh29`HWo*n#Oh%Kj)?&J17Ox*Np^QKRpNfoVXHq>= z>zz%!_Qq0V>Dl)-oz8ak3*q{z1p6ANI;MhNmlQ<~-{FGObGOUs@Mb#x3Ic} zo&y{%>_}lYln&3%`gl81!JEOEGl-LkTFK!G6lJ5zObuGhEjxw}1$b#VHpS`^^@)Zw z&DLCu?-N7l*&Ae&$QuOhB2p~HYQd|s6u!Fk+-fGoCjv0wT2eyCf-Wj7+((3kL{wN% zMTLbbL|72bZP-|dM1=+TiwIz$6kx#+5f-SZq6H09Sjab&G*DpyRc=8vw_#%;8Wk4cFCu`2M3Cne0mzRHnpQzf+@m5YhH5WD zwu>W+eT?%vNWv}I6-cOq%nzaXfY)4Tn2&Mi1f9NYz#-&1SA<9$H+XF zL7>i|2DaFpg(CyPJOkKI?0DV2ftZDm)1m(yj%o(W&gRry=XLuA0xIrHgmmD;-Z){O zi+SC?f!+wb#K(|?O_&dF2HfV0S-?xIfux$jyik1+vL`A-GDch3B(HCDd*v;L47@~6 z*JG+_mafCX-rL8#kHB1d9k@!5d&f zsM~{$1&N$aTrBh2YOSU|9d02a8He}uX{*jSLr>BPlCAClAYu^`c;ii-sV zi)bqwknpAP41q6!-VBrn8HZBAZv6M=IR-*($31mb?wilt=#eY)5iKTkz zF7?ujR$qMOi#I*b=WM_Aizb{Kuz=H*0Y|PsijvwvY~7aY6PE3wnZq}oNbK1< zVY$dUVJ)yu7{%&rXZivyoFmU^U_)Vbyd$aLKf8=Oy7jt92S{Qs3*l4 zn0L+RbUKo-suJGyD%wA7#$`*>Osfpwdo(=i*{)-}(5~Y|Sd#V=WokSItj(x@@Z2r% zL}L#4l=WTxyvIH(YOVXd+nsps7J>i9qd`{a(Xa`4G;F)ici%Pi;rW8ZYyHE1yZ_BY zG?zndOXrB3`zqTtT5%QMDFS*lt&t1JHwxt2Tg?AAPA8#4r;}U2>10k-8;cHl=lyK& zWpO9nPaEp#GZf02viTk{Zaq7ls0f`-o&u+nnh1I!w{_Lex>AZg7k;+sR|;j8SAHAc zBj#|=PA5x+PAAjlZOjw2_uw#g3YCs(75%I$WqMu(MS;%uh_US1=|o55bYcMPf`r!g zKkG^v2n&g*u<*0ZtHj0vs>GuuDlGhL^Q!;iMFg-Q zPV*{ppNNVoS`c|6SiIv{u?yjiL$Owk0l!dv2GQ6nB@(B`vi{4m5$42LXw%DN4C=Ij{hIT^&Oa1w_ zzGCSLuy?4Gm7tqA5@jU`*%vVpJrTx0^+m|kuc(xjcriMdi=nKH!{R|U6(@{>W^=;W z;eOwBi5`Sy=jmhxlt@Lz#X?__ipKGjO$1a}KqWXbL=`Qd(gBIIXRt4p zAd~0x1*zx*?3Rb&(ud;|(#@{ysJq_w_FaE|jujp|0Q$1^~ zH-d}b-AiTanL{&28{IRb4V+g^)u6@rk!j`5@{FO5taxdnCee~6-}<2Ym3du8Sjg64 zD@|>bHy-?#o4K5gd79wLe792Bje;BbH^LPt%0{_G?aV<&)#ducS+oI}`Lo!;S^~F|ZkMYd%>~hEP-sF@>RRejnm?E(bIRGht8Kt3R-;;`rq{l57kv)v zo=<+GY(Q>BcN3CNq1juN;_{YW)jMx6U0!HHVhc=2hyoLmZV|HsV=iMit)HfgDkBDS za-LC=V9OMcpn}t&d(G zzFtw&S=%f442v%B^&r!Z;X@fj3{Pn)iTZpY65-9_~8E?2>NqQ6JXu&~fAVupo#A_7=o0xXEM z-;kpP1W8nW%Fz&2w9xIQ1|%#{QDLFm1qxVLK$Tk%&289N=;pNz3k&c=?!s!U6Kn8c zv+4P5EW;GwhE;~cUUKq*VQMy;<%_^$d@kX2cLq-7$I>~Efs_lz1jot|eG#cA z0U?Z6hwn+(2LpD59&~+BLI!3Jj)^eBR1kP`r`j^mUcNA{kebzEms92pqhf^lk+{C5 zmux5V=-=JOhB527w>$qXiG(s4KoEp1@@Z@Wwr}PF>F&cv4HA~EYSywi-o=nYZP-{qRi(Q^vssF?oF>@6eF-(J$OL=+b_c0U#(0y zuy~|TY{ko6WgT1okeYaLjh9jr$M8e^jA{4REwuAG{OItlbxpClM17*BS9tbTr(ven zrh21JI6N`CI`XAl@xq?X6BYyWgwd?d4y-GSQ*)jAQqP{9R^4JqU?0W2Q|Gz-%hVu{ zYidB}8eC|#?w#EJKs8e>Qz0$iX||!7h*=t~&wbt7B_8>MX z$O-#g%oSknDPwgUBXb^OX|ywxe|Z4p01tq6CU8$+05?7L!0O2IsPe&OE{3Ny!jz64 zkTbtra#J~J|83Kj13mj&C?~}wn|I}KsCY8zYaO@SH?_f^{ltz`Lvm!S{Kj{J4tyuN zxMl;ya1&?w9M*lG0-uluibheiX~eQ6VcKgv-^kc3bU3$rNzc|GGB)NV+It8XKCzS< z*kb1}=sKOqdx@W^lZm?D*fcPKO#_E(aFLlmnlgy)@0#wKo=c?3*DfBrXu`$3gV*kO zg(i(nu`;>XvwK2ll6Ji^m5kA!*AsF&^nn=HcOLI0ex<8ts(xb);s>ljFs>g&xr-t# z*w;AKF}2Kj9wV&zywZ7<)s+ulI~bW3AF#bT`elzEBnH5Pq$Pr0iY21@A`+@sM@92R zH?a8Ub|idL9k*vSwP7n8w6%k@j_?FF``&e4D`~J`3$IhFAkDhk>r|Y7i=91xdV^10 z=>?6U-CLWKI+$FeH*eE9qi_3!gyM#RL|lWz<|uSIpwIk_PLQ z1U_-fT>bLC@eFDNo^E*pnZRuc<9ZV{Ql!0dXPu>`(7Y*Ht$Djv$*hvSw$*LRWX*G1mgrk6_H2Bk z4vcSh-)GiiU+b9CPHZ*X+`4ovG9G;T-(EyFu;<)Y2VNKwEZj$gg+x?XP(_7>DnwYY zM1_S&R9FzsZP-}QMTG?fi|7VM23Vk?iWc$^VS#`O3-YM2P>Bc&hN!R*h6oFyxeXf& z8mO>hoZGOmFbfqH5GFauHzxj|vOYh_Jvxm0Q4}!a@ilEQsbdY%D0E!UBRtbOWS?0TzTrg&i#v zAi@F_6&5s5VF6Wcfq)7N(WtN>oZGOmV2BC}2o})|P?jQdI6?sBw}Ae)5EJ*vh>B`2 z!cgtv$l@Q#5Q$X_1x1{`G(UQ3t1d6D6KEue^<89PDzX3{K~zV^ zfEq(|)`JZO$q@SgUigPQ6tL*MW5>9}HdVmFy%ndRYsPI9@*Q)m=^%)Nf1XNg%NI1pCLLZWF z0xWa_EQn-ou(5zDTIfsaGaeS`sIVZBaEgnCJ|y7;Sf~Y9zzM5Hkg*_9pNX68#-qZ5 zM8YX97EsA%5G*2qg*Jc%QE>`37EnbCeMx=Bix#M`uz-~&m$#< zo2SKFoqN?IcF*?x(6n*(c&e=DrI~eRHt&K;c2)C*TyflA9sax7@mDxb8|r+WWerU1u@3NwVzkgFcwOAO{`%mG$Nm++H4Z6p zZWxs@$V=8S*Wq-k*^PxhQe}BWnxS>5mFl?MgoAo>)RPnr$`*$|3=5+Sv(0n3Y8$#m zIo7H`W~R1vtktaZYDrozT3BB?aF*=s2e0Y(RP1+CI4y;*>CWE!-wn(dl`+6JPtRWA zRMoo?$+>UmY?G&{qy^uZy&-m8_`AVrVGR_*Rhe@-i-IR>+iWwi)*PprqHd=}|j&pTgV{iy|iwj&_+8g<_U$`@yLef%|Q?%N?5vfJit z8XZpygFJtGFfwCkhJu%TnG4lQ*>pw3Ku5Er5B67$7U@{y z#%ZYMt+to-Jm;XCwD=cOHSO0iRx?e@BW$k{7nK&iswWw@w2fRtlCp6Al-p5?TSE%D zGh&}9Vz&-9Ag?oJu(S^IFZvjt7Aq$+0SHmz-%H1)LnJ?F-So>Y=ei?M!` zYULfV{ObHgQw%~cQB+Dy?~JpK-W;lDc6G$LEunXnQ>+>yZp2?H#r*4-GcR)nC)|4( z(n7|APo6VA=sc`>s76t-&D}y9R$Jt(P*QZz@m>N&ExBNX=ZCo;j3|@6!r7*aWoC|5 z@fvaM(1vqwl}=a%MXa-zv2dA?9JXcgRrMD#HZfK+Op9f9YCD{JtGpg(c>_CDeT_Qn zc!#F_01L&EOpa7QIMl~dK=N2*jP;tXxty(FuVzJ2tJl7~AVdOJJPhIWQUDQz(wPn*7aLZRuMvD43WC}mKT67rVW z%NIvkO+K%jH2mDA&?MzLv)iV3wC~P8>x6y#0;wGEDwCfbI5p;&w%xsDz*53x&FOg| zGwtV@`}B9rv!$rJCm*aoPgFwG2annoXsg*L-L*4GK(@WVRSNyJ*{Py{i(6D7ECd}vG*vr zcb|WGw%=e+3Nh~8fV9vQ=gCF(+NERD_j$X_V`%7^UX?xQ{A9_|QS!z6ABNT~{E%mA zFQ@M^*;?Q9PK4Q2*U*#7f9FMoGdf=6qT@vfI$jJ$#|tzI>ju^WR+flOH?VsZE->Mq ziEbZ}eAWMRBbK~C$qW2GK6}(copZJ$Q^@v;794FJ)Xh;8$iUx+C13Ub3}hrPQ1Sx5 zi*Fh0u@}B=*xYv*f%EBu=H98wmkCXO1?+7)lie_{D!WGWf$x0m6NfV?JK%0v?dU!JSmmeud__MT-Ncwv)A;FAz9K1* z^_3joM#t0R%idI$J#LG};VY>A9i3M?eW@8(*_Fc1=ZS4ka(1yezVuoqmA#4d_)4Lo zVm$6FCkJ!7jsN_qat()F$13csC3Q6_(wTl3tGe9Ju=z!_FQKcJKnnElV7jeim)3St zo!Fl(N$t<5)4~53UNONmOz6~IjAwrln>}#>JGy9g8bJ)N9jDH;(8yCdXq~=N=~#zt z6Dj!-b4thiuYVcg>zg_3jd-RTwoBLDq`f|RetX%AhO%2*K7TwPUmoLg>el>*`X?oB z+2ltZ$V%F?AW^luF>SFfGfmB)Na#3IvcgQ|`NdDvbktIM+Ny6O9@{4b(kMQzZV z(vO)h8Zw*Dc7nh6=`Z5$lI?``t!FZ*$Eh7otynVgjo(L(;^*|=Djb{Zz>nXq*skX3jdiUl zC*piaE%bgZc-E7gnQdx#awU06XUXXpAKhA$wvF_YHGicUGs&~TuVa{{m+yKWREhV< zDJPlFVH%b@t#41sz#f8^@R1E3EMU9IT@xl5{O#71Ik@t(ZGI}`DP1M+Fz4a5Y`6A0 zjGgk8)A-3JsEw7+!M9;$wQJgIx9{m{`ugdVh93?;zw1kDb-5ymQ=_q&w7Y#0R{1L4 zvV~*uM`ty=e_?#QVtiryCsw6l;@KRw&evD@`L&%IiuiZb_C1z{75MpqyRoKMoM^1n z*Z4+G*MsUrLjGTwHO+>=Hn4gl=W`tq^SwaV%E@`bsjtH`!xHg_u3sPo4ao^!a+Vs( zreYj@j>^mH7w8EJ)X*=rhGT=is$tXv>w~_U)V!B}cs3Cq@U>2V5BNn-6vu|t8YU)E zyH0ApUKjK===FQnsoFwcryS019EsSn@v?JM`>oo-#O%Q4mie64x+hHk!SU3fJzWi@ zUG1H|zhj+k&l9OZI)-H5oQm2+@GC-|zyGTH{5k&X$tMKxNA{!ltmxW8L#I6jiF^E7 zYT_4!6f)1^sGTRN+kI~2JRPJkn$+CYe(D%Gr=l=E-OikJT$A%xQ)?|wtAcY1lV17$ ztNF{q%*3;#vwO1G6s-T(X(UpMv0f{S6YqyLw|)6S3TSB_{>D-Cyhyx|QSo?ld27O8v6>S5Y=X{EG}3knqt+~2;N zKXkH(wCP{tEIyeh&cE35@ky-f`TGl-Ms8WVZ;WrSR^XLN3du2R@B5gFs^P{Svz7BN z?{c8NipY4n6~9P*P}SOniQ5BhqE=WAUAuot&Uo)7L$^;_b7kB~MaGiJ*SB1HNf`Xg zjLWpO3LfsBN}X#iVw8ntL-(iUj?(%XxFKwM?)q_4mM_=ZsIc1U)Ext3tMr)(@vkYe z_$NW`>iBF=|I&|N4;mfTOm7R_)9kR4zH&<|`{NMqYudjR8&CpX!r}q_e(;)xcY95| z7c`ywg3g>Q+xB+Ju*Fno&b}%Wv!H{o|Cl;yl%*TvM5^xL`>ZVG0~_@At{Xu3+@`H+ zE=^>vsW~}I({N@(P>IJi&B4Bj3DHFh*OF_C>#lkZJ>+v`-HPjP0$Uocc7CevoOP~j zt*_4YH*Tv^9$#pT-&P(pugkm1zL;K`zA@v|FH*@R=H+G2J~mQH9W8yI)VKv%l^?zS z(QuYc_Gzz^gnHlXmi6mbZYqmTh(5dGP;&a|r*`Fu+M`OyBQD&{IAQtZ@Rr?F1G`g+ zA+Kv(Z+cv&=A5CYkYdvUqxL%%UDP>1lHpG?A!~30`$#JluCz3`yZ=LdX zBi&cNBCGbxp6qK0S8AT8Pc1J>&N}hV(1@8-P#l<+;q7!w`h+I|vocBBy8FPD=lQ334TXo^Fi5Tsr01yC2QtJ z>{|5prAyJpX<8qb&wT|x%mg2Hb3e>6`MCV4!(#AZH}}KR z><{le8#gv6JmcIwmwk)nJz)A|nE?mSsti=oQXM$JL|f*=u9Zp=&B0?1e4Mag%v1f~ zy|)N510FjSF4_NJwCdp42{w=aq^ai3b_y!Br5BX`S~Y0F7}lELU#m8N|GE#{cmKKU zfJnmqB|{?#Dg%A}2IiJ&EodT|E3L!D$%fQRU0WSjpD*jO%_)d(OD`1sdwTj{xfz>=SbvO}Wqg z+Yu*2*X>s{9u}N7e9go)I?iqb7)Qnx%1)j5e&FznM;<<`&WTJ^QSh;qmvcEf(e0@0 zL)9yhIO`#e&hm1Vb&JPdijFb+B;h<*I7N(-|*z^riZ~Hogact9iBhB>GsfJUqEfJ>D!NM z)rVOm^pC&eW|j2%JL3 zKIQUq9(Ru9+`d?|bs=Hu#8+D;1$iueQaObRzSrWDg@wbE=q-=Nq$IpN#{Fqb^wUjN zzyE$eciQ7hjVr?{u=GMbnK;sl^rh+Cgg7j3kLrNj_ytr!Ar+vQ{ zJMO-xoE`FcRQ+OK%clxa{hgk+FjObhL_Uf>a<*N4m~K}4$H-+1<{f@J=g7E(fdwjt z3I482tqfSMk-7<+ujo4&uUa%{ZM+{ZICR?nyw;%_*QF~B zQlln(Et;mAdS5T$gW%5@_J>q0Za3c!=^neC?KtjM{3P1gX0dd?eoVa|ZN)!~Sa=&UFJg&( zZXuU9RcY{hRsZm*0f*D%l|A0Z%9JlNxp!bWj;1p5Gzjb_+L76P({p+3SYcEV_H>Nyf7cY{^ zmg{i*$KEb9*GpLP#bmMUX{ui$<$dI!RYzTIQg`>~zJ##;Eo!$xw4vAkM=wE@ACK(V zywQ83A@6^AvD!1cGM{&2l-R)>sjBSU((Fl@t8SjM!8zE}rPa+yWnIdp4KVWHc8*6@v!3` zW0EUXm7BISe^Md4nNA;YWS**i*8a#N1#)ARC(cmU*tOtzhkA{1{^}LGVoc+3YTjlC zH>{m;r1D7a+eGREeEj)e#$+1L-W2*MDpWP<(xEAbZYwEGJv}KlJXC4Y`;X&4CmedY z@W}qXpBMgqRFP7dy`H0NoKv=X=;*2I7g}Ir-mW`8_}3bx^it|bJE^>Y+6nWoRB2Z2 z4jj2R2;CBEr-^P-(qiAnp-fce%kwtt}~B69C&X!c|*OL z>#8+{1BPW-h0CtoR)2BSE#F=Kdi9^)O_DZn%&eJ3JZidjt$TCp0i!Rw)#cahB`+ly z=GiCf=V>WV^CRfyr4?OropavR1%GA02%A;XgWlitYhF3Vz*fJ;{n zy-_F|A?y3;Ov+0wzB{AoYSHO> z{geGPJcnPaU#@V=lqIXaaIZ)5Xx)9us%-o$i`=kxE(firvadzqEhbd%y?o+r{iYEU zJ@33Jde`wsRYFPOlTmdVCl)Eoeh9sECdpUr(O;#rf}bqiV|`w6X}e70Uk9;!daF3^ zrl=0TY-;po$QmE7Mx*HL`lR_$+J?sLz2_DO*T=a!eNX(;y7mmOUe6a0S zWY(O+#eo}U{l#=}%hGR2ZnG?Vbn~k;ccE>(u+L?pRKI>HLw~f;hVd8L_RTKaHoC3Z zvCYHBeLFYkkF_t`RyJFO9n6+KGWz4Q>e;F8SBT!0j}A3lwM{?tVSKa9!4)bSl$`rn zC3Llv9T_ztUrMie(*@0EIj85B|Ji~oTOF-1hn$@8X?<764c&+1jcjzNpG;Cl7wuun z;w~<|l(yez_q@;9cpq$MLy%Hnar-GJWz&|#=Ix2Yte0WeQyx;r-@0*RAGY&r26@z@ z*BXn?y{=`_vpXBIjy(Rd$kkKTXE&2XWkkNcN}j1uv2y;pRv&Wq-Rz<1QjWG=-l{jA z=Qp(M+U~DpJaL6t!mxQH8YyS;2@4JD^Lie6n`!D(Hm>!^Yt9+E{``d0CpwjG&+ZIa z@z6WgBl-VWa++QO^b!E?yggv{m1!>QyG~~R+ml<|Let@yIZa+9BngNbu)96RQjzU zdn|nxe%gDx_3@~C1Fc+@JhoVyRn)2K*cmMe+FG_rdrh&6Z+c4W`n+cWzm82f=Mm^I z$0M-Hx;Suqqjlt0d)vAbX8l3~4p&T)O?1+U_MpEieO_YX{x&C>sJ6fCWo6NayW14l z2jYru8wRauyjL@eWq+bJjd3t$vdzukW7Z8B=l%7S>nNLZIn&ndeUKUPxYl&g%g0Pr zlCGBOq?umBn*WkMdh}`8%PWs2ZhK1}9(QEVktyqcJGbn?Q`uV^rq4-xp(uCDpn2eA ze}b(`+t*B6$NA^1m*x-ch+4N{a>c^rtuN!5pa0NIylDIB)P5#sdG$n91@8+o^EO1p zj`-LSr3u)qcW~3xY8F!uG1cb z9bccDJZb-{oZ%yMd>P8kcdOZ^6I`!u`#jB%Gk(m2bGM#$^)GUFsA)A=e=gJYdDehy zZAto_Yu#H73s{za?T=h`+GP6?^8p@7{WO*pluyXoJ>lS-48xF^jV@D;Ua)Suxc8IP z&W4qKMcx-YUg8Y;-#vIMqd0Skk^8wZr6>LjKN(GO)?)>YGu^XK0 zr`WnOaG@pb!Ly;-(-Q30MG*Wiw3F?BJvj8#{)m^=IaMcas4+J?4UrpE_AJ=(o@rLI zY0$o8uf0QY84JyCd6U)aZ0`wVWHDV^P_C`UhFRqfpQZt;`s zm3yt?aGh8EE7iMBhg`d|yjd;&cIC*DCD%S3x37|Qcdp-HSB?w$k~$}qXnT44AF*W2Rqs%SVyxsqxAbQERQa#ct%I15;!|#^Z_(_do zF5Y`cY3kH>(S%o3i=Jzdohpl~7Hwmg8I|sdUUYo(9`6CpW+f3vcXrK}b>+<7XR&Ad z=l!?(J5JfP_(o^t%g;%ZSFr4kZn|C-esgF4PQTeBpWb`5=G+ydPgaBhN7e)$dhYt_ zaN5C_&(luqymoxqhBrG^)*X3x@9{-Nm18GAtX!MA_t}LP`%8Acs=#LNV;&fCYOj8Q zW#zb!u?cfJLoS3E$*HrA`)BKFSx<_;9_7C~>z>?)wS%oY+|I@Z_5bpr|K)`-N>RT^ zjS9-bw0+6)9mCol~PO-OMw0-bi?8V_W%gIz23SsdmnE zJMswstiS%;`FW6axQgbVtH$+LAF9ecn3f%SzjNRg=Cl=O$7owzUUDTZ>(5bnsVm*& z=trH-rIH;6S?^G~M!#pr9_&2At)h0;_)z8XTU~y2ZhN-V6u5{9SwuF*-+GJGj`44Fa z2bfIXkYPJ%^p}p|(`^1abbWCY)BS6~OtX?zHmlF6S+Gv74LlXJEZI?>nC|v;?5|cv z1s1h+nxViI<)zq*L+@@{;N?Ahatdzzpb@Q|goumlDkHYO8ZyP>w@~d} zF1L%1)~h+FthdQ>E?lxvJN)MT`RB~_e!VhZX7SC7f0}B#sW%U+-GyIQk$lx{+E&-uY8Au$yKcZz&La27S37IRD%H!* zy|S@(+BD-|s_q*p960A}`fk^8da-SE|6gaSMNPv$9=0&{bJCp^_6eshJ3LyKrsYuT zYO=58;`r#PFOJmHnwPh}D)5o@rqZS;*eT99vt6UZ z>b#a=S58cw%a_7GcRx7!zID4tlKT$nd3W=*%5xn*?I}L^I$^#uCt$jTce^Uhq-?;D zr|&Pw<~;EKLZ4RQsFLqDqmi;`e#~==M@z4eo2SvPq?er985r&3cB{NCs%XKZHx7Ot z?8p;Ui5#4%^Dl(oD*uSe3E48>_{KF_!^%IGGk_a~y?V0~|2s&%#>xF?YAf=mHaAP{>g(&t%eo%2@ClhZ zY_Z*+CS#tfE<9o_E9bV_=JCa(*TnvDY#H0G1!)T(HFl2K`}xH0aWSb(*1@3kOtb4( z2iIPjIb!L@X_5D~>R+6*=|gR2P@2v`#iuftllR4}yLWg!=O+73;|@yeFqewPpTH z)xW>bwSPmv0!wZF@?sI0^9rZ9Sw+c6Q3Ck#) z;ML~++%)M`&z!lQ)yHzKWEgACn}02eclPWQ%d@{<8kv_Ar{7mu{eR-58EPk)vrf)? zpR`Ntv9hQC;U4`<;VSa4zrD=Z_x8s=`P*e|I%&FlZ8Q`nCQ2=je;d_wH~0A716h+# zEETf96Q{#j>oGlu!=U`(QQwL};kd1dRu&u@OBg>kTK5094Bk_`q`B}PxMjRn?fQ>! zVD~c_*gD2t+(<#<1TtNK95dkV_ufgqS%(b-T7eS=9XGFUn!9a^kmYQl6We_G71nG_ zP4ae{_3y{Gxn?G%3N!S4!XMchzOT*La<7JGZ^hvmR_{ebBKeqN-}*j}V%7is_N#4& z%Pq;f)$LqvJ{wl9yXJo*`_asl-4j^acPu#|)XJ_IoLhK7^E0FDeG@yrSrNy=*ka{N zx;LHqY%RH5GGK0M*W5sX@?{Jg<(dDf-Zu9Qf4q2oJbOvWLMNf~O6;$0C~5wf=Dzua z1<#Yzwj$3qm*n&L6-^eecK*7$=xdm}$$62=gTY-ZZP|-AtDM>0-<~4)Qv69u?ZQun zyJy_4Z_}(#cyjamdOL7IZU0GQ^Cw`qxZw>sZlDTCut7&E9Qm3I1XwQsM=H|31r;Rr zEZktImcuKzV4Jg|!}844hu*#o>gAq3`RC`lWoxEaCh>nsRM1{W5pV+LBOP4e%%DB8t+5YqlxBMNG zv!<~9)I0zE&VK2D+8JvuGSw{RPI&w3gZ%7Wc>xtlrSmTylNXKeRPoL?;EGWDr(%Dv zt&8`p;XVvMeKR{AsPy2Fp(R-7SBONBy(zY5*9zBlt`@7tS; zE@|Cdxct(r9^Xrb-WNEuy*Hn`ar{+f$$25J1Qm^JgJgD9|>3a5~SN z;H3=$wIAnB6knn|`}tCb%%fq)r<5$edg-v;uC$ZEqLH_%l4g9=W>NYW8CRMb*S;}% z=}PyjZx${pDXG>J2wWu^m;Aa`^P~RO$)7nUaUEF@x@&vg6B;7SAWZV`)tYi+0(24v4Ubo$}S{2 z5*RB#SwY#Ckx7IBG4&^JCF9}=Y)MQ2=3W6{?4bhSL|}4$ZZ0sciowH4=(@wL!|Wfk zFfg=6F)&D@Xl)0Y3DliZlvobxA?ugr=D0xEhI&9Yx6R|o6w<-U4u$lrM9Yl8v@;oW3TRedy1E_POh*?o|Q;??-l@Zcv#eFn4MfaEqML#|nuzMGW7_DZAUO*$jEZg`@~8=D5E21S>wpbJACg2j z0J$v-8eBmD69cdT7(*@SCLlK%Ky6+GxNinA0p0>e*NR-Tf!Y)Zu*(u29IzG!x@P3U z9aQ-tfS)y3Gmfed-5lhS6I2x-K!=S0a>anI5jkU{hJCTE00Wj{Ho%(|m@gR^_<`^r LFst#}gYrB8|6Jo{ literal 474640 zcmeFa3s{uZ`abL-oIEimc}`K#JnQbDRtA%2)QqAswx)m`QIvKEG|(9n)W|$wY6o|c zg}L2nPUWF88AmKCcac~!9)~nV1so7L2+YiX%?rc4>wVvO*LwOhKj(GUcU|B0{l4pR z)0+Ez*0Y{Gp8z0H~N1G^wK|LFWum%w&gu5{ft@xS+N{K5Rrwr=h3 zXgB)mFB^(G9bUd}#V5sIHE(hEnThXBdF997V$GfRzEhGpW6HdqpZw?PPZBMU9#pj- z^xw}SlI9#4_jB%dp9F@dZ;c*q~q0=K`_zwO9BPab=5`~EZOy!VzT+P?PYk&58w*8l6#^|J#<23~Cc#FnbtGIC$9S-H7t z{j<-!b~-Fj4wOyJ9NCd?TnW{ znt#WOzr1ngm5&DcUwfnZqQ4%>yW?Vjs``I#%)9TmPX5={H(ykv8IZXs<=wac8~*5I z)vfFEVuIC8n>6XvqDhlS-GbSz4$Nm?j+q}j?}b-}Cd`c+Tlat8H3a?N#qXV-xA7mh zXQxM7qQBXD>A;%s+yC?FBl}O@Irqbaf8L+pd)~^GZ;$zDlQw(Jr{$kMGU}z4t&A1d zOYXNBf6*;^yr9{W55N2LPo3Xc9XkHuPY0ZPxzoAy%K3Sd-<~w)x$#Ta4*Frj)UzA^ z$~v*kIQZ~?-Yh-yUeML=?mqq1zc&OvY3yy*#vemc! z)vssYs>l+*VKto#0*-v}TH$~b6MlK=tJEWxQ#Vhz_|d%+nznpp-g|pGJefA7$^DP_ z=`(rd;66We9pAb5-e2zfuE~^@m;3)PR~`RW==_pB)oZJa|I1wb%Of3zUSHOF-l`*; zUg*+1a{7?5|4qrgEAzy`@AE%8v1sR+9*d{Un{nIvksE*7JE7TQ#yRiJAJFshoQv!J z75rlLEz5WHKbrjf`-8h4-+Aae^Ny6&8N0iFwEMAPZx>#iYC5B7KJnVzvRi+xTv_(i zb48nv9qIJs7g48*;@@xA=Z?dgfv;U_p8w4d-HzXn^nL%z`bU1eC9TV;lCr)p9{crR z%MVU`^v>$?(9W-^CagX6*kfP*Q1NB6W0uSJmll8A-Q>USzQ4Yl@xaQBe}41DQ}0=p z{CjoJk#DrQV@=tpQENkcb_)LSk)C5zf6aPy&8WaNhi`kf@0!O|f4%(ZnwY>fpE>^j z?os_U`_VN=d-NQmyXAPxzfLthekv>N-{rj~j$iv>*pR2!KKtm}ve4eiY0vguJNeyb z|IzQKae-_94Er+Rr}dNXzGK~AU#fq)6!zuDe);?QZB738>GDzcUmn^0v2UBHyG;GF z*P`B=URt-{fiGVj*5hvdk4Gn*Z#iN8*5JucUFel{`N53UzXhxs9X?^h=ec8+txpUK z+|l=r-J4bon(@W*HlJ0jIs8|ToxhH|s&ee32lu`Go4r|+CUd*X?W4|ueN?}pxa9QV zZ!_i{{6`yANkEbRlV@V5bq*MF`^?`S`GIqYIb!Qwj<}etwF^} zGq-+u+oHF#rcIg}@<9IGZ7v?&)%LHRpRRpiTgzW3CQSYHv&-YIK6L8`Nr%2pzw_*6 zWAhK1pDVLX$xGQYtX1Wx5AUeHuUAUPS=D}(&*yL7ruzJ`kVk8q{-9fO&s)uw58p80 z>%#uW!$w;lYy@jwJ(16xpwmC|NUGWxa?m=0Z$}8f8jrO6?S{=K)1hg;%#|R2HWMQbheVyl~LN7 zU*a|2)Re!FUVAxfMAX6>OO&=O&|rP`{iC|qt$#gbwwGKVVYgj>%B(H>b8mWW-g1lP zdX%9?r!9Lo-cX}4+Y6SfHMN(sJ5^n%F>9};Yidifb=GS~ErzNbb(GF#-D$9%TOO~i zeMhsf=5$`Vz2uxhTN#+HwP#yG7uqZu^R@D)($DBBj+bpk|NQ)j^xEPMw(@=UpXMyA zS*}@l{rlxrCx_aum7~8=b#leR%0EBL(N&ce>+I=Kw$d7d;Y6P9{P|4V)fJXZtL-HE z&le8Ov{t|SRCQ_hg{7C48?>c=7L2%-`1+VAU8&~v3FyCZ+J60Lp#6OIyS3+5Th5v@ zYcC%Tv=tUqmX|(ft34TRyLNhnz54K++QZp!VzIw%;Sb5EES$`$8=Gv7Z3$|tFSpQj@V?I_8wQ%8(&LQTD1V`%bg2>heiLZN)o*ny(E9s?O_b3)C9pR`kEx z8fdAxzM}lFT6Z1&{+-(D&i0dg&9?M(+m@=z^m)~%<84*fM+9oiqmBmZp1%67`OUyg z>oe9r)ta&BKXVy8h@rwAcK( zF+I~>iT+0=--ieO8a40w$;q|0KeH#>&6d#GKjWipcP;#Ib$spCy|3A-EtU}L_2yOQ za`IPb7TM2DxxUCz*fK(U^|PIZ+6(da+S;8Od)ZK3%{%W_cC(ibt~8u_*~q;8XWEa~Bvzl_uyys`Q|JSIWv@X0a^CA&!}%-e z))_Ok-xQob7g9OY{@2OxY%d=!%$|P6c6|QpHRm_%t(>1=FI=8yuh_IN#}<0w1*X)D{YSdw_sq8 zUv>NP$Dj=~<7!pulb^IZ+iq>U+;(5KyV~xpc0afKZ@bIwK4^EM-M8(k+ll|w(|Zhrn6S}dV}2a{Lp)arBF0E{?u9rt|2|W8NG6-k8YI zkz-7wO=IrsF>g?1)xW;Ue(9TbA4C3w+1(C@EPDD%|EGtf^h>!frFY7`DT7iTObJT4 zJ7qx111Wc=3{M%75}ML0<*t&@zzTVvY9w2JYMX&KWtrge<^&jp!ZoI0F+e&)gR zqd`A!Ci;2R|N15m`t$O-9o~&vIFg?xW%seQe@GA!j#*piH}Wq*aeu`X=s?_tTi z!j@nAaq-(fru^^6CEI^oR`lb)=709%sr`N5ANfI>_Py>}+q3`LUiU}z>=V&zSZ>e3 zxxGT}?iqY{uY11iIq=I~BVRssdiJpSmM<=>nwC5^?CsuRZ#^5f>h`eIC&E_V8@A%r zu+?pTeDmQS-yZbiTX8?Gx?}#{0l%J3`r(^T&h@;leQ?XQL0#4c`$YtGhzM?*8`M2F zxcS{d0e1(t{xYcBm%-VmcVxa&*<-<#eh*SDx%Sllt?46AsHv7bdcNhci>n5t&@6fO zk<&>-zWt+AB-V<77j2)0MzH7#~2QntKcy{ca&yMf-?6~32PFPhlz56BG z{@~L`(>ubXwX;;i6b3>H1l{ zcwb1+g?na&_P+4=tk63zyfQ1a--UN(g$}sz)vVA#7mm&f9de;;R_H%21UwUZ_l0|& z3BC8i27EZO~Z~sW!g!Xj+&5}2veZ3Vec`VJ6x1uFqLMR`h zLHQCw8MNd_vY$@+b+>9pQts{vGm?(&UOpq~#O~}FNoRJeW+t88Jz-|jh26_%CSBg0 zJu~UbZdFv$)!h@Kk}7sDk4mcEogIbFjBpfjsWcH6jw0?T+9V&-Y?7mBlUzHKwux$A zzlt`={`nbwsW!>!%V9Za$?wxFIR`Dd3@!OnnkAQ^CD)=QQ|;@8Xvyeget~Mq2xZSL zd119C;uB^4zQgE~Y^GWAVf0C^o=KZY6-6(97Q7!FXq{+2$#>{L8;YW6DNPg&MN!0- zTvzy)I#5Oj+EY|0qXTUxLU}z6$~zItg(xt#&;&*y3XEzL7*u;TkuAC5dgVa*Btn@g zW1K`NSDZ;ZL$&=-J-Htx@ex#kfs%MU3XGLBff3J^+;HzMMJS(MRMBItw)%m{C*R75 zoRsmz&lyh-$cXrF#GUddUbEAzX!nf{@{bxk)?<0b?MBI5kqSyL}K7T|6?~dqO zp4)R}Ztq`mgLdTJS)BW?&C$gLM^8L4r2pDk{nH})zw`38HIufjoxLq>+O~HRW7mw2 zUHg1&+SJ&05-xrHsJ`NG?A+>iZ=d+Zy0C5QCVulo*p??I?*2V&$L|yO-y8PHy%WFM z753S#iThrCx?f~X`L5y5Jxm3wHDTJu=kKI|_1n)E&7U1Rf6u-Bs200z%jx5}A5o#T zbwk1nlar}FSNgOQ9}aFy^}`nV{9^NVTfzqypV`oY;_J3L7P@;^()6x$;q`m&mASEx zQpNYmAa@x>OR!+Ar+v-JDs9r}F}4%j#Jhog@#_SG3R*MHC51lTuw==aTW z`hD{P{U-PE#eP1=@b76SR?zR8q4fJ^Kj3hjMZd{?d$GU0R-E_v>I#&^E~~&*+{?1eSER+?zU)>;$t<7x^Ev$bsx(dxns)Y zcc^Z~=JaEqZlNSG9+`7AmyX0(jYy1GIuc{+(G$Dwr6V!QV&_i#fbN!ge%J89Q>gCx z*2HNWH_(t6t&VAFVV#keIdb=|k@VT?N*w)__$&HU`zw8__3_0Po~T4rQapY3+E1Uo zD(O@0>66s=cOPFYD((OLJ+}w_zDd&4?;9iizERO{avxvp=W{fhrk(hNe&4L7-!~yA zsP|39i}ah^w-<{_`>m+7|B`;+{6xQR`qJ;4O@K}A+lxh|{leL?Ie>jbf8JEY(eInD z=r_5KFE(#?)FXq7zo*|fo#^+?Ou)YRf_{_x_F~aHOX0RH`vK?8Z2Eok8U4Q5Nx#W` ze6i@A1zpBQ(C?cwfPDkFjQv8t$$fmWhfk=}_wU`6p6P#V109L+AvK9%38yA8)bu1q zHa&@Pl%B-6PETUIOiyBjP;)~D5v+gMCoEg^OiTZ658eLV+UFDgH}B#2QL6Ue*~eYG zJvI6{>ww~-$qqHi?HP4?mN9ST_MZ{4_R8B=_iB0!F3#G}LM*-Ut5>P4`S{gI@2<-j z`AOc%)f*~eCMS!fH%sbODq)X3ux0Y3+z*cw7EhR5gYI===?yYkaN?hgejn!c>2vAV zi{%xcY*~aJ0L0Q8WY*!tKN0I5xwLlet1nzjtT~b!igJKRdK0mxPW0>aK zJ_gZqJ8cX$HmpCJZDlXU>geN@{nHzX0Qy{syLJtwkL`EqWBV|DY(GaI+vrM78{6oi zh%#kl(#LBQeadKbSg)Tnqr+$}Jy=LTKnoVSdeeeMpI^=NV8zqN;9mL|JV_sejSXu* zT}{D}TrGWMY3RWUqz7v?Jy_ZFU_C=0gXk_#8G}~(f~e79Js)omopxd;Jy?14V9lWi z3uysp!JzD*D)iFY|4uR~>qFB1eDNtI4tX52{LrM6gu z&MiP$%>L<(M4+~KCn8{dnIPZ@SY_}o>kL-JR{JtRQ1=L+4BqAHULATd0c`G@jv(M( zOq9X9pcfO%CtIw(Ob~FdcFN#g5Cva@UQFmY8um|bBm(GjRlXQ&r>Aw-Zlr>N3zwU30Zf>|3E!A7W05il0!}5!gc-^p2b1Oa!# zF<}Oido(@*Oqfxp@4u013+@g zN!*JWImg5fuiG>F^%3=A_D5zYvBRrX#JaVjUd+pp$4u<-^6NioqNo@1800Y%JG_?M zzNNRQ7jrM>d0Xi4>N&3eL{Ts1Fyt{4JG>eNR*}Pt2$t)y zj06@>X+#2xr!*pg#S?Imz~VW)NMO101Th9(4liO1x}Jd>2UZa?MFNXw86ttjldh1! za#@CmV7U}QM6g_zAre?TW{MPpQ7*L`DF%6#p~ivr`bj$yZlt?>4Wv)N{^^ZGKiX2`fuy~Fc5?C%GkqDN{;Y9?C z{^aI4yhvaf=wp!Q@FK+^&*9ZLuoe|tgj9z-w3x&}9t6yUA-h~n51zz9K4Q!G&JNi> zYM}q4m~KM$8|XAVyNG;b z99|@_ZaRWMNF_)^)81hkYj+&v+@SPp5Wj)hIn2+6(e(%Y|wTr4l1KDp+t z!Gj-d-+$%0aX$xlNc%bL$&3dg0=BLEeH{A_c?ERWi!JCQt@;}u$?|uif&GUZ8_8>- zyI!1*q9OHfL__-Di3au`azumILU+B`jG|%X--rhD--!nHA96&4*Ftx_ShsgW#n3&w z9-5eOZ$!ubtDhJhI$(2bHHS3wtJ`f9@Tzsk_FX2r5on74||# z;i#SQ=4mGkebAZUHsf5TqOxHF>LwiUlm=o+*#?bEPVGWz6p zja{*8!UI7crhTs3pSfsGtbNwx*6YSj3Vtr_YS_4pyCXVmTlM?c*}<=+RfmnqxGVSe z*j2m6P79u!RuMKKCIQif7|0)b;XV?))jwaC+WV};x{R1OWK!VuV(~BblLXS z6BA|!?N0kPY*9w9+|IFY-8*4g(2le{VM!Umxm_+L{#JPM|L7yFj@Q*zn(f)U>?3E| zm-W%#zQOo%WYd8$9kwqUrtf&nm}qL!EhZpt*OcO9 zdDM%q=x^C@@a{on_>$ zfB0`W5E0qpaE#yflqdCFj~$p6sVacGs2TB`GuLuzm-L| z9JKT~{T)*eOp5gTET--DrLXCG3_md5bj!w=)^SVc>boZ#c*In`tI|Ic{qZeo>OWq9 z{&@&EDN;@;SyZ@VYU-_&y7riwGh{e86`^=&aZy8oc$^ZI5}4-SZIJ12VZ_T+MX)8Pm2 zG_{!?Juoi0Sl>M1;OATS&wt618hA0)NVj%NceZp%)K3@-5bPg=U{8m^-WL`zsj!G) zOPAQFwck`8(!jn_;I%{48SF|(sT%fCRUvmpHlxh!N#V80pct@?3U5Q5@y-O;VM#{! zTLASj^R)+I&-1sPNje(^`%FV&pQ#hbSapl(x8nBJeXi7 zjRqDmz$2I~U23BySyBx!*nvkX@Qj2VdTi-Z8`X~L(?D1{Rl^FO<)G|q8v`qRV8^>1 zR-fu%(XN5jn;wJxo8;B@c_F2`)s_AqQe zb5!YQ?Tp6}*BcJfG98wHy@fqXC@D}ZbyDfi7%RzFmzg80Pywt^>Lf{pvJ7LaBp+%{ zC!J+Hj+-|oSa}@ru4b1-7&I}kBr zJ2k&u(yU##(94t{jMYvU1yuw4rQd*lDbguHmac=4Z6}P`OiCoB;8L&(3W?8<`oUYs z5C!u%-n8@+#&jn3aibDdE@M@k??~NI4|M}arQ}&>mAI5Ax z_&@#8Y6L~9%iGY@ofkqsa!;jtQ%GsIkh{KUQ2Y-%;KotVIw8BlX8g)QYTmiQ=yZtq zMK+f& z3uyz&lG9)8*Oe4G1ca2J=c%;_b)>NdppMuz2DEl6O-VUrs@U*{2R9g^2w9`@dh)KmpVDU2ss*;5#i`q9Gka*dCM;>zY}$mk zvp}7@={@RSYKHw%Ywf5L0guz>>e>f&Ybp-?PJ3<`aso3#?%GXvhE*HWQErE2Jmf)v zWM5!X0wzedblhHwDh-r=Yl9}LmQ4bcX0#QNu2I!E~z)BP3 zj)feO4}lKJK-eMK9CSz`>n$WBsbQ6gr$FBsxGaiJtd|VBHrP>)-`+9|=Z40FEWmFH|V9WWC<1GYRd9nd<4!{fv%hrtQ5mPGaO;qYNVGB2Zg+>}VL5bzl4<;fOwL-mw4h6$3y?RJ?Ui68@G6qtwt zV}c}=ME7SW-3z>G!0Jp-QD8`rRL%rR68?)i5`hVl#GTijB3uou1Y<0fn-Yv#bio8k zQhneXRNlb+>m>vm6C_Ct8fdtoQtu7!bxsWvX)r+&KHi}Lby#WQ6BHN|BpnkE>~LCO zm>@|ooW@xqd5kaNtVB$ZBy~e&f+W#=BIgZNnVvi*NRk+T<;*ZlkW{O2%&Z;0w#j29 zlTOBcxwP$$$A0_TKCWWr^3hA*kJ(xtbI+gyt`Szw8V5D!;z`{x)25%vHD$~RGfux? zrp+d0lI(DT$bWNXI{79ud12b%bi(6la|3!WG-_)`oKN4E56(U~WqZ6WRr{9;cG z0nBMc-W!Ize5Jz z+l-jOFxMV2gGIqI7-p3uep57S5OP-<3X3mHoJTx146sOS8(|| zo(Dlk237Qa%Gj7+^it9oWl~_;64VOT0OP=@wJ{22W4LY)zzWH01W5%veslQ)e`B`ot|K0f+T%YZsw5GT_zn?X)r-jK-@AZ z**36Z0~Ru{cSVH~Y)p{koT4gF^>C%HG6^;&NK$vJo6IP6LuG;_Y0?y*(WVqOMq)-A z@x6)(lElJP$MpeN_A&}gR3tM&QoV~@U=LF;1y-uoGC`8FznrKDuVR8EZajog=ik7_ z*m9OFdZy*7TgKo1UGAO_Hhs~n)wIJkQ7NlmeY4)adjIyt>-9}Oiynq4h9!KVF1Ds) zbcgNBumf7c7wWQ)HQT=A57HpgK-Z0Q@ss+ln8r=Q7wQr$wbr+qnuW>p#AaNcXRqm0 z<80FOSC?mR(18JwZ862Lgc;Y>=EX14@3R<85!V_s<685}5J%?HI@6%;GA2=>?vldL zpw8m~Xi#_Y092^E%sn)yyWC(@sJo;vB-FXB;3?3{lXoJ2s>@74gL)J!)?H=_D%4%i z_cW-x%oJ3pyY4PDs2f~#Fioht%oJ3i?kUjo)S1Zl=F;_3q3$wM(4g)zQ&6GqdcLPZ z9Tw{@GX)juuDc6OsGDJ-?kUib`WKD8aEUpoP+V8@x=SfagSrNW zx{Fk&33Z->g(lQJ2D(uFO9Kq>BLUYA#1ZyQePZcI+Je--E}EQbZ@Aw3X+ppN+Z!&C z1=Zewl{`@mo;s?8;dsksgR~4nqK)rc{>R+nx zbs4>>wvx-EPP47;uu@Y4+j+jQ^p5CuYOvc3eQo9i)+QT_FGn^V7(V-tQ~&Wibtu;2i2RAL z7DvSIkD2PI(f~bO(!gOwGma{zTio*Q`hWz~Fb-X27FHZmCSAfcmSP+gvH}U2!NTJK z2G|+qC3Fcl{DyHo_Gme;+TaAq(6Lt zqe9H!qKZR6U>GmtW+V`drt}!<<;gnalk^30rA~k33zXLPnyM~w`Q*Twf|HkCRy*oMz~j`c6Tc}qxeV9w+bxk9 zFkMbyM#x?D-O@?KP_;3eF++8tZa-01`#{*El9#BL3RUSS{d$RzhA~4uhSym_ab^gn zUJ^Pl$Vq^ym)xQ5Ep(i)6)f?DO4)i>d$%Dk|TWQS3S8dy=nmM*?5Tk}!pI>ro%#^7;#BMPRWfT?ag z26}n2qh&LYGJ{FXfNKZh$d(?5nnU1sFl~tib(n-H-*vF`7zoSkuGyJn3V|(MYNBM7 zD%~EEc-Fqk)rgy@(!m;WllhW#2mxX<=J7jglb>^u90@}8@Oy}pmyY!iC)XNg7^#Kz z5GVgqtcN(EmK8SQCjV5Fu9;>?vY2JQwqWsD;CMhwhvjzWYZKj;Z>X=WLK9~ivB4D9 zY^-tM;Nx%29W&>nk1V>hMdvm@8uPp<*6PibjztMO0~NL-88^x8VEJ2kL1$LP_5l1KB2*pE!{yf;T4ZiR!Frs zU>V7!Sfkn-E?$!6n;Kwy!$mYw#TTsPagm->vF;*|8yECab*POn?X9EmKH#u|6{l{i zH?a}R7>Bv5;?VDRNBR$p?nC~ufqYJi3_LQ_#fCpTxXvO+4uWz%Cq>Lj3pJpnYhX(^ z@Hr{+XO*4yHWEZv%aPPT2lDEp#~>I-ZP#|x-o1)-NvVCBgCxi%Cr0&%sUGfz=P`nfH0@0)Bl!XwLzwm^dH8w<1=i7? zUq+br7WanmbyjxVy|{S9L^))trxZr@z*wp%7}Zk=W2rEc9Fe-IO#<<8TE0n+#Ilwr zYtUJsOumG%RQjge1T5j9C+tYbs2;w)M42p=u+JGyokXvVQ7{|B*`AmnNq-ZuF`NvH z36hLA5gWrL7$!(^^u@br*cgY-)BvM{Ws+M8s2DO8Y@$plHxiMXQO!30V5b7h$ziB|E3HTNWPi69vm6C@SJ zIGwv%^QNu5G%-Y8!EP!3(!M7W34pBTLuoY0e-oLD`###zIvTdWrKA6CTF{C{p(2O++JV zR;Woj>m{5Q7wgKDeR&hns4YRp3oqfkxL5~TBN)*rBI~M+7R1&ml1)*rps224xQ9TW zUYoqr(OXG(&YDbZOv5@3k#sXw)Mbs=T$=nE4>W^e4a1504ZLAE(Xod$3@86mtYJ9W z$A&cwCog>wK-`4JGJ*&UrVw(Y5OVYo@)iqTwb6|1G(KSla}+WPrHx=qXYBzZ)iO-B z$As68eeE&1d!Z^2YgI=+3Yhb;u1&Ys5{>AFisq3sHb&G6gR2~r+5AgeQeKoA1#5-D zoR40uwW~H(qS-X84^bGFu^AB=;~E4&yg*`;BW|ek z5smOehbhor;2riZkFqf*xx*B8!Q-`B|+23QS7k2-4)P%cB^dW`DfPHc~{RN9i#qSQcG z$atzNxPoP0-sF6&HWr{8D(pEg9M=6ynQV+;S_93Q3iQ}Y6^8s5=X3JH?9VQ);3#LXZT zTHu)=sfFoQcQ#^JQerHX8~*|%{W3w4dy5n>|I$-E+;!Gd1RE11F+oz2L&K(ljjU0@ z3P?rvq4FjQj0uwDZm7znz?dLO=7y@wX@p7>B-vlc`t^(E6Pg9Lni*?)cErSPOBb2n zsEHaI{&LFbrSHdVE$7YF;nHDU-}uGn_06Up6t|)k4QJ)3qt^O6rXH9SDWZ5q!&&Q^ zW;NZA)he>3*f}B^&RS<6Jn(X4(}6MKM|RP0R&I))pPOk+qT#G&j>KqkIL2>#iul!> zKb(~}#jj)Z{o5ByIDJLaS?h#6%?2&+pl>f`VE7Y_IMnOBY}BZ8>M3f}>uyHWsMk?P z)Tnc}G-}lAs3RKGIol?8ckuw|s48AmaVUy=hoMHDE79pu=j`{?sMlQ=s8Q$CQ`D%} zU0tYA=cprk)Vaqm>QMI-=qq$3H4ep+Wr4lt?lzRG&#rG@O^Kva;6(Rh8_a2Rz&CI~ zbV1;>;ZgolrwxxXerxIlPL#jYIXI8*mo_x&run7i$*U1T&D}33zmoHboo+Em3&TCJ zQ{spodpV6J9WY3vsfHyPZqyUyM{-{3sFO_HrH%%5*Au%3KHe*c|r*4y-_EGpbi1<7D&H0UIRNxqRvQlw?Jytxy~%qs7Jw2=e$7lsB=OH>QEmFI|jIRI356}AAz+gtWK`e zic;eUEMW#`-yr^-k^VL!B zym;6*^#x|g)mn-Q^lGESd;z;Y0835A3^{sl|KHJZyhh#Br*)mhi@HPt9$}0ba?F|# zQP1?CA5n+eYb^Gpv-XvF>gXp zI|v*^Qex1cWXi+6@_KSc--CBY(p|&sus?3C9hDmpLkl9Bn+E|AO}4u>HnIiP#^ZJW zrTat;o$e)$!}{4^r+7XR9dcfB_!XKEVqCQP-AS zFG^J=UE*q;LY0v?QI0QgRMo~j#F{ITF5%itGLGs_6KX)hfBWYTNT5C+880;4G1*S^ z`0p*0mNnmuuBVI_;`HbuF^V!NExz%MdZT(uNCTux9F+s(sNx*5egQMs(21MwLWrKY zfu$zns6?nc{LC8IgAzUHJmVWR9~%YZV_~N+Jzc`<#7&)Ge1M}u#<$h>9wDW=>>AZJ zTIMFy+4+YKNlkqxZpzy)Vv%CQA0AB03zgTmXQI3P);il+)1@R^h;B{AA=ILrj&(A_ zerXQumpU6!(fm?$pfYBt>F|T1D*<==Ri=7LTT+19Q^U?Y;8CFF>@;-S8c~U`XB@Wl zlqrre@VIC@G(Du0>nK8*9-VDms1IOzAq``O8U}xgp62R$=g@$TMB9lKhrC2c!yd-(gjrY(aGiV}>Nf1qRqN4)e9Sxjw+kUZ7|nSc1b01id)! z59$g9r(?6(_BVFx{f{;Dwi7Y@bwVqrV{`E^eaB62}(Z*lD4 z1FlvR7-8$64h`IK==8}pJ$7JPq{=m9n}2iRSaPg;)1U)gBU=|nOV-dG?fGT8)tjo! zobAo&td;v;pqA%O+Z*NTuL~M=%OknaN$vO#jPB#;OW$Np^x*Bu?#e|cwL`gdC$&Sl zbf;s_=^^%uY(6KZ`}XB+^|whp##K3)Ai9_lwIrAStPQp|nh@jJ-Y9>n)AmLkV_0Wd zLc}<2Z*({|*xu+uKsa29xUuUbMRXsjfvuxK-DP|80O)z@21cH4$|K*0)DK^`cm> z6RS|8j*Yq|9%4~2)Un}8WYn?FvT~?%EfeZ^AP<0U&96BgP*>4Y$9i2wPmMZvjiQcq zGYoZX&JP)NY`78;^?2^lks5WZvn)B(VF`vF^z!6%ba}=42@+#n14Esw=&92>KIeys zdY!J68g=d(>h3z>fr5I}k_UH}#37OH9NihA%#A zgt(Oqux$;z6LKO8>Ye8kOGhPArEoSYv5L{aju~uV2l2?OlQ>czzjjyw<`YZj+1{w5 z-51yxiE(noj1&cnby$j_2fb9CX{)@LYF}BYjyT-V=1hL4E_|?F#Y1-jr`M}^D9fb0 zdKC}lPDNI;69JFYF1;4Ebe&U~MOXM3V87JaoQZNTA;;dXzMpO|($E4Z{W3PDd7M}v z!qKeCq`<8CWvKNN?6TwwYz)T>D3by!Pu_`csEmz~eqM!DU|vFj<*74~0*$dT0ddO) z>qW0;ilo5MVfuQ-A>hs37uXo?Fa=T++@m&43B&7#!@wP=j-qo!KN*#@tihB!E6lA zRY%7-pxcAj2$E`;Ajz!~j0uurZZbATJX}ehG-ZOMh9Q?C;|LQZNwzP<=Znj|C@?{i zoT`=ylElUiPV%ToHiqK`m>|i`(+2P=?j>xD<1huXD@>3SEbbBGup9t!1k#$o`0^Ch z!(Eg-wsa;)a_f~qugc2QQZYf2dovDV&OJu;I8u_wv{X!xByA5-@a!=W4Sv<42)8vK~@&Z1I_+CZEL+oWXqY6b0&h@e~E>d@CCn z^>i5Od@Gwg>RkU!o|UapLFdf|t5+?OQ8)1RB?any9S;TSeDM?+^(YwXeCCJ(b)J=t z0`;Lh1u#XZ^ZkR32|9W;N9q<03>g0Ho8lw!#W3Wx*EKeyP8n?JVtTJU*?_VmznuU% zeCzr#)xVmPw-R4tPO+`|dUuLwXG<5eJG|Lob@CR9)0!_tB!@s<-(~8Z$7f+FzA4`p zO3nfXp3<2jzWBCKij2gkzR9s}hGj>3(0Q}Ls8Q$BUKFUqaxb4fq(B{b4)EzfGU~v@ z&Zj2Hq0aZ>QXJOwpo=*Pa;yV$DPOZj5$k+~2pM$)EY^XE8djJB4-LLasxd+5x3;6s zymhVZ>h6~mABk&iM_p6fVWp-H_Dy|Z>4R;?N=K(|L#b`l>@I`oz7rbvmb>Y_X)P$f zQyJ#iB4wGXL|f0|RMa(`F2roOm5p=~=+ZS|NwcVbsRi~+aeWiPlDUsomt zrY$KiN{xaYOTNIy@ET0h9Z3TJAi2Kt80ghTN4p)^b%RkoZgf1rix@QGB6$e~hHj`xU=BT&V26gsD6ndy0hLIM>XB%|jINu?WU0;u*4A2%1lYS-0yCV= zc}NFG)dCRJ6AI&QcEY$DL2qr+4FYdNMEs>%&@a{E4VOqe+YI}qX1ukO{4dp(l;XX$ zDbg>!Hb%K@43~bDNr5pzl3RmnQEEDjjA4Q#vFd^|RWU&lv73|p!!i>j$qpcaU1q$6 zU}J(LxiK*cWvQ4TNoKAP6C{b5M+LJnu0im0kJg()N|_+ZO^M_sYz#MKO_3BB6C}x& zNQxxbkRZvz1W9g3?=eA=`w@o9WMh;|fiXdnTZ5`%J$b$?NGeC()mM;r^#Jm&b{+oH z^GAP}X_}vJ>vZIuJL=4^hm{b?ICMzN4X)VXfyC#d&pYbOn!7N-zw>_ z))G+XTO}z_=QERJ)T4NOFa_#-ah^QtT;BH-=wfXP1?oJf5e4e}i#-MEe5Vl^bu$cg zzSD>Tb)L3`BGmcX7K%{k3yK;ObadHSB%YQ1N_@=;Q%4a6Ydjpu*`Qki^gybR6r`IN%9XyjRyGGSuHX{{yp|~!Glw~x6 zL1=`HU4ZLyNWhm1M!w0{$qO}tX?5~7yTB($`lac(0*RE{1qvk6FRcOmQbbCKdQ1~9 zV*E})q{ZNBC{o0r_Yb}riX87+o;Qsm$*5uH4Brq)`bfATkRr+O`8QI)ApIvj=-QHk z;{p69doV*t2#4(rzJrirZ@_NL%4CLM zpi8x1mp^3~GqiZ6xY+b4GsI~R=;=6Xe$DX!11#1VGbC+M_7pS3Ns;M67i-YSRSDJ< zi(DZAZzsT;67T{6yUZwb>DrRAqEukb!71TohQxCsWiNzcmlU}w;WxygD3WzB zDv{q1hoZpe>rdFy0}_l^OsGUcBt9_TF=j}_$8jtu>^9&j&{v=*bFU*Xvu6uFDHi+oEe@Bb_ajNZSLM(sFx?_AS%&IgfuX^gqz^SII1c7 zE_)74HMKYyqbf?7p&z*?Po0T2o|gz|fOLstf)`USiTWC#vR7Mi$V-GYK)OUcB9Qpt zZiXGc%2Y2|^Bqs(K0&T<^W1^P_+RBTm_K{~a zVS{P4eWd_lj0Fw2!I}_}Zoh(dOQe%P&~AxDm(*ZQ!AV?o6+{ArektA*oTR?9!(?58 zc1!ZV)S7>eF+=*>L{|dt_Nz?wQhBll2^WB`XRs;>SUdm=8Mbt(sY2KB=1-*bh&T$S zUXp%5^%6Rc`PyXqoJGMn3NNAKn6FJV>Da37RfgAduj3~FKl_w|Js>iUGOW~ z@$EV!eBb>v_w39awtV`HVvGe}twf$8#FvQ4_casIZ}QzO#SSU?ewE5?P~$UQfyB30 ziaBMx+bgNrDzYc@={Jg4=PNA8vChA}Qp7s{_9`Fi9M#NcRLP-k;H7bj&a8aOpfN#b z0}{5&^@0Gx4hsQbIMQ#8LX{mAxqQ(VMfma=GV)g9^O6+Xn$Js8L_1r$=<$AquB6m3 zA-p#JJKY-U0dBz7*f=Xi%8&~~F=HAjTSwuZI#Lp=#65MSgj$9XYNVyt!j>-Z)R8um z4)ROc)S>R%m$!AtGihL_Bwv0)`by{ljQ=h~k@9$NRPreg9je|leNMss&N*2QHR>W_ zl9Z7U7s$6&%13}TzYNjAytiahjzRCSeD4@VIP%#SQoh3}FN!0TPkE7YFKQ|TtJ?Wu zC<@g1hCO-I9kLvcfnJ`x6D0wDS0OU$eD;L`bw2w-fjaN8S3bjVu|Aad3QmDK-#bP| zoiB!>2z7odCyG$_6zE8ThTd2Cx*Q7Bd0mAlP*)}!BN9WAL){EJdp!j@I!s@$IK+P_ zp@?v4&TB#YB+}9aou5cK%mQPnfV1Z+0i>4LBt`nD z0+SR))eftw_|0=D@&>T*0TyA(TzYx(YIH;8_gf-u4%|RU5dwSzAt~AsFW@C?495%b zx+9XZfS|J&MXY-YbaDG63eM! zBE#@I`A}pSeq(KNTK5t*h6$2Xg)zWiemwx>vSl521>_Ig@jM;qffBK`}UBSt}dE!h*uaSRWe=o*&1F?)gvDs0oXkxvb5KR@Lzxe4QZb z)IV5~2Z~&L`iuQSt1Rkx;ASps1L}O8AQ^Q&GfjayUneM!y2vWqn4lvGL}=1kzD|$= zbv{W-Mx9TRQlQQ!Nhwh0k)#x;^S31h>U^Cb1?oJf14XEN3iR(aRkh|%`r1Yank&g} zjsj7KBDt&~(V<9gUpxALR~-7C*Nj>w$!1 zBPE+Pw6LX%n=8pI-I||+dQieL9=|A}2uWa40wzed^x;_@O|4Ewk1SeTf99d|E1q*K z8(~O+2232VBqp45ESCn5VGo$xePZci1seH~4CK8eQXG9UImfccby2DvhNA}dO?_hN z)y4wcwMnrz_#`RC-r&17DfR}efaF_cDXMn9PLRAe(qRdSZ|K2HNcNl^#U&&JkdQxtOGATi~_qS?u{M#wtKStO)d9D zJBY_>qhmq>EU)_l8^aNg23Uge4hn2~ZSqcgNa9)DIcqXCccX(5AO_s^Mmoc?aqAc< zvs++P&q5H@lL`B!Xp&s+ruQ1UP?2&qkdH%y=ZaIe@kZv!WK(pPLDn8%#sg+wM)ioO z9`1R=W2jdf&FK2esGhiGgY_Nu7!yoQN5*t&c;W))UoT;)#0oTu8>cU@G2EM|GAS@? zz8RHCjOvk2j~dvO(@R(?bVEgNsEm#IMen!g;Bb@w$mqUBOB{Lu?uM#N3JlFTE=px= zjPy2DCIwb)tVDFLr?fE&W@8-E7-dpmOpuh-!gTA#Xb~GDH6M`hk_)_=c!~mJf+Tgf z=wQLfo`%B|cERI!i=$9~0IxmNDljBSvN1uDgaf`#Bgq6wi&yGfN>>`dq{LV%Q=940 z1LKm5_01Cw4rvg+(#yb@AW2Hp-JmyydIKr49 zsmq=NQ%x;S#;A%?X6T(hC3+PY6C}yqP?;dmM_CdVH9%mYnkpJ_? zamN1L6W)o-T{h^&!51`Xd#}t7ZPnrVWgi}^H)3LBP;0$A7iql_6aUXQb!#H6x4&X~ zs6hwZnMf0|JKFOL9Q~Ed3+z32x7m=@DzfEg(Zl5a7sxOx6crIxFI49Expk>J{Iw#d zTr;=!U55i!Fdyy@eUmwEOs(AWT9iOOMfjzH`EYFszf>rnBK*?V1sWvz&#FxqnEV#I zGb$smufzqGuy)~HN`5iORE5b22sq+BowqNO2SzZ~jPy;BejU?rbc}XqRIYbeYcTz~ ze0+&6uyUw#?Iy4bY$Jj$r9zVrb_5K@?-4%|?v*629Vf|%IO5bKTYBpRhX`1tLL-JR zPLdI~67cB2-!zEPj`4eJ=?TUwCZs}JSaArq;1Hu76MYbI@{1M%3vXa-_N;*SWVI5s>6x;4M>cmRImC8CatK8UDeGy@U!D2&`8qK^5V$f#q! zCt`-deNV(t$9zx3Q1=+<<;fN#0LFYzMAXeN)G^-^8Ffr)Lqt6ull~D=$7lvJ>X`3| z80xt1i5Tjh0$qyZCjx_MB8eXfSE3RF#tthraXBYjdR>X+=;DF7(};TmSZZR@9OB*p zmc8o4S+iW7S%`ZBGlCG~O9M+t!0UjgKrd7o(A@-9I^xnCVnza%vEISPaLveYOCT}S zqhQB?r$8@NYq^1MD=XCzhokS`zIeU96{#{6bvcqxcp|5q{9Y0|Q7=!Pz1V=^JBM$F_A$xA3O3DYsL zL}FBrK#1t{vw8`^hDs##n9JChJ2A(D^CKyf0@Ie%6r~zq92m7WM!{?hr$VDIG&$XZ zcTiv*(My}bZqtR=>duunk8E)`#&3Jdllra%PUGD5pFGn^V7}G(XUO{rFL|e~Gsd`%J6%r&(3{P>jEt0?E z*+O({u8pMz5ec;bzZ3Cm)W4I_NRlHT>T4urDybNaMSDO1$LRkDmmGD%XV1{h`PC88ejJTFEgp%%jRb%qA^{O=`P z40k_O=F%CBlw2twRB$Oo5;y15<$3ic(!d_H?}k#dl7K!28`)dH!K#j zq_}mPju>=^OXavF#jOW(+0wdUvEf*O=GNw`ZwG1q+JHJ%(GyX}MG$hRbN47rdD4iW zONb!IsAHBCBI@|;_8Ad%+y_KN9lN~}QICR!I;K2nM9`%~5Jc25 zO9~lvSghl>S0d_|C54E(8HPIM10ti2i6Drfjw??Z5p-*Q!SMhcEY|Vobt3ARl9PzK z28KGODkY+hJ4}eE>~l!4#bfy9anESDjsb~KuA1UR|JmhQMc z02(Y6Ij;{Oo2Cdtn~!(Fa@#*Uc$z3Bs+{<@e&FQ9j0YPsf_Abf=%$NEAJIcuobFw z=^>@SOCIdP$*3MN)x*_a9z$Ki$w)j;8P(%vUwa9`h9qccd@3+xe1MIqdqIa~Brl=B z(8RZD`iXD#1W0M^s1pH?ySgpO7lfit+48sFC>YfvR1^`COc`kDwZcx>@+^WaRM2fn z{+EinEy)ugWIT-?FHS#ZdBF14Mx_L6U@a&MA%2 zD3StWf~4hb^|uYj=N~!5cVasYA+OVp0C$k=T;aUpyRro$^=R73rJ}t1o5C9X01)_7z3l)Jt34ll4fU4if+q{rBM*GcDIluuv6+9{e%? zAfZ(unP&m(#Z5tc4=$q^z_=#rC5d8|#hs!&4Q zqUgp@tWEdL*rt0S5&+}=L1LYRb#o#ljiS_atU&~^fW-WR#3L1Np(U4*IO2$&jp2@W z%(O{JrbwI#tJ*yVy0)ZTD4rssj)|wpsADa(h^P;R6;+G^YdJitqp8)&=#fQ>Kh)Pv zuC7G3aIBjX5%qW&>R1acVyt@$8>1^JN;Sh04Aw%69O|9|y-?+7pv2f1QLJ-KZZXp) zG1R?;0+Vvn5D!ydU}Lz$6h=|#V23G?E};iqLV-pMM@IDsrKRX1A4D!W`OPG9$;q9O<;knjnfkIu86c`gE$&DORCI!X>Nm72A`k`h_kaSRbN;~W- z?k#ML<1huXD@>3iwBy%nWPvyW88%pad5r3jXo)3v+vGeT^h;-gB!8LQt4u9bsanef zNp8g}OpqjH$gWeUE0c}kG9=b2o5-$cVXt!@qrjLTNiO{=lchp8R3=DjI^0dw&ICzf z=Fy=SP$nD04aLQ~$Pu4trI&sN6_PY!CmvrW<~XK0&Fk1Yn2kY_;lSvHNF?z z_5EzEuh(c}d%^AWkf!xhx$y+#uFHG_>O-+tK{?bp=?tcbY(&td=wKr1RPE#%P{;QI z5p`@YkWt6Pc|_FXVW?wtFd21ButW@X+@IQrpi9ufMAWgzRU+!RKb43&UWXE69aBUS zQO93yiKydrFcEd^6`7b|G+5eiM9?MtsYKMHV6l#IUS!l^v5r%RMAR{H9uai|40VhS zCWkuqpxt<&qiJvH_8uXny6hSi&kQCXGqwjQn^8MX>l!qILEs&e2Y$6cP(%mbnwwv12kG;z!cK zij6=_a7o0GEnUP>KxS>$l|3j`V=O5#1T?T>7PoB@zbWRGCGL%MSbSk#S#m;x6|?lr zkk~6L3p!xdWn6=56q1J^`y3&SF_ZTxI_R7jtJdjzN zP8O6gL*hcyfjaP3Gm_kk+f zS#ou6N?OR$A=6A6LJ~$-1F7>s7@-WzVLq{R2`{;PgrV8%2H1@NNVUU~JFe1YOLy$+ zJas5zhJ*_9h8KFwLP|I{Jje`j5+Q0L9F<9xMX7d}bU_14k61SW!g2joU%H_%4L2*c zbi7kRoq8pmF+;a*jFv2Bao;X6v3rae;-;-q({V_>5|VV5F+*O>4AIa1tbdlV3LARK zUkK3Q%QQpJo0?6J=@z%VyFMVn*l_rIiBPNBn1fC*>eH9&(+Iq5z@Ef`7a!pBJnSap zCCm^I^g@;6MI3f{06uX8FEX&_cHpH7_P%aW#h!H5zA{f8?P@qJ z$NF27H93L3LvC|5zm_i@s*sc>Hz0=gk0V9W+D*3}j=q2U;`RDgQ?uk{5e_2hQmVd< zv-K09s4gf|O$<+Q_2HI3WgN|!5`zXMpVv2=dT>BwTf$Yw3i_Rhj)VNpP~DnqV=14w zB^*+Or5B|F(<3ldGhRsgiGUt;q%lJ*J}`v=(iPNU&c|n=csA|hZl7l`BLwuALp;%@a+6| zcJ*pKZADGgv*rc;o_McI!n8o=l}@%Xg#^t+Y|e_`UF5sgBEkcsnTX9<@rs_KM&LL><4Q5mCozCNk<6 z%|s0KDC~Wb80y#sun|EoRfpO4|vq=8P6ZI^T=h$?xac>3~sbvuO-Ux@1(Dx=^J&Js9^5=%g_a=9SN$4Pmhgcwt z+{SbeBht+HN3p){YtUm}5^>kRMdkS=Pmr1NRG!%9@!CF-iQ8!@r zD`KpB2^+&T)5ki;l0zNqKtxP19s^xMDoPAT;1ehCxfS>d340OsiKR zj|rD^*7vgZ7J{ujS%)eIM)gSdURNkfr7aQp-iR9&(-e`<8LU?}@tlc=9qx<*YdJit zqp8)&=#fQ>Kh(EI?+;9n6sdMQB0&QyWPzms?9N7CmM}q*ROd41TN~`o<~4$(OeRS3 zcQ?h436j{jx4w8IV`Al?hE)#q6qq%i36k3Cg}rtp=lCdv0%L+Cz54{CObUz%l9(Wg z>pkEtdzle8wW&;ktx&}TNpXu;>P2h}*8)(H6c`gE$!$|* zdh(bc$sOZ>bPK=-s2k)d6>y7oI|532cL%;tmt(;uzY zci<0OJsY^tYB>^M?`8?ipzfEnz>~ePQSYXVkh^x%HcS%w*qv>lrxB|dH&Mp@trB>7fi$nbzEkO=YR!EV8<$A`EoZs>b} zE0E;7rXeu_ra&TWQ`B?_dqQZ$#wvv>9a;=7>L!LGR$35p2D&q1k50t3;}2j&9NE(K zUG^N9YHD#ZMpcwDL+_YO!RAPrnskc^5Y0^E{9U+CjM#Sy6Xy|Q9cL!x`!b?}4j1Ri z?K?I{DyDf{$`o;|J6I{)I7CDpHx9|6&M{<|afo>Mnz8qLx%9>6NG%sX+BEcN#zc!m z)PaWvrkWrgzVt1c5p&4qNR2n)D#3=Pk60TQGU~9B2UkrH(>mtEl}+o`d<$}fVs~j` zIMR0)=6cTo*AB#yEgch}IqqPHIZUcJq@zyNoO+$jtd%}}y<}4GV4Jbh-Xo;cP-+`B z8_-ERchh^*T2PKfE)#VAk-yATm4T=pkxx!OiJ4(6RgR#W6CsBQ+cU`*Rke#ie4H&r zx2EFI?{`P~4~*`!eaRnsxnEkS3KaUmWb-vQDh2b%$gf@G2O}1QUc$z}W;bznA6$VX zhdSr3#S}=52s)Zi6Pk1u_k$5p$NXS~=q*Z3hvjxJVPnKCk;tfHCOl%Odkl1KNdcpJ z+?Kw|WU2DhnTQ<3TzkZ_U73Axfm6MKvzr`#|0q~O@)YRkhN`VNgnL+s=K$tmA!a0H zvN2qVj~R!^p^m90K@3h3{9Lhi}pU~LC}%>7ZtsX>X9C_sZfHg+Gs!_vwYKglw+qj z4K3E!fOu>$mI`ke*ziK&Db&vf*48pXk~{HAEfXY(8s9d|1c50Xyo8P6?mkSAB%X|| zU^YhF62MGT9i% zHdQ7C#so=BkfcIyt@PR$<+3qc$)ijPj0uuL++9x5TfQ<0HYP~gE|+^fMfGqm1fC+; zkRZvz1W9g3s4_v4$c?RVd)Q4PNU}QYtNu^7e7oPbTQt322>U_b*7A#O#K*yXMt>3? zIpXt+9rW#|8fQlmJ6K~nF=ET$K~YDOwd4MtqE*GfX6@RN>q4Cv5p|3tBX<_X z9!-h;!NOtv!C13)Q7?;XV;=HKV()82)Q7@Q$NXTdS-Yd3E0^~@1v=t`(U1iE4WF2K zu^TM$Bl$#ABd*jnz|I(tp>EALvngvWMDK|812i?TjN~Q#n2@MjlXMpMRuVTV=B*@_ zNH~8?JghPPn0#1cYChtzfvfq5Z6z@YB{3u6{4sIHhsQwImXsBxYG6qN^Hvg3$Gw$A z)B|B#1ACz&qK>Qih^XVQWyDa&B$UKZ_ZaBaMu(jdR+!?P8Zp*kr!TJNBccvGlQ0P- z5q04Ci1EkdQ1=k%(`%E{9XyjRyGFI`IsF||4@`>m`z%I2J=%ma9{H~tC@`B5er$oj zY(@aST;P+F4+4?djPOf^W;6L;Dzw!ReyNbfBK%UJtxoQjB2M`AibKFe08C1-1c`TY zAtr0KbU_ai#8I#@elmTXHJEKvZf{6v)`$nNr|38~#?P22mbW5#o?BO(_id&$ohe| zDo@dIQmxM9Z`ML(Au*Q%k1)mz-DzqwJ$hhVaqWfOj>0rpF4 zV88Tr&@a`d1Ab|FvIgxvU?PCg)j;YTNaM4mi;n_{_UiJR1696EGbCO1c#0X~Zp-wb zOSD&)Pmidn2-6G+dIHyT6ka0KDpWgCBgv`@W6Ny9yEXkbbQwsffy$tv`m5=$h;3`v(ro??c$5{Vx4YGV#k zuV5y4Vu=L2Y`~txffpa(^E~Vl<|WLKMB6nvVyIAMV9b!n3REwvR;Ezvh&t0=W3eZl zwXe)mN4t8j$0d`Iqur6gc_1g2`n3yF&!#}ffP>PWOL>VGc3ONGKx~N`R#apC&t><9qY;9}OVmru*CsPU74Lse40SJ2FOhw1S2b~_y}LV)Y&O=o zu43ZaiWhf0X-h4--s2zrzB)Xw@ZfNh|H$aRMN3ZW`yvg`!A(_|AHi))=WZ2;Dr}=n zl>KZHvNoB{Xl@mnK-_iqpJxg{4^%PXwbs_(1COd#%ha~3TNL2t3`Xj?k}4bZEN;U>zK&JC#JcMBrw*g;N2 z9lu);QO8bZBI@{sj)*#5CAjNe-heuGp(BPmes;R+qy0BPNB0~Q>zIg(h&s+P5>dwl zWn|PbKLQc;DD3PcqK;9RWYnpqSTvxH6MMu^_Y~-e3T~Nn78s7etpVGn!02U5$GcHG zj)C%I$3BIHFYX{FZYAKh21YwuIyU%~JFK-OLyJ=FSbW2;nw_ST7Kb?2ff*rpxx`I`@03%biVc5wa03q{|DEy& z3VdwxAy(y2IR&k5=~~#*&9J41S0(T2`>Bh3lh0u#BVfO@lR(@gSIHns0+sC;4M6xx zsBFhx1mxF_%66OvAeJ&14L~eqG_Wi~*Lb_(u7pWd)I>YB|)oyOPI1*Oqh< zN>zxcW9@CosKW|KoCY8kkQfa>L_HmbIwn;ihdQik$Mr#t2zs^gDZ~rFVx4Z>c|)v^ z1|5-6Fw`*<6B%`^y$vzJ426{rm{f%r>K+5VP-SLpjBv)hvMDfhLq&%v@X850Oo4Yu zFJWUi;t_VY*1!^s$3WMXpqPw;Wf<6<5I0`PSFwoh1>R3R#l~; zK})x#2#jg+cWYf1h>z3#sm|T>-n15nWBj(KJgM(0dsnJ9PA~~X8N^b?C)gOr%e68o zutHTjx}h>QrpulKQ%x;S#;A%?X6T(aRE;7jFhut*rJXU~pwjRKHio;QDw6`!mUQ=^ zHiik3nsgI3mScjXrLRdgmUGI$fcIHnpum_QDW-XxJGxhy6c`gENlAa5WrIzbEEN+Z zNwt@Bo_Go+*q9(m-7Pv;XkT%v)0IiERjHzwAW350TV4KTf+Y84yE54r?uN<)N&1_J zjp5!vc6_@I3Ey`=-D+wU{%RMwc!$32 zo-BV;%YD)H1Jm&NSNMx#Ykh}3#spK-kujZ|BMIdErcL*_ys~xucFi&hjzPR&BFBa0S)sBajXDCakA;yQw^AY(1^ugfKrj^fU*atWmwPY3Y~*G9}B^L~Vb zjy5ss8lX;`HOtkOf{40YY>QEsi){(i<>*~8>au=QG3s*CDGAi&6pmul<+M;Z>Reke zkAbc&sVPd8BU2<$mlNAbpf0Ce7o#qxaFjq@P6{P~I(4jbsLKh2Bod6A!ciRR9s|AF zXh7XMu=xc7!GstXe13sI=q~<9I#_bV=NAxD23xwr$%vtTHgKWMawNds%@Ua5)~$v8 zFV1MH%48Kk!Ym`2uZH`Egn1xT*mPU|v*rl8XcHo`P|!tNJ|e5MvPLuE(zURqn_){g z3x?nc6uo#N(3TV&55VWE$^TST4FJzb;L!m)#@NztLE2J0!1C0#(4@1#a}0QT>k1M1t`c=-LudJ7@XI6ivMF1vZAep(>LClW6Bm%|1s!TS%haS>Oz$cl|78=akKeg_jU~|<#`NsiP6=vWFprC9Ckqk9yN@mayX#HmqPkVMym6= zd`=Q}UMGe?AS`^ngpJ{N0cBEP5}nuOPbHM9eSwYPZm7znz$7}a%hx4{?)3>a#&O0d zlLA9+&Jf+}DQ%2`*%*#wXM!Z@lO0$KdI=lD9j36CTqa23)VyMn9atiJij84{B$pjf z{E>99nwPOuZZ68y?@vgOWM_gTlhfNJh)5<#8h&8BNi2=w#(sK?FL6xcVuBP(R2 zY7ZbJtI^|(GPP7pkfd)q{NSC^Rl71NFeXT9aFL6*sg?%HG+J?mNby6NX8v84}k5Y&X5ILU^v%kVdOrK{QsvKR+ z{tAEemK@0)cWdmgFz+cZYTXsHzrse$KJiN(s0W~8_E%W?r{vID7(9`%{LhEk+6sL_W}^-U-w)2Ie7)K{g7giyd&R8mZPs5h(+733kY!fDzGTphAG^ zkU@PUpbmgF8K`ii+LENBF6brzJ7j(-=+)UJ0Clo-3d;j9P=_5dXw<{V(kZOTz(AcW zox%Scf$k7^uS=QZ(wYLk1(k zzz!LVP;V&E0UHdm9ezzESltQhJF;4nux$y1P=!Jj>S(NFa3uysy6&l7m zL$}57kZ?DEEd}*pjAaxd7eH#nGR_ezF*_5VwM6VqZ zHu{!PmP)KG7RE$v3T%v+3JtYU0wq-=p}@pcXfzvRknj6SI89}f0;2^zi0TD4T4IV24Tzl2{^_ zJ#8x$>>% zLND3WQqh8>NWaoLqm&qhE1LuxEl85GL!|{t5>`mrWMgF5lSd1ZBry&^%uaX!)kp+M z)j*KM9mPXmoQ+%*FOb=aqYfjaEdK!7k3uti(327=)u#^B}Zjdbl@a7dGA;FthbV7BYMgk)oJ0Xr_-?T{#U7X*?SWlUdDhFdK!6Z4xw1y4G=xFDWl>$v+ z=(DQ)cJM6L=dj;a`#r5?jZoi7m+BoueWzTiOAhs&N+~WmRET*oDZQLfLuZl=U8KVi zDu+=!9HDZUNG~VUn~F%Mq_2^{BSo_@wcXeMHz+WWe!a?)X*R}|e>Z`Bdh<+{a=!l@ zPK_!@HYu>`>^!P02bBZ>-P;t{7=Z#!HYu=Dzd{kq0BXU@4{8!@j6i`#w)bfy6j&O= z8!V=TJ9nsS2C5JMM;nAJLL*^g1QJ&=cBPR}U|=yV$q%Bb9tK~U{fAR{#rmg+XMqAKfz0oUv`b8KI~_Z$WL#NPZ~>{5je#bi_uQ0bHT%8B0|{H1sNJha*%D6X|e-T4>_P-c+QQlk_!`79>g0=`+a4ZMZ+VbkzBKB_*x7O(VU~6wt%8AW1?W0h*=yPgyEjkR;h% zCDPFkBRw__f(;0gF4BS|X}-3{M?z=Tx&cuv0xd|A?8k2;Y>Z%$lu1us;}9fm=UriC zr90=Ts4M+7XuW;#r(uP!xMl-#7d4y2n*Q?9ro)_;Yf{PtdvEAS9;2TeOzxq4v?6Xp zlu4IL?n&<_Cump+lY1BqE8%cL-`S!IiNK|I38g!)OEcEOZbLNcVc4h(&NN|t+plbQ z4<<3)d0o*(LX8f)4KYxM$UTe%1MAx`5)90!N>4D=*_A+52uZClG7K!W!pJbN+YlY= zS!A&elY1DbLvBM1)ZL&n8w}K8x1n^@MfGjJ6!cQRFrX@g84NV)OfuAAeH$8e*lmb` zI!x|ipbqQX(5S;K69(!G$l{3+>J0@tP!)n}OkhhD2I`QH4Fh#p#Djr4?0LdKoh-q? zbO#3NFl~em^*FLnZz#~gVp<7Qg=D}Gek8)Nli^4YUHmvRPnib}oOH>OM&Oaqx^^b+@e3`m3%)E_+=7V^}r*e1qiDu!eWCSdVTjC zi}Zd%O^znQ#?YPD|L52ky7Rg;(T{AhF|yowJr?XxX*Q<*s~u#L0s}kLbyT+@#$rlV zl*lFY;X9 zLaiJk-Ih>8XOaya^wnNsXH(}ML=BxPZbBW0RFqR3d(z(&*p5M&L{mKyOa^2HVPhfK zO8s^Ka&kb6TB<+?TxcxcmK!NHu#6TT(8)8)Lv>-|B;Kx&T*%(2B zkxdGW79>eAk<)@C2|EJWWMlXVMm8xhT972|Jc&$5Lkp55UFuGTBP~dx1xZaoO9cc; zCA1((;yq-vAW8CN!8A+tUuLPm87eJEl4zMxwCI1S_LfGJERlKxAd10lNYJaZOK3KR zqah}~qXkI~C`hVgg6mfMMs1gyw8Fakr;O0oo|-Rtqd!z_)$5%fY<{!eyHFMKw-?lB z8Lt1LRR^C}mu~ToOm!j2IOsko;TG4HwcYgLNeo&CNVqyxz8+&OzprTh_mB38ueseG zHr9gsI-b{m|EN-W=S)GD7ZIPfgqv37qUU*vO=5lnxB4%M)plCzA|SG1N)>c7k#GZT z9qKTp3c6b&P!A(R9rk!)pbmL~Fi^LHd~X=2!#p#)ZY19h@khmExu2?kabq7zIOS*XKO&R+?-xT+8Xb@&h&jXF%JVq_TDc7cI9 z?D0gS&Ll$}=CRSJ!^T>SP=}4RzZ7&aRUroIu*VYvb(ji7qaH_wIxL>UK%Hzcg;j+Z zsKcs4j8G>_Fxa5?yv)6?2C#?a(K%El1Nn0ri)g7VZqn^g#TGCXHipbrWwaNt#L-lbj)?59ZgQ~6 zR>?*}u!*Y*QA>eHn=>@q$0XAWG!iyO%vg(BuBoa*j5UlwCeokEJX_KJ9 zXh9N7T>8sDu;TAfX+aXTRao7UB%5rEfbOLQN#cjIvdhK@7E{@zz-U2Ix}3zCS0*Vi zAV?~t1xXAYr|u$s&V<@`T972U(x6$YW(Qd9M% z+Usm2g!z|{nI}6Xz?Xs1f~5NTvecPqXkLz*x&1>DJ@8Sf`N*My}<5U*#NYG4oudqyG-~%~qQZuuhd0rV9ip#t^BB>Jti>Y*=fB z?wbd{8b;qd*!hOhHxG8cp_-892RTB=4boe`iaXyh4Dyik4Z|Q06HOSX!_GGh)FERE z2I{cZ3IlbRXhNf&g^jv^@_?OhzY=tD=Nks<@ToQ$bvATrgMm7{0l+{Vmi?enhtHj* z$GRBNghm~9zF~yAE?I)X2VIP4!a&`a?0Pu3phu$~M;7bw<^ltCNcMw)I=s=r2z6L% zg%Rpx2?iVVzCRKQ*}Q7DT~%E15BWZR?>P$giM<_A$OF6CV=Y##Qw}wmQgaz0M^qj- z4T<#G%V~j%nW}YMy-z_L+)gRLS4Z-2PojsXl_-z1^T%yp9t-YoTi*>EM4(ZfH|gh_SjQv;N} z^hL)Uc~kM`oC4zzVFgB34Z`#;Mykdy*yxLnS97|UN?IXdtE}|NA)r6lWNR2KLc~bz zFf%QEnW@gsqv~=nLZ*?>C4wy^+?@$yafhsF7#~SCIjT~>LQu%cBwZqAO~cqiHU*9f zn4~}p4_KFjj`hYumxzj?FcJ)56(f@z6)2H5lqKV@zJkJ`anL2=)-?3?p($`wphbbLdl%Qg7C^`--s3qX;SF+PE!b2j$ z3XH5Up@%L`mw?`NpcyRoL5{F8A*+&jWYe0kkfDbzexOjDodtT=jj*%9J|xNy;*rg3 zCK)ZyAi9)*9=fPsn%}$5%fd5Z-mX3vdD!Po%97YO^fT z<{L%zh_v}eu`ARDN+>>Aq=6EO)FOOSkp@cAhwfceOfy62;>BZQx-wqCQQ*^YKN51O z&0SIR6!390GxXnOh6D>LKIr28@=?q-IBq4YdhnGrg0VBnYH-3LsYwi7+@2~uRrBd& z!YYZdcpxlf$cm~aF?4Zzs&vv{klGteNh46mk?Bj=Wb?X73|+i|5_+OKlHo{ehNx|b zYOjo>eQn}gHGfvek;$-WUz_+jjzGOaR%ra!nW1zZhn1Di(pObix_DJjPLnfh+4(Q* zT^ru6o+dD^DvRx0%<@%1kD6!-p(eSXV19tbvD-|K@?@CXk=(@b702Leg>vDM3K%xY zO&oQ~{Iz-6ue4y;B=;6xlXT=^j&6)+4qPirzEWd(y4K8Zepzens^Bt2Vz=P*)}B^C z4D%%j=5{3aXpUytEiPufwkU>6BFSAG>rjWd9Sqdr@(crYnA^cX9ZC@xsKbPsbkwW- z8W8k1fM+WI9K_pJp^VW=TlkqQUsIGbsL?Y4g=NvdP7Q_ns=1ZQOYCg=);jP|5mw3_ z{z7X?t)~tJyjL7W-h>JQb{5f_vdP{wmF!I`3EuR$t{0fuu<;G`l|YPPU6xZfv2~$} z3u9u#dPo5^PUI ztpi^uo=}X0)KH+00{2LjCmWMxBv>7QMm>%!Bf*jk4AkL0AR2XeabY{Bh<+f3_j@J z{Ng|*K)Br?+xox^EJnZ(?oQ~TQ*~DS4X1ZeAt;f^k_MY>D!~ja#}v)U_qs+9;!91mhF>Kma00tjs;!V{L6Yx39Hpp4({wd+Cxib6OGOKkr0uO`lVE$qpan@B4O0or1}#Xc zzeFO;y^X{kCewnXLf%}9;y4Yc6E{jZm_nxN$t6?uc=7ZKg0Nk7v1Beg-j$!uRXJ6K zI_K)N)dJ^gTq3p!F9@_yWxruOJ`##0#V*pK^r@2S8gKy}%meUE zc$s<1x-5Jro3kfRkJ^q2H5h+tqi$&d#mA9@?_>kOsFx)(aK-eXlX4=ylMQ^N;pvn{ z-BM2}!Tr1{1opwqO63Lw9rP6q!1qYippNU25~7YR5D}t|>yfHK9oNDjL>=2BB}5&U zk`RV^7%mSF<{b!iT#pnn=-x#J)JEMH;fSr$7JejL@v?C2T->@vh$HqfqVStGiJ_-4 zxL}@Q7cRo^#Z`3+rxM(#TPp1-oYvTyC z)gcOFJ&PNlVv13YobC}Z-G&C0;C&(lP2D-?n@_a!9B@ax!5`W#; zLB`z-B;#%fWjd{iNUc~}kYp;}S4c>+>XMP$vdPBKf~0gg9hS&7ECCk6BL&%HV+1lV zT971WGN1)XrJVYFyTWYOU<4a2NUHC`Xq__QxuT2`Y_uRr%Ccchb|y*-l2q&8LC`GK zf6P+Rf+QE8Z5#>lMGKN7)JU?)#_&xfv>-`Btji=DBe3ppWmJ$<#ia#Fl9DeiNK$n1 z7rA@Ac1OS@Q*A4+cXsa3C$KF?(>_7!O&G!x1>D=^nh*s>3zGPI8J=6x1p9z7Eljq) z4)##|%=_o~t#J#ERN4$IelUnD%ZW)OSSz_QOqC5IL$`RLj$YgZHmf!xlp zc9P$hIKV;8$f-x9uY|iZYLID3_Nw3n0(0!I6X>D;?jRnI$2-T&^~^CMgFToG_Txkm zbCE1!=%I^}mHdgC38MWN5$tYcuoLDa{3IiosPxcvoVvR}yUyHKV4^yD=9rUB)a_&w z^#oDG6p}>@J@on}YRWZ!&jped6&$yctfCY$yU@b zvWTIFUf)Db0~3{OS#l(Uy&YM^Y$A&odgx*+>T>gnXU4n@T&6$o)$txGS}gUGi8i4v zTe1uz{jYH}q7o;hw^V-9>yZDI6&e>3ZLhavyy@_Ur~P$HT=kn2U0#=1US)Y!^@qT) zSRVN6*UGT!Z+T2^QDzu#Dz~VB$*caJlEvmlvjZwJAF#73QXJVop0FJ&zBo>_R#wUH zcIusZS7o_tMHA#ES}QhdBd4OGBDZVX0ed;O$T9`#{(3Zu`W7cVW< z`Yutn`q<6-)0i;J@X`+twmBb99#PbB>5PqfZoZwpPQBrh>oie{A1#OCugTHXk(b zWcrNOOBO9tubdLj&bHuUh6Y-;$Oe*+wqj6 z%6zb4kv8+zGLN(m-*=hr*7>X4-@9bygscfm%c?)L;=>fMf~W8tfG|oyP6|xz#b6Qu zG=LA#;XRovUzn%|gdHu+eq?dC=dk#B=1=?|KfG$&^GVXRZY?7dLWYKTWfvIftmu}! z>D1b>np6|*>(P4mYd9CO3(?9OHpbF?13NiNUb z+4X+HBlY`T)h@l7Y-6vmf9r}3d&Y)zcg;DsRr|Bcylp4uwXr^yY`^1@lfmwBK3$iX zd{XEeIjj|9T=LGB`)}Xv)pB>vwhvQvZ_d7TGI+S*I**lGf3$bCTl|G#v@h&U&rr1o z1+7-8?zjKZGqgI)u!yBT`}E1Xhi?}-sFe3KwRsY^>q)Twq*GqI#_5kgJY~Y%@KfU# z2C%Oi+&DeYNxOWiM?|#EUrM1PIfZ#@>|SS{1zt(JP<&9mvW&HRrmb$q>hi>Y4qu-- zlQU*zOgFi?eypfn`;KM>@?q$ z6=k&lhrOiv&?iT2u8pr!vG1vAsZrifBR$#A+Q!BCy{4II@$DWbO)sqpI$-OyI_QS& z(3{EUZCz$Nv$V2iJ1^0)o8EIx|EGo1cWybuz3w}EYiVxVcg`15r|&FJu)3m_TVVcW zOz%mqvB^hTotZJ=#yG#_%*q{ZUm5)9@na_yRLIN8#VbjR9;uT|5JQ4Vwk_4VMWTs% z^K31TKoig1Q7tu=yx6AlYP?1KP8;3yo?U}>yngM{re(j`|5p8NR<)q|kii-Q-O
-lAf-urou^$|FV6>IlYD90t6+lk20%#8G+M$bjGoJ{|eH}KhrapztmH&_T?((+)7BhWf(o_^1*4kGpBuy`aJMbaYRD8g6R@&YAbW`Yu zt&wlEG>Vp%eA2u)-)exu9&;_Dn1G-?w_9}8=rvHg-MZnSKeXQuO`2@GZmZRH-L|fy zcg>qIaL=1P2`|Fp?l5;8AEXyObnrs|d%^x%!4V<-LawT-n;bIS7U-{TnEgTj>%Nf3 zBlZONd>wIgFN5>u)*PSsF51f2o6UTEgv4dHu6*R2{zmZfCYt z-+6g$ohMC6QD}2xVxa1Tm3iTvuDGr9=$-fJrJ-`4S<&y!*6g*KF=J6l*-q1M>$O`> z@wqt8(Kyi|(kQXBM*p>r28mJsMmP^S?#yDIQs^*klCo0vTc>dtM$C<;EI+Wb@eA=;fVe|Vp z2Ns?F_fVeEpK|S%wLg<*)B1{4v8wh6pCyr93^qn;RWr@36E?kM?V4&*eI}S`-Q$hV z$pbI)7Ix^h>{`aZFMnLm+4nr_^eyodmq!xd>@SSo_d@yu0rL@ z$6dVm-jld5`)Rd5X=R$xYRYn#FQ!{=<(;(*?ruD^+UM9P-@NV4b3e45y+dcn=uR`2 zFnbT$ml*BA-hQF-@|42IhZgIV+?$nO{b$Uv`<3&gH5Gg`#n5In1uJe6LI71 zhjioZ^63VF0tp}+d5xT8FicXLi?hwpjS_FQ_4s5a5hb2;WW z6Xt8~UYwU@cGKz8&4(#3R}EY>@WA|U=i7FAv~EeS1=Y)U$WLaCAD6l3{MQ+|8#gk1 z#~*9Ox4@A5W5*|eK)*&*{;xjk?@_!WQ)%%OBiY-D|vK*XHLd zj;86X?5p3u*WVkh?tiIlrKVr5eCVka`|joB2YpmCk{9ckPZ{fRSJPX2naS=J;}*L- zVXgV}dSqeZZL1Z3{C&#y^OpCS>2JF{zf)j(-)p${WwZAei>`Ee!JFos)_&kfbDKx) zCcJpKvT&*6*cZRO85r{DvQLlYCYHypk6S&@=h@0fORd^#9nkx?!wZ|d@y(|W@Gfk& z*Vo`pj;WKym8iw+**DTnzkgo+y62Ab(=@F;G%onR9C!Zho!@MAb7!o{F=^*9^0$iH zLoYa%De^zVmk{HJqd=~Ukys%HH@V{k$Z+WJPAk!sy+8B@8*(}8ODkpgE zixIQ+rjI}F(rtFLkO}X-HUx&xfAGhXyTfPca00HxtQ+`l;)Lb13?FI@+_!9RPR9IT zjVTcquFpJGk+LOmST$&uP6nCfhf9j?<Dh=+J{Kv9kyLvnvk+StZYvb?ht}WBs@4HHi<(sAR+V`T_mo3Ml zi@VyloV%_|UTTte-&5Q?R&ZLY`93#NwYyAQbj((1)uZXZr`!tuX0=bn-n`9d`5(7? z$L_7TeW7pegWD@LLe}N>=^q>asDFaF^`YgX1AQ(Ud_1)8#JuC4>dvgga<07&sF!#7 zaO`!tbMuL=+m5HE^}fAgS;d9YZk_f_m^$mg1MlGnN9TWW3fwziqvzR`ou?nUXEMje z@~-Fi*cexfkYW2CzTRA=q_{tOZCLMSncLoc{v%@5m&A_!Y*Vb6hL=3sR}Z>6Cxlc#mJfLI4ee|;MTHsagsE`~t?z7$|y`yFizHq!?ak%`I zrHm(?&Id9zGmQBmT6E*DsKp>Wx2Z_W6bxaA@{50GH@9ViVm8Ejxt~d!QPUq<=%s3n z*fUkN#r(E^i+zjYY* zp?^^P3Zw8L3*Y5dZiwo+i}AP0$;gdcXUFfJ!@XR6?Tb67tPSgR#nwGtry52a*?;sv zSZ0e>7uq~uqP^nt_NUX;LW_C~dl=j=r(*BYo~>_aPBz=b+G4fR<4RRzg1=GnMrZkg z4TeU{hwdf*PeRP|Ts1zt{Cvc}`5~*MV_Gw_RF_!Z9y@UD@6!j4v|s$k&hY`(xxYDo z-g@ZpIL|vSPZtj~JQDVNX6u6o=MVX(^3wn__f?Cs^w05jg@pFJr?~XqkwWL2+Hbp$ zvrF1){CK*)ZeH1^#jynyvAUUSn)g}Q_twx}db?O1PdOIM^nK-;aw~r6?z<71%$IZf zsBRd$f3k|n+BdgtJ^s*|dyVz`V3l6s^2Hm6?BETV60<7Y?+>mZd!O%_Rxuru0 zOD>Z-3crbP7Y2VBL5X-P#CBC18s%#YsLEbw}Gyyhll!zr$RJTxqk@0>NrQteNNJNC`z=(=yY{CA0Y zhf^IU9$pZ9c#`_slX91I6}de!&1|Q?J#o=d+1>q^m1b%;<tD7DSHgek#iERPoN8o&oPwn2#-*D_}|LD+6 zc7P$<>0L(oMN2_}$^6>u%2$BPXsO7x1pf~qY&F&Na5Y~Ob)|=(nqF8oc?E0hF;4%U zF0H#9jT+H)*r_Gw5(^3@Z)>@K_xBR-lac$^IWxYo^o)+)UFo#A?Wcr}@@Zu;7IG~o z&FpJ%xtG&zxz*PUjR)TgU2es^9quc7RM|X7FItJ-myP33b=*iV*zTSMN z&$0M(A?%?Jw?I%RtAx89)4L2_q!+T5o;AX4x%-0U?v7K}tyr*X4uA6Ap88-p*g#bI za!0&dHmX&pvuC@l=v8p({L~-vvph$1s|raQR#Ex8>QsdY&1qVtnwjRW4`ggB$T?1D+lgLoj%7BqJGtpN4?-v4yo+&XfXUCLYYevzt+6MH@F&4 zG$q1EeM9l#UG2iVAIyyyw&b>b${zPq&mJdP-duQZO4}JP);ot58#U`zJY(+a1#<&0 z&5JlQ=2`x+UBhU$~fww*gKZ-Zg6@wMG0Dj_YBk50S!m-myuXZ>SV^hU{D|NY*a zEWP4|q2Vdxc^N70gLS9+jQQThYpBlC_wQXsgjvq_)QcXpL;Y~iTiig$k7^m^D<-DD zDr(+g!VHHwW6ZDFIb3YbD9%Xgcdhy2IK|gj7ux)`=fkOUWlIV^gr^?d@5xo-f0>S! zQ)kTpU*)@Ct0%9}M(!u0vNw&@odNz`yXJCo>fq~9e*nKS&&|~pe5+N0Ezd-2>TeH? z-ujRSlC^7RIXNB5uiAoVg5RFMlC_p!#Tl=0br~uAbN_ze&!P`fc3$GA1b#&s%o9Fi z@$+YIGwOqCo>=d2BtIn^ygEFbnx_bMu%csu=_l$~jFd$wr=Mh#=u=>Jru)y=0e_0@ zrHn&di9QhCuv3Ti#8C8sKPev3r@%X2>aaBWh&~14(|&ICMIQ)P_WX_V&mZl+f(MFj zn?)Z0*QERnz|SAHiQoZZ+X2xhz$F8}cK!L&e1Px?b(O5>ufi)Ezoz*4b7oK-9JLjO z=r6;`oxk|~{IM_<{IZ0lQ1m%)=HxF0KY!MmDZ>kc=r6((n~J^jU}d>_((FWQB{0wB RU diff --git a/templates/ScRNA-seqLevel3.xlsx b/templates/ScRNA-seqLevel3.xlsx new file mode 100644 index 0000000000000000000000000000000000000000..0f9d63e6b58c8e8f7e5c583db32b798fc15ccbe2 GIT binary patch literal 1045349 zcmeEv2{_eT`*!Da(uhh@rdHGiOjQoN)j?xlIc`CQVNYCcBW9F zgV4av5RrKv_x{#zZ`3)R_x=9*TI>5C*M6_-?HpIm=J#9obFb%l*8SXT*Up*0EtxTA z&YT%;?)&!4_~w5L!M{6OiX5^&apJI*z1^k_&L=D%?mMB&CAp9?YmAkXuu3fV>;ntg zB?Ze=I5}%LS6DqmJR0H)S}tY?lPPeViI@8PZQ`{Ku>v#dLQQGuWJs(s|M= zBb|*q7BFpy+{JH5E+^XPFFT+bl;kM4QSqv%jOf0cAeNXDCp_@UdTOlIR@aVI`j@uz zy?k@YtX*J7rqK19YC_fT$rl4+mwj1^>vx(R>+wwc_?WM)=a6DMXgn zI%VsajqxBCX|1Sa^%8G;N?F{p!ehF@CBs^2?@nHLP&=ri(xe_oj5m07A@S}fo@6FXzBR1e$Yz+cx~aIBF?A!@f}M`V`}`LFugUTzDxS;%x%C1Ue( zX+ec395?kz9yP|=qt*ZA6;bcS92W}{%o4P-;+fXZV*Yd~)N{{cX zzS{X}WFqmPp6b3b`H%UkMI0xjj<8+S=nOutwnMx5;EuBjd4HU{xaU^LMaK>Ejth+n z=5MN#l9l1|dv0?<)P6rjTCw!?oii!f7mit;=6ilS%3#ML|Hqv|=ZX*WSc%wm=k)jI z-_4|i_VzuD@O`||VUflkvsP#qUpU`>cerMCpW)rtIn2g`F4fXrf~xDy@6FSevnaDO zNmy!qVRl@Gcl%vVtuRh@*7mO7zEbSn{Tb!kkL)f| ztk_+aWYKejhi#zk_spnc<%TENubm4_J$AywX2GH7X6gGo`)jI36T{D*7EHIQ+Ysi; zN<1Ls{@cvEyfdXM2fF;sPrVXQ3p@It``7JlngUrDa&7iWTr9Pl8W%(cHI@hdcdj4*qs}rlz zGp+6N-MeQI4)0@H`Z@R9MyuzRf-`t@UOB&lp zRed|L<*Gr(C(J(bJUJaNQ7rS@o{CPfvnw~AXTOjw7CqEB;->v;&^qzo4(y+|^xl@> zi-$g3ySu$#?7X--=OP8xq_aL+COr2gq@4_lhSzI&Ij~gy?vqfb*-8v(ELvT<>aCP} ziuf$wSJHmeU>0AS=(lAZ1M_xsUHbFsVbQIX(L*fjX7bPLpSgfJIOy)>S&>hcAEIXK zv3v^8sGr7^b zPyLd+g{k;X`Ad_4&0$#!&%0bPw&|*sQoesK=)Q{4!55{kxL^MIXqkt!!Ja&KY3lnw zFQhp5+xnH`3j|NpnjKg1-qyig)@v(okf=>KE>@OZw0T|kGI6H_+kr!TAA zd*1f_neElNUAqz@i{17m$7X4jv_GsEAy@y&?Tf+)+W|vI>WUHTDaH&5tf+7I}9xMZfxw zzVM#n?e>>z^eYQ(TxAWFkGamo{>U=`fB4GzW)OMeS13z}t+;L?_@!kr+*sY|;_UmdtGn)`vy7D7aQjf0gpw}j zQO~!pM4s6--JEnerMt={wDx#@?tbca71O=I=f>gtg2x3;1h@7g(gPDX#x2!UzF zjOUy)X6*Wpn->>-^D?tFak8*7w-a$ZVY!3;@0&J&e{cIxWc6NY;j=Em&$0_&y$MXk z5iPTHb`d-8tba}Xyy=g^i+PtD7B}n<8R<1tyH{@!lI;~yzf6B!NcwGlYX7I%`I0ym z!^qZZsm+w<#6IlH_T_c&?c27Q?@RgoB2KHszqPWt zzAC9$*uYU^^KhYc&f!n#Z!(X^<_}T1njXK8vuzR)5qlx2zV`O()}TnY7)R%vbxt=w zyevMO`cm@M@=-}imdxhuX-~RtTkK)EyFPaGkV?NzRVhpz_=MOb@ zZeQ;B+Hm~o>9ukXZL;ppwTg0jU|cjmce5~g;O@L0 z{fg#gu{R3G_Eu<&GD)@niBBvm+x+xh?@RWlHDg54=o0ep`A+X7b?qu2XgKe0yOQR( zsp65v`xlQr4dOc-x7Ik=LYlB}OS9h4JaJ2K*O!!ncK<`PBWgiXzsHWGgmd&j$b zuID71t#0uu?W-&sx}QdG2BR=t>2AqQaw|ht$P81xRF%053dlHnlOw zU6=K?@mS5+n={qQm5+3vuBS@d?)C8N`WQ^$kxuk%za5Q}Y+0r4;+|X5x~fns>6M~s zlWNnZp3nIot?Spn{cx$RA+RYXDEB^L&^ppmK?)y{^z3nvAwkC8)6;#})`WbBve9hi zO6`@K=j=;9t9K!I=Um@;7F!DVkE>|Rb>Rnpv3`zA9%t#UZALp)^a{AoJUzl}F?Xeg z0Qj5v3%dtD3P&{5+Af8oNsld~dp&xKHZ zwYps^ywOw!D7o?6-?ugBtsI6@S4AfAq4Po2T647j!K+ zh`oF3qce@yU5b>oU+2#oUU6Vs-=9xguCHl5YpFr(1K|7Gue($$ z>wd`h8v)-p@aNO^>ucK&<#`0JzdCZXk=$|hzkFMmKkdKSMEh_4=U;r>&-q#5Y^8^I zo``iv|CaFNR2t+8+ctXutL$=j!}jAL19%zi^q_7g-M;=z`B>511QP#D&Tv%q>=R z)Gxl>qS(D<&K0-Z)L4PKmaLgqX4dymG%C+L+B|PyYc%(;)XFnUO^0U<9Ql}-F#E2y z{I1boo)b=s`Tgo6aY-ok%i6ap+s5SPN>Mobsta^7U%W9cs9uu)3y)ULx+mLR3w%-p zj55OxD>=2FdVF*y LMsZxXW)hR-S5)ao1Tc#M*+)nnRDGuza{Yt}C_X3U=X z1FupPE0-9r@<(2!leO(}yQ7B>+uMoI{y{@!RQ20?t1BJWSBcyt{84N8n`T(_`G$vz z19MnAR>^S&wKM-3wpjh>-WgRlGc#W+#+=06zO0vFuywngh*s1S$t_}c+XEE#e?knqOK|dIn<8`+Op0j5SD-shvZTgyGTK*5L0) zv?xtu1F@sA_)%lh$jD>z*uVg_k21ze8nSr?zLgS29j^5ujgG{}dQ$TU8PwsP4#G&A zaSfrTp4w1C_8jPI!jBGuf5w7u2=AyNP~u}*J;vU|2gQ2y50@q3sojxUo)MiLP#XtfYWUv5~mObS<(5rI+gL z+()%8%`uNvkb9*hPiQZxGo~K$pyc_e8dHxSQV{R{!akJK;mIrQKHx+47^%c%4tGZm zEd}hdlPF$GV2vNa!aFr4$+)=dzM1H{7UAI6v@)`bMWdZOZQ?Q{Gb*gafFmP_BI@E{0v86G9K+4!Li<{p>{tW?JTsW^ioP< zseQL`e%2%zkD+)R<%_c0Xxo=~*36Oq4qSGU=Sbrlt=QqZ_eq)5A?ldJyS9&lq@m%L z)}BL2vDEq|>hORuMbO%arBRueAm2S$TkwUfKOybwrTIXGa`wP0d)dLTOps zHn|Vg=X}TtV?DT<`ZhJWOatFNxS<2CPpi-6`w)imI|plH=LQYz>EP?=>vCMl8{3}r zXTE0jhTQs|vG;=on`z$|&ehd9d>v1Ef6>`}j5IWoX6TnMN%e2)a!zLtvhJW}D)b9J zt@h7%a$+X5;_@FK@3JSXSLk-?vrp&HqWTkb?(j(~oz(Rj$b| zYtxs@NV9G^M0k3Dq?Ob`iS7z%8nM4U&|EYYuh1>&aD1ToMsC%d?WlZe62|6x=4I}kwUAmwfAvt8+>1RJ{nmqI#SCUTF@FVJDl$kHD(`F=nekV zD!lMkYanXJ5q$N|#SvrnNrkb8`^y3v7AX{aJ`It}$$wiS>DLe>Hu8&d#H)z0GlxtX zE&BNa8>AJAJfCaxN4#Z~4iy{{A6cs$ZFU6Tcr^6YXwwIQh@p}vJ4Jh9?PARu@l6dU z6p9GNh4t<+)F_|TVpM6tk{%a|on}o_&uCMW-0P;H5^0yKB|Wh{mucS~pgdkn=pJMex$*VBV|we-tcRcxyr0f)@+konQ2%!>&6q1}}HJ zY3Tly?VEhMT_}l-$x*n3M&CDb+9hm7-0!6A?LIdp#}E#S`IvZ`$!fJWCdcNOu++PM zwuzA{Vr!B%XgnERGUwL(G=EbC0X5P2XDHXU9o=}0xOG2qyXzTVuT_V(+!XyRx<>4% zm{LP#N#T9hzS?~m*n=&xTVq@l`-b~c58oTPlq-TQF4rQq%lcTcjB!`=Bw03Yd=+Hb z z2EU=pYYNvb9QL1gHS1;wlSK$i^CH&;e&>I=`r?n5f4usmXj#aJf?!EYk&k)b5%4Cl z6%-@r+wCn5((B1R7IU-7_XtZHcbass-QE(?y@;HR_&T0CL9}o#H?)u?UmxoHkYngU%FC$ThP{!O)K=4+b_Sc{K0ZQTXIvw zzKpTX#F}F8CjF!@ST~g%V|h6gax7+V5nG?!pRcY)ZDu>Shk@iRWn#M!dR^Q+9Sw!dz({&|IqM{5@`SYeVqD*Im zyf%1=dPyAG(LNF-ciRaU^Co>9GS#E|icF;OIz?=^U9QClUXgxa_qp+PiHSV*#SxaA z(E`Vqsv;A-PY(CvG&e@a<%C4of6#o z++JpdCNE8jOiDJXg~i2pbXrlHPdQ12|GJiNaRmI6KVC>wSafp)ZIwedli#hF8UM)4 zv4B^41z%W@nWkBB!K^2ug6lS0Zl0&4XmM=iTT8vrYNhp?b%Y&sMBbjN zyzLex0bF5JK~%_m+ryfBk5wI8a^A1BeA~UZH&>?z>_0}-Zy_4pt4*$3wt6Sa0hZ$| zZh_iY#N|DFL?UsliJmKF=_n+RomwZoJ7ix-LLr@L5{D|7mPtw30<>Z!b?~ zqMux{@M*9F&(h}HYtU0Xq8KMoMnmPj#sgetAImSjVtLCq+sv#x>Z`7n`<=IuZ|2*yZ8R)4W(l@G+X$&ScC(&-fKwyl-!uywCsjzS(($|y#w9PZ0G8% z_%w5bzaUhXJ%T;riaHGw1y`(31fSA9AS!DX#2p+`s4OZdYTj_#AcE}@=OfNp*RP2` z47QXIDzv(Oi8JA%OhUM&RH779VQ9{!oGUpohb{T1wm!!frp3aGvp{I_sTXl{W@QbVj|`Ql4LE*b}#!B*s5Uumg&dZ=}efWP`9bd>30!=9U~N!$5{_=O6swN*U> zz<;GjA@y7E8iW78jo&(t=x!Fvw9od|s{5;S!{~eczMebGq9>2-JmS+DGE-D^NTqQ{ z<9UN%VY_Ud9R2GD^)AFM4J}gQe|w@_hwq_|U|%S+4}1QKeYRD$d+n<1&X*FKn`PbK z#=C$I2G1Sh!3lwM563ow4<>GTq1slOmN0*{*6(kmvo6)zm3isn) z3!>hIzFq0o@cVgng;41bX+DmI7g5RO$#2#yW51E$ZFXN<)sgFAxyqe#)eN&7le|qT zm$)BsS8(@pUl+G<9cE#?{Qtb)QGOi^_qZZRd;76fklua__+S8iQ&`Xk9}J-H3kCY^ zRMABv;$S<{YAu7Y9gT=%9}IGV6fG|Z+Yz91@WFu2b79dr_+UWiY*6U@r9u(-V8+Y; zr$mhUvO{D?;GT!O~%{*&mEk9Gk63$I{QFUa-5bg8^hXl zpB|wlw3}gVi;Q3YKR3@>%NTF}zclCm&DgK0jRdu>BrRjk1Z^TXeV80tO3MYSQNsB3 z|7#bF@%I1o!N$KC`%iNogKF2B-a~x}s~o*VYjQq@RWCAr{r_^Rq}9WC`~UgK@ZXGm z7oQHJev2A(&e?{`fWeJHv+lCE&rKav+9?tJq2F~PPQUg9#8qb+7F>kNsv@2^Ub4b8lM(%^!s zRmk2_7d>D8JIc{}!}dn*4c{BPx71_xr~Kf(I)v3@%C^6(dh*LA0f~&6_kBiA4xHSV z6*4d3>7Na?_s-U5y(oX7cj6YUV6$lBkSzU}btfVEK{!k4=fUdKBuXx+* zt8)&UD`QU;=JT>9aJI0nuo2#2Qe zHOtP+SBz*_>dPOkd~t87Yq{@c--o^qzJ0#@)yg`a3w-(eluHS#IaY*nEj(meCcDus zRm+JroFA7E{DMn^cZ0tIZ=(7g^*3?!LaV~lhL4%|!&R z>31JIeC+Toi8r(ef6(vGWzqSuqFnRc&e<0BqkoncmhVeb*<-G#FU+IctJ-lenhqU04hgNmzidn5Ko+|r;cq3(>;DRIiBZhjcnU%Hi(ham1C>Tqd8 z>6?8aWL-L_F_@sMB5zF8>!0;k#%cM zXv(Kb&!SVIgPk8tDoig*m@OIq2c6-qG;JU#ZJU{XA`TxsZ* zOBvyEeMZQIMiVkGggcL(L9DD-r?BmRs7Z@*2Q3{=OGS7_5E7x$4$Me)=2n*gO6@8 ze{k+W;hVqk?eFVMM|cL)QX|84NrSfY%0q@PI&y@I#Gg#w=wNnB^o`0)i`5!LHmb8g zk({$hi&|PpJJGuyr!F7i8d5`KHCJp2?2QhrFWuR`LLfT+oa&bZQw__7TzLYUniX_B zk8Dc7mlDi=S;ZBsXi1uB%;D5y+rnY2c}hlyRN7wG{b>oy(zrnN-Eo{2D*}kV_I0=t zV#I6_bwgFj(&z^#N4*jRbwx@edutO_szWl%Yz$lrd2)$8OEy`^?@sh(Hoac8TA*6_ zMaepWKIP${bz974-aFUk^zlobm67IH-OIJRlw0<^Gc?GI%FfCz4@r2T$Hz+^m!qwlt8ivCphU(KSpViakNL)JZ0Ar^pkp%l0v=1n$K9ZBE&0xg;_d z^y-Hq@<6Me8Zzsg<(8!>V=V55ABtWk7`sc)YEcF2FSG zvOR7s{{H21Tr>XOj1cC6RgcK0lKj(Mr2G6u;+>rW9?< z#bNDypUjtr4fBmDFI{o(mwmbYvYie#k|Ob*U7wcR5zY+dntGbNVqOc0xyem~J zB>Xf?OFf9AuS|6aL~6mWJ0w>4S9#9P+|b_msazy8>Q@J%=Z)&TPcPSUuT$rVxTU_i zbPJ~{TXQZxMpcZ}=yF=96;alrc5t??R-6%0vN>m8NE)9#sBbqG%e(;Rt zjok-(g3oyLxY=x_cERIn93oWbpg}bOQKG|&DAB1!gK9jYEnx!GkP{tBCz>q*e(+H0 zC|ITg(ob5Zlacxd)fry;E`kWvAT30ZzLOB48q`!M(sv4|sZgZv#)!6r2~a~$-wB8k z9q7Sx(8-2CiKS9)Tc{ocLjxVG05&ivCCI@kOh*pc*>nK|eOlXqLnIy&?+i3G*42Gl zl0dIZjWl89I`~L`|8QL*yVf=_ty} zd%2c|XhVaiQFV}tUql!nNOFL9QK5HqKnTI;=p>U;@e-h=GoI<35ZUk<&kL{Bl7%LH z$0JJLXCq2AMypR2L%J5)h^Df{3;R=)uz}(vAmYKt+@pplazL>V%j%kx7A+0$luK%GFv_Uwsf3*-(Ws@@T*mK&l@C8{13V|ji^2Qqz@2b?EZ1Em3B zJhguBKYus~Mtg!TIHBaD$q}jbXetsaA^{B*Q5$3e2C(%_ctj-$4p9ytgr;JIA3mUQ zVEm0d5O(8$A=_if_NI|+Z<=XdLF1qUh+fHPasy9>Z10D}sEFEO4B6ffDY>VO=Cz+= zpae*{C;A|5d9%jyAsv~61O!#rjUn6nAylJkB2F9G9=-QEZ8Wc7J^`EVnNT=Eo=+el zI`>1>Lqv4$hpM+X(Me{=_NFwlhNzPaKX|J1#+s<3RB*!BG4iD@6jQo2)`dbFSi+&v z?cot67U6eU~vf6XtbM%Fp&Nv)md7R zKEDd2uTW&dU|1;y3@c3t!ypeUO&h@$eJY!wcKo5!I2@wTkX4>IR9SfB_V2M z<7;M>9fE((x1i2nd;3)4mZn$9C2|{Pk~aCrhzGZi)_aL}f6Ogc->)KUQ9l?B3_WHy zE4tdzoGI2yZMe}O1S}RF0%r=PMD{Pat|?n-Ru0-55sbyh9AAcLGiuJVcJ>BD!V7$J7gzY%c=iko~}Kg|EWT!8D_41Fya4JA-w$)nl;5{UCB7kxcy+hMRjI#Fi0J(wR3eZZ z;VSA73_LLCek-Tzb=2-I2F4-&s$VQ}_orwka&XZMN|t{$D3M6{f*F*Qy-dKiLLrq; zJ{#!1E=O9P>*eU}Y*CT7SW!KcKii@q%Qqq7L9l-5^DbH7w82v9-`hy@ThTpfpjNmW z7>67Kek%ccg)4mfOo1&5FethH)u2Scu^JeZxVh5vyIBdNuRqazT`JV8FCV*nOqC}= zkeMh;9b6G0C$(vF*wRw9cT%3_z-ePEFp#19t;`GDx%P<~Fb-J{{8knn&yz_pvRp_r zC|NRTQ1UkSE@n`oH9pO<;vz21fadFRC4ozqS$91c4I`eiZ^Ge-A+rVJj+AcOugaC* z0c>hyRDgjD-ESq!W-b37U)83BJYt`?>7BiT75>aLgOc-K4N4-b9592D=1=8V9?4GZ z-X2c(brEwobj#!xzXS2-p}I0p{u@x+(tKTx$62XwR(}Xa(88EXqY3W8O1x2*uc*$q z;6K4l5(73hD}aFv-EU=9{*4O;{J?c*X;?+sxre6FdqpJ9(cFFfCf$83O)D{XpLn4A z2XYa;;1{fhbYGW$aqzg>5U}XMG}2h~WYWf+p`jYv3Q?dMYXBlZH75K=fog0k#HboJ zs=-Mo3RGiTA&M}J;pqhk; zt1%}w6sX1|T?i5#V??ONoY+uo37C)+!ImI`XiI<|JgG(>$RN`pjqeH3v~g#6={sg7 zg#guLM5xA8DJW2lNxBfA+8Pn6F()<@TLPj)2a|N6*b<-zkAX;gEGT~Qgl0XNv00ix(ZMLMY9hAK)K%QMBZIQpr@v{@d54ece=9;&hC7^x%4e<#)z z)#L~V)<|$_1*$aWUAKy!!_x#;P@0uvNI^kDMbr!zinX9ta9;nja2=whqk?2f^+G zKYT#rp#B?qU=MBF8BW5>knJ&Kd(%v|H_bG!U-HIWfarBX;RHE1V954B=!h})>_UR%bWy^$)3bq&(mEr_ZQHn}O zHEm>j^x6Drqj?4M2^bkr$KeJ$Ge8wRh)8FGLt$qisG^jyJpbI^ZKd9`5L8WEWf<)J zSTCsv?_>1`aqh2InH)xpRrWC_{~9fpqtKJOVD$MqzpB;xdBhQwp?$eTiV8Jk);Y^9 z`YH982Szne^Z-?HdGNac7P<$H5FKgI1SjgV0hU~biAHJ zvkqy!+!DcgnN!tUJVeN%5m!R=o-Lwos47_+{lIqA3s|85Yl_}ln%73zNrU}`(ZHg_ z9$1txrD!Lf(=gplvqDk)YK6is+y1P!jxvO&Qh{7xgp!s@JX>z{AU%}`E_{dbOauAt zG}YD0hg>|EXszpDzFtZBvvL(7qOYE+7}Z%|y_~a2i&|PpJMm&Y4)|>VR}bR&ZCYpR zOV!#}1A_{-unMtr0j7$Ui*M8XHr9Rh+qhk2gZXWgRMT{X+mA`gVBUvyS%C>L38xZ5 z^iI=c`r~&c|PN742Jmwd?e)LWdZdOVQ(+?zU1a=#Wu3_W; zW1N9Ig`b20a~DnZ{Us|T{Mb`e6a6r|jr->&?KTok^D(;(k`qlw$ed99`6PBd_H5ZW z*Eps)C7qQTM71kJ`C=BeS@U)Glm^%f-r=Sm1ZF7yy#gL|r+0DgaD7`r;E59rJaM*K zE)g~j+sjTfLs>LwhO#d&5Hmxew$gNjoI2@$)?%x~>ZsnQ&a56l+;&CfqIge`d1 zLDi-=Vw*Q^4xMMQYIo@?e2nURR-?;lp;km$i%)~Ifx!>35o#W{x2jEj5Go5Cahh|9 zeG5#l?_Cs`dy8i9<5`q*^u@FkQv}WtMQmh zo01RB=ILJ?JSU%~;<4z#3JMTCZ8Y}-I8=?H8Z-DofoepF8>SRMfoja)ho0p?MRhD9 zRAWj36kEbLs6h@2bxXjM0w}fw=)ogp^uZYH3D}`3wkPz{+z;S!HD>UG0M*8bP>m@C zP@oz!_(729h#*2WrW8Q1B}{-Cb}f%71yF1W(1V8?+}Q>)9rAeejL_T<;FP3T0)iR* zAV9S>B2;5a0Tif4l;~gvKPXU*DFqO02@{}(oxWpA0Tf#T^xz2ucea7z7duqNGMzEn z5Cfbx7)U@cr2vYe6jKVIKsBZmK!9pIqC^KX_(6bbno^gg#wpWgd3^jw2EMu98QW3YY4D7EE**$6%hu~5iAa99He}e z2OcHRZfAs}6K2TvepH#xknJ%vuP8LHpicPkRUY_&M7y04ijo^UxnRilehAeJ+1?bV zZs=7UblD!59l?~`h)zi02M?G}Xah~rafK7?9wI}w_d}>=$o8f@5`}g8q09E@lZ(cP zI*8DN2h1mszL5vQo=;%N_I?P}4B6h4$1uMEHSGC>X`^`s^9lHG)2tH3dTh4AqE=(uo7+|F5z=n(N4U zA??MAkM$x*g|Du1edd$-CG_Y3Dfk{|!94qp1+tA@%Le`TEg*)>7L1D_0%L_M(w-*A z4j?90Kq6 zn@dCU%A*smB%Cb|mC@01?F^b}(U9evAlMA-D2@agU)~?_PDQr)Bh5KP_oRVZVKs0L z(F4vQ$5NCM*}vqv(i}>ZzB-ibYfS?VB?I900!&T%%?-kv9L#SWxwY~kF|a(0ceH*B zr^`vx7FEo|Bch%oPCrhfR8xk&cP!x!*RhoZ#uOKUF~$DGMaT1GQjBO0CE8ydN|vU# zKl`T(;`G(4BW^_;Q(2$D*GHU9l?qnkjk@d_3akh$8V9`-E+zy#2xFn!dCbbcap8jo zu=C&-xD&thc<%lb%|s5G0mhO^1B{5gyRyJqkp!$2J+UD=aJ|I1ffBUm`Kt}Ca9q3k z8}-e^OXVT1rCtPX6+Tu?b$M0b=OS)5nqB^)TA}jaae_} z|7O!Wdj%`}G2aj|ze(SaSEiMiZwPjI{aHD-hJs%yTkur8N{AkQ}*fsw!lMNNIb*7}Nb4^5-@iqMQh)=V0Qi2561#vw7| zRr1$MM%Zg;S$k#Ekzv;4H^!K!5X4P-!RaWdJorC6^>Z~HM-o&-Vp!TeL= z-5+zy!+L>dj99*i`W^KX#AthZd9+q)!;J>FwLM@U|j!dfw9i9 z8dzYs0lWXddPqY+HL!Kj`U>iCYel~VS>4UL%nAGs#F*ZXxY?xzUTnHrrNA_%h?}(W zq3FX9$I`5QA!&Rb@gGw!gr);Wj|AZ8QEnQrSGdBrkLI~^{;TKC{VE5{a|c{GgiVH` zAOq;Z1FRLvSoDmO=(x2aG*ti91{WHt$%s(>R~uY-sK$odzTN}`4b@nci~`kv^^k_Q zB_PTSu*uMG?$P@91`n`S#BOoKk4F#vf@f%`{+kUhG*n}A87NTwR~uYtsK$odP~^K< zm5c(_fAx@twk1q}dfaUnTB3tZhSKlB1?4i!zc_d{a12xerQ*v3x?du8v7Wt+Dz)n% zoYXr1@3+*#;e(RD-@6P4aNk{s3~hDYEUcU5hWm)@DfD=G68D()huxKgYT~;{r3hB=pW*-Rtt6=S1!N7)_F`_7CEYA;}CQP5@akZf;fFXv7zBv7IXE>ESIE5i2f;FlJFQUFU z0nu>+V|jk)BzyWS54h^R2`DEf8t_dt|5RvoDb0BY!6_LY5$m98z#}@hU@Xs%2|=dK z^4#SZAb+FRf-N=p>-~N3SZBNq0y~8#Az~d&Mu?(6!C0Oj(os#DoByaQ&e&T;ZX-j4JHak$igGqMGFWD1%{mNhlKX1x-ASX z>eS{2#ue7kn@6BdC;`nqL|p@hoNkI-O`p0!)dZO~ayt6lzyzqnX_qGMg`(Dy2Mu^c zO#}GB6Yf7ULZD!`HhT~Z4Ro+0MsRsExV0IIeqy8^jnJ(Ljo1;9(2Wp_K!FBq8ST@Z<=vR zh<&}LUR7%(e2ZxI2YO$&Zf>VXhVpS2*+t@($ z;_MQ2LzO+H0S|0OqZ4M+92Xkto-0xt0va@dYs7xw8j(@8Lc&kO^#1?H#wqpwRsj2SL-d^iGB2yj_HWw+jbXu2PDs8yI18hJlh6a;B;=a1)pAK>?h%@k z(5>(p+^IUi}+mKJJ7 z45;r=m#3Qw(R1)@8;jLWi^Gb`{8Ya*=P{*dTP}{I889V$^+JiPvcbGi#_ttiM?eP9 zgGUOK6j=0NB?X8cy0;=cRAVIt0#wH$LNzv_g96o9Nr3>>w2}e=s<8gWh_tRkJJg%W_d6V zcC1do=JgQN37Ad|!KOef{1Ma%w6Q=0n*t{CL_luFh%zdy&4ePO8V5D(I)T>yLBQ3} zg9p?JWRMz=5Y-8oP7ML7$%s&m&4!{tHKtQTP$yU;%0RH$P!wANqQs3R@_d0?P2j~}Z{tMmBB@*%bQ$L~X)M?+lQrzNa#nw69c+FiKx);R5=VkoWgk&^a0 z@DK@fdc#}>;k2xS=ob~!Q>v#?b&!tZV(C|J)7i~gIu8;CsO@y|C2S15qdQH~^7p)# zYkA=ul8qsPnmO%GZ2B1)O-c&ks5IYyq!JvDOjL`oGXq4$FRGpas%jBYkxkQbAgJOP z%aid#0uAWV1L_2}YM!w?KXjfjZI%a|Cs12~ zvSqyf9lz}zLJ~5~^jZu#-T!Ji9bI<9bn%?1qF9z(YGshkzj!3A{L z-gMKvI@=I1(d)Rv>7B8`Yl2)Al#UxFMrFwMen^?lknR1Dk{h~gk6tduB09^49z0l` zfRO>_mIpe?urq^cqt_ZwL_eXCPB7GtKh|_(EYB489#AK|19ifFnvb`TdHAA-dLud2QWqb5F=4qpOl`{B1qBH^5#IgkHK+~5N zKlYSH!U-q0JWAO8I}I|0eWBw90tXt>Z|}W$-@MQ;_pYgAibkeQ_=oMbS}EaG2O9I1 zu6#6it*B@Kzt-7D%ofZiaHU)ce`C{Q2vp->cmXGZ1+~AHGjf%uM&&E$w#cgJP?YBis81E~i5I z)dNf1d@~LkSuQe-3|_@owzu2t===%sXCF&VVUou zJx6$$ETQxVoP?|*>qO_XE9og+P%2l_ue};ruR$GiDf1sN zPM)VvY8#2;uzuD_UYgG4$m1w)`FlX}T*v25BFW3C8KzEN>yu?I^CWqzn8LGGS{y-(hr6jN+Ep&UE0QQ~F z4$2n$Z#$=^;?1Xf{Oz3G+xK5}RS|6U_By#lbKCAkheP(=+;~m&n)o$|d-GTwxUGlr zv630ip-i_A_Px)vcI{fnOg)hzYf@=anZr~yC-R`V`@pY}U1VWL$*Nz|bM)QoPgS#} zGxwivlMRrSw7d3 zIw&yf3HZSJG(>oOX~1JaSsFrS$jB*4TkqY;!zaj+Jk||<)JIj($zPJcn9Q_1qme9@ z>2|7Uu!B9F%kosUiEw7uvv%KVCbuldC=Tz17lY?1$5q^0bnEPcZGFL-Rr6=pu8BHx zYt@TY_jj4>IK0DR#|blb-WI8v-V#Y$e5cagaRR6hFzA9p07FXcvug_2^|M+YdywtH z+oQZUb;`b*bJvGCd67g`@nHKbiF(qWR;%P$jy`t=pU+GebmVHC_1?y4$u_-hLfjGi zUnjeyNrnl_nGS_7vJ(*l6!Trl>G>q$190Rkm$ z^Pn)mw`le#>r%QqXzgD;H=QM&SK^sc)o-%(=^Rz(ssGQ^?9MkZ)4E|EooHmh+xyoB z4WNJ~@X}(@P(U3L3eZAB0lsJ`0Du?)1qh;{fLtULFo|Zk6u^dt0$>LXpnyt10mf)3 zpcV-Qh@hbWZzL2zLX!n>prL?lBor`-X1EkE9}NY-4jMoK1Aqd^Xea=rvIq(RYcv!P zfQAClWC4n$7fEN-9AfU+tSkX{G z77_}WL^E6pn2m%2pa%`0fDS+bBs3HNyQ~S690Tn@V>A@tkA?!!WC0>*C?F3B1x%tD zE(LI)p#a!H11KOC^qr{_`*Wp+NGl#%6CDw6qSMIusC5^0nfB20Uj%;ryAPr9KJXYAgXn1n5UfotAcAj2Pf$w&hJzw`jKhS4;Tl#TxXW z0TeI_UfQJS2`U9>p-G?^627Ucco`DDsf`O@(swld8t6d-C}0>+z@+F2Dg}t3p#X-2 zZ|W4lknl~N0wx-1aN8)*g9cCl1yI1G=m{zXSfil;hJ3K#J0(DSY4DXrNX(z)Qbdc>btJyBCEnp7b3o$sr>Fvb5p< zLu5f7rv^VKuGamNh8e*5fuqXLsieyA;GQbxN3}SoR$$CwB2vXgrdwHP#Z`2#1|}0{ z{%SIzKWQ={08A$2nnz@9NjA#ZJY~|!U^&(Bpm2@+A*WM@CX!WW2_I724i22jIB4xocg#=#!~bEx%VN=Ay)5=k zdRatbUKYfTj)Jl0Jhb8el#Z}KS=+pHX2RFE7)d#sKHu>$q0HptPMpp*Sm}3z5vSyW5=_|?ngJat1ddq+%4`m?*qT$VZb_A2>gw``+i$xOQYL#+Cp zPpZH$Va{I-6A~v46ErZxgwg@022Zf;U{H=yHK3Z$^Q5ktDShdrlL7ECnf0iyTFjB7 zirvxc#9%&8I`A2(n&1C?fNuX1mhez+?(XfJf3r;4J!zRT7g(lf4O0R?Sc7E;jv2TS zg=X;fp1wa=X*y|{B1TDnrvKFKdHb*F*;dKS)YL-*&)Vm@Wz`JQ-5=b6nTa6qvf=xy zm(9Ju1Wk@A^*(rMvnO7fCZ;EZ^)xuxPeZ2wFC-K|IEjP;SkX{G77_};qoIIFG()8T z%10y=06k~`1*8KC;6OqF#%L(O9}NYd$pS>sP(U6M3Lv4OfJrpNrGPpl6aYPFI>IPD z)VB75F>+29F&yaPg4(oPEg&TVL1U^S9W?bF$ZLDM0}X~?q|akb6k@m&O??MaL01>$ zyY4VDPRemY=}TFf`VN#F8Bh84Wd8gltzMOCj^@WWq4_anG;8CA=4tNZn?Lc;l#!r< zGO7s?Cc`MysMWM!v7i?nSOh_+ZBCXFT0uehYm6`||3h+ik0VFh800$Zhm_RdJ3NS`P z0nmfyWGVG6I8B@Eq(VIxz@vF-h+64rjvuIK${NPfO#N_px-5-P7^MT8L6Rn-)1eex zK>(rYKs!*SplLr7(4@7{JGS(bPDEX9#?nmXNPT)OO;j%xs|8pmvUI4402NKfNtj?X zxJnc}nqmNlCV!qp0Mu?R#Ro}gL(M^Q*hxiGbwUpt7QwNBZ`DXLn4plMtz&5G7}~nO z+!Oa#ZQZmIqyh>k0Th6n*wdg=00B)NfT$tB(AG^^UOQd1b<;|a3Mc^U2Tazsa47&y zq0Z3OO)J(16BpY5{yd zO;CsZ6fiRaRCb@BjHbkn&_r9nbPyY}07|ZIDDw|VXk?GEXnqVC&5t3VS(^?tPg8?8VPD!kfE)c`sg4-TQ~K@W)jU%Tb$EHkP0Z^37~*UH4;<`U})>6 zP5}&U-P9>y63uWa08MQJJ!k+0JOmUlsYZfI0Ss;3)G2_Wt(!UpOrjYs1)w<^gdQ}2 z0?dI^#sBnNfNEY=9CBHa^Mt=<^BZI1<1sVXuZ8XM`t22Ag~;9Oz}aJ;%?$JSaILEI zgr~`FhaNxEuR8m^(}aH2T({a4+}^iVy;v1C=`^u)!f68c_w)Vs^T3~D_7{_xmS+q* z$-5{GO$+KJMMs@{pI9j(Zt(y0~^LwX>d9o%V+-I)u+P!0++2RSOiC2?O6W^ta z(J8>6-$#teiOk~Z?BU}Zuzb8 zSD$p6*f;4k@tx354D;tm^kGh3%I(M&N z^@Kf3g!hC!%Xc-F>>=RKk>y%7gUf_tbYNa&XFGGcZ0j#>*+)j}y{oy>XFbZ6_}-r7 zLAGYq{Mof@^w_nRMx2?)C&Z`5cZ~1;q&>@b^GoKKsm)$iu7iB7r>RCJY&97sPCoJn z|Ca|1kQ3SgrkKo1qkFR{IiRBlR{L;TOXaEHq2NW=wl|rQeV>A@-UAhQ|0=`QZp-{kg=^`8o_-=j) z3I&kRWC4?ChD!n8%`ZWr0O&yjD8TJoXFI4AKt@9W-&xMVp@8o!=b%u4HJU=;JD)~4 z6o4iRko>y@8%`GRolhea3V$g;DBwF;92^Qj(+l`c z76+#g_)ZoFhXT-K0h4HkO99_aV?v<-=s`mk9LuM^uMQa@`P8do_ZQ>d$M%*&>If44 zNlN(h-y0R!CIY9y2Xtp}U_bZ*2qS+!q^a#le#}4WFMs|^`$zrd&(CZANq_nCQvon1 z_r2}p&p&6tgt7cscaeA zx~WsZbP=R#4tD?wAfurGhPH0%6oBSbouRFpIt5G@L8|6(ET8~95(;2w>!v*| z@@N>Yum;Up+9aAM%%|b>0uUVyLmy7n93}$_AfcfEG`)by^9{K2S~Lye?=DpM`I;J! zZ*!}f(?pQ!9@`sBwRTc&r}730W?R+D#-s|4@MX_8)Fph45n@ zBM??~5s~P(z>ldy^3n)sWRD~?T2b;pSsVWR*opJqh&M!Tgs=2-CbaGn+qgJ?Xae z`sTNZ?5tk?=ws`wbm3N}^c;Qn`cu_stJ(TbXLJ#?=V;GO=nPMIC^vWacFwD=D&P89 zC{FlU(0+^+I6>rkf^+7hpSd`cfoqG*|DwY^(@~r}%Uq<&&_uF|=TRLOYpX2`CL!xAUuur zFeTsv>(db7M9iQxvl%>A)QRM8q(p3)vN=nmG7dU~cI0x@s+!;boT|8T2R|{}IIg1m|FHM|aZ#0d|NoYu0*j;s ztPzsZinl*vzgfU7+T3fY(XODo{zy$2wDdMn%&h^PY*Il?1#_wG+XI!4X5Qw{!4mQw z$B`k$YRkt`=1~|X#O^-WIDjETAalO&bIx^+;LM^&&-?n`&7Q}jKm4onV6N+WUhf~T z>-BzQTF|1L%Y(bRbA(Cm9K*q#<5)vS{Bljx#Dhj&BE7pl|M{0oyLQ7Sw>f`3XIbkS zTc~cWEq%oC<`YXRoc{Xq+BVCuoIN?y+P?T^_V%2;gY&11+tt;bV~FU^F^hBOh+oA{ zboQw|9mg;Sp320V0i=a?nAbL`{XId(VNVODm;QS0#MI!hXh3gVZaJm1@N;|#~unMP-n zpAXc{WP)^g2ii{cG6k7p9De$GcIW*&2mGln_Rot~4A{Hw@$uK*>S}4TQL?lN1xuUS zmae;b)z{4v4<=M=yNG>ee^US;yuuprf@_6PL`1O9dhh`~s5F?Hj(?P&R zDhNoSgMc^bAOJQo1q8&+%pSqdG*h@)wA5Ku=20kL!tkV^#t z7CKQtI2{C7sUSew&A12%q=NwTL$ee*h!IEabPxccEQLfMlMVv%=^%hk6cA4b0jH=S zK-$f?2#BDA0Q5t%6gr3zM>SLs;HFaxh@yjlwNwybpc4fI(?LKv6$D7T85aS4s2~9U z&@6=xV#HAk9R#4KHGDZRjSd1f(m?>7C?J*&0!~svfV7)&5fDxX0qBQjX}bpM&a8Mp zpPL-((4ZC3DRGm|T|?=9rWDhtOC!IH;wwwD>}$3RIvg7D>ilnRhB;P?i>;t?4Y24X z6h7Qw=>+KpF+{_?)TAAN+e?k26K@35xuWx^go60Trl!RJU3<3}r5!3tWejNDR7xQy zoiLq6kJ5P7P>O8TrI976@u{V8O=de-9Z-PXTt8WG9<+1LgDBdKC>n~VOprTFjpT+M%e1%|Aq^PGG4yP21s6(k}nf1Y@7EQS&V9OA$JB7XS?f)vU8TJ+5A7>Xyb zo#P~ERf2kl)1{rk5DBq1JGUT<1eF-KN+`M-_B@@>l+pRoOcXv-x0_|UsNT}z%|><^ z#<@}DX#d)BH2(TjHJtK`59k_BKtK&3KvccqB0!a+$ycQMiX4qcfU4n?j{x*T0|>YP z2oP0oxCl_?Xz~%@D{?d*0jh>mJ_67W4IrQv5Fo1Fa1o%&(c~k*SLA3s0#psBd<38$ z8bH8#K!B)v!$p89N0W~LO1*ngBjQ4R&q=ANF79UB_nee8BIt((5MToYi0w371W;-~ ziH%O&*Qu16cD^D<YHTf5q`n|Xk|}YM(p^L8 zepY3V@@*aDE{%KhFE2`tQRpsPFsxER3H}d--tA11L_3qm0>L#Ur5z^8MAZ-j5M0kN zbtJF+!5gY=;Bmn;rP#Y`&L1V$oLQV}PL(U`lCOAe0s>5c0Lf?#6#?i#t534qA^k}t z9zZdXS(i4T%rAvGUz9EZN@I~!+d%mU@DZ=g#zJ=^wK2v~bUfqEbSA|%5-}m~?DzB1 zt}bn+?<_N!oUBa7mLAN6#MMW|I%=6w#?VrEBR)V(NM%&6p3bOTN)vhQbbho(I-jBR zqfr`T%)s@znp~f0F(4*v!ZQJ)Z}MqEd1Uzv`@=Y#4kIvq>? zTnt~Cj>RKD9VsUt0qBPY5O4tykV^#t>U1pm2=JBZSUdt^=~RWq-E2oK3Hi!MIY2-y zARwO#0@UeP@)6)G)3JC2WYR%^xSNp?;3FgD00CTUP?}q{jgt{zrO%Xxa8c?&O6}B? zF;L@Z?Dilx(5=s%ob6g?i)?*kT>5Btv(=ezyLV1{g#79=ou-|-H2=Cw(=Vpe0F5rT zg4ECs6@t|W+UR!;oogV9PTes$i;SVbg+Lw&(Qq#{X$Lf-R#90xQ>-EBqmD6-*9B(eE@?~U z=TW`peIVIm{^CHg1>8U~UW}yb5#^s6I;o9@&IL^=9aP5{%aJjA& z`6Bt^&C-P2>c#oTa$`zjqQ)|hn-6tEqk34!6|&4DO7VVbI~lb_p&N>SYEqlQksP8Foe=|cko{sIV))JUiZD5iq|Ra++? z0iseA83A;<>e6n;)uew)MU#$xXaE6=0RfVP4;2AvbP%9w>*OOq)z-vjX-tqf<=bzgT9o@F#-j@5f3D_0JC-(eFD)%T?iNzVMdWeBPB*8F}>Lt!f6Nm;=Um$J#qJ0m+225kx1ql*I(< zMmT~xzSB?bJJtWgrq8~ay*+2|;QT4$c7^J!sR?~2?by5i@aadU{buUGsSk=35bntj zsZkfLy1kfWjV(Z5@ud6}BqhoPw-?8iY0Ip&#$Y+3wPjTXN8{;E;XR)D{JA6;V0f(C z=#59)8bjmiY!SLFrdMmumu;1SCO=bX>$+8P@{-EJ;~-lk$voa)!*8_Lg`P_-)F{COM`7e*(R>gg3 z`O;i-dX)TYT-?pLq=^zPzW9#YYg7HNJv4v-Cm=vbf3Oiil6h%807>StqX6_n0|;mY1f1e4AlL{X$vid!ApB1c-H(j`@=y*N z0YWm5jsQAQ04YsjBS75ExCkH>Fl+>%ADU%VELRH zAc&T+5n!Mb1&}wa*a#4JGcE!&bP@sdL({Q~{n_p;s9{%ur83N~HJ=B&w$`ZHZc}o@ zue$<@nw&wVM8`dP>w@d`xwbp0Z?cO;|2%F-bCNPU%4Z~-KHSepj&r!5$)fY4m1sC+ zAHM@!yl3OB9!%d+v5u|bT_9nCF-PdzQIp<5i8~vTTT!&ir8c*tCcUFNsznm5a-qQO z2qW*P$)S;ik#OI%TrGJ1mL{5aP~uK*PvgvV#U%R2UExR+;GBWclN+G{MJFMoltfc1 zJg7?}zc=VBO9S};=Qkwg9k*vZdIzlG?Pe$?QIrx-I?1|$PJu&R8u<-XUs)QE5}ko5 zAyR>Q&oC6r{OedIOzgjZ%V3sVIP+6AHnTx-|0DJHE0sTU!j==@bQAxFR9q&VgMQ z5?=pe*V2eP2X_6@LZ|$sE{%Mdn6E4iI1k>KLa_3q+cO=zQ+1`P6H~>NBlfR3i``IB z#g%fzm4JX7QwXpTpz6frBLH0|Cg`hGaix5HH62+6`k?^?+?YaujQ~|ACLaNG>h-US zeIeW@7L*FrTV6Uj#Rl!LGox3V-J&fdz zlvSL7>*Y!PW|UuswgC4p95tF*({M8K-=Fi_$LY7=Unmcup`W@7o^@*l%^Updma|;% zNK(Ps=hbXkJKf035o@;Ga!Sk{EsUl$#{5ZipMBbEAmoOB-O_>nj#|S8Cza*DP~38{ z;31*x$o&gP^-5=xff^M$T*iPIoZ=Dwg|H^cTzxM^Cl-wnio0q?NMVsNc*n?ix<2#a>KT#pO_ZUu0GaQu;$*seHfZ_ z`g~KP@F_F2iC_T`zo*h>{<2C&$=e;KDQezPNa;0;%Eu?jg z`DNbO{lSOcoAE{Ro(HP}&py?=ZrIkGkCye{yJ6VI{o`}{ztjJN{ztYEQ~$W~1QwDO^IIX z$}wv*w}$85|IS;zC+$9aIArg-mhso#0>cv?kbP6qpMLS_MNcnzAtdb8 zx8ql_6P;1Vw(Q%#`bbpA@rLZ^nX9VjXPsDjVrkA~nTQ`I41W5zyUMpLI^qDE5%ZLBFWg^XO-cw1=WRxYi#8+Yb0$Q7KiO{C z($OdL((uLFE0xDH$JCylZf|8GjS?Z>8=T^jP0Xb&qV#-8g0X)3aU(9lmMLreXPe z@-wVE3$E^Nw1b%mm5mk!>prX3V(=&ax_RQk_R>n{8@4xWeT%fCGge17TVj|EnP-@} z+L=sHX`RN&j5F%3smA!PcxR5a(OebSe+ z8JQv3j0_!ld01wD#5ytdq^=l5a zwQjQc>2ht_2zPyft(Pgr;is=ZHY{gP&f^J>9r)X}DNpPQ-<$Vq>(m7Qg>^%wg-#8d zl^YN}Jo?$_m!gY|d)`0R&~-QClBN$F{BKWO*u2XA3jBJ%+(T2-Qq28ma8`Ic<09Zw zDhMd1gMbh^2)IZE0V#A4@FpDuh`SjV0WowCfPQFdTG9Xk7CKRYl?npV=pZ1F4g%_^ zARv|w0&=M!K-$f?2neTx0Q5ss(_-fkAaWBo3OGdt0d_hFh@gW2NSY}m0-1CWkWU8z z;%>%8Ks+4;pdXr=77ZXks?*>ifKJg#Lk9trszG#W0hB6eYpEbW+ReBK2&RJo^g~nA zV&M=VauXK;C#ggM7CHzBrxFFY>C^(!=tKb<=^#Md&A14NrGo(ULsJ893ZW?^e&Ul#ORuP@jk49&sv2+e6C7`KGBfpK}D@${6H=7B)RD*bRzWViuj$pJVXC9SnfUTes zZm@Jpb*xyc#l6&|9e~?Q)zFDIqUc=F!E{1F>|;~kv77yg)j=%4Zoazv9M|f+lDTpT zTZhtw)^rr5TDI&vAV@c^MI3EM`ON0d$%pKx&kB9pmiGMTJ28YPoj7{C08&{8+Q9zD~5p?6`;mIhdm3xY<7TO|vILIkAi+=46-)DGM# zq1-sEGm~48QbCFYt8^Jfhd}Ey)f9fTm%nDuchx*CUHKvs1we|T5rYogD~D3WhEA1> zrBfMHmqxxA$yb(ULy>zvqy&=a$=33@y8=rq8byZzs)SFz@Ku%Y{mbfJ0Revj1W2MM zR0I^$L4YdZlaByZ!Y3aA=n_8ujRpFl0R$`t1W2MMR0O2aL4YdZlaByZ!Y3aA=n_62 z0qBPY5TFMHNTMfH1lZ{yK$Y;xM}R8flaBy&2_KID^g{y(SO^G^N@%DE(9l7ED&dol z06N7@Rl+C#u{HXk0R&_L0wj?LDgrEY5THu<+8TZfpg~AC^>V44!R5@E5VP3jH&@&hAJ@K?e2RsxvlZnbDErf zCh+AjRm`|v4<;j~Ag~!}Hgk{vr?tKC(x?i{ zPrWd9MX*?NGhW7*#?@IyXOx@59pGi+=r^Z%Gq`^^;yC{g7w4Gqr@F!qkBkMAi3fMA zd}f3r$Gq(R0^Vd|f@Crg5d7*x{O~Peu@(ikSD!@B>~4EC^m^91QQ59FHn8QerH^no zpK!iu>kaM?JT5L}p#ukQL$hiaEl(Y8(`IVj`2n zer5D)Of{Oo|0OZwqy`*QN~*QsnbNb@a+qW?F?{SdFDEqcgGvO0YB%F$P>F(njW9t3 z@vj-%z>Q!OoTCje9}^rmo0qP&4K#(B`h8o`o9SEBWFJ`ioh?uYCL_AM18tSyWTA`T zye#ybInReppM5iXI~dL6PZ_r>RA)_1=sSrwni(P*&CJTp8&eRo$}q`EMtfi*Ko}u| zjQ}!p0~-P0-4+1OXV?f3cQY;m(u5J#*a*NrG|j833~q}p@+hkpCKz{?bSA}K(V#Gm zm8Rr!JKA%Cu|jv}jVZa@JrLV?`W=+(=Ejs<4mR&*UHTk>&|@2JOv&ZW=NE~~zc&Tx z7CL4-#yl4sp^a855-@->;j!qMv;Fp=eukAs3#0yMEI1&pm~`;tfElQtq4cA1-jp!z z`@ovB9Bw=YB`XuyB)4ydXfO)m88GzJw0dzTR4z<=olck*Oo!3JR2=NUMzd_vLGY)< z4s6IMDeS=JMC4KH@aM1t8)-M=<~F^k1UC4GCb|6#AfT8I0_cQkDRdChV<-&P|g&|?~MJ8v3Sqeu^u@7l2yR3bqZJ$T~V!z`Urok0xIa4$7!2jDil zqd*n_1FNv(jbJKQv^$SVD2RV-wu0>#%q$c8&|XFtDyR{m)KtgrslF^A4ZT*wv&KRP z0_xJpR|)yb(sUbN+CD!m#%yG}58+c#SVJZ;VqXJvvH=a9!$~Pj7t=vpVGX7D8C_c^ zsL|*|g6M|^5MTpAqIh%SB7o9eBgQni@>)ulfU2#NFRvAMGn%~Crv$04B=#DsgIu7o zF1zXvoQ@L|V;|!L0-cp^PEhx(pcdtnT(6atJ2%bUIJeJ_>Af;?6v{c=e=%@^x(|fT zJtu!VUaieKb@1fDwbzXI#90**KeIuk{r{YC?mBivq-k8ZH7b~N7X^rF zBwPfj+B*3NP_=dP5g_hnTm<-vAT^pWLwR zzh52mmp)V0Cyx)h{6Ctv!Yxnz>gXS5WSsc9>I>e`B4Wo&&y1KB+`v0PSd;b)-#PNJ zK+&8bOfYAt-O?eXB`c3~CRIiry=V(Fh3F!6<1*gJH~Q;N8DfnC8&gX-3y?k;<(ln` z*{H90(inSVKfV|}Eof2h<-yyG;r*;r6a1%7czePE$(&&bm@|xRs7_q25yZZSN;QJh z#Jnu)!HR= zpNY4#xG%BZ63%SOI>c}mAiYYzi%M~%GUoIsCj5q>#o_*Y*L@6*Cdo`-pSodNb2vwn zk0eKv{=B2f73l%n%xYrKQj(Z{F8v&D0HIxY-F0tKvoq8L79jc)Vb|;5v;~^t9lbg( z-mrj(14ok?;AkS)rWEpyCSjtZ$wh ziA~jxt~Jlg0t=8}W{qKNi9X%6Zk0Bz3&bbxd9W(r>{DZS+mvMk_HG!q@$ZtO$pqff zq)bY(QVoVj^(`Ip~owl&)WGftUiI=}+NanGEl%`v)IN3Ai~vGIlr%=y04 zpPCJhCNYlOwaXqz<{eFDNscCcc}J7hf*O*R?7Je^vy?L1j6WKMTDx(yTfh3tY}W=G zm}ZRA2D+O+b>`Y4T34^?;sSHaLsOB&9)TZ?Jd$|HRG7*bvdfVE8WLgQ{Wajv0tgV& z5^MyJCqLK-AWwd<5g?=`*a%1ygcsNd5O*^&0)(^#8v*Et1`uEd1dvA($Os@27B&Ke zv;-XibfN(AAiu;$0Fhr}BS75E$OsTxl-LMBKQx_5tczXZJl$!pXx{ZMJo-9Y zDo6=23PMrUqInunK#&q*R2?*QKEuK}+dcY)+K zn&5JHyc(g7+UaT)MXOK~6l9(VrAPNdJrS*P_YLoEseHAr9xmx|M6}8w`d!Z5Qu(Sd zJS$+JjwXowRvxh>#X7)w6k%;vL5-U@+hN~pg8B~oUW=lW-4bUz>>4+n&^DM(FevV3 zaUsT?2Av^FNi=#6CA1$X<(+hLb#-av_XgcQvNZi- zIt|e4CT<4i3(j5Ptx>g05Q3-UfEo>*Yk>G!V22yT&jR^|CVm#!6%J_!;0gqY4GeZ3 z&CVrRqcS%5=64OIO3vDWy;Jk5C^oU?V4hTpSqZ(WU_=vPh)g#`iBw5uX%9kXg9~!VA2L#yZ zAizhYRRRK3J)-%oNAV5O}0lp%w5)h#35#=L*P9a^|&A1PfDD{QV zo3_dAc0hoI4g%=Z1Eu07)-x*s0d%TCWYjWt3z|}KQ`IBNjso1+hsKf8eugbO8tpO! zR~DwiY}%RC+gqxTDuRX#ab_&HqrtH6DoXQ#rSuv2r35!XuFdrYH#QjKg(_>K@)^TY zDr;k*qpq~mkv$gEkv%q2kUi!Vy61P1@ZqY2qQr;;H%wEtb#mU13xSQQt&^YI_=q4C z5O4;J3Zxv0>kDX#TK}3evTE7lSDyW^%jVa=jMNT}zbAA8xO!-kE2k`fVphrOuL{lA zgB#LcLJk#l+Q0i$4? z(cPV6IPcC;d}A(3sTU7%#~L;nOh6uG=B9%`N9o0=V8?c5i7`B*@`gLdSpVryJqYFu zBOJWh$W7)90lYcG4fwszC zrWjp>!>_u_;YtBRi-}-p5s=7xO>{T3*v}hUxK~KZi%gg?4+K2c%?kO^w#NIwH)D-0 zR0oz8Bizj=oNwBC>&targ2qBH0qMUt?_;ar&(YlkWFKz=VgR)_c`H+WT*!gcrBRn= zp<}jV%yXQni87}qxqb5)@XitRSC%V33VK3g;{0>-&Xw~PE#cR*)_j?rRqhPnJbFUe zY_03lrEAUF#2XGh-zR}VOW(6k%}y7*Q@R_pOy><+G+=5&>~@hEK!Or`tCwM4bDQk` zUiUhyE)I$S8BJM{MZ%$kU5W8Ju1QZK-2{rRGA#NCXG0AdD*jR5pR141G|fQ3#JKO z?PgpA5HmPz1fU-p5E5|+5V?sP1rWPkWCYmhAb|KRGA#NCXG z0AdD*jR5pR141G|fPqdFAm~UskrAMwg8-r7AmS_RT7V$FYR5)^xSMeiK*U$r2tYqH z$?fcuP^%}e<*SbikBfVoM(alDBKLEC`U=*aSuxnaT^j=(259KqoWw5yd#6b|0Jr;? zm$*C^#>yf?fcPa~UpB-q0XsxPKQ{K5P8ZwpNwkZNDgeX5fEku6Kka&#vl>C@aZOZ_=-8gylUjfgecTb zODh)b4Y_6tFOCe-Dcyulf!dR3J;}u!yrLB2#yRtYXm1Gc6g(j@6e2D-E5b}}$Ot`W zax2w@wo~|PI4u#Us}b*M+>C%uPRI)HF|Z*`srEoA^;DNezC^@VmS$^6(|> zWvaHW+fXu9_NdApUwtU0-G>yZ;6B>cRrQ8i7EtAA@-@l6B1hv-O%$DijjG|4BT5GZ zTn7Y5sy9>wsB$#<2=Em-8jpZtItY+w#L_9Jt8z5? zFFDZVXgmVa=paDa&A15g5e+9GzzqnHRBxyV$fSb+RgNYf0qAlx9szbb2#|I&E&_Z+ z!wCrZ84w_;-cS*s%F*N}0+b5R=yEh30UA08kajaF0(?co2?*!}1W2kkR0ODUH2Dbd z6*(G@01F)iNV^#q0e4*sU@LcTi!RwPvgW~URf)C(WB#Y#lz;qT&+l#5`&_-4)%W3d zKid$Lkhbze{!RWE-pFFvfbMVdC-86b%Oqb8X$arixf|!^&E@8Q>{5H?a0>6x4W{qKNi9X%6Zk4v{m?z?x@rpGyq3@)+N4h&^Y~&p?GNDB& zs3Q^on(ZxJjTXh1-(Z+x{4u>(M$Tm8Xt#d#m)WijHt-l3rww#Bf9lM&MYOJ7<>d$q zuh|KBO^bJ>r9L|-2o5M*ME)K@}r5+ll zxW(YM|4%^;JMN*Bm5W06r!LV~{h@>N8d81}uq7VTSTTM#wnkL>Nv44q=hLu6RQX9x zix^wl;yJ`v`HNtCiyOW zOEAt2L^i}Z2m4+N7Aln3_u5T%ei#sddrc$AJSCrEEzZ40qzc&g+D&$T7>Bd#ZpIA; zZ}PzW#U2{3W6QAq8akmZ>AGSgKyc2%4sD4K6gC2gQ~?_Sf^!abK3FVXXt)RRkt$## z0R7N-9b1Nk0Md0ujA{5NfJhav5pdJkG9(0$C!g2|AW{Wv1l%;X3<&`mItaLFY}qgN z(16uQDYPI32Z)tNY)P>W4VdZU6rBuo)<#389!NYuu#XM#071TNq#e+iR2g~nq78{? z!~+Do8bCZiurC{yPL_s#Y`je?sW4$Njm|wl>F%TyZ&12!)TQxs7`T<(!B>_B90t0I zk(^`<368FYlB|M`6osYJk-|%*bX)hN&<~_*;Rkor@i(PsFE%ivdb`P_M1J2z9N(!I)CsS`f5}@u5mBc zbMAZ}2z!mV4kD;4&2-e2=c%YG*)lqR%|~=TW1{mJ&pFo0C+o|q3>nhEK=TFMe85+v zReTRZ)g#K+*{ga)`Hxf34-Ft-DIh>paN#1rSEN-u0#rSsd<3X^MEM9nKQw@VC4c}? z!G((eUy)X+dc-??ZKvuH_O69}*+B9!z2svgnPMfX-l72s?_AS6rQCbVj);+;PwdP6KnA zH}}z{IO3SV(t1yyflwXqo5A}G44L+usRO4zI5lEcF6T4Q`BOm+=^%0wUSL)lRNI}K zzy_p`;Aqj-`0F`MPCwHK2e>oLxL&{77Ger&U30}#tgt9ouub5+84mXioj7gc+Y`T; zID_|QV8JYi^xVA8tqO4`R)ihXmpcPEM~hH4TkHCC=~}Zk(X)RvJ6*7v;2cdxj?eA? zPX7=3AK5Y;98DltcpW;3;)r=Ka|()@>;p@`vjysAGT_f~psli(DMlCJ@T>O1y?{jC zI)!)V=s$eZo=wB@_vG*A-8tMVCOJvQi1*iIS8+oZdYJv5VKppd)?~#pbJM|}qx51_ zuwy&3#2B7Y>FLff!oeG7@a`NF_WW+=V>=(;8Fx5L;xwXU`GMsZbn8x52KP544u&r4U`OC0|baO>u?be>^vPhqx>>90)&jw z>i}B?5ul-i08(aw@t9-a*8?NCZ6%0irQrsaK-W$x*Nh=^2vE8y20FDTO7%MQa*fdGq*LNj zmqu1g-KUnOUrc8)^g3BVeS@6~P^xj!sS8pn3sEYisY@eY@8T;h$L}7nCX@a zb2gPw*b4}tQxrx&G=KoEBq)`)P!V9Kg8)@q=lK@rW2-QomKz%DO<_-`@JL1~U<+%c z-HeL>9}%Pi0)7GnNNOZh1Ze0WfKqWwETZDJpea?IRBfG{cXmP)K&SAGerOIAx?L>% z2Lb_0UPV$KCl!o}iENFkU1C%|d@{VYz2#!TL;Kg9<>aC#BmW)d9VjnFg4Cu8igm_- z8QgUPrA{2#qw9wxs63Vre~uIHq}FWVY}=JDp=dz3`AKviaDxQ7@XD7b^+S;hv#(QG znCoM?MSsq3ANSM}mI&vuEuG~DohWQAZRmbpBil-2!6 z?8lWq{@jaRRqrPMMK7IT!&mff!i!#UH>)Di508xXpZ?T?J61mP&!533x2J)yQqsE} zDokZK-(egl1WI)pQSgZTVuVgT5WO5!pTwC|D6%wcaFMRy(~(vGIp>vU8xI{C_0xTO z{_k(U`9DkDy^c0NbnodG4`2M%SIMzwpBlqEOe`C~Sy}vDs)@bcer&zz>sF}hestuffK(X%)yls~rSaBu%VlHUIJ=imOr1aqS8 zz@GF*QaSADcqIMB8(9VKi&bx8rcbN+s(KU4M}X>0ds95soun%dZ;_`CRRQQAdP)&1W+gk zvfP{^andKQJvn)`gjd`Y>dtg#3a1J764+6I@M;M=3hQ|J($U^q6h zsoK%C=6PA*3Lng@F^nzIr@Pjz(#l*OHj~b@--UEOQ$lBOZH;JZ$K^I(Brg9R$ zr4w97b*Bum#(|BgCENgtJ{jej?Tp!|uXxfZGleoN5l!v5ioo}gN3Vh`4y^P|gW^t1 zWbR9>w}dmBvJNral!IQS-$kW3QWomt#8J_9BrhH5Yw zsfavk9sV5l>|za_7&=PuIL3|!g0n6Ka8utq3JVgKpF}yHoUA4;!9FQOdJ zt~&rXh-T?@ZCF80h+XA0&`Al+%%+QvrKKRPgz_S97S4N3Q6CW2UA9KQ`_BtH~s1iQ;Q$(d( zFqRGig!fC>2(Zw}Y*h)Ld<39N_yh!?ADZO$MnHg_4gypOpS(&s6i`$NpZr&Y(r(68 z@uExk1O%WTn&kFkK!An{0#pf~%w`%OfYKvaO2th&4~M1QjEewt2_KID{6mx6ZU+Qd z=pX<+t>NGDs1iQ;cxDpkTK`wgrc{m>-0TeyCm_?@h(z>Z+BvpT}O$_Qg3nSreN z#DZh`lg{3zia|y{HhZ4S>I~{Qal9?{f$`JE4}a~kBY%t8@zOKV(}Ejv%**aCuqN#p zzH{VbfuR$pO?-ReHxt9^b`;bn*}Lcwk-O=1HX0>;?LP&YJE}8%1|;$ZApAS_0pdIM{lYtTOSFrSV)H8Te(hpN6@J|nP}JlMG9_lL8)Xb-v$d{I zm##HyGd+cVUHwnr%L#}c9{p_eOVRt9rc^fXYJ_&1AoOdW@69I0k2PC|9@AGi`xT`J zW}MUvV#bwJYh#%R&m8N3F{IV{`-A{atu$0pD-Gw>N*&UscQalLBX#A5Lq`9`TBE6A z0dw!1=FNR{DULWMu=SK{=lwee{HdP|zxq&0ySt!>NlW8`5d{Vl{A~J!?JZScu~*WW6njO}-7fIaw#Lx7I$MM;i~02&?Fe`C z3Fn)(-um)dPgpF<71U%rEc``S%-~_cmheI~{wrYQ2YN4iH}6A*_8MEm3)L2d?&mf^ zY~$&7x;yy=y7jq}vt8?Kk#QAa%m%|)qkdjld8#qq6XdhgV;s3_mp#B4=loGJ&Y8{| z=NJT`8b~k=4sTOs7247kmngvF_8O5B-f%y3tYK5rLu$?GS$SU?{Yo!J1v|DgON`-; zd{2L#8H`|P!TIwPO8z{dyg!eoLlodefng+(6W(yyQ|jcT(fN#>&Sxn7XciiO4TuOj zB@uz9^;HrwY%76R(^_7-s?fP{Ng@JlMiUVMx1k{!LP46{E)8QwzSoEk5XTxQA~koL zFK_zJGLy;4%4BTmqcc_?XshgHiqS>ZpxW!$b%oi#O~ z@1z}j*B?Ip$h6-~9XR#DsS&es^Trg!tTIe;5)lD*EI`aDOBzK5rt(DVx|?w?Y2pJ^ zc|2td=vPrL8!CqeLjGcE#%hyWV_=!XVG1b~1vItUQ@q1Xr@A_8m#5EE47D1e9vun|B+1lR~51AdSZ zAnj&c1P~DcHUiKO4TuN;0d_hF5c;9m2*?z4MA!%*1Aed(0QDxAxPXlS;sb<@05aeQ z83EF6#zg=T5nv+#{m_7j01%*|f&kJF#YO;mA%%?qGT;Xp0YpTAjQ}Ddz(xQW@Pmv1 zX*c5{fQSf?5rBVaU`_!vQw(CXaV{y=fzuS=Drj^XKx-{}-2)?p3d4=vXa5|;v3AHas z2GL;Ggeis3lu`~#5htA}U0oWPDiml8;-8wWEe7s8f&#Cz#LLjKUy|fWRimjwK~*Ry zSHlTH!E35eP!$SN(!8b7(7dIz+v$9U(vN1L@zsb#)%x1NK6S&Ug-#87FIV)< z*vR{4a5nWfPs_Fq*J&)=_H=c6jmG>-zft zBkA>jfByA*`gv@EQpdy+%d~UL)S7 zW#4%Cn_<2E$w*y|8U8LAGfd!(8Oq>+xe)x`7%uDFGG3~Agu*8BxAfWS+dJ(dH>rt*y-k(;l*Ib!=Lts057iY_QyPRHBPyC z%u_X(Q{L=Pn{^5%3$7LXg08#nEoyd#nj#$i^e4iu*S~2C{AVNPyFM@ZDa`V>qAq}_~*0FP10 zI0(Rw0$O7_?feX5LvUqbDnD8lya(MCFo;w6O<>6IGACF0-%aCXPANfH%hR zVtj_qU&DHvVXXYxSm^v{_G-~W@x}~egovZq%M4@XuQj-&cfFf+=~-b+uBTV0BKaUZ zE}9QXv^cm<7h^WEP2HUB6fAH>(Ye=%8QhK8!pb9!D{$RBh7n<-L6jCOMrpYB+UlDJ zB`ePWC~#@83tU1;NZie>F_Br9He^LOaDqWW7-_yBPJKqW1)wU7erNyze*pv#&$+X> z2q>n50FQ}sI0&E<+NRJ!fX5g{90Xv8wgLjg-HeO?K^TdR0Q5t{Ju!y6Mk5|haegt% zsUeRgv41r5GK#R#D3zWlmFwt~IMt}vH5~?S9ohwZMW$F ziewzZ)MrZdIy&VVY03+3iOVA58CM^mF3riFXOVc3A^6JD)a_z3Ar~-+I}JAw$fJ^U zvK73|HFmtg(hU8YK_ zy3g+DCan^(fp9t-P1PgHj-ORMqL)dz|6Gp<2;gemqJj$-0X`zF5)h#35#>vgRXyS@ z#`t-WB%>diga!jd0g{3X7XdyZtr8HR>JjB5fKq{zPSciBQ5gNu00Ov@pxEZZMF5>z zovKHa|1gPCbt{}s`Yi5d++wYd=n-LFFxz1$g6YJrWn&vYm~LEo1jJ7_PbVI##N(ub zn9fQHil<6W?!Zm)<^LEMwd^sSSfNKF>_R%9$)fWaJDs&zOy{pLkK-mR!yIg`Ec|ZP zrO#1RLhSkNEmsSkhdJ2XBPiH&-=hd@*`*W&wh0Xyt|%x5P`I&xDo4A;+k7uC6n#XF zCiI6@4X6By0Q#W;1aL(`F@VBFfGS6mj{qN$qX`I5HJtJhfPQEa8rTdl#1JbFHqW7C z3grUa)Bc{zD4lG^g+B~9{7l7xfBf6F_RHqDtT%FN9{ByVt?Yle6C!(kcJ_sny~m`q zUJWQ}at4_OmY#4LL)mPt>rhbu=k0oli!fHcD2EYv4@o-n?2-6&&X#!1Z} zW?YHBJdTk+wT5VkdLG7Dlpg5lH>Y`XA6<$g)fm(&-)WJg^qSV5EOr(!_nInZT(4hk z3o(UftTo@Fsy9IN8rd&+jaZ^xL`&53{6ckU9^V;vIDoe_fk8jMvNWJ2VqkWe5S6sg zPxE|QWctoBlgY`-WWF@|>GBS=RrWH0dk)iEFMr@0dGdk1(Qd~JJH8@}i7dSs73|o~ zn6(j({Kg4`pZ@JGYs{Y)uNbg*-Q(l0z17tSs8BKj3gwM}VC-v@Aiu&soFvBXc~IuB z=V-H-4TiBs{XEy2B}VzPaY)994K(sjs^{slqcc|9(nq+PPdLFnr?kBG78k64=)`Fg z-=6r*#2Ixv3hI+?*FgU6F9GsSs%PKGU%;UO1k?ZmM9Xbl1dt~m*a)~CFYLQVKrtNz zkQf^q0Yb)zjR5ja3L639Znk@QUFgS}twWFLD-=M0@J%8fJKmcV+qTm+EE z(%4Y|`k?^?*Z=`y6&*JUpj3Aj$1yh+79=h|*-hKwSi`2Kht!(W?;ZgbItU>0JLFmb z5tCvgfXMH#5g_hnWCYNO0?-c)H^7+HfuNYJXx{ZMJjmR9C1vFzw$9eubi->#S8h0D z^lz*+-eo9wy8~bE@-u9!Xa~rZ>pdi1N@2j@qVk!j+Z;Bdw0AS-2*2)9qSMXV_yqyUB8O;CajYWw z;Ib+{9gu=fPZM&bC;5a4ldK!~?mjMS{1H?E5JC8Qd zN!B!Us+{P@2C4$4t~xPK!y%<2XkZO_`-i;+DCM4%@^v~j4s~hdE31fAA2y%Smj>pM zR05zS1=pB{+|Io2@39orRnTdws(M8EVqsN}_%EwR1O)s52#^$9xCo$APDPhi2?YUF zkJz&p*dL|Yq|^D?q%P?N8+LU=+RaZkKvHlFqbSIwwmzaq1O%J|1jLGo4JrbBMOq~w zK-DA4M}VqFv~L{0{@G`8Q+9uQ^^s{oi*hax?rH}(bcc2Q=j*H1UpPH{>^CouZRn83 z6XT`NfB+XDAd?OP=tKeN(kcM~svc230#rSsd<0-08bH7qK!Bv+LX84^MOq~wK-DA4 zMu4hEl;3|uKQw@VMnHg6MaM+|HqgKk)G*13F0B#}K&Mu(>JjDpEl9f=w-)dV)gzu} zOBO{X{e4J&>4g7kd2-IR_>?ySGGBPBi2aY$nu2?`?E7p(uUB-ff133|sAw^f0TvVX zn9gFh%oObshZt*0H4Pu|t%KQ)F^-kYuOiYzGEN!7nGIQIn7P`SOi*cERF(tGInraj zS#xYNhWE2hP4J&S;q3`Cr2JHJ3NB6Z_3-pDul$JJW`GftWoIvzESaP+Qj z+MK9^_y5LlZ?FH8nZQ1E!?xz^9rF2*ebVdy5dQUlu{Qx;n5my>P~3@$%zZ`8cE8e# zw$Zw9CRDd}Nn2&42|PfUKyMBpF^=4|%N|G`KfV8pTc+>%-Ok5$J`Oe${=Ch^Auj^F zxf|!^%?*ywMrW+~vaRvnInB<2ra(u4sXXp_eSrQBg=EMoMHw1VGPado|m=|R1A6LHMde-U#*{)4CKV7a(8{vMr z(g{{0t!um)jri;99)2jdaLV+jZ`uXm=eW>|0PozqbLrdo6ElwKPdV>3 zS(h4v*iYuWPB{Jb-k$$A;Uftf>ioC)GVNEp%$wEXm5Ph_{;Ys`Eqm z45hy&lfv3mB(WtRB9Qt=qMT6qa|3ZnuvncCNv`}(^J+AqJkp?~qq(^osyqa^@W-PY zs{DTD9GX1bS(N9qH+L50iFUl}ZWbS99${W(t{Lx%vkql8v5y)<8@HF3P8>8wWK?LJ z%s8Xon(ED+WlVbPLpkp+8?bl7u#NkrR>)+j72=^L{AC^*K)_M>(Ih_$R0Mc5c5o2j z(b&O3z|9#D4gx&7p*RTe=!T*op!jBy9}WVf-HeL>4|f(61fU-pK)?||faGU^ihx); zQGkch1PTH?x}i7-@GzRdL4Zd$6a@ikbPyozW?Te#bVE@PfPQEI0cJpe(d7z@r~S^)Z?0R$|By0dgYiy8uyQ{(wq9)+8f z?ixz>Go6@5T^cWgE_&)da%~h}S(@Z_3$(bTff}O00L}$XiO+QIG><2rIH>^oH6VEQ zt4rf$o<;dKzY+#2YLfZGeGJ{4DJN+)|B) zVFpfW^6<3NQCAkz z`3$AM#y~^)n%us*tAgv*s=$um#yCd#bK{amC3kscuKZ3@^@y@X$*LYvzQWp<^oYsr zX8-}kV$_L?06OK=6fwKOjcrvuqUX@qTh-E3J)-BM%v(v4(GN{>`yoI;8XW}qh_p&5 zrKx&E`3O+;i1HDDerS^08vy}!ItcI)X_bHgRgWki0jeHRJ_67WO>%oNAV5O}0lp%w z5)eSAL9FT#y-bep>Fs#e-Mp#_q+Ho$-%|ZtO=xI$#dso{O+**LD zN0c80(9v#4yBQY&wW3Tj<*<#vsb!vtrBW6>_6DJ@%7{0daVYQ2v}N_5-< zgCyL|pDsPQbgfyN=oyvFP8V!5xaZP0oMR`zbLnMO21Bhh#dt|i^9yb1!OXAcG;NO2 zjnG9n{Hkx)3VS4&nt+|fib+oLP6qF<$*$6X(u>5Ur9BP!$jTe19i36G+0GnbmKeh` zDqTD8-#OqyBmlc_!~DrC2nK-*Qz`?E+>t0G(9_|oXdX3r~|S5}^CjJ#b3ydk^^OfhtIgt+we z>Yk>Rm?{Pt2bO*pmExG;h+_gvz36X3b-V`%Z=3RnXqz%iuub_%^1#gO5Hap;pjZ~u zE3P8!di|TW4YuC;a-AoVKDG)017|eyUQR&t@aSiwUy9zy8;x|`%{|R8boSGqSir0? zj4hc{Qmu_;3K}O2e)_k&tTBIHykfxKb&rp~_SOtWuxH^MZ3-nvoBq6`%^5Hb6=da> zD;>Mw*K77Z>+KhCXh2N#8X$m#zsLw6I$Uf7kasf32q0M&HUdaoii`k~%wZ!SO6clf zBS75ExCkK095w>b4-FvTbwB_Ke~}S@9@7X>0EtVH5kTTnYy^S zfVi8H5kMyjKtD7cyVy?4W_Vc8NTwKPUlB!r1O~$IzQS^ zE4U%q+_2;&Jq}C0yWEED94m@&;aW?r-7?~z3`@StiU5}mtWI2>%l$dH6#-(Qhn)@( z3q9mmAWEpXV#fl+5E3~ScwMm2!;S@l>7)bVZpMuTG{V~w>~sMA&_Gd;O9zND4jBQ& zLJu1OM6!mAfMPlbAQpPq2%wV=5S=G>Iw0<5WCYMj2ha}s^nivSCqC;#l&JCTEc8Zu(EEhVy@`hLf9O3<%JOHzz6rR5_abOMp_Q zE>(oEMCk$o=%monZpM{yQ>qAIH*L8o#()4RLc>J>olHPVYj8#BbV79Eaf;o7rj*vG z8cx|SIo#NX=6G_uhIJWO7K{fQ>y}lehwgv9x-uz`pHQrPMIfp;#{5ZipMBbEP)J+( z@}z!XY^Hq9q0#XFZ=w{uSnv?SQ>$!fscvt9|Mz}D_INV#-;Y&mm45-lf*1{8V+@$V zQ2>;~O(;)OETG}6*|L^M-ad)WLn%EP=q!wZ%EJ6SwgDFXIlq0JL=2V)r;y%(zx>b^ zsE6lVl6VWXAgG~JtVLH<2~n*oMU;J|sZvDwsUZ5H0R;R62#~~ExCrnORh57MRf;Gd z0oYM(K}=`Y-He+G`iK+}5bz`XXp(pf6#*7HQ2@HCNpBs%tN>lSC35n8H_z4Y~)-KlJxHF5$TMxXyW^4ltU?Kq) zH$Omdf4~_gM6wd>9YC^@5=q^o{FDN)q>2(cN7$!^JdmoCEK^h?{NM)O%f_0tXZX&M zhXX<-yY$=-@6Z4Oxak2x9Oq_m5ukc{dz$8`p5E7t_rzI;GMm^( zjiHU(OH3yY8Y40)G)`umQEyE(#(Vl^{r~Ri&70qm96L&KO;Ucm4~GEsLzB>8;i3T1 z1sN9ss;9Sn1gM_g@)02JX301WWgHI4v9S?=erNyzTofR>AmbuH_4JmH0M*l5J_5wu zjEjIw;f*9V0?-dlLW2RK03z?hP6Sj>Z}|uyx;x}r0MXrH*8+US)0#H!d)0QRA2UIpd?1{1t2b}bv* z!1<=lhe4?qxTnR+cT(JE+@e7r)P#vaAHruWJ~g?vlFpCz7lY`W2eoJOvFMq{tF_A4 zx7Z_e##h%;8DGshsEn^R&=_C6wS`Xy#Gq3&7*PIra?@VP%N6Wy8hQZ5ha9Z%*aLeK zGo?UXU7Ay#BPfKa9m)I%is{k_3Q2|FD@z0Z0-1(MPJ`GU7GD*i^le4M47^sSa5{-) z3UV4v3^TAHzzXUsY_)^51H{L8IM;xNP99BsX0UG?;xmIRcfdb32@R~Xix^2X9>&qt zP|Bm=^-TagUBX@)I{7-K8i%?x@+Tzv%F~P!9~wZwQ9uB(xUM{oihvY42tb!s36f;tl@xZ6PQ0hF!&>r63ORo& z7IRMAj6>SZ;uJ@e)K*g0;`SiW4-FvT2q1u1Tq7eOmJR~YrByrv$SWyq1dvx!*a%Sd zi1MQVAJHQM0?dE_GW`}A0hx3VfG({P5I`pih>`Whb_Vao;9V>ZM7$88s1*)U~*Y0Q#W;1egE;QWYH)0hH>_ z*wU((`6z%=L0HuzHk*g#?8%wd_QFe}QpTTsYvP_kRsQ3vw8P=yFD+@UhinN^q&`>?>qge**jJ~(^cd% zOA`6?1*?(Fb`71+Q2J}w)_C)4(KES2+`8)PFXESfZ+6s4EKhjs$lvm(Jh3ZuZ(i3&^Y7&bL=TUCHu|OLjZIT3n|C+b zPj{Y(IBFgKTxUsRQ9=CjlL&uJZA)jw(Wva`ncy19{bP~+%I}R?U88=-_VdBL!lDn9SjvJus znn}b8nPX~Chq6mb64TG6pR4H2^exgZe9d)lQL}x7E}n^OePdMHsSs1BDLiAX`Q_9H z#!nkR{Gs<|e=%{-gH-`%pX&N({_o>+`@hrwgZ@XhOvv6-pZ&Ef^U~|zPok!lQTJ+)$L->Lo|E`!TFV#iC*jF{HVH{-ED(KjQE^UauSw}5X(JU=FTzCAuN z^U?;kl-Xwd(fDI}uZ*0@#?i<1tG{e(3^heK`sq)Ey;lFGZG$baw7fPUHem4Z!J!3z zJn&-lw4g<~mj`b%hWE2hP4J&S;q3_vc39VczP@Vxh0{aEe)ICNhOWE0V|RW2^Ud}! zQ;057H!kCie51eaR938UAZwnNwU(P>zb12R$(#~>c^nh*!-T<4|8|#k%ZEoYa`p~B zFlF4XkXGyO69Qs(>|KBO^vG$ynL2RlgHt1B<>ZYih+oA{boPN|=W9ClSK!zCb0iRMqKrtNzgwR32MJfnLp@V=o=^#Md&A14Np@RVQLsQd|1_-dwi2|%t z5RgU(0fBT7P)7v;v2+lSO9cVaZpKAGI2{C_ADWsLJBI*~o4AR(0C6|tA|RFy0?-dl z4Ok3hUUG}5IaHL&7|@F7l(sb!lXFAEAxnD@#+in>9g;OG28h#peorp1}>i|-D#BK0Q75sZ>6eBBfn$o_K~IO7vE`sT!5`0Q95oQprI3SM$rkAJhRTc??LJKD-MA2?&Xegd) zLGD0BjdrMWa;*LIJAy={10FgV!+>Pws^VPJ+gJ zPuh81nj1qT1Oj$W9#|!)#5m0$iy=mXr!rJNL+P){q_8#>li8B4s<)+_*N7@dQ{`w% zD^gVr=bcEOX=peB0Y?D=lIjf=0jeBLz9Q9EC4JROg zQwT`iZd3$NYTc`HH2F~goo2U%4g#dzjEev|wE*-(0|;0M&!DCI`M(=-k@|w13_;b_ z-QMA3D|ee8DS2~b&4b&jj?8^EBR=bmfaV8QKK#g+hKJ+b1^1pl`@+fIW71mxBzSXd zZ@ChA)cy(Ym|y{~82Hz*YHijj7$ve+@R_*ISs6IRXZhEKXZfw`RyBEA`2-}U$3B$v zK5ymI-7%r?xLLBNJl7f%nRRJHR)pg#28?};yfZ@%3l1Q)(zASn@GQU980=~2H#=SM z0NJ}?*v6Y26ROH?jLW{@-UZfv%}dwX26Be@-}253O?I#{FiBn(n*}e6h}Lq?X+k3$ zIp$^e7x2@Bx*Lt8w6_-25Esm}>f%>wwv4DioCwV$1 z^o!{{13wzEKufFM#t90s{utfv(#C@ z%_K{5=7v2q1=j*a#qoe#i(A4gHW2 zAnj&c1P~WYWCWle8bClJAb?n)VIu$=XaWL=p&vE^$iO0G1X$=q0mRS`8v(@74;cZ{ zZpK9balyn!0QRA2jp;0A%Z}b~C$yA~BkqLChk}L-Y3wTm0$(I9{~jgY(3J6Wc)_KO zyF0&+JbD%7icYI8Os(Y|^dRDFxmxi2&nSVdhR$a!bUwqDQdt{2oxi5|N>XeiuP253 zhRo$wI!-U(E@^T6Hz1mfm{vL;%qw)yhX}fl;EI3fN-`N-h7#IF(Ye>i6gK30?R7G@ z3i)0OhMX4s0I{=MGVBfcUegeRcjSCf+ReE6AQ|?C91Nl#8bH8b00Cq?7BT{g=^%j2 zt-?kCozOOg4g$!qH*5r8hqgjKDD7rk1dw5G$Ou3`G=PA`fB-Tc3mE}vbPzzMuwf&B z%&kI>0%GYPfDC&>Mu3G*6d>(pTm+C|Z^#HhKQw>lvv@$ z%?5(A_*pc_S*IKQ*d#Pqx+=JwyI>lTDy`~SS|wxyWWX@C5`hdDMkbnFyajL>K*nVw zpPJXnfMMiXjj!kt6B-PqkPL`zE?floh_p&TfT~B7FG;49LW{c@SCUMrB7}Zu00CS* zK+J7%5kMzV7Y7U@x1cFy&|;+qSCULAwN>?q@+*(nho(f+z`8A8MjmDL3ENvZH@G7p ze!7BF6$B{~ClBPT?VupQsqE|+uQ}MG<2ZRB|HpLlO0LE@M)@ZL?1k-|Ja7@r426jE z-Kkup=1d+;C5Ad_-DR z$-lN!^@#HCHC2x&|9u+zq1oC}%ppKjaN#1rN2FB(0#rSsd<3X^MEM9nKQvog(zsX3 zVh0Kr0X`zF5)h#35#=L5)g#JB0Q#W;kr3Ax5Ord>A|Xnpbh(w(PD9+4hu)mE>mQ~6 z_wCfqYe)Xaf6Cx7{!ct};(DK}7smuV{b*rmpJlq0M^DUP*7fWFP&g(1=@*|~^z@P! z!UkQ25=&>~(I}zmrfFT}=>ajf$vz^(YKnI_jeQ*cMa`STb(xMZCZPHj754$dH|^Op zEPqe_->pwY0+1}xE|Qj19{17_4|MBuCuh6X*&&l<3Kh$ z-F0f|>I250o=rf8?y#=^e0|mW3#Uhp{pRJd4IMXHSnX6KyH3ojM>OGb$czV;9o;t zeBk{x&AS?*GC?A&l15J(7{?kmH9e%(oSv08PMgAPG8{AN=a=0P0*dJ%fTShZ2q66< zWCW0BQrHL(cQY~qNRo|=0Q5rx2)FFLjwq?1q2ZPG-L!2^&K_>i24p00d_hFAnH481Q7KdG6IPD z4jTdDZbn7`ohShP&;SC?0|H2vjf?S$2D6K9fZSdK zRbhA2L8U6(7CN8VOy@`YftN!HgOa`Y=PA_Va4+V~CWS%CUi|YEY74Mt-fU7BlM+rg%I=QFl zYlI8|b!p_QgnVUbI1BQwY9!BzL<$OPqUc-$sB}nBg$N>S88VMBvX><^vYU|`9K-JdCM}UtA zQUL*aK!Bu1LPda`4gyqdoqPnS+B*3N@DV{OAYdUNKvE;2B0xh20hBs}bl%xfYT1dc zVPs*A*nGlmJxIG5>z$pD2+(N_qaPYTKo%fCs-mMJz(NNBQhx*WsjcYKh+L~rqtoJ| z)87#7Ad%&@(r(5@fR6}L?J=D$w%WF(!;)8@6nkLJ*(jK_Tjj3kHa1wPrhq}1tqNm< zxd-=O+&rCFsn4*&q}Y!GW*G2*2U36rR3+c!nO%!C0 z@Mz#8aH^03D5O}Rjm^05?*l%1=KUrA_&0O=h4wE){?GW2#|PcJ$ldE`^Fw|^-u-Mt zuY^SNSl*qZCjnMblRYrwlxe18sS$h=<}_`N(T&hWIQ;bWJ)1L(6wMiC<%s4CJq6lB zue{9Q5unIM{gh-NX~`cxTKL#%ONV`_=196U`j$~D`W1I!X*xFf%3 zE;f(4b)tcPa z=oeRS8=;G5z;I|(TV;qT)D+aZ#@uWkma`{kTH6aRjY=7R_N|F~22}+lrpG>%^Zu0S zPtSTGOmsCGd0VbV$^oq>SEIN(OE|MB>kwnpg5glDG4gz{oUMPrw9$qpkhyZCfdoeas5CJ_YFBC)o_Mrg;oC5?%J}{^V zu=G$qRuBP_Bmx%!Jv5OOL_iuH1oWi5P!Itnc$KQw><7a$;0 ztWx7502^q6Q==q_z(qh0O=JZTV5ftCo|G2~BA^FXBLxv4?PgpA^rXB{5CPbS1`u!t z5FnM%P!T|>=p@xZaS_l%6Inq7Xy_n-QgO2f<%NO>kajaJ0(w$jD2D*_LjwqC1O!OE zYFq?h15JnmdTJsoSPST(iL4+3EOZdilk!5jD4-|hg@Oo>b~7#ldQx5}hyd(E0|>B# zo4%y*@ZvC_;HjbWqxJOWQ^Ac!>2Oj4nz}Ud+bF)WG+;GU4Yq@lUxKHCK*2k$C&vs0 zPbW*K?r5NMLu=pLjAoR(qI)u$`6V5j*NR&VtlbH2Lk2R$ zxC9hmw>89AzN&`3h5kyRrVR^|nZa)GpW4nT6xy&gJ=@MHw5JWXP)91Xr!6kt2k@V1 zJ(b$inx18gN?ir^o@I*)wV)t~=IsXmnUkhcpSgvTrZPWTa=QlRE3sn5=3G*&<90@w z%clT0EQ(V3iB8E5y<#KOI4D)Q)TQ~?RirMfGH~vrqU!BXVJc(DE-QC#n!9mspC8kE zW#p)GwEiz{QRQfg=(tr4r~KkWPwrWY1e|~XXO~%ixCl_?X!4&W_=p@$h-p*}r+fsU z9~wZw6+nQfdc#G4Do2x#03VT~2?$U%obnNXerNyzoHw|rdc#G4Do2x#03VT~2?$U% zobnNXerUjdoT~+hB{W35w{dqyg{>l_lQ`)+7C)xc|1C2fw*u82sY& zUZKl1PZiA7Uj6y+?+>W@u5i&2N6y~C<|*S|xWB-fln@xcWAFOIr-zHq9OrW;M4n9I z?MMJg!xw9>R31-W`663q8)WLG>!pj%So5XPPxq-I#TeSSy~K3lpfMt&LgQq{8TD4l zGoyF$ANRc&GcBkg_wwMi%N|I!&ibV9^a*cIm?3!#3>|rSn0UeN+rRn<8DVLzo}YDM z>4~K|lZ^vQPZYE@`j=j`jn;)Tp}Mt8+A1SWeRL_(6Z6~qYraq7nv`(CzVn2!RTx>c zH%ss6#{@C?M*p~qFs45{u6)KZ{VC_YChJmT5c|n|*9oV;L)IB)u68C9R9Y96To4Qs_SIe~Nz}$`MkCd~e1V$$K8G z3OxH%@48`Ib3R(ufA5B28~015DU+Z3W-4zqqXGTZtX_*bS1ORot}Lr`zF~XA*0)GI zI%9QYvppo^q-mk!QR4_l@9L(_iMn9N_8X=t3exw|>omY}Y26pDx#?jc~tQ z>0E6Kk$f2*Z+l_(sKgyFJrg@Ecwo-^%LaU9ov>&4&XI=$M5CFw^r@3pRJma0Cq$($ z2JP<@yy-6gVh;@i0$5zP)fogFE3la3{pL2ZBLL z=GeSj_!O8g{7ul2W)yUuYK_}hcj7d=I~$s_o@vFnqQRRX_l)t<3u5pTzih?$f>$wa zHE@xyyb`nc5DROHOG2huF`_3y=t=Q04w@gWj^<;Cel&0=gu`-B=P!$F~<90m^o5t3px^tdks`k1ov7n&AkRX5*DSQ-fMyv7{R^fM-vRnyIFKz zN6QCwH2EO0C_j#BEU)$1)v`qKtL5B z0OTqJ2ml=k1p+`7MSuVY4FW(%LV*DA0wX{Gc!5z=h2`Chi~yP_0R7Ma0;EX=>~L;x zIEhpd6f8|>xCw9ZC^i~V1B#|;r!9@-*{-HH=pjpUe`u>ocwJmBU7a8$Itwogk@~he zn$ros85H3L_+}8?&~EU}5JNQFOHJ7UqWlI;ARySy5X2ii&23|%2?f!Q4JZVJ`Graw zGP-t4YbKViM(_h8*aB9XwIS-=)94+vrIDsysZmyW%F;}1&Ve{xCm)+7m0>M@nzZWs z)s>naQPU%OkREYjv*13e+?==wpa}z%m_~f_gCqe&6jYgrYQ zbWMsVjlfp%G!6aG00N}3q!b9CiE7bRRSW@|6j40_Xi`BSSEJx2L z8;=(pD_H%F`R)i?H;s1@tXVV@t{Oy?^W`oa6zx>RDwuzii@9IYcpP9E6 zpPBX7CRNmn)+~@Q+J;YWW!5Zc#z*Lf1`zNfAOK=)0t6({AOPLZl_3CvUjhU`@JoRJ z%>-FJ0%S{XT<fO@IIg4Fb^pTp0o&_$5FYelS-Y??7KC{p1u`~6d&I~Y773?$rs@P|aTbftH5I|E408J!CA^@7mj49@3X4AUP z80h?%JH#z94~Zy^<+^D&s$kO!bz`&lR1>pltzWp>KFBiA()Y9SUR)o|1Q|SM4=A3q z{f1nIS;7=1$ly0v!JoHpZn0+8#D(vLx)b;fR>JFIU&B1-OlS0Tzrf^>?s9b&{06Hw zhY6noeuFSz_$!nF0z?yX1x?)1kZIWSeoZuEg>z`uW*^PG-zInNTgFRIv5R2YE8`26 zW6a=$0J`$Sn8oihb_$!J1fyKbgWn(=7Tjsv)r#Mscol%(pc(uIkr)jkKNfM|8r92F zSaHL&V4A=NeQqTyZ_wm6el&p%_ze;SHiF2HAh1C{G=KofW`rOeFwy*IL`gJJ;ejUa z)Rrc)Bp~CyEpMnv2t8zJ`nK7Oh^RnGDk+*l1d-289}P2YuY+V?wt|8>$9&OO7NYZetGC#^MFPh3?&n0xIM4T za2q!2)0f1tXF8gCx}p@t1)7Iw>pV-4I811s$r1+dW7b;ct3)kDdEPXBFGl_d+YODd=2ID@?o^0fL6n!2X z?@Z*1^}$>~TS;eszx*`^$9(e!a~ar{p5KY+|0uDQI4LUW3&~N7i9XH z`$d#}e7&w`M2$Vn5Xl8KzBb}|#Q;lyA(iXhc&usXeLMUAt~&d@Ln%Lj0k+^g(t%j z{A$yS7u}a-i_06n^U=qA{9_Yh-;Dhn_Iig;%5lpy=R$Lg^X^&KHia6(omFN(=lZ&FL!bCrt}XQUFP`l)W$es%mOaVd z<4hbgrQdU#XXO3+&c}BCVrRtuK7LCE$2T`-U62%|c;BWb&QT@KV+ZlgvO}$L6+uTX z+6P(&7=jG!agpJ;Dcn4$F0s&3<}&wADbwxXip^=|kDJ5WcKvf9(AvwmJaoG`ps#Im zlvii1z4I}PCG27E0111i8$*MPm)03)IVW;UIA%1$4eIb#s>$Z^Z7D6eo_PP5gfYXH zKX&Mk8^JciKR@$jv3XGaP-nIosdXn>8TPPGO)v}Rr=6F|6NNGQGx{^)WzRnGNV)DqU;yK3EcD*0B$~3AlP2aR; zMRHO*5y9<|M#5g=0#hZ_cYnNx1`u!rel*FT2N?nJOihT50Op*7jsRBI$3}qE-N!}% z>+WMCAcqD4@@_^(04sxGBLMx-00IsH0;GN@G6JOTJ~jfFa}G8FtStG#Mu61a$3_6_ z?qee$i3S1kZbn7`lf+;n0R7Ma0*V0vQa=W3mDKFpra`|NJa+OH?(AA@B;FsChq{;UaDkdfE{m0Mh4io4Np@OMn5(! z+3v6T1+EjVyyQE$djY5lk%9p}Mb?rDS+wXoh|##$70HHx(1aHBi{GLsL~_o{E{c%d zFmF2yO~t;eqVN)i!~kxXw;h5IrM0P1cIpG%2=0)M1qhvc_q;U8sZYq&L_uly>s@Lf z!5u9*^$EBUMT;1s3aXDuCHT=GC79PcmP{_6OZC!X6sr^m-{CC)J(FF01P znt2&?_W0kwsI018!Vn5x79k0K^D~$+Lq{(Qz^g;qD7QIWw#l|IV}ZE~vxL}2X)V0H zxpl?nS^7Zd#x}={SNi9#`32aFOy!uDL1#82;OQ%El-r%h8t$CR^-5Fk87FNNVd5uT z=tqBOK%$RD?a~PE3arYzf{GHRAn0WoX&7M$+9TSgRCnUdve)d}c)ZOtWt7*Hu@8XF zNSIUfGwIZ3#GQ2k{oAmO#_sXkoyeP}KWvNOx?mj2-W6c)0O=mzwBojmL&0dq`+Ra2 z=5ElO8YwE(HQt_aXn-LsWp!~o*PM8;8Hoj(5$_n$Yp7G3k@ma!w#Ha@nKbMkcXLh5 z&gRE@XzH@vE&Nqb6FSQ4bKe5V+9puO32H)&FSJRu$y!&?+4`mG5w=~~Ywj0SkFZrw zXb{E~tF=Jv5(d;8I(F&g@Tv_RyY_7k(EMns#|wAu+t}6mMs{Is7FC*@isMvk;q6T? z?8><*0YQIkr(x$d z@@~dOKn@K8&<_nD;3^0ZgxijR46%4Lb@@Hyy3Z zQGmRgaS@P2g8=kH0|*d8CwZO}E&|jIdg?L)nDhd>Sd&VF0H#+$M*vL}pl&)^mk}WE zW?Td~Xb^yYXckrSLM=d^Cxwdub%UO|iU3J^fsKG*8U(P{YuE^o{L`?b0O>I%b|N6} zW?Tg5Xb^yYXaE6+p-`uj_j7b@Mr-B|&5`M9(Md9zz;4@0MibZ!kc=jpPQ;Y`BDb`te(AocIIrcwYzG2y~8KvxMiAip*hBR_pEE1 zLJi^0Dzl$+eMj4jiJVXG>PNPvcV?Rbwp2Mxu>>PtUItlN)dKU2g;&g1^gUA2CzwaN z(^h`8v}v8)*N{0n*~eY~0cd>#8&|IA1HNH0Ddc^=sfFYIZ-FU2{ zYeuLuWA&o@CwA(Z(U^5X%6{c(oDtk1ZVAWCS-3%baq06%(~h}%S;~i)d-6-?G<7g@ zlk8b)MQaXQT&MOd;Nx?P6Lv4lKucfCkciS)?%tT1PAou*^}$?#WBr)5Pd%9tzw5KF z9!l_?pMH5L^MHx+nlkRqanHYFTYGYC<=S&6hK>64rKnmfj4pdswn1gCL|EVE7E|Bu z|2Cs)!D2~zB%^qFC7+pdMt`Qf7uRQN^1RNRb0VERS}vwd?lalzy=#B@bmorq{Gl5s zjm{m=X!}i+cj!C$YxkdcG~uU{2Tgupa^Q^g%xLIS!h9Dgke4Ty1q!kY=Q8fDK>Yyc z20k%)WL5DT<7&I!k6UFLRhXu4TC*ZKshuxX_N3cFz%8b}NC-%xL4Xv`7aIZShXxQJa8tHH#YMm^roLDRV2@<55g-Nf*a*1A)E5Z>4jKeVfjl+> z_bzitF^ivf6uzWj~)zOgZ_IG7o=7Gw#Bawqa45&c9<)RkwNnZ zXg;Rnlw6c=({X$)%Gw;E`O(hp5JpOi8%@;531ZUjuL+t`JB-T4xNl4yM`dF~Y1WRT zvb(>$(dqC~jI|N!4sz0g%V<9uMl&-&VIp@$(2?PiHsvJ*KIS~rC#@gz#tv2(ST#5h11CW9M0X-lK3rS4HnlbP+df<#2J=t*3F z8wf~lGuRQQfm8Ej<800B!dkBW8xn9%O zseWgtC`EA*kVI2KlXo*R0%)QD^h4v$<=v*OAP;C-G^+Mpp~QVPF8nG^MX4XYPiuL!dAHpFv%)2ciA4EP&F7m%BM2F{8;1Fc_Y zUC^-(q5}+PfCV8Ine!5g=?jKKv8*O$2!>j3}ymxv(rRG z^*dQLas1JcCMj<`yh1hsiJ1%S-7;oqAe(^PGfN-Itub9FOiOM`ziJNXc(`WjnQ_L= z?i>?DcMhGhPns7vLW7K#)^$F(>Tu~)&bO#K*ytR>jn>CFGden&Oy!u_$jy!>1BP6V z+R<=I(XGCEzDd?$j}%@OXiFn_n*6UV&9;W%93@(K_52x0MPNJ*7A>opcZzJ!(X+_5 z(Co{k-tp!;Xk)H6H(Tdy6|HkjP@iDY0`^AJvDS|DYD+G>IImy0+CE5- z{C_68ja-u)dIoadma>Q&HCgr^me7>U;%mi^r01n4Tz~cl{QXmGV}mNP-LH&yNlJX| z!^xtB)}rql#WyQC%-QSwwM{VwKj#i}P@}D*bxxR5bhWv~I>*az$>8|rFN2N*(*R9U z;-4@19>=hSEBBfMQ_6KNZnQbgX5f4}TIcLFGas0nt#cj*>zq-w?RPUSX{2Z&73}cg z*ZYo{2tR^Dv#lXV_|e$AOl$-&^CWZxu%Zq&0wjS4HUgL`3L62EDhfNMkyKIG2#|L( zE&}3NB@`P0=!a%oLy~|1=Fx0`OXb>P3bdeFD>}Fg9NJVh$L;(HJ zY-_Lz2#~WU+;Sijc%UPICJK-Q9@tTUG$a?f9B8FMfaExajR1K!<03#(MPVZV{m^V{ zFbPc|`E!y&i_QEstRgzmk4Ci7Xbz_|^BFs)(UwMi8^u$WrYVkZ;U9OMXyr3&;=*C( zZ)yvO3cqWB@g4St`4zJGO6Uy>5;>5PZ7+m@7s+fAg*3Y14jV)Ka*~hHJuYj!gaZmH z$&)Az^_(10LI_izg@QdO@xEi~^BuMZ_ni{uo#GDozNyc5D5+@rQkF(S{3I97LiA$;dcx%(-%%tTc>I3G}+@nqaqc?7uL5|y=`x>xy!*EdY&+2Yq~i9&L$0vyTh1MlcRM> zlk6#SG*K+9lLJoNa6{8@su86F0=@+VD5^J91mw^}f|?vny^I@Oj>Zr`)3;G}GwvG; z57BS}0=@wRD5^J91SHWQK$D}XM*zAUO+wIA{={ z$0Vv%&XuqPKvhYNdzgk~Gr(Euj;fBDcj z9#Rr8cnWH5+Av6!2%+JQTflo{xSyep8xZ1Aw<5rnQ6{hK%)~rZQ z>X@6pEV}blKXkLv$a>Legy&?PpFjag8HX^!mcq+zRIQa}gsp>Ogl&9t4vhsO(Z@Jw zzKw}yZ79A?-%zj)&AK49s&`+Ng+$s!-pubqS}MH9&|Cvm-)ov{p!yk!lJEjA7z6}- z2?&U13QTMSu<9}1x5)}!k)|jjutQsII+}U}uwn~#KB(+wxp;htTf#B-JZ_Nme8ttv zQa;4olV3Wg$>#EHDJ|(Jz4;fJjs^%g0|*EwL4edl#zuhDL&in`>mg$gNK9h&)@kSE zIvBjgGBa~i^GMlu)Yp(XI@!lv|A8yR9@w~Yh5ETD+H^Ga2=I{UXn=qwKtL)D0%)QD zsfUb>0M1cp}Q-FYA5(G#+Wb7zF>LFtzfc22E5ul?%K&Qs; z?BTcJxb&jLQsy%EPASvv;EK&@<&T@gRVM~u z8gxWCoH4Z-qQ^k@HwANJCH<&lL%pSYA*gTDG={L_*=_k%q5pGVJ%ocrV zKuY9*T!5DY4%|RM@=L%zoy=xr*&*B@O|lumP6i~K5$yO`*#SCfrUuMA(w`A0wV(gOQBmE0twBpQ7nUd4e~)lS!{@Ec;lVN*KunHNH0Ddc^=sfFYIZ z-FU3ytS~k$aN;eq!up7_!sDz~_N8EKEMkoGlu_tlC~LjaOS}j&a^S z>)NJJL%6fb?B`S&+Uh{^c46~sVTv^j7j~Vfw)YZ7xLJlol*V%R#?(lI9PP(;sg%3$De=o*8sAqM$ozgtCO9>Af9Z+0kZdw5$--C(7DgLj+|{sFva`Vs z1T`t5>h^;sMO4LRK)_*TBw^wL+!^M~&IUVA*U^+}Bs&{y1ZYx3^$4Iz1wBQI7zIyX zl#ztk2=EY96;mT?QbhHMttLfOuR}sVG=Kmh3SdLruo2)Psw##6O^T=<0h$z1Jp#}V zO;oK3q5ws_g_{V_s8AHO6K;!(NFJg|5mhGw%5KJ0hy~L$AHVz1H1Ov6;c!+CGy+i zk%IVUk5C0Sl$rLKz3QsWmh$JhduG*d>TQU3MsPlj$2-=*!<^~Gi|)%3Yv6Ht|Gx9F zoxj)_vEN&)fxDHrOTjIVOMU8g^If{-+d#w3vAIRE*_`VL4KiL@ck>{jo_w+G;iGBg zuD)CKJ}Jj^L%7j}=aa*^K*#zqYoB^DBYxLsUp5AR zB&HzH!SE$0>_D%@wE_Ady~RgTv#&YAQfweiaG3`cl}^1;v(i4m;@h~YxRap7n;F_n zn)1YqXZsJ|khkHHjd>gQ*v1A`WS6wx&9Z`^ow<&WJ1t|v(xx@`posE;+&a@JbK0E4 zWr^m9pzoei(;rliw- zisobLXgdFzD=6wXZbF>2s#cH?xw;Me?V9JMbMGT;nQ1zorzVO!yGpa{OzV% z4R04GJwBj83jK{t>6?w0b#qDqq!YC=r0)>^nPJCQS?6>ECP5eF)xB`Fy;qy1ia<5oC>X#yMcLjwqK0Rp4}Y{&?Z#tFg=9SuP)0??LL3iVo= zFinz@Vdpl|I6>s{hNQp5E^kQsOKb$lyBQY&IW!1BKQ!>L@GNxGlrjoxYmlfWL{vwk zsXa=jDcCWMwlwOS!=ADgBbXwoZ-0o*}?P1gV1kI3OTc4r@^nplR#WE9{Ai zbxKhfHxpp4(AcrFvYT)X{v5mF8o3nzc!y`8IVlvPUAVsF6VS2#*E|;n9GiMnaVc zXxcjUuZJ~lo%+B=+0CfAji(4w0Rcw<0g4(46#<&IPCWuNZJl}qD7(2E5Wwe5h#5a; z;QWIlqTg*gbLNk)+>@|&YTj?`H+nCw`PIE|eE96KySHsml+8JOWOI&zV9o)hL-3E6 zYAtPpH`;>V6x;2OdTZ}y@K?pnV4Ub?a2VWzZuO+G4-(9yKNF`&T)TaP>h=y02NVYg zVfMh7D`}T8r1Oc%Bddz%7+2f%e%vb4sKPXT)0!2@Nk8CcksaMgaPu+18K* z2(Z#b0nF8^ZORu80+MJD(7|mNB@TSGI_nud8;1fL`{q}l-53Rgvko#g0y?pXTG1W3vo>?ojv+b#+M zl--Pr0O<)Ub|Qd&Xtp(21q8_4#Ek;j^EK=!z)FJvNqK`@3vkoa0wm=PHUgOP2D==n z>}Fg9NOCo71fU<9Z4D-&^B{kYJh~XCh)(pQ(QGuH=5P`LOx>G3yqLLfc<#%`(eayJDx>@?A&H_8sc6$nV43D`lj{o=?`KRo}ev-ReqBk7!8cdN-;+HJTpr;`a}w``^$b0s<}o0%QdjE&@D7S|uVN zhvt6P^oT#;0n&*iS>Da9aTP&FF5dLKv>Q`fMO}-V45A+zK)^XbfUMxcMS!PBt3(7O z(I7z6BdSM$yqj?m;3;}UKtL5BKvrd8H_In!odNKS}&QZ;X3j;l_!zN6$3pAL;SPrCpEg{0De?T&(-)lLZflMf|^4_P@2X zX`S7-sMKZl=a(ioeXwwKadK)qD~s5?2P(Z!kB!!c4^IE{qW<~o9$DXJ%rQkY=4evn zvC5o+5r$A_v~wAESD=1?bA#fTF~S^^a!fab8(nxlIh<=Zv1ot4{51#1eDlUc&Zl?v zBiqvRhn*bOX3XIa#vD5uT7!;AKdmwqXT9Ca($^yT`rjK?~LGl z8jm;ayl-d!-&JS7cPJ%2f9T#xqjLu|+I|z|9r{lG+WjZmItLk<(OID@OygbBu2-hx z%`w^v$_p}m&HW66G9N*l@5MzYjt+OG<$6V>NGiUn+CWoY~ z+Fq~Nv-C7%?!8{o!xCx;boNYZXBHGO=JXp=^M+J-OcTiQ|hq4$3Wz(Vx+u5v^vD=P9-sDJ$*zFn4{a>vemtw6dypm+Zz#zs&W| z&wSaI7}aNd^+O5%FnB>Rf!QsZ!0=}~49YFywwte*ujqTEq)#x9RP0&q=z#JrQF(dL zd#Z49M4{g-=R|G^_l^1P2;0NlAjQ#SRXBuTrn{&7<(cEs%&vPLOzVkCK58ZAK z02iPruPNi+9M@(wGF-G8;hi)e!&I^DrwgO}XdQl+biGRxwV~k_dqWDc=-)oXXk1~M?foOG#trd1G5X|yM!EYB5 zh^2>rtcRxaA;w7G<`&O5ECk%*hmC}QczM8s@M z1z2gK0I4I6jR1K!<08O8g8=kH18)nRfB@Eb$40;{v$2p6;HIes1k)gZb;Plw0I4I6 z9R)}-5^My>yBQY&IvNC^9~wY_3lPBiRM-fRnr_I6faK7F9R;AbY*;yvb;QvTKobQ> zooZ|Z$h#RA0ah9WpdT7Qz*#6dDX3u%14!vJ5jTnM8k+lAdcuqiG;L{Ab|0aQ;wej$ zneDcM+CehraC2wa<6@-xw&XE^eGNz+6WHMf^O(TCp(T$A>>ii01De=tJfv%YXVxs( zDTj&Xiq_F&gXqUb&=W$}UWwASH`v_e7Nk0=rzopfn2sK$iAo2_6A~K&+S2^%>Jedx zaZaa0j4|rZoeVL?piL)3j4|%DeXX)1AVfCIMiE2y*d#jV366je*)V@YgvPCV9*ykL zLL+-TK=U!FG(TD=LyWsURPTI(oCR z(X@5y5rD3(W14gi5u^eF4navkQ6r%?2Q+P+dIV_NI`s%pb~Em?6b})k0s@Kw0g4(4 z6#<&IPCWuNZJl}qD7zUK0Ujbq1q2)b1kgwXG;N)F1Q6*RG;N)Fp8^jNqyhqj-k{Rw zLX846ZJl}qC|%o}m!Tb9wcw7Q+J4KYoQv!K=My^@{O#Xb*Zwtd+}A&Sq~Dgi;`08B z|8+@m-!<1xKYRA>=<{g>w^&WEhNxuec|g+O`5M}0GCNoC6U~F_e$LI-M=CZG-~qz* zcB~(>_NgZ`;&*-a)kE<5KmGF1y=LZ|(b?;N(BDW8m{R2@xn=DJvd+Hd@QSFh_q2pL zdnvvd0Z!kR&u`b*Te0VmlB|zPI+?xVx0{&A{&eu`sHUH zv@y4l&Wss^w>Z*>@w1ZlqL-y@AgiIw6v}Nd1~?1Mfr{4%_$4@3*Nq$c#LseVp}&9e zmHzo_egT#yox9;HmL^F|6cO1XJz{M?LEz`t>+aoJ?^_4%CVU##thiSENP1p+ z!u4lg7!ePi8L{A*;TAhdXfvHWO(_?4qnQzK>nA*I` z;>9ZP%;?~OX!+baAmzBl$1siaRqRZ_(x$Pj&246s*OajjfH_O&L-Lq83v^qgBx~ym z2^Hpcqa_1w7*~C?)L7>7wv@>ZJ+7W<<&U@X83_fqnUDm(`5DZcqodmlLx5!IiH!gz zUB*U$vYT-cAdMJDMgaPu0R+qg1V~{iG6Hlo2#~TLWCTbLn6MEbC0W=AkSsls5gGO^Tm&5_KX*$GT_FU}@$Ow>hao7l8o^#j;$e}@iq>IBw08MTaPlEty zbRlwXqoc`f&<_nDKu{4VWfauD08vedsE$Tdd!#8nX-lKNGvxM=rRf{m>S!CQklMJU z(x=4_A>*je6&k8EwI`nDPD3x(uudmYiA!4=H7#||TAHX@{ygLYlAi%`Yd~_ez)m`O znmo-!lMLu+;%8+C;Fi-RBN*h=#?6dimLX>Yk`WAc)`@>?CN}SbNFYhx(9yLSt(j=T z8uk_g8v@}p$41lE{mW|WSRf!hU_u7ktLTSjVsjlJz(IomOZw9+7erdFqE z>(oE8Au2q2h_;R)z(WM7%X1nWe5!H0iyx8|S`1TTQ;T%9?;@20Ov=z$K~(W!%;GOB z7_ZZGO`3d2Vky^mF7ot(8wN%w4!y2 z?1*|=O)&Ibge+Fxh;^r$a zel+0ML!-TZ`C#t1ewU6dxqt054~O;r+}ZF|-?Y+!H|8F5y>9OXh6e4<@J2AS@XybD z*_Ig9XMFWTHyc{4zc#6&z5eQlMx$8DhnRcv(+kt)94-S(i#FGU=R&{)B;)c>W-}1w zb+ZY`uu-4BG^$n@!ozAhKQtf7W$v9)rkm>A!7VTcI5)QWW}NLaW$a9FO<>jx6UR*H z_uS?gdH=riv7Nuz8L_{Q-;%-c&9EJ%0+mko8u<>>^%&>fv#xFOw}cu3ojucT*O}~5 z+t{F+L_R+-9LK3G4O^Ot&6}WjD24JmNl*A4!$l35qmzByg>#xdShyPeX4>&J7VJ5^ zPmhfj9ZeSXzuBH++|s-nX6kx-UQTzq(WLh)!LmWicUZdzHNH0Ddc`{X0E-%5=YiGl zWHEaV7Gq-{PTlQI`Z01niarkxGsHV1)R>{CXGSybN$*#%PYsK)e`x-SUGK-OGVS3; z7oJZBhnBXs>;8WEYYu`#53>Q8v)Fx4;=wCQGlc+#6|$~>BB~V zg9ZV&XNG>q2tYqHH)#ox5g=&^v5QVpJr5fJw>QZAP78ICmJmA;khFx@2w+-5Yy{|N z5TIE5GyNq}0S*7q+@vMMMgV$RBi5ZIEg?1n*n?c`DBw0n3*TuiK++OoBYeao$nZ*`_4~c7E>+>pMYoYnztvhh|uJy`6fqiU2znpos>FB50zlgDB|K zmZrXKdPgA4ZU{^8t4%LnbYGS&?&jGIZOvg%S(D?0!;x@8_9*jbe10fL=)NFE^AH7@jHbF=A~$$2F=pfUKnCS=`F zXxnBwhQ0-`^C(U9rs)xd$yY?B6!h{_RIRSjcuBILc5`Rq!kxOK=QVBJq|v!-#9rt- z`D^!|cr@XslLt+HU~=FLOCwoW|)en%y|^j9gV(fm>Yv(b+B)?J@DM?2{fbK7ZM6p-;nU#Rb>;Bst%WcR_bN_PfLEru z3XMVLp4L6RhvWRbPd?r}y~6*&^$Xu~O#kMipZxCFjGevy^Bg}WdZ%yE6N7&r+JEOC zs)r5_c`D?Eka6$to@@HV^lDW@^TuZu`0lYgTXvmEy>$6NkYTi;han_o)ko%@h7XMK zX8(DoxY^0mINzz)HpUqIoI3>541WEXwNE{{+WPeFFMb1-30|ki_NsnlTl#@T{RGQ| zJ!3NZZRz)JzeAgcT{vB6t+hU$x~w&}ps3ep3maE_awT%{H)s1=hFI>l^ouBap1UXJ zq9v4DcVM3L=jJeHudwUKgDkxb@xt?ee%#O}ewJI7wCnU&4<`85re7YqdeQw8Z8P5Q zBUpe;eaE);t{)W~5%WJaiJuIPuHwVA-zMcImKM()pg;(y&U-L3N%>PZ4cWCva z&xjB6cgqj+bNd*VI8&Q*PHj!JZr;6j<)N)B9Kz4HqNu!}VqxjR^aKTcR5yTkF1@u+MSg^k=2#J}MD^zQ@n&&&-WXjWd<~epeYc@W!1ZAgv zz43zI(apQ}h#UH4`0HZ>_YLREZ8UpDln>(MZ^nKayKd363imEk2@HOY zT)gF%X2XHHtyz(aPoqHKRODjawb+9Fj5YPK1<@$S=G$0T@2V41*y)Uhzvjg_mpOYm zW4U{`>V2GR>vklEeY~U4Qd(dR-1B*$(K&=0tp^VfJ|N@1EpPNPy*>5A)!>~pAV2db zw#iXm^Qwml-bphuyhGaaS?4&>S{iuddJ}H6zR+C26bnMx`Bh-D9yWG_Oj%P?(n7ln%x@Hz(o=S#M2<)bs7Y~!6!gKC=CKWAVGk#n{g2^fCd5BhXxRE1`v=$gMexh z1ccKdAcF(}R+=avfCd3J5(Fr_85aRQGzh>xG=P96K!Ae=0TBKZBm${42-rx20GcQu zk_G|CNf4myW?TdW(jWl)&;SBX0RnU+2yoNX0)lA}u$lw`CYmU~j|Kr{BnVJ;GcE#p zlOO>7&;SDJ00CAS1YoB%jghTT4osp!z;wH)@#fV`BLshyqiBQ#q2RKR-b{!B zf8nUNOrU!FCbq96;Df(VBtkq$I4^G;%*0#5UnqGe|Me@M?2cS)W~wUq3uh|}Dna~B z#uF@z@e|YXc7nHkTNBSB9e+)U_OGl&V>yQ=-&9|BK$mX<0)&EqEO^63fTl!KFGlqc zB^pD3Cf`(#0Q5rx2v`9KkOgnJ2+)*h>Ji`}N;HN5O}?of0qBPY5FosKkp*wK2+)*h z>Ji`}N;HN5O}?of0qBRu_z5r60%XA(E&}{$ngTTH03A)?nW$|q%R_K`0!00Ec{k%e zye{|8&wSaI7$v;P7G9UXt-LN@e{E7leXcO1 zK#j-VsKQx==ab7;Sce+I41t0zN1EW5@!qw+d^$4%UYAeJ8&c_&RxMa&h_A~B%CE~G zwT%s`$QCT>)y%K0|6t*^cHedF*u^0ct$!}{xIjgef@MlfjWvMVVBE*qli4`It|LIr z(C2^VL$j^HDj-1SCN2Wh%&+Y_0#teIbsYf##!KG2lfQw1lF_ac{@*|D^$rjqJ4WIn zK$XW{*Abw`nDPz~An#^e1gM!*bO#8)J~Y=KuhqF7E*K{`dT{(QakQ{I_pKiqSk}ca z#H*ae+r@*Ub{20J_nO*Syj^6PsZn%roXIkqA0GMJ)sJZ+`56AHx;e>RT^pKjqiYcd zSMObQ`u64|cQHzHfK_PSi7ivhF5ljqb2y`GGg>phe};7z*9IaE zotoLDUHLXyp({+|UA^IIW6aGe!Lcby&o9B*Y&_=Wz6D? zDdyW7!ud~pXaE6U!jBeDg8-T^EtCcUYG#Rb9RWEs2pB+;+bEOqaB~}FH{&8e%>ceT zKmhik0R)@@1cZ|yz)BMZ1kfNr%`CC5BOr+e0X{ScP%}%c>rsHRn{g4KW&mH;5rBSZ z00B7=ZYq^j+@c^&S(v8@H+3|Jlc@TvEsgr-u%|3dR4wm<%vP@0CWRK8`D<9+6r%Do zQOO>=V#~x1O3wzj%B?MpdL4?VEKPYF?|@u@m!ovtK){bA;&f+{lxp~Ll9C`#6F)0E z0GBl;n&?R<=eD@nKrl_#iGFMrRhrsM`1WNda;Bw+kGaxkXU_HuOoka=+v^=ZDaS3- zoD0n{&bwz_+tl^0x~8quv~?668%>a^Mv%Iwl6OKfAWQgg5uj=7)FXfv2MF{=S00M-1fSlXnB7i7S*R*x274}4_t%qpqSf$2Flh&XgnwDJthRG7M zm~UD%s`gz$?f~Mab2zzxd#8^SI{T4IlNNv;jyx78CulO3~ zIcGYfr;EKkn9$Hgk@z9s+NM^vgr{ng=x6eiP;0 z(VHQvR#(*a;^UkvH$Zq^XpWhCX3m+iW!znX`T_2=l^-o_T4(n)WR6buao2y~%CLK< zl|SCjY9#cX7oH4B@SC5(Od#@x?|k$zAOF~d*f(Q8jU8D1PF78vqiS=D^b`Z{+l;C` z-}ZiKfvFN=prwb)TpMPupWXY4zDG*>gzI%ZBWmnnhDa``@wE}xD+X8s3}H^+me1R) zMs|SH#71zM@HdFgDevU3-GAcIgr80xH2Hzafiu!Gqv8Ehn(}^W-&OX=ID*?=_+sIe zW(y_NV$;RUa#|l<|W4=4W_Hf5Si;u;>am|WrZB`@kV9yc@_AK5p`tZT&f9}+t zr8uNXdcSn0F*L|{X`M09`7w8hTVfV10Mhxy!fyzFo$IjF<=al?)kF5Xen2df~`n}ul(B^SV^J9&Wdr-OOiTwSACfpr!9; zV%_Lkhkkgtb1E0uSk`7WGRkYp*ayI#CCr&#yy(8HPVHG5mDhMl=X2Ntwjb-E0R#v? zniQ2HBS3nJfsFtu`9Vg26fR;TK+3U@5s<@5;n)a}-Y;PzK;F%`2#|6tYy_Ymny6Z< z5Cuq4DKY}2rx?fxkdq%|1W4f`HUgv^3mE}PGzgI1FJU7<-p#lOka8?+1fU-pK!6Yh zfH9Ns^cxuglI0vW0%)QD$#M=G0g@~Z837I&1V~y^Yy`-=85aSmOtg%R0Q5r>RcnGM zKz6o6Mt~%XLq>osi$jhABv~9b0wh@+G6Hlo2#{oP$Ouq&GcE#xX%K*ZXaE5a1-Rwx z3AY?5Jz&H}08JDi$>OjPAc;JY5n!c3KmdDIhK&GuH{&8edX0%41z;bVLR~HIwtf_J zgiiyBq@cb#bTuygs_y7{gqpDXRAcU2#!F9uSto3Q;-ewcN>Dz=3SWVFw88mY_R9Ez zGXl9v4-g>o&ZWWTa^e`9D{gP0D;L8m<~+=)Yh66g#O zMbPL0l-Plk9Zg`TiAL8*4Je{OU0WLUy+Kb|n(ACW6?)w!IUbA=jYpCCw(|Rb>yft|Bs!lN$>x$^Bc)F1Mk>?;n2c%Vk8T* z89>t25am%sxhGA&EXlWVvNT{gRM<|zWniXbNRh1{O*vK5BWij?VNeY6 z1ugrjBS(VhhXxRE1P~xAxNs2=PlEt-X%&+s)AS%TJ)(L^vb>v-CCM~B2=qe(2si`? zkQH3G2neS^0J^kFM1ZD8R3AGh$z>fxYz%A@gM6ZM8C55k6|h0 zuT1VU+3USU&%Q7s5L`3D68vgKmjPQ`C$1S2c%$i)4gu6(y<5zKt!oQFQYZ0l{e^bsuL>HgY|R zJ{P@4(#ofDYrfuj-_HKOt3L7R%m}c6mSu(`_* z-!hOFd^47}`DTb-BY{P>h;0EG_icH@d;G4?_V>$Qa}W$Im}|zi^p1uWRSm6yM}n7z zOq(uF<^H5Tw%~gAf18S}B_=SmNWCO9kl;s)hOgx);avd8At~D7~r}l!{&> zshs!uMTz&1NfcMk#WzFr8gco~(g%LLe$3jZp3DgO{flS&Oc^^93@w;z#>7qxEmE7^8!z}B-5j<@ zn3i2q3%}lSjE&~7f(uNfG>|tkDD~31)LG7n+!BsCjc|i_Fq^sFsF=;b;AbC8WJ<<@ zsBrJ0!-x83J-zq25b(6gxIC0u%|v;1^t3rz+Y-50cP+NS>^;@wY}r+_@tOJs>+N2a zz82AGy z?06Y|y^>oTY6Y{I^NQIF%-#rhR+;^as*gUBo|m2w_1K|5ZUh$?|NP9CMXQHgw1)-|@CW$OLP-#iLxX?;Gzhpzf`E7$1iVgz03bgB0+ij1 zi+~SE5P*JY00A!o0s=@7kVJz39~uNylOQ0R1_2o)2(Z#b0m^R1MSzV20qBPY5Re84 zh$KOPg9ZVCGzfrDR+%p0R+qg1o)94Ku3ds z-XsWc)6@cjX%MiQ1OX+%p0R$KU0pTPFu+ktPfCd3HwSXiV1gxh) z08JF2>}Fg993w#h`k?^?oPxTuf|@0t__X+8717-^+$6edi0)^im_}O~b!|bRjp8Xw zbD_ZmEiSi=w0&D)hB;clj)>1RcN$L<2cTaAtd*)QjrxwQrz}nNElx8JQ2zQ*= zf|9K9PEmq(kg0b-mv$0GBxGt51$ChH)HSXURCZsW=xR)`i9xrA{xLM)hQCU%Ht*N! z8r!Mf&P)L3K~0XP$LGG8h5${&slNV*erVpWwF*&yoZsRiK$D}XM}UXO(HH_W4X1hppdT7QfDi@9syAE& zXmT|52=EX&8bg4l;Z%=J88ljP;}QAvEX>xBQ!^U-|VX&DoiHm$J-HNG}lKhj-qb8WQWGfN-* z1J>^8-XX(7o(g#(gfy6`!adP*toqW{ysd=Qfy* zn$zYUE}hEtb}*NT_+6iU^$-{{q+cGo*UUT<1Y?GW-?6Pdxwdlcxf73$`V{=HT4EOS z%>Jm#+0t=1mgRHnG%nqk%GvdP+<=IhVDL-eMwtB@e_#SrT;9L$d~D}0c1AqrKw>Z;6^@*(EXl;b*Rw-wGx4s-s131apn z{S(hUG5?7L&kh`N8K!Wy-_5wBkxUSucZ3ERFRi&`fN0z>j8?@r;WAbfAd{ zko?@R5x`6k(GkF`kg*X!baApFPuK`hb~7#lBojnz1YjSUkVlj`_WJn!qOnYbq@Pp3znla+tt#?#virIso=gQ+5Du*N&%& z19+Nv(?r8(^kW0F%jQ9USm~*wRs{Lavjodt?0Y~*vo=IMbs8OlwlrN333AC zjGqVb(>W80E*+#uf;{jkFgJwyvoLD7I|z#q~H^1w=_5elz6u?0t6Sw*6*jsqIv{qdPMaIKtD85 zU^@s1kUO`y2=EYT6+?igM^ujhO^>J^0qBPY5FkVWvVsd20Ujc)`cdc+Z5wq`Ey&`i3cP3l}DQg`0t!{BH#C+qoIU@w42r(BB_S$;cnN9o!58`r0N(dCe2u z42H>W1~W1&(T$-i(#E@>+`4W!K#dk;&fvu9e3Xqqtp+F$M;F$)|ZLKFOIGgdFUf1+)M-~h3|kL&<3wYngy zHO^7Bxdp0i!(UAPVy_1T&{(z%x3k?d17daiNhY<(oR&UB$LEx9SZI60M- zb$uUyd*^du3BI*poKn2#zARf@l#gJXGEgy28Ghk(p|19P%wpl06v0M=Tz<-Dr6(&y zvzaM%1}?~ar7$o#BxTh{<`8$KQ%4f|)^2 z@p-+mw4h?)Ya7j85#?Fe>%59Sw~sUgaQ=qXd#_gnS$Z4dIiJSkO*`+~*}wAh?0=hC zH0Jah6Z3{t`t+`TWLx@yNmHJf@oYcYpl6S5c2G-pNpVOMULvi@`?c5N@i_YWDgB;1PD-eGcE!km#07g_Mrg;oB;%c zlORBNCPfehKrT;#0C-zSfPf?#1VAoNfdHsX5g&A14FT%G^{=!XUn&;$rbr9l8T z&{)O^Zwo090B;Kk5a6Ie0K6@vKmb&x2oRv`W?Te70gM6x*oOuXa0(C*Oo9LtO%wpn zeJBtB0&D^V=x7iCl2rl(xM^wu%5KI*06Z!pKmhuoDT!~c_o@r-FwBFa6@y}Gp#5earE%3tq)& z3qav1_l)t<3#?vWToN+Pic#QnznE5eC1&v>OcJVPhQAI!!3i2uEe%n8PdXIPi_HR?F=D9x#N*)$I?!KOX*S)bWZ_Url|Fwtv z^_MZlUl+EUvl^2gr&V*t2w z{4Bxmy^M`!e}gSiaOZeTap!ox`kkzrIKCvL3Bs)HdtTcTd|r^_#}v=f8;=znFIaiV z-1oEch1ctXB0jhGHh@#ZX#Gfcz0I}Je$Om@AhXT5C+F$+z8IJH!0*7F;{|<4O2&3` zfZ)#Y6UCil#?ri+rIl9jW`J8ZG%WdxipJ0&WIF-{pcG+u!`v+?MRDn8p8X409H6r@3F62YyzzjPvD-%X=MdDP0Jr zFrg{Ob%|VY;jHAalycFX<9FcBap-8DDPxC&p~Z-l^u6W*jiRB&Z)8J@$9(*jz@*%! zpd-OFhZ9UdCQdCqx#?;=3}xS5wbyK!Gi~mf(wWnHU(rY2XzCky&DFyKMmjspgZQQT zrsE4&?lt=|caD|uyFUGDSc30+-~w~V+^@(skrQ2DdMPe2kB<8ErBSsG(Vmv#)c65k zX51a7E7H}%uea>5&9!d!#@Rhy)CcX!v|n??q?B6xoM1kbW_$idO@=+t(zD1G!7Och zKK}OaK3oqjF#Yp0Kefej-ZA=c!3AcJ;sSHv+N6s5TvNN zF4X>L4-FvTRrt}M8$y5p=A`>0s-=F#zg@1_9&tN^g{y(5NZK19*-aj2&ahx zz!jPR0ah9WfRi=_0%&Rh;66@)0C_hfBY-9fKtD8qfL3SAo{TZi-8uC`xI{tY2t_U4Gj|7&?~mT%)t<2gvKrZ z^@_@Py);wB*A7E@KK2oqcmTig@SCra1WDtC3841XWyAmO z%|tb=FOTnwBC2sXLWTd$Lhs3{{BmD2_OoQ;> zF^h4watp~;wh}D=wgyv4JM9*3O)!`y5Fjd}(UcyEDo@(ds8@)2%F#MC1IT_VOb{F<&(y|kL9 zmx6w100GT_07Z$0ihyvMOhA)}sei_!=_=JDfTp~OerNyzZa{#dL_ zXu3-E2=EYHB_QBiK!8$0Lqz~l(MgktsYd`!aZ}S(s(&<&erNyzf>D->=%+wked=Y&_^&(tqmZ}+nFwG4?Ug=gzAHP!%bgK-~c zPd0KriarmHcY?owK9~z&@nS~&uFv*^jm1H*v4FSuy{jMDmYzTCSXm0oGp4-U@A79AM|%8m?=ijE8=Fg^m}IPcxb-@G8odyZK~ z7($)V&Sl(Pg4e?aJ~4S@Rq-6-YP;T#TV)zmn5J)9vm!Z(J;?We{Oy?^#^yax>3w=^ zv_5=r`kxo|7py=2s#t%F6RkfE!=xIRx}x{rlej?eF)3Jj_?RnwcIIrqz+^BL*qOhb{E?FP;TQhMC~V0Inaa7u`QmbYz$zJ2LF= zBRVp$A-Q3DR-N80S|#|`6>;0mSIk%RJyO8yVWc~42lhKF~725M&sg@){Vi7>=95&4cO^3oT_XbMKTg-43qUoL2t0Ih^6uJLl=W z&xIuT&d<0!6r57}+9pSNO&Ry*xaSo|hGC*3!}*xS&^#1zhBhmWt<^^B;ohZ!QdpvKomT(1~l0aFgHcjGbUVo{y_-k}t*nAr;!GXolJzlrh= z6)k2Sl`Upwqze`^E7Hch;6;J|)UwN`MH$&T<1FVyZVC5|`R)iXuNlM_mp*?q?U<{V zrF@9FC%<$~lg;JZQd+_+W`-|+>^2S!pu!G68eFjAk7kbx7iJY9eH#!h<9?g^Tmb=a z^AR8bZaxYGKpaPbfQuvufE$Sd0rGA}MgYK)00HQS#tr%b(^k01n--0#eOEx|)wuAh zI23?^D7kMLFFnOBwZy8;VGfMD)BT6E$`4}}i(jTSF1+r<7L@CTKQy}bi=ZQwEZ%_c zbrONl^|^f2j)t$Yo|(_CX!u@VphN!2COg*EX@eQG#yQt2F_^|fekpP5d=2DG=U8$d%01VBRgsvHgCA^=RFC=fssrh&qT0s)}#AwWP54FW)~Mu7l%H{&88o(2Kv zhbF4lDntP=M@Fm(;UWMOJ_HD`(nJAZ0!4uUQ1}oaAc+P6pjV?nfV`V=5daDwit+~f zp#cO4Q2-Rs2@n7Z9|{D}L;+v|MS%cN_z)n#L4yF$t5G08-p#lO09hOb0?-dlR4t#v z9u|s+6SprAO!K1=b<=1%kVFkAZE4guhdpI!%Hwzk^lf=LdXA~h0IQ+y??JMz9T;;E zTmx<}<{$_+1Y-_@8ybu`C_4Ab4iM%7;5EBVH1URx=C%Pp8;Vd6{n&uvn4k~{kdCJ% zJ5g{LLDGm=X|@1*Pn98!rVkAQED8u{OQT*T^a3rZzM5UFAno=n# zQc|gGCD~gop-D)o2$jm#qLRpHAx(@W(drzMDa$0}$k?)PGyi+$J2S_@>HOyTyYK)1 z_|5Zro##=<<7>X(`+9$``?@~&=gI?GM<5TxG}fsv6t}0r5I^@8p^-hhqmeyYqqz(P z%}r}Sa~VW84TbCx92y{lk^ozc1h+ZB)7Ei+ZiuI? zKnXwqTa5%40X%IT_Xyx=>$pb%do@Ew02(O@^q>I<_yQ2XRwKbh08d-TJpy>zI_?p` zUd?b3KthuRKo1&#fHHspwi*d80(jaw?h(M#)^U#j_G*TV05n+u^q>IL|JMF zR$ri-{`tv~>Bd36yKZkiUTqxlp=6}W8r6?eE`G;dlp)<-S-D_m;>c<}wM5OmMV3Vw zn5D%44+zI>NAFZ~r#^-jA;1JgJl5|?Cg#sEmd)^v zw}&6Iv>50CAw?8vJC)jJJsJQL5S^IG`9hjZe~v*-K)`SpRwkd5#<0ScYEUOfB-$m` znq!t013Vy-Et4}$2^xPHT2$!*6A*#I)g~60KgVDuAnlwpUo>*NZjOA)w^BahLgzWo z@^MT{i}C@+DaKTFvT)n0zYHz31h=i82uwg!sZ4*4K}|qt0VS+cG78-*Fe#C_%d3ak z54|xh@z3GjW6cUF{lX$n2?EO@?Co=O7bq1{w{LV59Fuh zV+5uTjL!h$lwFC%=4xcQzg%E`P6s9+K0l_$6EJ^{!AwB9H4o#k7{*h(F|!%(Qdy!j zar`Hy4@~0#;}lhAIqF#VioaZ7B7q6W1z-Xq<;*m-8Po&>zpkE@$p?By9R<>*G6%wc zG-$$G%)m`!0M;fOHUgjrO?V55fdDo);bsAt8z5{1kkBB2rC5ZG08Ft68v!iEB5VX;r!b%+ zfW4aGB7mh>gpB~$LDR9KhTcOel~19&FNtgc270}Ty_o4Bgn|$~5y!IWV^9Dy9fVLr zp*!JOrh|;NhG_|5d>U&smvKRJnG`h7=1UaI+mHb@rXeJZIx4<_ZPUl735GHZAz_pr z@omiIWis{wqxQ@+goIJzCUvtVxC}%yO$Ud*Dy-iX2ukS+?APZprs*JzXTzv*W7dYS z-)o}S0aMuTHB7Ju`@M!^Z`9zv*I0rz*zYyWK@oN`$XU&B8$&FWC*))he$eQ5(c6Fv zJ$5p`Yp)r0x)4$`1AvJj$D8lv(e@6m8CcNi{@CcFg?(sUZT z`jCKmjX=`XAS$JxDL=8CCSbp9NNhaA&7OFVhI?hzaCtP0lSO?LTyS>-!$n%fOgEy? z1Se0A$o&hNr$^*Q#LGBY1Q5VhaKS~uaFJFq5nzS}0X#h-_XuFGX1K)-5}I-V^q^s! zECL8%E4bhyV7N%Dm$yW$UOqss~Iu^&?ph02Ms{LXMg~pkf9f)bj(Z8Qd+}PkWl14eTELv+X+AGz{WS zY7TrxEQ*-U4CdAYjV6SN8r0FiJ)-d@Z$ngBi{1kBEauyBAoOTBNY zT$`6?zjg9|umbwIlZr5WMw~G_6X#b0+*wiy?pZ4ceP(a44NaCYT~iK93}$GO%n^H= zIE){jUZMK)@jGq>w%hOG5w~0sSU_Lqb3lRyTl+ zfPU_zun^F1@&Y6T82o*pm^#C12m%5y4Z-oJkP(2@4PYYxde8s_4B}1-2?4BjC~O4u zoBRz40cL0r(9fL|76STBNQ8s{H8cq5=S~VK3t(voU?Tu}&;SGs;!X+)0jzc?Yy|Y1 z{0#{K6f_9v=S~U>0sSU_LqdQP8U*xnCxwLoG+6-jpaBT@40cag*Y)^QmO(Kj1hCqn zun~YAkV*YQW0_9EsRiKBAb_PIuw{*4gM?Lt!HT(-6Q$00|8OSQ-M@2tZQ{Fhi3Cuvar=1fa{DHP9c;c%@!E=y0&iA5y>6v)sqw zw776+UIQ%q57_Aj%l-rQ8yYi!fnDI{tN^(CCzkyO>@5c!O~($8CKZGpHody^Ub;H4 z7@+qXVGJV~z=QF~V4^UvX#?#vmYNX4W_^%J$uLS>gG@?>P)8YTQZixa8BH5FDH%rF zj{bN#%XyOV{tU(Z0Eb%d(gZfRkt}yZ25#PJ9`+_{j<7~r$^-J5r>Z+ z5g?!%Ab_Lbf{Oq&DhvTUJ>tL_i~lA`M$?1ftY)~9M+69H00=N+SJB}j z05;G9lsv)lWVYl9^6_Le@*SQYk$VJiRx?}#3==&fKmdi&uVV+NW{q#J9~j{_^etN_ zU}b{lrm-diz!st)3Qj~o`@iAQWYH6Cs@KO&6HeB-*P`$8ARuM5(HZ?4d|r#_UN1W2 z$4(1r4E4f5lL=!o<^VF7$pm94 z4i;RD0f}HE)buxlE#g;_r2Q-6cB&&mlR9!&W1y0=sEc~# zAxb`l*Gk-#SZuCFmK(U4izi^NDTBF8^d0;RcLlIeG3abGnI4x@?_JydOGTXhmYWOH znqE3)J9?*@I}J3Nd6J2_rWi>XN?-F8QdCjgplGXju5oitQ*;BM_%Hk%hcIebcxBA{ z1o7jV+}D$APa{Q8y`ogrS%WO!c5+TfjwDfvDAIN+br5S7Ax)-h%An>veOEI(U5H2o z;wy8eIg2n&Gh_b?_w0H;V%B8BSh}lavSo6HDM4dk1;oSxb4?k{nx!46?|v~~`o9!3 z4IwlVJ(;N3ju*`dF=dQn1;#0Nm>I(dh6x0LY0xr6frI$9hPf4afx&0X;dcflzY+ zQLI1#FSEgNfnSXm9wMZHTmbirc@;wh0Z%-~rVVy3z&58G#M^nO_}q6`Hr!l*vznpi z0>2tBJX9~6fAPQ^Dg>ke1aO99K}7&d;Q<=~znWS#ga|;hA!Ny-U?TvNMGZP!cnA>? zg`LNNy&d4JX1EAIvmJmQG$0Fj3J|~L*3n~H>&>-MfQ>%s!0W4V*>@0vKi-L^+ zOcn(j0XQ@W;H+k-2w>T?!A1b|paBS=fSLoHUE8W!}^lUJ9j;_6MdxI=@4%lJCa_4}((l{#sZl@EE1_C%VFB_Jr4QxI`51WJe z%=x7pbV5x85WNQwy*tt58}wgH79GM(C-2d4FA*6okH#;A)&MdA5*yIR@`bxap}nHf zNKuB1fD3DLa`anpvnSr8;YM3GydF(>3#qT_4eo9L%|hb<4Q>k>QE;N^Kk+o2+^cwp ziH5UdMGd`&R4SiBcV80OlCQF(HxcOH>ToZL&0SuBxpdylfpJ5kL#O~!q+btx9iq|$ zz2w(JUx!F8iU;GK-PS#PB4o^{3x;AAdPA?SB(<}>8W}xxmW7@*v6L@+=uFodG4;pr$^-ecoI*K$UOp}2aSGL0ziNn8UzdzX%&_Q@brk>BY>wz ze0Hm**hn447}qAdd#f2<(8H7u(j?St*r3 zZ*+t-t%S8L0W*t^f^B`71BCHAX<(tT4wgV3Dt3bBw>!|E<^OBHUCf(~y_zADW|){% z0|dAO1hCGp6v9OSYg+;v0jz^1un~YIaPS2JV; z3=@-TfBtG3N1Pl|uT`UV=uV%;y7$zpw00Az2 zY<=No0VJ$40UH4yIXpKCx3TY+fFXxj`!3j6L%xcec@QhO&ke4dr(F z_$}j^RC8Yo=nkP((;ez_dnpJ;7!R-6!cld)Y7M!UjWd3LiRp~d%xN%|G?+6VVp8a^|_c(3OtQYA{PaAl8p~ffmpjber?m%Z?Ai*V~8DUKBGl{WO zSB=UL6vJUOKR8;9#f`j6r9U)FbWE_u7?uq-?Z6uv!nkzc@2-F*v0)kLK~8K~f;HHQ zjVLDZf}Pl4u9L9K8#pv$_@D<3m||W65Wt?q2p0joxuV>(Y;r;vO%9fU9&7|)f;HF( zV5vM|BY?e{dv$ZwW1Xvw$*kxfvbu>h^M>M4; z-lI_)DDnB1dCat7@@T-=B7CvtVU~AJ>X&+!-w+txK&Z7CIvE1?PQ#(e1X(sPV5bgs z$HB6Jf&7N1VeUz=^IFadfV+QUxhKKSH|S`xbUd2fAoQ>Su49be0H*@Y_8WqdKJliC znGICo9?djeBCxJ}`e37icmv-1Byh3_Ab^4f0X%IT_Xt2!dE#m7xG&cZ7eOjG zSp*P(LxKR-$s*XBK}0n{p0ob=g`o>l^}868%t>evfTsV%scf*V zI)`4kK>^)VG+RNQw(i`((c##n<#3`OQgwnXhC9`e%fGWA=XTa`GC>kMr5|Yc%9gy5Kx+9XykkH&T3L4oX zBCTix0@))tG_V&m2H0vOxDo*ccE$mh(L8M(cZyU-V#Cwcalf}2CW2IefFl3_Y&8;G z1Vo`h!2dPcI=XeihoBwV(#q%b@1IChe=m7s%~6SXvFr4eD!0a69`klz_Q-J0RQD`= z17T!C0C^KZHYwe>r^2iBbg5)gmMI1bA&&)juE^Z9T|dJ}^uF%}f|PTnDO0*GAf;oZ zb4ll;j&b?T03cm|!4#84#GSnC)V%_n`*As*oLTR`=fa-Rb{6t+ex;2RP5X4BqO+v^ z={W=`x~qAzMY~TOK?YObjEdTLziMsF#4Un_t8Fb5?R|mQK&-#=xpCUQ;+Mtmh(8V5 z<{DGsnvZM9?FF?KB~|mPV&>qgh_ZMB(Q^CVqI8oT{IwPuJ?-P=8tc!LjtR36w$H{* zCOeRqTWC^!u}wp|(pFnH@z~Qw+N~E&$O5}8KslVTY4F}`vBqkR%^HV&Qj>oGtL;3X ziuoE)@>*y|XA*NL`#l#`>O*oNc`-ry6PUy$LQl=&d!cEmk+GjVYFASrzq6dP0eQT8 zIr9+Htj5=uOiaNcrpw?EleBuKF*W81+(8yIzAWgOu}jsx5Wm4&hq!< z^U4=uF2rT7md^>HxiM1`6blVNJVc7{(}6jCfILpTYG6O-_6W3Z_ebO`I4)m_3@Ba zO_WO|I8}fmYQU)i&7C7vDZq36(7O5-N8eH@;zT0fr%YhGPAn(6kWad-qs}Cc+hwjw zYf5*_suwJ_P{ZEhV^>_;^7h>3#nBS6ejhV+$U>SHY7F6ptdEeQisA-ETg3;Bn{%3? z@qJe_qjCg|G~iT0{l2kr9>whp<#NG)HfR6>PJo*Rbl33>5Fh}0&;SH@0t5iJT?7aKMo=ga0F0mzAixX_0)TrO z3IvoRL4X<>1aMX}R0NRFWC75F1|WcuIsv~a1PB0P6%+^nMoNILV*CF z@ItW>;H+k-2mr@1QEUXD2Ms^~qZR-(F$l5%aMl9_0>Fq=1PCCZ$pU~_1qA}o)B=FQ z3k3o=s~Ii=&}0G7g9ad=7c_-9*I8Dh1ZJ2+Dxw2f913nCT4;!Z6AjRKkB0j;3T>D? z8Z)I{3cVRmqk|E~?FX0C5Ez}#is&pztwB;=$cg8Q{8)3it0rI)l;$vgg#qJdvpU`P zG!MJN=yc;fB3laNm+rv2Tm~+cjWD`g^d7Am@ClgDr8_#RKDQi72fEcQAAACHtjUEd z4T94d?rvs$f()!_4;F$Sl%{=NwJ!Js-dJO}_vpIuP~K@2G)ox=e<_1JpdIw=@$9^| zHaZFz4npcbGYm7Z9S77LjbWI9U@rg+Gf?cHfnf%U<2;eBupdvsG&1R4%5##;e@5W@xei zo*8T3MfOm(CDF?y4PDu?R>U) z*&UbNh0EW|-^i4ct^AI=D1%?;m0P$kn{Sy}+mx*q6t4=~#o{wIiWk4G9*8^{V;%#U z<^rl^e;dImOW$LzTDE+zi`O0t4f1JxNus-XyHBdQ)3051cKWi<2igS=QQ-7e)7Z0X z!6Fzq@OOyT8qE&RnqAwqmomus;vsoFzyK(f>ED=-#pl3DyhDTm`e&wpqm5J?V@VI3 z#5+WhgX%J+Xg*CcnrDOJ(}45ERPZXm4Ay!R6GBYMcxa4f*#$yoG;0(uY(|U1W^{!v zg~GNAWUywy05N_ z8f*lB<}Tcw8kPkBMTGA*0&E13&}0F?GzSF&*sB>X0?g1L0D8~>1TbnspofeA0jvp6 zu(JScEE;SC07V1}1OP<@3Iw3Z0)S}_3IwoMGh75v&>#SM(14?bj9LITND6i>fHmO> zG6Gm*(O@G$0Sy9xA_4&d!1+li0SNdEicXyC44hs* zR80ZU+)}biZV)LtEcWj^sO`1Vh9zB`( z*Z5)_7%Y4T5(RK=?18@wQN>%$!&Oj3sZre_3_)EyCa|pPKP7pnDjW%DWRLA=WRKQp zWRHk0NKg^L)7Ej10G_svdjxP+Gh76q zDGEXl8i0UQfB=pf2`U1d(A3g-+B)t}5A(EjT%R63F-!!h00EBy0???0c-lJdvj9Yr zC!V&BYXl4zK`KCiHE^on1Sizi;J+%XXn6Iy8G_ra%0C?ltv7LxYE}L)LgVL_m4;8~ zA}LMV$4y@sBrX}_u~YAb=HBFVM}nq(HVzz>O)NGa^ssC^L9#7#)e<3w3&>243y2Ea z1!TZ6nNnGzG;#c=EIzUT@hfRN*~i72Doqw~_KWYx0UjXEa)Y~oNI7SkE)iIFGxp4* z-05r=ke$AM%L0@(7^tB4*SRr0A~Z?Jpg@2Xz5? zlBrJ?<}X(^k}{OO=EHUYdBAZ28E{O-n$h3gAu4CCNIgY2wU8`}NZe(vL6%SYrT{!Z z$PRBZ5T?2N zZgO>b<>*yv?n3s*YZ2TnlQRZ&0Wq;qqWXFtoDl1;d~PGh1!NoB1!UmavW3oboaN*E zLH=cpiyi)sQMomHfgsxj#2C1M z{KMI@4-BavVX}I<4tXp+HFM_w+n`xeLjp=aPV!Tvs|F?(6`RBPGy_ukq5d>lHNXgn z)c=?a90UwFCIbfn15$Y?2%w-r0B2*$-p#{7z<^X93IYb~fB&OFv!n*!2E@K>@j6@t z3{c`jLBN1xGH?(uAeD!MfB~sI6a?VVAb_(mg^B>qYUX%>K|uf~#a>YZ?jE%FCiI{I z20<_^Qp0x0pmF#N`bem6+lJBY+<=Fi`qPdI{ znrHJA&8I0F#C34!aYLsvO)Z~bC$mFcD&GJl{?NbH@a=}qM?tP zzN?w-4Gm{MI6&t49}SxDmMF$eV`tEC5ir0F4hjOI&>&!dVhs)g1}N5`q_zfV5HP?( z5e@>_s~Ii=2FN_&AOL#MfFb6Lq9D8U#5Nus`n>?dA0AO14SE@c*?t(<5QP$)h{|=m zM>EKTfPd)?4wpv*MwSpkbaF~u5iOatEO6=%$_skHX-POK8lrLyq7oOHvLNr#3^I)5 zUt|aa4O;%2Q3GrS@L(^%F=v3A2;k6UoCEAR;3R1S>^Y!p251B9IiTdvoE5+^>w~hO z2ikK$$({z-bHI7q;L+?lp@+>s9W8?LY=(=p3KJu->!@(Iojg6_AV-UMdc+~rBmUFT zA}9zLF48KV9`S#aBva75IC*-+frAPES(5xuM~k2!KmpBG08LGhr$-!QHtD~dN7(17v84fNvDpl*_1g{~UIsINGxB_C2_Kw&UDz@djt-XL~>Lthc?W*+1+Ai?%AuEGu0hR zKb51dh1(c{5Hy{1`!7o+9hAv$s5{7B_wV*(nhB=O&S&S_M?AD=I5HK zzu9Jt*XYfmT__QK!JNk#=2^OHR>>?sdGtTyRl}36Q_o+#qT{~Y|=M5hC2ta03q|!WqidhUlhV$GkF`bd2zIOtluw8K<+kB zz!?cS#$1fl&+VIX}9dy)S8Fe3fp@#C(Cm)xS{R6tp{mGZGgVLq5u= z-FGW4>^_wA_cLszz|rKhoU;pg+%9v~G^RU;aNB9mM!cbbq2T?-(ECrd1h=i8c=P!B ze-`>Vb@g4%l%rr>e^4j)6?mipN0TM)S@q+?EQIZ|H5isQzygFIN>dY>sxnoIw&3X% zrJJ_v6^%syx#C{2i9!nM_R?U?UpfA`AuK@SaQ1&TXaEAL!A&zjg8&ft2oRuz1_3XT zARr120wmEO;2RPIa8@&11e`^K0N6nT5KsgVpoRniBs5uo3>pMvB0+!|8UzTVK|nbY z1aMX}Tm<+cK>+li0SIUZ2yjA!0N6kaU~U97&>-Ly5(H4tAV3Zc0zmqYU?ad;&2SNL z0Sy9R2Ms_#9zcKs5(MDUWC5aR5Ricc0XQ@W;75W08k$-FXEnn`fHx8ZKo1&#fChj7 zGc*W*4KyqZP(y=&Y$OOEp+SHQ8U&!J1#ng~Tm+m$g8!oxyG5ZD z(b3#AI+}%sC^!)TjrVA{Z=(#8N7Lk4fbS)h%B9fh6|Mz(56oNlcZUJjK`1RdAivwB zM#;Twobdy+?2dQpJk)~G83gC0!%WkdBaFj5DJ?%Q>~@3Fe+oqNX{u>=L!Bx&Fdhv> zBh^E3dnAn3Ak7Y6@K)n6@SS9|xfr)E4@Nf)OvkFJl1s_Q+Nq4i0Of^4|IB>uHdqG| z+`czZ8lCid<|+oRgN#l$xP4VndV@$V^Q?wW1-)+e_9h|BlnjRgjK)2py&9tZEt;AD z^erK_iQ+vP?xh>U<oD~39zlBFr zo--ypYPrQrk!s0RpO ztKQ%ufG0=eUXeOXItv8tKQ%ufG0=e9s$Edj)ozCr{Uxt0nmfyU;(o$z^-t^MF665Jx`9t^?6Q2 z1#X^(lY0a}4;p{~MlFD?dV`Aqo*a$)EC7vsha(e%+Y&&et6{HZxJSAX$;6-s4M0FC zI0ntWj+q898afC?Qvh;AC9g@z_Ld9ugPHP=_a4xBD&X$X92*~V_){j@CegP>7I(SrNTt1q>QpY)+!f(m4#HS-_cCdB?9Zp zryEHbN?-F8QdCjgplGXju5oitQ#51TXFsdWT~vMYF>)(mqdQdDNQ#VHC*6ansQaVODmvlbrNSEIXsL-V+4jf^d zsA*ATQIy3;76>!9?r9$t)>JP=l%tM!Pye6q8@*(}2-_rb1fiBtYcbm1XA@x|&E4z0 zYrB7`h_l~vb75N3%X;5Zp<;6<56oy{1#lYC0j?QBg{zlYs7>;@eNZCSU-{fSZC~-r z;&;TK2Ca3Csc_B5*9{n9JLHcCIH8gTjgS(#|iN~IP0t`*`$-?~Q%Hck-)80&byxC%n)f$^M4*SF> z{{W93H_)3LAJp(k(g0W;J44f0dp3@E(~65;MSsB>W>6Ok4-Y@8pLVwT&W;&JaMvmx(<1aW(7%x zeBLF2Tx#w@9-Z`60r;7a;|U^deP)W;1FxBQ;58%Jmbq$)kkZZAGmmm-8~tV|YdFzR zZl{mmvH+#Qd?R68W)MS17&ncC;@RkT1@;~Mdn_LuE@*%eH-k*%g>lnp0VVw%@E{kLx7zn(xsK#VI_dc$H>cFDO7+5q3x|dIx_h1dqvGN#qChC8U_OT zIpD!UK);E+kPy({0S^)a`c348gaFQJhKqoHwvn(906l2*yAl8b%s{LFYdc&UTm+N{ zFsvqMPPtQoreFkPy&+IvOMdWXdy)8haC26A~dI zfU}z6B0$)MY1EjLh7Co4g#hS5quap#O9l|kTwFG)eIK_{idVALICuj(eJ{6x-*^qelF4l=L(@!&=7GG&ASHC`x#MA z!+SK`bsrgRl;QGd4(8L7L5Bm!-as#_@$L0w$WQ#80Q zHO>lv+elGBv*i#)Qmdo+At?yK51a57Jm}if*jZXa2=E$$)=fo}a-vDo>Cm$@CTkF7 zw!BBfrQ8YZI)}@nY1gG!)9dPUdns8>(V@T+Fc9e9Z0O}s+IE2h2l7JL;DYH&(V;F( zt3J@RIqtUZp$80!2(aqQf2+x`>SJ^VQ(q`1Kd*yh#JH^JtFsK?%AsuZY=k-z*Ok~tmm)GxGXpviA?^xkvs*XN7N2%^+;4Qr>anGv0-wAIc{BKGv6e=%mL zlTTsY+k_+>c8Jxy$nw{o85-2l-QU~|1q=o6H@^O85(yj=F8tat!P9+RJ!?HasKX90 zsgs}n+H0g8YuT?X0ZCmWas+G9G6C+Gxay%-@#XeoO3@ z#Fp}q`%kq5w=uo_e`Pb#7Er>5^e0i-#Bo%u0!z++AZ|J9%Y2zU%`8Y?S- zi~v@S4I2Sijtv_DEKMd^8*_J(1QjbfCv!4 zO64IV0D4Y?WdT@@4IKe!vH(_&4I2U2juAEjNNBPE_G*TV08C8^8v)RRrdOBVOjif{ zr-pLZe8v!C+u{%~#Mm_%Mp_eC#}r%v#UfbInEDRF2CBEZjjbiL#q8QB4iGXjK zOUQr?Q%E-S`!wLxXpQDF6f`%j0nKIH(cHAh%WJCSnIoA&-67Pa@(q-Y8oe}0l>X-UxnKp$o7;%#ZG7gq33WO)rof_6ZfX!%8tau1}Z{x*0 z!2&z6!C^N`rXb=EBXn=~~Gw7zVE2(f>gE%xd4N)l_P5Xgm0|Ogqyhp=* zb9lHs8ov-438)=d_8g`TF3b@GFv?qu#y!hv0`_Zw^Um{ zZnK+Z&;q;afJgJT!J$b7p@&U*G_yU(ZbCULf!Sq^JZ06dl~q_55>XQhP2+C3h~9XQ zMwrO09&x-Dc-lJd5x`!}aLXGf(ClrX z2Ms{LQ-A=r8VN1}c-lJd5%B*@Z5^GolUNs2u`F*)&-N#$2^8tqo2RcmEIB&)fk|QO zr#-z}dfP7S_~WctwvqD00J`UC=lmZJpG!B5C;ZmwJ$ujdyrqk8cW)H2j#NCXM3!~V zIAJJ$Yi4x%m06c}3lyF<(r%sllpvmzsZSOz^pBC2^-qok*&=8Wa{Ee{t8e?TSU|COi0REmXsar$u%US2+q7XS5N-ttVa7 zoaS;W!a{~BBQ@1lTgd*}me;nRr9LCdZ%UkEBD)}R$j?1%w0^7{*-Z?EL8o_V)Q4+i^ZAFgyr@x zW%(-uawE*G$z!|Mu03=8;;3DBjSf#WlG`F!==U*Ghb*LNp=P9d%VeKe>~Dq(Z`rOX z%~cM6viEp_lXYcU#`%(WLOa}^c83MXrhNV)lrrP+;=>|wzQ+iYlQL86$S0r5RVESS z?M3Ady&9SFzdW9jmeAydht=k@o=^SVJgR0Kto!DERyO6D6yc|ByN3M2!;haz9oDO~ zt(>?+xYm5Rz3-7C!bm%fTn7tH@?`aI=SLr2SE)}}NIlhiYucJk>%Hb|RY?(x6}j*8 zW3{b?qP=efK_*tpaLxjOZRcZT4Hw^X+&4l0%ly=uz8?qja+?7jzH$1S2c?vwVBvi- z&YctVAjr;qPMmiuLF&VvEWWtXDapQd=I-P(3&-cm2We(}APBde^A}q@b!^hc`<2=; z>d_LhqW66-5Tu+lO=FDLJk6bAH2>EAHHBxM2N^E0$!WPu`H-9X68bV=MrkOBnVln5 z6P)n{U_I>GH8pw7L!F0SPYL5cWf?DV5s@P}dzVNjdDmGeepoWaWljAU&8)d(H5KiT zJ`>0b?gR_p{Bm(a%!+7f^-N>3p!-b|@xp1|o3qbc7vHA%Lr14PTD~Ccgr;J<1e)kE zwbXIkKQ`{gm)=b|=S%Dzd`l!!CZ_Ox%3QWXbXR%FV*B(jB8PX8$0zw+SWgiV-lB++zOr(uTP{wyRZcc3m_f3+%E0UOTpHjn0kJmQu9UF}e^VC+i#HywRzv z?tF$?A3TQ(%oy*USFHO+3|sNIfdDOYTa0KKus;sGjEeaxEkd*mCL&@e$l6i7 zO6?Fa^a3J=veRnFc_{qgsl1DK2btR(c9fR3T=VpUmcLUFWp2rcqLg#n;O-MV&!Jh? zyvOrDZR3W~<8kZ?163UjcKEmyShvZ;+y26@f-v9NoR0%}`-`Y}RA!FmosFpG=I)IK zZm3F?BJ5Ww+;>7M{NO2RNd`4HCw8s_xrB)59mn}NkW)8AsX=Nsn(Z&Dj7l2KzNZXP zBDxFFz6W~n9C9g8pwXJ}MGt62`0FLdET+!JXN1+x?a_a$IwN$$rwv$XxO~IC1Yhqf zPM1oATryJ+eq6;rBXC2ck9GN4_tR2>n!(z|clSB3vNG6W`1#VukEg$E(X=(NGRw@| zcjM6l3+v2$pZM47BigK>DFIxwEsvptYeriq=v77DsDSI6;5bt$_ES7bn#ECD584 z&^w**Jsq8RnRE5{-kx%bX-{hut-OJz+ANB1FDgjuxe(bva--%L{6VC5E$YRs=r~vH z*;rTM?G)AWm7-PayAiFU$~ZOe6K1mt+K%zyMr$) zl6~;aEbbE8~)UGe^1L1d2` z<$7-xk*2$;^E>!5$Im5)d8Ne)X4ehetxq(+Xn0qbMO30q>A6O^7Kr!ArSw$$b>G!$ z7PVGT=&^}vvZjTA-*&s(m-g+H9z5Re1RboSEbvrad+0g%_T~w+=B4o5XFS9;Do1o@6w}`5^zNu=pYftS1vnIdIY0o+@7xb)FrvIFJ$&Bt# zS2a>Q(P>4Yj*dyw!nd|+kiJzrnf3hi4*uMnY!*rCU954ywdrl1{Qf|khg(m1Z4s#~ z$Bfib#ZP&hV}^I@X)U7Ajw{f6zJ*d6-c6?WR5j(1zUSb3Ms?xoU7ew7QQ1XKWwhf_ z_|9*kX6^4H@tswjp``CWHNa(4d#O!fYJn7wUR4@Z0bJGZ#^(wJk`}G0sONHX3;2jRHYBDgxH`jXh^wej+*LdFSB!8kkl<{Ab9+|7@p-#HERC+;Z!#!MTcX^Xsr9o@E zTH1O4-j4F9GI|s)v;g1!-t1K_t);1e)MIsqnoJ+LS&v_!{x|8A7cWIe99@5P#AdzG zVGt#+16i5R*aux!>|44G`*U2Q7fWb zzrVd;dF$os#)-B&y{0&wlJ~e*PQdSaaq{c=vTwg>*(?#yy6a{_Dmat!?jUZB^w@7Z zS4SQ3*yg{(iz?tRH`5*4BH|u8UIF&v{^bC*O>3(Zajrogy~Yc4FOIqv?dz z#p6#WWlWOq^w{gWAY;$8xf?giTZwEj4SPCUYjg7AD}f&gg1EPy*3!6CJJ+J`ok8j$ za>?yJCz?(4Df+f;z2C<%Zqw<5^iiL{O;|f>#4m2sZv$=<^9C(o+@Of-d$vy0op2hT zLF4!D&TYwgw@5lT^O@`)rG@Wj&aapEn!jb_tBH+@^b_kWzo!>B+<(-j-*hd>Gw;at z`YRd5_o{9+Z~j#4_H@~g>)z4Dv$hx5s+)Og{y5RqLEH4F^QW-aw(2{L9{h~yzP;Op zG9E9dW!&1{>af#s+4~U>S`FKsAE#(iTR#;PA6~js!N{d5w)6F-ZE8wk-;29;IeBgm z4f))5v+9<0$n@GdO3mBas|Ea8?Ow$=I({$s8GXG>?QP-r>M6%kuG(L(NpPxmsWrPj zC+b%Dm1dhg@ejh@XFM@UJOA;W`4`owyH(EG7Eao4YwY$v3I9lGXee8>x@_^|j%8-= zG;m4Hwtj9)ev}nG$O@fb_N2h|#CJkxub=4KY_*Qp9Yyaog&tFC8{X4iN7J3AhqRpc zy4f@R!?)Ig>l=%Mt|Z9ajn6$dEi1!0_wDf|G4&efI%8kNY1VdINzwu<4jV3?d`#|; znQ6y7x--%3#7&J!EnljW%se7P18XA^H1j6n<6|50DCe!+Me80lB#(7EQQdMP_5PK6 zRe5F>&m(raEle@9FWYwRL8twZ;urfx7Zjz@ZXUNUZ<%5cuq#PfLQd!QL z=LQqz2h~a5n;+C5S#edM`{mA!E$wHI1pnsK#lLDwAx>~qB5kc$ZtJNjV$>O{rhFy| zj{4)o6oGx+qN}Eq1dj1KiW4uMQkn<8NDvrRb7HDMwEHHp_3dV-Rz6qE_mTc4AEf@| zV#Arm)5d5`i$5^6T--*7Up#QV=CWMZH52n!yu@A0vTN5}1BsmDu{81v-ZXdi84`f|1(2i`ig*{5r6*y!BfOKq*hI7 zusgM;SU8jYPm7yPLDCbO7q?Hp1i$3Bd*Jdp;GaAJaCylw5~L~M^15OIJt{f}-JZ?7 zZLS+2=v}*PmY1%CX>wfrE}hAzVkeyUdKA8Z@5h4u<0gDRKYxepD|4IQMn6s2zwxVA zm4o?GHvx@#J{biSSLciM$nHHj)^gnBL%&sYDop%>TXfN{@yUnZVqRXIzxnLKSIU?F zOqQgE_z@(0GD5yzoxelym2#MT$diSO1l`89YfdwIpz*WbB3HschjL2Wq-x*I#rp~~6%VbNdhh%kyRfOk z<0pp*3)w7JdK)~|ZtUa;@U^w|&dsxT@@ahv*4{8DK2GXN=~T-(v!Xxd*H7xwZT@ES z;>N`-daCk{x@O;GQ<-1Cx6^%F{u+F3tXHF_XEHvod93dflMQAj`G;L|)s&+Pw{+zP zUwM1WWWo9ecUtbunB#Yk4t|+Achu(CEPWxVtPFm*uGup1-CH+rUVr~iNZL`V@nk#Q zsdujEcjX6N$=c<63j8jmAGV2t@3;Ny`k?~{XZBllBu32KUblvk=MX{=-mFsVh zsrvXm+Hg{h*Nwtm$J51Ay&na(-bz;b&X+wx?fdbzylGZBm1{Q`cnJGTntC*^xpQNW zZe5A4xZWwtvod;GiPM#@xF)`o)O+$)O6`iPrLI}x%X2d#cjRxM-DG)I=}L=~-j>Aa zGg$v?MOQPLt(zTuiSh3T{I82+_L&);*}>pj&d%_x6VjipyH_vHdGsa!88-H3H%(yt zqziKr&syrvys|HGhPvVG*Dr(5_rBecI9*cj5m_Qk`N}>^UFltxlG(uE7(FO{!UTIzmSvG_*c zKkLt)?>{4DN3bO0+vi@Xd?`^EJX=QZu;p3s8@N1NdUl3!;&kSpx6OW?9UQ*nR%yc6 z#OY#sahAGbdZW6(o^e)CxiZG`tTVsN%ixu>6a8nbnl1QJ;=v9H#vlKvuQ|0t;tb=5 zoSEUZi80YqXBe&gIulGw&>SXiwK( zbNkSv)6-{9xbaZE>e|fnH8aQE7M?wI=K9|(kMd7FHSxf!^mxUP;16B0dnbCTO^Q`* zo9;imSdi|p^67$|w`X+dRHuK*{sWg(_uTN0KVpkF&ZN0ceUh_I<;wb&^Ubftpc$}H9`HpOrdIHi6m65-?36fYMa`b?egOwWdznMwe`|ZV!B~!$DPtity zOU)=sokcW!6t+#lWZRFV9}5$k?qrZhsoT)fesg#5(7Ux?(aLO8#X`S@3)3&YeL#{O zE9!G@k+t0cvmIh$(v=o(zAf%)JwkUI>2>j{@73?;9d!zg{F!tFO-&XTXnTdx=Jf+%O_H-5%*632 zP6^A4S~Xq0De|@{DW6UDoJh`gAN`_skD5oace}|8oJ6g?^=J7PlyBBquGSjFx;XEm z8$NfbCr&0gP$-UeM@OGM+*M`edQSV*hxHfxv998qv*@4@~vkcUrH@dnKOUE=t2wY(il>$;{DqJTQ-RPJR6*#ttYW`Q&#GN zA7`CygLhB2-Jw>Lkv*w){@0YAh&PoNziQ9fTPtO0xHV_ggp|#Gg8GMRqbEIfa&uLw zttpwsKYJIkO2hfG_RgKw&21OeTaHT$Z#|iyYo?aDBTh9_UVOfbnNnubhdY)_Z&_O4 z?v0Y&X2?JG>m$1k(>nrZMr@V1axAvTpm4eSoqNHbMT%twooXWD^X0`~IoJBnOR_k% zI$t9y<sh`POFaL?Wx)TOVjUCy94Ex>P#}R!Ko~|l1X&M2R!V4w6!5W{J@mv*Sn~_*I(RxBfq^W zuDJb}R_$F}KfH@D{D6z! z@cPQWxZi)=I?_`gleK=vGAR|(pCx%t<5xIeJ+}MKZrimo5sN>6xc3(KA^zAqvu$m+ zwl3M;>*;zRfSt|$4jChllxwO{!`)o0?t6VzropLpEqv2{WD ztFvp2cBiZ&%?fXN6zo&Ir{>F=g+J#$cTyTyj_z4p*p+D#Ay5_>5V_ONtmn$R;QYzDHojk^B`*c5P19XvW&X5e z@8O5?p}Ufgsc+s^r|ukPn;=1XQLOTEkKK)WNh)r5x!3sYx``{N?taj+ z;b6znD9y6wt5sj(!XAmc=)`@mRoQa&F2+$^XyH#ZcdtJAM*5x$-y>%IfL9q(=YGc z+7o>+)auHOn-AZQaMkBVi9vL~#Ll=EMW@d`_@?aciaf5_v>@y0BI+q=gb zmCHY!(CJc{^G3i+b!@;5yROC4o$JRPGuVOvq@~yE!9K%w*D5!uB{Bo#=P8t9F}jOj~~OkLz-F zInN7E-;h}!gS-7!i~kYr*;~FhTj#f(Id0nRuxfgo+Tlm@)o81y)yUPkm1J~AOh{R= zzWUF(#f{3Vr!BWzjk8-zzf?!lT9qqtTXbAi&`NFTuiCRbT;{7rp0zsdl%Kv=dE>Kr zmlou8&(oWdPRXD4&R<0bpFLY_9tg<7R* zr$1cKI_JjJGTo_Zqg3>6WbLBd^d=tCn)D;*5hy#n-R@ z9P4+GZ_B4Un?1s;Ecawrb$t#kFds4Y(DHFx`6tC`Z~M^x&TG~sZP#g2&dnwWv_IoN zD>{9`B>Tv)1J7jy#opBKjq){%x`q$W_$aC3kv+}fYWl=kz5!=P8Y~$tr=V#^|1G`x zeWLFlS`lJ?i(@T17D@PSdb!G_tSv&1OA)9y`n!F4q$rG*P$m{3QqQ*(RPHdVr6T5qwq(Eb}zVRn19 zTnMl01m=FODwEUEv`?v&O{u@9_xSPMMcI_~nZ{L7sb7{*DYP3d{E_v-%L{eSb&cDw zG@HL|kNxp{mEbPow!53&yxMKkuxx(RrQGy4&yGzByrb(|aW zR8`C7<@WDCmW~d*H|P0joR@8fgFuUNhS}b6qnv`0=J0=Y7?qMN5He%szVEa0&s;V; zkW_vkYk^n82G!rmF0&@7Og!^(ZutXeL8}_qvR0?{0$GQ?YWscYP}FL!HQ(~}XU)Of zXHu1i&hEOc(6&_jab`Wu7dJlsSSWoo6Jd_EyZ- zQK511;bJWD%W^-jW+Q1m-Kr#@utu+2%=&J^4sCVGxf9dxhbJ_Qx}ug?psa7I@_s#m z7`}W`#;wYvpi#>g>`gJAHMynhxB1)t41TcIzrngQd$G&tJCUaq*gPG#l26#{D?MgOiXw@+0|Jm>9X_6twsh2Ctm(8v2OL1lcxh@FR$iz`11Ie zNXmq`FagPLre~!+5|2_u_P8imKK**9Is4*@C}9r4W>pniKPLr* ze9ja$im=<7IoJM}{I^eQzUW*LFkU)AeX@tV@z2XI^FHMsT_V3}-PCKMA0#TOs9H1E zSf4F8Ry|d$R&d!ptLpjlwHAGQsV;Kyrnz>B+f_=T@wt&J7fboi$Gw@b`ohoHr<->%RvgNt zPEsr4QH4K5id>wQ$q$?QzS)Vi-xbo zIqk!)k9*=Wd{ke0S&pppoTZBU{b;jKL9k}6gZTH7ACW$M;o4a@B~2)THY>8%FLYV9 zec>A81BWhdIIUN`*z(8u@CaS^SN0zdESwb?^~ppeENtJ>_uVxMG>#szrc8f84+_3I z^Yv)k*O3jD&!sCAbq%u4tL1N>u29=nb0Dp*BTb>$nQ!*~IjLI8Q-Ule-ZQH+IaTVA zlbUWDl6yx2S7JI_&~tt07J+##<=LBD4@sInwOF=9KskD3lh@Kf`qHg0jzoJOqA`=; z_?bl=+rdtAFGz&{88;KLXM(i^`aT)vPCGStlWo>KF<;OWIP%S?XzDr**VNs4qG;spteS@T7<)ZI@=XCvYM!%qfeyKmR_5igGMdlsE8;mbd3tHYt+XEl$Mrz~1A{`!tr z#(aAej-Gq;u31y|p6uobEB^>XF_*g|5*0?%W)y2|+Fo%x!Hoat(VN;5dDHlRkf+V+ zxU%kX?vinpR;Lf^o?f#z&&l=Fk{>Bug|}Lb*DcDM;Fht~|Ne6RBaf%QBL@2I6R(k} z+~;}o=X~PTV*Ke@c=O87?FlQG`*hq-<;Oq4ebM>lof8J%f!#J%QDW8jQ}e{e{tk)~ z``fl0v^am0Fn^}K$mAPItEaBKXY(Mlu5QZ(;n0xI<`Z}0LftGyTP&ui-pD;{en6@w zW8%o7winAs2pgKrQF^3oo;~8&(^+auUSD<8#yv}yu=GB;LdT_2D`v8_?1IAw3hpZ6 z-d@#ldKO}PiLY~RUV8~iZnNjrxIadD+!i*k`_ZTn_S|u^>$GE0f4owVGCMn6&uN~} zj+wOSxUw^^X5UPI5RBK_k;<&gL_6J_@(6qo<$o{{*Qc+|@AsF{)5L8~Ks7{Qxu z^wts7VR}x{R#)1s9XBa9cG^MZy2N;+u93UkS5NB+E?U{qy-d(()E$X!lC2WOnq}8M zU#RKUsaZz7vf4#(a1JPW>?uZTjL=nPU>ykp-cd#>!7tQ1)eH5@A40@9q6|_IEw7C2%RMX(z6R|o6w<+qtwh$ImzypEkZb6<4MRiLNa1a1!3ex;1V&)Uw6y&Kw zWrTNttdh(8Xr^GDMMXCddE67#S+lR88;F>1L^lO_;1JbW@^{cpL2?#i#1!2?(D*y$`?!V2rAun}FP80JV7$K>0bu1b7P=T`O|U25M6v zz`vL9;DEI-&^03$?x4yK0Vcf$YsOI(qML(Ua)PP?1UU1CAGu;c*NB|4QNw=wTYd&C Y#cY5#D==R&Fz^H6KVVi1d=K(804%hERsaA1 literal 0 HcmV?d00001 diff --git a/templates/ScRNA-seqLevel4.xlsx b/templates/ScRNA-seqLevel4.xlsx new file mode 100644 index 0000000000000000000000000000000000000000..3b7c420d3a8264c8d48779d1924d5d8cb48f0d75 GIT binary patch literal 1045358 zcmeEv2{_eT`*!Da(uhh@rdHGiOjQoN)j?xlIc`CQVNYCcBW9F zgV4av5RrKv_x{#zZ`3)R_x=9*TI>5C*M6_-?HpIm=J#9obFb%l*8SXT*Up*0EtxTA z&YT%R?)&!4_~w5L!M{6OiX5^&apJI*z1^k_&L=D%?mMB&CAp9?YmAkXuu3fV>;ntg zB?Ze=I5}%LS6DqmJR0H)S}tY?lPPeViI@8PZQ`{Ku>v#dLQQGuWJs(s|M= zBb|*q7BFpy+{JH5E+^XPFFT+bl;kM4QSqv%jOf0cAeNXDCp_@UdTOlIR@aVI`j@uz zy?k@YtX*J7rqK19YC_fT$rl4+mwj1^>vx(R>+wwc_?WM)=a6DMXgn zI%VsajqxBCX|1Sa^%8G;N?F{p!ehF@CBs^2?@nHLP&=ri(xe_oj5m07A@S}fo@6FXzBR1e$Yz+cx~aIBF?A!@f}M`V`}`LFugUTzDxS;%x%C1Ue( zX+ec395?kz9yP|=qt*ZA6;bcS92W}{%o4P-;+fXZV*Yd~)N{{cX zzS{X}WFqmPp6b3b`H%UkMI0xjj<8+S=nOutwnMx5;EuBjd4HU{xaU^LMaK>Ejth+n z=5MN#l9l1|dv0?<)P6rjTCw!?oii!f7mit;=6ilS%3#ML|Hqv|=ZX*WSc%wm=k)jI z-_4|i_VzuD@O`||VUflkvsP#qUpU`>cerMCpW)rtIn2g`F4fXrf~xDy@6FSevnaDO zNmy!qVRl@Gcl%vVtuRh@*7mO7zEbSn{Tb!kkL)f| ztk_+aWYKejhi#zk_spnc<%TENubm4_J$AywX2GH7X6gGo`)jI36T{D*7EHIQ+Ysi; zN<1Ls{@cvEyfdXM2fF;sPrVXQ3p@It``7JlngUrDa&7iWTr9Pl8W%(cHI@hdcdj4*qs}rlz zGp+6N-MeQI4)0@H`Z@R9MyuzRf-`t@UOB&lp zRed|L<*Gr(C(J(bJUJaNQ7rS@o{CPfvnw~AXTOjw7CqEB;->v;&^qzo4(y+|^xl@> zi-$g3ySu$#?7X--=OP8xq_aL+COr2gq@4_lhSzI&Ij~gy?vqfb*-8v(ELvT<>aCP} ziuf$wSJHmeU>0AS=(lAZ1M_xsUHbFsVbQIX(L*fjX7bPLpSgfJIOy)>S&>hcAEIXK zv3v^8sGr7^b zPyLd+g{k;X`Ad_4&0$#!&%0bPw&|*sQoesK=)Q{4!55{kxL^MIXqkt!!Ja&KY3lnw zFQhp5+xnH`3j|NpnjKg1-qyig)@v(okf=>KE>@OZw0T|kGI6H_+kr!TAA zd*1f_neElNUAqz@i{17m$7X4jv_GsEAy@y&?Tf+)+W|vI>WUHTDaH&5tf+7I}9xMZfxw zzVM#n?e>>z^eYQ(TxAWFkGamo{>U=`fB4GzW)OMeS13z}t+;L?_@!kr+*sY|;_UmdtGn)`vy7D7aQjf0gpw}j zQO~!pM4s6--JEnerMt={wDx#@?tbca71O=I=f>gtg2x3;1h@7g(gPDX#x2!UzF zjOUy)X6*Wpn->>-^D?tFak8*7w-a$ZVY!3;@0&J&e{cIxWc6NY;j=Em&$0_&y$MXk z5iPTHb`d-8tba}Xyy=g^i+PtD7B}n<8R<1tyH{@!lI;~yzf6B!NcwGlYX7I%`I0ym z!^qZZsm+w<#6IlH_T_c&?c27Q?@RgoB2KHszqPWt zzAC9$*uYU^^KhYc&f!n#Z!(X^<_}T1njXK8vuzR)5qlx2zV`O()}TnY7)R%vbxt=w zyevMO`cm@M@=-}imdxhuX-~RtTkK)EyFPaGkV?NzRVhpz_=MOb@ zZeQ;B+Hm~o>9ukXZL;ppwTg0jU|cjmce5~g;O@L0 z{fg#gu{R3G_Eu<&GD)@niBBvm+x+xh?@RWlHDg54=o0ep`A+X7b?qu2XgKe0yOQR( zsp65v`xlQr4dOc-x7Ik=LYlB}OS9h4JaJ2K*O!!ncK<`PBWgiXzsHWGgmd&j$b zuID71t#0uu?W-&sx}QdG2BR=t>2AqQaw|ht$P81xRF%053dlHnlOw zU6=K?@mS5+n={qQm5+3vuBS@d?)C8N`WQ^$kxuk%za5Q}Y+0r4;+|X5x~fns>6M~s zlWNnZp3nIot?Spn{cx$RA+RYXDEB^L&^ppmK?)y{^z3nvAwkC8)6;#})`WbBve9hi zO6`@K=j=;9t9K!I=Um@;7F!DVkE>|Rb>Rnpv3`zA9%t#UZALp)^a{AoJUzl}F?Xeg z0Qj5v3%dtD3P&{5+Af8oNsld~dp&xKHZ zwYps^ywOw!D7o?6-?ugBtsI6@S4AfAq4Po2T647j!K+ zh`oF3qce@yU5b>oU+2#oUU6Vs-=9xguCHl5YpFr(1K|7Gue($$ z>wd`h8v)-p@aNO^>ucK&<#`0JzdCZXk=$|hzkFMmKkdKSMEh_4=U;r>&-q#5Y^8^I zo``iv|CaFNR2t+8+ctXutL$=j!}jAL19%zi^q_7g-M;=z`B>511QP#D&Tv%q>=R z)Gxl>qS(D<&K0-Z)L4PKmaLgqX4dymG%C+L+B|PyYc%(;)XFnUO^0U<9Ql}-F#E2y z{I1boo)b=s`Tgo6aY-ok%i6ap+s5SPN>Mobsta^7U%W9cs9uu)3y)ULx+mLR3w%-p zj55OxD>=2FdVF*y LMsZxXW)hR-S5)ao1Tc#M*+)nnRDGuza{Yt}C_X3U=X z1FupPE0-9r@<(2!leO(}yQ7B>+uMoI{y{@!RQ20?t1BJWSBcyt{84N8n`T(_`G$vz z19MnAR>^S&wKM-3wpjh>-WgRlGc#W+#+=06zO0vFuywngh*s1S$t_}c+XEE#e?knqOK|dIn<8`+Op0j5SD-shvZTgyGTK*5L0) zv?xtu1F@sA_)%lh$jD>z*uVg_k21ze8nSr?zLgS29j^5ujgG{}dQ$TU8PwsP4#G&A zaSfrTp4w1C_8jPI!jBGuf5w7u2=AyNP~u}*J;vU|2gQ2y50@q3sojxUo)MiLP#XtfYWUv5~mObS<(5rI+gL z+()%8%`uNvkb9*hPiQZxGo~K$pyc_e8dHxSQV{R{!akJK;mIrQKHx+47^%c%4tGZm zEd}hdlPF$GV2vNa!aFr4$+)=dzM1H{7UAI6v@)`bMWdZOZQ?Q{Gb*gafFmP_BI@E{0v86G9K+4!Li<{p>{tW?JTsW^ioP< zseQL`e%2%zkD+)R<%_c0Xxo=~*36Oq4qSGU=Sbrlt=QqZ_eq)5A?ldJyS9&lq@m%L z)}BL2vDEq|>hORuMbO%arBRueAm2S$TkwUfKOybwrTIXGa`wP0d)dLTOps zHn|Vg=X}TtV?DT<`ZhJWOatFNxS<2CPpi-6`w)imI|plH=LQYz>EP?=>vCMl8{3}r zXTE0jhTQs|vG;=on`z$|&ehd9d>v1Ef6>`}j5IWoX6TnMN%e2)a!zLtvhJW}D)b9J zt@h7%a$+X5;_@FK@3JSXSLk-?vrp&HqWTkb?(j(~oz(Rj$b| zYtxs@NV9G^M0k3Dq?Ob`iS7z%8nM4U&|EYYuh1>&aD1ToMsC%d?WlZe62|6x=4I}kwUAmwfAvt8+>1RJ{nmqI#SCUTF@FVJDl$kHD(`F=nekV zD!lMkYanXJ5q$N|#SvrnNrkb8`^y3v7AX{aJ`It}$$wiS>DLe>Hu8&d#H)z0GlxtX zE&BNa8>AJAJfCaxN4#Z~4iy{{A6cs$ZFU6Tcr^6YXwwIQh@p}vJ4Jh9?PARu@l6dU z6p9GNh4t<+)F_|TVpM6tk{%a|on}o_&uCMW-0P;H5^0yKB|Wh{mucS~pgdkn=pJMex$*VBV|we-tcRcxyr0f)@+konQ2%!>&6q1}}HJ zY3Tly?VEhMT_}l-$x*n3M&CDb+9hm7-0!6A?LIdp#}E#S`IvZ`$!fJWCdcNOu++PM zwuzA{Vr!B%XgnERGUwL(G=EbC0X5P2XDHXU9o=}0xOG2qyXzTVuT_V(+!XyRx<>4% zm{LP#N#T9hzS?~m*n=&xTVq@l`-b~c58oTPlq-TQF4rQq%lcTcjB!`=Bw03Yd=+Hb z z2EU=pYYNvb9QL1gHS1;wlSK$i^CH&;e&>I=`r?n5f4usmXj#aJf?!EYk&k)b5%4Cl z6%-@r+wCn5((B1R7IU-7_XtZHcbass-QE(?y@;HR_&T0CL9}o#H?)u?UmxoHkYngU%FC$ThP{!O)K=4+b_Sc{K0ZQTXIvw zzKpTX#F}F8CjF!@ST~g%V|h6gax7+V5nG?!pRcY)ZDu>Shk@iRWn#M!dR^Q+9Sw!dz({&|IqM{5@`SYeVqD*Im zyf%1=dPyAG(LNF-ciRaU^Co>9GS#E|icF;OIz?=^U9QClUXgxa_qp+PiHSV*#SxaA z(E`Vqsv;A-PY(CvG&e@a<%C4of6#o z++JpdCNE8jOiDJXg~i2pbXrlHPdQ12|GJiNaRmI6KVC>wSafp)ZIwedli#hF8UM)4 zv4B^41z%W@nWkBB!K^2ug6lS0Zl0&4XmM=iTT8vrYNhp?b%Y&sMBbjN zyzLex0bF5JK~%_m+ryfBk5wI8a^A1BeA~UZH&>?z>_0}-Zy_4pt4*$3wt6Sa0hZ$| zZh_iY#N|DFL?UsliJmKF=_n+RomwZoJ7ix-LLr@L5{D|7mPtw30<>Z!b?~ zqMux{@M*9F&(h}HYtU0Xq8KMoMnmPj#sgetAImSjVtLCq+sv#x>Z`7n`<=IuZ|2*yZ8R)4W(l@G+X$&ScC(&-fKwyl-!uywCsjzS(($|y#w9PZ0G8% z_%w5bzaUhXJ%T;riaHGw1y`(31fSA9AS!DX#2p+`s4OZdYTj_#AcE}@=OfNp*RP2` z47QXIDzv(Oi8JA%OhUM&RH779VQ9{!oGUpohb{T1wm!!frp3aGvp{I_sTXl{W@QbVj|`Ql4LE*b}#!B*s5Uumg&dZ=}efWP`9bd>30!=9U~N!$5{_=O6swN*U> zz<;GjA@y7E8iW78jo&(t=x!Fvw9od|s{5;S!{~eczMebGq9>2-JmS+DGE-D^NTqQ{ z<9UN%VY_Ud9R2GD^)AFM4J}gQe|w@_hwq_|U|%S+4}1QKeYRD$d+n<1&X*FKn`PbK z#=C$I2G1Sh!3lwM563ow4<>GTq1slOmN0*{*6(kmvo6)zm3isn) z3!>hIzFq0o@cVgng;41bX+DmI7g5RO$#2#yW51E$ZFXN<)sgFAxyqe#)eN&7le|qT zm$)BsS8(@pUl+G<9cE#?{Qtb)QGOi^_qZZRd;76fklua__+S8iQ&`Xk9}J-H3kCY^ zRMABv;$S<{YAu7Y9gT=%9}IGV6fG|Z+Yz91@WFu2b79dr_+UWiY*6U@r9u(-V8+Y; zr$mhUvO{D?;GT!O~%{*&mEk9Gk63$I{QFUa-5bg8^hXl zpB|wlw3}gVi;Q3YKR3@>%NTF}zclCm&DgK0jRdu>BrRjk1Z^TXeV80tO3MYSQNsB3 z|7#bF@%I1o!N$KC`%iNogKF2B-a~x}s~o*VYjQq@RWCAr{r_^Rq}9WC`~UgK@ZXGm z7oQHJev2A(&e?{`fWeJHv+lCE&rKav+9?tJq2F~PPQUg9#8qb+7F>kNsv@2^Ub4b8lM(%^!s zRmk2_7d>D8JIc{}!}dn*4c{BPx71_xr~Kf(I)v3@%C^6(dh*LA0f~&6_kBiA4xHSV z6*4d3>7Na?_s-U5y(oX7cj6YUV6$lBkSzU}btfVEK{!k4=fUdKBuXx+* zt8)&UD`QU;=JT>9aJI0nuo2#2Qe zHOtP+SBz*_>dPOkd~t87Yq{@c--o^qzJ0#@)yg`a3w-(eluHS#IaY*nEj(meCcDus zRm+JroFA7E{DMn^cZ0tIZ=(7g^*3?!LaV~lhL4%|!&R z>31JIeC+Toi8r(ef6(vGWzqSuqFnRc&e<0BqkoncmhVeb*<-G#FU+IctJ-lenhqU04hgNmzidn5Ko+|r;cq3(>;DRIiBZhjcnU%Hi(ham1C>Tqd8 z>6?8aWL-L_F_@sMB5zF8>!0;k#%cM zXv(Kb&!SVIgPk8tDoig*m@OIq2c6-qG;JU#ZJU{XA`TxsZ* zOBvyEeMZQIMiVkGggcL(L9DD-r?BmRs7Z@*2Q3{=OGS7_5E7x$4$Me)=2n*gO6@8 ze{k+W;hVqk?eFVMM|cL)QX|84NrSfY%0q@PI&y@I#Gg#w=wNnB^o`0)i`5!LHmb8g zk({$hi&|PpJJGuyr!F7i8d5`KHCJp2?2QhrFWuR`LLfT+oa&bZQw__7TzLYUniX_B zk8Dc7mlDi=S;ZBsXi1uB%;D5y+rnY2c}hlyRN7wG{b>oy(zrnN-Eo{2D*}kV_I0=t zV#I6_bwgFj(&z^#N4*jRbwx@edutO_szWl%Yz$lrd2)$8OEy`^?@sh(Hoac8TA*6_ zMaepWKIP${bz974-aFUk^zlobm67IH-OIJRlw0<^Gc?GI%FfCz4@r2T$Hz+^m!qwlt8ivCphU(KSpViakNL)JZ0Ar^pkp%l0v=1n$K9ZBE&0xg;_d z^y-Hq@<6Me8Zzsg<(8!>V=V55ABtWk7`sc)YEcF2FSG zvOR7s{{H21Tr>XOj1cC6RgcK0lKj(Mr2G6u;+>rW9?< z#bNDypUjtr4fBmDFI{o(mwmbYvYie#k|Ob*U7wcR5zY+dntGbNVqOc0xyem~J zB>Xf?OFf9AuS|6aL~6mWJ0w>4S9#9P+|b_msazy8>Q@J%=Z)&TPcPSUuT$rVxTU_i zbPJ~{TXQZxMpcZ}=yF=96;alrc5t??R-6%0vN>m8NE)9#sBbqG%e(;Rt zjok-(g3oyLxY=x_cERIn93oWbpg}bOQKG|&DAB1!gK9jYEnx!GkP{tBCz>q*e(+H0 zC|ITg(ob5Zlacxd)fry;E`kWvAT30ZzLOB48q`!M(sv4|sZgZv#)!6r2~a~$-wB8k z9q7Sx(8-2CiKS9)Tc{ocLjxVG05&ivCCI@kOh*pc*>nK|eOlXqLnIy&?+i3G*42Gl zl0dIZjWl89I`~L`|8QL*yVf=_ty} zd%2c|XhVaiQFV}tUql!nNOFL9QK5HqKnTI;=p>U;@e-h=GoI<35ZUk<&kL{Bl7%LH z$0JJLXCq2AMypR2L%J5)h^Df{3;R=)uz}(vAmYKt+@pplazL>V%j%kx7A+0$luK%GFv_Uwsf3*-(Ws@@T*mK&l@C8{13V|ji^2Qqz@2b?EZ1Em3B zJhguBKYus~Mtg!TIHBaD$q}jbXetsaA^{B*Q5$3e2C(%_ctj-$4p9ytgr;JIA3mUQ zVEm0d5O(8$A=_if_NI|+Z<=XdLF1qUh+fHPasy9>Z10D}sEFEO4B6ffDY>VO=Cz+= zpae*{C;A|5d9%jyAsv~61O!#rjUn6nAylJkB2F9G9=-QEZ8Wc7J^`EVnNT=Eo=+el zI`>1>Lqv4$hpM+X(Me{=_NFwlhNzPaKX|J1#+s<3RB*!BG4iD@6jQo2)`dbFSi+&v z?cot67U6eU~vf6XtbM%Fp&Nv)md7R zKEDd2uTW&dU|1;y3@c3t!ypeUO&h@$eJY!wcKo5!I2@wTkX4>IR9SfB_V2M z<7;M>9fE((x1i2nd;3)4mZn$9C2|{Pk~aCrhzGZi)_aL}f6Ogc->)KUQ9l?B3_WHy zE4tdzoGI2yZMe}O1S}RF0%r=PMD{Pat|?n-Ru0-55sbyh9AAcLGiuJVcJ>BD!V7$J7gzY%c=iko~}Kg|EWT!8D_41Fya4JA-w$)nl;5{UCB7kxcy+hMRjI#Fi0J(wR3eZZ z;VSA73_LLCek-Tzb=2-I2F4-&s$VQ}_orwka&XZMN|t{$D3M6{f*F*Qy-dKiLLrq; zJ{#!1E=O9P>*eU}Y*CT7SW!KcKii@q%Qqq7L9l-5^DbH7w82v9-`hy@ThTpfpjNmW z7>67Kek%ccg)4mfOo1&5FethH)u2Scu^JeZxVh5vyIBdNuRqazT`JV8FCV*nOqC}= zkeMh;9b6G0C$(vF*wRw9cT%3_z-ePEFp#19t;`GDx%P<~Fb-J{{8knn&yz_pvRp_r zC|NRTQ1UkSE@n`oH9pO<;vz21fadFRC4ozqS$91c4I`eiZ^Ge-A+rVJj+AcOugaC* z0c>hyRDgjD-ESq!W-b37U)83BJYt`?>7BiT75>aLgOc-K4N4-b9592D=1=8V9?4GZ z-X2c(brEwobj#!xzXS2-p}I0p{u@x+(tKTx$62XwR(}Xa(88EXqY3W8O1x2*uc*$q z;6K4l5(73hD}aFv-EU=9{*4O;{J?c*X;?+sxre6FdqpJ9(cFFfCf$83O)D{XpLn4A z2XYa;;1{fhbYGW$aqzg>5U}XMG}2h~WYWf+p`jYv3Q?dMYXBlZH75K=fog0k#HboJ zs=-Mo3RGiTA&M}J;pqhk; zt1%}w6sX1|T?i5#V??ONoY+uo37C)+!ImI`XiI<|JgG(>$RN`pjqeH3v~g#6={sg7 zg#guLM5xA8DJW2lNxBfA+8Pn6F()<@TLPj)2a|N6*b<-zkAX;gEGT~Qgl0XNv00ix(ZMLMY9hAK)K%QMBZIQpr@v{@d54ece=9;&hC7^x%4e<#)z z)#L~V)<|$_1*$aWUAKy!!_x#;P@0uvNI^kDMbr!zinX9ta9;nja2=whqk?2f^+G zKYT#rp#B?qU=MBF8BW5>knJ&Kd(%v|H_bG!U-HIWfarBX;RHE1V954B=!h})>_UR%bWy^$)3bq&(mEr_ZQHn}O zHEm>j^x6Drqj?4M2^bkr$KeJ$Ge8wRh)8FGLt$qisG^jyJpbI^ZKd9`5L8WEWf<)J zSTCsv?_>1`aqh2InH)xpRrWC_{~9fpqtKJOVD$MqzpB;xdBhQwp?$eTiV8Jk);Y^9 z`YH982Szne^Z-?HdGNac7P<$H5FKgI1SjgV0hU~biAHJ zvkqy!+!DcgnN!tUJVeN%5m!R=o-Lwos47_+{lIqA3s|85Yl_}ln%73zNrU}`(ZHg_ z9$1txrD!Lf(=gplvqDk)YK6is+y1P!jxvO&Qh{7xgp!s@JX>z{AU%}`E_{dbOauAt zG}YD0hg>|EXszpDzFtZBvvL(7qOYE+7}Z%|y_~a2i&|PpJMm&Y4)|>VR}bR&ZCYpR zOV!#}1A_{-unMtr0j7$Ui*M8XHr9Rh+qhk2gZXWgRMT{X+mA`gVBUvyS%C>L38xZ5 z^iI=c`r~&c|PN742Jmwd?e)LWdZdOVQ(+?zU1a=#Wu3_W; zW1N9Ig`b20a~DnZ{Us|T{Mb`e6a6r|jr->&?KTok^D(;(k`qlw$ed99`6PBd_H5ZW z*Eps)C7qQTM71kJ`C=BeS@U)Glm^%f-r=Sm1ZF7yy#gL|r+0DgaD7`r;E59rJaM*K zE)g~j+sjTfLs>LwhO#d&5Hmxew$gNjoI2@$)?%x~>ZsnQ&a56l+;&CfqIge`d1 zLDi-=Vw*Q^4xMMQYIo@?e2nURR-?;lp;km$i%)~Ifx!>35o#W{x2jEj5Go5Cahh|9 zeG5#l?_Cs`dy8i9<5`q*^u@FkQv}WtMQmh zo01RB=ILJ?JSU%~;<4z#3JMTCZ8Y}-I8=?H8Z-DofoepF8>SRMfoja)ho0p?MRhD9 zRAWj36kEbLs6h@2bxXjM0w}fw=)ogp^uZYH3D}`3wkPz{+z;S!HD>UG0M*8bP>m@C zP@oz!_(729h#*2WrW8Q1B}{-Cb}f%71yF1W(1V8?+}Q>)9rAeejL_T<;FP3T0)iR* zAV9S>B2;5a0Tif4l;~gvKPXU*DFqO02@{}(oxWpA0Tf#T^xz2ucea7z7duqNGMzEn z5Cfbx7)U@cr2vYe6jKVIKsBZmK!9pIqC^KX_(6bbno^gg#wpWgd3^jw2EMu98QW3YY4D7EE**$6%hu~5iAa99He}e z2OcHRZfAs}6K2TvepH#xknJ%vuP8LHpicPkRUY_&M7y04ijo^UxnRilehAeJ+1?bV zZs=7UblD!59l?~`h)zi02M?G}Xah~rafK7?9wI}w_d}>=$o8f@5`}g8q09E@lZ(cP zI*8DN2h1mszL5vQo=;%N_I?P}4B6h4$1uMEHSGC>X`^`s^9lHG)2tH3dTh4AqE=(uo7+|F5z=n(N4U zA??MAkM$x*g|Du1edd$-CG_Y3Dfk{|!94qp1+tA@%Le`TEg*)>7L1D_0%L_M(w-*A z4j?90Kq6 zn@dCU%A*smB%Cb|mC@01?F^b}(U9evAlMA-D2@agU)~?_PDQr)Bh5KP_oRVZVKs0L z(F4vQ$5NCM*}vqv(i}>ZzB-ibYfS?VB?I900!&T%%?-kv9L#SWxwY~kF|a(0ceH*B zr^`vx7FEo|Bch%oPCrhfR8xk&cP!x!*RhoZ#uOKUF~$DGMaT1GQjBO0CE8ydN|vU# zKl`T(;`G(4BW^_;Q(2$D*GHU9l?qnkjk@d_3akh$8V9`-E+zy#2xFn!dCbbcap8jo zu=C&-xD&thc<%lb%|s5G0mhO^1B{5gyRyJqkp!$2J+UD=aJ|I1ffBUm`Kt}Ca9q3k z8}-e^OXVT1rCtPX6+Tu?b$M0b=OS)5nqB^)TA}jaae_} z|7O!Wdj%`}G2aj|ze(SaSEiMiZwPjI{aHD-hJs%yTkur8N{AkQ}*fsw!lMNNIb*7}Nb4^5-@iqMQh)=V0Qi2561#vw7| zRr1$MM%Zg;S$k#Ekzv;4H^!K!5X4P-!RaWdJorC6^>Z~HM-o&-Vp!TeL= z-5+zy!+L>dj99*i`W^KX#AthZd9+q)!;J>FwLM@U|j!dfw9i9 z8dzYs0lWXddPqY+HL!Kj`U>iCYel~VS>4UL%nAGs#F*ZXxY?xzUTnHrrNA_%h?}(W zq3FX9$I`5QA!&Rb@gGw!gr);Wj|AZ8QEnQrSGdBrkLI~^{;TKC{VE5{a|c{GgiVH` zAOq;Z1FRLvSoDmO=(x2aG*ti91{WHt$%s(>R~uY-sK$odzTN}`4b@nci~`kv^^k_Q zB_PTSu*uMG?$P@91`n`S#BOoKk4F#vf@f%`{+kUhG*n}A87NTwR~uYtsK$odP~^K< zm5c(_fAx@twk1q}dfaUnTB3tZhSKlB1?4i!zc_d{a12xerQ*v3x?du8v7Wt+Dz)n% zoYXr1@3+*#;e(RD-@6P4aNk{s3~hDYEUcU5hWm)@DfD=G68D()huxKgYT~;{r3hB=pW*-Rtt6=S1!N7)_F`_7CEYA;}CQP5@akZf;fFXv7zBv7IXE>ESIE5i2f;FlJFQUFU z0nu>+V|jk)BzyWS54h^R2`DEf8t_dt|5RvoDb0BY!6_LY5$m98z#}@hU@Xs%2|=dK z^4#SZAb+FRf-N=p>-~N3SZBNq0y~8#Az~d&Mu?(6!C0Oj(os#DoByaQ&e&T;ZX-j4JHak$igGqMGFWD1%{mNhlKX1x-ASX z>eS{2#ue7kn@6BdC;`nqL|p@hoNkI-O`p0!)dZO~ayt6lzyzqnX_qGMg`(Dy2Mu^c zO#}GB6Yf7ULZD!`HhT~Z4Ro+0MsRsExV0IIeqy8^jnJ(Ljo1;9(2Wp_K!FBq8ST@Z<=vR zh<&}LUR7%(e2ZxI2YO$&Zf>VXhVpS2*+t@($ z;_MQ2LzO+H0S|0OqZ4M+92Xkto-0xt0va@dYs7xw8j(@8Lc&kO^#1?H#wqpwRsj2SL-d^iGB2yj_HWw+jbXu2PDs8yI18hJlh6a;B;=a1)pAK>?h%@k z(5>(p+^IUi}+mKJJ7 z45;r=m#3Qw(R1)@8;jLWi^Gb`{8Ya*=P{*dTP}{I889V$^+JiPvcbGi#_ttiM?eP9 zgGUOK6j=0NB?X8cy0;=cRAVIt0#wH$LNzv_g96o9Nr3>>w2}e=s<8gWh_tRkJJg%W_d6V zcC1do=JgQN37Ad|!KOef{1Ma%w6Q=0n*t{CL_luFh%zdy&4ePO8V5D(I)T>yLBQ3} zg9p?JWRMz=5Y-8oP7ML7$%s&m&4!{tHKtQTP$yU;%0RH$P!wANqQs3R@_d0?P2j~}Z{tMmBB@*%bQ$L~X)M?+lQrzNa#nw69c+FiKx);R5=VkoWgk&^a0 z@DK@fdc#}>;k2xS=ob~!Q>v#?b&!tZV(C|J)7i~gIu8;CsO@y|C2S15qdQH~^7p)# zYkA=ul8qsPnmO%GZ2B1)O-c&ks5IYyq!JvDOjL`oGXq4$FRGpas%jBYkxkQbAgJOP z%aid#0uAWV1L_2}YM!w?KXjfjZI%a|Cs12~ zvSqyf9lz}zLJ~5~^jZu#-T!Ji9bI<9bn%?1qF9z(YGshkzj!3A{L z-gMKvI@=I1(d)Rv>7B8`Yl2)Al#UxFMrFwMen^?lknR1Dk{h~gk6tduB09^49z0l` zfRO>_mIpe?urq^cqt_ZwL_eXCPB7GtKh|_(EYB489#AK|19ifFnvb`TdHAA-dLud2QWqb5F=4qpOl`{B1qBH^5#IgkHK+~5N zKlYSH!U-q0JWAO8I}I|0eWBw90tXt>Z|}W$-@MQ;_pYgAibkeQ_=oMbS}EaG2O9I1 zu6#6it*B@Kzt-7D%ofZiaHU)ce`C{Q2vp->cmXGZ1+~AHGjf%uM&&E$w#cgJP?YBis81E~i5I z)dNf1d@~LkSuQe-3|_@owzu2t===%sXCF&VVUou zJx6$$ETQxVoP?|*>qO_XE9og+P%2l_ue};ruR$GiDf1sN zPM)VvY8#2;uzuD_UYgG4$m1w)`FlX}T*v25BFW3C8KzEN>yu?I^CWqzn8LGGS{y-(hr6jN+Ep&UE0QQ~F z4$2n$Z#$=^;?1Xf{Oz3G+xK5}RS|6U_By#lbKCAkheP(=+;~m&n)o$|d-GTwxUGlr zv630ip-i_A_Px)vcI{fnOg)hzYf@=anZr~yC-R`V`@pY}U1VWL$*Nz|bM)QoPgS#} zGxwivlMRrSw7d3 zIw&yf3HZSJG(>oOX~1JaSsFrS$jB*4TkqY;!zaj+Jk||<)JIj($zPJcn9Q_1qme9@ z>2|7Uu!B9F%kosUiEw7uvv%KVCbuldC=Tz17lY?1$5q^0bnEPcZGFL-Rr6=pu8BHx zYt@TY_jj4>IK0DR#|blb-WI8v-V#Y$e5cagaRR6hFzA9p07FXcvug_2^|M+YdywtH z+oQZUb;`b*bJvGCd67g`@nHKbiF(qWR;%P$jy`t=pU+GebmVHC_1?y4$u_-hLfjGi zUnjeyNrnl_nGS_7vJ(*l6!Trl>G>q$190Rkm$ z^Pn)mw`le#>r%QqXzgD;H=QM&SK^sc)o-%(=^Rz(ssGQ^?9MkZ)4E|EooHmh+xyoB z4WNJ~@X}(@P(U3L3eZAB0lsJ`0Du?)1qh;{fLtULFo|Zk6u^dt0$>LXpnyt10mf)3 zpcV-Qh@hbWZzL2zLX!n>prL?lBor`-X1EkE9}NY-4jMoK1Aqd^Xea=rvIq(RYcv!P zfQAClWC4n$7fEN-9AfU+tSkX{G z77_}WL^E6pn2m%2pa%`0fDS+bBs3HNyQ~S690Tn@V>A@tkA?!!WC0>*C?F3B1x%tD zE(LI)p#a!H11KOC^qr{_`*Wp+NGl#%6CDw6qSMIusC5^0nfB20Uj%;ryAPr9KJXYAgXn1n5UfotAcAj2Pf$w&hJzw`jKhS4;Tl#TxXW z0TeI_UfQJS2`U9>p-G?^627Ucco`DDsf`O@(swld8t6d-C}0>+z@+F2Dg}t3p#X-2 zZ|W4lknl~N0wx-1aN8)*g9cCl1yI1G=m{zXSfil;hJ3K#J0(DSY4DXrNX(z)Qbdc>btJyBCEnp7b3o$sr>Fvb5p< zLu5f7rv^VKuGamNh8e*5fuqXLsieyA;GQbxN3}SoR$$CwB2vXgrdwHP#Z`2#1|}0{ z{%SIzKWQ={08A$2nnz@9NjA#ZJY~|!U^&(Bpm2@+A*WM@CX!WW2_I724i22jIB4xocg#=#!~bEx%VN=Ay)5=k zdRatbUKYfTj)Jl0Jhb8el#Z}KS=+pHX2RFE7)d#sKHu>$q0HptPMpp*Sm}3z5vSyW5=_|?ngJat1ddq+%4`m?*qT$VZb_A2>gw``+i$xOQYL#+Cp zPpZH$Va{I-6A~v46ErZxgwg@022Zf;U{H=yHK3Z$^Q5ktDShdrlL7ECnf0iyTFjB7 zirvxc#9%&8I`A2(n&1C?fNuX1mhez+?(XfJf3r;4J!zRT7g(lf4O0R?Sc7E;jv2TS zg=X;fp1wa=X*y|{B1TDnrvKFKdHb*F*;dKS)YL-*&)Vm@Wz`JQ-5=b6nTa6qvf=xy zm(9Ju1Wk@A^*(rMvnO7fCZ;EZ^)xuxPeZ2wFC-K|IEjP;SkX{G77_};qoIIFG()8T z%10y=06k~`1*8KC;6OqF#%L(O9}NYd$pS>sP(U6M3Lv4OfJrpNrGPpl6aYPFI>IPD z)VB75F>+29F&yaPg4(oPEg&TVL1U^S9W?bF$ZLDM0}X~?q|akb6k@m&O??MaL01>$ zyY4VDPRemY=}TFf`VN#F8Bh84Wd8gltzMOCj^@WWq4_anG;8CA=4tNZn?Lc;l#!r< zGO7s?Cc`MysMWM!v7i?nSOh_+ZBCXFT0uehYm6`||3h+ik0VFh800$Zhm_RdJ3NS`P z0nmfyWGVG6I8B@Eq(VIxz@vF-h+64rjvuIK${NPfO#N_px-5-P7^MT8L6Rn-)1eex zK>(rYKs!*SplLr7(4@7{JGS(bPDEX9#?nmXNPT)OO;j%xs|8pmvUI4402NKfNtj?X zxJnc}nqmNlCV!qp0Mu?R#Ro}gL(M^Q*hxiGbwUpt7QwNBZ`DXLn4plMtz&5G7}~nO z+!Oa#ZQZmIqyh>k0Th6n*wdg=00B)NfT$tB(AG^^UOQd1b<;|a3Mc^U2Tazsa47&y zq0Z3OO)J(16BpY5{yd zO;CsZ6fiRaRCb@BjHbkn&_r9nbPyY}07|ZIDDw|VXk?GEXnqVC&5t3VS(^?tPg8?8VPD!kfE)c`sg4-TQ~K@W)jU%Tb$EHkP0Z^37~*UH4;<`U})>6 zP5}&U-P9>y63uWa08MQJJ!k+0JOmUlsYZfI0Ss;3)G2_Wt(!UpOrjYs1)w<^gdQ}2 z0?dI^#sBnNfNEY=9CBHa^Mt=<^BZI1<1sVXuZ8XM`t22Ag~;9Oz}aJ;%?$JSaILEI zgr~`FhaNxEuR8m^(}aH2T({a4+}^iVy;v1C=`^u)!f68c_w)Vs^T3~D_7{_xmS+q* z$-5{GO$+KJMMs@{pI9j(Zt(y0~^LwX>d9o%V+-I)u+P!0++2RSOiC2?O6W^ta z(J8>6-$#teiOk~Z?BU}Zuzb8 zSD$p6*f;4k@tx354D;tm^kGh3%I(M&N z^@Kf3g!hC!%Xc-F>>=RKk>y%7gUf_tbYNa&XFGGcZ0j#>*+)j}y{oy>XFbZ6_}-r7 zLAGYq{Mof@^w_nRMx2?)C&Z`5cZ~1;q&>@b^GoKKsm)$iu7iB7r>RCJY&97sPCoJn z|Ca|1kQ3SgrkKo1qkFR{IiRBlR{L;TOXaEHq2NW=wl|rQeV>A@-UAhQ|0=`QZp-{kg=^`8o_-=j) z3I&kRWC4?ChD!n8%`ZWr0O&yjD8TJoXFI4AKt@9W-&xMVp@8o!=b%u4HJU=;JD)~4 z6o4iRko>y@8%`GRolhea3V$g;DBwF;92^Qj(+l`c z76+#g_)ZoFhXT-K0h4HkO99_aV?v<-=s`mk9LuM^uMQa@`P8do_ZQ>d$M%*&>If44 zNlN(h-y0R!CIY9y2Xtp}U_bZ*2qS+!q^a#le#}4WFMs|^`$zrd&(CZANq_nCQvon1 z_r2}p&p&6tgt7cscaeA zx~WsZbP=R#4tD?wAfurGhPH0%6oBSbouRFpIt5G@L8|6(ET8~95(;2w>!v*| z@@N>Yum;Up+9aAM%%|b>0uUVyLmy7n93}$_AfcfEG`)by^9{K2S~Lye?=DpM`I;J! zZ*!}f(?pQ!9@`sBwRTc&r}730W?R+D#-s|4@MX_8)Fph45n@ zBM??~5s~P(z>ldy^3n)sWRD~?T2b;pSsVWR*opJqh&M!Tgs=2-CbaGn+qgJ?Xae z`sTNZ?5tk?=ws`wbm3N}^c;Qn`cu_stJ(TbXLJ#?=V;GO=nPMIC^vWacFwD=D&P89 zC{FlU(0+^+I6>rkf^+7hpSd`cfoqG*|DwY^(@~r}%Uq<&&_uF|=TRLOYpX2`CL!xAUuur zFeTsv>(db7M9iQxvl%>A)QRM8q(p3)vN=nmG7dU~cI0x@s+!;boT|8T2R|{}IIg1m|FHM|aZ#0d|NoYu0*j;s ztPzsZinl*vzgfU7+T3fY(XODo{zy$2wDdMn%&h^PY*Il?1#_wG+XI!4X5Qw{!4mQw z$B`k$YRkt`=1~|X#O^-WIDjETAalO&bIx^+;LM^&&-?n`&7Q}jKm4onV6N+WUhf~T z>-BzQTF|1L%Y(bRbA(Cm9K*q#<5)vS{Bljx#Dhj&BE7pl|M{0oyLQ7Sw>f`3XIbkS zTc~cWEq%oC<`YXRoc{Xq+BVCuoIN?y+P?T^_V%2;gY&11+tt;bV~FU^F^hBOh+oA{ zboQw|9mg;Sp320V0i=a?nAbL`{XId(VNVODm;QS0#MI!hXh3gVZaJm1@N;|#~unMP-n zpAXc{WP)^g2ii{cG6k7p9De$GcIW*&2mGln_Rot~4A{Hw@$uK*>S}4TQL?lN1xuUS zmae;b)z{4v4<=M=yNG>ee^US;yuuprf@_6PL`1O9dhh`~s5F?Hj(?P&R zDhNoSgMc^bAOJQo1q8&+%pSqdG*h@)wA5Ku=20kL!tkV^#t z7CKQtI2{C7sUSew&A12%q=NwTL$ee*h!IEabPxccEQLfMlMVv%=^%hk6cA4b0jH=S zK-$f?2#BDA0Q5t%6gr3zM>SLs;HFaxh@yjlwNwybpc4fI(?LKv6$D7T85aS4s2~9U z&@6=xV#HAk9R#4KHGDZRjSd1f(m?>7C?J*&0!~svfV7)&5fDxX0qBQjX}bpM&a8Mp zpPL-((4ZC3DRGm|T|?=9rWDhtOC!IH;wwwD>}$3RIvg7D>ilnRhB;P?i>;t?4Y24X z6h7Qw=>+KpF+{_?)TAAN+e?k26K@35xuWx^go60Trl!RJU3<3}r5!3tWejNDR7xQy zoiLq6kJ5P7P>O8TrI976@u{V8O=de-9Z-PXTt8WG9<+1LgDBdKC>n~VOprTFjpT+M%e1%|Aq^PGG4yP21s6(k}nf1Y@7EQS&V9OA$JB7XS?f)vU8TJ+5A7>Xyb zo#P~ERf2kl)1{rk5DBq1JGUT<1eF-KN+`M-_B@@>l+pRoOcXv-x0_|UsNT}z%|><^ z#<@}DX#d)BH2(TjHJtK`59k_BKtK&3KvccqB0!a+$ycQMiX4qcfU4n?j{x*T0|>YP z2oP0oxCl_?Xz~%@D{?d*0jh>mJ_67W4IrQv5Fo1Fa1o%&(c~k*SLA3s0#psBd<38$ z8bH8#K!B)v!$p89N0W~LO1*ngBjQ4R&q=ANF79UB_nee8BIt((5MToYi0w371W;-~ ziH%O&*Qu16cD^D<YHTf5q`n|Xk|}YM(p^L8 zepY3V@@*aDE{%KhFE2`tQRpsPFsxER3H}d--tA11L_3qm0>L#Ur5z^8MAZ-j5M0kN zbtJF+!5gY=;Bmn;rP#Y`&L1V$oLQV}PL(U`lCOAe0s>5c0Lf?#6#?i#t534qA^k}t z9zZdXS(i4T%rAvGUz9EZN@I~!+d%mU@DZ=g#zJ=^wK2v~bUfqEbSA|%5-}m~?DzB1 zt}bn+?<_N!oUBa7mLAN6#MMW|I%=6w#?VrEBR)V(NM%&6p3bOTN)vhQbbho(I-jBR zqfr`T%)s@znp~f0F(4*v!ZQJ)Z}MqEd1Uzv`@=Y#4kIvq>? zTnt~Cj>RKD9VsUt0qBPY5O4tykV^#t>U1pm2=JBZSUdt^=~RWq-E2oK3Hi!MIY2-y zARwO#0@UeP@)6)G)3JC2WYR%^xSNp?;3FgD00CTUP?}q{jgt{zrO%Xxa8c?&O6}B? zF;L@Z?Dilx(5=s%ob6g?i)?*kT>5Btv(=ezyLV1{g#79=ou-|-H2=Cw(=Vpe0F5rT zg4ECs6@t|W+UR!;oogV9PTes$i;SVbg+Lw&(Qq#{X$Lf-R#90xQ>-EBqmD6-*9B(eE@?~U z=TW`peIVIm{^CHg1>8U~UW}yb5#^s6I;o9@&IL^=9aP5{%aJjA& z`6Bt^&C-P2>c#oTa$`zjqQ)|hn-6tEqk34!6|&4DO7VVbI~lb_p&N>SYEqlQksP8Foe=|cko{sIV))JUiZD5iq|Ra++? z0iseA83A;<>e6n;)uew)MU#$xXaE6=0RfVP4;2AvbP%9w>*OOq)z-vjX-tqf<=bzgT9o@F#-j@5f3D_0JC-(eFD)%T?iNzVMdWeBPB*8F}>Lt!f6Nm;=Um$J#qJ0m+225kx1ql*I(< zMmT~xzSB?bJJtWgrq8~ay*+2|;QT4$c7^J!sR?~2?by5i@aadU{buUGsSk=35bntj zsZkfLy1kfWjV(Z5@ud6}BqhoPw-?8iY0Ip&#$Y+3wPjTXN8{;E;XR)D{JA6;V0f(C z=#59)8bjmiY!SLFrdMmumu;1SCO=bX>$+8P@{-EJ;~-lk$voa)!*8_Lg`P_-)F{COM`7e*(R>gg3 z`O;i-dX)TYT-?pLq=^zPzW9#YYg7HNJv4v-Cm=vbf3Oiil6h%807>StqX6_n0|;mY1f1e4AlL{X$vid!ApB1c-H(j`@=y*N z0YWm5jsQAQ04YsjBS75ExCkH>Fl+>%ADU%VELRH zAc&T+5n!Mb1&}wa*a#4JGcE!&bP@sdL({Q~{n_p;s9{%ur83N~HJ=B&w$`ZHZc}o@ zue$<@nw&wVM8`dP>w@d`xwbp0Z?cO;|2%F-bCNPU%4Z~-KHSepj&r!5$)fY4m1sC+ zAHM@!yl3OB9!%d+v5u|bT_9nCF-PdzQIp<5i8~vTTT!&ir8c*tCcUFNsznm5a-qQO z2qW*P$)S;ik#OI%TrGJ1mL{5aP~uK*PvgvV#U%R2UExR+;GBWclN+G{MJFMoltfc1 zJg7?}zc=VBO9S};=Qkwg9k*vZdIzlG?Pe$?QIrx-I?1|$PJu&R8u<-XUs)QE5}ko5 zAyR>Q&oC6r{OedIOzgjZ%V3sVIP+6AHnTx-|0DJHE0sTU!j==@bQAxFR9q&VgMQ z5?=pe*V2eP2X_6@LZ|$sE{%Mdn6E4iI1k>KLa_3q+cO=zQ+1`P6H~>NBlfR3i``IB z#g%fzm4JX7QwXpTpz6frBLH0|Cg`hGaix5HH62+6`k?^?+?YaujQ~|ACLaNG>h-US zeIeW@7L*FrTV6Uj#Rl!LGox3V-J&fdz zlvSL7>*Y!PW|UuswgC4p95tF*({M8K-=Fi_$LY7=Unmcup`W@7o^@*l%^Updma|;% zNK(Ps=hbXkJKf035o@;Ga!Sk{EsUl$#{5ZipMBbEAmoOB-O_>nj#|S8Cza*DP~38{ z;31*x$o&gP^-5=xff^M$T*iPIoZ=Dwg|H^cTzxM^Cl-wnio0q?NMVsNc*n?ix<2#a>KT#pO_ZUu0GaQu;$*seHfZ_ z`g~KP@F_F2iC_T`zo*h>{<2C&$=e;KDQezPNa;0;%Eu?jg z`DNbO{lSOcoAE{Ro(HP}&py?=ZrIkGkCye{yJ6VI{o`}{ztjJN{ztYEQ~$W~1QwDO^IIX z$}wv*w}$85|IS;zC+$9aIArg-mhso#0>cv?kbP6qpMLS_MNcnzAtdb8 zx8ql_6P;1Vw(Q%#`bbpA@rLZ^nX9VjXPsDjVrkA~nTQ`I41W5zyUMpLI^qDE5%ZLBFWg^XO-cw1=WRxYi#8+Yb0$Q7KiO{C z($OdL((uLFE0xDH$JCylZf|8GjS?Z>8=T^jP0Xb&qV#-8g0X)3aU(9lmMLreXPe z@-wVE3$E^Nw1b%mm5mk!>prX3V(=&ax_RQk_R>n{8@4xWeT%fCGge17TVj|EnP-@} z+L=sHX`RN&j5F%3smA!PcxR5a(OebSe+ z8JQv3j0_!ld01wD#5ytdq^=l5a zwQjQc>2ht_2zPyft(Pgr;is=ZHY{gP&f^J>9r)X}DNpPQ-<$Vq>(m7Qg>^%wg-#8d zl^YN}Jo?$_m!gY|d)`0R&~-QClBN$F{BKWO*u2XA3jBJ%+(T2-Qq28ma8`Ic<09Zw zDhMd1gMbh^2)IZE0V#A4@FpDuh`SjV0WowCfPQFdTG9Xk7CKRYl?npV=pZ1F4g%_^ zARv|w0&=M!K-$f?2neTx0Q5ss(_-fkAaWBo3OGdt0d_hFh@gW2NSY}m0-1CWkWU8z z;%>%8Ks+4;pdXr=77ZXks?*>ifKJg#Lk9trszG#W0hB6eYpEbW+ReBK2&RJo^g~nA zV&M=VauXK;C#ggM7CHzBrxFFY>C^(!=tKb<=^#Md&A14NrGo(ULsJ893ZW?^e&Ul#ORuP@jk49&sv2+e6C7`KGBfpK}D@${6H=7B)RD*bRzWViuj$pJVXC9SnfUTes zZm@Jpb*xyc#l6&|9e~?Q)zFDIqUc=F!E{1F>|;~kv77yg)j=%4Zoazv9M|f+lDTpT zTZhtw)^rr5TDI&vAV@c^MI3EM`ON0d$%pKx&kB9pmiGMTJ28YPoj7{C08&{8+Q9zD~5p?6`;mIhdm3xY<7TO|vILIkAi+=46-)DGM# zq1-sEGm~48QbCFYt8^Jfhd}Ey)f9fTm%nDuchx*CUHKvs1we|T5rYogD~D3WhEA1> zrBfMHmqxxA$yb(ULy>zvqy&=a$=33@y8=rq8byZzs)SFz@Ku%Y{mbfJ0Revj1W2MM zR0I^$L4YdZlaByZ!Y3aA=n_8ujRpFl0R$`t1W2MMR0O2aL4YdZlaByZ!Y3aA=n_62 z0qBPY5TFMHNTMfH1lZ{yK$Y;xM}R8flaBy&2_KID^g{y(SO^G^N@%DE(9l7ED&dol z06N7@Rl+C#u{HXk0R&_L0wj?LDgrEY5THu<+8TZfpg~AC^>V44!R5@E5VP3jH&@&hAJ@K?e2RsxvlZnbDErf zCh+AjRm`|v4<;j~Ag~!}Hgk{vr?tKC(x?i{ zPrWd9MX*?NGhW7*#?@IyXOx@59pGi+=r^Z%Gq`^^;yC{g7w4Gqr@F!qkBkMAi3fMA zd}f3r$Gq(R0^Vd|f@Crg5d7*x{O~Peu@(ikSD!@B>~4EC^m^91QQ59FHn8QerH^no zpK!iu>kaM?JT5L}p#ukQL$hiaEl(Y8(`IVj`2n zer5D)Of{Oo|0OZwqy`*QN~*QsnbNb@a+qW?F?{SdFDEqcgGvO0YB%F$P>F(njW9t3 z@vj-%z>Q!OoTCje9}^rmo0qP&4K#(B`h8o`o9SEBWFJ`ioh?uYCL_AM18tSyWTA`T zye#ybInReppM5iXI~dL6PZ_r>RA)_1=sSrwni(P*&CJTp8&eRo$}q`EMtfi*Ko}u| zjQ}!p0~-P0-4+1OXV?f3cQY;m(u5J#*a*NrG|j833~q}p@+hkpCKz{?bSA}K(V#Gm zm8Rr!JKA%Cu|jv}jVZa@JrLV?`W=+(=Ejs<4mR&*UHTk>&|@2JOv&ZW=NE~~zc&Tx z7CL4-#yl4sp^a855-@->;j!qMv;Fp=eukAs3#0yMEI1&pm~`;tfElQtq4cA1-jp!z z`@ovB9Bw=YB`XuyB)4ydXfO)m88GzJw0dzTR4z<=olck*Oo!3JR2=NUMzd_vLGY)< z4s6IMDeS=JMC4KH@aM1t8)-M=<~F^k1UC4GCb|6#AfT8I0_cQkDRdChV<-&P|g&|?~MJ8v3Sqeu^u@7l2yR3bqZJ$T~V!z`Urok0xIa4$7!2jDil zqd*n_1FNv(jbJKQv^$SVD2RV-wu0>#%q$c8&|XFtDyR{m)KtgrslF^A4ZT*wv&KRP z0_xJpR|)yb(sUbN+CD!m#%yG}58+c#SVJZ;VqXJvvH=a9!$~Pj7t=vpVGX7D8C_c^ zsL|*|g6M|^5MTpAqIh%SB7o9eBgQni@>)ulfU2#NFRvAMGn%~Crv$04B=#DsgIu7o zF1zXvoQ@L|V;|!L0-cp^PEhx(pcdtnT(6atJ2%bUIJeJ_>Af;?6v{c=e=%@^x(|fT zJtu!VUaieKb@1fDwbzXI#90**KeIuk{r{YC?mBivq-k8ZH7b~N7X^rF zBwPfj+B*3NP_=dP5g_hnTm<-vAT^pWLwR zzh52mmp)V0Cyx)h{6Ctv!Yxnz>gXS5WSsc9>I>e`B4Wo&&y1KB+`v0PSd;b)-#PNJ zK+&8bOfYAt-O?eXB`c3~CRIiry=V(Fh3F!6<1*gJH~Q;N8DfnC8&gX-3y?k;<(ln` z*{H90(inSVKfV|}Eof2h<-yyG;r*;r6a1%7czePE$(&&bm@|xRs7_q25yZZSN;QJh z#Jnu)!HR= zpNY4#xG%BZ63%SOI>c}mAiYYzi%M~%GUoIsCj5q>#o_*Y*L@6*Cdo`-pSodNb2vwn zk0eKv{=B2f73l%n%xYrKQj(Z{F8v&D0HIxY-F0tKvoq8L79jc)Vb|;5v;~^t9lbg( z-mrj(14ok?;AkS)rWEpyCSjtZ$wh ziA~jxt~Jlg0t=8}W{qKNi9X%6Zk0Bz3&bbxd9W(r>{DZS+mvMk_HG!q@$ZtO$pqff zq)bY(QVoVj^(`Ip~owl&)WGftUiI=}+NanGEl%`v)IN3Ai~vGIlr%=y04 zpPCJhCNYlOwaXqz<{eFDNscCcc}J7hf*O*R?7Je^vy?L1j6WKMTDx(yTfh3tY}W=G zm}ZRA2D+O+b>`Y4T34^?;sSHaLsOB&9)TZ?Jd$|HRG7*bvdfVE8WLgQ{Wajv0tgV& z5^MyJCqLK-AWwd<5g?=`*a%1ygcsNd5O*^&0)(^#8v*Et1`uEd1dvA($Os@27B&Ke zv;-XibfN(AAiu;$0Fhr}BS75E$OsTxl-LMBKQx_5tczXZJl$!pXx{ZMJo-9Y zDo6=23PMrUqInunK#&q*R2?*QKEuK}+dcY)+K zn&5JHyc(g7+UaT)MXOK~6l9(VrAPNdJrS*P_YLoEseHAr9xmx|M6}8w`d!Z5Qu(Sd zJS$+JjwXowRvxh>#X7)w6k%;vL5-U@+hN~pg8B~oUW=lW-4bUz>>4+n&^DM(FevV3 zaUsT?2Av^FNi=#6CA1$X<(+hLb#-av_XgcQvNZi- zIt|e4CT<4i3(j5Ptx>g05Q3-UfEo>*Yk>G!V22yT&jR^|CVm#!6%J_!;0gqY4GeZ3 z&CVrRqcS%5=64OIO3vDWy;Jk5C^oU?V4hTpSqZ(WU_=vPh)g#`iBw5uX%9kXg9~!VA2L#yZ zAizhYRRRK3J)-%oNAV5O}0lp%w5)h#35#=L*P9a^|&A1PfDD{QV zo3_dAc0hoI4g%=Z1Eu07)-x*s0d%TCWYjWt3z|}KQ`IBNjso1+hsKf8eugbO8tpO! zR~DwiY}%RC+gqxTDuRX#ab_&HqrtH6DoXQ#rSuv2r35!XuFdrYH#QjKg(_>K@)^TY zDr;k*qpq~mkv$gEkv%q2kUi!Vy61P1@ZqY2qQr;;H%wEtb#mU13xSQQt&^YI_=q4C z5O4;J3Zxv0>kDX#TK}3evTE7lSDyW^%jVa=jMNT}zbAA8xO!-kE2k`fVphrOuL{lA zgB#LcLJk#l+Q0i$4? z(cPV6IPcC;d}A(3sTU7%#~L;nOh6uG=B9%`N9o0=V8?c5i7`B*@`gLdSpVryJqYFu zBOJWh$W7)90lYcG4fwszC zrWjp>!>_u_;YtBRi-}-p5s=7xO>{T3*v}hUxK~KZi%gg?4+K2c%?kO^w#NIwH)D-0 zR0oz8Bizj=oNwBC>&targ2qBH0qMUt?_;ar&(YlkWFKz=VgR)_c`H+WT*!gcrBRn= zp<}jV%yXQni87}qxqb5)@XitRSC%V33VK3g;{0>-&Xw~PE#cR*)_j?rRqhPnJbFUe zY_03lrEAUF#2XGh-zR}VOW(6k%}y7*Q@R_pOy><+G+=5&>~@hEK!Or`tCwM4bDQk` zUiUhyE)I$S8BJM{MZ%$kU5W8Ju1QZK-2{rRGA#NCXG0AdD*jR5pR141G|fQ3#JKO z?PgpA5HmPz1fU-p5E5|+5V?sP1rWPkWCYmhAb|KRGA#NCXG z0AdD*jR5pR141G|fPqdFAm~UskrAMwg8-r7AmS_RT7V$FYR5)^xSMeiK*U$r2tYqH z$?fcuP^%}e<*SbikBfVoM(alDBKLEC`U=*aSuxnaT^j=(259KqoWw5yd#6b|0Jr;? zm$*C^#>yf?fcPa~UpB-q0XsxPKQ{K5P8ZwpNwkZNDgeX5fEku6Kka&#vl>C@aZOZ_=-8gylUjfgecTb zODh)b4Y_6tFOCe-Dcyulf!dR3J;}u!yrLB2#yRtYXm1Gc6g(j@6e2D-E5b}}$Ot`W zax2w@wo~|PI4u#Us}b*M+>C%uPRI)HF|Z*`srEoA^;DNezC^@VmS$^6(|> zWvaHW+fXu9_NdApUwtU0-G>yZ;6B>cRrQ8i7EtAA@-@l6B1hv-O%$DijjG|4BT5GZ zTn7Y5sy9>wsB$#<2=Em-8jpZtItY+w#L_9Jt8z5? zFFDZVXgmVa=paDa&A15g5e+9GzzqnHRBxyV$fSb+RgNYf0qAlx9szbb2#|I&E&_Z+ z!wCrZ84w_;-cS*s%F*N}0+b5R=yEh30UA08kajaF0(?co2?*!}1W2kkR0ODUH2Dbd z6*(G@01F)iNV^#q0e4*sU@LcTi!RwPvgW~URf)C(WB#Y#lz;qT&+l#5`&_-4)%W3d zKid$Lkhbze{!RWE-pFFvfbMVdC-86b%Oqb8X$arixf|!^&E@8Q>{5H?a0>6x4W{qKNi9X%6Zk4v{m?z?x@rpGyq3@)+N4h&^Y~&p?GNDB& zs3Q^on(ZxJjTXh1-(Z+x{4u>(M$Tm8Xt#d#m)WijHt-l3rww#Bf9lM&MYOJ7<>d$q zuh|KBO^bJ>r9L|-2o5M*ME)K@}r5+ll zxW(YM|4%^;JMN*Bm5W06r!LV~{h@>N8d81}uq7VTSTTM#wnkL>Nv44q=hLu6RQX9x zix^wl;yJ`v`HNtCiyOW zOEAt2L^i}Z2m4+N7Aln3_u5T%ei#sddrc$AJSCrEEzZ40qzc&g+D&$T7>Bd#ZpIA; zZ}PzW#U2{3W6QAq8akmZ>AGSgKyc2%4sD4K6gC2gQ~?_Sf^!abK3FVXXt)RRkt$## z0R7N-9b1Nk0Md0ujA{5NfJhav5pdJkG9(0$C!g2|AW{Wv1l%;X3<&`mItaLFY}qgN z(16uQDYPI32Z)tNY)P>W4VdZU6rBuo)<#389!NYuu#XM#071TNq#e+iR2g~nq78{? z!~+Do8bCZiurC{yPL_s#Y`je?sW4$Njm|wl>F%TyZ&12!)TQxs7`T<(!B>_B90t0I zk(^`<368FYlB|M`6osYJk-|%*bX)hN&<~_*;Rkor@i(PsFE%ivdb`P_M1J2z9N(!I)CsS`f5}@u5mBc zbMAZ}2z!mV4kD;4&2-e2=c%YG*)lqR%|~=TW1{mJ&pFo0C+o|q3>nhEK=TFMe85+v zReTRZ)g#K+*{ga)`Hxf34-Ft-DIh>paN#1rSEN-u0#rSsd<3X^MEM9nKQw@VC4c}? z!G((eUy)X+dc-??ZKvuH_O69}*+B9!z2svgnPMfX-l72s?_AS6rQCbVj);+;PwdP6KnA zH}}z{IO3SV(t1yyflwXqo5A}G44L+usRO4zI5lEcF6T4Q`BOm+=^%0wUSL)lRNI}K zzy_p`;Aqj-`0F`MPCwHK2e>oLxL&{77Ger&U30}#tgt9ouub5+84mXioj7gc+Y`T; zID_|QV8JYi^xVA8tqO4`R)ihXmpcPEM~hH4TkHCC=~}Zk(X)RvJ6*7v;2cdxj?eA? zPX7=3AK5Y;98DltcpW;3;)r=Ka|()@>;p@`vjysAGT_f~psli(DMlCJ@T>O1y?{jC zI)!)V=s$eZo=wB@_vG*A-8tMVCOJvQi1*iIS8+oZdYJv5VKppd)?~#pbJM|}qx51_ zuwy&3#2B7Y>FLff!oeG7@a`NF_WW+=V>=(;8Fx5L;xwXU`GMsZbn8x52KP544u&r4U`OC0|baO>u?be>^vPhqx>>90)&jw z>i}B?5ul-i08(aw@t9-a*8?NCZ6%0irQrsaK-W$x*Nh=^2vE8y20FDTO7%MQa*fdGq*LNj zmqu1g-KUnOUrc8)^g3BVeS@6~P^xj!sS8pn3sEYisY@eY@8T;h$L}7nCX@a zb2gPw*b4}tQxrx&G=KoEBq)`)P!V9Kg8)@q=lK@rW2-QomKz%DO<_-`@JL1~U<+%c z-HeL>9}%Pi0)7GnNNOZh1Ze0WfKqWwETZDJpea?IRBfG{cXmP)K&SAGerOIAx?L>% z2Lb_0UPV$KCl!o}iENFkU1C%|d@{VYz2#!TL;Kg9<>aC#BmW)d9VjnFg4Cu8igm_- z8QgUPrA{2#qw9wxs63Vre~uIHq}FWVY}=JDp=dz3`AKviaDxQ7@XD7b^+S;hv#(QG znCoM?MSsq3ANSM}mI&vuEuG~DohWQAZRmbpBil-2!6 z?8lWq{@jaRRqrPMMK7IT!&mff!i!#UH>)Di508xXpZ?T?J61mP&!533x2J)yQqsE} zDokZK-(egl1WI)pQSgZTVuVgT5WO5!pTwC|D6%wcaFMRy(~(vGIp>vU8xI{C_0xTO z{_k(U`9DkDy^c0NbnodG4`2M%SIMzwpBlqEOe`C~Sy}vDs)@bcer&zz>sF}hestuffK(X%)yls~rSaBu%VlHUIJ=imOr1aqS8 zz@GF*QaSADcqIMB8(9VKi&bx8rcbN+s(KU4M}X>0ds95soun%dZ;_`CRRQQAdP)&1W+gk zvfP{^andKQJvn)`gjd`Y>dtg#3a1J764+6I@M;M=3hQ|J($U^q6h zsoK%C=6PA*3Lng@F^nzIr@Pjz(#l*OHj~b@--UEOQ$lBOZH;JZ$K^I(Brg9R$ zr4w97b*Bum#(|BgCENgtJ{jej?Tp!|uXxfZGleoN5l!v5ioo}gN3Vh`4y^P|gW^t1 zWbR9>w}dmBvJNral!IQS-$kW3QWomt#8J_9BrhH5Yw zsfavk9sV5l>|za_7&=PuIL3|!g0n6Ka8utq3JVgKpF}yHoUA4;!9FQOdJ zt~&rXh-T?@ZCF80h+XA0&`Al+%%+QvrKKRPgz_S97S4N3Q6CW2UA9KQ`_BtH~s1iQ;Q$(d( zFqRGig!fC>2(Zw}Y*h)Ld<39N_yh!?ADZO$MnHg_4gypOpS(&s6i`$NpZr&Y(r(68 z@uExk1O%WTn&kFkK!An{0#pf~%w`%OfYKvaO2th&4~M1QjEewt2_KID{6mx6ZU+Qd z=pX<+t>NGDs1iQ;cxDpkTK`wgrc{m>-0TeyCm_?@h(z>Z+BvpT}O$_Qg3nSreN z#DZh`lg{3zia|y{HhZ4S>I~{Qal9?{f$`JE4}a~kBY%t8@zOKV(}Ejv%**aCuqN#p zzH{VbfuR$pO?-ReHxt9^b`;bn*}Lcwk-O=1HX0>;?LP&YJE}8%1|;$ZApAS_0pdIM{lYtTOSFrSV)H8Te(hpN6@J|nP}JlMG9_lL8)Xb-v$d{I zm##HyGd+cVUHwnr%L#}c9{p_eOVRt9rc^fXYJ_&1AoOdW@69I0k2PC|9@AGi`xT`J zW}MUvV#bwJYh#%R&m8N3F{IV{`-A{atu$0pD-Gw>N*&UscQalLBX#A5Lq`9`TBE6A z0dw!1=FNR{DULWMu=SK{=lwee{HdP|zxq&0ySt!>NlW8`5d{Vl{A~J!?JZScu~*WW6njO}-7fIaw#Lx7I$MM;i~02&?Fe`C z3Fn)(-um)dPgpF<71U%rEc``S%-~_cmheI~{wrYQ2YN4iH}6A*_8MEm3)L2d?&mf^ zY~$&7x;yy=y7jq}vt8?Kk#QAa%m%|)qkdjld8#qq6XdhgV;s3_mp#B4=loGJ&Y8{| z=NJT`8b~k=4sTOs7247kmngvF_8O5B-f%y3tYK5rLu$?GS$SU?{Yo!J1v|DgON`-; zd{2L#8H`|P!TIwPO8z{dyg!eoLlodefng+(6W(yyQ|jcT(fN#>&Sxn7XciiO4TuOj zB@uz9^;HrwY%76R(^_7-s?fP{Ng@JlMiUVMx1k{!LP46{E)8QwzSoEk5XTxQA~koL zFK_zJGLy;4%4BTmqcc_?XshgHiqS>ZpxW!$b%oi#O~ z@1z}j*B?Ip$h6-~9XR#DsS&es^Trg!tTIe;5)lD*EI`aDOBzK5rt(DVx|?w?Y2pJ^ zc|2td=vPrL8!CqeLjGcE#%hyWV_=!XVG1b~1vItUQ@q1Xr@A_8m#5EE47D1e9vun|B+1lR~51AdSZ zAnj&c1P~DcHUiKO4TuN;0d_hF5c;9m2*?z4MA!%*1Aed(0QDxAxPXlS;sb<@05aeQ z83EF6#zg=T5nv+#{m_7j01%*|f&kJF#YO;mA%%?qGT;Xp0YpTAjQ}Ddz(xQW@Pmv1 zX*c5{fQSf?5rBVaU`_!vQw(CXaV{y=fzuS=Drj^XKx-{}-2)?p3d4=vXa5|;v3AHas z2GL;Ggeis3lu`~#5htA}U0oWPDiml8;-8wWEe7s8f&#Cz#LLjKUy|fWRimjwK~*Ry zSHlTH!E35eP!$SN(!8b7(7dIz+v$9U(vN1L@zsb#)%x1NK6S&Ug-#87FIV)< z*vR{4a5nWfPs_Fq*J&)=_H=c6jmG>-zft zBkA>jfByA*`gv@EQpdy+%d~UL)S7 zW#4%Cn_<2E$w*y|8U8LAGfd!(8Oq>+xe)x`7%uDFGG3~Agu*8BxAfWS+dJ(dH>rt*y-k(;l*Ib!=Lts057iY_QyPRHBPyC z%u_X(Q{L=Pn{^5%3$7LXg08#nEoyd#nj#$i^e4iu*S~2C{AVNPyFM@ZDa`V>qAq}_~*0FP10 zI0(Rw0$O7_?feX5LvUqbDnD8lya(MCFo;w6O<>6IGACF0-%aCXPANfH%hR zVtj_qU&DHvVXXYxSm^v{_G-~W@x}~egovZq%M4@XuQj-&cfFf+=~-b+uBTV0BKaUZ zE}9QXv^cm<7h^WEP2HUB6fAH>(Ye=%8QhK8!pb9!D{$RBh7n<-L6jCOMrpYB+UlDJ zB`ePWC~#@83tU1;NZie>F_Br9He^LOaDqWW7-_yBPJKqW1)wU7erNyze*pv#&$+X> z2q>n50FQ}sI0&E<+NRJ!fX5g{90Xv8wgLjg-HeO?K^TdR0Q5t{Ju!y6Mk5|haegt% zsUeRgv41r5GK#R#D3zWlmFwt~IMt}vH5~?S9ohwZMW$F ziewzZ)MrZdIy&VVY03+3iOVA58CM^mF3riFXOVc3A^6JD)a_z3Ar~-+I}JAw$fJ^U zvK73|HFmtg(hU8YK_ zy3g+DCan^(fp9t-P1PgHj-ORMqL)dz|6Gp<2;gemqJj$-0X`zF5)h#35#>vgRXyS@ z#`t-WB%>diga!jd0g{3X7XdyZtr8HR>JjB5fKq{zPSciBQ5gNu00Ov@pxEZZMF5>z zovKHa|1gPCbt{}s`Yi5d++wYd=n-LFFxz1$g6YJrWn&vYm~LEo1jJ7_PbVI##N(ub zn9fQHil<6W?!Zm)<^LEMwd^sSSfNKF>_R%9$)fWaJDs&zOy{pLkK-mR!yIg`Ec|ZP zrO#1RLhSkNEmsSkhdJ2XBPiH&-=hd@*`*W&wh0Xyt|%x5P`I&xDo4A;+k7uC6n#XF zCiI6@4X6By0Q#W;1aL(`F@VBFfGS6mj{qN$qX`I5HJtJhfPQEa8rTdl#1JbFHqW7C z3grUa)Bc{zD4lG^g+B~9{7l7xfBf6F_RHqDtT%FN9{ByVt?Yle6C!(kcJ_sny~m`q zUJWQ}at4_OmY#4LL)mPt>rhbu=k0oli!fHcD2EYv4@o-n?2-6&&X#!1Z} zW?YHBJdTk+wT5VkdLG7Dlpg5lH>Y`XA6<$g)fm(&-)WJg^qSV5EOr(!_nInZT(4hk z3o(UftTo@Fsy9IN8rd&+jaZ^xL`&53{6ckU9^V;vIDoe_fk8jMvNWJ2VqkWe5S6sg zPxE|QWctoBlgY`-WWF@|>GBS=RrWH0dk)iEFMr@0dGdk1(Qd~JJH8@}i7dSs73|o~ zn6(j({Kg4`pZ@JGYs{Y)uNbg*-Q(l0z17tSs8BKj3gwM}VC-v@Aiu&soFvBXc~IuB z=V-H-4TiBs{XEy2B}VzPaY)994K(sjs^{slqcc|9(nq+PPdLFnr?kBG78k64=)`Fg z-=6r*#2Ixv3hI+?*FgU6F9GsSs%PKGU%;UO1k?ZmM9Xbl1dt~m*a)~CFYLQVKrtNz zkQf^q0Yb)zjR5ja3L639Znk@QUFgS}twWFLD-=M0@J%8fJKmcV+qTm+EE z(%4Y|`k?^?*Z=`y6&*JUpj3Aj$1yh+79=h|*-hKwSi`2Kht!(W?;ZgbItU>0JLFmb z5tCvgfXMH#5g_hnWCYNO0?-c)H^7+HfuNYJXx{ZMJjmR9C1vFzw$9eubi->#S8h0D z^lz*+-eo9wy8~bE@-u9!Xa~rZ>pdi1N@2j@qVk!j+Z;Bdw0AS-2*2)9qSMXV_yqyUB8O;CajYWw z;Ib+{9gu=fPZM&bC;5a4ldK!~?mjMS{1H?E5JC8Qd zN!B!Us+{P@2C4$4t~xPK!y%<2XkZO_`-i;+DCM4%@^v~j4s~hdE31fAA2y%Smj>pM zR05zS1=pB{+|Io2@39orRnTdws(M8EVqsN}_%EwR1O)s52#^$9xCo$APDPhi2?YUF zkJz&p*dL|Yq|^D?q%P?N8+LU=+RaZkKvHlFqbSIwwmzaq1O%J|1jLGo4JrbBMOq~w zK-DA4M}VqFv~L{0{@G`8Q+9uQ^^s{oi*hax?rH}(bcc2Q=j*H1UpPH{>^CouZRn83 z6XT`NfB+XDAd?OP=tKeN(kcM~svc230#rSsd<0-08bH7qK!Bv+LX84^MOq~wK-DA4 zMu4hEl;3|uKQw@VMnHg6MaM+|HqgKk)G*13F0B#}K&Mu(>JjDpEl9f=w-)dV)gzu} zOBO{X{e4J&>4g7kd2-IR_>?ySGGBPBi2aY$nu2?`?E7p(uUB-ff133|sAw^f0TvVX zn9gFh%oObshZt*0H4Pu|t%KQ)F^-kYuOiYzGEN!7nGIQIn7P`SOi*cERF(tGInraj zS#xYNhWE2hP4J&S;q3`Cr2JHJ3NB6Z_3-pDul$JJW`GftWoIvzESaP+Qj z+MK9^_y5LlZ?FH8nZQ1E!?xz^9rF2*ebVdy5dQUlu{Qx;n5my>P~3@$%zZ`8cE8e# zw$Zw9CRDd}Nn2&42|PfUKyMBpF^=4|%N|G`KfV8pTc+>%-Ok5$J`Oe${=Ch^Auj^F zxf|!^%?*ywMrW+~vaRvnInB<2ra(u4sXXp_eSrQBg=EMoMHw1VGPado|m=|R1A6LHMde-U#*{)4CKV7a(8{vMr z(g{{0t!um)jri;99)2jdaLV+jZ`uXm=eW>|0PozqbLrdo6ElwKPdV>3 zS(h4v*iYuWPB{Jb-k$$A;Uftf>ioC)GVNEp%$wEXm5Ph_{;Ys`Eqm z45hy&lfv3mB(WtRB9Qt=qMT6qa|3ZnuvncCNv`}(^J+AqJkp?~qq(^osyqa^@W-PY zs{DTD9GX1bS(N9qH+L50iFUl}ZWbS99${W(t{Lx%vkql8v5y)<8@HF3P8>8wWK?LJ z%s8Xon(ED+WlVbPLpkp+8?bl7u#NkrR>)+j72=^L{AC^*K)_M>(Ih_$R0Mc5c5o2j z(b&O3z|9#D4gx&7p*RTe=!T*op!jBy9}WVf-HeL>4|f(61fU-pK)?||faGU^ihx); zQGkch1PTH?x}i7-@GzRdL4Zd$6a@ikbPyozW?Te#bVE@PfPQEI0cJpe(d7z@r~S^)Z?0R$|By0dgYiy8uyQ{(wq9)+8f z?ixz>Go6@5T^cWgE_&)da%~h}S(@Z_3$(bTff}O00L}$XiO+QIG><2rIH>^oH6VEQ zt4rf$o<;dKzY+#2YLfZGeGJ{4DJN+)|B) zVFpfW^6<3NQCAkz z`3$AM#y~^)n%us*tAgv*s=$um#yCd#bK{amC3kscuKZ3@^@y@X$*LYvzQWp<^oYsr zX8-}kV$_L?06OK=6fwKOjcrvuqUX@qTh-E3J)-BM%v(v4(GN{>`yoI;8XW}qh_p&5 zrKx&E`3O+;i1HDDerS^08vy}!ItcI)X_bHgRgWki0jeHRJ_67WO>%oNAV5O}0lp%w z5)eSAL9FT#y-bep>Fs#e-Mp#_q+Ho$-%|ZtO=xI$#dso{O+**LD zN0c80(9v#4yBQY&wW3Tj<*<#vsb!vtrBW6>_6DJ@%7{0daVYQ2v}N_5-< zgCyL|pDsPQbgfyN=oyvFP8V!5xaZP0oMR`zbLnMO21Bhh#dt|i^9yb1!OXAcG;NO2 zjnG9n{Hkx)3VS4&nt+|fib+oLP6qF<$*$6X(u>5Ur9BP!$jTe19i36G+0GnbmKeh` zDqTD8-#OqyBmlc_!~DrC2nK-*Qz`?E+>t0G(9_|oXdX3r~|S5}^CjJ#b3ydk^^OfhtIgt+we z>Yk>Rm?{Pt2bO*pmExG;h+_gvz36X3b-V`%Z=3RnXqz%iuub_%^1#gO5Hap;pjZ~u zE3P8!di|TW4YuC;a-AoVKDG)017|eyUQR&t@aSiwUy9zy8;x|`%{|R8boSGqSir0? zj4hc{Qmu_;3K}O2e)_k&tTBIHykfxKb&rp~_SOtWuxH^MZ3-nvoBq6`%^5Hb6=da> zD;>Mw*K77Z>+KhCXh2N#8X$m#zsLw6I$Uf7kasf32q0M&HUdaoii`k~%wZ!SO6clf zBS75ExCkK095w>b4-FvTbwB_Ke~}S@9@7X>0EtVH5kTTnYy^S zfVi8H5kMyjKtD7cyVy?4W_Vc8NTwKPUlB!r1O~$IzQS^ zE4U%q+_2;&Jq}C0yWEED94m@&;aW?r-7?~z3`@StiU5}mtWI2>%l$dH6#-(Qhn)@( z3q9mmAWEpXV#fl+5E3~ScwMm2!;S@l>7)bVZpMuTG{V~w>~sMA&_Gd;O9zND4jBQ& zLJu1OM6!mAfMPlbAQpPq2%wV=5S=G>Iw0<5WCYMj2ha}s^nivSCqC;#l&JCTEc8Zu(EEhVy@`hLf9O3<%JOHzz6rR5_abOMp_Q zE>(oEMCk$o=%monZpM{yQ>qAIH*L8o#()4RLc>J>olHPVYj8#BbV79Eaf;o7rj*vG z8cx|SIo#NX=6G_uhIJWO7K{fQ>y}lehwgv9x-uz`pHQrPMIfp;#{5ZipMBbEP)J+( z@}z!XY^Hq9q0#XFZ=w{uSnv?SQ>$!fscvt9|Mz}D_INV#-;Y&mm45-lf*1{8V+@$V zQ2>;~O(;)OETG}6*|L^M-ad)WLn%EP=q!wZ%EJ6SwgDFXIlq0JL=2V)r;y%(zx>b^ zsE6lVl6VWXAgG~JtVLH<2~n*oMU;J|sZvDwsUZ5H0R;R62#~~ExCrnORh57MRf;Gd z0oYM(K}=`Y-He+G`iK+}5bz`XXp(pf6#*7HQ2@HCNpBs%tN>lSC35n8H_z4Y~)-KlJxHF5$TMxXyW^4ltU?Kq) zH$Omdf4~_gM6wd>9YC^@5=q^o{FDN)q>2(cN7$!^JdmoCEK^h?{NM)O%f_0tXZX&M zhXX<-yY$=-@6Z4Oxak2x9Oq_m5ukc{dz$8`p5E7t_rzI;GMm^( zjiHU(OH3yY8Y40)G)`umQEyE(#(Vl^{r~Ri&70qm96L&KO;Ucm4~GEsLzB>8;i3T1 z1sN9ss;9Sn1gM_g@)02JX301WWgHI4v9S?=erNyzTofR>AmbuH_4JmH0M*l5J_5wu zjEjIw;f*9V0?-dlLW2RK03z?hP6Sj>Z}|uyx;x}r0MXrH*8+US)0#H!d)0QRA2UIpd?1{1t2b}bv* z!1<=lhe4?qxTnR+cT(JE+@e7r)P#vaAHruWJ~g?vlFpCz7lY`W2eoJOvFMq{tF_A4 zx7Z_e##h%;8DGshsEn^R&=_C6wS`Xy#Gq3&7*PIra?@VP%N6Wy8hQZ5ha9Z%*aLeK zGo?UXU7Ay#BPfKa9m)I%is{k_3Q2|FD@z0Z0-1(MPJ`GU7GD*i^le4M47^sSa5{-) z3UV4v3^TAHzzXUsY_)^51H{L8IM;xNP99BsX0UG?;xmIRcfdb32@R~Xix^2X9>&qt zP|Bm=^-TagUBX@)I{7-K8i%?x@+Tzv%F~P!9~wZwQ9uB(xUM{oihvY42tb!s36f;tl@xZ6PQ0hF!&>r63ORo& z7IRMAj6>SZ;uJ@e)K*g0;`SiW4-FvT2q1u1Tq7eOmJR~YrByrv$SWyq1dvx!*a%Sd zi1MQVAJHQM0?dE_GW`}A0hx3VfG({P5I`pih>`Whb_Vao;9V>ZM7$88s1*)U~*Y0Q#W;1egE;QWYH)0hH>_ z*wU((`6z%=L0HuzHk*g#?8%wd_QFe}QpTTsYvP_kRsQ3vw8P=yFD+@UhinN^q&`>?>qge**jJ~(^cd% zOA`6?1*?(Fb`71+Q2J}w)_C)4(KES2+`8)PFXESfZ+6s4EKhjs$lvm(Jh3ZuZ(i3&^Y7&bL=TUCHu|OLjZIT3n|C+b zPj{Y(IBFgKTxUsRQ9=CjlL&uJZA)jw(Wva`ncy19{bP~+%I}R?U88=-_VdBL!lDn9SjvJus znn}b8nPX~Chq6mb64TG6pR4H2^exgZe9d)lQL}x7E}n^OePdMHsSs1BDLiAX`Q_9H z#!nkR{Gs<|e=%{-gH-`%pX&N({_o>+`@hrwgZ@XhOvv6-pZ&Ef^U~|zPok!lQTJ+)$L->Lo|E`!TFV#iC*jF{HVH{-ED(KjQE^UauSw}5X(JU=FTzCAuN z^U?;kl-Xwd(fDI}uZ*0@#?i<1tG{e(3^heK`sq)Ey;lFGZG$baw7fPUHem4Z!J!3z zJn&-lw4g<~mj`b%hWE2hP4J&S;q3_vc39VczP@Vxh0{aEe)ICNhOWE0V|RW2^Ud}! zQ;057H!kCie51eaR938UAZwnNwU(P>zb12R$(#~>c^nh*!-T<4|8|#k%ZEoYa`p~B zFlF4XkXGyO69Qs(>|KBO^vG$ynL2RlgHt1B<>ZYih+oA{boPN|=W9ClSK!zCb0iRMqKrtNzgwR32MJfnLp@V=o=^#Md&A14Np@RVQLsQd|1_-dwi2|%t z5RgU(0fBT7P)7v;v2+lSO9cVaZpKAGI2{C_ADWsLJBI*~o4AR(0C6|tA|RFy0?-dl z4Ok3hUUG}5IaHL&7|@F7l(sb!lXFAEAxnD@#+in>9g;OG28h#peorp1}>i|-D#BK0Q75sZ>6eBBfn$o_K~IO7vE`sT!5`0Q95oQprI3SM$rkAJhRTc??LJKD-MA2?&Xegd) zLGD0BjdrMWa;*LIJAy={10FgV!+>Pws^VPJ+gJ zPuh81nj1qT1Oj$W9#|!)#5m0$iy=mXr!rJNL+P){q_8#>li8B4s<)+_*N7@dQ{`w% zD^gVr=bcEOX=peB0Y?D=lIjf=0jeBLz9Q9EC4JROg zQwT`iZd3$NYTc`HH2F~goo2U%4g#dzjEev|wE*-(0|;0M&!DCI`M(=-k@|w13_;b_ z-QMA3D|ee8DS2~b&4b&jj?8^EBR=bmfaV8QKK#g+hKJ+b1^1pl`@+fIW71mxBzSXd zZ@ChA)cy(Ym|y{~82Hz*YHijj7$ve+@R_*ISs6IRXZhEKXZfw`RyBEA`2-}U$3B$v zK5ymI-7%r?xLLBNJl7f%nRRJHR)pg#28?};yfZ@%3l1Q)(zASn@GQU980=~2H#=SM z0NJ}?*v6Y26ROH?jLW{@-UZfv%}dwX26Be@-}253O?I#{FiBn(n*}e6h}Lq?X+k3$ zIp$^e7x2@Bx*Lt8w6_-25Esm}>f%>wwv4DioCwV$1 z^o!{{13wzEKufFM#t90s{utfv(#C@ z%_K{5=7v2q1=j*a#qoe#i(A4gHW2 zAnj&c1P~WYWCWle8bClJAb?n)VIu$=XaWL=p&vE^$iO0G1X$=q0mRS`8v(@74;cZ{ zZpK9balyn!0QRA2jp;0A%Z}b~C$yA~BkqLChk}L-Y3wTm0$(I9{~jgY(3J6Wc)_KO zyF0&+JbD%7icYI8Os(Y|^dRDFxmxi2&nSVdhR$a!bUwqDQdt{2oxi5|N>XeiuP253 zhRo$wI!-U(E@^T6Hz1mfm{vL;%qw)yhX}fl;EI3fN-`N-h7#IF(Ye>i6gK30?R7G@ z3i)0OhMX4s0I{=MGVBfcUegeRcjSCf+ReE6AQ|?C91Nl#8bH8b00Cq?7BT{g=^%j2 zt-?kCozOOg4g$!qH*5r8hqgjKDD7rk1dw5G$Ou3`G=PA`fB-Tc3mE}vbPzzMuwf&B z%&kI>0%GYPfDC&>Mu3G*6d>(pTm+C|Z^#HhKQw>lvv@$ z%?5(A_*pc_S*IKQ*d#Pqx+=JwyI>lTDy`~SS|wxyWWX@C5`hdDMkbnFyajL>K*nVw zpPJXnfMMiXjj!kt6B-PqkPL`zE?floh_p&TfT~B7FG;49LW{c@SCUMrB7}Zu00CS* zK+J7%5kMzV7Y7U@x1cFy&|;+qSCULAwN>?q@+*(nho(f+z`8A8MjmDL3ENvZH@G7p ze!7BF6$B{~ClBPT?VupQsqE|+uQ}MG<2ZRB|HpLlO0LE@M)@ZL?1k-|Ja7@r426jE z-Kkup=1d+;C5Ad_-DR z$-lN!^@#HCHC2x&|9u+zq1oC}%ppKjaN#1rN2FB(0#rSsd<3X^MEM9nKQvog(zsX3 zVh0Kr0X`zF5)h#35#=L5)g#JB0Q#W;kr3Ax5Ord>A|Xnpbh(w(PD9+4hu)mE>mQ~6 z_wCfqYe)Xaf6Cx7{!ct};(DK}7smuV{b*rmpJlq0M^DUP*7fWFP&g(1=@*|~^z@P! z!UkQ25=&>~(I}zmrfFT}=>ajf$vz^(YKnI_jeQ*cMa`STb(xMZCZPHj754$dH|^Op zEPqe_->pwY0+1}xE|Qj19{17_4|MBuCuh6X*&&l<3Kh$ z-F0f|>I250o=rf8?y#=^e0|mW3#Uhp{pRJd4IMXHSnX6KyH3ojM>OGb$czV;9o;t zeBk{x&AS?*GC?A&l15J(7{?kmH9e%(oSv08PMgAPG8{AN=a=0P0*dJ%fTShZ2q66< zWCW0BQrHL(cQY~qNRo|=0Q5rx2)FFLjwq?1q2ZPG-L!2^&K_>i24p00d_hFAnH481Q7KdG6IPD z4jTdDZbn7`ohShP&;SC?0|H2vjf?S$2D6K9fZSdK zRbhA2L8U6(7CN8VOy@`YftN!HgOa`Y=PA_Va4+V~CWS%CUi|YEY74Mt-fU7BlM+rg%I=QFl zYlI8|b!p_QgnVUbI1BQwY9!BzL<$OPqUc-$sB}nBg$N>S88VMBvX><^vYU|`9K-JdCM}UtA zQUL*aK!Bu1LPda`4gyqdoqPnS+B*3N@DV{OAYdUNKvE;2B0xh20hBs}bl%xfYT1dc zVPs*A*nGlmJxIG5>z$pD2+(N_qaPYTKo%fCs-mMJz(NNBQhx*WsjcYKh+L~rqtoJ| z)87#7Ad%&@(r(5@fR6}L?J=D$w%WF(!;)8@6nkLJ*(jK_Tjj3kHa1wPrhq}1tqNm< zxd-=O+&rCFsn4*&q}Y!GW*G2*2U36rR3+c!nO%!C0 z@Mz#8aH^03D5O}Rjm^05?*l%1=KUrA_&0O=h4wE){?GW2#|PcJ$ldE`^Fw|^-u-Mt zuY^SNSl*qZCjnMblRYrwlxe18sS$h=<}_`N(T&hWIQ;bWJ)1L(6wMiC<%s4CJq6lB zue{9Q5unIM{gh-NX~`cxTKL#%ONV`_=196U`j$~D`W1I!X*xFf%3 zE;f(4b)tcPa z=oeRS8=;G5z;I|(TV;qT)D+aZ#@uWkma`{kTH6aRjY=7R_N|F~22}+lrpG>%^Zu0S zPtSTGOmsCGd0VbV$^oq>SEIN(OE|MB>kwnpg5glDG4gz{oUMPrw9$qpkhyZCfdoeas5CJ_YFBC)o_Mrg;oC5?%J}{^V zu=G$qRuBP_Bmx%!Jv5OOL_iuH1oWi5P!Itnc$KQw><7a$;0 ztWx7502^q6Q==q_z(qh0O=JZTV5ftCo|G2~BA^FXBLxv4?PgpA^rXB{5CPbS1`u!t z5FnM%P!T|>=p@xZaS_l%6Inq7Xy_n-QgO2f<%NO>kajaJ0(w$jD2D*_LjwqC1O!OE zYFq?h15JnmdTJsoSPST(iL4+3EOZdilk!5jD4-|hg@Oo>b~7#ldQx5}hyd(E0|>B# zo4%y*@ZvC_;HjbWqxJOWQ^Ac!>2Oj4nz}Ud+bF)WG+;GU4Yq@lUxKHCK*2k$C&vs0 zPbW*K?r5NMLu=pLjAoR(qI)u$`6V5j*NR&VtlbH2Lk2R$ zxC9hmw>89AzN&`3h5kyRrVR^|nZa)GpW4nT6xy&gJ=@MHw5JWXP)91Xr!6kt2k@V1 zJ(b$inx18gN?ir^o@I*)wV)t~=IsXmnUkhcpSgvTrZPWTa=QlRE3sn5=3G*&<90@w z%clT0EQ(V3iB8E5y<#KOI4D)Q)TQ~?RirMfGH~vrqU!BXVJc(DE-QC#n!9mspC8kE zW#p)GwEiz{QRQfg=(tr4r~KkWPwrWY1e|~XXO~%ixCl_?X!4&W_=p@$h-p*}r+fsU z9~wZw6+nQfdc#G4Do2x#03VT~2?$U%obnNXerNyzoHw|rdc#G4Do2x#03VT~2?$U% zobnNXerUjdoT~+hB{W35w{dqyg{>l_lQ`)+7C)xc|1C2fw*u82sY& zUZKl1PZiA7Uj6y+?+>W@u5i&2N6y~C<|*S|xWB-fln@xcWAFOIr-zHq9OrW;M4n9I z?MMJg!xw9>R31-W`663q8)WLG>!pj%So5XPPxq-I#TeSSy~K3lpfMt&LgQq{8TD4l zGoyF$ANRc&GcBkg_wwMi%N|I!&ibV9^a*cIm?3!#3>|rSn0UeN+rRn<8DVLzo}YDM z>4~K|lZ^vQPZYE@`j=j`jn;)Tp}Mt8+A1SWeRL_(6Z6~qYraq7nv`(CzVn2!RTx>c zH%ss6#{@C?M*p~qFs45{u6)KZ{VC_YChJmT5c|n|*9oV;L)IB)u68C9R9Y96To4Qs_SIe~Nz}$`MkCd~e1V$$K8G z3OxH%@48`Ib3R(ufA5B28~015DU+Z3W-4zqqXGTZtX_*bS1ORot}Lr`zF~XA*0)GI zI%9QYvppo^q-mk!QR4_l@9L(_iMn9N_8X=t3exw|>omY}Y26pDx#?jc~tQ z>0E6Kk$f2*Z+l_(sKgyFJrg@Ecwo-^%LaU9ov>&4&XI=$M5CFw^r@3pRJma0Cq$($ z2JP<@yy-6gVh;@i0$5zP)fogFE3la3{pL2ZBLL z=GeSj_!O8g{7ul2W)yUuYK_}hcj7d=I~$s_o@vFnqQRRX_l)t<3u5pTzih?$f>$wa zHE@xyyb`nc5DROHOG2huF`_3y=t=Q04w@gWj^<;Cel&0=gu`-B=P!$F~<90m^o5t3px^tdks`k1ov7n&AkRX5*DSQ-fMyv7{R^fM-vRnyIFKz zN6QCwH2EO0C_j#BEU)$1)v`qKtL5B z0OTqJ2ml=k1p+`7MSuVY4FW(%LV*DA0wX{Gc!5z=h2`Chi~yP_0R7Ma0;EX=>~L;x zIEhpd6f8|>xCw9ZC^i~V1B#|;r!9@-*{-HH=pjpUe`u>ocwJmBU7a8$Itwogk@~he zn$ros85H3L_+}8?&~EU}5JNQFOHJ7UqWlI;ARySy5X2ii&23|%2?f!Q4JZVJ`Graw zGP-t4YbKViM(_h8*aB9XwIS-=)94+vrIDsysZmyW%F;}1&Ve{xCm)+7m0>M@nzZWs z)s>naQPU%OkREYjv*13e+?==wpa}z%m_~f_gCqe&6jYgrYQ zbWMsVjlfp%G!6aG00N}3q!b9CiE7bRRSW@|6j40_Xi`BSSEJx2L z8;=(pD_H%F`R)i?H;s1@tXVV@t{Oy?^W`oa6zx>RDwuzii@9IYcpP9E6 zpPBX7CRNmn)+~@Q+J;YWW!5Zc#z*Lf1`zNfAOK=)0t6({AOPLZl_3CvUjhU`@JoRJ z%>-FJ0%S{XT<fO@IIg4Fb^pTp0o&_$5FYelS-Y??7KC{p1u`~6d&I~Y773?$rs@P|aTbftH5I|E408J!CA^@7mj49@3X4AUP z80h?%JH#z94~Zy^<+^D&s$kO!bz`&lR1>pltzWp>KFBiA()Y9SUR)o|1Q|SM4=A3q z{f1nIS;7=1$ly0v!JoHpZn0+8#D(vLx)b;fR>JFIU&B1-OlS0Tzrf^>?s9b&{06Hw zhY6noeuFSz_$!nF0z?yX1x?)1kZIWSeoZuEg>z`uW*^PG-zInNTgFRIv5R2YE8`26 zW6a=$0J`$Sn8oihb_$!J1fyKbgWn(=7Tjsv)r#Mscol%(pc(uIkr)jkKNfM|8r92F zSaHL&V4A=NeQqTyZ_wm6el&p%_ze;SHiF2HAh1C{G=KofW`rOeFwy*IL`gJJ;ejUa z)Rrc)Bp~CyEpMnv2t8zJ`nK7Oh^RnGDk+*l1d-289}P2YuY+V?wt|8>$9&OO7NYZetGC#^MFPh3?&n0xIM4T za2q!2)0f1tXF8gCx}p@t1)7Iw>pV-4I811s$r1+dW7b;ct3)kDdEPXBFGl_d+YODd=2ID@?o^0fL6n!2X z?@Z*1^}$>~TS;eszx*`^$9(e!a~ar{p5KY+|0uDQI4LUW3&~N7i9XH z`$d#}e7&w`M2$Vn5Xl8KzBb}|#Q;lyA(iXhc&usXeLMUAt~&d@Ln%Lj0k+^g(t%j z{A$yS7u}a-i_06n^U=qA{9_Yh-;Dhn_Iig;%5lpy=R$Lg^X^&KHia6(omFN(=lZ&FL!bCrt}XQUFP`l)W$es%mOaVd z<4hbgrQdU#XXO3+&c}BCVrRtuK7LCE$2T`-U62%|c;BWb&QT@KV+ZlgvO}$L6+uTX z+6P(&7=jG!agpJ;Dcn4$F0s&3<}&wADbwxXip^=|kDJ5WcKvf9(AvwmJaoG`ps#Im zlvii1z4I}PCG27E0111i8$*MPm)03)IVW;UIA%1$4eIb#s>$Z^Z7D6eo_PP5gfYXH zKX&Mk8^JciKR@$jv3XGaP-nIosdXn>8TPPGO)v}Rr=6F|6NNGQGx{^)WzRnGNV)DqU;yK3EcD*0B$~3AlP2aR; zMRHO*5y9<|M#5g=0#hZ_cYnNx1`u!rel*FT2N?nJOihT50Op*7jsRBI$3}qE-N!}% z>+WMCAcqD4@@_^(04sxGBLMx-00IsH0;GN@G6JOTJ~jfFa}G8FtStG#Mu61a$3_6_ z?qee$i3S1kZbn7`lf+;n0R7Ma0*V0vQa=W3mDKFpra`|NJa+OH?(AA@B;FsChq{;UaDkdfE{m0Mh4io4Np@OMn5(! z+3v6T1+EjVyyQE$djY5lk%9p}Mb?rDS+wXoh|##$70HHx(1aHBi{GLsL~_o{E{c%d zFmF2yO~t;eqVN)i!~kxXw;h5IrM0P1cIpG%2=0)M1qhvc_q;U8sZYq&L_uly>s@Lf z!5u9*^$EBUMT;1s3aXDuCHT=GC79PcmP{_6OZC!X6sr^m-{CC)J(FF01P znt2&?_W0kwsI018!Vn5x79k0K^D~$+Lq{(Qz^g;qD7QIWw#l|IV}ZE~vxL}2X)V0H zxpl?nS^7Zd#x}={SNi9#`32aFOy!uDL1#82;OQ%El-r%h8t$CR^-5Fk87FNNVd5uT z=tqBOK%$RD?a~PE3arYzf{GHRAn0WoX&7M$+9TSgRCnUdve)d}c)ZOtWt7*Hu@8XF zNSIUfGwIZ3#GQ2k{oAmO#_sXkoyeP}KWvNOx?mj2-W6c)0O=mzwBojmL&0dq`+Ra2 z=5ElO8YwE(HQt_aXn-LsWp!~o*PM8;8Hoj(5$_n$Yp7G3k@ma!w#Ha@nKbMkcXLh5 z&gRE@XzH@vE&Nqb6FSQ4bKe5V+9puO32H)&FSJRu$y!&?+4`mG5w=~~Ywj0SkFZrw zXb{E~tF=Jv5(d;8I(F&g@Tv_RyY_7k(EMns#|wAu+t}6mMs{Is7FC*@isMvk;q6T? z?8><*0YQIkr(x$d z@@~dOKn@K8&<_nD;3^0ZgxijR46%4Lb@@Hyy3Z zQGmRgaS@P2g8=kH0|*d8CwZO}E&|jIdg?L)nDhd>Sd&VF0H#+$M*vL}pl&)^mk}WE zW?Td~Xb^yYXckrSLM=d^Cxwdub%UO|iU3J^fsKG*8U(P{YuE^o{L`?b0O>I%b|N6} zW?Tg5Xb^yYXaE6+p-`uj_j7b@Mr-B|&5`M9(Md9zz;4@0MibZ!kc=jpPQ;Y`BDb`te(AocIIrcwYzG2y~8KvxMiAip*hBR_pEE1 zLJi^0Dzl$+eMj4jiJVXG>PNPvcV?Rbwp2Mxu>>PtUItlN)dKU2g;&g1^gUA2CzwaN z(^h`8v}v8)*N{0n*~eY~0cd>#8&|IA1HNH0Ddc^=sfFYIZ-FU2{ zYeuLuWA&o@CwA(Z(U^5X%6{c(oDtk1ZVAWCS-3%baq06%(~h}%S;~i)d-6-?G<7g@ zlk8b)MQaXQT&MOd;Nx?P6Lv4lKucfCkciS)?%tT1PAou*^}$?#WBr)5Pd%9tzw5KF z9!l_?pMH5L^MHx+nlkRqanHYFTYGYC<=S&6hK>64rKnmfj4pdswn1gCL|EVE7E|Bu z|2Cs)!D2~zB%^qFC7+pdMt`Qf7uRQN^1RNRb0VERS}vwd?lalzy=#B@bmorq{Gl5s zjm{m=X!}i+cj!C$YxkdcG~uU{2Tgupa^Q^g%xLIS!h9Dgke4Ty1q!kY=Q8fDK>Yyc z20k%)WL5DT<7&I!k6UFLRhXu4TC*ZKshuxX_N3cFz%8b}NC-%xL4Xv`7aIZShXxQJa8tHH#YMm^roLDRV2@<55g-Nf*a*1A)E5Z>4jKeVfjl+> z_bzitF^ivf6uzWj~)zOgZ_IG7o=7Gw#Bawqa45&c9<)RkwNnZ zXg;Rnlw6c=({X$)%Gw;E`O(hp5JpOi8%@;531ZUjuL+t`JB-T4xNl4yM`dF~Y1WRT zvb(>$(dqC~jI|N!4sz0g%V<9uMl&-&VIp@$(2?PiHsvJ*KIS~rC#@gz#tv2(ST#5h11CW9M0X-lK3rS4HnlbP+df<#2J=t*3F z8wf~lGuRQQfm8Ej<800B!dkBW8xn9%O zseWgtC`EA*kVI2KlXo*R0%)QD^h4v$<=v*OAP;C-G^+Mpp~QVPF8nG^MX4XYPiuL!dAHpFv%)2ciA4EP&F7m%BM2F{8;1Fc_Y zUC^-(q5}+PfCV8Ine!5g=?jKKv8*O$2!>j3}ymxv(rRG z^*dQLas1JcCMj<`yh1hsiJ1%S-7;oqAe(^PGfN-Itub9FOiOM`ziJNXc(`WjnQ_L= z?i>?DcMhGhPns7vLW7K#)^$F(>Tu~)&bO#K*ytR>jn>CFGden&Oy!u_$jy!>1BP6V z+R<=I(XGCEzDd?$j}%@OXiFn_n*6UV&9;W%93@(K_52x0MPNJ*7A>opcZzJ!(X+_5 z(Co{k-tp!;Xk)H6H(Tdy6|HkjP@iDY0`^AJvDS|DYD+G>IImy0+CE5- z{C_68ja-u)dIoadma>Q&HCgr^me7>U;%mi^r01n4Tz~cl{QXmGV}mNP-LH&yNlJX| z!^xtB)}rql#WyQC%-QSwwM{VwKj#i}P@}D*bxxR5bhWv~I>*az$>8|rFN2N*(*R9U z;-4@19>=hSEBBfMQ_6KNZnQbgX5f4}TIcLFGas0nt#cj*>zq-w?RPUSX{2Z&73}cg z*ZYo{2tR^Dv#lXV_|e$AOl$-&^CWZxu%Zq&0wjS4HUgL`3L62EDhfNMkyKIG2#|L( zE&}3NB@`P0=!a%oLy~|1=Fx0`OXb>P3bdeFD>}Fg9NJVh$L;(HJ zY-_Lz2#~WU+;Sijc%UPICJK-Q9@tTUG$a?f9B8FMfaExajR1K!<03#(MPVZV{m^V{ zFbPc|`E!y&i_QEstRgzmk4Ci7Xbz_|^BFs)(UwMi8^u$WrYVkZ;U9OMXyr3&;=*C( zZ)yvO3cqWB@g4St`4zJGO6Uy>5;>5PZ7+m@7s+fAg*3Y14jV)Ka*~hHJuYj!gaZmH z$&)Az^_(10LI_izg@QdO@xEi~^BuMZ_ni{uo#GDozNyc5D5+@rQkF(S{3I97LiA$;dcx%(-%%tTc>I3G}+@nqaqc?7uL5|y=`x>xy!*EdY&+2Yq~i9&L$0vyTh1MlcRM> zlk6#SG*K+9lLJoNa6{8@su86F0=@+VD5^J91mw^}f|?vny^I@Oj>Zr`)3;G}GwvG; z57BS}0=@wRD5^J91SHWQK$D}XM*zAUO+wIA{={ z$0Vv%&XuqPKvhYNdzgk~Gr(Euj;fBDcj z9#Rr8cnWH5+Av6!2%+JQTflo{xSyep8xZ1Aw<5rnQ6{hK%)~rZQ z>X@6pEV}blKXkLv$a>Legy&?PpFjag8HX^!mcq+zRIQa}gsp>Ogl&9t4vhsO(Z@Jw zzKw}yZ79A?-%zj)&AK49s&`+Ng+$s!-pubqS}MH9&|Cvm-)ov{p!yk!lJEjA7z6}- z2?&U13QTMSu<9}1x5)}!k)|jjutQsII+}U}uwn~#KB(+wxp;htTf#B-JZ_Nme8ttv zQa;4olV3Wg$>#EHDJ|(Jz4;fJjs^%g0|*EwL4edl#zuhDL&in`>mg$gNK9h&)@kSE zIvBjgGBa~i^GMlu)Yp(XI@!lv|A8yR9@w~Yh5ETD+H^Ga2=I{UXn=qwKtL)D0%)QD zsfUb>0M1cp}Q-FYA5(G#+Wb7zF>LFtzfc22E5ul?%K&Qs; z?BTcJxb&jLQsy%EPASvv;EK&@<&T@gRVM~u z8gxWCoH4Z-qQ^k@HwANJCH<&lL%pSYA*gTDG={L_*=_k%q5pGVJ%ocrV zKuY9*T!5DY4%|RM@=L%zoy=xr*&*B@O|lumP6i~K5$yO`*#SCfrUuMA(w`A0wV(gOQBmE0twBpQ7nUd4e~)lS!{@Ec;lVN*KunHNH0Ddc^=sfFYIZ z-FU3ytS~k$aN;eq!up7_!sDz~_N8EKEMkoGlu_tlC~LjaOS}j&a^S z>)NJJL%6fb?B`S&+Uh{^c46~sVTv^j7j~Vfw)YZ7xLJlol*V%R#?(lI9PP(;sg%3$De=o*8sAqM$ozgtCO9>Af9Z+0kZdw5$--C(7DgLj+|{sFva`Vs z1T`t5>h^;sMO4LRK)_*TBw^wL+!^M~&IUVA*U^+}Bs&{y1ZYx3^$4Iz1wBQI7zIyX zl#ztk2=EY96;mT?QbhHMttLfOuR}sVG=Kmh3SdLruo2)Psw##6O^T=<0h$z1Jp#}V zO;oK3q5ws_g_{V_s8AHO6K;!(NFJg|5mhGw%5KJ0hy~L$AHVz1H1Ov6;c!+CGy+i zk%IVUk5C0Sl$rLKz3QsWmh$JhduG*d>TQU3MsPlj$2-=*!<^~Gi|)%3Yv6Ht|Gx9F zoxj)_vEN&)fxDHrOTjIVOMU8g^If{-+d#w3vAIRE*_`VL4KiL@ck>{jo_w+G;iGBg zuD)CKJ}Jj^L%7j}=aa*^K*#zqYoB^DBYxLsUp5AR zB&HzH!SE$0>_D%@wE_Ady~RgTv#&YAQfweiaG3`cl}^1;v(i4m;@h~YxRap7n;F_n zn)1YqXZsJ|khkHHjd>gQ*v1A`WS6wx&9Z`^ow<&WJ1t|v(xx@`posE;+&a@JbK0E4 zWr^m9pzoei(;rliw- zisobLXgdFzD=6wXZbF>2s#cH?xw;Me?V9JMbMGT;nQ1zorzVO!yGpa{OzV% z4R04GJwBj83jK{t>6?w0b#qDqq!YC=r0)>^nPJCQS?6>ECP5eF)xB`Fy;qy1ia<5oC>X#yMcLjwqK0Rp4}Y{&?Z#tFg=9SuP)0??LL3iVo= zFinz@Vdpl|I6>s{hNQp5E^kQsOKb$lyBQY&IW!1BKQ!>L@GNxGlrjoxYmlfWL{vwk zsXa=jDcCWMwlwOS!=ADgBbXwoZ-0o*}?P1gV1kI3OTc4r@^nplR#WE9{Ai zbxKhfHxpp4(AcrFvYT)X{v5mF8o3nzc!y`8IVlvPUAVsF6VS2#*E|;n9GiMnaVc zXxcjUuZJ~lo%+B=+0CfAji(4w0Rcw<0g4(46#<&IPCWuNZJl}qD7(2E5Wwe5h#5a; z;QWIlqTg*gbLNk)+>@|&YTj?`H+nCw`PIE|eE96KySHsml+8JOWOI&zV9o)hL-3E6 zYAtPpH`;>V6x;2OdTZ}y@K?pnV4Ub?a2VWzZuO+G4-(9yKNF`&T)TaP>h=y02NVYg zVfMh7D`}T8r1Oc%Bddz%7+2f%e%vb4sKPXT)0!2@Nk8CcksaMgaPu+18K* z2(Z#b0nF8^ZORu80+MJD(7|mNB@TSGI_nud8;1fL`{q}l-53Rgvko#g0y?pXTG1W3vo>?ojv+b#+M zl--Pr0O<)Ub|Qd&Xtp(21q8_4#Ek;j^EK=!z)FJvNqK`@3vkoa0wm=PHUgOP2D==n z>}Fg9NOCo71fU<9Z4D-&^B{kYJh~XCh)(pQ(QGuH=5P`LOx>G3yqLLfc<#%`(eayJDx>@?A&H_8sc6$nV43D`lj{o=?`KRo}ev-ReqBk7!8cdN-;+HJTpr;`a}w``^$b0s<}o0%QdjE&@D7S|uVN zhvt6P^oT#;0n&*iS>Da9aTP&FF5dLKv>Q`fMO}-V45A+zK)^XbfUMxcMS!PBt3(7O z(I7z6BdSM$yqj?m;3;}UKtL5BKvrd8H_In!odNKS}&QZ;X3j;l_!zN6$3pAL;SPrCpEg{0De?T&(-)lLZflMf|^4_P@2X zX`S7-sMKZl=a(ioeXwwKadK)qD~s5?2P(Z!kB!!c4^IE{qW<~o9$DXJ%rQkY=4evn zvC5o+5r$A_v~wAESD=1?bA#fTF~S^^a!fab8(nxlIh<=Zv1ot4{51#1eDlUc&Zl?v zBiqvRhn*bOX3XIa#vD5uT7!;AKdmwqXT9Ca($^yT`rjK?~LGl z8jm;ayl-d!-&JS7cPJ%2f9T#xqjLu|+I|z|9r{lG+WjZmItLk<(OID@OygbBu2-hx z%`w^v$_p}m&HW66G9N*l@5MzYjt+OG<$6V>NGiUn+CWoY~ z+Fq~Nv-C7%?!8{o!xCx;boNYZXBHGO=JXp=^M+J-OcTiQ|hq4$3Wz(Vx+u5v^vD=P9-sDJ$*zFn4{a>vemtw6dypm+Zz#zs&W| z&wSaI7}aNd^+O5%FnB>Rf!QsZ!0=}~49YFywwte*ujqTEq)#x9RP0&q=z#JrQF(dL zd#Z49M4{g-=R|G^_l^1P2;0NlAjQ#SRXBuTrn{&7<(cEs%&vPLOzVkCK58ZAK z02iPruPNi+9M@(wGF-G8;hi)e!&I^DrwgO}XdQl+biGRxwV~k_dqWDc=-)oXXk1~M?foOG#trd1G5X|yM!EYB5 zh^2>rtcRxaA;w7G<`&O5ECk%*hmC}QczM8s@M z1z2gK0I4I6jR1K!<08O8g8=kH18)nRfB@Eb$40;{v$2p6;HIes1k)gZb;Plw0I4I6 z9R)}-5^My>yBQY&IvNC^9~wY_3lPBiRM-fRnr_I6faK7F9R;AbY*;yvb;QvTKobQ> zooZ|Z$h#RA0ah9WpdT7Qz*#6dDX3u%14!vJ5jTnM8k+lAdcuqiG;L{Ab|0aQ;wej$ zneDcM+CehraC2wa<6@-xw&XE^eGNz+6WHMf^O(TCp(T$A>>ii01De=tJfv%YXVxs( zDTj&Xiq_F&gXqUb&=W$}UWwASH`v_e7Nk0=rzopfn2sK$iAo2_6A~K&+S2^%>Jedx zaZaa0j4|rZoeVL?piL)3j4|%DeXX)1AVfCIMiE2y*d#jV366je*)V@YgvPCV9*ykL zLL+-TK=U!FG(TD=LyWsURPTI(oCR z(X@5y5rD3(W14gi5u^eF4navkQ6r%?2Q+P+dIV_NI`s%pb~Em?6b})k0s@Kw0g4(4 z6#<&IPCWuNZJl}qD7zUK0Ujbq1q2)b1kgwXG;N)F1Q6*RG;N)Fp8^jNqyhqj-k{Rw zLX846ZJl}qC|%o}m!Tb9wcw7Q+J4KYoQv!K=My^@{O#Xb*Zwtd+}A&Sq~Dgi;`08B z|8+@m-!<1xKYRA>=<{g>w^&WEhNxuec|g+O`5M}0GCNoC6U~F_e$LI-M=CZG-~qz* zcB~(>_NgZ`;&*-a)kE<5KmGF1y=LZ|(b?;N(BDW8m{R2@xn=DJvd+Hd@QSFh_q2pL zdnvvd0Z!kR&u`b*Te0VmlB|zPI+?xVx0{&A{&eu`sHUH zv@y4l&Wss^w>Z*>@w1ZlqL-y@AgiIw6v}Nd1~?1Mfr{4%_$4@3*Nq$c#LseVp}&9e zmHzo_egT#yox9;HmL^F|6cO1XJz{M?LEz`t>+aoJ?^_4%CVU##thiSENP1p+ z!u4lg7!ePi8L{A*;TAhdXfvHWO(_?4qnQzK>nA*I` z;>9ZP%;?~OX!+baAmzBl$1siaRqRZ_(x$Pj&246s*OajjfH_O&L-Lq83v^qgBx~ym z2^Hpcqa_1w7*~C?)L7>7wv@>ZJ+7W<<&U@X83_fqnUDm(`5DZcqodmlLx5!IiH!gz zUB*U$vYT-cAdMJDMgaPu0R+qg1V~{iG6Hlo2#~TLWCTbLn6MEbC0W=AkSsls5gGO^Tm&5_KX*$GT_FU}@$Ow>hao7l8o^#j;$e}@iq>IBw08MTaPlEty zbRlwXqoc`f&<_nDKu{4VWfauD08vedsE$Tdd!#8nX-lKNGvxM=rRf{m>S!CQklMJU z(x=4_A>*je6&k8EwI`nDPD3x(uudmYiA!4=H7#||TAHX@{ygLYlAi%`Yd~_ez)m`O znmo-!lMLu+;%8+C;Fi-RBN*h=#?6dimLX>Yk`WAc)`@>?CN}SbNFYhx(9yLSt(j=T z8uk_g8v@}p$41lE{mW|WSRf!hU_u7ktLTSjVsjlJz(IomOZw9+7erdFqE z>(oE8Au2q2h_;R)z(WM7%X1nWe5!H0iyx8|S`1TTQ;T%9?;@20Ov=z$K~(W!%;GOB z7_ZZGO`3d2Vky^mF7ot(8wN%w4!y2 z?1*|=O)&Ibge+Fxh;^r$a zel+0ML!-TZ`C#t1ewU6dxqt054~O;r+}ZF|-?Y+!H|8F5y>9OXh6e4<@J2AS@XybD z*_Ig9XMFWTHyc{4zc#6&z5eQlMx$8DhnRcv(+kt)94-S(i#FGU=R&{)B;)c>W-}1w zb+ZY`uu-4BG^$n@!ozAhKQtf7W$v9)rkm>A!7VTcI5)QWW}NLaW$a9FO<>jx6UR*H z_uS?gdH=riv7Nuz8L_{Q-;%-c&9EJ%0+mko8u<>>^%&>fv#xFOw}cu3ojucT*O}~5 z+t{F+L_R+-9LK3G4O^Ot&6}WjD24JmNl*A4!$l35qmzByg>#xdShyPeX4>&J7VJ5^ zPmhfj9ZeSXzuBH++|s-nX6kx-UQTzq(WLh)!LmWicUZdzHNH0Ddc`{X0E-%5=YiGl zWHEaV7Gq-{PTlQI`Z01niarkxGsHV1)R>{CXGSybN$*#%PYsK)e`x-SUGK-OGVS3; z7oJZBhnBXs>;8WEYYu`#53>Q8v)Fx4;=wCQGlc+#6|$~>BB~V zg9ZV&XNG>q2tYqHH)#ox5g=&^v5QVpJr5fJw>QZAP78ICmJmA;khFx@2w+-5Yy{|N z5TIE5GyNq}0S*7q+@vMMMgV$RBi5ZIEg?1n*n?c`DBw0n3*TuiK++OoBYeao$nZ*`_4~c7E>+>pMYoYnztvhh|uJy`6fqiU2znpos>FB50zlgDB|K zmZrXKdPgA4ZU{^8t4%LnbYGS&?&jGIZOvg%S(D?0!;x@8_9*jbe10fL=)NFE^AH7@jHbF=A~$$2F=pfUKnCS=`F zXxnBwhQ0-`^C(U9rs)xd$yY?B6!h{_RIRSjcuBILc5`Rq!kxOK=QVBJq|v!-#9rt- z`D^!|cr@XslLt+HU~=FLOCwoW|)en%y|^j9gV(fm>Yv(b+B)?J@DM?2{fbK7ZM6p-;nU#Rb>;Bst%WcR_bN_PfLEru z3XMVLp4L6RhvWRbPd?r}y~6*&^$Xu~O#kMipZxCFjGevy^Bg}WdZ%yE6N7&r+JEOC zs)r5_c`D?Eka6$to@@HV^lDW@^TuZu`0lYgTXvmEy>$6NkYTi;han_o)ko%@h7XMK zX8(DoxY^0mINzz)HpUqIoI3>541WEXwNE{{+WPeFFMb1-30|ki_NsnlTl#@T{RGQ| zJ!3NZZRz)JzeAgcT{vB6t+hU$x~w&}ps3ep3maE_awT%{H)s1=hFI>l^ouBap1UXJ zq9v4DcVM3L=jJeHudwUKgDkxb@xt?ee%#O}ewJI7wCnU&4<`85re7YqdeQw8Z8P5Q zBUpe;eaE);t{)W~5%WJaiJuIPuHwVA-zMcImKM()pg;(y&U-L3N%>PZ4cWCva z&xjB6cgqj+bNd*VI8&Q*PHj!JZr;6j<)N)B9Kz4HqNu!}VqxjR^aKTcR5yTkF1@u+MSg^k=2#J}MD^zQ@n&&&-WXjWd<~epeYc@W!1ZAgv zz43zI(apQ}h#UH4`0HZ>_YLREZ8UpDln>(MZ^nKayKd363imEk2@HOY zT)gF%X2XHHtyz(aPoqHKRODjawb+9Fj5YPK1<@$S=G$0T@2V41*y)Uhzvjg_mpOYm zW4U{`>V2GR>vklEeY~U4Qd(dR-1B*$(K&=0tp^VfJ|N@1EpPNPy*>5A)!>~pAV2db zw#iXm^Qwml-bphuyhGaaS?4&>S{iuddJ}H6zR+C26bnMx`Bh-D9yWG_Oj%P?(n7ln%x@Hz(o=S#M2<)bs7Y~!6!gKC=CKWAVGk#n{g2^fCd5BhXxRE1`v=$gMexh z1ccKdAcF(}R+=avfCd3J5(Fr_85aRQGzh>xG=P96K!Ae=0TBKZBm${42-rx20GcQu zk_G|CNf4myW?TdW(jWl)&;SBX0RnU+2yoNX0)lA}u$lw`CYmU~j|Kr{BnVJ;GcE#p zlOO>7&;SDJ00CAS1YoB%jghTT4osp!z;wH)@#fV`BLshyqiBQ#q2RKR-b{!B zf8nUNOrU!FCbq96;Df(VBtkq$I4^G;%*0#5UnqGe|Me@M?2cS)W~wUq3uh|}Dna~B z#uF@z@e|YXc7nHkTNBSB9e+)U_OGl&V>yQ=-&9|BK$mX<0)&EqEO^63fTl!KFGlqc zB^pD3Cf`(#0Q5rx2v`9KkOgnJ2+)*h>Ji`}N;HN5O}?of0qBPY5FosKkp*wK2+)*h z>Ji`}N;HN5O}?of0qBRu_z5r60%XA(E&}{$ngTTH03A)?nW$|q%R_K`0!00Ec{k%e zye{|8&wSaI7$v;P7G9UXt-LN@e{E7leXcO1 zK#j-VsKQx==ab7;Sce+I41t0zN1EW5@!qw+d^$4%UYAeJ8&c_&RxMa&h_A~B%CE~G zwT%s`$QCT>)y%K0|6t*^cHedF*u^0ct$!}{xIjgef@MlfjWvMVVBE*qli4`It|LIr z(C2^VL$j^HDj-1SCN2Wh%&+Y_0#teIbsYf##!KG2lfQw1lF_ac{@*|D^$rjqJ4WIn zK$XW{*Abw`nDPz~An#^e1gM!*bO#8)J~Y=KuhqF7E*K{`dT{(QakQ{I_pKiqSk}ca z#H*ae+r@*Ub{20J_nO*Syj^6PsZn%roXIkqA0GMJ)sJZ+`56AHx;e>RT^pKjqiYcd zSMObQ`u64|cQHzHfK_PSi7ivhF5ljqb2y`GGg>phe};7z*9IaE zotoLDUHLXyp({+|UA^IIW6aGe!Lcby&o9B*Y&_=Wz6D? zDdyW7!ud~pXaE6U!jBeDg8-T^EtCcUYG#Rb9RWEs2pB+;+bEOqaB~}FH{&8e%>ceT zKmhik0R)@@1cZ|yz)BMZ1kfNr%`CC5BOr+e0X{ScP%}%c>rsHRn{g4KW&mH;5rBSZ z00B7=ZYq^j+@c^&S(v8@H+3|Jlc@TvEsgr-u%|3dR4wm<%vP@0CWRK8`D<9+6r%Do zQOO>=V#~x1O3wzj%B?MpdL4?VEKPYF?|@u@m!ovtK){bA;&f+{lxp~Ll9C`#6F)0E z0GBl;n&?R<=eD@nKrl_#iGFMrRhrsM`1WNda;Bw+kGaxkXU_HuOoka=+v^=ZDaS3- zoD0n{&bwz_+tl^0x~8quv~?668%>a^Mv%Iwl6OKfAWQgg5uj=7)FXfv2MF{=S00M-1fSlXnB7i7S*R*x274}4_t%qpqSf$2Flh&XgnwDJthRG7M zm~UD%s`gz$?f~Mab2zzxd#8^SI{T4IlNNv;jyx78CulO3~ zIcGYfr;EKkn9$Hgk@z9s+NM^vgr{ng=x6eiP;0 z(VHQvR#(*a;^UkvH$Zq^XpWhCX3m+iW!znX`T_2=l^-o_T4(n)WR6buao2y~%CLK< zl|SCjY9#cX7oH4B@SC5(Od#@x?|k$zAOF~d*f(Q8jU8D1PF78vqiS=D^b`Z{+l;C` z-}ZiKfvFN=prwb)TpMPupWXY4zDG*>gzI%ZBWmnnhDa``@wE}xD+X8s3}H^+me1R) zMs|SH#71zM@HdFgDevU3-GAcIgr80xH2Hzafiu!Gqv8Ehn(}^W-&OX=ID*?=_+sIe zW(y_NV$;RUa#|l<|W4=4W_Hf5Si;u;>am|WrZB`@kV9yc@_AK5p`tZT&f9}+t zr8uNXdcSn0F*L|{X`M09`7w8hTVfV10Mhxy!fyzFo$IjF<=al?)kF5Xen2df~`n}ul(B^SV^J9&Wdr-OOiTwSACfpr!9; zV%_Lkhkkgtb1E0uSk`7WGRkYp*ayI#CCr&#yy(8HPVHG5mDhMl=X2Ntwjb-E0R#v? zniQ2HBS3nJfsFtu`9Vg26fR;TK+3U@5s<@5;n)a}-Y;PzK;F%`2#|6tYy_Ymny6Z< z5Cuq4DKY}2rx?fxkdq%|1W4f`HUgv^3mE}PGzgI1FJU7<-p#lOka8?+1fU-pK!6Yh zfH9Ns^cxuglI0vW0%)QD$#M=G0g@~Z837I&1V~y^Yy`-=85aSmOtg%R0Q5r>RcnGM zKz6o6Mt~%XLq>osi$jhABv~9b0wh@+G6Hlo2#{oP$Ouq&GcE#xX%K*ZXaE5a1-Rwx z3AY?5Jz&H}08JDi$>OjPAc;JY5n!c3KmdDIhK&GuH{&8edX0%41z;bVLR~HIwtf_J zgiiyBq@cb#bTuygs_y7{gqpDXRAcU2#!F9uSto3Q;-ewcN>Dz=3SWVFw88mY_R9Ez zGXl9v4-g>o&ZWWTa^e`9D{gP0D;L8m<~+=)Yh66g#O zMbPL0l-Plk9Zg`TiAL8*4Je{OU0WLUy+Kb|n(ACW6?)w!IUbA=jYpCCw(|Rb>yft|Bs!lN$>x$^Bc)F1Mk>?;n2c%Vk8T* z89>t25am%sxhGA&EXlWVvNT{gRM<|zWniXbNRh1{O*vK5BWij?VNeY6 z1ugrjBS(VhhXxRE1P~xAxNs2=PlEt-X%&+s)AS%TJ)(L^vb>v-CCM~B2=qe(2si`? zkQH3G2neS^0J^kFM1ZD8R3AGh$z>fxYz%A@gM6ZM8C55k6|h0 zuT1VU+3USU&%Q7s5L`3D68vgKmjPQ`C$1S2c%$i)4gu6(y<5zKt!oQFQYZ0l{e^bsuL>HgY|R zJ{P@4(#ofDYrfuj-_HKOt3L7R%m}c6mSu(`_* z-!hOFd^47}`DTb-BY{P>h;0EG_icH@d;G4?_V>$Qa}W$Im}|zi^p1uWRSm6yM}n7z zOq(uF<^H5Tw%~gAf18S}B_=SmNWCO9kl;s)hOgx);avd8At~D7~r}l!{&> zshs!uMTz&1NfcMk#WzFr8gco~(g%LLe$3jZp3DgO{flS&Oc^^93@w;z#>7qxEmE7^8!z}B-5j<@ zn3i2q3%}lSjE&~7f(uNfG>|tkDD~31)LG7n+!BsCjc|i_Fq^sFsF=;b;AbC8WJ<<@ zsBrJ0!-x83J-zq25b(6gxIC0u%|v;1^t3rz+Y-50cP+NS>^;@wY}r+_@tOJs>+N2a zz82AGy z?06Y|y^>oTY6Y{I^NQIF%-#rhR+;^as*gUBo|m2w_1K|5ZUh$?|NP9CMXQHgw1)-|@CW$OLP-#iLxX?;Gzhpzf`E7$1iVgz03bgB0+ij1 zi+~SE5P*JY00A!o0s=@7kVJz39~uNylOQ0R1_2o)2(Z#b0m^R1MSzV20qBPY5Re84 zh$KOPg9ZVCGzfrDR+%p0R+qg1o)94Ku3ds z-XsWc)6@cjX%MiQ1OX+%p0R$KU0pTPFu+ktPfCd3HwSXiV1gxh) z08JF2>}Fg993w#h`k?^?oPxTuf|@0t__X+8717-^+$6edi0)^im_}O~b!|bRjp8Xw zbD_ZmEiSi=w0&D)hB;clj)>1RcN$L<2cTaAtd*)QjrxwQrz}nNElx8JQ2zQ*= zf|9K9PEmq(kg0b-mv$0GBxGt51$ChH)HSXURCZsW=xR)`i9xrA{xLM)hQCU%Ht*N! z8r!Mf&P)L3K~0XP$LGG8h5${&slNV*erVpWwF*&yoZsRiK$D}XM}UXO(HH_W4X1hppdT7QfDi@9syAE& zXmT|52=EX&8bg4l;Z%=J88ljP;}QAvEX>xBQ!^U-|VX&DoiHm$J-HNG}lKhj-qb8WQWGfN-* z1J>^8-XX(7o(g#(gfy6`!adP*toqW{ysd=Qfy* zn$zYUE}hEtb}*NT_+6iU^$-{{q+cGo*UUT<1Y?GW-?6Pdxwdlcxf73$`V{=HT4EOS z%>Jm#+0t=1mgRHnG%nqk%GvdP+<=IhVDL-eMwtB@e_#SrT;9L$d~D}0c1AqrKw>Z;6^@*(EXl;b*Rw-wGx4s-s131apn z{S(hUG5?7L&kh`N8K!Wy-_5wBkxUSucZ3ERFRi&`fN0z>j8?@r;WAbfAd{ zko?@R5x`6k(GkF`kg*X!baApFPuK`hb~7#lBojnz1YjSUkVlj`_WJn!qOnYbq@Pp3znla+tt#?#virIso=gQ+5Du*N&%& z19+Nv(?r8(^kW0F%jQ9USm~*wRs{Lavjodt?0Y~*vo=IMbs8OlwlrN333AC zjGqVb(>W80E*+#uf;{jkFgJwyvoLD7I|z#q~H^1w=_5elz6u?0t6Sw*6*jsqIv{qdPMaIKtD85 zU^@s1kUO`y2=EYT6+?igM^ujhO^>J^0qBPY5FkVWvVsd20Ujc)`cdc+Z5wq`Ey&`i3cP3l}DQg`0t!{BH#C+qoIU@w42r(BB_S$;cnN9o!58`r0N(dCe2u z42H>W1~W1&(T$-i(#E@>+`4W!K#dk;&fvu9e3Xqqtp+F$M;F$)|ZLKFOIGgdFUf1+)M-~h3|kL&<3wYngy zHO^7Bxdp0i!(UAPVy_1T&{(z%x3k?d17daiNhY<(oR&UB$LEx9SZI60M- zb$uUyd*^du3BI*poKn2#zARf@l#gJXGEgy28Ghk(p|19P%wpl06v0M=Tz<-Dr6(&y zvzaM%1}?~ar7$o#BxTh{<`8$KQ%4f|)^2 z@p-+mw4h?)Ya7j85#?Fe>%59Sw~sUgaQ=qXd#_gnS$Z4dIiJSkO*`+~*}wAh?0=hC zH0Jah6Z3{t`t+`TWLx@yNmHJf@oYcYpl6S5c2G-pNpVOMULvi@`?c5N@i_YWDgB;1PD-eGcE!km#07g_Mrg;oB;%c zlORBNCPfehKrT;#0C-zSfPf?#1VAoNfdHsX5g&A14FT%G^{=!XUn&;$rbr9l8T z&{)O^Zwo090B;Kk5a6Ie0K6@vKmb&x2oRv`W?Te70gM6x*oOuXa0(C*Oo9LtO%wpn zeJBtB0&D^V=x7iCl2rl(xM^wu%5KI*06Z!pKmhuoDT!~c_o@r-FwBFa6@y}Gp#5earE%3tq)& z3qav1_l)t<3#?vWToN+Pic#QnznE5eC1&v>OcJVPhQAI!!3i2uEe%n8PdXIPi_HR?F=D9x#N*)$I?!KOX*S)bWZ_Url|Fwtv z^_MZlUl+EUvl^2gr&V*t2w z{4Bxmy^M`!e}gSiaOZeTap!ox`kkzrIKCvL3Bs)HdtTcTd|r^_#}v=f8;=znFIaiV z-1oEch1ctXB0jhGHh@#ZX#Gfcz0I}Je$Om@AhXT5C+F$+z8IJH!0*7F;{|<4O2&3` zfZ)#Y6UCil#?ri+rIl9jW`J8ZG%WdxipJ0&WIF-{pcG+u!`v+?MRDn8p8X409H6r@3F62YyzzjPvD-%X=MdDP0Jr zFrg{Ob%|VY;jHAalycFX<9FcBap-8DDPxC&p~Z-l^u6W*jiRB&Z)8J@$9(*jz@*%! zpd-OFhZ9UdCQdCqx#?;=3}xS5wbyK!Gi~mf(wWnHU(rY2XzCky&DFyKMmjspgZQQT zrsE4&?lt=|caD|uyFUGDSc30+-~w~V+^@(skrQ2DdMPe2kB<8ErBSsG(Vmv#)c65k zX51a7E7H}%uea>5&9!d!#@Rhy)CcX!v|n??q?B6xoM1kbW_$idO@=+t(zD1G!7Och zKK}OaK3oqjF#Yp0Kefej-ZA=c!3AcJ;sSHv+N6s5TvNN zF4X>L4-FvTRrt}M8$y5p=A`>0s-=F#zg@1_9&tN^g{y(5NZK19*-aj2&ahx zz!jPR0ah9WfRi=_0%&Rh;66@)0C_hfBY-9fKtD8qfL3SAo{TZi-8uC`xI{tY2t_U4Gj|7&?~mT%)t<2gvKrZ z^@_@Py);wB*A7E@KK2oqcmTig@SCra1WDtC3841XWyAmO z%|tb=FOTnwBC2sXLWTd$Lhs3{{BmD2_OoQ;> zF^h4watp~;wh}D=wgyv4JM9*3O)!`y5Fjd}(UcyEDo@(ds8@)2%F#MC1IT_VOb{F<&(y|kL9 zmx6w100GT_07Z$0ihyvMOhA)}sei_!=_=JDfTp~OerNyzZa{#dL_ zXu3-E2=EYHB_QBiK!8$0Lqz~l(MgktsYd`!aZ}S(s(&<&erNyzf>D->=%+wked=Y&_^&(tqmZ}+nFwG4?Ug=gzAHP!%bgK-~c zPd0KriarmHcY?owK9~z&@nS~&uFv*^jm1H*v4FSuy{jMDmYzTCSXm0oGp4-U@A79AM|%8m?=ijE8=Fg^m}IPcxb-@G8odyZK~ z7($)V&Sl(Pg4e?aJ~4S@Rq-6-YP;T#TV)zmn5J)9vm!Z(J;?We{Oy?^#^yax>3w=^ zv_5=r`kxo|7py=2s#t%F6RkfE!=xIRx}x{rlej?eF)3Jj_?RnwcIIrqz+^BL*qOhb{E?FP;TQhMC~V0Inaa7u`QmbYz$zJ2LF= zBRVp$A-Q3DR-N80S|#|`6>;0mSIk%RJyO8yVWc~42lhKF~725M&sg@){Vi7>=95&4cO^3oT_XbMKTg-43qUoL2t0Ih^6uJLl=W z&xIuT&d<0!6r57}+9pSNO&Ry*xaSo|hGC*3!}*xS&^#1zhBhmWt<^^B;ohZ!QdpvKomT(1~l0aFgHcjGbUVo{y_-k}t*nAr;!GXolJzlrh= z6)k2Sl`Upwqze`^E7Hch;6;J|)UwN`MH$&T<1FVyZVC5|`R)iXuNlM_mp*?q?U<{V zrF@9FC%<$~lg;JZQd+_+W`-|+>^2S!pu!G68eFjAk7kbx7iJY9eH#!h<9?g^Tmb=a z^AR8bZaxYGKpaPbfQuvufE$Sd0rGA}MgYK)00HQS#tr%b(^k01n--0#eOEx|)wuAh zI23?^D7kMLFFnOBwZy8;VGfMD)BT6E$`4}}i(jTSF1+r<7L@CTKQy}bi=ZQwEZ%_c zbrONl^|^f2j)t$Yo|(_CX!u@VphN!2COg*EX@eQG#yQt2F_^|fekpP5d=2DG=U8$d%01VBRgsvHgCA^=RFC=fssrh&qT0s)}#AwWP54FW)~Mu7l%H{&88o(2Kv zhbF4lDntP=M@Fm(;UWMOJ_HD`(nJAZ0!4uUQ1}oaAc+P6pjV?nfV`V=5daDwit+~f zp#cO4Q2-Rs2@n7Z9|{D}L;+v|MS%cN_z)n#L4yF$t5G08-p#lO09hOb0?-dlR4t#v z9u|s+6SprAO!K1=b<=1%kVFkAZE4guhdpI!%Hwzk^lf=LdXA~h0IQ+y??JMz9T;;E zTmx<}<{$_+1Y-_@8ybu`C_4Ab4iM%7;5EBVH1URx=C%Pp8;Vd6{n&uvn4k~{kdCJ% zJ5g{LLDGm=X|@1*Pn98!rVkAQED8u{OQT*Tl}e>jC^Dr| zQluP8<?)ZO6Oxs2$}xwT|2^}anYGyVH_zXF z|NrYZ&+E0%s>kDNzTf+Lf3N$xKKJJ;23kiT55zRqnHlmXSun)U{bgumj~-}bkJe}| zLqT)Xn$cVa(M>}kdjy9D$e<*^RwKb}4)C;f+@BlbY3sN@H^g4ea1RaO*u`|XrBvua z0}${LAb_n#f{Os2wvKxQ@U(T@BY?e{AtL~d6a{+F00evh2wYd6JZ&BK z2w<;fxCkJj$pWAU4M0F8Kmc2f1Q!83Z5{Ur;A!i)M*w>@Lq-6aEC71Y00cY%P8A|7 zwF9d!&`W>+^w?bEQ2)JmcAcyvWZp)en?e zmE~ZT7DGHB9P=H0GcBA37+Qn_6A-cZfTy{bKgVz;Ak9Fwh@Fz@Pi_tmR(H-P3cFfU zO{r^kGc7H0hj>6Fk{t+A)C+$ZTAUD%KeG~;fEbf8e~#fyK>B6VqcO1puG0(i&B$pA z+JAokB+Sxcs0V~3QMmJT=79C64@^L`<7So!sx$pLhBW~J!(CXJd_fk&3R|*Sg&dV^ zm)u~1Sy~M7fJn1S%P}LU{$*%Us{>3x_)9mKT4Mej!_y_%Sm$inUU zqx?s{n5D%~Ciz(#;M8U(O1dDsZR)P%4Rz&a%Z8v$4*4;ulT z)eIK_tV|v@0-y&?WIKg{05&(_A^sE01gcTSm&1@BY@=w2pa*cgGI0rfVly} zMgV6u!$kmVlMNdI(1Rwjoy0%@o11X60L%>#HUda!5WrF_!bSk5ScHuLmSPb$0fV1W*S1mC~=c|*%Dj^qM4?HBVQHP>j?p+bUF6x^ElIV5XQ4%)VMKg zL)h;%5$u2|?DrZbScCmu!?8DNaNlbz!5ZxM8s?w~I~nAxX1I+ZmdX=yG6+9t^m^!> zz=a+=ncs8396MbIshNUjlLqdyVI4Au%>dRRbJ$_SI%E!crEyjO+^!wVn*lZiSl$e< zUp90!e1;x2;Cx{*=nv!A;R!Vnpg}Kj+-wI~4WhCTqEZ^7@+0rja4&ZlEsrL$9S_oU z8oTnr)0~B0vcLSqETE$E^ zqR|8=Pmjp`3!0}#-MqT*?jk>Y|fx7ZY37!g$_OlgSaC?KJ zMOvlb12h#pJtFsK?s(IB zPf$Dcsu-**751qA6N}+uk%t3n4eGm`g+X=jr2dZ;^#l&ceYQs)2*akile=9;26tf2{*j>UrO!$!6{3-B2s zV|FHF=^^ecUAaxdz1dkqHx2bn*OXkHVGT_NcwHAPKeI75?iU}%DM50X+@?xg?KpaBRN#+?+>r(tObU?X7AvE6YKOu` zz@W+BkPu*w1_6WINns&i(1b)t2v9X?0`(>2O7(C5>71uhXw&G4S_9d1REp-usn@m*8*4?0@$?x_G*T^5nyQuU}pi) zg9adgF~1n=y23^Ps~rj(0hopWHUda!5Wvz9z(xR?T7Ws4EP%b5AtL}y763hH00M}h z^T56i%cC4p?#!|^gUwAu3k^|lq5&H3(Qw~JVI9VW{jP!jXr?Ii<3WdmW&V))p^4=_ z4yVP1L-QJ7*?+)JH(2%`u;0*_0SxQ{H)jRF-9NGHKVWY;=x922cr>XX^swpIq4(2O zfW-iP&OiG4P;u>aBGK4zHaFdb=BhP5s&`HTK z+II9OYgx{djQ8hN%nxv+^)9VogL{+ZZpgq*k-Bp&7AJ2YiZ-lO>+wgjW((SR*M!9WF<-bqX5xdNWFD&U{hl{`HnPmefy z^oRffbpQbz1s7Zdped(9msVj2;OP;E&RG06Niv!q1ZOqFl_ZZ6Jt9Cr89)F>!37lo zBsAq3=+Y_-0X#h-_XyzW5r>Xh{g+b-(1QjbpbH>?qu_#z05n+ubZHfa0G=L^dj#6axfsN@!3KfT-vMU0Q`908KTBr$^-eY$9hh!`%ps5We^OHS?1KG8XdG({w$8bhBA9F{gqs#TbwXHbSj`GuR@2B1zakCz?66uK(-)@oh~RdlotsM zp9$9-yaGAMEs0!V;YJ>x`bkcoYD`rj3w3fo+yVNhsnMYfFj^eWnrwCXi|M{r(d~u1y%^V2CTIZ zqP0GA%y;z7v~U_~H1jkUb4@XnG?;eXUr>IL{8o8e`SUG13R+{E0mXmd=Qx53A%Al!^GjujZE++}7AuNfu~1g1gD2n7!A$3tI7YOO{8*femY9#7Jb z-TX%AMbO{%V>iDMiX7U%jAR~>_f3rsor31m6r;IJGn&i%%N*+wc{U&yNCx!exCTPa z1w^m{1-#4#%LRTkUU-C%266%159U>j5CpvN9Gf=Sxd7Xoau{#tk>c~fVcBqV0nTcM znhX4Byzof9Z2rXqbEFWE4iLZ@js+C~EQJSb1pH`f)d(U0&4!RAi-L^+OcpilaN!X| zKs0t92ljS=vzp-|0L^v)deDF@AO#?RGaL&l0+i5X0Y92rHF5}GDLi1;gjljD*a*O6 zQLqtUjs^jo)eIK_m@I18@wFqE1waoPfPhSZ0M2kMs0eUEgMc4Rtr|fDpveMQvMAUH zz+_Rd5kNtM0M2TLivUa(1seg-g9aer2|xg6I2Kd{$e}^NkET|Q90FLfDA-v5OBMwi z0hlZbHUe;H5Wrc@P!YhgX@iXb=s^PzKmj!eI=i;j!15YVKLCah$b<<0@d z)vReMlx$WZ!|B;z?i@V_;PwVt?i{eghULxyd!=z!0NhR|9t{L=XkIofQybWPh8{LY zN|^IYIp~C%2q1b7AbNMA$v5afm@GPin@--N;a(y#S{_Y6IIS6E0wgw|kCzDbia>is zqmiPF76BL5=H%$N;AT&}N5hS_Zgf4G$ac~|)f?R10Gfry0UF#EG@{@{(|_V=IJsBx zjuH)Lw`M)Pk5nO>PWMo|*j@dC;DWjz7%kE&o*wakJ)6MOBXWH<0e;Zv zfl>Cd>Cs3^0^Vp+TYWT@VV)k5`{PMGJtFrAfF3k@JxKro=4cQwN~Bd-7QoXZa*qI> z9+7(lKo1(do@Rgm3K|5A5@{8N0G=L^dj#l%(zFuRwgk*9ask`=N(Ttzce21jV;wAkJXFk^=eIl5pXL8+zg^6mj=h>8lV+5d zR09Nf00gkkuav??0Bc(U8v(3?C9n~IC33J0&{zjcU=RPsc0aI(B$BYxSg?oKvR5-? z1dI}sYJdQ1fB=>T7cv4^+Y;CaKr~DYQ~JV20PA20Yy^xFzg;W~V6SG#2pASr{xNx!IPX^Kk(+yKz~5aCO=80`(1V=Vumo$c z6B`js;srag!CWU{mp5=|#_&N88ZgEDBR~Lq5+hs$@aBqg)3PZDXEZrj270g&fC<)M zBY>sygpC09YVOx5kWH_y;3LAB$Bm}K2|Z{40-k_{#xA44tq8C>;;_rYi0WvFYL942 zPrOH?G*sgAFY}mbqvX+mu|@cDb!V1$PUeRumfsK<-9Tut961>R_D;j0$pl$8Fkq(+ zb;rT7fr0#nreW?$u=85Z3V^$RV!0>5&Nt|2vUEI}-5~U^0j^_=-Th&-tnUl~U08RgiQ`ul! zb&kAng95s#XtshpZQc2yqr746xNma3unA?2H30qj}mo?i8tv#D=G><9=^5N(89@0mlFW*lHxW z2#7|5fd6Z>b#&`DuS0j|Pg`(a?}2xg$}5Rm8(qW`MQ_m8EsB|Zc|y^_{IQW%WVqWe_{W4J4@MwfQlB1x_vfL-c`c> z%o2hm-Q6P1vdgcLAcd)K#zk*?P`fE^`c8q;4Yro@_Wr-TVwc74ilu}a zxyRMGm*AQU`$4TmLD8bNoH@8Esxpy4v@$tRmTkIwQiG*xU)L0wmZq~66Cx~y?DKIm z$qwYTmg-c0Y}1gfu*>#@So|47t&WSPWd6ODpd8NFH2ChY+<0iC%|?fVk~6;otL&WNHQuFjA;6ZZ)*3!txJ@&N-u7Wo4Hd+#!`{$m&r7n5nU7% z7qs9)+=YbP4YCE{v=hvf1jRxF5D%9md~;xqF4Jo^Cht#vm~3aUBmwxY%g{Umgx%eq zIi7w+n3!5ECqh-B-XzF&=61!1#)$9y6uvMegWqVwBG7VKV(*tokmzK#T-I}1E`p%t zqTf@;JXL^V1%S*)&p7+HG%rSirJlLh(k=hd^G7}@gemXx9J`xkRX$aS5d~E8rjY~j z8iaC!N3JVb2y0UK=-+$$ZH}Sv1HZ4cQwU+=p_Cw(!jkiZN z>Z9F0gHr`4q6VBQP~S6Fkpeu|k8W;icl582Bu*#ty~_o*>%=OO8~K#mX6k(MS( zwAO6Lye5HiOC{_rK2h`f&Z6@>R>g|P2fWSICJU-tDlvo?(td*Si{!V;+sZ#|*-_9M ziyyd}8I>bwqyeW2nhs7(@GS3QD3{;-XM+YHz#H5&puID3z5Fh}ERZt)R7(pRG00j*KfLH|u0>Ew- z!S>k+4FWi;87>0QWC75F223z!)B-ql8mP4ZaDov90)SWr0Rj+JgMe5C0Rn)+3k3pz z!VASlfU}yRA^;r6M6nTo9y9;}j9LKD#30B5z*!Fz2mm8e5g>qsCJO*!6%+_SQwsnJ zFBAyitY)|fK$8VP4;p}ge$W)+TxU(a0+?YAsfZ3_aVWTnXrUnrPBcK{JsR%YD6~=X zXv`J*DfBixjSfZ_cO6lyConplHL-b+T7#tGaPME`Ct=Oup8DV!P@2PdO?}4CW_7yn zt2?{H=yc;fZ??aYUA-IYa_PH$Zh_I|qW5XkgHOPGF1@kQO@&oZI?x>_O28+uz?xjR zicmP6;odgJC&)@ag(R3It*m~$R~KJz?&uevkKE)Y*; z^xOwcMts%X47@9vq=`aQL1KCk?PojHQP{l-7{|XBk+R=h0p9+c2)0zKb8Z5~+v9M>FSY(ly?>#{< zwzPn0Vg7DZsj-LfKV{Ea~d&&|M%)oCIu4ggT#NCKgrU z!~2FCaZD@(m?jpq;Ey1J6%$UE$}z292911HrV+D^Gd!L*jU(nd5`^i$9O%k!67a~W z{IM0)V?nmVj0$j=X%45=&>IJgFAf1Sa&72Uf3pi5sSgx_&3MID^iaFN5el6CIvRU+ zEm#CY2mX%GTBF(FS+i?<4p4>}Upyj@2N(clGW{D%u=pH0iFbrBK!4BlZ?ut2U@YmO zlXyoca!_5S0?nsML-TAU}Rm~x zp-|X%feh9R8Ng=$94|!Kmh0=GqXXs2w>R-!bSjQ zg$^45`e+b4do{yFKr|WzKo1&#fJT4-&_hOm03cOBuv24= zMT3n1(AB#@N5g#$b+kMhFr}m!L??-jwBsd0z-dT@ zJYde>2(^V64OKKvXhe;B=zUwP8UQq22r4MNN5fT1eRMsV$aXrTA_)8vu$2Zi5ul^V zIPq+vF~(fLQ=;I|YzBa128t~-X9X}EVBqO$fMW)NtqsFy27%-W7|oza(x8XU6or09 zCct^Ct*Q414g)e&Q|cP(N%9yOONkL|K_hxa^R#t5Z5@hoEjGUzcE<*K&}8ZN6w}j) ze~mB3fx*IeAyEL=$sYL25LFbZJJ&)HrAGILGX!;sn831j@Ra0{s&FKskv(>ykv&?Y zkv$^1j2oIyLqYRwP<)y^9eOg5S##7#P&WiTZ5{WA26);!?h_l%YKFSG87+cTfPi#> z0FD|7Dgt=gI_?p`)7Ej10M2TLi-1ugNCgN;0SMrzk)R@gr>)~20X%IT_XyyuX1EAI zQxt?AGynma00A5|5>x~@p{b?wv~}E{9_DH5xIR7XJxT+dl9`n_O-&>|xnNf<$NTdNo0Y3&?zq3&vY(qZbsAaNH6XFO0C<47$_(!UBI%lIrpCYdcKq4L zg>%_1Abb1+)&whffqOe7l~+GdW>uEMY`jYKbqPkaGzC?RBjz*_BRCX1j z@)7fl`)Ys(2vK-=7Z5>pOQjipcXk+U+;dQz?E;d(aRC{U%10&JB{x{CwLf)%AVl-< z-|p`A+|j4P!i^k=*C2RUrR5Ck0%B^ZK=t=MGBrMM!TD_*7Z4-13&_y3Wy-EgTxAmi zgb8AjGlqj~)JwTNJZ+g#g*XuN#)@nU`Q$t1pzoT2;gi?p(22@nmJxzP!PaLu{G<#-GlbtgdQ{i z0Rs)x;38m%`U(yL&}0EaB#UqmFytf#6aP&+^<2rwU91&5Obzz&*L zuM+xqJP}xjb{)~EzsvBm07|?M48O6F-wo0Z3?uOx`TIssAI1xAZ=9@Lj`ba7X%05ZNvVHqkitv7d%m zDd1D=Kp6SBVOW|Baf2J_Pjj;!*xbsYd9Mvotd0CaW7KNc8#TD8tq7X;n$O^~MI#?I z16MQK8ye1jaEQ$FKN>WV?a_>z#?GMOB4CIc925jZqd~wB#Tpz03{k8>Np1DfAYh1v zA{+#;S2J7$43T-lK>+li0Yl6gML~AyiETVO@_PY>KRlv38uT&>v;8o%Aqpip5tZwB zk7k$&0sqn)94(Iqj4UC7=;V~RqS|w5dEnF^lo#}n(~@vfG(_bZL?tdXWkKGf8D<#C zzsL}V8npa3qXyUv;K5#iW6l6K5x}9zIEUDCz)8}E*mFSH4A6$yb3nvf;Nv5EAaq{$tLkAQ7vn2VSjut^dfE=2w0GgU0PmegvY|?)@m4K*< z#?vEmi2z1PkW=1bA25c307SJq*wU(_%q##=5sg!7(17v8&Ghn$&|XqNjgAt-sINS_y#!KYKyElYz>$Yd@i2CPBVQ5fk4AGD3YyE{ z(L9^stQsLao8hb)N50!l8_q)!g7OuGRur@c$pePqnk!@y=q--EBmZm|2X04;w2G%k z{2ve8^7M$qSWW!PDRt;U0}${LAb_plf{TFBBCTQ~AR0|-%hMxrv%AI4+_P6RXR14t zekw;@3%4-@A!xqS?LVv*f3oF{!ygMXdq}A-C2ncCh>PEHq>WE+oiQ%7=xtzl?)&=M zzu9I?QSC3FUHB-H!JNk#;Z?!V620dG#u9&-Gq?eB25TpBg{88+Ph$6ThC2ta0O`!3 zZ<@VvUTm)Uy?5W{8VcL^eVzT!CLkI0y{gW*7H!6qJf}{tH?7)_)CSoZGy!u4sxVRA z{>&1BB!%J5(KOK`PqUk}z%S0vu)FB3=}o`**%x-Kjs0i5s(R72nJtcn$j5BPxz$h~F? zI3pp$n2VA5zH57dOnSBb-xDk%a5Q_GTk|(sKULU=rN)(;ybI9cG;Z} zk3X|gtK;H7m)k1a`(@JQ+~rMnPkgA_n^h0Kiv0V54^QA|a-{Q2g{(^6G;*L5!=0n+ zbf%?TpZQcRL#;)9hisSVYn5Kqj+Ab|z})kqM)S!1jR0pg!$rUa zGzfqlGynm`00DAH5P(OM1&E+QKn@ZF;Lspo5)uT^(9{Ars~Ii=e32jkde8s_Gy?>f zqd@>{pkY~n5*h^LBS8QO4FaUlAOKA*fU}z6BH%n41i%g&fB*`pJLB2cIsQhdR|HxS z9nDRnqgiN(f)f$Yc#nqrHp(b@G_785@cpC;nRGh6#{G@%LyL~Xy%E555K7Aq$nUl* zQ3@{`=X?b%yOZCwA8Eko41)905oTG;5ylZ-l=g2I_ML#ze+ohKY3gYAt~!0*%6K#s z)l5%$lbbMFgETw*n<7`(?n5!7L4l+93;P%x*=?x;e%rEtHD(H2yw>L=po?arAdV`Aqo*a#P1dI|n8ioL#hLd{) zKo1�LJkbw(1Qo0(f#X?h!Cb}kKp9P?i?{H*da9aY1bT#bN4EIPkBAFQUpaBS| z0LP%&*D+TGMngxSXlg+B5z$RUw9wE5Cr|eHKiE3_|LoDwLbj`Kwwh-1bjg~#T`3(` zPmEizQQkNhS+ zV%|)`M7q0GSFWSK17X1Il|%Bt{=@(4>?nfNlw1Qf0i#WqHXXj5d-k`pC1*br&e3?w zm|{#LRmi5(J=AWt1DRKUGVsD{#ATFQx#d2}dlVo{5L3x{-Q7GPugs>$4{R3c+#+TN(AXJ5cXQiPzTr)zvnmF zUeR7&TS9<$7S)){=P|%FPz6{t83T(Z0gtL#GyKDM7;W5haN44vxS$0W z;w~)C-5^^K&X~qIXpHrLHfZ#Eios3e812DDz#wyHNC?pX$h1$B>(#9PMcxETR>MHR zAO}2H2pBYx7ZL&nJK#Y=z@Uk|kPyIG&2SMg$Tkud0-y(tUQZH0fH{a2U~Px%go}Wx zV20HMjohVEAe&xY0SN(0Xb|A9&hVV;IRG~cAPt(11_=R!r=vkaK&~vqsIfnpH6ala z0ywJ~E&_zym`05SS=dknSO|a~GcdaIO$q1q~55(Y$LAy`K@~ zG`vT{UH6gEMj0)S=12)W4Rkng><#pqdjI|aH%MtMJr7AHNQYiRVWt~&G^IK`J4J*0 zQsb-uxQ!G!G+Pc4B(*wP0Fr_b{IH2^$Ahjtjh&?>g#)i4Xx&sqDJPmVoen)qW3mQO zX3KjtT*{rmu5+|Jnl2rB9lf!su%D9G8haI30)_znn+?4RO4}}E=s;cw8(c75DfX%x z)2a`2ZBCxp{KylALPk8l&1JyE z?{C5TfWIN5+pW}Gco~Ycj$VP_GDk}ARG>`GX65Q|lY!A9tzy2Vd3r?dH`0SA@TnT&s1ME7JHS1afT%&t(<5?!=AONp;no6hXlen_g9adgQ42uR8yqdtDrOd7 z&K6a`ZKAkRAm>s3kBvs0$dfwryJAFR z#CKMOKSHw!1{vSKd0MdA4XMW5a@R*aqe>G?T0-k`I#>z?{ zBY>4-!$ts>W5Y%OOH&LR0V0?H4>kg@92+(QSUEOq1h7{#Tm-Pr{J=&4^q>IDQsR(N)0y zskzF%gfYa}wmcjRF?LUbk=BGXG6h#au?SW)roMx)f$Fd8WNQg+F}pU31B8r|X6M1u z5;9=J6q1enJ`FfETBErP1InID>Br8?y*VZ==q$T(QCC=i}dcWPMw05+pVu;L-?y^Rm^ z1PkoM28SJ$g1xt4X$fH`Htf|5wvMAUHK$E8Fqd@@X zZ3rC!X!bTNEg@_Kuvar&1Vp1j0Q8^%2yg%hz_f(05x|l~!A1af#u#=Mpo9hin71Kp z1dz~V0W2*cYy_}ZGh76iqd@@lpaCj^_n@1`uB5_k4dT$;G(@FzH0=kL4Ge6c@g5EL z&Ee7VXad4%B%pR+*>jjVxG_f%z$kAq8uu)x3D~azmeT~}bc5wI0s9Tja+-i$v*)Y; zxXo^sK@04v10K!W28SjUgdR3kvCQ@$y9wp00A`o9@RU_QR#stMNJLF2G>yB_B6{OJ z8X+RLdc-LT{aphke0nD>fzb$0TgTJZ@w9b68n8Et1gQW4#Q*^uH4;<=@U(T@i_#J8 z)Y%mwxJ}#9qOHS{4Kx)Y=s^Pz&(vKcr-VSgyu5MXl`0D8rh>80@))tG>|+%!UwlM$kWzw ze|VIqt>gaaAare=dr2BNIyg!MsQ>}#00C?@5?loEv~}DgfTykF9s%st47a@Djb?8H zJ!k*|QUC(jY9zP_;A!i)N5KCtwRLpT9*^?Snl(=*^evjc;Tmzho59>o&i3Pr#2yr? z9nzjTN8jz)Sy!P%mC{R-(SUq? zDURPjVy8vXrL9Z-Y&R^r-E+~D%)i$X*iqPSGCV(7OH$re+wel1jI@8a>o%vJ#-NWT z*Fq!qj8#l>#lKlDuex{d?6i%Kv>*AT5T?A#GgfmGmLa(Mew>!-+h{5OT5Xow#-<7C zc}vMki?rVQO(n0m8zyx7!^N#}nz7SVa*fFX9=A=!O6U0Q$Ul2S%t-#Lwsuvl?3)O0 zb@?vI!=DcuXaDxFg5vVB@YOrx!X=>(L+vb0t zc<0TZ^$5z;)BQ1XHg4bIvt-wzbkTU>2Yz2S*jmcl`$rL^;w251tl&2aijy{272|kt zs@{j?ne}PP&gPcdj)x~EWPIq~UJ&%r-ogK)c>45ozIVB6c8lz-`nbwI`-8CaUh|S2+tO z_#Y?COwCQVBcDo<`J76SwHJ{&`h0A0I3zY`OO_TOpr2RH1Zn}Z$3PFX&YnAN-KMv&OCa&zPtY}eN+T^qbEId2K&sPdd z3s(`Qy~{aC7OZ<@IsTpF#qwNN!dm-h(vv<17e-lFlPC6W+I05D#c_M@89L84l-Vgz z8t^t(n=Ghqsbr`aV|q|D{wD+F7~72%g$p8|9ys~N$@;UI74&7mj8a_?GYO|In-EF$ zU_B%zUfes!M7}KBboZnNOT|dy8R6Z;^^QX2Ih_PC>lqi-=eV7YvXr7qNzS&_612a* z^M(Hohb{9A<#r0mSSnKeGIu1NwGCY#XSMOw*?6(z@^_Au1lMmTMTL5tLlZqp05wm> z8JjiI?j6u}Oik5tJh$({zVUXJvIzl+N1CRqSTypbFR`Cgo~IpobY0Wgj{>e|_7ltv z{o(``5)N&hC#97#`|=L2ElceE5(yHWS}AklH}TyL6k8=9ul@EyP_B;pJ=K0!?WTEX zpo1WIKDL_x>Le{=-M6ND#Z;LDXv+W*L^&S^@-jg5?#awW!%$SOY(Yc}h5ssLGE@-} zL*WNcdVLb(-2>3cOhGEPN55Cy4J~t#CqjkK4{zDN((gGU(UyYy#4h>^Uii+Z{r~EdxR0avvbhAvsDqj zv-!{@yaqKB+cZSW08t5XFZ-1MnW5(qF%;3hX9*&P zLJyu_i1i}$zHU;35xpF@z3Eqi=oMVetK(AMcWN((>CUs8hn0qp+D!x7ylnaCjh_a{sZCrR9npd#)3d zEp2k&9gNlUXiHNPrnlFSJiA+VeW%^;3P}&a_jMAZvwFJ=x+wUz);FX~dj0)oT6chw zcVCyjoHzaZ$&9`GNvHa}d+#^nJX_zGdv~`)n0s}H$Z2|Yw-yu}BK1_4)4RR;8=bs6 z+h5==C-F zbmDFodP9K-omTBcZ*Rc&czh|Nx2L_)q+ht%Ome4ISM6_&E%0tl2=pG#d^i$yFvscb0swv-WB#NUGHDt?qBha4Py*wZ9|w zhK5FS!((rE6I^3@beF>(%?!op&X2{tk25qfh#HBM;@(uxK9!#RH#<9etFD`03n);) zX*9lw?z-^3dwdO%ME|{;;`Oc0%Vz1!$|W~l)uX!-Pk6h#d6yg`xmTursjsT2w<+$= zaC-HnYJc0)I`1!XD+&rCR%X*@xR z453)9ZB$Q4y4m&WdV$=jZzA*wF7(gEy-j^zsw!0VJ({d({nQ$TKIU)rx;Bqk`{riv z2}(qW`Ocf&lC|I~a1WbwoL+&Ska)t=-OcmEF*+V^=iLj|Qvg^*UETB$dQ-u|zPe-H z^okH%|JU>2Z|SYYq+VLT9KFK{f2vbSj=qoH8i4D6i}U7hrngiDp4X4o^!_y;EULaV zIq#lVNrCw9V0np{d-m0UwMgG$?%7*kBSP`+Ypa<=?=ruh+5O$*F#Y>-jXu||?;_*P z`$Ci&l*}_c`ik<38Vb5vx{p@inw4?*Kq*xU`IYABsnIyU0#a7bL_B}(`G_=1--ZSB zp4peoX{YImhDzQv|5obwI87YBqt=AVAUvY;99DeNuq)_U@}u z`mR`4pI=O}ySbKD-&PZy)%O)#W2%O<{d_xP7H}{5dgH*LM8!$!GL`SO2N;Kyj?-)^iFGI|@_hP7+Q1vc5oMvGs?Knp2k8Ow#&u zj&A+tXwBG;FGUxuVxDbinQptsXO`1xS4XjCQ_iI3%#i)=dBA@~&i*+|w{4R>B)rosB4x40jgux0&iu^lUr(zf5M_rZY$ATu)W~r%4uP_zexX4QTl5B@+MiI*(_{NqmG)w`#gw*61ncM&gaRrVM@ z{1(@HXP+Bo3SLITxTCAXVUOdQS7RP_7<9QlNmr+Kyn9pbyn2tEp<8YI_ZQoZloTSq zl=tj)@-n#^{=V~eZH#sJ+=e9zZAM*n`~e+y&*K~&zr6Vtd!tgRsPs$StmEm|>~DYq zcb!{<`JE-vF;!REZ1yKUjChsv)HEyT?MsUfiqZFKU9~Kow2JEO4nK{2OKEPdT)Clg z)syZu<}X!oscp6aC)B=HmOae7y1eq~8+Y$7gzxWv zJIxJm5AwO)H}`dQ$D145%0sUt$=pjUJU=Hd$F;ENq*`2)>iO^S842nQy@w=dAvMkh zYiAypIcjd!y^QWkJmGy?bw>M#x>R$|n^!{`qLS2$r{fdjn~Nzy)*d2_kDJpbI(gT% zduKkla=*6N-166`JtvgY&Fw3V&OiKaf2=&?u*izCEZXgp_Eqh(^rHhP!R{;GZ#(1r z>q+X{;+n~m-qa~+zdE~JX;srok%R~nxic?rb^X50rblZ=f!}+D%6z{H1wE_WMhQ}Z zA4Q?EVB@d)QA6M@^n?KfLyXclK^V92ol`rv| zRxKN<^7LZ!*;R8UXv|6cd3KeUjrJt5kS*$K3f(tOFIitGUlKND=giQ1E~0H`pWe-j z)H$%`<#m^P;0rtOMLXk*V<*Ai+%JgK@c>`6GrsU;{7oGA;ymMT;;u$|yy`XVJ$wkC zxhL~UtMWw~G5LiXPi__6;<8PYzddNy#k$q&XT26Wz3#@<2|mlfFZvq%q6@$;y0TO4 z@QRgJ3>R)VpwEBcM92QUUQ)R6=cFe1Jku8#cP<3{6D>AD9H+oP*L%I_mcA9*&is9W zvo3Z?ojz4uHX)~@>e{kjG%qfy{Y5iUbbd`~mqUkF-{iSwqTv5CkAJRaaOjx7|A4Sr zqTQ0~XEocM-dHY_%l@bRgw31Or#2aP&O8IZWc7V;`2z4yF+aGx!~}8DEO2=pQU1O~ z+DA_OGXIW+POyM)!djnf*Kw`5ckUo|8i~lZh_|uB4op#Dz6kcF}X{9>gm*bP&}}Ja$3u@_TcSR2TOD1kFKA6 zKWK?v#B8A{GsA@hZPqFjh0V5`I5P@-ZEd}0$KpMF8t=liwk}Cbki1ec+iJ8wg;jE)}nhM8Nmk{`LK%y{l z#fr~c?o6nC`z6+3M!nCi(!D3M#WH;#hjhfGDSY9}AEWf;WM}c5Lj|8VZPoV_3Y0MO zY})LO>1rg;U2w%c`I&_7(;`WwEACc0=E={_&%3$1#AI=+)j5SL z?UK4XljqK3{reDI$#Ahwe%K|(|32j3ZjSk9=XvFafp0lC&#O^TZ?Vn+-2~V1mjdV6 z*q_@zmGP4gH}4z_F75ghizN@ z!b;aZW_Q@Rd3)^7l`f5W9QBaM{ub@U%Rj8Wy*o@yH;DPOo{8Vt9d>@+>f~n&u6(xA zd9AtX*1$jOEnXftFMW5I1moM6Uith?yfJLCl&-VYIq(~}Jz9Nko^kSA=AVrgzsL`Z z+#OSqG%GqXL#z+? z>ST5vh|8mcckU$qC6Ir9A3=Rztg?WYPY-S@ihrE1@y{zwH^1vzcIxt}%0YisXWd&4aE z?plYgY^{xVjy^s!ck$F)k5p=}&kw4fKlzT(;@R`J{AA@aY4+*qKR?e-ln)Pk-6MTq zx|h<7c*V}Sfs4xp=nm^rR_wVmuUoq=`$PU8xYWj94gUBezI@w!n)~dh1)CRL+0wpt zlRzZNEt>G@+(d)RRz}Gu$1-k$|JV-6ry$K(H1|xeTz)>}a7c;y-^?WKl}Wkd z$62ENr)lG>Gjqx^7ZME~M;OVO8huUus+`<l%L+0aZlmnEN zvo97sBuP&c@jJiL+U{rb-J+t?K3o1)y{fO{82!XppNrT0uYCzhsFDzCv2CjtPdccz zV%#Nl3B`;v=Pu<7&K6ssJWcAv`fEMYYBln9Za)#E6)Y#|pdET(kMgCeOF18+NzZX1 zF)L>gHPjCKy$JM^2)rA%H0-IU=(5O#7Xti57k>IO_uG}Qk`0&6ocgxm)@2bwRpx%0 zm_}Cl&M7mO?cbnFpY>s14Bxt1(X=wsbd&M99(D6H?^nxIpY)u5%6HwS<@?HyO`}yl zOy-N5J|*2LX>D1Dy1Oq$);2x;z3G1Mw0w{884dfDJkxx;Ofzue4ffXWWiu$%)_LyM zs>H?w-?CeN_o&{dQXME1M?07C=bU?L54oS$dj9%B-}T53o26;tZJFc#td4JdamsVi z7QgZS#4ii)&0A|Grr{{^?3!%H*(aAW-z-|Pe8u=uOY4d_QiJ@1JHb1*ihMg4mZYUC zzIuCJ=8CW9Ty4Yl&9&XFRF;!Jqha}{^uDOyK41K#wd6p9q?N(0f^k#RcLWINIXA@4 zc;a-zeNjXG$Ayy??E9LG^P|TGTTkdAAkemAY zuGQ)oD@)w{aneQxlO}$8Y}ajem;daTUE)`c$M@-%uJyQkKkU75xwL>&eNEJ4cmmDXtfGV z+i=PzVWxslfgggKZ^IZ7oo@c7KSSx+iwtNVmrDF}PfO+fhx*^!g?2F{S5Si85GfZu8i&kFACA#B-AN4-o)m#$!^Q^WPd#U|5 zGH(ASYf>9hdA!KK!}F@U$A)FGOP=3NuPM2AvOrpH!gJ>*=Q37@mwFyh{j=HhV1{Bx zLYIE|i^tz5F#_$-9UsdDWtZ?X43EF{&V>0t&WuXz)M#Tez^4UJAS+O&x#u~QYMBf)>ggvqtTQ>H|= z%)4y+=I!+!KM})4;!V|Ba)k4rU0!e3d!&C^ahAx!q#4(*l`F+ubve}?NQ}*<3a7^$ z-M^H7M&z!Y3z~_MJLhef>|*D#e^qHuu4xp1<;~!md+f~nuDlE@nWo&i=M6YdwxH?>bLpYhE)*~@>`!BFg~|= z`nuWs9=2~i((MwhUfFi7_CrF%V=*`Fgf9(?cAoqiT5>^SHbHuhw85fZKAf4k_0R2h z_wGEZD>Hd^;lVXcraiPx5e3`6-oF;UT~>cV)(o%u_nM8%?9F;^&zNH$p7PZ6NN1po ze&Ncwmk;dfi#>An(3M-a9~J$UNXoEXuchK%5yF=`M4+Up-s|$TLw?z3Olub#Dy;l`bg^5)yd_?^Nuh<$*HkYE!c{*~c{WX^ z=%(?lx%V>7+Nf*GT{I_Tj7cJz*t@Du_3G3Nth=hEYc>0++C7V;-AX}QuJyWMrZlyExXM>A3R{z7qGEJ^+Ve) zzHRCYoxLu;{$qb?mBE>fC*Pg%eiukvSl)l)^u>AFazFhh@8h>P+ka9J<+Md1akhdDUyL@-5SkdnhlcD15)M==g+J>LwR$Cbr+}d_h?u=@I30 zN@<4{d6k#mx$l46)(u_foOa;Xl&sqdE=Qi^ZwZ=ruYjsglIzR6cQLlHGCQXImly8y z?W$Cl7M=7zwg1r9z3Vn)gllKek z)BR+hwrW+a(3Gmlu?f1jyH$#w{Tf)*@kHr<&KSY!lRw>?qPE*VKC=1x_+1P9TQ;tn zw#P!O>8Oaf+?EAuWDV6nT$IFTU8*S16e4LV)75+*C>VAJZu+pyXVp$YS&8vCkMOBz zy1t_=KUExYK)Vu3e*U(keO*TUpKd|;L#kHiA}s4ESN_;3 z@LW>$xzl;l0Z+YCpWmfQ;j*i1F4UbdStjFlcyrF;jM>{{ckmtft}I^gy5ySi(qG(X zjCGs+O=0YLzI_*r%3^GtPE}-XxjlEntRDq;bRC+>JeH z@>5@~Q&cH??%re(UM{xpaZ#pfkSp2wg|c&n{?)_Q+ie0#p?-HvfL+ z-HAUc``*sFU8Zb5E_xwdYq3@3mYW{k!4p}!8IR^qElO& zOYfBE?^v7eTQ4f_H|N!@U`=z8PdWztggY(IP9?gXnH#@+l0 z?Go3w3Vqx+-_FFn2Av0{p(-|h4MICE$m<+AauqaO1+>|fC@gr8yBu$0bxEAelSFf-&EGv*j5HT`qBPMGyp zayemti1|7yH7<89#}dChk02!*3G2CsJ_eW8>-LIT-%Hx9r6RF(diI0Jq~>u~l#<^p z&@)@~Y72oFxpqcQ%;(h5acfr`NH<}=ny^>MHSOTb+3R+w?KJ{b1l=A-N5^zUAXo$~A9_4W=wElHG{J5jo` z*ZgekzN)iF-b`LbtiE9Dih)k zE}j);h%)}g`p#vP2!}B9 z+L~SOQ-j0b=L#7{+3m_*YJXg|`rXD4+E@6ES5H-$=_zac?eeqYcZDu$vfDS$zAo}w zyr!0_F@K}=xi`n_W{Wlmths-vZuxSJmDSHwgfHH<(E51d8l}|u{MdD?Bmgq6)7n zFGweO#xEl;6*du3jyfjQvm-`UsV^(&t7Ut^?%B`u z-(JzQpn0s&b?BBLuPq-p`Q@iO0$I=9+bPQ{_loDaDK`-|Y6cbSzR_KkZ$_ zanJLP2cJ}Q1-@SY;=QSxP5-&;)zLILEsK@rN2`7b%<{DzckR$F*{N+M_uJd%)ZJW0 zyWy>QG?zL~d@Cn+N9loFT zxId-Ih0r=8g zy7*32f6Mb)&hAh85_0?$pZQpgZS-2Gi2L28&F@W^dV_=5mycg>`te0-<=vJrr3lz) z=5JAUTVtZU(fH@17q_0#ty^XFH7GJl$K$#E+n<#e-i&@{DjX4UaP_O+`W31!$E+!H zAJRj^uFZcj-uA`KW~*PP)yV7U=LIR1n9P-H=&b)atFb#vuH2Px@!=(z8VhEHT28-j z-e`Kd!l58D+cv!Lt~l}vS~qCjolz<)kI%Zcbel=_+U3n&KR>PXoSf;NcWq7c)Tw)>jN9M1 zz0P!^Qg36&+Or!!NLP3S2x@O5Jb3g@pKMos{UGt;gn(aSv&H=c-p*j)$JxVcaqE}xwzcc5-*-J z=_`58!tN`ZpA@Q1{(R_+v(A}~2a28CPpf@R?BI`>YW+(^`6k z^UrVY$>WNyX*>NAZhMLE`_kgBk0hBLUe^--80UFM$fEIUi(JI7jyv4v9FP9vxtyf= zxw*Pd%LI4Nr_IGxo_)UfcJ{+CyvFWKW?d%M>GrJ0;Dapq*OJ8E4Ni_Oha6qZ4Nn|7 zbZkE(c=HX596=qX?=)@0XS+?4XT-|T!zbNa%{)^+!;5ilHgSKLUV zL%dwQ^7{J=jqhVh7QMfHzvM>H_LAkg|IaRPXnSuycjNf0%98U!TnQ=~*#^n%D%)n< zKNH5@KIKS?v!u3D0soxI8Uf5puPyBK$lKc{Fum@qYzOa}iT=kQTkEai%s8ZRMJC5C zI*Bh@bkcFNxZrf2Il)UC1ZqFdohZIUdG_#Dlt&=}%v_-=kL2)J?g1Dm8@WJIjH^;Z9g^}PHaZywg$%9gR8`QDZ^AJZw%maqPn`S#h8 z^RuT{|6>IesZw?!(UHJd`N;~(zKl#F43O!)e&F=p-fw4r*8^J;$AGz402q6y065u~ zoS&NujH_bs$Pv2kyRRp$yT-!6urq>zK^jHtUZ9yk-6=(h<)F^6epzmg3xsW`2V|og z#GaJd%nEcOJ20Psrq2-I4lr{d8w52Gt8;Lhq7G~eVKD_f5Qy#;ntj|fym>YsLon)1>Hczd?UIk$ODI{&eFJp zZVHmK5F@7O1|koTfW{jUK=&@#K=jc^bOVsvvY>Gk1eo>!Yyifn3c3l%O$Jb#7Xfsh zLrj3TfYG%g*KD9R1p=_Yf(Hkzg@LXaxo`(neh4u8HCQu_su0~A$`ITGV@xrvYF6b=Lp@ literal 0 HcmV?d00001 From eb9289406fad9fb508cf6d6496efa2aa08f25df5 Mon Sep 17 00:00:00 2001 From: gf-dcc-service Date: Wed, 25 Oct 2023 22:48:54 +0000 Subject: [PATCH 5/5] Build jsonld --- GF.jsonld | 15801 ++++++++++++++++++++++++++-------------------------- 1 file changed, 7878 insertions(+), 7923 deletions(-) diff --git a/GF.jsonld b/GF.jsonld index 6e7607e..f5580f8 100644 --- a/GF.jsonld +++ b/GF.jsonld @@ -9,1920 +9,1280 @@ }, "@id" : "http://schema.biothings.io/", "@graph" : [ { - "rdfs:subClassOf" : [ { - "@id" : "bts:Assay" - } ], - "@id" : "bts:ImagingLevel2", + "@id" : "bts:IndicatorEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "IndicatorEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "ImagingLevel2", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:LabID" - }, { - "@id" : "bts:ChannelMetadataFilename" - }, { - "@id" : "bts:ImagingAssayType" - }, { - "@id" : "bts:ProtocolLink" - }, { - "@id" : "bts:SoftwareandVersion" - }, { - "@id" : "bts:Microscope" - }, { - "@id" : "bts:Objective" - }, { - "@id" : "bts:NominalMagnification" - }, { - "@id" : "bts:LensNA" - }, { - "@id" : "bts:WorkingDistance" - }, { - "@id" : "bts:WorkingDistanceUnit" - }, { - "@id" : "bts:Immersion" - }, { - "@id" : "bts:Pyramid" - }, { - "@id" : "bts:Zstack" - }, { - "@id" : "bts:Tseries" - }, { - "@id" : "bts:PassedQC" - }, { - "@id" : "bts:Comment" - }, { - "@id" : "bts:FOVnumber" - }, { - "@id" : "bts:FOVX" - }, { - "@id" : "bts:FOVXUnit" - }, { - "@id" : "bts:FOVY" - }, { - "@id" : "bts:FOVYUnit" - }, { - "@id" : "bts:FrameAveraging" - }, { - "@id" : "bts:ImageID" - }, { - "@id" : "bts:DimensionOrder" - }, { - "@id" : "bts:PhysicalSizeX" - }, { - "@id" : "bts:PhysicalSizeXUnit" - }, { - "@id" : "bts:PhysicalSizeY" - }, { - "@id" : "bts:PhysicalSizeYUnit" - }, { - "@id" : "bts:PhysicalSizeZ" - }, { - "@id" : "bts:PhysicalSizeZUnit" - }, { - "@id" : "bts:PixelsBigEndian" - }, { - "@id" : "bts:PlaneCount" - }, { - "@id" : "bts:SizeC" - }, { - "@id" : "bts:SizeT" - }, { - "@id" : "bts:SizeX" - }, { - "@id" : "bts:SizeY" - }, { - "@id" : "bts:SizeZ" - }, { - "@id" : "bts:PixelType" - } ], - "sms:displayName" : "ImagingLevel2" + "sms:displayName" : "IndicatorEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Publication" - } ], - "@id" : "bts:PublicationTemplate", + "@id" : "bts:BreastCancerAssessmentTestsEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCancerAssessmentTestsEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "PublicationTemplate", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:PublicationDOI" - }, { - "@id" : "bts:Title" - }, { - "@id" : "bts:Authors" - }, { - "@id" : "bts:LinkedProject" - }, { - "@id" : "bts:LinkedDatasets" - } ], - "sms:displayName" : "PublicationTemplate" + "sms:displayName" : "BreastCancerAssessmentTestsEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" - } ], - "@id" : "bts:Exposure", + "@id" : "bts:HereditaryCancerPredispositionSyndromeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "HereditaryCancerPredispositionSyndromeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Exposure", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:StartDaysfromIndex" - }, { - "@id" : "bts:SmokingExposure" - }, { - "@id" : "bts:AlcoholExposure" - }, { - "@id" : "bts:EnvironmentalTobaccoSmokeExposure" - } ], - "sms:displayName" : "Exposure" + "sms:displayName" : "HereditaryCancerPredispositionSyndromeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Exposure" - } ], - "@id" : "bts:Yes-SmokingExposure", + "@id" : "bts:BreastCarcinomaDetectionMethodTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCarcinomaDetectionMethodTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Yes-SmokingExposure", - "rdfs:comment" : "TBD", + "sms:displayName" : "BreastCarcinomaDetectionMethodTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CancerAssociatedGeneMutationsEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:StartDaysfromIndex" - }, { - "@id" : "bts:SmokingExposure" - }, { - "@id" : "bts:AlcoholExposure" - }, { - "@id" : "bts:EnvironmentalTobaccoSmokeExposure" - }, { - "@id" : "bts:YearsSmoked" - }, { - "@id" : "bts:PackYearsSmoked" - }, { - "@id" : "bts:CigarettesperDay" - }, { - "@id" : "bts:SmokingFrequency" - }, { - "@id" : "bts:TypeofSmokeExposure" - }, { - "@id" : "bts:TimebetweenWakingandFirstSmoke" - }, { - "@id" : "bts:TobaccoSmokingOnsetYear" - }, { - "@id" : "bts:TobaccoSmokingQuitYear" - }, { - "@id" : "bts:TobaccoSmokingStatus" - }, { - "@id" : "bts:TypeofTobaccoUsed" - }, { - "@id" : "bts:SecondhandSmokeasChild" - }, { - "@id" : "bts:SmokeExposureDuration" - }, { - "@id" : "bts:TobaccoUseperDay" - }, { - "@id" : "bts:SmokelessTobaccoQuitAge" - } ], - "sms:displayName" : "Yes-SmokingExposure" + "rdfs:comment" : "TBD", + "rdfs:label" : "CancerAssociatedGeneMutationsEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CancerAssociatedGeneMutationsEnum", + "sms:required" : "sms:false" }, { + "@id" : "bts:RelativewithCancerHistoryEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "RelativewithCancerHistoryEnum", "rdfs:subClassOf" : [ ], - "@id" : "bts:MolecularTest", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "MolecularTest", + "sms:displayName" : "RelativewithCancerHistoryEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:EthnicityEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "EthnicityEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "EthnicityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ImmersionEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:StartDaysfromIndex" - }, { - "@id" : "bts:StopDaysfromIndex" - }, { - "@id" : "bts:GeneSymbol" - }, { - "@id" : "bts:MolecularAnalysisMethod" - }, { - "@id" : "bts:TestResult" - }, { - "@id" : "bts:AAChange" - }, { - "@id" : "bts:Antigen" - }, { - "@id" : "bts:ClinicalBiospecimenType" - }, { - "@id" : "bts:BloodTestNormalRangeUpper" - }, { - "@id" : "bts:BloodTestNormalRangeLower" - }, { - "@id" : "bts:CellCount" - }, { - "@id" : "bts:Chromosome" - }, { - "@id" : "bts:Clonality" - }, { - "@id" : "bts:CopyNumber" - }, { - "@id" : "bts:Cytoband" - }, { - "@id" : "bts:Exon" - }, { - "@id" : "bts:HistoneFamily" - }, { - "@id" : "bts:HistoneVariant" - }, { - "@id" : "bts:Intron" - }, { - "@id" : "bts:LaboratoryTest" - }, { - "@id" : "bts:LociAbnormalCount" - }, { - "@id" : "bts:LociCount" - }, { - "@id" : "bts:Locus" - }, { - "@id" : "bts:MismatchRepairMutation" - }, { - "@id" : "bts:MolecularConsequence" - }, { - "@id" : "bts:Pathogenicity" - }, { - "@id" : "bts:Ploidy" - }, { - "@id" : "bts:SecondExon" - }, { - "@id" : "bts:SecondGeneSymbol" - }, { - "@id" : "bts:SpecializedMolecularTest" - }, { - "@id" : "bts:TestAnalyteType" - }, { - "@id" : "bts:TestUnits" - }, { - "@id" : "bts:TestValue" - }, { - "@id" : "bts:Transcript" - }, { - "@id" : "bts:VariantOrigin" - }, { - "@id" : "bts:VariantType" - }, { - "@id" : "bts:Zygosity" - } ], - "sms:displayName" : "MolecularTest" + "rdfs:comment" : "TBD", + "rdfs:label" : "ImmersionEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ImmersionEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:FamilyHistory" - } ], - "@id" : "bts:Yes-CancerHistoryRelative", + "@id" : "bts:BreastCancerGenomicTestPerformedEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCancerGenomicTestPerformedEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastCancerGenomicTestPerformedEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:FileFormatEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "FileFormatEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "FileFormatEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:DimensionOrderEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "DimensionOrderEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "DimensionOrderEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SexEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SexEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SexEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AlcoholIntensityEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AlcoholIntensityEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AlcoholIntensityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ImagingAssayTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ImagingAssayTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ImagingAssayTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PassedQCEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "PassedQCEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PassedQCEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ExtentofTumorResectionEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ExtentofTumorResectionEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ExtentofTumorResectionEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ReverseTranscriptionPrimerEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ReverseTranscriptionPrimerEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ReverseTranscriptionPrimerEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CountryofResidenceEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "CountryofResidenceEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CountryofResidenceEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:TobaccoSmokingStatusEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "TobaccoSmokingStatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TobaccoSmokingStatusEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:OncotypeRiskGroupEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "OncotypeRiskGroupEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "OncotypeRiskGroupEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PathogenicityEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "PathogenicityEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PathogenicityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LabTestsforMMRStatusEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LabTestsforMMRStatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LabTestsforMMRStatusEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LibraryConstructionMethodEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LibraryConstructionMethodEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LibraryConstructionMethodEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:TotalVolumeUnitEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "TotalVolumeUnitEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TotalVolumeUnitEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BooleanEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BooleanEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BooleanEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MolecularAnalysisMethodEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "MolecularAnalysisMethodEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MolecularAnalysisMethodEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ClonalityEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ClonalityEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ClonalityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:InvasiveDuctalBreastCarcinomaHistologicCategoryEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "InvasiveDuctalBreastCarcinomaHistologicCategoryEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "InvasiveDuctalBreastCarcinomaHistologicCategoryEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:IschemicTemperatureEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "IschemicTemperatureEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "IschemicTemperatureEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AgeIsObfuscatedEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AgeIsObfuscatedEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AgeIsObfuscatedEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LaboratoryTestEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LaboratoryTestEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LaboratoryTestEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SiteofResectionorBiopsyEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SiteofResectionorBiopsyEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SiteofResectionorBiopsyEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:VascularInvasionTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "VascularInvasionTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "VascularInvasionTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:StainingIntensityEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "StainingIntensityEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "StainingIntensityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MutationalSignaturesEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "MutationalSignaturesEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MutationalSignaturesEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PriorInvasiveBreastDiseaseEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "PriorInvasiveBreastDiseaseEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PriorInvasiveBreastDiseaseEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MismatchRepairSystemStatusEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "MismatchRepairSystemStatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MismatchRepairSystemStatusEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AnalyteTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AnalyteTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AnalyteTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ModeofCancerDetectionEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ModeofCancerDetectionEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ModeofCancerDetectionEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BreastBiopsyProcedureFindingTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastBiopsyProcedureFindingTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Yes-CancerHistoryRelative", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:RelativewithCancerHistory" - }, { - "@id" : "bts:RelativeswithCancerHistoryCount" - }, { - "@id" : "bts:RelationshipType" - }, { - "@id" : "bts:RelationshipPrimaryDiagnosis" - }, { - "@id" : "bts:RelationshipGender" - }, { - "@id" : "bts:RelationshipAgeatDiagnosis" - } ], - "sms:displayName" : "Yes-CancerHistoryRelative" + "sms:displayName" : "BreastBiopsyProcedureFindingTypeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" - } ], - "@id" : "bts:PatientExtended", + "@id" : "bts:AlcoholTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AlcoholTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "PatientExtended", - "rdfs:comment" : "TBD", + "sms:displayName" : "AlcoholTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:VitalStatusEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:StartDaysfromIndex" - }, { - "@id" : "bts:StopDaysfromIndex" - }, { - "@id" : "bts:SentinelLymphNodeCount" - }, { - "@id" : "bts:SentinelNodePositiveAssessmentCount" - }, { - "@id" : "bts:TumorExtranodalExtensionIndicator" - }, { - "@id" : "bts:SatelliteMetastasisPresentIndicator" - }, { - "@id" : "bts:OtherBiopsyResectionSite" - }, { - "@id" : "bts:ExtentofTumorResection" - }, { - "@id" : "bts:PrecancerousConditionType" - }, { - "@id" : "bts:PriorSitesofRadiation" - }, { - "@id" : "bts:Immunosuppression" - }, { - "@id" : "bts:ConcomitantMedicationReceivedType" - }, { - "@id" : "bts:FamilyMemberVitalStatusIndicator" - }, { - "@id" : "bts:COVID19OccurrenceIndicator" - }, { - "@id" : "bts:COVID19CurrentStatus" - }, { - "@id" : "bts:COVID19PositiveLabTestIndicator" - }, { - "@id" : "bts:COVID19AntibodyTesting" - }, { - "@id" : "bts:COVID19ComplicationsSeverity" - }, { - "@id" : "bts:COVID19CancerTreatmentFollowup" - }, { - "@id" : "bts:Ecigvapeuse" - }, { - "@id" : "bts:Ecigvape30dayusenum" - }, { - "@id" : "bts:Ecigvapetimesperday" - }, { - "@id" : "bts:Typeofsmokeexposurecumulativeyears" - }, { - "@id" : "bts:Chewingtobaccodailyusecount" - }, { - "@id" : "bts:Secondhandsmokeexposureyears" - }, { - "@id" : "bts:KnownGeneticPredispositionMutation" - }, { - "@id" : "bts:HereditaryCancerPredispositionSyndrome" - }, { - "@id" : "bts:CancerAssociatedGeneMutations" - }, { - "@id" : "bts:MutationalSignatures" - }, { - "@id" : "bts:MismatchRepairSystemStatus" - }, { - "@id" : "bts:LabTestsforMMRStatus" - }, { - "@id" : "bts:ModeofCancerDetection" - }, { - "@id" : "bts:EducationLevel" - }, { - "@id" : "bts:CountryofBirth" - }, { - "@id" : "bts:MedicallyUnderservedArea" - }, { - "@id" : "bts:RuralvsUrban" - }, { - "@id" : "bts:CancerIncidence" - }, { - "@id" : "bts:CancerIncidenceLocation" - } ], - "sms:displayName" : "PatientExtended" + "rdfs:comment" : "TBD", + "rdfs:label" : "VitalStatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "VitalStatusEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:SingleCellSequencing" - } ], - "@id" : "bts:ScRNA-seqLevel3", + "@id" : "bts:InvasiveLobularBreastCarcinomaHistologicCategoryEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "InvasiveLobularBreastCarcinomaHistologicCategoryEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "ScRNA-seqLevel3", + "sms:displayName" : "InvasiveLobularBreastCarcinomaHistologicCategoryEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:DimensionsUnitEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "DimensionsUnitEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "DimensionsUnitEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PrimaryDiagnosisEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:DissociationMethod" - }, { - "@id" : "bts:CryopreservedCellsinSample" - }, { - "@id" : "bts:SingleCellIsolationMethod" - }, { - "@id" : "bts:TotalNumberofInputCells" - }, { - "@id" : "bts:InputCellsandNuclei" - }, { - "@id" : "bts:ReverseTranscriptionPrimer" - }, { - "@id" : "bts:SpikeIn" - }, { - "@id" : "bts:EndBias" - }, { - "@id" : "bts:DataCategory" - }, { - "@id" : "bts:MatrixType" - }, { - "@id" : "bts:LinkedMatrices" - }, { - "@id" : "bts:CellMedianNumberReads" - }, { - "@id" : "bts:CellMedianNumberGenes" - }, { - "@id" : "bts:CellTotal" - }, { - "@id" : "bts:ScRNAseqWorkflowType" - }, { - "@id" : "bts:ScRNAseqWorkflowParametersDescription" - }, { - "@id" : "bts:WorkflowLink" - }, { - "@id" : "bts:WorkflowVersion" - } ], - "sms:displayName" : "ScRNA-seqLevel3" + "rdfs:comment" : "TBD", + "rdfs:label" : "PrimaryDiagnosisEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PrimaryDiagnosisEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:TestAnalyteTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "TestAnalyteTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TestAnalyteTypeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" - } ], - "@id" : "bts:AnalyteBiospecimenType", + "@id" : "bts:ZygosityEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ZygosityEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "AnalyteBiospecimenType", + "sms:displayName" : "ZygosityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:NucleicAcidSourceEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "NucleicAcidSourceEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "NucleicAcidSourceEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:OvarianCancerSurgicalOutcomeEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" - }, { - "@id" : "bts:ParentID" - }, { - "@id" : "bts:ParentBiospecimenID" - }, { - "@id" : "bts:AdjacentBiospecimenIDs" - }, { - "@id" : "bts:BiospecimenType" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:SpecimenLaterality" - }, { - "@id" : "bts:AnalyteType" - }, { - "@id" : "bts:FixationDuration" - }, { - "@id" : "bts:SlideChargeType" - }, { - "@id" : "bts:SectionThicknessValue" - }, { - "@id" : "bts:SectioningDaysfromIndex" - }, { - "@id" : "bts:ShippingConditionType" - }, { - "@id" : "bts:IschemicTime" - }, { - "@id" : "bts:IschemicTemperature" - } ], - "sms:displayName" : "AnalyteBiospecimenType" + "rdfs:comment" : "TBD", + "rdfs:label" : "OvarianCancerSurgicalOutcomeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "OvarianCancerSurgicalOutcomeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Exposure" - } ], - "@id" : "bts:Yes-AlcoholExposure", + "@id" : "bts:RaceEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "RaceEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Yes-AlcoholExposure", + "sms:displayName" : "RaceEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BreastCarcinomaSurgicalProcedureNameEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCarcinomaSurgicalProcedureNameEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastCarcinomaSurgicalProcedureNameEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SmokingFrequencyEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:StartDaysfromIndex" - }, { - "@id" : "bts:SmokingExposure" - }, { - "@id" : "bts:AlcoholExposure" - }, { - "@id" : "bts:EnvironmentalTobaccoSmokeExposure" - }, { - "@id" : "bts:AlcoholDaysPerWeek" - }, { - "@id" : "bts:AlcoholDrinksPerDay" - }, { - "@id" : "bts:AlcoholHistory" - }, { - "@id" : "bts:AlcoholIntensity" - }, { - "@id" : "bts:AlcoholType" - } ], - "sms:displayName" : "Yes-AlcoholExposure" + "rdfs:comment" : "TBD", + "rdfs:label" : "SmokingFrequencyEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SmokingFrequencyEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:SingleCellSequencing" - } ], - "@id" : "bts:ScRNA-seqLevel1", + "@id" : "bts:PixelTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "PixelTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "ScRNA-seqLevel1", + "sms:displayName" : "PixelTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SpikeInEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "SpikeInEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SpikeInEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ReadEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:DissociationMethod" - }, { - "@id" : "bts:CryopreservedCellsinSample" - }, { - "@id" : "bts:SingleCellIsolationMethod" - }, { - "@id" : "bts:TotalNumberofInputCells" - }, { - "@id" : "bts:InputCellsandNuclei" - }, { - "@id" : "bts:ReverseTranscriptionPrimer" - }, { - "@id" : "bts:SpikeIn" - }, { - "@id" : "bts:EndBias" - }, { - "@id" : "bts:UMIBarcodeOffset" - }, { - "@id" : "bts:UMIBarcodeLength" - }, { - "@id" : "bts:MedianUMIsperCellNumber" - }, { - "@id" : "bts:CellBarcodeOffset" - }, { - "@id" : "bts:CellBarcodeLength" - }, { - "@id" : "bts:ValidBarcodesCellNumber" - } ], - "sms:displayName" : "ScRNA-seqLevel1" + "rdfs:comment" : "TBD", + "rdfs:label" : "ReadEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ReadEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BreastCarcinomaHER2StatusEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCarcinomaHER2StatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastCarcinomaHER2StatusEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ClinicalBiospecimenTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ClinicalBiospecimenTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ClinicalBiospecimenTypeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" - } ], - "@id" : "bts:BreastCancerPatient", + "@id" : "bts:RelationshipPrimaryDiagnosisEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "RelationshipPrimaryDiagnosisEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "BreastCancerPatient", + "sms:displayName" : "RelationshipPrimaryDiagnosisEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BIRADSMammographyBreastDensityCategoryEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "BIRADSMammographyBreastDensityCategoryEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BIRADSMammographyBreastDensityCategoryEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SingleNucleusBufferEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:BreastCarcinomaDetectionMethodType" - }, { - "@id" : "bts:BreastCarcinomaHistologyCategory" - }, { - "@id" : "bts:InvasiveLobularBreastCarcinomaHistologicCategory" - }, { - "@id" : "bts:InvasiveDuctalBreastCarcinomaHistologicCategory" - }, { - "@id" : "bts:BreastBiopsyProcedureFindingType" - }, { - "@id" : "bts:BreastQuadrantSite" - }, { - "@id" : "bts:BreastCancerAssessmentTests" - }, { - "@id" : "bts:BreastCancerGenomicTestPerformed" - }, { - "@id" : "bts:MammaprintRiskGroup" - }, { - "@id" : "bts:OncotypeRiskGroup" - }, { - "@id" : "bts:ERReceptorStatus" - }, { - "@id" : "bts:PRReceptorStatus" - }, { - "@id" : "bts:BreastCancerAllredEstrogenReceptorScore" - }, { - "@id" : "bts:PriorInvasiveBreastDisease" - }, { - "@id" : "bts:BreastCarcinomaERStatusPercentageValue" - }, { - "@id" : "bts:BreastCarcinomaPRStatusPercentageValue" - }, { - "@id" : "bts:HER2BreastCarcinomaCopyNumberTotal" - }, { - "@id" : "bts:BreastCarcinomaCentromere17CopyNumber" - }, { - "@id" : "bts:BreastCarcinomaHER2Centromere17CopynumberTotal" - }, { - "@id" : "bts:BreastCarcinomaHER2Chromosome17Ratio" - }, { - "@id" : "bts:BreastCarcinomaSurgicalProcedureName" - }, { - "@id" : "bts:BreastCarcinomaHER2RatioDiagnosis" - }, { - "@id" : "bts:BreastCarcinomaHER2Status" - }, { - "@id" : "bts:HormoneTherapyBreastCancerPreventionIndicator" - }, { - "@id" : "bts:ERStainingIntensity" - }, { - "@id" : "bts:PRStainingIntensity" - }, { - "@id" : "bts:OncotypeScore" - }, { - "@id" : "bts:BreastImagingPerformedType" - }, { - "@id" : "bts:MultifocalBreastCarcinomaPresentIndicator" - }, { - "@id" : "bts:MulticentricBreastCarcinomaPresentIndicator" - }, { - "@id" : "bts:BIRADSMammographyBreastDensityCategory" - } ], - "sms:displayName" : "BreastCancerPatient" + "rdfs:comment" : "TBD", + "rdfs:label" : "SingleNucleusBufferEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SingleNucleusBufferEnum", + "sms:required" : "sms:false" }, { + "@id" : "bts:BiospecimenTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BiospecimenTypeEnum", "rdfs:subClassOf" : [ ], - "@id" : "bts:Patient", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Patient", + "sms:displayName" : "BiospecimenTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AntibioticUseEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AntibioticUseEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AntibioticUseEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:HormoneTherapyBreastCancerPreventionIndicatorEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "HormoneTherapyBreastCancerPreventionIndicatorEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "HormoneTherapyBreastCancerPreventionIndicatorEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PreservationMethodEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - } ], - "sms:displayName" : "Patient" + "rdfs:comment" : "TBD", + "rdfs:label" : "PreservationMethodEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PreservationMethodEnum", + "sms:required" : "sms:false" }, { + "@id" : "bts:TumorExtranodalExtensionIndicatorEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "TumorExtranodalExtensionIndicatorEnum", "rdfs:subClassOf" : [ ], - "@id" : "bts:Sequencing", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Sequencing", - "rdfs:comment" : "Base template for some type of sequencing data, for which below properties are relevant/in common.", + "sms:displayName" : "TumorExtranodalExtensionIndicatorEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:TseriesEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - } ], - "sms:displayName" : "Sequencing" + "rdfs:comment" : "TBD", + "rdfs:label" : "TseriesEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TseriesEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:DissociationMethodEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "DissociationMethodEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "DissociationMethodEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LibraryLayoutEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LibraryLayoutEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LibraryLayoutEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BreastCancerAllredEstrogenReceptorScoreEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCancerAllredEstrogenReceptorScoreEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastCancerAllredEstrogenReceptorScoreEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:SingleCellSequencing" - } ], - "@id" : "bts:ScRNA-seqLevel2", + "@id" : "bts:PrecancerousConditionTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "PrecancerousConditionTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "ScRNA-seqLevel2", + "sms:displayName" : "PrecancerousConditionTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:VariantTypeEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "VariantTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "VariantTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:RelationshipTypeEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:DissociationMethod" - }, { - "@id" : "bts:CryopreservedCellsinSample" - }, { - "@id" : "bts:SingleCellIsolationMethod" - }, { - "@id" : "bts:TotalNumberofInputCells" - }, { - "@id" : "bts:InputCellsandNuclei" - }, { - "@id" : "bts:ReverseTranscriptionPrimer" - }, { - "@id" : "bts:SpikeIn" - }, { - "@id" : "bts:EndBias" - }, { - "@id" : "bts:ScRNAseqWorkflowType" - }, { - "@id" : "bts:ScRNAseqWorkflowParametersDescription" - }, { - "@id" : "bts:WorkflowVersion" - }, { - "@id" : "bts:WorkflowLink" - }, { - "@id" : "bts:GenomicReference" - }, { - "@id" : "bts:GenomicReferenceURL" - }, { - "@id" : "bts:GenomeAnnotationURL" - }, { - "@id" : "bts:WhitelistCellBarcodeFileLink" - }, { - "@id" : "bts:CellBarcodeTag" - }, { - "@id" : "bts:UMITag" - }, { - "@id" : "bts:AppliedHardTrimming" - } ], - "sms:displayName" : "ScRNA-seqLevel2" + "rdfs:comment" : "TBD", + "rdfs:label" : "RelationshipTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "RelationshipTypeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Diagnosis" - } ], - "@id" : "bts:Yes-VascularInvasionPresent", + "@id" : "bts:SmokingExposureEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SmokingExposureEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Yes-VascularInvasionPresent", + "sms:displayName" : "SmokingExposureEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:OvarianCancerPlatinumStatusEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "OvarianCancerPlatinumStatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "OvarianCancerPlatinumStatusEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:HistoneFamilyEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:VascularInvasionType" - } ], - "sms:displayName" : "Yes-VascularInvasionPresent" + "rdfs:comment" : "TBD", + "rdfs:label" : "HistoneFamilyEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "HistoneFamilyEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Sequencing" - } ], - "@id" : "bts:SingleCellSequencing", + "@id" : "bts:ChromosomeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ChromosomeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "SingleCellSequencing", + "sms:displayName" : "ChromosomeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:OvarianCancerHistologicSubtypeEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "OvarianCancerHistologicSubtypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "OvarianCancerHistologicSubtypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MicroscopyUnitEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:DissociationMethod" - }, { - "@id" : "bts:CryopreservedCellsinSample" - }, { - "@id" : "bts:SingleCellIsolationMethod" - }, { - "@id" : "bts:TotalNumberofInputCells" - }, { - "@id" : "bts:InputCellsandNuclei" - }, { - "@id" : "bts:ReverseTranscriptionPrimer" - }, { - "@id" : "bts:SpikeIn" - }, { - "@id" : "bts:EndBias" - } ], - "sms:displayName" : "SingleCellSequencing" + "rdfs:comment" : "TBD", + "rdfs:label" : "MicroscopyUnitEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MicroscopyUnitEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:SingleCellSequencing" - } ], - "@id" : "bts:ScATAC-seqLevel1", + "@id" : "bts:HistoryEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "HistoryEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "ScATAC-seqLevel1", + "sms:displayName" : "HistoryEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CauseofDeathEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "CauseofDeathEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CauseofDeathEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:TestResultEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:DissociationMethod" - }, { - "@id" : "bts:CryopreservedCellsinSample" - }, { - "@id" : "bts:SingleCellIsolationMethod" - }, { - "@id" : "bts:TotalNumberofInputCells" - }, { - "@id" : "bts:InputCellsandNuclei" - }, { - "@id" : "bts:ReverseTranscriptionPrimer" - }, { - "@id" : "bts:SpikeIn" - }, { - "@id" : "bts:EndBias" - }, { - "@id" : "bts:SingleNucleusBuffer" - }, { - "@id" : "bts:TranspositionReaction" - }, { - "@id" : "bts:NucleusIdentifier" - }, { - "@id" : "bts:NucleiBarcodeLength" - }, { - "@id" : "bts:NucleiBarcodeRead" - } ], - "sms:displayName" : "ScATAC-seqLevel1" + "rdfs:comment" : "TBD", + "rdfs:label" : "TestResultEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TestResultEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" - } ], - "@id" : "bts:TotalVolume", + "@id" : "bts:AntigenEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AntigenEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "TotalVolume", + "sms:displayName" : "AntigenEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MolecularConsequenceEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "MolecularConsequenceEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MolecularConsequenceEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ReceptorStatusEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" - }, { - "@id" : "bts:ParentID" - }, { - "@id" : "bts:ParentBiospecimenID" - }, { - "@id" : "bts:AdjacentBiospecimenIDs" - }, { - "@id" : "bts:BiospecimenType" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:SpecimenLaterality" - }, { - "@id" : "bts:TotalVolumeUnit" - } ], - "sms:displayName" : "TotalVolume" + "rdfs:comment" : "TBD", + "rdfs:label" : "ReceptorStatusEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ReceptorStatusEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Sequencing" - } ], - "@id" : "bts:BulkMethylation-seqLevel1", + "@id" : "bts:TumorTissueTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "TumorTissueTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "BulkMethylation-seqLevel1", + "sms:displayName" : "TumorTissueTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BreastQuadrantSiteEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "BreastQuadrantSiteEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastQuadrantSiteEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PloidyEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:GenomicCoverageType" - } ], - "sms:displayName" : "BulkMethylation-seqLevel1" + "rdfs:comment" : "TBD", + "rdfs:label" : "PloidyEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PloidyEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" - } ], - "@id" : "bts:UrineBiospecimenType", + "@id" : "bts:SpecimenLateralityEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SpecimenLateralityEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SpecimenLateralityEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:FamilyMemberVitalStatusIndicatorEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "FamilyMemberVitalStatusIndicatorEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "UrineBiospecimenType", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" - }, { - "@id" : "bts:ParentID" - }, { - "@id" : "bts:ParentBiospecimenID" - }, { - "@id" : "bts:AdjacentBiospecimenIDs" - }, { - "@id" : "bts:BiospecimenType" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:SpecimenLaterality" - }, { - "@id" : "bts:IschemicTime" - }, { - "@id" : "bts:IschemicTemperature" - }, { - "@id" : "bts:SiteofResectionorBiopsy" - }, { - "@id" : "bts:PortionWeight" - }, { - "@id" : "bts:TotalVolume" - }, { - "@id" : "bts:TumorTissueType" - }, { - "@id" : "bts:HistologicMorphologyCode" - }, { - "@id" : "bts:PreservationMethod" - } ], - "sms:displayName" : "UrineBiospecimenType" + "sms:displayName" : "FamilyMemberVitalStatusIndicatorEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:ImagingLevel2" - } ], - "@id" : "bts:ImagingLevel2Channels", + "@id" : "bts:SequencingPlatformEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SequencingPlatformEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "ImagingLevel2Channels", - "rdfs:comment" : "TBD", + "sms:displayName" : "SequencingPlatformEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:VariantOriginEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:LabID" - }, { - "@id" : "bts:ChannelMetadataFilename" - }, { - "@id" : "bts:ImagingAssayType" - }, { - "@id" : "bts:ProtocolLink" - }, { - "@id" : "bts:SoftwareandVersion" - }, { - "@id" : "bts:Microscope" - }, { - "@id" : "bts:Objective" - }, { - "@id" : "bts:NominalMagnification" - }, { - "@id" : "bts:LensNA" - }, { - "@id" : "bts:WorkingDistance" - }, { - "@id" : "bts:WorkingDistanceUnit" - }, { - "@id" : "bts:Immersion" - }, { - "@id" : "bts:Pyramid" - }, { - "@id" : "bts:Zstack" - }, { - "@id" : "bts:Tseries" - }, { - "@id" : "bts:PassedQC" - }, { - "@id" : "bts:Comment" - }, { - "@id" : "bts:FOVnumber" - }, { - "@id" : "bts:FOVX" - }, { - "@id" : "bts:FOVXUnit" - }, { - "@id" : "bts:FOVY" - }, { - "@id" : "bts:FOVYUnit" - }, { - "@id" : "bts:FrameAveraging" - }, { - "@id" : "bts:ImageID" - }, { - "@id" : "bts:DimensionOrder" - }, { - "@id" : "bts:PhysicalSizeX" - }, { - "@id" : "bts:PhysicalSizeXUnit" - }, { - "@id" : "bts:PhysicalSizeY" - }, { - "@id" : "bts:PhysicalSizeYUnit" - }, { - "@id" : "bts:PhysicalSizeZ" - }, { - "@id" : "bts:PhysicalSizeZUnit" - }, { - "@id" : "bts:PixelsBigEndian" - }, { - "@id" : "bts:PlaneCount" - }, { - "@id" : "bts:SizeC" - }, { - "@id" : "bts:SizeT" - }, { - "@id" : "bts:SizeX" - }, { - "@id" : "bts:SizeY" - }, { - "@id" : "bts:SizeZ" - }, { - "@id" : "bts:PixelType" - }, { - "@id" : "bts:ChannelID" - }, { - "@id" : "bts:ChannelName" - }, { - "@id" : "bts:ChannelPassedQC" - }, { - "@id" : "bts:CycleNumber" - }, { - "@id" : "bts:SubCycleNumber" - }, { - "@id" : "bts:TargetName" - }, { - "@id" : "bts:AntibodyName" - }, { - "@id" : "bts:RRIDidentifier" - }, { - "@id" : "bts:Fluorophore" - }, { - "@id" : "bts:Clone" - }, { - "@id" : "bts:Lot" - }, { - "@id" : "bts:Vendor" - }, { - "@id" : "bts:CatalogNumber" - }, { - "@id" : "bts:ExcitationWavelength" - }, { - "@id" : "bts:EmissionWavelength" - }, { - "@id" : "bts:ExcitationBandwidth" - }, { - "@id" : "bts:EmissionBandwidth" - }, { - "@id" : "bts:MetalIsotopeElement" - }, { - "@id" : "bts:MetalIsotopeMass" - }, { - "@id" : "bts:OligoBarcodeUpperStrand" - }, { - "@id" : "bts:OligoBarcodeLowerStrand" - }, { - "@id" : "bts:Dilution" - }, { - "@id" : "bts:Concentration" - } ], - "sms:displayName" : "ImagingLevel2Channels" + "rdfs:comment" : "TBD", + "rdfs:label" : "VariantOriginEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "VariantOriginEnum", + "sms:required" : "sms:false" }, { + "@id" : "bts:AnaplasiaPresentTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AnaplasiaPresentTypeEnum", "rdfs:subClassOf" : [ ], - "@id" : "bts:SampleCoreTemplate", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "SampleCoreTemplate", + "sms:displayName" : "AnaplasiaPresentTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:TranspositionReactionEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "TranspositionReactionEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TranspositionReactionEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:EndBiasEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:DetailedSampleID" - }, { - "@id" : "bts:AdjacentSampleIDs" - }, { - "@id" : "bts:SampleSite" - }, { - "@id" : "bts:ERStatus" - }, { - "@id" : "bts:PRStatus" - }, { - "@id" : "bts:HER2Status" - }, { - "@id" : "bts:Laterality" - } ], - "sms:displayName" : "SampleCoreTemplate" + "rdfs:comment" : "TBD", + "rdfs:label" : "EndBiasEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "EndBiasEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Diagnosis" - } ], - "@id" : "bts:Yes-ProgressionorRecurrence", + "@id" : "bts:HistoneVariantEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "HistoneVariantEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Yes-ProgressionorRecurrence", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:ProgressionorRecurrenceType" - }, { - "@id" : "bts:DaystoProgression" - }, { - "@id" : "bts:DaystoProgressionFree" - }, { - "@id" : "bts:DaystoRecurrence" - }, { - "@id" : "bts:ProgressionorRecurrenceAnatomicSite" - } ], - "sms:displayName" : "Yes-ProgressionorRecurrence" + "sms:displayName" : "HistoneVariantEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" - } ], - "@id" : "bts:OvarianCancerPatient", + "@id" : "bts:BreastCarcinomaHistologyCategoryEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastCarcinomaHistologyCategoryEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "OvarianCancerPatient", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:OvarianCancerHistologicSubtype" - }, { - "@id" : "bts:OvarianCancerSurgicalOutcome" - }, { - "@id" : "bts:OvarianCancerPlatinumStatus" - } ], - "sms:displayName" : "OvarianCancerPatient" + "sms:displayName" : "BreastCarcinomaHistologyCategoryEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" - } ], - "@id" : "bts:BoneMarrowBiospecimenType", + "@id" : "bts:BreastImagingPerformedTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "BreastImagingPerformedTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "BoneMarrowBiospecimenType", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" - }, { - "@id" : "bts:ParentID" - }, { - "@id" : "bts:ParentBiospecimenID" - }, { - "@id" : "bts:AdjacentBiospecimenIDs" - }, { - "@id" : "bts:BiospecimenType" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:SpecimenLaterality" - }, { - "@id" : "bts:IschemicTime" - }, { - "@id" : "bts:IschemicTemperature" - }, { - "@id" : "bts:SiteofResectionorBiopsy" - }, { - "@id" : "bts:PortionWeight" - }, { - "@id" : "bts:TotalVolume" - }, { - "@id" : "bts:TumorTissueType" - }, { - "@id" : "bts:HistologicMorphologyCode" - }, { - "@id" : "bts:PreservationMethod" - }, { - "@id" : "bts:BiospecimenDimension1" - }, { - "@id" : "bts:BiospecimenDimension2" - }, { - "@id" : "bts:BiospecimenDimension3" - }, { - "@id" : "bts:SectionNumberinSequence" - } ], - "sms:displayName" : "BoneMarrowBiospecimenType" + "sms:displayName" : "BreastImagingPerformedTypeEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Demographics" - } ], - "@id" : "bts:Dead", + "@id" : "bts:AlcoholExposureEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AlcoholExposureEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "Dead", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:Ethnicity" - }, { - "@id" : "bts:Gender" - }, { - "@id" : "bts:Race" - }, { - "@id" : "bts:VitalStatus" - }, { - "@id" : "bts:DaystoBirth" - }, { - "@id" : "bts:CountryofResidence" - }, { - "@id" : "bts:AgeIsObfuscated" - }, { - "@id" : "bts:YearOfBirth" - }, { - "@id" : "bts:YearofDeath" - }, { - "@id" : "bts:CauseofDeath" - }, { - "@id" : "bts:CauseofDeathSource" - }, { - "@id" : "bts:DaystoDeath" - } ], - "sms:displayName" : "Dead" + "sms:displayName" : "AlcoholExposureEnum", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Sequencing" - } ], - "@id" : "bts:BulkDNA-seqLevel1", + "@id" : "bts:SlideChargeTypeEnum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SlideChargeTypeEnum", + "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "BulkDNA-seqLevel1", + "sms:displayName" : "SlideChargeTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ShippingConditionTypeEnum", + "@type" : "rdfs:Class", "rdfs:comment" : "TBD", + "rdfs:label" : "ShippingConditionTypeEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ShippingConditionTypeEnum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SingleCellIsolationMethodEnum", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:TargetCaptureKit" - } ], - "sms:displayName" : "BulkDNA-seqLevel1" + "rdfs:comment" : "TBD", + "rdfs:label" : "SingleCellIsolationMethodEnum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SingleCellIsolationMethodEnum", + "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" + "@id" : "bts:Assay" } ], - "@id" : "bts:CohortCoreTemplate", + "@id" : "bts:ImagingLevel2", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "CohortCoreTemplate", + "rdfs:label" : "ImagingLevel2", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:Component" - }, { - "@id" : "bts:ParticipantID" - }, { - "@id" : "bts:TimepointLabel" - }, { - "@id" : "bts:Age" - }, { - "@id" : "bts:Sex" - }, { - "@id" : "bts:BMI" - }, { - "@id" : "bts:Race" - }, { - "@id" : "bts:Ethnicity" + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:VitalStatus" + "@id" : "bts:Filename" }, { - "@id" : "bts:Height" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:Weight" + "@id" : "bts:LabID" }, { - "@id" : "bts:Gravidity" + "@id" : "bts:ChannelMetadataFilename" }, { - "@id" : "bts:Parity" + "@id" : "bts:ImagingAssayType" }, { - "@id" : "bts:AgeAtMenarche" + "@id" : "bts:ProtocolLink" }, { - "@id" : "bts:MenstrualCyclePhase" + "@id" : "bts:SoftwareandVersion" }, { - "@id" : "bts:MenopauseStatus" + "@id" : "bts:Microscope" }, { - "@id" : "bts:PrimaryDiagnosis" + "@id" : "bts:Objective" }, { - "@id" : "bts:AgeatDiagnosis" + "@id" : "bts:NominalMagnification" }, { - "@id" : "bts:DiagnosisStatusType" + "@id" : "bts:LensNA" }, { - "@id" : "bts:ClassBRCA1" + "@id" : "bts:WorkingDistance" }, { - "@id" : "bts:ClassBRCA2" + "@id" : "bts:WorkingDistanceUnit" }, { - "@id" : "bts:TobaccoUse" + "@id" : "bts:Immersion" }, { - "@id" : "bts:PackYearsSmoked" + "@id" : "bts:Pyramid" }, { - "@id" : "bts:AlcoholUse" + "@id" : "bts:Zstack" }, { - "@id" : "bts:NumberofDrinksPerWeek" + "@id" : "bts:Tseries" }, { - "@id" : "bts:AntibioticUse" + "@id" : "bts:PassedQC" }, { - "@id" : "bts:SampleCollectionCenter" + "@id" : "bts:Comment" }, { - "@id" : "bts:SampleCollectionYear" + "@id" : "bts:FOVnumber" }, { - "@id" : "bts:ERStatus" + "@id" : "bts:FOVX" }, { - "@id" : "bts:PRStatus" + "@id" : "bts:FOVXUnit" }, { - "@id" : "bts:HER2Status" - } ], - "sms:displayName" : "CohortCoreTemplate" - }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" - } ], - "@id" : "bts:TissueBiospecimenType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "TissueBiospecimenType", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" + "@id" : "bts:FOVY" }, { - "@id" : "bts:ParentID" + "@id" : "bts:FOVYUnit" }, { - "@id" : "bts:ParentBiospecimenID" + "@id" : "bts:FrameAveraging" }, { - "@id" : "bts:AdjacentBiospecimenIDs" + "@id" : "bts:ImageID" }, { - "@id" : "bts:BiospecimenType" + "@id" : "bts:DimensionOrder" }, { - "@id" : "bts:TimepointLabel" + "@id" : "bts:PhysicalSizeX" }, { - "@id" : "bts:SpecimenLaterality" + "@id" : "bts:PhysicalSizeXUnit" }, { - "@id" : "bts:IschemicTime" + "@id" : "bts:PhysicalSizeY" }, { - "@id" : "bts:IschemicTemperature" + "@id" : "bts:PhysicalSizeYUnit" }, { - "@id" : "bts:SiteofResectionorBiopsy" + "@id" : "bts:PhysicalSizeZ" }, { - "@id" : "bts:PortionWeight" + "@id" : "bts:PhysicalSizeZUnit" }, { - "@id" : "bts:TotalVolume" + "@id" : "bts:PixelsBigEndian" }, { - "@id" : "bts:TumorTissueType" + "@id" : "bts:PlaneCount" }, { - "@id" : "bts:HistologicMorphologyCode" + "@id" : "bts:SizeC" }, { - "@id" : "bts:PreservationMethod" + "@id" : "bts:SizeT" }, { - "@id" : "bts:BiospecimenDimension1" + "@id" : "bts:SizeX" }, { - "@id" : "bts:BiospecimenDimension2" + "@id" : "bts:SizeY" }, { - "@id" : "bts:BiospecimenDimension3" + "@id" : "bts:SizeZ" }, { - "@id" : "bts:SectionNumberinSequence" + "@id" : "bts:PixelType" } ], - "sms:displayName" : "TissueBiospecimenType" + "sms:displayName" : "ImagingLevel2" }, { "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" + "@id" : "bts:Publication" } ], - "@id" : "bts:FamilyHistory", + "@id" : "bts:PublicationTemplate", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "FamilyHistory", + "rdfs:label" : "PublicationTemplate", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", "sms:requiresDependency" : [ { - "@id" : "bts:Component" + "@id" : "bts:PublicationDOI" }, { - "@id" : "bts:ParticipantID" + "@id" : "bts:Title" }, { - "@id" : "bts:TimepointLabel" + "@id" : "bts:Authors" }, { - "@id" : "bts:RelativewithCancerHistory" + "@id" : "bts:LinkedProject" + }, { + "@id" : "bts:LinkedDatasets" } ], - "sms:displayName" : "FamilyHistory" + "sms:displayName" : "PublicationTemplate" }, { "rdfs:subClassOf" : [ { - "@id" : "bts:SingleCellSequencing" + "@id" : "bts:Patient" } ], - "@id" : "bts:ScRNA-seqLevel4", + "@id" : "bts:Exposure", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "ScRNA-seqLevel4", + "rdfs:label" : "Exposure", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", "sms:requiresDependency" : [ { "@id" : "bts:Component" - }, { - "@id" : "bts:Filename" - }, { - "@id" : "bts:FileFormat" }, { "@id" : "bts:ParticipantID" }, { - "@id" : "bts:SampleID" - }, { - "@id" : "bts:AltSampleID" - }, { - "@id" : "bts:SequencingPlatform" - }, { - "@id" : "bts:NucleicAcidSource" - }, { - "@id" : "bts:LibraryConstructionMethod" - }, { - "@id" : "bts:LibrarySelectionMethod" - }, { - "@id" : "bts:LibraryLayout" - }, { - "@id" : "bts:LibraryPrepKitName" - }, { - "@id" : "bts:LibraryPrepKitVersion" - }, { - "@id" : "bts:LibraryPrepKitVendor" - }, { - "@id" : "bts:ReadIndicator" - }, { - "@id" : "bts:ReadContent" - }, { - "@id" : "bts:TargetDepth" - }, { - "@id" : "bts:AdapterName" - }, { - "@id" : "bts:AdapterSequence" - }, { - "@id" : "bts:BatchID" - }, { - "@id" : "bts:LaneNumber" - }, { - "@id" : "bts:TechnicalReplicateGroup" - }, { - "@id" : "bts:DissociationMethod" - }, { - "@id" : "bts:CryopreservedCellsinSample" - }, { - "@id" : "bts:SingleCellIsolationMethod" - }, { - "@id" : "bts:TotalNumberofInputCells" - }, { - "@id" : "bts:InputCellsandNuclei" - }, { - "@id" : "bts:ReverseTranscriptionPrimer" - }, { - "@id" : "bts:SpikeIn" - }, { - "@id" : "bts:EndBias" - }, { - "@id" : "bts:DataCategory" - }, { - "@id" : "bts:MatrixType" - }, { - "@id" : "bts:LinkedMatrices" - }, { - "@id" : "bts:CellMedianNumberReads" - }, { - "@id" : "bts:CellMedianNumberGenes" - }, { - "@id" : "bts:CellTotal" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:ScRNAseqWorkflowType" + "@id" : "bts:StartDaysfromIndex" }, { - "@id" : "bts:ScRNAseqWorkflowParametersDescription" + "@id" : "bts:SmokingExposure" }, { - "@id" : "bts:WorkflowLink" + "@id" : "bts:AlcoholExposure" }, { - "@id" : "bts:WorkflowVersion" + "@id" : "bts:EnvironmentalTobaccoSmokeExposure" } ], - "sms:displayName" : "ScRNA-seqLevel4" + "sms:displayName" : "Exposure" }, { "rdfs:subClassOf" : [ { - "@id" : "bts:Patient" + "@id" : "bts:Exposure" } ], - "@id" : "bts:Demographics", + "@id" : "bts:Yes-SmokingExposure", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "Demographics", + "rdfs:label" : "Yes-SmokingExposure", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", "sms:requiresDependency" : [ { @@ -1932,8256 +1292,8161 @@ }, { "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:Ethnicity" + "@id" : "bts:StartDaysfromIndex" }, { - "@id" : "bts:Gender" + "@id" : "bts:SmokingExposure" }, { - "@id" : "bts:Race" + "@id" : "bts:AlcoholExposure" }, { - "@id" : "bts:VitalStatus" + "@id" : "bts:EnvironmentalTobaccoSmokeExposure" }, { - "@id" : "bts:DaystoBirth" + "@id" : "bts:YearsSmoked" }, { - "@id" : "bts:CountryofResidence" + "@id" : "bts:PackYearsSmoked" }, { - "@id" : "bts:AgeIsObfuscated" + "@id" : "bts:CigarettesperDay" }, { - "@id" : "bts:YearOfBirth" + "@id" : "bts:SmokingFrequency" + }, { + "@id" : "bts:TypeofSmokeExposure" + }, { + "@id" : "bts:TimebetweenWakingandFirstSmoke" + }, { + "@id" : "bts:TobaccoSmokingOnsetYear" + }, { + "@id" : "bts:TobaccoSmokingQuitYear" + }, { + "@id" : "bts:TobaccoSmokingStatus" + }, { + "@id" : "bts:TypeofTobaccoUsed" + }, { + "@id" : "bts:SecondhandSmokeasChild" + }, { + "@id" : "bts:SmokeExposureDuration" + }, { + "@id" : "bts:TobaccoUseperDay" + }, { + "@id" : "bts:SmokelessTobaccoQuitAge" } ], - "sms:displayName" : "Demographics" + "sms:displayName" : "Yes-SmokingExposure" }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:ScRNA-seqLevel1" - } ], - "@id" : "bts:CEL-seq2", + "rdfs:subClassOf" : [ ], + "@id" : "bts:MolecularTest", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "CEL-seq2", + "rdfs:label" : "MolecularTest", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", "sms:requiresDependency" : [ { "@id" : "bts:Component" }, { - "@id" : "bts:Filename" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:FileFormat" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:ParticipantID" + "@id" : "bts:StartDaysfromIndex" }, { - "@id" : "bts:SampleID" + "@id" : "bts:StopDaysfromIndex" }, { - "@id" : "bts:AltSampleID" + "@id" : "bts:GeneSymbol" }, { - "@id" : "bts:SequencingPlatform" + "@id" : "bts:MolecularAnalysisMethod" }, { - "@id" : "bts:NucleicAcidSource" + "@id" : "bts:TestResult" }, { - "@id" : "bts:LibraryConstructionMethod" + "@id" : "bts:AAChange" }, { - "@id" : "bts:LibrarySelectionMethod" + "@id" : "bts:Antigen" }, { - "@id" : "bts:LibraryLayout" + "@id" : "bts:ClinicalBiospecimenType" }, { - "@id" : "bts:LibraryPrepKitName" + "@id" : "bts:BloodTestNormalRangeUpper" }, { - "@id" : "bts:LibraryPrepKitVersion" + "@id" : "bts:BloodTestNormalRangeLower" }, { - "@id" : "bts:LibraryPrepKitVendor" + "@id" : "bts:CellCount" }, { - "@id" : "bts:ReadIndicator" + "@id" : "bts:Chromosome" }, { - "@id" : "bts:ReadContent" + "@id" : "bts:Clonality" }, { - "@id" : "bts:TargetDepth" + "@id" : "bts:CopyNumber" }, { - "@id" : "bts:AdapterName" + "@id" : "bts:Cytoband" }, { - "@id" : "bts:AdapterSequence" + "@id" : "bts:Exon" }, { - "@id" : "bts:BatchID" + "@id" : "bts:HistoneFamily" }, { - "@id" : "bts:LaneNumber" + "@id" : "bts:HistoneVariant" }, { - "@id" : "bts:TechnicalReplicateGroup" + "@id" : "bts:Intron" }, { - "@id" : "bts:DissociationMethod" + "@id" : "bts:LaboratoryTest" }, { - "@id" : "bts:CryopreservedCellsinSample" + "@id" : "bts:LociAbnormalCount" }, { - "@id" : "bts:SingleCellIsolationMethod" + "@id" : "bts:LociCount" }, { - "@id" : "bts:TotalNumberofInputCells" + "@id" : "bts:Locus" }, { - "@id" : "bts:InputCellsandNuclei" + "@id" : "bts:MismatchRepairMutation" }, { - "@id" : "bts:ReverseTranscriptionPrimer" + "@id" : "bts:MolecularConsequence" }, { - "@id" : "bts:SpikeIn" + "@id" : "bts:Pathogenicity" }, { - "@id" : "bts:EndBias" + "@id" : "bts:Ploidy" }, { - "@id" : "bts:UMIBarcodeOffset" + "@id" : "bts:SecondExon" }, { - "@id" : "bts:UMIBarcodeLength" + "@id" : "bts:SecondGeneSymbol" }, { - "@id" : "bts:MedianUMIsperCellNumber" + "@id" : "bts:SpecializedMolecularTest" }, { - "@id" : "bts:CellBarcodeOffset" + "@id" : "bts:TestAnalyteType" }, { - "@id" : "bts:CellBarcodeLength" + "@id" : "bts:TestUnits" }, { - "@id" : "bts:ValidBarcodesCellNumber" + "@id" : "bts:TestValue" }, { - "@id" : "bts:EmptyWellBarcode" + "@id" : "bts:Transcript" }, { - "@id" : "bts:WellIndex" + "@id" : "bts:VariantOrigin" + }, { + "@id" : "bts:VariantType" + }, { + "@id" : "bts:Zygosity" } ], - "sms:displayName" : "CEL-seq2" + "sms:displayName" : "MolecularTest" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:Biospecimen", + "rdfs:subClassOf" : [ { + "@id" : "bts:FamilyHistory" + } ], + "@id" : "bts:Yes-CancerHistoryRelative", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "Biospecimen", + "rdfs:label" : "Yes-CancerHistoryRelative", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" + "@id" : "bts:Component" }, { - "@id" : "bts:ParentID" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:ParentBiospecimenID" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:AdjacentBiospecimenIDs" + "@id" : "bts:RelativewithCancerHistory" }, { - "@id" : "bts:BiospecimenType" + "@id" : "bts:RelativeswithCancerHistoryCount" }, { - "@id" : "bts:TimepointLabel" + "@id" : "bts:RelationshipType" }, { - "@id" : "bts:SpecimenLaterality" + "@id" : "bts:RelationshipPrimaryDiagnosis" + }, { + "@id" : "bts:RelationshipGender" + }, { + "@id" : "bts:RelationshipAgeatDiagnosis" } ], - "sms:displayName" : "Biospecimen" + "sms:displayName" : "Yes-CancerHistoryRelative" }, { "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" + "@id" : "bts:Patient" } ], - "@id" : "bts:BiospecimenDimension1", + "@id" : "bts:PatientExtended", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "sms:requiresComponent" : "", - "rdfs:label" : "BiospecimenDimension1", + "rdfs:label" : "PatientExtended", "rdfs:comment" : "TBD", "@type" : "rdfs:Class", "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" + "@id" : "bts:Component" }, { - "@id" : "bts:ParentID" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:ParentBiospecimenID" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:AdjacentBiospecimenIDs" + "@id" : "bts:StartDaysfromIndex" }, { - "@id" : "bts:BiospecimenType" + "@id" : "bts:StopDaysfromIndex" }, { - "@id" : "bts:TimepointLabel" + "@id" : "bts:SentinelLymphNodeCount" }, { - "@id" : "bts:SpecimenLaterality" + "@id" : "bts:SentinelNodePositiveAssessmentCount" }, { - "@id" : "bts:DimensionsUnit" - } ], - "sms:displayName" : "BiospecimenDimension1" - }, { - "rdfs:subClassOf" : [ { - "@id" : "bts:Biospecimen" - } ], - "@id" : "bts:BloodBiospecimenType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "sms:requiresComponent" : "", - "rdfs:label" : "BloodBiospecimenType", - "rdfs:comment" : "TBD", - "@type" : "rdfs:Class", - "sms:requiresDependency" : [ { - "@id" : "bts:BiospecimenID" + "@id" : "bts:TumorExtranodalExtensionIndicator" }, { - "@id" : "bts:ParentID" + "@id" : "bts:SatelliteMetastasisPresentIndicator" }, { - "@id" : "bts:ParentBiospecimenID" + "@id" : "bts:OtherBiopsyResectionSite" }, { - "@id" : "bts:AdjacentBiospecimenIDs" + "@id" : "bts:ExtentofTumorResection" }, { - "@id" : "bts:BiospecimenType" + "@id" : "bts:PrecancerousConditionType" }, { - "@id" : "bts:TimepointLabel" + "@id" : "bts:PriorSitesofRadiation" }, { - "@id" : "bts:SpecimenLaterality" + "@id" : "bts:Immunosuppression" }, { - "@id" : "bts:ShippingConditionType" - } ], - "sms:displayName" : "BloodBiospecimenType" - }, { - "@id" : "bts:YearsSmoked", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value (or unknown) to represent the number of years a person has been smoking.", - "rdfs:label" : "YearsSmoked", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "YearsSmoked", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:RelationshipGender", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:ConcomitantMedicationReceivedType" }, { - "@id" : "bts:NotReported" + "@id" : "bts:FamilyMemberVitalStatusIndicator" }, { - "@id" : "bts:female" + "@id" : "bts:COVID19OccurrenceIndicator" }, { - "@id" : "bts:male" + "@id" : "bts:COVID19CurrentStatus" }, { - "@id" : "bts:unspecified" - } ], - "rdfs:label" : "RelationshipGender", - "rdfs:comment" : "The text term used to describe the gender of the patient's relative with a history of cancer.", - "@type" : "rdfs:Class", - "sms:displayName" : "RelationshipGender" - }, { - "@id" : "bts:AdjacentSampleIDs", - "@type" : "rdfs:Class", - "rdfs:comment" : "List of Identifiers (separated by commas) of adjacent biospecimens cut from the same sample", - "rdfs:label" : "AdjacentSampleIDs", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AdjacentSampleIDs", - "sms:required" : "sms:false" - }, { - "@id" : "bts:AdapterSequence", - "@type" : "rdfs:Class", - "rdfs:comment" : "Base sequence of the sequencing adapter. String", - "rdfs:label" : "AdapterSequence", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AdapterSequence", - "sms:required" : "sms:false" - }, { - "@id" : "bts:DaystoDeath", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days between the date used for index and the date from a person's date of death represented as a calculated number of days.", - "rdfs:label" : "DaystoDeath", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "DaystoDeath", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SentinelLymphNodeCount", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric count of sentinel lymph nodes.", - "rdfs:label" : "SentinelLymphNodeCount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SentinelLymphNodeCount", - "sms:required" : "sms:false" + "@id" : "bts:COVID19PositiveLabTestIndicator" + }, { + "@id" : "bts:COVID19AntibodyTesting" + }, { + "@id" : "bts:COVID19ComplicationsSeverity" + }, { + "@id" : "bts:COVID19CancerTreatmentFollowup" + }, { + "@id" : "bts:Ecigvapeuse" + }, { + "@id" : "bts:Ecigvape30dayusenum" + }, { + "@id" : "bts:Ecigvapetimesperday" + }, { + "@id" : "bts:Typeofsmokeexposurecumulativeyears" + }, { + "@id" : "bts:Chewingtobaccodailyusecount" + }, { + "@id" : "bts:Secondhandsmokeexposureyears" + }, { + "@id" : "bts:KnownGeneticPredispositionMutation" + }, { + "@id" : "bts:HereditaryCancerPredispositionSyndrome" + }, { + "@id" : "bts:CancerAssociatedGeneMutations" + }, { + "@id" : "bts:MutationalSignatures" + }, { + "@id" : "bts:MismatchRepairSystemStatus" + }, { + "@id" : "bts:LabTestsforMMRStatus" + }, { + "@id" : "bts:ModeofCancerDetection" + }, { + "@id" : "bts:EducationLevel" + }, { + "@id" : "bts:CountryofBirth" + }, { + "@id" : "bts:MedicallyUnderservedArea" + }, { + "@id" : "bts:RuralvsUrban" + }, { + "@id" : "bts:CancerIncidence" + }, { + "@id" : "bts:CancerIncidenceLocation" + } ], + "sms:displayName" : "PatientExtended" }, { - "@id" : "bts:StopDaysfromIndex", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days from the date of birth (index date) to the end date of the event (e.g. exposure to environmental factor, treatment start, etc.). Note: if the event occurs at a single time point, e.g. a diagnosis or a lab test, the values for this column is 'Not Applicable'", - "rdfs:label" : "StopDaysfromIndex", - "rdfs:subClassOf" : [ ], + "rdfs:subClassOf" : [ { + "@id" : "bts:SingleCellSequencing" + } ], + "@id" : "bts:ScRNA-seqLevel3", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "StopDaysfromIndex", - "sms:required" : "sms:false" - }, { - "@id" : "bts:NumberofDrinksPerWeek", - "@type" : "rdfs:Class", + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "ScRNA-seqLevel3", "rdfs:comment" : "TBD", - "rdfs:label" : "NumberofDrinksPerWeek", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "NumberofDrinksPerWeek", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SentinelNodePositiveAssessmentCount", "@type" : "rdfs:Class", - "rdfs:comment" : "The number or amount of metastatic neoplasms related to the confirmed presence of disease or specific microorganisms during examination of the first rounded mass of lymphatic tissue to which cancer is likely to spread from the primary tumor.", - "rdfs:label" : "SentinelNodePositiveAssessmentCount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SentinelNodePositiveAssessmentCount", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:PreservationMethod", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Negative80DegC" + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Filename" }, { - "@id" : "bts:Cryopreservationindryice-deadtissue" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:unknown" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:Fresh" + "@id" : "bts:SampleID" }, { - "@id" : "bts:Cryopreservationinliquidnitrogen-deadtissue" + "@id" : "bts:AltSampleID" }, { - "@id" : "bts:Formalinfixedparaffinembedded-FFPE" + "@id" : "bts:SequencingPlatform" }, { - "@id" : "bts:Archival" + "@id" : "bts:NucleicAcidSource" }, { - "@id" : "bts:Formalinfixed-buffered" + "@id" : "bts:LibraryConstructionMethod" }, { - "@id" : "bts:Formalinfixed-unbuffered" + "@id" : "bts:LibrarySelectionMethod" }, { - "@id" : "bts:Cryopreserved" + "@id" : "bts:LibraryLayout" }, { - "@id" : "bts:Frozen" + "@id" : "bts:LibraryPrepKitName" }, { - "@id" : "bts:Freshdissociatedandsinglecellsorted" + "@id" : "bts:LibraryPrepKitVersion" }, { - "@id" : "bts:FreshdissociatedandsinglecellsortedintoplatesinNP40buffer" + "@id" : "bts:LibraryPrepKitVendor" }, { - "@id" : "bts:Methacarnfixedparaffinembedded-MFPE" + "@id" : "bts:ReadIndicator" }, { - "@id" : "bts:Freshdissociated" + "@id" : "bts:ReadContent" }, { - "@id" : "bts:Freshdissociatedandsinglecellsortedintoplates" + "@id" : "bts:TargetDepth" }, { - "@id" : "bts:Cryopreservationinliquidnitrogen-livecells" + "@id" : "bts:AdapterName" }, { - "@id" : "bts:OCT" + "@id" : "bts:AdapterSequence" }, { - "@id" : "bts:SnapFrozen" + "@id" : "bts:BatchID" }, { - "@id" : "bts:LiquidNitrogen" + "@id" : "bts:LaneNumber" + }, { + "@id" : "bts:TechnicalReplicateGroup" + }, { + "@id" : "bts:DissociationMethod" + }, { + "@id" : "bts:CryopreservedCellsinSample" + }, { + "@id" : "bts:SingleCellIsolationMethod" + }, { + "@id" : "bts:TotalNumberofInputCells" + }, { + "@id" : "bts:InputCellsandNuclei" + }, { + "@id" : "bts:ReverseTranscriptionPrimer" + }, { + "@id" : "bts:SpikeIn" + }, { + "@id" : "bts:EndBias" + }, { + "@id" : "bts:DataCategory" + }, { + "@id" : "bts:MatrixType" + }, { + "@id" : "bts:LinkedMatrices" + }, { + "@id" : "bts:CellMedianNumberReads" + }, { + "@id" : "bts:CellMedianNumberGenes" + }, { + "@id" : "bts:CellTotal" + }, { + "@id" : "bts:ScRNAseqWorkflowType" + }, { + "@id" : "bts:ScRNAseqWorkflowParametersDescription" + }, { + "@id" : "bts:WorkflowLink" + }, { + "@id" : "bts:WorkflowVersion" } ], - "rdfs:label" : "PreservationMethod", - "rdfs:comment" : "Text term that represents the method used to preserve the sample.", - "@type" : "rdfs:Class", - "sms:displayName" : "PreservationMethod" + "sms:displayName" : "ScRNA-seqLevel3" }, { - "@id" : "bts:Ecigvapeuse", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Ecigvapeuse", - "rdfs:subClassOf" : [ ], + "rdfs:subClassOf" : [ { + "@id" : "bts:Biospecimen" + } ], + "@id" : "bts:AnalyteBiospecimenType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Ecigvapeuse", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PublicationDOI", - "@type" : "rdfs:Class", + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "AnalyteBiospecimenType", "rdfs:comment" : "TBD", - "rdfs:label" : "PublicationDOI", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PublicationDOI", - "sms:required" : "sms:false" - }, { - "@id" : "bts:DaystoBirth", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days between the date used for index and the date from a person's date of birth represented as a calculated negative number of days.", - "rdfs:label" : "DaystoBirth", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "DaystoBirth", - "sms:required" : "sms:false" - }, { - "@id" : "bts:TestUnits", - "@type" : "rdfs:Class", - "rdfs:comment" : "The text term used to describe the units of the test value for a molecular test. This property is used in conjunction with test_value. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "TestUnits", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TestUnits", - "sms:required" : "sms:false" - }, { - "@id" : "bts:AdjacentBiospecimenIDs", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AdjacentBiospecimenIDs", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AdjacentBiospecimenIDs", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastBiopsyProcedureFindingType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" }, { - "@id" : "bts:Atypicalhyperplasia" + "@id" : "bts:ParentID" }, { - "@id" : "bts:DCIS" + "@id" : "bts:ParentBiospecimenID" }, { - "@id" : "bts:LCIS" + "@id" : "bts:AdjacentBiospecimenIDs" }, { - "@id" : "bts:Cancer" + "@id" : "bts:BiospecimenType" }, { - "@id" : "bts:Nocancer" - } ], - "rdfs:label" : "BreastBiopsyProcedureFindingType", - "rdfs:comment" : "Text term to describe the result of the examination of the breast tissue specimen or fluid as related to the presence and nature of disease.", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastBiopsyProcedureFindingType" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:LibraryLayout", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:PairedEnd" + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:SpecimenLaterality" + }, { + "@id" : "bts:AnalyteType" + }, { + "@id" : "bts:FixationDuration" }, { - "@id" : "bts:SingleRead" + "@id" : "bts:SlideChargeType" }, { - "@id" : "bts:Mid-length" + "@id" : "bts:SectionThicknessValue" }, { - "@id" : "bts:LongRead" + "@id" : "bts:SectioningDaysfromIndex" + }, { + "@id" : "bts:ShippingConditionType" + }, { + "@id" : "bts:IschemicTime" + }, { + "@id" : "bts:IschemicTemperature" } ], - "rdfs:label" : "LibraryLayout", - "rdfs:comment" : "Sequencing read type", - "@type" : "rdfs:Class", - "sms:displayName" : "LibraryLayout" + "sms:displayName" : "AnalyteBiospecimenType" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:SpecimenLaterality", + "rdfs:subClassOf" : [ { + "@id" : "bts:Exposure" + } ], + "@id" : "bts:Yes-AlcoholExposure", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:NotApplicable" + "sms:requiresComponent" : "", + "rdfs:label" : "Yes-AlcoholExposure", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:unknown" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:NotReported" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:Bilateral" + "@id" : "bts:StartDaysfromIndex" }, { - "@id" : "bts:Left" + "@id" : "bts:SmokingExposure" }, { - "@id" : "bts:Right" + "@id" : "bts:AlcoholExposure" + }, { + "@id" : "bts:EnvironmentalTobaccoSmokeExposure" + }, { + "@id" : "bts:AlcoholDaysPerWeek" + }, { + "@id" : "bts:AlcoholDrinksPerDay" + }, { + "@id" : "bts:AlcoholHistory" + }, { + "@id" : "bts:AlcoholIntensity" + }, { + "@id" : "bts:AlcoholType" } ], - "rdfs:label" : "SpecimenLaterality", - "rdfs:comment" : "For samples in paired organs, designates the side from which obtained.", - "@type" : "rdfs:Class", - "sms:displayName" : "SpecimenLaterality" + "sms:displayName" : "Yes-AlcoholExposure" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastCarcinomaHistologyCategory", + "rdfs:subClassOf" : [ { + "@id" : "bts:SingleCellSequencing" + } ], + "@id" : "bts:ScRNA-seqLevel1", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "sms:requiresComponent" : "", + "rdfs:label" : "ScRNA-seqLevel1", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:Infiltratingductalcarcinoma" + "@id" : "bts:Filename" }, { - "@id" : "bts:Infiltratinglobularcarcinoma" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:InvasivemammarycarcinomaNOS" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:Invasivemixedductalandlobularcarcinoma" - } ], - "rdfs:label" : "BreastCarcinomaHistologyCategory", - "rdfs:comment" : "Classification of the type of invasive breast carcinoma diagnosed based on histologic attributes.", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastCarcinomaHistologyCategory" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:SingleCellIsolationMethod", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:MicrofluidicsChip" + "@id" : "bts:SampleID" }, { - "@id" : "bts:Droplets" + "@id" : "bts:AltSampleID" }, { - "@id" : "bts:FACS" + "@id" : "bts:SequencingPlatform" }, { - "@id" : "bts:Plates" + "@id" : "bts:NucleicAcidSource" }, { - "@id" : "bts:10x" + "@id" : "bts:LibraryConstructionMethod" }, { - "@id" : "bts:NucleiIsolation" + "@id" : "bts:LibrarySelectionMethod" + }, { + "@id" : "bts:LibraryLayout" + }, { + "@id" : "bts:LibraryPrepKitName" + }, { + "@id" : "bts:LibraryPrepKitVersion" + }, { + "@id" : "bts:LibraryPrepKitVendor" + }, { + "@id" : "bts:ReadIndicator" + }, { + "@id" : "bts:ReadContent" + }, { + "@id" : "bts:TargetDepth" + }, { + "@id" : "bts:AdapterName" + }, { + "@id" : "bts:AdapterSequence" + }, { + "@id" : "bts:BatchID" + }, { + "@id" : "bts:LaneNumber" + }, { + "@id" : "bts:TechnicalReplicateGroup" + }, { + "@id" : "bts:DissociationMethod" + }, { + "@id" : "bts:CryopreservedCellsinSample" + }, { + "@id" : "bts:SingleCellIsolationMethod" + }, { + "@id" : "bts:TotalNumberofInputCells" + }, { + "@id" : "bts:InputCellsandNuclei" + }, { + "@id" : "bts:ReverseTranscriptionPrimer" + }, { + "@id" : "bts:SpikeIn" + }, { + "@id" : "bts:EndBias" + }, { + "@id" : "bts:UMIBarcodeOffset" + }, { + "@id" : "bts:UMIBarcodeLength" + }, { + "@id" : "bts:MedianUMIsperCellNumber" + }, { + "@id" : "bts:CellBarcodeOffset" + }, { + "@id" : "bts:CellBarcodeLength" + }, { + "@id" : "bts:ValidBarcodesCellNumber" } ], - "rdfs:label" : "SingleCellIsolationMethod", - "rdfs:comment" : "The method by which cells are isolated into individual reaction containers at a single cell resolution (e.g. wells, micro-droplets)", - "@type" : "rdfs:Class", - "sms:displayName" : "SingleCellIsolationMethod" - }, { - "@id" : "bts:UMIBarcodeOffset", - "@type" : "rdfs:Class", - "rdfs:comment" : "Start position of UMI barcode in the sequence. Values: number, 0 for start of read", - "rdfs:label" : "UMIBarcodeOffset", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "UMIBarcodeOffset", - "sms:required" : "sms:false" + "sms:displayName" : "ScRNA-seqLevel1" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:DimensionsUnit", + "rdfs:subClassOf" : [ { + "@id" : "bts:Patient" + } ], + "@id" : "bts:BreastCancerPatient", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:cm" - }, { - "@id" : "bts:mm" - } ], - "rdfs:label" : "DimensionsUnit", - "rdfs:comment" : "Unit of measurement used for dimension CDEs in metric system (i.e. cm, mm, etc)", - "@type" : "rdfs:Class", - "sms:displayName" : "DimensionsUnit" - }, { - "@id" : "bts:TypeofSmokeExposure", - "@type" : "rdfs:Class", + "sms:requiresComponent" : "", + "rdfs:label" : "BreastCancerPatient", "rdfs:comment" : "TBD", - "rdfs:label" : "TypeofSmokeExposure", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TypeofSmokeExposure", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SizeC", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of channels. Integer >= 1", - "rdfs:label" : "SizeC", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SizeC", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SpecializedMolecularTest", "@type" : "rdfs:Class", - "rdfs:comment" : "Text term used to describe a specific test that is not covered in the list of molecular analysis methods. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "SpecializedMolecularTest", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SpecializedMolecularTest", - "sms:required" : "sms:false" + "sms:requiresDependency" : [ { + "@id" : "bts:Component" + }, { + "@id" : "bts:ParticipantID" + }, { + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:BreastCarcinomaDetectionMethodType" + }, { + "@id" : "bts:BreastCarcinomaHistologyCategory" + }, { + "@id" : "bts:InvasiveLobularBreastCarcinomaHistologicCategory" + }, { + "@id" : "bts:InvasiveDuctalBreastCarcinomaHistologicCategory" + }, { + "@id" : "bts:BreastBiopsyProcedureFindingType" + }, { + "@id" : "bts:BreastQuadrantSite" + }, { + "@id" : "bts:BreastCancerAssessmentTests" + }, { + "@id" : "bts:BreastCancerGenomicTestPerformed" + }, { + "@id" : "bts:MammaprintRiskGroup" + }, { + "@id" : "bts:OncotypeRiskGroup" + }, { + "@id" : "bts:ERReceptorStatus" + }, { + "@id" : "bts:PRReceptorStatus" + }, { + "@id" : "bts:BreastCancerAllredEstrogenReceptorScore" + }, { + "@id" : "bts:PriorInvasiveBreastDisease" + }, { + "@id" : "bts:BreastCarcinomaERStatusPercentageValue" + }, { + "@id" : "bts:BreastCarcinomaPRStatusPercentageValue" + }, { + "@id" : "bts:HER2BreastCarcinomaCopyNumberTotal" + }, { + "@id" : "bts:BreastCarcinomaCentromere17CopyNumber" + }, { + "@id" : "bts:BreastCarcinomaHER2Centromere17CopynumberTotal" + }, { + "@id" : "bts:BreastCarcinomaHER2Chromosome17Ratio" + }, { + "@id" : "bts:BreastCarcinomaSurgicalProcedureName" + }, { + "@id" : "bts:BreastCarcinomaHER2RatioDiagnosis" + }, { + "@id" : "bts:BreastCarcinomaHER2Status" + }, { + "@id" : "bts:HormoneTherapyBreastCancerPreventionIndicator" + }, { + "@id" : "bts:ERStainingIntensity" + }, { + "@id" : "bts:PRStainingIntensity" + }, { + "@id" : "bts:OncotypeScore" + }, { + "@id" : "bts:BreastImagingPerformedType" + }, { + "@id" : "bts:MultifocalBreastCarcinomaPresentIndicator" + }, { + "@id" : "bts:MulticentricBreastCarcinomaPresentIndicator" + }, { + "@id" : "bts:BIRADSMammographyBreastDensityCategory" + } ], + "sms:displayName" : "BreastCancerPatient" }, { - "@id" : "bts:Locus", - "@type" : "rdfs:Class", - "rdfs:comment" : "Alphanumeric value used to describe the locus of a specific genetic variant. Example: NM_001126114.", - "rdfs:label" : "Locus", "rdfs:subClassOf" : [ ], + "@id" : "bts:Patient", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Locus", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PlaneCount", + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "Patient", + "rdfs:comment" : "TBD", "@type" : "rdfs:Class", - "rdfs:comment" : "Number of Z-planes (not to be confused with downsampled \"\"pyramid\"\"). Integer >=1", - "rdfs:label" : "PlaneCount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PlaneCount", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:DissociationMethod", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:NotApplicable" - }, { - "@id" : "bts:gentleMACS" + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:Dounce" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:EnzymaticDigestion" + "@id" : "bts:TimepointLabel" } ], - "rdfs:label" : "DissociationMethod", - "rdfs:comment" : "The tissue dissociation method used for scRNASeq or scATAC-seq assays", - "@type" : "rdfs:Class", - "sms:displayName" : "DissociationMethod" + "sms:displayName" : "Patient" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:PRStainingIntensity", + "@id" : "bts:Sequencing", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "sms:requiresComponent" : "", + "rdfs:label" : "Sequencing", + "rdfs:comment" : "Base template for some type of sequencing data, for which below properties are relevant/in common.", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:unknown" + "@id" : "bts:Filename" }, { - "@id" : "bts:Strong" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:Moderate" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:Weak" + "@id" : "bts:SampleID" }, { - "@id" : "bts:Weak-Moderate" + "@id" : "bts:AltSampleID" }, { - "@id" : "bts:Moderate-Strong" + "@id" : "bts:SequencingPlatform" }, { - "@id" : "bts:Weak-Strong" - } ], - "rdfs:label" : "PRStainingIntensity", - "rdfs:comment" : "Text term to indicate the PR staining intensity on pathology assessment in a participant with breast cancer", - "@type" : "rdfs:Class", - "sms:displayName" : "PRStainingIntensity" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastCarcinomaSurgicalProcedureName", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Radicalmastectomy" + "@id" : "bts:NucleicAcidSource" }, { - "@id" : "bts:unknown" + "@id" : "bts:LibraryConstructionMethod" }, { - "@id" : "bts:Simplemastectomy" + "@id" : "bts:LibrarySelectionMethod" }, { - "@id" : "bts:Modifiedradicalmastectomy" + "@id" : "bts:LibraryLayout" }, { - "@id" : "bts:Partialmastectomy" + "@id" : "bts:LibraryPrepKitName" }, { - "@id" : "bts:Surgerynotperformed" + "@id" : "bts:LibraryPrepKitVersion" }, { - "@id" : "bts:Other" + "@id" : "bts:LibraryPrepKitVendor" }, { - "@id" : "bts:Lumpectomy" + "@id" : "bts:ReadIndicator" }, { - "@id" : "bts:Re-excision" + "@id" : "bts:ReadContent" + }, { + "@id" : "bts:TargetDepth" + }, { + "@id" : "bts:AdapterName" + }, { + "@id" : "bts:AdapterSequence" + }, { + "@id" : "bts:BatchID" + }, { + "@id" : "bts:LaneNumber" + }, { + "@id" : "bts:TechnicalReplicateGroup" } ], - "rdfs:label" : "BreastCarcinomaSurgicalProcedureName", - "rdfs:comment" : "Text name of a surgical procedure performed for a person with a diagnosis of breast cancer", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastCarcinomaSurgicalProcedureName" - }, { - "@id" : "bts:BreastCarcinomaERStatusPercentageValue", - "@type" : "rdfs:Class", - "rdfs:comment" : "A numerical quantity measured or assigned or computed which captures the estrogen receptor level measured in a participant with breast cancer", - "rdfs:label" : "BreastCarcinomaERStatusPercentageValue", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BreastCarcinomaERStatusPercentageValue", - "sms:required" : "sms:false" - }, { - "@id" : "bts:BreastCarcinomaPRStatusPercentageValue", - "@type" : "rdfs:Class", - "rdfs:comment" : "A numerical quantity measured or assigned or computed which captures the progesterone receptor level measured in a participant with breast cancer", - "rdfs:label" : "BreastCarcinomaPRStatusPercentageValue", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BreastCarcinomaPRStatusPercentageValue", - "sms:required" : "sms:false" + "sms:displayName" : "Sequencing" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:TobaccoSmokingStatus", + "rdfs:subClassOf" : [ { + "@id" : "bts:SingleCellSequencing" + } ], + "@id" : "bts:ScRNA-seqLevel2", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:NotReported" + "sms:requiresComponent" : "", + "rdfs:label" : "ScRNA-seqLevel2", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:unknown" + "@id" : "bts:Filename" }, { - "@id" : "bts:CurrentReformedSmoker" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:CurrentSmoker" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:CurrentReformedSmokerfor>15yrs" + "@id" : "bts:SampleID" + }, { + "@id" : "bts:AltSampleID" + }, { + "@id" : "bts:SequencingPlatform" + }, { + "@id" : "bts:NucleicAcidSource" + }, { + "@id" : "bts:LibraryConstructionMethod" + }, { + "@id" : "bts:LibrarySelectionMethod" + }, { + "@id" : "bts:LibraryLayout" + }, { + "@id" : "bts:LibraryPrepKitName" + }, { + "@id" : "bts:LibraryPrepKitVersion" + }, { + "@id" : "bts:LibraryPrepKitVendor" + }, { + "@id" : "bts:ReadIndicator" + }, { + "@id" : "bts:ReadContent" + }, { + "@id" : "bts:TargetDepth" + }, { + "@id" : "bts:AdapterName" + }, { + "@id" : "bts:AdapterSequence" + }, { + "@id" : "bts:BatchID" + }, { + "@id" : "bts:LaneNumber" + }, { + "@id" : "bts:TechnicalReplicateGroup" + }, { + "@id" : "bts:DissociationMethod" + }, { + "@id" : "bts:CryopreservedCellsinSample" + }, { + "@id" : "bts:SingleCellIsolationMethod" + }, { + "@id" : "bts:TotalNumberofInputCells" + }, { + "@id" : "bts:InputCellsandNuclei" + }, { + "@id" : "bts:ReverseTranscriptionPrimer" + }, { + "@id" : "bts:SpikeIn" + }, { + "@id" : "bts:EndBias" + }, { + "@id" : "bts:ScRNAseqWorkflowType" + }, { + "@id" : "bts:ScRNAseqWorkflowParametersDescription" + }, { + "@id" : "bts:WorkflowVersion" + }, { + "@id" : "bts:WorkflowLink" + }, { + "@id" : "bts:GenomicReference" + }, { + "@id" : "bts:GenomicReferenceURL" + }, { + "@id" : "bts:GenomeAnnotationURL" }, { - "@id" : "bts:DurationNotSpecified" + "@id" : "bts:WhitelistCellBarcodeFileLink" }, { - "@id" : "bts:Smokinghistorynotdocumented" + "@id" : "bts:CellBarcodeTag" }, { - "@id" : "bts:LifelongNon-Smoker" + "@id" : "bts:UMITag" }, { - "@id" : "bts:CurrentReformedSmokerfor= 1", - "rdfs:label" : "SizeX", - "rdfs:subClassOf" : [ ], + "rdfs:subClassOf" : [ { + "@id" : "bts:Sequencing" + } ], + "@id" : "bts:BulkMethylation-seqLevel1", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SizeX", - "sms:required" : "sms:false" - }, { - "@id" : "bts:GenomeAnnotationURL", - "@type" : "rdfs:Class", + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "BulkMethylation-seqLevel1", "rdfs:comment" : "TBD", - "rdfs:label" : "GenomeAnnotationURL", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "GenomeAnnotationURL", - "sms:required" : "sms:false" - }, { - "@id" : "bts:OligoBarcodeLowerStrand", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "OligoBarcodeLowerStrand", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "OligoBarcodeLowerStrand", - "sms:required" : "sms:false" + "sms:requiresDependency" : [ { + "@id" : "bts:Component" + }, { + "@id" : "bts:Filename" + }, { + "@id" : "bts:FileFormat" + }, { + "@id" : "bts:ParticipantID" + }, { + "@id" : "bts:SampleID" + }, { + "@id" : "bts:AltSampleID" + }, { + "@id" : "bts:SequencingPlatform" + }, { + "@id" : "bts:NucleicAcidSource" + }, { + "@id" : "bts:LibraryConstructionMethod" + }, { + "@id" : "bts:LibrarySelectionMethod" + }, { + "@id" : "bts:LibraryLayout" + }, { + "@id" : "bts:LibraryPrepKitName" + }, { + "@id" : "bts:LibraryPrepKitVersion" + }, { + "@id" : "bts:LibraryPrepKitVendor" + }, { + "@id" : "bts:ReadIndicator" + }, { + "@id" : "bts:ReadContent" + }, { + "@id" : "bts:TargetDepth" + }, { + "@id" : "bts:AdapterName" + }, { + "@id" : "bts:AdapterSequence" + }, { + "@id" : "bts:BatchID" + }, { + "@id" : "bts:LaneNumber" + }, { + "@id" : "bts:TechnicalReplicateGroup" + }, { + "@id" : "bts:GenomicCoverageType" + } ], + "sms:displayName" : "BulkMethylation-seqLevel1" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:Read2", + "rdfs:subClassOf" : [ { + "@id" : "bts:Biospecimen" + } ], + "@id" : "bts:UrineBiospecimenType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:CellBarcodeandDNAInsert" + }, + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "UrineBiospecimenType", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" }, { - "@id" : "bts:SampleIndexandDNAInsert" + "@id" : "bts:ParentID" }, { - "@id" : "bts:DNAInsert" + "@id" : "bts:ParentBiospecimenID" }, { - "@id" : "bts:SampleIndex" + "@id" : "bts:AdjacentBiospecimenIDs" }, { - "@id" : "bts:CellBarcode" + "@id" : "bts:BiospecimenType" + }, { + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:SpecimenLaterality" + }, { + "@id" : "bts:IschemicTime" + }, { + "@id" : "bts:IschemicTemperature" + }, { + "@id" : "bts:SiteofResectionorBiopsy" + }, { + "@id" : "bts:PortionWeight" + }, { + "@id" : "bts:TotalVolume" + }, { + "@id" : "bts:TumorTissueType" + }, { + "@id" : "bts:HistologicMorphologyCode" + }, { + "@id" : "bts:PreservationMethod" } ], - "rdfs:label" : "Read2", - "rdfs:comment" : "Read 2 content description", - "@type" : "rdfs:Class", - "sms:displayName" : "Read2" - }, { - "@id" : "bts:TotalReads", - "@type" : "rdfs:Class", - "rdfs:comment" : "Total number of reads per sample. Integer", - "rdfs:label" : "TotalReads", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TotalReads", - "sms:required" : "sms:false" + "sms:displayName" : "UrineBiospecimenType" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:HistoneVariant", + "rdfs:subClassOf" : [ { + "@id" : "bts:ImagingLevel2" + } ], + "@id" : "bts:ImagingLevel2Channels", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:mH2A" + "sms:requiresComponent" : "", + "rdfs:label" : "ImagingLevel2Channels", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:mH2A.1" + "@id" : "bts:Filename" }, { - "@id" : "bts:NotReported" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:H2A.Z" + "@id" : "bts:LabID" }, { - "@id" : "bts:H3.2" + "@id" : "bts:ChannelMetadataFilename" }, { - "@id" : "bts:unknown" + "@id" : "bts:ImagingAssayType" }, { - "@id" : "bts:H3t(H3.4)" + "@id" : "bts:ProtocolLink" }, { - "@id" : "bts:H3.X" + "@id" : "bts:SoftwareandVersion" }, { - "@id" : "bts:H2A.Z.2.2" + "@id" : "bts:Microscope" }, { - "@id" : "bts:H3.Y" + "@id" : "bts:Objective" }, { - "@id" : "bts:H3.5" + "@id" : "bts:NominalMagnification" }, { - "@id" : "bts:H3.3" + "@id" : "bts:LensNA" }, { - "@id" : "bts:H3.1" + "@id" : "bts:WorkingDistance" }, { - "@id" : "bts:H2A-Bbd" + "@id" : "bts:WorkingDistanceUnit" }, { - "@id" : "bts:mH2A.2" + "@id" : "bts:Immersion" }, { - "@id" : "bts:CENP-A" + "@id" : "bts:Pyramid" }, { - "@id" : "bts:H2A.Z.2" + "@id" : "bts:Zstack" }, { - "@id" : "bts:H2A.X" + "@id" : "bts:Tseries" }, { - "@id" : "bts:H2A.Z.1" - } ], - "rdfs:label" : "HistoneVariant", - "rdfs:comment" : "The text term used to describe a specific histone variants, which are proteins that substitute for the core canonical histones.", - "@type" : "rdfs:Class", - "sms:displayName" : "HistoneVariant" - }, { - "@id" : "bts:Chewingtobaccodailyusecount", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Chewingtobaccodailyusecount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Chewingtobaccodailyusecount", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SecondGeneSymbol", - "@type" : "rdfs:Class", - "rdfs:comment" : "The text term used to describe a secondary gene targeted or included in molecular analysis. For rearrangements, this is should represent the location of the variant. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "SecondGeneSymbol", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SecondGeneSymbol", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CycleNumber", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CycleNumber", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CycleNumber", - "sms:required" : "sms:false" - }, { - "@id" : "bts:GeneSymbol", - "@type" : "rdfs:Class", - "rdfs:comment" : "The text term used to describe a gene targeted or included in molecular analysis. For rearrangements, this is should be used to represent the reference gene. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "GeneSymbol", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "GeneSymbol", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:GenomicCoverageType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:WholeGenome" + "@id" : "bts:PassedQC" }, { - "@id" : "bts:TargetedGenome" + "@id" : "bts:Comment" }, { - "@id" : "bts:BeadchipArray" - } ], - "rdfs:label" : "GenomicCoverageType", - "rdfs:comment" : "Genomic coverage", - "@type" : "rdfs:Class", - "sms:displayName" : "GenomicCoverageType" - }, { - "@id" : "bts:TargetDepth", - "@type" : "rdfs:Class", - "rdfs:comment" : "Targeted read depth prior to sequencing. Integer", - "rdfs:label" : "TargetDepth", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TargetDepth", - "sms:required" : "sms:false" + "@id" : "bts:FOVnumber" + }, { + "@id" : "bts:FOVX" + }, { + "@id" : "bts:FOVXUnit" + }, { + "@id" : "bts:FOVY" + }, { + "@id" : "bts:FOVYUnit" + }, { + "@id" : "bts:FrameAveraging" + }, { + "@id" : "bts:ImageID" + }, { + "@id" : "bts:DimensionOrder" + }, { + "@id" : "bts:PhysicalSizeX" + }, { + "@id" : "bts:PhysicalSizeXUnit" + }, { + "@id" : "bts:PhysicalSizeY" + }, { + "@id" : "bts:PhysicalSizeYUnit" + }, { + "@id" : "bts:PhysicalSizeZ" + }, { + "@id" : "bts:PhysicalSizeZUnit" + }, { + "@id" : "bts:PixelsBigEndian" + }, { + "@id" : "bts:PlaneCount" + }, { + "@id" : "bts:SizeC" + }, { + "@id" : "bts:SizeT" + }, { + "@id" : "bts:SizeX" + }, { + "@id" : "bts:SizeY" + }, { + "@id" : "bts:SizeZ" + }, { + "@id" : "bts:PixelType" + }, { + "@id" : "bts:ChannelID" + }, { + "@id" : "bts:ChannelName" + }, { + "@id" : "bts:ChannelPassedQC" + }, { + "@id" : "bts:CycleNumber" + }, { + "@id" : "bts:SubCycleNumber" + }, { + "@id" : "bts:TargetName" + }, { + "@id" : "bts:AntibodyName" + }, { + "@id" : "bts:RRIDidentifier" + }, { + "@id" : "bts:Fluorophore" + }, { + "@id" : "bts:Clone" + }, { + "@id" : "bts:Lot" + }, { + "@id" : "bts:Vendor" + }, { + "@id" : "bts:CatalogNumber" + }, { + "@id" : "bts:ExcitationWavelength" + }, { + "@id" : "bts:EmissionWavelength" + }, { + "@id" : "bts:ExcitationBandwidth" + }, { + "@id" : "bts:EmissionBandwidth" + }, { + "@id" : "bts:MetalIsotopeElement" + }, { + "@id" : "bts:MetalIsotopeMass" + }, { + "@id" : "bts:OligoBarcodeUpperStrand" + }, { + "@id" : "bts:OligoBarcodeLowerStrand" + }, { + "@id" : "bts:Dilution" + }, { + "@id" : "bts:Concentration" + } ], + "sms:displayName" : "ImagingLevel2Channels" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:PixelType", + "@id" : "bts:SampleCoreTemplate", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:int32" + "sms:requiresComponent" : "", + "rdfs:label" : "SampleCoreTemplate", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:int16" + "@id" : "bts:SampleID" }, { - "@id" : "bts:double" + "@id" : "bts:DetailedSampleID" }, { - "@id" : "bts:float" + "@id" : "bts:AdjacentSampleIDs" }, { - "@id" : "bts:uint16" + "@id" : "bts:SampleSite" }, { - "@id" : "bts:int8" + "@id" : "bts:ERStatus" }, { - "@id" : "bts:uint32" + "@id" : "bts:PRStatus" }, { - "@id" : "bts:bit" + "@id" : "bts:HER2Status" }, { - "@id" : "bts:uint8" + "@id" : "bts:Laterality" } ], - "rdfs:label" : "PixelType", - "rdfs:comment" : "Data type for each pixel value. E.g. \"\"uint16\"\"", - "@type" : "rdfs:Class", - "sms:displayName" : "PixelType" + "sms:displayName" : "SampleCoreTemplate" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:VitalStatus", + "rdfs:subClassOf" : [ { + "@id" : "bts:Diagnosis" + } ], + "@id" : "bts:Yes-ProgressionorRecurrence", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Dead" + "sms:requiresComponent" : "", + "rdfs:label" : "Yes-ProgressionorRecurrence", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:ProgressionorRecurrenceType" }, { - "@id" : "bts:unknown" + "@id" : "bts:DaystoProgression" }, { - "@id" : "bts:NotReported" + "@id" : "bts:DaystoProgressionFree" }, { - "@id" : "bts:Alive" + "@id" : "bts:DaystoRecurrence" + }, { + "@id" : "bts:ProgressionorRecurrenceAnatomicSite" } ], - "rdfs:label" : "VitalStatus", - "rdfs:comment" : "The survival state of the person registered on the protocol.", - "@type" : "rdfs:Class", - "sms:displayName" : "VitalStatus" + "sms:displayName" : "Yes-ProgressionorRecurrence" }, { - "@id" : "bts:ParentID", - "@type" : "rdfs:Class", - "rdfs:comment" : "ID of parent biospecimen", - "rdfs:label" : "ParentID", - "rdfs:subClassOf" : [ ], + "rdfs:subClassOf" : [ { + "@id" : "bts:Patient" + } ], + "@id" : "bts:OvarianCancerPatient", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ParentID", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "OvarianCancerPatient", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" + }, { + "@id" : "bts:ParticipantID" + }, { + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:OvarianCancerHistologicSubtype" + }, { + "@id" : "bts:OvarianCancerSurgicalOutcome" + }, { + "@id" : "bts:OvarianCancerPlatinumStatus" + } ], + "sms:displayName" : "OvarianCancerPatient" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:FileFormat", + "rdfs:subClassOf" : [ { + "@id" : "bts:Biospecimen" + } ], + "@id" : "bts:BoneMarrowBiospecimenType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:dat" + "sms:requiresComponent" : "", + "rdfs:label" : "BoneMarrowBiospecimenType", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" }, { - "@id" : "bts:Rscript" + "@id" : "bts:ParentID" }, { - "@id" : "bts:tif" + "@id" : "bts:ParentBiospecimenID" }, { - "@id" : "bts:bam" + "@id" : "bts:AdjacentBiospecimenIDs" }, { - "@id" : "bts:M" + "@id" : "bts:BiospecimenType" }, { - "@id" : "bts:7z" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:csv" + "@id" : "bts:SpecimenLaterality" }, { - "@id" : "bts:png" + "@id" : "bts:IschemicTime" }, { - "@id" : "bts:tar" + "@id" : "bts:IschemicTemperature" }, { - "@id" : "bts:bai" + "@id" : "bts:SiteofResectionorBiopsy" }, { - "@id" : "bts:OME-TIFF" + "@id" : "bts:PortionWeight" }, { - "@id" : "bts:dup" + "@id" : "bts:TotalVolume" }, { - "@id" : "bts:hic" + "@id" : "bts:TumorTissueType" }, { - "@id" : "bts:cellam" + "@id" : "bts:HistologicMorphologyCode" }, { - "@id" : "bts:idat" + "@id" : "bts:PreservationMethod" }, { - "@id" : "bts:txt" + "@id" : "bts:BiospecimenDimension1" }, { - "@id" : "bts:raw" + "@id" : "bts:BiospecimenDimension2" }, { - "@id" : "bts:hdf5" + "@id" : "bts:BiospecimenDimension3" }, { - "@id" : "bts:bgzip" + "@id" : "bts:SectionNumberinSequence" + } ], + "sms:displayName" : "BoneMarrowBiospecimenType" + }, { + "rdfs:subClassOf" : [ { + "@id" : "bts:Sequencing" + } ], + "@id" : "bts:BulkDNA-seqLevel1", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "BulkDNA-seqLevel1", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:seg" + "@id" : "bts:Filename" }, { - "@id" : "bts:rmd" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:scn" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:vcf" + "@id" : "bts:SampleID" }, { - "@id" : "bts:maf" + "@id" : "bts:AltSampleID" }, { - "@id" : "bts:tsv" + "@id" : "bts:SequencingPlatform" }, { - "@id" : "bts:pdf" + "@id" : "bts:NucleicAcidSource" }, { - "@id" : "bts:sam" + "@id" : "bts:LibraryConstructionMethod" }, { - "@id" : "bts:bedgraph" + "@id" : "bts:LibrarySelectionMethod" }, { - "@id" : "bts:sra" + "@id" : "bts:LibraryLayout" }, { - "@id" : "bts:abf" + "@id" : "bts:LibraryPrepKitName" }, { - "@id" : "bts:fastq" + "@id" : "bts:LibraryPrepKitVersion" }, { - "@id" : "bts:pzfx" + "@id" : "bts:LibraryPrepKitVendor" }, { - "@id" : "bts:bednarrowPeak" + "@id" : "bts:ReadIndicator" }, { - "@id" : "bts:fig" + "@id" : "bts:ReadContent" }, { - "@id" : "bts:am" + "@id" : "bts:TargetDepth" }, { - "@id" : "bts:gct" + "@id" : "bts:AdapterName" }, { - "@id" : "bts:tagAlign" + "@id" : "bts:AdapterSequence" }, { - "@id" : "bts:gzip" + "@id" : "bts:BatchID" }, { - "@id" : "bts:gtf" + "@id" : "bts:LaneNumber" }, { - "@id" : "bts:DICOM" + "@id" : "bts:TechnicalReplicateGroup" }, { - "@id" : "bts:cloupe" + "@id" : "bts:TargetCaptureKit" + } ], + "sms:displayName" : "BulkDNA-seqLevel1" + }, { + "rdfs:subClassOf" : [ { + "@id" : "bts:Patient" + } ], + "@id" : "bts:CohortCoreTemplate", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "CohortCoreTemplate", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:czi" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:tiff" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:powerpoint" + "@id" : "bts:Age" }, { - "@id" : "bts:zip" + "@id" : "bts:Sex" }, { - "@id" : "bts:bed" + "@id" : "bts:BMI" }, { - "@id" : "bts:mex" + "@id" : "bts:Race" }, { - "@id" : "bts:ab1" + "@id" : "bts:Ethnicity" }, { - "@id" : "bts:Pythonscript" + "@id" : "bts:VitalStatus" }, { - "@id" : "bts:msf" + "@id" : "bts:Height" }, { - "@id" : "bts:mzML" + "@id" : "bts:Weight" }, { - "@id" : "bts:svg" + "@id" : "bts:Gravidity" }, { - "@id" : "bts:cel" + "@id" : "bts:Parity" + }, { + "@id" : "bts:AgeAtMenarche" }, { - "@id" : "bts:mtx" + "@id" : "bts:MenstrualCyclePhase" }, { - "@id" : "bts:bigwig" + "@id" : "bts:MenopauseStatus" }, { - "@id" : "bts:chp" + "@id" : "bts:PrimaryDiagnosis" }, { - "@id" : "bts:svs" + "@id" : "bts:AgeatDiagnosis" }, { - "@id" : "bts:wiggle" + "@id" : "bts:DiagnosisStatusType" }, { - "@id" : "bts:mov" + "@id" : "bts:ClassBRCA1" }, { - "@id" : "bts:bcf" + "@id" : "bts:ClassBRCA2" }, { - "@id" : "bts:hyperlink" + "@id" : "bts:TobaccoUse" }, { - "@id" : "bts:sdf" + "@id" : "bts:PackYearsSmoked" }, { - "@id" : "bts:recal" + "@id" : "bts:AlcoholUse" }, { - "@id" : "bts:idx" + "@id" : "bts:NumberofDrinksPerWeek" }, { - "@id" : "bts:sif" + "@id" : "bts:AntibioticUse" }, { - "@id" : "bts:json" + "@id" : "bts:SampleCollectionCenter" }, { - "@id" : "bts:avi" + "@id" : "bts:SampleCollectionYear" }, { - "@id" : "bts:HEIC" + "@id" : "bts:ERStatus" }, { - "@id" : "bts:gff3" + "@id" : "bts:PRStatus" }, { - "@id" : "bts:bpm" + "@id" : "bts:HER2Status" + } ], + "sms:displayName" : "CohortCoreTemplate" + }, { + "rdfs:subClassOf" : [ { + "@id" : "bts:Biospecimen" + } ], + "@id" : "bts:TissueBiospecimenType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "TissueBiospecimenType", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" }, { - "@id" : "bts:bedbroadPeak" + "@id" : "bts:ParentID" }, { - "@id" : "bts:excel" + "@id" : "bts:ParentBiospecimenID" }, { - "@id" : "bts:flagstat" + "@id" : "bts:AdjacentBiospecimenIDs" }, { - "@id" : "bts:mpg" + "@id" : "bts:BiospecimenType" }, { - "@id" : "bts:RData" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:Sentrixdescriptorfile" + "@id" : "bts:SpecimenLaterality" }, { - "@id" : "bts:jpg" + "@id" : "bts:IschemicTime" }, { - "@id" : "bts:doc" + "@id" : "bts:IschemicTemperature" }, { - "@id" : "bts:bedgappedPeak" + "@id" : "bts:SiteofResectionorBiopsy" }, { - "@id" : "bts:xml" + "@id" : "bts:PortionWeight" }, { - "@id" : "bts:sqlite" + "@id" : "bts:TotalVolume" }, { - "@id" : "bts:tranches" + "@id" : "bts:TumorTissueType" }, { - "@id" : "bts:plink" + "@id" : "bts:HistologicMorphologyCode" }, { - "@id" : "bts:sav" + "@id" : "bts:PreservationMethod" }, { - "@id" : "bts:locs" + "@id" : "bts:BiospecimenDimension1" }, { - "@id" : "bts:html" + "@id" : "bts:BiospecimenDimension2" }, { - "@id" : "bts:md" + "@id" : "bts:BiospecimenDimension3" }, { - "@id" : "bts:fasta" + "@id" : "bts:SectionNumberinSequence" } ], - "rdfs:label" : "FileFormat", - "rdfs:comment" : "Format of a file (e.g. txt, csv, fastq, bam, etc.)", - "@type" : "rdfs:Class", - "sms:displayName" : "FileFormat" - }, { - "@id" : "bts:LinkedMatrices", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LinkedMatrices", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LinkedMatrices", - "sms:required" : "sms:false" + "sms:displayName" : "TissueBiospecimenType" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AlcoholExposure", + "rdfs:subClassOf" : [ { + "@id" : "bts:Patient" + } ], + "@id" : "bts:FamilyHistory", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes-AlcoholExposure" + "sms:requiresComponent" : "", + "rdfs:label" : "FamilyHistory", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:NotReported" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:No-AlcoholExposure" + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:RelativewithCancerHistory" } ], - "rdfs:label" : "AlcoholExposure", - "rdfs:comment" : "Indicate if individual has alcohol exposure", - "@type" : "rdfs:Class", - "sms:displayName" : "AlcoholExposure" - }, { - "@id" : "bts:ScRNAseqWorkflowParametersDescription", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ScRNAseqWorkflowParametersDescription", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ScRNAseqWorkflowParametersDescription", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ExcitationBandwidth", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ExcitationBandwidth", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ExcitationBandwidth", - "sms:required" : "sms:false" + "sms:displayName" : "FamilyHistory" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:PriorInvasiveBreastDisease", + "rdfs:subClassOf" : [ { + "@id" : "bts:SingleCellSequencing" + } ], + "@id" : "bts:ScRNA-seqLevel4", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "sms:requiresComponent" : "", + "rdfs:label" : "ScRNA-seqLevel4", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:unknown" + "@id" : "bts:Filename" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:DCIS" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:LCIS" + "@id" : "bts:SampleID" }, { - "@id" : "bts:Invasivebreastcancer(unrelatedtothecurrentcancer)" - } ], - "rdfs:label" : "PriorInvasiveBreastDisease", - "rdfs:comment" : "Text term to indicate prior invasive breast condition in the participant", - "@type" : "rdfs:Class", - "sms:displayName" : "PriorInvasiveBreastDisease" - }, { - "@id" : "bts:SizeT", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of time points. Integer >= 1", - "rdfs:label" : "SizeT", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SizeT", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Intron", - "@type" : "rdfs:Class", - "rdfs:comment" : "Intron number targeted or included in molecular analysis. If a specific genetic variant is being reported, this property can be used to capture the intron where that variant is located.", - "rdfs:label" : "Intron", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Intron", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastCancerGenomicTestPerformed", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "@id" : "bts:AltSampleID" + }, { + "@id" : "bts:SequencingPlatform" + }, { + "@id" : "bts:NucleicAcidSource" + }, { + "@id" : "bts:LibraryConstructionMethod" + }, { + "@id" : "bts:LibrarySelectionMethod" + }, { + "@id" : "bts:LibraryLayout" + }, { + "@id" : "bts:LibraryPrepKitName" + }, { + "@id" : "bts:LibraryPrepKitVersion" + }, { + "@id" : "bts:LibraryPrepKitVendor" + }, { + "@id" : "bts:ReadIndicator" + }, { + "@id" : "bts:ReadContent" + }, { + "@id" : "bts:TargetDepth" + }, { + "@id" : "bts:AdapterName" + }, { + "@id" : "bts:AdapterSequence" + }, { + "@id" : "bts:BatchID" + }, { + "@id" : "bts:LaneNumber" + }, { + "@id" : "bts:TechnicalReplicateGroup" + }, { + "@id" : "bts:DissociationMethod" + }, { + "@id" : "bts:CryopreservedCellsinSample" + }, { + "@id" : "bts:SingleCellIsolationMethod" + }, { + "@id" : "bts:TotalNumberofInputCells" + }, { + "@id" : "bts:InputCellsandNuclei" + }, { + "@id" : "bts:ReverseTranscriptionPrimer" + }, { + "@id" : "bts:SpikeIn" }, { - "@id" : "bts:unknown" + "@id" : "bts:EndBias" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:DataCategory" }, { - "@id" : "bts:Oncotype" + "@id" : "bts:MatrixType" }, { - "@id" : "bts:MammaPrint" + "@id" : "bts:LinkedMatrices" }, { - "@id" : "bts:Notperformed" - } ], - "rdfs:label" : "BreastCancerGenomicTestPerformed", - "rdfs:comment" : "Text term that represents the name of the genomic test performed for breast cancer.", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastCancerGenomicTestPerformed" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:EnvironmentalTobaccoSmokeExposure", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" + "@id" : "bts:CellMedianNumberReads" }, { - "@id" : "bts:No" + "@id" : "bts:CellMedianNumberGenes" }, { - "@id" : "bts:unknown" + "@id" : "bts:CellTotal" + }, { + "@id" : "bts:ScRNAseqWorkflowType" + }, { + "@id" : "bts:ScRNAseqWorkflowParametersDescription" + }, { + "@id" : "bts:WorkflowLink" + }, { + "@id" : "bts:WorkflowVersion" } ], - "rdfs:label" : "EnvironmentalTobaccoSmokeExposure", - "rdfs:comment" : "The yes/no/unknown indicator used to describe whether a patient was exposed to smoke that is emitted from burning tobacco, including cigarettes, pipes, and cigars. This includes tobacco smoke exhaled by smokers.", - "@type" : "rdfs:Class", - "sms:displayName" : "EnvironmentalTobaccoSmokeExposure" - }, { - "@id" : "bts:ProtocolLink", - "@type" : "rdfs:Class", - "rdfs:comment" : "URL to a free/open protocol resource describing the assay protocol (e.g. surface markers used in Smart-seq, dissociation duration, lot/batch numbers for key reagents such as primers, sequencing reagent kits, etc.) or the protocol by which the sample was obtained or generated.", - "rdfs:label" : "ProtocolLink", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ProtocolLink", - "sms:required" : "sms:false" + "sms:displayName" : "ScRNA-seqLevel4" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:RelativewithCancerHistory", + "rdfs:subClassOf" : [ { + "@id" : "bts:Patient" + } ], + "@id" : "bts:Demographics", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes-CancerHistoryRelative" + "sms:requiresComponent" : "", + "rdfs:label" : "Demographics", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:unknown" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:NotReported" + "@id" : "bts:TimepointLabel" }, { - "@id" : "bts:None" + "@id" : "bts:Ethnicity" + }, { + "@id" : "bts:Gender" + }, { + "@id" : "bts:Race" + }, { + "@id" : "bts:VitalStatus" + }, { + "@id" : "bts:DaystoBirth" + }, { + "@id" : "bts:CountryofResidence" + }, { + "@id" : "bts:AgeIsObfuscated" + }, { + "@id" : "bts:YearOfBirth" } ], - "rdfs:label" : "RelativewithCancerHistory", - "rdfs:comment" : "The yes/no/unknown indicator used to describe whether any of the patient's relatives have a history of cancer.", - "@type" : "rdfs:Class", - "sms:displayName" : "RelativewithCancerHistory" - }, { - "@id" : "bts:LibraryPrepKitVendor", - "@type" : "rdfs:Class", - "rdfs:comment" : "Vendor of Library Prep Kit. String", - "rdfs:label" : "LibraryPrepKitVendor", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LibraryPrepKitVendor", - "sms:required" : "sms:false" + "sms:displayName" : "Demographics" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:PrecancerousConditionType", + "rdfs:subClassOf" : [ { + "@id" : "bts:ScRNA-seqLevel1" + } ], + "@id" : "bts:CEL-seq2", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:CarcinomaNOS" + "sms:requiresComponent" : "", + "rdfs:label" : "CEL-seq2", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:Component" }, { - "@id" : "bts:Atypicalmelanocyticproliferation" + "@id" : "bts:Filename" }, { - "@id" : "bts:Superficialspreading" + "@id" : "bts:FileFormat" }, { - "@id" : "bts:Melanomainsituarisinginagiantcongenitalnevus" + "@id" : "bts:ParticipantID" }, { - "@id" : "bts:Invasivemelanoma" + "@id" : "bts:SampleID" }, { - "@id" : "bts:Invasivemelanoma-acrallentiginous" + "@id" : "bts:AltSampleID" }, { - "@id" : "bts:Melanomainsitunototherwiseclassified" + "@id" : "bts:SequencingPlatform" }, { - "@id" : "bts:Milddysplasia" + "@id" : "bts:NucleicAcidSource" }, { - "@id" : "bts:Adenocarcinomainsitu-nonmucinous" + "@id" : "bts:LibraryConstructionMethod" }, { - "@id" : "bts:Reservecellhyperplasia" + "@id" : "bts:LibrarySelectionMethod" }, { - "@id" : "bts:Invasivemelanoma-nevoid" + "@id" : "bts:LibraryLayout" }, { - "@id" : "bts:Nodiagnosispossible" + "@id" : "bts:LibraryPrepKitName" }, { - "@id" : "bts:Hamartoma" + "@id" : "bts:LibraryPrepKitVersion" }, { - "@id" : "bts:Adenocarcinomainsitu-mucinous" + "@id" : "bts:LibraryPrepKitVendor" }, { - "@id" : "bts:Squamousmetaplasia-immature" + "@id" : "bts:ReadIndicator" }, { - "@id" : "bts:Severedysplasia" + "@id" : "bts:ReadContent" }, { - "@id" : "bts:Invasivemelanoma-lentigomaligna" + "@id" : "bts:TargetDepth" }, { - "@id" : "bts:Squamousmetaplasia-mature" + "@id" : "bts:AdapterName" }, { - "@id" : "bts:Acral-lentiginous" + "@id" : "bts:AdapterSequence" }, { - "@id" : "bts:Invasivemelanoma-superficialspreading" + "@id" : "bts:BatchID" }, { - "@id" : "bts:Atypicaladenomatoushyperplasia" + "@id" : "bts:LaneNumber" }, { - "@id" : "bts:Moderatedysplasia" + "@id" : "bts:TechnicalReplicateGroup" }, { - "@id" : "bts:AtypicalAdenomatousLungHyperplasia" + "@id" : "bts:DissociationMethod" }, { - "@id" : "bts:NormalWDA" + "@id" : "bts:CryopreservedCellsinSample" }, { - "@id" : "bts:Other" + "@id" : "bts:SingleCellIsolationMethod" }, { - "@id" : "bts:Persistentmelanomainsitu" + "@id" : "bts:TotalNumberofInputCells" }, { - "@id" : "bts:PancreaticIntraepithelialNeoplasia" + "@id" : "bts:InputCellsandNuclei" }, { - "@id" : "bts:DuctalCarcinomaInSitu" + "@id" : "bts:ReverseTranscriptionPrimer" }, { - "@id" : "bts:PancreaticIntraductalPapillary-MucinousNeoplasm" + "@id" : "bts:SpikeIn" }, { - "@id" : "bts:Melanocytichyperplasia" + "@id" : "bts:EndBias" }, { - "@id" : "bts:Melanomainsitu" + "@id" : "bts:UMIBarcodeOffset" }, { - "@id" : "bts:Invasivemelanoma-desmoplastic" + "@id" : "bts:UMIBarcodeLength" }, { - "@id" : "bts:BenigntumorNOS" + "@id" : "bts:MedianUMIsperCellNumber" }, { - "@id" : "bts:Lentigomalignatype" + "@id" : "bts:CellBarcodeOffset" }, { - "@id" : "bts:Scar-noresidualmelanoma" + "@id" : "bts:CellBarcodeLength" }, { - "@id" : "bts:Invasivemelanoma-nodulartype" + "@id" : "bts:ValidBarcodesCellNumber" }, { - "@id" : "bts:ProstaticIntraepithelialNeoplasia" + "@id" : "bts:EmptyWellBarcode" + }, { + "@id" : "bts:WellIndex" } ], - "rdfs:label" : "PrecancerousConditionType", - "rdfs:comment" : "The classification of pre-cancerous cells found in a specific collection of data being studied by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).", - "@type" : "rdfs:Class", - "sms:displayName" : "PrecancerousConditionType" - }, { - "@id" : "bts:CellBarcodeOffset", - "@type" : "rdfs:Class", - "rdfs:comment" : "Offset in sequence for cell barcode read (in bp): number", - "rdfs:label" : "CellBarcodeOffset", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CellBarcodeOffset", - "sms:required" : "sms:false" - }, { - "@id" : "bts:UMIBarcodeLength", - "@type" : "rdfs:Class", - "rdfs:comment" : "Length of UMI barcode read (in bp): number", - "rdfs:label" : "UMIBarcodeLength", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "UMIBarcodeLength", - "sms:required" : "sms:false" + "sms:displayName" : "CEL-seq2" }, { - "@id" : "bts:IschemicTime", - "@type" : "rdfs:Class", - "rdfs:comment" : "Duration of time, in seconds, between when the specimen stopped receiving oxygen and when it was preserved or processed. Integer value.", - "rdfs:label" : "IschemicTime", "rdfs:subClassOf" : [ ], + "@id" : "bts:Biospecimen", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "IschemicTime", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ProgressionorRecurrenceType", - "@type" : "rdfs:Class", + "sms:required" : "sms:false", + "sms:requiresComponent" : "", + "rdfs:label" : "Biospecimen", "rdfs:comment" : "TBD", - "rdfs:label" : "ProgressionorRecurrenceType", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ProgressionorRecurrenceType", - "sms:required" : "sms:false" + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" + }, { + "@id" : "bts:ParentID" + }, { + "@id" : "bts:ParentBiospecimenID" + }, { + "@id" : "bts:AdjacentBiospecimenIDs" + }, { + "@id" : "bts:BiospecimenType" + }, { + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:SpecimenLaterality" + } ], + "sms:displayName" : "Biospecimen" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AlcoholType", + "rdfs:subClassOf" : [ { + "@id" : "bts:Biospecimen" + } ], + "@id" : "bts:BiospecimenDimension1", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "sms:requiresComponent" : "", + "rdfs:label" : "BiospecimenDimension1", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" }, { - "@id" : "bts:unknown" + "@id" : "bts:ParentID" }, { - "@id" : "bts:NotReported" + "@id" : "bts:ParentBiospecimenID" }, { - "@id" : "bts:Beer" + "@id" : "bts:AdjacentBiospecimenIDs" }, { - "@id" : "bts:Liquor" + "@id" : "bts:BiospecimenType" }, { - "@id" : "bts:Wine" + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:SpecimenLaterality" + }, { + "@id" : "bts:DimensionsUnit" } ], - "rdfs:label" : "AlcoholType", - "rdfs:comment" : "Type of alcohol use", - "@type" : "rdfs:Class", - "sms:displayName" : "AlcoholType" + "sms:displayName" : "BiospecimenDimension1" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:MismatchRepairMutation", + "rdfs:subClassOf" : [ { + "@id" : "bts:Biospecimen" + } ], + "@id" : "bts:BloodBiospecimenType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" + "sms:requiresComponent" : "", + "rdfs:label" : "BloodBiospecimenType", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:requiresDependency" : [ { + "@id" : "bts:BiospecimenID" }, { - "@id" : "bts:No" + "@id" : "bts:ParentID" }, { - "@id" : "bts:unknown" + "@id" : "bts:ParentBiospecimenID" + }, { + "@id" : "bts:AdjacentBiospecimenIDs" + }, { + "@id" : "bts:BiospecimenType" + }, { + "@id" : "bts:TimepointLabel" + }, { + "@id" : "bts:SpecimenLaterality" + }, { + "@id" : "bts:ShippingConditionType" } ], - "rdfs:label" : "MismatchRepairMutation", - "rdfs:comment" : "The yes/no/unknown indicator used to describe whether the mutation included in molecular testing was known to have an affect on the mismatch repair process. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "@type" : "rdfs:Class", - "sms:displayName" : "MismatchRepairMutation" - }, { - "@id" : "bts:Filename", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Filename", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Filename", - "sms:required" : "sms:false" - }, { - "@id" : "bts:AdapterName", - "@type" : "rdfs:Class", - "rdfs:comment" : "Name of the sequencing adapter. String", - "rdfs:label" : "AdapterName", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AdapterName", - "sms:required" : "sms:false" + "sms:displayName" : "BloodBiospecimenType" }, { - "@id" : "bts:CountryofBirth", + "@id" : "bts:YearsSmoked", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CountryofBirth", + "rdfs:comment" : "Numeric value (or unknown) to represent the number of years a person has been smoking.", + "rdfs:label" : "YearsSmoked", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CountryofBirth", + "sms:displayName" : "YearsSmoked", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:LibraryConstructionMethod", + "@id" : "bts:RelationshipGender", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:true", + "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:10xV3" - }, { - "@id" : "bts:inDropsV2" - }, { - "@id" : "bts:10xV1.1" - }, { - "@id" : "bts:10xV3.1" - }, { - "@id" : "bts:Drop-seq" - }, { - "@id" : "bts:10xV2" - }, { - "@id" : "bts:10xV1.0" - }, { - "@id" : "bts:Smart-seq2" - }, { - "@id" : "bts:Smart-SeqV4" + "@id" : "bts:unknown" }, { - "@id" : "bts:sci-ATAC-seq" + "@id" : "bts:NotReported" }, { - "@id" : "bts:inDropsV3" + "@id" : "bts:female" }, { - "@id" : "bts:CEL-seq2" + "@id" : "bts:male" }, { - "@id" : "bts:TruDrop" + "@id" : "bts:unspecified" } ], - "rdfs:label" : "LibraryConstructionMethod", - "rdfs:comment" : "Process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors [OBI_0000711]", + "rdfs:label" : "RelationshipGender", + "rdfs:comment" : "The text term used to describe the gender of the patient's relative with a history of cancer.", "@type" : "rdfs:Class", - "sms:displayName" : "LibraryConstructionMethod" + "sms:displayName" : "RelationshipGender" }, { - "@id" : "bts:OtherBiopsyResectionSite", + "@id" : "bts:AdjacentSampleIDs", "@type" : "rdfs:Class", - "rdfs:comment" : "A description of the location on or within the human body where the surgical biopsy/resection procedure was performed (Not covered under Clinical Data Tier 1)", - "rdfs:label" : "OtherBiopsyResectionSite", + "rdfs:comment" : "List of Identifiers (separated by commas) of adjacent biospecimens cut from the same sample", + "rdfs:label" : "AdjacentSampleIDs", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "OtherBiopsyResectionSite", + "sms:displayName" : "AdjacentSampleIDs", "sms:required" : "sms:false" }, { - "@id" : "bts:MedianPassingReadPercentage", + "@id" : "bts:AdapterSequence", "@type" : "rdfs:Class", - "rdfs:comment" : "Non-PCR duplicate nuclear genomic sequence reads not aligning to unanchored contigs out of total reads assigned to the nucleus barcode", - "rdfs:label" : "MedianPassingReadPercentage", + "rdfs:comment" : "Base sequence of the sequencing adapter. String", + "rdfs:label" : "AdapterSequence", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MedianPassingReadPercentage", + "sms:displayName" : "AdapterSequence", "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:ReadIndicator", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:I1" - }, { - "@id" : "bts:R1" - }, { - "@id" : "bts:R2" - }, { - "@id" : "bts:R1&R2" - }, { - "@id" : "bts:R3" - }, { - "@id" : "bts:NotApplicable" - } ], - "rdfs:label" : "ReadIndicator", - "rdfs:comment" : "TBD", + "@id" : "bts:DaystoDeath", "@type" : "rdfs:Class", - "sms:displayName" : "ReadIndicator" - }, { + "rdfs:comment" : "Number of days between the date used for index and the date from a person's date of death represented as a calculated number of days.", + "rdfs:label" : "DaystoDeath", "rdfs:subClassOf" : [ ], - "@id" : "bts:InvasiveLobularBreastCarcinomaHistologicCategory", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" - }, { - "@id" : "bts:Datanotavailable" - }, { - "@id" : "bts:Alveolartype" - }, { - "@id" : "bts:Classicaltype" - }, { - "@id" : "bts:Pleomorphictype" - } ], - "rdfs:label" : "InvasiveLobularBreastCarcinomaHistologicCategory", - "rdfs:comment" : "The histologic subtype for an infiltrating lobular carcinoma of the breast.", - "@type" : "rdfs:Class", - "sms:displayName" : "InvasiveLobularBreastCarcinomaHistologicCategory" + "sms:displayName" : "DaystoDeath", + "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:TumorExtranodalExtensionIndicator", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Absent" - }, { - "@id" : "bts:Notapplicable" - }, { - "@id" : "bts:YES" - }, { - "@id" : "bts:unspecified" - }, { - "@id" : "bts:Nosourcedocumentation" - }, { - "@id" : "bts:UNKNOWN" - }, { - "@id" : "bts:Present" - }, { - "@id" : "bts:Present-extensive" - }, { - "@id" : "bts:Notsampledordissected" - }, { - "@id" : "bts:Present-minimal" - }, { - "@id" : "bts:NO" - }, { - "@id" : "bts:Indeterminate" - } ], - "rdfs:label" : "TumorExtranodalExtensionIndicator", - "rdfs:comment" : "The indicator to determine extranodal involvement or extent of the disease.", + "@id" : "bts:SentinelLymphNodeCount", "@type" : "rdfs:Class", - "sms:displayName" : "TumorExtranodalExtensionIndicator" - }, { + "rdfs:comment" : "Numeric count of sentinel lymph nodes.", + "rdfs:label" : "SentinelLymphNodeCount", "rdfs:subClassOf" : [ ], - "@id" : "bts:ERReceptorStatus", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" - }, { - "@id" : "bts:Borderline" - }, { - "@id" : "bts:Equivocal" - }, { - "@id" : "bts:Indeterminate" - }, { - "@id" : "bts:Negative" - }, { - "@id" : "bts:NotPerformed" - }, { - "@id" : "bts:PerformedbutNotAvailable" - }, { - "@id" : "bts:Positive" - } ], - "rdfs:label" : "ERReceptorStatus", - "rdfs:comment" : "Text term to represent the overall result of Estrogen Receptor (ER) testing in a participant with breast cancer", + "sms:displayName" : "SentinelLymphNodeCount", + "sms:required" : "sms:false" + }, { + "@id" : "bts:StopDaysfromIndex", + "@type" : "rdfs:Class", + "rdfs:comment" : "Number of days from the date of birth (index date) to the end date of the event (e.g. exposure to environmental factor, treatment start, etc.). Note: if the event occurs at a single time point, e.g. a diagnosis or a lab test, the values for this column is 'Not Applicable'", + "rdfs:label" : "StopDaysfromIndex", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "StopDaysfromIndex", + "sms:required" : "sms:false" + }, { + "@id" : "bts:NumberofDrinksPerWeek", "@type" : "rdfs:Class", - "sms:displayName" : "ERReceptorStatus" + "rdfs:comment" : "TBD", + "rdfs:label" : "NumberofDrinksPerWeek", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "NumberofDrinksPerWeek", + "sms:required" : "sms:false" }, { - "@id" : "bts:Comment", + "@id" : "bts:SentinelNodePositiveAssessmentCount", "@type" : "rdfs:Class", - "rdfs:comment" : "Free text field (generally for QC comment)", - "rdfs:label" : "Comment", + "rdfs:comment" : "The number or amount of metastatic neoplasms related to the confirmed presence of disease or specific microorganisms during examination of the first rounded mass of lymphatic tissue to which cancer is likely to spread from the primary tumor.", + "rdfs:label" : "SentinelNodePositiveAssessmentCount", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Comment", + "sms:displayName" : "SentinelNodePositiveAssessmentCount", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastQuadrantSite", + "@id" : "bts:PreservationMethod", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { + "@id" : "bts:Negative80DegC" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:Cryopreservationindryice-deadtissue" + }, { "@id" : "bts:unknown" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:Fresh" }, { - "@id" : "bts:Upperouterquadrant" + "@id" : "bts:Cryopreservationinliquidnitrogen-deadtissue" }, { - "@id" : "bts:Lowerouterquadrant" + "@id" : "bts:Formalinfixedparaffinembedded-FFPE" }, { - "@id" : "bts:Upperinnerquadrant" + "@id" : "bts:Archival" }, { - "@id" : "bts:Lowerinnerquadrant" + "@id" : "bts:Formalinfixed-buffered" }, { - "@id" : "bts:Central" + "@id" : "bts:Formalinfixed-unbuffered" }, { - "@id" : "bts:Nipple" + "@id" : "bts:Cryopreserved" + }, { + "@id" : "bts:Frozen" + }, { + "@id" : "bts:Freshdissociatedandsinglecellsorted" + }, { + "@id" : "bts:FreshdissociatedandsinglecellsortedintoplatesinNP40buffer" + }, { + "@id" : "bts:Methacarnfixedparaffinembedded-MFPE" + }, { + "@id" : "bts:Freshdissociated" + }, { + "@id" : "bts:Freshdissociatedandsinglecellsortedintoplates" + }, { + "@id" : "bts:Cryopreservationinliquidnitrogen-livecells" + }, { + "@id" : "bts:OCT" + }, { + "@id" : "bts:SnapFrozen" + }, { + "@id" : "bts:LiquidNitrogen" } ], - "rdfs:label" : "BreastQuadrantSite", - "rdfs:comment" : "The breast quadrant or structure from which the breast tissue specimen was removed for microscopic examination.", + "rdfs:label" : "PreservationMethod", + "rdfs:comment" : "Text term that represents the method used to preserve the sample.", "@type" : "rdfs:Class", - "sms:displayName" : "BreastQuadrantSite" + "sms:displayName" : "PreservationMethod" }, { - "@id" : "bts:LinkedDatasets", + "@id" : "bts:Ecigvapeuse", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "LinkedDatasets", + "rdfs:label" : "Ecigvapeuse", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "LinkedDatasets", + "sms:displayName" : "Ecigvapeuse", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCarcinomaHER2Chromosome17Ratio", + "@id" : "bts:PublicationDOI", "@type" : "rdfs:Class", - "rdfs:comment" : "HER2 chromosome 17 ratio in participants with breast cancer", - "rdfs:label" : "BreastCarcinomaHER2Chromosome17Ratio", + "rdfs:comment" : "TBD", + "rdfs:label" : "PublicationDOI", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaHER2Chromosome17Ratio", + "sms:displayName" : "PublicationDOI", "sms:required" : "sms:false" }, { - "@id" : "bts:PhysicalSizeY", + "@id" : "bts:DaystoBirth", "@type" : "rdfs:Class", - "rdfs:comment" : "Physical size (Y-dimension) of a pixel. Units are set by PhysicalSizeYUnit. Floating point value > 0.", - "rdfs:label" : "PhysicalSizeY", + "rdfs:comment" : "Number of days between the date used for index and the date from a person's date of birth represented as a calculated negative number of days.", + "rdfs:label" : "DaystoBirth", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PhysicalSizeY", + "sms:displayName" : "DaystoBirth", "sms:required" : "sms:false" }, { - "@id" : "bts:MetalIsotopeMass", + "@id" : "bts:TestUnits", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MetalIsotopeMass", + "rdfs:comment" : "The text term used to describe the units of the test value for a molecular test. This property is used in conjunction with test_value. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "TestUnits", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MetalIsotopeMass", + "sms:displayName" : "TestUnits", "sms:required" : "sms:false" }, { - "@id" : "bts:BiospecimenDimension2", + "@id" : "bts:AdjacentBiospecimenIDs", "@type" : "rdfs:Class", - "rdfs:comment" : "Second dimension of tissue fragment (number, up to one decimal place) measured in units as defined by the \"\"dimensions_unit\"\" CDE", - "rdfs:label" : "BiospecimenDimension2", + "rdfs:comment" : "TBD", + "rdfs:label" : "AdjacentBiospecimenIDs", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BiospecimenDimension2", + "sms:displayName" : "AdjacentBiospecimenIDs", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Laterality", + "@id" : "bts:BreastBiopsyProcedureFindingType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:NotApplicable" + "@id" : "bts:Other" }, { - "@id" : "bts:unknown" + "@id" : "bts:Atypicalhyperplasia" }, { - "@id" : "bts:NotReported" + "@id" : "bts:DCIS" }, { - "@id" : "bts:Bilateral" + "@id" : "bts:LCIS" }, { - "@id" : "bts:Left" + "@id" : "bts:Cancer" }, { - "@id" : "bts:Right" + "@id" : "bts:Nocancer" } ], - "rdfs:label" : "Laterality", - "rdfs:comment" : "For samples in paired organs, designates the side from which obtained.", + "rdfs:label" : "BreastBiopsyProcedureFindingType", + "rdfs:comment" : "Text term to describe the result of the examination of the breast tissue specimen or fluid as related to the presence and nature of disease.", "@type" : "rdfs:Class", - "sms:displayName" : "Laterality" + "sms:displayName" : "BreastBiopsyProcedureFindingType" }, { - "@id" : "bts:MedianFractionofReadsinPeaks", - "@type" : "rdfs:Class", - "rdfs:comment" : "Median fraction of reads in peaks (FRIP)", - "rdfs:label" : "MedianFractionofReadsinPeaks", "rdfs:subClassOf" : [ ], + "@id" : "bts:LibraryLayout", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MedianFractionofReadsinPeaks", - "sms:required" : "sms:false" + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:PairedEnd" + }, { + "@id" : "bts:SingleRead" + }, { + "@id" : "bts:Mid-length" + }, { + "@id" : "bts:LongRead" + } ], + "rdfs:label" : "LibraryLayout", + "rdfs:comment" : "Sequencing read type", + "@type" : "rdfs:Class", + "sms:displayName" : "LibraryLayout" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:VariantType", + "@id" : "bts:SpecimenLaterality", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Duplication" - }, { - "@id" : "bts:Conversion" - }, { - "@id" : "bts:Chrimerism" - }, { - "@id" : "bts:NotReported" - }, { - "@id" : "bts:PartialMethylation" + "@id" : "bts:NotApplicable" }, { "@id" : "bts:unknown" }, { - "@id" : "bts:Substitution" - }, { - "@id" : "bts:Deletion-Insertion" - }, { - "@id" : "bts:Loss" - }, { - "@id" : "bts:Insertion" - }, { - "@id" : "bts:Hypermethylation" - }, { - "@id" : "bts:Alleles" - }, { - "@id" : "bts:Methylation" - }, { - "@id" : "bts:Inversion" - }, { - "@id" : "bts:Extension" - }, { - "@id" : "bts:Mosaicism" - }, { - "@id" : "bts:Deletion" - }, { - "@id" : "bts:Other" - }, { - "@id" : "bts:Rearrangement" - }, { - "@id" : "bts:Translocation" - }, { - "@id" : "bts:Amplification" + "@id" : "bts:NotReported" }, { - "@id" : "bts:RepeatedSequences" + "@id" : "bts:Bilateral" }, { - "@id" : "bts:Splice" + "@id" : "bts:Left" }, { - "@id" : "bts:Gain" + "@id" : "bts:Right" } ], - "rdfs:label" : "VariantType", - "rdfs:comment" : "The text term used to describe the type of genetic variation.", + "rdfs:label" : "SpecimenLaterality", + "rdfs:comment" : "For samples in paired organs, designates the side from which obtained.", "@type" : "rdfs:Class", - "sms:displayName" : "VariantType" + "sms:displayName" : "SpecimenLaterality" }, { - "@id" : "bts:CigarettesperDay", - "@type" : "rdfs:Class", - "rdfs:comment" : "The average number of cigarettes smoked per day.", - "rdfs:label" : "CigarettesperDay", "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastCarcinomaHistologyCategory", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CigarettesperDay", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CellBarcodeTag", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" + }, { + "@id" : "bts:Infiltratingductalcarcinoma" + }, { + "@id" : "bts:Infiltratinglobularcarcinoma" + }, { + "@id" : "bts:InvasivemammarycarcinomaNOS" + }, { + "@id" : "bts:Invasivemixedductalandlobularcarcinoma" + } ], + "rdfs:label" : "BreastCarcinomaHistologyCategory", + "rdfs:comment" : "Classification of the type of invasive breast carcinoma diagnosed based on histologic attributes.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CellBarcodeTag", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CellBarcodeTag", - "sms:required" : "sms:false" + "sms:displayName" : "BreastCarcinomaHistologyCategory" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:ReadContent", + "@id" : "bts:SingleCellIsolationMethod", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:true", "schema:rangeIncludes" : [ { - "@id" : "bts:CellBarcodeandDNAInsert" + "@id" : "bts:MicrofluidicsChip" }, { - "@id" : "bts:SampleIndexandDNAInsert" + "@id" : "bts:Droplets" }, { - "@id" : "bts:DNAInsert" + "@id" : "bts:FACS" }, { - "@id" : "bts:SampleIndex" + "@id" : "bts:Plates" }, { - "@id" : "bts:CellBarcode" + "@id" : "bts:10x" + }, { + "@id" : "bts:NucleiIsolation" } ], - "rdfs:label" : "ReadContent", - "rdfs:comment" : "Read content description", + "rdfs:label" : "SingleCellIsolationMethod", + "rdfs:comment" : "The method by which cells are isolated into individual reaction containers at a single cell resolution (e.g. wells, micro-droplets)", "@type" : "rdfs:Class", - "sms:displayName" : "ReadContent" + "sms:displayName" : "SingleCellIsolationMethod" }, { - "@id" : "bts:DaystoProgressionFree", + "@id" : "bts:UMIBarcodeOffset", "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days between the date used for index and the date the patient's disease was formally confirmed as progression-free.", - "rdfs:label" : "DaystoProgressionFree", + "rdfs:comment" : "Start position of UMI barcode in the sequence. Values: number, 0 for start of read", + "rdfs:label" : "UMIBarcodeOffset", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "DaystoProgressionFree", + "sms:displayName" : "UMIBarcodeOffset", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:MultifocalBreastCarcinomaPresentIndicator", + "@id" : "bts:DimensionsUnit", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" - }, { - "@id" : "bts:No" + "@id" : "bts:cm" }, { - "@id" : "bts:unknown" + "@id" : "bts:mm" } ], - "rdfs:label" : "MultifocalBreastCarcinomaPresentIndicator", - "rdfs:comment" : "A response to indicate if there is breast cancer characterized by the presence of multiple cancerous tumors that originate from the same clone and usually located in the same quadrant of the breast.", + "rdfs:label" : "DimensionsUnit", + "rdfs:comment" : "Unit of measurement used for dimension CDEs in metric system (i.e. cm, mm, etc)", "@type" : "rdfs:Class", - "sms:displayName" : "MultifocalBreastCarcinomaPresentIndicator" + "sms:displayName" : "DimensionsUnit" }, { - "@id" : "bts:BiospecimenID", + "@id" : "bts:TypeofSmokeExposure", "@type" : "rdfs:Class", - "rdfs:comment" : " Alias for Sample ID", - "rdfs:label" : "BiospecimenID", + "rdfs:comment" : "TBD", + "rdfs:label" : "TypeofSmokeExposure", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BiospecimenID", - "sms:required" : "sms:true" + "sms:displayName" : "TypeofSmokeExposure", + "sms:required" : "sms:false" }, { - "@id" : "bts:BloodTestNormalRangeLower", + "@id" : "bts:SizeC", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the lower limit of the normal range used to describe a healthy individual at the institution where the test was completed.", - "rdfs:label" : "BloodTestNormalRangeLower", + "rdfs:comment" : "Number of channels. Integer >= 1", + "rdfs:label" : "SizeC", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BloodTestNormalRangeLower", + "sms:displayName" : "SizeC", "sms:required" : "sms:false" }, { - "@id" : "bts:RuralvsUrban", + "@id" : "bts:SpecializedMolecularTest", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "RuralvsUrban", + "rdfs:comment" : "Text term used to describe a specific test that is not covered in the list of molecular analysis methods. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "SpecializedMolecularTest", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RuralvsUrban", + "sms:displayName" : "SpecializedMolecularTest", "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:MulticentricBreastCarcinomaPresentIndicator", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" - }, { - "@id" : "bts:No" - }, { - "@id" : "bts:unknown" - } ], - "rdfs:label" : "MulticentricBreastCarcinomaPresentIndicator", - "rdfs:comment" : "A response to indicate if there is breast cancer characterized by the presence of multiple cancerous tumors that originate from different clones and usually located in different quadrants of the breast.", - "@type" : "rdfs:Class", - "sms:displayName" : "MulticentricBreastCarcinomaPresentIndicator" - }, { - "@id" : "bts:UMITag", + "@id" : "bts:Locus", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "UMITag", + "rdfs:comment" : "Alphanumeric value used to describe the locus of a specific genetic variant. Example: NM_001126114.", + "rdfs:label" : "Locus", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "UMITag", + "sms:displayName" : "Locus", "sms:required" : "sms:false" }, { - "@id" : "bts:CellBarcodeLength", + "@id" : "bts:PlaneCount", "@type" : "rdfs:Class", - "rdfs:comment" : "Length of cell barcode read (in bp): number", - "rdfs:label" : "CellBarcodeLength", + "rdfs:comment" : "Number of Z-planes (not to be confused with downsampled \"\"pyramid\"\"). Integer >=1", + "rdfs:label" : "PlaneCount", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CellBarcodeLength", + "sms:displayName" : "PlaneCount", "sms:required" : "sms:false" }, { - "@id" : "bts:ClassBRCA1", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ClassBRCA1", "rdfs:subClassOf" : [ ], + "@id" : "bts:DissociationMethod", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ClassBRCA1", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SectionNumberinSequence", + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:NotApplicable" + }, { + "@id" : "bts:gentleMACS" + }, { + "@id" : "bts:Dounce" + }, { + "@id" : "bts:EnzymaticDigestion" + } ], + "rdfs:label" : "DissociationMethod", + "rdfs:comment" : "The tissue dissociation method used for scRNASeq or scATAC-seq assays", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value (integer, including ranges) provided to a sample in a series of sections (list all adjacent sections in the Adjacent Biospecimen IDs field)", - "rdfs:label" : "SectionNumberinSequence", + "sms:displayName" : "DissociationMethod" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:PRStainingIntensity", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SectionNumberinSequence", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SampleCollectionCenter", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Strong" + }, { + "@id" : "bts:Moderate" + }, { + "@id" : "bts:Weak" + }, { + "@id" : "bts:Weak-Moderate" + }, { + "@id" : "bts:Moderate-Strong" + }, { + "@id" : "bts:Weak-Strong" + } ], + "rdfs:label" : "PRStainingIntensity", + "rdfs:comment" : "Text term to indicate the PR staining intensity on pathology assessment in a participant with breast cancer", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SampleCollectionCenter", + "sms:displayName" : "PRStainingIntensity" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastCarcinomaSurgicalProcedureName", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SampleCollectionCenter", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Radicalmastectomy" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Simplemastectomy" + }, { + "@id" : "bts:Modifiedradicalmastectomy" + }, { + "@id" : "bts:Partialmastectomy" + }, { + "@id" : "bts:Surgerynotperformed" + }, { + "@id" : "bts:Other" + }, { + "@id" : "bts:Lumpectomy" + }, { + "@id" : "bts:Re-excision" + } ], + "rdfs:label" : "BreastCarcinomaSurgicalProcedureName", + "rdfs:comment" : "Text name of a surgical procedure performed for a person with a diagnosis of breast cancer", + "@type" : "rdfs:Class", + "sms:displayName" : "BreastCarcinomaSurgicalProcedureName" }, { - "@id" : "bts:CopyNumber", + "@id" : "bts:BreastCarcinomaERStatusPercentageValue", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the number of times a section of the genome is repeated or copied within an insertion, duplication or deletion variant. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "CopyNumber", + "rdfs:comment" : "A numerical quantity measured or assigned or computed which captures the estrogen receptor level measured in a participant with breast cancer", + "rdfs:label" : "BreastCarcinomaERStatusPercentageValue", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CopyNumber", + "sms:displayName" : "BreastCarcinomaERStatusPercentageValue", "sms:required" : "sms:false" }, { - "@id" : "bts:SectioningDaysfromIndex", + "@id" : "bts:BreastCarcinomaPRStatusPercentageValue", "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days from the research participant's index date that the biospecimen was sectioned after collection", - "rdfs:label" : "SectioningDaysfromIndex", + "rdfs:comment" : "A numerical quantity measured or assigned or computed which captures the progesterone receptor level measured in a participant with breast cancer", + "rdfs:label" : "BreastCarcinomaPRStatusPercentageValue", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SectioningDaysfromIndex", + "sms:displayName" : "BreastCarcinomaPRStatusPercentageValue", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Immersion", + "@id" : "bts:TobaccoSmokingStatus", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Air" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Oil" + "@id" : "bts:unknown" }, { - "@id" : "bts:Water" + "@id" : "bts:CurrentReformedSmoker" }, { - "@id" : "bts:Other" + "@id" : "bts:CurrentSmoker" + }, { + "@id" : "bts:CurrentReformedSmokerfor>15yrs" + }, { + "@id" : "bts:DurationNotSpecified" + }, { + "@id" : "bts:Smokinghistorynotdocumented" + }, { + "@id" : "bts:LifelongNon-Smoker" + }, { + "@id" : "bts:CurrentReformedSmokerfor= 1", + "rdfs:label" : "SizeX", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RelationshipAgeatDiagnosis", + "sms:displayName" : "SizeX", "sms:required" : "sms:false" }, { + "@id" : "bts:GenomeAnnotationURL", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "GenomeAnnotationURL", "rdfs:subClassOf" : [ ], - "@id" : "bts:SmokingExposure", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes-SmokingExposure" - }, { - "@id" : "bts:NotReported" - }, { - "@id" : "bts:No-SmokingExposure" - } ], - "rdfs:label" : "SmokingExposure", - "rdfs:comment" : "Indicate if individual has smoking exposure", - "@type" : "rdfs:Class", - "sms:displayName" : "SmokingExposure" + "sms:displayName" : "GenomeAnnotationURL", + "sms:required" : "sms:false" }, { - "@id" : "bts:AltSampleID", + "@id" : "bts:OligoBarcodeLowerStrand", "@type" : "rdfs:Class", - "rdfs:comment" : "Additional alternative ID associated with a biosample", - "rdfs:label" : "AltSampleID", + "rdfs:comment" : "TBD", + "rdfs:label" : "OligoBarcodeLowerStrand", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AltSampleID", + "sms:displayName" : "OligoBarcodeLowerStrand", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:TestResult", + "@id" : "bts:Read2", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", + "sms:required" : "sms:true", "schema:rangeIncludes" : [ { - "@id" : "bts:Normal" - }, { - "@id" : "bts:NotReported" - }, { - "@id" : "bts:TestValueReported" - }, { - "@id" : "bts:unknown" - }, { - "@id" : "bts:Overexpressed" - }, { - "@id" : "bts:Intermediate" - }, { - "@id" : "bts:NotApplicable" - }, { - "@id" : "bts:LossofExpression" - }, { - "@id" : "bts:Low" - }, { - "@id" : "bts:High" - }, { - "@id" : "bts:Equivocal" + "@id" : "bts:CellBarcodeandDNAInsert" }, { - "@id" : "bts:CopyNumberReported" + "@id" : "bts:SampleIndexandDNAInsert" }, { - "@id" : "bts:Positive" + "@id" : "bts:DNAInsert" }, { - "@id" : "bts:Negative" + "@id" : "bts:SampleIndex" }, { - "@id" : "bts:AbnormalNOS" + "@id" : "bts:CellBarcode" } ], - "rdfs:label" : "TestResult", - "rdfs:comment" : "The text term used to describe the result of the molecular test. If the test result was a numeric value see test_value. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "Read2", + "rdfs:comment" : "Read 2 content description", "@type" : "rdfs:Class", - "sms:displayName" : "TestResult" + "sms:displayName" : "Read2" }, { - "@id" : "bts:MedianFractionofReadsinAnnotatedcisDNAElements", + "@id" : "bts:TotalReads", "@type" : "rdfs:Class", - "rdfs:comment" : "Median fraction of reads in annotated cis-DNA elements (FRIADE)", - "rdfs:label" : "MedianFractionofReadsinAnnotatedcisDNAElements", + "rdfs:comment" : "Total number of reads per sample. Integer", + "rdfs:label" : "TotalReads", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MedianFractionofReadsinAnnotatedcisDNAElements", + "sms:displayName" : "TotalReads", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Zygosity", + "@id" : "bts:HistoneVariant", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:mH2A" }, { - "@id" : "bts:NotReported" + "@id" : "bts:mH2A.1" }, { - "@id" : "bts:Heterozygous" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Hemizygous" + "@id" : "bts:H2A.Z" }, { - "@id" : "bts:Homozygous" + "@id" : "bts:H3.2" }, { - "@id" : "bts:Nullizygous" - } ], - "rdfs:label" : "Zygosity", - "rdfs:comment" : "The text term used to describe the zygosity of a specific genetic variant.", - "@type" : "rdfs:Class", - "sms:displayName" : "Zygosity" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastImagingPerformedType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { "@id" : "bts:unknown" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:H3t(H3.4)" }, { - "@id" : "bts:Mammogram" + "@id" : "bts:H3.X" }, { - "@id" : "bts:Ultrasound" + "@id" : "bts:H2A.Z.2.2" }, { - "@id" : "bts:MRI" + "@id" : "bts:H3.Y" }, { - "@id" : "bts:PET/CT" + "@id" : "bts:H3.5" }, { - "@id" : "bts:CT" + "@id" : "bts:H3.3" }, { - "@id" : "bts:Multipleimagingmodalities" - } ], - "rdfs:label" : "BreastImagingPerformedType", - "rdfs:comment" : "The kind of technology or method performed for screening, diagnosis, surgical procedures or therapy that aids in the visualization of the breast(s).", + "@id" : "bts:H3.1" + }, { + "@id" : "bts:H2A-Bbd" + }, { + "@id" : "bts:mH2A.2" + }, { + "@id" : "bts:CENP-A" + }, { + "@id" : "bts:H2A.Z.2" + }, { + "@id" : "bts:H2A.X" + }, { + "@id" : "bts:H2A.Z.1" + } ], + "rdfs:label" : "HistoneVariant", + "rdfs:comment" : "The text term used to describe a specific histone variants, which are proteins that substitute for the core canonical histones.", "@type" : "rdfs:Class", - "sms:displayName" : "BreastImagingPerformedType" + "sms:displayName" : "HistoneVariant" }, { - "@id" : "bts:PackYearsSmoked", + "@id" : "bts:Chewingtobaccodailyusecount", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.", - "rdfs:label" : "PackYearsSmoked", + "rdfs:comment" : "TBD", + "rdfs:label" : "Chewingtobaccodailyusecount", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PackYearsSmoked", + "sms:displayName" : "Chewingtobaccodailyusecount", "sms:required" : "sms:false" }, { - "@id" : "bts:TobaccoUseperDay", + "@id" : "bts:SecondGeneSymbol", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value that represents the number of times the patient uses tobacco each day.", - "rdfs:label" : "TobaccoUseperDay", + "rdfs:comment" : "The text term used to describe a secondary gene targeted or included in molecular analysis. For rearrangements, this is should represent the location of the variant. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "SecondGeneSymbol", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TobaccoUseperDay", + "sms:displayName" : "SecondGeneSymbol", "sms:required" : "sms:false" }, { - "@id" : "bts:TechnicalReplicateGroup", + "@id" : "bts:CycleNumber", "@type" : "rdfs:Class", - "rdfs:comment" : "A common term for all files belonging to the same cell or library. Provide a numbering of each library prep batch (can differ from encapsulation and sequencing batch)", - "rdfs:label" : "TechnicalReplicateGroup", + "rdfs:comment" : "TBD", + "rdfs:label" : "CycleNumber", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TechnicalReplicateGroup", + "sms:displayName" : "CycleNumber", "sms:required" : "sms:false" }, { - "@id" : "bts:Dilution", + "@id" : "bts:GeneSymbol", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Dilution", + "rdfs:comment" : "The text term used to describe a gene targeted or included in molecular analysis. For rearrangements, this is should be used to represent the reference gene. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "GeneSymbol", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Dilution", + "sms:displayName" : "GeneSymbol", "sms:required" : "sms:false" }, { - "@id" : "bts:FOVY", + "rdfs:subClassOf" : [ ], + "@id" : "bts:GenomicCoverageType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:WholeGenome" + }, { + "@id" : "bts:TargetedGenome" + }, { + "@id" : "bts:BeadchipArray" + } ], + "rdfs:label" : "GenomicCoverageType", + "rdfs:comment" : "Genomic coverage", "@type" : "rdfs:Class", - "rdfs:comment" : "Field of view Y dimension. Floating point value", - "rdfs:label" : "FOVY", + "sms:displayName" : "GenomicCoverageType" + }, { + "@id" : "bts:TargetDepth", + "@type" : "rdfs:Class", + "rdfs:comment" : "Targeted read depth prior to sequencing. Integer", + "rdfs:label" : "TargetDepth", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "FOVY", + "sms:displayName" : "TargetDepth", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:SiteofResectionorBiopsy", + "@id" : "bts:PixelType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Tonsillarfossa" - }, { - "@id" : "bts:Overlappinglesionoflung" - }, { - "@id" : "bts:Overlappinglesionofotherandunspecifiedpartsofmouth" - }, { - "@id" : "bts:Endometrium" - }, { - "@id" : "bts:BoneoflimbNOS" - }, { - "@id" : "bts:Posteriorwallofnasopharynx" - }, { - "@id" : "bts:SmallintestineNOS" - }, { - "@id" : "bts:Anteriorwallofnasopharynx" - }, { - "@id" : "bts:Thoracicesophagus" - }, { - "@id" : "bts:Parietallobe" - }, { - "@id" : "bts:HeadfaceorneckNOS" - }, { - "@id" : "bts:Endocervix" - }, { - "@id" : "bts:Supraglottis" - }, { - "@id" : "bts:Ethmoidsinus" - }, { - "@id" : "bts:Ileum" - }, { - "@id" : "bts:Overlappinglesionofheartmediastinumandpleura" - }, { - "@id" : "bts:Exocervix" - }, { - "@id" : "bts:PancreasNOS" - }, { - "@id" : "bts:Epididymis" - }, { - "@id" : "bts:KidneyNOS" - }, { - "@id" : "bts:AnusNOS" - }, { - "@id" : "bts:Cerebrum" - }, { - "@id" : "bts:Overlappinglesionofbreast" - }, { - "@id" : "bts:Overlappinglesionofperipheralnervesandautonomicnervoussystem" - }, { - "@id" : "bts:Fundusofstomach" - }, { - "@id" : "bts:OropharynxNOS" - }, { - "@id" : "bts:Urachus" - }, { - "@id" : "bts:Labiummajus" - }, { - "@id" : "bts:Parametrium" - }, { - "@id" : "bts:Vestibuleofmouth" - }, { - "@id" : "bts:Lowerthirdofesophagus" + "@id" : "bts:int32" }, { - "@id" : "bts:Overlappinglesionofdigestivesystem" + "@id" : "bts:int16" }, { - "@id" : "bts:Bonesofskullandfaceandassociatedjoints" + "@id" : "bts:double" }, { - "@id" : "bts:Lymphnodesofaxillaorarm" + "@id" : "bts:float" }, { - "@id" : "bts:SoftpalateNOS" + "@id" : "bts:uint16" }, { - "@id" : "bts:Hepaticflexureofcolon" + "@id" : "bts:int8" }, { - "@id" : "bts:Subglottis" + "@id" : "bts:uint32" }, { - "@id" : "bts:Overlappinglesionoflip" + "@id" : "bts:bit" }, { - "@id" : "bts:Extrahepaticbileduct" + "@id" : "bts:uint8" + } ], + "rdfs:label" : "PixelType", + "rdfs:comment" : "Data type for each pixel value. E.g. \"\"uint16\"\"", + "@type" : "rdfs:Class", + "sms:displayName" : "PixelType" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:VitalStatus", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Dead" }, { - "@id" : "bts:Vallecula" + "@id" : "bts:unknown" }, { - "@id" : "bts:TongueNOS" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Liver" + "@id" : "bts:Alive" + } ], + "rdfs:label" : "VitalStatus", + "rdfs:comment" : "The survival state of the person registered on the protocol.", + "@type" : "rdfs:Class", + "sms:displayName" : "VitalStatus" + }, { + "@id" : "bts:ParentID", + "@type" : "rdfs:Class", + "rdfs:comment" : "ID of parent biospecimen", + "rdfs:label" : "ParentID", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ParentID", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:FileFormat", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:dat" }, { - "@id" : "bts:Overlappinglesionofbonesjointsandarticularcartilage" + "@id" : "bts:Rscript" }, { - "@id" : "bts:NotReported" + "@id" : "bts:tif" }, { - "@id" : "bts:Peripheralnervesandautonomicnervoussystemofupperlimbandshoulder" + "@id" : "bts:bam" }, { - "@id" : "bts:Lymphnodesofmultipleregions" + "@id" : "bts:M" }, { - "@id" : "bts:Duodenum" + "@id" : "bts:7z" }, { - "@id" : "bts:Maxillarysinus" + "@id" : "bts:csv" }, { - "@id" : "bts:Intrahepaticbileduct" + "@id" : "bts:png" }, { - "@id" : "bts:Lateralwallofbladder" + "@id" : "bts:tar" }, { - "@id" : "bts:Overlappinglesionofhypopharynx" + "@id" : "bts:bai" }, { - "@id" : "bts:Overlappinglesionofrectumanusandanalcanal" + "@id" : "bts:OME-TIFF" }, { - "@id" : "bts:Middlethirdofesophagus" + "@id" : "bts:dup" }, { - "@id" : "bts:Lateralfloorofmouth" + "@id" : "bts:hic" }, { - "@id" : "bts:Anteriormediastinum" + "@id" : "bts:cellam" }, { - "@id" : "bts:Anteriorfloorofmouth" + "@id" : "bts:idat" }, { - "@id" : "bts:NervoussystemNOS" + "@id" : "bts:txt" }, { - "@id" : "bts:Waldeyerring" + "@id" : "bts:raw" }, { - "@id" : "bts:Ribsternumclavicleandassociatedjoints" + "@id" : "bts:hdf5" }, { - "@id" : "bts:Longbonesoflowerlimbandassociatedjoints" + "@id" : "bts:bgzip" }, { - "@id" : "bts:Frontalsinus" + "@id" : "bts:seg" }, { - "@id" : "bts:Uterineadnexa" + "@id" : "bts:rmd" }, { - "@id" : "bts:Trachea" + "@id" : "bts:scn" }, { - "@id" : "bts:RectumNOS" + "@id" : "bts:vcf" }, { - "@id" : "bts:AdrenalglandNOS" + "@id" : "bts:maf" }, { - "@id" : "bts:PleuraNOS" + "@id" : "bts:tsv" }, { - "@id" : "bts:LowerlimbNOS" + "@id" : "bts:pdf" }, { - "@id" : "bts:Transversecolon" + "@id" : "bts:sam" }, { - "@id" : "bts:Lymphnodesofheadfaceandneck" + "@id" : "bts:bedgraph" }, { - "@id" : "bts:GreatercurvatureofstomachNOS" + "@id" : "bts:sra" }, { - "@id" : "bts:UpperrespiratorytractNOS" + "@id" : "bts:abf" }, { - "@id" : "bts:Overlappinglesionofpancreas" + "@id" : "bts:fastq" }, { - "@id" : "bts:CerebellumNOS" + "@id" : "bts:pzfx" }, { - "@id" : "bts:Overlappinglesionsoforopharynx" + "@id" : "bts:bednarrowPeak" }, { - "@id" : "bts:Axillarytailofbreast" + "@id" : "bts:fig" }, { - "@id" : "bts:unknown" + "@id" : "bts:am" }, { - "@id" : "bts:VulvaNOS" + "@id" : "bts:gct" }, { - "@id" : "bts:FloorofmouthNOS" + "@id" : "bts:tagAlign" }, { - "@id" : "bts:Overlappinglesionofmalegenitalorgans" + "@id" : "bts:gzip" }, { - "@id" : "bts:UterusNOS" + "@id" : "bts:gtf" }, { - "@id" : "bts:Bodyofstomach" + "@id" : "bts:DICOM" }, { - "@id" : "bts:Urethra" + "@id" : "bts:cloupe" }, { - "@id" : "bts:Middlelobelung" + "@id" : "bts:czi" }, { - "@id" : "bts:Tailofpancreas" + "@id" : "bts:tiff" }, { - "@id" : "bts:Pinealgland" + "@id" : "bts:powerpoint" }, { - "@id" : "bts:Spermaticcord" + "@id" : "bts:zip" }, { - "@id" : "bts:Carotidbody" + "@id" : "bts:bed" }, { - "@id" : "bts:ReticuloendothelialsystemNOS" + "@id" : "bts:mex" }, { - "@id" : "bts:Otherspecifiedpartsofpancreas" + "@id" : "bts:ab1" }, { - "@id" : "bts:Externalear" + "@id" : "bts:Pythonscript" }, { - "@id" : "bts:Meckeldiverticulum" + "@id" : "bts:msf" }, { - "@id" : "bts:PenisNOS" + "@id" : "bts:mzML" }, { - "@id" : "bts:Lower-innerquadrantofbreast" + "@id" : "bts:svg" }, { - "@id" : "bts:Superiorwallofnasopharynx" + "@id" : "bts:cel" }, { - "@id" : "bts:Retina" + "@id" : "bts:mtx" }, { - "@id" : "bts:Borderoftongue" + "@id" : "bts:bigwig" }, { - "@id" : "bts:Intra-abdominallymphnodes" + "@id" : "bts:chp" }, { - "@id" : "bts:Peripheralnervesandautonomicnervoussystemofthorax" + "@id" : "bts:svs" }, { - "@id" : "bts:Caudaequina" + "@id" : "bts:wiggle" }, { - "@id" : "bts:Overlappinglesionofpalate" + "@id" : "bts:mov" }, { - "@id" : "bts:NasopharynxNOS" + "@id" : "bts:bcf" }, { - "@id" : "bts:Placenta" + "@id" : "bts:hyperlink" }, { - "@id" : "bts:ExternallipNOS" + "@id" : "bts:sdf" }, { - "@id" : "bts:BoneNOS" + "@id" : "bts:recal" }, { - "@id" : "bts:Ciliarybody" + "@id" : "bts:idx" }, { - "@id" : "bts:HematopoieticsystemNOS" + "@id" : "bts:sif" }, { - "@id" : "bts:Prepuce" + "@id" : "bts:json" }, { - "@id" : "bts:Pelviclymphnodes" + "@id" : "bts:avi" }, { - "@id" : "bts:Postcricoidregion" + "@id" : "bts:HEIC" }, { - "@id" : "bts:Externalupperlip" + "@id" : "bts:gff3" }, { - "@id" : "bts:Peripheralnervesandautonomicnervoussystemofpelvis" + "@id" : "bts:bpm" }, { - "@id" : "bts:PelvisNOS" + "@id" : "bts:bedbroadPeak" }, { - "@id" : "bts:Connectivesubcutaneousandothersofttissuesofabdomen" + "@id" : "bts:excel" }, { - "@id" : "bts:Vertebralcolumn" + "@id" : "bts:flagstat" }, { - "@id" : "bts:Bodyofpancreas" + "@id" : "bts:mpg" }, { - "@id" : "bts:Trigoneofbladder" + "@id" : "bts:RData" }, { - "@id" : "bts:Commissureoflip" + "@id" : "bts:Sentrixdescriptorfile" }, { - "@id" : "bts:Peripheralnervesandautonomicnervoussystemofabdomen" + "@id" : "bts:jpg" }, { - "@id" : "bts:Upper-innerquadrantofbreast" + "@id" : "bts:doc" }, { - "@id" : "bts:PalateNOS" + "@id" : "bts:bedgappedPeak" }, { - "@id" : "bts:Hypopharyngealaspectofaryepiglotticfold" + "@id" : "bts:xml" }, { - "@id" : "bts:Uppergum" + "@id" : "bts:sqlite" }, { - "@id" : "bts:ThoraxNOS" + "@id" : "bts:tranches" }, { - "@id" : "bts:Spinalcord" + "@id" : "bts:plink" }, { - "@id" : "bts:BrainNOS" + "@id" : "bts:sav" }, { - "@id" : "bts:MouthNOS" + "@id" : "bts:locs" }, { - "@id" : "bts:Connectivesubcutaneousandothersofttissuesofupperlimbandshoulder" + "@id" : "bts:html" }, { - "@id" : "bts:Retroperitoneum" + "@id" : "bts:md" }, { - "@id" : "bts:Longbonesofupperlimbscapulaandassociatedjoints" + "@id" : "bts:fasta" + } ], + "rdfs:label" : "FileFormat", + "rdfs:comment" : "Format of a file (e.g. txt, csv, fastq, bam, etc.)", + "@type" : "rdfs:Class", + "sms:displayName" : "FileFormat" + }, { + "@id" : "bts:LinkedMatrices", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LinkedMatrices", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LinkedMatrices", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:AlcoholExposure", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes-AlcoholExposure" }, { - "@id" : "bts:Hardpalate" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Gallbladder" + "@id" : "bts:No-AlcoholExposure" + } ], + "rdfs:label" : "AlcoholExposure", + "rdfs:comment" : "Indicate if individual has alcohol exposure", + "@type" : "rdfs:Class", + "sms:displayName" : "AlcoholExposure" + }, { + "@id" : "bts:ScRNAseqWorkflowParametersDescription", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ScRNAseqWorkflowParametersDescription", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ScRNAseqWorkflowParametersDescription", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ExcitationBandwidth", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ExcitationBandwidth", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ExcitationBandwidth", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:PriorInvasiveBreastDisease", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" }, { - "@id" : "bts:EndocrineglandNOS" + "@id" : "bts:unknown" }, { - "@id" : "bts:Brainstem" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:CorneaNOS" + "@id" : "bts:DCIS" }, { - "@id" : "bts:Overlappinglesionofnasopharynx" + "@id" : "bts:LCIS" }, { - "@id" : "bts:DorsalsurfaceoftongueNOS" + "@id" : "bts:Invasivebreastcancer(unrelatedtothecurrentcancer)" + } ], + "rdfs:label" : "PriorInvasiveBreastDisease", + "rdfs:comment" : "Text term to indicate prior invasive breast condition in the participant", + "@type" : "rdfs:Class", + "sms:displayName" : "PriorInvasiveBreastDisease" + }, { + "@id" : "bts:SizeT", + "@type" : "rdfs:Class", + "rdfs:comment" : "Number of time points. Integer >= 1", + "rdfs:label" : "SizeT", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SizeT", + "sms:required" : "sms:false" + }, { + "@id" : "bts:Intron", + "@type" : "rdfs:Class", + "rdfs:comment" : "Intron number targeted or included in molecular analysis. If a specific genetic variant is being reported, this property can be used to capture the intron where that variant is located.", + "rdfs:label" : "Intron", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Intron", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastCancerGenomicTestPerformed", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" }, { - "@id" : "bts:MajorsalivaryglandNOS" + "@id" : "bts:unknown" }, { - "@id" : "bts:Abdominalesophagus" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:Olfactorynerve" + "@id" : "bts:Oncotype" }, { - "@id" : "bts:Shortbonesofupperlimbandassociatedjoints" + "@id" : "bts:MammaPrint" }, { - "@id" : "bts:Overlappinglesionoftonsil" + "@id" : "bts:Notperformed" + } ], + "rdfs:label" : "BreastCancerGenomicTestPerformed", + "rdfs:comment" : "Text term that represents the name of the genomic test performed for breast cancer.", + "@type" : "rdfs:Class", + "sms:displayName" : "BreastCancerGenomicTestPerformed" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:EnvironmentalTobaccoSmokeExposure", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" }, { - "@id" : "bts:AutonomicnervoussystemNOS" + "@id" : "bts:No" }, { - "@id" : "bts:Ill-definedsiteswithinrespiratorysystem" + "@id" : "bts:unknown" + } ], + "rdfs:label" : "EnvironmentalTobaccoSmokeExposure", + "rdfs:comment" : "The yes/no/unknown indicator used to describe whether a patient was exposed to smoke that is emitted from burning tobacco, including cigarettes, pipes, and cigars. This includes tobacco smoke exhaled by smokers.", + "@type" : "rdfs:Class", + "sms:displayName" : "EnvironmentalTobaccoSmokeExposure" + }, { + "@id" : "bts:ProtocolLink", + "@type" : "rdfs:Class", + "rdfs:comment" : "URL to a free/open protocol resource describing the assay protocol (e.g. surface markers used in Smart-seq, dissociation duration, lot/batch numbers for key reagents such as primers, sequencing reagent kits, etc.) or the protocol by which the sample was obtained or generated.", + "rdfs:label" : "ProtocolLink", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ProtocolLink", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:RelativewithCancerHistory", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes-CancerHistoryRelative" }, { - "@id" : "bts:Lymphnodesofinguinalregionorleg" + "@id" : "bts:unknown" }, { - "@id" : "bts:Overlappinglesionofmajorsalivaryglands" + "@id" : "bts:NotReported" }, { - "@id" : "bts:PeripheralnervesandautonomicnervoussystemoftrunkNOS" + "@id" : "bts:None" + } ], + "rdfs:label" : "RelativewithCancerHistory", + "rdfs:comment" : "The yes/no/unknown indicator used to describe whether any of the patient's relatives have a history of cancer.", + "@type" : "rdfs:Class", + "sms:displayName" : "RelativewithCancerHistory" + }, { + "@id" : "bts:LibraryPrepKitVendor", + "@type" : "rdfs:Class", + "rdfs:comment" : "Vendor of Library Prep Kit. String", + "rdfs:label" : "LibraryPrepKitVendor", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LibraryPrepKitVendor", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:PrecancerousConditionType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:CarcinomaNOS" }, { - "@id" : "bts:Fundusuteri" + "@id" : "bts:Atypicalmelanocyticproliferation" }, { - "@id" : "bts:TestisNOS" + "@id" : "bts:Superficialspreading" }, { - "@id" : "bts:Parotidgland" + "@id" : "bts:Melanomainsituarisinginagiantcongenitalnevus" }, { - "@id" : "bts:AmpullaofVater" + "@id" : "bts:Invasivemelanoma" }, { - "@id" : "bts:CardiaNOS" + "@id" : "bts:Invasivemelanoma-acrallentiginous" }, { - "@id" : "bts:SkinoflipNOS" + "@id" : "bts:Melanomainsitunototherwiseclassified" }, { - "@id" : "bts:Overlappinglesionofstomach" + "@id" : "bts:Milddysplasia" }, { - "@id" : "bts:Rectosigmoidjunction" + "@id" : "bts:Adenocarcinomainsitu-nonmucinous" }, { - "@id" : "bts:Gastricantrum" + "@id" : "bts:Reservecellhyperplasia" }, { - "@id" : "bts:Cortexofadrenalgland" + "@id" : "bts:Invasivemelanoma-nevoid" }, { - "@id" : "bts:Renalpelvis" + "@id" : "bts:Nodiagnosispossible" }, { - "@id" : "bts:Middleear" + "@id" : "bts:Hamartoma" }, { - "@id" : "bts:Overlappinglesionoffemalegenitalorgans" + "@id" : "bts:Adenocarcinomainsitu-mucinous" }, { - "@id" : "bts:GastrointestinaltractNOS" + "@id" : "bts:Squamousmetaplasia-immature" }, { - "@id" : "bts:Connectivesubcutaneousandothersofttissuesofthorax" + "@id" : "bts:Severedysplasia" }, { - "@id" : "bts:SkinNOS" + "@id" : "bts:Invasivemelanoma-lentigomaligna" }, { - "@id" : "bts:Parathyroidgland" + "@id" : "bts:Squamousmetaplasia-mature" }, { - "@id" : "bts:Pituitarygland" + "@id" : "bts:Acral-lentiginous" }, { - "@id" : "bts:Overlappinglesionoftongue" + "@id" : "bts:Invasivemelanoma-superficialspreading" }, { - "@id" : "bts:LungNOS" + "@id" : "bts:Atypicaladenomatoushyperplasia" }, { - "@id" : "bts:Cervixuteri" + "@id" : "bts:Moderatedysplasia" }, { - "@id" : "bts:Skinofotherandunspecifiedpartsofface" + "@id" : "bts:AtypicalAdenomatousLungHyperplasia" }, { - "@id" : "bts:Submandibulargland" + "@id" : "bts:NormalWDA" }, { - "@id" : "bts:Clitoris" + "@id" : "bts:Other" }, { - "@id" : "bts:Centralportionofbreast" + "@id" : "bts:Persistentmelanomainsitu" }, { - "@id" : "bts:Ovary" + "@id" : "bts:PancreaticIntraepithelialNeoplasia" }, { - "@id" : "bts:Lateralwalloforopharynx" + "@id" : "bts:DuctalCarcinomaInSitu" }, { - "@id" : "bts:StomachNOS" + "@id" : "bts:PancreaticIntraductalPapillary-MucinousNeoplasm" }, { - "@id" : "bts:VentralsurfaceoftongueNOS" + "@id" : "bts:Melanocytichyperplasia" }, { - "@id" : "bts:Overlappinglesionofurinaryorgans" + "@id" : "bts:Melanomainsitu" }, { - "@id" : "bts:Sigmoidcolon" + "@id" : "bts:Invasivemelanoma-desmoplastic" }, { - "@id" : "bts:Overlappinglesionofbrain" + "@id" : "bts:BenigntumorNOS" }, { - "@id" : "bts:Overlappinglesionofcolon" + "@id" : "bts:Lentigomalignatype" }, { - "@id" : "bts:Glanspenis" + "@id" : "bts:Scar-noresidualmelanoma" }, { - "@id" : "bts:MediastinumNOS" + "@id" : "bts:Invasivemelanoma-nodulartype" }, { - "@id" : "bts:VaginaNOS" + "@id" : "bts:ProstaticIntraepithelialNeoplasia" + } ], + "rdfs:label" : "PrecancerousConditionType", + "rdfs:comment" : "The classification of pre-cancerous cells found in a specific collection of data being studied by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).", + "@type" : "rdfs:Class", + "sms:displayName" : "PrecancerousConditionType" + }, { + "@id" : "bts:CellBarcodeOffset", + "@type" : "rdfs:Class", + "rdfs:comment" : "Offset in sequence for cell barcode read (in bp): number", + "rdfs:label" : "CellBarcodeOffset", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CellBarcodeOffset", + "sms:required" : "sms:false" + }, { + "@id" : "bts:UMIBarcodeLength", + "@type" : "rdfs:Class", + "rdfs:comment" : "Length of UMI barcode read (in bp): number", + "rdfs:label" : "UMIBarcodeLength", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "UMIBarcodeLength", + "sms:required" : "sms:false" + }, { + "@id" : "bts:IschemicTime", + "@type" : "rdfs:Class", + "rdfs:comment" : "Duration of time, in seconds, between when the specimen stopped receiving oxygen and when it was preserved or processed. Integer value.", + "rdfs:label" : "IschemicTime", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "IschemicTime", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ProgressionorRecurrenceType", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ProgressionorRecurrenceType", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ProgressionorRecurrenceType", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:AlcoholType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" }, { - "@id" : "bts:Lower-outerquadrantofbreast" + "@id" : "bts:unknown" }, { - "@id" : "bts:PharynxNOS" + "@id" : "bts:NotReported" }, { - "@id" : "bts:IntestinaltractNOS" + "@id" : "bts:Beer" }, { - "@id" : "bts:Peripheralnervesandautonomicnervoussystemofheadfaceandneck" + "@id" : "bts:Liquor" }, { - "@id" : "bts:Overlappinglesionofbladder" + "@id" : "bts:Wine" + } ], + "rdfs:label" : "AlcoholType", + "rdfs:comment" : "Type of alcohol use", + "@type" : "rdfs:Class", + "sms:displayName" : "AlcoholType" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:MismatchRepairMutation", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" }, { - "@id" : "bts:Pyriformsinus" + "@id" : "bts:No" }, { - "@id" : "bts:Conjunctiva" + "@id" : "bts:unknown" + } ], + "rdfs:label" : "MismatchRepairMutation", + "rdfs:comment" : "The yes/no/unknown indicator used to describe whether the mutation included in molecular testing was known to have an affect on the mismatch repair process. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "@type" : "rdfs:Class", + "sms:displayName" : "MismatchRepairMutation" + }, { + "@id" : "bts:Filename", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "Filename", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Filename", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AdapterName", + "@type" : "rdfs:Class", + "rdfs:comment" : "Name of the sequencing adapter. String", + "rdfs:label" : "AdapterName", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AdapterName", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CountryofBirth", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "CountryofBirth", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CountryofBirth", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:LibraryConstructionMethod", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:10xV3" }, { - "@id" : "bts:ConnectivesubcutaneousandothersofttissuesNOS" + "@id" : "bts:inDropsV2" }, { - "@id" : "bts:Acousticnerve" + "@id" : "bts:10xV1.1" }, { - "@id" : "bts:LessercurvatureofstomachNOS" + "@id" : "bts:10xV3.1" }, { - "@id" : "bts:Mucosaoflowerlip" + "@id" : "bts:Drop-seq" }, { - "@id" : "bts:BladderNOS" + "@id" : "bts:10xV2" }, { - "@id" : "bts:Intrathoraciclymphnodes" + "@id" : "bts:10xV1.0" }, { - "@id" : "bts:Pylorus" + "@id" : "bts:Smart-seq2" }, { - "@id" : "bts:Blood" + "@id" : "bts:Smart-SeqV4" }, { - "@id" : "bts:BiliarytractNOS" + "@id" : "bts:sci-ATAC-seq" }, { - "@id" : "bts:AccessorysinusNOS" + "@id" : "bts:inDropsV3" }, { - "@id" : "bts:Mandible" + "@id" : "bts:CEL-seq2" }, { - "@id" : "bts:Overlappinglesionofretroperitoneumandperitoneum" + "@id" : "bts:TruDrop" + } ], + "rdfs:label" : "LibraryConstructionMethod", + "rdfs:comment" : "Process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors [OBI_0000711]", + "@type" : "rdfs:Class", + "sms:displayName" : "LibraryConstructionMethod" + }, { + "@id" : "bts:OtherBiopsyResectionSite", + "@type" : "rdfs:Class", + "rdfs:comment" : "A description of the location on or within the human body where the surgical biopsy/resection procedure was performed (Not covered under Clinical Data Tier 1)", + "rdfs:label" : "OtherBiopsyResectionSite", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "OtherBiopsyResectionSite", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MedianPassingReadPercentage", + "@type" : "rdfs:Class", + "rdfs:comment" : "Non-PCR duplicate nuclear genomic sequence reads not aligning to unanchored contigs out of total reads assigned to the nucleus barcode", + "rdfs:label" : "MedianPassingReadPercentage", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MedianPassingReadPercentage", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ReadIndicator", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:I1" }, { - "@id" : "bts:UrinarysystemNOS" + "@id" : "bts:R1" }, { - "@id" : "bts:Sublingualgland" + "@id" : "bts:R2" }, { - "@id" : "bts:TonsilNOS" + "@id" : "bts:R1&R2" }, { - "@id" : "bts:Anteriorsurfaceofepiglottis" + "@id" : "bts:R3" }, { - "@id" : "bts:Branchialcleft" + "@id" : "bts:NotApplicable" + } ], + "rdfs:label" : "ReadIndicator", + "rdfs:comment" : "TBD", + "@type" : "rdfs:Class", + "sms:displayName" : "ReadIndicator" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:InvasiveLobularBreastCarcinomaHistologicCategory", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" }, { - "@id" : "bts:PeritoneumNOS" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:Lacrimalgland" + "@id" : "bts:Alveolartype" }, { - "@id" : "bts:Spleen" + "@id" : "bts:Classicaltype" }, { - "@id" : "bts:Opticnerve" + "@id" : "bts:Pleomorphictype" + } ], + "rdfs:label" : "InvasiveLobularBreastCarcinomaHistologicCategory", + "rdfs:comment" : "The histologic subtype for an infiltrating lobular carcinoma of the breast.", + "@type" : "rdfs:Class", + "sms:displayName" : "InvasiveLobularBreastCarcinomaHistologicCategory" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:TumorExtranodalExtensionIndicator", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Absent" }, { - "@id" : "bts:Cervicalesophagus" + "@id" : "bts:Notapplicable" }, { - "@id" : "bts:Fallopiantube" + "@id" : "bts:YES" }, { - "@id" : "bts:BaseoftongueNOS" + "@id" : "bts:unspecified" }, { - "@id" : "bts:Skinofupperlimbandshoulder" + "@id" : "bts:Nosourcedocumentation" }, { - "@id" : "bts:Craniopharyngealduct" + "@id" : "bts:UNKNOWN" }, { - "@id" : "bts:Specifiedpartsofperitoneum" + "@id" : "bts:Present" }, { - "@id" : "bts:Pancreaticduct" + "@id" : "bts:Present-extensive" }, { - "@id" : "bts:Externallowerlip" + "@id" : "bts:Notsampledordissected" }, { - "@id" : "bts:Overlappinglesionofcervixuteri" + "@id" : "bts:Present-minimal" }, { - "@id" : "bts:Anteriorwallofbladder" + "@id" : "bts:NO" }, { - "@id" : "bts:Uvula" + "@id" : "bts:Indeterminate" + } ], + "rdfs:label" : "TumorExtranodalExtensionIndicator", + "rdfs:comment" : "The indicator to determine extranodal involvement or extent of the disease.", + "@type" : "rdfs:Class", + "sms:displayName" : "TumorExtranodalExtensionIndicator" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ERReceptorStatus", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" }, { - "@id" : "bts:Upper-outerquadrantofbreast" + "@id" : "bts:Borderline" }, { - "@id" : "bts:Overlappinglesionofesophagus" + "@id" : "bts:Equivocal" }, { - "@id" : "bts:Shortbonesoflowerlimbandassociatedjoints" + "@id" : "bts:Indeterminate" }, { - "@id" : "bts:Ascendingcolon" + "@id" : "bts:Negative" }, { - "@id" : "bts:Mucosaofupperlip" + "@id" : "bts:NotPerformed" }, { - "@id" : "bts:Connectivesubcutaneousandothersofttissuesofheadfaceandneck" + "@id" : "bts:PerformedbutNotAvailable" }, { - "@id" : "bts:Analcanal" + "@id" : "bts:Positive" + } ], + "rdfs:label" : "ERReceptorStatus", + "rdfs:comment" : "Text term to represent the overall result of Estrogen Receptor (ER) testing in a participant with breast cancer", + "@type" : "rdfs:Class", + "sms:displayName" : "ERReceptorStatus" + }, { + "@id" : "bts:Comment", + "@type" : "rdfs:Class", + "rdfs:comment" : "Free text field (generally for QC comment)", + "rdfs:label" : "Comment", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Comment", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastQuadrantSite", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" }, { - "@id" : "bts:HypopharynxNOS" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:Aorticbodyandotherparaganglia" + "@id" : "bts:Upperouterquadrant" }, { - "@id" : "bts:Overlappinglesionofendocrineglandsandrelatedstructures" + "@id" : "bts:Lowerouterquadrant" }, { - "@id" : "bts:LarynxNOS" + "@id" : "bts:Upperinnerquadrant" }, { - "@id" : "bts:Ureter" + "@id" : "bts:Lowerinnerquadrant" }, { - "@id" : "bts:EyeNOS" + "@id" : "bts:Central" }, { - "@id" : "bts:Medullaofadrenalgland" + "@id" : "bts:Nipple" + } ], + "rdfs:label" : "BreastQuadrantSite", + "rdfs:comment" : "The breast quadrant or structure from which the breast tissue specimen was removed for microscopic examination.", + "@type" : "rdfs:Class", + "sms:displayName" : "BreastQuadrantSite" + }, { + "@id" : "bts:LinkedDatasets", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LinkedDatasets", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LinkedDatasets", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BreastCarcinomaHER2Chromosome17Ratio", + "@type" : "rdfs:Class", + "rdfs:comment" : "HER2 chromosome 17 ratio in participants with breast cancer", + "rdfs:label" : "BreastCarcinomaHER2Chromosome17Ratio", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastCarcinomaHER2Chromosome17Ratio", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PhysicalSizeY", + "@type" : "rdfs:Class", + "rdfs:comment" : "Physical size (Y-dimension) of a pixel. Units are set by PhysicalSizeYUnit. Floating point value > 0.", + "rdfs:label" : "PhysicalSizeY", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PhysicalSizeY", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MetalIsotopeMass", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "MetalIsotopeMass", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MetalIsotopeMass", + "sms:required" : "sms:false" + }, { + "@id" : "bts:BiospecimenDimension2", + "@type" : "rdfs:Class", + "rdfs:comment" : "Second dimension of tissue fragment (number, up to one decimal place) measured in units as defined by the \"\"dimensions_unit\"\" CDE", + "rdfs:label" : "BiospecimenDimension2", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BiospecimenDimension2", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:Laterality", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:NotApplicable" }, { - "@id" : "bts:ColonNOS" + "@id" : "bts:unknown" }, { - "@id" : "bts:Lowerlobelung" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Eyelid" + "@id" : "bts:Bilateral" }, { - "@id" : "bts:Overlappinglesionofrespiratorysystemandintrathoracicorgans" + "@id" : "bts:Left" }, { - "@id" : "bts:Overlappinglesionofconnectivesubcutaneousandothersofttissues" + "@id" : "bts:Right" + } ], + "rdfs:label" : "Laterality", + "rdfs:comment" : "For samples in paired organs, designates the side from which obtained.", + "@type" : "rdfs:Class", + "sms:displayName" : "Laterality" + }, { + "@id" : "bts:MedianFractionofReadsinPeaks", + "@type" : "rdfs:Class", + "rdfs:comment" : "Median fraction of reads in peaks (FRIP)", + "rdfs:label" : "MedianFractionofReadsinPeaks", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MedianFractionofReadsinPeaks", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:VariantType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Duplication" }, { - "@id" : "bts:EsophagusNOS" + "@id" : "bts:Conversion" }, { - "@id" : "bts:Overlappinglesionofbrainandcentralnervoussystem" + "@id" : "bts:Chrimerism" }, { - "@id" : "bts:Choroid" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Bladderneck" + "@id" : "bts:PartialMethylation" }, { - "@id" : "bts:Overlappinglesionofskin" + "@id" : "bts:unknown" }, { - "@id" : "bts:Thyroidgland" + "@id" : "bts:Substitution" }, { - "@id" : "bts:Sphenoidsinus" + "@id" : "bts:Deletion-Insertion" }, { - "@id" : "bts:Roundligament" + "@id" : "bts:Loss" }, { - "@id" : "bts:BreastNOS" + "@id" : "bts:Insertion" }, { - "@id" : "bts:Upperlobelung" + "@id" : "bts:Hypermethylation" }, { - "@id" : "bts:Splenicflexureofcolon" + "@id" : "bts:Alleles" }, { - "@id" : "bts:CranialnerveNOS" + "@id" : "bts:Methylation" }, { - "@id" : "bts:Paraurethralgland" + "@id" : "bts:Inversion" }, { - "@id" : "bts:Posteriorwalloforopharynx" + "@id" : "bts:Extension" }, { - "@id" : "bts:Otherspecifiedpartsofmalegenitalorgans" + "@id" : "bts:Mosaicism" }, { - "@id" : "bts:Undescendedtestis" + "@id" : "bts:Deletion" }, { - "@id" : "bts:Nasalcavity" + "@id" : "bts:Other" }, { - "@id" : "bts:Cerebralmeninges" + "@id" : "bts:Rearrangement" }, { - "@id" : "bts:Overlappinglesionoffloorofmouth" + "@id" : "bts:Translocation" }, { - "@id" : "bts:Overlappinglesionofcorpusuteri" + "@id" : "bts:Amplification" }, { - "@id" : "bts:LipNOS" + "@id" : "bts:RepeatedSequences" }, { - "@id" : "bts:Cheekmucosa" + "@id" : "bts:Splice" }, { - "@id" : "bts:UpperlimbNOS" + "@id" : "bts:Gain" + } ], + "rdfs:label" : "VariantType", + "rdfs:comment" : "The text term used to describe the type of genetic variation.", + "@type" : "rdfs:Class", + "sms:displayName" : "VariantType" + }, { + "@id" : "bts:CigarettesperDay", + "@type" : "rdfs:Class", + "rdfs:comment" : "The average number of cigarettes smoked per day.", + "rdfs:label" : "CigarettesperDay", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CigarettesperDay", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CellBarcodeTag", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "CellBarcodeTag", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CellBarcodeTag", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ReadContent", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:CellBarcodeandDNAInsert" }, { - "@id" : "bts:Domeofbladder" + "@id" : "bts:SampleIndexandDNAInsert" }, { - "@id" : "bts:Connectivesubcutaneousandothersofttissuesofpelvis" + "@id" : "bts:DNAInsert" }, { - "@id" : "bts:unknownprimarysite" + "@id" : "bts:SampleIndex" }, { - "@id" : "bts:Posteriormediastinum" + "@id" : "bts:CellBarcode" + } ], + "rdfs:label" : "ReadContent", + "rdfs:comment" : "Read content description", + "@type" : "rdfs:Class", + "sms:displayName" : "ReadContent" + }, { + "@id" : "bts:DaystoProgressionFree", + "@type" : "rdfs:Class", + "rdfs:comment" : "Number of days between the date used for index and the date the patient's disease was formally confirmed as progression-free.", + "rdfs:label" : "DaystoProgressionFree", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "DaystoProgressionFree", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:MultifocalBreastCarcinomaPresentIndicator", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" }, { - "@id" : "bts:Uretericorifice" + "@id" : "bts:No" }, { - "@id" : "bts:Otherill-definedsites" + "@id" : "bts:unknown" + } ], + "rdfs:label" : "MultifocalBreastCarcinomaPresentIndicator", + "rdfs:comment" : "A response to indicate if there is breast cancer characterized by the presence of multiple cancerous tumors that originate from the same clone and usually located in the same quadrant of the breast.", + "@type" : "rdfs:Class", + "sms:displayName" : "MultifocalBreastCarcinomaPresentIndicator" + }, { + "@id" : "bts:BiospecimenID", + "@type" : "rdfs:Class", + "rdfs:comment" : " Alias for Sample ID", + "rdfs:label" : "BiospecimenID", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BiospecimenID", + "sms:required" : "sms:true" + }, { + "@id" : "bts:BloodTestNormalRangeLower", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value used to describe the lower limit of the normal range used to describe a healthy individual at the institution where the test was completed.", + "rdfs:label" : "BloodTestNormalRangeLower", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BloodTestNormalRangeLower", + "sms:required" : "sms:false" + }, { + "@id" : "bts:RuralvsUrban", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "RuralvsUrban", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "RuralvsUrban", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:MulticentricBreastCarcinomaPresentIndicator", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" }, { - "@id" : "bts:Bonemarrow" + "@id" : "bts:No" }, { - "@id" : "bts:Peripheralnervesandautonomicnervoussystemoflowerlimbandhip" + "@id" : "bts:unknown" + } ], + "rdfs:label" : "MulticentricBreastCarcinomaPresentIndicator", + "rdfs:comment" : "A response to indicate if there is breast cancer characterized by the presence of multiple cancerous tumors that originate from different clones and usually located in different quadrants of the breast.", + "@type" : "rdfs:Class", + "sms:displayName" : "MulticentricBreastCarcinomaPresentIndicator" + }, { + "@id" : "bts:UMITag", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "UMITag", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "UMITag", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CellBarcodeLength", + "@type" : "rdfs:Class", + "rdfs:comment" : "Length of cell barcode read (in bp): number", + "rdfs:label" : "CellBarcodeLength", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CellBarcodeLength", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ClassBRCA1", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ClassBRCA1", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ClassBRCA1", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SectionNumberinSequence", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value (integer, including ranges) provided to a sample in a series of sections (list all adjacent sections in the Adjacent Biospecimen IDs field)", + "rdfs:label" : "SectionNumberinSequence", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SectionNumberinSequence", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SampleCollectionCenter", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SampleCollectionCenter", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SampleCollectionCenter", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CopyNumber", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value used to describe the number of times a section of the genome is repeated or copied within an insertion, duplication or deletion variant. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "CopyNumber", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CopyNumber", + "sms:required" : "sms:false" + }, { + "@id" : "bts:SectioningDaysfromIndex", + "@type" : "rdfs:Class", + "rdfs:comment" : "Number of days from the research participant's index date that the biospecimen was sectioned after collection", + "rdfs:label" : "SectioningDaysfromIndex", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SectioningDaysfromIndex", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:Immersion", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Air" }, { - "@id" : "bts:LymphnodeNOS" + "@id" : "bts:Oil" }, { - "@id" : "bts:Skinofscalpandneck" + "@id" : "bts:Water" }, { - "@id" : "bts:Retromolararea" + "@id" : "bts:Other" + } ], + "rdfs:label" : "Immersion", + "rdfs:comment" : "Immersion medium", + "@type" : "rdfs:Class", + "sms:displayName" : "Immersion" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:Pyramid", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ ], + "rdfs:label" : "Pyramid", + "rdfs:comment" : "Does data file contain pyramid of images", + "@type" : "rdfs:Class", + "sms:displayName" : "Pyramid" + }, { + "@id" : "bts:SampleSite", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "SampleSite", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "SampleSite", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:MismatchRepairSystemStatus", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:MismatchrepairdeficiencyMMRD" }, { - "@id" : "bts:Overlappinglesionofliporalcavityandpharynx" + "@id" : "bts:MismatchrepairproficiencyMMPP" }, { - "@id" : "bts:Overlappinglesionofaccessorysinuses" + "@id" : "bts:MicrosatelliteinstabilityhighMSIH" }, { - "@id" : "bts:Overlappinglesionofpenis" + "@id" : "bts:MicrosatellitestableMSS" }, { - "@id" : "bts:Overlappinglesionofvulva" + "@id" : "bts:unknownorother" + } ], + "rdfs:label" : "MismatchRepairSystemStatus", + "rdfs:comment" : "The text that best describes the condition or state of MMR (mismatch repair system) in the patient", + "@type" : "rdfs:Class", + "sms:displayName" : "MismatchRepairSystemStatus" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:Tseries", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" }, { - "@id" : "bts:Overlappinglesionofill-definedsites" + "@id" : "bts:No" + } ], + "rdfs:label" : "Tseries", + "rdfs:comment" : "Does data file contain a time-series of images", + "@type" : "rdfs:Class", + "sms:displayName" : "Tseries" + }, { + "@id" : "bts:Component", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "Component", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Component", + "sms:required" : "sms:false" + }, { + "@id" : "bts:RelativeswithCancerHistoryCount", + "@type" : "rdfs:Class", + "rdfs:comment" : "The number of relatives the patient has with a known history of cancer.", + "rdfs:label" : "RelativeswithCancerHistoryCount", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "RelativeswithCancerHistoryCount", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AlcoholDrinksPerDay", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value used to describe the average number of alcoholic beverages a person consumes per day.", + "rdfs:label" : "AlcoholDrinksPerDay", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AlcoholDrinksPerDay", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:EndBias", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:3Prime" }, { - "@id" : "bts:Occipitallobe" + "@id" : "bts:5Prime" }, { - "@id" : "bts:Overlappinglesionofeyeandadnexa" + "@id" : "bts:FullLengthTranscript" + } ], + "rdfs:label" : "EndBias", + "rdfs:comment" : "The end of the cDNA molecule that is preferentially sequenced, e.g. 3/5 prime tag/end or the full length transcript", + "@type" : "rdfs:Class", + "sms:displayName" : "EndBias" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:SatelliteMetastasisPresentIndicator", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ ], + "rdfs:label" : "SatelliteMetastasisPresentIndicator", + "rdfs:comment" : "A yes/no indicator to ask if intransit metastases or satellite lesions are present.", + "@type" : "rdfs:Class", + "sms:displayName" : "SatelliteMetastasisPresentIndicator" + }, { + "@id" : "bts:ParentBiospecimenID", + "@type" : "rdfs:Class", + "rdfs:comment" : "Biospecimen identifier indicating the biospecimen(s) from which these files were derived; multiple parent biospecimen should be comma-separated", + "rdfs:label" : "ParentBiospecimenID", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ParentBiospecimenID", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AlcoholUse", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "AlcoholUse", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AlcoholUse", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:NucleusIdentifier", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ ], + "rdfs:label" : "NucleusIdentifier", + "rdfs:comment" : "Unique nuclei barcode; added at transposition step. Determines which nucleus the reads originated from", + "@type" : "rdfs:Class", + "sms:displayName" : "NucleusIdentifier" + }, { + "@id" : "bts:Title", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "Title", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Title", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ClinicalBiospecimenType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:ConnectiveTissue" }, { - "@id" : "bts:Lingualtonsil" + "@id" : "bts:PeritonealFluid" }, { - "@id" : "bts:GumNOS" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Thymus" + "@id" : "bts:Saliva" }, { - "@id" : "bts:MalegenitalorgansNOS" + "@id" : "bts:TissueNOS" }, { - "@id" : "bts:IsletsofLangerhans" + "@id" : "bts:Skin" }, { - "@id" : "bts:Isthmusuteri" + "@id" : "bts:unknown" }, { - "@id" : "bts:Spinalmeninges" + "@id" : "bts:Feces" }, { - "@id" : "bts:Myometrium" + "@id" : "bts:UninvolvedTissueNOS" }, { - "@id" : "bts:Pelvicbonessacrumcoccyxandassociatedjoints" + "@id" : "bts:Plasma" }, { - "@id" : "bts:Connectivesubcutaneousandothersofttissuesoflowerlimbandhip" + "@id" : "bts:Granulocyte" }, { - "@id" : "bts:Anterior2/3oftongueNOS" + "@id" : "bts:EmbryonicTissue" }, { - "@id" : "bts:Upperthirdofesophagus" + "@id" : "bts:BuccalMucosa" }, { - "@id" : "bts:MeningesNOS" + "@id" : "bts:Blood" }, { - "@id" : "bts:Prostategland" + "@id" : "bts:MuscleTissue" }, { - "@id" : "bts:Overlappinglesionofsmallintestine" + "@id" : "bts:CerebrospinalFluid" }, { - "@id" : "bts:Lowergum" + "@id" : "bts:SoftTissue" }, { - "@id" : "bts:Paraspinal" + "@id" : "bts:Urine" }, { - "@id" : "bts:Appendix" + "@id" : "bts:PleuralFluid" }, { - "@id" : "bts:ScrotumNOS" + "@id" : "bts:BoneMarrow" }, { - "@id" : "bts:Overlappinglesionoflarynx" + "@id" : "bts:Serum" }, { - "@id" : "bts:Mainbronchus" + "@id" : "bts:EmbryonicFluid" }, { - "@id" : "bts:Descendedtestis" + "@id" : "bts:NerveTissue" }, { - "@id" : "bts:Cloacogeniczone" + "@id" : "bts:BuffyCoat" + } ], + "rdfs:label" : "ClinicalBiospecimenType", + "rdfs:comment" : "The text term used to describe the biological material used for testing, diagnostic, treatment or research purposes. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "@type" : "rdfs:Class", + "sms:displayName" : "ClinicalBiospecimenType" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:Antigen", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:CA19-9" }, { - "@id" : "bts:ConnectivesubcutaneousandothersofttissuesoftrunkNOS" + "@id" : "bts:CD79A" }, { - "@id" : "bts:Heart" + "@id" : "bts:CD5" }, { - "@id" : "bts:MucosaoflipNOS" + "@id" : "bts:CD30" }, { - "@id" : "bts:Broadligament" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Headofpancreas" + "@id" : "bts:CD20" }, { - "@id" : "bts:Overlappinglesionofbonesjointsandarticularcartilageoflimbs" + "@id" : "bts:CD14" }, { - "@id" : "bts:Temporallobe" + "@id" : "bts:CD19" }, { - "@id" : "bts:Bodyofpenis" + "@id" : "bts:unknown" }, { - "@id" : "bts:Overlappinglesionofbiliarytract" + "@id" : "bts:CD34" }, { - "@id" : "bts:Labiumminus" + "@id" : "bts:CCND1" }, { - "@id" : "bts:Descendingcolon" + "@id" : "bts:CD25" }, { - "@id" : "bts:Lateralwallofnasopharynx" + "@id" : "bts:HLA-DR" }, { - "@id" : "bts:Posteriorwallofhypopharynx" + "@id" : "bts:Mesothelin" }, { - "@id" : "bts:Nipple" + "@id" : "bts:CD10" }, { - "@id" : "bts:Jejunum" + "@id" : "bts:CD56" }, { - "@id" : "bts:Posteriorwallofbladder" + "@id" : "bts:CD3" }, { - "@id" : "bts:Laryngealcartilage" + "@id" : "bts:NSE" }, { - "@id" : "bts:Cecum" + "@id" : "bts:CA-125" }, { - "@id" : "bts:Skinoflowerlimbandhip" + "@id" : "bts:CD22" }, { - "@id" : "bts:Corpusuteri" + "@id" : "bts:CD23" }, { - "@id" : "bts:FemalegenitaltractNOS" + "@id" : "bts:SquamousCellCarcinomaAntigen" }, { - "@id" : "bts:AbdomenNOS" + "@id" : "bts:CEA" }, { - "@id" : "bts:Tonsillarpillar" + "@id" : "bts:CD33" }, { - "@id" : "bts:Otherspecifiedpartsoffemalegenitalorgans" + "@id" : "bts:CD138" }, { - "@id" : "bts:Glottis" + "@id" : "bts:BCL6" }, { - "@id" : "bts:OrbitNOS" + "@id" : "bts:CD7" }, { - "@id" : "bts:Skinoftrunk" + "@id" : "bts:CD117" }, { - "@id" : "bts:VentricleNOS" + "@id" : "bts:CD15" }, { - "@id" : "bts:Frontallobe" + "@id" : "bts:CD45" } ], - "rdfs:label" : "SiteofResectionorBiopsy", - "rdfs:comment" : "The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).", + "rdfs:label" : "Antigen", + "rdfs:comment" : "The text term used to describe an antigen included in molecular testing. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", "@type" : "rdfs:Class", - "sms:displayName" : "SiteofResectionorBiopsy" + "sms:displayName" : "Antigen" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Clonality", + "@id" : "bts:OncotypeRiskGroup", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Clonal" + "@id" : "bts:unknown" }, { - "@id" : "bts:Non-clonal" + "@id" : "bts:Datanotavailable" + }, { + "@id" : "bts:Highrisk" + }, { + "@id" : "bts:Intermediaterisk" + }, { + "@id" : "bts:Lowrisk" } ], - "rdfs:label" : "Clonality", - "rdfs:comment" : "The text term used to describe whether a genomic variant is related by descent from a single progenitor cell. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "OncotypeRiskGroup", + "rdfs:comment" : "Text term that represents the risk group for breast cancer as determined by assessment of the Oncotype recurrence score.", "@type" : "rdfs:Class", - "sms:displayName" : "Clonality" + "sms:displayName" : "OncotypeRiskGroup" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Sex", + "@id" : "bts:ModeofCancerDetection", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:true", + "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:NotReported" + "@id" : "bts:StandardofCareScreening" }, { - "@id" : "bts:female" + "@id" : "bts:ClinicalExaminationofunrelatedcancersymptoms" }, { - "@id" : "bts:male" + "@id" : "bts:Incidentaloma" }, { - "@id" : "bts:unspecified" + "@id" : "bts:IntervalCancer" } ], - "rdfs:label" : "Sex", - "rdfs:comment" : "Sex of individual", + "rdfs:label" : "ModeofCancerDetection", + "rdfs:comment" : "Text term used to describe the mode of cancer detection, like standard of care screening or random detection", "@type" : "rdfs:Class", - "sms:displayName" : "Sex" + "sms:displayName" : "ModeofCancerDetection" }, { - "@id" : "bts:YearOfBirth", + "@id" : "bts:RelationshipType", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value to represent the calendar year in which an individual was born.", - "rdfs:label" : "YearOfBirth", + "rdfs:comment" : "The subgroup that describes the state of connectedness between members of the unit of society organized around kinship ties.", + "rdfs:label" : "RelationshipType", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "YearOfBirth", + "sms:displayName" : "RelationshipType", "sms:required" : "sms:false" }, { + "@id" : "bts:FeatureReferenceId", + "@type" : "rdfs:Class", + "rdfs:comment" : "Unique ID for this feature. Must not contain whitespace, quote or comma characters. Each ID must be unique and must not collide with a gene identifier from the transcriptome [https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/using/feature-bc-analysis#feature-ref]", + "rdfs:label" : "FeatureReferenceId", "rdfs:subClassOf" : [ ], - "@id" : "bts:FOVXUnit", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "FeatureReferenceId", + "sms:required" : "sms:false" + }, { + "@id" : "bts:RelationshipAgeatDiagnosis", + "@type" : "rdfs:Class", + "rdfs:comment" : "The age (in years) when the patient's relative was first diagnosed.", + "rdfs:label" : "RelationshipAgeatDiagnosis", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "RelationshipAgeatDiagnosis", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:SmokingExposure", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:cm" - }, { - "@id" : "bts:mm" - }, { - "@id" : "bts:µm" + "@id" : "bts:Yes-SmokingExposure" }, { - "@id" : "bts:nm" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Å" + "@id" : "bts:No-SmokingExposure" } ], - "rdfs:label" : "FOVXUnit", - "rdfs:comment" : "Field of view X dimension units. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", + "rdfs:label" : "SmokingExposure", + "rdfs:comment" : "Indicate if individual has smoking exposure", "@type" : "rdfs:Class", - "sms:displayName" : "FOVXUnit" + "sms:displayName" : "SmokingExposure" }, { + "@id" : "bts:AltSampleID", + "@type" : "rdfs:Class", + "rdfs:comment" : "Additional alternative ID associated with a biosample", + "rdfs:label" : "AltSampleID", "rdfs:subClassOf" : [ ], - "@id" : "bts:Pathogenicity", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AltSampleID", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:TestResult", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Benign" + "@id" : "bts:Normal" }, { - "@id" : "bts:LikelyBenign" + "@id" : "bts:NotReported" }, { - "@id" : "bts:LikelyPathogenic" + "@id" : "bts:TestValueReported" }, { - "@id" : "bts:Pathogenic" + "@id" : "bts:unknown" }, { - "@id" : "bts:UncertainSignificance" + "@id" : "bts:Overexpressed" + }, { + "@id" : "bts:Intermediate" + }, { + "@id" : "bts:NotApplicable" + }, { + "@id" : "bts:LossofExpression" + }, { + "@id" : "bts:Low" + }, { + "@id" : "bts:High" + }, { + "@id" : "bts:Equivocal" + }, { + "@id" : "bts:CopyNumberReported" + }, { + "@id" : "bts:Positive" + }, { + "@id" : "bts:Negative" + }, { + "@id" : "bts:AbnormalNOS" } ], - "rdfs:label" : "Pathogenicity", - "rdfs:comment" : "The text used to describe a variant's level of involvement in the cause of the patient's disease according to the standards outlined by the American College of Medical Genetics and Genomics (ACMG).", + "rdfs:label" : "TestResult", + "rdfs:comment" : "The text term used to describe the result of the molecular test. If the test result was a numeric value see test_value. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", "@type" : "rdfs:Class", - "sms:displayName" : "Pathogenicity" + "sms:displayName" : "TestResult" }, { - "@id" : "bts:SmokelessTobaccoQuitAge", + "@id" : "bts:MedianFractionofReadsinAnnotatedcisDNAElements", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SmokelessTobaccoQuitAge", + "rdfs:comment" : "Median fraction of reads in annotated cis-DNA elements (FRIADE)", + "rdfs:label" : "MedianFractionofReadsinAnnotatedcisDNAElements", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SmokelessTobaccoQuitAge", + "sms:displayName" : "MedianFractionofReadsinAnnotatedcisDNAElements", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:PixelsBigEndian", + "@id" : "bts:Zygosity", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "schema:rangeIncludes" : [ ], - "rdfs:label" : "PixelsBigEndian", - "rdfs:comment" : "Boolean (True/False)", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:Heterozygous" + }, { + "@id" : "bts:Hemizygous" + }, { + "@id" : "bts:Homozygous" + }, { + "@id" : "bts:Nullizygous" + } ], + "rdfs:label" : "Zygosity", + "rdfs:comment" : "The text term used to describe the zygosity of a specific genetic variant.", "@type" : "rdfs:Class", - "sms:displayName" : "PixelsBigEndian" + "sms:displayName" : "Zygosity" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastCarcinomaDetectionMethodType", + "@id" : "bts:BreastImagingPerformedType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Other" - }, { "@id" : "bts:unknown" - }, { - "@id" : "bts:ClinicalExam" }, { "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:NippleDischarge" + "@id" : "bts:Mammogram" }, { - "@id" : "bts:ScreeningMammography" + "@id" : "bts:Ultrasound" }, { - "@id" : "bts:ScreeningMRI" + "@id" : "bts:MRI" }, { - "@id" : "bts:Selfexam" + "@id" : "bts:PET/CT" + }, { + "@id" : "bts:CT" + }, { + "@id" : "bts:Multipleimagingmodalities" } ], - "rdfs:label" : "BreastCarcinomaDetectionMethodType", - "rdfs:comment" : "The means, manner of procedure, or systematic course of actions performed in order to discover or identify breast cancer.", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastCarcinomaDetectionMethodType" - }, { - "@id" : "bts:SizeZ", - "@type" : "rdfs:Class", - "rdfs:comment" : "Size of image: Z dimension (in pixels). Integer >= 1", - "rdfs:label" : "SizeZ", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SizeZ", - "sms:required" : "sms:false" - }, { - "@id" : "bts:COVID19AntibodyTesting", + "rdfs:label" : "BreastImagingPerformedType", + "rdfs:comment" : "The kind of technology or method performed for screening, diagnosis, surgical procedures or therapy that aids in the visualization of the breast(s).", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "COVID19AntibodyTesting", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "COVID19AntibodyTesting", - "sms:required" : "sms:false" + "sms:displayName" : "BreastImagingPerformedType" }, { - "@id" : "bts:BMI", + "@id" : "bts:PackYearsSmoked", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BMI", + "rdfs:comment" : "Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.", + "rdfs:label" : "PackYearsSmoked", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BMI", + "sms:displayName" : "PackYearsSmoked", "sms:required" : "sms:false" }, { - "@id" : "bts:EmptyWellBarcode", + "@id" : "bts:TobaccoUseperDay", "@type" : "rdfs:Class", - "rdfs:comment" : "Unique cell barcode assigned to empty cells used as controls in CEL-seq2 assays.", - "rdfs:label" : "EmptyWellBarcode", + "rdfs:comment" : "Numeric value that represents the number of times the patient uses tobacco each day.", + "rdfs:label" : "TobaccoUseperDay", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "EmptyWellBarcode", + "sms:displayName" : "TobaccoUseperDay", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCarcinomaHER2RatioDiagnosis", + "@id" : "bts:TechnicalReplicateGroup", "@type" : "rdfs:Class", - "rdfs:comment" : "HER2 ratio of the participant at diagnosis", - "rdfs:label" : "BreastCarcinomaHER2RatioDiagnosis", + "rdfs:comment" : "A common term for all files belonging to the same cell or library. Provide a numbering of each library prep batch (can differ from encapsulation and sequencing batch)", + "rdfs:label" : "TechnicalReplicateGroup", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaHER2RatioDiagnosis", + "sms:displayName" : "TechnicalReplicateGroup", "sms:required" : "sms:false" }, { - "@id" : "bts:TimebetweenWakingandFirstSmoke", + "@id" : "bts:Dilution", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "TimebetweenWakingandFirstSmoke", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TimebetweenWakingandFirstSmoke", - "sms:required" : "sms:false" - }, { - "@id" : "bts:MedianPercentageofMitochondrialReadsperNucleus", - "@type" : "rdfs:Class", - "rdfs:comment" : "Contamination from mitochondrial sequences", - "rdfs:label" : "MedianPercentageofMitochondrialReadsperNucleus", + "rdfs:label" : "Dilution", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MedianPercentageofMitochondrialReadsperNucleus", + "sms:displayName" : "Dilution", "sms:required" : "sms:false" }, { - "@id" : "bts:PhysicalSizeZ", + "@id" : "bts:FOVY", "@type" : "rdfs:Class", - "rdfs:comment" : "Physical size (Z-dimension) of a pixel. Units are set by PhysicalSizeZUnit. Floating point value > 0.", - "rdfs:label" : "PhysicalSizeZ", + "rdfs:comment" : "Field of view Y dimension. Floating point value", + "rdfs:label" : "FOVY", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PhysicalSizeZ", + "sms:displayName" : "FOVY", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:LibrarySelectionMethod", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:hybridselection" - }, { - "@id" : "bts:PCR" - }, { - "@id" : "bts:affinityenrichment" - }, { - "@id" : "bts:poly-Tenrichment" - }, { - "@id" : "bts:random" - }, { - "@id" : "bts:rRNAdepletion" - }, { - "@id" : "bts:miRNAsizefractionation" - }, { - "@id" : "bts:other" - } ], - "rdfs:label" : "LibrarySelectionMethod", - "rdfs:comment" : "How RNA molecules are isolated", - "@type" : "rdfs:Class", - "sms:displayName" : "LibrarySelectionMethod" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:CountryofResidence", + "@id" : "bts:SiteofResectionorBiopsy", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:TrinidadandTobago" + "@id" : "bts:Tonsillarfossa" }, { - "@id" : "bts:Botswana" + "@id" : "bts:Overlappinglesionoflung" }, { - "@id" : "bts:Malaysia" + "@id" : "bts:Overlappinglesionofotherandunspecifiedpartsofmouth" }, { - "@id" : "bts:Suriname" + "@id" : "bts:Endometrium" }, { - "@id" : "bts:Uruguay" + "@id" : "bts:BoneoflimbNOS" }, { - "@id" : "bts:Gibraltar" + "@id" : "bts:Posteriorwallofnasopharynx" }, { - "@id" : "bts:Andorra" + "@id" : "bts:SmallintestineNOS" }, { - "@id" : "bts:CaymanIslands" + "@id" : "bts:Anteriorwallofnasopharynx" }, { - "@id" : "bts:Mozambique" + "@id" : "bts:Thoracicesophagus" }, { - "@id" : "bts:Dominica" + "@id" : "bts:Parietallobe" }, { - "@id" : "bts:Tajikistan" + "@id" : "bts:HeadfaceorneckNOS" }, { - "@id" : "bts:Barbados" + "@id" : "bts:Endocervix" }, { - "@id" : "bts:Seychelles" + "@id" : "bts:Supraglottis" }, { - "@id" : "bts:Curacao" + "@id" : "bts:Ethmoidsinus" }, { - "@id" : "bts:Coted'Ivoire" + "@id" : "bts:Ileum" }, { - "@id" : "bts:Albania" + "@id" : "bts:Overlappinglesionofheartmediastinumandpleura" }, { - "@id" : "bts:China" + "@id" : "bts:Exocervix" }, { - "@id" : "bts:Oman" + "@id" : "bts:PancreasNOS" }, { - "@id" : "bts:Congo" + "@id" : "bts:Epididymis" }, { - "@id" : "bts:Burundi" + "@id" : "bts:KidneyNOS" }, { - "@id" : "bts:FalklandIslands(Malvinas)" + "@id" : "bts:AnusNOS" }, { - "@id" : "bts:Kazakhstan" + "@id" : "bts:Cerebrum" }, { - "@id" : "bts:Australia" + "@id" : "bts:Overlappinglesionofbreast" }, { - "@id" : "bts:France" + "@id" : "bts:Overlappinglesionofperipheralnervesandautonomicnervoussystem" }, { - "@id" : "bts:Bahrain" + "@id" : "bts:Fundusofstomach" }, { - "@id" : "bts:SolomonIslands" + "@id" : "bts:OropharynxNOS" }, { - "@id" : "bts:Tanzania" + "@id" : "bts:Urachus" }, { - "@id" : "bts:FrenchGuiana" + "@id" : "bts:Labiummajus" }, { - "@id" : "bts:FederatedStatesofMicronesia" + "@id" : "bts:Parametrium" }, { - "@id" : "bts:AntiguaandBarbuda" + "@id" : "bts:Vestibuleofmouth" }, { - "@id" : "bts:Colombia" + "@id" : "bts:Lowerthirdofesophagus" }, { - "@id" : "bts:Fiji" + "@id" : "bts:Overlappinglesionofdigestivesystem" }, { - "@id" : "bts:SaoTomeandPrincipe" + "@id" : "bts:Bonesofskullandfaceandassociatedjoints" }, { - "@id" : "bts:Brazil" + "@id" : "bts:Lymphnodesofaxillaorarm" }, { - "@id" : "bts:Guam" + "@id" : "bts:SoftpalateNOS" }, { - "@id" : "bts:SouthAfrica" + "@id" : "bts:Hepaticflexureofcolon" }, { - "@id" : "bts:Denmark" + "@id" : "bts:Subglottis" }, { - "@id" : "bts:Kyrgyzstan" + "@id" : "bts:Overlappinglesionoflip" }, { - "@id" : "bts:Tunisia" + "@id" : "bts:Extrahepaticbileduct" }, { - "@id" : "bts:Mexico" + "@id" : "bts:Vallecula" }, { - "@id" : "bts:Martinique" + "@id" : "bts:TongueNOS" }, { - "@id" : "bts:BurkinaFaso" + "@id" : "bts:Liver" }, { - "@id" : "bts:India" + "@id" : "bts:Overlappinglesionofbonesjointsandarticularcartilage" }, { - "@id" : "bts:Myanmar" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Malawi" + "@id" : "bts:Peripheralnervesandautonomicnervoussystemofupperlimbandshoulder" }, { - "@id" : "bts:Sweden" + "@id" : "bts:Lymphnodesofmultipleregions" }, { - "@id" : "bts:Macau" + "@id" : "bts:Duodenum" }, { - "@id" : "bts:Cambodia" + "@id" : "bts:Maxillarysinus" }, { - "@id" : "bts:EquatorialGuinea" + "@id" : "bts:Intrahepaticbileduct" }, { - "@id" : "bts:Senegal" + "@id" : "bts:Lateralwallofbladder" }, { - "@id" : "bts:Guernsey" + "@id" : "bts:Overlappinglesionofhypopharynx" }, { - "@id" : "bts:Azerbaijan" + "@id" : "bts:Overlappinglesionofrectumanusandanalcanal" }, { - "@id" : "bts:Angola" + "@id" : "bts:Middlethirdofesophagus" }, { - "@id" : "bts:Kuwait" + "@id" : "bts:Lateralfloorofmouth" }, { - "@id" : "bts:PapuaNewGuinea" + "@id" : "bts:Anteriormediastinum" }, { - "@id" : "bts:CentralAfricanRepublic" + "@id" : "bts:Anteriorfloorofmouth" }, { - "@id" : "bts:Bhutan" + "@id" : "bts:NervoussystemNOS" }, { - "@id" : "bts:Uzbekistan" + "@id" : "bts:Waldeyerring" }, { - "@id" : "bts:Portugal" + "@id" : "bts:Ribsternumclavicleandassociatedjoints" }, { - "@id" : "bts:IsleofMan" + "@id" : "bts:Longbonesoflowerlimbandassociatedjoints" }, { - "@id" : "bts:Guatemala" + "@id" : "bts:Frontalsinus" }, { - "@id" : "bts:SaintHelenaAscensionandTristandaCunha" + "@id" : "bts:Uterineadnexa" }, { - "@id" : "bts:Kiribati" + "@id" : "bts:Trachea" }, { - "@id" : "bts:Peru" + "@id" : "bts:RectumNOS" }, { - "@id" : "bts:SouthSudan" + "@id" : "bts:AdrenalglandNOS" }, { - "@id" : "bts:NorthMacedonia" + "@id" : "bts:PleuraNOS" }, { - "@id" : "bts:DemocraticRepublicoftheCongo" + "@id" : "bts:LowerlimbNOS" }, { - "@id" : "bts:Belarus" + "@id" : "bts:Transversecolon" }, { - "@id" : "bts:Madagascar" + "@id" : "bts:Lymphnodesofheadfaceandneck" }, { - "@id" : "bts:Singapore" + "@id" : "bts:GreatercurvatureofstomachNOS" }, { - "@id" : "bts:Togo" + "@id" : "bts:UpperrespiratorytractNOS" }, { - "@id" : "bts:Gambia" + "@id" : "bts:Overlappinglesionofpancreas" }, { - "@id" : "bts:Georgia" + "@id" : "bts:CerebellumNOS" }, { - "@id" : "bts:Italy" + "@id" : "bts:Overlappinglesionsoforopharynx" }, { - "@id" : "bts:Tuvalu" + "@id" : "bts:Axillarytailofbreast" }, { - "@id" : "bts:Eswatini" + "@id" : "bts:unknown" }, { - "@id" : "bts:Nepal" + "@id" : "bts:VulvaNOS" }, { - "@id" : "bts:Kenya" + "@id" : "bts:FloorofmouthNOS" }, { - "@id" : "bts:Niger" + "@id" : "bts:Overlappinglesionofmalegenitalorgans" }, { - "@id" : "bts:Israel" + "@id" : "bts:UterusNOS" }, { - "@id" : "bts:Iran" + "@id" : "bts:Bodyofstomach" }, { - "@id" : "bts:Liberia" + "@id" : "bts:Urethra" }, { - "@id" : "bts:Mali" + "@id" : "bts:Middlelobelung" }, { - "@id" : "bts:Belize" + "@id" : "bts:Tailofpancreas" }, { - "@id" : "bts:Hungary" + "@id" : "bts:Pinealgland" }, { - "@id" : "bts:HolySee" + "@id" : "bts:Spermaticcord" }, { - "@id" : "bts:Serbia" + "@id" : "bts:Carotidbody" }, { - "@id" : "bts:Belgium" + "@id" : "bts:ReticuloendothelialsystemNOS" }, { - "@id" : "bts:Bermuda" + "@id" : "bts:Otherspecifiedpartsofpancreas" }, { - "@id" : "bts:Anguilla" + "@id" : "bts:Externalear" }, { - "@id" : "bts:Jamaica" + "@id" : "bts:Meckeldiverticulum" }, { - "@id" : "bts:Lebanon" + "@id" : "bts:PenisNOS" }, { - "@id" : "bts:Svalbard&JanMayenIslands" + "@id" : "bts:Lower-innerquadrantofbreast" }, { - "@id" : "bts:Cyprus" + "@id" : "bts:Superiorwallofnasopharynx" }, { - "@id" : "bts:Norway" + "@id" : "bts:Retina" }, { - "@id" : "bts:Somalia" + "@id" : "bts:Borderoftongue" }, { - "@id" : "bts:Japan" + "@id" : "bts:Intra-abdominallymphnodes" }, { - "@id" : "bts:Guyana" + "@id" : "bts:Peripheralnervesandautonomicnervoussystemofthorax" }, { - "@id" : "bts:Paraguay" + "@id" : "bts:Caudaequina" }, { - "@id" : "bts:NewZealand" + "@id" : "bts:Overlappinglesionofpalate" }, { - "@id" : "bts:Palau" + "@id" : "bts:NasopharynxNOS" }, { - "@id" : "bts:Laos" + "@id" : "bts:Placenta" }, { - "@id" : "bts:Latvia" + "@id" : "bts:ExternallipNOS" }, { - "@id" : "bts:Ethiopia" + "@id" : "bts:BoneNOS" }, { - "@id" : "bts:Cuba" + "@id" : "bts:Ciliarybody" }, { - "@id" : "bts:FrenchPolynesia" + "@id" : "bts:HematopoieticsystemNOS" }, { - "@id" : "bts:Slovenia" + "@id" : "bts:Prepuce" }, { - "@id" : "bts:Philippines" + "@id" : "bts:Pelviclymphnodes" }, { - "@id" : "bts:Mongolia" + "@id" : "bts:Postcricoidregion" }, { - "@id" : "bts:Switzerland" + "@id" : "bts:Externalupperlip" }, { - "@id" : "bts:Bahamas" + "@id" : "bts:Peripheralnervesandautonomicnervoussystemofpelvis" }, { - "@id" : "bts:Samoa" + "@id" : "bts:PelvisNOS" }, { - "@id" : "bts:ElSalvador" + "@id" : "bts:Connectivesubcutaneousandothersofttissuesofabdomen" }, { - "@id" : "bts:Chad" + "@id" : "bts:Vertebralcolumn" }, { - "@id" : "bts:Honduras" + "@id" : "bts:Bodyofpancreas" }, { - "@id" : "bts:Bangladesh" + "@id" : "bts:Trigoneofbladder" }, { - "@id" : "bts:Tonga" + "@id" : "bts:Commissureoflip" }, { - "@id" : "bts:Croatia" + "@id" : "bts:Peripheralnervesandautonomicnervoussystemofabdomen" }, { - "@id" : "bts:BosniaandHerzegovina" + "@id" : "bts:Upper-innerquadrantofbreast" }, { - "@id" : "bts:Eritrea" + "@id" : "bts:PalateNOS" }, { - "@id" : "bts:SaintKittsandNevis" + "@id" : "bts:Hypopharyngealaspectofaryepiglotticfold" }, { - "@id" : "bts:Vietnam" + "@id" : "bts:Uppergum" }, { - "@id" : "bts:NorthernMarianaIslands" + "@id" : "bts:ThoraxNOS" }, { - "@id" : "bts:CapeVerde" + "@id" : "bts:Spinalcord" }, { - "@id" : "bts:CookIslands" + "@id" : "bts:BrainNOS" }, { - "@id" : "bts:Turkmenistan" + "@id" : "bts:MouthNOS" }, { - "@id" : "bts:WesternSahara" + "@id" : "bts:Connectivesubcutaneousandothersofttissuesofupperlimbandshoulder" }, { - "@id" : "bts:Jordan" + "@id" : "bts:Retroperitoneum" }, { - "@id" : "bts:Romania" + "@id" : "bts:Longbonesofupperlimbscapulaandassociatedjoints" }, { - "@id" : "bts:Uganda" + "@id" : "bts:Hardpalate" }, { - "@id" : "bts:Aruba" + "@id" : "bts:Gallbladder" }, { - "@id" : "bts:HongKong" + "@id" : "bts:EndocrineglandNOS" }, { - "@id" : "bts:Syria" + "@id" : "bts:Brainstem" }, { - "@id" : "bts:Germany" + "@id" : "bts:CorneaNOS" }, { - "@id" : "bts:Chile" + "@id" : "bts:Overlappinglesionofnasopharynx" }, { - "@id" : "bts:Austria" + "@id" : "bts:DorsalsurfaceoftongueNOS" }, { - "@id" : "bts:Gabon" + "@id" : "bts:MajorsalivaryglandNOS" }, { - "@id" : "bts:Kosovo" + "@id" : "bts:Abdominalesophagus" }, { - "@id" : "bts:Qatar" + "@id" : "bts:Olfactorynerve" }, { - "@id" : "bts:Comoros" + "@id" : "bts:Shortbonesofupperlimbandassociatedjoints" }, { - "@id" : "bts:Mayotte" + "@id" : "bts:Overlappinglesionoftonsil" }, { - "@id" : "bts:Spain" + "@id" : "bts:AutonomicnervoussystemNOS" }, { - "@id" : "bts:Libya" + "@id" : "bts:Ill-definedsiteswithinrespiratorysystem" }, { - "@id" : "bts:CostaRica" + "@id" : "bts:Lymphnodesofinguinalregionorleg" }, { - "@id" : "bts:Bolivia" + "@id" : "bts:Overlappinglesionofmajorsalivaryglands" }, { - "@id" : "bts:Taiwan" + "@id" : "bts:PeripheralnervesandautonomicnervoussystemoftrunkNOS" }, { - "@id" : "bts:Iraq" + "@id" : "bts:Fundusuteri" }, { - "@id" : "bts:Finland" + "@id" : "bts:TestisNOS" }, { - "@id" : "bts:Netherlands" + "@id" : "bts:Parotidgland" }, { - "@id" : "bts:Venezuela" + "@id" : "bts:AmpullaofVater" }, { - "@id" : "bts:Malta" + "@id" : "bts:CardiaNOS" }, { - "@id" : "bts:Niue" + "@id" : "bts:SkinoflipNOS" }, { - "@id" : "bts:Algeria" + "@id" : "bts:Overlappinglesionofstomach" }, { - "@id" : "bts:Guinea" + "@id" : "bts:Rectosigmoidjunction" }, { - "@id" : "bts:Ireland" + "@id" : "bts:Gastricantrum" }, { - "@id" : "bts:Montenegro" + "@id" : "bts:Cortexofadrenalgland" }, { - "@id" : "bts:UnitedArabEmirates" + "@id" : "bts:Renalpelvis" }, { - "@id" : "bts:Maldives" + "@id" : "bts:Middleear" }, { - "@id" : "bts:Zambia" + "@id" : "bts:Overlappinglesionoffemalegenitalorgans" }, { - "@id" : "bts:Slovakia" + "@id" : "bts:GastrointestinaltractNOS" }, { - "@id" : "bts:Lesotho" + "@id" : "bts:Connectivesubcutaneousandothersofttissuesofthorax" }, { - "@id" : "bts:DominicanRepublic" + "@id" : "bts:SkinNOS" }, { - "@id" : "bts:SaintPierreandMiquelon" + "@id" : "bts:Parathyroidgland" }, { - "@id" : "bts:Moldova" + "@id" : "bts:Pituitarygland" }, { - "@id" : "bts:SanMarino" + "@id" : "bts:Overlappinglesionoftongue" }, { - "@id" : "bts:Nauru" + "@id" : "bts:LungNOS" }, { - "@id" : "bts:Luxembourg" + "@id" : "bts:Cervixuteri" }, { - "@id" : "bts:Monaco" + "@id" : "bts:Skinofotherandunspecifiedpartsofface" }, { - "@id" : "bts:Zimbabwe" + "@id" : "bts:Submandibulargland" }, { - "@id" : "bts:SaudiArabia" + "@id" : "bts:Clitoris" }, { - "@id" : "bts:Mauritania" + "@id" : "bts:Centralportionofbreast" }, { - "@id" : "bts:Panama" + "@id" : "bts:Ovary" }, { - "@id" : "bts:UnitedStates" + "@id" : "bts:Lateralwalloforopharynx" }, { - "@id" : "bts:Montserrat" + "@id" : "bts:StomachNOS" }, { - "@id" : "bts:Nicaragua" + "@id" : "bts:VentralsurfaceoftongueNOS" }, { - "@id" : "bts:FaroeIslands" + "@id" : "bts:Overlappinglesionofurinaryorgans" }, { - "@id" : "bts:UnitedKingdom" + "@id" : "bts:Sigmoidcolon" }, { - "@id" : "bts:Canada" + "@id" : "bts:Overlappinglesionofbrain" }, { - "@id" : "bts:Ghana" + "@id" : "bts:Overlappinglesionofcolon" }, { - "@id" : "bts:Armenia" + "@id" : "bts:Glanspenis" }, { - "@id" : "bts:Bulgaria" + "@id" : "bts:MediastinumNOS" }, { - "@id" : "bts:Egypt" + "@id" : "bts:VaginaNOS" }, { - "@id" : "bts:Reunion" + "@id" : "bts:Lower-outerquadrantofbreast" }, { - "@id" : "bts:Cameroon" + "@id" : "bts:PharynxNOS" }, { - "@id" : "bts:Rwanda" + "@id" : "bts:IntestinaltractNOS" }, { - "@id" : "bts:Timor-Leste" + "@id" : "bts:Peripheralnervesandautonomicnervoussystemofheadfaceandneck" }, { - "@id" : "bts:Yemen" + "@id" : "bts:Overlappinglesionofbladder" }, { - "@id" : "bts:SaintLucia" + "@id" : "bts:Pyriformsinus" }, { - "@id" : "bts:Poland" + "@id" : "bts:Conjunctiva" }, { - "@id" : "bts:Namibia" + "@id" : "bts:ConnectivesubcutaneousandothersofttissuesNOS" }, { - "@id" : "bts:Guinea-Bissau" + "@id" : "bts:Acousticnerve" }, { - "@id" : "bts:Thailand" + "@id" : "bts:LessercurvatureofstomachNOS" }, { - "@id" : "bts:Argentina" + "@id" : "bts:Mucosaoflowerlip" }, { - "@id" : "bts:Turkey" + "@id" : "bts:BladderNOS" }, { - "@id" : "bts:Djibouti" + "@id" : "bts:Intrathoraciclymphnodes" }, { - "@id" : "bts:Greece" + "@id" : "bts:Pylorus" }, { - "@id" : "bts:Jersey" + "@id" : "bts:Blood" }, { - "@id" : "bts:Mauritius" + "@id" : "bts:BiliarytractNOS" }, { - "@id" : "bts:WallisandFutuna" + "@id" : "bts:AccessorysinusNOS" }, { - "@id" : "bts:Pakistan" + "@id" : "bts:Mandible" }, { - "@id" : "bts:Ukraine" + "@id" : "bts:Overlappinglesionofretroperitoneumandperitoneum" }, { - "@id" : "bts:StateofPalestine" + "@id" : "bts:UrinarysystemNOS" }, { - "@id" : "bts:Ecuador" + "@id" : "bts:Sublingualgland" }, { - "@id" : "bts:SouthKorea" + "@id" : "bts:TonsilNOS" }, { - "@id" : "bts:Russia" + "@id" : "bts:Anteriorsurfaceofepiglottis" }, { - "@id" : "bts:Greenland" + "@id" : "bts:Branchialcleft" }, { - "@id" : "bts:Liechtenstein" + "@id" : "bts:PeritoneumNOS" }, { - "@id" : "bts:Nigeria" + "@id" : "bts:Lacrimalgland" }, { - "@id" : "bts:Benin" + "@id" : "bts:Spleen" }, { - "@id" : "bts:Vanuatu" + "@id" : "bts:Opticnerve" }, { - "@id" : "bts:SriLanka" + "@id" : "bts:Cervicalesophagus" }, { - "@id" : "bts:Tokelau" + "@id" : "bts:Fallopiantube" }, { - "@id" : "bts:CzechRepublic(Czechia)" + "@id" : "bts:BaseoftongueNOS" }, { - "@id" : "bts:MarshallIslands" + "@id" : "bts:Skinofupperlimbandshoulder" }, { - "@id" : "bts:Estonia" + "@id" : "bts:Craniopharyngealduct" }, { - "@id" : "bts:SaintVincentandtheGrenadines" + "@id" : "bts:Specifiedpartsofperitoneum" }, { - "@id" : "bts:PuertoRico" + "@id" : "bts:Pancreaticduct" }, { - "@id" : "bts:Grenada" + "@id" : "bts:Externallowerlip" }, { - "@id" : "bts:Guadeloupe" + "@id" : "bts:Overlappinglesionofcervixuteri" }, { - "@id" : "bts:SierraLeone" + "@id" : "bts:Anteriorwallofbladder" }, { - "@id" : "bts:Afghanistan" + "@id" : "bts:Uvula" }, { - "@id" : "bts:Haiti" + "@id" : "bts:Upper-outerquadrantofbreast" }, { - "@id" : "bts:Lithuania" + "@id" : "bts:Overlappinglesionofesophagus" }, { - "@id" : "bts:Indonesia" + "@id" : "bts:Shortbonesoflowerlimbandassociatedjoints" }, { - "@id" : "bts:VirginIslandsBritish" + "@id" : "bts:Ascendingcolon" }, { - "@id" : "bts:VirginIslandsU.S." + "@id" : "bts:Mucosaofupperlip" }, { - "@id" : "bts:Sudan" + "@id" : "bts:Connectivesubcutaneousandothersofttissuesofheadfaceandneck" }, { - "@id" : "bts:Morocco" + "@id" : "bts:Analcanal" }, { - "@id" : "bts:Iceland" + "@id" : "bts:HypopharynxNOS" }, { - "@id" : "bts:NorthKorea" + "@id" : "bts:Aorticbodyandotherparaganglia" }, { - "@id" : "bts:NewCaledonia" + "@id" : "bts:Overlappinglesionofendocrineglandsandrelatedstructures" }, { - "@id" : "bts:Brunei" - } ], - "rdfs:label" : "CountryofResidence", - "rdfs:comment" : "Country of Residence at enrollment", - "@type" : "rdfs:Class", - "sms:displayName" : "CountryofResidence" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastCancerAssessmentTests", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "@id" : "bts:LarynxNOS" }, { - "@id" : "bts:unknown" + "@id" : "bts:Ureter" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:EyeNOS" }, { - "@id" : "bts:EstrogenreceptorIHC" + "@id" : "bts:Medullaofadrenalgland" }, { - "@id" : "bts:ProgesteronereceptorIHC" + "@id" : "bts:ColonNOS" }, { - "@id" : "bts:HER2IHC" + "@id" : "bts:Lowerlobelung" }, { - "@id" : "bts:HER2FISH-CISH" + "@id" : "bts:Eyelid" }, { - "@id" : "bts:HER2FISH" - } ], - "rdfs:label" : "BreastCancerAssessmentTests", - "rdfs:comment" : "Text term to identify assessment tests done in participants during diagnosis", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastCancerAssessmentTests" - }, { - "@id" : "bts:EmissionBandwidth", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "EmissionBandwidth", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "EmissionBandwidth", - "sms:required" : "sms:false" - }, { - "@id" : "bts:MatrixType", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MatrixType", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "MatrixType", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:SpikeIn", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:ERCC" + "@id" : "bts:Overlappinglesionofrespiratorysystemandintrathoracicorgans" }, { - "@id" : "bts:OtherSpikeIn" + "@id" : "bts:Overlappinglesionofconnectivesubcutaneousandothersofttissues" }, { - "@id" : "bts:NoSpikeIn" + "@id" : "bts:EsophagusNOS" }, { - "@id" : "bts:PhiX" - } ], - "rdfs:label" : "SpikeIn", - "rdfs:comment" : "A set of known synthetic RNA molecules with known sequence that are added to the cell lysis mix", - "@type" : "rdfs:Class", - "sms:displayName" : "SpikeIn" - }, { - "@id" : "bts:TypeofTobaccoUsed", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TypeofTobaccoUsed", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TypeofTobaccoUsed", - "sms:required" : "sms:false" - }, { - "@id" : "bts:HistologicMorphologyCode", - "@type" : "rdfs:Class", - "rdfs:comment" : "Histologic Morphology Code, based on ICD-O-3. Any valid ICD-O-3 morphology code. See https://seer.cancer.gov/icd-o-3/ and https://seer.cancer.gov/icd-o-3/sitetype.icdo3.20200629.xlsx. Examples: 80510", - "rdfs:label" : "HistologicMorphologyCode", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "HistologicMorphologyCode", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PhysicalSizeX", - "@type" : "rdfs:Class", - "rdfs:comment" : "Physical size (X-dimension) of a pixel. Units are set by PhysicalSizeXUnit. Floating point value > 0.", - "rdfs:label" : "PhysicalSizeX", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PhysicalSizeX", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Ecigvape30dayusenum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Ecigvape30dayusenum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Ecigvape30dayusenum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CauseofDeathSource", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CauseofDeathSource", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CauseofDeathSource", - "sms:required" : "sms:false" - }, { - "@id" : "bts:YearofDeath", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value to represent the year of the death of an individual.", - "rdfs:label" : "YearofDeath", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "YearofDeath", - "sms:required" : "sms:false" - }, { - "@id" : "bts:LinkedProject", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LinkedProject", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LinkedProject", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CancerIncidence", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CancerIncidence", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CancerIncidence", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BreastCancerAllredEstrogenReceptorScore", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Overlappinglesionofbrainandcentralnervoussystem" }, { - "@id" : "bts:10" + "@id" : "bts:Choroid" }, { - "@id" : "bts:0" + "@id" : "bts:Bladderneck" }, { - "@id" : "bts:4" + "@id" : "bts:Overlappinglesionofskin" }, { - "@id" : "bts:7" + "@id" : "bts:Thyroidgland" }, { - "@id" : "bts:1" + "@id" : "bts:Sphenoidsinus" }, { - "@id" : "bts:8" + "@id" : "bts:Roundligament" }, { - "@id" : "bts:2" + "@id" : "bts:BreastNOS" }, { - "@id" : "bts:5" + "@id" : "bts:Upperlobelung" }, { - "@id" : "bts:3" + "@id" : "bts:Splenicflexureofcolon" }, { - "@id" : "bts:6" - } ], - "rdfs:label" : "BreastCancerAllredEstrogenReceptorScore", - "rdfs:comment" : "The numeric Allred score, that is cell staining percentage plus intensity, to determine estrogen receptor status.", - "@type" : "rdfs:Class", - "sms:displayName" : "BreastCancerAllredEstrogenReceptorScore" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:ERStainingIntensity", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "@id" : "bts:CranialnerveNOS" }, { - "@id" : "bts:unknown" + "@id" : "bts:Paraurethralgland" }, { - "@id" : "bts:Strong" + "@id" : "bts:Posteriorwalloforopharynx" }, { - "@id" : "bts:Moderate" + "@id" : "bts:Otherspecifiedpartsofmalegenitalorgans" }, { - "@id" : "bts:Weak" + "@id" : "bts:Undescendedtestis" }, { - "@id" : "bts:Weak-Moderate" + "@id" : "bts:Nasalcavity" }, { - "@id" : "bts:Moderate-Strong" + "@id" : "bts:Cerebralmeninges" }, { - "@id" : "bts:Weak-Strong" - } ], - "rdfs:label" : "ERStainingIntensity", - "rdfs:comment" : "Text term to indicate the ER staining intensity on pathology assessment in a participant with breast cancer", - "@type" : "rdfs:Class", - "sms:displayName" : "ERStainingIntensity" - }, { - "@id" : "bts:FOVX", - "@type" : "rdfs:Class", - "rdfs:comment" : "Field of view X dimension. Floating point", - "rdfs:label" : "FOVX", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "FOVX", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:HormoneTherapyBreastCancerPreventionIndicator", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:NotApplicable" + "@id" : "bts:Overlappinglesionoffloorofmouth" }, { - "@id" : "bts:Yes" + "@id" : "bts:Overlappinglesionofcorpusuteri" }, { - "@id" : "bts:No" + "@id" : "bts:LipNOS" }, { - "@id" : "bts:unknown" - } ], - "rdfs:label" : "HormoneTherapyBreastCancerPreventionIndicator", - "rdfs:comment" : "Did the patient receive hormonal therapy for prevention of breast cancer?", - "@type" : "rdfs:Class", - "sms:displayName" : "HormoneTherapyBreastCancerPreventionIndicator" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:SequencingPlatform", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:454GSFLXTitanium" + "@id" : "bts:Cheekmucosa" }, { - "@id" : "bts:ABSOLiD3" + "@id" : "bts:UpperlimbNOS" }, { - "@id" : "bts:ABSOLiD4ABSOLiD2" + "@id" : "bts:Domeofbladder" }, { - "@id" : "bts:CompleteGenomics" + "@id" : "bts:Connectivesubcutaneousandothersofttissuesofpelvis" }, { - "@id" : "bts:GridION" + "@id" : "bts:unknownprimarysite" }, { - "@id" : "bts:IlluminaGenomeAnalyzerII" + "@id" : "bts:Posteriormediastinum" }, { - "@id" : "bts:IlluminaGenomeAnalyzerIIx" + "@id" : "bts:Uretericorifice" }, { - "@id" : "bts:IlluminaHiSeq2000" + "@id" : "bts:Otherill-definedsites" }, { - "@id" : "bts:IlluminaHiSeq2500" + "@id" : "bts:Bonemarrow" }, { - "@id" : "bts:IlluminaHiSeq4000" + "@id" : "bts:Peripheralnervesandautonomicnervoussystemoflowerlimbandhip" }, { - "@id" : "bts:IlluminaHiSeqXFive" + "@id" : "bts:LymphnodeNOS" }, { - "@id" : "bts:IlluminaHiSeqXTen" + "@id" : "bts:Skinofscalpandneck" }, { - "@id" : "bts:IlluminaMiSeq" + "@id" : "bts:Retromolararea" }, { - "@id" : "bts:IlluminaNextSeq1000" + "@id" : "bts:Overlappinglesionofliporalcavityandpharynx" }, { - "@id" : "bts:IlluminaNextSeq2000" + "@id" : "bts:Overlappinglesionofaccessorysinuses" }, { - "@id" : "bts:IlluminaNextSeq2500" + "@id" : "bts:Overlappinglesionofpenis" }, { - "@id" : "bts:IlluminaNextSeq500" + "@id" : "bts:Overlappinglesionofvulva" }, { - "@id" : "bts:IlluminaNextSeq550" + "@id" : "bts:Overlappinglesionofill-definedsites" }, { - "@id" : "bts:IlluminaNovaSeq6000" + "@id" : "bts:Occipitallobe" }, { - "@id" : "bts:IonTorrentPGM" + "@id" : "bts:Overlappinglesionofeyeandadnexa" }, { - "@id" : "bts:IonTorrentProton" + "@id" : "bts:Lingualtonsil" }, { - "@id" : "bts:IonTorrentS5" + "@id" : "bts:GumNOS" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Thymus" }, { - "@id" : "bts:NovaSeq6000" + "@id" : "bts:MalegenitalorgansNOS" }, { - "@id" : "bts:NovaSeqS4" + "@id" : "bts:IsletsofLangerhans" }, { - "@id" : "bts:Other" + "@id" : "bts:Isthmusuteri" }, { - "@id" : "bts:OxfordNanoporeminION" + "@id" : "bts:Spinalmeninges" }, { - "@id" : "bts:PacBioRS" + "@id" : "bts:Myometrium" }, { - "@id" : "bts:PacBioSequel2" + "@id" : "bts:Pelvicbonessacrumcoccyxandassociatedjoints" }, { - "@id" : "bts:PromethION" + "@id" : "bts:Connectivesubcutaneousandothersofttissuesoflowerlimbandhip" }, { - "@id" : "bts:Revio" + "@id" : "bts:Anterior2/3oftongueNOS" }, { - "@id" : "bts:UltimaGenomicsUG100" + "@id" : "bts:Upperthirdofesophagus" }, { - "@id" : "bts:Unknown" - } ], - "rdfs:label" : "SequencingPlatform", - "rdfs:comment" : "A platform is an object aggregate that is the set of instruments and software needed to perform a process [OBI_0000050]. Specific model of the sequencing instrument.", - "@type" : "rdfs:Class", - "sms:displayName" : "SequencingPlatform" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:SlideChargeType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "@id" : "bts:MeningesNOS" }, { - "@id" : "bts:Uncharged" + "@id" : "bts:Prostategland" }, { - "@id" : "bts:Charged" + "@id" : "bts:Overlappinglesionofsmallintestine" }, { - "@id" : "bts:Coverslip" + "@id" : "bts:Lowergum" }, { - "@id" : "bts:Notapplicable" - } ], - "rdfs:label" : "SlideChargeType", - "rdfs:comment" : "A description of the charge on the glass slide.", - "@type" : "rdfs:Class", - "sms:displayName" : "SlideChargeType" - }, { - "@id" : "bts:COVID19CancerTreatmentFollowup", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "COVID19CancerTreatmentFollowup", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "COVID19CancerTreatmentFollowup", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ChannelName", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ChannelName", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ChannelName", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ConcomitantMedicationReceivedType", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ConcomitantMedicationReceivedType", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ConcomitantMedicationReceivedType", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CellTotal", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of sequenced cells. Applies to raw counts matrix only.", - "rdfs:label" : "CellTotal", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CellTotal", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:MolecularAnalysisMethod", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:WXS" + "@id" : "bts:Paraspinal" + }, { + "@id" : "bts:Appendix" + }, { + "@id" : "bts:ScrotumNOS" + }, { + "@id" : "bts:Overlappinglesionoflarynx" + }, { + "@id" : "bts:Mainbronchus" + }, { + "@id" : "bts:Descendedtestis" + }, { + "@id" : "bts:Cloacogeniczone" + }, { + "@id" : "bts:ConnectivesubcutaneousandothersofttissuesoftrunkNOS" + }, { + "@id" : "bts:Heart" + }, { + "@id" : "bts:MucosaoflipNOS" }, { - "@id" : "bts:WGS" + "@id" : "bts:Broadligament" }, { - "@id" : "bts:ISH" + "@id" : "bts:Headofpancreas" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Overlappinglesionofbonesjointsandarticularcartilageoflimbs" }, { - "@id" : "bts:MicrosatelliteAnalysis" + "@id" : "bts:Temporallobe" }, { - "@id" : "bts:unknown" + "@id" : "bts:Bodyofpenis" }, { - "@id" : "bts:NotApplicable" + "@id" : "bts:Overlappinglesionofbiliarytract" }, { - "@id" : "bts:TargetedSequencing" + "@id" : "bts:Labiumminus" }, { - "@id" : "bts:NuclearStaining" + "@id" : "bts:Descendingcolon" }, { - "@id" : "bts:FISH" + "@id" : "bts:Lateralwallofnasopharynx" }, { - "@id" : "bts:IHC" + "@id" : "bts:Posteriorwallofhypopharynx" }, { - "@id" : "bts:Karyotype" + "@id" : "bts:Nipple" }, { - "@id" : "bts:FlowCytometry" + "@id" : "bts:Jejunum" }, { - "@id" : "bts:Other" + "@id" : "bts:Posteriorwallofbladder" }, { - "@id" : "bts:RNASequencing" + "@id" : "bts:Laryngealcartilage" }, { - "@id" : "bts:SequencingNOS" + "@id" : "bts:Cecum" }, { - "@id" : "bts:SouthernBlotting" + "@id" : "bts:Skinoflowerlimbandhip" }, { - "@id" : "bts:Microarray" + "@id" : "bts:Corpusuteri" }, { - "@id" : "bts:ComparativeGenomicHybridization" + "@id" : "bts:FemalegenitaltractNOS" }, { - "@id" : "bts:CytogeneticsNOS" + "@id" : "bts:AbdomenNOS" }, { - "@id" : "bts:RT-PCR" + "@id" : "bts:Tonsillarpillar" + }, { + "@id" : "bts:Otherspecifiedpartsoffemalegenitalorgans" + }, { + "@id" : "bts:Glottis" + }, { + "@id" : "bts:OrbitNOS" + }, { + "@id" : "bts:Skinoftrunk" + }, { + "@id" : "bts:VentricleNOS" + }, { + "@id" : "bts:Frontallobe" } ], - "rdfs:label" : "MolecularAnalysisMethod", - "rdfs:comment" : "The text term used to describe the method used for molecular analysis. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "@type" : "rdfs:Class", - "sms:displayName" : "MolecularAnalysisMethod" - }, { - "@id" : "bts:LaneNumber", - "@type" : "rdfs:Class", - "rdfs:comment" : "Basic machine unit for sequencing. For Illumina machines, this reflects the physical lane number. Wrong or missing information may affect analysis results. Integer", - "rdfs:label" : "LaneNumber", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LaneNumber", - "sms:required" : "sms:true" - }, { - "@id" : "bts:ParticipantID", - "@type" : "rdfs:Class", - "rdfs:comment" : "ID associated with a patient", - "rdfs:label" : "ParticipantID", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ParticipantID", - "sms:required" : "sms:true" - }, { - "@id" : "bts:COVID19CurrentStatus", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "COVID19CurrentStatus", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "COVID19CurrentStatus", - "sms:required" : "sms:false" - }, { - "@id" : "bts:FrameAveraging", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of frames averaged together (if no averaging, set to 1). Integer >= 1", - "rdfs:label" : "FrameAveraging", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "FrameAveraging", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ChannelID", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ChannelID", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ChannelID", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Vendor", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Vendor", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Vendor", - "sms:required" : "sms:false" - }, { - "@id" : "bts:LociCount", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the number of loci tested.", - "rdfs:label" : "LociCount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LociCount", - "sms:required" : "sms:false" - }, { - "@id" : "bts:DaystoRecurrence", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "DaystoRecurrence", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "DaystoRecurrence", - "sms:required" : "sms:false" - }, { - "@id" : "bts:AcquisitionMethodOtherSpecify", + "rdfs:label" : "SiteofResectionorBiopsy", + "rdfs:comment" : "The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).", "@type" : "rdfs:Class", - "rdfs:comment" : "A custom acquisition method [Text - max length 100 characters]", - "rdfs:label" : "AcquisitionMethodOtherSpecify", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AcquisitionMethodOtherSpecify", - "sms:required" : "sms:false" + "sms:displayName" : "SiteofResectionorBiopsy" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:ReadLength", + "@id" : "bts:Clonality", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", - "sms:validationRules" : [ "num" ], - "rdfs:label" : "ReadLength", - "rdfs:comment" : "Length of the sequencing reads. Can be integer, null", + "schema:rangeIncludes" : [ { + "@id" : "bts:Clonal" + }, { + "@id" : "bts:Non-clonal" + } ], + "rdfs:label" : "Clonality", + "rdfs:comment" : "The text term used to describe whether a genomic variant is related by descent from a single progenitor cell. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", "@type" : "rdfs:Class", - "sms:displayName" : "ReadLength" + "sms:displayName" : "Clonality" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:WellIndex", + "@id" : "bts:Sex", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ ], - "rdfs:label" : "WellIndex", - "rdfs:comment" : "Indicate if protein expression (EPCAM/CD45) positive/negative data is available for each cell in CEL-seq2 assays", + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:female" + }, { + "@id" : "bts:male" + }, { + "@id" : "bts:unspecified" + } ], + "rdfs:label" : "Sex", + "rdfs:comment" : "Sex of individual", "@type" : "rdfs:Class", - "sms:displayName" : "WellIndex" + "sms:displayName" : "Sex" }, { - "@id" : "bts:BreastCarcinomaCentromere17CopyNumber", + "@id" : "bts:YearOfBirth", "@type" : "rdfs:Class", - "rdfs:comment" : "Result of Centromere 17 testing in a sample or specimen of metastatic breast carcinoma, expressed as a range of values.", - "rdfs:label" : "BreastCarcinomaCentromere17CopyNumber", + "rdfs:comment" : "Numeric value to represent the calendar year in which an individual was born.", + "rdfs:label" : "YearOfBirth", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaCentromere17CopyNumber", + "sms:displayName" : "YearOfBirth", "sms:required" : "sms:false" }, { - "@id" : "bts:NominalMagnification", - "@type" : "rdfs:Class", - "rdfs:comment" : "The magnification of the lens as specified by the manufacturer - i.e. '60' is a 60X lens. floating point value > 1(no units)", - "rdfs:label" : "NominalMagnification", "rdfs:subClassOf" : [ ], + "@id" : "bts:FOVXUnit", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "NominalMagnification", - "sms:required" : "sms:false" - }, { - "@id" : "bts:COVID19OccurrenceIndicator", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:cm" + }, { + "@id" : "bts:mm" + }, { + "@id" : "bts:µm" + }, { + "@id" : "bts:nm" + }, { + "@id" : "bts:Å" + } ], + "rdfs:label" : "FOVXUnit", + "rdfs:comment" : "Field of view X dimension units. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "COVID19OccurrenceIndicator", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "COVID19OccurrenceIndicator", - "sms:required" : "sms:false" + "sms:displayName" : "FOVXUnit" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:OvarianCancerHistologicSubtype", + "@id" : "bts:Pathogenicity", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:High-gradeserous" - }, { - "@id" : "bts:Datanotavailable" - }, { - "@id" : "bts:unknown" - }, { - "@id" : "bts:Germcell" - }, { - "@id" : "bts:High-gradeendometrioid" - }, { - "@id" : "bts:Other" - }, { - "@id" : "bts:Low-gradeserous" + "@id" : "bts:Benign" }, { - "@id" : "bts:Clearcell" + "@id" : "bts:LikelyBenign" }, { - "@id" : "bts:Low-gradeendometrioid" + "@id" : "bts:LikelyPathogenic" }, { - "@id" : "bts:Mucinous" + "@id" : "bts:Pathogenic" }, { - "@id" : "bts:Sex-cordstromal" + "@id" : "bts:UncertainSignificance" } ], - "rdfs:label" : "OvarianCancerHistologicSubtype", - "rdfs:comment" : "Text term to describe the histological subtype of ovarian cancer in the participant", + "rdfs:label" : "Pathogenicity", + "rdfs:comment" : "The text used to describe a variant's level of involvement in the cause of the patient's disease according to the standards outlined by the American College of Medical Genetics and Genomics (ACMG).", "@type" : "rdfs:Class", - "sms:displayName" : "OvarianCancerHistologicSubtype" + "sms:displayName" : "Pathogenicity" }, { - "@id" : "bts:TotalVolume", + "@id" : "bts:SmokelessTobaccoQuitAge", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value for the total amount of sample or specimen", - "rdfs:label" : "TotalVolume", + "rdfs:comment" : "TBD", + "rdfs:label" : "SmokelessTobaccoQuitAge", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TotalVolume", + "sms:displayName" : "SmokelessTobaccoQuitAge", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:TumorTissueType", + "@id" : "bts:PixelsBigEndian", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ ], + "rdfs:label" : "PixelsBigEndian", + "rdfs:comment" : "Boolean (True/False)", + "@type" : "rdfs:Class", + "sms:displayName" : "PixelsBigEndian" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastCarcinomaDetectionMethodType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Normal" - }, { - "@id" : "bts:Normaladjacent" - }, { - "@id" : "bts:Recurrent" - }, { - "@id" : "bts:Posttherapyneoadjuvant" - }, { - "@id" : "bts:Normaldistant" - }, { - "@id" : "bts:Posttherapyadjuvant" - }, { - "@id" : "bts:Posttherapy" - }, { - "@id" : "bts:Atypia-hyperplasia" + "@id" : "bts:Other" }, { - "@id" : "bts:NotOtherwiseSpecified" + "@id" : "bts:unknown" }, { - "@id" : "bts:Metastatic" + "@id" : "bts:ClinicalExam" }, { - "@id" : "bts:Localrecurrence" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:Premalignant-insitu" + "@id" : "bts:NippleDischarge" }, { - "@id" : "bts:AdditionalPrimary" + "@id" : "bts:ScreeningMammography" }, { - "@id" : "bts:Premalignant" + "@id" : "bts:ScreeningMRI" }, { - "@id" : "bts:Primary" + "@id" : "bts:Selfexam" } ], - "rdfs:label" : "TumorTissueType", - "rdfs:comment" : "Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint (add rows to select multiple values along with timepoints)", + "rdfs:label" : "BreastCarcinomaDetectionMethodType", + "rdfs:comment" : "The means, manner of procedure, or systematic course of actions performed in order to discover or identify breast cancer.", "@type" : "rdfs:Class", - "sms:displayName" : "TumorTissueType" + "sms:displayName" : "BreastCarcinomaDetectionMethodType" }, { - "@id" : "bts:CellMedianNumberGenes", + "@id" : "bts:SizeZ", "@type" : "rdfs:Class", - "rdfs:comment" : "Median number of genes detected per cell. Number", - "rdfs:label" : "CellMedianNumberGenes", + "rdfs:comment" : "Size of image: Z dimension (in pixels). Integer >= 1", + "rdfs:label" : "SizeZ", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CellMedianNumberGenes", + "sms:displayName" : "SizeZ", "sms:required" : "sms:false" }, { - "@id" : "bts:Lot", + "@id" : "bts:COVID19AntibodyTesting", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "Lot", + "rdfs:label" : "COVID19AntibodyTesting", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Lot", + "sms:displayName" : "COVID19AntibodyTesting", "sms:required" : "sms:false" }, { - "@id" : "bts:COVID19ComplicationsSeverity", + "@id" : "bts:BMI", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "COVID19ComplicationsSeverity", + "rdfs:label" : "BMI", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "COVID19ComplicationsSeverity", + "sms:displayName" : "BMI", "sms:required" : "sms:false" }, { - "@id" : "bts:ProgressionorRecurrenceAnatomicSite", + "@id" : "bts:EmptyWellBarcode", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ProgressionorRecurrenceAnatomicSite", + "rdfs:comment" : "Unique cell barcode assigned to empty cells used as controls in CEL-seq2 assays.", + "rdfs:label" : "EmptyWellBarcode", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ProgressionorRecurrenceAnatomicSite", + "sms:displayName" : "EmptyWellBarcode", "sms:required" : "sms:false" }, { - "@id" : "bts:EmissionWavelength", + "@id" : "bts:BreastCarcinomaHER2RatioDiagnosis", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "EmissionWavelength", + "rdfs:comment" : "HER2 ratio of the participant at diagnosis", + "rdfs:label" : "BreastCarcinomaHER2RatioDiagnosis", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "EmissionWavelength", + "sms:displayName" : "BreastCarcinomaHER2RatioDiagnosis", "sms:required" : "sms:false" }, { - "@id" : "bts:ImageID", + "@id" : "bts:TimebetweenWakingandFirstSmoke", "@type" : "rdfs:Class", - "rdfs:comment" : "Unique internal image identifier. eg \"\"Image:0\"\". (To be extracted from OME-XML)", - "rdfs:label" : "ImageID", + "rdfs:comment" : "TBD", + "rdfs:label" : "TimebetweenWakingandFirstSmoke", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ImageID", + "sms:displayName" : "TimebetweenWakingandFirstSmoke", "sms:required" : "sms:false" }, { - "@id" : "bts:LibraryPrepKitName", + "@id" : "bts:MedianPercentageofMitochondrialReadsperNucleus", "@type" : "rdfs:Class", - "rdfs:comment" : "Name of Library Prep Kit. String", - "rdfs:label" : "LibraryPrepKitName", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LibraryPrepKitName", - "sms:required" : "sms:true" - }, { + "rdfs:comment" : "Contamination from mitochondrial sequences", + "rdfs:label" : "MedianPercentageofMitochondrialReadsperNucleus", "rdfs:subClassOf" : [ ], - "@id" : "bts:SingleNucleusBuffer", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:10x" - }, { - "@id" : "bts:NIB" - }, { - "@id" : "bts:Omni" - } ], - "rdfs:label" : "SingleNucleusBuffer", - "rdfs:comment" : "Nuclei isolation buffer", - "@type" : "rdfs:Class", - "sms:displayName" : "SingleNucleusBuffer" + "sms:displayName" : "MedianPercentageofMitochondrialReadsperNucleus", + "sms:required" : "sms:false" }, { - "@id" : "bts:LensNA", + "@id" : "bts:PhysicalSizeZ", "@type" : "rdfs:Class", - "rdfs:comment" : "The numerical aperture of the lens. Floating point value > 0.", - "rdfs:label" : "LensNA", + "rdfs:comment" : "Physical size (Z-dimension) of a pixel. Units are set by PhysicalSizeZUnit. Floating point value > 0.", + "rdfs:label" : "PhysicalSizeZ", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "LensNA", + "sms:displayName" : "PhysicalSizeZ", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:PhysicalSizeZUnit", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:cm" - }, { - "@id" : "bts:mm" - }, { - "@id" : "bts:µm" - }, { - "@id" : "bts:nm" - }, { - "@id" : "bts:Å" - } ], - "rdfs:label" : "PhysicalSizeZUnit", - "rdfs:comment" : "The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", - "@type" : "rdfs:Class", - "sms:displayName" : "PhysicalSizeZUnit" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:HereditaryCancerPredispositionSyndrome", + "@id" : "bts:LibrarySelectionMethod", "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:SDHassociatedrenalcancer" - }, { - "@id" : "bts:Constitutionalmismatchrepairdeficiency" - }, { - "@id" : "bts:Cirrhosisunknownetiology" - }, { - "@id" : "bts:Beckwith-Wiedemann" - }, { - "@id" : "bts:Hereditarymelanoma" - }, { - "@id" : "bts:NotReported" - }, { - "@id" : "bts:Gorlinsyndrome" - }, { - "@id" : "bts:vonHippel-LindauSyndrome" - }, { - "@id" : "bts:Tuberoussclerosiscomplex" - }, { - "@id" : "bts:RhabdoidtumorpredispositionsyndrometypeI" - }, { - "@id" : "bts:unknown" - }, { - "@id" : "bts:Tyrosinemia" - }, { - "@id" : "bts:Familialgastrointestinalstromaltumor" - }, { - "@id" : "bts:NotApplicable" - }, { - "@id" : "bts:Li-Fraumenisyndrome" - }, { - "@id" : "bts:Fanconianemia" - }, { - "@id" : "bts:Turcotsyndrome" - }, { - "@id" : "bts:Attenuatedfamilialadenomatouspolyposis" - }, { - "@id" : "bts:BAP1mutantdisease" - }, { - "@id" : "bts:Lynchsyndrome" - }, { - "@id" : "bts:Hereditaryparaganglioma–pheochromocytomasyndrome" - }, { - "@id" : "bts:Nevoidbasalcellcarcinomasyndrome" - }, { - "@id" : "bts:MultipleendocrineneoplasiatypeII" - }, { - "@id" : "bts:Rubinstein-Taybisyndrome" - }, { - "@id" : "bts:Cowdensyndrome" - }, { - "@id" : "bts:Hereditaryrenaloncocytoma" - }, { - "@id" : "bts:HereditarypapillaryRCC" - }, { - "@id" : "bts:Peutz–Jegherssyndrome" - }, { - "@id" : "bts:Familialadenomatouspolyposis" - }, { - "@id" : "bts:Biliarydisorder" - }, { - "@id" : "bts:MUTYH-associatedpolyposis" - }, { - "@id" : "bts:RhabdoidtumorpredispositionsyndrometypeII" - }, { - "@id" : "bts:Hereditaryretinoblastoma" - }, { - "@id" : "bts:GlycogenStorageDisease" - }, { - "@id" : "bts:Carneycomplex" - }, { - "@id" : "bts:Hereditarydiffusegastriccancer" - }, { - "@id" : "bts:Juvenilepolyposissyndrome" - }, { - "@id" : "bts:Hereditarymixedpolyposissyndrome" - }, { - "@id" : "bts:Serratedpolyposissyndrome" - }, { - "@id" : "bts:Familialrenalcancer" - }, { - "@id" : "bts:Hereditarypapillaryrenalcellcarcinoma" - }, { - "@id" : "bts:Hereditaryleiomyoma-renalcellcarcinoma" + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:hybridselection" }, { - "@id" : "bts:MultipleendocrineneoplasiatypeI" + "@id" : "bts:PCR" }, { - "@id" : "bts:Birt-Hogg-Dubesyndrome" + "@id" : "bts:affinityenrichment" }, { - "@id" : "bts:Familialpancreaticcancer" + "@id" : "bts:poly-Tenrichment" }, { - "@id" : "bts:Hereditarybreast–ovariancancersyndrome" + "@id" : "bts:random" }, { - "@id" : "bts:Familialprostatecancer" + "@id" : "bts:rRNAdepletion" }, { - "@id" : "bts:Melanoma–astrocytomasyndrome" + "@id" : "bts:miRNAsizefractionation" }, { - "@id" : "bts:Alpha-1antitrypsin" + "@id" : "bts:other" } ], - "rdfs:label" : "HereditaryCancerPredispositionSyndrome", - "rdfs:comment" : "History of presence of inherited genetic predisposition syndrome that confers heightened susceptibility to cancer in the patient.", + "rdfs:label" : "LibrarySelectionMethod", + "rdfs:comment" : "How RNA molecules are isolated", "@type" : "rdfs:Class", - "sms:displayName" : "HereditaryCancerPredispositionSyndrome" + "sms:displayName" : "LibrarySelectionMethod" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:PrimaryDiagnosis", + "@id" : "bts:CountryofResidence", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Pagetdiseaseandintraductalcarcinomaofbreast" + "@id" : "bts:TrinidadandTobago" }, { - "@id" : "bts:Papillarymicrocarcinoma" + "@id" : "bts:Botswana" }, { - "@id" : "bts:Kaposisarcoma" + "@id" : "bts:Malaysia" }, { - "@id" : "bts:CarcinomaNOS" + "@id" : "bts:Suriname" }, { - "@id" : "bts:AcutemyeloidleukemiaNOS" + "@id" : "bts:Uruguay" }, { - "@id" : "bts:TumorNOS" + "@id" : "bts:Gibraltar" }, { - "@id" : "bts:Renalcelladenocarcinoma" + "@id" : "bts:Andorra" }, { - "@id" : "bts:MalignantlymphomalymphoblasticNOS" + "@id" : "bts:CaymanIslands" }, { - "@id" : "bts:Mammarycarcinomainsitu" + "@id" : "bts:Mozambique" }, { - "@id" : "bts:Adenocarcinomainsituintubularadenoma" + "@id" : "bts:Dominica" }, { - "@id" : "bts:MalignantlymphomasmallBlymphocyticNOS" + "@id" : "bts:Tajikistan" }, { - "@id" : "bts:Eosinophilicleukemia" + "@id" : "bts:Barbados" }, { - "@id" : "bts:AcutelymphoblasticleukemiaNOS" + "@id" : "bts:Seychelles" }, { - "@id" : "bts:MalignantlymphomalymphocyticnodularNOS" + "@id" : "bts:Curacao" }, { - "@id" : "bts:Basalcellepithelioma" + "@id" : "bts:Coted'Ivoire" }, { - "@id" : "bts:Intracysticpapilloma" + "@id" : "bts:Albania" }, { - "@id" : "bts:Lobularandductalcarcinoma" + "@id" : "bts:China" }, { - "@id" : "bts:Cancer" + "@id" : "bts:Oman" }, { - "@id" : "bts:Tlymphoblasticleukemia/lymphoma" + "@id" : "bts:Congo" }, { - "@id" : "bts:ClassicalHodgkinlymphomalymphocyte-rich" + "@id" : "bts:Burundi" }, { - "@id" : "bts:Esophagealintraepithelialneoplasiahighgrade" + "@id" : "bts:FalklandIslands(Malvinas)" }, { - "@id" : "bts:Burkittcellleukemia" + "@id" : "bts:Kazakhstan" }, { - "@id" : "bts:MonocyticleukemiaNOS" + "@id" : "bts:Australia" }, { - "@id" : "bts:AcuteleukemiaNOS" + "@id" : "bts:France" }, { - "@id" : "bts:Renalmedullarycarcinoma" + "@id" : "bts:Bahrain" }, { - "@id" : "bts:Diffusemelanocytosis" + "@id" : "bts:SolomonIslands" }, { - "@id" : "bts:Intraductalandlobularcarcinoma" + "@id" : "bts:Tanzania" }, { - "@id" : "bts:MelanoticpsammomatousMPNST" + "@id" : "bts:FrenchGuiana" }, { - "@id" : "bts:MalignantmelanomainHutchinsonmelanoticfreckle" + "@id" : "bts:FederatedStatesofMicronesia" }, { - "@id" : "bts:Pigmentedadenoma" + "@id" : "bts:AntiguaandBarbuda" }, { - "@id" : "bts:ChronicgranulocyticleukemiaBCR/ABL" + "@id" : "bts:Colombia" }, { - "@id" : "bts:CervicalintraepithelialneoplasiagradeIII" + "@id" : "bts:Fiji" }, { - "@id" : "bts:High-gradeserouscarcinoma" + "@id" : "bts:SaoTomeandPrincipe" }, { - "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosisgrade1" + "@id" : "bts:Brazil" }, { - "@id" : "bts:Meningiomamalignant" + "@id" : "bts:Guam" }, { - "@id" : "bts:InterstitialcelltumorNOS" + "@id" : "bts:SouthAfrica" }, { - "@id" : "bts:BronchialadenomaNOS" + "@id" : "bts:Denmark" }, { - "@id" : "bts:PrecursorT-celllymphoblasticlymphoma" + "@id" : "bts:Kyrgyzstan" }, { - "@id" : "bts:Tubularandroblastomawithlipidstorage" + "@id" : "bts:Tunisia" }, { - "@id" : "bts:Combinedlargecellneuroendocrinecarcinoma" + "@id" : "bts:Mexico" }, { - "@id" : "bts:NephroblastomaNOS" + "@id" : "bts:Martinique" }, { - "@id" : "bts:Tumorcellsbenign" + "@id" : "bts:BurkinaFaso" }, { - "@id" : "bts:Tumorletbenign" + "@id" : "bts:India" }, { - "@id" : "bts:Pleomorphiclipoma" + "@id" : "bts:Myanmar" }, { - "@id" : "bts:Adenocarcinomaofanalducts" + "@id" : "bts:Malawi" }, { - "@id" : "bts:Gastrointestinalstromaltumormalignant" + "@id" : "bts:Sweden" }, { - "@id" : "bts:Malignantmelanomainjunctionalnevus" + "@id" : "bts:Macau" }, { - "@id" : "bts:Rhabdosarcoma" + "@id" : "bts:Cambodia" }, { - "@id" : "bts:EndometrioidadenomaNOS" + "@id" : "bts:EquatorialGuinea" }, { - "@id" : "bts:Hodgkinsarcoma" + "@id" : "bts:Senegal" }, { - "@id" : "bts:MalignantlymphomaimmunoblasticNOS" + "@id" : "bts:Guernsey" }, { - "@id" : "bts:Smallcongenitalnevus" + "@id" : "bts:Azerbaijan" }, { - "@id" : "bts:TumormalignantNOS" + "@id" : "bts:Angola" }, { - "@id" : "bts:Undifferentiatedepithelioidsarcoma" + "@id" : "bts:Kuwait" }, { - "@id" : "bts:NeuroendocrinecarcinomaNOS" + "@id" : "bts:PapuaNewGuinea" }, { - "@id" : "bts:Acutelymphoblasticleukemiaprecursorcelltype" + "@id" : "bts:CentralAfricanRepublic" }, { - "@id" : "bts:Inflammatoryadenocarcinoma" + "@id" : "bts:Bhutan" }, { - "@id" : "bts:Tubularadenocarcinoma" + "@id" : "bts:Uzbekistan" }, { - "@id" : "bts:Combinedsmallcell-adenocarcinoma" + "@id" : "bts:Portugal" }, { - "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosiscellularphase" + "@id" : "bts:IsleofMan" }, { - "@id" : "bts:Mixedadenocarcinomaandepidermoidcarcinoma" + "@id" : "bts:Guatemala" }, { - "@id" : "bts:EpidermoidcarcinomainsituNOS" + "@id" : "bts:SaintHelenaAscensionandTristandaCunha" }, { - "@id" : "bts:Undifferentiatedhigh-gradepleomorphicsarcoma" + "@id" : "bts:Kiribati" }, { - "@id" : "bts:Sclerosinghepaticcarcinoma" + "@id" : "bts:Peru" }, { - "@id" : "bts:Pagetoidreticulosis" + "@id" : "bts:SouthSudan" }, { - "@id" : "bts:Centralneurocytoma" + "@id" : "bts:NorthMacedonia" }, { - "@id" : "bts:Bronchiolo-alveolarcarcinomaNOS" + "@id" : "bts:DemocraticRepublicoftheCongo" }, { - "@id" : "bts:Chroniclymphoidleukemia" + "@id" : "bts:Belarus" }, { - "@id" : "bts:Paragangliomamalignant" + "@id" : "bts:Madagascar" }, { - "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosisgrade2" + "@id" : "bts:Singapore" }, { - "@id" : "bts:B-ALL" + "@id" : "bts:Togo" }, { - "@id" : "bts:Skinappendagecarcinoma" + "@id" : "bts:Gambia" }, { - "@id" : "bts:Epithelialtumorbenign" + "@id" : "bts:Georgia" }, { - "@id" : "bts:Blymphoblasticleukemia/lymphomaNOS" + "@id" : "bts:Italy" }, { - "@id" : "bts:HodgkinlymphomanodularsclerosisNOS" + "@id" : "bts:Tuvalu" }, { - "@id" : "bts:MalignantlymphomalymphocyticdiffuseNOS" + "@id" : "bts:Eswatini" }, { - "@id" : "bts:Pro-BALL" + "@id" : "bts:Nepal" }, { - "@id" : "bts:GastrinomaNOS" + "@id" : "bts:Kenya" }, { - "@id" : "bts:Intraductalcarcinomaclinging" + "@id" : "bts:Niger" }, { - "@id" : "bts:Non-invasivelowgradeserouscarcinoma" + "@id" : "bts:Israel" }, { - "@id" : "bts:AcutepromyelocyticleukemiaNOS" + "@id" : "bts:Iran" }, { - "@id" : "bts:Malignantlymphomanon-HodgkinNOS" + "@id" : "bts:Liberia" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Mali" }, { - "@id" : "bts:Melanoticschwannoma" + "@id" : "bts:Belize" }, { - "@id" : "bts:SplenicmarginalzonelymphomaNOS" + "@id" : "bts:Hungary" }, { - "@id" : "bts:Transitionalcellcarcinomainsitu" + "@id" : "bts:HolySee" }, { - "@id" : "bts:Chronicmonocyticleukemia" + "@id" : "bts:Serbia" }, { - "@id" : "bts:Gastrincelltumor" + "@id" : "bts:Belgium" }, { - "@id" : "bts:Papillaryserouscystadenocarcinoma" + "@id" : "bts:Bermuda" }, { - "@id" : "bts:TeratomamalignantNOS" + "@id" : "bts:Anguilla" }, { - "@id" : "bts:ClassicalHodgkinlymphomalymphocytedepletionreticular" + "@id" : "bts:Jamaica" }, { - "@id" : "bts:Tumorcellsuncertainwhetherbenignormalignant" + "@id" : "bts:Lebanon" }, { - "@id" : "bts:Epithelialtumormalignant" + "@id" : "bts:Svalbard&JanMayenIslands" }, { - "@id" : "bts:TubularandroblastomaNOS" + "@id" : "bts:Cyprus" }, { - "@id" : "bts:Papillarycarcinomainsitu" + "@id" : "bts:Norway" }, { - "@id" : "bts:PituitarycarcinomaNOS" + "@id" : "bts:Somalia" }, { - "@id" : "bts:Typicalcarcinoid" + "@id" : "bts:Japan" }, { - "@id" : "bts:Non-smallcellcarcinoma" + "@id" : "bts:Guyana" }, { - "@id" : "bts:MeningiomaNOS" + "@id" : "bts:Paraguay" }, { - "@id" : "bts:EndometrialsarcomaNOS" + "@id" : "bts:NewZealand" }, { - "@id" : "bts:NeuroblastomaNOS" + "@id" : "bts:Palau" }, { - "@id" : "bts:BcelllymphomaNOS" + "@id" : "bts:Laos" }, { - "@id" : "bts:PeripheralT-celllymphomalargecell" + "@id" : "bts:Latvia" }, { - "@id" : "bts:RenalcellcarcinomaNOS" + "@id" : "bts:Ethiopia" }, { - "@id" : "bts:Renalcellcarcinomaspindlecell" + "@id" : "bts:Cuba" }, { - "@id" : "bts:Hepatocholangiocarcinoma" + "@id" : "bts:FrenchPolynesia" }, { - "@id" : "bts:MalignantlymphomanodularNOS" + "@id" : "bts:Slovenia" }, { - "@id" : "bts:Bronchiolo-alveolarcarcinomanon-mucinous" + "@id" : "bts:Philippines" }, { - "@id" : "bts:unknown" + "@id" : "bts:Mongolia" + }, { + "@id" : "bts:Switzerland" + }, { + "@id" : "bts:Bahamas" + }, { + "@id" : "bts:Samoa" + }, { + "@id" : "bts:ElSalvador" + }, { + "@id" : "bts:Chad" + }, { + "@id" : "bts:Honduras" }, { - "@id" : "bts:Bronchiolo-alveolarcarcinomaindeterminatetype" + "@id" : "bts:Bangladesh" }, { - "@id" : "bts:Pleomorphiccarcinoma" + "@id" : "bts:Tonga" }, { - "@id" : "bts:PapillarycystadenomaNOS" + "@id" : "bts:Croatia" }, { - "@id" : "bts:Burkitttumor" + "@id" : "bts:BosniaandHerzegovina" }, { - "@id" : "bts:BasalcellcarcinomaNOS" + "@id" : "bts:Eritrea" }, { - "@id" : "bts:HepatocellularcarcinomaNOS" + "@id" : "bts:SaintKittsandNevis" }, { - "@id" : "bts:Undifferentiatedleukaemia" + "@id" : "bts:Vietnam" }, { - "@id" : "bts:Gastrincelltumormalignant" + "@id" : "bts:NorthernMarianaIslands" }, { - "@id" : "bts:Melanoameloblastoma" + "@id" : "bts:CapeVerde" }, { - "@id" : "bts:ProstaticintraepithelialneoplasiagradeIII" + "@id" : "bts:CookIslands" }, { - "@id" : "bts:Mixedpinealtumor" + "@id" : "bts:Turkmenistan" }, { - "@id" : "bts:Smallcellsarcoma" + "@id" : "bts:WesternSahara" }, { - "@id" : "bts:Carcinomainadenomatouspolyp" + "@id" : "bts:Jordan" }, { - "@id" : "bts:Pagetdiseaseextramammary" + "@id" : "bts:Romania" }, { - "@id" : "bts:Intraductalcarcinomasolidtype" + "@id" : "bts:Uganda" }, { - "@id" : "bts:Livercellcarcinoma" + "@id" : "bts:Aruba" }, { - "@id" : "bts:Undifferentiatedsarcoma" + "@id" : "bts:HongKong" }, { - "@id" : "bts:Squamouscellcarcinomaclearcelltype" + "@id" : "bts:Syria" }, { - "@id" : "bts:PituitaryadenomaNOS" + "@id" : "bts:Germany" }, { - "@id" : "bts:EndometrioidcarcinomaNOS" + "@id" : "bts:Chile" }, { - "@id" : "bts:PapillaryadenocarcinomaNOS" + "@id" : "bts:Austria" }, { - "@id" : "bts:Ductcarcinomadesmoplastictype" + "@id" : "bts:Gabon" }, { - "@id" : "bts:Chroniclymphaticleukemia" + "@id" : "bts:Kosovo" }, { - "@id" : "bts:SquamouscellcarcinomainsituNOS" + "@id" : "bts:Qatar" }, { - "@id" : "bts:Intraductalpapillaryadenocarcinomawithinvasion" + "@id" : "bts:Comoros" }, { - "@id" : "bts:Adenocarcinomacombinedwithothertypesofcarcinoma" + "@id" : "bts:Mayotte" }, { - "@id" : "bts:Combinedhepatocellularcarcinomaandcholangiocarcinoma" + "@id" : "bts:Spain" }, { - "@id" : "bts:Primaryamyloidosis" + "@id" : "bts:Libya" }, { - "@id" : "bts:Preleukemia" + "@id" : "bts:CostaRica" }, { - "@id" : "bts:Adenocarcinomaofanalglands" + "@id" : "bts:Bolivia" }, { - "@id" : "bts:Secondarycarcinoma" + "@id" : "bts:Taiwan" }, { - "@id" : "bts:Dermalnevus" + "@id" : "bts:Iraq" }, { - "@id" : "bts:Infiltratingductandcribriformcarcinoma" + "@id" : "bts:Finland" }, { - "@id" : "bts:Eosinophiladenocarcinoma" + "@id" : "bts:Netherlands" }, { - "@id" : "bts:Chronicmyeloproliferativedisorder" + "@id" : "bts:Venezuela" }, { - "@id" : "bts:Malignantmelanomaregressing" + "@id" : "bts:Malta" }, { - "@id" : "bts:Osteoblastomamalignant" + "@id" : "bts:Niue" }, { - "@id" : "bts:Papillotubularadenocarcinoma" + "@id" : "bts:Algeria" }, { - "@id" : "bts:CarcinomametastaticNOS" + "@id" : "bts:Guinea" }, { - "@id" : "bts:Sclerosinghemangioma" + "@id" : "bts:Ireland" }, { - "@id" : "bts:LymphocyticleukemiaNOS" + "@id" : "bts:Montenegro" }, { - "@id" : "bts:PrecursorcelllymphoblasticleukemiaNOS" + "@id" : "bts:UnitedArabEmirates" }, { - "@id" : "bts:PapillarycarcinomaNOS" + "@id" : "bts:Maldives" }, { - "@id" : "bts:Bronchio-alveolarcarcinomamucinous" + "@id" : "bts:Zambia" }, { - "@id" : "bts:CarcinomainapolypNOS" + "@id" : "bts:Slovakia" }, { - "@id" : "bts:AcutemyeloidleukemiaMLL" + "@id" : "bts:Lesotho" }, { - "@id" : "bts:Tubulocysticrenalcellcarcinoma" + "@id" : "bts:DominicanRepublic" }, { - "@id" : "bts:MelanocytomaNOS" + "@id" : "bts:SaintPierreandMiquelon" }, { - "@id" : "bts:ChronicmyelogenousleukemiaPhiladelphiachromosome(Ph1)positive" + "@id" : "bts:Moldova" }, { - "@id" : "bts:Ewingsarcoma" + "@id" : "bts:SanMarino" }, { - "@id" : "bts:GliomaNOS" + "@id" : "bts:Nauru" }, { - "@id" : "bts:Bronchial-associatedlymphoidtissuelymphoma" + "@id" : "bts:Luxembourg" }, { - "@id" : "bts:Papillotubularadenoma" + "@id" : "bts:Monaco" }, { - "@id" : "bts:Papillomaofbladder" + "@id" : "bts:Zimbabwe" }, { - "@id" : "bts:Bronchio-alveolarcarcinomamixedmucinousandnon-mucinous" + "@id" : "bts:SaudiArabia" }, { - "@id" : "bts:Carcinomainpleomorphicadenoma" + "@id" : "bts:Mauritania" }, { - "@id" : "bts:Chondrosarcomagrade2/3" + "@id" : "bts:Panama" }, { - "@id" : "bts:Neoplasmsecondary" + "@id" : "bts:UnitedStates" }, { - "@id" : "bts:Rhabdomyosarcomawithganglionicdifferentiation" + "@id" : "bts:Montserrat" }, { - "@id" : "bts:Chroniclymphocyticleukemia" + "@id" : "bts:Nicaragua" }, { - "@id" : "bts:Liposarcomawelldifferentiated" + "@id" : "bts:FaroeIslands" }, { - "@id" : "bts:Undifferentiatedpleomorphicsarcoma" + "@id" : "bts:UnitedKingdom" }, { - "@id" : "bts:Secretorycarcinomaofbreast" + "@id" : "bts:Canada" }, { - "@id" : "bts:Lobularcarcinomanoninfiltrating" + "@id" : "bts:Ghana" }, { - "@id" : "bts:Mixedadenocarcinomaandsquamouscellcarcinoma" + "@id" : "bts:Armenia" }, { - "@id" : "bts:Melanoticneurofibroma" + "@id" : "bts:Bulgaria" }, { - "@id" : "bts:ChronicgranulocyticleukemiaPhiladelphiachromosome(Ph1)positive" + "@id" : "bts:Egypt" }, { - "@id" : "bts:Hepatocellularadenoma" + "@id" : "bts:Reunion" }, { - "@id" : "bts:BurkittlymphomaNOS(Includesallvariants)" + "@id" : "bts:Cameroon" }, { - "@id" : "bts:ParagangliomaNOS" + "@id" : "bts:Rwanda" }, { - "@id" : "bts:DiffuselargeB-celllymphomaNOS" + "@id" : "bts:Timor-Leste" }, { - "@id" : "bts:NevusNOS" + "@id" : "bts:Yemen" }, { - "@id" : "bts:Hepatoidcarcinoma" + "@id" : "bts:SaintLucia" }, { - "@id" : "bts:MixedtumormalignantNOS" + "@id" : "bts:Poland" }, { - "@id" : "bts:Rhabdoidsarcoma" + "@id" : "bts:Namibia" }, { - "@id" : "bts:Tubulolobularcarcinoma" + "@id" : "bts:Guinea-Bissau" }, { - "@id" : "bts:Papillomatosisglandular" + "@id" : "bts:Thailand" }, { - "@id" : "bts:Bronchialadenomacarcinoid" + "@id" : "bts:Argentina" }, { - "@id" : "bts:Tumorembolus" + "@id" : "bts:Turkey" }, { - "@id" : "bts:DuctcarcinomaNOS" + "@id" : "bts:Djibouti" }, { - "@id" : "bts:RhabdomyosarcomaNOS" + "@id" : "bts:Greece" }, { - "@id" : "bts:LobularcarcinomaNOS" + "@id" : "bts:Jersey" }, { - "@id" : "bts:Bronchialadenomacylindroid" + "@id" : "bts:Mauritius" }, { - "@id" : "bts:EpidermoidcarcinomaNOS" + "@id" : "bts:WallisandFutuna" }, { - "@id" : "bts:Papillaryglioneuronaltumor" + "@id" : "bts:Pakistan" }, { - "@id" : "bts:DuctalcarcinomainsituNOS" + "@id" : "bts:Ukraine" }, { - "@id" : "bts:Unclassifiedtumormalignantuncertainwhetherprimaryormetastatic" + "@id" : "bts:StateofPalestine" }, { - "@id" : "bts:Glioblastoma" + "@id" : "bts:Ecuador" }, { - "@id" : "bts:Papillaryandfollicularcarcinoma" + "@id" : "bts:SouthKorea" }, { - "@id" : "bts:DuctalcarcinomaNOS" + "@id" : "bts:Russia" }, { - "@id" : "bts:Tumorbenign" + "@id" : "bts:Greenland" }, { - "@id" : "bts:Pagetdiseasemammary" + "@id" : "bts:Liechtenstein" }, { - "@id" : "bts:Diffuseastrocytomalowgrade" + "@id" : "bts:Nigeria" }, { - "@id" : "bts:Ductcellcarcinoma" + "@id" : "bts:Benin" }, { - "@id" : "bts:Preleukemicsyndrome" + "@id" : "bts:Vanuatu" }, { - "@id" : "bts:Carcinomadiffusetype" + "@id" : "bts:SriLanka" }, { - "@id" : "bts:Neurosarcoma" + "@id" : "bts:Tokelau" }, { - "@id" : "bts:PapillomatosisNOS" + "@id" : "bts:CzechRepublic(Czechia)" }, { - "@id" : "bts:Therapyrelatedmyeloidneoplasm" + "@id" : "bts:MarshallIslands" }, { - "@id" : "bts:Renalcarcinomacollectingducttype" + "@id" : "bts:Estonia" }, { - "@id" : "bts:NeurofibromaNOS" + "@id" : "bts:SaintVincentandtheGrenadines" }, { - "@id" : "bts:Meningiomaanaplastic" + "@id" : "bts:PuertoRico" }, { - "@id" : "bts:CementomaNOS" + "@id" : "bts:Grenada" }, { - "@id" : "bts:DermatofibromaNOS" + "@id" : "bts:Guadeloupe" }, { - "@id" : "bts:AstrocytomaNOS" + "@id" : "bts:SierraLeone" }, { - "@id" : "bts:Livercelladenoma" + "@id" : "bts:Afghanistan" }, { - "@id" : "bts:TubulovillousadenomaNOS" + "@id" : "bts:Haiti" }, { - "@id" : "bts:MelanomaNOS" + "@id" : "bts:Lithuania" }, { - "@id" : "bts:PapillomaNOS" + "@id" : "bts:Indonesia" }, { - "@id" : "bts:Esophagealglandulardysplasia(intraepithelialneoplasia)highgrade" + "@id" : "bts:VirginIslandsBritish" }, { - "@id" : "bts:Tumorcellsmalignant" + "@id" : "bts:VirginIslandsU.S." }, { - "@id" : "bts:MalignantlymphomadiffuseNOS" + "@id" : "bts:Sudan" }, { - "@id" : "bts:Renalcellcarcinomachromophobetype" + "@id" : "bts:Morocco" }, { - "@id" : "bts:Tubularcarcinoid" + "@id" : "bts:Iceland" }, { - "@id" : "bts:Nonpigmentednevus" + "@id" : "bts:NorthKorea" }, { - "@id" : "bts:Rodentulcer" + "@id" : "bts:NewCaledonia" }, { - "@id" : "bts:HodgkindiseaseNOS" + "@id" : "bts:Brunei" + } ], + "rdfs:label" : "CountryofResidence", + "rdfs:comment" : "Country of Residence at enrollment", + "@type" : "rdfs:Class", + "sms:displayName" : "CountryofResidence" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastCancerAssessmentTests", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" }, { - "@id" : "bts:Acinarcellcarcinoma" + "@id" : "bts:unknown" }, { - "@id" : "bts:Papillaryadenofibroma" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:Oatcellcarcinoma" + "@id" : "bts:EstrogenreceptorIHC" }, { - "@id" : "bts:Adenocarcinomainadenomatouspolyp" + "@id" : "bts:ProgesteronereceptorIHC" }, { - "@id" : "bts:SpindlecellcarcinomaNOS" + "@id" : "bts:HER2IHC" }, { - "@id" : "bts:Adenocarcinomainpolypoidadenoma" + "@id" : "bts:HER2FISH-CISH" }, { - "@id" : "bts:Papillaryserousadenocarcinoma" + "@id" : "bts:HER2FISH" + } ], + "rdfs:label" : "BreastCancerAssessmentTests", + "rdfs:comment" : "Text term to identify assessment tests done in participants during diagnosis", + "@type" : "rdfs:Class", + "sms:displayName" : "BreastCancerAssessmentTests" + }, { + "@id" : "bts:EmissionBandwidth", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "EmissionBandwidth", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "EmissionBandwidth", + "sms:required" : "sms:false" + }, { + "@id" : "bts:MatrixType", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "MatrixType", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "MatrixType", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:SpikeIn", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:ERCC" }, { - "@id" : "bts:SplenicdiffuseredpulpsmallB-celllymphoma" + "@id" : "bts:OtherSpikeIn" }, { - "@id" : "bts:ChondromaNOS" + "@id" : "bts:NoSpikeIn" }, { - "@id" : "bts:Bileductadenoma" + "@id" : "bts:PhiX" + } ], + "rdfs:label" : "SpikeIn", + "rdfs:comment" : "A set of known synthetic RNA molecules with known sequence that are added to the cell lysis mix", + "@type" : "rdfs:Class", + "sms:displayName" : "SpikeIn" + }, { + "@id" : "bts:TypeofTobaccoUsed", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "TypeofTobaccoUsed", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TypeofTobaccoUsed", + "sms:required" : "sms:false" + }, { + "@id" : "bts:HistologicMorphologyCode", + "@type" : "rdfs:Class", + "rdfs:comment" : "Histologic Morphology Code, based on ICD-O-3. Any valid ICD-O-3 morphology code. See https://seer.cancer.gov/icd-o-3/ and https://seer.cancer.gov/icd-o-3/sitetype.icdo3.20200629.xlsx. Examples: 80510", + "rdfs:label" : "HistologicMorphologyCode", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "HistologicMorphologyCode", + "sms:required" : "sms:false" + }, { + "@id" : "bts:PhysicalSizeX", + "@type" : "rdfs:Class", + "rdfs:comment" : "Physical size (X-dimension) of a pixel. Units are set by PhysicalSizeXUnit. Floating point value > 0.", + "rdfs:label" : "PhysicalSizeX", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "PhysicalSizeX", + "sms:required" : "sms:false" + }, { + "@id" : "bts:Ecigvape30dayusenum", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "Ecigvape30dayusenum", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Ecigvape30dayusenum", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CauseofDeathSource", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "CauseofDeathSource", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CauseofDeathSource", + "sms:required" : "sms:false" + }, { + "@id" : "bts:YearofDeath", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value to represent the year of the death of an individual.", + "rdfs:label" : "YearofDeath", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "YearofDeath", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LinkedProject", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "LinkedProject", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LinkedProject", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CancerIncidence", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "CancerIncidence", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CancerIncidence", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:BreastCancerAllredEstrogenReceptorScore", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" }, { - "@id" : "bts:Adenocarcinomainvillousadenoma" + "@id" : "bts:10" }, { - "@id" : "bts:SpindlecellmelanomaNOS" + "@id" : "bts:0" }, { - "@id" : "bts:ClassicalHodgkinlymphomamixedcellularityNOS" + "@id" : "bts:4" }, { - "@id" : "bts:Combinedsmallcell-largecarcinoma" + "@id" : "bts:7" }, { - "@id" : "bts:Eosinophilcarcinoma" + "@id" : "bts:1" }, { - "@id" : "bts:PancreaticendocrinetumorNOS" + "@id" : "bts:8" }, { - "@id" : "bts:AdenocarcinomaNOS" + "@id" : "bts:2" }, { - "@id" : "bts:SarcomaNOS" + "@id" : "bts:5" }, { - "@id" : "bts:ChronicmyelocyticleukemiaNOS" + "@id" : "bts:3" }, { - "@id" : "bts:Adenocarcinomainsitunon-mucinous" + "@id" : "bts:6" + } ], + "rdfs:label" : "BreastCancerAllredEstrogenReceptorScore", + "rdfs:comment" : "The numeric Allred score, that is cell staining percentage plus intensity, to determine estrogen receptor status.", + "@type" : "rdfs:Class", + "sms:displayName" : "BreastCancerAllredEstrogenReceptorScore" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ERStainingIntensity", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" }, { - "@id" : "bts:ChronicleukemiaNOS" + "@id" : "bts:unknown" }, { - "@id" : "bts:Pro-TALL" + "@id" : "bts:Strong" }, { - "@id" : "bts:Esophagealglandulardysplasia(intraepithelialneoplasia)lowgrade" + "@id" : "bts:Moderate" }, { - "@id" : "bts:Lymphoblastoma" + "@id" : "bts:Weak" }, { - "@id" : "bts:Mixedmedullary-papillarycarcinoma" + "@id" : "bts:Weak-Moderate" }, { - "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosisNOS" + "@id" : "bts:Moderate-Strong" }, { - "@id" : "bts:OsteoblastomaNOS" + "@id" : "bts:Weak-Strong" + } ], + "rdfs:label" : "ERStainingIntensity", + "rdfs:comment" : "Text term to indicate the ER staining intensity on pathology assessment in a participant with breast cancer", + "@type" : "rdfs:Class", + "sms:displayName" : "ERStainingIntensity" + }, { + "@id" : "bts:FOVX", + "@type" : "rdfs:Class", + "rdfs:comment" : "Field of view X dimension. Floating point", + "rdfs:label" : "FOVX", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "FOVX", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:HormoneTherapyBreastCancerPreventionIndicator", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:NotApplicable" }, { - "@id" : "bts:CerebellarsarcomaNOS" + "@id" : "bts:Yes" }, { - "@id" : "bts:Paragangliomabenign" + "@id" : "bts:No" }, { - "@id" : "bts:Intraductaltubular-papillaryneoplasmlowgrade" + "@id" : "bts:unknown" + } ], + "rdfs:label" : "HormoneTherapyBreastCancerPreventionIndicator", + "rdfs:comment" : "Did the patient receive hormonal therapy for prevention of breast cancer?", + "@type" : "rdfs:Class", + "sms:displayName" : "HormoneTherapyBreastCancerPreventionIndicator" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:SequencingPlatform", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:454GSFLXTitanium" }, { - "@id" : "bts:Familialadenomatouspolyposis" + "@id" : "bts:ABSOLiD3" }, { - "@id" : "bts:Mixedsquamouscellandglandularpapilloma" + "@id" : "bts:ABSOLiD4ABSOLiD2" }, { - "@id" : "bts:IntraductalcarcinomaNOS" + "@id" : "bts:CompleteGenomics" }, { - "@id" : "bts:Transitionalcarcinoma" + "@id" : "bts:GridION" }, { - "@id" : "bts:Gastrinomamalignant" + "@id" : "bts:IlluminaGenomeAnalyzerII" }, { - "@id" : "bts:Melanocytomaeyeball" + "@id" : "bts:IlluminaGenomeAnalyzerIIx" }, { - "@id" : "bts:Mixedmedullary-follicularcarcinoma" + "@id" : "bts:IlluminaHiSeq2000" }, { - "@id" : "bts:ChronicmyelogenousleukemiaBCR-ABLpositive" + "@id" : "bts:IlluminaHiSeq2500" }, { - "@id" : "bts:Basophilcarcinoma" + "@id" : "bts:IlluminaHiSeq4000" }, { - "@id" : "bts:NeuroepitheliomaNOS" + "@id" : "bts:IlluminaHiSeqXFive" }, { - "@id" : "bts:Adenocarcinomapancreatobiliarytype" + "@id" : "bts:IlluminaHiSeqXTen" }, { - "@id" : "bts:PrecancerousmelanosisNOS" + "@id" : "bts:IlluminaMiSeq" }, { - "@id" : "bts:Undifferentiatedroundcellsarcoma" + "@id" : "bts:IlluminaNextSeq1000" }, { - "@id" : "bts:MalignantlymphomalargecellNOS" + "@id" : "bts:IlluminaNextSeq2000" }, { - "@id" : "bts:Tubulo-papillaryadenoma" + "@id" : "bts:IlluminaNextSeq2500" }, { - "@id" : "bts:ClassicalHodgkinlymphomalymphocytedepletiondiffusefibrosis" + "@id" : "bts:IlluminaNextSeq500" }, { - "@id" : "bts:Cerebellarliponeurocytoma" + "@id" : "bts:IlluminaNextSeq550" }, { - "@id" : "bts:Pulmonaryblastoma" + "@id" : "bts:IlluminaNovaSeq6000" }, { - "@id" : "bts:Burkitt-likelymphoma" + "@id" : "bts:IonTorrentPGM" }, { - "@id" : "bts:GangliogliomaNOS" + "@id" : "bts:IonTorrentProton" }, { - "@id" : "bts:T-celllymphomaNOS" + "@id" : "bts:IonTorrentS5" }, { - "@id" : "bts:Papillarytumorofthepinealregion" + "@id" : "bts:NotReported" }, { - "@id" : "bts:IntraductalpapillaryadenocarcinomaNOS" + "@id" : "bts:NovaSeq6000" }, { - "@id" : "bts:MalignantlymphomaNOS" + "@id" : "bts:NovaSeqS4" }, { - "@id" : "bts:Hepatoidadenocarcinoma" + "@id" : "bts:Other" }, { - "@id" : "bts:PapillaryadenomaNOS" + "@id" : "bts:OxfordNanoporeminION" }, { - "@id" : "bts:Carcinomainsituinadenomatouspolyp" + "@id" : "bts:PacBioRS" }, { - "@id" : "bts:Eosinophilicgranuloma" + "@id" : "bts:PacBioSequel2" }, { - "@id" : "bts:Medullaryadenocarcinoma" + "@id" : "bts:PromethION" }, { - "@id" : "bts:Malignantlymphomamixedcelltypenodular" + "@id" : "bts:Revio" }, { - "@id" : "bts:IntraductalcarcinomanoninfiltratingNOS" + "@id" : "bts:UltimaGenomicsUG100" }, { - "@id" : "bts:Interstitialcelltumormalignant" + "@id" : "bts:Unknown" + } ], + "rdfs:label" : "SequencingPlatform", + "rdfs:comment" : "A platform is an object aggregate that is the set of instruments and software needed to perform a process [OBI_0000050]. Specific model of the sequencing instrument.", + "@type" : "rdfs:Class", + "sms:displayName" : "SequencingPlatform" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:SlideChargeType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" }, { - "@id" : "bts:LymphomaNOS" + "@id" : "bts:Uncharged" }, { - "@id" : "bts:Unclassifiedtumorborderlinemalignancy" + "@id" : "bts:Charged" }, { - "@id" : "bts:Adenocarcinomaintubularadenoma" + "@id" : "bts:Coverslip" }, { - "@id" : "bts:Intraductalpapillarycarcinoma" + "@id" : "bts:Notapplicable" + } ], + "rdfs:label" : "SlideChargeType", + "rdfs:comment" : "A description of the charge on the glass slide.", + "@type" : "rdfs:Class", + "sms:displayName" : "SlideChargeType" + }, { + "@id" : "bts:COVID19CancerTreatmentFollowup", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "COVID19CancerTreatmentFollowup", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "COVID19CancerTreatmentFollowup", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ChannelName", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ChannelName", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ChannelName", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ConcomitantMedicationReceivedType", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ConcomitantMedicationReceivedType", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ConcomitantMedicationReceivedType", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CellTotal", + "@type" : "rdfs:Class", + "rdfs:comment" : "Number of sequenced cells. Applies to raw counts matrix only.", + "rdfs:label" : "CellTotal", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CellTotal", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:MolecularAnalysisMethod", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:WXS" }, { - "@id" : "bts:MyelocyticleukemiaNOS" + "@id" : "bts:WGS" }, { - "@id" : "bts:TumorcellsNOS" + "@id" : "bts:ISH" }, { - "@id" : "bts:LiposarcomaNOS" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Interstitialcelltumorbenign" + "@id" : "bts:MicrosatelliteAnalysis" }, { - "@id" : "bts:Neoplasmmetastatic" + "@id" : "bts:unknown" }, { - "@id" : "bts:Chronicneutrophilicleukemia" + "@id" : "bts:NotApplicable" }, { - "@id" : "bts:Bronchiolo-alveolarcarcinomagobletcelltype" + "@id" : "bts:TargetedSequencing" }, { - "@id" : "bts:Papillaryadenocarcinomafollicularvariant" + "@id" : "bts:NuclearStaining" }, { - "@id" : "bts:Hepatocarcinoma" + "@id" : "bts:FISH" }, { - "@id" : "bts:Undifferentiateduterinesarcoma" + "@id" : "bts:IHC" }, { - "@id" : "bts:Renalcellcarcinomaunclassified" + "@id" : "bts:Karyotype" }, { - "@id" : "bts:Papillaryepidermoidcarcinoma" + "@id" : "bts:FlowCytometry" }, { - "@id" : "bts:PigmentednevusNOS" + "@id" : "bts:Other" }, { - "@id" : "bts:MyeloidleukemiaNOS" + "@id" : "bts:RNASequencing" }, { - "@id" : "bts:Esophagealsquamousintraepithelialneoplasia(dysplasia)highgrade" + "@id" : "bts:SequencingNOS" }, { - "@id" : "bts:MalignantlymphomalargeB-cellNOS" + "@id" : "bts:SouthernBlotting" }, { - "@id" : "bts:Non-lymphocyticleukemiaNOS" + "@id" : "bts:Microarray" }, { - "@id" : "bts:Basalcelladenocarcinoma" + "@id" : "bts:ComparativeGenomicHybridization" }, { - "@id" : "bts:AdultT-celllymphoma/leukemia" + "@id" : "bts:CytogeneticsNOS" }, { - "@id" : "bts:Mixedpancreaticendocrineandexocrinetumormalignant" + "@id" : "bts:RT-PCR" + } ], + "rdfs:label" : "MolecularAnalysisMethod", + "rdfs:comment" : "The text term used to describe the method used for molecular analysis. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "@type" : "rdfs:Class", + "sms:displayName" : "MolecularAnalysisMethod" + }, { + "@id" : "bts:LaneNumber", + "@type" : "rdfs:Class", + "rdfs:comment" : "Basic machine unit for sequencing. For Illumina machines, this reflects the physical lane number. Wrong or missing information may affect analysis results. Integer", + "rdfs:label" : "LaneNumber", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LaneNumber", + "sms:required" : "sms:true" + }, { + "@id" : "bts:ParticipantID", + "@type" : "rdfs:Class", + "rdfs:comment" : "ID associated with a patient", + "rdfs:label" : "ParticipantID", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ParticipantID", + "sms:required" : "sms:true" + }, { + "@id" : "bts:COVID19CurrentStatus", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "COVID19CurrentStatus", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "COVID19CurrentStatus", + "sms:required" : "sms:false" + }, { + "@id" : "bts:FrameAveraging", + "@type" : "rdfs:Class", + "rdfs:comment" : "Number of frames averaged together (if no averaging, set to 1). Integer >= 1", + "rdfs:label" : "FrameAveraging", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "FrameAveraging", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ChannelID", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ChannelID", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ChannelID", + "sms:required" : "sms:false" + }, { + "@id" : "bts:Vendor", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "Vendor", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Vendor", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LociCount", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value used to describe the number of loci tested.", + "rdfs:label" : "LociCount", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LociCount", + "sms:required" : "sms:false" + }, { + "@id" : "bts:DaystoRecurrence", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "DaystoRecurrence", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "DaystoRecurrence", + "sms:required" : "sms:false" + }, { + "@id" : "bts:AcquisitionMethodOtherSpecify", + "@type" : "rdfs:Class", + "rdfs:comment" : "A custom acquisition method [Text - max length 100 characters]", + "rdfs:label" : "AcquisitionMethodOtherSpecify", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "AcquisitionMethodOtherSpecify", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ReadLength", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "sms:validationRules" : [ "num" ], + "rdfs:label" : "ReadLength", + "rdfs:comment" : "Length of the sequencing reads. Can be integer, null", + "@type" : "rdfs:Class", + "sms:displayName" : "ReadLength" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:WellIndex", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ ], + "rdfs:label" : "WellIndex", + "rdfs:comment" : "Indicate if protein expression (EPCAM/CD45) positive/negative data is available for each cell in CEL-seq2 assays", + "@type" : "rdfs:Class", + "sms:displayName" : "WellIndex" + }, { + "@id" : "bts:BreastCarcinomaCentromere17CopyNumber", + "@type" : "rdfs:Class", + "rdfs:comment" : "Result of Centromere 17 testing in a sample or specimen of metastatic breast carcinoma, expressed as a range of values.", + "rdfs:label" : "BreastCarcinomaCentromere17CopyNumber", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "BreastCarcinomaCentromere17CopyNumber", + "sms:required" : "sms:false" + }, { + "@id" : "bts:NominalMagnification", + "@type" : "rdfs:Class", + "rdfs:comment" : "The magnification of the lens as specified by the manufacturer - i.e. '60' is a 60X lens. floating point value > 1(no units)", + "rdfs:label" : "NominalMagnification", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "NominalMagnification", + "sms:required" : "sms:false" + }, { + "@id" : "bts:COVID19OccurrenceIndicator", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "COVID19OccurrenceIndicator", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "COVID19OccurrenceIndicator", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:OvarianCancerHistologicSubtype", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:High-gradeserous" }, { - "@id" : "bts:EpendymomaNOS" + "@id" : "bts:Datanotavailable" }, { - "@id" : "bts:PeripheralT-celllymphomaNOS" + "@id" : "bts:unknown" }, { - "@id" : "bts:Pulmonaryadenomatosis" + "@id" : "bts:Germcell" }, { - "@id" : "bts:Pleomorphiclobularcarcinoma" + "@id" : "bts:High-gradeendometrioid" }, { - "@id" : "bts:Pagetdiseaseofbreast" + "@id" : "bts:Other" }, { - "@id" : "bts:HodgkinparagranulomaNOS" + "@id" : "bts:Low-gradeserous" }, { - "@id" : "bts:MalignantmelanomaNOS" + "@id" : "bts:Clearcell" }, { - "@id" : "bts:Papillarytransitionalcellcarcinoma" + "@id" : "bts:Low-gradeendometrioid" }, { - "@id" : "bts:Acutelymphocyticleukemia" + "@id" : "bts:Mucinous" }, { - "@id" : "bts:Seroussurfacepapillarycarcinoma" + "@id" : "bts:Sex-cordstromal" + } ], + "rdfs:label" : "OvarianCancerHistologicSubtype", + "rdfs:comment" : "Text term to describe the histological subtype of ovarian cancer in the participant", + "@type" : "rdfs:Class", + "sms:displayName" : "OvarianCancerHistologicSubtype" + }, { + "@id" : "bts:TotalVolume", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value for the total amount of sample or specimen", + "rdfs:label" : "TotalVolume", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "TotalVolume", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:TumorTissueType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Normal" }, { - "@id" : "bts:Basalcelltumor" + "@id" : "bts:Normaladjacent" }, { - "@id" : "bts:ChronicmyelomonocyticleukemiaNOS" + "@id" : "bts:Recurrent" }, { - "@id" : "bts:LymphaticleukemicNOS" + "@id" : "bts:Posttherapyneoadjuvant" }, { - "@id" : "bts:TeratomaNOS" + "@id" : "bts:Normaldistant" }, { - "@id" : "bts:Malignantlymphomamixedcelltypefollicular" + "@id" : "bts:Posttherapyadjuvant" }, { - "@id" : "bts:Bronchiolaradenocarcinoma" + "@id" : "bts:Posttherapy" }, { - "@id" : "bts:Basophiladenocarcinoma" + "@id" : "bts:Atypia-hyperplasia" }, { - "@id" : "bts:Non-HodgkinlymphomaNOS" + "@id" : "bts:NotOtherwiseSpecified" }, { - "@id" : "bts:Haemangioblastoma" + "@id" : "bts:Metastatic" }, { - "@id" : "bts:Intraductaltubular-papillaryneoplasmhighgrade" + "@id" : "bts:Localrecurrence" }, { - "@id" : "bts:ChronicmyeloproliferativediseaseNOS" + "@id" : "bts:Premalignant-insitu" }, { - "@id" : "bts:Rhabdoidmeningioma" + "@id" : "bts:AdditionalPrimary" }, { - "@id" : "bts:RhabdoidtumorNOS" + "@id" : "bts:Premalignant" }, { - "@id" : "bts:Carcinomaintestinaltype" + "@id" : "bts:Primary" + } ], + "rdfs:label" : "TumorTissueType", + "rdfs:comment" : "Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint (add rows to select multiple values along with timepoints)", + "@type" : "rdfs:Class", + "sms:displayName" : "TumorTissueType" + }, { + "@id" : "bts:CellMedianNumberGenes", + "@type" : "rdfs:Class", + "rdfs:comment" : "Median number of genes detected per cell. Number", + "rdfs:label" : "CellMedianNumberGenes", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CellMedianNumberGenes", + "sms:required" : "sms:false" + }, { + "@id" : "bts:Lot", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "Lot", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "Lot", + "sms:required" : "sms:false" + }, { + "@id" : "bts:COVID19ComplicationsSeverity", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "COVID19ComplicationsSeverity", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "COVID19ComplicationsSeverity", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ProgressionorRecurrenceAnatomicSite", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ProgressionorRecurrenceAnatomicSite", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ProgressionorRecurrenceAnatomicSite", + "sms:required" : "sms:false" + }, { + "@id" : "bts:EmissionWavelength", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "EmissionWavelength", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "EmissionWavelength", + "sms:required" : "sms:false" + }, { + "@id" : "bts:ImageID", + "@type" : "rdfs:Class", + "rdfs:comment" : "Unique internal image identifier. eg \"\"Image:0\"\". (To be extracted from OME-XML)", + "rdfs:label" : "ImageID", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "ImageID", + "sms:required" : "sms:false" + }, { + "@id" : "bts:LibraryPrepKitName", + "@type" : "rdfs:Class", + "rdfs:comment" : "Name of Library Prep Kit. String", + "rdfs:label" : "LibraryPrepKitName", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LibraryPrepKitName", + "sms:required" : "sms:true" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:SingleNucleusBuffer", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:10x" }, { - "@id" : "bts:ClassicalHodgkinlymphomalymphocytedepletionNOS" + "@id" : "bts:NIB" }, { - "@id" : "bts:ChronicmyeloidleukemiaNOS" + "@id" : "bts:Omni" + } ], + "rdfs:label" : "SingleNucleusBuffer", + "rdfs:comment" : "Nuclei isolation buffer", + "@type" : "rdfs:Class", + "sms:displayName" : "SingleNucleusBuffer" + }, { + "@id" : "bts:LensNA", + "@type" : "rdfs:Class", + "rdfs:comment" : "The numerical aperture of the lens. Floating point value > 0.", + "rdfs:label" : "LensNA", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LensNA", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:PhysicalSizeZUnit", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:cm" }, { - "@id" : "bts:Melanoticmedulloblastoma" + "@id" : "bts:mm" }, { - "@id" : "bts:Melanoticneuroectodermaltumor" + "@id" : "bts:µm" }, { - "@id" : "bts:LobularcarcinomainsituNOS" + "@id" : "bts:nm" }, { - "@id" : "bts:Mixedsmallcellcarcinoma" + "@id" : "bts:Å" + } ], + "rdfs:label" : "PhysicalSizeZUnit", + "rdfs:comment" : "The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", + "@type" : "rdfs:Class", + "sms:displayName" : "PhysicalSizeZUnit" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:HereditaryCancerPredispositionSyndrome", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:SDHassociatedrenalcancer" }, { - "@id" : "bts:Intradermalnevus" + "@id" : "bts:Constitutionalmismatchrepairdeficiency" }, { - "@id" : "bts:Bronchiolo-alveolarcarcinomaClaracell" + "@id" : "bts:Cirrhosisunknownetiology" }, { - "@id" : "bts:Papillarysquamouscellcarcinomainsitu" + "@id" : "bts:Beckwith-Wiedemann" }, { - "@id" : "bts:Smallcellneuroendocrinecarcinoma" + "@id" : "bts:Hereditarymelanoma" }, { - "@id" : "bts:Malignantmelanomainprecancerousmelanosis" + "@id" : "bts:NotReported" }, { - "@id" : "bts:CarcinomaanaplasticNOS" + "@id" : "bts:Gorlinsyndrome" }, { - "@id" : "bts:Dysplasticnevus" + "@id" : "bts:vonHippel-LindauSyndrome" }, { - "@id" : "bts:Liposarcomadifferentiated" + "@id" : "bts:Tuberoussclerosiscomplex" }, { - "@id" : "bts:Combinedsmallcell-squamouscellcarcinoma" + "@id" : "bts:RhabdoidtumorpredispositionsyndrometypeI" }, { - "@id" : "bts:Acutelymphaticleukemia" + "@id" : "bts:unknown" }, { - "@id" : "bts:Gliomamalignant" + "@id" : "bts:Tyrosinemia" }, { - "@id" : "bts:AdenocarcinomainsituNOS" + "@id" : "bts:Familialgastrointestinalstromaltumor" }, { - "@id" : "bts:Mucosal-associatedlymphoidtissuelymphoma" + "@id" : "bts:NotApplicable" }, { - "@id" : "bts:Spleniclymphomawithvillouslymphocytes" + "@id" : "bts:Li-Fraumenisyndrome" }, { - "@id" : "bts:LargecellcarcinomaNOS" + "@id" : "bts:Fanconianemia" }, { - "@id" : "bts:MicropapillarycarcinomaNOS" + "@id" : "bts:Turcotsyndrome" }, { - "@id" : "bts:Undifferentiatedspindlecellsarcoma" + "@id" : "bts:Attenuatedfamilialadenomatouspolyposis" }, { - "@id" : "bts:IntraepidermalsquamouscellcarcinomaBowentype" + "@id" : "bts:BAP1mutantdisease" }, { - "@id" : "bts:EndometrioidadenofibromaNOS" + "@id" : "bts:Lynchsyndrome" }, { - "@id" : "bts:MedullarycarcinomaNOS" + "@id" : "bts:Hereditaryparaganglioma–pheochromocytomasyndrome" }, { - "@id" : "bts:T-celllargegranularlymphocytosis" + "@id" : "bts:Nevoidbasalcellcarcinomasyndrome" }, { - "@id" : "bts:IntraductaladenocarcinomanoninfiltratingNOS" + "@id" : "bts:MultipleendocrineneoplasiatypeII" }, { - "@id" : "bts:OsteosarcomaNOS" + "@id" : "bts:Rubinstein-Taybisyndrome" }, { - "@id" : "bts:Pancreatobiliary-typecarcinoma" + "@id" : "bts:Cowdensyndrome" }, { - "@id" : "bts:Adenocarcinoidtumor" + "@id" : "bts:Hereditaryrenaloncocytoma" }, { - "@id" : "bts:DiffuseastrocytomaIDH-mutant" + "@id" : "bts:HereditarypapillaryRCC" }, { - "@id" : "bts:Medullaryosteosarcoma" + "@id" : "bts:Peutz–Jegherssyndrome" }, { - "@id" : "bts:Adenocarcinomaintestinaltype" + "@id" : "bts:Familialadenomatouspolyposis" }, { - "@id" : "bts:CarcinomainsituinapolypNOS" + "@id" : "bts:Biliarydisorder" }, { - "@id" : "bts:CarcinosarcomaNOS" + "@id" : "bts:MUTYH-associatedpolyposis" }, { - "@id" : "bts:Basalcelladenoma" + "@id" : "bts:RhabdoidtumorpredispositionsyndrometypeII" }, { - "@id" : "bts:AdultT-celllymphoma" + "@id" : "bts:Hereditaryretinoblastoma" }, { - "@id" : "bts:Lobularadenocarcinoma" + "@id" : "bts:GlycogenStorageDisease" }, { - "@id" : "bts:Melanocyticnevus" + "@id" : "bts:Carneycomplex" }, { - "@id" : "bts:AdenocarcinomametastaticNOS" + "@id" : "bts:Hereditarydiffusegastriccancer" }, { - "@id" : "bts:Pigmentedbasalcellcarcinoma" + "@id" : "bts:Juvenilepolyposissyndrome" }, { - "@id" : "bts:Astrocytomaanaplastic" + "@id" : "bts:Hereditarymixedpolyposissyndrome" }, { - "@id" : "bts:Melanomamalignantofsoftparts" + "@id" : "bts:Serratedpolyposissyndrome" }, { - "@id" : "bts:Smallcellosteosarcoma" + "@id" : "bts:Familialrenalcancer" }, { - "@id" : "bts:Unclassifiedtumoruncertainwhetherbenignormalignant" + "@id" : "bts:Hereditarypapillaryrenalcellcarcinoma" }, { - "@id" : "bts:Transitionalcellcarcinoma" + "@id" : "bts:Hereditaryleiomyoma-renalcellcarcinoma" }, { - "@id" : "bts:Intraductalcarcinomaandlobularcarcinomainsitu" + "@id" : "bts:MultipleendocrineneoplasiatypeI" }, { - "@id" : "bts:RhabdomyomaNOS" + "@id" : "bts:Birt-Hogg-Dubesyndrome" }, { - "@id" : "bts:B-celllymphocyticleukemia/smalllymphocyticlymphoma" + "@id" : "bts:Familialpancreaticcancer" }, { - "@id" : "bts:Capillaryhemangioma" + "@id" : "bts:Hereditarybreast–ovariancancersyndrome" }, { - "@id" : "bts:PrecursorB-celllymphoblasticleukemia" + "@id" : "bts:Familialprostatecancer" }, { - "@id" : "bts:Bronchiolo-alveolarcarcinomaClaracellandgobletcelltype" + "@id" : "bts:Melanoma–astrocytomasyndrome" }, { - "@id" : "bts:Eosinophiladenoma" + "@id" : "bts:Alpha-1antitrypsin" + } ], + "rdfs:label" : "HereditaryCancerPredispositionSyndrome", + "rdfs:comment" : "History of presence of inherited genetic predisposition syndrome that confers heightened susceptibility to cancer in the patient.", + "@type" : "rdfs:Class", + "sms:displayName" : "HereditaryCancerPredispositionSyndrome" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:PrimaryDiagnosis", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Pagetdiseaseandintraductalcarcinomaofbreast" }, { - "@id" : "bts:SplenicB-celllymphoma/leukemiaunclassifiable" + "@id" : "bts:Papillarymicrocarcinoma" }, { - "@id" : "bts:CompositeHodgkinandnon-Hodgkinlymphoma" + "@id" : "bts:Kaposisarcoma" }, { - "@id" : "bts:Pagetdiseaseandinfiltratingductcarcinomaofbreast" + "@id" : "bts:CarcinomaNOS" }, { - "@id" : "bts:NeurofibromatosisNOS" + "@id" : "bts:AcutemyeloidleukemiaNOS" }, { - "@id" : "bts:HodgkinlymphomaNOS" + "@id" : "bts:TumorNOS" }, { - "@id" : "bts:Melanomainsitu" + "@id" : "bts:Renalcelladenocarcinoma" }, { - "@id" : "bts:SerouscystadenocarcinomaNOS" + "@id" : "bts:MalignantlymphomalymphoblasticNOS" }, { - "@id" : "bts:MalignantlymphomaHodgkin" + "@id" : "bts:Mammarycarcinomainsitu" }, { - "@id" : "bts:Acutelymphoblasticleukemia-lymphomaNOS" + "@id" : "bts:Adenocarcinomainsituintubularadenoma" }, { - "@id" : "bts:Unclassifiedtumormalignant" + "@id" : "bts:MalignantlymphomasmallBlymphocyticNOS" }, { - "@id" : "bts:Adultrhabdomyoma" + "@id" : "bts:Eosinophilicleukemia" }, { - "@id" : "bts:Neoplasmuncertainwhetherbenignormalignant" + "@id" : "bts:AcutelymphoblasticleukemiaNOS" }, { - "@id" : "bts:ChronicmyelomonocyticleukemiaType1" + "@id" : "bts:MalignantlymphomalymphocyticnodularNOS" }, { - "@id" : "bts:DuctadenomaNOS" + "@id" : "bts:Basalcellepithelioma" }, { - "@id" : "bts:Neoplasmbenign" + "@id" : "bts:Intracysticpapilloma" }, { - "@id" : "bts:CarcinomaundifferentiatedNOS" + "@id" : "bts:Lobularandductalcarcinoma" }, { - "@id" : "bts:Malignancy" + "@id" : "bts:Cancer" }, { - "@id" : "bts:Adenocarcinomainsitumucinous" + "@id" : "bts:Tlymphoblasticleukemia/lymphoma" }, { - "@id" : "bts:Papillarysquamouscellcarcinoma" + "@id" : "bts:ClassicalHodgkinlymphomalymphocyte-rich" }, { - "@id" : "bts:Blymphoblasticleukemia/lymphomawithhyperdiploidy" + "@id" : "bts:Esophagealintraepithelialneoplasiahighgrade" }, { - "@id" : "bts:PrecursorT-celllymphoblasticleukemia" + "@id" : "bts:Burkittcellleukemia" }, { - "@id" : "bts:Tumorsecondary" + "@id" : "bts:MonocyticleukemiaNOS" }, { - "@id" : "bts:Pancreatobiliaryneoplasmnon-invasive" + "@id" : "bts:AcuteleukemiaNOS" }, { - "@id" : "bts:Malignantmelanomaingiantpigmentednevus" + "@id" : "bts:Renalmedullarycarcinoma" }, { - "@id" : "bts:Squamouscellcarcinomaadenoid" + "@id" : "bts:Diffusemelanocytosis" }, { - "@id" : "bts:Acutemyelomonocyticleukemia" + "@id" : "bts:Intraductalandlobularcarcinoma" }, { - "@id" : "bts:Bileductcystadenocarcinoma" + "@id" : "bts:MelanoticpsammomatousMPNST" }, { - "@id" : "bts:Pancreaticendocrinetumornonfunctioning" + "@id" : "bts:MalignantmelanomainHutchinsonmelanoticfreckle" }, { - "@id" : "bts:Pleomorphicadenoma" + "@id" : "bts:Pigmentedadenoma" }, { - "@id" : "bts:Blymphoblasticleukemia/lymphomawithhypodiploidy(HypodiploidALL)" + "@id" : "bts:ChronicgranulocyticleukemiaBCR/ABL" }, { - "@id" : "bts:Renalcellcarcinomasarcomatoid" + "@id" : "bts:CervicalintraepithelialneoplasiagradeIII" }, { - "@id" : "bts:SplenicmarginalzoneB-celllymphoma" + "@id" : "bts:High-gradeserouscarcinoma" }, { - "@id" : "bts:MalignantlymphomalargeB-celldiffuseNOS" + "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosisgrade1" }, { - "@id" : "bts:Infiltratingductandcolloidcarcinoma" + "@id" : "bts:Meningiomamalignant" }, { - "@id" : "bts:ChronicmyelomonocyticleukemiaTypeII" + "@id" : "bts:InterstitialcelltumorNOS" }, { - "@id" : "bts:DuctadenocarcinomaNOS" + "@id" : "bts:BronchialadenomaNOS" }, { - "@id" : "bts:Combined/mixedcarcinoidandadenocarcinoma" + "@id" : "bts:PrecursorT-celllymphoblasticlymphoma" }, { - "@id" : "bts:Haemangiosarcoma" + "@id" : "bts:Tubularandroblastomawithlipidstorage" }, { - "@id" : "bts:Acutelymphoidleukemia" + "@id" : "bts:Combinedlargecellneuroendocrinecarcinoma" }, { - "@id" : "bts:DiffuseastrocytomaIDH-wildtype" + "@id" : "bts:NephroblastomaNOS" }, { - "@id" : "bts:Intraductaltubulopapillaryneoplasm" + "@id" : "bts:Tumorcellsbenign" }, { - "@id" : "bts:Acutebasophilicleukaemia" + "@id" : "bts:Tumorletbenign" }, { - "@id" : "bts:Unclassifiedtumorbenign" + "@id" : "bts:Pleomorphiclipoma" }, { - "@id" : "bts:Intraductalmicropapillarycarcinoma" + "@id" : "bts:Adenocarcinomaofanalducts" }, { - "@id" : "bts:Hodgkingranuloma" + "@id" : "bts:Gastrointestinalstromaltumormalignant" }, { - "@id" : "bts:ChroniclymphocyticleukemiaB-celltype(includesallvariantsofBCLL)" + "@id" : "bts:Malignantmelanomainjunctionalnevus" }, { - "@id" : "bts:Pancreatoblastoma" + "@id" : "bts:Rhabdosarcoma" }, { - "@id" : "bts:Bileductadenocarcinoma" + "@id" : "bts:EndometrioidadenomaNOS" }, { - "@id" : "bts:Meningealmelanocytoma" + "@id" : "bts:Hodgkinsarcoma" }, { - "@id" : "bts:HodgkinlymphomamixedcellularityNOS" + "@id" : "bts:MalignantlymphomaimmunoblasticNOS" }, { - "@id" : "bts:InfiltratingductcarcinomaNOS" + "@id" : "bts:Smallcongenitalnevus" }, { - "@id" : "bts:Esophagealsquamousintraepithelialneoplasia(dysplasia)lowgrade" + "@id" : "bts:TumormalignantNOS" }, { - "@id" : "bts:SmallcellcarcinomaNOS" + "@id" : "bts:Undifferentiatedepithelioidsarcoma" }, { - "@id" : "bts:Inflammatorycarcinoma" + "@id" : "bts:NeuroendocrinecarcinomaNOS" }, { - "@id" : "bts:Papillaryurothelialcarcinoma" + "@id" : "bts:Acutelymphoblasticleukemiaprecursorcelltype" }, { - "@id" : "bts:Melanoticprogonoma" + "@id" : "bts:Inflammatoryadenocarcinoma" }, { - "@id" : "bts:Centralneuroblastoma" + "@id" : "bts:Tubularadenocarcinoma" }, { - "@id" : "bts:MalignantlymphomalymphocyticNOS" + "@id" : "bts:Combinedsmallcell-adenocarcinoma" }, { - "@id" : "bts:MyelomaNOS" + "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosiscellularphase" }, { - "@id" : "bts:Adenocarcinomaendocervicaltype" + "@id" : "bts:Mixedadenocarcinomaandepidermoidcarcinoma" }, { - "@id" : "bts:AdenocarcinomainsituinapolypNOS" + "@id" : "bts:EpidermoidcarcinomainsituNOS" }, { - "@id" : "bts:Neoplasmmalignantuncertainwhetherprimaryormetastatic" + "@id" : "bts:Undifferentiatedhigh-gradepleomorphicsarcoma" }, { - "@id" : "bts:Pulmonaryarteryintimalsarcoma" + "@id" : "bts:Sclerosinghepaticcarcinoma" }, { - "@id" : "bts:IntraepidermalcarcinomaNOS" + "@id" : "bts:Pagetoidreticulosis" }, { - "@id" : "bts:PapillaryserouscystadenomaNOS" + "@id" : "bts:Centralneurocytoma" }, { - "@id" : "bts:CarcinomainsituNOS" + "@id" : "bts:Bronchiolo-alveolarcarcinomaNOS" }, { - "@id" : "bts:TubularadenomaNOS" + "@id" : "bts:Chroniclymphoidleukemia" }, { - "@id" : "bts:Tubulopapillaryadenocarcinoma" + "@id" : "bts:Paragangliomamalignant" }, { - "@id" : "bts:Pancreaticmicroadenoma" + "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosisgrade2" }, { - "@id" : "bts:AcutelymphoblasticleukemiamatureB-celltype" + "@id" : "bts:B-ALL" }, { - "@id" : "bts:c-ALL" + "@id" : "bts:Skinappendagecarcinoma" }, { - "@id" : "bts:AcuteleukemiaBurkitttype" + "@id" : "bts:Epithelialtumorbenign" }, { - "@id" : "bts:Cervicalintraepithelialneoplasialowgrade" + "@id" : "bts:Blymphoblasticleukemia/lymphomaNOS" }, { - "@id" : "bts:MixedtumorNOS" + "@id" : "bts:HodgkinlymphomanodularsclerosisNOS" }, { - "@id" : "bts:Bronchiolo-alveolaradenocarcinomaNOS" + "@id" : "bts:MalignantlymphomalymphocyticdiffuseNOS" }, { - "@id" : "bts:Myoepithelioma" + "@id" : "bts:Pro-BALL" }, { - "@id" : "bts:Pancreaticendocrinetumormalignant" + "@id" : "bts:GastrinomaNOS" }, { - "@id" : "bts:EndometrioidadenocarcinomaNOS" + "@id" : "bts:Intraductalcarcinomaclinging" }, { - "@id" : "bts:InfiltratingbasalcellcarcinomaNOS" + "@id" : "bts:Non-invasivelowgradeserouscarcinoma" }, { - "@id" : "bts:PrecursorB-celllymphoblasticlymphoma" + "@id" : "bts:AcutepromyelocyticleukemiaNOS" }, { - "@id" : "bts:Pleomorphiclobularcarcinomainsitu" + "@id" : "bts:Malignantlymphomanon-HodgkinNOS" }, { - "@id" : "bts:Mucousadenocarcinoma" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Meningealmelanoma" + "@id" : "bts:Melanoticschwannoma" }, { - "@id" : "bts:Acutemyeloidleukemiaminimaldifferentiation" + "@id" : "bts:SplenicmarginalzonelymphomaNOS" }, { - "@id" : "bts:LymphoblasticleukemiaNOS" + "@id" : "bts:Transitionalcellcarcinomainsitu" }, { - "@id" : "bts:MelanoticMPNST" + "@id" : "bts:Chronicmonocyticleukemia" }, { - "@id" : "bts:Astrocytomalowgrade" + "@id" : "bts:Gastrincelltumor" }, { - "@id" : "bts:Multiplemyeloma" + "@id" : "bts:Papillaryserouscystadenocarcinoma" }, { - "@id" : "bts:Papillaryrenalcellcarcinoma" + "@id" : "bts:TeratomamalignantNOS" }, { - "@id" : "bts:MedulloblastomaNOS" + "@id" : "bts:ClassicalHodgkinlymphomalymphocytedepletionreticular" }, { - "@id" : "bts:AdenocarcinomainapolypNOS" + "@id" : "bts:Tumorcellsuncertainwhetherbenignormalignant" }, { - "@id" : "bts:Combinedsmallcellcarcinoma" + "@id" : "bts:Epithelialtumormalignant" }, { - "@id" : "bts:Bileductcarcinoma" + "@id" : "bts:TubularandroblastomaNOS" }, { - "@id" : "bts:ChronicgranulocyticleukemiaNOS" + "@id" : "bts:Papillarycarcinomainsitu" }, { - "@id" : "bts:Juvenilemyelomonocyticleukemia" + "@id" : "bts:PituitarycarcinomaNOS" }, { - "@id" : "bts:NeoplasmNOS" + "@id" : "bts:Typicalcarcinoid" }, { - "@id" : "bts:Capillarylymphangioma" + "@id" : "bts:Non-smallcellcarcinoma" }, { - "@id" : "bts:Malignantlymphomamixedcelltypediffuse" + "@id" : "bts:MeningiomaNOS" }, { - "@id" : "bts:Neoplasmmalignant" + "@id" : "bts:EndometrialsarcomaNOS" }, { - "@id" : "bts:Papillarymeningioma" + "@id" : "bts:NeuroblastomaNOS" }, { - "@id" : "bts:Bileductcystadenoma" + "@id" : "bts:BcelllymphomaNOS" }, { - "@id" : "bts:Malignantmelanomaincongenitalmelanocyticnevus" + "@id" : "bts:PeripheralT-celllymphomalargecell" }, { - "@id" : "bts:Adenocarcinomadiffusetype" + "@id" : "bts:RenalcellcarcinomaNOS" }, { - "@id" : "bts:Pancreaticendocrinetumorbenign" + "@id" : "bts:Renalcellcarcinomaspindlecell" }, { - "@id" : "bts:SquamouscellcarcinomaNOS" + "@id" : "bts:Hepatocholangiocarcinoma" }, { - "@id" : "bts:Chronicmyelomonocyticleukemiaintransformation" + "@id" : "bts:MalignantlymphomanodularNOS" }, { - "@id" : "bts:T-celllargegranularlymphocyticleukemia" + "@id" : "bts:Bronchiolo-alveolarcarcinomanon-mucinous" }, { - "@id" : "bts:Basophiladenoma" + "@id" : "bts:unknown" }, { - "@id" : "bts:Bronchiolarcarcinoma" + "@id" : "bts:Bronchiolo-alveolarcarcinomaindeterminatetype" }, { - "@id" : "bts:Tubularcarcinoma" + "@id" : "bts:Pleomorphiccarcinoma" }, { - "@id" : "bts:Neurofibrosarcoma" + "@id" : "bts:PapillarycystadenomaNOS" }, { - "@id" : "bts:Adenocarcinomainsituinadenomatouspolyp" + "@id" : "bts:Burkitttumor" }, { - "@id" : "bts:IntravascularB-celllymphoma" + "@id" : "bts:BasalcellcarcinomaNOS" }, { - "@id" : "bts:Pleomorphicliposarcoma" + "@id" : "bts:HepatocellularcarcinomaNOS" }, { - "@id" : "bts:Tumormetastatic" - } ], - "rdfs:label" : "PrimaryDiagnosis", - "rdfs:comment" : "Text term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).", - "@type" : "rdfs:Class", - "sms:displayName" : "PrimaryDiagnosis" - }, { - "@id" : "bts:Gravidity", - "@type" : "rdfs:Class", - "rdfs:comment" : "Total number of pregnancies regardless of outcome", - "rdfs:label" : "Gravidity", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Gravidity", - "sms:required" : "sms:false" - }, { - "@id" : "bts:TotalNumberofPassingNuclei", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of nuclei sequenced", - "rdfs:label" : "TotalNumberofPassingNuclei", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TotalNumberofPassingNuclei", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Objective", - "@type" : "rdfs:Class", - "rdfs:comment" : "Objective", - "rdfs:label" : "Objective", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Objective", - "sms:required" : "sms:false" - }, { - "@id" : "bts:BatchID", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BatchID", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BatchID", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:VascularInvasionType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Undifferentiatedleukaemia" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Gastrincelltumormalignant" }, { - "@id" : "bts:Extramural" + "@id" : "bts:Melanoameloblastoma" }, { - "@id" : "bts:Intramural" + "@id" : "bts:ProstaticintraepithelialneoplasiagradeIII" }, { - "@id" : "bts:Macro" + "@id" : "bts:Mixedpinealtumor" }, { - "@id" : "bts:Micro" + "@id" : "bts:Smallcellsarcoma" }, { - "@id" : "bts:NoVascularInvasion" - } ], - "rdfs:label" : "VascularInvasionType", - "rdfs:comment" : "Text term that represents the type of vascular tumor invasion.", - "@type" : "rdfs:Class", - "sms:displayName" : "VascularInvasionType" - }, { - "@id" : "bts:AntibodyName", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AntibodyName", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AntibodyName", - "sms:required" : "sms:false" - }, { - "@id" : "bts:TestValue", - "@type" : "rdfs:Class", - "rdfs:comment" : "The text term or numeric value used to describe a specific result of a molecular test. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here", - "rdfs:label" : "TestValue", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TestValue", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Concentration", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Concentration", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Concentration", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PRStatus", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PRStatus", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PRStatus", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:IschemicTemperature", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Carcinomainadenomatouspolyp" }, { - "@id" : "bts:LiquidNitrogen" + "@id" : "bts:Pagetdiseaseextramammary" }, { - "@id" : "bts:WarmIschemia" + "@id" : "bts:Intraductalcarcinomasolidtype" }, { - "@id" : "bts:ColdIschemia" + "@id" : "bts:Livercellcarcinoma" }, { - "@id" : "bts:Ambientair" + "@id" : "bts:Undifferentiatedsarcoma" }, { - "@id" : "bts:4Cwetice" + "@id" : "bts:Squamouscellcarcinomaclearcelltype" }, { - "@id" : "bts:Negative-20C" + "@id" : "bts:PituitaryadenomaNOS" }, { - "@id" : "bts:DryIce" - } ], - "rdfs:label" : "IschemicTemperature", - "rdfs:comment" : "Specify whether specimen experienced warm or cold ischemia.", - "@type" : "rdfs:Class", - "sms:displayName" : "IschemicTemperature" - }, { - "@id" : "bts:Microscope", - "@type" : "rdfs:Class", - "rdfs:comment" : "Microscope type (manufacturer, model, etc) used for this experiment", - "rdfs:label" : "Microscope", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Microscope", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:TranspositionReaction", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Tn5" + "@id" : "bts:EndometrioidcarcinomaNOS" }, { - "@id" : "bts:EZ-Tn5" + "@id" : "bts:PapillaryadenocarcinomaNOS" }, { - "@id" : "bts:Tn5-059" + "@id" : "bts:Ductcarcinomadesmoplastictype" }, { - "@id" : "bts:NexteraTn5" + "@id" : "bts:Chroniclymphaticleukemia" }, { - "@id" : "bts:Diagenode-unloadedApex-Bio" + "@id" : "bts:SquamouscellcarcinomainsituNOS" }, { - "@id" : "bts:Diagenode-loadedApex-Bio" + "@id" : "bts:Intraductalpapillaryadenocarcinomawithinvasion" }, { - "@id" : "bts:In-House" - } ], - "rdfs:label" : "TranspositionReaction", - "rdfs:comment" : "Name of the transposase, transposon sequences", - "@type" : "rdfs:Class", - "sms:displayName" : "TranspositionReaction" - }, { - "@id" : "bts:MedicallyUnderservedArea", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MedicallyUnderservedArea", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "MedicallyUnderservedArea", - "sms:required" : "sms:false" - }, { - "@id" : "bts:WorkflowLink", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "WorkflowLink", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "WorkflowLink", - "sms:required" : "sms:false" - }, { - "@id" : "bts:HER2Status", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "HER2Status", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "HER2Status", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:PassedQC", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:No-ChannelsQC" + "@id" : "bts:Adenocarcinomacombinedwithothertypesofcarcinoma" }, { - "@id" : "bts:Yes" - } ], - "rdfs:label" : "PassedQC", - "rdfs:comment" : "Did all channels pass QC (if not add free text Comment)", - "@type" : "rdfs:Class", - "sms:displayName" : "PassedQC" - }, { - "@id" : "bts:AgeAtMenarche", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AgeAtMenarche", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AgeAtMenarche", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ScRNAseqWorkflowType", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ScRNAseqWorkflowType", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ScRNAseqWorkflowType", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:InvasiveDuctalBreastCarcinomaHistologicCategory", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Invasivecarcinoma-typecannotbedetermined" + "@id" : "bts:Combinedhepatocellularcarcinomaandcholangiocarcinoma" }, { - "@id" : "bts:Medullarycarcinoma" + "@id" : "bts:Primaryamyloidosis" }, { - "@id" : "bts:Invasivepapillarycarcinoma" + "@id" : "bts:Preleukemia" }, { - "@id" : "bts:Invasivetubularcarcinoma" + "@id" : "bts:Adenocarcinomaofanalglands" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:Secondarycarcinoma" }, { - "@id" : "bts:unknown" + "@id" : "bts:Dermalnevus" }, { - "@id" : "bts:Invasivecribriformcarcinoma" + "@id" : "bts:Infiltratingductandcribriformcarcinoma" }, { - "@id" : "bts:Invasivemicropapillarycarcinoma" + "@id" : "bts:Eosinophiladenocarcinoma" }, { - "@id" : "bts:Tubulolobularcarcinoma" + "@id" : "bts:Chronicmyeloproliferativedisorder" }, { - "@id" : "bts:Other" + "@id" : "bts:Malignantmelanomaregressing" }, { - "@id" : "bts:Classicaltype" + "@id" : "bts:Osteoblastomamalignant" }, { - "@id" : "bts:Mucinouscarcinoma" - } ], - "rdfs:label" : "InvasiveDuctalBreastCarcinomaHistologicCategory", - "rdfs:comment" : "The histologic subtype for the most common type of invasive breast carcinoma.", - "@type" : "rdfs:Class", - "sms:displayName" : "InvasiveDuctalBreastCarcinomaHistologicCategory" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:TestAnalyteType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Papillotubularadenocarcinoma" }, { - "@id" : "bts:NotReported" + "@id" : "bts:CarcinomametastaticNOS" }, { - "@id" : "bts:DNA" + "@id" : "bts:Sclerosinghemangioma" }, { - "@id" : "bts:mRNA" + "@id" : "bts:LymphocyticleukemiaNOS" }, { - "@id" : "bts:miRNA" + "@id" : "bts:PrecursorcelllymphoblasticleukemiaNOS" }, { - "@id" : "bts:ProteinAnalyte" + "@id" : "bts:PapillarycarcinomaNOS" }, { - "@id" : "bts:TotalRNA" - } ], - "rdfs:label" : "TestAnalyteType", - "rdfs:comment" : "The text term used to describe the type of analyte used for molecular testing. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "@type" : "rdfs:Class", - "sms:displayName" : "TestAnalyteType" - }, { - "@id" : "bts:DataCategory", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "DataCategory", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "DataCategory", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:Ethnicity", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Bronchio-alveolarcarcinomamucinous" + }, { + "@id" : "bts:CarcinomainapolypNOS" + }, { + "@id" : "bts:AcutemyeloidleukemiaMLL" + }, { + "@id" : "bts:Tubulocysticrenalcellcarcinoma" + }, { + "@id" : "bts:MelanocytomaNOS" + }, { + "@id" : "bts:ChronicmyelogenousleukemiaPhiladelphiachromosome(Ph1)positive" + }, { + "@id" : "bts:Ewingsarcoma" + }, { + "@id" : "bts:GliomaNOS" + }, { + "@id" : "bts:Bronchial-associatedlymphoidtissuelymphoma" + }, { + "@id" : "bts:Papillotubularadenoma" + }, { + "@id" : "bts:Papillomaofbladder" + }, { + "@id" : "bts:Bronchio-alveolarcarcinomamixedmucinousandnon-mucinous" + }, { + "@id" : "bts:Carcinomainpleomorphicadenoma" + }, { + "@id" : "bts:Chondrosarcomagrade2/3" + }, { + "@id" : "bts:Neoplasmsecondary" + }, { + "@id" : "bts:Rhabdomyosarcomawithganglionicdifferentiation" + }, { + "@id" : "bts:Chroniclymphocyticleukemia" + }, { + "@id" : "bts:Liposarcomawelldifferentiated" + }, { + "@id" : "bts:Undifferentiatedpleomorphicsarcoma" + }, { + "@id" : "bts:Secretorycarcinomaofbreast" + }, { + "@id" : "bts:Lobularcarcinomanoninfiltrating" + }, { + "@id" : "bts:Mixedadenocarcinomaandsquamouscellcarcinoma" + }, { + "@id" : "bts:Melanoticneurofibroma" + }, { + "@id" : "bts:ChronicgranulocyticleukemiaPhiladelphiachromosome(Ph1)positive" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Hepatocellularadenoma" }, { - "@id" : "bts:hispanicorlatino" + "@id" : "bts:BurkittlymphomaNOS(Includesallvariants)" }, { - "@id" : "bts:nothispanicorlatino" + "@id" : "bts:ParagangliomaNOS" }, { - "@id" : "bts:notallowedtocollect" - } ], - "rdfs:label" : "Ethnicity", - "rdfs:comment" : "An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.", - "@type" : "rdfs:Class", - "sms:displayName" : "Ethnicity" - }, { - "@id" : "bts:WorkingDistance", - "@type" : "rdfs:Class", - "rdfs:comment" : "The working distance of the lens, expressed as a floating point number. Floating point > 0.", - "rdfs:label" : "WorkingDistance", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "WorkingDistance", - "sms:required" : "sms:false" - }, { - "@id" : "bts:FixationDuration", - "@type" : "rdfs:Class", - "rdfs:comment" : "The length of time, from beginning to end, required to process or preserve biospecimens in fixative (measured in minutes)", - "rdfs:label" : "FixationDuration", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "FixationDuration", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:LaboratoryTest", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:AbsoluteNeutrophil" + "@id" : "bts:DiffuselargeB-celllymphomaNOS" }, { - "@id" : "bts:Myeloblasts" + "@id" : "bts:NevusNOS" }, { - "@id" : "bts:TotalProtein" + "@id" : "bts:Hepatoidcarcinoma" }, { - "@id" : "bts:NotReported" + "@id" : "bts:MixedtumormalignantNOS" }, { - "@id" : "bts:Hemoglobin" + "@id" : "bts:Rhabdoidsarcoma" }, { - "@id" : "bts:NOS" + "@id" : "bts:Tubulolobularcarcinoma" }, { - "@id" : "bts:Basophil" + "@id" : "bts:Papillomatosisglandular" }, { - "@id" : "bts:C-ReactiveProtein" + "@id" : "bts:Bronchialadenomacarcinoid" }, { - "@id" : "bts:MProtein" + "@id" : "bts:Tumorembolus" }, { - "@id" : "bts:Lambda" + "@id" : "bts:DuctcarcinomaNOS" }, { - "@id" : "bts:unknown" + "@id" : "bts:RhabdomyosarcomaNOS" }, { - "@id" : "bts:CirculatingTumorCells" + "@id" : "bts:LobularcarcinomaNOS" }, { - "@id" : "bts:Epstein-BarrVirus" + "@id" : "bts:Bronchialadenomacylindroid" }, { - "@id" : "bts:Promonocytes" + "@id" : "bts:EpidermoidcarcinomaNOS" }, { - "@id" : "bts:LactateDehydrogenase" + "@id" : "bts:Papillaryglioneuronaltumor" }, { - "@id" : "bts:Cellularity" + "@id" : "bts:DuctalcarcinomainsituNOS" }, { - "@id" : "bts:HumanChorionicGonadotropin" + "@id" : "bts:Unclassifiedtumormalignantuncertainwhetherprimaryormetastatic" }, { - "@id" : "bts:AlphaFetoprotein" + "@id" : "bts:Glioblastoma" }, { - "@id" : "bts:Hematocrit" + "@id" : "bts:Papillaryandfollicularcarcinoma" }, { - "@id" : "bts:Promyelocytes" + "@id" : "bts:DuctalcarcinomaNOS" }, { - "@id" : "bts:Testosterone" + "@id" : "bts:Tumorbenign" }, { - "@id" : "bts:Lymphoblasts" + "@id" : "bts:Pagetdiseasemammary" }, { - "@id" : "bts:ImmunoglobulinM" + "@id" : "bts:Diffuseastrocytomalowgrade" }, { - "@id" : "bts:Lymphocytes" + "@id" : "bts:Ductcellcarcinoma" }, { - "@id" : "bts:Leukocytes" + "@id" : "bts:Preleukemicsyndrome" }, { - "@id" : "bts:HPV-E6/E7" + "@id" : "bts:Carcinomadiffusetype" }, { - "@id" : "bts:LuteinizingHormone" + "@id" : "bts:Neurosarcoma" }, { - "@id" : "bts:SegmentedNeutrophil" + "@id" : "bts:PapillomatosisNOS" }, { - "@id" : "bts:ImmunoglobulinG" + "@id" : "bts:Therapyrelatedmyeloidneoplasm" }, { - "@id" : "bts:Beta2Microglobulin" + "@id" : "bts:Renalcarcinomacollectingducttype" }, { - "@id" : "bts:Creatinine" + "@id" : "bts:NeurofibromaNOS" }, { - "@id" : "bts:Glucose" + "@id" : "bts:Meningiomaanaplastic" }, { - "@id" : "bts:SerumFreeImmunoglobulinLightChain" + "@id" : "bts:CementomaNOS" }, { - "@id" : "bts:Calcium" + "@id" : "bts:DermatofibromaNOS" }, { - "@id" : "bts:Metamyelocytes" + "@id" : "bts:AstrocytomaNOS" }, { - "@id" : "bts:Kappa" + "@id" : "bts:Livercelladenoma" }, { - "@id" : "bts:Prolymphocytes" + "@id" : "bts:TubulovillousadenomaNOS" }, { - "@id" : "bts:HumanPapillomavirus" + "@id" : "bts:MelanomaNOS" }, { - "@id" : "bts:Platelets" + "@id" : "bts:PapillomaNOS" }, { - "@id" : "bts:NeutrophilBands" + "@id" : "bts:Esophagealglandulardysplasia(intraepithelialneoplasia)highgrade" }, { - "@id" : "bts:Myelocytes" + "@id" : "bts:Tumorcellsmalignant" }, { - "@id" : "bts:Albumin" + "@id" : "bts:MalignantlymphomadiffuseNOS" }, { - "@id" : "bts:BloodUreaNitrogen" + "@id" : "bts:Renalcellcarcinomachromophobetype" }, { - "@id" : "bts:TotalBilirubin" + "@id" : "bts:Tubularcarcinoid" }, { - "@id" : "bts:Eosinophil" + "@id" : "bts:Nonpigmentednevus" }, { - "@id" : "bts:ImmunoglobulinA" + "@id" : "bts:Rodentulcer" }, { - "@id" : "bts:B-cellgenotyping" - } ], - "rdfs:label" : "LaboratoryTest", - "rdfs:comment" : "The text term used to describe the medical testing used to diagnose, treat or further understand a patient's disease.", - "@type" : "rdfs:Class", - "sms:displayName" : "LaboratoryTest" - }, { - "@id" : "bts:LociAbnormalCount", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the number of loci determined to be abnormal.", - "rdfs:label" : "LociAbnormalCount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LociAbnormalCount", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CatalogNumber", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CatalogNumber", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CatalogNumber", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:ImagingAssayType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:MIBI" + "@id" : "bts:HodgkindiseaseNOS" }, { - "@id" : "bts:MxIF" + "@id" : "bts:Acinarcellcarcinoma" }, { - "@id" : "bts:IMC" + "@id" : "bts:Papillaryadenofibroma" }, { - "@id" : "bts:NotApplicable" + "@id" : "bts:Oatcellcarcinoma" }, { - "@id" : "bts:mIHC" + "@id" : "bts:Adenocarcinomainadenomatouspolyp" }, { - "@id" : "bts:H&E" + "@id" : "bts:SpindlecellcarcinomaNOS" }, { - "@id" : "bts:IHC" + "@id" : "bts:Adenocarcinomainpolypoidadenoma" }, { - "@id" : "bts:CODEX" + "@id" : "bts:Papillaryserousadenocarcinoma" }, { - "@id" : "bts:SABER" + "@id" : "bts:SplenicdiffuseredpulpsmallB-celllymphoma" }, { - "@id" : "bts:MERFISH" + "@id" : "bts:ChondromaNOS" }, { - "@id" : "bts:CyCIF" + "@id" : "bts:Bileductadenoma" }, { - "@id" : "bts:t-CyCIF" + "@id" : "bts:Adenocarcinomainvillousadenoma" }, { - "@id" : "bts:GeoMX-DSP" + "@id" : "bts:SpindlecellmelanomaNOS" }, { - "@id" : "bts:ExSeq" - } ], - "rdfs:label" : "ImagingAssayType", - "rdfs:comment" : "Type of imaging assay", - "@type" : "rdfs:Class", - "sms:displayName" : "ImagingAssayType" - }, { - "@id" : "bts:NucleiBarcodeRead", - "@type" : "rdfs:Class", - "rdfs:comment" : "Nuclei Barcode Read", - "rdfs:label" : "NucleiBarcodeRead", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "NucleiBarcodeRead", - "sms:required" : "sms:false" - }, { - "@id" : "bts:OligoBarcodeUpperStrand", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "OligoBarcodeUpperStrand", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "OligoBarcodeUpperStrand", - "sms:required" : "sms:false" - }, { - "@id" : "bts:BreastCarcinomaHER2Centromere17CopynumberTotal", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of Cells Counted for HER2 & Centromere 17 Copy Numbers in a participant with breast cancer", - "rdfs:label" : "BreastCarcinomaHER2Centromere17CopynumberTotal", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BreastCarcinomaHER2Centromere17CopynumberTotal", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BiospecimenType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:FluidsBiospecimenType" + "@id" : "bts:ClassicalHodgkinlymphomamixedcellularityNOS" + }, { + "@id" : "bts:Combinedsmallcell-largecarcinoma" + }, { + "@id" : "bts:Eosinophilcarcinoma" + }, { + "@id" : "bts:PancreaticendocrinetumorNOS" + }, { + "@id" : "bts:AdenocarcinomaNOS" + }, { + "@id" : "bts:SarcomaNOS" + }, { + "@id" : "bts:ChronicmyelocyticleukemiaNOS" }, { - "@id" : "bts:SputumBiospecimenType" + "@id" : "bts:Adenocarcinomainsitunon-mucinous" }, { - "@id" : "bts:TissueBiospecimenType" + "@id" : "bts:ChronicleukemiaNOS" }, { - "@id" : "bts:MouthRinseBiospecimenType" + "@id" : "bts:Pro-TALL" }, { - "@id" : "bts:AscitesBiospecimenType" + "@id" : "bts:Esophagealglandulardysplasia(intraepithelialneoplasia)lowgrade" }, { - "@id" : "bts:CellsBiospecimenType" + "@id" : "bts:Lymphoblastoma" }, { - "@id" : "bts:BloodBiospecimenType" + "@id" : "bts:Mixedmedullary-papillarycarcinoma" }, { - "@id" : "bts:AnalyteBiospecimenType" + "@id" : "bts:ClassicalHodgkinlymphomanodularsclerosisNOS" }, { - "@id" : "bts:BoneMarrowBiospecimenType" + "@id" : "bts:OsteoblastomaNOS" }, { - "@id" : "bts:UrineBiospecimenType" + "@id" : "bts:CerebellarsarcomaNOS" }, { - "@id" : "bts:StoolBiospecimenType" - } ], - "rdfs:label" : "BiospecimenType", - "rdfs:comment" : "Biospecimen Type", - "@type" : "rdfs:Class", - "sms:displayName" : "BiospecimenType" - }, { - "@id" : "bts:SmokeExposureDuration", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SmokeExposureDuration", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SmokeExposureDuration", - "sms:required" : "sms:false" - }, { - "@id" : "bts:MenstrualCyclePhase", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MenstrualCyclePhase", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "MenstrualCyclePhase", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ThresholdforMinimumPassingReads", - "@type" : "rdfs:Class", - "rdfs:comment" : "Threshold for calling cells", - "rdfs:label" : "ThresholdforMinimumPassingReads", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ThresholdforMinimumPassingReads", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:ShippingConditionType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:LiquidNitrogen" + "@id" : "bts:Paragangliomabenign" }, { - "@id" : "bts:DryIce" + "@id" : "bts:Intraductaltubular-papillaryneoplasmlowgrade" }, { - "@id" : "bts:AmbientPack" + "@id" : "bts:Familialadenomatouspolyposis" }, { - "@id" : "bts:ColdPack" + "@id" : "bts:Mixedsquamouscellandglandularpapilloma" }, { - "@id" : "bts:IcePack" + "@id" : "bts:IntraductalcarcinomaNOS" }, { - "@id" : "bts:SpecimenatRoomTemperature" + "@id" : "bts:Transitionalcarcinoma" }, { - "@id" : "bts:OtherShippingEnvironment" + "@id" : "bts:Gastrinomamalignant" }, { - "@id" : "bts:NotShipped" - } ], - "rdfs:label" : "ShippingConditionType", - "rdfs:comment" : "Text descriptor of the shipping environment of a biospecimen.", - "@type" : "rdfs:Class", - "sms:displayName" : "ShippingConditionType" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AntibioticUse", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:No" + "@id" : "bts:Melanocytomaeyeball" }, { - "@id" : "bts:unknown" + "@id" : "bts:Mixedmedullary-follicularcarcinoma" }, { - "@id" : "bts:Yes-withinlastmonthh" + "@id" : "bts:ChronicmyelogenousleukemiaBCR-ABLpositive" }, { - "@id" : "bts:Yes-withinlast1-6months" + "@id" : "bts:Basophilcarcinoma" }, { - "@id" : "bts:Yes-over6monthsago" - } ], - "rdfs:label" : "AntibioticUse", - "rdfs:comment" : "Antibiotic use", - "@type" : "rdfs:Class", - "sms:displayName" : "AntibioticUse" - }, { - "@id" : "bts:ERStatus", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ERStatus", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ERStatus", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:MolecularConsequence", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:TFBindingSiteVariant" + "@id" : "bts:NeuroepitheliomaNOS" }, { - "@id" : "bts:TranscriptAmplification" + "@id" : "bts:Adenocarcinomapancreatobiliarytype" }, { - "@id" : "bts:SpliceRegionVariant" + "@id" : "bts:PrecancerousmelanosisNOS" }, { - "@id" : "bts:DownstreamGeneVariant" + "@id" : "bts:Undifferentiatedroundcellsarcoma" }, { - "@id" : "bts:5PrimeUTRVariant" + "@id" : "bts:MalignantlymphomalargecellNOS" }, { - "@id" : "bts:SpliceDonorVariant" + "@id" : "bts:Tubulo-papillaryadenoma" }, { - "@id" : "bts:SpliceAcceptorVariant" + "@id" : "bts:ClassicalHodgkinlymphomalymphocytedepletiondiffusefibrosis" }, { - "@id" : "bts:StopGain" + "@id" : "bts:Cerebellarliponeurocytoma" }, { - "@id" : "bts:StopRetainedVariant" + "@id" : "bts:Pulmonaryblastoma" }, { - "@id" : "bts:TFBSAmplification" + "@id" : "bts:Burkitt-likelymphoma" }, { - "@id" : "bts:3PrimeUTRVariant" + "@id" : "bts:GangliogliomaNOS" }, { - "@id" : "bts:UpstreamGeneVariant" + "@id" : "bts:T-celllymphomaNOS" }, { - "@id" : "bts:IntergenicVariant" + "@id" : "bts:Papillarytumorofthepinealregion" }, { - "@id" : "bts:RegulatoryRegionAblation" + "@id" : "bts:IntraductalpapillaryadenocarcinomaNOS" }, { - "@id" : "bts:NMDTranscriptVariant" + "@id" : "bts:MalignantlymphomaNOS" }, { - "@id" : "bts:TranscriptAblation" + "@id" : "bts:Hepatoidadenocarcinoma" }, { - "@id" : "bts:Non-codingTranscriptExonVariant" + "@id" : "bts:PapillaryadenomaNOS" }, { - "@id" : "bts:SynonymousVariant" + "@id" : "bts:Carcinomainsituinadenomatouspolyp" }, { - "@id" : "bts:RegulatoryRegionVariant" + "@id" : "bts:Eosinophilicgranuloma" }, { - "@id" : "bts:StopLost" + "@id" : "bts:Medullaryadenocarcinoma" }, { - "@id" : "bts:MaturemiRNAVariant" + "@id" : "bts:Malignantlymphomamixedcelltypenodular" }, { - "@id" : "bts:InframeInsertion" + "@id" : "bts:IntraductalcarcinomanoninfiltratingNOS" }, { - "@id" : "bts:InframeDeletion" + "@id" : "bts:Interstitialcelltumormalignant" }, { - "@id" : "bts:ProteinAlteringVariant" + "@id" : "bts:LymphomaNOS" }, { - "@id" : "bts:IncompleteTerminalCodonVariant" + "@id" : "bts:Unclassifiedtumorborderlinemalignancy" }, { - "@id" : "bts:TFBSAblation" + "@id" : "bts:Adenocarcinomaintubularadenoma" }, { - "@id" : "bts:IntronVariant" + "@id" : "bts:Intraductalpapillarycarcinoma" }, { - "@id" : "bts:CodingSequenceVariant" + "@id" : "bts:MyelocyticleukemiaNOS" }, { - "@id" : "bts:MissenseVariant" + "@id" : "bts:TumorcellsNOS" }, { - "@id" : "bts:FrameshiftVariant" + "@id" : "bts:LiposarcomaNOS" }, { - "@id" : "bts:Non-codingTranscriptVariant" + "@id" : "bts:Interstitialcelltumorbenign" }, { - "@id" : "bts:FeatureTruncation" + "@id" : "bts:Neoplasmmetastatic" }, { - "@id" : "bts:RegulatoryRegionAmplification" + "@id" : "bts:Chronicneutrophilicleukemia" }, { - "@id" : "bts:StartLost" + "@id" : "bts:Bronchiolo-alveolarcarcinomagobletcelltype" }, { - "@id" : "bts:FeatureElongation" - } ], - "rdfs:label" : "MolecularConsequence", - "rdfs:comment" : "The text term used to describe the molecular consequence of genetic variation. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "@type" : "rdfs:Class", - "sms:displayName" : "MolecularConsequence" - }, { - "@id" : "bts:SampleCollectionYear", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SampleCollectionYear", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SampleCollectionYear", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:WorkingDistanceUnit", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:cm" + "@id" : "bts:Papillaryadenocarcinomafollicularvariant" }, { - "@id" : "bts:mm" + "@id" : "bts:Hepatocarcinoma" }, { - "@id" : "bts:µm" + "@id" : "bts:Undifferentiateduterinesarcoma" }, { - "@id" : "bts:nm" + "@id" : "bts:Renalcellcarcinomaunclassified" }, { - "@id" : "bts:Å" - } ], - "rdfs:label" : "WorkingDistanceUnit", - "rdfs:comment" : "The units of the working distance. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", - "@type" : "rdfs:Class", - "sms:displayName" : "WorkingDistanceUnit" - }, { - "@id" : "bts:PriorSitesofRadiation", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PriorSitesofRadiation", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PriorSitesofRadiation", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AlcoholHistory", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" + "@id" : "bts:Papillaryepidermoidcarcinoma" + }, { + "@id" : "bts:PigmentednevusNOS" }, { - "@id" : "bts:No" + "@id" : "bts:MyeloidleukemiaNOS" }, { - "@id" : "bts:unknown" + "@id" : "bts:Esophagealsquamousintraepithelialneoplasia(dysplasia)highgrade" }, { - "@id" : "bts:NotReported" - } ], - "rdfs:label" : "AlcoholHistory", - "rdfs:comment" : "A response to a question that asks whether the participant has consumed at least 12 drinks of any kind of alcoholic beverage in their lifetime.", - "@type" : "rdfs:Class", - "sms:displayName" : "AlcoholHistory" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AgeIsObfuscated", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:True" + "@id" : "bts:MalignantlymphomalargeB-cellNOS" }, { - "@id" : "bts:False" - } ], - "rdfs:label" : "AgeIsObfuscated", - "rdfs:comment" : "The age of the patient has been modified for compliance reasons. The actual age differs from what is reported. Other date intervals for this patient may also be modified.", - "@type" : "rdfs:Class", - "sms:displayName" : "AgeIsObfuscated" - }, { - "@id" : "bts:TargetName", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TargetName", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TargetName", - "sms:required" : "sms:false" - }, { - "@id" : "bts:TargetCaptureKit", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TargetCaptureKit", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "TargetCaptureKit", - "sms:required" : "sms:true" - }, { - "@id" : "bts:SecondExon", - "@type" : "rdfs:Class", - "rdfs:comment" : "The second exon number involved in molecular variation. If a specific genetic variant is being reported, this property can be used to capture the second exon where that variant is located. This property is typically used for a translocation where two different locations are involved in the variation.", - "rdfs:label" : "SecondExon", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SecondExon", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:HistoneFamily", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Non-lymphocyticleukemiaNOS" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Basalcelladenocarcinoma" }, { - "@id" : "bts:H1" + "@id" : "bts:AdultT-celllymphoma/leukemia" }, { - "@id" : "bts:H2A" + "@id" : "bts:Mixedpancreaticendocrineandexocrinetumormalignant" }, { - "@id" : "bts:H2B" + "@id" : "bts:EpendymomaNOS" }, { - "@id" : "bts:H3" + "@id" : "bts:PeripheralT-celllymphomaNOS" }, { - "@id" : "bts:H4" - } ], - "rdfs:label" : "HistoneFamily", - "rdfs:comment" : "The text term used to describe the family, or classification of a group of basic proteins found in chromatin, called histones.", - "@type" : "rdfs:Class", - "sms:displayName" : "HistoneFamily" - }, { - "@id" : "bts:BloodTestNormalRangeUpper", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the upper limit of the normal range used to describe a healthy individual at the institution where the test was completed.", - "rdfs:label" : "BloodTestNormalRangeUpper", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BloodTestNormalRangeUpper", - "sms:required" : "sms:false" - }, { - "@id" : "bts:LibraryPrepKitVersion", - "@type" : "rdfs:Class", - "rdfs:comment" : "Version of Library Prep Kit. String", - "rdfs:label" : "LibraryPrepKitVersion", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LibraryPrepKitVersion", - "sms:required" : "sms:true" - }, { - "@id" : "bts:Immunosuppression", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Immunosuppression", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Immunosuppression", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Authors", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Authors", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Authors", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:OvarianCancerPlatinumStatus", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Pulmonaryadenomatosis" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:Pleomorphiclobularcarcinoma" }, { - "@id" : "bts:Platinum-refractory" + "@id" : "bts:Pagetdiseaseofbreast" }, { - "@id" : "bts:Platinum-sensitive" + "@id" : "bts:HodgkinparagranulomaNOS" }, { - "@id" : "bts:Platinum-resistant" - } ], - "rdfs:label" : "OvarianCancerPlatinumStatus", - "rdfs:comment" : "Text term to indicate the status of treatment with platinum in participant with ovarian cancer", - "@type" : "rdfs:Class", - "sms:displayName" : "OvarianCancerPlatinumStatus" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AlcoholIntensity", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:MalignantmelanomaNOS" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Papillarytransitionalcellcarcinoma" }, { - "@id" : "bts:Drinker" + "@id" : "bts:Acutelymphocyticleukemia" }, { - "@id" : "bts:HeavyDrinker" + "@id" : "bts:Seroussurfacepapillarycarcinoma" }, { - "@id" : "bts:LifelongNon-Drinker" + "@id" : "bts:Basalcelltumor" }, { - "@id" : "bts:Non-Drinker" + "@id" : "bts:ChronicmyelomonocyticleukemiaNOS" }, { - "@id" : "bts:OccasionalDrinker" - } ], - "rdfs:label" : "AlcoholIntensity", - "rdfs:comment" : "Category to describe the patient's current level of alcohol use as self-reported by the patient.", - "@type" : "rdfs:Class", - "sms:displayName" : "AlcoholIntensity" - }, { - "@id" : "bts:Transcript", - "@type" : "rdfs:Class", - "rdfs:comment" : "Alphanumeric value used to describe the transcript of a specific genetic variant. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "Transcript", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Transcript", - "sms:required" : "sms:false" - }, { - "@id" : "bts:EducationLevel", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "EducationLevel", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "EducationLevel", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:DimensionOrder", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:XYZCT" + "@id" : "bts:LymphaticleukemicNOS" }, { - "@id" : "bts:XYZTC" + "@id" : "bts:TeratomaNOS" }, { - "@id" : "bts:XYCTZ" + "@id" : "bts:Malignantlymphomamixedcelltypefollicular" }, { - "@id" : "bts:XYCZT" + "@id" : "bts:Bronchiolaradenocarcinoma" }, { - "@id" : "bts:XYTZC" + "@id" : "bts:Basophiladenocarcinoma" }, { - "@id" : "bts:ZYX" - } ], - "rdfs:label" : "DimensionOrder", - "rdfs:comment" : "The order in which the individual planes of data are interleaved.", - "@type" : "rdfs:Class", - "sms:displayName" : "DimensionOrder" - }, { - "@id" : "bts:Parity", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of pregnancies carried over the threshold of viability", - "rdfs:label" : "Parity", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Parity", - "sms:required" : "sms:false" - }, { - "@id" : "bts:AlcoholDaysPerWeek", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the average number of days each week that a person consumes an alcoholic beverage.", - "rdfs:label" : "AlcoholDaysPerWeek", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AlcoholDaysPerWeek", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AnalyteType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:TissueSectionAnalyte" + "@id" : "bts:Non-HodgkinlymphomaNOS" }, { - "@id" : "bts:SerumAnalyte" + "@id" : "bts:Haemangioblastoma" }, { - "@id" : "bts:PBMCsorPlasmaorSerumAnalyte" + "@id" : "bts:Intraductaltubular-papillaryneoplasmhighgrade" }, { - "@id" : "bts:Plasma" + "@id" : "bts:ChronicmyeloproliferativediseaseNOS" }, { - "@id" : "bts:TissueBlockAnalyte" + "@id" : "bts:Rhabdoidmeningioma" }, { - "@id" : "bts:cfDNAAnalyte" + "@id" : "bts:RhabdoidtumorNOS" }, { - "@id" : "bts:DNAAnalyte" + "@id" : "bts:Carcinomaintestinaltype" }, { - "@id" : "bts:RNAAnalyte" + "@id" : "bts:ClassicalHodgkinlymphomalymphocytedepletionNOS" }, { - "@id" : "bts:cDNALibrariesAnalyte" + "@id" : "bts:ChronicmyeloidleukemiaNOS" }, { - "@id" : "bts:PBMCs" + "@id" : "bts:Melanoticmedulloblastoma" }, { - "@id" : "bts:TotalRNAAnalyte" - } ], - "rdfs:label" : "AnalyteType", - "rdfs:comment" : "The kind of molecular specimen analyte: a molecular derivative (I.e. RNA / DNA / Protein Lysate) obtained from a specimen", - "@type" : "rdfs:Class", - "sms:displayName" : "AnalyteType" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:FOVYUnit", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:cm" + "@id" : "bts:Melanoticneuroectodermaltumor" }, { - "@id" : "bts:mm" + "@id" : "bts:LobularcarcinomainsituNOS" }, { - "@id" : "bts:µm" + "@id" : "bts:Mixedsmallcellcarcinoma" }, { - "@id" : "bts:nm" + "@id" : "bts:Intradermalnevus" }, { - "@id" : "bts:Å" - } ], - "rdfs:label" : "FOVYUnit", - "rdfs:comment" : "Field of view Y dimension units. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", - "@type" : "rdfs:Class", - "sms:displayName" : "FOVYUnit" - }, { - "@id" : "bts:AgeatDiagnosis", - "@type" : "rdfs:Class", - "rdfs:comment" : "Age at the time of diagnosis expressed in number of days since birth.", - "rdfs:label" : "AgeatDiagnosis", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "AgeatDiagnosis", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Cytoband", - "@type" : "rdfs:Class", - "rdfs:comment" : "Alphanumeric value used to describe the cytoband or chromosomal location targeted or included in molecular analysis. If a specific genetic variant is being reported, this property can be used to capture the cytoband where the variant is located. Format: [chromosome][chromosome arm].[band+sub-bands]. Example: 17p13.1. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "Cytoband", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Cytoband", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PeaksCallingSoftware", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PeaksCallingSoftware", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PeaksCallingSoftware", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:SecondhandSmokeasChild", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" + "@id" : "bts:Bronchiolo-alveolarcarcinomaClaracell" }, { - "@id" : "bts:No" + "@id" : "bts:Papillarysquamouscellcarcinomainsitu" }, { - "@id" : "bts:unknown" + "@id" : "bts:Smallcellneuroendocrinecarcinoma" }, { - "@id" : "bts:NotReported" - } ], - "rdfs:label" : "SecondhandSmokeasChild", - "rdfs:comment" : "The text term used to indicate whether the patient was exposed to secondhand smoke as a child.", - "@type" : "rdfs:Class", - "sms:displayName" : "SecondhandSmokeasChild" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:PhysicalSizeXUnit", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:cm" + "@id" : "bts:Malignantmelanomainprecancerousmelanosis" }, { - "@id" : "bts:mm" + "@id" : "bts:CarcinomaanaplasticNOS" }, { - "@id" : "bts:µm" + "@id" : "bts:Dysplasticnevus" }, { - "@id" : "bts:nm" + "@id" : "bts:Liposarcomadifferentiated" }, { - "@id" : "bts:Å" - } ], - "rdfs:label" : "PhysicalSizeXUnit", - "rdfs:comment" : "The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", - "@type" : "rdfs:Class", - "sms:displayName" : "PhysicalSizeXUnit" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:CancerAssociatedGeneMutations", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:PMS2mutation" + "@id" : "bts:Combinedsmallcell-squamouscellcarcinoma" }, { - "@id" : "bts:POT1mutation" + "@id" : "bts:Acutelymphaticleukemia" }, { - "@id" : "bts:TP53mutation" + "@id" : "bts:Gliomamalignant" }, { - "@id" : "bts:H3K27Mmutation" + "@id" : "bts:AdenocarcinomainsituNOS" }, { - "@id" : "bts:SMARCA4mutation" + "@id" : "bts:Mucosal-associatedlymphoidtissuelymphoma" }, { - "@id" : "bts:SDHDmutation" + "@id" : "bts:Spleniclymphomawithvillouslymphocytes" }, { - "@id" : "bts:BRCA1mutation" + "@id" : "bts:LargecellcarcinomaNOS" }, { - "@id" : "bts:CHKmutation" + "@id" : "bts:MicropapillarycarcinomaNOS" }, { - "@id" : "bts:RB1mutation" + "@id" : "bts:Undifferentiatedspindlecellsarcoma" }, { - "@id" : "bts:H3G34R/Vmutation" + "@id" : "bts:IntraepidermalsquamouscellcarcinomaBowentype" }, { - "@id" : "bts:SDHCmutation" + "@id" : "bts:EndometrioidadenofibromaNOS" }, { - "@id" : "bts:SDHBmutation" + "@id" : "bts:MedullarycarcinomaNOS" }, { - "@id" : "bts:TSC2mutation" + "@id" : "bts:T-celllargegranularlymphocytosis" }, { - "@id" : "bts:NotReported" + "@id" : "bts:IntraductaladenocarcinomanoninfiltratingNOS" }, { - "@id" : "bts:HOXB13mutation" + "@id" : "bts:OsteosarcomaNOS" }, { - "@id" : "bts:NF1mutation" + "@id" : "bts:Pancreatobiliary-typecarcinoma" }, { - "@id" : "bts:VHLmutation" + "@id" : "bts:Adenocarcinoidtumor" }, { - "@id" : "bts:BAP1mutation" + "@id" : "bts:DiffuseastrocytomaIDH-mutant" }, { - "@id" : "bts:SETD2mutation" + "@id" : "bts:Medullaryosteosarcoma" }, { - "@id" : "bts:BRCA1and2mutation" + "@id" : "bts:Adenocarcinomaintestinaltype" }, { - "@id" : "bts:unknown" + "@id" : "bts:CarcinomainsituinapolypNOS" }, { - "@id" : "bts:PTENmutation" + "@id" : "bts:CarcinosarcomaNOS" }, { - "@id" : "bts:NotApplicable" + "@id" : "bts:Basalcelladenoma" }, { - "@id" : "bts:STK11mutation" + "@id" : "bts:AdultT-celllymphoma" }, { - "@id" : "bts:PAX5mutation" + "@id" : "bts:Lobularadenocarcinoma" }, { - "@id" : "bts:RETmutation" + "@id" : "bts:Melanocyticnevus" }, { - "@id" : "bts:NF2mutation" + "@id" : "bts:AdenocarcinomametastaticNOS" }, { - "@id" : "bts:ETV6mutation" + "@id" : "bts:Pigmentedbasalcellcarcinoma" }, { - "@id" : "bts:PolDmutation" + "@id" : "bts:Astrocytomaanaplastic" }, { - "@id" : "bts:IKZF1mutation" + "@id" : "bts:Melanomamalignantofsoftparts" }, { - "@id" : "bts:PALB2mutation" + "@id" : "bts:Smallcellosteosarcoma" }, { - "@id" : "bts:SDHAF2mutation" + "@id" : "bts:Unclassifiedtumoruncertainwhetherbenignormalignant" }, { - "@id" : "bts:EGFRmutation" + "@id" : "bts:Transitionalcellcarcinoma" }, { - "@id" : "bts:PDGFRAmutation" + "@id" : "bts:Intraductalcarcinomaandlobularcarcinomainsitu" }, { - "@id" : "bts:ARFmutation" + "@id" : "bts:RhabdomyomaNOS" }, { - "@id" : "bts:PTCHmutation" + "@id" : "bts:B-celllymphocyticleukemia/smalllymphocyticlymphoma" }, { - "@id" : "bts:PRKAR1Amutation" + "@id" : "bts:Capillaryhemangioma" }, { - "@id" : "bts:MUTYHmutation" + "@id" : "bts:PrecursorB-celllymphoblasticleukemia" }, { - "@id" : "bts:MSH6mutation" + "@id" : "bts:Bronchiolo-alveolarcarcinomaClaracellandgobletcelltype" }, { - "@id" : "bts:CDKN2Aandp14ARFmutation" + "@id" : "bts:Eosinophiladenoma" }, { - "@id" : "bts:GREM1mutation" + "@id" : "bts:SplenicB-celllymphoma/leukemiaunclassifiable" }, { - "@id" : "bts:MAXmutation" + "@id" : "bts:CompositeHodgkinandnon-Hodgkinlymphoma" }, { - "@id" : "bts:FHmutation" + "@id" : "bts:Pagetdiseaseandinfiltratingductcarcinomaofbreast" }, { - "@id" : "bts:PHOX2Bmutation" + "@id" : "bts:NeurofibromatosisNOS" }, { - "@id" : "bts:CDH1mutation" + "@id" : "bts:HodgkinlymphomaNOS" }, { - "@id" : "bts:MSH2mutation" + "@id" : "bts:Melanomainsitu" }, { - "@id" : "bts:MLH1mutation" + "@id" : "bts:SerouscystadenocarcinomaNOS" }, { - "@id" : "bts:METmutation" + "@id" : "bts:MalignantlymphomaHodgkin" }, { - "@id" : "bts:ATRXmutation" + "@id" : "bts:Acutelymphoblasticleukemia-lymphomaNOS" }, { - "@id" : "bts:KRASmutation" + "@id" : "bts:Unclassifiedtumormalignant" }, { - "@id" : "bts:KITmutation" + "@id" : "bts:Adultrhabdomyoma" }, { - "@id" : "bts:PolEmutation" + "@id" : "bts:Neoplasmuncertainwhetherbenignormalignant" }, { - "@id" : "bts:TSC1mutation" + "@id" : "bts:ChronicmyelomonocyticleukemiaType1" }, { - "@id" : "bts:BLMmutation" + "@id" : "bts:DuctadenomaNOS" }, { - "@id" : "bts:ATMmutation" + "@id" : "bts:Neoplasmbenign" }, { - "@id" : "bts:ACVR1mutation" + "@id" : "bts:CarcinomaundifferentiatedNOS" }, { - "@id" : "bts:FLCNmutation" + "@id" : "bts:Malignancy" + }, { + "@id" : "bts:Adenocarcinomainsitumucinous" + }, { + "@id" : "bts:Papillarysquamouscellcarcinoma" + }, { + "@id" : "bts:Blymphoblasticleukemia/lymphomawithhyperdiploidy" + }, { + "@id" : "bts:PrecursorT-celllymphoblasticleukemia" + }, { + "@id" : "bts:Tumorsecondary" + }, { + "@id" : "bts:Pancreatobiliaryneoplasmnon-invasive" + }, { + "@id" : "bts:Malignantmelanomaingiantpigmentednevus" }, { - "@id" : "bts:MEN1mutation" + "@id" : "bts:Squamouscellcarcinomaadenoid" }, { - "@id" : "bts:TMEM127mutation" + "@id" : "bts:Acutemyelomonocyticleukemia" }, { - "@id" : "bts:BRAFmutation" + "@id" : "bts:Bileductcystadenocarcinoma" }, { - "@id" : "bts:ROS1mutation" + "@id" : "bts:Pancreaticendocrinetumornonfunctioning" }, { - "@id" : "bts:SMAD4mutation" + "@id" : "bts:Pleomorphicadenoma" }, { - "@id" : "bts:ALKmutation" + "@id" : "bts:Blymphoblasticleukemia/lymphomawithhypodiploidy(HypodiploidALL)" }, { - "@id" : "bts:BMPR1Amutation" + "@id" : "bts:Renalcellcarcinomasarcomatoid" }, { - "@id" : "bts:APCmutation" + "@id" : "bts:SplenicmarginalzoneB-celllymphoma" }, { - "@id" : "bts:BRCA2mutation" + "@id" : "bts:MalignantlymphomalargeB-celldiffuseNOS" }, { - "@id" : "bts:SMARCB1mutation" + "@id" : "bts:Infiltratingductandcolloidcarcinoma" }, { - "@id" : "bts:CDKN2Amutation" + "@id" : "bts:ChronicmyelomonocyticleukemiaTypeII" }, { - "@id" : "bts:RAD51Cmutation" + "@id" : "bts:DuctadenocarcinomaNOS" }, { - "@id" : "bts:p14ARFmutation" - } ], - "rdfs:label" : "CancerAssociatedGeneMutations", - "rdfs:comment" : "Type of inherited germline or other gene mutations that confers heightened susceptibility to cancer identified in patient history", - "@type" : "rdfs:Class", - "sms:displayName" : "CancerAssociatedGeneMutations" - }, { - "@id" : "bts:FOVnumber", - "@type" : "rdfs:Class", - "rdfs:comment" : "Index of FOV (as it pertains to its sequence order). Integer >= 1", - "rdfs:label" : "FOVnumber", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "FOVnumber", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ChannelMetadataFilename", - "@type" : "rdfs:Class", - "rdfs:comment" : "Full path of uploaded companion CSV file containing channel-level metadata details", - "rdfs:label" : "ChannelMetadataFilename", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ChannelMetadataFilename", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Secondhandsmokeexposureyears", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Secondhandsmokeexposureyears", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Secondhandsmokeexposureyears", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:Read3", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:true", - "schema:rangeIncludes" : [ { - "@id" : "bts:CellBarcodeandDNAInsert" + "@id" : "bts:Combined/mixedcarcinoidandadenocarcinoma" }, { - "@id" : "bts:SampleIndexandDNAInsert" + "@id" : "bts:Haemangiosarcoma" }, { - "@id" : "bts:DNAInsert" + "@id" : "bts:Acutelymphoidleukemia" }, { - "@id" : "bts:SampleIndex" + "@id" : "bts:DiffuseastrocytomaIDH-wildtype" }, { - "@id" : "bts:CellBarcode" - } ], - "rdfs:label" : "Read3", - "rdfs:comment" : "Read 3 content description", - "@type" : "rdfs:Class", - "sms:displayName" : "Read3" - }, { - "@id" : "bts:CellMedianNumberReads", - "@type" : "rdfs:Class", - "rdfs:comment" : "Median number of reads per cell. Number", - "rdfs:label" : "CellMedianNumberReads", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CellMedianNumberReads", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:Gender", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Intraductaltubulopapillaryneoplasm" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Acutebasophilicleukaemia" }, { - "@id" : "bts:female" + "@id" : "bts:Unclassifiedtumorbenign" }, { - "@id" : "bts:male" + "@id" : "bts:Intraductalmicropapillarycarcinoma" }, { - "@id" : "bts:unspecified" - } ], - "rdfs:label" : "Gender", - "rdfs:comment" : "Text designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]", - "@type" : "rdfs:Class", - "sms:displayName" : "Gender" - }, { - "@id" : "bts:WorkflowVersion", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "WorkflowVersion", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "WorkflowVersion", - "sms:required" : "sms:false" - }, { - "@id" : "bts:MenopauseStatus", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MenopauseStatus", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "MenopauseStatus", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SubCycleNumber", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SubCycleNumber", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SubCycleNumber", - "sms:required" : "sms:false" - }, { - "@id" : "bts:GenomicReferenceURL", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "GenomicReferenceURL", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "GenomicReferenceURL", - "sms:required" : "sms:false" - }, { - "@id" : "bts:GenomicReference", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "GenomicReference", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "GenomicReference", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SizeY", - "@type" : "rdfs:Class", - "rdfs:comment" : "Size of image: Y dimension (in pixels). Integer >= 1", - "rdfs:label" : "SizeY", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SizeY", - "sms:required" : "sms:false" - }, { - "@id" : "bts:CellCount", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value used to describe the number of cells used for molecular testing. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "CellCount", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "CellCount", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:AnaplasiaPresentType", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Hodgkingranuloma" }, { - "@id" : "bts:NotReported" + "@id" : "bts:ChroniclymphocyticleukemiaB-celltype(includesallvariantsofBCLL)" }, { - "@id" : "bts:Equivocal" + "@id" : "bts:Pancreatoblastoma" }, { - "@id" : "bts:Absent" + "@id" : "bts:Bileductadenocarcinoma" }, { - "@id" : "bts:Present" + "@id" : "bts:Meningealmelanocytoma" }, { - "@id" : "bts:Diffuse" + "@id" : "bts:HodgkinlymphomamixedcellularityNOS" }, { - "@id" : "bts:Focal" + "@id" : "bts:InfiltratingductcarcinomaNOS" }, { - "@id" : "bts:Sclerosis" - } ], - "rdfs:label" : "AnaplasiaPresentType", - "rdfs:comment" : "The text term used to describe the morphologic findings indicating the presence of a malignant cellular infiltrate characterized by the presence of large pleomorphic cells, necrosis, and high mitotic activity in a tissue sample.", - "@type" : "rdfs:Class", - "sms:displayName" : "AnaplasiaPresentType" - }, { - "@id" : "bts:SampleID", - "@type" : "rdfs:Class", - "rdfs:comment" : " ID associated with a biosample", - "rdfs:label" : "SampleID", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SampleID", - "sms:required" : "sms:true" - }, { - "@id" : "bts:ExcitationWavelength", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ExcitationWavelength", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ExcitationWavelength", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:BIRADSMammographyBreastDensityCategory", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" + "@id" : "bts:Esophagealsquamousintraepithelialneoplasia(dysplasia)lowgrade" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:SmallcellcarcinomaNOS" }, { - "@id" : "bts:Predominantlyfatty" + "@id" : "bts:Inflammatorycarcinoma" }, { - "@id" : "bts:Scatteredfibroglandulardensities" + "@id" : "bts:Papillaryurothelialcarcinoma" }, { - "@id" : "bts:Heterogeneouslydense" + "@id" : "bts:Melanoticprogonoma" }, { - "@id" : "bts:Extremelydense" - } ], - "rdfs:label" : "BIRADSMammographyBreastDensityCategory", - "rdfs:comment" : "The category that describes the relative amount of different tissues present in the breast on a mammogram based on the updated 2015 edition of the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS) reporting guidelines.", - "@type" : "rdfs:Class", - "sms:displayName" : "BIRADSMammographyBreastDensityCategory" - }, { - "@id" : "bts:Weight", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Weight", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Weight", - "sms:required" : "sms:false" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:OvarianCancerSurgicalOutcome", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Other" + "@id" : "bts:Centralneuroblastoma" }, { - "@id" : "bts:unknown" + "@id" : "bts:MalignantlymphomalymphocyticNOS" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:MyelomaNOS" }, { - "@id" : "bts:R0resection" + "@id" : "bts:Adenocarcinomaendocervicaltype" }, { - "@id" : "bts:Optimalcytoreduction" + "@id" : "bts:AdenocarcinomainsituinapolypNOS" }, { - "@id" : "bts:Sub-optimalcytoreduction" - } ], - "rdfs:label" : "OvarianCancerSurgicalOutcome", - "rdfs:comment" : "Text term that describes the kind of surgical treatment administered.", - "@type" : "rdfs:Class", - "sms:displayName" : "OvarianCancerSurgicalOutcome" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:RelationshipPrimaryDiagnosis", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:ProstateCancer" + "@id" : "bts:Neoplasmmalignantuncertainwhetherprimaryormetastatic" }, { - "@id" : "bts:TesticularCancer" + "@id" : "bts:Pulmonaryarteryintimalsarcoma" }, { - "@id" : "bts:Cancer" + "@id" : "bts:IntraepidermalcarcinomaNOS" }, { - "@id" : "bts:KaposiSarcoma" + "@id" : "bts:PapillaryserouscystadenomaNOS" }, { - "@id" : "bts:BoneCancer" + "@id" : "bts:CarcinomainsituNOS" }, { - "@id" : "bts:LiverCancer" + "@id" : "bts:TubularadenomaNOS" }, { - "@id" : "bts:CNSCancer" + "@id" : "bts:Tubulopapillaryadenocarcinoma" }, { - "@id" : "bts:UterineCancer" + "@id" : "bts:Pancreaticmicroadenoma" }, { - "@id" : "bts:NotReported" + "@id" : "bts:AcutelymphoblasticleukemiamatureB-celltype" }, { - "@id" : "bts:LymphNodeCancer" + "@id" : "bts:c-ALL" }, { - "@id" : "bts:RectalCancer" + "@id" : "bts:AcuteleukemiaBurkitttype" }, { - "@id" : "bts:WilmsTumor" + "@id" : "bts:Cervicalintraepithelialneoplasialowgrade" }, { - "@id" : "bts:unknown" + "@id" : "bts:MixedtumorNOS" }, { - "@id" : "bts:Osteosarcoma" + "@id" : "bts:Bronchiolo-alveolaradenocarcinomaNOS" }, { - "@id" : "bts:Chondrosarcoma" + "@id" : "bts:Myoepithelioma" }, { - "@id" : "bts:Mesothelioma" + "@id" : "bts:Pancreaticendocrinetumormalignant" }, { - "@id" : "bts:GastricCancer" + "@id" : "bts:EndometrioidadenocarcinomaNOS" }, { - "@id" : "bts:CervicalCancer" + "@id" : "bts:InfiltratingbasalcellcarcinomaNOS" }, { - "@id" : "bts:EwingSarcoma" + "@id" : "bts:PrecursorB-celllymphoblasticlymphoma" }, { - "@id" : "bts:Glioblastoma" + "@id" : "bts:Pleomorphiclobularcarcinomainsitu" }, { - "@id" : "bts:SkinCancer" + "@id" : "bts:Mucousadenocarcinoma" }, { - "@id" : "bts:TonsillarCancer" + "@id" : "bts:Meningealmelanoma" }, { - "@id" : "bts:BileDuctCancer" + "@id" : "bts:Acutemyeloidleukemiaminimaldifferentiation" }, { - "@id" : "bts:TongueCancer" + "@id" : "bts:LymphoblasticleukemiaNOS" }, { - "@id" : "bts:LaryngealCancer" + "@id" : "bts:MelanoticMPNST" }, { - "@id" : "bts:Melanoma" + "@id" : "bts:Astrocytomalowgrade" }, { - "@id" : "bts:HematologicCancer" + "@id" : "bts:Multiplemyeloma" }, { - "@id" : "bts:ThroatCancer" + "@id" : "bts:Papillaryrenalcellcarcinoma" }, { - "@id" : "bts:ColorectalCancer" + "@id" : "bts:MedulloblastomaNOS" }, { - "@id" : "bts:KidneyCancer" + "@id" : "bts:AdenocarcinomainapolypNOS" }, { - "@id" : "bts:SpleenCancer" + "@id" : "bts:Combinedsmallcellcarcinoma" }, { - "@id" : "bts:BreastCancer" + "@id" : "bts:Bileductcarcinoma" }, { - "@id" : "bts:Leukemia" + "@id" : "bts:ChronicgranulocyticleukemiaNOS" }, { - "@id" : "bts:Sarcoma" + "@id" : "bts:Juvenilemyelomonocyticleukemia" }, { - "@id" : "bts:BloodCancer" + "@id" : "bts:NeoplasmNOS" }, { - "@id" : "bts:Neuroblastoma" + "@id" : "bts:Capillarylymphangioma" }, { - "@id" : "bts:GynecologicCancer" + "@id" : "bts:Malignantlymphomamixedcelltypediffuse" }, { - "@id" : "bts:Rhabdomyosarcoma" + "@id" : "bts:Neoplasmmalignant" }, { - "@id" : "bts:PancreasCancer" + "@id" : "bts:Papillarymeningioma" }, { - "@id" : "bts:AdrenalGlandCancer" + "@id" : "bts:Bileductcystadenoma" }, { - "@id" : "bts:ThyroidCancer" + "@id" : "bts:Malignantmelanomaincongenitalmelanocyticnevus" }, { - "@id" : "bts:MultipleMyeloma" + "@id" : "bts:Adenocarcinomadiffusetype" }, { - "@id" : "bts:LungCancer" + "@id" : "bts:Pancreaticendocrinetumorbenign" }, { - "@id" : "bts:BasalCellCancer" + "@id" : "bts:SquamouscellcarcinomaNOS" }, { - "@id" : "bts:BrainCancer" + "@id" : "bts:Chronicmyelomonocyticleukemiaintransformation" }, { - "@id" : "bts:EsophagealCancer" + "@id" : "bts:T-celllargegranularlymphocyticleukemia" }, { - "@id" : "bts:Lymphoma" + "@id" : "bts:Basophiladenoma" }, { - "@id" : "bts:OvarianCancer" + "@id" : "bts:Bronchiolarcarcinoma" }, { - "@id" : "bts:GallbladderCancer" + "@id" : "bts:Tubularcarcinoma" }, { - "@id" : "bts:HeadandNeckCancer" + "@id" : "bts:Neurofibrosarcoma" }, { - "@id" : "bts:BladderCancer" + "@id" : "bts:Adenocarcinomainsituinadenomatouspolyp" + }, { + "@id" : "bts:IntravascularB-celllymphoma" + }, { + "@id" : "bts:Pleomorphicliposarcoma" + }, { + "@id" : "bts:Tumormetastatic" } ], - "rdfs:label" : "RelationshipPrimaryDiagnosis", - "rdfs:comment" : "The text term used to describe the malignant diagnosis of the patient's relative with a history of cancer.", + "rdfs:label" : "PrimaryDiagnosis", + "rdfs:comment" : "Text term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).", "@type" : "rdfs:Class", - "sms:displayName" : "RelationshipPrimaryDiagnosis" + "sms:displayName" : "PrimaryDiagnosis" }, { - "@id" : "bts:AppliedHardTrimming", + "@id" : "bts:Gravidity", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AppliedHardTrimming", + "rdfs:comment" : "Total number of pregnancies regardless of outcome", + "rdfs:label" : "Gravidity", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AppliedHardTrimming", + "sms:displayName" : "Gravidity", "sms:required" : "sms:false" }, { - "@id" : "bts:AAChange", + "@id" : "bts:TotalNumberofPassingNuclei", "@type" : "rdfs:Class", - "rdfs:comment" : "Alphanumeric value used to describe the amino acid change for a specific genetic variant. Example: R116Q. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "rdfs:label" : "AAChange", + "rdfs:comment" : "Number of nuclei sequenced", + "rdfs:label" : "TotalNumberofPassingNuclei", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AAChange", + "sms:displayName" : "TotalNumberofPassingNuclei", "sms:required" : "sms:false" }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:NucleicAcidSource", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:SingleCell" - }, { - "@id" : "bts:SingleNucleus" - }, { - "@id" : "bts:BulkNuclei" - }, { - "@id" : "bts:BulkWholeCell" - }, { - "@id" : "bts:Micro-region" - } ], - "rdfs:label" : "NucleicAcidSource", - "rdfs:comment" : "The source of the input nucleic molecule", + "@id" : "bts:Objective", "@type" : "rdfs:Class", - "sms:displayName" : "NucleicAcidSource" - }, { + "rdfs:comment" : "Objective", + "rdfs:label" : "Objective", "rdfs:subClassOf" : [ ], - "@id" : "bts:ExtentofTumorResection", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Minor" - }, { - "@id" : "bts:OpenBiopsy" - }, { - "@id" : "bts:NotReported" - }, { - "@id" : "bts:GrossTotalResection" - }, { - "@id" : "bts:unknown" - }, { - "@id" : "bts:NotApplicable" - }, { - "@id" : "bts:Segmental" - }, { - "@id" : "bts:NTR" - }, { - "@id" : "bts:Suboptimaldebulking" - }, { - "@id" : "bts:SubtotalResection" - }, { - "@id" : "bts:Other" - }, { - "@id" : "bts:Partialdebulking" - }, { - "@id" : "bts:Suboptimal" - }, { - "@id" : "bts:Optimaldebulking" - }, { - "@id" : "bts:ExtensiveSubtotal" - } ], - "rdfs:label" : "ExtentofTumorResection", - "rdfs:comment" : "The degree to which the lesion has been cut out, or resected.", - "@type" : "rdfs:Class", - "sms:displayName" : "ExtentofTumorResection" + "sms:displayName" : "Objective", + "sms:required" : "sms:false" }, { - "@id" : "bts:TimepointLabel", + "@id" : "bts:BatchID", "@type" : "rdfs:Class", - "rdfs:comment" : "Label to identify the time point at which the clinical data or biospecimen was obtained (e.g. Baseline, End of Treatment, Overall survival, Final). NO PHI/PII INFORMATION IS ALLOWED.", - "rdfs:label" : "TimepointLabel", + "rdfs:comment" : "TBD", + "rdfs:label" : "BatchID", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TimepointLabel", + "sms:displayName" : "BatchID", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Ploidy", + "@id" : "bts:VascularInvasionType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, @@ -10191,289 +9456,239 @@ }, { "@id" : "bts:NotReported" }, { - "@id" : "bts:Aneuploid" - }, { - "@id" : "bts:Diploid" + "@id" : "bts:Extramural" }, { - "@id" : "bts:Hyperdiploid" + "@id" : "bts:Intramural" }, { - "@id" : "bts:Hypodiploid" + "@id" : "bts:Macro" }, { - "@id" : "bts:NearDiploid" + "@id" : "bts:Micro" }, { - "@id" : "bts:Tetraploid" + "@id" : "bts:NoVascularInvasion" } ], - "rdfs:label" : "Ploidy", - "rdfs:comment" : "Text term used to describe the number of sets of homologous chromosomes.", - "@type" : "rdfs:Class", - "sms:displayName" : "Ploidy" - }, { - "@id" : "bts:PortionWeight", - "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value that represents the sample portion weight, measured in milligrams.", - "rdfs:label" : "PortionWeight", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PortionWeight", - "sms:required" : "sms:false" - }, { - "@id" : "bts:DaystoProgression", + "rdfs:label" : "VascularInvasionType", + "rdfs:comment" : "Text term that represents the type of vascular tumor invasion.", "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days between the date used for index and the date the patient's disease progressed.", - "rdfs:label" : "DaystoProgression", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "DaystoProgression", - "sms:required" : "sms:false" + "sms:displayName" : "VascularInvasionType" }, { - "@id" : "bts:RRIDidentifier", + "@id" : "bts:AntibodyName", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "RRIDidentifier", + "rdfs:label" : "AntibodyName", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RRIDidentifier", + "sms:displayName" : "AntibodyName", "sms:required" : "sms:false" }, { - "@id" : "bts:ClassBRCA2", + "@id" : "bts:TestValue", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ClassBRCA2", + "rdfs:comment" : "The text term or numeric value used to describe a specific result of a molecular test. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here", + "rdfs:label" : "TestValue", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ClassBRCA2", + "sms:displayName" : "TestValue", "sms:required" : "sms:false" }, { - "@id" : "bts:WhitelistCellBarcodeFileLink", + "@id" : "bts:Concentration", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "WhitelistCellBarcodeFileLink", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "WhitelistCellBarcodeFileLink", - "sms:required" : "sms:false" - }, { - "@id" : "bts:StartDaysfromIndex", - "@type" : "rdfs:Class", - "rdfs:comment" : "Number of days from the date of birth (index date) to the date of an event (e.g. exposure to environmental factor, treatment start, etc.). If not applicable please enter 'Not Applicable'", - "rdfs:label" : "StartDaysfromIndex", + "rdfs:label" : "Concentration", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "StartDaysfromIndex", + "sms:displayName" : "Concentration", "sms:required" : "sms:false" }, { - "@id" : "bts:Ecigvapetimesperday", + "@id" : "bts:PRStatus", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "Ecigvapetimesperday", + "rdfs:label" : "PRStatus", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Ecigvapetimesperday", + "sms:displayName" : "PRStatus", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:FamilyMemberVitalStatusIndicator", + "@id" : "bts:IschemicTemperature", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" + "@id" : "bts:unknown" }, { - "@id" : "bts:No" + "@id" : "bts:LiquidNitrogen" }, { - "@id" : "bts:unknown" + "@id" : "bts:WarmIschemia" + }, { + "@id" : "bts:ColdIschemia" + }, { + "@id" : "bts:Ambientair" + }, { + "@id" : "bts:4Cwetice" + }, { + "@id" : "bts:Negative-20C" + }, { + "@id" : "bts:DryIce" } ], - "rdfs:label" : "FamilyMemberVitalStatusIndicator", - "rdfs:comment" : "The response indicates whether the family member of the patient with a history of cancer is alive. (Extension to GDC attributes in Family History Tier 1)", - "@type" : "rdfs:Class", - "sms:displayName" : "FamilyMemberVitalStatusIndicator" - }, { - "@id" : "bts:SectionThicknessValue", + "rdfs:label" : "IschemicTemperature", + "rdfs:comment" : "Specify whether specimen experienced warm or cold ischemia.", "@type" : "rdfs:Class", - "rdfs:comment" : "Numeric value to describe the thickness of a slice to tissue taken from a biospecimen, measured in microns (um).", - "rdfs:label" : "SectionThicknessValue", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SectionThicknessValue", - "sms:required" : "sms:false" + "sms:displayName" : "IschemicTemperature" }, { - "@id" : "bts:SoftwareandVersion", + "@id" : "bts:Microscope", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SoftwareandVersion", + "rdfs:comment" : "Microscope type (manufacturer, model, etc) used for this experiment", + "rdfs:label" : "Microscope", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SoftwareandVersion", + "sms:displayName" : "Microscope", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:KnownGeneticPredispositionMutation", + "@id" : "bts:TranspositionReaction", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:Yes" + "@id" : "bts:Tn5" }, { - "@id" : "bts:No" + "@id" : "bts:EZ-Tn5" }, { - "@id" : "bts:unknown" + "@id" : "bts:Tn5-059" + }, { + "@id" : "bts:NexteraTn5" + }, { + "@id" : "bts:Diagenode-unloadedApex-Bio" + }, { + "@id" : "bts:Diagenode-loadedApex-Bio" + }, { + "@id" : "bts:In-House" } ], - "rdfs:label" : "KnownGeneticPredispositionMutation", - "rdfs:comment" : "A yes/no/unknown indicator to identify whether there is a known genetic predisposition mutation present in the patient.", + "rdfs:label" : "TranspositionReaction", + "rdfs:comment" : "Name of the transposase, transposon sequences", "@type" : "rdfs:Class", - "sms:displayName" : "KnownGeneticPredispositionMutation" + "sms:displayName" : "TranspositionReaction" }, { - "@id" : "bts:BiospecimenDimension1", + "@id" : "bts:MedicallyUnderservedArea", "@type" : "rdfs:Class", - "rdfs:comment" : "First dimension of tissue fragment (number, up to one decimal place) measured in units as defined by the \"\"dimensions_unit\"\" CDE", - "rdfs:label" : "BiospecimenDimension1", + "rdfs:comment" : "TBD", + "rdfs:label" : "MedicallyUnderservedArea", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BiospecimenDimension1", + "sms:displayName" : "MedicallyUnderservedArea", "sms:required" : "sms:false" }, { - "@id" : "bts:NucleiBarcodeLength", + "@id" : "bts:WorkflowLink", "@type" : "rdfs:Class", - "rdfs:comment" : "Nuclei Barcode Length", - "rdfs:label" : "NucleiBarcodeLength", + "rdfs:comment" : "TBD", + "rdfs:label" : "WorkflowLink", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "NucleiBarcodeLength", + "sms:displayName" : "WorkflowLink", "sms:required" : "sms:false" }, { - "@id" : "bts:HER2BreastCarcinomaCopyNumberTotal", + "@id" : "bts:HER2Status", "@type" : "rdfs:Class", - "rdfs:comment" : "Result of HER2 Copy Number testing (in a participant with breast cancer), expressed as a range of values.", - "rdfs:label" : "HER2BreastCarcinomaCopyNumberTotal", + "rdfs:comment" : "TBD", + "rdfs:label" : "HER2Status", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "HER2BreastCarcinomaCopyNumberTotal", + "sms:displayName" : "HER2Status", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:MammaprintRiskGroup", + "@id" : "bts:PassedQC", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:unknown" - }, { - "@id" : "bts:Datanotavailable" - }, { - "@id" : "bts:Highrisk" - }, { - "@id" : "bts:Intermediaterisk" + "@id" : "bts:No-ChannelsQC" }, { - "@id" : "bts:Lowrisk" + "@id" : "bts:Yes" } ], - "rdfs:label" : "MammaprintRiskGroup", - "rdfs:comment" : "Text term that represents the risk group for breast cancer as determined by assessment of the MammaPrint test.", + "rdfs:label" : "PassedQC", + "rdfs:comment" : "Did all channels pass QC (if not add free text Comment)", "@type" : "rdfs:Class", - "sms:displayName" : "MammaprintRiskGroup" + "sms:displayName" : "PassedQC" }, { - "@id" : "bts:Height", + "@id" : "bts:AgeAtMenarche", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "Height", + "rdfs:label" : "AgeAtMenarche", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Height", + "sms:displayName" : "AgeAtMenarche", "sms:required" : "sms:false" }, { + "@id" : "bts:ScRNAseqWorkflowType", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "ScRNAseqWorkflowType", "rdfs:subClassOf" : [ ], - "@id" : "bts:Race", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:required" : "sms:true", + "sms:displayName" : "ScRNAseqWorkflowType", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:InvasiveDuctalBreastCarcinomaHistologicCategory", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:americanindianoralaskanative" + "@id" : "bts:Invasivecarcinoma-typecannotbedetermined" }, { - "@id" : "bts:NotReported" + "@id" : "bts:Medullarycarcinoma" }, { - "@id" : "bts:white" + "@id" : "bts:Invasivepapillarycarcinoma" + }, { + "@id" : "bts:Invasivetubularcarcinoma" + }, { + "@id" : "bts:Datanotavailable" }, { "@id" : "bts:unknown" }, { - "@id" : "bts:blackorafricanamerican" + "@id" : "bts:Invasivecribriformcarcinoma" }, { - "@id" : "bts:notallowedtocollect" + "@id" : "bts:Invasivemicropapillarycarcinoma" }, { - "@id" : "bts:asian" + "@id" : "bts:Tubulolobularcarcinoma" }, { "@id" : "bts:Other" }, { - "@id" : "bts:nativehawaiianorotherpacificislander" - } ], - "rdfs:label" : "Race", - "rdfs:comment" : "An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation withina a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution.", - "@type" : "rdfs:Class", - "sms:displayName" : "Race" - }, { - "@id" : "bts:BiospecimenDimension3", - "@type" : "rdfs:Class", - "rdfs:comment" : "Third dimension of tissue fragment (number, up to one decimal place) measured in units as defined by the \"\"dimensions_unit\"\" CDE", - "rdfs:label" : "BiospecimenDimension3", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BiospecimenDimension3", - "sms:required" : "sms:false" - }, { - "@id" : "bts:OncotypeScore", - "@type" : "rdfs:Class", - "rdfs:comment" : "OncotypeDX recurrence score", - "rdfs:label" : "OncotypeScore", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "OncotypeScore", - "sms:required" : "sms:false" - }, { - "@id" : "bts:InputCellsandNuclei", + "@id" : "bts:Classicaltype" + }, { + "@id" : "bts:Mucinouscarcinoma" + } ], + "rdfs:label" : "InvasiveDuctalBreastCarcinomaHistologicCategory", + "rdfs:comment" : "The histologic subtype for the most common type of invasive breast carcinoma.", "@type" : "rdfs:Class", - "rdfs:comment" : "Number of cells and number of nuclei input; entry format: number, number", - "rdfs:label" : "InputCellsandNuclei", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "InputCellsandNuclei", - "sms:required" : "sms:false" + "sms:displayName" : "InvasiveDuctalBreastCarcinomaHistologicCategory" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:PRReceptorStatus", + "@id" : "bts:TestAnalyteType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, @@ -10481,1394 +9696,2134 @@ "schema:rangeIncludes" : [ { "@id" : "bts:unknown" }, { - "@id" : "bts:Borderline" - }, { - "@id" : "bts:Equivocal" + "@id" : "bts:NotReported" }, { - "@id" : "bts:Indeterminate" + "@id" : "bts:DNA" }, { - "@id" : "bts:Negative" + "@id" : "bts:mRNA" }, { - "@id" : "bts:NotPerformed" + "@id" : "bts:miRNA" }, { - "@id" : "bts:PerformedbutNotAvailable" + "@id" : "bts:ProteinAnalyte" }, { - "@id" : "bts:Positive" + "@id" : "bts:TotalRNA" } ], - "rdfs:label" : "PRReceptorStatus", - "rdfs:comment" : "Text term to represent the overall result of Progresterone Receptor (PR) testing in a participant with breast cancer", + "rdfs:label" : "TestAnalyteType", + "rdfs:comment" : "The text term used to describe the type of analyte used for molecular testing. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", "@type" : "rdfs:Class", - "sms:displayName" : "PRReceptorStatus" + "sms:displayName" : "TestAnalyteType" }, { - "@id" : "bts:Fluorophore", + "@id" : "bts:DataCategory", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "Fluorophore", + "rdfs:label" : "DataCategory", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Fluorophore", + "sms:displayName" : "DataCategory", "sms:required" : "sms:false" }, { - "@id" : "bts:Typeofsmokeexposurecumulativeyears", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Typeofsmokeexposurecumulativeyears", "rdfs:subClassOf" : [ ], + "@id" : "bts:Ethnicity", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "Typeofsmokeexposurecumulativeyears", - "sms:required" : "sms:false" - }, { - "@id" : "bts:Clone", + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:hispanicorlatino" + }, { + "@id" : "bts:nothispanicorlatino" + }, { + "@id" : "bts:notallowedtocollect" + } ], + "rdfs:label" : "Ethnicity", + "rdfs:comment" : "An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "Clone", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Clone", - "sms:required" : "sms:false" + "sms:displayName" : "Ethnicity" }, { - "@id" : "bts:DiagnosisStatusType", + "@id" : "bts:WorkingDistance", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "DiagnosisStatusType", + "rdfs:comment" : "The working distance of the lens, expressed as a floating point number. Floating point > 0.", + "rdfs:label" : "WorkingDistance", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "DiagnosisStatusType", + "sms:displayName" : "WorkingDistance", "sms:required" : "sms:false" }, { - "@id" : "bts:Age", - "@type" : "rdfs:Class", - "rdfs:comment" : "Age of individual", - "rdfs:label" : "Age", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "Age", - "sms:required" : "sms:true" - }, { - "@id" : "bts:TobaccoUse", + "@id" : "bts:FixationDuration", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TobaccoUse", + "rdfs:comment" : "The length of time, from beginning to end, required to process or preserve biospecimens in fixative (measured in minutes)", + "rdfs:label" : "FixationDuration", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TobaccoUse", + "sms:displayName" : "FixationDuration", "sms:required" : "sms:false" }, { "rdfs:subClassOf" : [ ], - "@id" : "bts:Zstack", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ ], - "rdfs:label" : "Zstack", - "rdfs:comment" : "Does data file contain a Z-stack of images", - "@type" : "rdfs:Class", - "sms:displayName" : "Zstack" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:Chromosome", + "@id" : "bts:LaboratoryTest", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, "sms:required" : "sms:false", "schema:rangeIncludes" : [ { - "@id" : "bts:chr7" - }, { - "@id" : "bts:chr15" - }, { - "@id" : "bts:NotReported" - }, { - "@id" : "bts:chr3" - }, { - "@id" : "bts:chr1" - }, { - "@id" : "bts:chr18" - }, { - "@id" : "bts:unknown" - }, { - "@id" : "bts:chrY" + "@id" : "bts:AbsoluteNeutrophil" }, { - "@id" : "bts:chr22" + "@id" : "bts:Myeloblasts" }, { - "@id" : "bts:chr14" + "@id" : "bts:TotalProtein" }, { - "@id" : "bts:chr12" + "@id" : "bts:NotReported" }, { - "@id" : "bts:chr11" + "@id" : "bts:Hemoglobin" }, { - "@id" : "bts:chr17" + "@id" : "bts:NOS" }, { - "@id" : "bts:chrM" + "@id" : "bts:Basophil" }, { - "@id" : "bts:chr4" + "@id" : "bts:C-ReactiveProtein" }, { - "@id" : "bts:chr21" + "@id" : "bts:MProtein" }, { - "@id" : "bts:chr6" + "@id" : "bts:Lambda" }, { - "@id" : "bts:chr10" + "@id" : "bts:unknown" }, { - "@id" : "bts:chr16" + "@id" : "bts:CirculatingTumorCells" }, { - "@id" : "bts:chrX" + "@id" : "bts:Epstein-BarrVirus" }, { - "@id" : "bts:chr23" + "@id" : "bts:Promonocytes" }, { - "@id" : "bts:chr8" + "@id" : "bts:LactateDehydrogenase" }, { - "@id" : "bts:chr2" + "@id" : "bts:Cellularity" }, { - "@id" : "bts:chr13" + "@id" : "bts:HumanChorionicGonadotropin" }, { - "@id" : "bts:chr19" + "@id" : "bts:AlphaFetoprotein" }, { - "@id" : "bts:chr20" + "@id" : "bts:Hematocrit" }, { - "@id" : "bts:chr5" + "@id" : "bts:Promyelocytes" }, { - "@id" : "bts:chr9" - } ], - "rdfs:label" : "Chromosome", - "rdfs:comment" : "The text term used to describe a chromosome targeted or included in molecular testing. If a specific genetic variant is being reported, this property can be used to capture the chromosome where that variant is located. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", - "@type" : "rdfs:Class", - "sms:displayName" : "Chromosome" - }, { - "rdfs:subClassOf" : [ ], - "@id" : "bts:MutationalSignatures", - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:required" : "sms:false", - "schema:rangeIncludes" : [ { - "@id" : "bts:Signature19" + "@id" : "bts:Testosterone" }, { - "@id" : "bts:Signature1A" + "@id" : "bts:Lymphoblasts" }, { - "@id" : "bts:Iggenehypermutation" + "@id" : "bts:ImmunoglobulinM" }, { - "@id" : "bts:alteredactivityoftheerror-pronepolymerasePOLε(POLE)" + "@id" : "bts:Lymphocytes" }, { - "@id" : "bts:Signature3" + "@id" : "bts:Leukocytes" }, { - "@id" : "bts:Signature20" + "@id" : "bts:HPV-E6/E7" }, { - "@id" : "bts:NotReported" + "@id" : "bts:LuteinizingHormone" }, { - "@id" : "bts:Signature17" + "@id" : "bts:SegmentedNeutrophil" }, { - "@id" : "bts:Signature4" + "@id" : "bts:ImmunoglobulinG" }, { - "@id" : "bts:Datanotavailable" + "@id" : "bts:Beta2Microglobulin" }, { - "@id" : "bts:Signature5" + "@id" : "bts:Creatinine" }, { - "@id" : "bts:Signature9" + "@id" : "bts:Glucose" }, { - "@id" : "bts:unknown" + "@id" : "bts:SerumFreeImmunoglobulinLightChain" }, { - "@id" : "bts:Signature14" + "@id" : "bts:Calcium" }, { - "@id" : "bts:Signature13" + "@id" : "bts:Metamyelocytes" }, { - "@id" : "bts:NotApplicable" + "@id" : "bts:Kappa" }, { - "@id" : "bts:Signature12" + "@id" : "bts:Prolymphocytes" }, { - "@id" : "bts:Signature8" + "@id" : "bts:HumanPapillomavirus" }, { - "@id" : "bts:ActivationInducedDeaminases(AID)associatedmutations" + "@id" : "bts:Platelets" }, { - "@id" : "bts:Signature7" + "@id" : "bts:NeutrophilBands" }, { - "@id" : "bts:microsatelliteinstability(additionsanddeletions)" + "@id" : "bts:Myelocytes" }, { - "@id" : "bts:AlkylatingAgents(Temozolomide)inducedmutations" + "@id" : "bts:Albumin" }, { - "@id" : "bts:localizedsubstitutionhypermutation(kataegis)" + "@id" : "bts:BloodUreaNitrogen" }, { - "@id" : "bts:Signature16" + "@id" : "bts:TotalBilirubin" }, { - "@id" : "bts:Signature6" + "@id" : "bts:Eosinophil" }, { - "@id" : "bts:Other" + "@id" : "bts:ImmunoglobulinA" }, { - "@id" : "bts:Signature21" + "@id" : "bts:B-cellgenotyping" + } ], + "rdfs:label" : "LaboratoryTest", + "rdfs:comment" : "The text term used to describe the medical testing used to diagnose, treat or further understand a patient's disease.", + "@type" : "rdfs:Class", + "sms:displayName" : "LaboratoryTest" + }, { + "@id" : "bts:LociAbnormalCount", + "@type" : "rdfs:Class", + "rdfs:comment" : "Numeric value used to describe the number of loci determined to be abnormal.", + "rdfs:label" : "LociAbnormalCount", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "LociAbnormalCount", + "sms:required" : "sms:false" + }, { + "@id" : "bts:CatalogNumber", + "@type" : "rdfs:Class", + "rdfs:comment" : "TBD", + "rdfs:label" : "CatalogNumber", + "rdfs:subClassOf" : [ ], + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:displayName" : "CatalogNumber", + "sms:required" : "sms:false" + }, { + "rdfs:subClassOf" : [ ], + "@id" : "bts:ImagingAssayType", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:MIBI" }, { - "@id" : "bts:DNAMMRDeficiency" + "@id" : "bts:MxIF" }, { - "@id" : "bts:APOBECenzymesassociatedmutations" + "@id" : "bts:IMC" }, { - "@id" : "bts:Tobaccouseassociatedmutations" + "@id" : "bts:NotApplicable" }, { - "@id" : "bts:transcriptionalstrandbias" + "@id" : "bts:mIHC" }, { - "@id" : "bts:Signature1B" + "@id" : "bts:H&E" }, { - "@id" : "bts:Signature10" + "@id" : "bts:IHC" }, { - "@id" : "bts:UVlightinducedmutations" + "@id" : "bts:CODEX" }, { - "@id" : "bts:Signature18" + "@id" : "bts:SABER" }, { - "@id" : "bts:Signature11" + "@id" : "bts:MERFISH" }, { - "@id" : "bts:Signature2" + "@id" : "bts:CyCIF" }, { - "@id" : "bts:methylatedCpGsequencesmutagenesis(deaminationof5-methyl-cytosine)" + "@id" : "bts:t-CyCIF" }, { - "@id" : "bts:Signature15" + "@id" : "bts:GeoMX-DSP" }, { - "@id" : "bts:ageofcancerdiagnosis" + "@id" : "bts:ExSeq" } ], - "rdfs:label" : "MutationalSignatures", - "rdfs:comment" : "Mutational signatures identified in the patient, includes signatures linked to selected exogenous carcinogens, endogenous and enzymatic modification of DNA or defective DNA repair. Note: Include only outputs of tests that were completed clinically for the participant and only include data from a diagnostic array that was completed prior to research sequencing was done. ", + "rdfs:label" : "ImagingAssayType", + "rdfs:comment" : "Type of imaging assay", "@type" : "rdfs:Class", - "sms:displayName" : "MutationalSignatures" + "sms:displayName" : "ImagingAssayType" }, { - "@id" : "bts:LabID", + "@id" : "bts:NucleiBarcodeRead", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LabID", + "rdfs:comment" : "Nuclei Barcode Read", + "rdfs:label" : "NucleiBarcodeRead", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "LabID", + "sms:displayName" : "NucleiBarcodeRead", "sms:required" : "sms:false" }, { - "@id" : "bts:CancerIncidenceLocation", + "@id" : "bts:OligoBarcodeUpperStrand", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "CancerIncidenceLocation", + "rdfs:label" : "OligoBarcodeUpperStrand", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CancerIncidenceLocation", + "sms:displayName" : "OligoBarcodeUpperStrand", "sms:required" : "sms:false" }, { - "@id" : "bts:IndicatorEnum", + "@id" : "bts:BreastCarcinomaHER2Centromere17CopynumberTotal", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "IndicatorEnum", + "rdfs:comment" : "Number of Cells Counted for HER2 & Centromere 17 Copy Numbers in a participant with breast cancer", + "rdfs:label" : "BreastCarcinomaHER2Centromere17CopynumberTotal", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "IndicatorEnum", + "sms:displayName" : "BreastCarcinomaHER2Centromere17CopynumberTotal", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCancerAssessmentTestsEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCancerAssessmentTestsEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:BiospecimenType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCancerAssessmentTestsEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:FluidsBiospecimenType" + }, { + "@id" : "bts:SputumBiospecimenType" + }, { + "@id" : "bts:TissueBiospecimenType" + }, { + "@id" : "bts:MouthRinseBiospecimenType" + }, { + "@id" : "bts:AscitesBiospecimenType" + }, { + "@id" : "bts:CellsBiospecimenType" + }, { + "@id" : "bts:BloodBiospecimenType" + }, { + "@id" : "bts:AnalyteBiospecimenType" + }, { + "@id" : "bts:BoneMarrowBiospecimenType" + }, { + "@id" : "bts:UrineBiospecimenType" + }, { + "@id" : "bts:StoolBiospecimenType" + } ], + "rdfs:label" : "BiospecimenType", + "rdfs:comment" : "Biospecimen Type", + "@type" : "rdfs:Class", + "sms:displayName" : "BiospecimenType" }, { - "@id" : "bts:HereditaryCancerPredispositionSyndromeEnum", + "@id" : "bts:SmokeExposureDuration", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "HereditaryCancerPredispositionSyndromeEnum", + "rdfs:label" : "SmokeExposureDuration", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "HereditaryCancerPredispositionSyndromeEnum", + "sms:displayName" : "SmokeExposureDuration", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCarcinomaDetectionMethodTypeEnum", + "@id" : "bts:MenstrualCyclePhase", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCarcinomaDetectionMethodTypeEnum", + "rdfs:label" : "MenstrualCyclePhase", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaDetectionMethodTypeEnum", + "sms:displayName" : "MenstrualCyclePhase", "sms:required" : "sms:false" }, { - "@id" : "bts:CancerAssociatedGeneMutationsEnum", + "@id" : "bts:ThresholdforMinimumPassingReads", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "CancerAssociatedGeneMutationsEnum", + "rdfs:comment" : "Threshold for calling cells", + "rdfs:label" : "ThresholdforMinimumPassingReads", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CancerAssociatedGeneMutationsEnum", + "sms:displayName" : "ThresholdforMinimumPassingReads", "sms:required" : "sms:false" }, { - "@id" : "bts:RelativewithCancerHistoryEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "RelativewithCancerHistoryEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:ShippingConditionType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RelativewithCancerHistoryEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:EthnicityEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:LiquidNitrogen" + }, { + "@id" : "bts:DryIce" + }, { + "@id" : "bts:AmbientPack" + }, { + "@id" : "bts:ColdPack" + }, { + "@id" : "bts:IcePack" + }, { + "@id" : "bts:SpecimenatRoomTemperature" + }, { + "@id" : "bts:OtherShippingEnvironment" + }, { + "@id" : "bts:NotShipped" + } ], + "rdfs:label" : "ShippingConditionType", + "rdfs:comment" : "Text descriptor of the shipping environment of a biospecimen.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "EthnicityEnum", + "sms:displayName" : "ShippingConditionType" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:AntibioticUse", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "EthnicityEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:No" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Yes-withinlastmonthh" + }, { + "@id" : "bts:Yes-withinlast1-6months" + }, { + "@id" : "bts:Yes-over6monthsago" + } ], + "rdfs:label" : "AntibioticUse", + "rdfs:comment" : "Antibiotic use", + "@type" : "rdfs:Class", + "sms:displayName" : "AntibioticUse" }, { - "@id" : "bts:ImmersionEnum", + "@id" : "bts:ERStatus", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "ImmersionEnum", + "rdfs:label" : "ERStatus", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ImmersionEnum", + "sms:displayName" : "ERStatus", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCancerGenomicTestPerformedEnum", + "rdfs:subClassOf" : [ ], + "@id" : "bts:MolecularConsequence", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:TFBindingSiteVariant" + }, { + "@id" : "bts:TranscriptAmplification" + }, { + "@id" : "bts:SpliceRegionVariant" + }, { + "@id" : "bts:DownstreamGeneVariant" + }, { + "@id" : "bts:5PrimeUTRVariant" + }, { + "@id" : "bts:SpliceDonorVariant" + }, { + "@id" : "bts:SpliceAcceptorVariant" + }, { + "@id" : "bts:StopGain" + }, { + "@id" : "bts:StopRetainedVariant" + }, { + "@id" : "bts:TFBSAmplification" + }, { + "@id" : "bts:3PrimeUTRVariant" + }, { + "@id" : "bts:UpstreamGeneVariant" + }, { + "@id" : "bts:IntergenicVariant" + }, { + "@id" : "bts:RegulatoryRegionAblation" + }, { + "@id" : "bts:NMDTranscriptVariant" + }, { + "@id" : "bts:TranscriptAblation" + }, { + "@id" : "bts:Non-codingTranscriptExonVariant" + }, { + "@id" : "bts:SynonymousVariant" + }, { + "@id" : "bts:RegulatoryRegionVariant" + }, { + "@id" : "bts:StopLost" + }, { + "@id" : "bts:MaturemiRNAVariant" + }, { + "@id" : "bts:InframeInsertion" + }, { + "@id" : "bts:InframeDeletion" + }, { + "@id" : "bts:ProteinAlteringVariant" + }, { + "@id" : "bts:IncompleteTerminalCodonVariant" + }, { + "@id" : "bts:TFBSAblation" + }, { + "@id" : "bts:IntronVariant" + }, { + "@id" : "bts:CodingSequenceVariant" + }, { + "@id" : "bts:MissenseVariant" + }, { + "@id" : "bts:FrameshiftVariant" + }, { + "@id" : "bts:Non-codingTranscriptVariant" + }, { + "@id" : "bts:FeatureTruncation" + }, { + "@id" : "bts:RegulatoryRegionAmplification" + }, { + "@id" : "bts:StartLost" + }, { + "@id" : "bts:FeatureElongation" + } ], + "rdfs:label" : "MolecularConsequence", + "rdfs:comment" : "The text term used to describe the molecular consequence of genetic variation. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCancerGenomicTestPerformedEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BreastCancerGenomicTestPerformedEnum", - "sms:required" : "sms:false" + "sms:displayName" : "MolecularConsequence" }, { - "@id" : "bts:FileFormatEnum", + "@id" : "bts:SampleCollectionYear", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "FileFormatEnum", + "rdfs:label" : "SampleCollectionYear", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "FileFormatEnum", + "sms:displayName" : "SampleCollectionYear", "sms:required" : "sms:false" }, { - "@id" : "bts:DimensionOrderEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "DimensionOrderEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:WorkingDistanceUnit", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "DimensionOrderEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:SexEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:cm" + }, { + "@id" : "bts:mm" + }, { + "@id" : "bts:µm" + }, { + "@id" : "bts:nm" + }, { + "@id" : "bts:Å" + } ], + "rdfs:label" : "WorkingDistanceUnit", + "rdfs:comment" : "The units of the working distance. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SexEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "SexEnum", - "sms:required" : "sms:false" + "sms:displayName" : "WorkingDistanceUnit" }, { - "@id" : "bts:AlcoholIntensityEnum", + "@id" : "bts:PriorSitesofRadiation", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "AlcoholIntensityEnum", + "rdfs:label" : "PriorSitesofRadiation", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AlcoholIntensityEnum", + "sms:displayName" : "PriorSitesofRadiation", "sms:required" : "sms:false" }, { - "@id" : "bts:ImagingAssayTypeEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ImagingAssayTypeEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:AlcoholHistory", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ImagingAssayTypeEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PassedQCEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" + }, { + "@id" : "bts:No" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + } ], + "rdfs:label" : "AlcoholHistory", + "rdfs:comment" : "A response to a question that asks whether the participant has consumed at least 12 drinks of any kind of alcoholic beverage in their lifetime.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PassedQCEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PassedQCEnum", - "sms:required" : "sms:false" + "sms:displayName" : "AlcoholHistory" }, { - "@id" : "bts:ExtentofTumorResectionEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ExtentofTumorResectionEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:AgeIsObfuscated", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ExtentofTumorResectionEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ReverseTranscriptionPrimerEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:True" + }, { + "@id" : "bts:False" + } ], + "rdfs:label" : "AgeIsObfuscated", + "rdfs:comment" : "The age of the patient has been modified for compliance reasons. The actual age differs from what is reported. Other date intervals for this patient may also be modified.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ReverseTranscriptionPrimerEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ReverseTranscriptionPrimerEnum", - "sms:required" : "sms:false" + "sms:displayName" : "AgeIsObfuscated" }, { - "@id" : "bts:CountryofResidenceEnum", + "@id" : "bts:TargetName", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "CountryofResidenceEnum", + "rdfs:label" : "TargetName", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CountryofResidenceEnum", + "sms:displayName" : "TargetName", "sms:required" : "sms:false" }, { - "@id" : "bts:TobaccoSmokingStatusEnum", + "@id" : "bts:TargetCaptureKit", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "TobaccoSmokingStatusEnum", + "rdfs:label" : "TargetCaptureKit", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TobaccoSmokingStatusEnum", - "sms:required" : "sms:false" + "sms:displayName" : "TargetCaptureKit", + "sms:required" : "sms:true" }, { - "@id" : "bts:OncotypeRiskGroupEnum", + "@id" : "bts:SecondExon", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "OncotypeRiskGroupEnum", + "rdfs:comment" : "The second exon number involved in molecular variation. If a specific genetic variant is being reported, this property can be used to capture the second exon where that variant is located. This property is typically used for a translocation where two different locations are involved in the variation.", + "rdfs:label" : "SecondExon", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "OncotypeRiskGroupEnum", + "sms:displayName" : "SecondExon", "sms:required" : "sms:false" }, { - "@id" : "bts:PathogenicityEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PathogenicityEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:HistoneFamily", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PathogenicityEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:H1" + }, { + "@id" : "bts:H2A" + }, { + "@id" : "bts:H2B" + }, { + "@id" : "bts:H3" + }, { + "@id" : "bts:H4" + } ], + "rdfs:label" : "HistoneFamily", + "rdfs:comment" : "The text term used to describe the family, or classification of a group of basic proteins found in chromatin, called histones.", + "@type" : "rdfs:Class", + "sms:displayName" : "HistoneFamily" }, { - "@id" : "bts:LabTestsforMMRStatusEnum", + "@id" : "bts:BloodTestNormalRangeUpper", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LabTestsforMMRStatusEnum", + "rdfs:comment" : "Numeric value used to describe the upper limit of the normal range used to describe a healthy individual at the institution where the test was completed.", + "rdfs:label" : "BloodTestNormalRangeUpper", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "LabTestsforMMRStatusEnum", + "sms:displayName" : "BloodTestNormalRangeUpper", "sms:required" : "sms:false" }, { - "@id" : "bts:LibraryConstructionMethodEnum", + "@id" : "bts:LibraryPrepKitVersion", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LibraryConstructionMethodEnum", + "rdfs:comment" : "Version of Library Prep Kit. String", + "rdfs:label" : "LibraryPrepKitVersion", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "LibraryConstructionMethodEnum", - "sms:required" : "sms:false" + "sms:displayName" : "LibraryPrepKitVersion", + "sms:required" : "sms:true" }, { - "@id" : "bts:TotalVolumeUnitEnum", + "@id" : "bts:Immunosuppression", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "TotalVolumeUnitEnum", + "rdfs:label" : "Immunosuppression", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TotalVolumeUnitEnum", + "sms:displayName" : "Immunosuppression", "sms:required" : "sms:false" }, { - "@id" : "bts:BooleanEnum", + "@id" : "bts:Authors", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BooleanEnum", + "rdfs:label" : "Authors", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BooleanEnum", + "sms:displayName" : "Authors", "sms:required" : "sms:false" }, { - "@id" : "bts:MolecularAnalysisMethodEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MolecularAnalysisMethodEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:OvarianCancerPlatinumStatus", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MolecularAnalysisMethodEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ClonalityEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Datanotavailable" + }, { + "@id" : "bts:Platinum-refractory" + }, { + "@id" : "bts:Platinum-sensitive" + }, { + "@id" : "bts:Platinum-resistant" + } ], + "rdfs:label" : "OvarianCancerPlatinumStatus", + "rdfs:comment" : "Text term to indicate the status of treatment with platinum in participant with ovarian cancer", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ClonalityEnum", + "sms:displayName" : "OvarianCancerPlatinumStatus" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:AlcoholIntensity", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ClonalityEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:Drinker" + }, { + "@id" : "bts:HeavyDrinker" + }, { + "@id" : "bts:LifelongNon-Drinker" + }, { + "@id" : "bts:Non-Drinker" + }, { + "@id" : "bts:OccasionalDrinker" + } ], + "rdfs:label" : "AlcoholIntensity", + "rdfs:comment" : "Category to describe the patient's current level of alcohol use as self-reported by the patient.", + "@type" : "rdfs:Class", + "sms:displayName" : "AlcoholIntensity" }, { - "@id" : "bts:InvasiveDuctalBreastCarcinomaHistologicCategoryEnum", + "@id" : "bts:Transcript", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "InvasiveDuctalBreastCarcinomaHistologicCategoryEnum", + "rdfs:comment" : "Alphanumeric value used to describe the transcript of a specific genetic variant. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "Transcript", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "InvasiveDuctalBreastCarcinomaHistologicCategoryEnum", + "sms:displayName" : "Transcript", "sms:required" : "sms:false" }, { - "@id" : "bts:IschemicTemperatureEnum", + "@id" : "bts:EducationLevel", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "IschemicTemperatureEnum", + "rdfs:label" : "EducationLevel", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "IschemicTemperatureEnum", + "sms:displayName" : "EducationLevel", "sms:required" : "sms:false" }, { - "@id" : "bts:AgeIsObfuscatedEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AgeIsObfuscatedEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:DimensionOrder", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AgeIsObfuscatedEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:XYZCT" + }, { + "@id" : "bts:XYZTC" + }, { + "@id" : "bts:XYCTZ" + }, { + "@id" : "bts:XYCZT" + }, { + "@id" : "bts:XYTZC" + }, { + "@id" : "bts:ZYX" + } ], + "rdfs:label" : "DimensionOrder", + "rdfs:comment" : "The order in which the individual planes of data are interleaved.", + "@type" : "rdfs:Class", + "sms:displayName" : "DimensionOrder" }, { - "@id" : "bts:LaboratoryTestEnum", + "@id" : "bts:Parity", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LaboratoryTestEnum", + "rdfs:comment" : "Number of pregnancies carried over the threshold of viability", + "rdfs:label" : "Parity", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "LaboratoryTestEnum", + "sms:displayName" : "Parity", "sms:required" : "sms:false" }, { - "@id" : "bts:SiteofResectionorBiopsyEnum", + "@id" : "bts:AlcoholDaysPerWeek", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SiteofResectionorBiopsyEnum", + "rdfs:comment" : "Numeric value used to describe the average number of days each week that a person consumes an alcoholic beverage.", + "rdfs:label" : "AlcoholDaysPerWeek", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SiteofResectionorBiopsyEnum", + "sms:displayName" : "AlcoholDaysPerWeek", "sms:required" : "sms:false" }, { - "@id" : "bts:VascularInvasionTypeEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "VascularInvasionTypeEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:AnalyteType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "VascularInvasionTypeEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:StainingIntensityEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:TissueSectionAnalyte" + }, { + "@id" : "bts:SerumAnalyte" + }, { + "@id" : "bts:PBMCsorPlasmaorSerumAnalyte" + }, { + "@id" : "bts:Plasma" + }, { + "@id" : "bts:TissueBlockAnalyte" + }, { + "@id" : "bts:cfDNAAnalyte" + }, { + "@id" : "bts:DNAAnalyte" + }, { + "@id" : "bts:RNAAnalyte" + }, { + "@id" : "bts:cDNALibrariesAnalyte" + }, { + "@id" : "bts:PBMCs" + }, { + "@id" : "bts:TotalRNAAnalyte" + } ], + "rdfs:label" : "AnalyteType", + "rdfs:comment" : "The kind of molecular specimen analyte: a molecular derivative (I.e. RNA / DNA / Protein Lysate) obtained from a specimen", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "StainingIntensityEnum", + "sms:displayName" : "AnalyteType" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:FOVYUnit", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "StainingIntensityEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:cm" + }, { + "@id" : "bts:mm" + }, { + "@id" : "bts:µm" + }, { + "@id" : "bts:nm" + }, { + "@id" : "bts:Å" + } ], + "rdfs:label" : "FOVYUnit", + "rdfs:comment" : "Field of view Y dimension units. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", + "@type" : "rdfs:Class", + "sms:displayName" : "FOVYUnit" }, { - "@id" : "bts:MutationalSignaturesEnum", + "@id" : "bts:AgeatDiagnosis", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MutationalSignaturesEnum", + "rdfs:comment" : "Age at the time of diagnosis expressed in number of days since birth.", + "rdfs:label" : "AgeatDiagnosis", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MutationalSignaturesEnum", + "sms:displayName" : "AgeatDiagnosis", "sms:required" : "sms:false" }, { - "@id" : "bts:PriorInvasiveBreastDiseaseEnum", + "@id" : "bts:Cytoband", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PriorInvasiveBreastDiseaseEnum", + "rdfs:comment" : "Alphanumeric value used to describe the cytoband or chromosomal location targeted or included in molecular analysis. If a specific genetic variant is being reported, this property can be used to capture the cytoband where the variant is located. Format: [chromosome][chromosome arm].[band+sub-bands]. Example: 17p13.1. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "Cytoband", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PriorInvasiveBreastDiseaseEnum", + "sms:displayName" : "Cytoband", "sms:required" : "sms:false" }, { - "@id" : "bts:MismatchRepairSystemStatusEnum", + "@id" : "bts:PeaksCallingSoftware", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "MismatchRepairSystemStatusEnum", + "rdfs:label" : "PeaksCallingSoftware", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MismatchRepairSystemStatusEnum", + "sms:displayName" : "PeaksCallingSoftware", "sms:required" : "sms:false" }, { - "@id" : "bts:AnalyteTypeEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AnalyteTypeEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:SecondhandSmokeasChild", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AnalyteTypeEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ModeofCancerDetectionEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" + }, { + "@id" : "bts:No" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + } ], + "rdfs:label" : "SecondhandSmokeasChild", + "rdfs:comment" : "The text term used to indicate whether the patient was exposed to secondhand smoke as a child.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ModeofCancerDetectionEnum", + "sms:displayName" : "SecondhandSmokeasChild" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:PhysicalSizeXUnit", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ModeofCancerDetectionEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:cm" + }, { + "@id" : "bts:mm" + }, { + "@id" : "bts:µm" + }, { + "@id" : "bts:nm" + }, { + "@id" : "bts:Å" + } ], + "rdfs:label" : "PhysicalSizeXUnit", + "rdfs:comment" : "The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um)", + "@type" : "rdfs:Class", + "sms:displayName" : "PhysicalSizeXUnit" }, { - "@id" : "bts:BreastBiopsyProcedureFindingTypeEnum", + "rdfs:subClassOf" : [ ], + "@id" : "bts:CancerAssociatedGeneMutations", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:PMS2mutation" + }, { + "@id" : "bts:POT1mutation" + }, { + "@id" : "bts:TP53mutation" + }, { + "@id" : "bts:H3K27Mmutation" + }, { + "@id" : "bts:SMARCA4mutation" + }, { + "@id" : "bts:SDHDmutation" + }, { + "@id" : "bts:BRCA1mutation" + }, { + "@id" : "bts:CHKmutation" + }, { + "@id" : "bts:RB1mutation" + }, { + "@id" : "bts:H3G34R/Vmutation" + }, { + "@id" : "bts:SDHCmutation" + }, { + "@id" : "bts:SDHBmutation" + }, { + "@id" : "bts:TSC2mutation" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:HOXB13mutation" + }, { + "@id" : "bts:NF1mutation" + }, { + "@id" : "bts:VHLmutation" + }, { + "@id" : "bts:BAP1mutation" + }, { + "@id" : "bts:SETD2mutation" + }, { + "@id" : "bts:BRCA1and2mutation" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:PTENmutation" + }, { + "@id" : "bts:NotApplicable" + }, { + "@id" : "bts:STK11mutation" + }, { + "@id" : "bts:PAX5mutation" + }, { + "@id" : "bts:RETmutation" + }, { + "@id" : "bts:NF2mutation" + }, { + "@id" : "bts:ETV6mutation" + }, { + "@id" : "bts:PolDmutation" + }, { + "@id" : "bts:IKZF1mutation" + }, { + "@id" : "bts:PALB2mutation" + }, { + "@id" : "bts:SDHAF2mutation" + }, { + "@id" : "bts:EGFRmutation" + }, { + "@id" : "bts:PDGFRAmutation" + }, { + "@id" : "bts:ARFmutation" + }, { + "@id" : "bts:PTCHmutation" + }, { + "@id" : "bts:PRKAR1Amutation" + }, { + "@id" : "bts:MUTYHmutation" + }, { + "@id" : "bts:MSH6mutation" + }, { + "@id" : "bts:CDKN2Aandp14ARFmutation" + }, { + "@id" : "bts:GREM1mutation" + }, { + "@id" : "bts:MAXmutation" + }, { + "@id" : "bts:FHmutation" + }, { + "@id" : "bts:PHOX2Bmutation" + }, { + "@id" : "bts:CDH1mutation" + }, { + "@id" : "bts:MSH2mutation" + }, { + "@id" : "bts:MLH1mutation" + }, { + "@id" : "bts:METmutation" + }, { + "@id" : "bts:ATRXmutation" + }, { + "@id" : "bts:KRASmutation" + }, { + "@id" : "bts:KITmutation" + }, { + "@id" : "bts:PolEmutation" + }, { + "@id" : "bts:TSC1mutation" + }, { + "@id" : "bts:BLMmutation" + }, { + "@id" : "bts:ATMmutation" + }, { + "@id" : "bts:ACVR1mutation" + }, { + "@id" : "bts:FLCNmutation" + }, { + "@id" : "bts:MEN1mutation" + }, { + "@id" : "bts:TMEM127mutation" + }, { + "@id" : "bts:BRAFmutation" + }, { + "@id" : "bts:ROS1mutation" + }, { + "@id" : "bts:SMAD4mutation" + }, { + "@id" : "bts:ALKmutation" + }, { + "@id" : "bts:BMPR1Amutation" + }, { + "@id" : "bts:APCmutation" + }, { + "@id" : "bts:BRCA2mutation" + }, { + "@id" : "bts:SMARCB1mutation" + }, { + "@id" : "bts:CDKN2Amutation" + }, { + "@id" : "bts:RAD51Cmutation" + }, { + "@id" : "bts:p14ARFmutation" + } ], + "rdfs:label" : "CancerAssociatedGeneMutations", + "rdfs:comment" : "Type of inherited germline or other gene mutations that confers heightened susceptibility to cancer identified in patient history", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BreastBiopsyProcedureFindingTypeEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "BreastBiopsyProcedureFindingTypeEnum", - "sms:required" : "sms:false" + "sms:displayName" : "CancerAssociatedGeneMutations" }, { - "@id" : "bts:AlcoholTypeEnum", + "@id" : "bts:FOVnumber", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AlcoholTypeEnum", + "rdfs:comment" : "Index of FOV (as it pertains to its sequence order). Integer >= 1", + "rdfs:label" : "FOVnumber", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AlcoholTypeEnum", + "sms:displayName" : "FOVnumber", "sms:required" : "sms:false" }, { - "@id" : "bts:VitalStatusEnum", + "@id" : "bts:ChannelMetadataFilename", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "VitalStatusEnum", + "rdfs:comment" : "Full path of uploaded companion CSV file containing channel-level metadata details", + "rdfs:label" : "ChannelMetadataFilename", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "VitalStatusEnum", + "sms:displayName" : "ChannelMetadataFilename", "sms:required" : "sms:false" }, { - "@id" : "bts:InvasiveLobularBreastCarcinomaHistologicCategoryEnum", + "@id" : "bts:Secondhandsmokeexposureyears", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "InvasiveLobularBreastCarcinomaHistologicCategoryEnum", + "rdfs:label" : "Secondhandsmokeexposureyears", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "InvasiveLobularBreastCarcinomaHistologicCategoryEnum", + "sms:displayName" : "Secondhandsmokeexposureyears", "sms:required" : "sms:false" }, { - "@id" : "bts:DimensionsUnitEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "DimensionsUnitEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:Read3", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "DimensionsUnitEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:PrimaryDiagnosisEnum", + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:CellBarcodeandDNAInsert" + }, { + "@id" : "bts:SampleIndexandDNAInsert" + }, { + "@id" : "bts:DNAInsert" + }, { + "@id" : "bts:SampleIndex" + }, { + "@id" : "bts:CellBarcode" + } ], + "rdfs:label" : "Read3", + "rdfs:comment" : "Read 3 content description", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PrimaryDiagnosisEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "PrimaryDiagnosisEnum", - "sms:required" : "sms:false" + "sms:displayName" : "Read3" }, { - "@id" : "bts:TestAnalyteTypeEnum", + "@id" : "bts:CellMedianNumberReads", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TestAnalyteTypeEnum", + "rdfs:comment" : "Median number of reads per cell. Number", + "rdfs:label" : "CellMedianNumberReads", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TestAnalyteTypeEnum", + "sms:displayName" : "CellMedianNumberReads", "sms:required" : "sms:false" }, { - "@id" : "bts:ZygosityEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ZygosityEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:Gender", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ZygosityEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:NucleicAcidSourceEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:female" + }, { + "@id" : "bts:male" + }, { + "@id" : "bts:unspecified" + } ], + "rdfs:label" : "Gender", + "rdfs:comment" : "Text designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "NucleicAcidSourceEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "NucleicAcidSourceEnum", - "sms:required" : "sms:false" + "sms:displayName" : "Gender" }, { - "@id" : "bts:OvarianCancerSurgicalOutcomeEnum", + "@id" : "bts:WorkflowVersion", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "OvarianCancerSurgicalOutcomeEnum", + "rdfs:label" : "WorkflowVersion", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "OvarianCancerSurgicalOutcomeEnum", + "sms:displayName" : "WorkflowVersion", "sms:required" : "sms:false" }, { - "@id" : "bts:RaceEnum", + "@id" : "bts:MenopauseStatus", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "RaceEnum", + "rdfs:label" : "MenopauseStatus", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RaceEnum", + "sms:displayName" : "MenopauseStatus", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCarcinomaSurgicalProcedureNameEnum", + "@id" : "bts:SubCycleNumber", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCarcinomaSurgicalProcedureNameEnum", + "rdfs:label" : "SubCycleNumber", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaSurgicalProcedureNameEnum", + "sms:displayName" : "SubCycleNumber", "sms:required" : "sms:false" }, { - "@id" : "bts:SmokingFrequencyEnum", + "@id" : "bts:GenomicReferenceURL", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "SmokingFrequencyEnum", + "rdfs:label" : "GenomicReferenceURL", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SmokingFrequencyEnum", + "sms:displayName" : "GenomicReferenceURL", "sms:required" : "sms:false" }, { - "@id" : "bts:PixelTypeEnum", + "@id" : "bts:GenomicReference", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "PixelTypeEnum", + "rdfs:label" : "GenomicReference", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PixelTypeEnum", + "sms:displayName" : "GenomicReference", "sms:required" : "sms:false" }, { - "@id" : "bts:SpikeInEnum", + "@id" : "bts:SizeY", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SpikeInEnum", + "rdfs:comment" : "Size of image: Y dimension (in pixels). Integer >= 1", + "rdfs:label" : "SizeY", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SpikeInEnum", + "sms:displayName" : "SizeY", "sms:required" : "sms:false" }, { - "@id" : "bts:ReadEnum", + "@id" : "bts:CellCount", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ReadEnum", + "rdfs:comment" : "Numeric value used to describe the number of cells used for molecular testing. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "CellCount", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ReadEnum", + "sms:displayName" : "CellCount", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCarcinomaHER2StatusEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCarcinomaHER2StatusEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:AnaplasiaPresentType", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaHER2StatusEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:ClinicalBiospecimenTypeEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:Equivocal" + }, { + "@id" : "bts:Absent" + }, { + "@id" : "bts:Present" + }, { + "@id" : "bts:Diffuse" + }, { + "@id" : "bts:Focal" + }, { + "@id" : "bts:Sclerosis" + } ], + "rdfs:label" : "AnaplasiaPresentType", + "rdfs:comment" : "The text term used to describe the morphologic findings indicating the presence of a malignant cellular infiltrate characterized by the presence of large pleomorphic cells, necrosis, and high mitotic activity in a tissue sample.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ClinicalBiospecimenTypeEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "ClinicalBiospecimenTypeEnum", - "sms:required" : "sms:false" + "sms:displayName" : "AnaplasiaPresentType" }, { - "@id" : "bts:RelationshipPrimaryDiagnosisEnum", + "@id" : "bts:SampleID", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "RelationshipPrimaryDiagnosisEnum", + "rdfs:comment" : " ID associated with a biosample", + "rdfs:label" : "SampleID", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RelationshipPrimaryDiagnosisEnum", - "sms:required" : "sms:false" + "sms:displayName" : "SampleID", + "sms:required" : "sms:true" }, { - "@id" : "bts:BIRADSMammographyBreastDensityCategoryEnum", + "@id" : "bts:ExcitationWavelength", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BIRADSMammographyBreastDensityCategoryEnum", + "rdfs:label" : "ExcitationWavelength", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BIRADSMammographyBreastDensityCategoryEnum", + "sms:displayName" : "ExcitationWavelength", "sms:required" : "sms:false" }, { - "@id" : "bts:SingleNucleusBufferEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SingleNucleusBufferEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:BIRADSMammographyBreastDensityCategory", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SingleNucleusBufferEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Datanotavailable" + }, { + "@id" : "bts:Predominantlyfatty" + }, { + "@id" : "bts:Scatteredfibroglandulardensities" + }, { + "@id" : "bts:Heterogeneouslydense" + }, { + "@id" : "bts:Extremelydense" + } ], + "rdfs:label" : "BIRADSMammographyBreastDensityCategory", + "rdfs:comment" : "The category that describes the relative amount of different tissues present in the breast on a mammogram based on the updated 2015 edition of the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS) reporting guidelines.", + "@type" : "rdfs:Class", + "sms:displayName" : "BIRADSMammographyBreastDensityCategory" }, { - "@id" : "bts:BiospecimenTypeEnum", + "@id" : "bts:Weight", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BiospecimenTypeEnum", + "rdfs:label" : "Weight", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BiospecimenTypeEnum", + "sms:displayName" : "Weight", "sms:required" : "sms:false" }, { - "@id" : "bts:AntibioticUseEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AntibioticUseEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:OvarianCancerSurgicalOutcome", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AntibioticUseEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:HormoneTherapyBreastCancerPreventionIndicatorEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Other" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Datanotavailable" + }, { + "@id" : "bts:R0resection" + }, { + "@id" : "bts:Optimalcytoreduction" + }, { + "@id" : "bts:Sub-optimalcytoreduction" + } ], + "rdfs:label" : "OvarianCancerSurgicalOutcome", + "rdfs:comment" : "Text term that describes the kind of surgical treatment administered.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "HormoneTherapyBreastCancerPreventionIndicatorEnum", + "sms:displayName" : "OvarianCancerSurgicalOutcome" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:RelationshipPrimaryDiagnosis", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "HormoneTherapyBreastCancerPreventionIndicatorEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:ProstateCancer" + }, { + "@id" : "bts:TesticularCancer" + }, { + "@id" : "bts:Cancer" + }, { + "@id" : "bts:KaposiSarcoma" + }, { + "@id" : "bts:BoneCancer" + }, { + "@id" : "bts:LiverCancer" + }, { + "@id" : "bts:CNSCancer" + }, { + "@id" : "bts:UterineCancer" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:LymphNodeCancer" + }, { + "@id" : "bts:RectalCancer" + }, { + "@id" : "bts:WilmsTumor" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Osteosarcoma" + }, { + "@id" : "bts:Chondrosarcoma" + }, { + "@id" : "bts:Mesothelioma" + }, { + "@id" : "bts:GastricCancer" + }, { + "@id" : "bts:CervicalCancer" + }, { + "@id" : "bts:EwingSarcoma" + }, { + "@id" : "bts:Glioblastoma" + }, { + "@id" : "bts:SkinCancer" + }, { + "@id" : "bts:TonsillarCancer" + }, { + "@id" : "bts:BileDuctCancer" + }, { + "@id" : "bts:TongueCancer" + }, { + "@id" : "bts:LaryngealCancer" + }, { + "@id" : "bts:Melanoma" + }, { + "@id" : "bts:HematologicCancer" + }, { + "@id" : "bts:ThroatCancer" + }, { + "@id" : "bts:ColorectalCancer" + }, { + "@id" : "bts:KidneyCancer" + }, { + "@id" : "bts:SpleenCancer" + }, { + "@id" : "bts:BreastCancer" + }, { + "@id" : "bts:Leukemia" + }, { + "@id" : "bts:Sarcoma" + }, { + "@id" : "bts:BloodCancer" + }, { + "@id" : "bts:Neuroblastoma" + }, { + "@id" : "bts:GynecologicCancer" + }, { + "@id" : "bts:Rhabdomyosarcoma" + }, { + "@id" : "bts:PancreasCancer" + }, { + "@id" : "bts:AdrenalGlandCancer" + }, { + "@id" : "bts:ThyroidCancer" + }, { + "@id" : "bts:MultipleMyeloma" + }, { + "@id" : "bts:LungCancer" + }, { + "@id" : "bts:BasalCellCancer" + }, { + "@id" : "bts:BrainCancer" + }, { + "@id" : "bts:EsophagealCancer" + }, { + "@id" : "bts:Lymphoma" + }, { + "@id" : "bts:OvarianCancer" + }, { + "@id" : "bts:GallbladderCancer" + }, { + "@id" : "bts:HeadandNeckCancer" + }, { + "@id" : "bts:BladderCancer" + } ], + "rdfs:label" : "RelationshipPrimaryDiagnosis", + "rdfs:comment" : "The text term used to describe the malignant diagnosis of the patient's relative with a history of cancer.", + "@type" : "rdfs:Class", + "sms:displayName" : "RelationshipPrimaryDiagnosis" }, { - "@id" : "bts:PreservationMethodEnum", + "@id" : "bts:AppliedHardTrimming", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "PreservationMethodEnum", + "rdfs:label" : "AppliedHardTrimming", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PreservationMethodEnum", + "sms:displayName" : "AppliedHardTrimming", "sms:required" : "sms:false" }, { - "@id" : "bts:TumorExtranodalExtensionIndicatorEnum", + "@id" : "bts:AAChange", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TumorExtranodalExtensionIndicatorEnum", + "rdfs:comment" : "Alphanumeric value used to describe the amino acid change for a specific genetic variant. Example: R116Q. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", + "rdfs:label" : "AAChange", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TumorExtranodalExtensionIndicatorEnum", + "sms:displayName" : "AAChange", "sms:required" : "sms:false" }, { - "@id" : "bts:TseriesEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TseriesEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:NucleicAcidSource", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TseriesEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:DissociationMethodEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:SingleCell" + }, { + "@id" : "bts:SingleNucleus" + }, { + "@id" : "bts:BulkNuclei" + }, { + "@id" : "bts:BulkWholeCell" + }, { + "@id" : "bts:Micro-region" + } ], + "rdfs:label" : "NucleicAcidSource", + "rdfs:comment" : "The source of the input nucleic molecule", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "DissociationMethodEnum", + "sms:displayName" : "NucleicAcidSource" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:ExtentofTumorResection", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "DissociationMethodEnum", - "sms:required" : "sms:false" - }, { - "@id" : "bts:LibraryLayoutEnum", + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Minor" + }, { + "@id" : "bts:OpenBiopsy" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:GrossTotalResection" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotApplicable" + }, { + "@id" : "bts:Segmental" + }, { + "@id" : "bts:NTR" + }, { + "@id" : "bts:Suboptimaldebulking" + }, { + "@id" : "bts:SubtotalResection" + }, { + "@id" : "bts:Other" + }, { + "@id" : "bts:Partialdebulking" + }, { + "@id" : "bts:Suboptimal" + }, { + "@id" : "bts:Optimaldebulking" + }, { + "@id" : "bts:ExtensiveSubtotal" + } ], + "rdfs:label" : "ExtentofTumorResection", + "rdfs:comment" : "The degree to which the lesion has been cut out, or resected.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "LibraryLayoutEnum", - "rdfs:subClassOf" : [ ], - "schema:isPartOf" : { - "@id" : "http://schema.biothings.io/" - }, - "sms:displayName" : "LibraryLayoutEnum", - "sms:required" : "sms:false" + "sms:displayName" : "ExtentofTumorResection" }, { - "@id" : "bts:BreastCancerAllredEstrogenReceptorScoreEnum", + "@id" : "bts:TimepointLabel", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCancerAllredEstrogenReceptorScoreEnum", + "rdfs:comment" : "Label to identify the time point at which the clinical data or biospecimen was obtained (e.g. Baseline, End of Treatment, Overall survival, Final). NO PHI/PII INFORMATION IS ALLOWED.", + "rdfs:label" : "TimepointLabel", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCancerAllredEstrogenReceptorScoreEnum", + "sms:displayName" : "TimepointLabel", "sms:required" : "sms:false" }, { - "@id" : "bts:PrecancerousConditionTypeEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PrecancerousConditionTypeEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:Ploidy", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PrecancerousConditionTypeEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:Aneuploid" + }, { + "@id" : "bts:Diploid" + }, { + "@id" : "bts:Hyperdiploid" + }, { + "@id" : "bts:Hypodiploid" + }, { + "@id" : "bts:NearDiploid" + }, { + "@id" : "bts:Tetraploid" + } ], + "rdfs:label" : "Ploidy", + "rdfs:comment" : "Text term used to describe the number of sets of homologous chromosomes.", + "@type" : "rdfs:Class", + "sms:displayName" : "Ploidy" }, { - "@id" : "bts:VariantTypeEnum", + "@id" : "bts:PortionWeight", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "VariantTypeEnum", + "rdfs:comment" : "Numeric value that represents the sample portion weight, measured in milligrams.", + "rdfs:label" : "PortionWeight", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "VariantTypeEnum", + "sms:displayName" : "PortionWeight", "sms:required" : "sms:false" }, { - "@id" : "bts:RelationshipTypeEnum", + "@id" : "bts:DaystoProgression", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "RelationshipTypeEnum", + "rdfs:comment" : "Number of days between the date used for index and the date the patient's disease progressed.", + "rdfs:label" : "DaystoProgression", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "RelationshipTypeEnum", + "sms:displayName" : "DaystoProgression", "sms:required" : "sms:false" }, { - "@id" : "bts:SmokingExposureEnum", + "@id" : "bts:RRIDidentifier", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "SmokingExposureEnum", + "rdfs:label" : "RRIDidentifier", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SmokingExposureEnum", + "sms:displayName" : "RRIDidentifier", "sms:required" : "sms:false" }, { - "@id" : "bts:OvarianCancerPlatinumStatusEnum", + "@id" : "bts:ClassBRCA2", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "OvarianCancerPlatinumStatusEnum", + "rdfs:label" : "ClassBRCA2", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "OvarianCancerPlatinumStatusEnum", + "sms:displayName" : "ClassBRCA2", "sms:required" : "sms:false" }, { - "@id" : "bts:HistoneFamilyEnum", + "@id" : "bts:WhitelistCellBarcodeFileLink", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "HistoneFamilyEnum", + "rdfs:label" : "WhitelistCellBarcodeFileLink", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "HistoneFamilyEnum", + "sms:displayName" : "WhitelistCellBarcodeFileLink", "sms:required" : "sms:false" }, { - "@id" : "bts:ChromosomeEnum", + "@id" : "bts:StartDaysfromIndex", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ChromosomeEnum", + "rdfs:comment" : "Number of days from the date of birth (index date) to the date of an event (e.g. exposure to environmental factor, treatment start, etc.). If not applicable please enter 'Not Applicable'", + "rdfs:label" : "StartDaysfromIndex", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ChromosomeEnum", + "sms:displayName" : "StartDaysfromIndex", "sms:required" : "sms:false" }, { - "@id" : "bts:OvarianCancerHistologicSubtypeEnum", + "@id" : "bts:Ecigvapetimesperday", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "OvarianCancerHistologicSubtypeEnum", + "rdfs:label" : "Ecigvapetimesperday", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "OvarianCancerHistologicSubtypeEnum", + "sms:displayName" : "Ecigvapetimesperday", "sms:required" : "sms:false" }, { - "@id" : "bts:MicroscopyUnitEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MicroscopyUnitEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:FamilyMemberVitalStatusIndicator", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MicroscopyUnitEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" + }, { + "@id" : "bts:No" + }, { + "@id" : "bts:unknown" + } ], + "rdfs:label" : "FamilyMemberVitalStatusIndicator", + "rdfs:comment" : "The response indicates whether the family member of the patient with a history of cancer is alive. (Extension to GDC attributes in Family History Tier 1)", + "@type" : "rdfs:Class", + "sms:displayName" : "FamilyMemberVitalStatusIndicator" }, { - "@id" : "bts:HistoryEnum", + "@id" : "bts:SectionThicknessValue", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "HistoryEnum", + "rdfs:comment" : "Numeric value to describe the thickness of a slice to tissue taken from a biospecimen, measured in microns (um).", + "rdfs:label" : "SectionThicknessValue", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "HistoryEnum", + "sms:displayName" : "SectionThicknessValue", "sms:required" : "sms:false" }, { - "@id" : "bts:CauseofDeathEnum", + "@id" : "bts:SoftwareandVersion", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "CauseofDeathEnum", + "rdfs:label" : "SoftwareandVersion", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "CauseofDeathEnum", + "sms:displayName" : "SoftwareandVersion", "sms:required" : "sms:false" }, { - "@id" : "bts:TestResultEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TestResultEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:KnownGeneticPredispositionMutation", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TestResultEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Yes" + }, { + "@id" : "bts:No" + }, { + "@id" : "bts:unknown" + } ], + "rdfs:label" : "KnownGeneticPredispositionMutation", + "rdfs:comment" : "A yes/no/unknown indicator to identify whether there is a known genetic predisposition mutation present in the patient.", + "@type" : "rdfs:Class", + "sms:displayName" : "KnownGeneticPredispositionMutation" }, { - "@id" : "bts:AntigenEnum", + "@id" : "bts:BiospecimenDimension1", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AntigenEnum", + "rdfs:comment" : "First dimension of tissue fragment (number, up to one decimal place) measured in units as defined by the \"\"dimensions_unit\"\" CDE", + "rdfs:label" : "BiospecimenDimension1", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AntigenEnum", + "sms:displayName" : "BiospecimenDimension1", "sms:required" : "sms:false" }, { - "@id" : "bts:MolecularConsequenceEnum", + "@id" : "bts:NucleiBarcodeLength", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "MolecularConsequenceEnum", + "rdfs:comment" : "Nuclei Barcode Length", + "rdfs:label" : "NucleiBarcodeLength", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "MolecularConsequenceEnum", + "sms:displayName" : "NucleiBarcodeLength", "sms:required" : "sms:false" }, { - "@id" : "bts:ReceptorStatusEnum", + "@id" : "bts:HER2BreastCarcinomaCopyNumberTotal", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "ReceptorStatusEnum", + "rdfs:comment" : "Result of HER2 Copy Number testing (in a participant with breast cancer), expressed as a range of values.", + "rdfs:label" : "HER2BreastCarcinomaCopyNumberTotal", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ReceptorStatusEnum", + "sms:displayName" : "HER2BreastCarcinomaCopyNumberTotal", "sms:required" : "sms:false" }, { - "@id" : "bts:TumorTissueTypeEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "TumorTissueTypeEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:MammaprintRiskGroup", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TumorTissueTypeEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Datanotavailable" + }, { + "@id" : "bts:Highrisk" + }, { + "@id" : "bts:Intermediaterisk" + }, { + "@id" : "bts:Lowrisk" + } ], + "rdfs:label" : "MammaprintRiskGroup", + "rdfs:comment" : "Text term that represents the risk group for breast cancer as determined by assessment of the MammaPrint test.", + "@type" : "rdfs:Class", + "sms:displayName" : "MammaprintRiskGroup" }, { - "@id" : "bts:BreastQuadrantSiteEnum", + "@id" : "bts:Height", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BreastQuadrantSiteEnum", + "rdfs:label" : "Height", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastQuadrantSiteEnum", + "sms:displayName" : "Height", "sms:required" : "sms:false" }, { - "@id" : "bts:PloidyEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "PloidyEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:Race", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "PloidyEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:true", + "schema:rangeIncludes" : [ { + "@id" : "bts:americanindianoralaskanative" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:white" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:blackorafricanamerican" + }, { + "@id" : "bts:notallowedtocollect" + }, { + "@id" : "bts:asian" + }, { + "@id" : "bts:Other" + }, { + "@id" : "bts:nativehawaiianorotherpacificislander" + } ], + "rdfs:label" : "Race", + "rdfs:comment" : "An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation withina a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution.", + "@type" : "rdfs:Class", + "sms:displayName" : "Race" }, { - "@id" : "bts:SpecimenLateralityEnum", + "@id" : "bts:BiospecimenDimension3", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SpecimenLateralityEnum", + "rdfs:comment" : "Third dimension of tissue fragment (number, up to one decimal place) measured in units as defined by the \"\"dimensions_unit\"\" CDE", + "rdfs:label" : "BiospecimenDimension3", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SpecimenLateralityEnum", + "sms:displayName" : "BiospecimenDimension3", "sms:required" : "sms:false" }, { - "@id" : "bts:FamilyMemberVitalStatusIndicatorEnum", + "@id" : "bts:OncotypeScore", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "FamilyMemberVitalStatusIndicatorEnum", + "rdfs:comment" : "OncotypeDX recurrence score", + "rdfs:label" : "OncotypeScore", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "FamilyMemberVitalStatusIndicatorEnum", + "sms:displayName" : "OncotypeScore", "sms:required" : "sms:false" }, { - "@id" : "bts:SequencingPlatformEnum", + "@id" : "bts:InputCellsandNuclei", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SequencingPlatformEnum", + "rdfs:comment" : "Number of cells and number of nuclei input; entry format: number, number", + "rdfs:label" : "InputCellsandNuclei", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SequencingPlatformEnum", + "sms:displayName" : "InputCellsandNuclei", "sms:required" : "sms:false" }, { - "@id" : "bts:VariantOriginEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "VariantOriginEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:PRReceptorStatus", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "VariantOriginEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Borderline" + }, { + "@id" : "bts:Equivocal" + }, { + "@id" : "bts:Indeterminate" + }, { + "@id" : "bts:Negative" + }, { + "@id" : "bts:NotPerformed" + }, { + "@id" : "bts:PerformedbutNotAvailable" + }, { + "@id" : "bts:Positive" + } ], + "rdfs:label" : "PRReceptorStatus", + "rdfs:comment" : "Text term to represent the overall result of Progresterone Receptor (PR) testing in a participant with breast cancer", + "@type" : "rdfs:Class", + "sms:displayName" : "PRReceptorStatus" }, { - "@id" : "bts:AnaplasiaPresentTypeEnum", + "@id" : "bts:Fluorophore", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "AnaplasiaPresentTypeEnum", + "rdfs:label" : "Fluorophore", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AnaplasiaPresentTypeEnum", + "sms:displayName" : "Fluorophore", "sms:required" : "sms:false" }, { - "@id" : "bts:TranspositionReactionEnum", + "@id" : "bts:Typeofsmokeexposurecumulativeyears", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "TranspositionReactionEnum", + "rdfs:label" : "Typeofsmokeexposurecumulativeyears", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "TranspositionReactionEnum", + "sms:displayName" : "Typeofsmokeexposurecumulativeyears", "sms:required" : "sms:false" }, { - "@id" : "bts:EndBiasEnum", + "@id" : "bts:Clone", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "EndBiasEnum", + "rdfs:label" : "Clone", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "EndBiasEnum", + "sms:displayName" : "Clone", "sms:required" : "sms:false" }, { - "@id" : "bts:HistoneVariantEnum", + "@id" : "bts:DiagnosisStatusType", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "HistoneVariantEnum", + "rdfs:label" : "DiagnosisStatusType", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "HistoneVariantEnum", + "sms:displayName" : "DiagnosisStatusType", "sms:required" : "sms:false" }, { - "@id" : "bts:BreastCarcinomaHistologyCategoryEnum", + "@id" : "bts:Age", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "BreastCarcinomaHistologyCategoryEnum", + "rdfs:comment" : "Age of individual", + "rdfs:label" : "Age", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastCarcinomaHistologyCategoryEnum", - "sms:required" : "sms:false" + "sms:displayName" : "Age", + "sms:required" : "sms:true" }, { - "@id" : "bts:BreastImagingPerformedTypeEnum", + "@id" : "bts:TobaccoUse", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "BreastImagingPerformedTypeEnum", + "rdfs:label" : "TobaccoUse", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "BreastImagingPerformedTypeEnum", + "sms:displayName" : "TobaccoUse", "sms:required" : "sms:false" }, { - "@id" : "bts:AlcoholExposureEnum", - "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "AlcoholExposureEnum", "rdfs:subClassOf" : [ ], + "@id" : "bts:Zstack", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "AlcoholExposureEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ ], + "rdfs:label" : "Zstack", + "rdfs:comment" : "Does data file contain a Z-stack of images", + "@type" : "rdfs:Class", + "sms:displayName" : "Zstack" }, { - "@id" : "bts:SlideChargeTypeEnum", + "rdfs:subClassOf" : [ ], + "@id" : "bts:Chromosome", + "schema:isPartOf" : { + "@id" : "http://schema.biothings.io/" + }, + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:chr7" + }, { + "@id" : "bts:chr15" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:chr3" + }, { + "@id" : "bts:chr1" + }, { + "@id" : "bts:chr18" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:chrY" + }, { + "@id" : "bts:chr22" + }, { + "@id" : "bts:chr14" + }, { + "@id" : "bts:chr12" + }, { + "@id" : "bts:chr11" + }, { + "@id" : "bts:chr17" + }, { + "@id" : "bts:chrM" + }, { + "@id" : "bts:chr4" + }, { + "@id" : "bts:chr21" + }, { + "@id" : "bts:chr6" + }, { + "@id" : "bts:chr10" + }, { + "@id" : "bts:chr16" + }, { + "@id" : "bts:chrX" + }, { + "@id" : "bts:chr23" + }, { + "@id" : "bts:chr8" + }, { + "@id" : "bts:chr2" + }, { + "@id" : "bts:chr13" + }, { + "@id" : "bts:chr19" + }, { + "@id" : "bts:chr20" + }, { + "@id" : "bts:chr5" + }, { + "@id" : "bts:chr9" + } ], + "rdfs:label" : "Chromosome", + "rdfs:comment" : "The text term used to describe a chromosome targeted or included in molecular testing. If a specific genetic variant is being reported, this property can be used to capture the chromosome where that variant is located. Note: This node is meant to capture molecular tests that were completed clinically for the participant and only includes data from diagnostic array that was completed prior to research sequencing was done. Do not include data related to research assay outputs here.", "@type" : "rdfs:Class", - "rdfs:comment" : "TBD", - "rdfs:label" : "SlideChargeTypeEnum", + "sms:displayName" : "Chromosome" + }, { "rdfs:subClassOf" : [ ], + "@id" : "bts:MutationalSignatures", "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SlideChargeTypeEnum", - "sms:required" : "sms:false" + "sms:required" : "sms:false", + "schema:rangeIncludes" : [ { + "@id" : "bts:Signature19" + }, { + "@id" : "bts:Signature1A" + }, { + "@id" : "bts:Iggenehypermutation" + }, { + "@id" : "bts:alteredactivityoftheerror-pronepolymerasePOLε(POLE)" + }, { + "@id" : "bts:Signature3" + }, { + "@id" : "bts:Signature20" + }, { + "@id" : "bts:NotReported" + }, { + "@id" : "bts:Signature17" + }, { + "@id" : "bts:Signature4" + }, { + "@id" : "bts:Datanotavailable" + }, { + "@id" : "bts:Signature5" + }, { + "@id" : "bts:Signature9" + }, { + "@id" : "bts:unknown" + }, { + "@id" : "bts:Signature14" + }, { + "@id" : "bts:Signature13" + }, { + "@id" : "bts:NotApplicable" + }, { + "@id" : "bts:Signature12" + }, { + "@id" : "bts:Signature8" + }, { + "@id" : "bts:ActivationInducedDeaminases(AID)associatedmutations" + }, { + "@id" : "bts:Signature7" + }, { + "@id" : "bts:microsatelliteinstability(additionsanddeletions)" + }, { + "@id" : "bts:AlkylatingAgents(Temozolomide)inducedmutations" + }, { + "@id" : "bts:localizedsubstitutionhypermutation(kataegis)" + }, { + "@id" : "bts:Signature16" + }, { + "@id" : "bts:Signature6" + }, { + "@id" : "bts:Other" + }, { + "@id" : "bts:Signature21" + }, { + "@id" : "bts:DNAMMRDeficiency" + }, { + "@id" : "bts:APOBECenzymesassociatedmutations" + }, { + "@id" : "bts:Tobaccouseassociatedmutations" + }, { + "@id" : "bts:transcriptionalstrandbias" + }, { + "@id" : "bts:Signature1B" + }, { + "@id" : "bts:Signature10" + }, { + "@id" : "bts:UVlightinducedmutations" + }, { + "@id" : "bts:Signature18" + }, { + "@id" : "bts:Signature11" + }, { + "@id" : "bts:Signature2" + }, { + "@id" : "bts:methylatedCpGsequencesmutagenesis(deaminationof5-methyl-cytosine)" + }, { + "@id" : "bts:Signature15" + }, { + "@id" : "bts:ageofcancerdiagnosis" + } ], + "rdfs:label" : "MutationalSignatures", + "rdfs:comment" : "Mutational signatures identified in the patient, includes signatures linked to selected exogenous carcinogens, endogenous and enzymatic modification of DNA or defective DNA repair. Note: Include only outputs of tests that were completed clinically for the participant and only include data from a diagnostic array that was completed prior to research sequencing was done. ", + "@type" : "rdfs:Class", + "sms:displayName" : "MutationalSignatures" }, { - "@id" : "bts:ShippingConditionTypeEnum", + "@id" : "bts:LabID", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "ShippingConditionTypeEnum", + "rdfs:label" : "LabID", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "ShippingConditionTypeEnum", + "sms:displayName" : "LabID", "sms:required" : "sms:false" }, { - "@id" : "bts:SingleCellIsolationMethodEnum", + "@id" : "bts:CancerIncidenceLocation", "@type" : "rdfs:Class", "rdfs:comment" : "TBD", - "rdfs:label" : "SingleCellIsolationMethodEnum", + "rdfs:label" : "CancerIncidenceLocation", "rdfs:subClassOf" : [ ], "schema:isPartOf" : { "@id" : "http://schema.biothings.io/" }, - "sms:displayName" : "SingleCellIsolationMethodEnum", + "sms:displayName" : "CancerIncidenceLocation", "sms:required" : "sms:false" }, { "@id" : "bts:Skinofupperlimbandshoulder",